,CUI1,CUI2,label
0,Cysticercus antibody,Cysticercosis Antibody Test,0
1,Cytomegalovirus antibody,Intravascular Cytomegalovirus Antibody Test,0
2,Cytomegalovirus antibody,Blood Cytomegalovirus Antibody Test,0
3,Cytomegalovirus IgM Antibody,Intravascular Cytomegalovirus IgM Antibody Test,0
4,Cytomegalovirus IgM Antibody,Blood Cytomegalovirus IgM Antibody Test,0
5,Dentition:behavior,Assessment of Family Behavior Related to Dentition,0
6,Dentition:behavior,Assessment of Patient Behavior Related to Dentition,0
7,Dentition:knowledge,Assessment of Family Knowledge Related to Dentition,0
8,Dentition:knowledge,Assessment of Patient Knowledge Related to Dentition,0
9,Dentition:status,Assessment of Family Status Related to Dentition,0
10,Dentition:status,Assessment of Patient Status Related to Dentition,0
11,Digestion-hydration:behavior,Assessment of Family Behavior Related to Digestion-hydration,0
12,Digestion-hydration:behavior,Assessment of Patient Behavior Related to Digestion-hydration,0
13,Digestion-hydration:knowledge,Assessment of Family Knowledge Related to Digestion-hydration,0
14,Digestion-hydration:knowledge,Assessment of Patient Knowledge Related to Digestion-hydration,0
15,Digestion-hydration:status,Assessment of Family Status Related to Digestion-hydration,0
16,Digestion-hydration:status,Assessment of Patient Status Related to Digestion-hydration,0
17,Direct reacting bilirubin,Intravascular Direct (Conjugated) Bilirubin Test,0
18,Direct reacting bilirubin,Plasma Direct (Conjugated) Bilirubin Test,0
19,Direct reacting bilirubin,Serum conjugated bilirubin measurement,0
20,deoxyribonuclease B,Dnase B Test,0
21,Dressing-grooming self-care deficit,Assessment of Patient Status Related to Dressing/grooming Deficit,0
22,Echinococcus species antibody,Intravascular Echinococcus Antibody Test,0
23,Emotional Stability:behavior,Assessment of Family Behavior Related to Emotional Stability,0
24,Emotional Stability:behavior,Assessment of Patient Behavior Related to Emotional Stability,0
25,Emotional Stability:knowledge,Assessment of Family Knowledge Related to Emotional Stability,0
26,Emotional Stability:knowledge,Assessment of Patient Knowledge Related to Emotional Stability,0
27,Emotional Stability:status,Assessment of Family Status Related to Emotional Stability,0
28,Emotional Stability:status,Assessment of Patient Status Related to Emotional Stability,0
29,Endomysial IgA Antibody,Endomysial IgA Antibody Test,0
30,Enterovirus antibody,Measurement of enterovirus antibody,0
31,Epinephrine induced platelet aggregation,Platelet Epinhephrine Aggregation Test,0
32,Epstein-Barr Virus Nuclear Antigens,Epstein Barr Nuclear Antigen Test,0
33,Epstein-Barr virus antibody,Epstein Barr Virus (EBV) Antibody Titer Test,0
34,Epstein-Barr virus antibody,Intravascular Epstein Barr Virus (EBV) Ab Test,0
35,Epstein-Barr virus antibody,Blood Epstein Barr Virus Antibody Test,0
36,Epstein Barr Virus IgA Antibody,Serum Epstein Barr Virus IgA Antibody Test,0
37,Epstein Barr Virus IgG Antibody,Serum Epstein Barr Virus IgG Antibody Test,0
38,Epstein Barr Virus IgM Antibody,Serum Epstein Barr Virus IgM Antibody Test,0
39,Mean corpuscular hemoglobin concentration determination,Whole Blood Mean Red Cell Hemoglobin Concentration Test,0
40,Finding of Mean Corpuscular Hemoglobin,Whole Blood Mean Red Cell Hemoglobin Test,0
41,Erythrocyte Size Distribution,Rdw Test,0
42,Erythrocytes,Heinz body screen,0
43,Erythrocytes,Howell Jolly Bodies Test,0
44,Erythrocytes,Red Blood Cell Count measurement,0
45,Erythropoietin,Intravascular Erythropoietin Test,0
46,Explicit Microorganism Result,Direct Exam Test,0
47,Explicit Microorganism Result,Ehrlichia HGE DNA Test,0
48,Explicit Microorganism Result,Enterovirus DNA assay (procedure),0
49,Explicit Microorganism Result,Hepatitis C virus genotype determination,0
50,Explicit Microorganism Result,"Hbv DNA Test, Quant",0
51,Explicit Microorganism Result,Hbv DNA Test,0
52,Explicit Microorganism Result,Hhv6 DNA Test,0
53,Explicit Microorganism Result,"Hsv DNA Test, CSF",0
54,Explicit Microorganism Result,Hsv DNA Test,0
55,Explicit Microorganism Result,Hsv Shell Vial Test,0
56,Explicit Microorganism Result,Hsv1 DNA Test,0
57,Explicit Microorganism Result,Hsv2 DNA Test,0
58,Explicit Microorganism Result,Influenza A Dfa Test,0
59,Explicit Microorganism Result,Influenza B Dfa Test,0
60,Explicit Microorganism Result,"Intravascular Cmv Test, Quantitative",0
61,Explicit Microorganism Result,Intravascular Cmv Viral Load Test,0
62,Explicit Microorganism Result,"Intravascular EBV,PCR Test",0
63,Explicit Microorganism Result,Intravascular HIV 1 Viral Load Test: Copies,0
64,Explicit Microorganism Result,Intravascular Hiv1 Viral Load: Log Copies,0
65,Explicit Microorganism Result,Jc Virus DNA Test,0
66,Explicit Microorganism Result,Lyme DNA Test Blood,0
67,Explicit Microorganism Result,Lyme DNA Test CSF,0
68,Explicit Microorganism Result,Misc Direct Exam Test,0
69,Explicit Microorganism Result,"Mycoplasma, Ureaplasma and Legionella Cultures",0
70,Explicit Microorganism Result,Parainfluenza 1 Dfa Test,0
71,Explicit Microorganism Result,Parainfluenza 2 Dfa Test,0
72,Explicit Microorganism Result,Parainfluenza 3 Dfa Test,0
73,Explicit Microorganism Result,Detection of parasite,0
74,Explicit Microorganism Result,Parvo B19 Pcr Test,0
75,Explicit Microorganism Result,Rsv Dfa Test,0
76,Explicit Microorganism Result,Sexually Transmitted Diseases Screen Test,0
77,Explicit Microorganism Result,Single Result Viral Test,0
78,Explicit Microorganism Result,Single-Result Organism Test,0
79,Explicit Microorganism Result,Specimen for Colony Count Test,0
80,Explicit Microorganism Result,Specimen for Culture Test,0
81,Explicit Microorganism Result,Specimen for Organism Test,0
82,Explicit Microorganism Result,Stains & Preparations Direct Exam Test,0
83,Explicit Microorganism Result,Tropheryma Whippelii DNA Test,0
84,Explicit Microorganism Result,Urine Bk Virus DNA Test,0
85,Explicit Microorganism Result,Urine Jc Virus DNA Test,0
86,Explicit Microorganism Result,Urinehistoplasma Antigen Test,0
87,Explicit Microorganism Result,Viral Direct Exam Test,0
88,Explicit Microorganism Result,Viral Hemadsorption Test,0
89,Explicit Microorganism Result,"Vzv DNA Test, CSF",0
90,Explicit Microorganism Result,Vzv Shell Vial Test,0
91,Explicit Microorganism Result,Babesia DNA Test,0
92,Explicit Microorganism Result,Bartonella DNA Test,0
93,Explicit Microorganism Result,Adenovirus Dfa Test,0
94,Explicit Microorganism Result,"CSF Evb,pcr,csf Test",0
95,Explicit Microorganism Result,Chlamydia culture,0
96,Explicit Microorganism Result,Chlamydia Immunofluorescence Test,0
97,Explicit Microorganism Result,Cmv Shell Vial Test,0
98,Family Planning:behavior,Assessment of Family Behavior Related to Family Planning,0
99,Family Planning:behavior,Assessment of Patient Behavior Related to Family Planning,0
100,Family Planning:status,Assessment of Family Status Related to Family Planning,0
101,Family Planning:status,Assessment of Patient Status Related to Family Planning,0
102,Alteration in family processes (finding),Assessment of Patient Status Related to Family Process Alteration,0
103,Febrile Agglutinin,Febrile Agglutinins Test,0
104,Fibrin fragment D,Ddimer Test,0
105,Fibrin split products,Fibrinogen degradation product screening,0
106,Fibrin split products,Operating Room Misc Labs: Fib/Fsp,0
107,Calcium ion,Intravascular Ionized Calcium Test,0
108,Calcium ion,Operating Room Misc Labs: Ica,0
109,Calcium ion,Plasma Ionized Calcium Test,0
110,Calcium ion,Whole Blood Ionized Calcium Test,0
111,Free thyroxin,Intravascular Free Thyroxine Index Test,0
112,galactose-1-phosphate,Plasma Galactose-1-Phosphate Test,0
113,Gamma-glutamyl transferase,Serum Gamma-Glutamyltransferase Test,0
114,Gamma-glutamyl transferase,Plasma Gamma-Glutamyltransferase Test,0
115,Gamma-glutamyl transferase,Serum Gamma-Glutamyltransferase Test,0
116,Gd1a Antibody,Anti-Gd1a Test,0
117,Gd1b Antibody,Anti-Gd1b Test,0
118,Genito-urinary Function:knowledge,Assessment of Family Knowledge Related to Genito-urinary Function,0
119,Genito-urinary Function:knowledge,Assessment of Patient Knowledge Related to Genito-urinary Function,0
120,Genito-urinary Function:status,Assessment of Family Status Related to Genito-urinary Function,0
121,Genito-urinary Function:status,Assessment of Patient Status Related to Genito-urinary Function,0
122,Giardia lamblia antibody,Giardia lamblia antibody test,0
123,Giardia lamblia antigen,Giardia lamblia antigen assay,0
124,Gm1 Antibody,Anti-Gm1 Test,0
125,Gonococcal DNA,Gonococcal DNA Probe Test,0
126,Gq1b Antibody,Anti-Gq1b Test,0
127,Granular Casts in Urine,Urine Granular Cast Test,0
128,Grief:behavior,Assessment of Family Behavior Related to Grief,0
129,Grief:behavior,Assessment of Patient Behavior Related to Grief,0
130,Grief:knowledge,Assessment of Family Knowledge Related to Grief,0
131,Grief:knowledge,Assessment of Patient Knowledge Related to Grief,0
132,Grief:status,Assessment of Family Status Related to Grief,0
133,Grief:status,Assessment of Patient Status Related to Grieving,0
134,Childhood growth AND/OR development alteration,Assessment of Patient Status Related to Growth & Development Alteration,0
135,Growth and Development:behavior,Assessment of Family Behavior Related to Growth and Development,0
136,Growth and Development:behavior,Assessment of Patient Behavior Related to Growth and Development,0
137,Growth and Development:knowledge,Assessment of Family Knowledge Related to Growth and Development,0
138,Growth and Development:knowledge,Assessment of Patient Knowledge Related to Growth and Development,0
139,Growth and Development:status,Assessment of Family Status Related to Growth and Development,0
140,Growth and Development:status,Assessment of Patient Status Related to Growth and Development,0
141,Blood group antigen H,Salmonella H Antigen Test,0
142,Hatts Antibody,Hatts-Abs Test,0
143,Health Care Supervision:behavior,Assessment of Family Behavior Related to Health Care Supervision,0
144,Health Care Supervision:behavior,Assessment of Patient Behavior Related to Health Care Supervision,0
145,Health Care Supervision:knowledge,Assessment of Family Knowledge Related to Health Care Supervision,0
146,Health Care Supervision:knowledge,Assessment of Patient Knowledge Related to Health Care Supervision,0
147,Health Care Supervision:status,Assessment of Family Status Related to Health Care Supervision,0
148,Health Care Supervision:status,Assessment of Patient Status Related to Health Care Supervision,0
149,Health seeking behavior alteration,Assessment of Patient Status Related to Health-seeking Behavior Alteration,0
150,Hearing:behavior,Assessment of Family Behavior Related to Hearing,0
151,Hearing:behavior,Assessment of Patient Behavior Related to Hearing,0
152,Hearing:knowledge,Assessment of Family Knowledge Related to Hearing,0
153,Hearing:knowledge,Assessment of Patient Knowledge Related to Hearing,0
154,Hearing:status,Assessment of Family Status Related to Hearing,0
155,Hearing:status,Assessment of Patient Status Related to Hearing,0
156,Helicobacter pylori antibody,Helicobacter pylori antibody Test,0
157,Anisocyte (cell),Whole Blood Anisocyte Counts,0
158,Hepatitis B Antibodies,Intravascular Hepatitis B Antibody Test,0
159,Hepatitis B Antibodies,Blood Hepatitis B Antibody Test,0
160,Hepatitis B Antigens,Hepatitis B Viral Antigen Test,0
161,Hepatitis B e Antigens,Hepatitis Be antigen measurement,0
162,Hepatitis C Antibodies,Intravascular Hepatitis C Antibody Test,0
163,Hepatitis Delta (D) Virus Antibodies,Hepatitis Delta Antibody Test,0
164,Antepartum/postpartum:behavior,Assessment of Family Behavior Related to Antepartum/postpartum,0
165,Antepartum/postpartum:behavior,Assessment of Patient Behavior Related to Antepartum/postpartum,0
166,Hepatitis E Virus IgG Antibodies (2),Intravascular Hepatitis E IgG Test,0
167,Hepatitis E virus IgM,Intravascular Hepatitis E IgM Test,0
168,Hepatitis Antibodies,Intravascular Hepatitis Antibody Test,0
169,Hepatitis Antibodies,Intravascular Hepatitis E Antibody Test,0
170,Hepatitis Antibodies,Blood Viral Hepatitis Antibody Test,0
171,Human herpes simplex virus antibody,Herpes EIA Test,0
172,Human herpes simplex virus antibody,Herpes Simplex Virus Type I Test,0
173,Human herpes simplex virus antibody,Herpes Simplex Virus Type II Test,0
174,Human herpes simplex virus antibody,Herpes Simplex Viruses IgG Test,0
175,Human herpes simplex virus antibody,Herpes Simplex Viruses IgM Test,0
176,Human herpes simplex virus antibody,Intravascular Herpes Simplex Viruses Test,0
177,Antepartum/postpartum:knowledge,Assessment of Family Status Related to Antepartum/postpartum,0
178,Antepartum/postpartum:knowledge,Assessment of Patient Status Related to Antepartum/postpartum,0
179,Hexacarboxylporphyrin,24 Hours Urine Hexacarboxylporphyrin Test,0
180,Histoplasmosis Antibody,Intravascular Histoplasmosis Antibody Test,0
181,HLA-B27 Antigen,Intravascular Hla-B27 Test,0
182,Antepartum/postpartum:status,Assessment of Family Knowledge Related to Antepartum/postpartum,0
183,Antepartum/postpartum:status,Assessment of Patient Knowledge Related to Antepartum/postpartum,0
184,HLA-DR Antigens,Ia (Hla-Dr) Test,0
185,Neuronal nuclear type 1 antibody,Serum Hu Antibody Test,0
186,Neuronal nuclear type 1 antibody,CSF Anti-Hu Test,0
187,Human Immunodeficiency Virus 1 (HIV-1) Antibodies,Intravascular Confirmatory HIV-1 Test,0
188,Human Immunodeficiency Virus 1 (HIV-1) Antibodies,Intravascular HIV 1 Antibody Test,0
189,Human Immunodeficiency Virus 1 (HIV-1) Antibodies,Intravascular HIV-1 & HIV-2 Antibody Combo Test,0
190,Human Immunodeficiency Virus 1 (HIV-1) Antibodies,Intravascular HIV-1-Only Antibody Test,0
191,Human Immunodeficiency Virus 1 (HIV-1) Antibodies,Serum Human Immunodeficiency Virus 1 (HIV-1) Only Antibody Test,0
192,Human Immunodeficiency Virus 2 (HIV-2 ) Antibodies,Intravascular HIV 2 Antibody Test,0
193,Human Immunodeficiency Virus 2 (HIV-2 ) Antibodies,Intravascular HIV-1 & HIV-2 Antibody Combo Test,0
194,Human Sexuality:behavior,Assessment of Family Behavior Related to Human Sexuality,0
195,Human Sexuality:behavior,Assessment of Patient Behavior Related to Human Sexuality,0
196,Human Sexuality:knowledge,Assessment of Family Knowledge Related to Human Sexuality,0
197,Human Sexuality:knowledge,Assessment of Patient Knowledge Related to Human Sexuality,0
198,Ribosomal ribonucleoprotein antibody,Serum Anti Rnp Test,0
199,Human Sexuality:status,Assessment of Family Status Related to Human Sexuality,0
200,Human Sexuality:status,Assessment of Patient Status Related to Human Sexuality,0
201,HTLV-I Antibodies,Measurement of Human T-lymphotropic virus 1 antibody,0
202,Urine microscopy: hyaline casts (finding),Urine Hyaline Cast Test,0
203,"Antibodies, Anticardiolipin",Serum Anticardiolipin Antibody Test,0
204,"Antibodies, Anticardiolipin",Serum Anticardiolipin IgG Antibody Test,0
205,"Antibodies, Anticardiolipin",Serum Anticardiolipin IgM Antibody Test,0
206,Hypochromic erythrocyte,Whole Blood Hypochromic Erythrocyte Counts,0
207,Centromere antibody,Serum Anti-Centromere Antibody Test,0
208,IgG/Total Protein Ratio,IgG/Total Protein Ratio Calculations,0
209,Income:behavior,Assessment of Family Behavior Related to Income,0
210,Income:behavior,Assessment of Patient Behavior Related to Income,0
211,Income:knowledge,Assessment of Family Knowledge Related to Income,0
212,Income:knowledge,Assessment of Patient Knowledge Related to Income,0
213,Income:status,Assessment of Family Status Related to Income,0
214,Income:status,Assessment of Patient Status Related to Income,0
215,Indirect reacting bilirubin,Intravascular Indirect (Unconjugated) Bilirubin Test,0
216,Indirect reacting bilirubin,Serum Indirect (Unconjugated) Bilirubin Test,0
217,Influenza A virus antibody,Intravascular Influenza A Antibody Test,0
218,Influenza antibody,Intravascular Influenza Antibody Test,0
219,Influenza antibody,Blood Influenza Antibody Measurement,0
220,Influenza B virus antibody,Intravascular Influenza B Antibody Test,0
221,Instrumental activity of daily living (IADLs) alteration,Assessment of Patient Status Related to Instrumental Activity of Daily Living Iadls) Alteration,0
222,Bovine insulin antibody,Serum Beef Insulin Antibody Test,0
223,Human insulin antibody,Serum Human Insulin Antibody Test,0
224,Insulin Pork Antibodies,Serum Pork Insulin Antibody Test,0
225,anti-extractable nuclear antigen antibodies,Serum Anti-Ena Antibody Test,0
226,Integument:behavior,Assessment of Family Behavior Related to Integument,0
227,Integument:behavior,Assessment of Patient Behavior Related to Integument,0
228,Integument:knowledge,Assessment of Family Knowledge Related to Integument,0
229,Integument:knowledge,Assessment of Patient Knowledge Related to Integument,0
230,Integument:status,Assessment of Family Status Related to Integument,0
231,Integument:status,Assessment of Patient Status Related to Integument,0
232,Interpersonal Relationship:behavior,Assessment of Family Behavior Related to Interpersonal Relationship,0
233,Interpersonal Relationship:behavior,Assessment of Patient Behavior Related to Interpersonal Relationship,0
234,Interpersonal Relationship:knowledge,Assessment of Family Knowledge Related to Interpersonal Relationship,0
235,Interpersonal Relationship:knowledge,Assessment of Patient Knowledge Related to Interpersonal Relationship,0
236,Interpersonal Relationship:status,Assessment of Family Status Related to Interpersonal Relationship,0
237,Interpersonal Relationship:status,Assessment of Patient Status Related to Interpersonal Relationship,0
238,Intestine Alkaline Phosphatase,Serum Intestine Alkaline Phosphatase Test,0
239,Gliadin antibody,Intravascular Gliadin IgA Antibody Test,0
240,Gliadin antibody,Intravascular Gliadin IgG Antibody Test,0
241,Histone antibody,Serum Anti-Histone Antibody Test,0
242,Jo-1 antibody,Anti Jo-1 Test,0
243,Jo-1 antibody,Anti-Jo-1 Spinal Fluid Test,0
244,Jo-1 antibody,Serum Anti Jo-1 Test,0
245,Anti-Microsomal Antibody,Serum Anti-Microsomal Antibody Test,0
246,Parietal cell antibody,Anti-Parietal Cell Antibodies Test,0
247,Anti-Scl70 Antibody,Anti-Scl70 Antibody Test,0
248,Antibody to Smith Antigen,Serum Anti Sm Test,0
249,Anti-Yo Antibody,Serum Anti-Yo Antibody Test,0
250,Thyroid microsomal antibodies,Intravascular Anti-thyroid Peroxidase Antibodies Test,0
251,Thyroid microsomal antibodies,Serum Anti-Thyroid Peroxidase Antibodies Test,0
252,Antibody to hepatitis Be antigen,Intravascular Hepatitis B E-Antibody Test,0
253,Antibody to hepatitis B core antigen,Intravascular Hepatitis B Core Antibody Test,0
254,"Antibody to Hepatitis Surface Antigen, Hbsag1",Intravascular Hepatitis B Surface Antibody Test,0
255,Antineutrophil Cytoplasmic Antibodies,Anti-Cytoplasmic Neutrophil Antibodies Test,0
256,Antineutrophil Cytoplasmic Antibodies,P-Anca Titer Test,0
257,Antineutrophil Cytoplasmic Antibodies,Serum Anti-Neutrophil Cytoplasmic Antibody Test,0
258,Antineutrophil Cytoplasmic Antibodies,C-Anca Titer Test,0
259,Vasopressin (USP),Intravascular Anti-Diuretic Hormone Test,0
260,Antierythrocyte Antibody,Blood Antierythrocyte Antibody Test,0
261,Antiproteus Antibodies,Blood Antiproteus Antibody Measurement,0
262,Antiproteus OX-19 Antibodies,Blood Antiproteus OX-19 Test,0
263,Intrinsic factor antibody,Intrinsic factor antibody measurement,0
264,Antiproteus OX-2 Antibodies,Blood Antiproteus OX-2 Test,0
265,Immunoglobulin kappa-Chains,Kappa Chain Test,0
266,Ketogenic Steroids,24 Hour Urine Ketogenic Steroid Test,0
267,Ketogenic Steroids,Urine Ketogenic Steroids Test,0
268,Antiproteus OX-K Antibodies,Blood Antiproteus OX-K Test,0
269,Lactic acid dehydrogenase isoenzyme 2,Serum Lactate Dehydrogenase Isoenzyme 2 Test,0
270,Lactic acid dehydrogenase isoenzyme 3,Serum Lactate Dehydrogenase Isoenzyme 3 Test,0
271,Lactic acid dehydrogenase isoenzyme 4,Serum Lactate Dehydrogenase Isoenzyme 4 Test,0
272,Lactic acid dehydrogenase isoenzyme 5,Serum Lactate Dehydrogenase Isoenzyme 5 Test,0
273,Immunoglobulin lambda-Chains,Lambda Chain Test,0
274,Legionella antibody,Intravascular Legionella Antibody Test,0
275,Thyroglobulin antibody,Intravascular Antithyroglobulin Antibody Test,0
276,Thyroglobulin antibody,Serum Antithyroglobulin Test,0
277,Leptospira species antibody,Leptospira antibody assay,0
278,Leptospira species antibody,Serum Leptospira Antibody Test,0
279,Leptospira species antibody,Blood Leptospira Agglutination Measurement,0
280,Leukocyte alkaline phosphatase,Leuk.Alk.P'Tase Test,0
281,Leukocyte alkaline phosphatase,Leukocyte Alkaline Phosphatase with Count,0
282,Antitreponemal Antibodies,Serum Anti Treponemal Antibody Test,0
283,Leucocyte esterase,Qualitative Urine Leukocyte Esterase Test,0
284,Leucocyte esterase,Backoffice Urine Leukocyte Esterase Test,0
285,Lupus erythematosus cell,Whole Blood LE Cell Test,0
286,Borrelia burgdorferi antibody,Lyme Ab Patient OD Test,0
287,Borrelia burgdorferi antibody,Lyme Ab Rea.Cut-Off: Test,0
288,Borrelia burgdorferi antibody,Lyme Antibody Test,0
289,Borrelia burgdorferi antibody,Lyme IgG Test,0
290,Borrelia burgdorferi antibody,Lyme IgM Test,0
291,Borrelia burgdorferi antibody,Lyme Wb IgG Band Test,0
292,Borrelia burgdorferi antibody,Lyme Wb IgG Result Test,0
293,Borrelia burgdorferi antibody,Lyme Wb IgM Band Test,0
294,Borrelia burgdorferi antibody,Lyme Wb IgM Result Test,0
295,Borrelia burgdorferi antibody,Lyme Western Blot Components Test,0
296,Borrelia burgdorferi antibody,Lyme Western Blot IG Bands Test,0
297,Borrelia burgdorferi antibody,Lyme Western Blot IG Results Test,0
298,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi 1gg 18kd,0
299,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 23kd,0
300,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 28kd,0
301,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 30kd,0
302,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 39kd,0
303,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 41kd,0
304,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 45kd,0
305,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 58kd,0
306,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 66kd,0
307,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG 93kd,0
308,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgG Interp,0
309,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgM 23kd,0
310,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgM 39kd,0
311,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgM 41kd,0
312,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi IgM Interp,0
313,Borrelia burgdorferi antibody,NYH Lab Procedure: B.burgdorferi Interp,0
314,Borrelia burgdorferi antibody,Blood Lyme Antibody Test,0
315,Borrelia burgdorferi antibody,Total Lyme Antibody Test,0
316,Borrelia burgdorferi antibody,Western Blot Lyme Antibody Test,0
317,Borrelia burgdorferi antibody,B.burgd 18kd(igg) Test,0
318,Borrelia burgdorferi antibody,B.burgd 23kd(igg) Test,0
319,Borrelia burgdorferi antibody,B.burgd 23kd(igm) Test,0
320,Borrelia burgdorferi antibody,B.burgd 28kd(igg) Test,0
321,Borrelia burgdorferi antibody,B.burgd 30kd(igg) Test,0
322,Borrelia burgdorferi antibody,B.burgd 39kd(igg) Test,0
323,Borrelia burgdorferi antibody,B.burgd 39kd(igm) Test,0
324,Borrelia burgdorferi antibody,B.burgd 41kd(igg) Test,0
325,Borrelia burgdorferi antibody,B.burgd 41kd(igm) Test,0
326,Borrelia burgdorferi antibody,B.burgd 45kd(igg) Test,0
327,Borrelia burgdorferi antibody,B.burgd 58kd(igg) Test,0
328,Borrelia burgdorferi antibody,B.burgd 66kd(igg) Test,0
329,Borrelia burgdorferi antibody,B.burgd 93kd(igg) Test,0
330,Borrelia burgdorferi antibody,B.burgd Ab(igg) Test,0
331,Borrelia burgdorferi antibody,B.burgd Ab(igm) Test,0
332,Borrelia burgdorferi antibody,B.burgd Interp(igg) Test,0
333,Borrelia burgdorferi antibody,B.burgd Interp(igm) Test,0
334,Borrelia burgdorferi antibody,B.burgd Interpretation Test,0
335,Borrelia burgdorferi antibody,Blood Lyme Antibody Test,0
336,Borrelia burgdorferi antibody,CSF Lyme Antibody Test,0
337,Lyme IgG Antibody,Borrelia burgdorferi IgG antibody test,0
338,Lyme IgM Antibody,Serum IgM Lyme Antibody Test,0
339,Lyme IgM Antibody,Blood Lyme IgM Antibody Test,0
340,Lymphocytic choriomeningitis virus antibody,lymphocytic choriomeningitis antibody assay (lab test),0
341,Lymphogranuloma Venereum Antibodies,Lymphogranuloma venereum antibody assay,0
342,Myelin-Associated Glycoprotein Antibody,Anti-Mag Test,0
343,Malaria antibody,Malaria Antibodies Test,0
344,Mature Erythrocytes,Unspecified Fluid Erythrocyte Test,0
345,Mature Erythrocytes,Urine Erythrocyte Count,0
346,Mature Erythrocytes,Whole Blood Mature Erythrocyte Counts,0
347,Mesothelial cell,Body Fluid Mesothelial Cell Test,0
348,methionine sulfoxide,Intravascular Methionine Sulfoxide Test,0
349,methionine sulfoxide,Methionine Sulfoxide Test,0
350,methionine sulfoxide,Plasma Methionine Sulfoxide Test,0
351,methionine sulfoxide,Urine Methionine Sulfoxide Test,0
352,Nongranular leukocyte,Intravascular CD45+(LYMPHOCYTES) Test,0
353,Nongranular leukocyte,Mononucleated Cell Body Fluid Test,0
354,Nongranular leukocyte,Unspecified Fluid Mononuclear Test,0
355,Nongranular leukocyte,Whole Blood Mononucleated Cell Count,0
356,Nongranular leukocyte,Whole Blood Percent Cd45+14+ Mononucleated Cell Counts,0
357,Nongranular leukocyte,Body Fluid Lg Imm Mononuclear Test,0
358,Nongranular leukocyte,Body Fluid Lg Mononuclear Test,0
359,Nongranular leukocyte,Body Fluids Mononuclear Test,0
360,Mumps virus antibody,Mumps Antibody Test,0
361,Muramidase,NYH Lab Procedure: Lysozyme,0
362,Muramidase,Urine Muramidase (Lysozyme) Test,0
363,Mycoplasma Ag,Mycoplasma CF Test,0
364,Mycoplasma pneumoniae antibody,Mycoplasma Pneumoniae IgM Antibody Test,0
365,Mycoplasma pneumoniae DNA,Mycoplasma Pneumoniae DNA Probe Test,0
366,Myelin Basic Proteins,"Myelin basic protein measurement, spinal fluid",0
367,N-telopeptide,Random Urine N-Telopeptide Test,0
368,N-telopeptide,Timed Urine N-Telopeptide Testa,0
369,N-telopeptide,Urine N-Telopeptide Test,0
370,Neglected Child/adult:behavior,Assessment of Family Behavior Related to Neglected Child/adult,0
371,Neglected Child/adult:behavior,Assessment of Patient Behavior Related to Neglected Child/adult,0
372,Neglected Child/adult:knowledge,Assessment of Family Knowledge Related to Neglected Child/adult,0
373,Neglected Child/adult:knowledge,Assessment of Patient Knowledge Related to Neglected Child/adult,0
374,Neglected Child/adult:status,Assessment of Family Status Related to Neglected Child/adult,0
375,Neglected Child/adult:status,Assessment of Patient Status Related to Neglected Child/adult,0
376,Neighborhood/workplace Safety:behavior,Assessment of Family Behavior Related to Neighborhood/workplace Safety,0
377,Neighborhood/workplace Safety:behavior,Assessment of Patient Behavior Related to Neighborhood/workplace Safety,0
378,Neighborhood/workplace Safety:knowledge,Assessment of Family Knowledge Related to Neighborhood/workplace Safety,0
379,Neighborhood/workplace Safety:knowledge,Assessment of Patient Knowledge Related to Neighborhood/workplace Safety,0
380,Neighborhood/workplace Safety:status,Assessment of Family Status Related to Neighborhood/workplace Safety,0
381,Neighborhood/workplace Safety:status,Assessment of Patient Status Related to Neighborhood/workplace Safety,0
382,Neuro-musculo-skeletal Function:behavior,Assessment of Family Behavior Related to Neuro-musculo-skeletal Function,0
383,Neuro-musculo-skeletal Function:behavior,Assessment of Patient Behavior Related to Neuro-musculo-skeletal Function,0
384,Neuro-musculo-skeletal Function:knowledge,Assessment of Family Knowledge Related to Neuro-musculo-skeletal Function,0
385,Neuro-musculo-skeletal Function:knowledge,Assessment of Patient Knowledge Related to Neuro-musculo-skeletal Function,0
386,Neuro-musculo-skeletal Function:status,Assessment of Family Status Related to Neuro-musculo-skeletal Function,0
387,Neuro-musculo-skeletal Function:status,Assessment of Patient Status Related to Neuro-musculo-skeletal Function,0
388,Nk Lymphocyte,Whole Blood Absolute Nk Lymphocyte Counts,0
389,Nk Lymphocyte,Whole Blood Nk Lymphocyte Counts,0
390,Nk Lymphocyte,Whole Blood Percent Nk Lymphocyte Counts,0
391,Noncompliance with diagnostic testing,Assessment of Patient Status Related to Noncompliance with Diagnostic Test,0
392,Noncompliance with dietary regimen,Assessment of Patient Status Related to Noncompliance with Dietary Regimen,0
393,Noncompliance with Fluid Volume,Assessment of Patient Status Related to Noncompliance with Fluid Volume,0
394,Medication Nonadherence,Assessment of Patient Status Related to Noncompliance with Medication Regimen,0
395,Actual Non Adherence To Safety Precautions,Assessment of Patient Status Related to Noncompliance with Safety Precautions,0
396,Noncompliance with therapeutic regimen,Assessment of Patient Status Related to Noncompliance with Therapeutic Regimen,0
397,Nutrition:behavior,Assessment of Family Behavior Related to Nutrition,0
398,Nutrition:behavior,Assessment of Patient Behavior Related to Nutrition,0
399,Nutrition:knowledge,Assessment of Family Knowledge Related to Nutrition,0
400,Nutrition:knowledge,Assessment of Patient Knowledge Related to Nutrition,0
401,Nutritional status,Assessment of Family Status Relaed to Nutrition,0
402,Nutritional status,Assessment of Patient Status Relaed to Nutrition,0
403,Octacarboxylorphyrin,Random Urine Octacarboxyporphyrin Test,0
404,Octacarboxylorphyrin,24 Hours Urine Octacarboxyporphyrin Test,0
405,Okt3 Lymphocyte,Whole Blood Absolute Okt3 Lymphocyte Counts,0
406,Okt3 Lymphocyte,Whole Blood Okt3 Lymphocyte Counts,0
407,Okt3 Lymphocyte,Whole Blood Percent Okt3 Lymphocyte Counts,0
408,Optical density units,Amniotic Fluid Optical Density Measurements,0
409,Orthochromic normoblast (cell),Bm Ortho.Normoblast Test,0
410,Osmolitic Fragility,Direct Osmotic Fragility Test,0
411,Osmolitic Fragility,Hemolysin acid test,0
412,Osmolitic Fragility,Indirect Osmotic Fragility Test,0
413,Osmolitic Fragility,Osmotic Fragility test,0
414,Pain:behavior,Assessment of Family Behavior Related to Pain,0
415,Pain:behavior,Assessment of Patient Behavior Related to Pain,0
416,Pain:knowledge,Assessment of Family Knowledge Related to Pain,0
417,Pain:knowledge,Assessment of Patient Knowledge Related to Pain,0
418,Pain:status,Assessment of Family Status Related to Pain,0
419,Pain:status,Assessment of Patient Status Related to Pain,0
420,Pancreatic-Islet Antibodies,Pancreatic-Islet Antibodies Test,0
421,Parainfluenza virus Ab,Intravascular Parainfluenza Ab Test,0
422,Parainfluenza virus Ab,Intravascular Parainfluenza Ab Test,0
423,Parainfluenza virus Ab,Intravascular Parainfluenza Type 1 Ab Measurements,0
424,Parainfluenza virus Ab,Intravascular Parainfluenza Type 2 Ab Measurements,0
425,Parainfluenza virus Ab,Intravascular Parainfluenza Type 3 Ab Measurements,0
426,Parainfluenza virus Ab,Intravascular Parainfluenza Types Ab Test,0
427,Parainfluenza virus Ab,Blood Parainfluenza Antibody Test,0
428,Parainfluenza virus Ab,Blood Parainfluenza Antibody Test,0
429,Aspergillus Antibody (substance),Intravascular Aspergillus Antibody Test,0
430,Aspergillus Antibody (substance),Intravascular Aspergillus Flavus Ab Test,0
431,Aspergillus Antibody (substance),Intravascular Aspergillus Fumigatus (2) Ab Test,0
432,Aspergillus Antibody (substance),Intravascular Aspergillus Niger Ab Test,0
433,carboxyl-terminal parathyroid hormone,Intravascular Pth C-Terminal Test,0
434,carboxyl-terminal parathyroid hormone,Serum Pth C-Terminal/Midregion Test,0
435,amino-terminal parathyroid hormone,Intravascular Pth N-Terminal Test,0
436,amino-terminal parathyroid hormone,Serum Pth N-Terminal Test,0
437,parathyroid hormone-related protein,Serum Pth Related Protein Test,0
438,Human parvovirus B19 antibody,Parvovirus B19 IgG Test,0
439,Human parvovirus B19 antibody,Parvovirus B19 IgM measurement,0
440,Human parvovirus B19 antibody,Parvovirus B19 Test,0
441,Pentacarboxylporphyrin,Random Urine Pentacarboxyporphyrin Test,0
442,Pentacarboxylporphyrin,24 Hours Urine Pentacarboxyporphyrin Test,0
443,Personal Hygiene:behavior,Assessment of Family Behavior Related to Personal Hygiene,0
444,Personal Hygiene:behavior,Assessment of Patient Behavior Related to Personal Hygiene,0
445,Personal Hygiene:knowledge,Assessment of Family Knowledge Related to Personal Hygiene,0
446,Personal Hygiene:knowledge,Assessment of Patient Knowledge Related to Personal Hygiene,0
447,Personal Hygiene:status,Assessment of Family Status Related to Personal Hygiene,0
448,Personal Hygiene:status,Assessment of Patient Status Related to Personal Hygiene,0
449,Physical activity behavior,Assessment of Family Behavior Related to Physical Activity,0
450,Physical activity behavior,Assessment of Patient Behavior Related to Physical Activity,0
451,Physical Activity:knowledge,Assessment of Family Knowledge Relate to Physical Activity,0
452,Physical Activity:knowledge,Assessment of Patient Knowledge Related to Physical Activity,0
453,Physical Activity:status,Assessment of Family Status Related to Physical Activity,0
454,Physical Activity:status,Assessment of Patient Status Related to Physical Activity,0
455,Plasma Clot Lysis,Intravascular Euglobulin Lysis Test,0
456,Platelet Size,Mean Platelet Volume Test,0
457,Platelet Size,Platelet Size Measurements,0
458,Pneumocystis Carinii Antibodies,Pneumocystis Carinii Antibodies Test,0
459,Polychromatocyte,Whole Blood Polychromatocyte Counts,0
460,Polychromic Normoblast,Bm Poly.Normoblast Test,0
461,Post-trauma response,Assessment of Patient Status Related to Post-trauma Response,0
462,Prescribed Medication Regimen:behavior,Assessment of Family Behavior Related to Prescribed Medication Regimen,0
463,Prescribed Medication Regimen:behavior,Assessment of Patient Behavior Related to Prescribed Medication Regimen,0
464,Prescribed Medication Regimen:knowledge,Assessment of Family Knowledge Related to Prescribed Medication Regimen,0
465,Prescribed Medication Regimen:knowledge,Assessment of Patient Knowledge Related to Prescribed Medication Regimen,0
466,Prescribed Medication Regimen:status,Assessment of Family Status Related to Prescribed Medication Regimen,0
467,Prescribed Medication Regimen:status,Assessment of Patient Status Related to Prescribed Medication Regimen,0
468,At risk of pressure ulcer,Braden Pressure Ulcer Risk Assessment,0
469,Antigen to protein S (substance),Protein S antigen measurement,0
470,Protein S,Protein s Activitiy Test,0
471,Coxiella burnetii antibody,Q Fever Antibodies Test,0
472,Reagins,Indirect Serologic Test for Syphilis (Reagin / VDRL Test),0
473,Reagins,Rapid Plasma Reagin (Rpr) Measurement,0
474,Reagins,CSF VDRL Test,0
475,Red Blood Cell Casts in Urine,Urine Erythrocyte Cast Test,0
476,Red blood cell morphology result,Red Blood Cell Morphology Test,0
477,Residence:behavior,Assessment of Family Behavior Related to Residence,0
478,Residence:behavior,Assessment of Patient Behavior Related to Residence,0
479,Residence:knowledge,Assessment of Family Knowledge Related to Residence,0
480,Residence:knowledge,Assessment of Patient Knowledge Related to Residence,0
481,Residence:status,Assessment of Family Status Related to Residence,0
482,Residence:status,Assessment of Patient Status Related to Residence,0
483,Respiration:behavior,Assessment of Family Behavoir Related to Respiration,0
484,Respiration:behavior,Assessment of Patient Behavoir Related to Respiration,0
485,Respiration:knowledge,Assessment of Family Knowledge Related to Respiration,0
486,Respiration:knowledge,Assessment of Patient Knowledge Related to Respiration,0
487,Respiration:status,Assessment of Family Status Related to Respiration,0
488,Respiration:status,Assessment of Patient Status Related to Respiration,0
489,Respiratory syncytial virus antigen,RSV antigen level,0
490,Reticulin antibody,Reticulin antibody measurement,0
491,Antigen in Rh blood group system,Whole Blood ABO & Rh Test,0
492,Antigen in Rh blood group system,Whole Blood Rh-Antigen Test,0
493,Ristocetin induced platelet aggregation,Platelet aggregation with ristocetin test,0
494,Role Change:behavior,Assessment of Family Behavior Related to Role Change,0
495,Role Change:behavior,Assessment of Patient Behavior Related to Role Change,0
496,Role Change:knowledge,Assessment of Family Knowledge Related to Role Change,0
497,Role Change:knowledge,Assessment of Patient Knowledge Related to Role Change,0
498,Role Change:status,Assessment of Family Status Related to Role Change,0
499,Role Change:status,Assessment of Patient Status Related to Role Change,0
500,rubella antibodies,Intravascular Rubella Antibody Test,0
501,rubella antibodies,Rubella antibody screening,0
502,rubella antibodies,Blood Rubella Antibodies Test,0
503,Rubella IgG Antibody,Intravascular Rubella IgG Antibody Test,0
504,Rubella IgG Antibody,Blood Rubella IgG Antibody Test,0
505,Rubella IgM Antibody,Intravascular Rubella IgM Antibody Test,0
506,Rubella IgM Antibody,Blood Rubella IgM Antibody Test,0
507,Salmonella Agglutinin Antibody,Blood Salmonella Agglutinin Antibody Measurement,0
508,Salmonella Group A Agglutinin Antibody,Blood Salmonella Group A Agglutinin Antibody Test,0
509,Salmonella Group B Agglutinin Antibody,Blood Salmonella Group B Agglutinin Antibody Test,0
510,Salmonella Group C Agglutinin Antibody,Blood Salmonella Group C Agglutinin Antibody Test,0
511,Salmonella Group D Agglutinin Antibody,Blood Salmonella Group D Agglutinin Antibody Test,0
512,Sanitation:behavior,Assessment of Family Behavior Related to Sanitation,0
513,Sanitation:behavior,Assessment of Patient Behavior Related to Sanitation,0
514,Sanitation:knowledge,Assessment of Family Knowledge Related to Sanitation,0
515,Sanitation:knowledge,Assessment of Patient Knowledge Related to Sanitation,0
516,Sanitation:status,Assessment of Family Status Related to Sanitation,0
517,Sanitation:status,Assessment of Patient Status Related to Sanitation,0
518,Schistosoma species antibody,Schistosomiasis Antibodies Test,0
519,Total self-care deficit,Assessment of Patient Status Related to Self-care Deficit,0
520,Self-esteem disturbance,Assessment of Patient Status Related to Self-concept Alteration,0
521,Drepanocyte (cell),Whole Blood Sickle Cell Test,0
522,Situational low self-esteem,Assessment of Patient Status Related to Situational Self-esteem Disturbance,0
523,Skin Integrity Alteration,Assessment of Patient Status Related to Skin Integrity Alteration,0
524,Sleep and Rest Pattern:behavior,Assessment of Family Behavior Related to Sleep and Rest Pattern,0
525,Sleep and Rest Pattern:behavior,Assessment of Patient Behavior Related to Sleep and Rest Pattern,0
526,Sleep and Rest Pattern:knowledge,Assessment of Family Knowledge Related to Sleep and Rest Pattern,0
527,Sleep and Rest Pattern:knowledge,Assessment of Patient Knowledge Related to Sleep and Rest Pattern,0
528,Sleep and Rest Pattern:status,Assessment of Family Status Related to Sleep and Rest Pattern,0
529,Sleep and Rest Pattern:status,Assessment of Patient Status Related to Sleep and Rest Pattern,0
530,Social Contact:behavior,Assessment of Family Behavior Related to Social Contact,0
531,Social Contact:behavior,Assessment of Patient Behavior Related to Social Contact,0
532,Social Contact:knowledge,Assessment of Family Knowledge Related to Social Contact,0
533,Social Contact:knowledge,Assessment of Patient Knowledge Related to Social Contact,0
534,Social Contact:status,Assessment of Family Status Related to Social Contact,0
535,Social Contact:status,Assessment of Patient Status Related to Social Contact,0
536,Speech and Language:behavior,Assessment of Family Behavior Related to Speech and Language,0
537,Speech and Language:behavior,Assessment of Patient Behavior Related to Speech and Language,0
538,Speech and Language:knowledge,Assessment of Family Knowledge Related to Speech and Language,0
539,Speech and Language:knowledge,Assessment of Patient Knowledge Related to Speech and Language,0
540,Speech and Language:status,Assessment of Family Status Related to Speech and Language,0
541,Speech and Language:status,Assessment of Patient Status Related to Speech and Language,0
542,Spiritual Distress:behavior,Assessment of Family Behavior Related to Spiritual Distress,0
543,Spiritual Distress:behavior,Assessment of Patient Behavior Related to Spiritual Distress,0
544,Spiritual Distress:knowledge,Assessment of Family Knowledge Related to Spiritual Distress,0
545,Spiritual Distress:knowledge,Assessment of Patient Knowledge Related to Spiritual Distress,0
546,Spiritual Distress:status,Assessment of Family Status Related to Spiritual Distress,0
547,Spiritual Distress:status,Assessment of Patient Status Related to Spiritual Distress,0
548,Sporothrix species antibody,Sporothrix Antibodies Test,0
549,SS A antibodies,Serum Anti-SSA Test,0
550,SS-B antibodies,Serum Anti-SSB Test,0
551,Stippled Erythrocyte,Whole Blood Stippled Erythrocyte Counts,0
552,Substance Use:behavior,Assessment of Family Behavior Related to Substance Use,0
553,Substance Use:behavior,Assessment of Patient Behavior Related to Substance Use,0
554,Substance Use:knowledge,Assessment of Family Knowledge Related to Substance Use,0
555,Substance Use:knowledge,Assessment of Patient Knowledge Related to Substance Use,0
556,Substance Use:status,Assessment of Family Status Related to Substance Use,0
557,Substance Use:status,Assessment of Patient Status Related to Substance Use,0
558,Anti-sulfatide antibody,Intravascular Anti-Sulfatide Test,0
559,T-Lymphocyte,Intravascular T Cell Interpretation,0
560,T-Lymphocyte,T-Cell Lymphocyte Lymphocyte Counts,0
561,T-Lymphocyte,Whole Blood Absolute Cd3+ Cell Count,0
562,T-Lymphocyte,Whole Blood Absolute Total T-Cell Lymphocyte Counts,0
563,T-Lymphocyte,Whole Blood Percent Total T-Cell Lymphocyte Counts,0
564,T-Lymphocyte,Whole Blood Percentage Cd3+ Cell Counts,0
565,T-Lymphocyte,Whole Blood Total T-Cell Lymphocyte Counts,0
566,T-Lymphocyte,Cd2 (T11) T-Cell Test,0
567,TSH receptor antibody,Intravascular TSH Receptor Antibodies Test,0
568,Tacrolimus (Fk 506),Intravascular Tacrolimus Test,0
569,Tacrolimus (Fk 506),Whole Blood Tacrolimus Test,0
570,Leptocyte,Whole Blood Target Cell Counts,0
571,tartrate-resistant acid phosphatase,Intravascular Tar.Res. Acid P'Tase Test,0
572,tartrate-resistant acid phosphatase,Whole Blood Tar.Res. Acid P'Tase Test,0
573,Technical Procedure:behavior,Assessment of Family Behavior Related to Technical Procedure,0
574,Technical Procedure:behavior,Assessment of Patient Behavior Related to Technical Procedure,0
575,Technical Procedure:knowledge,Assessment of Family Knowledge Related to Technical Procedure,0
576,Technical Procedure:knowledge,Assessment of Patient Knowledge Related to Technical Procedure,0
577,Technical Procedure:status,Assessment of Family Status Related to Technical Procedure,0
578,Technical Procedure:status,Assessment of Patient Status Related to Technical Procedure,0
579,Teichoic acid antibody,Whole Blood Teichoic Acid Antibody Test,0
580,Tetracarboxylporphyrin,Random Urine Tetracarboxyporphyrin Test,0
581,Tetracarboxylporphyrin,24 Hours Urine Tetracarboxyporphyrin Test,0
582,Altered thought processes,Assessment of Patient Status Related to Thought Process Alteration,0
583,Tissue factor induced coagulation,Calculation of international normalized ratio,0
584,Tissue factor induced coagulation,"Operating Room Misc Labs: Pt,Pt/Control",0
585,Tissue factor induced coagulation,Plasma Control Prothrombin Test,0
586,Tissue factor induced coagulation,Plasma Patient Prothrombin Test,0
587,Tissue factor induced coagulation,Prothrombin time assay,0
588,Toxicopathic Erythrocyte,Whole Blood Toxicopathic Erythrocyte Counts,0
589,Toxocara antibody,Toxocara antibody measurement,0
590,Toxoplasma species antibody,Intravascular Toxoplasma Gondii Antibody Test,0
591,Toxoplasma species antibody,Intravascular Toxoplasma Gondii Antibody Titer Test,0
592,Toxoplasma species antibody,Blood Toxoplasma Gondii Antibody Test,0
593,Toxoplasma species antibody,CSF Toxoplasma Antibody Test,0
594,Immunoglobulin G antibody to Toxoplasma gondii,Intravascular Toxoplasma Gondii IgG Antibody Test,0
595,Immunoglobulin G antibody to Toxoplasma gondii,Blood Toxoplasma Gondii IgG Antibody Test,0
596,Immunoglobulin M antibody to Toxoplasma gondii,Intravascular Toxoplasma Gondii IgM Antibody Test,0
597,Immunoglobulin M antibody to Toxoplasma gondii,Blood Toxoplasma Gondii IgM Antibody Test,0
598,Treponema pallidum,NYH Lab Term: Treponema Pallidum,0
599,Treponema pallidum,Treponema Pallidum Test,0
600,Trichinella species antibody,Intravascular Trichinella Antibody Test,0
601,Tularemia Agglutinin,Tularemia Agglutinin Test,0
602,Carbonyldiamide,Intravascular Urea Nitrogen Test,0
603,Carbonyldiamide,Random Urine Urea Nitrogen Test,0
604,Carbonyldiamide,Serum Urea Nitrogen Test,0
605,Carbonyldiamide,24 Hour Urine Urea Test,0
606,Carbonyldiamide,"Urea nitrogen measurement, urine",0
607,Carbonyldiamide,Whole Blood Urea Nitrogen Test,0
608,Carbonyldiamide,Body Fluid Urea Test,0
609,Carbonyldiamide,CHEM-7 Urea Nitrogen Measurement,0
610,Urine Casts,Nonspecific Urine Cast Observation Test,0
611,Urine Casts,Urine Cast Observation Test,0
612,Varicella Antibody,Serum Varicella Antibody Test,0
613,Very long chain fatty acid,Intravascular Very Long Chain Fatty Acids Test,0
614,Vision:behavior,Assessment of Family Behavior Related to Vision,0
615,Vision:behavior,Assessment of Patient Behavior Related to Vision,0
616,Vision:knowledge,Assessment of Family Knowledge Related to Vision,0
617,Vision:knowledge,Assessment of Patient Knowledge Related to Vision,0
618,Vision:status,Assessment of Family Status Related to Vision,0
619,Vision:status,Assessment of Patient Status Related to Vision,0
620,Von Willebrand antigen,Plasma Ristocetin Cofactor Test,0
621,Von Willebrand antigen,Plasma Von Willebrand Factor Antigen Test,0
622,WBC Casts in Urine,Urine Leukocyte Cast Test,0
623,Yersinia species antibody,Intravascular Yersinia Antibody Test,0
624,Yersinia species antibody,Blood Yersinia Antibody Measurement,0
625,Yersinia Type 3 Antibody,Intravascular Yersinia Type 3 Antibody Test,0
626,Yersinia Type 5 Antibody,Intravascular Yersinia Type 5 Antibody Test,0
627,Yersinia Type 8 Antibody,Intravascular Yersinia Type 8 Antibody Test,0
628,3-methylhistidine,Intravascular 3-Methyl-Histidine Test,0
629,Hydroxyindoleacetic Acid,24 Hour Urine Hydroxyindoleacetic Acid-5 Test,0
630,Phosphogluconate Dehydrogenase,Glucose-6-phosphate dehydrogenase Measurement,0
631,ABO Antigens,Whole Blood ABO & Rh Test,0
632,ABO Antigens,Blood ABO Antigen Test,0
633,ART Antibody,Serum ART Antibody Test,0
634,Abused Child/adult:behavior,Assessment of Family Behavior Related to Abused Child/adult,0
635,Abused Child/adult:behavior,Assessment of Patient Behavior Related to Abused Child/adult,0
636,Abused Child/adult:knowledge,Assessment of Family Knowledge Related to Abused Child/adult,0
637,Abused Child/adult:knowledge,Assessment of Patient Knowledge Related to Abused Child/adult,0
638,Atypical lymphocyte,Whole Blood Atypical Lymphocyte Counts,0
639,B-Lymphocytes,Percent B-Cell Lymphocyte Counts,0
640,B-Lymphocytes,Absolute B-Cell Lymphocyte Counts,0
641,B-Lymphocytes,B-Cell Lymphocyte Counts,0
642,B-Lymphocytes,Cd19 (B4) B-Cell Lymphocyte Counts,0
643,B-Lymphocytes,Cd20 (B1) B-Cell Test,0
644,B-Lymphocytes,Cd3-Cd19+ (B Cells) Counts,0
645,Abused Child/adult:status,Assessment of Family Status Related to Abused Child/adult,0
646,Abused Child/adult:status,Assessment of Patient Status Related to Abused Child/adult,0
647,Band Form Leukocytes,Whole Blood Band Form Leukocyte Counts,0
648,Band Form Leukocytes,Bm Band Test,0
649,Band Form Leukocytes,Body Fluid Band Test,0
650,Acetylcholine Receptor Antibody,Serum Acetylcholine Receptor Antibody Test,0
651,Bartonella henselae antibody,Cat Scratch Disease Test,0
652,Basophilic normoblast,Bm Baso.Normoblast Test,0
653,Self-bathing/hygiene deficit,Assessment of Patient Status Related to Bathing/hygiene Deficit,0
654,beta-Alanine,Intravascular Beta-Alanine Test,0
655,beta-Alanine,Plasma Beta-Alanine Test,0
656,beta-Alanine,Urine Beta-Alanine Test,0
657,beta-Alanine,beta-Alanine measurement,0
658,Beta-Amino-Iso-Butyric Acid,Intravascular Beta-Amino-Iso-Butyric Acid Test,0
659,Beta-Amino-Iso-Butyric Acid,Plasma Beta-Amino-Iso-Butyric Acid Test,0
660,Beta-Amino-Iso-Butyric Acid,Urine Beta-Amino-Iso-Butyric Acid Test,0
661,Beta-Amino-Iso-Butyric Acid,Beta-Amino-Iso-Butyric Acid Test,0
662,Blast Cell,Whole Blood Blast Cell Counts,0
663,Blast Cell,Body Fluid Blast Test,0
664,Blastomycosis Antibody,Intravascular Blastomycosis Antibody Test,0
665,Actinomyces Antibodies,Actinomyces antibody assay,0
666,Activity of daily living (ADL) alteration,Assessment of Patient Status Related to Activities of Daily Living (adls) Alteration,0
667,Adenosine Diphosphate-Induced Platelet Aggregation,Platelet aggregation with ADP test,0
668,Adenovirus antibody (substance),Intravascular Adenovirus Antibody Test,0
669,"Alkaline phosphatase isoenzyme, bone fraction",Serum Bone Alkaline Phosphatase Test,0
670,Bowel Function:behavior,Assessment of Family Behavior Related to Bowel Function,0
671,Bowel Function:behavior,Assessment of Patient Behavior Related to Bowel Function,0
672,Bowel Function:knowledge,Assessment of Family Knowledge Related to Bowel Function,0
673,Bowel Function:knowledge,Assessment of Patient Knowledge Related to Bowel Function,0
674,Bowel Function:status,Assessment of Family Status Related to Bowel Function,0
675,Bowel Function:status,Assessment of Patient Status Related to Bowel Function,0
676,Braden: Friction and Shear,Braden Pressure Ulcer Assessment Item: Friction and Shear,0
677,Brucella species antibody (substance),Brucella Titer Test,0
678,C5 Lymphocyte,Whole Blood Absolute Cd5 Lymphocyte Counts,0
679,C5 Lymphocyte,Whole Blood C5 Lymphocyte Counts,0
680,C5 Lymphocyte,Whole Blood Percent Cd5 Lymphocyte Counts,0
681,C5 Lymphocyte,Cd5 (Leu 1) T-Cell Test,0
682,Ca 19-9 Carbohydrate Ag,Intravascular Ca 19-9 Test,0
683,CA 27-29 antigen,Intravascular Ca27.29 Test,0
684,CA-125 Antigen,Serum Ca-125 Antigen Test,0
685,Mucin-1 Antigen,Ca15-3 Test,0
686,Cadmium/Creatinine Ratio,Urinary Cad/Creat Ratio Calculations,0
687,Candida species antibody (substance),Intravascular Candida Antibody Test,0
688,carbamazepine epoxide,"Intravascular Bound 10,11-Epoxide Test",0
689,carbamazepine epoxide,"Intravascular Carbamazepine 10,11-Epoxide Test",0
690,carbamazepine epoxide,"Intravascular Free 10,11-Epoxide Test",0
691,Antiplasmin,Intravascular Alpha 2 Anti-Plasmin Test,0
692,Caretaking/parenting:behavior,Assessment of Family Behavior Related to Caretaking/parenting,0
693,Caretaking/parenting:behavior,Assessment of Patient Behavior Related to Caretaking/parenting,0
694,Caretaking/parenting:knowledge,Assessment of Family Knowledge Related to Caretaking/parenting,0
695,Caretaking/parenting:knowledge,Assessment of Patient Knowledge Related to Caretaking/parenting,0
696,Caretaking/parenting:status,Assessment of Family Status Related to Caretaking/parenting,0
697,Caretaking/parenting:status,Assessment of Patient Status Related to Caretaking/parenting,0
698,CD4 Positive T Lymphocytes,Whole Blood Absolute Cd4 Lymphocyte Counts,0
699,CD4 Positive T Lymphocytes,Whole Blood Cd4 Lymphocyte Counts,0
700,CD4 Positive T Lymphocytes,Whole Blood Percent Cd4 Lymphocyte Counts,0
701,CD8-Positive T-Lymphocytes,Whole Blood Absolute Cd8 Lymphocyte Counts,0
702,CD8-Positive T-Lymphocytes,Whole Blood Cd8 Lymphocyte Counts,0
703,CD8-Positive T-Lymphocytes,Whole Blood Percent Cd8 Lymphocyte Counts,0
704,American trypanosomiasis antibody,Chagas Disease Antibodies Test,0
705,alpha-Fetoproteins,Intravascular Alpha Fetoprotein Test,0
706,alpha-Fetoproteins,Maternal Alpha Fetoprotein Test,0
707,alpha-Fetoproteins,Body Fluid Alpha Fetoproteins Test,0
708,alpha-Fetoproteins,"Alpha Fetoprotein Test, Not Specified as Maternal",0
709,alpha-Fetoproteins,Alpha Fetoproteins Serum Chemistry Test,0
710,Chlamydia DNA,Chlamydia DNA Probe Test,0
711,Chlamydia trachomatis antibody,Measurement of Chlamydia trachomatis antibody,0
712,Chronic low self-esteem,Assessment of Patient Status Related to Chronic Low Self-esteem Disturbance,0
713,Circulating anticoagulants,Circulating anticoagulants measurement,0
714,Circulation:behavior,Assessment of Family Behavior Related to Circulation,0
715,Circulation:behavior,Assessment of Patient Behavior Related to Circulation,0
716,Circulation:knowledge,Assessment of Family Knowledge Related to Circulation,0
717,Circulation:knowledge,Assessment of Patient Knowledge Related to Circulation,0
718,Circulation status,Assessment of Family Status Related to Circulation,0
719,Circulation status,Assessment of Patient Status Related to Circulation,0
720,Cognition:behavior,Assessment of Family Behavior Related to Cognition,0
721,Cognition:behavior,Assessment of Patient Behavior Related to Cognition,0
722,Cognition:knowledge,Assessment of Family Knowledge Related to Cognition,0
723,Cognition:knowledge,Assessment of Patient Knowledge Related to Cognition,0
724,Cognition:status,Assessment of Family Status Related to Cognition,0
725,Cognition:status,Assessment of Patient Status Related to Cognition,0
726,alpha 2-Glucoproteins,Intravascular Alpha-2 Macroglobulin Test,0
727,cold agglutinins,Cold Agglutinating Antibody Test,0
728,Collagen-Induced Patelet Aggregation,Platelet aggregation with collagen test,0
729,Communication with Community Resources:behavior,Assessment of Family Behavior Related to Communication with Community Resources,0
730,Communication with Community Resources:behavior,Assessment of Patient Behavior Related to Communication with Community Resources,0
731,Communication with Community Resources:status,Assessment of Family Status Related to Communication with Community Resources,0
732,Communication with Community Resources:status,Assessment of Patient Status Related to Communication with Community Resources,0
733,alpha-aminobutyric acid,Intravascular Alpha-Amino-N-Butyric Acid Test,0
734,alpha-aminobutyric acid,Plasma Alpha-Amino-N-Butyric Acid Test,0
735,alpha-aminobutyric acid,Urine Alpha-Amino-N-Butyric Acid Test,0
736,alpha-aminobutyric acid,Alpha-Amino-N-Butyric Acid Test,0
737,Conglutinin Immune Complex,Intravascular Conglutinin Immune Complex Test,0
738,Consciousness:behavior,Assessment of Family Behavior Related to Consciousness,0
739,Consciousness:behavior,Assessment of Patient Behavior Related to Consciousness,0
740,Consciousness:knowledge,Assessment of Family Knowledge Related to Consciousness,0
741,Consciousness:knowledge,Assessment of Patient Knowledge Related to Consciousness,0
742,Consciousness:status,Assessment of Family Status Related to Consciousness,0
743,Consciousness:status,Assessment of Patient Status Related to Consciousness,0
744,2-Aminoadipic Acid,Intravascular Alpha-Aminodipic Test,0
745,2-Aminoadipic Acid,Plasma Alpha-Aminodipic Test,0
746,2-Aminoadipic Acid,Urine Alpha-Aminodipic Test,0
747,2-Aminoadipic Acid,Alpha-Aminoadipic Acid Test,0
748,Creatine kinase isoenzyme,Intravascular CK Isoenzyme Test,0
749,Creatine kinase isoenzyme,Serum Creatine Kinase Isoenzyme Test,0
750,cryptococcal polysaccharide,Serum Cryptococcal Polysaccharide Test,0
751,cryptococcal polysaccharide,CSF Cryptococcal Polysaccharide Test,0
752,lactate dehydrogenase 1,Serum Lactate Dehydrogenase Isoenzyme 1 Test,0
753,Legionella pneumophila antigen,Urine Legionella Antigen Test,0
754,Cytomegalovirus IgG Antibody,Intravascular Cytomegalovirus IgG Antibody Test,0
755,Cytomegalovirus IgG Antibody,Blood Cytomegalovirus IgG Test,0
756,Cytomegalovirus IgG Antibody,CSF Cmv-IgG Test,0
757,Family Planning:knowledge,Assessment of Family Knowledge Related to Family Planning,0
758,Family Planning:knowledge,Assessment of Patient Knowledge Related to Family Planning,0
759,Genito-urinary Function:behavior,Assessment of Family Behavior Related to Genito-urinary Function,0
760,Genito-urinary Function:behavior,Assessment of Patient Behavior Related to Genito-urinary Function,0
761,"Alkaline phosphatase isoenzyme, liver fraction",Serum Liver Alkaline Phosphatase Test,0
762,Communication with Community Resources:knowledge,Assessment of Family Knowledge Related to Communication with Community Resources,0
763,Communication with Community Resources:knowledge,Assessment of Patient Knowledge Related to Communication with Community Resources,0
764,Cell Migration Inhibition function,Cell Migration Inhibition measurement,0
765,vascular endothelial growth factor activity,Vascular Endothelial Growth Factor Measurement,0
766,L-alanine:2-oxoglutarate aminotransferase activity,Alanine aminotransferase measurement,0
767,Blood flow,Radiolabelled antifibrin study,0
768,Blood flow,Pulmonary ventilation-perfusion study by radioactive krypton,0
769,Lewis blood group system antigens,Blood group antigen A>1< Le^b^,0
770,Blood flow,Radionuclide limb blood flow assessment,0
771,Iron,Total iron binding capacity function,0
772,Blood flow,Radiolabelled antiplatelet study,0
773,Blood flow,Isotope phlebography,0
774,Antigen in Kidd (JK) blood group system,Kidd antigen type,0
775,Hemoglobin,Hemoglobinuria,0
776,Blood flow,Radiolabelled HMPAO cerebral blood flow study,0
777,Lewis blood group system antigens,Blood group antigen Le^ab^,0
778,Blood flow,Xenon flow scan of cardiovascular system,0
779,Blood flow,"Pulmonary perfusion imaging, gaseous, with ventilation, rebreathing and washout",0
780,Blood flow,Kidney imaging with vascular flow and function study,0
781,Blood flow,Liver imaging with vascular flow,0
782,Blood flow,Radionuclide venous blood pool study,0
783,Blood flow,Brain imaging with vascular flow,0
784,Blood Platelets,Platelet aggregation,0
785,Blood flow,Liver and spleen imaging with vascular flow,0
786,Blood flow,Radionuclide soft tissue blood pool study - early and delayed,0
787,Blood flow,Kidney imaging with vascular flow,0
788,Lewis blood group system antigens,Blood group antigen Le^bH^,0
789,Blood flow,Radionuclide arteriogram,0
790,Blood flow,Radionuclide venogram,0
791,Reducing substances,Urine reducing substances NOS (finding),0
792,Blood flow,Lung perfusion study with Tc99m-albumin,0
793,Erythrocytes,Erythrocyte sedimentation rate measurement,0
794,Blood flow,Radionuclide thrombus-specific peptide study,0
795,Lewis blood group system antigens,Blood group antigen Le^b^,0
796,Blood flow,"Pulmonary perfusion imaging, gaseous",0
797,Blood flow,Spleen imaging with vascular flow,0
798,Blood flow,Lung perfusion study with Krypton 81m,0
799,Corneal curvature radius,Keratometry,0
800,Blood Platelets,Collagen induced platelet aggregation,0
801,Blood flow,Peritoneal venous shunt patency test for Leveen shunt,0
802,Blood flow,"Radionuclide venogram, unilateral",0
803,Reducing substances,Finding of presence of urinary reducing substances,0
804,Blood Platelets,Serotonin induced platelet aggregation,0
805,Blood flow,Pulmonary ventilation-perfusion study by radioactive oxygen,0
806,Blood flow,Pulmonary perfusion study,0
807,Lewis blood group system antigens,Blood group antigen Le^a^,0
808,Corneal curvature meridian,Keratometry,0
809,Blood Platelets,Calcium ionophore induced platelet aggregation,0
810,Lewis blood group system antigens,Lewis blood group system antigens,0
811,Cold reacting blood group autoantibody,Cold agglutinin titer,0
812,Blood flow,"Radionuclide venogram, unilateral",0
813,Blood Platelets,"Platelet adhesion, function",0
814,Blood Platelets,Arachidonic acid induced platelet aggregation,0
815,Antigen in Kell (KEL) blood group system,Kell antigen type,0
816,Blood Platelets,Induced platelet aggregation,0
817,Blood flow,Pulmonary ventilation perfusion study,0
818,Blood flow,Isotope brain angiography,0
819,Blood flow,Radiolabelled Tc99m HSA cerebral blood flow study,0
820,Blood flow,Testicular imaging with vascular flow,0
821,Blood flow,Cerebral blood flow radionuclide study,0
822,Reducing substances,Urine: no reducing substances,0
823,Blood Platelets,Platelet mean volume determination (procedure),0
824,Blood flow,Scanning or imaging with vascular flow,0
825,Lewis blood group system antigens,Blood group antigen BLe^b^,0
826,Erythrocytes,Erythrocyte sediment rate NOS,0
827,Erythrocytes,"Blood coagulation panel, DIC",0
828,Blood flow,Thyroid imaging with vascular flow,0
829,Blood Platelets,Ristocetin induced platelet aggregation,0
830,Blood flow,Pulmonary ventilation-perfusion study by radioactive nitrogen,0
831,Antigen in Duffy (FY) blood group system,Duffy antigen type,0
832,Blood Platelets,ADP induced platelet aggregation,0
833,Blood flow,Pulmonary ventilation-perfusion study by radioactive carbon,0
834,Blood flow,Radionuclide thrombus localization study,0
835,Blood flow,Radionuclide venous first pass study,0
836,Blood Platelets,Epinephrine induced platelet aggregation,0
837,Blood flow,Radionuclide imaging of radioisotope labeled platelets,0
838,Blood flow,Denver shunt patency test,0
839,Blood flow,Cardiac flow imaging,0
840,Blood Platelets,Prostaglandin induced platelet aggregation,0
841,Blood Platelets,Norepinephrine induced platelet aggregation,0
842,Blood Platelets,Thrombin induced platelet aggregation,0
843,Blood flow,"Pulmonary perfusion imaging, particulate",0
844,Blood flow,Pulmonary ventilation-perfusion study by radioactive xenon,0
845,Acetaminophen,Acetaminophen:SCnc:Pt:Ser/Plas:Qn,0
846,Amitriptyline+Nortriptyline,Amitriptyline+Nortriptyline:PrThr:Pt:Ser/Plas:Ord,0
847,Virus identified,Virus identified:Prid:Pt:Stool:Nom:Microscopy.electron,0
848,Diameter.hilum-cortex,Diameter.hilum-cortex:Len:Pt:Kidney.left:Qn:US.measured,0
849,Neutrophils.band form/100 leukocytes,Neutrophils.band form/100 leukocytes:NFr:Pt:CSF:Qn:Manual count,0
850,2-Hydroxyisovalerate/Creatinine,2-Hydroxyisovalerate/Creatinine:MRto:Pt:Urine:Qn,0
851,Beta aminoisobutyrate/Creatinine,Beta aminoisobutyrate/Creatinine:MRto:Pt:Urine:Qn,0
852,Glucose,Glucose^1H post 100 g glucose PO:MCnc:Pt:Ser/Plas:Qn,0
853,Cholesterol.in HDL,Cholesterol.in HDL:SCnc:Pt:Ser/Plas:Qn,0
854,Color,Color:Type:Pt:Pericard fld:Nom,0
855,Fagus grandifolia Ab.IgE.RAST class,Fagus grandifolia Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
856,Bellis perennis Ab.IgE.RAST class,Bellis perennis Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
857,Cefsulodin,Cefsulodin:Susc:Pt:Isolate:Qn:MLC,0
858,U Ab,U Ab:PrThr:Pt:Ser/Plas^Donor:Ord,0
859,Celtis occidentalis Ab.IgE.RAST class,Celtis occidentalis Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
860,Beta-hemolytic streptococcus,Streptococcus.beta-hemolytic:PrThr:Pt:Genital:Ord:Organism specific culture,0
861,urine sediment comments,Urine sediment comments:Find:Pt:Urine sed:Nar:Microscopy.light,0
862,Femur length/Abdominal circumference,Femur length/Abdominal circumference:LenRto:Pt:^Fetus:Qn:US.derived,0
863,ceforanide,Ceforanide:Susc:Pt:Isolate:OrdQn:MIC,0
864,Silicon,Silicon:MCnc:Pt:Ser/Plas:Qn,0
865,Blood group antigen Js^a^,J little s super little a Ag:PrThr:Pt:RBC:Ord,0
866,ED procedure result type,ED procedure result type:Type:Point in time:^Patient:Nominal,0
867,Date of last menstrual period,Deprecated Last menstrual period,0
868,Oxalates,Oxalate^8th specimen post XXX challenge:MCnc:Pt:Urine:Qn,0
869,Coxsackievirus A10 Ab,Deprecated Coxsackievirus A10 Ab [Units/volume] in Serum,0
870,Serine/Creatinine,Serine/Creatinine:MRto:Pt:Urine:Qn,0
871,Amphetamines,Amphetamines:PrThr:Pt:Urine:Ord:Screen>1000 ng/mL,0
872,dronabinol,THC Ur Cfm-mCnc,0
873,Quercus virginiana Ab.IgE.RAST class,Deprecated Virginia Live Oak IgE Ab RAST class in Serum,0
874,Outpatient visits,History of outpatient visits:Finding:Point in time:^Patient:Nominal:Reported,0
875,Symptoms & diseases,History of symptoms & diseases:Finding:Point in time:Allergic & Immunologic:Narrative:Reported,0
876,Blasts.CD5/100 blasts,Blasts.CD5/100 blasts:NFr:Pt:Bld:Qn,0
877,S' wave amplitude.lead V3,S' wave amplitude.lead V3:Elpot:Pt:Heart:Qn:EKG,0
878,Physical findings,Physical findings:Finding:Point in time:Calf:Narrative:Observed,0
879,Mesothelial cells/100 leukocytes,Mesothelial cells/100 leukocytes:NFr:Pt:Plr fld:Qn:Manual count,0
880,Rhizopus nigricans Ab.IgE.RAST class,Rhizopus nigricans Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
881,Erythrocytes.dual population,Erythrocytes.dual population:PrThr:Pt:Bld:Ord:Microscopy.light,0
882,Leptocyte,Target cells:PrThr:Pt:Bld:Ord:Microscopy.light,0
883,Physical findings,Physical findings:Finding:Point in time:Calf:Nominal:Observed,0
884,"Pulsatility index, arterial velocity waveform",Pulsatility index:VelRto:Pt:^Patient:Qn:US.doppler,0
885,Study observation,Study observation:Finding:Point in time:Aortic arch^Fetus:Narrative:ULTRASOUND,0
886,Norepinephrine,Norepinephrine^6th specimen post XXX challenge:MCnc:Pt:Plas:Qn,0
887,microscopic observation,Microscopic observation:Prid:Pt:Eye:Nom:Gram stain,0
888,Mononuclear cells/100 leukocytes,Mononuclear cells/100 leukocytes:NFr:Pt:Periton fld:Qn:Manual count,0
889,Physical findings,Physical findings:Finding:Point in time:Extremities:Narrative:Observed,0
890,Botulinum Toxins,Clostridium botulinum toxin:ACnc:Pt:Stool:Qn,0
891,"Hydrocarbons, Halogenated",Hydrocarbons.halogenated:Prid:Pt:Urine:Nom,0
892,Epithelial Cells,Epithelial cells:PrThr:Pt:Semen:Ord:Microscopy.light,0
893,Borrelia burgdorferi 25kD Ab,Borrelia burgdorferi 25kD Ab:PrThr:Pt:Body fld:Ord:IB,0
894,Iron/Transferrin,Iron/Transferrin:MRto:Pt:Ser/Plas:Qn,0
895,Carbonyldiamide,Urea nitrogen:MCnc:Pt:Gast fld:Qn,0
896,Calcium,Calcium:SCnc:Pt:Synv fld:Qn,0
897,Cryptococcus species antibody,Cryptococcus sp Ab:Titr:Pt:Ser:Qn,0
898,Proerythroblasts,Pronormoblasts:NCnc:Pt:Bld:Qn,0
899,Glucose,Glucose^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
900,Sodium,Sodium:SCnc:Pt:RBC:Qn,0
901,Valproate,Valproate:SCnc:Pt:Ser/Plas:Qn,0
902,Estradiol.free/Estradiol.total,Estradiol.free/Estradiol.total:MFr:Pt:Ser/Plas:Qn,0
903,Geotrichum candidum Ab.IgE.RAST class,Geotrichum candidum Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
904,(Hordeum vulgare+Oryza sativa+Secale cereale+Triticum aestivum) Ab.IgE,(Hordeum vulgare+Oryza sativa+Secale cereale+Triticum aestivum) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk,0
905,(Cynodon dactylon+Lolium perenne+Bromus inermis+Ambrosia elatior+Artemisia vulgaris+Plantago lanceolata) Ab.IgE,(Cynodon dactylon+Lolium perenne+Bromus inermis+Ambrosia elatior+Artemisia vulgaris+Plantago lanceolata) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk,0
906,PHOSPHOFRUCTOKINASE,Phosphofructokinase:CCnc:Pt:RBC:Qn,0
907,Blood group antigen P2,Deprecated P2 Ag [Presence] on Red Blood Cells from Donor,0
908,Propylene glycol,Propylene glycol:PrThr:Pt:Ser/Plas:Ord,0
909,ST slope.lead AVF,ST slope.lead AVF:ElpotRat:Pt:Heart:Qn:EKG,0
910,Progress note.total,Deprecated Progress note.total:Finding:Point in time:^Patient:Narrative,0
911,cyclohexanone,Cyclohexanone:MCnc:Pt:Bld:Qn,0
912,Iron.microscopic observation,Iron.microscopic observation:Prid:Pt:Bone mar:Nom:Potassium ferrocyanide stain,0
913,Aldosterone,Aldosterone:SCnc:Pt:Urine:Qn,0
914,Amylase.S1/Amylase.total,Amylase.S1/Amylase.total:CFr:Pt:Ser/Plas:Qn,0
915,Isopropyl Alcohol,Isopropanol:PrThr:Pt:Meconium:Ord,0
916,Thickness.diastolic,Thickness.diastolic:Len:Pt:Heart.ventricle.posterior wall.left^Fetus:Qn:US.measured.real time two dimension,0
917,Ciprofloxacin,Deprecated Ciprofloxacin [Mass/volume] in Serum or Plasma --trough,0
918,Follicle Stimulating Hormone,Follitropin:ARat:24H:Urine:Qn,0
919,BLV Antibodies,Bovine leukemia virus Ab:PrThr:Pt:Ser:Ord:IA,0
920,Neutrophils.band form/100 cells,Neutrophils.band form/100 cells:NFr:Pt:Bone mar:Qn:Manual count,0
921,Creatinine,Creatinine^12H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn,0
922,Fungus identified,Fungus identified:Prid:Pt:XXX:Nom:Environmental culture,0
923,jka antibody,J little k super little a Ab:PrThr:Pt:Ser/Plas^BPU:Ord,0
924,Chinchilla Ab.IgE,Chinchilla Ab.IgE:ACnc:Pt:Ser:Qn,0
925,M little g Ab,M little g Ab:PrThr:Pt:Ser/Plas^Donor:Ord,0
926,Epithelial Cells,Epithelial cells:PrThr:Pt:Vag:Ord:Wet preparation,0
927,Sulfatide Ab.IgM,Deprecated Sulfatide Antibody.immunoglobulin M:Arbitrary Concentration:Point in time:Serum/Plasma:Quantitative or Ordinal,0
928,Hepatitis B virus DNA,Deprecated Hepatitis B virus DNA [Presence] in Blood by Immunoblot (IB),0
929,Growth Hormone,Somatotropin^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
930,Acacia longifolia Ab.IgE.RAST class,Acacia longifolia Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
931,Glucose,Glucose^pre 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,0
932,Castanea sativa Ab.IgE.RAST class,Castanea sativa Antibody.immunoglobulin E.RAST class:Arbitrary Concentration:Point in time:Serum:Ordinal,0
933,Insulin,Insulin^post 12H CFst:MCnc:Pt:Ser/Plas:Qn,0
934,Cefoperazone,Cefoperazone:Titr:Pt:Isolate+Ser:Qn:SBT,0
935,Antiribosomal antibody,Ribosomal Ab:Titr:Pt:Ser:Qn,0
936,ethylene glycol,Deprecated Ethylene glycol,0
937,8-hydroxyamoxapine,8-Hydroxyamoxapine:SCnc:Pt:Ser/Plas:Qn,0
938,Streptococcus pneumoniae Danish serotype 14 Ab,Deprecated Streptococcus pneumoniae 14 Ab [Units/volume] in Serum by Immunoassay --1st specimen,0
939,Carboxy tetrahydrocannabinol cutoff,Carboxy tetrahydrocannabinol cutoff:MCnc:Pt:Urine:Qn:Screen,0
940,Chlorpheniramine cutoff,Chlorpheniramine cutoff:MCnc:Pt:Urine:Qn:Confirm,0
941,Carbon Dioxide,Carbon dioxide^post bronchodilation:PPres:Pt:BldC:Qn:Transcutaneous CO2 monitor,0
942,CATALASE,Catalase:CCnc:Pt:RBC:Qn,0
943,Glutamine,Glutamine:SCnc:Pt:CSF:Qn,0
944,TCRD gene rearrangements,TCRD gene rearrangements:Arb:Pt:Bld/Tiss:Ord:Molgen,0
945,Epstein Barr virus capsid IgA,Epstein Barr virus capsid Ab.IgA:Titr:Pt:Ser:Qn,0
946,Infectious bronchitis virus Ab,Infectious bronchitis virus Ab:Titr:Pt:Ser:Qn:Neut,0
947,Theileria mutans Ab,Theileria mutans Ab:Titr:Pt:Ser:Qn:IF,0
948,Legionella pneumophila 1 IgM,Legionella pneumophila 1 Ab.IgM:ACnc:Pt:Ser:Qn,0
949,Tetrahydrocannabinol cutoff,Tetrahydrocannabinol cutoff:Mass Concentration:Point in time:Urine:Quantitative:Screen,0
950,Cell positive for CD3 antigen,Cells.CD3:NCnc:Pt:XXX:Qn,0
951,Avian infectious laryngotracheitis virus Ag,Avian infectious laryngotracheitis virus Ag:PrThr:Pt:Trac:Ord:Immune diffusion,0
952,Leishmania sp identified,Leishmania sp identified:Prid:Pt:Tiss:Nom:IF,0
953,Lithium,Lithium:MCnc:Pt:Body fld:Qn,0
954,Toxaphene,Toxaphene:MCnc:Pt:Ser/Plas:Qn,0
955,Oxygen,Oxygen^post bronchodilation:PPres:Pt:BldC:Qn:Transcutaneous O2 monitor,0
956,Cell positive for CD4 antigen,Deprecated CD4 cells [#/volume] in Unspecified specimen,0
957,Lymphocytes.IgM/100 lymphocytes,Lymphocytes.IgM/100 lymphocytes:NFr:Pt:XXX:Qn,0
958,1-methylhistidine,1-Methylhistidine:SCnc:Pt:Ser/Plas:Qn,0
959,Asparagine,Asparagine:SCnc:Pt:Ser/Plas:Qn,0
960,Cystine+Cysteine,Cystine+Cysteine:MCnc:Pt:Ser/Plas:Qn,0
961,Leptospira interrogans serovar Grippotyphosa antibody,Leptospira interrogans serovar Grippotyphosa Ab:PrThr:Pt:Ser:Ord:Aggl,0
962,Sulfonylurea Compounds,Sulfonylurea:MCnc:Pt:Urine:Qn,0
963,Alpha 1 antitrypsin fecal clearance,Alpha 1 antitrypsin fecal clearance:VRat:24H:Ser/Plas+Stool:Qn,0
964,Cephradine,Cephradine:Susc:Pt:Isolate:OrdQn,0
965,CA-125 Antigen,Cancer Ag 125:PrThr:Pt:Ser/Plas:Ord,0
966,Census tract certainty 1970&80&90,Census tract certainty 1970&80&90:Type:Point in time:Census tract:Nominal:*,0
967,Lumpy skin disease virus Ab,Lumpy skin disease virus Ab:PrThr:Pt:Ser:Ord,0
968,Views 2,Views 2:Finding:Point in time:Hand:Narrative:XR,0
969,Dihydrocodeine.free,Dihydrocodeine.free:PrThr:Pt:Ser/Plas:Ord:Confirm,0
970,Echinococcus sp Ab.IgM,Echinococcus sp Ab.IgM:ACnc:Pt:Ser:Qn,0
971,Ethambutol,Ethambutol:Susc:Pt:Isolate:OrdQn,0
972,Hydroxyethylflurazepam cutoff,Hydroxyethylflurazepam cutoff:MCnc:Pt:Urine:Qn:Confirm,0
973,Pressure.inspiratory min setting,Pressure.inspiratory min setting:Pres:Pt:Ventilator.alarm:Qn,0
974,Spermatozoa.motile/100 spermatozoa,Spermatozoa.motile/100 spermatozoa^4H post ejaculation:NFr:Pt:Semen:Qn,0
975,CACNA1S gene.p.Arg1239Gly,CACNA1S gene.p.Arg1239Gly:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
976,Monosialoganglioside GM1 Ab.IgG+IgM,Deprecated Monosialoganglioside GM1 Ab.IgG+IgM,0
977,Magnesium,Magnesium:SCnt:Pt:Hair:Qn,0
978,Regan isoenzyme,Alkaline phosphatase.regan:CCnc:Pt:Ser/Plas:Qn,0
979,Streptococcus pneumoniae 18c Ab.IgG,Deprecated Streptococcus pneumoniae 56 IgG Ab [Units/volume] in Serum,0
980,Mesoridazine cutoff,Mesoridazine cutoff:MCnc:Pt:Urine:Qn:Confirm,0
981,Aspergillus niger antibody,Aspergillus niger Ab:PrThr:Pt:CSF:Ord:Immune diffusion,0
982,Stager.clinical,Stager.clinical:Type:Pt:Cancer.XXX:Nom,0
983,Acetazolamide,Acetazolamide:ACnc:Pt:Ser/Plas:Qn,0
984,Long acting metabolite of methadone,Methadone.long acting metabolite:MCnc:Pt:Ser/Plas:Qn,0
985,2-methylpentane,2-Methylpentane:MCnc:Pt:Bld:Qn,0
986,Methylenedioxymethamphetamine cutoff,Methylenedioxymethamphetamine cutoff:MCnc:Pt:Urine:Qn:Screen,0
987,Crossection,Crossection:Area:Pt:Aorta.root:Qn:US.calculated,0
988,Intravascular peak systolic.XXX,Intravascular peak systolic.XXX:Pres:Pt:Circulatory system.XXX:Qn:US,0
989,Bromides,Bromide:MCnc:Pt:Ocular fld:Qn,0
990,Measles virus IgM,Measles virus Ab.IgM:Titr:Pt:CSF:Qn:IF,0
991,SCL-70 extractable nuclear Ab.IgG,SCL-70 extractable nuclear Ab.IgG:PrThr:Pt:Ser:Ord,0
992,Sesamum indicum Ab.IgG.RAST class,Sesamum indicum Ab.IgG.RAST class:PrThr:Pt:Ser:Ord,0
993,Source of protocol in which patient enrolled,Source of protocol in which patient enrolled:Type:Pt:Cancer.XXX:Nom,0
994,Date last contact,Date last contact:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative,0
995,Vesicular stomatitis virus serotype,Vesicular stomatitis virus serotype:Prid:Pt:Tiss:Nom:IA,0
996,Alfentanil,Alfentanil:MCnc:Pt:Urine:Qn,0
997,Tellurium,Tellurium:PrThr:Pt:Urine:Ord,0
998,HLA-A24 Antigen,HLA-A24(9):PrThr:Pt:Bld/Tiss:Ord,0
999,Length,Length:Len:Pt:Region of interest.XXX:Qn:US,0
1000,Androstenedione,Androstenedione^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
1001,Rifabutin,Deprecated Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC),0
1002,Francisella tularensis IgA,Francisella tularensis Ab.IgA:PrThr:Pt:Ser:Ord:LA,0
1003,Pyridoxic Acid,4-Pyridoxate:MCnc:Pt:Ser/Plas:Qn,0
1004,Gas flow,Gas flow:VRat:Pt:Respiratory system.airway:Qn,0
1005,Pressure.support setting,Pressure.support setting:Pres:Pt:Ventilator:Qn,0
1006,Systole.mean/Systole 2.mean,Systole.mean/Systole 2.mean:VelRto:Pt:Circulatory system.XXX:Qn:US.doppler.calculated,0
1007,Streptococcus pneumoniae IgG,Streptococcus pneumoniae Ab.IgG^1st specimen/2nd specimen:Ratio:Pt:Ser:Qn,0
1008,Immunoglobulin M antibody to Toxoplasma gondii,Toxoplasma gondii Ab.IgM:Titr:Pt:Ser:Qn,0
1009,dalfopristin / quinupristin,Quinupristin+Dalfopristin:Susc:Pt:Isolate:OrdQn:MIC,0
1010,Deceleration 2,Deceleration 2:Vel:Pt:Circulatory system.XXX:Qn:US,0
1011,3-Hydroxybutyrylcarnitine (C4-OH),3-Hydroxybutyrylcarnitine (C4-OH):MCnc:Pt:Ser/Plas:Qn,0
1012,Oxazepam,Oxazepam:PrThr:Pt:Urine:Ord:Screen,0
1013,Magnesium,Magnesium:MCnc:Pt:Bld:Qn,0
1014,Rickettsia conorii IgM,Rickettsia conorii Ab.IgM:Titr:Pt:Ser:Qn,0
1015,CDH1 gene mutations tested for,CDH1 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen,0
1016,Avian reovirus Ab,Avian reovirus Ab:PrThr:Pt:Ser:Ord,0
1017,Rabies virus DNA,Deprecated Rabies virus deoxyribonucleic acid:Arbitrary Concentration:Point in time:To be specified in another part of the message:Ordinal:DNA NUCLEIC ACID PROBE.amp.tar,0
1018,Nairobi sheep disease virus Antigen,Nairobi sheep disease virus Ag:PrThr:Pt:XXX:Ord:IA,0
1019,Paratuberculosis reaction wheal,Paratuberculosis reaction wheal^3D post 0.1 mL johnin ID:Diam:Pt:Skin:Qn,0
1020,Aflatoxins,Aflatoxin:MCnt:Pt:Feed:Qn,0
1021,Benzoylecgonine,Benzoylecgonine:PrThr:Pt:Ser/Plas:Ord:Confirm,0
1022,Bicarbonates,Bicarbonate:SCnc:Pt:Amnio fld:Qn,0
1023,Psilocybin cutoff,Psilocybin cutoff:MCnc:Pt:Urine:Qn:Confirm,0
1024,Temazepam,Temazepam:PrThr:Pt:Urine:Ord:Screen,0
1025,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.right:Qn:US.2D.pulmonic valve flow area.calculated,0
1026,RR interval,RR interval^at tricuspid flow measurement:Time:Pt:Heart:Qn:US,0
1027,Deceleration slope,Deceleration slope:Vel:Pt:Tricuspid valve:Qn:US,0
1028,Encephalitozoon cuniculi Ab,Encephalitozoon cuniculi Ab:PrThr:Pt:Ser:Ord,0
1029,Borrelia burgdorferi antibody,Borrelia burgdorferi Ab:PrThr:Pt:CSF:Ord,0
1030,Lead,Lead:MCnt:Pt:XXX:Qn,0
1031,hexachloroethane,Hexachloroethane:MCnc:Pt:Bld:Qn,0
1032,Pheniramine,Pheniramine:MCnc:Pt:Urine:Qn,0
1033,Diameter (qualifier value),Diameter:Len:Pt:Mitral valve.annulus:Qn:US,0
1034,Lactose,Lactose^3H post 50 g lactose PO:MCnc:Pt:Ser/Plas:Qn,0
1035,Aspergillus fumigatus Ab.IgG,Aspergillus fumigatus Ab.IgG:PrThr:Pt:Ser:Ord,0
1036,Velocity-time integral.XXX,Velocity-time integral.XXX:Length:Point in time:Circulatory system.To be specified in another part of the message:Quantitative:ULTRASOUND.doppler,0
1037,Escherichia coli K99,Escherichia coli K99:PrThr:Pt:Isolate:Ord:Aggl,0
1038,Leptospira interrogans serovar Canicola antibody,Leptospira interrogans serovar Canicola Ab:Titr:Pt:Ser:Qn,0
1039,Erythromycin,Erythromycin:Susc:Pt:Isolate:OrdQn:MIC,0
1040,Diameter.anterior-posterior.systole/Diameter.aorta root,Diameter.anterior-posterior.systole/Diameter.aorta root:LenRto:Pt:Heart:Qn:US,0
1041,Ejection time,Ejection time:Time:Pt:Aortic valve:Qn:US.doppler,0
1042,Cytologist,Cytologist:ID:Pt:Cvx/Vag:Nom:Cyto stain,0
1043,Carnitine.free (C0),Carnitine.free (C0):MCnc:Pt:Ser/Plas:Qn,0
1044,Bovine herpesvirus 4 Antigen,Bovine herpesvirus 4 Ag:PrThr:Pt:Tiss:Ord:IF,0
1045,Influenza A virus antibody,Influenza virus A Ab:PrThr:Pt:Ser:Ord:HAI,0
1046,Estradiol.unconjugated,Estradiol.unconjugated:MRat:24H:Urine:Qn,0
1047,Proline/Creatinine,Proline/Creatinine:SRto:Pt:Urine:Qn,0
1048,Gradient.systole.max,Gradient.systole.max:Pres:Pt:Tricuspid valve.regurgitant jet:Qn:US.doppler,0
1049,Minor axis.end systole,Minor axis.end systole:Len:Pt:Heart.ventricle.right:Qn:US.2D,0
1050,Western equine encephalomyelitis virus antibody,Western equine encephalitis virus Ab:PrThr:Pt:Ser:Ord:Comp fix,0
1051,Biotin,Biotin:MCnc:Pt:Ser/Plas:Qn,0
1052,Intermediate density lipoprotein cholesterol,Deprecated Cholesterol.in IDL [Mass/volume] in Serum or Plasma,0
1053,Chlamydophila pneumoniae IgG,Chlamydophila pneumoniae Ab.IgG:Titr:Pt:CSF:Qn,0
1054,Chlamydophila psittaci IgG,Chlamydophila psittaci Ab.IgG:Titr:Pt:Ser:Qn,0
1055,Equine herpesvirus 1+4 Ab,Equine herpesvirus 1+4 Ab:Titr:Pt:Ser:Qn:IA,0
1056,GQ1b IgG ganglioside antibody,Ganglioside GQ1b Ab.IgG:Titr:Pt:CSF:Qn:IA,0
1057,Segmental wall motion,Segmental wall motion:Find:Pt:Heart.ventricle.left.apical septum:Ord:US,0
1058,Diagnosis,Diagnosis:Imp:Stdy:Gastrointestinal tract.lower:Nom,0
1059,Toxoplasma gondii antibody,Toxoplasma gondii Ab:Imp:Pt:Ser:Nom,0
1060,Cells.CD33+CD44+/100 cells,Cells.CD33+CD44+/100 cells:NFr:Pt:Bld:Qn,0
1061,Very low density lipoprotein cholesterol,Cholesterol.in VLDL [Mass/volume] in Serum or Plasma,0
1062,Swine vesicular disease virus Ab,Swine vesicular disease virus Ab:PrThr:Pt:Ser:Ord:Neut,0
1063,Thickness.systole,Thickness.systole:Len:Pt:Heart.ventricle.right.anterior wall:Qn:US,0
1064,Cocaine,Deprecated Benzoylmethylecgonine [Mass/volume] in Urine,0
1065,Dextroamphetamine,Dextroamphetamine:MCnc:Pt:Urine:Qn:Confirm,0
1066,Alcelaphine herpesvirus 1 antibody,Alcelaphine herpesvirus 1 Ab:PrThr:Pt:Ser:Ord:IF,0
1067,Salmonella typhi H D Ab,Salmonella typhi H D Antibody:Arbitrary Concentration:Point in time:Serum:Ordinal:LATEX AGGLUTINATION,0
1068,Flucytosine,5-fluorocytosine:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:MINIMUM INHIBITORY CONCENTRATION,0
1069,Ornithine,Ornithine:SCnc:24H:Urine:Qn,0
1070,alpha-hydroxyalprazolam,Alpha hydroxyalprazolam:MCnt:Pt:Hair:Qn,0
1071,Disopyramide,Disopyramide:MCnc:Pt:Gast fld:Qn,0
1072,Red green balance.binocular,Red green balance.binocular:Type:Pt:Eye:Nom:Phoropter,0
1073,Insulin,Insulin^4H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,0
1074,Tryptophan,Tryptophan:PrThr:Pt:Ser/Plas:Ord,0
1075,Adenovirus antibody (substance),HAdV Ab Fld-aCnc,0
1076,Bladder tumor Ag,Bladder tumor Ag:PrThr:Pt:Urine:Ord,0
1077,Hepatitis B Virus Surface Antibody,Hepatitis B virus surface Ab:Titr:Pt:Ser:Qn,0
1078,Fasciola species antibody,Fasciola sp Ab:Titr:Pt:Ser:Qn:IF,0
1079,Trigonella foenum-graecum Ab.IgE.RAST class,Trigonella foenum-graecum Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
1080,Urea/Creatinine Ratio,Urea/Creatinine:SRto:24H:Urine:Qn,0
1081,Valine,Valine:SCnc:24H:Urine:Qn,0
1082,Prism base distance,Prism base distance:InvLen:Pt:LM glasses.lens.left:Qn,0
1083,Jamestown Canyon virus IgM,Jamestown canyon virus Ab.IgM:ACnc:Pt:Ser:Qn:IF,0
1084,Trivittatus virus Ab,Trivittatus virus Ab:Titr:Pt:XXX:Qn,0
1085,Mycoplasma haemofelis,Haemobartonella felis:PrThr:Pt:Bld:Ord:Microscopy.light,0
1086,Flurazepam,Flurazepam:MCnt:Pt:Meconium:Qn,0
1087,Hydrogen-Ion Concentration,pH:LsCnc:Pt:BldV:Qn,0
1088,"1,2,3-trichlorobenzene","1,2,3-Trichlorobenzene:MCnc:Pt:Ser/Plas:Qn",0
1089,Axis distance,Axis distance:Angle:Pt:Glasses prescription.lens.left:Qn,0
1090,Proteins,Protein:MCnc:Pt:Synv fld:Qn,0
1091,Views oblique,View oblique:Find:Pt:Abdomen>Spine.lumbar:Doc:XR,0
1092,View lateral frog,View lateral frog:Find:Pt:Lower extremity>Hip:Doc:XR,0
1093,Secobarbital,Secobarbital:MCnt:Pt:Meconium:Qn,0
1094,Cytomegalovirus DNA,Cytomegalovirus DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar,0
1095,Insulin,Insulin^2.3H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,0
1096,Multisection,Multisection^WO & W contrast IV:Find:Pt:Head>Maxillofacial region:Doc:CT,0
1097,Campylobacter jejuni antibody,Campylobacter jejuni Ab:ACnc:Pt:Ser:Qn,0
1098,size,Size:Arb:Pt:Ear.left:Ord:Estimated,0
1099,drugs identified,Drugs identified:Prid:Pt:Hair:Nom:Screen,0
1100,Cells.hyperdiploid/100 cells,Cells.hyperdiploid/100 cells:NFr:Pt:XXX:Qn:Flow cytometry,0
1101,View,VIEWS^W CONTRAST.XXX INTRAVENOUS:FINDING:POINT IN TIME:VEIN.ADRENAL.BILATERAL:NARRATIVE:XR.FLUOR.ANGIO,0
1102,Canine parvovirus Ab.IgG,Canine parvovirus Ab.IgG:ACnc:Pt:Ser:Qn,0
1103,Coxiella burnetii phase 2 IgA,Coxiella burnetii phase 2 Ab.IgA:ACnc:Pt:Ser:Qn,0
1104,Cells.CD2+CD7+/100 cells,Cells.CD2+CD7+/100 cells:NFr:Pt:Bld:Qn,0
1105,Magnesium,Magnesium:MRat:Pt:Stool:Qn,0
1106,Multisection,Multisection:Find:Pt:Chest>Aortic arch & Neck>Neck vessels:Doc:MR.angio,0
1107,Coxsackievirus B5 Ab,Coxsackievirus B5 Ab:ACnc:Pt:CSF:Qn,0
1108,Xylose,Xylose:MCnc:Pt:Bld:Qn,0
1109,Cryptococcus sp Ag,Cryptococcus sp Ag:PrThr:Pt:CSF:Ord,0
1110,Multisection,Multisection:Find:Pt:Abdomen>Retroperitoneum:Doc:CT,0
1111,Somatomedins,Insulin-like growth factor^10th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
1112,Framycetin,Framycetin:Susc:Pt:Isolate:Qn:MLC,0
1113,View,Views:Find:Pt:Upper extremity.bilateral>Finger:Doc:XR,0
1114,Reovirus antibody,Reovirus Ab:Titr:Pt:Body fld:Qn:Comp fix,0
1115,Copper/Creatinine,Copper/Creatinine:MRto:24H:Urine:Qn,0
1116,beta Globulin,Beta globulin:PrThr:24H:Urine:Ord,0
1117,lomefloxacin,Lomefloxacin:Susc:Pt:Isolate:OrdQn:MIC,0
1118,Multisection,Multisection^WO & W contrast IV:Find:Pt:Chest>Brachial plexus:Doc:MR,0
1119,Histoplasma species antibody,Deprecated Histoplasma capsulatum Ab [Presence] in Serum,0
1120,Comment,Comment:Imp:Pt:LM glasses.lens.right:Nom,0
1121,Pemphigus antibody,Intercellular substance Ab:ACnc:Pt:Ser:Qn,0
1122,Alpha-mannosidase,Alpha mannosidase:CCnt:Pt:Fibroblasts:Qn,0
1123,Multisection,Multisection^WO & W contrast IV:Find:Pt:Upper extremity>Elbow:Doc:MR,0
1124,Fosfomycin,Fosfomycin:Susc:Pt:Isolate:OrdQn:MIC,0
1125,Gastrin,Gastrin^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
1126,Views screening,Views screening:Find:Pt:Breast.right:Doc:MG,0
1127,phosphate ion,Phosphate:MCnc:Pt:Bld:Qn,0
1128,Pressure spot code,Pressure spot code:Find:Pt:Eye.left:Nom:Perimetry,0
1129,Platelet mean diameter,Platelet mean diameter:EntLen:Pt:Bld:Qn,0
1130,Phleum pratense recombinant (rPhl p) 7 Ab.IgE,Phleum pratense recombinant (rPhl p) 7 Ab.IgE:ACnc:Pt:Ser:Qn,0
1131,Trichophyton mentagrophytes var goetzii Ab.IgE,Trichophyton mentagrophytes var goetzii Ab.IgE:ACnc:Pt:Ser:Qn,0
1132,Rubella virus IgM,Rubella virus Ab.IgM:PrThr:Pt:Ser/Plas:Ord:IA,0
1133,Epstein Barr virus nuclear IgM,Epstein Barr virus nuclear Ab.IgM:Titr:Pt:Ser:Qn,0
1134,Threonine,Threonine:SCnc:Pt:Amnio fld:Qn,0
1135,dronabinol,Tetrahydrocannabinol:MCnc:Pt:Vitr fld:Qn,0
1136,Metamyelocytes/100 leukocytes,Metamyelocytes/100 leukocytes:Number Fraction:Point in time:Whole blood:Quantitative,0
1137,Saquinavir,Saquinavir:ACnc:Pt:Ser/Plas:Qn,0
1138,(Alnus incana+Corylus avellana+Ulmus americana+Salix caprea+Populus deltoides) Ab.IgE,Deprecated (Alnus incana+Corylus avellana+Ulmus americana+Salix caprea+Populus deltoides) Ab.IgE:ACnc:Pt:Ser:Ord:Multidisk,0
1139,Hydroxyproline/Creatinine,Hydroxyproline/Creatinine:SRto:Pt:Urine:Qn,0
1140,Rotavirus IgM,Rotavirus Ab.IgM:ACnc:Pt:Ser:Qn:IA,0
1141,Somatomedins,Insulin-like growth factor^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
1142,Somatomedins,Insulin-like growth factor^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
1143,Multisection,Multisection:Find:Pt:Lower extremity.right>Hip:Doc:US,0
1144,Multisection,Multisection:Find:Pt:XXX>Joint:Doc:MR,0
1145,Specimen volume,Specimen volume:Vol:Pt:Amnio fld:Qn,0
1146,Polio virus 3 Ab,Polio virus 3 Ab^2nd specimen:Titr:Pt:Ser:Qn:Neut,0
1147,Coxsackievirus B1 Ab,Coxsackievirus B1 Ab^1st specimen:Titr:Pt:Ser:Qn:Comp fix,0
1148,Coxsackievirus B5 Ab,Coxsackievirus B5 Ab^2nd specimen:Titr:Pt:Ser:Qn:Comp fix,0
1149,Clostridium perfringens IgM,Clostridium perfringens Ab.IgM:ACnc:Pt:Ser:Qn,0
1150,Ephedrine+Pseudoephedrine,Ephedrine+Pseudoephedrine:MCnt:Pt:Stool:Qn,0
1151,Flurazepam,Flurazepam:MCnt:Pt:Hair:Qn,0
1152,Ephedrine+Pseudoephedrine,Ephedrine+Pseudoephedrine:MCnc:Pt:Urine:Qn,0
1153,Brompheniramine,Brompheniramine:MCnc:Pt:Urine:Qn,0
1154,Amino beta guanidinopropionate/Creatinine,Deprecated Amino beta guanidinopropionate/Creatinine [Ratio] in Urine,0
1155,loracarbef,Loracarbef:Susc:Pt:Isolate:Qn:MLC,0
1156,Coxsackievirus B6 Ab,Coxsackievirus B6 Ab:ACnc:Pt:CSF:Qn,0
1157,Antiribosomal antibody,Ribosomal Ab:ACnc:Pt:Ser:Qn,0
1158,Rickettsia prowazekii IgM,Rickettsia prowazekii Ab.IgM:ACnc:Pt:Ser:Qn,0
1159,Note (document),Note:Finding:Point in time:{Setting}:Document:Psychiatry,0
1160,Lactate,Lactate:SCnc:Pt:Periton fld:Qn,0
1161,Ciprofloxacin,Ciprofloxacin:MCnc:Pt:XXX:Qn,0
1162,Cysteic Acid,Cysteate:SCnc:24H:Urine:Qn,0
1163,Beta aminoadipate/Creatinine,Beta aminoadipate/Creatinine:SRto:Pt:Urine:Qn,0
1164,Free T4 & TSH panel,Free T4 & TSH panel:-:Pt:Ser/Plas:Qn,0
1165,Alloisoleucine,Alloisoleucine:ACnc:Pt:Ser/Plas:Qn,0
1166,Add 1,Add 1:InvLen:Pt:Eye.right:Qn:Phoropter,0
1167,Cocaine,Cocaine:MCnc:Pt:Gast fld:Qn,0
1168,(Olea europaea+Salix caprea+Pinus strobus+Eucalyptus spp+Acacia longifolia+Melaleuca leucadendron) Ab.IgE,(Olea europaea+Salix caprea+Pinus strobus+Eucalyptus spp+Acacia longifolia+Melaleuca leucadendron) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk,0
1169,Cortisol.free/Creatinine,Cortisol.free/Creatinine:MRto:24H:Urine:Qn,0
1170,Intravascular peak systolic,Intravascular peak systolic^during MR max vel measurement:Pres:Pt:Arterial system.XXX:Qn,0
1171,Aspartate,Aspartate:SRat:24H:Urine:Qn,0
1172,Aspergillus versicolor Ab.IgE.RAST class,Aspergillus versicolor Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
1173,Neuronal nuclear type 3 Ab,Neuronal nuclear type 3 Ab:PrThr:Pt:Ser:Ord,0
1174,Guidance for change of dialysis catheter,Guidance for change of dialysis catheter^W contrast IV:Find:Pt:XXX:Doc:RF,0
1175,Coxiella burnetii phase 2 IgM,Coxiella burnetii phase 2 Ab.IgM:PrThr:Pt:Ser:Ord:IF,0
1176,Cells.CD55/100 cells,Cells.CD55/100 cells:NFr:Pt:Body fld:Qn,0
1177,Immature granulocyte,Granulocytes.immature:PrThr:Pt:Bld:Ord,0
1178,Ristocetin,Ristocetin:Susc:Pt:Isolate:Qn:MLC,0
1179,Complement 3,Complement C3:MCnc:Pt:Plr fld:Qn,0
1180,Lipoprotein (a),Lipoprotein (little a):SCnc:Pt:Ser/Plas:Qn,0
1181,Purine-Nucleoside Phosphorylase,Purine nucleoside phosphorylase:EntCat:Pt:WBC:Qn,0
1182,Morphine,Morphine:PrThr:Pt:Hair:Ord,0
1183,Salmonella gallinarum Ab,Salmonella gallinarum Ab:PrThr:Pt:Bld:Ord,0
1184,Pivampicillin,Pivampicillin:Susc:Pt:Isolate:OrdQn:MIC,0
1185,Thallium/Creatinine,Thallium/Creatinine:SRto:Pt:Urine:Qn,0
1186,SPL patient package insert section,SPL patient package insert section:-:-:^FDA package insert:Nar,0
1187,Flurazepam,Flurazepam:Mass:Pt:Dose:Qn,0
1188,Thrombomodulin factor B,Deprecated Properdin factor B:Mass Concentration:Point in time:Plasma:Quantitative,0
1189,HLA-B61(40),HLA-B61(40):PrThr:Pt:Bld/Tiss:Ord,0
1190,Tyrosine/Amino acids.total,Tyrosine/Amino acids.total:SFr:Pt:XXX:Qn,0
1191,Herpes virus 8 IgG,Herpes virus 8 Ab.IgG:PrThr:Pt:Ser:Ord,0
1192,lomefloxacin,Lomefloxacin:Susc:Pt:Isolate:OrdQn:Gradient strip,0
1193,oritavancin,Oritavancin:Susc:Pt:Isolate:OrdQn:Gradient strip,0
1194,View,Views^W gastrografin PR:Find:Pt:Abdomen+Pelvis>Colon:Doc:RF,0
1195,Acetylcholine receptor binding antibody,Acetylcholine receptor binding Ab:PrThr:Pt:Ser:Ord,0
1196,Bilirubin,Bilirubin:PrThr:24H:Urine:Ord:Test strip,0
1197,Blood pressure systolic & diastolic,Blood pressure systolic & diastolic^post phlebotomy:Pres:Pt:Arterial system:Qn,0
1198,Erythrocyte sedimentation rate measurement,Erythrocyte sedimentation rate:Vel:Pt:Bld:Qn:Westergren,0
1199,Propranolol,Propranolol:PrThr:Pt:Ser/Plas:Ord,0
1200,Sulbactam,Sulbactam:Susc:Pt:Isolate:OrdQn:MIC,0
1201,Dopamine/Creatinine,Dopamine/Creatinine:SRto:24H:Urine:Qn,0
1202,Erythrocyte sedimentation rate measurement,Erythrocyte sedimentation rate:Vel:Pt:Bld:Qn:Wintrobe,0
1203,Streptococcus pneumoniae Danish serotype 43 IgG,Deprecated Streptococcus pneumoniae 43 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen,0
1204,Tetracaine,Tetracaine:MCnc:Pt:Ser/Plas:Qn,0
1205,Multisection,Multisection^WO contrast:Find:Pt:Head>Head vessels:Doc:CT.angio,0
1206,Cells.CD20+CD23+/100 cells,Cells.CD20+CD23+/100 cells:NFr:Pt:Bld:Qn,0
1207,Uranium.depleted cutoff,Uranium.depleted cutoff:MCnc:Pt:Urine:Qn,0
1208,Reagins,Reagin Ab:Titr:Pt:CSF:Qn,0
1209,Creatinine,Creatinine^1H pre XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
1210,11-oxo-etiocholanolone,11-Oxo-Etiocholanolone:MRat:24H:Urine:Qn,0
1211,Pivampicillin,Pivampicillin:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
1212,Bacteria identified,Bacteria identified:Prid:Pt:Sinus:Nom:Culture,0
1213,Betamethasone,Betamethasone:MCnc:Pt:Urine:Qn,0
1214,TCR alpha beta Ag,TCR alpha beta Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
1215,Ehrlichia chaffeensis IgG,Ehrlichia chaffeensis Ab.IgG:Titr:Pt:Ser:Qn:IF,0
1216,Glucose,Glucose^8.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
1217,Protriptyline,Protriptyline^trough:MCnc:Pt:Ser/Plas:Qn,0
1218,Mezlocillin,Mezlocillin:Mass:Pt:Dose:Qn,0
1219,Multisection,Multisection^W Tc-99m glucoheptonate IV:Find:Pt:Abdomen>Kidney:Doc:NM.SPECT,0
1220,Trimethoprim,Trimethoprim:Mass:Pt:Dose:Qn,0
1221,Influenzavirus A antigen,Influenza virus A Ag:PrThr:Pt:Bronchial:Ord:IF,0
1222,Guidance for aspiration or injection of cyst,Guidance for aspiration or injection of cyst:Find:Pt:XXX:Doc:US,0
1223,Multisection,Multisection:Find:Pt:Upper extremity.right>Upper extremity artery:Doc:US,0
1224,Views post mortem,Views post mortem:Find:Pt:XXX:Doc:XR,0
1225,View scaphoid,View scaphoid:Find:Pt:Upper extremity.bilateral>Wrist:Doc:XR,0
1226,Cells.CD38+Kappa+/100 cells,Cells.CD38+Kappa+/100 cells:NFr:Pt:Bld:Qn,0
1227,PlA1 Ab,PlA1 Ab:PrThr:Pt:PRP:Ord,0
1228,Multisection limited,Multisection limited:Find:Pt:Extremity>Extremity artery:Doc:US,0
1229,Influenza B virus antibody,Influenza virus B Ab:PrThr:Pt:Ser:Ord:Comp fix,0
1230,CD8 Antigens,CD8 Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
1231,Oxygen saturation test result,Deprecated Oxygen saturation^pre exercise: SFr: Pt: BldA: Qn: Oximetry,0
1232,Views magnification,View magnification:Find:Pt:Neck:Doc:XR,0
1233,Cells.CD138/100 cells,Cells.CD138/100 cells:NFr:Pt:Tiss:Qn,0
1234,Blood product units requested,Blood product units requested:Num:Pt:^BPU:Qn,0
1235,Views 2,Views 2:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar:Doc:XR,0
1236,Streptococcus pneumoniae 20 Ab.IgG,Deprecated Streptococcus pneumoniae 20 IgG Ab [Mass/volume] in Serum --1st specimen,0
1237,Creatinine,Creatinine^baseline:SCnc:Pt:Urine:Qn,0
1238,External rotation.active range of motion,External rotation.active range of motion:Angle:Pt:Hip:Qn,0
1239,Alnus rugosa Ab.IgG,Alnus rugosa Ab.IgG:ACnc:Pt:Ser:Qn,0
1240,Study observation.general 3rd trimester,Study observation.general 3rd trimester:Imp:Pt:^Fetus:Nar:US,0
1241,Phenylalanine/Creatinine,Phenylalanine/Creatinine:MRto:24H:Urine:Qn,0
1242,Influenza A virus H7 RNA,Influenza virus A H7 RNA:ACnc:Pt:XXX:Qn:Probe.amp.tar,0
1243,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Lower extremity vessels:Doc:CT.angio,0
1244,Epstein Barr virus early IgA,Epstein Barr virus early Ab.IgA:Titr:Pt:Ser:Qn:IF,0
1245,History of procedures,History of procedures:Find:Pt:{Setting}:Doc:{Role},0
1246,Glucose,Glucose^2.5H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
1247,Glucose,Glucose^2M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
1248,Extension.passive range of motion,Extension.passive range of motion:Angle:Pt:Shoulder:Qn,0
1249,Hantavirus antibody,Hantavirus Ab:PrThr:Pt:Ser:Ord,0
1250,Benzodiazepines,Benzodiazepines:PrThr:Pt:XXX:Ord,0
1251,Creatinine,Creatinine^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
1252,Total metabolism,Total metabolism:Mass:24H:^Patient:Qn,0
1253,VWF gene targeted mutation analysis,VWF GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN,0
1254,Walking Speed,Walking speed:Vel:24H^mean:^Patient:Qn:Calculated,0
1255,Netilmicin,Netilmicin:Mass:Pt:Dose:Qn,0
1256,Sulfamethoxazole,Sulfamethoxazole:Mass:Pt:Dose:Qn,0
1257,Chlamydia species antigen,Chlamydia sp Ag:PrThr:Pt:Nph:Ord:IA,0
1258,Multisection,Multisection:Find:Pt:XXX>Artery:Doc:US,0
1259,Parvovirus B19 IgM,Parvovirus B19 Ab.IgM:PrThr:Pt:Ser:Ord:IA,0
1260,Blastomyces dermatitidis antibody,Deprecated Blastomyces dermatitidis Ab [Presence] in Body fluid,0
1261,Multiple tumors reported as single primary,Multiple tumors reported as single primary:Prid:Pt:Cancer.XXX:Nom,0
1262,Date of diagnosis of multiple tumors,Date of diagnosis of multiple tumors:TmStp:Pt:Cancer.XXX:Qn,0
1263,Norepinephrine,Norepinephrine^1H post 300 ug clonidine PO:SCnc:Pt:Plas:Qn,0
1264,HLA-B52(5),HLA-B52(5):PrThr:Pt:Bld/Tiss:Ord,0
1265,Hydrocortisone,Cortisol^1.5H post 1 ug/kg CRH IV:SCnc:Pt:Ser/Plas:Qn,0
1266,Creatinine,Creatinine^6H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
1267,rubella antibodies,Rubella virus Ab:PrThr:Pt:CSF:Ord:LA,0
1268,Acebutolol,Acebutolol:Mass:Pt:Dose:Qn,0
1269,Methadone/Creatinine,Methadone/Creatinine:MRto:Pt:Urine:Qn,0
1270,Antigen of Cryptosporidium parvum,Cryptosporidium parvum Ag:PrThr:Pt:Stool:Ord:IA,0
1271,3rd course treatment.other therapy,3rd course treatment.other therapy:Prid:Pt:Subsequent cancer Rx:Nom,0
1272,Loxapine,Loxapine:Mass:Pt:Dose:Qn,0
1273,Bordetella pertussis filamentous hemagglutinin IgA,Bordetella pertussis.filamentous hemagglutinin Ab.IgA:PrThr:Pt:Ser:Ord,0
1274,Appearance,Appearance^post transfusion reaction:Aper:Pt:Ser:Nom,0
1275,Lactose,Lactose^30M post dose lactose PO:SCnc:Pt:Ser/Plas:Qn,0
1276,Febrile agglutinin Ab panel,Febrile agglutinin Ab panel:Titr:Pt:Ser:Qn,0
1277,Derived American Joint Committee on cancer conversion method,Derived American Joint Committee on cancer conversion method:Arbitrary:Point in time:Cancer.To be specified in another part of the message:Ordinal,0
1278,Palliative procedure at this facility,Palliative procedure at this facility:Type:Pt:Cancer.XXX:Nom,0
1279,Arbovirus IgG,Arbovirus Ab.IgG:PrThr:Pt:Ser:Ord,0
1280,Propionylglycine/Creatinine,Propionylglycine/Creatinine:MRto:24H:Urine:Qn,0
1281,Tyrosine/Creatinine,Tyrosine/Creatinine:MRto:24H:Urine:Qn,0
1282,Reason for transplant,Reason for transplant:Finding:Point in time:^Patient:Nominal,0
1283,Lymphocytic choriomeningitis virus IgM,Lymphocytic choriomeningitis virus Ab.IgM:PrThr:Pt:Ser:Ord,0
1284,Interleukin-4,Interleukin 4:ACnc:Pt:Ser/Plas:Qn,0
1285,Chlamydia trachomatis antigen,Chlamydia trachomatis Ag:PrThr:Pt:Body fld:Ord,0
1286,Medication or other side effects associated with HIV Rx,Medication or other side effects associated with HIV Rx:Type:Pt:^Patient:Nom:Reported,0
1287,Spironolactone,Spironolactone:Mass Concentration:Point in time:Urine:Quantitative,0
1288,Basophils,Basophils:Naric:Pt:Periton fld:Qn:Microscopy.light.HPF,0
1289,arachidate,Arachidate:SCnc:Pt:Ser/Plas:Qn,0
1290,Multisection limited,Multisection limited:Find:Pt:Lower extremity>Hip:Doc:CT,0
1291,Chlamydia species antibody (substance),Chlamydia sp Ab:PrThr:Pt:CSF:Ord,0
1292,VA C&P exam.extremity joints note,VA C&P exam.extremity joints note:Find:Pt:{Setting}:Doc:{Role},0
1293,Ketones,Ketones:SCnc:Pt:Ser/Plas:Qn:Test strip,0
1294,Tuberculosis reaction wheal,Tuberculosis reaction wheal^1D post dose mammalian tuberculin ID:Diam:Pt:Skin:Qn,0
1295,Fibrinogen; antigen,Deprecated Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunologic method,0
1296,Date of last menstrual period,Last menstrual period:Date:Pt:^Patient:Qn:Estimated from EDD,0
1297,Blood group antibody E,E Antibody:Dilution Factor (Titer):Point in time:Serum/Plasma:Quantitative,0
1298,Corynebacterium diphtheriae toxin Ab,Corynebacterium diphtheriae toxin Ab:ACnc:Pt:Ser:Qn,0
1299,Escherichia coli O157:H7 Antigen,Escherichia coli O157:H7 Ag:PrThr:Pt:Mlk.raw:Ord:IA,0
1300,Multisection limited,Multisection limited:Find:Pt:Extremity:Doc:US,0
1301,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from CRL.Daya 1993,0
1302,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from FL.Jeanty 1982,0
1303,Chlorpheniramine,Chlorpheniramine:MCnc:Pt:Ser/Plas:Qn,0
1304,Multisection,Multisection^W contrast IV:Find:Pt:Lower extremity.right>Knee:Doc:MR,0
1305,Multisection,Multisection^WO contrast:Find:Pt:Head>Sinuses:Doc:CT,0
1306,Multisection stereotactic,Deprecated Unspecified body region CT stereotactic,0
1307,Chorionic Gonadotropin,Choriogonadotropin:MCnc:Pt:Ser/Plas:Qn,0
1308,phosphate ion,Phosphate [Mass or Molecules/volume] in Serum or Plasma,0
1309,Mersalyl,Mersalyl:MRat:24H:Urine:Qn,0
1310,View,Views^W contrast:Find:Pt:Abdomen>Jejunum:Doc:RF,0
1311,View,Views^W contrast intra lymphatic:Find:Pt:Abdomen>Abdominal lymphatic vessels & Pelvis>Pelvic lymphatic vessels:Doc:RF.angio,0
1312,Views limited,Views limited^W contrast IT:Find:Pt:Chest>Spine.thoracic:Doc:RF,0
1313,Views perfusion,Views perfusion^W stress+W Tl-201 IV:Find:Pt:Chest>Heart:Doc:NM,0
1314,Cyclic AMP,Adenosine monophosphate.cyclic:SCnc:24H:Urine:Qn,0
1315,Ampicillin Ab.IgG,Ampicillin Ab.IgG:ACnc:Pt:Ser:Qn,0
1316,Chlamydia sp rRNA,Chlamydia sp rRNA:PrThr:Pt:Thrt:Ord:Probe,0
1317,Coagulation factor VIII activity.X(little a) activator,Coagulation factor VIII activity.X(little a) activator:ACnc:Pt:PPP:Qn:Chromo,0
1318,Clarity,Clarity:Type:Pt:Urine:Nom,0
1319,Distance of carcinoma from deep margin,Distance of carcinoma from deep margin:Len:Pt:Specimen:Qn,0
1320,Extent of invasion deepest,Extent of invasion deepest:Type:Pt:Specimen:Ord,0
1321,Copper,Copper:SCnc:Pt:Urine:Qn,0
1322,Views 2,Views 2:Find:Pt:Upper extremity>Elbow:Doc:XR,0
1323,View Zanca,View Zanca:Find:Pt:Upper extremity.left>Acromioclavicular joint:Doc:XR,0
1324,Views 6,Views 6:Find:Pt:Upper extremity>Wrist:Doc:XR,0
1325,Glucose,Glucose^2D post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
1326,Color,Periwound color:Type:Point in time:Wound:Nominal,0
1327,Views diagnostic,Views diagnostic:Find:Pt:Breast:Doc:MG.FFD,0
1328,Canrenone,Canrenone:MRat:24H:Urine:Qn,0
1329,View,Views^W manual stress:Find:Pt:Lower extremity.right>Ankle:Doc:XR,0
1330,Interleukin-13,Interleukin 13:MCnc:Pt:Ser/Plas:Qn,0
1331,Lymphocytes.immunoblastic,Lymphocytes.immunoblastic:NCnc:Pt:Bld:Qn:Manual count,0
1332,cell type,Cell type:Type:Pt:XXX:Nom,0
1333,microscopic observation,Microscopic observation:Prid:Pt:Bld:Nom:Malaria thin smear,0
1334,Immune complex.IgE,Immune complex.IgE:ACnc:Pt:Ser/Plas:Qn,0
1335,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Speech-language pathology+Audiology,0
1336,Platelet aggregation.XXX induced,Platelet aggregation.XXX induced:RelACnc:Pt:PRP^Donor:Qn,0
1337,Views 3,Views 3:Find:Pt:Chest:Doc:XR,0
1338,Multisection,Multisection^WO contrast:Find:Pt:Abdomen+Pelvis>Spine.lumbosacral junction:Doc:CT,0
1339,Views magnification,Views magnification:Find:Pt:Breast:Doc:MG,0
1340,Influenza A virus H9 Ab,Influenza virus A H9 Ab:Titr:Pt:Ser:Qn:HAI,0
1341,Blood flow.max.kidney artery/Blood flow.max.aorta,Blood flow.max.kidney artery/Blood flow.max.aorta:VelRto:Pt:{Circulatory system}:Qn:US,0
1342,diethylene glycol,Diethylene glycol:MCnc:Pt:Ser/Plas:Qn,0
1343,Surgical operation note,Surgical operation note:Find:Pt:{Setting}:Doc:Orthopaedic surgery,0
1344,Post-operative evaluation and management note,Postoperative evaluation and management note:Find:Pt:{Setting}:Doc:Surgery.nurse,0
1345,Views 3,Views 3:Find:Pt:Lower extremity.left>Foot:Doc:XR,0
1346,Multisection,Multisection:Find:Pt:Upper extremity.left>Upper extremity joint:Doc:MR,0
1347,Multisection,Multisection:Find:Pt:Head>Mastoid:Doc:XR.tomography,0
1348,Simazine,Simazine:MCnc:Pt:Water:Qn,0
1349,Cells.CD3+CD8+CD45RO-CD45RA-/100 cells,Cells.CD3+CD8+CD45RO-CD45RA-/100 cells:NFr:Pt:Bld:Qn,0
1350,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Foot:Doc:CT,0
1351,Multisection,Multisection^WO & W contrast IV:Find:Pt:Upper extremity.left>Forearm:Doc:MR,0
1352,Multisection,Multisection:Finding:Point in time:Ovary:Narrative:MRI,0
1353,Multisection,Multisection:Find:Pt:Head>Temporomandibular joint.bilateral:Doc:MR,0
1354,Views 2,Views 2:Find:Pt:Upper extremity.right>Shoulder:Doc:XR,0
1355,Views perfusion,Deprecated Views perfusion^at rest & W stress & W 99m Tc Sestamibi IV:Find:Pt:Heart:Nar:Radnuc,0
1356,Hydrocortisone,Cortisol^1H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
1357,Follicle Stimulating Hormone,Follitropin^baseline:ACnc:Pt:Ser/Plas:Qn,0
1358,DNA index 3,DNA index 3:ACnc:Pt:XXX:Qn:Flow cytometry,0
1359,LACROSSE VIRUS ANTIBODY,La Crosse virus Ab:Titr:Pt:Body fld:Qn,0
1360,View Zanca,View Zanca:Find:Pt:Upper extremity>Acromioclavicular joint:Doc:XR,0
1361,Mycobacterium tuberculosis complex rRNA,Deprecated Mycobacterium tuberculosis complex rRNA [Presence] in Unspecified specimen by DNA probe,0
1362,Color,Color:Type:Pt:Amnio fld:Nom,0
1363,Hematocrit procedure,Hematocrit:VFr:Pt:BldA:Qn,0
1364,Prothrombin antigen,Prothrombin Ag:ACnc:Pt:PPP:Qn:IA,0
1365,Chromosome 7 uniparental disomy,Chromosome 7 uniparental disomy:Arb:Pt:Bld/Tiss:Ord:Cytogenetics,0
1366,Multisection,Multisection:Find:Pt:Upper extremity>Humerus:Doc:XR.tomography,0
1367,View,Views:Find:Pt:Upper extremity>Humerus.bicipital groove:Doc:XR,0
1368,Views 5,Views 5:Find:Pt:Head>Sinuses:Doc:XR,0
1369,Legionella antibody,Legionella sp Ab:PrThr:Pt:Ser:Ord,0
1370,Oxacillin,Oxacillin:MCnc:Pt:Ser/Plas:Qn,0
1371,Multisection,Multisection:Find:Pt:Lower extremity>Lower extremity artery:Doc:US.doppler,0
1372,Urea,Urea^pre dialysis:SCnc:Pt:Ser/Plas:Qn,0
1373,West Nile virus Ag,West Nile virus Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
1374,Recession,Recession:Len:Pt:{Tooth}.{probe site}:Qn:Measured,0
1375,Lymphocytes.variant,Lymphocytes.variant:NCnc:Pt:Plr fld:Qn,0
1376,Blastomyces dermatitidis IgM,Blastomyces dermatitidis Ab.IgM:PrThr:Pt:Ser:Ord:IA,0
1377,Calcium,Calcium^3D post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
1378,Trifluoperazine,Trifluoperazine:SCnc:Pt:Ser/Plas:Qn,0
1379,Physical findings,Physical findings:Find:Pt:Larynx:Nom:Observed,0
1380,Hepatitis B virus little e Ab.IgG,Hepatitis B virus little e Ab.IgG:PrThr:Pt:Ser:Ord:IA,0
1381,Note (document),Note:Find:Pt:{Setting}:Doc:Radiation oncology,0
1382,Patient History,Patient history:-:Point in time:^Patient:-,0
1383,Multisection,Multisection:Find:Pt:Lower extremity>Knee:Doc:XR.tomography,0
1384,Multisection,Multisection:Finding:Point in time:Neck:Narrative:Computerized Tomography,0
1385,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity.left>Elbow:Doc:MR,0
1386,CFTR gene.c.1078delT,CFTR gene.c.1078delT:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
1387,LITAF gene targeted mutation analysis,LITAF GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NAR:MOLGEN,0
1388,HTLV-I Antibodies,HTLV I Ab:PrThr:Pt:CSF:Ord,0
1389,Stable status,Stability:Imp:Pt:{Dental arch}.denture.complete:Ord:Reported,0
1390,Acetaminophen,Acetaminophen:PrThr:Pt:Urine:Ord,0
1391,Kelp Ab.IgE.RAST class,Kelp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
1392,Methane/Expired gas,Methane/Expired gas^3H post dose lactose PO:VFr:Pt:Exhl gas:Qn,0
1393,HIV 1 p65+p66 Ab,HIV 1 p65+p66 Ab:PrThr:Pt:Ser:Ord:IB,0
1394,Clarity,Clarity:Type:Pt:XXX:Nom,0
1395,Multisection,Multisection:Find:Pt:Lower extremity>Lower extremity veins:Doc:MR.angio,0
1396,Multisection,Multisection^W contrast IS:Find:Pt:Upper extremity>Wrist:Doc:MR,0
1397,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity>Wrist:Doc:CT,0
1398,VA C&P exam.miscellaneous arteries &or veins note,VA C&P exam.miscellaneous arteries &or veins note:Find:Pt:{Setting}:Doc:{Role},0
1399,Platelet aggregation.arachidonate induced,Platelet aggregation.arachidonate induced:RelACnc:Pt:PRP^Control:Qn,0
1400,Diameter.biparietal outer to inner,Diameter.biparietal outer to inner:Len:Pt:Head^Fetus:Qn:US.estimated from Chitty 1994,0
1401,Methadone cutoff,Methadone cutoff:MCnc:Pt:Saliva:Qn:Confirm,0
1402,Carnitine biosynthesis intermediates panel,Carnitine biosynthesis intermediates panel:-:Pt:CSF:-,0
1403,Cardiolipin IgM,Deprecated Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay,0
1404,Actin.filamentous Ab,Actin.filamentous Ab:PrThr:Pt:Ser:Ord:Line blot,0
1405,Latex recombinant (rHev b) 11 Ab.IgE.RAST class,Latex recombinant (rHev b) 11 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
1406,Phencyclidine,Phencyclidine:MCnc:Pt:Unk sub:Qn,0
1407,Collagen induced platelet aggregation,Platelet aggregation.collagen induced:ACnc:Pt:Bld:Qn,0
1408,Surgical operation note,Surgical operation note:Find:Pt:{Setting}:Doc:Obstetrics and Gynecology,0
1409,trimethyllysine,Trimethyllysine:SCnc:Pt:CSF:Qn,0
1410,Cells,Cells:Num:Pt:Anterior chamber.right:Qn:Slit lamp biomicroscopy,0
1411,Enhanced encounter note - recommended CDP Set 1 R1.0 & R1.1 sections,Enhanced encounter note - recommended CDP Set 1 R1.0 & R1.1 sections:-:Pt:{Setting}:-,0
1412,Verified side &or site of procedure,Verified side &or site of procedure:Find:Pt:^Patient:Ord,0
1413,Antiribosomal P protein antibody,Deprecated Ribosomal P Ab [Presence] in Cerebral spinal fluid by Immunoblot,0
1414,Service comment 12,Service comment 12:Impression/interpretation of study:Point in time:To be specified in another part of the message:Nominal,0
1415,Service comment 19,Service comment 19:Impression/interpretation of study:Point in time:To be specified in another part of the message:Nominal,0
1416,St. Louis encephalitis virus antibody,Saint Louis encephalitis virus Ab:Titr:Pt:CSF:Qn:IF,0
1417,Electroretinography (ERG) measurements panel,Electroretinography (ERG) measurements panel:-:Pt:Eye:-:Electroretinogram,0
1418,Objective refraction measurements panel,Objective refraction measurements panel:-:Pt:Eye:-:Objective refraction,0
1419,Pressure half time.diastole,Pressure half time.diastole:Time:Pt:Mitral valve:Qn:US.doppler,0
1420,Orifice area/Body surface area,Orifice area/Body surface area:ArArea:Pt:Aortic valve:Qn:US.2D+Measured by planimetry,0
1421,Sjogrens syndrome-A extractable nuclear 52kD Ab,Deprecated Sjogrens syndrome-A extractable nuclear 52kD Ab [Presence] in Cerebral spinal fluid by Immunoblot,0
1422,Body Temperature,Body temperature:Temp:12H^max:XXX:Qn,0
1423,Body Temperature,Body temperature:Temp:10H:XXX:Qn,0
1424,Fluid intake.intravascular,Fluid intake.intravascular:VRat:12H:Vascular system:Qn,0
1425,Urine volume finding,Fluid output.urine:VRat:8H:Urinary tract:Qn,0
1426,Borrelia burgdorferi 39kD IgG,Borrelia burgdorferi 39kD Ab.IgG:PrThr:Pt:Ser:Ord:IB,0
1427,Aluminum,Aluminum:SCnc:Pt:Water:Qn,0
1428,Norovirus genogroup I+II orf1-orf2 junction region,Norovirus genogroup I+II orf1-orf2 junction region:PrThr:Pt:Stool:Ord:Probe.amp.tar,0
1429,Cefixime,Cefixime:Susc:Pt:Isolate:Qn:MLC,0
1430,PISA velocity.diastole,PISA velocity.diastole:Vel:Pt:Aortic valve:Qn:US.doppler,0
1431,Immunoglobulin light chains.lambda.free,Immunoglobulin light chains.lambda.free:MCnc:Pt:Ser:Qn:Nephelometry,0
1432,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Surgical oncology,0
1433,Discharge teaching note,Discharge teaching note:Find:Pt:{Setting}:Doc:Geriatric medicine,0
1434,Intrachamber diastolic,Intrachamber diastolic:Pres:Pt:Heart.ventricle.left:Qn,0
1435,Stizostedion vitreum Ab.IgE,Stizostedion vitreum Ab.IgE:ACnc:Pt:Ser:Qn,0
1436,End-systolic volume,End-systolic volume:Vol:Pt:Heart.atrium.left:Qn:US.2D.A2C+Calc by single plane method of disks,0
1437,Distance of tumor from circumferential resection margin,Distance of tumor from circumferential resection margin:Len:Pt:Specimen:Qn:Microscopy.light,0
1438,(Chicken feather+Cow dander+Goose feather+Horse dander) Ab.IgE.RAST class,(Chicken feather+Cow dander+Goose feather+Horse dander) Ab.IgE.RAST class:PrThr:Pt:Ser:Ord:Multidisk,0
1439,Blood group antibody screen.cell III,Blood group antibody screen.cell III:PrThr:Pt:Ser/Plas:Ord:Prewarmed,0
1440,Coxsackievirus A16 Ab,Coxsackievirus A16 Ab:Titr:Pt:CSF:Qn:Comp fix,0
1441,HPD gene full mutation analysis,HPD gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing,0
1442,Measles antibody,Measles virus Ab:ACnc:Pt:Ser:Qn,0
1443,Blood velocity-time integral.systole,Blood velocity-time integral.systole:Len:Pt:Heart.ventricle.left.outflow tract:Qn:US.doppler,0
1444,Guidance for biopsy.vacuum,Guidance for biopsy.vacuum:Find:Pt:Breast.left:Doc:US,0
1445,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Clinical pharmacology,0
1446,Airway resistance,Resistance.airway^pre bronchodilation:FldResist:Pt:Respiratory system.airway:Qn,0
1447,RMRP gene targeted mutation analysis,RMRP gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
1448,Calorie intake.total,Calorie intake.total:Power = Energy/Time:Point in time:^Patient:Quantitative,0
1449,Effective regurgitant orifice area.systole,Effective regurgitant orifice area.systole:Area:Pt:Mitral valve:Qn:US.doppler+Calculated by PISA method,0
1450,Cerebral ventricle drain site,Cerebral ventricle drain site:Anatomy:Point in time:*^Patient:Nominal,0
1451,Cells.aneuploid.S phase population/100 cells,Cells.aneuploid.S phase population/100 cells:NFr:Pt:Cells.XXX:Qn:Flow cytometry,0
1452,Cells.aneuploid.S phase population 2/100 cells,Cells.aneuploid.S phase population 2/100 cells:NFr:Pt:Cells.XXX:Qn:Flow cytometry,0
1453,Aneuploid G1 phase cell population peak channel,Aneuploid G1 phase cell population peak channel:Num:Pt:Cells.XXX:Qn:Flow cytometry,0
1454,Sensory or speech status,Sensory or speech status:Finding:Point in time:^Patient:Nominal,0
1455,formate,Formate:SCnc:Pt:Ser/Plas:Qn:Confirm,0
1456,Inosine triphosphate pyrophosphatase,Inosine triphosphate pyrophosphatase:CSub:Pt:RBC:Qn,0
1457,Transfer summary note,Transfer summary note:Find:Pt:{Setting}:Doc:Cardiac surgery,0
1458,P' wave amplitude.lead V5,P' wave amplitude.lead V5:Elpot:Pt:Heart:Qn:EKG,0
1459,QRS terminal amplitude.lead V2,QRS terminal amplitude.lead V2:Elpot:Pt:Heart:Qn:EKG,0
1460,Condition- or population-specific panel,Condition- or population-specific panel:-:Pt:^Patient:-:APTA,0
1461,Amphetamine,Amphetamine:MCnt:Pt:Hair:Qn:Confirm,0
1462,A2 antigen,A2 Ag:PrThr:Pt:RBC:Ord,0
1463,Comparison.study,Comparison.study:Impression/interpretation of study:Point in time:Heart:Nominal:EKG,0
1464,Wound drain site,Wound drain site:Anatomy:Point in time:*^Patient:Nominal,0
1465,output.stool,Output.stool:MRat:8H:Lower GI tract:Qn,0
1466,B variant NOS Ag,Deprecated B variant NOS Ag [Presence] on Red Blood Cells,0
1467,Rickettsia typhus group IgG,Rickettsia typhus group Ab.IgG:ACnc:Pt:Ser:Qn,0
1468,phosphate ion,Phosphate:SCnc:XXX:Urine:Qn,0
1469,Fat intake panel,Fat intake panel:-:-:^Patient:-,0
1470,Study observation.overall,Study observation.overall:Finding:Point in time:Heart:Nominal:EKG,0
1471,DLD gene targeted mutation analysis,DLD gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
1472,Spermatozoa morphology normal,Spermatozoa.normal morphology:Num:Pt:Semen:Qn:Automated count,0
1473,Views for therapy,Views for therapy^W I-131 PO:Find:Pt:Neck>Thyroid gland:Doc:NM,0
1474,Childhood diseases,History of childhood diseases:Finding:Point in time:^Patient:Nominal:Reported,0
1475,Amikacin.free,Amikacin.free:MCnc:Pt:Ser/Plas:Qn,0
1476,Homocysteine intake,Homocysteine intake:MRat:24H:^Patient:Qn:Measured,0
1477,Blood group antigen A3,A3 Ag:PrThr:Pt:RBC:Ord,0
1478,Phencyclidine cutoff,Phencyclidine cutoff:MCnc:Pt:Saliva:Qn:Confirm,0
1479,Referral note,Referral note:Find:Pt:{Setting}:Doc:Neonatal perinatal medicine,0
1480,HIV 1 RNA tropism,human immunodeficiency virus 1 ribonucleic acid tropism:Presence or Identity:Point in time:Plasma:Nominal,0
1481,Lymphocyte proliferation.Interleukin 2.maximum/CD45,Lymphocyte proliferation.Interleukin 2.maximum/CD45:NFr:Pt:Bld:Qn:Flow cytometry,0
1482,Surgical operation note preoperative Dx,Operative note preoperative Dx:Impression/interpretation of study:Point in time:^Patient:Nominal,0
1483,Borates,Borate:MCnc:Pt:XXX:Qn,0
1484,Propoxyphene+Norpropoxyphene,Propoxyphene+Norpropoxyphene:SCnc:Pt:XXX:Qn,0
1485,Indocyanine Green,Indocyanine green^15M post dose indocyanine green:MCnc:Pt:Plas:Qn,0
1486,Nitrogen,Nitrogen:MCnt:24H:Stool:Qn,0
1487,Human immunodeficiency virus 1 RNA,HIV 1 RNA:PrThr:Pt:Semen:Ord:Probe.amp.tar,0
1488,Schistosoma mansoni+haematobium+intercalatum,Schistosoma mansoni+haematobium+intercalatum:Titr:Pt:Ser:Qn:HA,0
1489,Admission history and physical note,Admission history and physical note:Find:Pt:{Setting}:Doc:Cardiovascular disease+Pulmonary disease,0
1490,Admission history and physical note,Admission history and physical note:Find:Pt:{Setting}:Doc:Oral and maxillofacial surgery,0
1491,cold agglutinins,Cold agglutinin^24H post incubation:Titr:Pt:Ser:Qn:4 deg C incubation,0
1492,Murmur quality,Murmur quality:Type:Pt:Heart:Nom:Auscultation,0
1493,Cells.CD27+CD45RA+/100 Cells.CD3+CD8+,Cells.CD27+CD45RA+/100 Cells.CD3+CD8+:NFr:Pt:Bld:Qn,0
1494,Biotin intake,Vitamin B7 intake:MRat:24H:^Patient:Qn:Estimated,0
1495,Complex carbohydrate intake,Complex carbohydrate intake:MRat:24H:^Patient:Qn:Measured,0
1496,"Human immunodeficiency virus, type II antibody",HIV 2 Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid,0
1497,Artemisia vulgaris native (nArt v) 3 Ab.IgE.RAST class,Artemisia vulgaris native (nArt v) 3 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
1498,Dermatophagoides pteronyssinus recombinant (rDer p) 10 Ab.IgE.RAST class,Dermatophagoides pteronyssinus recombinant (rDer p) 10 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
1499,Cocaine,Cocaine:PrThr:Pt:Unk sub:Ord:Screen,0
1500,Stroke volume/Body surface area,Stroke volume/Body surface area:ArVol:Pt:Heart.ventricle.left:Qn:Angiography.biplane,0
1501,Morphine,Morphine:Arbitrary Concentration:Point in time:Gastric fluid/contents:Ordinal,0
1502,Discharge instructions,Discharge instructions:Find:Pt:{Setting}:Doc:Pediatrics,0
1503,4-Hydroxycyclohexylacetate/creatinine,4-Hydroxycyclohexylacetate/creatinine:SRto:Pt:Urine:Qn,0
1504,Congenital cranial dysinnervation syndrome (CCDS) suspected,Congenital cranial dysinnervation syndrome (CCDS) suspected:Type:Pt:^Patient:Nom,0
1505,Vertical diameter,Vertical diameter:Len:Pt:Cornea.right:Qn,0
1506,Suspected organism,Suspected organism:Prid:Pt:XXX:Nom,0
1507,Hemodynamic resistance,Hemodynamic resistance:Resis:Pt:Systemic vasculature:Qn:Fick,0
1508,HLA-B Antigens,HLA-B:Type:Pt:Bld/Tiss:Nom:Low resolution,0
1509,Past employer address,Past employer address:Address:Point in time:^Patient:Nominal,0
1510,Percutaneous coronary intervention individual lesion procedure results panel,Percutaneous coronary intervention individual lesion procedure results panel:-:Pt:Heart:-,0
1511,Frequency of muscle-strengthening physical activity,Frequency of muscle-strengthening physical activity:Number = Count/Time:Reporting period:^Patient:Quantitative,0
1512,CPT2 gene.p.R549DC,Deprecated CPT2 gene p.R549DC [Presence] in Blood by Molecular genetics method,0
1513,Pregnenolone,Pregnenolone^baseline:MCnc:Pt:Ser/Plas:Qn,0
1514,Leptospira sp DNA,Leptospira sp DNA:PrThr:Pt:Urine:Ord:Probe.amp.tar,0
1515,desoxycorticosterone,11-Deoxycorticosterone:SCnc:Pt:Bld.dot:Qn,0
1516,CACT gene targeted mutation analysis,CACT gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
1517,Rh Factors,Rh:Type:Pt:Bld^Fetus:Nom,0
1518,Whole blood pediatric units given,Whole blood pediatric units given:Num:Pt:^BPU:Qn,0
1519,Phleum pratense Ab.IgG4,Phleum pratense Ab.IgG4:MCnc:Pt:Ser:Qn,0
1520,Piromidate,Piromidate:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
1521,Tinidazole,Tinidazole:Susc:Pt:Isolate:OrdQn:Gradient strip,0
1522,Aluminum,Aluminum:MCnc:Pt:Ser/Plas:Qn,0
1523,Catecholamines,Catecholamines:Impression/interpretation of study:Point in time:Urine:Narrative,0
1524,SH3TC2 gene targeted mutation analysis,SH3TC2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
1525,Poa pratensis Ab.IgG,Poa pratensis Ab.IgG:MCnc:Pt:Ser:Qn,0
1526,Lupinus albus seed Ab.IgE,Lupinus albus seed Ab.IgE:ACnc:Pt:Ser:Qn,0
1527,Cytomegalovirus antibody,Cytomegalovirus Ab:ACnc:Pt:Ser/Plas:Qn:IF,0
1528,NPM1 gene targeted mutation analysis,NPM1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
1529,Genetic analysis summary panel,"Genetic analysis summary panel:-:Point in time:Whole blood/Tissue, unspecified:-:Molecular Genetics",0
1530,HBB gene.c.251G>A,HBB gene.c.251G>A:PrThr:Pt:Bld:Ord:Molgen,0
1531,EGFR gene.c.2573T>G,EGFR gene.c.2573T>G:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
1532,Poa pratensis leukotriene release,Poa pratensis leukotriene release:MCnc:Pt:WBC:Qn,0
1533,Minor determinant mixture leukotriene release,Minor determinant mixture leukotriene release:MCnc:Pt:WBC:Qn,0
1534,Plasmodium ovale IgG,Plasmodium ovale Ab.IgG:Titr:Pt:Ser:Qn:IF,0
1535,Pyruvate,Pyruvate:SCnc:Pt:BldV:Qn,0
1536,Tobramycin,Tobramycin:MCnc:Pt:CSF:Qn,0
1537,Licensed minimally manipulated cells label,Licensed minimally manipulated cells label:-:-:^FDA product label:Nar,0
1538,No change notification,No change notification:-:-:^FDA product label:Nar,0
1539,fibroblast growth factor 23,Fibroblast growth factor 23.intact ^4th specimen post XXX challenge:MCnc:Pt:Plas:Qn:IA,0
1540,Food colorant mix II leukotriene release,Food colorant mix II leukotriene release:MCnc:Pt:WBC:Qn,0
1541,Sperm evaluation by cervical mucus penetration test,Spermatozoa evaluation.cervical mucus penetration test:Impression/interpretation of study:Point in time:Seminal fluid:Narrative,0
1542,Ketones,Ketones:MCnc:Pt:Urine:Qn,0
1543,Tetracycline,Tetracycline:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
1544,Magnolia grandiflora Ab.IgE,Magnolia grandiflora Ab.IgE:ACnc:Pt:Ser:Qn,0
1545,Creatine kinase.MB/Creatine kinase.total,Creatine kinase.total/Creatine kinase.MB:CRto:Pt:Bld:Qn,0
1546,Cells.CD42/100 cells,Cells.CD42/100 cells:NFr:Pt:CSF:Qn,0
1547,Maximum clot firmness.intrinsic coagulation system activated.heparin insensitive,Maximum clot firmness.intrinsic coagulation system activated.heparin insensitive:Len:Pt:Bld:Qn:Thromboelastography.rotational,0
1548,Carnitine palmitoyltransferase 2,Carnitine palmitoyltransferase 2:CCnt:Pt:Amnio fld cells:Qn,0
1549,Estradiol,Estradiol:MCnc:Pt:Body fld:Qn,0
1550,Histidine,Histidine:SCnt:Pt:Hair:Qn,0
1551,Streptococcus pneumoniae serogroup 23 antibody,Deprecated Streptococcus pneumoniae 23 Ab [Units/volume] in Serum by Immunoassay --1st specimen,0
1552,Glucose,Glucose^5th specimen:MCnc:Pt:Ser/Plas:Qn,0
1553,risk factors,Risk factors:Find:Pt:{Setting}:Doc:{Role},0
1554,CD81 antigen,Deprecated CD81:Arbitrary Concentration:Point in time:Leukocytes:Quantitative,0
1555,VIM gene methylation,VIM gene methylation:Arb:Pt:Stool:Ord:Molgen,0
1556,Cortolone,Alpha cortolone:MCnc:24H:Urine:Qn,0
1557,ALPHA-D-GALACTOSIDASE ENZYME,Alpha galactosidase A:CCnc:Pt:Bld.dot:Qn,0
1558,Hydrocortisone,Cortisol^post dose dexamethasone:Mass Concentration:Point in time:Serum/Plasma:Quantitative,0
1559,Norvenlafaxine,Norvenlafaxine:SCnc:Pt:Ser/Plas:Qn,0
1560,Collagen type 1 Ab,Collagen type 1 Ab:ACnc:Pt:Ser:Qn,0
1561,Heparin Ab.IgE,Heparin Ab.IgE:ACnc:Pt:Ser:Qn,0
1562,HLA-Dw15,HLA-Dw15:PrThr:Pt:Bld/Tiss:Ord,0
1563,Organic acids panel,Organic acids panel:-:Pt:Urine:-,0
1564,Neural tube defect risk,Neural tube defect risk:Likelihood:Pt:^Fetus:Qn,0
1565,3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine,3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine:SRto:Pt:Urine:Qn,0
1566,Arsenic/Creatinine,Arsenic/Creatinine:SRto:24H:Urine:Qn,0
1567,Beryllium,Beryllium:SRat:24H:Urine:Qn,0
1568,Cells.terminal deoxyribonucleotidyl transferase/100 cells,Cells.terminal deoxyribonucleotidyl transferase/100 cells:NFr:Pt:Tiss:Qn:Flow cytometry,0
1569,microscopic observation,Microscopic observation:Prid:Pt:Bronchial:Nom:Rhodamine-auramine fluorochrome stain,0
1570,Nuclear Ab pattern.atypic speckled,Nuclear Ab pattern.atypic speckled:PrThr:Pt:Ser:Ord:IF,0
1571,Neopterin,Neopterin:SCnc:Pt:Urine:Qn,0
1572,John Cunningham virus DNA,JC virus DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar,0
1573,SMN1 gene+SMN2 gene targeted mutation analysis,SMN1 gene+SMN2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
1574,Tetracycline,Tetracycline:Titr:Pt:Isolate+Ser:Qn:SBT,0
1575,Novocaine Ab.IgE,Novocaine Ab.IgE:ACnc:Pt:Ser:Qn,0
1576,Sodium,Sodium^^corrected for glucose:SCnc:Pt:Ser/Plas:Qn,0
1577,Lysozyme antibody,Lysozyme Ab:PrThr:Pt:Ser:Ord,0
1578,West Nile virus Ab.IgG & IgM panel,West Nile virus Ab.IgG & IgM panel:-:Pt:Ser:Qn,0
1579,PhenX measure - birth weight,PhenX measure - birth weight:-:Point in time:^Patient:-:PhenX,0
1580,Glutamate decarboxylase 65 antibody,Glutamate decarboxylase 65 Ab:ACnc:Pt:Ser:Qn:IA,0
1581,Growth Hormone,Somatotropin^2H post dose ornithine:ACnc:Pt:Ser/Plas:Qn,0
1582,Multisection,Multisection^WO & W contrast IT:Find:Pt:Neck>Spine.cervical:Doc:MR,0
1583,temafloxacin,Temafloxacin:Susc:Pt:Isolate:OrdQn:MIC,0
1584,Anaplasma phagocytophilum IgM,Anaplasma phagocytophilum Ab.IgM:Titr:Pt:Body fld:Qn:IF,0
1585,Streptococcus pneumoniae capsular polysaccharide IgG,Streptococcus pneumoniae capsular polysaccharide Ab.IgG:MCnc:Pt:Ser:Qn,0
1586,14-3-3 Proteins,Deprecated 14-3-3 protein [Presence] in Cerebral spinal fluid by Immunoblot,0
1587,CD43 Antigen,Deprecated CD43 cells/100 cells in Blood,0
1588,Naproxen Ab.IgE,Naproxen Ab.IgE:ACnc:Pt:Ser:Qn,0
1589,Birth plan,Birth plan:Finding:Point in time:^Patient:Narrative,0
1590,Thyrotropin,Thyrotropin^1.5H post dose lutenizing releasing hormone IV:ACnc:Pt:Ser/Plas:Qn,0
1591,Tin,Tin:SCnt:Pt:Hair:Qn,0
1592,Vancomycin,Vancomycin:SCnc:Pt:Body fld:Qn,0
1593,Mycoplasma pneumoniae antibody,Mycoplasma pneumoniae Ab:ACnc:Pt:Ser:Qn:LA,0
1594,Anti-striated muscle antibody,Striated muscle Ab:Titr:Pt:Ser:Qn:IF,0
1595,Newborn hearing screen,Deprecated Newborn hearing screen,0
1596,Double stranded anti DNA antibody,DNA double strand Ab:ACnc:Pt:Ser:Qn:IF,0
1597,Bupropion,Bupropion:SCnc:Pt:Ser/Plas:Qn,0
1598,MVK gene targeted mutation analysis,MVK gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
1599,Calcium oxalate monohydrate/Total,Calcium oxalate monohydrate/Total:MFr:Pt:Calculus:Qn:Infrared spectroscopy,0
1600,Glucose,Glucose:SCnc:Pt:Flu.nonbiological:Qn,0
1601,Mycobacterium sp identified,Mycobacterium sp identified:Prid:Pt:Bone mar:Nom:Organism specific culture,0
1602,Method of best overall fetal weight estimate,Method of best overall fetal weight estimate:Finding:Point in time:^Fetus:Nominal:Reported,0
1603,Tissue transglutaminase Ab,Tissue transglutaminase Ab:Titr:Pt:Ser:Qn:IF,0
1604,ricinine,Ricinine:MCnc:Pt:Urine:Qn,0
1605,Reverse primer,Reverse primer:Seq:Pt:Bld/Tiss:Nom:Molgen,0
1606,Influenza A virus H3 RNA,Influenza virus A H3 RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar,0
1607,Growth Hormone,Somatotropin^11 PM specimen:ACnc:Pt:Ser/Plas:Qn,0
1608,Adenine Phosphoribosyltransferase,Adenine phosphoribosyltransferase:CCnt:Pt:CVS:Qn,0
1609,Coccidioides immitis antibody,Coccidioides immitis Ab:ACnc:Pt:Ser:Qn:IA,0
1610,Phosphoethanolamine Ab.IgG,Phosphoethanolamine Ab.IgG:PrThr:Pt:Ser/Plas:Ord,0
1611,Streptobacillus moniliformis antibody,Streptobacillus moniliformis Ab:ACnc:Pt:Ser:Qn,0
1612,Lymphocyte antigen CD50,Deprecated CD50 cells/100 cells in Blood,0
1613,hydroxybupropion,Hydroxybupropion:SCnc:Pt:Ser/Plas:Qn,0
1614,PKLR gene targeted mutation analysis,PKLR gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
1615,TSC2 gene targeted mutation analysis,TSC2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
1616,Immune complex.IgG,Immune complex.IgG:MCnc:Pt:Body fld:Qn:C1q binding assay,0
1617,Growth Hormone,Somatotropin^5.30 AM specimen:ACnc:Pt:Ser/Plas:Qn,0
1618,Corticotropin,Corticotropin^40M post 100 ug CRH IV:MCnc:Pt:Plas:Qn,0
1619,posaconazole,Posaconazole:MCnc:Pt:Ser/Plas:Qn,0
1620,Strongyloides species antibody,Strongyloides sp Ab:ACnc:Pt:Ser:Qn:HA,0
1621,Cholesterol in intermediate density lipoprotein subfraction 1,Cholesterol.in IDL 1:SCnc:Pt:Ser/Plas:Qn,0
1622,Giardia lamblia+Cryptosporidium sp Ag,Giardia lamblia+Cryptosporidium sp Ag:PrThr:Pt:Stool:Ord:IA,0
1623,Coxiella burnetii antibody,Coxiella burnetii Ab:Titr:Pt:Ser:Qn:Comp fix,0
1624,Clot formation.intrinsic coagulation system activated,Clot formation.intrinsic coagulation system activated:Time:Pt:Bld:Qn:Thromboelastography.rotational,0
1625,Taenia solium adult Ab,Taenia solium adult Ab:ACnc:Pt:Ser:Qn:IA,0
1626,Drug screen comment,Drug screen comment:Imp:Pt:Urine:Nom,0
1627,Urea,Urea:SCnc:XXX:Urine:Qn,0
1628,Aspergillus niger Ab.IgG4,Aspergillus niger Ab.IgG4:MCnc:Pt:Ser:Qn,0
1629,Calcidiol & Calciferol,Calcidiol & Calciferol:Imp:Pt:Ser/Plas:Nar,0
1630,rubella antibodies,Rubella virus Ab:Titr:Pt:Ser:Qn:HAI,0
1631,Follicle Stimulating Hormone,Follitropin^8th specimen:ACnc:Pt:Ser/Plas:Qn,0
1632,Blasts.CD123/100 blasts,Blasts.CD123/100 blasts:NFr:Pt:XXX:Qn,0
1633,Influenza A virus RNA,Influenza virus A RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar,0
1634,Chromium panel,Chromium panel:-:Pt:Urine:-,0
1635,glycolate,Glycolate:SCnc:Pt:CSF:Qn,0
1636,"Antigens, CD79b",Deprecated CD79b cells/100 cells in Blood,0
1637,Cefamandole+Sulbactam,Cefamandole+Sulbactam:Susc:Pt:Isolate:OrdQn:Gradient strip,0
1638,Phragmites communis Ab.IgG4,Phragmites communis Ab.IgG4:MCnc:Pt:Ser:Qn,0
1639,Hydrogen/Expired gas,Hydrogen/Expired gas^15M post dose lactose PO:VFr:Pt:Exhl gas:Qn,0
1640,SCA10 gene allele 2.ATTCT repeats,SCA10 gene allele 2.ATTCT repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen,0
1641,(Arachis hypogaea+Bean white+Glycine max+Lens esculenta+Pisum sativum) Ab.IgE,(Arachis hypogaea+Bean white+Glycine max+Lens esculenta+Pisum sativum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk,0
1642,Blasts.CD14/100 blasts,Blasts.CD14/100 blasts:NFr:Pt:Bone mar:Qn,0
1643,Blasts.CD14/100 blasts,Blasts.CD14/100 blasts:NFr:Pt:XXX:Qn,0
1644,Epstein Barr virus capsid IgM,Epstein Barr virus capsid Ab.IgM:ACnc:Pt:Ser:Qn:IA,0
1645,La Crosse virus IgM,La Crosse virus Ab.IgM:PrThr:Pt:CSF:Ord:IA,0
1646,Chloroamphetamine,Chloroamphetamine:MCnc:Pt:Ser:Qn,0
1647,Risperidone & 9-Hydroxyrisperidone panel,Risperidone & 9-Hydroxyrisperidone panel:-:Pt:Ser/Plas:Qn,0
1648,Human T-lymphotrophic virus recombinant glycoprotein 21 antibody,HTLV I rgp21 Ab:PrThr:Pt:Ser:Ord:IB,0
1649,HIV nucleoside reverse transcriptase susceptibility panel,HIV nucleoside reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Phenotyping,0
1650,Advanced Oxidation Protein Products,Advanced oxidation protein products:SCnc:Pt:Ser/Plas:Qn,0
1651,Hemicystine/Amino acids.total,Hemicystine/Amino acids.total:SFr:Pt:Bld.dot:Qn,0
1652,VFD Type C medicated feed animal drug label,VFD Type C medicated feed animal drug label:-:-:^FDA product label:Nar,0
1653,Blasts.CD24/100 blasts,Blasts.CD24/100 blasts:NFr:Pt:XXX:Qn,0
1654,Corynebacterium diphtheriae antibody,Corynebacterium diphtheriae Ab:ACnc:Pt:Ser:Qn:IA,0
1655,Hepatitis D antibody,Hepatitis D virus Ab:PrThr:Pt:Body fld:Ord,0
1656,Rotavirus antibody,Rotavirus Ab:ACnc:Pt:Ser:Qn:CIE,0
1657,Pipecolate,Pipecolate:SCnc:Pt:Amnio fld:Qn,0
1658,Zygosity,Zygosity:Prid:Pt:Buccal:Nom:Molgen,0
1659,Isoniazid 10.0 ug/mL,Isoniazid 10.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria,0
1660,Human leukocyte antigen Cw9(w3),HLA-Cw9(w3):PrThr:Pt:Bld/Tiss:Ord,0
1661,Pancytokeratin Ag,Pancytokeratin Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
1662,Nordiazepam/Creatinine,Nordiazepam/Creatinine:MRto:Pt:Urine:Qn,0
1663,Corticotropin,Corticotropin^pre dose metyraPONE:MCnc:Pt:Plas:Qn,0
1664,Cells.CD19+CD38+,Cells.CD19+CD38+:NCnc:Pt:Bld:Qn,0
1665,"Do you ever have to stop for breath after walking about 100 yards, or after a few Ms, on the level","Do you ever have to stop for breath after walking about 100 yards, or after a few Ms, on the level:Find:Pt:^Patient:Ord:PhenX",0
1666,Franseria acanthicarpa Ab.IgG,Franseria acanthicarpa Ab.IgG:MCnc:Pt:Ser:Qn,0
1667,Macrophages/100 cells,Macrophages/100 cells:NFr:Pt:Bone mar:Qn:Manual count,0
1668,KIR gene allele 3DL2,KIR gene allele 3DL2:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
1669,At what age was diabetes first treated,At what age was diabetes first treated:Time:Pt:^Patient:Qn:PhenX,0
1670,When did you last eat or drink anything other than plain water,When did you last eat or drink anything other than plain water:TmStp:Pt:^Patient:Qn:PhenX,0
1671,Sit and reach stretch distance,Sit and reach stretch distance:Len:Pt:^Patient:Qn:PhenX,0
1672,Adjudication date by MD fracture coordinator,Adjudication date by MD fracture coordinator:Date:Pt:^Patient:Qn:PhenX,0
1673,Date abstracted,Date abstracted:Date:Pt:^Patient:Qn:PhenX,0
1674,11-ketoetiocholanolone,11-Ketoetiocholanolone^pre dose dexamethasone:MRat:24H:Urine:Qn,0
1675,Cortodoxone,11-Deoxycortisol^2D post dose metyraPONE:SCnc:Pt:Ser/Plas:Qn,0
1676,Hydrocortisone,Cortisol^4 AM specimen:MCnc:Pt:Saliva:Qn,0
1677,3-Hydroxybutyrate,Beta hydroxybutyrate:SCnc:Pt:Vitr fld:Qn,0
1678,ST amplitude.derived lead V6,ST amplitude.derived lead V6:Elpot:Pt:Heart:Qn:EKG,0
1679,"How often did you take garlic, as a pill, tablet, or capsule","How often did you take garlic, as a pill, tablet, or capsule:Find:Pt:^Patient:Ord:PhenX",0
1680,microarray platform version number,Microarray platform version number:ID:Pt:Bld/Tiss:Nar:Molgen,0
1681,Nonesterified Fatty Acids,Fatty acids.nonesterified^9th specimen post CFst:SCnc:Pt:Ser/Plas:Qn,0
1682,Sigmoidoscopy or colonoscopy,Sigmoidoscopy or colonoscopy:Find:Pt:^Patient:Ord:PhenX,0
1683,Multiple polyps in specimen jar,Multiple polyps in specimen jar:Find:Pt:^Patient:Ord:PhenX,0
1684,Non-advanced adenomas,Non-advanced adenomas:Num:Pt:^Patient:Qn:PhenX,0
1685,Prunus avium Ab.IgE,Prunus avium Ab.IgE:ACnc:Pt:Ser:Qn,0
1686,Lymphocyte proliferation. 0.5 ug phytohemagglutinin stimulation actual/Normal,Lymphocyte proliferation. 0.5 ug phytohemagglutinin stimulation actual/Normal:RelRto:Pt:Bld:Qn,0
1687,Derived post treatment-7 stage group,Derived post treatment-7 stage group:Prid:Pt:Cancer.XXX:Nom,0
1688,Apnea interval,Apnea interval:Time:Pt:Ventilator.alarm:Qn,0
1689,Piper nigrum Ab.IgG,Piper nigrum Ab.IgG:MCnc:Pt:Ser:Qn,0
1690,Rumex acetosella Ab.IgE,Rumex acetosella Ab.IgE:ACnc:Pt:Ser:Qn,0
1691,About how long has it been since you completely quit smoking cigarettes,About how long has it been since you completely quit smoking cigarettes:Time:Pt:^Patient:Qn:TUS-CPS,0
1692,Did you continue to use marijuana after you knew it caused this problem,Did you continue to use marijuana after you knew it caused this problem:Find:Pt:^Patient:Ord:SSAGA II,0
1693,Which best describes the way you usually treat severe headaches,Which best describes the way you usually treat severe headaches:Find:Pt:^Patient:Ord:PhenX,0
1694,Right or left ear,Right or left ear:Find:Pt:Ear:Nom:PhenX,0
1695,My child's ability to make grown up sentences is,My child's ability to make grown up sentences is:Find:Pt:^Patient:Ord:PhenX,0
1696,Testosterone,Testosterone:SCnc:Pt:Body fld:Qn,0
1697,Dengue virus 4 RNA,Dengue virus 4 RNA:PrThr:Pt:Ser:Ord:Probe.amp.tar,0
1698,Enflurane gas delivered.total,Enflurane gas delivered.total:Vol:RptPeriod:Gas delivery system:Qn,0
1699,Keratin Ab,Keratin Ab:PrThr:Pt:Ser:Ord:IF,0
1700,Effect this medication has on your child,Effect this medication has on your child:Find:Pt:^Patient:Nom:PhenX,0
1701,Booster date,Booster date:Date:Pt:^Patient:Qn:PhenX,0
1702,6-alpha hydroxytetrahydro-11-deoxycortisol,6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre dose dexamethasone:MCnc:24H:Urine:Qn,0
1703,Velocity-time integral.pulmonary vein A wave/Velocity-time integral.mitral valve A wave,Velocity-time integral.pulmonary vein A wave/Velocity-time integral.mitral valve A wave:LenFr:Pt:Pulmonary vein:Qn:US,0
1704,lacosamide,Lacosamide:MCnc:Pt:Bld:Qn,0
1705,Liver kidney microsomal 1 Ab,Liver kidney microsomal 1 Ab:Titr:Pt:CSF:Qn:IF,0
1706,"Over the past 4W when you had sexual stimulation or intercourse, how often did you ejaculate","Over the past 4W when you had sexual stimulation or intercourse, how often did you ejaculate:Find:4W:^Patient:Ord:PhenX",0
1707,"When you urinate, pass water, do you usually feel like you have not completely emptied your bladder","When you urinate, pass water, do you usually feel like you have not completely emptied your bladder:Find:Pt:^Patient:Ord:PhenX",0
1708,"When you wake up in the morning or from a nap, do you feel out of it and confused","When you wake up in the morning or from a nap, do you feel out of it and confused:Find:Pt:^Patient:Ord:PhenX",0
1709,Luteinizing Hormone,Lutropin^10M post XXX challenge:ACnc:Pt:Ser/Plas:Qn,0
1710,Luteinizing Hormone,Lutropin^3H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,0
1711,Corticotropin,Corticotropin^2H post XXX challenge:MCnc:Pt:Plas:Qn,0
1712,Human antihuman Ab,Human antihuman Ab:MCnc:Pt:Plas:Qn,0
1713,Waxy casts (substance),Waxy casts:Naric:Pt:Urine sed:Qn:Microscopy.light.LPF,0
1714,Coxsackievirus B IgG,Coxsackievirus B Ab.IgG:Titr:Pt:Ser:Qn,0
1715,Do you still have chronic bronchitis,Do you still have chronic bronchitis:Find:Pt:^Patient:Ord:PhenX,0
1716,I sympathize with others problems,I sympathize with others problems:Find:Pt:^Patient:Ord:PhenX,0
1717,I don't like being away from my family,I don't like being away from my family:Find:Pt:^Patient:Ord:SCARED-R,0
1718,"What is the longest period of time that you have felt this overwhelming desire to go to sleep, on most Ds","What is the longest period of time that you have felt this overwhelming desire to go to sleep, on most Ds:Time:Pt:^Patient:Qn:PhenX",0
1719,During what part of the night do these events most often occur,During what part of the night do these events most often occur:Find:Pt:^Patient:Nom:PhenX,0
1720,Lab or imaging sequence,Lab or imaging sequence:Find:Pt:^Patient:Nom:PhenX,0
1721,Gold,Gold:MCnc:Pt:Bld:Qn,0
1722,Pentachlorophenol,Pentachlorophenol:Mass Concentration:Point in time:Urine:Quantitative,0
1723,Protein.monoclonal.beta,Deprecated Protein.monoclonal.beta [Mass/volume] in Urine by Electrophoresis,0
1724,Ever diagnosed by a doctor as having an abdominal aortic aneurysm,Ever diagnosed by a doctor as having an abdominal aortic aneurysm:Finding:Point in time:^Patient:Ordinal,0
1725,Mononuclear cells/100 leukocytes,Mononuclear cells/100 leukocytes:NFr:Pt:Dial fld prt:Qn,0
1726,Desethylvardenafil,Desethylvardenafil:MCnc:Pt:Urine:Qn,0
1727,Corticotropin,Corticotropin^5M post XXX challenge:SCnc:Pt:Plas:Qn,0
1728,Ribosomal ribonucleoprotein antibody,Ribonucleoprotein extractable nuclear Ab:PrThr:Pt:Body fld:Ord:Immune diffusion,0
1729,Echinococcus species antibody,Echinococcus sp Ab:ACnc:Pt:Ser:Qn:IA,0
1730,Screening for cancer,Cancer screening:Find:Pt:^Patient:Nom:PLCO,0
1731,Other relative,Other relative:Find:Pt:^Patient:Nom:PhenX,0
1732,Other drugs or medications occurring with insomnia,Other drugs or medications occurring with insomnia:Find:Pt:^Patient:Ord:PhenX,0
1733,Hydrocortisone,Cortisol^9th specimen:MCnc:Pt:Saliva:Qn,0
1734,Hydrocortisone,Cortisol^6th specimen:MCnc:Pt:Saliva:Qn,0
1735,Sample condition,Sample condition:Type:Point in time:Blood filter paper:Nominal,0
1736,Hydrocortisone,Cortisol^20th specimen:MCnc:Pt:Ser/Plas:Qn,0
1737,Finding of Mean Corpuscular Hemoglobin,Erythrocyte mean corpuscular hemoglobin:EntSub:Pt:RBC:Qn,0
1738,Severe acute respiratory syndrome coronavirus RNA,SARS coronavirus RNA:PrThr:Pt:Ser/Plas:Ord:Probe.amp.tar,0
1739,Assembly or installation instructions,Assembly or installation instructions:-:-:^FDA package insert:Nar,0
1740,Budgerigar feather Ab.IgE,Deprecated Budgerigar feather IgE Ab [Units/volume] in Serum,0
1741,PhenX measure - general distress screener,PhenX measure - general distress screener:-:Point in time:^Patient:-:PhenX,0
1742,Date of major illness or surgery,Date of major illness or surgery:Date:Pt:^Patient:Qn:PhenX,0
1743,"While you were having numbness, tingling and loss of sensation, did any of these things occur","While you were having numbness, tingling and loss of sensation, did any of these things occur:Find:Pt:^Patient:Ord:PhenX",0
1744,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
1745,Growth Hormone,Somatotropin^28th specimen:MCnc:Pt:Ser/Plas:Qn,0
1746,Collaborative staging post treatment extension,Collaborative staging post treatment extension:Prid:Pt:Cancer.XXX:Nom,0
1747,Nordazepam,Nordiazepam:MCnt:Pt:Stool:Qn:Confirm,0
1748,Indium,Indium:MCnc:Pt:RBC:Qn,0
1749,Protein C Antigen,Protein C Ag:ACnc:Pt:PPP:Qn:IA,0
1750,"Does your child now take vitamins with fluoride in them or any other kind of fluoride tablets, drops or supplements","Does your child now take vitamins with fluoride in them or any other kind of fluoride tablets, drops or supplements:Find:Pt:^Patient:Ord:PhenX",0
1751,Sometimes I do impulsive things that I later regret,Sometimes I do impulsive things that I later regret:Finding:Point in time:^Patient:Ordinal:UPPS,0
1752,Trimipramine & Nortrimipramine panel,Trimipramine & Nortrimipramine panel:-:Pt:Ser/Plas:Qn,0
1753,Cortodoxone,11-Deoxycortisol^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
1754,Chicken droppings Ab.IgG,Chicken droppings Ab.IgG:MCnc:Pt:Ser:Qn,0
1755,Fusarium culmorum Ab.IgE,Fusarium culmorum Ab.IgE:ACnc:Pt:Ser:Qn,0
1756,Enterovirus 71 RNA,Enterovirus 71 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
1757,Tooth site - periodontal,Tooth site - periodontal:Find:Pt:Tooth:Nom:PhenX,0
1758,Admission evaluation note,Admission evaluation note:Find:Pt:Hospital:Doc:Thoracic and cardiac surgery,0
1759,"How many times in the last Y have you sold marijuana or hashish, pot, grass, hash","How many times in the last Y have you sold marijuana or hashish, pot, grass, hash:NRat:1Y:^Patient:Qn:Denver Youth Survey",0
1760,Have you done anything else in the past year that could have gotten you in trouble with the police,Have you done anything else in the past year that could have gotten you in trouble with the police:Find:Pt:^Patient:Ord:Denver Youth Survey,0
1761,Insulin,Insulin^1D post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
1762,Topoisomerase-1 antibody,SCL-70 extractable nuclear Ab:PrThr:Pt:Ser:Ord:IB,0
1763,Lead,Deprecated Lead:Mass Concentration:Point in time:Whole blood:Ordinal,0
1764,prasterone,Dehydroepiandrosterone^pre dose dexamethasone:MCnc:24H:Urine:Qn,0
1765,HEDIS 2010 Codes to identify LDLc screening (CDC-H),HEDIS 2010 Codes to identify LDLc screening (CDC-H):-:Point in time:^Patient:-,0
1766,HEDIS 2010 panel,HEDIS 2010 panel:-:Point in time:^Patient:-,0
1767,Flag for Hospital admission.first contact not populated,Flag for Hospital admission.first contact not populated:Prid:Pt:Cancer.XXX:Nom,0
1768,People often tell me that I keep going on and on about the same thing,People often tell me that I keep going on and on about the same thing:Find:Pt:^Patient:Ord:AQ,0
1769,Herpes simplex virus 2 Antigen,Herpes simplex virus 2 Ag:PrThr:Pt:Genital:Ord:IF,0
1770,House dust Allergopharma Ab.IgE,House dust Allergopharma Ab.IgE:ACnc:Pt:Ser:Qn,0
1771,Alternaria alternata Ab.IgE,Alternaria alternata Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative,0
1772,Blatella germanica Ab.IgE,Blatella germanica Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative,0
1773,Indexing - Indication,Indexing - Indication:-:-:^FDA product label:Nar,0
1774,pregabalin,Pregabalin:PrThr:Pt:Urine:Ord:Screen,0
1775,Your child finds it easy to do more than one thing at once,Your child finds it easy to do more than one thing at once:Find:Pt:^Patient:Ord:AQ Adolescent,0
1776,Your child is a good diplomat,Your child is a good diplomat:Find:Pt:^Patient:Ord:AQ Adolescent,0
1777,Do you have an unreasonably strong fear or avoid this social situation,Do you have an unreasonably strong fear or avoid this social situation:Find:Pt:^Patient:Ord:CIDI-SF,0
1778,Allium ampeloprasum Ab.IgE,Allium ampeloprasum Ab.IgE:ACnc:Pt:Ser:Qn,0
1779,Factor VIII antibody,Coagulation factor VIII Ab:PrThr:Pt:PPP:Ord:IA,0
1780,C-Peptide,C peptide^15M post dose glucose:MCnc:Pt:Ser/Plas:Qn,0
1781,Coagulation surface induced normal/Actual,Coagulation surface induced normal/Actual:RelTime:Pt:PPP:Qn:Coag,0
1782,Legionella sp identified,Legionella sp identified:Prid:Pt:Sputum:Nom:Organism specific culture,0
1783,Benzoylecgonine,Benzoylecgonine:MCnc:Pt:Ser/Plas:Qn:Confirm,0
1784,Hydrogen/Expired gas,Hydrogen/Expired gas^3H post dose fructose PO:VFr:Pt:Exhl gas:Qn,0
1785,Cells counted,"Cells counted:Number:Point in time:Whole blood/Tissue, unspecified:Quantitative:Molecular Genetics",0
1786,Dermatophagoides farinae Ab.IgG,Dermatophagoides farinae Ab.IgG:MCnc:Pt:Ser:Qn,0
1787,Coxiella burnetii phase 1 IgM,Coxiella burnetii phase 1 Ab.IgM:PrThr:Pt:Ser:Ord:IF,0
1788,"If disabled from walking by any condition other than heart or lung disease, please describe nature of conditions","If disabled from walking by any condition other than heart or lung disease, please describe nature of conditions:Find:Pt:^Patient:Nom:PhenX",0
1789,"Does your child like to do things over and over again, in the same way all the time","Does your child like to do things over and over again, in the same way all the time:Find:Pt:^Patient:Ord:CAST",0
1790,Have you ever been nearby when an explosion or a blast occurred,Have you ever been nearby when an explosion or a blast occurred:Find:Pt:^Patient:Ord:PhenX,0
1791,"If more injuries with LOC, longest knocked out","If more injuries with LOC, longest knocked out:Time:Pt:^Patient:Qn:PhenX",0
1792,Hands resting in lap for 15S,Hands resting in lap for 15S:Find:Pt:^Patient:Ord:PhenX,0
1793,Has anyone ever damaged or destroyed something on purpose that belonged to you or to someone who you lived with,Has anyone ever damaged or destroyed something on purpose that belonged to you or to someone who you lived with:Find:Pt:^Patient:Ord:LTVH,0
1794,ED transferring provider,ED transferring provider:Identifier:Point in time:Provider:Nominal,0
1795,phosphate ion,Phosphate:MCnc:12H:Urine:Qn,0
1796,ADNFLE gene targeted mutation analysis,ADNFLE gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
1797,CACNA1S+SCN4A gene targeted mutation analysis,CACNA1S+SCN4A gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
1798,Calcium,Calcium:MCnc:Pt:Flu.nonbiological:Qn,0
1799,C-Peptide,C peptide^4H post dose glucose:MCnc:Pt:Ser/Plas:Qn,0
1800,Estazolam,Estazolam:MCnc:Pt:Bld:Qn:Confirm,0
1801,Chest operations you had,Chest operations you had:Find:Pt:^Patient:Nom:PhenX,0
1802,I see myself as someone who is curious about many different things,I see myself as someone who is curious about many different things:Find:Pt:^Patient:Ord:BFI,0
1803,I see myself as someone who is generally trusting,I see myself as someone who is generally trusting:Find:Pt:^Patient:Ord:BFI,0
1804,Disease Progression,Course of disorder:Finding:Point in time:^Patient:Nominal,0
1805,Blunted affect,Blunted affect:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4,0
1806,Strychnine,Strychnine:PrThr:Pt:Ser/Plas:Ord,0
1807,Corticotropin,Corticotropin^1st specimen post XXX challenge:SCnc:Pt:Plas:Qn,0
1808,A wave.max,A wave.max:Vel:Pt:Heart.valve.XXX:Qn:US,0
1809,Brompheniramine,Brompheniramine:SCnc:Pt:XXX:Qn,0
1810,Blastomyces dermatitidis antigen,Blastomyces dermatitidis Ag:PrThr:Pt:Ser:Ord:IA,0
1811,Micropterus salmoides Ab.IgG,Micropterus salmoides Ab.IgG:MCnc:Pt:Ser:Qn,0
1812,House dust Hollister Stier Ab.IgG,House dust Hollister Stier Ab.IgG:MCnc:Pt:Ser:Qn,0
1813,Where was your mother's mother born,Where was your mother's mother born:Find:Pt:^Patient:Nom:PhenX,0
1814,"On a typical weekday in the summer, about how many H did you generally spend in the mid-day sun","On a typical weekday in the summer, about how many H did you generally spend in the mid-day sun:NRat:Pt:^Patient:Qn:NHL",0
1815,"During the past 30D, about how often did you feel worthless","During the past 30D, about how often did you feel worthless:Find:30D:^Patient:Ord:Kessler 6 Distress",0
1816,microscopic observation,"Microscopic observation:Presence or Identity:Point in time:Tissue, unspecified:Nominal:Dark field examination",0
1817,Pathology biopsy report,Pathology biopsy report:Find:Pt:Breast:Nar,0
1818,How many times in the last Y have you been drunk in a public place,How many times in the last Y have you been drunk in a public place:NRat:1Y:^Patient:Qn:Denver Youth Survey,0
1819,(Ambrosia elatior+Artemisia vulgaris+Chrysanthemum leucathemum+Taraxacum vulgare+Solidago virgaurea) Ab.IgE,(Ambrosia elatior+Artemisia vulgaris+Chrysanthemum leucathemum+Taraxacum vulgare+Solidago virgaurea) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk,0
1820,Muscle specific receptor tyrosine kinase Ab.IgG,Muscle specific receptor tyrosine kinase Ab.IgG:MCnc:Pt:Ser:Qn:IA,0
1821,I like to stop and think things over before I do them,I like to stop and think things over before I do them:Finding:Point in time:^Patient:Ordinal:UPPS,0
1822,"When I am in a great mood, I tend to do things that could cause me problems","When I am in a great mood, I tend to do things that could cause me problems:Find:Pt:^Patient:Ord:UPPS-R-C",0
1823,eosinophil,Eosinophils:NCnc:Pt:Bld^Fetus:Qn:Manual count,0
1824,Coagulation surface induced.lupus sensitive.factor substitution,Coagulation surface induced.lupus sensitive.factor substitution^immediately after addition of normal plasma:Time:Pt:PPP:Qn:Coag,0
1825,Medicago sativa Ab.IgG,Medicago sativa Ab.IgG:ACnc:Pt:Ser:Qn,0
1826,Enalapril induced platelet Ab.IgG,Enalapril induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1827,Respiratory syncytial virus RNA,Respiratory syncytial virus RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar,0
1828,Multisection,Multisection:Find:Pt:Extremity.right>Extremity artery:Doc:US,0
1829,Bipolanis curvularia Ab.IgE,Bipolanis curvularia Ab.IgE:ACnc:Pt:Ser:Qn,0
1830,Trimethoprim induced platelet Ab.IgG,Trimethoprim induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1831,1p36 deletion prior risk,1p36 deletion prior risk:Likelihood:Pt:^Fetus:Qn:Based on general population risk,0
1832,Pinus ponderosa Ab.IgE,Pinus ponderosa Ab.IgE:ACnc:Pt:Ser:Qn,0
1833,Basophils/leukocytes,Basophils/leukocytes:NFr.DF:Pt:Pericard fld:Qn:Manual count,0
1834,Nail assessment panel,Nail assessment panel:-:Point in time:Nail:-,0
1835,Wound dressing panel,Wound dressing panel:-:Point in time:Wound:-,0
1836,Signs and Symptoms,Clinical finding:Find:Pt:^Family member:Nom,0
1837,Phenytoin,Phenytoin^trough:MCnc:Pt:Ser/Plas:Qn,0
1838,Sesamum indicum basophil bound Ab,Sesamum indicum basophil bound Ab:ACnc:Pt:Bld:Qn:LHR,0
1839,Note (document),Note:Find:Pt:{Setting}:Doc:Pediatric otolaryngology,0
1840,Platelets.reticulated/platelets.total,Deprecated Platelets reticulated in Blood by Automated count,0
1841,Monocytes/leukocytes,Monocytes/leukocytes:NFr.DF:Pt:Synv fld:Qn:Manual count,0
1842,Chloride & sodium panel,Chloride & sodium panel:SCnc:Pt:Sweat:Qn,0
1843,Electrolytes 3 panel,Electrolytes 3 panel:-:Pt:CSF:Qn,0
1844,Mononuclear cells,Mononuclear cells:Num:Pt:CSF:Qn:Manual count,0
1845,Secretory Immunoglobulin A,IgA.secretory:MCnc:Pt:Tear:Qn,0
1846,Eosinophils/leukocytes,Eosinophils/leukocytes:NFr.DF:Pt:CSF:Qn:Manual count,0
1847,Racial group,Race:Type:Pt:^Patient:Nom:OMB.1997,0
1848,Discase Ab.IgE,Discase Ab.IgE:ACnc:Pt:Ser:Qn,0
1849,Simethicone induced platelet Ab.IgG,Simethicone induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1850,danofloxacin,Danofloxacin:Susc:Pt:Isolate:OrdQn:MIC,0
1851,3-Hydroxymyristoleylcarnitine (C14:1-OH),3-Hydroxymyristoleylcarnitine (C14:1-OH):CCnt:Pt:Fibroblasts:Qn,0
1852,Cells.CD158e/100 cells,Cells.CD158e/100 cells:NFr:Pt:XXX:Qn,0
1853,Cancer related large scale gene targeted mutation analysis,Cancer related large scale gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
1854,Citrobacter sp (ompA+mrkC) genes,Deprecated Citrobacter sp (ompA+mrkC) genes [Presence] by Nucleic acid capture and probe detection in Positive blood culture,0
1855,Cancer detection basis,Cancer detection basis:Type:Point in time:^Patient:Nominal,0
1856,Do you feel that your tinnitus problem has placed stress on your relationship with members of your family and friends,Do you feel that your tinnitus problem has placed stress on your relationship with members of your family and friends:Find:Pt:^Patient:Ord:PhenX,0
1857,My voice sounds creaky and dry,My voice sounds creaky and dry:Find:Pt:^Patient:Ord:PhenX,0
1858,Acetohexamide,Acetohexamide:MCnc:Pt:XXX:Qn,0
1859,Activation of the destination healthcare facility team,Activation of the destination healthcare facility team:Find:Pt:^Patient:Ord:NEMSIS,0
1860,Burkholderia mallei antigen,Burkholderia mallei Ag:PrThr:Pt:XXX:Ord:IF,0
1861,Ictalurus punctatus Ab.IgE,Ictalurus punctatus Ab.IgE:ACnc:Pt:Ser:Qn,0
1862,Rosiglitazone induced platelet Ab.IgG,Rosiglitazone induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1863,Father identifier,Father identifier:ID:Pt:^Father:Nom,0
1864,Cryptococcus sp Ag,Cryptococcus sp Ag:PrThr:Pt:Ser:Ord:IA.rapid,0
1865,Prunus armeniaca Ab.IgG,Prunus armeniaca Ab.IgG:ACnc:Pt:Ser:Qn,0
1866,Rotavirus IgG,Rotavirus Ab.IgG:Titr:Pt:Ser:Qn:IA,0
1867,Acetoacetates,Acetoacetate^post meal:SCnc:Pt:Bld:Qn,0
1868,Candida sp 6 panel,Candida sp 6 panel:-:Pt:Vag:-:Probe.amp.tar,0
1869,Octanoylcarnitine (C8),Octanoylcarnitine (C8):CCnt:Pt:Fibroblasts:Qn,0
1870,Butyrylcarnitine (C4),Butyrylcarnitine (C4):CCnt:Pt:Fibroblasts:Qn,0
1871,Fatty acids pattern,Fatty acids pattern:Imp:Pt:RBC:Nar,0
1872,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by cube method,0
1873,Turnip Ab.IgE,Turnip Ab.IgE:ACnc:Pt:Ser:Qn,0
1874,Have you ever had heart surgery,Have you ever had heart surgery:Hx:Pt:^Patient:Ord:PhenX,0
1875,Bacteria antigenic formula,Bacteria antigenic formula:ID:Pt:Isolate:Nom,0
1876,Ancillary eye tests,Ancillary eye tests:Finding:Point in time:^Patient:Narrative,0
1877,CYP2D6 gene drug metabolism analysis overall interpretation,CYP2D6 gene drug metabolism analysis overall interpretation:Imp:Pt:Bld/Tiss/Sal:Ord:Molgen,0
1878,Glycosaminoglycans/Creatinine,Glycosaminoglycans/Creatinine:Ratio:24H:Urine:Qn,0
1879,deoxyinosine,Deoxyinosine:SCnc:Pt:CSF:Qn,0
1880,Guidance for percutaneous biopsy,Guidance for percutaneous biopsy:Find:Pt:XXX>Intervertebral disc:Doc:RF,0
1881,Trifluoperazine,Trifluoperazine:PrThr:Pt:Bld/Urine:Ord:Screen,0
1882,heart rate,Heart rate^standing:NRat:Pt:Arterial system:Qn,0
1883,Granulocytes.immature/100 leukocytes,Granulocytes.immature/100 leukocytes:NFr:Pt:Synv fld:Qn,0
1884,Dicarboxytetradecenoylcarnitine (C14:1-DC),Dicarboxytetradecenoylcarnitine (C14:1-DC):SCnc:Pt:CSF:Qn,0
1885,Drug induced neutrophil Ab panel,Drug induced neutrophil Ab panel:-:Pt:Ser/Plas:-,0
1886,Moxifloxacin induced platelet Ab.IgG,Moxifloxacin induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1887,Albuterol induced platelet Ab.IgG,Albuterol induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1888,Drug induced platelet antibody,Drug induced platelet Ab:Imp:Pt:Ser/Plas:Nar,0
1889,Mesothelin Ag,Mesothelin Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
1890,Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10),Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10):SRto:Pt:Bld.dot:Qn,0
1891,Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC),Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC):SRto:Pt:Bld.dot:Qn,0
1892,Progress note,Progress note:Find:Pt:{Setting}:Doc:Urology,0
1893,Current severity of limitation,Current severity of limitation:Find:Pt:^Patient:Ord,0
1894,Projected goal of limitation,Projected goal of limitation:Find:Pt:^Patient:Ord,0
1895,People have acted as if they think you are not smart,People have acted as if they think you are not smart:Find:Pt:^Patient:Ord:PhenX,0
1896,Dicarboxytetradecenoylcarnitine (C14:1-DC),Dicarboxytetradecenoylcarnitine (C14:1-DC):SCnc:Pt:Urine:Qn,0
1897,Midazolam induced platelet Ab.IgG,Midazolam induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1898,RR interval.coefficient of variation,RR interval.coefficient of variation:TRto:Procedure dur:Heart:Qn:EKG,0
1899,Teachers at my school help us children with our problems,Teachers at my school help us children with our problems:Find:Pt:^Patient:Ord:PhenX,0
1900,Glutamate decarboxylase 65 antibody,Glutamate decarboxylase 65 Ab:PrThr:Pt:Ser/Plas:Ord:IF,0
1901,raltegravir,Raltegravir:Susc:Pt:Isolate:Ord:Genotyping,0
1902,Tacrolimus induced neutrophil Ab.IgM,Tacrolimus induced neutrophil Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1903,ceftaroline,Ceftaroline:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
1904,Methadone panel,Methadone panel:-:Pt:Saliva:-:Screen,0
1905,Inspiration/Inspiration+Expiration,Inspiration/Inspiration+Expiration:TimeFr:Pt:Respiratory system:Qn,0
1906,End-diastolic volume,End-diastolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.M-mode+Calculated by cube method,0
1907,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.M-mode+Calculated by Gibson method,0
1908,EMS physical assessment,EMS physical assessment:-:Pt:^Patient:Nar:NEMSIS,0
1909,Progress note,Progress note:Find:Pt:Hospital:Doc:Cardiovascular disease.medical student,0
1910,"inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript","inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen",0
1911,Levodopa induced platelet Ab.IgM,Levodopa induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1912,Blasts assessment,Blasts assessment:Find:Pt:Bone mar:Nar,0
1913,Blood group antigens present,Blood group antigens present:Prid:Pt:Bld:Nom:Immediate spin,0
1914,Other cells/100 leukocytes,Other cells/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count,0
1915,Pseudomonas aeruginosa regA gene,Pseudomonas aeruginosa regA gene:PrThr:Pt:XXX.swab:Ord:Probe.amp.tar,0
1916,Length-based tape measure category,Deprecated Length-based tape measure category NEMSIS,0
1917,2-hydroxyisovalerate,2-Hydroxyisovalerate:SCnc:Pt:CSF:Qn,0
1918,Minocycline,Minocycline:Susc:Pt:Isolate:OrdQn:Gradient strip,0
1919,Rotavirus dsRNA,Rotavirus dsRNA:Prid:Pt:Stool:Nom:PAGE,0
1920,Beta globulin/Protein.total,Beta globulin/Protein.total:MFr.DF:Pt:Ser/Plas:Qn:Electrophoresis,0
1921,albumin/protein.total,Albumin/Protein.total:MFr.DF:Pt:CSF:Qn:Electrophoresis,0
1922,Ketorolac induced platelet Ab.IgM,Ketorolac induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1923,Ipratropium induced platelet Ab.IgM,Ipratropium induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1924,(Ambrosia elatior+Ambrosia psilostachya+Ambrosia trifida) Ab.IgE,(Ambrosia elatior+Ambrosia psilostachya+Ambrosia trifida) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk,0
1925,Personal belief,Personal belief:Finding:Point in time:^Patient:Nominal,0
1926,Consultation note,Consultation note:Find:Pt:Hospital:Doc:Ophthalmology,0
1927,Letter [Publication Type],Letter:Find:Pt:Hospital:Doc:Ophthalmology,0
1928,Chlamydia trachomatis IgA,Chlamydia trachomatis Ab.IgA:Titr:Pt:Ser:Qn:IF,0
1929,Methylsuccinate,Methylsuccinate:SCnc:Pt:Amnio fld:Qn,0
1930,rivaroxaban,Rivaroxaban:MCnc:Pt:Ser/Plas:Qn,0
1931,MICA*036 Ab.IgG,MICA*036 Ab.IgG:PrThr:Pt:Ser:Ord,0
1932,Temperature,Temperature:Temp:Pt:Transcutaneous monitor sensor:Qn,0
1933,Proteins,Protein^2nd tube:MCnc:Pt:CSF:Qn,0
1934,Proteins,Protein^4th tube:MCnc:Pt:CSF:Qn,0
1935,Lymphocyte,Lymphocytes:NCnc:Pt:Plr fld^Fetus:Qn,0
1936,Discharge summary note,Discharge summary note:Find:Pt:{Setting}:Doc:Allergy+Immunology,0
1937,Note (document),Note:Find:Pt:{Setting}:Doc:Allergy+Immunology,0
1938,Mianserin,Mianserin^trough:MCnc:Pt:Ser/Plas:Qn,0
1939,Citalopram induced neutrophil Ab.IgM,Citalopram induced neutrophil Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1940,Celecoxib induced neutrophil Ab.IgM,Celecoxib induced neutrophil Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
1941,Immunoglobulin kappa-Chains,Immunoglobulin light chains.kappa:PrThr:Pt:Ser:Ord:IA,0
1942,Pre-operative evaluation and management note,Preoperative evaluation and management note:Find:Pt:{Setting}:Doc:Clinical genetics,0
1943,Letter [Publication Type],Letter:Find:Pt:Hospital:Doc:Clinical genetics,0
1944,Cryptococcus terreus Ab.IgE,Cryptococcus terreus Ab.IgE:ACnc:Pt:Ser:Qn,0
1945,Human immunodeficiency virus 1 proviral DNA,HIV 1 proviral DNA:LnCnc:Pt:XXX:Qn:Probe.amp.tar,0
1946,Note (document),Note:Find:Pt:Outpatient:Doc:Urology,0
1947,Aspergillus sp DNA,Aspergillus sp DNA:PrThr:Pt:BAL:Ord:Probe.amp.tar,0
1948,Epinephrine,Epinephrine^2H post 300 ug cloNIDine PO:MCnc:Pt:Plas:Qn,0
1949,Glucose,Glucose^2H post 50 g lactose PO:MCnc:Pt:Ser/Plas:Qn,0
1950,Institution inventory number,Institution inventory number:ID:Pt:IO tube:Nom,0
1951,3-methoxytyrosine,3-O-Methyldopa:MCnc:Pt:Ser/Plas:Qn,0
1952,Diameter (qualifier value),Diameter:Len:Pt:Small bowel^Fetus:Qn:US.measured,0
1953,Immunoglobulin M antibody to Toxoplasma gondii,Toxoplasma gondii Ab.IgM:Titr:Pt:Ser:Qn:IA,0
1954,Cells.CD3-CD19+/100 cells,Cells.CD3-CD19+/100 cells:NFr:Pt:Bld:Qn,0
1955,Bean kidney red Ab.IgE.RAST class,Bean kidney red Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
1956,Prolactin,Prolactin^30 minutes post dose insulin Intravenous:Mass Concentration:Point in time:Serum/Plasma:Quantitative,0
1957,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Acetate esterase stain,0
1958,Diameter.max,Diameter.max:Len:Pt:Ovary.left.largest follicle:Qn:US,0
1959,Corticotropin-Releasing Hormone,Corticotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn,0
1960,Diuretics,Diuretics:Prid:Pt:Urine:Nom,0
1961,Insulin-Like Growth-Factor Binding Protein 1,Insulin-like growth factor binding protein 1:MCnc:Pt:Ser/Plas:Qn,0
1962,Azelate/Creatinine,Azelate/Creatinine:MRto:Pt:Urine:Qn,0
1963,Citrulline/Creatinine,Citrulline/Creatinine:MRto:Pt:Urine:Qn,0
1964,Pseudotsuga taxifolia Ab.IgE.RAST class,Pseudotsuga taxifolia Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
1965,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Silver impregnation stain.Dieterle,0
1966,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Silver stain.Grimelius,0
1967,Hematocrit procedure,Hematocrit:VFr:Pt:BldCo:Qn:Automated count,0
1968,Cyclohexane,Cyclohexane:MCnc:Pt:Bld:Qn,0
1969,Thiothixene,Thiothixene:PrThr:Pt:Urine:Ord,0
1970,Glyoxylate/Creatinine,Glyoxylate/Creatinine:MRto:Pt:Urine:Qn,0
1971,2-Methylcitrate/Creatinine,2-Methylcitrate/Creatinine:MRto:Pt:Urine:Qn,0
1972,Horse epithelium Ab.IgE.RAST class,Horse epithelium Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
1973,Feeding and dietary status,Feeding and dietary status:Finding:Point in time:^Patient:Nominal:Reported,0
1974,Dihydrocodeine.free,Dihydrocodeine.free:MCnc:Pt:Ser/Plas:Qn,0
1975,Glucose,Glucose:SCnc:Pt:BldC:Qn:Glucometer,0
1976,Glucose,Glucose^2H post meal:SCnc:Pt:Ser/Plas:Qn,0
1977,Glucose,Glucose^30M post 50 g lactose PO:SCnc:Pt:Ser/Plas:Qn,0
1978,Mucor racemosus Ab.IgE.RAST class,Mucor racemosus Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
1979,Leishmania braziliensis IgM,Leishmania braziliensis Ab.IgM:ACnc:Pt:Ser:Qn,0
1980,Phosphoserine,Phosphoserine:MCnc:Pt:Amnio fld:Qn,0
1981,"V antigen, unspecified",V Ag:PrThr:Pt:RBC^Donor:Ord,0
1982,Free fractionated catecholamine,Catecholamines.free fractionated^1H post 300 ug cloNIDine PO:MCnc:Pt:Plas:Qn,0
1983,C-Peptide,C peptide^5M post 1 mg glucagon IV:MCnc:Pt:Ser/Plas:Qn,0
1984,Squamous Epithelial Cells,Epithelial cells.squamous:PrThr:Pt:Sputum:Ord:Microscopy.light,0
1985,Para-aminosalicylate,Para aminosalicylate:Susc:Pt:Isolate:OrdQn:MIC,0
1986,Low-Density Lipoproteins,Lipoprotein.beta:SCnc:Pt:Ser/Plas:Qn:Electrophoresis,0
1987,S wave duration.lead AVR,S wave duration.lead AVR:Time:Pt:Heart:Qn:EKG,0
1988,Amyloid P component antigen,Amyloid P component Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
1989,"Human immunodeficiency virus, type II glycoprotein 125 antibody",HIV 2 gp125 Ab:PrThr:Pt:Ser:Ord:IB,0
1990,Immunization,History of immunization:Finding:Point in time:^Patient:Narrative:Reported,0
1991,Immunization status,Immunization status:Find:Pt:^Patient:Nom:Reported,0
1992,Position.placenta,Position.placenta:Finding:Point in time:Uterus:Narrative:ULTRASOUND.measured,0
1993,demoxepam,Demoxepam:MCnc:Pt:Ser/Plas:Qn,0
1994,Clozapine+Norclozapine,Clozapine+Norclozapine:SCnc:Pt:Ser/Plas:Qn,0
1995,Norepinephrine,Norepinephrine^10M post standing:MCnc:Pt:Plas:Qn,0
1996,Gastrin Ag,Gastrin Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
1997,Blood group antigen KEL 1,K Antigen:Arbitrary Concentration:Point in time:Erythrocytes^Blood product unit (Pack):Ordinal,0
1998,Study observation,Study observation:Finding:Point in time:Aorta descending^Fetus:Nominal:ULTRASOUND,0
1999,Borrelia burgdorferi 29kD Ab,Borrelia burgdorferi 29kD Ab:PrThr:Pt:Body fld:Ord:IB,0
2000,microscopic observation,Microscopic observation:Prid:Pt:Vag:Nom:Gram stain,0
2001,phosphate ion,Phosphate:SRat:24H:Urine:Qn,0
2002,Phleum pratense Ab.IgE.RAST class,Phleum pratense Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
2003,Trichophyton Ab.IgE.RAST class,Trichophyton Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
2004,Psychiatric findings,Psychiatric findings:Finding:Point in time:^Patient:Narrative:Observed,0
2005,Clostridium tetani immunization status,Clostridium tetani immunization status:History:Point in time:^Patient:Nominal,0
2006,Bacillus anthracis antibody,Bacillus anthracis Ab:ACnc:Pt:XXX:Qn:IF,0
2007,microscopic observation,Microscopic observation:Prid:Pt:Stool:Nom:Acid fast stain,0
2008,calcium/albumin,Calcium/Albumin:MRto:Pt:Ser/Plas:Qn,0
2009,Xylene,Dimethylbenzene:MCnc:Pt:Bld:Qn,0
2010,Carbonyldiamide,Urea nitrogen:MCnc:Pt:Amnio fld:Qn,0
2011,Carbonyldiamide,Urea nitrogen:MCnc:Pt:Plr fld:Qn,0
2012,Calcium,Calcium:SCnc:Pt:Gast fld:Qn,0
2013,Bartonella henselae IgM,Bartonella henselae Ab.IgM:PrThr:Pt:CSF:Ord,0
2014,(Amylase+Glycine max+Sitophilus granarius+Triticum sativum) Ab.IgE,(Amylase+Glycine max+Sitophilus granarius+Triticum sativum) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk,0
2015,(Aspergillus fumigatus+Aspergillus niger) Ab.IgE,(Aspergillus fumigatus+Aspergillus niger) Ab.IgE:ACnc:Pt:Ser:Qn,0
2016,C-reactive protein,C reactive protein:PrThr:Pt:Ser/Plas:Ord,0
2017,M1 Ag,M1 Ag:PrThr:Pt:RBC^BPU:Ord,0
2018,Lipids,Lipids:MCnc:Pt:Body fld:Qn,0
2019,Monoamine Oxidase,Monoamine oxidase:CCnc:Pt:Bld:Qn,0
2020,P2 Ab,Deprecated P2 Antibody:Arbitrary Concentration:Point in time:Serum/Plasma^Donor:Ordinal:AGGLUTINATION RBC,0
2021,Aldosterone/Creatinine,Aldosterone/Creatinine:MRto:Pt:Urine:Qn,0
2022,phosphate ion,Phosphate:Substance Concentration:Point in time:Urine:Quantitative,0
2023,Ionized calcium,Calcium.ionized:SCnc:Pt:Ser/Plas:Qn:Calculated,0
2024,Zingiber officinale Ab.IgE.RAST class,Zingiber officinale Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
2025,Leptospira interrogans serovar Grippotyphosa antibody,Leptospira interrogans serovar Grippotyphosa Ab:Titr:Pt:Ser:Qn:Aggl,0
2026,Cotinine,Cotinine:MCnc:Pt:Urine:Qn,0
2027,ALPHA-N-ACETYLGALACTOSAMINIDASE,Alpha-N-acetylgalactosaminidase:CCnc:Pt:Ser/Plas:Qn,0
2028,HDL Cholesterol to LDL Cholesterol Ratio Measurement,Cholesterol.in LDL/Cholesterol.in HDL:Mass Concentration Ratio:Point in time:Serum/Plasma:Quantitative,0
2029,Triose-Phosphate Isomerase,Triosephosphate isomerase:CCnc:Pt:RBC:Qn,0
2030,Hydrogen-Ion Concentration,pH:LsCnc:Pt:Bld:Qn,0
2031,Cadmium/Creatinine,Cadmium/Creatinine:MRto:24H:Urine:Qn,0
2032,Platelet associated Ab.IgA,Deprecated Platelet associated IgA Ab [Units/volume] in Blood,0
2033,CD3+CD8+ cell,Cells.CD3+CD8+:NCnc:Pt:Bld:Qn,0
2034,Gastrin,Gastrin^5M post 0.2 U/kg secretin:MCnc:Pt:Ser/Plas:Qn,0
2035,Leishmania mexicana IgG,Leishmania mexicana Ab.IgG:Titr:Pt:Ser:Qn,0
2036,Catecholamines,Catecholamines^7th specimen post XXX challenge:MCnc:Pt:Urine:Qn,0
2037,Erythroblasts,Erythrocytes.nucleated:NCnc:Pt:Body fld:Qn:Manual count,0
2038,"2,3-Diphosphoglycerate","2,3-Diphosphoglycerate:SCnc:Pt:RBC:Qn",0
2039,Width,Width:Len:Pt:Prostate:Qn:US.measured,0
2040,Codeine,Codeine:MCnc:Pt:Urine:Qn:Confirm,0
2041,ST wave displacement.mid.lead AVR,ST wave displacement.mid.lead AVR:Elpot:Pt:Heart:Qn:EKG,0
2042,ST wave displacement.mid.lead V3,ST wave displacement.mid.lead V3:Elpot:Pt:Heart:Qn:EKG,0
2043,ceforanide,Ceforanide:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
2044,Cervical mucous arborization,Ferning:Type:Pt:Cvm:Nom,0
2045,Germ cells.immature,Germ cells.immature:NCnc:Pt:Semen:Qn,0
2046,Biophysical profile.breathing movement,Biophysical profile.breathing movement:Fcn:Pt:^Fetus:Ord:US,0
2047,Systolic flow/Diastolic flow,Systolic flow/Diastolic flow:VelRto:Pt:Cerebral artery anterior^Fetus:Qn:US.doppler,0
2048,C-Peptide,C peptide^6H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
2049,Gentamicin,Gentamicin:MCnc:Pt:Body fld:Qn,0
2050,cyclobenzaprine,Cyclobenzaprine:PrThr:Pt:Urine:Ord,0
2051,Lithium.saliva/Lithium.serum,Lithium.saliva/Lithium.serum:Relative Ratio:Point in time:Serum+Saliva:Quantitative,0
2052,Blood flow.mean,Blood flow.mean:Vel:Pt:Pulmonary valve:Qn:US.doppler,0
2053,Blood flow.mean,Blood flow.mean:Vel:Pt:Umbilical artery.between fetus and placenta^Fetus:Qn:US.doppler,0
2054,Creatinine,Creatinine^2H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn,0
2055,Asialoganglioside GM1 Ab,Deprecated Asialoganglioside GM1 Ab,0
2056,Monosialoganglioside GM1 Ab.IgA,Deprecated Monosialoganglioside GM1 Antibody.immunoglobulin A:Arbitrary Concentration:Point in time:Serum/Plasma:Quantitative or Ordinal,0
2057,Theophylline,Theophylline:MCnc:Pt:CSF:Qn,0
2058,Cyclosporine,Cyclosporine:SCnc:Pt:Ser:Qn,0
2059,Mental state,Mental status:Finding:Point in time:^Patient:Narrative:Observed,0
2060,Physical findings,Physical findings:Finding:Point in time:Neurologic system:Narrative:Observed,0
2061,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes:Number Fraction:Point in time:Cerebral spinal fluid:Quantitative:Manual count,0
2062,Glucose,Glucose^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
2063,Glucose,Glucose^50M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
2064,Insulin,Insulin^2.5H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,0
2065,Color,Color:Type:Pt:Gast fld:Nom,0
2066,Growth Hormone,Somatotropin^40M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
2067,Rubella virus antigen,Rubella virus Ag:PrThr:Pt:Penis:Ord:IF,0
2068,Cheese swiss Ab.IgE.RAST class,Cheese swiss Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
2069,Human papilloma virus (antigen),Human papilloma virus Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
2070,Diameter (qualifier value),Diameter:Len:Pt:Bowel:Qn:US.measured,0
2071,Diameter (qualifier value),Diameter:Len:Pt:Cervical canal.external os:Qn:US.measured,0
2072,Neutrophils/100 leukocytes,Neutrophils Fr Fld Manual,0
2073,Populus deltoides Ab.IgG,Populus deltoides Ab.IgG:ACnc:Pt:Ser:Qn,0
2074,Spermatozoa.motile/100 spermatozoa,Deprecated Spermatozoa Motile/100 spermatozoa in Semen,0
2075,Carnitine esters/Creatinine,Carnitine esters/Creatinine:MRto:Pt:Urine:Qn,0
2076,Blastomyces dermatitidis exoantigen identification,Blastomyces dermatitidis exoantigen identification:Prid:Pt:Isolate:Nom,0
2077,Chlorpheniramine,Chlorpheniramine:MCnc:Pt:Urine:Qn:Confirm,0
2078,hepatitis A virus antibodies,Hepatitis A virus Ab:ACnc:Pt:Ser:Qn,0
2079,Colistin,Colistin:MCnc:Pt:Ser/Plas:Qn,0
2080,Hydrocortisone,Cortisol^70M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
2081,Transfer summary note,Transfer summary note:Find:Pt:{Setting}:Doc:{Role},0
2082,Oxyhemoglobin/Hemoglobin.total,Deprecated Fractional oxyhemoglobin by Pulse oximetry --pre physiotherapy,0
2083,Cells.CD34/100 cells,Cells.CD34/100 cells:NFr:Pt:XXX:Qn,0
2084,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone:MCnc:Pt:Ser/Plas:Qn,0
2085,Testosterone,Testosterone^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
2086,cholesterol/triglyceride,Cholesterol/Triglyceride:MRto:Pt:Ser/Plas:Qn,0
2087,Thallium,Thallium:MCnt:Pt:Tiss:Qn,0
2088,"Cells.t(5;12)(q33.1;p13)(PDGFRB,ETV6)/Cells.total","Cells.t(5;12)(q33.1;p13)(PDGFRB,ETV6)/Cells.total:NFr:Pt:Bld/Tiss:Qn:Molgen",0
2089,Avian pox virus Ab,Avian pox virus Ab:PrThr:Pt:Ser:Ord:IA,0
2090,Magnesium,Magnesium:SRat:24H:Stool:Qn,0
2091,Parakeet serum Ab.IgE.RAST class,Parakeet serum Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
2092,Cells.CD48/100 cells,Cells.CD48/100 cells:NFr:Pt:Bld:Qn,0
2093,Triamterene,Triamterene:ACnc:Pt:Urine:Qn,0
2094,Cinoxacin,Cinoxacin:Susc:Pt:Isolate:OrdQn,0
2095,Peak inspiratory flow rate,Deprecated Peak inspiratory flow Respiratory system airway opening by Airway pressure monitor --at 2.0 liter per second on ventilator,0
2096,Border disease virus RNA,Border disease virus RNA:PrThr:Pt:Tiss^Fetus:Ord:Probe.amp.tar,0
2097,tungsten,Tungsten:MCnc:Pt:Ser/Plas:Qn,0
2098,Oxytetracycline,Oxytetracycline:Susc:Pt:Isolate:OrdQn,0
2099,Piper nigrum Ab.IgG.RAST class,Piper nigrum Ab.IgG.RAST class:PrThr:Pt:Ser:Ord,0
2100,SEER summary stage 1977,SEER summary stage 1977:Type:Pt:Cancer.XXX:Nom,0
2101,Polio virus 2 Ab,Polio virus 2 Ab:Titr:Pt:CSF:Qn,0
2102,Mareks disease virus Ab,Mareks disease virus Ab:PrThr:Pt:Ser:Ord:Immune diffusion,0
2103,Acetaminophen,Acetaminophen:ACnc:Pt:Urine:Qn,0
2104,Creatinine/Protein,Creatinine/Protein:MRto:Pt:Urine:Qn,0
2105,Emetine,Emetine:ACnc:Pt:Ser/Plas:Qn,0
2106,Cells.FMC7/100 cells,Cells.FMC7/100 cells:NFr:Pt:Bld:Qn,0
2107,Menthol,Menthol:MCnc:Pt:Bld:Qn,0
2108,"Alkaline phosphatase isoenzyme, liver fraction",Alkaline phosphatase.liver:CCnc:Pt:Ser/Plas:Qn,0
2109,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes:NFr:Pt:Body fld:Qn,0
2110,BETA-N-ACETYLHEXOSAMINIDASE,Beta-N-acetylhexosaminidase:CCnt:Pt:Tiss:Qn,0
2111,Volume,Volume:Vol:Pt:Breathing bag:Qn,0
2112,Ammonia,Ammonia:MCnc:Pt:Urine:Qn,0
2113,Fraxinus pennsylvanica Ab.IgE,Fraxinus pennsylvanica Ab.IgE:ACnc:Pt:Ser:Qn,0
2114,Bovine herpesvirus 1 Antigen,Bovine herpesvirus 1 Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
2115,Low-Density Lipoproteins,Lipoprotein.beta:PrThr:Pt:Ser/Plas:Ord,0
2116,Ureaplasma urealyticum,Ureaplasma urealyticum:PrThr:Pt:XXX:Ord:Organism specific culture,0
2117,Carbamoyl-Phosphate Synthase (Ammonia),Carbamoyl phosphate synthetase(ammonia):CCnt:Pt:Tiss:Qn,0
2118,Brucella abortus antibody,Brucella abortus Ab:PrThr:Pt:Milk:Ord:Aggl.serial ring test,0
2119,Secale cereale Ab.IgG.RAST class,Deprecated Rye IgG Ab RAST class in Serum,0
2120,Measles virus IgM,Measles virus Ab.IgM:Titr:Pt:Ser:Qn,0
2121,Mycoplasma gallisepticum antigen,Mycoplasma gallisepticum Ag:PrThr:Pt:XXX:Ord:IF,0
2122,Vesicular stomatitis Indiana virus Ab,Vesicular stomatitis Indiana virus Ab:PrThr:Pt:Ser:Ord:Comp fix,0
2123,Myelin basic protein antibody,Myelin basic protein Ab:MCnc:Pt:Ser:Qn,0
2124,Bile Acids,Bile acid:MCnc:Pt:Ser:Qn,0
2125,Gradient.max,Gradient.max:Pres:Pt:Mitral valve.regurgitant jet:Qn:US+Calculated,0
2126,Brucella abortus antibody,Brucella abortus Ab:PrThr:Pt:Ser:Ord:EIA.RST,0
2127,Choriogonadotropin.beta subunit (pregnancy test),Choriogonadotropin.beta subunit (pregnancy test):PrThr:Pt:Urine:Ord,0
2128,Snapper red Ab.IgG.RAST class,Snapper red Ab.IgG.RAST class:PrThr:Pt:Ser:Ord,0
2129,Salmonella enterica subspecies enterica serovar Paratyphi B O antibody,Salmonella paratyphi B O Ab:PrThr:Pt:Ser:Ord,0
2130,Brucella sp Antigen,Brucella sp Ag:PrThr:Pt:Placenta:Ord:Immune stain,0
2131,Viral hemorrhagic disease virus Ag,Viral hemorrhagic disease virus Ag:PrThr:Pt:Tiss:Ord:IF,0
2132,Bacteria identified,Bacteria identified^^^3:Prid:Pt:Tiss:Nom:Anaerobic culture,0
2133,Blood flow 2.mean,Blood flow 2.mean:Vel:Pt:Tricuspid valve.regurgitant jet:Qn:US,0
2134,Acceleration slope,Acceleration slope:Vel:Pt:Pulmonary artery:Qn:US,0
2135,Immunoglobulin G antibody to Toxoplasma gondii,Toxoplasma gondii Ab.IgG:PrThr:Pt:Ser:Ord:Dye test,0
2136,Correction comments battery,Correction comments battery:Complex:Point in time::Multi,0
2137,"Dicarboxylate, C6-C8-C10",Dicarboxylate C6-C8-C10:MCnc:Pt:Urine:Qn,0
2138,Immunoglobulin G antibody to Toxoplasma gondii,Toxoplasma gondii Ab.IgG:Titr:Pt:CSF:Qn,0
2139,Myxoma virus Ag,Myxoma virus Ag:PrThr:Pt:XXX:Ord:IF,0
2140,Azithromycin,Azithromycin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria,0
2141,Doxycycline,Deprecated Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria,0
2142,Streptomycin,Deprecated Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria,0
2143,Glucose,Glucose^6th specimen post XXX challenge:PrThr:Pt:Urine:Ord,0
2144,Tube number,Tube number:ID:Pt:CSF:Nom,0
2145,p-Hydroxyamphetamine,Para hydroxyamphetamine:PrThr:Pt:Urine:Ord:Confirm,0
2146,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by bullet method,0
2147,Varicella zoster virus IgM,Varicella zoster virus Ab.IgM:Titr:Pt:CSF:Qn:IF,0
2148,Avian encephalomyelitis virus antibody,Avian encephalomyelitis virus Ab:PrThr:Pt:Ser:Ord,0
2149,Trichinella spiralis IgM,Deprecated Trichinella spiralis IgM Ab [Presence] in Serum,0
2150,Bluetongue virus 2 Ab,Bluetongue virus 2 Ab:Titr:Pt:Ser:Qn:Neut,0
2151,benzthiazide,Benzthiazide:MCnc:Pt:Ser/Plas:Qn,0
2152,Free prostate specific antigen,Prostate specific Ag.free:SCnc:Pt:Semen:Qn,0
2153,Bicarbonates,Bicarbonate^^standard:SCnc:Pt:BldMV:Qn,0
2154,Psilocybin,Deprecated Psilocybin [Mass/volume] in Urine,0
2155,Flow,Flow:Area:Pt:Tricuspid valve:Qn:US.calculated,0
2156,Blood flow.max,Blood flow.max:Vel:Pt:Circulatory system.XXX:Qn:US.doppler,0
2157,regional,Region:Area:Pt:Heart.valve.XXX:Qn:US.doppler.VTI+Diameter.calculated,0
2158,Peste des petits ruminants virus Ab,Peste des petits ruminants virus Ab:PrThr:Pt:Ser:Ord:IA,0
2159,Peste des petits ruminants virus Ag,Peste des petits ruminants virus Ag:PrThr:Pt:Tiss:Ord:IA,0
2160,Deceleration,Deceleration:Time:Pt:Aortic valve.regurgitant jet:Qn:US.doppler,0
2161,Defect.gradient.systole.max,Defect.gradient.systole.max:Pres:Pt:Heart.ventricle.septum:Qn:US.doppler,0
2162,Amphetamine or methamphetamine Assay,AMPHETAMINES TESTED FOR:PRID:PT:UR:NOM:SCREEN,0
2163,Urobilinogen,Urobilinogen:MCnc:Pt:Urine:Qn:Test strip,0
2164,CFTR gene.p.Phe508del,CFTR gene.p.Phe508del:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
2165,Ejection fraction (finding),Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by single-plane ellipse method,0
2166,QT interval feature (observable entity),QT interval:Time:Pt:Lead V5:Qn:EKG,0
2167,Pigeon serum Ab.IgG,Pigeon serum Ab.IgG:PrThr:Pt:Ser:Ord,0
2168,General categories,General categories:Imp:Pt:Cvx/Vag:Nom:Cyto stain,0
2169,PRSS1 gene targeted mutation analysis,PRSS1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
2170,Leptospira interrogans serovar Icterohaemorrhagiae antibody,Leptospira interrogans serovar Icterohaemorrhagiae Ab:Titr:Pt:Ser:Qn,0
2171,Estriol,Estriol:MRat:24H:Urine:Qn,0
2172,Brucella canis IgG,Brucella canis Ab.IgG:ACnc:Pt:Ser:Qn,0
2173,Dopamine,Dopamine:MCnc:Pt:Ser/Plas:Qn,0
2174,Etiocholanolone,Etiocholanolone:MRat:24H:Urine:Qn,0
2175,Rift valley fever virus Ag,Rift valley fever virus Ag:PrThr:Pt:Bld:Ord:Neut,0
2176,Chlorphentermine,Chlorphentermine:ACnc:Pt:Bld:Qn,0
2177,Gradient.systole.max,Gradient.systole.max:Pres:Pt:Heart.ventricle.left.outflow tract:Qn:US.doppler,0
2178,Ketamine,Ketamine:MCnc:Pt:Urine:Qn:Screen,0
2179,Cells.CD16+CD57+/100 cells,Cells.CD16+CD57-/100 cells:NFr:Pt:XXX:Qn,0
2180,Cerebroside-Sulfatase,Cerebroside sulfatase:Arbitrary Concentration:Point in time:Serum/Plasma:Ordinal,0
2181,Epithelial Cells,Epithelial cells:PrThr:Pt:Urine sed:Ord:Microscopy.light,0
2182,Leukocytes,Leukocytes:PrThr:Pt:Urine sed:Ord:Microscopy.light,0
2183,Bacteria identified,Bacteria identified:Prid:Pt:Milk:Nom:Aerobic culture,0
2184,Leucine,Leucine:SCnc:Pt:XXX:Qn,0
2185,Equine arteritis virus antibody,Equine arteritis virus Ab:PrThr:Pt:Ser:Ord:IF,0
2186,All-Trans-Retinol,Retinol^6H post dose:MCnc:Pt:Ser/Plas:Qn,0
2187,Salmonella gallinarum Ab,Deprecated Salmonella gallinarum Ab [Presence] in Serum,0
2188,Salmonella enterica enterica serovar Gallinarum DNA,Salmonella gallinarum DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
2189,GQ1b ganglioside antibody,Ganglioside GQ1b Antibody:Arbitrary Concentration:Point in time:Serum:Ordinal,0
2190,Study observation.overall,Study observation.overall:Impression/interpretation of study:Point in time:Cardiovascular.central:Narrative:ULTRASOUND,0
2191,Ciprofloxacin,Ciprofloxacin:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
2192,Echovirus 4 Ab,Echovirus 4 Ab:Titr:Pt:Ser:Qn,0
2193,Foot and mouth disease virus serotype,Foot and mouth disease virus serotype:Prid:Pt:Tiss:Nom:Comp fix,0
2194,Theileria equi antibody,Theileria equi Ab:PrThr:Pt:Ser:Ord:IF,0
2195,(Cynodon dactylon+Lolium perenne+Phleum pratense+Poa pratensis+Sorghum halepense) Ab.IgE,(Cynodon dactylon+Lolium perenne+Phleum pratense+Poa pratensis+Sorghum halepense) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk,0
2196,Specimen volume,Specimen volume:Vol:24H:Stool:Qn,0
2197,5-Hydroxyindoleacetate,5-Hydroxyindoleacetate:SCnc:24H:Urine:Qn,0
2198,Views 2,Views 2:Find:Pt:Upper extremity.bilateral>Humerus:Doc:XR,0
2199,Betula verrucosa Ab.IgG4.RAST class,Betula verrucosa Ab.IgG4.RAST class:PrThr:Pt:Ser:Ord,0
2200,C-Peptide,C peptide^40M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
2201,Warfarin,Warfarin:MCnc:Pt:Urine:Qn,0
2202,Echovirus 30 Ab,Echovirus 30 Ab:PrThr:Pt:Ser:Ord:Comp fix,0
2203,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity>Shoulder:Doc:MR,0
2204,Tryptophan,Deprecated Tryptophan [Mass/volume] in Serum or Plasma,0
2205,Canine distemper virus Ab,Canine distemper virus Ab:PrThr:Pt:Ser:Ord,0
2206,Cyanides,Cyanide:SCnc:Pt:Ser/Plas:Qn,0
2207,Taurine/Creatinine,Taurine/Creatinine:SRto:24H:Urine:Qn,0
2208,Lactalbumin alpha Ab.IgG4,Lactalbumin alpha Ab.IgG4:ACnc:Pt:Ser:Qn,0
2209,Axis N 2,Axis N 2:Angle:Pt:LM glasses.lens.right:Qn,0
2210,loracarbef,Loracarbef:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
2211,Free tryptophan,Tryptophan.free:MCnc:Pt:Ser/Plas:Qn,0
2212,Bovine diarrhea virus Antigen,Bovine diarrhea virus Ag:PrThr:Pt:Stool:Ord,0
2213,Bovine herpesvirus 2 Ag,Bovine herpesvirus 2 Ag:PrThr:Pt:Exudate:Ord,0
2214,Respiratory syncytial virus antigen,Respiratory syncytial virus Ag:PrThr:Pt:Nose:Ord:IF,0
2215,Herpes virus 6 IgG,Herpes virus 6 Ab.IgG:Titr:Pt:Ser:Qn:IF,0
2216,Glycine,Glycine:SRat:24H:Urine:Qn,0
2217,Monocytes/100 leukocytes,Monocytes/100 leukocytes:NFr:Pt:Bld:Qn,0
2218,Sphere N 1,Sphere N 1:InvLen:Pt:Glasses prescription:Qn,0
2219,Sphere N 2,Sphere N 2:InvLen:Pt:Glasses prescription.lens.left:Qn,0
2220,Neutrophils.segmented/100 leukocytes,Neutrophils.segmented/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count,0
2221,View,Views^W standing:Find:Pt:Lower extremity.bilateral>Knee:Doc:XR,0
2222,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes:NFr:Pt:CSF:Qn,0
2223,Thyroxine measurement,Thyroxine:MCnc:Pt:Saliva:Qn,0
2224,Canary serum proteins Ab,Canary serum proteins Ab:PrThr:Pt:Ser:Ord,0
2225,Pentacarboxylporphyrin,Pentacarboxylporphyrins:SRat:24H:Urine:Qn,0
2226,View,Views:Find:Pt:Lower extremity.right>Acetabulum:Doc:XR,0
2227,Chlamydia trachomatis D+K Ab.IgA,Chlamydia trachomatis D+K Ab.IgA:ACnc:Pt:Ser:Qn,0
2228,Amobarbital,Amobarbital:MCnc:Pt:Vitr fld:Qn,0
2229,Phencyclidine,Phencyclidine:MCnt:Pt:Meconium:Qn,0
2230,Beta alanine/Creatinine,Beta alanine/Creatinine:SRto:Pt:Urine:Qn,0
2231,phosphate ion,Phosphate:Mass Concentration:Point in time:Serum/Plasma:Quantitative,0
2232,Glucose,Glucose^2H post 1.2 g/kg lactose PO:MCnc:Pt:Ser/Plas:Qn,0
2233,Coxsackievirus B4 Ab,Coxsackievirus B4 Ab:ACnc:Pt:Body fld:Qn,0
2234,Epstein Barr virus early IgG,Epstein Barr virus early Ab.IgG:Titr:Pt:CSF:Qn:IF,0
2235,Pyridoxine congeners,Pyridoxine congeners:MCnc:Pt:Ser/Plas:Qn,0
2236,Equine arteritis virus antibody,Equine arteritis virus Ab:ACnc:Pt:Ser:Qn,0
2237,Feline herpesvirus Ab,Feline herpesvirus Ab:ACnc:Pt:Ser:Qn,0
2238,Blatta orientalis Ab.IgE.RAST class,Blatta orientalis Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
2239,Leishmania donovani antibody,Leishmania donovani Ab:Titr:Pt:Ser:Qn,0
2240,Phenylalanine,Phenylalanine:MRat:24H:Urine:Qn,0
2241,Tetrahydrodeoxycortisol,Tetrahydrodeoxycortisol:MRat:24H:Urine:Qn,0
2242,Lymphocytes.variant/100 leukocytes,Lymphocytes.variant/100 leukocytes:NFr:Pt:Body fld:Qn,0
2243,Bordetella pertussis filamentous hemagglutinin IgA,Bordetella pertussis.filamentous hemagglutinin Ab.IgA:ACnc:Pt:Ser:Qn:IA,0
2244,Glucose,Glucose^4.5H post dose glucose:SCnc:Pt:Ser/Plas:Qn,0
2245,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Ankle:Doc:MR,0
2246,Legionella pneumophila 3 Ab,Legionella pneumophila 3 Ab:ACnc:Pt:Ser:Qn,0
2247,Multisection,Multisection:Find:Pt:Chest>Brachial plexus.right:Doc:MR,0
2248,Physical findings,Physical findings:Find:Pt:Eye lid.right:Nar,0
2249,Pyruvate dehydrogenase (cytochrome),Pyruvate dehydrogenase.cytochrome:CCnc:Pt:Ser/Plas:Qn,0
2250,Somatostatin,Somatostatin:PrThr:Pt:Plas:Ord,0
2251,3-hydroxyglutarate,3-Hydroxyglutarate:PrThr:Pt:Urine:Ord,0
2252,Lymphocytic choriomeningitis virus IgM,Lymphocytic choriomeningitis virus Ab.IgM:ACnc:Pt:CSF:Qn,0
2253,4-Hydroxyphenylacetate/Creatinine,4-Hydroxyphenylacetate/Creatinine:SRto:Pt:Urine:Qn,0
2254,Plasmodium species antibody,Plasmodium sp Ab:Titr:Pt:Ser:Qn:IF,0
2255,Midomafetamine,Methylenedioxymethamphetamine:MCnc:Pt:Vitr fld:Qn,0
2256,Argon laser trabeculoplasty Rx,Argon laser trabeculoplasty Rx:EngRat:Pt:Eye.left:Qn,0
2257,Metanephrine,Metanephrine:MCnc:Pt:Ser/Plas:Qn,0
2258,Neisseria gonorrhoeae antigen,Neisseria gonorrhoeae Ag:PrThr:Pt:XXX:Ord,0
2259,View,Views:Finding:Point in time:Elbow:Narrative:XR,0
2260,Free thyroxin,Thyroxine.free^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
2261,Free thyroxin,Thyroxine.free^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
2262,Streptococcus pneumoniae Danish serotype 3 IgG,Deprecated Streptococcus pneumoniae 3 IgG Ab [Mass/volume] in Serum by Immunoassay,0
2263,para-Aminohippurate renal clearance,Para aminohippurate renal clearance:VRat:24H:Urine+Ser/Plas:Qn,0
2264,Gerbil epithelium Ab.IgE.RAST class,Gerbil epithelium Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
2265,Amikacin,Amikacin^trough post extended interval dosing:MCnc:Pt:Ser/Plas:Qn,0
2266,Rickettsia spotted fever group IgG,Rickettsia spotted fever group Ab.IgG^1st specimen:Titr:Pt:Ser:Qn:IF,0
2267,Staphylococcus aureus enterotoxin C Ab.IgE,Staphylococcus aureus enterotoxin C Ab.IgE:ACnc:Pt:Ser:Qn,0
2268,Amino beta guanidinopropionate/Creatinine,Amino beta guanidinopropionate/Creatinine:Relative Density:Point in time:Urine:Quantitative,0
2269,Alpha aminobutyrate/Creatinine,Alpha aminobutyrate/Creatinine:Ratio:24H:Urine:Qn,0
2270,Rickettsia sibirica Ab,Rickettsia sibirica Ab:Titr:Pt:Ser:Qn,0
2271,Gerbil hair Ab.IgE.RAST class,Gerbil hair Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
2272,Vanillylmandelate,Vanillylmandelate:MRat:24H:Urine:Qn,0
2273,Ethanol,Ethanol:SCnc:Pt:XXX:Qn,0
2274,LACROSSE VIRUS ANTIBODY,La Crosse virus Ab^1st specimen:Titr:Pt:Ser:Qn:IF,0
2275,Multisection,Multisection:Find:Pt:Head>Internal auditory canal+Posterior fossa:Doc:MR,0
2276,Guidance for placement of peripherally-inserted central venous catheter,Guidance for placement of peripherally-inserted central venous catheter:Find:Pt:XXX>Vein.right:Doc:RF.angio,0
2277,Arginine,Arginine:SCnc:Pt:Urine:Qn,0
2278,Fetal Hemoglobin,Hemoglobin F:PrThr:Pt:Bld:Ord:Kleihauer-Betke,0
2279,Respiratory syncytial virus antigen,Respiratory syncytial virus Ag:PrThr:Pt:Thrt:Ord,0
2280,Rubella virus antigen,Rubella virus Ag:PrThr:Pt:Urethra:Ord,0
2281,Guidance for injection,Guidance for injection:Find:Pt:Pelvis>Sacroiliac joint.left:Doc:CT,0
2282,Methyltestosterone,Methyltestosterone:MCnc:Pt:Urine:Qn,0
2283,Invertase,Deprecated Beta fructofuranosidase [Enzymatic activity/volume] in Red Blood Cells,0
2284,Color,Deprecated Color of Unspecified specimen,0
2285,Physical findings,Physical findings:Finding:Point in time:Integumentary system:Narrative:Observed,0
2286,Dispensing medication,Medication dispensed:Type:Point in time:^Patient:Nominal,0
2287,View,Views^W radionuclide IV:Find:Pt:Lower extremity>Knee:Doc:NM,0
2288,Insulin Antibodies,Insulin Ab:PrThr:Pt:Ser:Ord,0
2289,Multisection,Multisection^W Tc-99m IV:Find:Pt:Abdomen>Liver:Doc:NM.SPECT,0
2290,Macroglobulins,Macroglobulin:MCnc:Pt:Ser/Plas:Qn,0
2291,Oxazepam,Oxazepam:MCnc:Pt:Vitr fld:Qn,0
2292,6-O-monoacetylmorphine,6-Monoacetylmorphine:MCnt:Pt:Meconium:Qn,0
2293,Gentamicin,Gentamicin^peak post extended interval dosing:MCnc:Pt:Ser/Plas:Qn,0
2294,microscopic observation,Microscopic observation:Prid:Pt:Neck mass.FNA:Nom:Cyto stain,0
2295,Vesicular stomatitis Indiana virus Ab,Vesicular stomatitis Indiana virus Ab:ACnc:Pt:Ser:Qn,0
2296,Western equine encephalomyelitis virus antigen,Western equine encephalitis virus Ag:PrThr:Pt:Ser:Ord,0
2297,Chlamydia species antigen,Chlamydia sp Ag:PrThr:Pt:Urine:Ord:IA,0
2298,Xanthurenates,Xanthurenate:MCnc:Pt:Ser/Plas:Qn,0
2299,Guidance for placement of tube,Guidance for placement of tube:Find:Pt:Chest:Doc:US,0
2300,Babesia microti antibody,Babesia microti Ab:PrThr:Pt:Ser:Ord,0
2301,CV2 Ab.IgG,CV2 Ab.IgG:ACnc:Pt:Ser:Qn,0
2302,Porphyrin fractions,Porphyrins fractionated:Impression/interpretation of study:24 hours:Urine:Nominal,0
2303,Platelet mean volume finding,Platelet mean volume:EntVol:Pt:BldCo:Qn,0
2304,Brucella abortus Ab.IgG & IgM panel,Brucella abortus Ab.IgG & IgM panel:-:Pt:Ser:-,0
2305,Dissolved solids,Dissolved solids:MCnc:Pt:Water:Qn,0
2306,Nitrogen,Nitrogen:SRat:24H:Urine:Qn,0
2307,Cells.CD4/100 cells,Deprecated CD4 cells/100 cells in Cerebral spinal fluid,0
2308,Centromere antibody,Centromere Ab:Titr:Pt:Body fld:Qn,0
2309,Coxsackievirus A6 Ab,Deprecated Coxsackievirus A6 Ab [Titer] in Serum,0
2310,Uroporphyrin 3 isomer,Uroporphyrin 3 isomer:SCnt:Pt:Stool:Qn,0
2311,Growth Hormone,Somatotropin^pre dose glucagon:ACnc:Pt:Ser/Plas:Qn,0
2312,Porphyrins,Porphyrins:SRat:24H:Urine:Qn,0
2313,Views 2,Views 2:Find:Pt:Pelvis & Lower extremity.left>Hip:Doc:XR,0
2314,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA:PrThr:Pt:Anal:Ord:Probe.amp.sig,0
2315,Time of analysis,Time of analysis:TmStp:Pt:XXX:Qn,0
2316,coproporphyrin I,Coproporphyrin 1:SRat:24H:Urine:Qn,0
2317,Trichophyton reaction wheal,Trichophyton reaction wheal [Diameter] --2 days post dose trichophyton intradermal,0
2318,ramoplanin,Ramoplanin:Susc:Pt:Isolate:OrdQn:Gradient strip,0
2319,Malignant cells/100 cells,Malignant cells/100 cells:NFr:Pt:Plr fld:Qn,0
2320,Hemoglobin C/Hemoglobin.total,Hemoglobin C/Hemoglobin.total:MFr:Pt:Bld:Qn:HPLC,0
2321,Streptococcus pneumoniae Danish serotype 5 IgG,Deprecated Streptococcus pneumoniae 5 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen,0
2322,Multisection,Multisection^W radionuclide IV:Find:Pt:Abdomen>Kidney:Doc:NM.SPECT,0
2323,ceftobiprole,Ceftobiprole:Susc:Pt:Isolate:OrdQn:MLC,0
2324,Cells.CD3/Cells.CD4,Cells.CD3/Cells.CD4:NRto:Pt:XXX:Qn,0
2325,Powassan virus polyvalent E Ab,Powassan virus polyvalent E Ab:PrThr:Pt:XXX:Ord:IA,0
2326,Influenza virus A hemagglutinin H5 RNA,Deprecated Influenza virus A hemagglutinin H5 RNA [Presence] in Unspecified specimen by Probe & target amplification method,0
2327,Leukocytes,Leukocytes:Naric:Pt:Vag:Qn:Wet preparation,0
2328,Neisseria meningitidis,Neisseria meningitidis:Prid:Pt:Isolate:Nom:Organism specific culture,0
2329,Australian cervix cytology code,Australian cervix cytology code:Imp:Pt:XXX:Nom,0
2330,Sisomicin,Sisomicin:Titr:Pt:Isolate+Ser:Qn:SBT,0
2331,Phosphate crystals.amorphous,Phosphate crystals.amorphous:Naric:Pt:Urine sed:Qn:Microscopy.light.LPF,0
2332,Homovanillate,Homovanillate:SCnc:Pt:CSF:Qn,0
2333,Leishmania sp Ab.IgG,Leishmania sp Ab.IgG:ACnc:Pt:Ser:Qn,0
2334,Voltage-gated calcium channel Ab.IgG,Voltage-gated calcium channel Ab.IgG:SCnc:Pt:Ser:Qn,0
2335,AKT1 gene targeted mutation analysis,AKT1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
2336,Multisection,Multisection^W contrast IV:Find:Pt:Lower extremity.bilateral>Lower extremity vessels:Doc:MR.angio,0
2337,Jamestown Canyon virus IgM,Jamestown canyon virus Ab.IgM:Titr:Pt:Ser:Qn:Neut,0
2338,Cells.CD11c+CD19+/100 cells,Cells.CD11c+CD19+/100 cells:NFr:Pt:Body fld:Qn,0
2339,Yeasts,Yeast:PrThr:Pt:CSF:Ord:Microscopy.light,0
2340,Xylose,Xylose^2H post 25 g xylose PO:MCnc:Pt:Urine:Qn,0
2341,Triamcinolone Acetonide,Triamcinolone acetonide:MCnc:Pt:Ser/Plas:Qn,0
2342,Multisection,Multisection^W In-111 tagged WBC IV:Find:Pt:XXX>Bone:Doc:NM.SPECT,0
2343,Immune complex.C3d,Immune complex.C3d:ACnc:Pt:Ser/Plas:Qn,0
2344,Protriptyline,Protriptyline:Mass:Pt:Dose:Qn,0
2345,HLA-A33(19),HLA-A33(19):PrThr:Pt:Bld/Tiss^Donor:Ord,0
2346,Monocytes/100 leukocytes,Monocytes/100 leukocytes:NFr:Pt:Dial fld prt:Qn:Manual count,0
2347,Uranium 235/Uranium 238,Uranium 235/Uranium 238:MRto:Pt:Urine:Qn,0
2348,Multisection limited,Multisection limited:Find:Pt:Upper extremity>Upper extremity artery:Doc:US,0
2349,Multisection endorectal,Multisection endorectal:Find:Pt:Pelvis>Prostate:Doc:MR,0
2350,Rat epithelium+Serum proteins+Urine proteins Ab.IgE.RAST class,Rat epithelium+Serum proteins+Urine proteins Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
2351,Casts body substance,Casts:Naric:Pt:Urine sed:Qn:Automated count,0
2352,Legionella pneumophila 10 IgM,Legionella pneumophila 10 Ab.IgM:Titr:Pt:Ser:Qn,0
2353,Creatinine,Creatinine^45M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
2354,Tobramycin,Tobramycin [Mass/volume] in Serum or Plasma --trough,0
2355,Internal rotation.active range of motion,Internal rotation.active range of motion:Angle:Pt:Shoulder.right:Qn,0
2356,External rotation.active range of motion,External rotation.active range of motion:Angle:Pt:Shoulder.right:Qn,0
2357,Glucose,Glucose^15M pre XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
2358,Blast Cell,Deprecated Blasts [#/volume] in Blood by Automated count,0
2359,Campylobacter sp Ab.IgA,Campylobacter sp Ab.IgA:PrThr:Pt:Ser:Ord:IA,0
2360,Ricin,Ricin toxin:PrThr:Pt:XXX:Ord:IF,0
2361,Passive range of motion panel,Passive range of motion panel:Angle:Pt:^Patient:Qn,0
2362,Abduction.active range of motion,Abduction.active range of motion:Angle:Pt:Hip:Qn,0
2363,Chlamydia trachomatis DNA,Deprecated Chlamydia trachomatis DNA [Presence] in Penis by Probe and target amplification method,0
2364,LOINC class types,Class:Type:Pt:Oxygen saturation device:Nom,0
2365,Herpes simplex virus 1 IgG,Herpes simplex virus 1 Ab.IgG:PrThr:Pt:CSF:Ord,0
2366,Isovalerylcarnitine (C5),Isovalerylcarnitine (C5):SCnc:Pt:Bld.dot:Qn,0
2367,Histologic type,Histologic type:Type:Pt:Prostate tumor:Nom,0
2368,Chlamydia species antigen,Chlamydia sp Ag:PrThr:Pt:Cvx:Ord:IA,0
2369,Hemoglobin H/Hemoglobin.total,Hemoglobin H/Hemoglobin.total:MFr:Pt:Bld:Qn:Electrophoresis,0
2370,Gentamicin,Gentamicin:SCnc:Pt:Ser/Plas:Qn,0
2371,Bicarbonates,Bicarbonate:SRat:24H:Urine:Qn,0
2372,Fenfluramine,Fenfluramine:Mass:Pt:Dose:Qn,0
2373,Multisection,Multisection^WO & W contrast IV:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic:Doc:MR,0
2374,Coccidioides sp Ab.IgG,Coccidioides sp Ab.IgG:PrThr:Pt:Ser:Ord:IA,0
2375,Multisection,Multisection:Find:Pt:Lower extremity.bilateral>Lower extremity vein:Doc:US,0
2376,HTLV I+II Ab,HTLV I+II Ab:Titr:Pt:Ser:Qn,0
2377,Lesion size.max.dimension,Lesion size.max.dimension:Len:Pt:Skin:Qn,0
2378,Intact parathyrin,Parathyrin.intact^baseline:SCnc:Pt:Ser/Plas:Qn,0
2379,Ribosomal ribonucleoprotein antibody,Ribonucleoprotein extractable nuclear Ab:MCnc:Pt:Ser:Qn,0
2380,lopinavir,Lopinavir:Susc:Pt:Isolate:Ord:Genotyping,0
2381,COC site & type override flag,COC site & type override flag:Arb:Pt:Cancer case.XXX:Ord,0
2382,Collaborative staging regional nodes evaluation,Collaborative staging regional nodes evaluation:Prid:Pt:Cancer.XXX:Nom,0
2383,Contributing factor.patient-related,Contributing factor.patient-related:Find:Pt:^Patient:Nom:Observed.MERSTH,0
2384,Contributing factor.technical,Contributing factor.technical:Find:Pt:^Patient:Nom:Observed.MERSTH,0
2385,Feline leukemia virus Ab,Feline leukemia virus Ab:Titr:Pt:Ser:Qn,0
2386,Purkinje cell antibody,Purkinje cells Ab:ACnc:Pt:Ser:Qn:IF,0
2387,Egg whole Ab.IgG,Egg whole Ab.IgG:MCnc:Pt:Ser:Qn,0
2388,Hemosiderin,Hemosiderin:MCnc:Pt:Urine:Qn,0
2389,Follicle Stimulating Hormone,Follitropin^2.5H post 100 ug lutenizing releasing hormone IV:ACnc:Pt:Ser/Plas:Qn,0
2390,Glutamate,Glutamate:SCnc:Pt:Bld.dot:Qn,0
2391,HLA-DRB3 Chains,HLA-DRB3:PrThr:Pt:Bld/Tiss:Ord,0
2392,Somatotropin/Creatinine,Somatotropin/Creatinine:MRto:Pt:Urine:Qn,0
2393,Disialylganglioside GD1b Ab.IgG,Deprecated Disialylganglioside GD1b IgG Ab [Presence] in Serum,0
2394,Neuronal nuclear Ab.IgG,Neuronal nuclear Ab.IgG:Titr:Pt:Ser:Qn:IF,0
2395,Cyclic AMP,Adenosine monophosphate.cyclic^2nd specimen post XXX challenge:SCnc:Pt:Urine:Qn,0
2396,procollagen Type I N-terminal peptide,Procollagen type I.N-terminal propeptide:MCnc:Pt:Ser:Qn,0
2397,Insulin,Insulin^20M post dose glucose:ACnc:Pt:Ser/Plas:Qn,0
2398,Insulin,Insulin^pre-meal:ACnc:Pt:Ser/Plas:Qn,0
2399,Prolactin,Prolactin^30M post dose triple bolus:MCnc:Pt:Ser/Plas:Qn,0
2400,Discharge summary note,Discharge summarization note:Finding:Point in time:Hospital:Document:Physician,0
2401,fatty acid oxidation,Fatty acid oxidation:Prid:Pt:Fibroblasts:Nom,0
2402,Potassium,Potassium:Sub:XXX:Urine:Qn,0
2403,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from AC.Lessoway 1998,0
2404,Doxepin,Doxepin:MCnc:Pt:Ser/Plas:Qn:Screen,0
2405,Multisection,Multisection^W contrast IS:Find:Pt:Lower extremity.right>Ankle:Doc:MR,0
2406,Multisection,Multisection^WO contrast:Find:Pt:Lower extremity.right>Hip:Doc:MR,0
2407,Multisection,Multisection^W contrast intradisc:Find:Pt:Abdomen>Spine.lumbar:Doc:CT,0
2408,Ampicillin / Sulbactam,Ampicillin+Sulbactam:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
2409,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from HC measured.Chitty 1997,0
2410,Diameter product,Diameter product:Len:Pt:Abdomen^Fetus:Qn:US.estimated from Shinozuka 1996,0
2411,Gamma globulin/Protein.total,Gamma globulin/Protein.total:MFr:24H:Urine:Qn,0
2412,View,Views:Find:Pt:Upper extremity.bilateral>Finger.fourth:Doc:XR,0
2413,Multisection perfusion,Multisection perfusion^W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM.SPECT,0
2414,Cells.G0+G1 phase/100 cells,Cells.G0+G1 phase/100 cells:NFr:Pt:XXX:Qn:Flow cytometry,0
2415,View,Views^W contrast IA:Find:Pt:Neck>Carotid artery.common.right:Doc:RF.angio,0
2416,Asbestos,Asbestos:MCnc:Pt:Air:Qn,0
2417,VA C&P exam.thyroid &or parathyroid diseases note,VA C&P exam.thyroid &or parathyroid diseases note:Find:Pt:{Setting}:Doc:{Role},0
2418,View,Views^W contrast intra lymphatic:Find:Pt:Pelvis>Pelvic lymphatic vessels.bilateral:Doc:RF.angio,0
2419,Multisection,Multisection:Find:Pt:Pelvis>Penis:Doc:US,0
2420,Protection,Protection:Type:Pt:Skin:Nom,0
2421,Platelets.large,Platelets.large:PrThr:Pt:Bld:Ord:Microscopy.light,0
2422,Cells,Cells:NCnc:Pt:Synv fld:Qn:Manual count,0
2423,Cefaclor Ab.IgG,Cefaclor Ab.IgG:ACnc:Pt:Ser:Qn,0
2424,cefditoren,Cefditoren:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
2425,Hexachlorobenzene,Hexachlorobenzene:MCnc:Pt:Air:Qn,0
2426,Color,Color:Type:Pt:Wound.base:Nom,0
2427,Oral assessment panel,Oral assessment panel:-:Point in time:^Patient:-,0
2428,Silicone Ab.IgM,Silicone Ab.IgM:ACnc:Pt:Ser:Qn:IA,0
2429,Calcium,Calcium^1st specimen post XXX challenge:SCnc:Pt:Urine:Qn,0
2430,Lead,Lead:SCnc:24H:Urine:Qn,0
2431,Cefotaxime+Clavulanate,Cefotaxime+Clavulanate:Susc:Pt:Isolate:OrdQn,0
2432,Multisection,Multisection^W contrast IV:Find:Pt:Neck>Neck vessels:Doc:CT.angio,0
2433,Braden scale skin assessment panel,Braden scale skin assessment panel:-:Point in time:^Patient:-,0
2434,"1,3-butadiene","1,3-Butadiene:MCnc:Pt:Air:Qn",0
2435,View,Views:Find:Pt:Chest>Sternoclavicular joint.bilateral:Doc:XR,0
2436,View,Views:Find:Pt:Upper extremity.right>Hand:Doc:XR,0
2437,Cannabinoids,Cannabinoids:MCnt:Pt:Meconium:Qn:Confirm,0
2438,Treponema pallidum Ab.IgG & IgM panel,Treponema pallidum Ab.IgG & IgM panel:-:Pt:Ser:Qn,0
2439,Vitamin D+Metabolites,Vitamin D+Metabolites:MCnc:Pt:Ser/Plas:Qn,0
2440,DMPK gene allele 1.CTG repeats,DMPK gene allele 1.CTG repeats:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
2441,Trospectinomycin,Trospectinomycin:Susc:Pt:Isolate:OrdQn:MIC,0
2442,dimazine,"1,1-Dimethylhydrazine:MCnc:Pt:Air:Qn",0
2443,phosphate ion,Phosphate:MCnc:Pt:Air:Qn,0
2444,Perca spp Ab.IgG.RAST class,Perca spp Ab.IgG.RAST class:PrThr:Pt:Ser:Ord,0
2445,Enterovirus RNA,Enterovirus RNA:PrThr:Pt:Tiss:Ord:Probe.amp.tar,0
2446,Views 4,Views 4:Finding:Point in time:Chest:Document:XR,0
2447,Tetrachlorodibenzodioxin,Dioxin:MCnc:Pt:Water:Qn,0
2448,"1,3-dichloro-1-propene","1,3-Dichloropropene:MCnc:Pt:Air:Qn",0
2449,Methylenedianiline,Methylenedianiline:MCnc:Pt:Air:Qn,0
2450,View,Views^W Ga-67 IV:Find:Pt:XXX:Doc:NM,0
2451,Views perfusion,Views perfusion^W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM,0
2452,Coagulation factor XI activity,Coagulation factor XI activity:ACnc:Pt:PPP:Qn:Chromo,0
2453,Acetone,Acetone:SCnc:Pt:Urine:Qn,0
2454,benzodiazepines positive,Benzodiazepines positive:Presence or Identity:Point in time:Urine:Nominal,0
2455,Coagulation tissue factor induced.factor substitution,Coagulation tissue factor induced.factor substitution^2H post incubation after 1:4 addition of normal plasma:Time:Pt:PPP:Qn:Coag,0
2456,Chlamydia sp DNA,Chlamydia sp DNA:PrThr:Pt:Nose:Ord:Probe.amp.tar,0
2457,Herpes simplex virus 1 IgG,Herpes simplex virus 1 Ab.IgG^1st specimen/2nd specimen:Ratio:Pt:Ser:Qn:IA,0
2458,s ANTIBODY,S Antibody:Dilution Factor (Titer):Point in time:Serum/Plasma:Quantitative,0
2459,Multisection,Multisection:Find:Pt:Breast.left:Doc:MR,0
2460,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Knee:Doc:CT,0
2461,Complement C3.nephritic,Complement C3.nephritic:PrThr:Pt:Ser/Plas:Ord,0
2462,View,Deprecated UE aa-R XRA W contr IA,0
2463,Herpes virus 6 deoxyribonucleic acid,Herpes virus 6 DNA:PrThr:Pt:Bld:Ord:Probe.amp.tar,0
2464,Multisection,Multisection^WO & W contrast IV:Find:Pt:Abdomen>Spleen:Doc:MR,0
2465,Multisection,Multisection^W contrast IV:Find:Pt:Pelvis>Ovary:Doc:MR,0
2466,Multisection,Multisection^W contrast IV:Find:Pt:Head>Head vessels:Doc:CT.angio,0
2467,Multisection,Multisection^WO contrast:Find:Pt:Head>Brain & Head+Neck>Larynx:Doc:MR,0
2468,Parainfluenza virus I antigen,Parainfluenza virus 1 Ag:PrThr:Pt:Nose:Ord:IF,0
2469,Pheniramine,Pheniramine:MCnc:Pt:Ser/Plas:Qn,0
2470,Cefotiam,Cefotiam:Susc:Pt:Isolate:OrdQn,0
2471,Reflex irritability,Reflex irritability^5M post birth:Fcn:Pt:^Patient:Ord:Apgar,0
2472,Respiratory therapy goal,Respiratory therapy goal:Type:Point in time:Respiratory therapy:Nominal,0
2473,lymphoblast,Lymphoblasts:NCnc:Pt:Bld:Qn,0
2474,Multisection,Multisection:Finding:Point in time:Hip:Narrative:MRI,0
2475,Fluorouracil,Fluorouracil:MCnc:Pt:Ser/Plas:Qn,0
2476,Multisection,Multisection^WO & W contrast IV:Find:Pt:Head>Orbit.right:Doc:MR,0
2477,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Lower extremity veins:Doc:MR.angio,0
2478,View,Views^W contrast IA:Find:Pt:Chest>Bronchial artery:Doc:RF.angio,0
2479,Views oblique,View oblique:Find:Pt:Upper extremity>Thumb:Doc:XR,0
2480,Multisection,Multisection:Find:Pt:Extremity.right>Extremity vein:Doc:US.doppler,0
2481,Views delayed,Views delayed^W In-111 Satumomab IV:Find:Pt:Whole body:Doc:NM,0
2482,Triglycerides,Triglyceride:SCnc:Pt:Plr fld:Qn,0
2483,Symptoms & diseases,Symptoms & diseases:Hx:Pt:Kidney:Nom,0
2484,Bile acid pattern,Bile acid pattern:Impression/interpretation of study:Point in time:Urine:Nominal,0
2485,Organic acids pattern,Organic acids pattern:Impression/interpretation of study:Point in time:Cerebral spinal fluid:Nominal,0
2486,Treatment urgency,Treatment urgency:Find:Pt:{Diagnosis}:Ord,0
2487,Basophils,Basophils:NCnc:Pt:Periton fld:Qn,0
2488,Basophils,Basophils:NCnc:Pt:Synv fld:Qn,0
2489,Large granular lymphocyte,Lymphocytes.large granular:NCnc:Pt:Bld:Qn,0
2490,Second trimester triple maternal screen panel,Second trimester triple maternal screen panel:-:Pt:Ser/Plas:-,0
2491,Acyclovir,Acyclovir^peak:MCnc:Pt:Ser/Plas:Qn,0
2492,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity.right>Elbow:Doc:CT,0
2493,Views AP,View AP:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:XR,0
2494,Methotrexate,Methotrexate^1-2w post dose:MCnc:Pt:Ser/Plas:Qn,0
2495,Aesthetics (quality),Aesthetics:Imp:Pt:{Dental arch}.denture.partial:Ord:Reported,0
2496,Glucose,Glucose^pre or post dose glucagon:SCnc:Pt:Ser/Plas:Qn,0
2497,Contraindications section,Contraindications section:-:-:^FDA package insert:Nar,0
2498,Cell count & Differential panel,Cell count & Differential panel:-:Pt:Body fld:Qn,0
2499,Coagulation dilute Russell viper venom induced.factor substitution,Coagulation dilute Russell viper venom induced.factor substitution^immediately after 1:2 addition of normal plasma:Time:Pt:PPP:Qn:Coag,0
2500,Multisection,Multisection:Find:Pt:Upper extremity.left>Shoulder:Doc:XR.tomography,0
2501,View,Views^W contrast IV:Find:Pt:Head>Sinus vein:Doc:RF.angio,0
2502,Multisection,Multisection:Finding:Point in time:Kidney:Narrative:Ultrasound,0
2503,VA C&P exam.acromegaly note,VA C&P exam.acromegaly note:Find:Pt:{Setting}:Doc:{Role},0
2504,Cells.CD3+CD8+/100 cells,Cells.CD3+CD8+/100 cells:NFr:Pt:Bone mar:Qn,0
2505,Ristocetin induced platelet aggregation,Platelet aggregation.ristocetin induced^600 ug/mL:RelACnc:Pt:PRP:Qn,0
2506,Color,Color:Type:Pt:Dial fld prt:Nom,0
2507,Jo-1 extractable nuclear Ab,Jo-1 extractable nuclear Ab:PrThr:Pt:Ser:Ord,0
2508,West Nile virus Kunjin strain Ab.IgM,West Nile virus Kunjin strain Ab.IgM:PrThr:Pt:Ser:Ord,0
2509,Gadolinium,Gadolinium:MRat:24H:Urine:Qn,0
2510,Arterial pulse intensity,Arterial pulse intensity:Force:Pt:Radial artery.right:Ord:Palpation,0
2511,Study observation,Study observation:Prid:Pt:Eyelid & Lashes & Adnexa:Nom:Slit lamp biomicroscopy,0
2512,Visual Acuity,Visual acuity^best corrected:LenRto:Pt:Eye.left:Qn:Snellen eye chart,0
2513,Study observation,Study observation:Find:Pt:Visual pathway.right:Ord:VEP,0
2514,Enhanced procedure note - recommended CDP Set 1 R1.0 & R1.1 sections,Enhanced procedure note - recommended CDP Set 1 R1.0 & R1.1 sections:-:Pt:{Setting}:-,0
2515,Medical equipment or product list,Medical equipment or product list:Find:Pt:{Setting}:Doc:Community health care,0
2516,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Hindfoot+Midfoot:Doc:CT,0
2517,View,Deprecated Hindfoot - right and Midfoot - right X-ray,0
2518,Views 2,Deprecated Hindfoot - right and Midfoot - right X-ray 2 views,0
2519,Discharge instructions,Discharge instructions:Find:Pt:{Setting}:Doc:Obstetrics and Gynecology,0
2520,Blood flow velocity.diastole.max,Blood flow velocity.diastole.max:Vel:Pt:Mitral valve:Qn:US.doppler,0
2521,Tissue velocity.A wave.max,Tissue velocity.A wave.max:Vel:Pt:Tricuspid valve.annulus:Qn:US.tissue doppler,0
2522,Blood flow velocity.diastole.max,Blood flow velocity.diastole.max:Vel:Pt:Tricuspid valve:Qn:US.doppler,0
2523,Body Temperature,Body temperature:Temp:1H^max:XXX:Qn,0
2524,Body Temperature,Body temperature:Temp:8H^min:XXX:Qn,0
2525,HIV 1 RNA+proviral DNA,HIV 1 RNA+proviral DNA:PrThr:Pt:Plas:Ord:Probe.amp.tar,0
2526,Catecholamine metabolites pattern,Catecholamine metabolites pattern:Imp:Pt:CSF:Nar,0
2527,Time to peak displacement.systole,Time to peak displacement.systole:Time:Pt:Heart.interventricular septum:Qn:US.M-mode+ECG,0
2528,History and physical note,History and physical note:Find:Pt:{Setting}:Doc:Geriatric medicine,0
2529,Initial evaluation note,Initial evaluation note:Find:Pt:{Setting}:Doc:Geriatric medicine,0
2530,(Carum carvi+Elettaria cardamomum+Mace+Syzygium aromaticum) Ab.IgE.RAST class,(Carum carvi+Elettaria cardamomum+Mace+Syzygium aromaticum) Ab.IgE.RAST class:PrThr:Pt:Ser:Ord:Multidisk,0
2531,Intravascular diastolic,Intravascular diastolic:Pres:Pt:Renal artery.right:Qn,0
2532,Pyridostigmine,Pyridostigmine:MCnc:Pt:Ser/Plas:Qn,0
2533,"t(6;9)(p22;q34)(DEK,NUP214) fusion transcript","t(6;9)(p22;q34)(DEK,NUP214) fusion transcript:Find:Pt:Bld/Tiss:Doc:FISH",0
2534,Platelet mean diameter,Platelet mean diameter:EntLen:Pt:Bld:Qn:Rees-Ecker,0
2535,Minor axis.end diastole/Body surface area,Minor axis.end diastole/Body surface area:ArLen:Pt:Heart.ventricle.left:Qn:US.2D,0
2536,Myocardial mass.end diastole/Body surface area,Myocardial mass.end diastole/Body surface area:ArMass:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by area-length method,0
2537,Duodenum length,Duodenum length:Len:Pt:Specimen:Qn,0
2538,Cardiac output/Body surface area,Cardiac output/Body surface area:ArVRat:Pt:Heart.ventricle.left:Qn:Angiography.single plane,0
2539,sodium intake,Sodium intake:SRat:12H:^Patient:Qn,0
2540,Toxocara canis IgA,Toxocara canis Ab.IgA:ACnc:Pt:Ser:Qn:IA,0
2541,Coxsackievirus B3 Ab,Coxsackievirus B3 Ab:Titr:Pt:CSF:Qn:Comp fix,0
2542,Vendor FISH product name,Vendor FISH product name:ID:Pt:Bld/Tiss:Nom,0
2543,BCL2 Gene Rearrangement,BCL2 gene rearrangements:PrThr:Pt:Bld/Tiss:Ord:FISH,0
2544,Promyelocytes/100 leukocytes,Deprecated Promyelocytes/100 leukocytes in Blood by Automated count,0
2545,Mirtazapine,Mirtazapine:PrThr:Pt:Urine:Ord:Confirm,0
2546,Myocardial mass.end diastole,Myocardial mass.end diastole:Mass:Pt:Heart.ventricle.left:Qn:US.M-mode+Calculated by dimension method,0
2547,Gradient.systole.max,Gradient.systole.max:PressDiff:Pt:Mitral valve:Qn:US.doppler+Calculated by simplified Bernoulli,0
2548,CTNS gene targeted mutation analysis,CTNS gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
2549,Western equine encephalitis virus IgG,Western equine encephalitis virus Ab.IgG:Titr:Pt:CSF:Qn:IF,0
2550,Intravascular systolic,Intravascular systolic^inspiration:Pres:Pt:Arterial system:Qn,0
2551,Intravascular diastolic,Intravascular diastolic:Pres:24H^mean:Arterial system:Qn,0
2552,protein intake,Protein intake:MRat:10H:^Patient:Qn,0
2553,Hydrocortisone,Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen,0
2554,Education note,Education note:Find:Pt:{Setting}:Doc:Colon and rectal surgery,0
2555,OPC3373,OPC3373:MCnc:Pt:Urine:Qn:Confirm,0
2556,Time to max tissue velocity.systole,Time to max tissue velocity.systole:Time:Pt:Heart.ventricle.left.basal inferior:Qn:US.tissue doppler,0
2557,Diameter.end diastole,Diameter.end diastole:Len:Pt:Tricuspid valve.annulus:Qn:US.2D.A4C,0
2558,ALDH3A2 gene full mutation analysis,ALDH3A2 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing,0
2559,(Cynodon dactylon+Lolium perenne+Bromus inermis+Ambrosia elatior+Artemisia vulgaris+Plantago lanceolata) Ab.IgE.RAST class,(Cynodon dactylon+Lolium perenne+Bromus inermis+Ambrosia elatior+Artemisia vulgaris+Plantago lanceolata) Ab.IgE.RAST class:PrThr:Pt:Ser:Ord:Multidisk,0
2560,dbSNP version,dbSNP version:Identifier:Point in time:^Patient:Nominal,0
2561,COSMIC structural variant,COSMIC structural variant:ID:Pt:^Patient:Nom,0
2562,Intravascular systolic,Intravascular systolic:Pres:8H^mean:Arterial system:Qn,0
2563,total fluid intake,Fluid intake.total:VRat:8H:^Patient:Qn,0
2564,Fluid output.cerebral ventricle drain,Fluid output.cerebral ventricle drain:Vol:Pt:Cerebral ventricles:Qn,0
2565,Rhythm segment,Rhythm segment:Impression/interpretation of study:Point in time:Heart:Narrative:EKG,0
2566,FGFR1 Gene Rearrangement,FGFR1 gene rearrangements:PrThr:Pt:Bld/Tiss:Ord:FISH,0
2567,Cells.FGFR1 gene rearrangements/Cells counted,Cells.FGFR1 gene rearrangements/Cells counted:NFr:Pt:Bld/Tiss:Qn:FISH,0
2568,Varicella zoster virus surveillance panel,Varicella zoster virus surveillance panel:-:Point in time:^Patient:-,0
2569,Intravascular systolic,Intravascular systolic:Pres:Pt:Digital artery.right:Qn,0
2570,Fluid output.gastric tube,Fluid output.gastric tube:Aper:Pt:Upper GI tract:Nom,0
2571,MLH1+MSH2+MSH6+PMS2 gene deletion+duplication & full mutation analysis,MLH1+MSH2+MSH6+PMS2 gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
2572,Start coordinates,Start coordinates:Type:Pt:Coronary arteries.segment:Nom,0
2573,Bifurcated lesion end segment position,Bifurcated lesion end segment position:Type:Pt:Coronary arteries:Nom,0
2574,output.stool,Output.stool:Mass:Pt:Lower GI tract:Qn,0
2575,Zirconium/Creatinine,Zirconium/Creatinine:SRto:Pt:Urine:Qn,0
2576,"WFDC2 protein, human",Deprecated Human epididymis protein 4 [Moles/volume] in Serum or Plasma by Immunoassay,0
2577,S-Adenosylmethionine,S-adenosylmethionine:SCnc:Pt:Ser/Plas:Qn,0
2578,Other genomic reference sequence coding system OID,Other genomic reference sequence coding system OID:Uniform Resource Identifier:Point in time:^Patient:Nominal,0
2579,Output.ileostomy,Output.ileostomy:MRat:10H:Lower GI tract:Qn,0
2580,Dispensing of blood product (procedure),Blood product dispensed:Vol:Pt:^BPU:Qn,0
2581,Ethyl glucuronide cutoff,Ethyl glucuronide cutoff:MCnc:Pt:Urine:Qn:Confirm,0
2582,R- & S-beta aminoisobutyrate & D- & L-serine panel,R- & S-beta aminoisobutyrate & D- & L-serine panel:-:Pt:CSF:-,0
2583,Xanthopterin,Xanthopterin:SCnc:Pt:CSF:Qn,0
2584,Influenza virus A & B identified,Influenza virus A & B identified:Prid:Pt:Nph:Nom:Shell vial culture,0
2585,"1,1'-Sulfonylbis-2-Methylthioethane","1,1'-Sulfonylbis-2-Methylthioethane:MCnc:Pt:Urine:Qn",0
2586,Gadolinium,Gadolinium:MCnt:Pt:Tiss:Qn,0
2587,Anti-somatotropin antibody,Somatotropin Ab:ACnc:Pt:Ser/Plas:Qn,0
2588,Additional pathological findings,Additional pathological findings:Prid:Pt:Specimen:Nom,0
2589,Amino acid.essential intake,Amino acid.essential intake:MRat:24H:^Patient:Qn:Measured,0
2590,Hospital discharge disposition,Hospital discharge disposition:Type:Point in time:^Patient:Narrative,0
2591,cis-11-Eicosenoate,cis-11-Eicosenoate:EntSub:Pt:RBC:Qn,0
2592,Eicosadienoate,Eicosadienoate:EntSub:Pt:RBC:Qn,0
2593,A wave amplitude,A wave amplitude:Pres:Pt:Pulmonary artery.wedge:Qn:Cardiac catheterization,0
2594,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Vascular neurology,0
2595,Views for glomerular filtration rate,Views for glomerular filtration rate^W radionuclide IV:Find:Pt:Abdomen>Kidney:Doc:NM,0
2596,Vitamin B1 Intake,Vitamin B1 intake:MRat:24H:^Patient:Qn:Measured,0
2597,Tyrosine intake,Tyrosine intake:MRat:24H:^Patient:Qn:Measured,0
2598,Vibrio cholerae DNA,Vibrio cholerae DNA:PrThr:Pt:Stool:Ord:Non-probe.amp.tar,0
2599,History source,History source:Type:Point in time:Interviewee:Nominal:*,0
2600,Bumetanide,Bumetanide:MCnc:Pt:Ser/Plas:Qn,0
2601,Manganese intake,Manganese intake:MRat:24H:^Patient:Qn:Estimated,0
2602,Platanus acerifolia recombinant (rPla a) 1 Ab.IgE.RAST class,Platanus acerifolia recombinant (rPla a) 1 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
2603,Chromosome region 16p13.3 deletion,Chromosome region 16p13.3 deletion:Find:Pt:Bld/Tiss:Doc:FISH,0
2604,Chromosome region 7q11.23 deletion,Chromosome region 7q11.23 deletion:Find:Pt:Amnio fld/CVS:Doc:FISH,0
2605,A3 B Ab,Deprecated A3 B Antibody:Arbitrary Concentration:Point in time:Serum:Ordinal:AGGLUTINATION RBC,0
2606,Heptacarboxylporphyrin,Heptacarboxylporphyrin:MRat:XXX:Stool:Qn,0
2607,Howell-Jolly Bodies,Howell-Jolly bodies:PrThr:Pt:Bld:Ord:Microscopy.light,0
2608,CYP2C9 gene product metabolic activity interpretation,CYP2C9 gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:CPIC,0
2609,Murmur radiating to body location,Murmur radiating to body location:Anat:Pt:^Patient:Nom:Auscultation,0
2610,CYTOMEGALOVIRUS ANTIGEN,Cytomegalovirus Ag:PrThr:Pt:BAL:Ord:IF,0
2611,Smudge cell,Smudge cells:PrThr:Pt:Bld:Ord:Microscopy.light,0
2612,Creatinine,Creatinine^4H dwell specimen:SCnc:Pt:Dial fld prt:Qn,0
2613,Docosahexaenoate intake,Docosahexaenoate intake:MRat:24H:^Patient:Qn:Estimated,0
2614,Tissue perfusion assessment panel,Tissue perfusion assessment panel:-:Point in time:^Patient:-,0
2615,Triticum aestivum recombinant (rTri a) 19 Ab.IgE.RAST class,Triticum aestivum recombinant (rTri a) 19 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
2616,ABO & Rh group,ABO & Rh group:Type:Pt:Bld:Nom,0
2617,Hemodynamic resistance,Hemodynamic resistance:Resistance:Point in time:Pulmonary vasculature:Quantitative,0
2618,Heptachlor,Heptachlor:MCnc:Pt:Ser/Plas:Qn,0
2619,Human papilloma virus 18 DNA,Human papilloma virus 18 DNA:PrThr:Pt:Anorectal:Ord:Probe.amp.tar,0
2620,Education note,Education note:Find:Pt:{Setting}:Doc:Critical Care Medicine,0
2621,Growth Hormone,Somatotropin^1.5H post dose arginine+insulin:MCnc:Pt:Ser/Plas:Qn,0
2622,Amobarbital,Amobarbital:MCnc:Pt:Body fld:Qn,0
2623,ISCEV standard protocol used,ISCEV standard protocol used:Type:Pt:^Patient:Nom:Electroretinogram,0
2624,Visual field defects,Visual field defects:Find:Pt:Eye.left:Nom,0
2625,Hexosaminidase A,Beta-N-acetylhexosaminidase.A:CCnc:Pt:Bld.dot:Qn,0
2626,Actinidia deliciosa native (nAct d) 1 Ab.IgE.RAST class,Actinidia deliciosa native (nAct d) 1 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
2627,Phencyclidine,Phencyclidine:PrThr:Pt:Gast fld:Ord:Screen,0
2628,Oxygen saturation test result,Oxygen saturation:MFr:Pt:Pulmonary artery.left:Qn,0
2629,California encephalitis virus Ab.IgG,California encephalitis virus Ab.IgG:ACnc:Pt:Ser:Qn,0
2630,2-Aminoadipate,Alpha aminoadipate:SCnc:Pt:Body fld:Qn,0
2631,Boron,Boron:SCnc:Pt:Ser/Plas:Qn,0
2632,Arachis hypogaea Ab.IgG4,Arachis hypogaea Ab.IgG4:MCnc:Pt:Ser:Qn,0
2633,(Acer negundo+Betula verrucosa+Corylus avellana+Quercus alba+Platanus acerifolia) Ab.IgE,(Acer negundo+Betula verrucosa+Corylus avellana+Quercus alba+Platanus acerifolia) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk,0
2634,Brucella abortus antibody,Brucella abortus Ab:Titr:Pt:Ser:Qn:LA,0
2635,Cells.CD10/100 cells,Cells.CD10/100 cells:NFr:Pt:Bone mar:Qn,0
2636,Pregnenolone,Pregnenolone^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
2637,Pregnenolone,Pregnenolone^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
2638,Cheese swiss Ab.IgG4,Cheese swiss Ab.IgG4:MCnc:Pt:Ser:Qn,0
2639,Glucose-6-Phosphate dehydrogenase phenotype,Glucose-6-phosphate dehydrogenase phenotype:Impression/interpretation of study:Point in time:Erythrocytes:Narrative,0
2640,5-Hydroxyindoleacetate,5-Hydroxyindoleacetate:SCnc:Pt:Ser/Plas:Qn,0
2641,Antineutrophil Cytoplasmic Antibodies,Neutrophil cytoplasmic Antibody:Arbitrary Concentration:Point in time:Serum:Quantitative,0
2642,Alpha aminobutyrate/Amino acids.total,Alpha aminobutyrate/Amino acids.total:SFr:Pt:Ser/Plas:Qn,0
2643,Beef Ab.IgG4,Beef Ab.IgG4:MCnc:Pt:Ser:Qn,0
2644,Amino acid pattern,Amino acids:Impression/interpretation of study:Point in time:Cerebral spinal fluid:Narrative,0
2645,Glycine,Glycine:SCnt:Pt:Hair:Qn,0
2646,Arsenic,Arsenic:MRat:24H:Urine:Qn,0
2647,reboxetine,Reboxetine:SCnc:Pt:Ser/Plas:Qn,0
2648,Rickettsia sp identified,Rickettsia sp identified:Prid:Pt:XXX:Nom:Sequencing,0
2649,Human polyomavirus 1 DNA,BK virus DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar,0
2650,Ehrlichia chaffeensis Ab.IgG+IgM,Ehrlichia chaffeensis Ab.IgG+IgM:PrThr:Pt:Ser/Plas:Ord,0
2651,Bacteria identified,Bacteria identified:Prid:Pt:Anal:Nom:Culture,0
2652,Glucose,Glucose^4 AM specimen:SCnc:Pt:Ser/Plas:Qn,0
2653,Staphylococcus aureus Panton-Valentine leukocidin gene,Staphylococcus aureus Panton-Valentine leukocidin gene:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
2654,Herpes virus 6 deoxyribonucleic acid,Herpes virus 6 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar,0
2655,Specimen drawn,Specimen drawn^1st specimen:TmStp:Pt:Ser/Plas:Qn,0
2656,17-Hydroxycorticosteroids,17-Hydroxycorticosteroids^post dose dexamethasone:MRat:24H:Urine:Qn,0
2657,Nonesterified Fatty Acids,Fatty acids.nonesterified^4th specimen post CFst:SCnc:Pt:Ser/Plas:Qn,0
2658,View,Views:Find:Pt:Upper extremity.left>Wrist+Hand:Doc:XR,0
2659,Oleoylcarnitine (C18:1),Oleoylcarnitine (C18:1):SCnc:Pt:Amnio fld:Qn,0
2660,Ribitol/Creatinine,Ribitol/Creatinine:SRto:Pt:Urine:Qn,0
2661,"Respiratory allergen panel, US - Central midwest a","Respiratory allergen panel, US - Central midwest a:-:Pt:Ser:-",0
2662,"Respiratory allergen panel, US - Southern coastal California","Respiratory allergen panel, US - Southern coastal California:-:Pt:Ser:-",0
2663,"Respiratory allergen panel, US - Alaska a","Respiratory allergen panel, US - Alaska a:-:Pt:Ser:-",0
2664,dechloroethylifosfamide,2-Dechloroethylifosfamide^2D post dose ifosfamide:MCnc:Pt:Bld:Qn,0
2665,Chromium,Chromium:SCnt:Pt:Hair:Qn,0
2666,Cobalt,Cobalt:SCnt:Pt:Hair:Qn,0
2667,Protons,Hydrogen ion:SCnc:Pt:BldC:Qn,0
2668,Cardiac ejection fraction method,Cardiac ejection fraction method:Type:Pt:Heart.ventricle.left:Nom,0
2669,Calories burned,Calories burned:EngRat:XXX:^Patient:Qn:Pedometer,0
2670,phosphate ion,Phosphate:SCnc:Pt:Periton fld:Qn,0
2671,Mixed cellular casts,Mixed cellular casts:PrThr:Pt:Urine:Ord:Computer assisted,0
2672,nickel,Nickel:SCnt:Pt:Tiss:Qn,0
2673,Hydrogen-Ion Concentration,pH:LsCnc:Pt:Plr fld:Qn:Test strip,0
2674,Selenium,Selenium:SCnc:Pt:Urine:Qn,0
2675,Hepatitis D virus IgG,Hepatitis D virus Ab.IgG:ACnc:Pt:Ser:Qn,0
2676,HEDIS 2009-2013 Codes to identify anticonvulsant serum concentration monitoring tests - Valproate (MPM-E),HEDIS 2009-2013 Codes to identify anticonvulsant serum concentration monitoring tests - Valproate (MPM-E):-:Point in time:^Patient:-,0
2677,Cortodoxone,11-Deoxycortisol^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn,0
2678,Cholesterol in low density lipoprotein pattern A,Cholesterol.in LDL pattern A:PrThr:Pt:Ser/Plas:Ord,0
2679,Rickettsia africae IgM,Rickettsia africae Ab.IgM:Titr:Pt:Body fld:Qn:IF,0
2680,POU3F4 gene targeted mutation analysis,POU3F4 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
2681,Budgerigar serum proteins+feathers+droppings Ab.IgG,Budgerigar serum proteins+feathers+droppings Ab.IgG:PrThr:Pt:Ser:Ord,0
2682,HEDIS 2009 Tests used in early prenatal care - Toxoplasma (PPC-C),HEDIS 2009 Tests used in early prenatal care - Toxoplasma (PPC-C):-:Point in time:^Patient:-,0
2683,Chloral Hydrate,Chloral hydrate:SCnc:Pt:Ser/Plas:Qn,0
2684,Clopenthixol,Clopenthixol:SCnc:Pt:Ser/Plas:Qn,0
2685,Platelet aggregation.adenosine diphosphate induced ATP secretion,Platelet aggregation.adenosine diphosphate induced ATP secretion^10 umol/L:RelACnc:Pt:Bld:Qn,0
2686,Pyrazinamide 300.0 ug/mL,Pyrazinamide 300.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria,0
2687,fondaparinux,Fondaparinux:MCnc:Pt:Ser/Plas:Qn,0
2688,Cells.CD81/100 cells,Cells.CD81/100 cells:NFr:Pt:Bone mar:Qn,0
2689,Levodopa,Levodopa:SCnc:Pt:CSF:Qn,0
2690,"Antigens, CD1",Deprecated CD1 cells/100 cells in Blood,0
2691,Thiamphenicol,Thiamphenicol:Susc:Pt:Isolate:OrdQn,0
2692,PhenX measure - current age,PhenX measure - current age:-:Point in time:^Patient:-:PhenX,0
2693,Views GE 3,Views GE 3:Find:Pt:Lower extremity.right>Foot:Doc:XR,0
2694,Views GE 3,Views GE 3:Find:Pt:Head>Facial bones:Doc:XR,0
2695,Midazolam,Midazolam:MCnc:Pt:XXX:Qn,0
2696,Propoxyphene,Propoxyphene:MCnc:Pt:XXX:Qn,0
2697,DCX gene targeted mutation analysis,DCX gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
2698,Alpha-1-Microglobulin.placental,Alpha-1-Microglobulin.placental:PrThr:Pt:Vag:Ord,0
2699,ADENOSINE DEAMINASE,Adenosine deaminase:CCnt:Pt:CVS:Qn,0
2700,Width.transverse,Width.transverse:Len:Pt:Head.lateral cerebral ventricle.right^Fetus:Qn:US.measured,0
2701,Antistreptolysin O,Streptolysin O Ab:Titr:Pt:Ser:Qn:LA,0
2702,Para-aminosalicylate,Para aminosalicylate:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
2703,Prednisone,Prednisone:SCnc:Pt:Ser/Plas:Qn,0
2704,Asparagine/Creatinine,Asparagine/Creatinine:Ratio:24H:Urine:Qn,0
2705,Knee height (observable entity),Knee height:Length:Point in time:^Patient:Quantitative,0
2706,Hand dominance - holding a toothbrush,Hand dominance - holding a toothbrush:Find:Pt:^Patient:Nom:ALSPAC,0
2707,Platelet glycoprotein Ia-IIa Ab.IgG,Platelet glycoprotein Ia-IIa Ab.IgG:PrThr:Pt:Bld:Ord:IA,0
2708,Fibrillarin Ab,Fibrillarin Ab:PrThr:Pt:Ser:Ord,0
2709,Blood pressure systolic & diastolic,Blood pressure systolic & diastolic^pre transfusion:Pres:Pt:Arterial system:Qn,0
2710,Protein.abnormal band/Protein.total,Protein.abnormal band/Protein.total:MFr:Pt:Urine:Qn:Electrophoresis,0
2711,Echovirus 5 Ab,Echovirus 5 Ab:Titr:Pt:Ser:Qn,0
2712,Parietal cell antibody,Parietal cell Ab:Titr:Pt:Ser:Qn:IF,0
2713,3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0),3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0):SRto:Pt:Bld.dot:Qn,0
2714,3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8),3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8):SRto:Pt:Bld.dot:Qn,0
2715,Neural tube defect risk cutoff,Neural tube defect risk cutoff:Find:Pt:^Fetus:Qn,0
2716,3-methoxytyramine,3-Methoxytyramine:SCnc:Pt:CSF:Qn,0
2717,Blasts.CD10,Blasts.CD10:ACnc:Pt:Bld:Qn,0
2718,Blasts.CD10,Blasts.CD10:ACnc:Pt:XXX:Qn,0
2719,vasoactive intestinal peptide,Vasoactive intestinal peptide:PrThr:Pt:Ser/Plas:Ord,0
2720,Penicillium roqueforti antibody,Penicillium roqueforti Ab:ACnc:Pt:Ser:Qn,0
2721,Prekallikrein,Deprecated Prekallikrein (Fletcher Factor) in Platelet poor plasma,0
2722,CEH volatile organic compounds panel,CEH volatile organic compounds panel:MCnc:Pt:Ser/Plas:-,0
2723,SmIg-CD79,Deprecated SmIg-CD79:Arbitrary Concentration:Point in time:Leukocytes:Quantitative,0
2724,Cholesterol.in HDL/Cholesterol.in HDL+Cholesterol.in VLDL,Cholesterol.in HDL/Cholesterol.in HDL+Cholesterol.in VLDL:SRto:Pt:Ser/Plas:Qn,0
2725,Protein feed time,Protein feed time:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative,0
2726,Views AP & lateral,Deprecated Views AP & lateral:Finding:Point in time:Abdomen:Narrative:XR,0
2727,Polio virus 1 Ab,Polio virus 1 Ab:Titr:Pt:Ser:Qn:Neut,0
2728,Carnitine.free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18),Carnitine.free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18):SRto:Pt:Bld.dot:Qn,0
2729,Enterovirus RNA,Enterovirus RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar,0
2730,Glucose,Glucose^2H post dose ornithine alpha-ketoglutarate:SCnc:Pt:Ser/Plas:Qn,0
2731,Glutarylcarnitine (C5-DC),Glutarylcarnitine (C5-DC):SCnc:Pt:Amnio fld:Qn,0
2732,Ulmus pumila Ab.IgG4,Ulmus pumila Ab.IgG4:MCnc:Pt:Ser:Qn,0
2733,Arbovirus Ab.IgG & IgM panel,Arbovirus Ab.IgG & IgM panel:-:Pt:CSF:-:IF,0
2734,HLA-Dw5 antigen,HLA-Dw5:PrThr:Pt:Bld/Tiss^Donor:Ord,0
2735,Muscle sarcolemma antibody,Muscle sarcolemma Ab:Titr:Pt:Plr fld:Qn:IF,0
2736,Bartonella henselae IgM,Bartonella henselae Ab.IgM:ACnc:Pt:Ser:Qn,0
2737,Aldosterone & renin activity panel,Aldosterone & renin activity panel:-:Pt:Plas:Qn,0
2738,Flunitrazepam & 7-Aminoflunitrazepam panel,Flunitrazepam & 7-Aminoflunitrazepam panel:MCnc:Pt:Urine:Qn,0
2739,Astacus astacus Ab.IgG4,Astacus astacus Ab.IgG4:MCnc:Pt:Ser:Qn,0
2740,Chrysops flavidus (whole body) Ab.IgG4,Chrysops flavidus (whole body) Ab.IgG4:MCnc:Pt:Ser:Qn,0
2741,Solenopsis invicta Ab.IgG4,Solenopsis invicta Ab.IgG4:MCnc:Pt:Ser:Qn,0
2742,HLA-Dw6 antigen,HLA-Dw6:PrThr:Pt:Bld/Tiss^Donor:Ord,0
2743,Rickettsia prowazekii IgM,Rickettsia prowazekii Ab.IgM:Titr:Pt:Body fld:Qn,0
2744,Blasts.cytoplasmic CD3/100 blasts,Blasts.cytoplasmic CD3/100 blasts:NFr:Pt:Bld:Qn,0
2745,Blood product unit 4 expiration,Blood product unit 4 expiration:TmStp:Pt:^BPU:Qn,0
2746,"t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel","t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel:-:Pt:Bld/Tiss:-:Molgen",0
2747,Platinum,Platinum:SCnc:Pt:Urine:Qn,0
2748,Beta 2 globulin+Gamma globulin/Protein.total,Beta 2 globulin+Gamma globulin/Protein.total:MFr:Pt:Urine:Qn:Electrophoresis,0
2749,Sodium urate crystal,Sodium urate crystals:PrThr:Pt:XXX:Ord:Microscopy.light,0
2750,Ciprofloxacin 1.0 ug/mL,Ciprofloxacin 1.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria,0
2751,Exercise duration,Exercise duration:Time:Point in time:^Patient:Quantitative,0
2752,Acetone,Acetone:MCnc:Pt:Ser/Plas:Qn,0
2753,Paromomycin,Deprecated Paramomycin [Susceptibility] by Minimum inhibitory concentration (MIC),0
2754,Cucumis melo spp Ab.IgG4,Deprecated Melon IgG4 Ab [Mass/volume] in Serum,0
2755,Melaleuca leucadendron Ab.IgG4,Melaleuca leucadendron Ab.IgG4:MCnc:Pt:Ser:Qn,0
2756,Citrus sinensis leukotriene release,Citrus sinensis leukotriene release:MCnc:Pt:WBC:Qn,0
2757,Coxiella burnetii phase 2 IgM,Coxiella burnetii phase 2 Ab.IgM:Titr:Pt:Body fld:Qn,0
2758,Cells.CD5+CD23+/100 cells,Cells.CD5+CD23+/100 cells:NFr:Pt:Bld:Qn,0
2759,Borrelia burgdorferi Ab.IgG+IgM with reflex to immune blot panel,Borrelia burgdorferi Ab.IgG+IgM with reflex to immune blot panel:-:Pt:Ser:-,0
2760,Chromosome analysis panel,Chromosome analysis panel:-:Pt:Bld^Fetus:-:G-banded,0
2761,Decreased appetite in past 7D,Decreased appetite in past 7D:Finding:Point in time:^Patient:Ordinal:PhenX,0
2762,"Are these dreams very intense, detailed and vivid, like watching a movie","Are these dreams very intense, detailed and vivid, like watching a movie:Find:Pt:^Patient:Ord:PhenX",0
2763,Have you ever had gallbladder surgery,Have you ever had gallbladder surgery:Find:Pt:^Patient:Ord:PhenX,0
2764,Coxiella burnetii IgG,Coxiella burnetii Ab.IgG:PrThr:Pt:Ser:Ord:IF,0
2765,Cortodoxone,11-Deoxycortisol^1D post dose dexamethasone:MCnc:Pt:Ser/Plas:Qn,0
2766,Hexacarboxylporphyrin,Hexacarboxylporphyrin:SCnc:Pt:Ser/Plas:Qn,0
2767,Mesoridazine,Mesoridazine:SCnc:Pt:XXX:Qn,0
2768,Cancer pagurus Ab.IgE,Cancer pagurus Ab.IgE:ACnc:Pt:Ser:Qn,0
2769,HLA-DQB1*06:02 antigen,HLA-DQB1*06:02:PrThr:Pt:Bld/Tiss:Ord,0
2770,My cough hurts,My cough hurts:Find:Pt:^Patient:Ord:PhenX,0
2771,Adenoma dysplasia,Adenoma dysplasia:Find:Pt:^Patient:Ord:PhenX,0
2772,AJCC cancer staging manual,AJCC cancer staging manual:Find:Pt:^Patient:Nom:PhenX,0
2773,Phencyclidine,Phencyclidine:PrThr:Pt:Bld:Ord:Confirm,0
2774,Mycoplasma pneumoniae Ab.IgG & IgM panel,Mycoplasma pneumoniae Ab.IgG & IgM panel:-:Pt:Ser:-,0
2775,Carbonyldiamide,Urea nitrogen [Mass/volume] in Dialysis fluid,0
2776,Proteins,Protein:MCnc:Pt:Dial fld:Qn,0
2777,gamma-Tocopherol,Gamma tocopherol:SCnc:Pt:Ser/Plas:Qn,0
2778,Taraxacum vulgare Ab.IgE,Taraxacum vulgare Ab.IgE:ACnc:Pt:Ser:Qn,0
2779,Perfusion (procedure),Perfusion:Pres:Pt:Cerebrum:Qn,0
2780,"Which cigarette would, or did, you hate most to give up","Which cigarette would, or did, you hate most to give up:Find:Pt:^Patient:Ord:FTND",0
2781,"Has your child experienced periods of several Ds or more when he or she was unable to sit still, and had to keep moving or jumping from one activity to another","Has your child experienced periods of several Ds or more when he or she was unable to sit still, and had to keep moving or jumping from one activity to another:Find:Pt:^Patient:Ord:P-GBI",0
2782,Date participant returned actigraph to clinic,Date participant returned actigraph to clinic:Date:Pt:^Patient:Qn:PhenX,0
2783,Iron/Creatinine,Iron/Creatinine:MRto:24H:Urine:Qn,0
2784,Chlorpheniramine,Chlorpheniramine:SCnc:Pt:Ser/Plas:Qn,0
2785,CYTOMEGALOVIRUS ANTIGEN,Cytomegalovirus Ag:PrThr:Pt:Ser/Plas:Ord:IA,0
2786,View of myself in past 7D,View of myself in past 7D:Find:7D:^Patient:Nom:QIDS,0
2787,Cow milk Ab,Cow milk Ab:PrThr:Pt:Ser:Ord:Immune diffusion,0
2788,didesethylflurazepam,N-desalkylflurazepam:PrThr:Pt:Urine:Ord,0
2789,"3,4-methylenedioxyethamphetamine",Methylenedioxyethylamphetamine:PrThr:Pt:XXX:Ord,0
2790,norfentanyl,Norfentanyl:PrThr:Pt:XXX:Ord,0
2791,Palinurus spp Ab.IgE,Palinurus spp Ab.IgE:ACnc:Pt:Ser:Qn,0
2792,Antimitochondrial antibody,Mitochondria Ab:Titr:Pt:CSF:Qn:IF,0
2793,Has there been renovation in your home during the past 12Mo,Has there been renovation in your home during the past 12Mo:Find:12Mo:^Patient:Ord:FEAS,0
2794,Is the wall material in your home plastic,Is the wall material in your home plastic:Find:Pt:^Patient:Ord:FEAS,0
2795,What is your normal work or school and sleep schedule,What is your normal work or school and sleep schedule:Find:Pt:^Patient:Nom:PhenX,0
2796,Do you prefer to keep a regular sleep schedule - one that does not change much from one night to the next,Do you prefer to keep a regular sleep schedule - one that does not change much from one night to the next:Find:Pt:^Patient:Ord:PhenX,0
2797,How strong is your preference,How strong is your preference:Find:Pt:^Patient:Ord:PhenX,0
2798,Apolipoprotein B/Apolipoprotein A-I,Deprecated Apolipoprotein B/Apolipoprotein A-I [Mass ratio] in Serum or Plasma,0
2799,Dehydroepiandrosterone Sulfate,Dehydroepiandrosterone sulfate^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
2800,Fluorides,Fluoride:MRat:24H:Urine:Qn,0
2801,C-Peptide,C peptide^70M pre XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
2802,Erythrocytes,Erythrocytes:Morph:Pt:Body fld:Nom:Microscopy.light,0
2803,Dinorsibutramine,Dinorsibutramine:MCnc:Pt:Urine:Qn,0
2804,tapentadol,Tapentadol:MCnc:Pt:Body fld:Qn,0
2805,Ethanol,Ethanol:PrThr:Pt:XXX:Ord:Screen,0
2806,Number of the largest bead that is at least as large as the right testis,Number of the largest bead that is at least as large as the right testis:Find:Pt:^Patient:Nom:PhenX,0
2807,Cornea thickness,Cornea thickness:Len:Pt:Eye.right:Qn:PhenX,0
2808,Activity that usually makes you feel breathless these days,Activity that usually makes you feel breathless these days:Find:Pt:^Patient:Nom:PhenX,0
2809,Volume expired during 6.0 s of forced expiration,Volume^at 6.0 s post forced expiration:Volume Ratio:Point in time:Respiratory system:Quantitative,0
2810,Epstein-Barr virus nuclear 1 IgG,Epstein Barr virus nuclear 1 Ab.IgG:ACnc:Pt:Ser:Qn,0
2811,Legionella pneumophila IgG,Legionella pneumophila Ab.IgG^1st specimen:PrThr:Pt:Ser:Ord:IF,0
2812,Adenovirus Antigen,Adenovirus Ag:PrThr:Pt:Stool:Ord:IF,0
2813,Specific gravity measurement,Specific gravity:Rden:Pt:Pericard fld:Qn,0
2814,didesethylflurazepam,N-desalkylflurazepam:PrThr:Pt:Gast fld:Ord,0
2815,During the last 12Mo has your child appeared to have difficulty seeing,During the last 12Mo has your child appeared to have difficulty seeing:Find:12Mo:^Patient:Ord:PhenX,0
2816,"Have you ever had a crossed or wandering eye, amblyopia","Have you ever had a crossed or wandering eye, amblyopia:Find:Pt:^Patient:Ord:PhenX",0
2817,"While you were having your episode of change in speech, did any of these things occur","While you were having your episode of change in speech, did any of these things occur:Find:Pt:^Patient:Ord:PhenX",0
2818,Have you been told by a rheumatologist that you have psoriatic arthritis,Have you been told by a rheumatologist that you have psoriatic arthritis:Find:Pt:^Patient:Ord:PhenX,0
2819,Congenital adrenal hyperplasia newborn screening comment-discussion,Congenital adrenal hyperplasia newborn screening comment-discussion:Text:Point in time:Blood filter paper:Narrative,0
2820,Chest discomfort ever or since last exam or medical history update,Chest discomfort ever or since last exam or medical history update:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative,0
2821,Virus identified,Virus identified:Prid:Pt:Bld:Nom:Culture,0
2822,PhenX measure - posttraumatic stress disorder (PTSD),PhenX measure - posttraumatic stress disorder (PTSD):-:Point in time:^Patient:-:PhenX,0
2823,Entamoeba histolytica DNA,Entamoeba histolytica DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
2824,Elastase antibody,Elastase Ab:ACnc:Pt:Ser:Qn:IA,0
2825,Nuclear Ab.IgG,Nuclear Ab.IgG:Titr:Pt:Ser:Qn:IF,0
2826,Referral note,Referral note:Find:Pt:{Setting}:Doc:Psychology,0
2827,Collaborative staging post treatment tumor size,Collaborative staging post treatment tumor size:Prid:Pt:Cancer.XXX:Nom,0
2828,Dichlorvos,Dichlorvos:MCnc:Pt:Bld:Qn,0
2829,Flounder Ab.IgG,Flounder Ab.IgG:MCnc:Pt:Ser:Qn,0
2830,Solenopsis invicta Ab.IgE,Solenopsis invicta Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative,0
2831,Linum usitatissimum Ab.IgG,Linum usitatissimum Ab.IgG:MCnc:Pt:Ser:Qn,0
2832,I am breathless when I bend over,I am breathless when I bend over:Find:Pt:^Patient:Ord:PhenX,0
2833,"When frightened, I feel like passing out","When frightened, I feel like passing out:Find:Pt:^Patient:Ord:SCARED-R",0
2834,"When frightened, I feel like going crazy","When frightened, I feel like going crazy:Find:Pt:^Patient:Ord:SCARED-R",0
2835,Did you have trouble seeing,Did you have trouble seeing:Find:Pt:^Patient:Ord:PhenX,0
2836,Pathology biopsy report,Pathology biopsy report:Find:Pt:Cervix:Nar,0
2837,Pathology biopsy report,Pathology biopsy report:Find:Pt:Rectum:Nar,0
2838,Scarring chronic alopecia,Scarring chronic alopecia:Hx:Pt:^Patient:Ord:PhenX,0
2839,I can solve most problems if I invest the necessary effort,I can solve most problems if I invest the necessary effort:Find:Pt:^Patient:Ord:GSE,0
2840,Pain severity,Pain severity:Find:Pt:^Patient:Ord:Reported.FPS-R,0
2841,Norvenlafaxine,Norvenlafaxine:MCnc:Pt:Body fld:Qn,0
2842,Spermatozoa.bent midpiece/100 spermatozoa,Spermatozoa.bent midpiece/100 spermatozoa:NFr:Pt:Semen:Qn,0
2843,View,Views^W radionuclide intra lymphatic:Find:Pt:Breast.left>Lymphatic vessels:Doc:NM,0
2844,I don't like being in a hospital,I don't like being in a hospital:Find:Pt:^Patient:Ord:SCARED-R,0
2845,Corylus avellana recombinant (rCor a) 1.0101 Ab.IgE,Corylus avellana recombinant (rCor a) 1.0101 Ab.IgE:ACnc:Pt:Ser:Qn,0
2846,View,Deprecated Sagittal sinus and Jugular veins - right Fluoroscopic angiogram W contrast IV,0
2847,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Methylene blue stain.Loeffler,0
2848,Testosterone free & total panel,Testosterone free & total panel:MCnc:Pt:Ser/Plas:Qn,0
2849,Bilevel positive airway pressure,Pressure.bilevel positive airway:Pres:Pt:Ventilator:Qn,0
2850,pentane,Pentane:MCnc:Pt:Urine:Qn,0
2851,phensuximide,Phensuximide:MCnc:Pt:Bld:Qn,0
2852,I enjoy social chit-chat,I enjoy social chit-chat:Find:Pt:^Patient:Ord:AQ,0
2853,Admission request,Admission request:Find:Pt:^Patient:Doc,0
2854,Erythrocytes,Erythrocytes:NCnc:Pt:Periton fld:Qn:Automated count,0
2855,Carisoprodol,Carisoprodol:SCnc:Pt:XXX:Qn,0
2856,Carbonyldiamide,Urea nitrogen:SCnc:Pt:Bld:Qn,0
2857,Sulfamethizole,Sulfamethizole:MCnc:Pt:Bld:Qn,0
2858,Potassium,Potassium:SCnc:Pt:Bld:Qn,0
2859,Dyspnea,Dyspnea^post exercise:Find:Pt:Respiratory system:Ord,0
2860,Your child is fascinated by dates,Your child is fascinated by dates:Find:Pt:^Patient:Ord:AQ Adolescent,0
2861,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Warthin-Starry stain,0
2862,How much does he or she appreciate you,How much does he or she appreciate you:Find:Pt:^Patient:Ord:MIDUS II,0
2863,C-Peptide,C peptide^100M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
2864,Estradiol,Estradiol^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn:High sensitivity,0
2865,Minimum alveolar concentration sum,Minimum alveolar concentration sum^^corrected for age:VFr:Pt:Anesthetic agent.XXX+Nitrous oxide:Qn,0
2866,PhenX measure - birthplace of parents,PhenX measure - birthplace of parents:-:Point in time:^Patient:-:PhenX,0
2867,Have you ever had chronic bronchitis,Have you ever had chronic bronchitis:Find:Pt:^Patient:Ord:PhenX,0
2868,Have you ever smoked cigarettes,Have you ever smoked cigarettes:Find:Pt:^Patient:Ord:PhenX,0
2869,How old were you when you started smoking cigars regularly,How old were you when you started smoking cigars regularly:Time:Pt:^Patient:Qn:PhenX,0
2870,Streptococcus pyogenes antigen,Deprecated Streptococcus pyogenes Ag [Presence] in Throat by Immunoassay,0
2871,Motor symptoms - legs,Motor symptoms - legs:Find:Pt:^Patient:Ord:PhenX,0
2872,Psychological stressor notes,Psychological stressor notes:Txt:Pt:^Patient:Nom:DI-PAD CGP V 1.4,0
2873,Reduced need for sleep,Reduced need for sleep:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4,0
2874,Excessive activity,Excessive activity:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4,0
2875,"Troponin T, Cardiac Muscle",Troponin T.cardiac:MCnc:Pt:Ser/Plas:Qn,0
2876,Have you ever seen or heard another person be threatened with a weapon - a gun or a knife,Have you ever seen or heard another person be threatened with a weapon - a gun or a knife:Find:Pt:^Patient:Ord:LTVH,0
2877,Modified dukes - astler-coller,Modified dukes - astler-coller:Find:Pt:^Patient:Ord:PhenX,0
2878,Episode unique identifier,Episode unique identifier:Identifier:Point in time:^Patient:nom,0
2879,Corticotropin,Corticotropin^1.5H post dose glucose:MCnc:Pt:Plas:Qn,0
2880,Coagulation Russell viper venom induced,Coagulation Russell viper venom induced:Time:Pt:PPP:Qn:Coag,0
2881,ST amplitude.lead AI,ST amplitude.lead AI:Elpot:Pt:Heart:Qn:EKG,0
2882,"Antigens, CD55",Complement decay accelerating factor:PrThr:Pt:RBC:Ord,0
2883,Fagopyrum esculentum Ab.IgG,Fagopyrum esculentum Ab.IgG:MCnc:Pt:Ser:Qn,0
2884,Negative formal thought disorder,Negative formal thought disorder:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4,0
2885,How many times in the last Y have you gone into or tried to go into a building to steal something,How many times in the last Y have you gone into or tried to go into a building to steal something:NRat:1Y:^Patient:Qn:Denver Youth Survey,0
2886,Presenting problem,Presenting problem:Finding:Point in time:^Patient:Nominal,0
2887,Corticotropin,Corticotropin^30M post XXX challenge:SCnc:Pt:Plas:Qn,0
2888,Aspergillus terreus Ab.IgE,Aspergillus terreus Ab.IgE:ACnc:Pt:Ser:Qn,0
2889,Phoenix dactylifera Ab.IgG,Phoenix dactylifera Ab.IgG:MCnc:Pt:Ser:Qn,0
2890,Where was your biological mother born,Where was your biological mother born:Find:Pt:^Patient:Nom:PhenX,0
2891,"Compared to other children, does this child give close attention to detail and avoid careless mistakes","Compared to other children, does this child give close attention to detail and avoid careless mistakes:Find:Pt:^Patient:Ord:SWAN ADHD",0
2892,Pathology biopsy report,Pathology biopsy report:Finding:Point in time:Bone marrow:Narrative,0
2893,Your work is boring and repetitive,Your work is boring and repetitive:Find:Pt:^Patient:Ord:PhenX,0
2894,Cardiac rhythm monitoring,Cardiac rhythm monitoring:Complex:-:^Patient:Set,0
2895,Glucose,Glucose^4th specimen post dose lactose:MCnc:Pt:Ser/Plas:Qn,0
2896,Musa spp Ab.IgE,Musa spp Ab.IgE:ACnc:Pt:Ser:Qn,0
2897,Imipramine,Imipramine:PrThr:Pt:Urine:Ord:Confirm,0
2898,norhydrocodone,Norhydrocodone:MCnc:Pt:Urine:Qn:Confirm,0
2899,Penicillium brevicompactum Ab.IgG,Penicillium brevicompactum Ab.IgG:MCnc:Pt:Ser:Qn,0
2900,I have taken money from someone's purse or wallet without asking,I have taken money from someone's purse or wallet without asking:Find:Pt:^Patient:Ord:PhenX,0
2901,I'm afraid of far fewer things than most people,I'm afraid of far fewer things than most people:Find:Pt:^Patient:Ord:PhenX,0
2902,I never worry about making a fool of myself with others,I never worry about making a fool of myself with others:Find:Pt:^Patient:Ord:PhenX,0
2903,I have stolen something out of a vehicle,I have stolen something out of a vehicle:Find:Pt:^Patient:Ord:PhenX,0
2904,Bilirubin.glucuronidated+Bilirubin.albumin bound,Bilirubin.glucuronidated+Bilirubin.albumin bound:MCnc:Pt:Periton fld:Qn,0
2905,Spermatozoa.progressive.grade 3/100 spermatozoa,Spermatozoa.progressive.grade 3/100 spermatozoa^post concentration:NFr:Pt:Semen:Qn,0
2906,Legionella pneumophila 1+3+4+5+6+8 Ab,Legionella pneumophila 1+3+4+5+6+8 Ab:PrThr:Pt:Ser:Ord,0
2907,Guidance for biopsy.needle,Deprecated US Guidance for needle biopsy of Muscle,0
2908,Valdecoxib induced platelet Ab.IgG,Valdecoxib induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
2909,Doxycycline induced platelet Ab.IgG,Doxycycline induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
2910,Cortolone,Alpha cortolone:SCnc:24H:Urine:Qn,0
2911,Steroid fractions panel,Steroid fractions panel:-:24H:Urine:-,0
2912,Trisomy 13 prior risk,Trisomy 13 prior risk:Likelihood:Point in time:^Fetus:Quantitative:Based on maternal age,0
2913,Carbon Dioxide,Carbon dioxide^during inspiration:VFr/PPres:Pt:Gas delivery system.inspiratory limb:Qn,0
2914,Spermatozoa.motile/100 spermatozoa,Spermatozoa.motile/100 spermatozoa:Number Fraction:Point in time:Seminal fluid:Quantitative,0
2915,Transfer summary note,Transfer summary note:Find:Pt:{Setting}:Doc:Pediatric gastroenterology,0
2916,Citrulline,Citrulline:MRat:24H:Urine:Qn,0
2917,GALACTOKINASE,Galactokinase:CCnt:Pt:WBC:Qn,0
2918,Citalopram,Deprecated Citalopram [Mass/volume] in Serum or Plasma --trough,0
2919,Progress note,Progress note:Find:Pt:Hospital:Doc:Pediatrics,0
2920,"Allergen specific antibody interpretation, semi-quantitative",RAST class:PrThr:Pt:Ser:Ord,0
2921,Cladosporium herbarum Ab.IgG,Cladosporium herbarum Ab.IgG:ACnc:Pt:Ser:Qn,0
2922,Clavulanate induced platelet Ab.IgG,Clavulanate induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
2923,Citalopram induced platelet Ab.IgG,Citalopram induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
2924,Glucose,Glucose^15M post 50 g lactose PO:SCnc:Pt:Ser/Plas:Qn,0
2925,Oxygen therapy was given,Oxygen therapy was given:Find:Pt:^Patient:Ord:NTDS,0
2926,Streptococcus sp tuf gene,Deprecated Streptococcus sp tuf gene [Presence] by Nucleic acid capture and probe detection in Positive blood culture,0
2927,Hydroxychloroquine,Hydroxychloroquine^trough:MCnc:Pt:Ser/Plas:Qn,0
2928,norketamine,Norketamine:MCnc:Pt:Urine:Qn:Confirm,0
2929,Anethum graveolens Ab.IgE,Anethum graveolens Ab.IgE:ACnc:Pt:Ser:Qn,0
2930,Buprenorphine,Buprenorphine:PrThr:Pt:Saliva:Ord:Screen,0
2931,Lactalbumin basophil bound Ab,Lactalbumin basophil bound Ab:ACnc:Pt:Bld:Qn:LHR,0
2932,Carnitine O-Palmitoyltransferase,Deprecated Carnitine acyltransferase I [Enzymatic activity/mass] in Leukocytes,0
2933,Note (document),Note:Find:Pt:{Setting}:Doc:Pediatric transplant hepatology,0
2934,Albumin/Globulin,Albumin/Globulin:MRto:Pt:CSF:Qn:Electrophoresis,0
2935,Clindamycin,Clindamycin:Susc:Pt:Isolate:OrdQn:Gradient strip,0
2936,Hantavirus saaremaa Ab.IgG,Hantavirus saaremaa Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IF,0
2937,Hantavirus seoul Ab.IgG,Hantavirus seoul Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IF,0
2938,Burkholderia mallei DNA,Burkholderia mallei DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
2939,"Influenza A Virus Antigen, B",Influenza virus A & B Ag:Prid:Pt:Nose:Nom:IA.rapid,0
2940,plazomicin,Plazomicin:Susc:Pt:Isolate:OrdQn,0
2941,Sildenafil citrate induced platelet Ab.IgM,Sildenafil citrate induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
2942,Von Willebrand factor activity (finding),von Willebrand factor.activity:ACnc:Pt:PPP:Qn:IA,0
2943,Manufacturer Name,Manufacturer name:ID:Pt:Syringe:Nom,0
2944,Acceleration index,Acceleration index:Accel:Pt:Aorta:Qn,0
2945,Jugular vein distension,Jugular vein distension:Finding:Point in time:^Patient:Ordinal,0
2946,Neutrophil Ab.IgM,Neutrophil Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
2947,Periodontal attachment - recommended CDA set,Periodontal attachment - recommended CDA set:-:Pt:{Setting}:-,0
2948,How close are you to this person,How close are you to this person:Find:Pt:^Patient:Ord:PhenX,0
2949,Note (document),Note:Find:Pt:{Setting}:Doc:Neurology w special qualifications in child neuro,0
2950,Dantu Ab,Dantu Ab:PrThr:Pt:Ser/Plas:Ord,0
2951,Guidance for percutaneous vertebroplasty,Guidance for percutaneous vertebroplasty:Find:Pt:Neck>Spine.cervical:Doc:RF,0
2952,Vision Tests,Vision testing:Finding:Point in time:^Patient:Narrative,0
2953,3-Hydroxybutyrate,Beta hydroxybutyrate^pre-meal:SCnc:Pt:Bld:Qn,0
2954,didesmethylcitalopram,Didesmethylcitalopram:MCnc:Pt:Ser/Plas:Qn,0
2955,Fumarate Hydratase,Fumarase:CCnt:Pt:Fibroblasts:Qn,0
2956,Docosahexaenoate,Docosahexaenoate:EntSub:Pt:RBC:Qn,0
2957,Raphanus sativus Ab.IgE,Raphanus sativus Ab.IgE:ACnc:Pt:Ser:Qn,0
2958,Fluconazole,Fluconazole:Susc:Pt:Isolate:OrdQn:Gradient strip,0
2959,Cannabinoids,Cannabinoids:PrThr:Pt:Urine:Ord:Screen>20 ng/mL,0
2960,NDC labeler code request.animal drug,NDC labeler code request.animal drug:-:-:^FDA product label:Nar,0
2961,Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH),Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH):SCnc:Pt:Ser/Plas:Qn,0
2962,Monoclonal band 3 observed,Monoclonal band 3 observed:Prid:Pt:Ser/Plas:Nom:Immunofixation,0
2963,How many of your brothers or sisters have hearing difficulties,How many of your brothers or sisters have hearing difficulties:Num:Pt:^Patient:Qn:PhenX,0
2964,Ear with hearing difficulty,Ear with hearing difficulty:Find:Pt:Ear:Nom:PhenX,0
2965,Nuclear antibody,Nuclear Ab:Titr:Pt:Plr fld:Qn:IF,0
2966,Lactose tolerance panel,Lactose tolerance panel^dosage unspecified:SCnc:Pt:Ser/Plas:-,0
2967,PMI - Common side effects section,PMI - Common side effects section:-:-:^FDA package insert:Nar,0
2968,HNA 4a-4a Ab,HNA 4a-4a Ab:PrThr:Pt:Ser:Ord:IA,0
2969,Granulocytes/100 leukocytes,Granulocytes/100 leukocytes:NFr:Pt:Body fld:Qn,0
2970,Monoclonal band observed,Monoclonal band observed:Prid:Pt:Urine:Nom:Immunofixation,0
2971,Cocaine metabolite,Cocaine+Metabolites:PrThr:Pt:Saliva:Ord:Confirm,0
2972,Chlorinated solvents,Chlorinated solvents:PrThr:Pt:Urine:Ord,0
2973,Ambrosia dumosa Ab.IgE,Ambrosia dumosa Ab.IgE:ACnc:Pt:Ser:Qn,0
2974,ghrelin,Ghrelin:MCnc:Pt:Ser/Plas:Qn,0
2975,Scene delay,Scene delay:Type:Pt:^Patient:Nom:NEMSIS,0
2976,Chief complaint per dispatch,Chief complaint per dispatch:Find:Pt:^Patient:Nom:Reported.dispatch,0
2977,You have been treated with less respect than other people,You have been treated with less respect than other people:Find:Pt:^Patient:Ord:PhenX,0
2978,Nuclear antibody,Nuclear Ab:Titr:Pt:Body fld:Qn:IF,0
2979,Methadone panel,Methadone panel:-:Pt:Saliva:-:Confirm,0
2980,Magnesium.ionized,Magnesium.ionized:SCnc:Pt:Bld:Qn:ISE,0
2981,RR interval,RR interval:Time:Stdy^max:Heart:Qn:EKG,0
2982,The rules of the school are fair,The rules of the school are fair:Find:Pt:^Patient:Ord:PhenX,0
2983,Monocytes,Monocytes:NCnc:Pt:Pericard fld:Qn:Manual count,0
2984,CFTR gene.c.394delTT,CFTR gene.c.394delTT:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
2985,Myelopoiesis assessment,Myelopoiesis assessment:Find:Pt:Bone mar:Nar,0
2986,End-systolic volume,End-systolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by cube method,0
2987,Admission evaluation note,Admission evaluation note:Find:Pt:Hospital:Doc:Cardiovascular disease,0
2988,Cell count panel,Cell count panel:-:Pt:Pericard fld:Qn,0
2989,"t(11;17)(q23;q21.1)(ZBTB16,RARA) fusion transcript","t(11;17)(q23;q21.1)(ZBTB16,RARA) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen",0
2990,Creatine kinase.MM/Creatine kinase.total,Creatine kinase.MM/Creatine kinase.total:CFr.DF:Pt:Ser/Plas:Qn:Electrophoresis,0
2991,Valproate,Valproate^peak:MCnc:Pt:Ser/Plas:Qn,0
2992,Additional cause of injury,Additional cause of injury:Find:Pt:^Patient:Nom:NTDS,0
2993,Acetylcholinesterase,Acetylcholinesterase:Imp:Pt:Amnio fld:Nar,0
2994,Apolipoprotein A-I,Apolipoprotein A-I:SCnc:Pt:Ser/Plas:Qn,0
2995,Have you ever smoked regularly,Have you ever smoked regularly:Find:Pt:^Patient:Ord:PhenX,0
2996,Diagram of device,Diagram of device:-:-:^FDA package insert:Nar,0
2997,2-hydroxyphenylacetate,2-Hydroxyphenylacetate:SCnc:Pt:Ser/Plas:Qn,0
2998,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone:SCnc:Pt:Amnio fld:Qn,0
2999,norcocaine,Norcocaine:PrThr:Pt:Meconium:Ord,0
3000,Pupil reaction,Pupil reaction:Time:Pt:Eye.right:Qn,0
3001,Snapper red Ab.IgE,Snapper red Ab.IgE:ACnc:Pt:Ser:Qn,0
3002,methylethyl ketone,Methyl ethyl ketone:MCnc:Pt:Body fld:Qn,0
3003,dechloroethylifosfamide,2-Dechloroethylifosfamide^4D post dose ifosfamide:MCnc:24H:Urine:Qn,0
3004,PAX5 & CD5 Ag,PAX5 & CD5 Ag:Prid:Pt:Tiss:Nom:Immune stain,0
3005,Air delivered.case,Air delivered.case:Vol:Procedure dur:Gas delivery system:Qn,0
3006,Process variables for assays,Process variables for assays:-:Pt:^Patient:-:PhenX,0
3007,Extrinsic coagulation factor activity 4 panel,Extrinsic coagulation factor activity 4 panel:-:Pt:PPP:-,0
3008,7-aminoflunitrazepam,7-Aminoflunitrazepam:MCnc:Pt:Ser/Plas/Bld:Qn,0
3009,Snowshoe hare virus IgM Ab,Snowshoe hare virus Ab.IgM:PrThr:Pt:Ser:Ord:IF,0
3010,Education note,Education note:Find:Pt:{Setting}:Doc:Primary care,0
3011,Transfer summary note,Transfer summary note:Find:Pt:{Setting}:Doc:Multi-specialty program,0
3012,C-reactive protein,C reactive protein:MCnc:Pt:Bld:Qn:High sensitivity,0
3013,Base excess.100% oxygenated,Base excess.100% oxygenated^^standard:SCnc:Pt:BldA:Qn:Calculated,0
3014,Alpha-cortol,Alpha cortol:SCnc:24H:Urine:Qn,0
3015,Iva xanthifolia Ab.IgG,Iva xanthifolia Ab.IgG:ACnc:Pt:Ser:Qn,0
3016,Note (document),Note:Find:Pt:Telehealth:Doc:{Role},0
3017,Lupus anticoagulant two screening tests W Reflex panel,Lupus anticoagulant two screening tests W Reflex panel:-:Pt:PPP:-:Coag,0
3018,Adenovirus DNA,Adenovirus DNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,0
3019,microscopic observation,Microscopic observation:PrThr:Pt:BAL:Ord:Acid fast stain.Ziehl-Neelsen,0
3020,Aldosterone,Aldosterone:SCnc:Pt:Ser/Plas:Qn,0
3021,Immunoglobulin A,IgA:PrThr:Pt:Ser:Ord:Immunoelectrophoresis,0
3022,Budgerigar serum proteins Ab.IgE.RAST class,Budgie Serum Prot IgE RAST Ql,0
3023,Populus tremula Ab.IgE.RAST class,Populus tremula Antibody.immunoglobulin E.RAST class:Arbitrary Concentration:Point in time:Serum:Ordinal,0
3024,Institution inventory number,Institution inventory number:ID:Pt:Oral tube:Nom,0
3025,F little y super little b Ab,F little y super little b Ab:PrThr:Pt:Ser/Plas^BPU:Ord,0
3026,Vendor model number,Vendor model number:Prid:Pt:GI tube:Nom,0
3027,Vendor serial number,Vendor serial number:ID:Pt:Chest tube:Nom,0
3028,Diameter (qualifier value),Diameter:Len:Pt:Umbilical vein^Fetus:Qn:US.measured,0
3029,Hydrocortisone,Cortisol^pre 250 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn,0
3030,Cotinine,Cotinine:PrThr:Pt:Urine:Ord,0
3031,Tranylcypromine,Tranylcypromine:MCnc:Pt:Ser/Plas:Qn,0
3032,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Methyl green-pyronine Y stain,0
3033,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:Estimated from ovulation date,0
3034,Benzyl Alcohol,Benzyl alcohol:PrThr:Pt:Ser/Plas:Ord,0
3035,Insulin,Insulin^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3036,Toxoplasma gondii antibody,Toxoplasma gondii Ab:ACnc:Pt:CSF:Qn,0
3037,Norepinephrine/Creatinine,Norepinephrine/Creatinine:MRto:Pt:Urine:Qn,0
3038,Hydrocortisone,Cortisol^50H post 500 ug dexamethasone PO 2.5 day low dose q6h:MCnc:Pt:Ser/Plas:Qn,0
3039,Follicle Stimulating Hormone,Follitropin^1H post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn,0
3040,Carya tomentosa Ab.IgE.RAST class,Carya tomentosa Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3041,Honeysuckle Ab.IgE.RAST class,Honeysuckle Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3042,Inject varicella zoster virus immune globulin,Inject varicella zoster virus immune globulin:Vol:Pt:^Patient:Qn,0
3043,Rh immune globulin given,Rh immune globulin given:Vol:Pt:^Patient:Qn,0
3044,Urate crystals.microscopic observation,Urate crystals.microscopic observation:Prid:Pt:Tiss:Nom:De Galantha stain,0
3045,ED procedure practitioner profession,ED procedure practitioner profession:Type:Point in time:Provider:Nominal,0
3046,IgM Ab.IgM,IgM Ab.IgM:ACnc:Pt:Ser/Plas:Qn,0
3047,Packed erythrocytes units available,Packed erythrocytes units available:Num:Pt:^BPU:Qn,0
3048,Haemophilus influenzae B Ag,Haemophilus influenzae B Ag:PrThr:Pt:CSF:Ord:LA,0
3049,Glucose,Glucose^30M post dose glucose:SCnc:Pt:Ser/Plas:Qn,0
3050,Homarus gammarus Ab.IgE.RAST class,Homarus gammarus Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3051,Octopus vulgaris Ab.IgE.RAST class,Octopus vulgaris Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3052,Transfuse whole blood autologous,Transfuse whole blood autologous:Vol:Pt:^Patient:Qn,0
3053,phosphate ion,Phosphate:MCnt:Pt:Stool:Qn,0
3054,Free prostate specific antigen,Prostate specific Ag.free:MCnc:Pt:Ser/Plas:Qn,0
3055,Proteins,Protein:MCnc:12H:Urine:Qn,0
3056,Blasts.CD33/100 blasts,Blasts.CD33/100 blasts:NFr:Pt:Bld:Qn,0
3057,Lymphocytes.CD3+CD26+/100 lymphocytes,Deprecated CD3+CD26+ cells/100 cells in Blood,0
3058,Ethanol,Ethanol:MCnc:Pt:Ser/Plas:Qn:GC,0
3059,Insulin,Insulin:SCnc:Pt:Ser/Plas:Qn,0
3060,Ipomoea batatas Ab.IgE.RAST class,Ipomoea batatas Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3061,S wave amplitude.lead V3,S wave amplitude.lead V3:Elpot:Pt:Heart:Qn:EKG,0
3062,Horse serum proteins Ab.IgE,Horse serum proteins Ab.IgE:ACnc:Pt:Ser:Qn,0
3063,Triglycerides,"Triglyceride:Mass Concentration:Point in time:Body fluid, unsp:Quantitative",0
3064,Cucurbita pepo seed Ab.IgE.RAST class,Cucurbita pepo seed Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3065,Physical findings,Physical findings:Finding:Point in time:Genitalia.female:Nominal:Observed,0
3066,"Human immunodeficiency virus, type II protein 41 antibody",HIV 2 p41 Ab:PrThr:Pt:Ser:Ord:IB,0
3067,Testes Ab.IgG,Testes Ab.IgG:Titr:Pt:Ser:Qn,0
3068,Loligo sp Ab.IgE.RAST class,Loligo sp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3069,Swine epithelium Ab.IgE.RAST class,Swine epithelium Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3070,Tetramin Ab.IgE.RAST class,Tetramin Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3071,Cryptococcus sp Ag,Cryptococcus sp Ag:Titr:Pt:XXX:Qn,0
3072,Myelin-Associated Glycoprotein Antibody,Myelin associated glycoprotein Ab:PrThr:Pt:CSF:Ord:IB,0
3073,thyrotropin-binding inhibitory immunoglobulin,Thyrotropin binding inhibitory immunoglobulins:PrThr:Pt:Ser:Ord,0
3074,Helicobacter pylori IgA,Helicobacter pylori Ab.IgA:PrThr:Pt:Ser:Ord,0
3075,Amyl ether,Amyl ether:MCnc:Pt:Bld:Qn,0
3076,Acanthamoeba sp identified,Acanthamoeba sp identified:Prid:Pt:Eye:Nom:Organism specific culture,0
3077,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Argentaffin stain,0
3078,Surgical operation note anesthesia duration,Surgical operation note anesthesia duration:Time:Duration of procedure:Surgical procedure:Quantitative,0
3079,Factor VIII Coagulant Antigen,Coagulation factor VIII Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
3080,Study observation,Study observation:Finding:Point in time:Mitral valve^Fetus:Nominal:ULTRASOUND,0
3081,Magnesium/Creatinine,Magnesium/Creatinine:MRto:Pt:Urine:Qn,0
3082,18-Hydroxydeoxycortisol/Creatinine,18-Hydroxydeoxycortisol/Creatinine:MRto:Pt:Urine:Qn,0
3083,Free cortisol,Cortisol.free^pre 2 mg dexamethasone PO 2.5 day high dose q6h:MCnc:24H:Urine:Qn,0
3084,Alpha 1 globulin/Protein.total,Alpha 1 globulin/Protein.total:MFr:Pt:CSF:Qn:Electrophoresis,0
3085,Albumin/Globulin,Albumin/Globulin:MRto:Pt:CSF:Qn,0
3086,Cholesterol,Deprecated Cholesterol [Mass/volume] in Pleural fluid,0
3087,Zinc,Zinc:SCnc:Pt:Ser/Plas:Qn,0
3088,Formaldehyde Ab.IgE.RAST class,Formaldehyde Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3089,Spermatozoa.motile with IgA/100 spermatozoa,Spermatozoa.motile with IgA/100 spermatozoa:NFr:Pt:Semen:Qn:Immunobead,0
3090,Amorphous urate crystals,Urate crystals.amorphous:NCnc:Pt:Urine sed:Qn,0
3091,Muromonab-CD3,OKT3:MCnc:Pt:Ser/Plas:Qn,0
3092,Study observation,Study observation:Finding:Point in time:Kidney.left^Fetus:Nominal:ULTRASOUND,0
3093,Hexobarbital,Hexobarbital:MCnc:Pt:Ser/Plas:Qn,0
3094,Carbonyldiamide,Urea nitrogen:MCnc:Pt:BldV:Qn,0
3095,Rubella virus antigen,Rubella virus Ag:PrThr:Pt:Cvx:Ord:IF,0
3096,ST initial amplitude 6 ms.lead V6,ST initial amplitude 6 ms.lead V6:Elpot:Pt:Heart:Qn:EKG,0
3097,Brucella canis antibody,Brucella canis Ab:ACnc:Pt:Ser:Qn,0
3098,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US.estimated from BPC,0
3099,Erythromycin / Sulfisoxazole,Erythromycin+Sulfisoxazole:Susc:Pt:Isolate:OrdQn:Gradient strip,0
3100,C-Peptide,C peptide^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3101,Prolactin,Prolactin^45M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn,0
3102,ST wave displacement.mid.lead AVL,ST wave displacement.mid.lead AVL:Elpot:Pt:Heart:Qn:EKG,0
3103,Hydrocortisone,Cortisol^10th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3104,Platelet Ab.circulating,Deprecated Platelet Ab [Units/volume] in Serum,0
3105,dezocine,Dezocine:PrThr:Pt:Urine:Ord,0
3106,Hydrocortisone,Cortisol^1M post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn,0
3107,Bacteria identified,Bacteria identified:Prid:Pt:Cvx:Nom:Aerobic culture,0
3108,Oxalates,Oxalate:SCnc:Pt:Urine:Qn,0
3109,estrone sulfate,Estrone sulfate:MCnc:Pt:Ser/Plas:Qn,0
3110,Varicella zoster virus immunoglobulin G antibody,Varicella zoster virus Ab.IgG:PrThr:Pt:Ser:Ord:IA,0
3111,Coagulation surface induced,Coagulation surface induced:Time:Pt:Bld^Control:Qn:Coag.saline 1:1,0
3112,Albumin/Globulin,Albumin/Globulin:MRto:Pt:Body fld:Qn,0
3113,Glucose,Glucose^pre dialysis:MCnc:Pt:Dial fld prt:Qn,0
3114,Beta tubulin Ab.IgM,Deprecated Beta tubulin Ab.IgM,0
3115,Porphyrins,Porphyrins:SRat:24H:Stool:Qn,0
3116,Uroporphyrins,Uroporphyrin:SRat:24H:Urine:Qn,0
3117,Digitoxin,Digitoxin:SCnc:Pt:Ser/Plas:Qn,0
3118,Midazolam,Midazolam:SCnc:Pt:Ser/Plas:Qn,0
3119,Acremonium sp Ab.IgE.RAST class,Acremonium sp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3120,Cortisol/Creatinine,Cortisol/Creatinine:MRto:Pt:Urine:Qn,0
3121,Blood flow.systolic.max,Blood flow.systolic.max:Vel:Pt:Cerebral artery middle:Qn:US.doppler,0
3122,Blood flow.systolic.max,Blood flow.systolic.max:Vel:Pt:Mitral valve:Qn:US.doppler,0
3123,Chymopapain Ab.IgE.RAST class,Chymopapain Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3124,Trichosporon pullulans Ab.IgE,Trichosporon pullulans Ab.IgE:ACnc:Pt:Ser:Qn,0
3125,P Blood group antibodies,Deprecated P NOS Ab [Presence] in Serum or Plasma,0
3126,C-Peptide,C peptide^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3127,Coagulation thrombin induced,Deprecated Thrombin time in Platelet poor plasma from control by Coagulation assay,0
3128,Dinoprost,Prostaglandin F2 alpha:MCnc:Pt:Ser/Plas:Qn,0
3129,Hemoglobin.gastrointestinal,Hemoglobin.gastrointestinal^3rd specimen:PrThr:Pt:Stool:Ord,0
3130,Cortodoxone,11-Deoxycortisol:SCnc:Pt:Ser/Plas:Qn,0
3131,Aldosterone,Aldosterone:MCnc:Pt:Bld:Qn,0
3132,Streptococcus pneumoniae IgG,Streptococcus pneumoniae Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn:IA,0
3133,Butorphanol cutoff,Butorphanol cutoff:MCnc:Pt:Urine:Qn:Screen,0
3134,Invertase,Beta fructofuranosidase:CCnc:Pt:Ser:Qn,0
3135,Diffusion capacity/Alveolar volume,Diffusion capacity/Alveolar volume:Inverse VI:Pt:Respiratory system:Qn:Predicted,0
3136,Chlamydophila psittaci antibody,Chlamydophila psittaci Ab:PrThr:Pt:Ser:Ord:Immune diffusion,0
3137,COLLAGENASE,Collagenase:CCnc:Pt:Ser:Qn,0
3138,Japanese encephalitis virus Antigen,Japanese encephalitis virus Ag:PrThr:Pt:XXX:Ord:HAI,0
3139,Hydrocortisone,Cortisol^1M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3140,Dextromethamphetamine,Dextromethamphetamine:PrThr:Pt:Urine:Ord:Screen,0
3141,Tritrichomonas foetus Ag,Tritrichomonas foetus Ag:PrThr:Pt:Placenta:Ord:Immune stain,0
3142,EKG impression,EKG impression:Impression/interpretation of study:Point in time:Heart:Narrative:EKG,0
3143,Beta-glucuronidase,Beta glucuronidase:CCnc:Pt:Urine:Qn,0
3144,ethylamphetamine,Ethylamphetamine:PrThr:Pt:Urine:Ord:Screen,0
3145,Oxygen,Oxygen^on room air and asleep:PPres:Stdy^max:BldC:Qn:Transcutaneous O2 monitor,0
3146,"t(6;9)(p22;q34)(DEK,NUP214) fusion transcript","t(6;9)(p22;q34)(DEK,NUP214) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen",0
3147,La Crosse virus IgG,La Crosse virus Ab.IgG:Titr:Pt:CSF:Qn,0
3148,Histoplasma species antibody,Deprecated Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID),0
3149,malaoxon,Malaoxon:MCnc:Pt:Bld:Qn,0
3150,Dehydroepiandrosterone Sulfate,Dehydroepiandrosterone sulfate^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3151,"Acid phosphatase isoenzyme, prostatic fraction",Acid phosphatase.prostatic:CCnc:Pt:Vag:Qn,0
3152,Hydroxyalprazolam,Hydroxyalprazolam:PrThr:Pt:Urine:Ord:Confirm,0
3153,Peak inspiratory flow rate,Deprecated Peak inspiratory flow Respiratory system airway opening by Airway pressure monitor --at 1.0 liter per second on ventilator,0
3154,Myelin-Associated Glycoprotein Antibody,Myelin associated glycoprotein Ab.IgM:Titr:Pt:Ser:Qn,0
3155,Sequence number central.patient,Sequence number central.patient:Arb:Pt:Cancer.XXX:Ord,0
3156,Coding system.original,Coding system.original:Type:Pt:Cancer.XXX.anatomic site:Nom,0
3157,Leptospira sp subtype,Leptospira sp subtype:Prid:Pt:XXX:Nom,0
3158,Calcium,Calcium^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3159,Dieldrin,Dieldrin:MCnc:Pt:Bld:Qn,0
3160,Echovirus 1 Ab,Echovirus 1 Ab:ACnc:Pt:Ser:Qn:Comp fix,0
3161,Varicella zoster virus immunoglobulin G antibody,Varicella zoster virus Ab.IgG:ACnc:Pt:Ser:Qn:IF,0
3162,Ova & parasites identified,Ova & parasites identified:Prid:Pt:Stool:Nom:Iron hematoxylin stain,0
3163,CACNA1S gene targeted mutation analysis,CACNA1S gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
3164,CACNA1S gene.p.Arg1239His,CACNA1S gene.p.Arg1239His:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
3165,3-Hydroxydodecanedioate/Creatinine,3-Hydroxydodecanedioate/Creatinine:MRto:Pt:Urine:Qn,0
3166,Nephrogenous cyclic AMP (substance),Adenosine monophosphate.cyclic.nephrogenous:SCnc:Pt:Urine+Ser/Plas:Qn,0
3167,Extension,Extension:Type:Pt:Cancer.XXX:Nom,0
3168,Bordetella bronchiseptica Ab,Bordetella bronchiseptica Ab:PrThr:Pt:Ser:Ord,0
3169,Erythromycin,Erythromycin:Titr:Pt:Isolate+Ser:Qn:SBT,0
3170,Lymphocytic choriomeningitis virus IgM,Lymphocytic choriomeningitis virus Ab.IgM:Titr:Pt:CSF:Qn,0
3171,Study report,Deprecated NM Thyroid gland Study report,0
3172,Propylene glycol,Propylene glycol:MCnc:Pt:Urine:Qn,0
3173,temafloxacin,Temafloxacin:Susc:Pt:Isolate:OrdQn,0
3174,Volume expired during 1.0 s of forced expiration,Volume expired during 1.0 s of forced expiration^post bronchodilation:Vol:Pt:Respiratory system:Qn,0
3175,Ampicillin,Ampicillin:MCnc:Pt:XXX:Qn,0
3176,Immunoglobulin G antibody to Rickettsia typhi,Rickettsia typhi Ab.IgG:Titr:Pt:Ser:Qn,0
3177,Mycobacterium avium subspecies paratuberculosis DNA,Mycobacterium avium subspecies paratuberculosis DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar,0
3178,Biperiden,Biperiden:MCnc:Pt:Ser/Plas:Qn,0
3179,Clindamycin,Clindamycin:Titr:Pt:Isolate+Ser:Qn:SBT,0
3180,Methyprylon cutoff,Methyprylon cutoff:MCnc:Pt:Urine:Qn:Screen,0
3181,Measles virus IgM,Measles virus Ab.IgM:Titr:Pt:CSF:Qn,0
3182,Alpha-aminoisobutyrate,Alpha aminoisobutyrate:PrThr:Pt:Plas:Ord,0
3183,Cephalothin,Cephalothin:Titr:Pt:Isolate+Ser:Qn:SBT,0
3184,Alanine,Alanine:MCnc:Pt:CSF:Qn,0
3185,Parvovirus B19 Ab.IgG+IgM,Parvovirus B19 Ab.IgG+IgM:ACnc:Pt:Ser:Qn,0
3186,Alpha-amino acid nitrogen,Alpha amino acid nitrogen:MRat:24H:Urine:Qn,0
3187,Curvularia lunata Ab.IgG,Curvularia lunata Ab.IgG:ACnc:Pt:Ser:Qn,0
3188,Nalbuphine cutoff,Nalbuphine cutoff:MCnc:Pt:Urine:Qn:Confirm,0
3189,Gradient 2.max,Gradient 2.max:Pres:Pt:Circulatory system.XXX:Qn:US+Calculated,0
3190,Brucella abortus antibody,Brucella abortus Ab:PrThr:Pt:Ser:Ord:Aggl.card,0
3191,Campylobacter fetus Ab,Campylobacter fetus Ab:PrThr:Pt:Genital muc:Ord:Aggl,0
3192,Mycoplasma mycoides subspecies mycoides large colony Ab,Mycoplasma mycoides subspecies mycoides large colony Ab:PrThr:Pt:Ser:Ord:Comp fix,0
3193,Glucosephosphate Dehydrogenase,Glucose-6-Phosphate dehydrogenase:CCnc:Pt:Ser:Qn,0
3194,Bacteria identified,Bacteria identified^^^5:Prid:Pt:Line:Nom:Intravascular line culture,0
3195,Methotrimeprazine,L-Mepromazine Ur Ql Cfm,0
3196,norfluoxetine,Norfluoxetine:PrThr:Pt:Urine:Ord:Confirm,0
3197,Systole.max/Systole 2.max,Systole.max/Systole 2.max:VelRto:Pt:Circulatory system.XXX:Qn:US.doppler,0
3198,Slope.XXX/Slope 2.XXX,Slope.XXX/Slope 2.XXX:VelRto:Pt:Circulatory system.XXX:Qn:US.M-mode+Calculated,0
3199,Toxoplasma gondii antibody,Toxoplasma gondii Ab:PrThr:Pt:Ser:Ord,0
3200,Choriogonadotropin.beta subunit.free,Choriogonadotropin.beta subunit.free:ACnc:Pt:Ser/Plas:Qn,0
3201,Q-wave to closure,Q-wave to closure:Time:Pt:Pulmonic valve:Qn:US.measured,0
3202,Carboxyhemoglobin/Hemoglobin.total,Carboxyhemoglobin/Hemoglobin.total:MFr:Pt:BldC:Qn,0
3203,Coliform bacteria,Coliform bacteria:NCnc:Pt:Envir:Qn:Viability count,0
3204,CDKN2B gene deletion,CDKN2B gene deletion:Arb:Pt:Bld/Tiss:Ord:Molgen,0
3205,Trypanosoma cruzi antibody,Trypanosoma cruzi Ab:Titr:Pt:Ser:Qn,0
3206,Ovine progressive pneumonia virus Ab,Deprecated Ovine progressive pneumonia virus Ab [Presence] in Serum,0
3207,Beryllium,Beryllium:PrThr:Pt:Urine:Ord,0
3208,Stemphylium botryosum Ab.IgG,Stemphylium botryosum Ab.IgG:ACnc:Pt:Ser:Qn,0
3209,Octenoylcarnitine (C8:1),Octenoylcarnitine (C8:1):MCnc:Pt:Ser/Plas:Qn,0
3210,Squamous cell carcinoma antigen,Squamous cell carcinoma Ag:ACnc:Pt:Ser/Plas:Qn,0
3211,Oxygen,Oxygen^^saturation adjusted to 0.5:PPres:Pt:BldV:Qn,0
3212,St. Louis encephalitis virus antibody,Saint Louis encephalitis virus Antibody:Arbitrary Concentration:Point in time:Serum:Ordinal,0
3213,ATP7B gene.c.2010_2016del,ATP7B gene.c.2010_2016del:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
3214,Varicella zoster virus IgM,Varicella zoster virus Ab.IgM:Titr:Pt:Ser:Qn,0
3215,Canine distemper virus Ag,Canine distemper virus Ag:PrThr:Pt:Cnjt:Ord,0
3216,butyrate,Butyrate:MCnc:Pt:Stool:Qn,0
3217,Phenolphthalein,Phenolphthalein:MCnc:Pt:Bld:Qn,0
3218,Bicarbonates,Bicarbonate^^standard:SCnc:Pt:BldC:Qn,0
3219,CBS gene.p.G307S,Deprecated CBS gene p.G307S [Presence] in Blood or Tissue by Molecular genetics method,0
3220,Threonine,Threonine:SCnc:Pt:CSF:Qn,0
3221,Duck hepatitis virus 3 Ab,Duck hepatitis virus 3 Ab:PrThr:Pt:Ser:Ord:Neut,0
3222,Prion protein.abnormal,Prion protein.abnormal:PrThr:Pt:Brain:Ord:Immune stain,0
3223,Feline immunodeficiency virus Ab,Feline immunodeficiency virus Ab:PrThr:Pt:Ser:Ord,0
3224,Myelin associated glycoprotein Ab.IgA,Myelin associated glycoprotein Ab.IgA:ACnc:Pt:Ser:Qn,0
3225,Amylase.P1,Amylase.P1:CCnc:Pt:Ser/Plas:Qn,0
3226,Glucose,Glucose^3H post dose glucose:MCnc:Pt:Ser/Plas:Qn,0
3227,Deer hair Ab.IgE.RAST class,Deer hair Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3228,Protoporphyrins,Protoporphyrin:MRat:XXX:Stool:Qn,0
3229,Isoleucine,Isoleucine:SCnc:Pt:CSF:Qn,0
3230,Rift valley fever virus Ab,Rift valley fever virus Ab:Titr:Pt:Ser:Qn:HAI,0
3231,Mycoplasma synoviae antibody,Mycoplasma synoviae Ab:Titr:Pt:Ser:Qn:HA,0
3232,Canary droppings Ab.IgE,Canary droppings Ab.IgE:ACnc:Pt:Ser:Qn,0
3233,Porphyrins,Porphyrins:ACnc:Pt:Stool:Qn,0
3234,Crossection,Crossection:Area:Pt:Pulmonary artery.main:Qn:US,0
3235,Study observation,Study observation:Finding:Duration of the study:Endoscopy procedure:Nominal,0
3236,Chlamydophila psittaci antibody,Chlamydophila psittaci Ab:Titr:Pt:Ser:Qn,0
3237,Chlamydia trachomatis IgA,Chlamydia trachomatis Ab.IgA:Titr:Pt:CSF:Qn,0
3238,Chlamydia trachomatis G+F+K Ab.IgG,Chlamydia trachomatis G+F+K Ab.IgG:Titr:Pt:Ser:Qn,0
3239,Creatinine,Creatinine:SCnc:Pt:XXX:Qn,0
3240,Rotavirus RNA,Rotavirus RNA:PrThr:Pt:XXX:Ord:Probe,0
3241,Histiocytes/100 cells,Histiocytes/100 cells:NFr:Pt:Body fld:Qn:Microscopy.light,0
3242,oleandrin,Oleandrin:MCnc:Pt:Urine:Qn,0
3243,Organochlorine pesticide,Organochlorine pesticides:PrThr:Pt:Tiss:Ord:Screen,0
3244,Gastrin,Gastrin^7M post 0.2 U/kg secretin:MCnc:Pt:Ser/Plas:Qn,0
3245,SNCA gene.p.Ala30Pro,SNCA gene.p.Ala30Pro:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
3246,Swine vesicular disease virus Ag,Swine vesicular disease virus Ag:PrThr:Pt:XXX:Ord:IA,0
3247,Rhodococcus equi Ab,Rhodococcus equi Ab:Titr:Pt:Ser:Qn,0
3248,Cerebroside sulfatase B,Deprecated Cerebroside sulfatase B:Catalytic Concentration:Point in time:Leukocytes:Quantitative,0
3249,oxychlordane,Oxychlordane:MCnc:Pt:Ser/Plas:Qn,0
3250,Afipia felis IgM,Afipia felis Ab.IgM:Titr:Pt:Ser:Qn,0
3251,Echovirus 18 Ab,Echovirus 18 Ab:Titr:Pt:Ser:Qn,0
3252,Echovirus 3 Ab,Echovirus 3 Ab:Titr:Pt:Ser:Qn,0
3253,Theileria equi rRNA,Theileria equi rRNA:PrThr:Pt:Bld:Ord:Probe,0
3254,Coccidioides reaction wheal,Coccidioides reaction wheal:Diam:Pt:Skin:Qn,0
3255,Salmonella enterica subspecies enterica serovar Typhi O antibody,Salmonella typhi O Ab:PrThr:Pt:Ser:Ord,0
3256,Magnesium,Magnesium:SCnc:Pt:RBC:Qn,0
3257,Views 2,Views 2:Find:Pt:Lower extremity.right>Ankle:Doc:XR,0
3258,Potassium,Potassium:SCnc:Pt:Saliva:Qn,0
3259,Prostaglandins,Prostaglandin:MCnc:Pt:Ser/Plas:Qn,0
3260,Accommodation width.measured 2,Accommodation width.measured 2:Len:Pt:Eye:Qn,0
3261,Polarization.binocular,Polarization.binocular:Prid:Pt:Eye:Nom:Phoropter,0
3262,Accommodation width.measured 3,Accommodation width.measured 3:Len:Pt:Eye:Qn:Hand optometer,0
3263,Nordazepam,Nordiazepam:MCnc:Pt:Gast fld:Qn,0
3264,succinylacetone,Succinylacetone:PrThr:Pt:Urine:Ord,0
3265,Methacycline,Methacycline:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
3266,Phosphatidylserine IgM,Phosphatidylserine Ab.IgM:ACnc:Pt:Ser:Qn:IA,0
3267,Myoglobin,Myoglobin:MCnc:Pt:Urine:Qn,0
3268,Cylinder N 2,Cylinder N 2:InvLen:Pt:LM glasses.lens.left:Qn,0
3269,Sphere N 1,Sphere N 1:InvLen:Pt:Glasses prescription.lens.right:Qn,0
3270,Cylinder N 1,Cylinder N 1:InvLen:Pt:Glasses prescription.lens.right:Qn,0
3271,Digoxin.free,Digoxin.free:SCnc:Pt:Ser/Plas:Qn,0
3272,Barbital,Barbital:PrThr:Pt:XXX:Ord,0
3273,butabarbital,Butabarbital:PrThr:Pt:XXX:Ord,0
3274,Malate Dehydrogenase,Malate dehydrogenase:CCnc:Pt:Ser:Qn,0
3275,Erythrocytes,Erythrocytes:NCnc:Pt:CSF:Qn,0
3276,Topoisomerase-1 antibody,SCL-70 extractable nuclear Ab:ACnc:Pt:Ser:Qn:IA,0
3277,Borrelia burgdorferi 58kD IgG,Borrelia burgdorferi 58kD Ab.IgG:PrThr:Pt:CSF:Ord:IB,0
3278,gamma hydroxybutyrate,Deprecated Gamma hydroxybutyrate [Mass/volume] in Urine,0
3279,Cylinder N 1,Cylinder N 1:InvLen:Pt:Glasses prescription.lens.left:Qn,0
3280,Proteins,Protein:MCnc:Pt:Ser/Plas:Qn,0
3281,Eastern equine encephalitis virus IgG,Eastern equine encephalitis virus Ab.IgG:PrThr:Pt:Ser:Ord,0
3282,3-Hydroxypalmitoylcarnitine (C16-OH),3OH-Palmitoylcarn SerPl-sCnc,0
3283,Aspergillus terreus Ab,Aspergillus terreus Ab:PrThr:Pt:Ser:Ord,0
3284,Lithium,Lithium:SCnc:Pt:Bld:Qn,0
3285,View,Views^W contrast IA:Find:Pt:Head+Neck>Carotid arteries.bilateral:Doc:RF.angio,0
3286,Bevel radius,Bevel radius:Len:Pt:Contact lens.right:Qn,0
3287,Lenticulation,Lenticulation:Arb:Pt:Contact lens.left:Ord,0
3288,Isovalerylglycine,Isovalerylglycine:PrThr:Pt:Urine:Ord,0
3289,Multisection,Multisection^W contrast IV:Find:Pt:Head>Maxillofacial region:Doc:CT,0
3290,Glycogen (Starch) Synthase,Glycogen synthase:CCnc:Pt:Ser:Qn,0
3291,(Quercus alba+Ulmus americana+Platanus acerifolia+Salix caprea+Populus deltoides) Ab.IgE.RAST class,(Quercus alba+Ulmus americana+Platanus acerifolia+Salix caprea+Populus deltoides) Ab.IgE.RAST class:PrThr:Pt:Ser:Ord:Multidisk,0
3292,Pigeon droppings Ab,Pigeon droppings Ab:PrThr:Pt:Ser:Ord:Immune diffusion,0
3293,Lactoferrin,Lactoferrin:MCnc:Pt:Ser:Qn,0
3294,Glutamine,Glutamine:SCnc:Pt:Urine:Qn,0
3295,Over refraction axis,Over refraction axis:Angle:Pt:Contact lens.left:Qn,0
3296,Materials,Material:Prid:Pt:Contact lens.prescription.left:Nom,0
3297,Torus,Torus:Prid:Pt:Contact lens.prescription.left:Nom,0
3298,Symptoms & diseases,History of symptoms & diseases:Finding:Point in time:Behavior:Nominal:Observed,0
3299,Transcobalamin,Transcobalamin:MCnc:Pt:Ser:Qn,0
3300,Chlamydia trachomatis B IgM,Chlamydia trachomatis B Ab.IgM:ACnc:Pt:Ser:Qn,0
3301,Cockatiel droppings Ab,Cockatiel droppings Ab:PrThr:Pt:Ser:Ord,0
3302,Coxsackievirus A10 Ab,Coxsackievirus A10 Ab:ACnc:Pt:Body fld:Qn,0
3303,Bartonella henselae IgM,Bartonella henselae Ab.IgM:Titr:Pt:CSF:Qn:IF,0
3304,Borrelia burgdorferi IgG,Borrelia burgdorferi Ab.IgG:Titr:Pt:CSF:Qn,0
3305,Multisection,Multisection:Find:Pt:Abdomen>Retroperitoneum:Doc:US,0
3306,Cells.CD3+CD56+,Cells.CD3+CD56+:NCnc:Pt:Bld:Qn,0
3307,Highlands J virus Ab,Highlands J virus Ab:ACnc:Pt:XXX:Qn,0
3308,Haemophilus influenzae B DNA,Haemophilus influenzae B DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
3309,Fungus identified,Fungus identified:Prid:Pt:Bronchial:Nom:Culture,0
3310,Guidance for placement of stent,Guidance for placement of stent:Find:Pt:XXX>Artery:Doc:RF.angio,0
3311,Insulin,Insulin^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
3312,C-Peptide,C peptide^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
3313,Babesia duncani Ab,Babesia duncani Ab:PrThr:Pt:Ser:Ord,0
3314,Cisapride,Cisapride:MCnc:Pt:Ser/Plas:Qn,0
3315,Multisection,Multisection:Find:Pt:Upper extremity>Upper extremity joint:Doc:MR,0
3316,Ethambutol,Ethambutol:Susc:Pt:Isolate:Qn:MLC,0
3317,Streptococcus pneumoniae Danish serotype 8 Ab,Deprecated Streptococcus pneumoniae 8 Ab [Mass/volume] in Serum,0
3318,Multisection,Multisection^W contrast IV:Find:Pt:XXX>Spine:Doc:CT,0
3319,Follicle Stimulating Hormone,Follitropin^2nd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:2nd IRP,0
3320,View,Views:Find:Pt:Head>Zygomatic arch.bilateral:Doc:XR,0
3321,Paracoccidioides brasiliensis antibody,Paracoccidioides brasiliensis Ab:PrThr:Pt:Ser:Ord,0
3322,Axis distance,Axis distance:Angle:Pt:Glasses prescription.lens.right:Qn,0
3323,Gold,Gold:MCnc:24H:Urine:Qn,0
3324,Mesothelial cells/100 leukocytes,Mesothelial cells/100 leukocytes:NFr:Pt:Plr fld:Qn,0
3325,Metamyelocytes,Metamyelocytes:NCnc:Pt:Bld:Qn,0
3326,Aluminum,Aluminum:MCnc:XXX:Urine:Qn,0
3327,Human herpesvirus 1 antibody,Herpes simplex virus 1 Ab:ACnc:Pt:CSF:Qn,0
3328,Infectious bursal disease virus antibody,Infectious bursal disease virus Ab:ACnc:Pt:Ser:Qn,0
3329,Views limited,Views limited:Find:Pt:Breast:Doc:MG,0
3330,Multisection,Multisection:Find:Pt:Head>Temporomandibular joint:Doc:MR,0
3331,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.left>Ankle:Doc:MR,0
3332,Oleate,Oleate:PrThr:Pt:Bld:Ord,0
3333,Neutrophils.segmented/100 leukocytes,Neutrophils.segmented/100 leukocytes:NFr:Pt:Body fld:Qn,0
3334,Vaccines due next,Vaccines due next:Complex:Point in time:^Patient:Set,0
3335,Aspergillus fumigatus recombinant (rAsp f) 2 Ab.IgE,Aspergillus fumigatus recombinant (rAsp f) 2 Ab.IgE:ACnc:Pt:Ser:Qn,0
3336,Legionella pneumophila 6 IgM,Legionella pneumophila 6 Ab.IgM:ACnc:Pt:Ser:Qn,0
3337,Multisection,Multisection^W contrast Intravenous:Finding:Point in time:Chest:Narrative:COMPUTERIZED TOMOGRAPHY,0
3338,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.left>Thigh:Doc:MR,0
3339,Methionine,Methionine:PrThr:Pt:Bld:Ord,0
3340,Gentamicin,Gentamicin:Susc:Pt:Isolate:Qn:MLC,0
3341,Bartonella quintana antibody,Bartonella quintana Ab:PrThr:Pt:Ser:Ord,0
3342,Multisection,Multisection:Imp:Pt:Eye.left:Nom:US.2D,0
3343,Myelin-Associated Glycoprotein Antibody,Myelin associated glycoprotein Ab.IgM:PrThr:Pt:Ser:Ord:IB,0
3344,Indinavir,Indinavir:MCnc:Pt:Ser/Plas:Qn,0
3345,Immunoglobulin G,IgG:MCnc:Pt:CSF:Qn,0
3346,Beta aminoisobutyrate/Creatinine,Beta aminoisobutyrate/Creatinine:Substance Concentration Ratio:Point in time:Urine:Quantitative,0
3347,Multisection,Multisection:Find:Pt:Lower extremity.left>Lower extremity joint:Doc:MR,0
3348,Protein S actual/Normal,Protein S actual/Normal:RelTime:Pt:PPP:Qn:Coag,0
3349,Mycobacterium DNA,Mycobacterium sp DNA:PrThr:Pt:Urine:Ord:Probe.amp.tar,0
3350,Borrelia burgdorferi IgM,Borrelia burgdorferi Ab.IgM:PrThr:Pt:Ser:Ord:IF,0
3351,Coxsackievirus B3 Ab,Coxsackievirus B3 Ab:Titr:Pt:Body fld:Qn:Comp fix,0
3352,Rumex acetosella Ab.IgG,Rumex acetosella Ab.IgG:ACnc:Pt:Ser:Qn,0
3353,Multisection,Multisection:Find:Pt:Extremity:Doc:US,0
3354,Follicle Stimulating Hormone,Follitropin^4th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,0
3355,Growth Hormone,Somatotropin^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3356,Hydrocortisone,Cortisol:PrThr:Pt:Urine:Ord,0
3357,Rickettsia honei Ab,Rickettsia honei Ab:Titr:Pt:Ser:Qn,0
3358,Casuarina equisetifolia Ab.IgE.RAST class,Casuarina equisetifolia Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3359,Specimen mass,Deprecated Weight of Unspecified specimen,0
3360,Legionella pneumophila antibody,Legionella pneumophila Ab^2nd specimen:Titr:Pt:Ser:Qn:IF,0
3361,Guidance for placement of decompression tube,Guidance for placement of decompression tube:Find:Pt:Abdomen+Pelvis>Gastrointestinal tract:Doc:RF,0
3362,Staphylococcus aureus enterotoxin D Ab.IgE,Staphylococcus aureus enterotoxin D Ab.IgE:ACnc:Pt:Ser:Qn,0
3363,PHOSPHOFRUCTOKINASE,Phosphofructokinase:CCnc:Pt:Ser:Qn,0
3364,normeperidine,Normeperidine:PrThr:Pt:Urine:Ord,0
3365,Benzoate/Creatinine,Benzoate/Creatinine:Ratio:Pt:Urine:Qn,0
3366,Eastern equine encephalitis virus Antibody,Eastern equine encephalitis virus Ab^1st specimen:Titr:Pt:Ser:Qn:IF,0
3367,Isoniazid 0.1 ug/mL,Isoniazid 0.1 ug/mL:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Slow-growing Mycobacteria,0
3368,Rubella virus antigen,Rubella virus Ag:PrThr:Pt:Thrt:Ord,0
3369,Multisection,Multisection^W contrast IV:Find:Pt:Abdomen>Kidney.bilateral:Doc:XR.tomography,0
3370,Phencyclidine,Phencyclidine:MCnt:Pt:Meconium:Qn:Screen,0
3371,"2,4-DICHLOROPHENOXYACETATE","2,4-Dichlorophenoxyacetate:MCnc:Pt:Ser/Plas:Qn",0
3372,Jamestown canyon virus Ab,Jamestown canyon virus Ab:PrThr:Pt:XXX:Ord:Neut,0
3373,Multisection,Multisection^W contrast IV:Find:Pt:Abdomen>Spine.lumbar:Doc:MR,0
3374,microscopic observation,Microscopic observation:Prid:Pt:Abdomen.FNA:Nom:Cyto stain,0
3375,14-3-3 Ag,14-3-3 Ag:ACnc:Pt:CSF:Qn,0
3376,Insulin-Like Growth Factor I,Insulin-Like growth factor-I [Mass/volume] in Serum or Plasma,0
3377,desmethyldoxepin,Deprecated Nordoxepin [Mass] of Dose,0
3378,Glucose,Glucose^12 AM specimen:SCnc:Pt:Ser/Plas:Qn,0
3379,Burkholderia species,Burkholderia sp:PrThr:Pt:XXX:Ord:Organism specific culture,0
3380,{HIV ART medication} doses missed yesterday,{HIV ART medication} doses missed yesterday:Num:Pt:^Patient:Qn:Reported.ACTG,0
3381,Cyclic AMP,Adenosine monophosphate.cyclic^1st specimen post XXX challenge:SCnc:Pt:Urine:Qn,0
3382,Views screening,Views screening:Find:Pt:Breast.bilateral:Doc:MG.FFD,0
3383,Number of specimens received,Number of specimens received:Num:Pt:XXX:Qn,0
3384,IgG subclass panel,IgG subclass panel:MCnc:Pt:Ser:Qn,0
3385,Phencyclidine,Phencyclidine:PrThr:Pt:Hair:Ord,0
3386,Ethambutol 10.0 ug/mL,Deprecated Ethambutol 10.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria,0
3387,Ethambutol 5.0 ug/mL,Deprecated Ethambutol 5.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria,0
3388,Borrelia burgdorferi antibody,Borrelia burgdorferi Ab:ACnc:Pt:CSF:Qn:IB,0
3389,Human herpesvirus 1,Herpes simplex virus 1:PrThr:Pt:Vag:Ord:Organism specific culture,0
3390,(Anacardium occidentale+Carya illinoinensis+Juglans spp+Pistacia vera) Ab.IgE,(Anacardium occidentale+Carya illinoinensis+Juglans spp+Pistacia vera) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk,0
3391,HTR2A gene+HTR2C gene targeted mutation analysis,HTR2A gene+HTR2C gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
3392,Alkaline Phosphatase,Alkaline phosphatase:CCnc:Pt:Periton fld:Qn,0
3393,Histoplasma capsulatum antigen,Histoplasma capsulatum Ag:PrThr:Pt:CSF:Ord,0
3394,Malignant cells/100 cells,Malignant cells/100 cells:NFr:Pt:Periton fld:Qn:Manual count,0
3395,Views multiple areas,Views multiple areas^W In-111 Satumomab IV:Find:Pt:XXX:Doc:NM,0
3396,Aztreonam,Aztreonam:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
3397,Creatinine,Creatinine^3.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3398,Creatinine,Creatinine^7D post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3399,Bromides,Bromide:MCnc:Pt:Bld:Qn,0
3400,Emetine,Emetine:Mass:Pt:Dose:Qn,0
3401,HTLV I+II Ab,HTLV I+II Ab:PrThr:Pt:Ser^Donor:Ord,0
3402,Trimethadione,Trimethadione:Mass:Pt:Dose:Qn,0
3403,Complement C3d-C3d+Gg-IC3b receptors,Deprecated Complement C3d-C3d+Gg-IC3b receptors [Presence] in Leukocytes,0
3404,Electrocardiograph lead,Electrocardiograph lead:Finding:Point in time:^Patient:Nominal,0
3405,Creatinine,Creatinine^4H specimen:SCnc:Pt:Dial fld:Qn,0
3406,Glucose,Glucose^110M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3407,Cells.CD3-CD57+/100 cells,Cells.CD3-CD57+/100 cells:Number Fraction:Point in time:Marrow (bone):Quantitative,0
3408,Chlamydia trachomatis D+K Ab.IgM,Chlamydia trachomatis D+K Ab.IgM:PrThr:Pt:Ser:Ord,0
3409,Chlamydia trachomatis D+K Ab.IgG,Chlamydia trachomatis D+K Ab.IgG:PrThr:Pt:Ser:Ord,0
3410,hemoglobin Yakima,Hemoglobin Yakima:PrThr:Pt:Bld:Ord,0
3411,Views AP,Views AP^WO & W L-bending:Find:Pt:Abdomen>Spine.lumbar:Doc:XR,0
3412,Morphine,Morphine:Mass:Pt:Dose:Qn,0
3413,Views AP,View AP^W standing:Find:Pt:Lower extremity.bilateral:Doc:XR,0
3414,Chlamydia trachomatis antibody,Chlamydia trachomatis Ab:PrThr:Pt:Ser:Ord:IF,0
3415,Multisection,Multisection^W contrast IV:Find:Pt:Whole body:Doc:CT,0
3416,Cryoglobulin.IgA,Cryoglobulin.IgA:MCnc:Pt:Ser:Qn:Cold incubation,0
3417,Inulin,Inulin:MCnc:Pt:Ser^Control:Qn,0
3418,Herpes simplex virus 2 Ab,Herpes simplex virus 2 Ab:ACnc:Pt:CSF:Qn:IF,0
3419,Views lateral,Deprecated Neck XR Lat,0
3420,HLA-A2 SBT,HLA-A2 SBT:Type:Pt:Bld/Tiss:Nom:High resolution,0
3421,Weight container+Specimen,Weight container+Specimen:Mass:Pt:Stool:Qn,0
3422,Streptococcus pneumoniae Danish serotype 1 IgG,Deprecated Streptococcus pneumoniae 1 IgG Ab [Mass/volume] in Serum --1st specimen,0
3423,Creatinine,Creatinine^4.5H post XXX challenge:SCnc:Pt:Urine:Qn,0
3424,Respiratory syncytial virus IgG,Respiratory syncytial virus Ab.IgG:PrThr:Pt:Ser:Ord:IA,0
3425,Group counseling note,Group counseling note:Finding:Point in time:{Setting}:Document:{Provider},0
3426,Legionella pneumophila 13 IgM,Legionella pneumophila 13 Ab.IgM:Titr:Pt:Ser:Qn:IF,0
3427,Epstein Barr virus capsid IgG,Epstein Barr virus capsid Ab.IgG:Titr:Pt:Body fld:Qn:IF,0
3428,Rhinovirus+Enterovirus RNA,Rhinovirus+Enterovirus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
3429,Acyclovir,Acyclovir:Mass:Pt:Dose:Qn,0
3430,Volume expired during 3.0 s of forced expiration,Volume expired during 3.0 s of forced expiration:Vol:Pt:Respiratory system:Qn:Predicted,0
3431,Vendor serial number,Vendor serial number:ID:Pt:Height device:Nom,0
3432,Ketamine,Ketamine:Mass:Pt:Dose:Qn,0
3433,Porphyrins/Creatinine,Porphyrins/Creatinine:MRto:24H:Urine:Qn,0
3434,Invasive component size.additional dimension 1,Invasive component size.additional dimension 1:Len:Pt:Breast tumor:Qn,0
3435,Chlamydia species antigen,Chlamydia sp Ag:PrThr:Pt:Cvx:Ord:IF,0
3436,Hemoglobin H/Hemoglobin.total,Hemoglobin H/Hemoglobin.total:MFr:Pt:Bld:Qn,0
3437,Multisection,Multisection^W reduced contrast volume IV:Find:Pt:Pelvis:Doc:CT,0
3438,Naproxen,naproxen:mass:point in time:dose med or substance:quantitative,0
3439,View,Views^during electroconvulsive shock treatment:Find:Pt:Head>Brain:Doc:NM,0
3440,Aspartate/Creatinine,Aspartate/Creatinine:MRto:24H:Urine:Qn,0
3441,Cortisol/Creatinine,Cortisol/Creatinine:MRto:24H:Urine:Qn,0
3442,Tissue cores.positive.carcinoma,Tissue cores.positive.carcinoma:Num:Pt:Tissue core:Qn,0
3443,T classification,Deprecated T classification in Prostate tumor by CAP cancer protocols,0
3444,Epinephrine,Epinephrine^3H post 300 ug cloNIDine PO:SCnc:Pt:Plas:Qn,0
3445,Growth Hormone,Somatotropin^1H post dose ornithine:ACnc:Pt:Ser/Plas:Qn,0
3446,Human coronavirus NL63 IgG,Human coronavirus NL63 Ab.IgG:PrThr:Pt:Ser:Ord,0
3447,Spermatozoa IgG binding location,Spermatozoa IgG binding location:Prid:Pt:Semen:Nom,0
3448,Guidance for placement of radiation therapy fields,Guidance for placement of radiation therapy fields:Find:Pt:XXX:Doc:US,0
3449,Views GE 3,Finger third - right Narrative X-ray GE 3 views,0
3450,BHD gene targeted mutation analysis,BHD gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
3451,Norepinephrine,Norepinephrine^2H post XXX challenge:SCnc:Pt:Plas:Qn,0
3452,Stage.summary & TNM-M override flag,Stage.summary & TNM-M override flag:Arb:Pt:Cancer case.XXX:Ord,0
3453,Event description.general nursing care,Event description.general nursing care:Find:Pt:^Patient:Nom:Observed.MERSTH,0
3454,Lipoprotein.beta.subparticle.intermediate,Lipoprotein.beta.subparticle.intermediate:EntLen:Pt:Ser/Plas:Qn,0
3455,Estradiol,Estradiol^1H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn,0
3456,Insulin,Insulin^1H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
3457,PRX gene targeted mutation analysis,PRX GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN,0
3458,Parainfluenza virus Ag panel,Parainfluenza virus Ag panel:-:Pt:XXX:-:IF,0
3459,Derived SEER summary stage 1977 conversion method,Derived SEER summary stage 1977 conversion method:Arb:Pt:Cancer.XXX:Ord,0
3460,Boost radiation treatment modality,Boost radiation treatment modality:Prid:Pt:Radiation.Rx:Nom,0
3461,Chlamydia trachomatis IgM,Chlamydia trachomatis Ab.IgM:Titr:Pt:CSF:Qn,0
3462,Chlamydia sp Ab.IgA,Chlamydia sp Ab.IgA:Titr:Pt:Ser:Qn,0
3463,Views 4,Deprecated Mandible - left X-ray 4 views,0
3464,Insulin,Insulin^pre dose glucagon:ACnc:Pt:Ser/Plas:Qn,0
3465,Growth Hormone,Somatotropin^15M post dose triple bolus:MCnc:Pt:Ser/Plas:Qn,0
3466,Phosphatidylethanolamine antibody,Phosphatidylethanolamine Ab:ACnc:Pt:Ser:Qn:IA,0
3467,Vaccenate,Vaccenate:SCnc:Pt:Ser/Plas:Qn,0
3468,arachidonate,Arachidonate:SCnc:Pt:Ser/Plas:Qn,0
3469,Eicosapentaenoate,Eicosapentaenoate:SCnc:Pt:Ser/Plas:Qn,0
3470,HIV 1 p40 Ab,HIV 1 p40 Ab:PrThr:Pt:Ser:Ord:IB,0
3471,Multisection,Multisection^WO contrast:Find:Pt:Head>Head vessels:Doc:MR.angio,0
3472,West Nile virus polyvalent E Ab,West Nile virus polyvalent E Ab:PrThr:Pt:XXX:Ord:IA,0
3473,Imipramine,Imipramine:PrThr:Pt:Ser/Plas:Ord,0
3474,View,Views^W contrast IA:Find:Pt:Upper extremity.left>Upper extremity arteries:Doc:RF.angio,0
3475,Carnitine.free (C0),Carnitine.free (C0):SCnc:Pt:Bld.dot:Qn,0
3476,Netilmicin,Netilmicin^peak:MCnc:Pt:Ser/Plas:Qn,0
3477,Multisection,Multisection:Find:Pt:Upper extremity.left>Upper extremity artery:Doc:US.doppler,0
3478,Coxiella burnetii antibody,Coxiella burnetii Ab:Titr:Pt:CSF:Qn,0
3479,Iron,Iron:MCnc:Pt:Stool:Qn,0
3480,cyclobenzaprine,Cyclobenzaprine:MCnc:Pt:Ser/Plas:Qn:Screen,0
3481,View,Views:Find:Pt:Upper extremity.bilateral>Finger.fifth:Doc:XR,0
3482,Sarcocystis neurona antibody,Sarcocystis neurona Ab:PrThr:Pt:Ser:Ord:IF,0
3483,FRANCISELLA TULARENSIS,Francisella tularensis:PrThr:Pt:Isolate:Ord:Organism specific culture,0
3484,Hemoglobin cast,Hemoglobin casts:PrThr:Pt:Urine sed:Ord:Microscopy.light,0
3485,desmethyldoxepin,Nordoxepin:MCnc:Pt:Ser/Plas:Qn:Screen,0
3486,Path report.final diagnosis section - text,Deprecated Pathology report final diagnosis section - text,0
3487,View,View^during surgery:Find:Pt:Lower extremity.left>Hip:Doc:XR,0
3488,Guidance for needle localization,Guidance for needle localization:Find:Pt:XXX:Doc:RF,0
3489,p-Hydroxyamphetamine,Para hydroxyamphetamine:MRat:24H:Urine:Qn,0
3490,Views multiple areas,Views multiple areas^W radionuclide IV:Find:Pt:XXX>Bone marrow:Doc:NM,0
3491,4-Aminobenzoate,Para aminobenzoate:MRat:24H:Urine:Qn,0
3492,Progesterone,Progesterone [Mass or Molecules/volume] in Serum or Plasma,0
3493,Testosterone,Testosterone [Mass or Molecules/volume] in Serum or Plasma,0
3494,Carbonyldiamide,Urea nitrogen [Mass or Molecules/volume] in Urine,0
3495,Colorado tick fever virus Ab.IgG & IgM panel,Colorado tick fever virus Ab.IgG & IgM panel:-:Pt:Ser:Qn,0
3496,View decubitus portable,Deprecated View decubitus portable,0
3497,View,Views^W manual stress:Find:Pt:Upper extremity.left>Thumb:Doc:XR,0
3498,View,Views^W contrast intra salivary duct:Find:Pt:Neck>Parotid gland.left:Doc:RF,0
3499,View,Views^W contrast IA:Find:Pt:Chest>Pulmonary arteries:Doc:RF.angio,0
3500,Glucose,Glucose^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3501,Glucose,Glucose^4H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
3502,Perphenazine,Perphenazine:PrThr:Pt:Urine:Ord,0
3503,Granular casts.fine (substance),Granular casts.fine:Naric:Pt:Urine sed:Qn:Microscopy.light.HPF,0
3504,Erythrocyte cast,Erythrocyte casts:Naric:Pt:Urine:Qn:Computer assisted,0
3505,Arsenic,Arsenic:SCnc:24H:Urine:Qn,0
3506,Views oblique,View oblique:Find:Pt:Upper extremity>Finger.third:Doc:XR,0
3507,View,Views^W contrast IA:Find:Pt:Head+Neck>Carotid artery.bilateral & Head>Cerebral artery.bilateral:Doc:RF.angio,0
3508,Basophils+Eosinophils+Monocytes/100 leukocytes,Basophils+Eosinophils+Monocytes/100 leukocytes:NFr:Pt:Bld:Qn:Automated count,0
3509,Catecholamines,Catecholamines:PrThr:24H:Urine:Ord,0
3510,"Polyp size, largest dimension",Polyp size greatest dimension:Len:Pt:Specimen:Qn,0
3511,Histone Ab.IgG,Histone Ab.IgG:PrThr:Pt:Ser:Ord,0
3512,RPS6KA3 gene targeted mutation analysis,RPS6KA3 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NAR:MOLGEN,0
3513,Views 2,Views 2:Find:Pt:Lower extremity.left>Acetabulum:Doc:XR,0
3514,Parainfluenza virus 2 IgG,Parainfluenza virus 2 Ab.IgG:ACnc:Pt:Ser:Qn,0
3515,Motile spermatozoa,Spermatozoa.motile:Naric:Pt:Semen:Qn:Microscopy.light.HPF,0
3516,Coagulation factor X inhibitor,Coagulation factor X inhibitor:ACnc:Pt:PPP:Qn:Coag,0
3517,Hepatitis B e Antigens,Hepatitis B virus little e Ag:Titr:Pt:Ser:Qn,0
3518,Creatine Kinase MB Isoenzyme,Creatine kinase.MB:CCnc:Pt:Ser/Plas:Qn,0
3519,Cryptococcus sp Ag,Cryptococcus sp Ag:Titr:Pt:CSF:Qn,0
3520,Lactate,Lactate:SCnc:Pt:Bld:Qn,0
3521,Acidity.total,Acidity.total:SCnc:Pt:Gast fld:Qn,0
3522,Hexacarboxylporphyrin,Hexacarboxylporphyrins:MCnt:Pt:Stool:Qn,0
3523,TRYPSIN,Trypsin^2nd specimen post dose sincalide:CCnc:Pt:Body fld:Qn,0
3524,Disulfiram,Disulfiram:MCnc:Pt:Ser/Plas:Qn,0
3525,beta 1 globulin,Beta 1 globulin:MRat:24H:Urine:Qn:Electrophoresis,0
3526,View transthoracic,View transthoracic:Find:Pt:Upper extremity.right>Shoulder:Doc:XR,0
3527,Note (document),Note:Find:Pt:{Setting}:Doc:Pathology,0
3528,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Physical therapy,0
3529,Doxepin,Doxepin:PrThr:Pt:Urine:Ord,0
3530,chloromethyl methyl ether,Chloromethyl methyl ether:MCnc:Pt:Air:Qn,0
3531,Spermatozoa.tail tip Ab.IgM/100 spermatozoa,Spermatozoa.tail tip Ab.IgM/100 spermatozoa:NFr:Pt:XXX:Qn:Immunobead,0
3532,Cystathionine,Cystathionine:SCnc:Pt:Vitr fld:Qn,0
3533,Methionine,Methionine:SCnc:Pt:Vitr fld:Qn,0
3534,Miocamycin,Miocamycin:Susc:Pt:Isolate:Qn:MLC,0
3535,Karyotype (cell structure),Karyotype:Prid:Pt:Bone mar:Nom,0
3536,Interleukin-1,Interleukin 1:MCnc:Pt:Ser/Plas:Qn,0
3537,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.left:Doc:CT,0
3538,Views 3,Views 3:Find:Pt:Upper extremity.left>Finger:Doc:XR,0
3539,Columbid circovirus DNA,Columbid circovirus DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
3540,hexachlorocyclopentadiene,Hexachlorocyclopentadiene:MCnc:Pt:Air:Qn,0
3541,Multisection for infection,Multisection for infection^W Ga-67 IV:Find:Pt:Whole body:Doc:NM.SPECT,0
3542,Minocycline,Minocycline:Susc:Pt:Isolate:OrdQn:MIC,0
3543,Sjogren's syndrome B antibody,Sjogrens syndrome-B extractable nuclear Ab:ACnc:Pt:Ser:Qn:IB,0
3544,Spore identification,Spore identification:Prid:Pt:XXX:Nom:Malachite green stain,0
3545,Counseling note,Counseling note:Find:Pt:{Setting}:Doc:Social worker,0
3546,Interventional procedure note,Interventional procedure note:Find:Pt:{Setting}:Doc:Gastroenterology,0
3547,Legionella pneumophila 1 IgG,Legionella pneumophila 1 Ab.IgG:PrThr:Pt:Ser:Ord,0
3548,Views 4,Views 4:Find:Pt:Breast:Doc:MG,0
3549,View,Views^W contrast IA:Find:Pt:Chest>Pulmonary arteries.right:Doc:RF.angio,0
3550,Views limited,Views limited^W Ga-67 IV:Find:Pt:XXX:Doc:NM,0
3551,Eastern equine encephalitis virus RNA,Eastern equine encephalitis virus RNA:PrThr:Pt:Bld:Ord:Probe.amp.tar,0
3552,Fibrinopeptide A,Deprecated Fibrinopeptide A Ag [Mass/volume] in Platelet poor plasma by EIA,0
3553,Leishmania tropica IgM,Leishmania tropica Ab.IgM:PrThr:Pt:Ser:Ord,0
3554,Views 4,Views 4:Find:Pt:Upper extremity.right>Shoulder:Doc:XR,0
3555,Nortriptyline,Nortriptyline^trough >12h post dose:MCnc:Pt:Ser/Plas:Qn,0
3556,Multisection,Multisection^WO contrast:Find:Pt:Abdomen>Kidney.bilateral:Doc:XR.tomography,0
3557,Multisection perfusion,Multisection perfusion^W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM.SPECT,0
3558,Monocyte+Macrophage/100 leukocytes,Monocytes+Macrophages/100 leukocytes:NFr:Pt:Bronchial:Qn,0
3559,Carbonyldiamide,Urea nitrogen:SCnc:24H:Urine:Qn,0
3560,Multisection,Multisection:Find:Pt:Head>Internal auditory canal:Doc:CT,0
3561,Multisection,Multisection:Find:Pt:Upper extremity>Elbow:Doc:XR.tomography,0
3562,Views AP,View AP^W R-bending:Find:Pt:Chest>Spine.thoracic:Doc:XR,0
3563,phendimetrazine,Phendimetrazine:MRat:24H:Urine:Qn,0
3564,Herpes virus 8 DNA,Herpes virus 8 DNA:PrThr:Pt:Ser/Plas:Ord:Probe.amp.tar,0
3565,SARS coronavirus Urbani ribonucleic acid,SARS coronavirus Urbani RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
3566,clorprenaline,Clorprenaline:MRat:24H:Urine:Qn,0
3567,View Towne,View Towne:Find:Pt:Head>Skull:Doc:XR,0
3568,Immunoglobulin G,IgG:MCnc:Pt:Urine:Qn,0
3569,LOINC class types,Class:Type:Pt:Intubation tube:Nom,0
3570,Mesothelial cell,Mesothelial cells:NCnc:Pt:Synv fld:Qn,0
3571,Leukocytes other,Leukocytes other:NCnc:Pt:Plr fld:Qn,0
3572,View,Views^W contrast IA:Find:Pt:Head+Neck>Carotid arteries+Vertebral artery:Doc:RF.angio,0
3573,View,Deprecated RF Kidney - left Views W contrast retrograde via urethra,0
3574,Probenecid,Probenecid:MCnc:Pt:Urine:Qn,0
3575,methicillin,Methicillin:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
3576,Physical findings,Physical findings:Find:Pt:Liver:Nom,0
3577,Clostridium tetani IgG,Clostridium tetani Ab.IgG:PrThr:Pt:Ser:Ord,0
3578,Furcation classification,Furcation classification:Class:Pt:{Tooth}:Ord:Glickman classification,0
3579,OB ultrasound panel,OB ultrasound panel:-:Point in time:^Patient:-,0
3580,Arterial patency,Arterial patency^pre arterial puncture:PrThr:Pt:Wrist artery:Ord,0
3581,Multisection,Multisection:Finding:Point in time:Larynx:Narrative:MRI,0
3582,MFN2 gene targeted mutation analysis,MFN2 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN,0
3583,Views static limited,Deprecated NM Bone Limited Static Views,0
3584,Views for endocrine tumor,Views for endocrine tumor^W I-131 MIBG IV:Find:Pt:Whole body:Doc:NM,0
3585,M8-nelfinavir,Nelfinavir M8:MCnc:Pt:Ser/Plas:Qn,0
3586,Multisection diffusion weighted,Deprecated Brain MR diffusion weighted,0
3587,View,Views^W contrast:Find:Pt:XXX>Visceral vessels:Doc:RF.angio,0
3588,West Nile virus RNA,West Nile virus RNA:PrThr:Pt:XXX:Ord:Probe,0
3589,Creatinine,Creatinine:SCnc:24H:Dial fld prt:Qn,0
3590,Cells.CD3+CD8+/100 cells,Cells.CD3+CD8+/100 cells:NFr:Pt:XXX:Qn,0
3591,Flowsheet,Flowsheet:Find:Pt:{Setting}:Doc:Speech-language pathology,0
3592,allysine,Alpha-aminoadipic semialdehyde:SCnc:Pt:Ser/Plas:Qn,0
3593,Strongyloides sp Ab.IgG,Strongyloides sp Ab.IgG:PrThr:Pt:Ser:Ord:IA,0
3594,creosol,Creosol:PrThr:Pt:XXX:Ord,0
3595,Treatment plan note,Deprecated Audiology Treatment plan note,0
3596,D- & L-2-hydroxyglutarate panel,D- & L-2-hydroxyglutarate panel:-:Pt:Bld.dot:-,0
3597,Cefmetazole,Cefmetazole:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
3598,Legionella pneumophila 4 IgM,Legionella pneumophila 4 Ab.IgM:Titr:Pt:Ser:Qn:IF,0
3599,Blood group antibody C^w^,C little w Ab:PrThr:Pt:Ser/Plas:Ord,0
3600,Methylone cutoff,Methylone cutoff:MCnc:Pt:Urine:Qn:Confirm,0
3601,Pathologic casts,Pathologic casts:NCnc:Pt:Urine:Qn:Automated count,0
3602,Blood flow velocity.S wave.max,Blood flow velocity.S wave.max:Vel:Pt:Pulmonary vein:Qn:US.doppler.PW,0
3603,Education note,Education note:Find:Pt:{Setting}:Doc:Pulmonary disease,0
3604,Cardiac Output,Cardiac output:VRat:Pt:Heart.ventricle.left:Qn:US.3D,0
3605,alminoprofen,Alminoprofen:MCnc:Pt:Bld:Qn,0
3606,Regurgitant blood flow rate.diastole,Regurgitant blood flow rate.diastole:VRat:Pt:Aortic valve:Qn:US.doppler+Calculated by PISA method,0
3607,Transfer summary note,Transfer summary note:Find:Pt:{Setting}:Doc:Geriatric medicine,0
3608,Guidance for peripheral venous access,Guidance for peripheral venous access:Find:Pt:XXX>Vein:Doc:US,0
3609,Radial strain rate.diastole.max,Radial strain rate.diastole.max:ARat:Pt:Heart.ventricle.left:Qn:US.2D,0
3610,Eicosatrienoate,Eicosatrienoate:EntSub:Pt:Ser/Plas:Qn,0
3611,Intravascular diastolic,Intravascular diastolic:Pres:Pt:Splenic artery:Qn,0
3612,Intravascular end diastolic,Intravascular end diastolic:Pres:Pt:Heart.ventricle.right:Qn,0
3613,Insulin,Insulin^30M post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn,0
3614,pyridinoline,Pyridinoline:MRat:2H:Urine:Qn,0
3615,Taenia solium larva 21kD Ab,Taenia solium larva 21kD Ab:PrThr:Pt:Ser:Ord:IB,0
3616,8-hydroxyloxapine,8-Hydroxyloxapine:MCnc:Pt:Ser/Plas:Qn,0
3617,Pepsin A+Pepsinogen A,Pepsin A+Pepsinogen A:MCnc:Pt:Respiratory.lower:Qn:IA,0
3618,Skin-fold thickness (finding),Skin fold thickness:Len:Pt:Waist:Qn,0
3619,sodium intake,Sodium intake:SRat:8H:^Patient:Qn,0
3620,ACSF3 gene full mutation analysis,ACSF3 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing,0
3621,Extraocular retinoblastoma classification,Extraocular retinoblastoma classification^at final disease stage:Class:Pt:Eye.left:Ord:Reese-Ellsworth system,0
3622,Methylphenidate,Methylphenidate:MCnt:Pt:Hair:Qn,0
3623,Peritoneal tube site,Peritoneal tube site:Anatomy:Point in time:*^Patient:Nominal,0
3624,DFNB31 gene mutation analysis limited to known familial mutations,DFNB31 gene mutation analysis limited to known familial mutations:Find:Pt:Bld/Tiss:Doc:Molgen,0
3625,liver fibrosis score,Liver fibrosis score:Score:Pt:Ser/Plas:Qn:Calculated.HepaScore,0
3626,Time to max tissue velocity.systole,Time to max tissue velocity.systole:Time:Pt:Heart.ventricle.left.basal lateral:Qn:US.tissue doppler,0
3627,Checklist,Checklist:Finding:Point in time:{Setting}:Document:{Role},0
3628,Certificate (record artifact),Certificate:Finding:Point in time:{Setting}:Document:{Role},0
3629,Care plan - recommended C-CDA R2.0 & R2.1 sections,Care plan - recommended C-CDA R2.0 & R2.1 sections:-:Pt:{Setting}:-,0
3630,Intravascular diastolic,Intravascular diastolic:Pres:Pt:Femoral artery:Qn,0
3631,LOINC class types,Class:Type:Pt:Rate control device:Nom,0
3632,Ventricular morphology,Ventricular morphology:Impression/interpretation of study:Point in time::Narrative:EKG,0
3633,Coxsackievirus A7 Ab,Coxsackievirus A7 Ab:ACnc:Pt:Ser:Qn,0
3634,Hexadecenoate,Hexadecenoate:EntSub:Pt:RBC:Qn,0
3635,suberylglycine,Suberylglycine:SCnc:Pt:Ser/Plas:Qn,0
3636,N-acetyltyrosine,N-acetyltyrosine:SCnc:Pt:Ser/Plas:Qn,0
3637,Q wave depth.lead V2,Q wave depth.lead V2:Elpot:Pt:Heart:Qn:EKG,0
3638,HLA-DQ Ab.IgG,HLA-DQ Ab.IgG:Prid:Pt:Ser/Plas:Nom:IA,0
3639,Bacteria identified,Bacteria identified:Prid:Pt:Implanted device:Nom:Culture,0
3640,Parainfluenza virus 3 NP gene,Parainfluenza virus 3 NP gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,0
3641,Respiratory syncytial virus B F gene,Respiratory syncytial virus B F gene:PrThr:Pt:Nph:Ord:Probe.amp.tar,0
3642,PSEN1 gene mutation analysis limited to known familial mutations,PSEN1 gene mutation analysis limited to known familial mutations:Find:Pt:Bld/Tiss:Doc:Molgen,0
3643,1-(3-chlorophenyl)piperazine,M-chlorophenylpiperazine:MCnc:Pt:Bld:Qn,0
3644,R- & S-beta aminoisobutyrate & D- & L-serine pattern,R- & S-beta aminoisobutyrate & D- & L-serine pattern:Imp:Pt:CSF:Nar,0
3645,Cholestanols,Bile alcohols:Imp:Pt:Urine:Ord,0
3646,Pterins pattern,Pterins pattern:Imp:Pt:Ser/Plas:Nar,0
3647,Azelate,Azelate:SCnc:Pt:Ser/Plas:Qn,0
3648,Hydantoin-5-propionate,Hydantoin-5-propionate:SCnc:Pt:Ser/Plas:Qn,0
3649,Discharge instructions,Discharge instructions:Find:Pt:{Setting}:Doc:Nephrology,0
3650,Discharge instructions,Discharge instructions:Find:Pt:{Setting}:Doc:Neurology,0
3651,Discharge instructions,Discharge instructions:Find:Pt:{Setting}:Doc:Nurse practitioner,0
3652,Beta alanine & Beta aminoisobutyrate & Gamma aminobutyrate pattern,Beta alanine & Beta aminoisobutyrate & Gamma aminobutyrate pattern:Imp:Pt:CSF:Nar,0
3653,Maprotiline+Normaprotiline,Maprotiline+Normaprotiline:MCnc:Pt:Ser/Plas:Qn,0
3654,View,Views^W radionuclide IV:Find:Pt:XXX>Lymph node:Doc:NM,0
3655,View,Views^W radionuclide IV:Find:Pt:XXX>Lymph node.bilateral:Doc:NM,0
3656,Mycoplasma hyopneumoniae Ab sample/Positive control,Mycoplasma hyopneumoniae Ab sample/Positive control:RelRto:Pt:Ser:Qn:IA,0
3657,Stenosis degree,Stenosis degree:LenFr:Pt:Posterolateral from right coronary artery:Qn,0
3658,"N,N-dimethylarginine","N,N-dimethylarginine:MCnc:Pt:Ser/Plas:Qn",0
3659,Vitamin B1 Intake,Vitamin B1 intake:MRat:24H:^Patient:Qn:Estimated,0
3660,Operative Surgical Procedures,History of surgical procedures:Finding:Point in time:^Patient:Nominal:Reported,0
3661,Carbon Tetrachloride,Carbon tetrachloride:Mass Concentration:Point in time:Whole blood:Quantitative,0
3662,IgA subclass 1/IgA.total,immunoglobulin A subclass 1/immunoglobulin A.total:Mass Fraction:Point in time:Serum:Quantitative,0
3663,Flurazepam,Flurazepam:SCnc:Pt:XXX:Qn,0
3664,Multisection,Multisection^W contrast IV:Find:Pt:Abdomen:Doc:CT,0
3665,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:Urine:Ord:Probe.amp.tar,0
3666,Calcium Oxalate,Calcium oxalate:EngDiff:24H:Urine:Qn,0
3667,Chromosome region 17p13.3 deletion,Chromosome region 17p13.3 deletion:Find:Pt:Amnio fld/CVS:Doc:FISH,0
3668,Physical findings,Physical findings:Finding:Point in time:Rectum:Nominal:Observed,0
3669,cold agglutinins,Cold agglutinin^1H post incubation:Titr:Pt:Ser:Qn:37 deg C incubation,0
3670,Cold agglutinin panel,Cold agglutinin panel:-:Pt:Ser:-,0
3671,Alpha linolenate intake,Alpha linolenate intake:MRat:24H:^Patient:Qn:Measured,0
3672,Casein intake,Casein intake:MRat:24H:^Patient:Qn:Measured,0
3673,Copper intake,Copper intake:MRat:24H:^Patient:Qn:Measured,0
3674,Body Weight,Body weight^ante partum:Mass:Pt:^Patient:Qn:Measured,0
3675,Intravascular diastolic,Intravascular diastolic:Pres:Pt:Superior mesenteric artery:Qn,0
3676,Ambrosia artemisiifolia native (nAmb a) 1 Ab.IgE.RAST class,Ambrosia artemisiifolia native (nAmb a) 1 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3677,Pholcodine Ab.IgE.RAST class,Pholcodine Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3678,Country of exposure to illness,Country of exposure to illness:Loc:Pt:^Patient:Nom,0
3679,Evidence supporting myopathy,Evidence supporting myopathy:Type:Pt:^Patient:Nom,0
3680,Intraocular retinoblastoma classification,Intraocular retinoblastoma classification^at initial diagnosis:Class:Pt:Eye.left:Ord:ICRB,0
3681,Tendon reflex assessment panel,Tendon reflex assessment panel:-:Pt:Neurologic deep tendon reflexes:-,0
3682,Skin assessment,Skin assessment:Imp:Pt:Skin:Nom,0
3683,Fructose intake,Fructose intake:MRat:24H:^Patient:Qn:Estimated,0
3684,Metabolic equivalent of task by population resting metabolic rate panel,Metabolic equivalent of task by population resting metabolic rate panel:-:1M^mean:^Patient:-,0
3685,Discharge teaching note,Discharge teaching note:Find:Pt:{Setting}:Doc:Physical therapy,0
3686,Flowsheet,Flowsheet:Find:Pt:{Setting}:Doc:Orthopaedic surgery,0
3687,Biotinidase,Biotinidase:CCnt:Pt:Ser/Plas:Qn,0
3688,Plan of care note,Plan of care note:Find:Pt:{Setting}:Doc:Dentistry,0
3689,heart rate,Heart rate:NRat:Pt:Capillary bed:Qn:Pulse oximetry,0
3690,Galactose,Galactose:MCnc:Pt:RBC:Qn,0
3691,Beta hydroxybutyrate/Acetoacetate,Beta hydroxybutyrate/Acetoacetate:SRto:Pt:CSF:Qn,0
3692,Hydrogen/Expired gas,Hydrogen/Expired gas^3.5H post XXX challenge:VFr:Pt:Exhl gas:Qn,0
3693,"Antigens, CD15",CD15 Ag:PrThr:Pt:Bone mar:Ord:Immune stain,0
3694,desoxycorticosterone,11-Deoxycorticosterone:MCnc:Pt:Bld.dot:Qn,0
3695,Cobalamins,Cobalamins:SCnc:Pt:Body fld:Qn,0
3696,Glucose,Glucose^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
3697,Potassium/Creatinine,Potassium/Creatinine:SRto:24H:Urine:Qn,0
3698,Tinidazole,Tinidazole:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
3699,Yersinia sp Ab.IgG & IgM panel,Yersinia sp Ab.IgG & IgM panel:-:Pt:Ser:-,0
3700,Leishmania mexicana IgM,Leishmania mexicana Ab.IgM:ACnc:Pt:Ser:Qn:IF,0
3701,prasterone,Dehydroepiandrosterone:MCnc:Pt:Saliva:Qn,0
3702,Festuca elatior Ab.IgG,Festuca elatior Ab.IgG:MCnc:Pt:Ser:Qn,0
3703,Cytomegalovirus antibody,Deprecated Cytomegalovirus Ab [Titer] in Serum by Latex agglutination,0
3704,Cells.CD13/100 cells,Cells.CD13/100 cells:NFr:Pt:CSF:Qn,0
3705,Mercury/Creatinine,Mercury/Creatinine:SRto:24H:Urine:Qn,0
3706,Calcium bilirubinate/Total,Calcium bilirubinate/Total:MFr:Pt:Calculus:Qn,0
3707,Leukocytes,Leukocytes^^corrected for nucleated erythrocytes:NCnc:Pt:Bone mar:Qn,0
3708,Rubus idaeus Ab.IgG4,Rubus idaeus Ab.IgG4:MCnc:Pt:Ser:Qn,0
3709,Sodium nitrite leukotriene release,Sodium nitrite leukotriene release:MCnc:Pt:WBC:Qn,0
3710,HLA-DPw4 antigen,HLA-DPw4:PrThr:Pt:Bld/Tiss^Donor:Ord,0
3711,Cocaine+Benzoylecgonine,Cocaine+Benzoylecgonine:PrThr:Pt:Ser/Plas:Ord:Screen,0
3712,3-hydroxypropionate,3-Hydroxypropionate:SCnc:Pt:Amnio fld:Qn,0
3713,Cells.CD3+CD16+/100 cells,"Cells.CD3+CD16+/100 cells:Number Fraction:Point in time:Body fluid, unsp:Quantitative",0
3714,Oxygen saturation test result,Oxygen saturation:MFr:Pt:BldV:Qn:Calculated from oxygen partial pressure,0
3715,Heptaporphyrin/Creatinine,Deprecated Heptaporphyrin/Creatinine [Mass Ratio] in Urine,0
3716,Alpha 2 globulin/Protein.total,Alpha 2 globulin/Protein.total:MFr:Pt:Dial fld:Qn:Electrophoresis,0
3717,Heparin 10000 U per mL given,Heparin 10000 U per mL given:Vol:Pt:^Patient:Qn,0
3718,Plan of care note,Plan of care:Finding:Point in time:^Patient:Document,0
3719,Influenza A virus antibody,Influenza virus A Ab:Titr:Pt:Ser:Qn:Comp fix,0
3720,Integrin alpha5,Deprecated CD49e cells/100 cells in Blood,0
3721,Bacteroides melaninogenicus antigen,Bacteroides melaninogenicus Ag:PrThr:Pt:XXX:Ord:IF,0
3722,Dicarboxydodecanoylcarnitine (C12-DC)/Creatinine,Dicarboxydodecanoylcarnitine (C12-DC)/Creatinine:SRto:Pt:Urine:Qn,0
3723,Dicarboxypalmitoylcarnitine (C16-DC),Dicarboxypalmitoylcarnitine (C16-DC):SCnc:Pt:Ser/Plas:Qn,0
3724,Human leukocyte antigen B44(12),HLA-B44(12):PrThr:Pt:Bld/Tiss:Ord,0
3725,Chylomicrons/Lipoprotein.total,Chylomicrons/Lipoprotein.total:MFr:Pt:Ser/Plas:Qn,0
3726,Legionella sp rRNA,Legionella rRNA XXX Ql Prb,0
3727,Ganglioside GM2 Ab.IgG/Ganglioside GM2 Ab.IgM,Ganglioside GM2 Ab.IgG/Ganglioside GM2 Ab.IgM:Ratio:Pt:Ser:Qn:IA,0
3728,Mucin-1 Antigen,Cancer Ag 15-3:ACnc:Pt:Periton fld:Qn,0
3729,multiple sclerosis panel,Multiple sclerosis panel:-:Pt:Ser+CSF:-,0
3730,Trichinella spiralis IgG,Trichinella spiralis Ab.IgG:Titr:Pt:Ser:Qn:IF,0
3731,CD8 Antigens,Deprecated CD8 cells/100 cells in Blood,0
3732,anidulafungin,Anidulafungin:Susc:Pt:Isolate:OrdQn:MIC,0
3733,prasterone,Dehydroepiandrosterone^pre 250 ug corticotropin:MCnc:Pt:Ser/Plas:Qn,0
3734,HLA-Dw16 antigen,HLA-Dw16:PrThr:Pt:Bld/Tiss:Ord,0
3735,3-Hydroxyisobutyrate/Creatinine,3-Hydroxyisobutyrate/Creatinine:SRto:24H:Urine:Qn,0
3736,Antigen of Hepatitis C virus core,Hepatitis C virus core Ag:PrThr:Pt:Bld/Bone mar^Donor:Ord,0
3737,21-deoxycortisol,21-Deoxycortisol:SCnc:Pt:Ser/Plas:Qn,0
3738,Echovirus 19 Ab,Echovirus 19 Ab:Titr:Pt:Ser:Qn:Neut,0
3739,Leukocytes,Leukocytes:Naric:Pt:Stool:Qn:Microscopy.light.HPF,0
3740,HIV 2 Ab Signal/Cutoff,HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA,0
3741,Cholesterol crystals (substance),Cholesterol crystals:Naric:Pt:Urine:Qn:Computer assisted,0
3742,Hemoglobin D+G/Hemoglobin.total,Hemoglobin D+G/Hemoglobin.total:MFr:Pt:Bld:Qn,0
3743,Tubular basement membrane Ab.IgG,Tubular basement membrane Ab.IgG:ACnc:Pt:Ser:Qn:IF,0
3744,Bartonella elizabethae IgG,Bartonella elizabethae Ab.IgG:Titr:Pt:Ser:Qn:IF,0
3745,Urea renal clearance/1.73 sq M,Urea renal clearance/1.73 sq M:ArVRat:XXX:Urine+Ser/Plas:Qn,0
3746,3-Hydroxymyristoleylcarnitine (C14:1-OH),3-Hydroxymyristoleylcarnitine (C14:1-OH):SCnc:Pt:Bld.dot:Qn,0
3747,3-dechloroethylifosfamide,3-Dechloroethylifosfamide^2D post dose ifosfamide:MCnc:Pt:Bld:Qn,0
3748,Domperidone,Domperidone:SCnc:Pt:Ser/Plas:Qn,0
3749,Bartonella quintana IgM,Bartonella quintana Ab.IgM:ACnc:Pt:Ser:Qn:IA,0
3750,Adenovirus IgG,Adenovirus Ab.IgG:ACnc:Pt:Ser:Qn:IA,0
3751,Erythrocytes.Plasmodium sp infected/100 erythrocytes,Erythrocytes.Plasmodium sp infected/100 erythrocytes:NFr:Pt:Bld:Qn,0
3752,Multisection,Multisection^W contrast IV:Find:Pt:Head+Neck>Nasopharynx:Doc:CT,0
3753,Ehrlichia sp identified,Ehrlichia sp identified:Prid:Pt:XXX:Nom:Organism specific culture,0
3754,Blasts.CD33,Blasts.CD33:ACnc:Pt:Bld:Qn,0
3755,BCL10 Ag,BCL10 Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
3756,Clusterin Ag,Clusterin Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
3757,Iron,Iron:SCnt:Pt:Hair:Qn,0
3758,Muscle specific receptor tyrosine kinase Ab,Muscle specific receptor tyrosine kinase Ab:SCnc:Pt:Ser:Qn,0
3759,DNA marker analysis test coverage panel,"deoxyribonucleic acid marker analysis test coverage panel:-:Point in time:Whole blood/Tissue, unspecified:-:Molecular Genetics",0
3760,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone^30M post dose corticotropin:SCnc:Pt:Ser/Plas:Qn,0
3761,Multisection,Multisection^W contrast IV:Find:Pt:Chest>Clavicle.left:Doc:MR,0
3762,Adenosine monophosphate.cyclic/Creatinine,Adenosine monophosphate.cyclic/Creatinine^1st specimen post XXX challenge:Ratio:Pt:Urine:Qn,0
3763,Zinc/Creatinine,Zinc/Creatinine:SRto:24H:Urine:Qn,0
3764,Thyroid newborn screening panel,Thyroid newborn screening panel:Mass Concentration:Point in time:Blood filter paper:-,0
3765,Newborn hearing screen,Newborn hearing screen:Arb:Pt:Ear.right:Ord,0
3766,HLA-B73 antigen,HLA-B73:PrThr:Pt:Bld/Tiss:Ord,0
3767,11-hydroxy-delta(9)-tetrahydrocannabinol,11-Hydroxy delta-9 tetrahydrocannabinol:MCnc:Pt:XXX:Qn,0
3768,"Respiratory allergen panel, US - North Atlantic states b","Respiratory allergen panel, US - North Atlantic states b:-:Pt:Ser:-",0
3769,Legionella sp Ab.IgG,Legionella sp Ab.IgG:PrThr:Pt:Ser:Ord,0
3770,Ribosomal ribonucleoprotein antibody,Ribonucleoprotein extractable nuclear Ab:ACnc:Pt:Ser:Qn:IA,0
3771,CD52 antigen,CD52 Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
3772,Clotrimazole,Clotrimazole:Susc:Pt:Isolate:OrdQn:Gradient strip,0
3773,Muramidase,Lysozyme:ACnc:Pt:Urine:Qn,0
3774,Lactalbumin alpha Ab.IgG4,Lactalbumin alpha Ab.IgG4:MCnc:Pt:Ser:Qn,0
3775,Multisection limited,Multisection limited:Find:Pt:Neck:Doc:MR,0
3776,Views AP,View AP:Find:Pt:Lower extremity.right>Knee:Doc:XR,0
3777,Methadone,Methadone:MCnc:Pt:XXX:Qn,0
3778,Bisacodyl,Bisacodyl:MCnc:Pt:Stool:Qn,0
3779,Mycobacterium bovis tuberculin stimulated gamma interferon panel,Mycobacterium bovis tuberculin stimulated gamma interferon panel:-:Pt:Bld:-,0
3780,Pheniramine,Pheniramine:SCnc:Pt:Ser/Plas:Qn,0
3781,RHE gene targeted mutation analysis,RHE gene targeted mutation analysis:Type:Pt:Amnio fld:Nom:Molgen,0
3782,epinephrine and norepinephrine,Epinephrine+Norepinephrine:MCnc:Pt:Urine:Qn,0
3783,Hydrocortisone,Cortisol^5D post dose dexamethasone:SCnc:Pt:Ser/Plas:Qn,0
3784,Coagulation thrombin induced.factor substitution,Coagulation thrombin induced.factor substitution^immediately after 1:4 addition of normal plasma:Time:Pt:PPP:Qn:Coag,0
3785,Lymphoma - CLL screen panel,Lymphoma - CLL screen panel:-:Pt:XXX:-:Flow cytometry,0
3786,Magnesium cutoff,Magnesium cutoff:MCnt:Pt:Stool:Qn,0
3787,reference lab test identifier and name,Reference lab test number and name:Identifier:time reported elsewhere:Reference lab test:Nominal,0
3788,HLA-DR14(6),HLA-DR14(6):PrThr:Pt:Bld/Tiss^Donor:Ord,0
3789,Blasts.CD1,Blasts.CD1:ACnc:Pt:XXX:Qn,0
3790,Aspergillus fumigatus recombinant (rAsp f) 1 Ab.IgE.RAST class,Aspergillus fumigatus recombinant (rAsp f) 1 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3791,Aspergillus fumigatus recombinant (rAsp f) 3 Ab.IgE.RAST class,Aspergillus fumigatus recombinant (rAsp f) 3 Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
3792,Hepatitis C Antibodies,Hepatitis C virus Ab:PrThr:Pt:Ser:Ord:IB,0
3793,Glucose,Glucose^4M post dose glucagon:SCnc:Pt:Ser/Plas:Qn,0
3794,Growth Hormone,Somatotropin^2.5H post dose glucagon:ACnc:Pt:Ser/Plas:Qn,0
3795,HLA-B14 antigen,HLA-B14:PrThr:Pt:Bld/Tiss:Ord,0
3796,Plasma cells/100 leukocytes,Plasma cells/100 leukocytes:NFr:Pt:CSF:Qn:Manual count,0
3797,Cichorium intybus Ab.IgG4,Cichorium intybus Ab.IgG4:MCnc:Pt:Ser:Qn,0
3798,Sonographer name,Sonographer name:Patient number:Point in time:^Patient:Nominal,0
3799,Blasts.CD179a,Blasts.CD179a:ACnc:Pt:XXX:Qn,0
3800,Transitional Epithelial Cells,Transitional cells:PrThr:Pt:Urine:Ord:Computer assisted,0
3801,Platelet aggregation.arachidonate induced,Platelet aggregation.arachidonate induced:ACnc:Pt:Bld:Qn,0
3802,Familial long QTS syndrome gene targeted mutation analysis,Familial long QTS syndrome gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
3803,GQ1b ganglioside antibody,Deprecated Ganglioside GQ1b Ab [Units/volume] in Serum,0
3804,Hepatitis B virus precore codon 28,Deprecated Hepatitis B virus precore codon 28 [Identifier] in Serum by Probe and target amplification method,0
3805,California encephalitis virus Ab.IgM,California encephalitis virus Ab.IgM:Titr:Pt:CSF:Qn:IF,0
3806,Lymphocyte proliferation.10 umol beryllium stimulation,Lymphocyte proliferation.10 umol beryllium stimulation^7D post incubation:ACnc:Pt:Bld:Qn,0
3807,VFD Type B medicated feed animal drug label,VFD Type B medicated feed animal drug label:-:-:^FDA product label:Nar,0
3808,Gastric analysis panel,Gastric analysis panel:-:Pt:Gast fld:-,0
3809,Blasts.CD23/100 blasts,Blasts.CD23/100 blasts:NFr:Pt:Bone mar:Qn,0
3810,Blasts.cytoplasmic CD3,Blasts.cytoplasmic CD3:ACnc:Pt:Bld:Qn,0
3811,Blasts.CD34,Blasts.CD34:ACnc:Pt:Bld:Qn,0
3812,Macroblasts/100 cells,Macroblasts/100 cells:NFr:Pt:Bone mar:Qn:Manual count,0
3813,Mean sphered cell volume,Mean sphered cell volume:EntVol:Pt:RBC:Qn,0
3814,Selenium,Selenium:SRat:24H:Urine:Qn,0
3815,Triple phosphate crystals,Triple phosphate crystals:NCnc:Pt:Urine:Qn:Computer assisted,0
3816,Triple phosphate crystals,Triple phosphate crystals:Naric:Pt:Urine:Qn:Computer assisted,0
3817,Phosphoserine,Phosphoserine:SCnc:Pt:Bld.dot:Qn,0
3818,Paromomycin,Paromomycin:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
3819,Bean green Ab.IgG4,Bean green Ab.IgG4:MCnc:Pt:Ser:Qn,0
3820,Homarus gammarus Ab.IgG4,Homarus gammarus Ab.IgG4:MCnc:Pt:Ser:Qn,0
3821,Albumin & Immunoglobulin Quotient,Albumin & Immunoglobulin Quotient:Imp:Pt:Ser+CSF:Nom,0
3822,Plasma cell Ag,Plasma cell Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
3823,Streptococcus agalactiae DNA,Streptococcus agalactiae DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
3824,Mycoplasma pneumoniae IgM,Mycoplasma pneumoniae Ab.IgM:PrThr:Pt:Ser:Ord:IF,0
3825,Immunoglobulin M,IgM:MRat:24H:Urine:Qn,0
3826,Varicella-zoster virus antigen,Varicella zoster virus Ag:PrThr:Pt:XXX:Ord:IF,0
3827,Hydrocortisone,Cortisol^12th specimen post XXX challenge:SCnc:Pt:Saliva:Qn,0
3828,Enterococcus species.vancomycin resistant,Enterococcus species.vancomycin resistant:PrThr:Pt:Urine:Ord:Organism specific culture,0
3829,Prunus avium Ab.IgG,Prunus avium Ab.IgG:MCnc:Pt:Ser:Qn,0
3830,Triazolam,Triazolam:MCnc:Pt:Body fld:Qn:Confirm,0
3831,Human reference sequence assembly release number,"Human reference sequence assembly release number:Identifier:Point in time:Whole blood/Tissue, unspecified:Nominal:Molecular Genetics",0
3832,Taenia solium larva IgG,Taenia solium larva Ab.IgG:PrThr:Pt:Ser:Ord:IB,0
3833,"What did they make, or what service did they provide - what type of business was it","What did they make, or what service did they provide - what type of business was it:Find:Pt:^Patient:Nom:NHANES",0
3834,How often do you take naps,How often do you take naps:NRat:Pt:^Patient:Ord:PhenX,0
3835,11-ketoetiocholanolone,11-Ketoetiocholanolone^2D post high dose dexamethasone:MCnc:24H:Urine:Qn,0
3836,desmethyldoxepin,Nordoxepin:PrThr:Pt:Urine:Ord,0
3837,Human papilloma virus 18 DNA,Human papilloma virus 18 DNA:PrThr:Pt:Cvx:Ord:Probe.amp.sig,0
3838,Epstein-Barr virus DNA,Epstein Barr virus DNA:PrThr:Pt:Body fld:Ord:Probe.amp.tar,0
3839,How often did you eat fruit in past 30D,How often did you eat fruit in past 30D:Finding:Point in time:^Patient:Ordinal:PhenX,0
3840,Cathepsin G antibody,Cathepsin G Ab:ACnc:Pt:Ser:Qn:IA,0
3841,Borrelia burgdorferi Ag,Borrelia burgdorferi Ag:ACnc:Pt:Ser:Qn,0
3842,Japanese encephalitis virus IgM,Japanese encephalitis virus Ab.IgM:PrThr:Pt:Ser:Ord:IA,0
3843,D little o super little b Ab,D little o super little b Ab:PrThr:Pt:Ser/Plas:Ord,0
3844,Derived post treatment-7 M,Derived post treatment-7 M:Prid:Pt:Cancer.XXX:Nom,0
3845,Duck meat Ab.IgE,Duck meat Ab.IgE:ACnc:Pt:Ser:Qn,0
3846,Ganglioside GD3 Ab.IgG+IgM,Ganglioside GD3 Ab.IgG+IgM:PrThr:Pt:Ser:Ord:IA,0
3847,About how much weight did you gain and lose,About how much weight did you gain and lose:Mass:Pt:^Patient:Qn:QIDS,0
3848,Kinds of physical activity you usually performed while on the job this last Y,Kinds of physical activity you usually performed while on the job this last Y:Find:1Y:^Patient:Nom:PhenX,0
3849,Aldosterone,Aldosterone^2H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
3850,I little n super little b Ab,In^b Antibody:Arbitrary Concentration:Point in time:Serum/Plasma:Ordinal,0
3851,Discharge summary note,Discharge summary note:Find:Pt:Emergency department:Doc:{Role},0
3852,Acetone,Acetone:SCnc:Pt:Gast fld:Qn,0
3853,Measles virus identified,Deprecated Measles virus identified in Unspecified specimen by Organism specific culture,0
3854,Halothane gas delivered.total,Halothane gas delivered.total:Vol:RptPeriod:Gas delivery system:Qn,0
3855,GQ1b IgG ganglioside antibody,Ganglioside GQ1b Ab.IgG:PrThr:Pt:Ser:Ord:IA,0
3856,Histone antibody,Histone Ab:PrThr:Pt:Body fld:Ord:IA,0
3857,At what age did you start living there,At what age did you start living there:Time:Pt:^Patient:Qn:NHEXAS,0
3858,Was the private well cased,Was the private well cased:Find:Pt:^Patient:Nom:Next-of-kin,0
3859,"Does anyone who lives here smoke cigarettes, cigars, or pipes anywhere inside this home","Does anyone who lives here smoke cigarettes, cigars, or pipes anywhere inside this home:Find:Pt:^Patient:Nom:NHANES",0
3860,Booster age,Booster age:Time:Pt:^Patient:Qn:PhenX,0
3861,Main presenting symptom,Main presenting symptom:Find:Pt:^Patient:Nom:PhenX,0
3862,Births.stillborn,Births.stillborn:Number:Point in time:^Patient:Quantitative:Reported,0
3863,date of delivery (history),Delivery date:Date:Pt:^Patient:Qn:Estimated from quickening date,0
3864,Squamous cell carcinoma antigen,Squamous cell carcinoma Ag:MCnc:Pt:Periton fld:Qn,0
3865,Levamisole,Levamisole:MCnc:Pt:Body fld:Qn,0
3866,Levamisole,Levamisole:MCnc:Pt:Urine:Qn,0
3867,milnacipran,Milnacipran:MCnc:Pt:Urine:Qn,0
3868,Mexiletine,Mexiletine:SCnc:Pt:Urine:Qn,0
3869,Lymphocytes.large granular/100 leukocytes,Lymphocytes.large granular/100 leukocytes:NFr:Pt:Bld:Qn:Flow cytometry,0
3870,PhenX measure - environmental exposures - current environmental tobacco smoke exposure,PhenX measure - environmental exposures - current environmental tobacco smoke exposure:-:Point in time:^Patient:-:PhenX,0
3871,Liver kidney microsomal 2 Ab,Liver kidney microsomal 2 Ab:PrThr:Pt:Ser:Ord:IF,0
3872,"During the last 3Mo of your pregnancy, how many alcoholic drinks did you have in an average W","During the last 3Mo of your pregnancy, how many alcoholic drinks did you have in an average W:NRat:Pt:^Patient:Qn:PhenX",0
3873,"Do you consider yourself to be a morning person - early bird, an evening person - night owl, or neither","Do you consider yourself to be a morning person - early bird, an evening person - night owl, or neither:Find:Pt:^Patient:Nom:PhenX",0
3874,Urobilinogen,Urobilinogen:PrThr:Pt:Urine:Ord:Test strip,0
3875,tapentadol,Tapentadol:MCnt:Pt:Tiss:Qn,0
3876,Human papilloma virus 68 DNA,Human papilloma virus 68 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
3877,Liquidambar styraciflua Ab.IgE,Liquidambar styraciflua Ab.IgE:ACnc:Pt:Ser:Qn,0
3878,PM-SCL extractable nuclear antibody,PM-SCL extractable nuclear Ab:PrThr:Pt:CSF:Ord:IA,0
3879,Country,Country:Loc:Pt:Facility:Nom,0
3880,Asialoglycoprotein receptor Ab,Asialoglycoprotein receptor Ab:ACnc:Pt:Ser:Qn:IA,0
3881,PhenX measure - peripheral arterial disease,PhenX measure - peripheral arterial disease:-:Point in time:^Patient:-:PhenX,0
3882,Conalbumin native (nGal d) 3 Ab.IgE,Conalbumin native (nGal d) 3 Ab.IgE:ACnc:Pt:Ser:Qn,0
3883,Prunus persica recombinant (rPru p) 3 Ab.IgE,Prunus persica recombinant (rPru p) 3 Ab.IgE:ACnc:Pt:Ser:Qn,0
3884,Lactate Dehydrogenase,Lactate dehydrogenase:CCnc:Pt:CSF:Qn:Reaction: pyruvate to lactate,0
3885,Lactate Dehydrogenase,Lactate dehydrogenase:CCnc:Pt:CSF:Qn:Reaction: lactate to pyruvate,0
3886,Ribosomal ribonucleoprotein antibody,Ribonucleoprotein extractable nuclear Ab:PrThr:Pt:CSF:Ord:IA,0
3887,I get really frightened for no reason,I get really frightened for no reason:Find:Pt:^Patient:Ord:SCARED-R,0
3888,meropenem,Meropenem:Susc:Pt:Isolate:Qn:MLC,0
3889,How thick is an average spot of your psoriasis,How thick is an average spot of your psoriasis:Find:Pt:^Patient:Ord:PhenX,0
3890,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3891,Avena sativa Ab.IgE,Avena sativa Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative,0
3892,Would you say that in general your health is,Would you say that in general your health is:Find:Pt:^Patient:Ord:HRQOL,0
3893,I'll try anything once,I'll try anything once:Finding:Point in time:^Patient:Ordinal:UPPS,0
3894,desoxycorticosterone,11-Deoxycorticosterone^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
3895,PhenX measure - migraine,PhenX measure - migraine:-:Point in time:^Patient:-:PhenX,0
3896,PhenX measure - total physical activity - comprehensive,PhenX measure - total physical activity - comprehensive:-:Point in time:^Patient:-:PhenX,0
3897,Phaseolus limensis Ab.IgG,Phaseolus limensis Ab.IgG:MCnc:Pt:Ser:Qn,0
3898,How old were you when you first needed to wear glasses to see clearly in the distance,How old were you when you first needed to wear glasses to see clearly in the distance:Time:Pt:^Patient:Qn:PhenX,0
3899,"When I feel bad, I often do things I later regret in order to make myself feel better now","When I feel bad, I often do things I later regret in order to make myself feel better now:Find:Pt:^Patient:Ord:UPPS-R-C",0
3900,Methyl formamide/Creatinine,Methyl formamide/Creatinine:Ratio:Pt:Urine:Qn,0
3901,TNFRSF13B gene mutations tested for,TNFRSF13B gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen,0
3902,Platelet factor 4 heparin complex induced Antibody,Platelet factor 4 heparin complex induced Ab:PrThr:Pt:Ser/Plas:Ord:IA,0
3903,tapentadol,Tapentadol:PrThr:Pt:Urine:Ord:Confirm,0
3904,Plasminogen activator tissue type Ag,Plasminogen activator tissue type Ag^20M post venistasis:MCnc:Pt:PPP:Qn:IA,0
3905,paramethadione,Paramethadione:MCnc:Pt:Bld:Qn,0
3906,Progress note,Progress note:Find:Pt:Hospital:Doc:Critical Care Medicine,0
3907,I get scared when I sleep away from home,I get scared when I sleep away from home:Find:Pt:^Patient:Ord:SCARED-R,0
3908,Arachis hypogaea recombinant (rAra h) 9 Ab.IgE,Arachis hypogaea recombinant (rAra h) 9 Ab.IgE:ACnc:Pt:Ser:Qn,0
3909,Cladosporium herbarum recombinant (rCla h) 8 Ab.IgE,Cladosporium herbarum recombinant (rCla h) 8 Ab.IgE:ACnc:Pt:Ser:Qn,0
3910,What kind of things did you do,What kind of things did you do:Find:Pt:^Patient:Nom:Denver Youth Survey,0
3911,Do you find it very difficult to follow a conversation if there is background noise,Do you find it very difficult to follow a conversation if there is background noise:Find:Pt:^Patient:Ord:PhenX,0
3912,How many times in the last Y have you skipped classes or school without an excuse,How many times in the last Y have you skipped classes or school without an excuse:NRat:1Y:^Patient:Qn:Denver Youth Survey,0
3913,Sodium benzoate Ab.IgE,Sodium benzoate Ab.IgE:ACnc:Pt:Ser:Qn,0
3914,"HEDIS 2010, 2011 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E)",HEDIS 2010 Codes to identify drug serum concentration monitoring tests (MPM-E):-:Point in time:^Patient:-,0
3915,Derived pre treatment-7 N,Derived pre treatment-7 N:Prid:Pt:Cancer.XXX:Nom,0
3916,Derived pre treatment-7 T descriptor,Derived pre treatment-7 T descriptor:Prid:Pt:Cancer.XXX:Nom,0
3917,pentane,Pentane:MCnc:Pt:Ser/Plas:Qn,0
3918,Penicillium brevicompactum Ab.IgE,Penicillium brevicompactum Ab.IgE:ACnc:Pt:Ser:Qn,0
3919,Double stranded anti DNA antibody,DNA double strand Ab:PrThr:Pt:CSF:Ord:IF,0
3920,I am not very good at remembering phone numbers,I am not very good at remembering phone numbers:Find:Pt:^Patient:Ord:AQ,0
3921,Adenovirus DNA,Adenovirus DNA:LnCnc:Pt:CSF:Qn:Probe.amp.tar,0
3922,Leukocytes,Leukocytes:NCnc:Pt:Dial fld:Qn:Manual count,0
3923,Phleum pratense recombinant (rPhl p) 5b Ab.IgE,Phleum pratense recombinant (rPhl p) 5b Ab.IgE:ACnc:Pt:Ser:Qn,0
3924,Tripelennamine,Tripelennamine:MCnc:Pt:Bld:Qn,0
3925,Isoflurane,Isoflurane^during expiration:VFr/PPres:Pt:Gas delivery system.expiratory limb:Qn,0
3926,Glycyphagus domesticus Ab.IgE,Glycyphagus domesticus Ab.IgE:ACnc:Pt:Ser:Qn,0
3927,PhenX measure - assessment of gallbladder disease and related conditions,PhenX measure - assessment of gallbladder disease and related conditions:-:Point in time:^Patient:-:PhenX,0
3928,Reason stopped or paused before 6M,Reason stopped or paused before 6M:Finding:Point in time:^Patient:Nominal,0
3929,"When your child is reading a story, your child can easily imagine what the characters might look like","When your child is reading a story, your child can easily imagine what the characters might look like:Find:Pt:^Patient:Ord:AQ Adolescent",0
3930,Condition causing difficulty with breathing,Condition causing difficulty with breathing:Find:Pt:^Patient:Nom:PhenX,0
3931,During these episodes of overeating and loss of control did you eat alone because you were embarrassed by how much you were eating,During these episodes of overeating and loss of control did you eat alone because you were embarrassed by how much you were eating:Find:Pt:^Patient:Ord:EDDS,0
3932,How well can you give yourself a pep talk when you feel low,How well can you give yourself a pep talk when you feel low:Find:Pt:^Patient:Nom:SEQ-C,0
3933,Cucumis melo cantalupenisis basophil bound Ab,Cucumis melo cantalupenisis basophil bound Ab:ACnc:Pt:Bld:Qn:LHR,0
3934,Zolazepam,Zolazepam:MCnc:Pt:Ser/Plas:Qn,0
3935,Hydrogen/Expired gas,Hydrogen/Expired gas^2.25H post dose lactose PO:VFr:Pt:Exhl gas:Qn,0
3936,Carbon dioxide setting,Carbon dioxide setting^during inspiration:VFr/PPres:Pt:Gas delivery system:Qn,0
3937,Carbon dioxide.gastric-Carbon dioxide.BldA,Carbon dioxide.gastric-Carbon dioxide.BldA:PPresDiff:Pt:Stomach+BldA:Qn:Gastric tonometry,0
3938,Nuclei scored,Nuclei scored:Num:Pt:Tiss:Qn,0
3939,TOP2A gene 17q21-22 deletion+duplication,TOP2A gene 17q21-22 deletion+duplication:PrThr:Pt:Tiss:Ord:FISH,0
3940,CD3+CD4+ cell,Cells.CD3+CD4+:NCnc:Pt:CSF:Qn,0
3941,Do or did you inhale the cigarette smoke,Do or did you inhale the cigarette smoke:Find:Pt:^Patient:Nom:PhenX,0
3942,Does your child enjoy sports,Does your child enjoy sports:Find:Pt:^Patient:Ord:CAST,0
3943,Does your child have any unusual and repetitive movements,Does your child have any unusual and repetitive movements:Find:Pt:^Patient:Ord:CAST,0
3944,Immunoglobulin G antibody to Influenza A virus,Influenza virus A Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn:IA,0
3945,Lymphocytes.cytoplasmic IgM/100 lymphocytes,Lymphocytes.cytoplasmic IgM/100 lymphocytes:NFr:Pt:Body fld:Qn,0
3946,"In the past 12Mo, have you had periods or episodes of cough with phlegm that lasted 1 W or more","In the past 12Mo, have you had periods or episodes of cough with phlegm that lasted 1 W or more:Finding:Point in time:^Patient:Ordinal:PhenX",0
3947,Bizarre delusion,Bizarre delusions:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4,0
3948,Did you feel like there was nothing you could do to stop what was happening,Did you feel like there was nothing you could do to stop what was happening:Find:Pt:^Patient:Ord:LTVH,0
3949,Has anyone ever stolen something from you without your knowing it,Has anyone ever stolen something from you without your knowing it:Find:Pt:^Patient:Ord:LTVH,0
3950,Problem location,Problem location:Anatomy:Point in time:^Patient:Nominal,0
3951,Oxalates,Oxalate:MCnc:12H:Urine:Qn,0
3952,Herpes simplex virus identified,Herpes simplex virus identified:Prid:Pt:Genital:Nom:Organism specific culture,0
3953,Complement C3 Ag,Complement C3 Ag:PrThr:Pt:Tiss:Ord:IF,0
3954,25-Hydroxyvitamin D2+25-Hydroxyvitamin D3,25-Hydroxyvitamin D2+25-Hydroxyvitamin D3:MCnc:Pt:Ser/Plas:Qn,0
3955,Secale cereale pollen Ab.IgG,Secale cereale pollen Ab.IgG:MCnc:Pt:Ser:Qn,0
3956,What kind of business or industry did you work in for the longest period of time,What kind of business or industry did you work in for the longest period of time:Find:Pt:^Patient:Nom:NHANES,0
3957,Chlamydia trachomatis,Chlamydia trachomatis:PrThr:Pt:XXX:Ord:Organism specific culture,0
3958,Are you unable to recall important parts of the event,Are you unable to recall important parts of the event:Find:Pt:^Patient:Ord:PhenX,0
3959,"How many of your daughters have had, or were suspected of having this eye problem","How many of your daughters have had, or were suspected of having this eye problem:Num:Pt:^Patient:Qn:PhenX",0
3960,How much difficulty do you have reading street signs or the names of stores,How much difficulty do you have reading street signs or the names of stores:Find:Pt:^Patient:Ord:PhenX,0
3961,Amount of dextrose solution administered,Amount of dextrose solution administered:Num:Pt:^Patient:Qn:PhenX,0
3962,A wave amplitude,A wave amplitude:Len:Pt:Heart.valve.XXX:Qn:US,0
3963,1-benzylpiperazine,Benzylpiperazine:MCnc:Pt:Urine:Qn:Confirm,0
3964,Chaetomium globosum Ab.IgG,Chaetomium globosum Ab.IgG:MCnc:Pt:Ser:Qn,0
3965,Centromere antibody,Centromere Ab:PrThr:Pt:Body fld:Ord:IF,0
3966,Bacteria identified,Bacteria identified:Prid:Pt:XXX:Nom:Anaerobic culture,0
3967,Did the need to drink a lot more before you got drunk increase 50 percent or more,Did the need to drink a lot more before you got drunk increase 50 percent or more:Find:Pt:^Patient:Ord:SSAGA II,0
3968,I have had problems at work because I was irresponsible,I have had problems at work because I was irresponsible:Find:Pt:^Patient:Ord:PhenX,0
3969,Was this the source of fracture confirmation,Was this the source of fracture confirmation:Find:Pt:^Patient:Ord:PhenX,0
3970,Mononuclear cells/100 leukocytes,Mononuclear cells/100 leukocytes:NFr:Pt:Plr fld^Fetus:Qn:Manual count,0
3971,Calcitriol,Calcitriol^3H post dose calcium:SCnc:Pt:Ser/Plas:Qn,0
3972,Basophils+Mast cells/100 leukocytes,Basophils+Mast cells/100 leukocytes:NFr:Pt:CSF:Qn,0
3973,(Beef+Chicken+Pork) Ab.IgE,(Beef+Chicken+Pork) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk,0
3974,Basophils/100 leukocytes,Basophils/100 leukocytes:NFr:Pt:BldCo:Qn,0
3975,Artemisia californica Ab.IgE,Artemisia californica Ab.IgE:ACnc:Pt:Ser:Qn,0
3976,PROCEDURE NOTE,Procedure note:Find:Pt:{Setting}:Doc:Pediatric hematology-oncology,0
3977,History and physical note,History and physical note:Find:Pt:{Setting}:Doc:Pediatric otolaryngology,0
3978,cefprozil,Cefprozil:Susc:Pt:Isolate:OrdQn:Gradient strip,0
3979,Vaccinium myrtillus Ab.IgE,Vaccinium myrtillus Ab.IgE:ACnc:Pt:Ser:Qn,0
3980,Newborn hearing screen reason not performed,Newborn hearing screen reason not performed:Find:Pt:Ear.right:Nom,0
3981,Monocytes/100 leukocytes,Monocytes/100 leukocytes:NFr:Pt:Bld:Qn:Manual count,0
3982,Xenon,Xenon^during expiration:VFr/PPres:Pt:Gas delivery system.expiratory limb:Qn,0
3983,Nitric Oxide,Nitric oxide:VFr/PPres:Pt:Gas delivery system:Qn,0
3984,Savinase Ab.IgE,Savinase Ab.IgE:ACnc:Pt:Ser:Qn,0
3985,Guidance for needle localization,Guidance for needle localization:Find:Pt:Breast.bilateral:Doc:MG,0
3986,Pre-operative evaluation and management note,Preoperative evaluation and management note:Find:Pt:Hospital:Doc:Pediatrics,0
3987,pyridoxine,Pyridoxine:SCnc:Pt:CSF:Qn,0
3988,Desflurane liquid delivered.case,Desflurane liquid delivered.case:Vol:Procedure dur:Gas delivery system:Qn,0
3989,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity>Finger:Doc:MR,0
3990,Neutrophils/leukocytes,Neutrophils/leukocytes:NFr.DF:Pt:Pericard fld:Qn:Manual count,0
3991,Polymorphonuclear cells/leukocytes,Polymorphonuclear cells/leukocytes:NFr.DF:Pt:Plr fld:Qn:Manual count,0
3992,Ceftizoxime induced platelet Ab.IgM,Ceftizoxime induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
3993,Penicillium chrysogenum IgG,Penicillium notatum Ab.IgG:ACnc:Pt:Ser:Qn,0
3994,Carbon dioxide production/Ideal body weight,Carbon dioxide production/Ideal body weight:VRat:Pt:Respiratory system:Qn,0
3995,PMI - Directions for use section,PMI - Directions for use section:-:-:^FDA package insert:Nar,0
3996,zinc protoporphyrin,Protoporphyrin.zinc:SCnc:Pt:RBC:Qn,0
3997,Clover Ab.IgE,Clover Ab.IgE:ACnc:Pt:Ser:Qn,0
3998,Warfarin induced platelet Ab.IgM,Warfarin induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
3999,Linum usitatissimum Ab.IgE,Linum usitatissimum Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative,0
4000,Buspirone induced platelet Ab.IgM,Buspirone induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
4001,Date of autopsy,Date of autopsy:Date:Pt:^Patient:Qn,0
4002,Cryptococcus sp Ag,Cryptococcus sp Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
4003,Pyruvate Kinase,Pyruvate kinase:CSub:Pt:RBC:Qn,0
4004,Milrinone induced platelet Ab.IgG,Milrinone induced platelet Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
4005,Ezetimibe induced platelet Ab.IgM,Ezetimibe induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
4006,Pravastatin induced platelet Ab.IgM,Pravastatin induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
4007,Carya laciniosa Ab.IgE,Carya laciniosa Ab.IgE:ACnc:Pt:Ser:Qn,0
4008,Suberylcarnitine (C8-DC),Suberylcarnitine (C8-DC):CCnt:Pt:Fibroblasts:Qn,0
4009,Fatty acids.very long chain.C24:0,Fatty acids.very long chain.C24:0:EntSub:Pt:RBC:Qn,0
4010,Solea solea Ab.IgG,Solea solea Ab.IgG:ACnc:Pt:Ser:Qn,0
4011,Do you suffer from migraine,Do you suffer from migraine:Hx:Pt:^Patient:Ord:PhenX,0
4012,p27 antigen,P27 Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
4013,Physical therapy provider specialty,Physical therapy provider specialty:Type:Pt:Provider:Nom:APTA,0
4014,Last oral intake,Last oral intake:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative,0
4015,First alternate healthcare agent,First alternate healthcare agent:Pn:Pt:^Patient:Nom:Reported,0
4016,Western equine encephalitis virus IgG,Western equine encephalitis virus Ab.IgG:Titr:Pt:Ser:Qn:IF,0
4017,TF gene full mutation analysis,TF gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing,0
4018,Zea mays pollen Ab.IgE,Zea mays pollen Ab.IgE:ACnc:Pt:Ser:Qn,0
4019,Egg whole basophil bound Ab,Egg whole basophil bound Ab:ACnc:Pt:Bld:Qn:LHR,0
4020,Poa compressa Ab.IgE,Poa compressa Ab.IgE:ACnc:Pt:Ser:Qn,0
4021,My teachers make it clear to me when I have misbehaved in class,My teachers make it clear to me when I have misbehaved in class:Find:Pt:^Patient:Ord:PhenX,0
4022,Latex glove extract ammoniated Ab.IgE,Latex glove extract ammoniated Ab.IgE:ACnc:Pt:Ser:Qn,0
4023,telavancin,Telavancin:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
4024,Fluid need,Fluid need:VRat:24H:^Patient:Qn:Estimated,0
4025,Forecast of outcome,Prognosis:Find:Pt:^Patient:Nom,0
4026,Restraint note,Restraint note:Find:Pt:Hospital:Doc:Physician,0
4027,"t(1;11)(p32;q23)(EPS15,MLL) fusion transcript","t(1;11)(p32;q23)(EPS15,MLL) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen",0
4028,Birth Certificates,Birth certificate:Finding:Point in time:{Setting}:Document:{Provider},0
4029,Myrica spp Ab.IgE,Myrica spp Ab.IgE:ACnc:Pt:Ser:Qn,0
4030,Guidance for laser ablation,Guidance for laser ablation:Find:Pt:Extremity.left>Extremity vein:Doc:US,0
4031,Populus fremontii Ab.IgE,Populus fremontii Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative,0
4032,Lidocaine induced platelet Ab.IgM,Lidocaine induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
4033,Other cells/100 leukocytes,Other cells/100 leukocytes:NFr:Pt:Pericard fld:Qn:Manual count,0
4034,Hypersegmented neutrophil,Neutrophils.hypersegmented:PrThr:Pt:Bld:Ord:Microscopy.light,0
4035,Do you suffer from white finger syndrome or raynaud's syndrome caused by excessive vibration from pneumatic hammers or drills,Do you suffer from white finger syndrome or raynaud's syndrome caused by excessive vibration from pneumatic hammers or drills:Find:Pt:^Patient:Ord:PhenX,0
4036,Beta globulin/Protein.total,Beta globulin/Protein.total:MFr.DF:24H:Urine:Qn:Electrophoresis,0
4037,Metoclopramide induced neutrophil Ab.IgG,Metoclopramide induced neutrophil Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
4038,Lolium perenne Ab.IgE,LOLIUM PERENNE ANTIBODY.IMMUNOGLOBULIN E:ARBITRARY CONCENTRATION:POINT IN TIME:SERUM:QUANTITATIVE,0
4039,Bile acid panel,Bile acid panel:-:24H:Stool:-,0
4040,Diphenylmethane diisocyanate (MDI) Ab.IgE,Diphenylmethane diisocyanate (MDI) Ab.IgE:ACnc:Pt:Ser:Qn,0
4041,Airway resistance,Resistance.airway^during expiration:FldResist:Pt:Respiratory system.airway:Qn,0
4042,Ampicillin,Ampicillin:Susc:Pt:Isolate:OrdQn:Gradient strip,0
4043,Grass sorghum Ab.IgE,Grass sorghum Ab.IgE:ACnc:Pt:Ser:Qn,0
4044,Oidiodendrum spp Ab.IgE,Oidiodendrum spp Ab.IgE:ACnc:Pt:Ser:Qn,0
4045,Glasgow coma score.motor,Deprecated Glasgow coma score motor NEMSIS,0
4046,Alkaline phosphatase.intestinal 3,Alkaline phosphatase.intestinal 3:CCnc:Pt:Ser/Plas:Qn,0
4047,Legionella species,Legionella sp:Prid:Pt:Isolate:Nom:Aggl,0
4048,Cheese mozzarella Ab.IgG,Cheese mozzarella Ab.IgG:ACnc:Pt:Ser:Qn,0
4049,MARS2 gene full mutation analysis,MARS2 gene full mutation analysis:Prid:Pt:Bld/Tiss/Sal:Nom:Sequencing,0
4050,Cell positive for CD20 antigen,Cells.CD20:NCnc:Pt:XXX:Qn,0
4051,Plasma cells/100 cells,Plasma cells/100 cells:NFr:Pt:Lymph node:Qn:Manual count,0
4052,Delta dRVVT,Delta dRVVT:TimeDif:Pt:PPP:Qn:Coag,0
4053,PROCEDURE NOTE,Procedure note:Find:Pt:{Setting}:Doc:Developmental-behavioral pediatrics,0
4054,Venlafaxine+Norvenlafaxine,Venlafaxine+Norvenlafaxine^trough:MCnc:Pt:Ser/Plas:Qn,0
4055,Bacteria identified,Bacteria identified:Prid:Pt:Bone^Donor:Nom:Aerobic culture,0
4056,Normirtazapine,Normirtazapine:MCnc:Pt:Body fld:Qn,0
4057,Arginosuccinate,Argininosuccinate^post therapeutic diet:SCnc:Pt:Bld.dot:Qn,0
4058,Anisakis Ab.IgE.RAST class,Anisakis Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4059,Fraxinus americana Ab.IgE.RAST class,Fraxinus americana Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4060,Vendor model number,Vendor model number:Prid:Pt:Biliary drain:Nom,0
4061,Diameter (qualifier value),Diameter:Len:Pt:Heart.ventricle.right.outflow tract:Qn:US.measured,0
4062,C-Peptide,C peptide^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
4063,Corticotropin,Corticotropin^pre 1 ug/kg CRH IV:MCnc:Pt:Plas:Qn,0
4064,2-Oxoadipate/Creatinine,2-Oxoadipate/Creatinine:MRto:Pt:Urine:Qn,0
4065,4-Hydroxyphenylpyruvate/Creatinine,4-Hydroxyphenylpyruvate/Creatinine:MRto:Pt:Urine:Qn,0
4066,Rheumatoid Factor,Rheumatoid factor:Titr:Pt:Ser:Qn:Nephelometry,0
4067,Glycine max Ab.IgE.RAST class,Glycine max Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4068,Beta-2 glycoprotein 1 IgG antibody,Beta 2 glycoprotein 1 Ab.IgG:ACnc:Pt:Ser:Qn,0
4069,Droperidol,Droperidol:PrThr:Pt:Ser/Plas:Ord,0
4070,Erythromycin,Erythromycin:PrThr:Pt:Urine:Ord,0
4071,Secretory Immunoglobulin A,IgA.secretory:ACnc:Pt:Ser/Plas:Qn,0
4072,Aspartate/Creatinine,Aspartate/Creatinine:MRto:Pt:Urine:Qn,0
4073,Benzoate/Creatinine,Benzoate/Creatinine:MRto:Pt:Urine:Qn,0
4074,Creatinine,Creatinine:SCnc:Pt:Ser/Plas:Qn,0
4075,Irregularly contracted cell,Irregularly contracted cells:PrThr:Pt:Bld:Ord:Microscopy.light,0
4076,microscopic observation,Microscopic observation:Prid:Pt:Tiss:Nom:Safranin stain,0
4077,Sporothrix schenckii Ab,Sporothrix schenckii Ab:PrThr:Pt:Ser:Ord,0
4078,Rubella virus IgM,Rubella virus Ab.IgM:ACnc:Pt:CSF:Qn,0
4079,Flurazepam,Flurazepam:SCnc:Pt:Ser/Plas:Qn,0
4080,Methyprylon,Methyprylon:PrThr:Pt:Urine:Ord:Confirm,0
4081,Lycopodium spp Ab.IgE.RAST class,Lycopodium spp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4082,microscopic observation,Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain,0
4083,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US.estimated from radius length,0
4084,Grade,Grade:Type:Point in time:Placenta^Fetus:Ordinal:ULTRASOUND,0
4085,heart rate,Heart rate:NRat:Pt:^Fetus:Qn:US.measured,0
4086,Long axis,Long axis:Len:Pt:Foot^Fetus:Qn:US.measured,0
4087,MNSs group Ag,MNSs group Ag:Type:Pt:RBC:Nom,0
4088,Herpes simplex virus 2 Ab,Herpes simplex virus 2 Ab:ACnc:Pt:Ser:Qn:IF,0
4089,Phenylpropionylglycine/Creatinine,Phenylpropionylglycine/Creatinine:MRto:Pt:Urine:Qn,0
4090,Follicle Stimulating Hormone,Follitropin^30M post dose gonadotropin releasing hormone:MCnc:Pt:Ser/Plas:Qn,0
4091,Cells.CD8+HLA-DR+/100 cells,Cells.CD8+HLA-DR+/100 cells:NFr:Pt:Bld:Qn,0
4092,Androstenedione,Androstenedione^30M post 250 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn,0
4093,Lithium,Lithium:SCnc:Pt:Ser/Plas:Qn,0
4094,17-Hydroxycorticosteroids,17-Hydroxycorticosteroids:SRat:24H:Urine:Qn,0
4095,Pigweed common Ab.IgE.RAST class,Pigweed common Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4096,Free cortisol,Cortisol.free^48H post 40 ug corticotropin IM BID 3 day:MCnc:24H:Urine:Qn,0
4097,Methanol,Methanol:SCnc:Pt:Ser/Plas:Qn,0
4098,Toxoplasma gondii,Toxoplasma gondii:PrThr:Pt:Tiss:Ord:Organism specific culture,0
4099,Ambrosia elatior Ab.IgE.RAST class,Deprecated Common Ragweed IgE RAST Ql,0
4100,Origanum majorana Ab.IgE,Origanum majorana Ab.IgE:ACnc:Pt:Ser:Qn,0
4101,Physical findings,Physical findings:Finding:Point in time:Knee:Narrative:Observed,0
4102,Physical findings,Physical findings:Finding:Point in time:Hand:Nominal:Observed,0
4103,Promazine,Promazine:MCnc:Pt:Ser/Plas:Qn,0
4104,Borrelia burgdorferi 30kD Ab,Borrelia burgdorferi 30kD Ab:PrThr:Pt:CSF:Ord:IB,0
4105,Succinylcholine Ab.IgE.RAST class,Succinylcholine Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4106,Blood group antigen H,Deprecated H NOS Ag [Presence] on Red Blood Cells,0
4107,Bacillus anthracis antibody,Bacillus anthracis Ab:ACnc:Pt:Ser:Qn:IB,0
4108,Cryptococcus neoformans antigen,Deprecated Cryptococcus neoformans Ag [Presence] in Unspecified specimen,0
4109,Creatinine dialysis fluid clearance,Creatinine dialysis fluid clearance:Volume Rate:Point in time:Dialysis fluid+Serum/Plasma:Quantitative,0
4110,Artemisia absinthium Ab.IgE.RAST class,Artemisia absinthium Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4111,Babesia microti IgG,Babesia microti Ab.IgG:Titr:Pt:Ser:Qn,0
4112,(Foeniculum vulgare seed+Ocimum basilicum+Pimpinella anisum+Zingiber officinale) Ab.IgE,(Foeniculum vulgare seed+Ocimum basilicum+Pimpinella anisum+Zingiber officinale) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk,0
4113,Glucose,Glucose^30M post 0.05-0.15 U insulin/kg IV post 12H CFst:MCnc:Pt:Ser/Plas:Qn,0
4114,Blood group antigen Kp^a^,K little p super little a Ag:PrThr:Pt:RBC:Ord,0
4115,Propoxyphene,Propoxyphene:MCnc:Pt:Meconium:Qn,0
4116,Progress note,Subsequent evaluation note:Finding:Point in time:{Setting}:Document:{Provider},0
4117,Glucose,Glucose^4H specimen:MCnc:Pt:Dial fld:Qn,0
4118,acid hemolysis,Acid hemolysis:PrThr:Pt:Bld:Ord,0
4119,Beta globulin/Protein.total,Beta globulin/Protein.total:MFr:Pt:CSF:Qn:Electrophoresis,0
4120,Streptococcus pneumoniae 7 Ab.IgG,Deprecated Streptococcus pneumoniae 7 IgG Ab [Units/volume] in Serum by Immunoassay,0
4121,Spermatozoa.viable/100 spermatozoa,Spermatozoa.viable/100 spermatozoa:NFr:Pt:Semen:Qn,0
4122,Study observation,Study observation:Finding:Point in time:Heart.ventricle.right.outflow tract^Fetus:Narrative:ULTRASOUND,0
4123,Primidone,Primidone:SCnc:Pt:Ser/Plas:Qn,0
4124,(Juniperus sabinoides+Quercus alba+Ulmus americana+Populus deltoides+Prosopis juliflora) Ab.IgE,(Juniperus sabinoides+Quercus alba+Ulmus americana+Populus deltoides+Prosopis juliflora) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk,0
4125,Chinchilla Ab.IgE.RAST class,Chinchilla Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4126,20-alpha-Dihydroprogesterone,20-Hydroxyprogesterone:MCnc:Pt:Ser:Qn,0
4127,"4,4'-methylene-bis-(2-chloroaniline)","4,4'-Methylene bis(2-Chloroaniline):MCnc:Pt:Urine:Qn",0
4128,Phyllostachys pubescens Ab.IgE,Phyllostachys pubescens Ab.IgE:ACnc:Pt:Ser:Qn,0
4129,HTLV-I Antibodies,HTLV I Ab:ACnc:Pt:Ser:Qn,0
4130,HTLV I+II p53 Ab,HTLV I+II p53 Ab:PrThr:Pt:Ser:Ord:IB,0
4131,Androsterone,Androsterone:SCnc:Pt:Ser/Plas:Qn,0
4132,Methamphetamine,Methamphetamine:MCnc:Pt:Meconium:Qn,0
4133,Glycerylphosphorylcholine,Glycerophosphocholine:SCnc:Pt:Semin plas:Qn,0
4134,Spermatid,Spermatids:NCnc:Pt:Semen:Qn:SAB,0
4135,Sperm-Zona Pellucida Penetration,Spermatozoa penetration:PrThr:Pt:Semen+Cvm:Ord:Kremer,0
4136,Blood flow.diastolic.early wave.max,Deprecated Tricuspid valve Peak E velocity US.doppler,0
4137,Thickness.systolic,Thickness.systolic:Len:Pt:Heart.ventricle.posterior wall.left^Fetus:Qn:US.measured.real time two dimension,0
4138,Nuclear Ab pattern,"Nuclear Antibody pattern:Impression/interpretation of study:Point in time:Body fluid, unsp:Nominal:IMMUNE FLUORESCENCE",0
4139,Coliform bacteria,Coliform bacteria:PrThr:Pt:Water:Ord,0
4140,Creatinine,Creatinine:SCnc:Pt:Amnio fld:Qn,0
4141,Coagulation surface induced,Deprecated Activated partial thrombplastin time (aPTT) in Blood from control by Coagulation assay,0
4142,Equine infectious anemia virus antibody,Equine infectious anemia virus Ab:PrThr:Pt:Ser:Ord:Immune diffusion,0
4143,Hospital discharge medications,Hospital discharge medications:Finding:Point in time:^Patient:Narrative,0
4144,Bran wheat Ab.IgE,Bran wheat Ab.IgE:ACnc:Pt:Ser:Qn,0
4145,Entamoeba histolytica,Entamoeba histolytica:PrThr:Pt:Stool:Ord:Trichrome stain,0
4146,Antigen of Measles morbillivirus,Measles virus Ag:PrThr:Pt:Skin:Ord:IF,0
4147,Poa compressa Ab.IgE.RAST class,Poa compressa Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4148,Agropyron repens Ab.IgE.RAST class,Agropyron repens Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4149,Oxygen content level,Oxygen content:SCnc:Pt:Vena cava.superior:Qn,0
4150,Pollachius virens Ab.IgE,Pollachius virens Ab.IgE:ACnc:Pt:Ser:Qn,0
4151,Body Weight,Body weight:Mass:Pt:^Fetus:Qn:US+Estimated from AC&FL.Hadlock 1984,0
4152,Reverse ABO group,Reverse ABO group:Type:Pt:Bld:Nom,0
4153,Naphthol AS D Esterase,Alpha naphthylesterase:CCnc:Pt:Ser:Qn,0
4154,Diffusion capacity.carbon monoxide,Diffusion capacity.carbon monoxide:FldConduct:Pt:Respiratory system:Qn:Predicted,0
4155,Gas flow,Gas flow:VRat:Pt:Respiratory system.airway:Qn:Rebreathing,0
4156,Carotene,Carotene:MCnc:Pt:Bld:Qn,0
4157,Equine influenza virus A1 Ab,Equine influenza virus A1 Ab:Titr:Pt:Ser:Qn,0
4158,Theileria parva Ab,Theileria parva Ab:PrThr:Pt:Ser:Ord:IA,0
4159,Glyceraldehyde-3-phosphate dehydrogenase,Glyceraldehyde 3 phosphate dehydrogenase:CCnc:Pt:Ser:Qn,0
4160,Dextroamphetamine cutoff,Dextroamphetamine cutoff:MCnc:Pt:Urine:Qn:Screen,0
4161,Oxygen,Oxygen:PPres:8H^max:BldC:Qn,0
4162,Ova & parasites identified,Ova & parasites identified:Prid:Pt:Stool:Nom:Concentration.Baerman,0
4163,Paraquat,Paraquat:MCnt:Pt:Tiss:Qn,0
4164,leptin,Leptin:MCnc:Pt:Ser/Plas:Qn,0
4165,Influenza A virus antibody,Deprecated Influenza virus A Ab [Titer] in Serum,0
4166,Coxsackievirus B IgG,Coxsackievirus B Ab.IgG:ACnc:Pt:Ser:Qn:Neut,0
4167,Cephapirin,Cephapirin:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
4168,Testosterone,Testosterone^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
4169,Diamorphine cutoff,Diamorphine cutoff:MCnc:Pt:Urine:Qn:Confirm,0
4170,Oxygen/Inspired gas setting,Oxygen/Inspired gas setting:VFr:Pt:Ventilator:Qn,0
4171,Oxygen,Oxygen^on room air and eating:PPres:Stdy^min:BldC:Qn:Transcutaneous O2 monitor,0
4172,Cells.CD7/100 cells,Cells.CD7/100 cells:NFr:Pt:XXX:Qn,0
4173,Monocyte+Macrophage/100 leukocytes,Deprecated Monocytes+Macrophages/100 leukocytes in Body fluid by Manual count,0
4174,Chlamydia species antibody (substance),Chlamydia sp Ab:Titr:Pt:CSF:Qn:Comp fix,0
4175,Dehydroepiandrosterone Sulfate,Dehydroepiandrosterone sulfate^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
4176,"Dengue virus, type 1 antibody",Dengue virus 1 Ab:Titr:Pt:Ser:Qn,0
4177,Nordazepam,Deprecated Nordiazepam [Presence] in Serum or Plasma,0
4178,N-desmethylmethsuximide,Deprecated Desmethylmethsuximide:Mass Concentration:Point in time:Serum:Quantitative,0
4179,Cells.CD3+IL2R1+/100 cells,Cells.CD3+IL2R1+/100 cells:NFr:Pt:Bld:Qn,0
4180,Cells.CD3+DR+/100 cells,Cells.CD3+DR+/100 cells:NFr:Pt:Bld:Qn,0
4181,Cells.CD30/100 cells,Cells.CD30/100 cells:NFr:Pt:Bld:Qn,0
4182,Calcium,Calcium^^corrected for total protein:SCnc:Pt:Ser/Plas:Qn,0
4183,Glycochenodeoxycholic Acid,Chenodeoxycholylglycine:MCnc:Pt:Ser:Qn,0
4184,Avena sativa Ab.IgG.RAST class,Avena sativa Ab.IgG.RAST class:PrThr:Pt:Ser:Ord,0
4185,Mycoplasma antibody,Mycoplasma sp Ab:PrThr:Pt:Ser:Ord,0
4186,Leptospira sp Ag,Leptospira sp Ag:PrThr:Pt:Tiss:Ord:IF,0
4187,Multisection,Multisection:Find:Pt:Pelvis>Anus:Doc:US,0
4188,Trypanosoma brucei DNA,Trypanosoma brucei DNA:PrThr:Pt:Bld:Ord:Probe.amp.tar,0
4189,Cephradine,Cephradine:Titr:Pt:Isolate+Ser:Qn:SBT,0
4190,Tryptophan,Tryptophan:PrThr:Pt:Urine:Ord,0
4191,Levo-methamphetamine,Levomethamphetamine:PrThr:Pt:Urine:Ord:Screen,0
4192,Macro-Creatine Kinase,Creatine kinase.macromolecular:CCnc:Pt:Ser/Plas:Qn,0
4193,Placental Lactogen,Choriomammotropin:MCnc:Pt:Ser:Qn,0
4194,phosphate ion,Phosphate:MCnc:24H:Urine:Qn,0
4195,Cells.cytoplasmic CD79/100 cells,Cells.cytoplasmic CD79/100 cells:NFr:Pt:Bld:Qn,0
4196,Dipeptidyl-Peptidase IV,Adenosine deaminase binding protein:MCnc:Pt:Urine:Qn,0
4197,Mephobarbital,Mephobarbital:MCnc:Pt:Urine:Qn:Confirm,0
4198,Metamyelocytes/100 leukocytes,Metamyelocytes/100 leukocytes:NFr:Pt:Body fld:Qn,0
4199,Tidal volume.spontaneous+mechanical,Tidal volume.spontaneous+mechanical^on ventilator^corrected for compressible gas volume:Vol:Pt:Respiratory system:Qn,0
4200,Volume expired during 1.0 s of forced expiration,Volume at 1.0 s post forced expiration:Volume:Point in time:Respiratory system:Quantitative:Predicted,0
4201,Anaplasma marginale antibody,Anaplasma marginale Ab:PrThr:Pt:Ser:Ord:Aggl.card,0
4202,Biogenic Amines,Amines.biogenic:MCnt:Pt:Feed:Qn,0
4203,Solanum tuberosum Ab.IgE,Deprecated Potato IgE Ab [Units/volume] in Serum,0
4204,Propranolol,Propranolol:MCnc:Pt:Gast fld:Qn,0
4205,Gamma-glutamyl transferase,Gamma glutamyl transferase:CCnc:Pt:Ser/Plas:Qn,0
4206,Glycine,Glycine:PrThr:Pt:Urine:Ord,0
4207,Methandrostenolone,Metandienone:MCnc:Pt:Ser/Plas:Qn,0
4208,butalbital,Butalbital:PrThr:Pt:Urine:Ord:Confirm,0
4209,Maximal Voluntary Ventilation,Voluntary ventilation.max:Volume Rate:Point in time:Respiratory system:Quantitative:Predicted,0
4210,Maximal Voluntary Ventilation,Voluntary ventilation.max:Volume Rate:Point in time:Respiratory system:Quantitative,0
4211,Cardiac output/Body surface area.4 chamber,Cardiac output/Body surface area.4 chamber:ArVRat:Pt:Heart.ventricle.left:Qn:US.mod.single-plane.calculated,0
4212,Circumference 2,Circumference 2:Circ:Pt:Region of interest.XXX:Qn:US,0
4213,Brucella melitensis antibody,Brucella melitensis Ab:PrThr:Pt:Ser:Ord:Comp fix,0
4214,Alkaline Phosphatase,Alkaline phosphatase:CCnc:Pt:Urine:Qn,0
4215,Aluminum,Aluminum:MCnc:Pt:Body fld:Qn,0
4216,Bacteria identified,Bacteria identified^^^5:Prid:Pt:Bone:Nom:Aerobic culture,0
4217,Chaetomium globosum Ab.IgG,Chaetomium globosum Ab.IgG:ACnc:Pt:Ser:Qn,0
4218,Rickettsia rickettsii IgM,Rickettsia rickettsii Ab.IgM:ACnc:Pt:CSF:Qn,0
4219,Fungus colony count,Fungus colony count:NCnc:Pt:XXX:Qn:Culture,0
4220,Aminolevulinate,Delta aminolevulinate:MRat:24H:Urine:Qn,0
4221,Salmonella Pullorum Ab,Salmonella pullorum Ab:PrThr:Pt:Ser:Ord,0
4222,Mycoplasma mycoides subspecies mycoides small colony Ab,Mycoplasma mycoides subspecies mycoides small colony Ab:PrThr:Pt:Ser:Ord:Aggl,0
4223,Anticonvulsants,Anticonvulsants:Prid:Pt:Urine:Nom,0
4224,Bacteria identified,Bacteria identified:Prid:Pt:Wound.shlw:Nom:Aerobic culture,0
4225,Gradient 2.mean,Gradient 2.mean:Pres:Pt:Circulatory system.XXX:Qn:US+Calculated,0
4226,Dicloxacillin,Dicloxacillin:Susc:Pt:Isolate:Qn:MLC,0
4227,Followup&recurrent&death battery,Deprecated Followup&recurrent&death battery,0
4228,Caprine arthritis encephalitis virus antibody,Caprine arthritis encephalitis virus Ab:PrThr:Pt:Milk:Ord,0
4229,Myxoma virus Ab,Myxoma virus Ab:Titr:Pt:Ser:Qn:IF,0
4230,Airway resistance,Resistance.airway:FldResist:Stdy^mean:Respiratory system.airway:Qn:Plethysmograph.body box,0
4231,Keratin-19,Cytokeratin 19:ACnc:Pt:Ser/Plas:Qn,0
4232,mucinous carcinoma-associated antigen,Mucin-like carcinoma associated Ag:ACnc:Pt:Plr fld:Qn,0
4233,p-Hydroxyamphetamine,Para hydroxyamphetamine:PrThr:Pt:Urine:Ord:Screen,0
4234,Stroke volume/Body surface area,Stroke volume/Body surface area:ArVol:Pt:Heart.ventricle.left:Qn:US.2D.LVOT area.calculated,0
4235,CCR5 gene mutations tested for,CCR5 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen,0
4236,Trichinella spiralis antibody,Trichinella spiralis Ab:Titr:Pt:Ser:Qn,0
4237,apramycin,Apramycin:Susc:Pt:Isolate:OrdQn,0
4238,Secobarbital cutoff,Secobarbital cutoff:MCnc:Pt:Urine:Qn:Screen,0
4239,Filling period.diastole,Filling period.diastole:Time:Pt:Heart.atrium.right:Qn:US.measured,0
4240,Borrelia burgdorferi IgG,Borrelia burgdorferi Ab.IgG:ACnc:Pt:Body fld:Qn:IA,0
4241,Hydrogen/Expired gas,Hydrogen/Expired gas^3.5H post dose glucose:VFr:Pt:Exhl gas:Qn,0
4242,Phenytoin,Phenytoin:MCnc:Pt:Urine:Qn,0
4243,Phosphatidylethanolamine Ab.IgM,Phosphatidylethanolamine Ab.IgM:PrThr:Pt:Ser:Ord,0
4244,Deoxyhemoglobin/Hemoglobin.total,Deoxyhemoglobin/Hemoglobin.total:MFr:Pt:BldC:Qn,0
4245,Cusp separation.max,Cusp separation.max:Len:Pt:Aortic valve:Qn:US,0
4246,Amphetamines cutoff,Amphetamines cutoff:MCnc:Pt:Urine:Qn:Confirm,0
4247,"Estrone, unconjugated",Estrone.unconjugated:MCnc:Pt:Amnio fld:Qn,0
4248,Duck hepatitis virus 3 Antigen,Duck hepatitis virus 3 Ag:PrThr:Pt:XXX:Ord:IF,0
4249,Eastern equine encephalitis virus Ag,Eastern equine encephalitis virus Ag:PrThr:Pt:Brain:Ord:Comp fix,0
4250,Porcine reproductive and respiratory syndrome virus antibody,Porcine reproductive and respiratory syndrome virus Ab:PrThr:Pt:Ser:Ord:Comp fix,0
4251,Feline herpesvirus 1 DNA,Feline herpesvirus 1 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
4252,PR interval feature,PR interval:Time:Pt:Lead V5:Qn:EKG,0
4253,QT interval feature (observable entity),QT interval:Time:Pt:Lead II:Qn:EKG,0
4254,benzodiazepines positive,Benzodiazepines positive:Prid:Pt:Urine:Nom:Confirm,0
4255,Opiates screen method,Opiates screen method:Prid:Pt:Urine:Nom:*,0
4256,Cuminum cyminum Ab.IgE.RAST class,Cuminum cyminum Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4257,Gauchers disease type 1 gene mutations tested for,Gauchers disease type 1 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen,0
4258,Brucella canis IgG,Brucella canis Ab.IgG:Titr:Pt:Ser:Qn,0
4259,Methionine/Creatinine,Methionine/Creatinine:SRto:Pt:Urine:Qn,0
4260,Rift valley fever virus Ab,Rift valley fever virus Ab:Titr:Pt:Ser:Qn,0
4261,Feline leukemia virus Ab,Feline leukemia virus Ab:Titr:Pt:Ser:Qn:Neut,0
4262,Carnosine,Carnosine:PrThr:Pt:Urine:Ord,0
4263,Chlorpyrifos,Chlorpyrifos:MCnc:Pt:Urine:Qn,0
4264,Streptococcus pneumoniae antibody,Streptococcus pneumoniae Ab:ACnc:Pt:Ser:Qn,0
4265,Procainamide,Procainamide:MCnc:Pt:Urine:Qn,0
4266,ST amplitude.J point+80 ms,ST amplitude.J point+80 ms:Elpot:Pt:Lead V1:Qn:EKG,0
4267,Thiazides confirm method,Thiazides confirm method:Prid:Pt:Urine:Nom:*,0
4268,Tidal volume.expired/Pressure.plateau,Tidal volume.expired/Pressure.plateau^post 1.5-2.0 s inspiratory hold on ventilator:Compli:Pt:Respiratory system:Qn,0
4269,Mycobacterium avium complex rRNA,Mycobacterium avium complex rRNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
4270,Estriol,Estriol.unconjugated^^adjusted:MoM:Pt:Ser/Plas:Qn,0
4271,Chlamydia trachomatis IgM,Chlamydia trachomatis Ab.IgM:ACnc:Pt:CSF:Qn,0
4272,GD1b IgG ganglioside antibody,Ganglioside GD1b Ab.IgG:Titr:Pt:CSF:Qn:IA,0
4273,Aspergillus fumigatus Ab.IgG.RAST class,Aspergillus fumigatus Ab.IgG.RAST class:PrThr:Pt:Ser:Ord,0
4274,Rheumatoid arthritis nuclear antibody,Rheumatoid arthritis nuclear Ab:PrThr:Pt:Ser:Ord,0
4275,Amylase/Creatinine renal clearance,Amylase/Creatinine renal clearance:Ratio:24H:Urine+Ser/Plas:Qn,0
4276,Segmental wall motion,Segmental wall motion:Find:Pt:Heart.ventricle.left.basal septum:Ord:US,0
4277,Minor axis.papillary level.systole,Minor axis.papillary level.systole:Area:Pt:Heart.ventricle.left:Qn:US.2D,0
4278,Breaths.spontaneous,Breaths.spontaneous^on ventilator:NRat:Pt:Respiratory system:Qn,0
4279,Functional Residual Capacity,Capacity.functional residual:Vol:Pt:Respiratory system:Qn:Helium single breath,0
4280,Follicle Stimulating Hormone,Follitropin^45M post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn,0
4281,SERPINA1 gene targeted mutation analysis,SERPINA1 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN,0
4282,Coxsackievirus A21 Ab,Coxsackievirus A21 Ab:Titr:Pt:Ser:Qn,0
4283,Bicarbonates,Bicarbonate:SCnc:Pt:XXX:Qn,0
4284,Spotted fever group rickettsia antibody,Rickettsia spotted fever group Ab:PrThr:Pt:Ser:Ord:IF,0
4285,Cerebroside-Sulfatase,Deprecated Cerebroside sulfatase [Enzymatic activity/mass] in Tissue,0
4286,Chlamydia species antigen,Chlamydia sp Ag:PrThr:Pt:Urine:Ord,0
4287,End-systolic volume,End-systolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane ellipse method,0
4288,Anserine,Anserine:MCnc:Pt:Ser/Plas:Qn,0
4289,aprobarbital,Aprobarbital:PrThr:Pt:Urine:Ord:Screen,0
4290,aprobarbital,Aprobarbital:PrThr:Pt:Urine:Ord:Confirm,0
4291,Carbon Dioxide,Carbon dioxide:PPres:8H^max:BldC:Qn:Transcutaneous CO2 monitor,0
4292,Vitis vinifera Ab.IgG.RAST class,Vitis vinifera Ab.IgG.RAST class:PrThr:Pt:Ser:Ord,0
4293,TP53 gene targeted mutation analysis,TP53 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
4294,Foot and mouth disease virus serotype,Foot and mouth disease virus serotype:Prid:Pt:Tiss:Nom:IA,0
4295,Stimulant,Stimulants:Prid:Pt:Ser/Plas:Nom,0
4296,pyridoxine,Pyridoxine:PrThr:Pt:Bld:Ord,0
4297,Prealbumin,Prealbumin:MCnc:Pt:Ser/Plas:Qn:Electrophoresis,0
4298,Meprobamate,Meprobamate:MCnc:Pt:Gast fld:Qn,0
4299,View,Views^W contrast IS:Find:Pt:Lower extremity.bilateral>Knee:Doc:RF,0
4300,Dermatophagoides pteronyssinus Ab.IgG4,Dermatophagoides pteronyssinus Ab.IgG4:ACnc:Pt:Ser:Qn,0
4301,Osmolality,Osmolality:Osmol:Pt:Urine:Qn,0
4302,alpha-hydroxyalprazolam,Alpha hydroxyalprazolam:MCnt:Pt:Stool:Qn,0
4303,Interleukin 2 Receptor,Interleukin 2 receptor:MCnc:Pt:Ser/Plas:Qn,0
4304,Horse meat Ab.IgE.RAST class,Horse meat Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4305,HLA-B27 Antigen,HLA-B27:PrThr:Pt:Bld/Tiss:Ord:Probe.amp.tar,0
4306,Thyroxine uptake,Deprecated Thyroxine (T4) uptake [Mass/volume] in Serum or Plasma,0
4307,Views 4,Views 4:Find:Pt:Lower extremity>Knee:Doc:XR,0
4308,Multisection,Multisection:Find:Pt:Pelvis:Doc:US,0
4309,Niacinamide,Nicotinamide:SCnc:Pt:Ser/Plas:Qn,0
4310,View,Views^W contrast IS:Find:Pt:Upper extremity.left>Shoulder:Doc:RF,0
4311,meat fibers,Meat fibers:Naric:Pt:Stool:Qn:Microscopy.light,0
4312,Glucose,Glucose^3.6H post dose glucose:SCnc:Pt:Ser/Plas:Qn,0
4313,Bluetongue virus 2 Ab,Bluetongue virus 2 Ab:ACnc:Pt:Ser:Qn,0
4314,Burkholderia pseudomallei IgG,Burkholderia pseudomallei Ab.IgG:ACnc:Pt:XXX:Qn,0
4315,Sodium,Sodium:Sub:XXX:Urine:Qn,0
4316,Pascopyrum smithii Ab.IgE,Pascopyrum smithii Ab.IgE:ACnc:Pt:Ser:Qn,0
4317,(Citharexylum caudatum+Juniperus monosperma+Juniperus scopulorum) Ab.IgE,(Citharexylum caudatum+Juniperus monosperma+Juniperus scopulorum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk,0
4318,Progesterone,Progesterone^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
4319,Glucose,Glucose^3H post dose glucose:PrThr:Pt:Urine:Ord:Test strip,0
4320,Cells.CD11b+CD56+/100 cells,Cells.CD11b+CD56+/100 cells:NFr:Pt:XXX:Qn,0
4321,Porphyrins,Porphyrins:PrThr:Pt:Urine:Ord,0
4322,Producer code,Producer code:Type:Pt:Contact lens.prescription.right:Nom,0
4323,zinc protoporphyrin,Protoporphyrin.zinc:PrThr:Pt:RBC:Ord,0
4324,Age,Age:Time:Pt:^Patient:Qn:Calculated,0
4325,Mercury,Mercury:MCnc:XXX:Urine:Qn,0
4326,View,Views^W contrast IA:Find:Pt:Abdomen>Adrenal artery.bilateral:Doc:RF.angio,0
4327,Chlamydia trachomatis D+K Ab.IgM,Chlamydia trachomatis D+K Ab.IgM:ACnc:Pt:Ser:Qn,0
4328,Coccidioides immitis antibody,Coccidioides immitis Ab:PrThr:Pt:Body fld:Ord,0
4329,Orosomucoid,Alpha-1-Acid glycoprotein:MCnc:Pt:Ser/Plas:Qn,0
4330,Lincomycin,Lincomycin:Susc:Pt:Isolate:Qn:MLC,0
4331,Cytomegalovirus DNA,Cytomegalovirus DNA:PrThr:Pt:CSF:Ord:Probe.amp.tar,0
4332,Glycosaminoglycans,Glycosaminoglycans:MCnc:Pt:Urine:Qn,0
4333,IgG.canine,IgG.canine:MCnc:Pt:Ser:Qn:Immune diffusion,0
4334,Multisection,Multisection^WO & W contrast IV:Find:Pt:Abdomen:Doc:MR,0
4335,Lactoglobulin Ab.IgE.RAST class,Lactoglobulin Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
4336,Rotavirus IgG,Rotavirus Ab.IgG:PrThr:Pt:Ser:Ord,0
4337,View,Deprecated Carpal bones - bilateral X-ray,0
4338,Legionella polyvalent A Ab,Legionella polyvalent A Ab:PrThr:Pt:Ser:Ord,0
4339,TRANSKETOLASE,Transketolase:CCnc:Pt:Ser:Qn,0
4340,Lymphocytes/100 leukocytes,Lymphocytes/100 leukocytes:NFr:Pt:Bld:Qn:Flow cytometry,0
4341,Blood Plasma Volume,Plasma volume:Vol:Pt:^Patient:Qn:Radnuc,0
4342,Equine influenza virus A1 Antigen,Equine influenza virus A1 Ag:ACnc:Pt:XXX:Qn,0
4343,Multisection,Multisection:Find:Pt:^Breast specimen:Doc:US,0
4344,Leucocyte esterase,Leukocyte esterase:CCnc:Pt:WBC:Qn,0
4345,Differential panel,Differential panel:-:Pt:Periton fld:-,0
4346,Heavy metals panel,Heavy metals panel:-:Pt:Urine:-,0
4347,Symptoms & diseases,History of symptoms & diseases:Finding:Point in time:^Patient:Narrative:Observed,0
4348,Erythroblasts,Erythrocytes.nucleated:NCnc:Pt:Bld:Qn,0
4349,Mesothelial cells/100 leukocytes,Mesothelial cells/100 leukocytes:NFr:Pt:Pericard fld:Qn,0
4350,Type - attribute,Type:ID:Pt:Vaccine:Nom,0
4351,Body Weight,Body weight:Mass:Pt:^Patient:Qn:Measured,0
4352,Fucosidase,Alpha fucosidase:CCnt:Pt:Fibroblasts:Qn,0
4353,Follicle Stimulating Hormone,Follitropin^7th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn:2nd IRP,0
4354,Glucose,Glucose^45M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
4355,Methemoglobin/Hemoglobin.total,Methemoglobin/Hemoglobin.total:MFr:Pt:BldV:Qn,0
4356,Pressure device type,Pressure device type:Type:Point in time:*:Nominal:Perimetry,0
4357,Viral susceptibility panel,Viral susceptibility panel:-:Point in time:Isolate:Quantitative or Ordinal,0
4358,CYP21A2 gene targeted mutation analysis,CYP21A2 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN,0
4359,Abnormal monocytes,Monocytes.abnormal:NCnc:Pt:Bld:Qn,0
4360,myeloblast,Myeloblasts:NCnc:Pt:Bld:Qn,0
4361,View,Views^W contrast IV:Find:Pt:Chest+Abdomen>Vena cava.superior &or Vena cava.inferior:Doc:RF.angio,0
4362,View,Deprecated Views:Finding:Point in time:Wrist:Narrative:XR,0
4363,hydrastine,Hydrastine:PrThr:Pt:Ser/Plas:Ord,0
4364,Physical findings,Physical findings:Find:Pt:Anterior chamber.left:Nar,0
4365,Mareks disease virus Ag,Mareks disease virus Ag:PrThr:Pt:Feather:Ord,0
4366,Guidance for radiosurgery,Guidance for radiosurgery:Find:Pt:XXX:Doc:CT,0
4367,Isoleucine,Isoleucine:MCnc:Pt:Urine:Qn,0
4368,Parvovirus B19 IgG,Parvovirus B19 Ab.IgG:Titr:Pt:Ser:Qn:IF,0
4369,Morphine.free,Morphine.free:MCnc:Pt:Vitr fld:Qn,0
4370,Growth Hormone,Somatotropin^23rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
4371,bromodiphenhydramine,Bromodiphenhydramine:MCnc:Pt:Ser/Plas:Qn,0
4372,carbinoxamine,Carbinoxamine:MCnc:Pt:Ser/Plas:Qn,0
4373,Neutrophil cytoplasmic Ab.classic,Neutrophil cytoplasmic Ab.classic:PrThr:Pt:Ser:Ord,0
4374,View,Views^W contrast PO:Find:Pt:Chest>Esophagus:Doc:RF,0
4375,Multisection,Multisection:Find:Pt:Upper extremity.right>Forearm:Doc:MR,0
4376,Cannabinoids,Cannabinoids:ACnc:Pt:Urine:Qn,0
4377,cocaethylene,Cocaethylene:MCnc:Pt:Ser/Plas:Qn,0
4378,Cells.CD33+HLA-DR+/100 cells,Cells.CD33+HLA-DR+/100 cells:NFr:Pt:Bld:Qn,0
4379,Yersinia sp identified,Yersinia sp identified:Prid:Pt:Stool:Nom:Organism specific culture,0
4380,Echovirus+Coxsackievirus Ab.IgA,Echovirus+Coxsackievirus Ab.IgA:PrThr:Pt:Ser:Ord,0
4381,Acetylcholinesterase,Acetylcholinesterase:PrThr:Pt:Amnio fld:Ord,0
4382,Triiodothyronine.true,Triiodothyronine.true:MCnc:Pt:Ser/Plas:Qn,0
4383,Rabies virus antibody,Rabies virus Ab:PrThr:Pt:Ser:Ord,0
4384,Cannabinoids,Cannabinoids:PrThr:Pt:Meconium:Ord:Screen,0
4385,PM-SCL extractable nuclear antibody,PM-SCL extractable nuclear Ab:PrThr:Pt:Ser:Ord,0
4386,Powassan virus IgG,Powassan virus Ab.IgG:ACnc:Pt:XXX:Qn,0
4387,Coagulation factor V inhibitor,Coagulation factor V inhibitor:ACnc:Pt:PPP:Qn:Coag,0
4388,View,Views:Finding:Point in time:Foot:Narrative:XR,0
4389,Cell positive for CD23 antigen,Cells.CD23:NCnc:Pt:Bld:Qn,0
4390,Amikacin 12.0 ug/mL,Amikacin 12.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria,0
4391,Lathyrus sativus Ab.IgE,Deprecated Blue vetch IgE Ab [Units/volume] in Serum,0
4392,Chlorphentermine,Chlorphentermine:MCnc:Pt:Vitr fld:Qn,0
4393,phosphoethanolamine,Phosphoethanolamine:MCnc:Pt:Urine:Qn,0
4394,2-Oxoadipate/Creatinine,2-Oxoadipate/Creatinine:Ratio:Pt:Urine:Qn,0
4395,Multisection,Multisection:Find:Pt:Abdomen>Liver:Doc:US,0
4396,Lymphocytes.kappa,Lymphocytes.kappa:NCnc:Pt:Bld:Qn,0
4397,Colony count,Colony count:NCnc:Pt:Dial fld:Qn,0
4398,Orientia tsutsugamushi IgG,Orientia tsutsugamushi Ab.IgG:ACnc:Pt:Ser:Qn,0
4399,Multisection,Multisection:Find:Pt:Lower extremity>Hip:Doc:US,0
4400,Kanamycin 30.0 ug/mL,Kanamycin 30.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria,0
4401,Ammonia,Ammonia:SCnc:24H:Urine:Qn,0
4402,Methylmalonate,Methylmalonate:MCnc:Pt:Ser/Plas:Qn,0
4403,Guidance for placement of large bore central venous catheter,Guidance for placement of large bore central venous catheter:Find:Pt:XXX>Vein.left:Doc:{Imaging modality},0
4404,Phosphofructokinase.F subunit/Phosphofructokinase.total,Phosphofructokinase.F subunit/Phosphofructokinase.total:CFr:Pt:Platelets:Qn,0
4405,Note (document),Note:Find:Pt:{Setting}:Doc:Social worker,0
4406,Zinc,Zinc:MCnt:Pt:Nail:Qn,0
4407,Mycoplasma pneumoniae DNA,Mycoplasma pneumoniae DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
4408,Collection Time,Collection time:TmStp:Pt:Bld:Qn,0
4409,Heterophils/100 leukocytes,Heterophils/100 leukocytes:NFr:Pt:Bld:Qn,0
4410,Multisection,Multisection^WO contrast:Find:Pt:Lower extremity:Doc:CT,0
4411,heart rate,Heart rate^10M post birth:Fcn:Pt:^Patient:Ord:Apgar,0
4412,Specimen volume,Specimen volume:Vol:72H:Stool:Qn,0
4413,Ethambutol,Ethambutol:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
4414,Cefixime,Cefixime:MCnc:Pt:XXX:Qn,0
4415,Guidance for percutaneous biopsy.core needle,Guidance for percutaneous biopsy.core needle:Find:Pt:Breast.left:Doc:MG,0
4416,Borrelia burgdorferi 41kD Ab,Deprecated Borrelia burgdorferi 41kD Ab [Presence] in Serum by Immunoblot (IB),0
4417,Fibrinogen fragments,Fibrinogen fragments:MCnc:Pt:PPP:Qn:LA,0
4418,Axis,Axis:Angle:Pt:Eye.left:Qn:Autorefractor.man,0
4419,Refraction comment,Refraction comment:Imp:Pt:Eye:Nar:Autorefractor.auto,0
4420,Narcotics,Narcotics:Presence or Identity:Point in time:Bil fld:Nominal,0
4421,View,Views^W contrast IS:Find:Pt:Lower extremity>Knee:Doc:RF,0
4422,Views AP,View AP^W standing:Find:Pt:Lower extremity>Knee:Doc:XR,0
4423,View,Deprecated Liver and Spleen NM W Tc-99m calcium colloid IV,0
4424,Streptococcus pneumoniae 19 Ab.IgG,Deprecated Streptococcus pneumoniae 19 IgG Ab [Units/volume] in Serum --1st specimen,0
4425,Measles virus IgG,Measles virus Ab.IgG^1st specimen/2nd specimen:Ratio:Pt:Ser:Qn,0
4426,Isoleucine,Isoleucine:SCnc:24H:Urine:Qn,0
4427,Magnesium,Magnesium:SCnc:Pt:CSF:Qn,0
4428,Angioplasty,Deprecated Brachiocephalic artery - bilateral Fluoroscopic angiogram Angioplasty W contrast IA,0
4429,Myelin Basic Proteins,Myelin basic protein:MCnc:Pt:CSF:Qn,0
4430,Axis degree N 1,Axis degree N 1:Angle:Pt:Eye.right:Qn:Phoropter,0
4431,Thyrotropin-Releasing Hormone,Thyrotropin releasing hormone:MCnc:Pt:Plas:Qn,0
4432,Valine,Valine:MCnc:Pt:Ser/Plas:Qn,0
4433,Vibrio cholerae antibody,Vibrio cholerae Ab:ACnc:Pt:Ser:Qn,0
4434,factor VII clotting antigen,Coagulation factor VII Ag:ACnc:Pt:PPP:Qn:IA,0
4435,Obstetric 1996 panel,Obstetric 1996 panel:-:Pt:Ser+Bld:-,0
4436,Multisection,Multisection:Find:Pt:Head+Neck>Nasopharynx & Neck:Doc:CT,0
4437,View,Views^W barium contrast PO:Find:Pt:Abdomen>Gastrointestinal tract.upper+Small bowel:Doc:RF,0
4438,Lysine/Amino acids.total,Lysine/Amino acids.total:SFr:Pt:Ser/Plas:Qn,0
4439,Mannitol/Creatinine,Mannitol/Creatinine:SRto:Pt:Urine:Qn,0
4440,Lipoprotein-X,Lipoprotein.X:PrThr:Pt:Ser/Plas:Ord,0
4441,Nidus,Nidus:Mass:Pt:Calculus:Qn,0
4442,Prekallikrein,Prekallikrein:MCnc:Pt:PPP:Qn,0
4443,Glutamate/Amino acids.total,Glutamate/Amino acids.total:SFr:Pt:Bld.dot:Qn,0
4444,Glutamate/Amino acids.total,Glutamate/Amino acids.total:SFr:Pt:XXX:Qn,0
4445,Phenylalanine/Amino acids.total,Phenylalanine/Amino acids.total:SFr:Pt:XXX:Qn,0
4446,Pipecolate/Creatinine,Pipecolate/Creatinine:SRto:Pt:Urine:Qn,0
4447,HLA-B61(40),HLA-B61(40):PrThr:Pt:Bld/Tiss^Donor:Ord,0
4448,Stanozolol,Stanozolol:MCnc:Pt:Urine:Qn,0
4449,Nicotine,Nicotine:PrThr:Pt:Gast fld:Ord,0
4450,Alprenolol,Alprenolol:Mass:Pt:Dose:Qn,0
4451,Manganese,Manganese:SCnc:Pt:Urine:Qn,0
4452,Adenovirus antibody (substance),Adenovirus Ab:PrThr:Pt:Ser:Ord,0
4453,Tocainide,Tocainide:Mass:Pt:Dose:Qn,0
4454,Glucose,Glucose^2.5H post 50 g lactose PO:SCnc:Pt:Ser/Plas:Qn,0
4455,Monomeric prolactin,Deprecated Prolactin monomeric [Mass/volume] in Serum or Plasma,0
4456,Thyrotropin,Thyrotropin^pre dose triple bolus:ACnc:Pt:Ser/Plas:Qn,0
4457,Thioguanine,6-Thioguanine:PrThr:Pt:RBC:Ord,0
4458,alpha-hydroxyglutarate,2-Hydroxyglutarate:PrThr:24H:Urine:Ord,0
4459,Lymphocyte proliferation. 5 ug concanavalin A stimulation,Lymphocyte proliferation. 5 ug concanavalin A stimulation:NRat:Pt:Bld:Qn,0
4460,HLA-B35 Antigen,Deprecated HLA-B35 [Presence] in Blood,0
4461,Liver kidney microsomal 1 Ab.IgG,Liver kidney microsomal 1 Ab.IgG:ACnc:Pt:Ser:Qn:IA,0
4462,Guidance for biopsy.needle,Deprecated CT Guidance for needle biopsy of Abdomen,0
4463,View,Views^W flexion + W extension:Find:Pt:XXX>Spine:Doc:XR,0
4464,Ouabain,Ouabain:Mass:Pt:Dose:Qn,0
4465,Multisection perfusion qualitative,Multisection perfusion qualitative^at rest+W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM.SPECT,0
4466,von Willebrand factor,von Willebrand factor.ristocetin cofactor:ACnc:Pt:PPP:Qn,0
4467,clostebol,Clostebol:Mass:Pt:Dose:Qn,0
4468,Haloperidol,Haloperidol:Mass:Pt:Dose:Qn,0
4469,Cells.CD4+CD7+/100 cells,Cells.CD4+CD7+/100 cells:Number Fraction:Point in time:Whole blood:Quantitative,0
4470,Oxazepam,Oxazepam:Mass:Pt:Dose:Qn,0
4471,Sickle Hemoglobin,Deprecated Hemoglobin S/Hemoglobin.total in Blood,0
4472,Views GE 3,Views GE 3:Find:Pt:Upper extremity.right>Hand:Doc:XR,0
4473,flunisolide,Flunisolide:MCnc:Pt:Ser/Plas:Qn,0
4474,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free:MRto:Pt:Urine:Qn,0
4475,Bordetella pertussis IgM,Bordetella pertussis Ab.IgM:ACnc:Pt:Ser:Qn:IA,0
4476,Avian reovirus Ab,Avian reovirus Ab:PrThr:Pt:Ser:Ord:IF,0
4477,Clenbuterol,Clenbuterol:MCnc:Pt:Urine:Qn,0
4478,Thioridazine,Thioridazine:MCnc:Pt:Ser/Plas:Qn,0
4479,Cells.CD3+CD16+/100 cells,Cells.CD3-CD16+/100 cells:Number Fraction:Point in time:Marrow (bone):Quantitative,0
4480,Yeasts,Yeast:Naric:Pt:Body fld:Qn:Microscopy.light.HPF,0
4481,tigecycline,Tigecycline:Susc:Pt:Isolate:OrdQn:MIC,0
4482,Methylphenidate,Methylphenidate:Mass:Pt:Dose:Qn,0
4483,4-hydroxybenzoate,4-Hydroxybenzoate:PrThr:24H:Urine:Ord,0
4484,Human papillomavirus DNA,Human papilloma virus DNA:PrThr:Pt:XXX:Ord:Probe.amp.sig,0
4485,Pseudoephedrine,Pseudoephedrine:MCnc:Pt:Urine:Qn,0
4486,Calcium,Calcium^4H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
4487,Vancomycin,Vancomycin^random:MCnc:Pt:Ser/Plas:Qn,0
4488,Multisection,Multisection^WO contrast:Find:Pt:Abdomen>Superior mesenteric vessels:Doc:MR.angio,0
4489,ECOG performance status grade,Deprecated ECOG performance status grade Observed,0
4490,Ibuprofen,Ibuprofen:Mass:Pt:Dose:Qn,0
4491,Spermatozoa IgM binding location,Spermatozoa IgM binding location:Prid:Pt:Semen:Nom,0
4492,Views GE 3,Views GE 3:Find:Pt:Upper extremity>Wrist:Doc:XR,0
4493,Legionella pneumophila 11 IgM,Legionella pneumophila 11 Ab.IgM:Titr:Pt:Ser:Qn,0
4494,Multisection,Multisection^W In-111 Satumomab IV:Find:Pt:Pelvis>Prostate:Doc:NM.SPECT,0
4495,Views 1 or 2,Views 1 or 2:Find:Pt:Lower extremity>Knee:Doc:XR,0
4496,Immunoglobulin G antigen,IgG Ag:PrThr:Pt:Skin:Ord:IF,0
4497,Monoclonal IgG,IgG.monoclonal:PrThr:Pt:CSF:Ord:Immunofixation,0
4498,Adenosine monophosphate.cyclic/Creatinine,Adenosine monophosphate.cyclic/Creatinine^4H post XXX challenge:Ratio:Pt:Urine:Qn,0
4499,Ofloxacin 2.0 ug/mL,Ofloxacin 2.0 ug/mL:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Slow-growing Mycobacteria,0
4500,Bacteria,Bacteria:PrThr:Pt:Cvx:Ord:Wet preparation,0
4501,Bacteria,Bacteria:PrThr:Pt:Vag:Ord:Wet preparation,0
4502,Propranolol,Propranolol:Mass:Pt:Dose:Qn,0
4503,Urease,Urease^4H post incubation:PrThr:Pt:Tiss:Ord,0
4504,Secobarbital,Secobarbital:Mass:Pt:Dose:Qn,0
4505,Influenza A virus H5 RNA,Influenza virus A H5 RNA:ACnc:Pt:XXX:Qn:Probe.amp.tar,0
4506,Glucose,Glucose^18H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
4507,Glucose,Glucose^3M pre XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
4508,Zinc,Zinc:PrThr:Pt:Urine:Ord,0
4509,Vendor serial number,Vendor serial number:ID:Pt:Oxygen saturation device:Nom,0
4510,Clomipramine,Clomipramine:Mass:Point in time:Dose med or substance:Quantitative,0
4511,Insulin,Insulin^pre 100 g glucose PO:MCnc:Pt:Ser/Plas:Qn,0
4512,Histoplasma capsulatum antigen,Histoplasma capsulatum Ag:PrThr:Pt:Urine:Ord:IA,0
4513,Bartonella henselae & Bartonella quintana Ab.IgG & IgM panel,Bartonella henselae & Bartonella quintana Ab.IgG & IgM panel:-:Pt:Ser:-,0
4514,Bilirubin,Bilirubin:PrThr:Pt:Body fld:Ord,0
4515,Phenytoin,Phenytoin:PrThr:Pt:XXX:Ord,0
4516,Arsenic.inorganic/Creatinine,Arsenic.inorganic/Creatinine:MRto:24H:Urine:Qn,0
4517,Chlamydia trachomatis rRNA,Deprecated Chlamydia trachomatis rRNA [Presence] in Cervix by DNA probe,0
4518,Chlamydia species antigen,Deprecated Chlamydia sp Ag [Presence] in Penis,0
4519,Ergocalciferol,Calciferol:SCnc:Pt:Ser/Plas:Qn,0
4520,ADENOSINE DEAMINASE,Adenosine deaminase:EntCat:Pt:WBC:Qn,0
4521,Vendor software version,Vendor software version:ID:Pt:Pedometer device:Nom,0
4522,tipranavir,Tipranavir:Susc:Pt:Isolate:OrdQn,0
4523,Salmonella enterica subspecies enterica serovar Paratyphi C O antibody,Salmonella paratyphi C O Ab:Titr:Pt:Ser:Qn,0
4524,Citrulline/Creatinine,Citrulline/Creatinine:MRto:24H:Urine:Qn,0
4525,Vesicular stomatitis Indiana virus Ag,Vesicular stomatitis Indiana virus Ag:PrThr:Pt:XXX:Ord:Comp fix,0
4526,Hemoglobin Hope,Hemoglobin Hope:PrThr:Pt:Bld:Ord:Electrophoresis pH 6.3,0
4527,Promyelocytes/100 leukocytes,Promyelocytes/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count,0
4528,"Surgery of other regional site(s), distant site(s), or distant lymph node(s) at this facility 98-02","Surgery of other regional site(s), distant site(s), or distant lymph node(s) at this facility 98-02:Prid:Pt:Cancer.XXX:Nom",0
4529,View,View:Find:90M:XXX:Doc:RF,0
4530,Views GE 3,Views GE 3:Find:Pt:Upper extremity.left>Thumb:Doc:XR,0
4531,Carbonyl hemoglobin/Hemoglobin.total,Deprecated Carboxyhemoglobin/Hemoglobin.total in Blood,0
4532,"3,4-methylenedioxyethamphetamine",Methylenedioxyethylamphetamine:MCnc:Pt:Urine:Qn:Confirm,0
4533,Phenylalanine hydroxylase Ab,Phenylalanine hydroxylase Ab:ACnc:Pt:Ser:Qn,0
4534,Norepinephrine,Norepinephrine^5th specimen post XXX challenge:SCnc:Pt:Urine:Qn,0
4535,Campylobacter sp Ab.IgA,Campylobacter sp Ab.IgA:PrThr:Pt:Ser:Ord,0
4536,thyrotropin alfa,Thyrotropin.alpha subunit:MCnc:Pt:Ser/Plas:Qn,0
4537,Special use section,Special use section:-:Point in time:^Patient:Set:NAACCR v.11,0
4538,Toxoplasma gondii antibody,Deprecated Toxoplasma gondii Ab [Presence] in Serum by Latex agglutination,0
4539,Arsenic,Arsenic:MCnc:Pt:Dial fld:Qn,0
4540,Human immunodeficiency virus 1 RNA,HIV 1 RNA:LnCnc:Pt:Ser/Plas:Qn:Probe.amp detection limit = 1.9 log copies/mL,0
4541,Comorbidities and complications 7,Comorbidities and complications 7:Presence or Identity:Point in time:^Patient:Nominal,0
4542,Comorbidities and complications 10,Comorbidities and complications 10:Presence or Identity:Point in time:^Patient:Nominal,0
4543,Views GE 5,Views GE 5:Find:Pt:Head>Skull:Doc:XR,0
4544,Selenium/Creatinine,Selenium/Creatinine:SRto:24H:Urine:Qn,0
4545,Treponema pallidum IgM,Treponema pallidum Ab.IgM:PrThr:Pt:Ser:Ord:IA,0
4546,Cells.CD23+CD38+,Cells.CD23+CD38+:NCnc:Pt:Bld:Qn,0
4547,Multisection limited,Multisection limited:Find:Pt:Chest:Doc:CT,0
4548,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity>Wrist:Doc:MR,0
4549,Oxymetholone,Oxymetholone:MRat:24H:Urine:Qn,0
4550,Multisection,Multisection:Find:Pt:Abdomen+Pelvis>Iliac vessels:Doc:US.doppler,0
4551,Views first pass,Views first pass^at rest+W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM,0
4552,Amino Acids,Amino acids:Presence or Identity:Point in time:Cerebral spinal fluid:Nominal,0
4553,Cholesterol,Cholesterol [Mass or Molecules/volume] in Serum or Plasma,0
4554,Norclomipramine,Norclomipramine:MCnc:Pt:Ser/Plas:Qn:Screen,0
4555,Cryptosporidium species antigen,Cryptosporidium sp Ag:PrThr:Pt:Stool:Ord:IF,0
4556,Views 2 phase,Views 2 phase^W radionuclide IV:Find:Pt:XXX>Bone:Doc:NM,0
4557,Hepatitis C virus Ab.IgG band pattern,Hepatitis C virus Ab.IgG band pattern:Imp:Pt:Ser:Nom:IB,0
4558,Platelets.large,Platelets.large:PrThr:Pt:Bld:Ord:Automated count,0
4559,Spermatozoa.immotile,Spermatozoa.immotile:NCnc:Pt:Semen:Qn,0
4560,Multisection,Multisection^WO contrast:Find:Pt:Pelvis>Sacrum:Doc:CT,0
4561,Multisection,Multisection^WO contrast:Find:Pt:Abdomen+Pelvis:Doc:CT,0
4562,HLA-B locus,human histocompatibility complex derived antigens-B locus:Type:Point in time:Whole blood:Nominal,0
4563,Spermatozoa.tail.motile with IgA/100 spermatozoa,Spermatozoa.tail.motile with IgA/100 spermatozoa:NFr:Pt:Semen:Qn:Immunobead,0
4564,Multisection for transplanted kidney,Multisection for transplanted kidney:Find:Pt:Pelvis:Doc:US,0
4565,Multisection,Multisection^at rest+W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM.SPECT,0
4566,Clostridium botulinum,Clostridium botulinum:PrThr:Pt:Isolate:Ord:Organism specific culture,0
4567,salicylamide,Salicylamide^peak:MCnc:Pt:Ser/Plas:Qn,0
4568,butabarbital,Butabarbital:PrThr:Pt:Urine:Ord,0
4569,Multisection,Deprecated Calcaneus - left CT W contrast IV,0
4570,View axillary,View axillary:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:XR,0
4571,View Brewerton,View Brewerton:Find:Pt:Upper extremity.bilateral>Hand:Doc:XR,0
4572,Beryllium,Beryllium:MCnc:Pt:Air:Qn,0
4573,Minute volume setting,Minute volume setting:VRat:Pt:Ventilator:Qn,0
4574,Francisella tularensis IgA,Francisella tularensis Ab.IgA:Titr:Pt:Ser:Qn,0
4575,Androsterone,Androsterone:SCnc:24H:Urine:Qn,0
4576,Cadmium,Cadmium:SCnc:24H:Urine:Qn,0
4577,Urate,Urate [Mass or Molecules/volume] in 24 hour Urine,0
4578,Chlamydia sp DNA,Chlamydia sp DNA:PrThr:Pt:Anal:Ord:Probe.amp.tar,0
4579,View Stryker Notch,View Stryker Notch:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:XR,0
4580,Views 4,Views 4:Find:Pt:Head>Optic foramen:Doc:XR,0
4581,Views 2,Views 2:Find:Pt:Pelvis:Doc:XR,0
4582,Multisection,Multisection:Find:Pt:Pelvis>Penis vessels:Doc:US,0
4583,Wound irrigation &or cleaning fluid,Wound irrigation &or cleaning fluid:Type:Pt:Flu.nonbiological:Nom,0
4584,Hexacarboxylporphyrin,Hexacarboxylporphyrin:MRat:24H:Stool:Qn,0
4585,Cells counted.total,Cells counted.total:Num:Pt:Pericard fld:Qn,0
4586,Afipia felis IgM,Afipia felis Ab.IgM:PrThr:Pt:Ser:Ord,0
4587,Anti-ovarian antibody,Ovary Ab:Titr:Pt:Ser:Qn,0
4588,Surgical margin tumor involvement.mucosal,Surgical margin tumor involvement.mucosal:Find:Pt:Specimen:Nom:CAP cancer protocols,0
4589,dipipanone,Dipipanone:MCnc:Pt:Urine:Qn,0
4590,Views 2,Views 2:Find:Pt:Upper extremity.right>Acromioclavicular joint:Doc:XR,0
4591,Borrelia burgdorferi C6 Ab,Borrelia burgdorferi C6 Ab:ACnc:Pt:CSF:Qn:IA,0
4592,Herpes virus 6 IgM,Herpes virus 6 Ab.IgM:Titr:Pt:Ser:Qn,0
4593,Digoxin.free,Digoxin.free:MCnc:Pt:Ser/Plas:Qn,0
4594,Flupenthixol,Flupenthixol:MCnc:Pt:Ser/Plas:Qn,0
4595,Iodine/Creatinine,Iodine/Creatinine:SRto:Pt:Urine:Qn,0
4596,Chromosome Breakage,Chromosome breakage:ACnc:Pt:Bld:Qn:Diepoxybutane,0
4597,Disopyramide,Disopyramide:MCnc:Pt:Ser/Plas:Qn,0
4598,Cefixime,Cefixime:Susc:Pt:Isolate:OrdQn:Gradient strip,0
4599,Pain primary location,Pain primary location:Anat:Pt:*:Nom:Reported,0
4600,Coagulation factor X+Acarboxy Ag actual/Normal,Coagulation factor X+Acarboxy Ag actual/Normal:RelMCnc:Pt:PPP:Qn:IA,0
4601,Spermatozoa Ab.IgA,Spermatozoa Ab.IgA:PrThr:Pt:Semen:Ord,0
4602,Insulin,Insulin^2nd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,0
4603,Pregnanediol,Pregnanediol:SCnc:24H:Urine:Qn,0
4604,Note (document),Note:Find:Pt:{Setting}:Doc:Nephrology,0
4605,enrofloxacin,Enrofloxacin:Susc:Pt:Isolate:OrdQn:MIC,0
4606,gemifloxacin,Gemifloxacin:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
4607,grepafloxacin,Grepafloxacin:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
4608,Multisection,Multisection^W contrast IV:Find:Pt:Chest>Chest vessels:Doc:CT.angio,0
4609,Levorphanol,Levorphanol:MRat:24H:Urine:Qn,0
4610,C-Peptide,C peptide^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
4611,metacresol,M-cresol:MCnc:Pt:Air:Qn,0
4612,Multisection for infarct,Multisection for infarct^W Tc-99m PYP IV:Find:Pt:Chest>Heart:Doc:NM.SPECT,0
4613,Glutamine,Glutamine:SCnc:Pt:Vitr fld:Qn,0
4614,5-methyltetrahydrofolate,5-Methyltetrahydrofolate:PrThr:Pt:CSF:Ord,0
4615,Histamine,Histamine:SCnc:Pt:Urine:Qn,0
4616,Salmonella enterica subspecies enterica serovar Typhi O antibody,Salmonella typhi O Ab:Titr:Pt:Ser:Qn:Aggl,0
4617,Saccharopolyspora rectivirgula IgG,Saccharopolyspora rectivirgula Ab.IgG:PrThr:Pt:Ser:Ord:Immune diffusion,0
4618,Mitochondria M4 Ab,Mitochondria M4 Ab:PrThr:Pt:Ser:Ord,0
4619,Pristinamycin,Pristinamycin:Susc:Pt:Isolate:OrdQn:MIC,0
4620,Loxapine,Loxapine:PrThr:Pt:Urine:Ord,0
4621,View,Views^W contrast IA:Find:Pt:Chest>Subclavian artery.bilateral:Doc:RF.angio,0
4622,Views lateral,View lateral:Find:Pt:Lower extremity.right>Knee:Doc:XR,0
4623,View XCCL,View XCCL:Find:Pt:Breast.right:Doc:MG,0
4624,Phenylpropanolamine,Phenylpropanolamine:MRat:24H:Urine:Qn,0
4625,Views for abscess,Views for abscess^W Ga-67 IV:Find:Pt:XXX:Doc:NM,0
4626,Phoma betae Ab.IgG.RAST class,Phoma betae Ab.IgG.RAST class:PrThr:Pt:Ser:Ord,0
4627,Admission evaluation note,Admission evaluation note:Find:Pt:{Setting}:Doc:Surgery,0
4628,Note (document),Note:Find:Pt:{Setting}:Doc:Emergency medicine,0
4629,4-phenylenediamine,"1,4-Benzenediamine:MCnc:Pt:Air:Qn",0
4630,microscopic observation,Microscopic observation:Prid:Pt:XXX:Nom:Chloracetate esterase stain,0
4631,Prolactin,Prolactin^1H post 200 ug TRH IV:SCnc:Pt:Ser/Plas:Qn,0
4632,Urobilinogen,Urobilinogen:SCnc:Pt:Urine:Qn,0
4633,Herpes simplex virus identified,Herpes simplex virus identified:Prid:Pt:Penis:Nom:Organism specific culture,0
4634,Blasts/100 leukocytes,Blasts/100 leukocytes:NFr:Pt:Synv fld:Qn,0
4635,Glomerular filtration rate/1.73 sq M.predicted,Glomerular filtration rate/1.73 sq M.predicted:ArVRat:Pt:Ser/Plas:Qn:Creatinine-based formula (MDRD),0
4636,Giardia lamblia antigen,Giardia lamblia Ag:PrThr:Pt:Bil fld:Ord,0
4637,Multisection,Multisection:Find:Pt:Lower extremity.left>Hip:Doc:MR,0
4638,Views 3,Views 3:Find:Pt:Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx:Doc:XR,0
4639,Ova & parasites identified,Deprecated Microscopic observation [Identifier] in Stool by Ova & Parasite Preparation,0
4640,Human polyomavirus 1 DNA,BK virus DNA:PrThr:Pt:Ser/Plas:Ord:Probe.amp.tar,0
4641,Chlamydia sp Ab.IgG,Chlamydia sp Ab.IgG:ACnc:Pt:Ser:Qn:IA,0
4642,SPINK1 gene targeted mutation analysis,SPINK1 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NAR:MOLGEN,0
4643,Multisection,Multisection^WO & W contrast IV:Find:Pt:Abdomen>Spine.lumbar:Doc:CT,0
4644,Crystal Structure,Crystals:Prid:Pt:Pericard fld:Nom:Microscopy.light,0
4645,Multisection limited,Multisection limited:Find:Pt:Extremity>Extremity vessels:Doc:US.doppler,0
4646,pipradrol,Pipradrol:MRat:24H:Urine:Qn,0
4647,Normoblasts/100 leukocytes,Normoblasts/100 leukocytes:NFr:Pt:Bld:Qn,0
4648,View,Views^W contrast IA:Find:Pt:Head+Neck>Carotid artery:Doc:RF.angio,0
4649,C-Peptide,C peptide^30M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
4650,C-Peptide,C peptide^2.5H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
4651,Sodium,Sodium:SCnc:Pt:BldV:Qn,0
4652,Sella-nasion plane to nasion-A point line,Sella-nasion plane to nasion-A point line:Angle:Pt:Skull:Qn:CT.measured,0
4653,Impacted tooth,Tooth impaction:Finding:Point in time:{Tooth}:Nominal,0
4654,Cimetidine,Cimetidine:PrThr:Pt:Urine:Ord,0
4655,Monocytes,Monocytes:NCnc:Pt:Body fld:Qn,0
4656,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Knee vessels:Doc:MR.angio,0
4657,Collagen induced platelet aggregation,Platelet aggregation.collagen induced^high dose:RelACnc:Pt:PRP:Qn,0
4658,Information for patients section,Information for patients section:-:-:^FDA package insert:Nar,0
4659,Multisection,Multisection:Find:Pt:Pelvis>Scrotum+Testicle:Doc:MR,0
4660,Views 4,Views 4:Find:Pt:Head>Mastoid:Doc:XR,0
4661,Multisection,Multisection:Find:Pt:Chest>Lung parenchyma:Doc:CT,0
4662,Cells.CD14/100 cells,Cells.CD14/100 cells:NFr:Pt:Tiss:Qn,0
4663,Ristocetin induced platelet aggregation,Platelet aggregation.ristocetin induced^900 ug/mL:RelACnc:Pt:PRP:Qn,0
4664,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN","Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN:PrThr:Pt:Cancer specimen:Ord:Immune stain",0
4665,Stroke volume/Body surface area,Stroke volume/Body surface area:ArVol:Pt:Heart.ventricle.right:Qn:CT spiral,0
4666,Cholinesterases,Deprecated Cholinesterase [Enzymatic activity/volume] in Serum or Plasma,0
4667,isoxanthopterin,Isoxanthopterin:SCnc:Pt:Ser/Plas:Qn,0
4668,Visual Acuity,Visual acuity^best corrected:LogLenRto:Pt:Eye.left:Qn:ETDRS eye chart,0
4669,Plan of care note,Plan of care note:Find:Pt:{Setting}:Doc:Orthopaedic surgery,0
4670,Leptospira interrogans serovar Szwajizak Ab,Leptospira interrogans serovar Szwajizak Ab:Titr:Pt:Ser:Qn:Aggl,0
4671,Allo-tetrahydrocorticosterone/Creatinine,Allo-tetrahydrocorticosterone/Creatinine:SRto:Pt:Urine:Qn,0
4672,Views Broden,Deprecated Hindfoot - bilateral and Midfoot - bilateral X-ray Broden,0
4673,Plan of care note,Plan of care note:Find:Pt:{Setting}:Doc:Obstetrics and Gynecology,0
4674,Diagnostic study note,Diagnostic study note:Find:Pt:{Setting}:Doc:Pulmonary disease,0
4675,(Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE.RAST class,(Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE.RAST class:PrThr:Pt:Ser:Ord:Multidisk,0
4676,Diameter (qualifier value),Diameter:Len:Pt:Aorta.root:Qn:US.2D,0
4677,HIV 1 RNA+proviral DNA,HIV 1 RNA+proviral DNA:PrThr:Pt:Bld:Ord:Probe.amp.tar,0
4678,Pressure half time.diastole,Pressure half time.diastole:Time:Pt:Aortic valve:Qn:US.doppler.CW,0
4679,Diameter.end systole,Diameter.end systole:Len:Pt:Aorta.root:Qn:US.2D,0
4680,Spotted fever group rickettsia antibody,Rickettsia spotted fever group Ab:ACnc:Pt:Ser:Qn,0
4681,Cells.CD16/100 cells,Cells.CD16/100 cells:NFr:Pt:Bld:Qn,0
4682,quinethazone,Quinethazone:MCnc:Pt:Urine:Qn,0
4683,Taenia solium larva 18kD Ab,Taenia solium larva 18kD Ab:PrThr:Pt:Ser:Ord:IB,0
4684,Transportation summary,Transportation summary:Find:Pt:{Setting}:Doc:{Role},0
4685,Calcitonin,Calcitonin^1M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
4686,BCL6 Gene Rearrangement,BCL6 gene rearrangements:Imp:Pt:Bld/Tiss:Nar:FISH,0
4687,Benzodiazepines,Benzodiazepines:PrThr:Pt:Ser/Plas:Ord:Screen>200 ng/mL,0
4688,Length.end diastole,Length.end diastole:Len:Pt:Heart.ventricle.left:Qn:US.2D.A4C,0
4689,Proteins,Protein:MCnc:Pt:Respiratory.lower:Qn,0
4690,Measurement site,MEASUREMENT SITE:ANATOMY:POINT IN TIME:PERIPHERAL ARTERY:NOMINAL,0
4691,Intravascular systolic,Intravascular systolic:Pres:Pt:Hepatic artery:Qn,0
4692,Fluid intake.synovial,Fluid intake.synovial:VRat:1H:Synovial space:Qn,0
4693,Du antigen,D little u Ag:PrThr:Pt:RBC:Ord,0
4694,Porphyrins,Porphyrins:MRat:24H:Stool:Qn,0
4695,d antibody,D Ab:PrThr:Pt:Ser/Plas^Donor:Ord,0
4696,Coxsackievirus A10 Ab,Coxsackievirus A10 Ab:Titr:Pt:CSF:Qn:Comp fix,0
4697,Cells.MYC gene rearrangements/Cells counted,Cells.MYC gene rearrangements/Cells counted:NFr:Pt:Bld/Tiss:Qn:FISH,0
4698,Cells.MLL gene rearrangements/Cells counted,Cells.MLL gene rearrangements/Cells counted:NFr:Pt:Bld/Tiss:Qn:FISH,0
4699,Hydroxylurasidone,Hydroxylurasidone:MCnc:Pt:Urine:Qn:Confirm,0
4700,dronabinol,Tetrahydrocannabinol:MCnt:Pt:Hair:Qn,0
4701,Amitriptyline & Nortriptyline panel,Amitriptyline & nortriptyline panel:-:Pt:Gast fld:-,0
4702,16-Alpha hydroxydehydroepiandrosterone/Creatinine,16-Alpha hydroxydehydroepiandrosterone/Creatinine:SRto:Pt:Urine:Qn,0
4703,LOINC class types,Class:Type:Pt:Oral tube:Nom,0
4704,Organochlorine pesticide,Organochlorine pesticides:Type:Pt:Ser/Plas:Nom,0
4705,dia antibody,D little i super little a Ab:PrThr:Pt:Ser/Plas^Donor:Ord,0
4706,TARDBP gene targeted mutation analysis,TARDBP gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
4707,Thickness.end diastole,Thickness.end diastole:Len:Pt:Heart.ventricle.right.anterior wall:Qn:US.M-mode,0
4708,Multisection for pregnancy+first trimester,Multisection for pregnancy+first trimester:Find:Pt:Pelvis+^Fetus:Doc:US,0
4709,(Ambrosia elatior+Chenopodium album+Cynodon dactylon+Lolium perenne+Plantago lanceolata+Paspalum notatum) Ab.IgE,(Ambrosia elatior+Chenopodium album+Cynodon dactylon+Lolium perenne+Plantago lanceolata+Paspalum notatum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk,0
4710,Vendor model number,Vendor model number:Prid:Pt:Cardiac pacemaker prosthetic lead:Nom:EKG,0
4711,intraventricular conduction,Intraventricular conduction:Impression/interpretation of study:Point in time:Heart:Narrative:EKG,0
4712,P wave duration.lead AVF,P wave duration.lead AVF:Time:Pt:Heart:Qn:EKG,0
4713,Energy content,Energy content:EngCnt:24H:Stool.dried:Qn,0
4714,Flowsheet,Flowsheet:Find:Pt:{Setting}:Doc:Clinical genetics,0
4715,Progress note,Progress note:Find:Pt:{Setting}:Doc:Dermatology,0
4716,Initial evaluation note,Initial evaluation note:Find:Pt:{Setting}:Doc:Multi-specialty program,0
4717,Cranial nerve assessment panel,Cranial nerve assessment panel:-:Pt:Nerves.cranial:-,0
4718,Intravascular mean,Intravascular mean:Pres:Pt:Iliac artery.left:Qn,0
4719,Blood group antigen Bg^a^,DBG Ag:PrThr:Pt:RBC^BPU:Ord,0
4720,QRS terminal amplitude.lead III,QRS terminal amplitude.lead III:Elpot:Pt:Heart:Qn:EKG,0
4721,CALR gene exon 9 targeted mutation analysis,CALR gene exon 9 targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
4722,depression scale,Depression scale:Find:Pt:^Patient:Ord:UPDRS,0
4723,Aldosterone & renin concentration panel,Aldosterone & renin concentration panel:-:Pt:Plas:Qn,0
4724,Views GE 2,Views GE 2:Find:Pt:Lower extremity>Hip:Doc:XR,0
4725,Japanese encephalitis virus RNA,Japanese encephalitis virus RNA:PrThr:Pt:Ser:Ord:Probe.amp.tar,0
4726,Platelet associated Ab.IgM,Platelet associated Ab.IgM:ACnc:Pt:Bld:Qn,0
4727,Acenocoumarol,Acenocoumarol:MCnt:Pt:Hair:Qn,0
4728,Output.colostomy,Output.colostomy:MRat:1H:Lower GI tract:Qn,0
4729,R wave amplitude.lead V4,R wave amplitude.lead V4:Elpot:Pt:Heart:Qn:EKG,0
4730,Hepatitis B virus little e Ag & Ab panel,Hepatitis B virus little e Ag & Ab panel:-:Pt:Ser:-,0
4731,Niobium,Niobium:SCnc:Pt:Urine:Qn,0
4732,Modified Hoen and Yahr stage,Modified Hoen and Yahr stage:Find:Pt:^Patient:Ord:UPDRS,0
4733,Budgerigar serum proteins+feathers+droppings Ab.IgG,Budgerigar serum proteins+feathers+droppings Ab.IgG:MCnc:Pt:Ser:Qn,0
4734,Neurofilament heavy chain Ab,Neurofilament heavy chain Ab:MCnc:Pt:CSF:Qn,0
4735,CYP2C8 gene targeted mutation analysis,CYP2C8 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
4736,homocarnosine,Homocarnosine:SCnc:Pt:Ser/Plas:Qn,0
4737,R- & S-beta aminoisobutyrate & D- & L-serine panel,R- & S-beta aminoisobutyrate & D- & L-serine panel:-:Pt:Urine:-,0
4738,Pterins pattern,Pterins pattern:Imp:Pt:Urine:Nar,0
4739,Q wave depth,Q wave depth:Electrical Potential (Voltage):Point in time:Heart:Quantitative:EKG,0
4740,Total fluid output,Fluid output.total:VRat:24H:^Patient:Qn,0
4741,7-Hydroxyquetiapine,7-Hydroxyquetiapine:MCnc:Pt:Urine:Qn:Confirm,0
4742,"3,4-Dihydroxyhydrocinnamate/Creatinine","3,4-Dihydroxyhydrocinnamate/Creatinine:SRto:Pt:Urine:Qn",0
4743,N(alpha)-acetyllysine,N-alpha acetyllysine:SCnc:Pt:Ser/Plas:Qn,0
4744,Cryoglobulin.IgM,Cryoglobulin.IgM:PrThr:Pt:Ser:Ord,0
4745,Escherichia coli K1 DNA,Escherichia coli K1 DNA:PrThr:Pt:CSF:Ord:Non-probe.amp.tar,0
4746,Cytomegalovirus DNA,Cytomegalovirus DNA:PrThr:Pt:CSF:Ord:Non-probe.amp.tar,0
4747,Hypersensitivity,History of allergies:Finding:Point in time:^Patient:Nominal:Reported,0
4748,Breath,Breaths:NRat:10H^max:Respiratory system:Qn,0
4749,Checklist,Checklist:Find:Pt:{Setting}:Doc:Cardiovascular disease+Pulmonary disease,0
4750,Oxypurinol,Oxipurinol:SCnc:Pt:CSF:Qn,0
4751,Eicosadienoate,Eicosadienoate:SCnc:Pt:Ser/Plas:Qn,0
4752,cis-13-Eicosenoate,cis-13-Eicosenoate:SCnc:Pt:Ser/Plas:Qn,0
4753,"Social, psychological & behavioral observations - 2015 Edition Health IT Certification Criteria set","Social, psychological & behavioral observations - 2015 Edition Health IT Certification Criteria set:-:Pt:{Setting}:-",0
4754,Physical findings,Physical findings:Finding:Point in time:Ear:Nominal:Observed,0
4755,Blood product unit expiration,Blood product unit expiration:TmStp:Pt:^BPU:Qn,0
4756,Ristocetin induced platelet aggregation,Platelet aggregation.ristocetin induced^500 ug/mL:RelACnc:Pt:PRP:Qn,0
4757,Trimeprazine,Trimeprazine:MCnt:Pt:Hair:Qn,0
4758,Surgical operation note postoperative Dx,Operative note postoperative Dx:Impression/interpretation of study:Point in time:^Patient:Nominal,0
4759,Surgical operation note procedure,Surgical operation note procedure:Presence or Identity:Point in time:^Patient:Nominal,0
4760,Hydrocortisone,Cortisol^3M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
4761,Flowsheet,Flowsheet:Find:Pt:{Setting}:Doc:Cardiovascular disease+Pulmonary disease,0
4762,Summary of encounters note,Summary of encounters note:Find:Pt:{Setting}:Doc:Ophthalmology,0
4763,Isoleucine intake,Isoleucine intake:MRat:24H:^Patient:Qn:Measured,0
4764,HIV 1 proviral DNA genotype,HIV 1 proviral DNA genotype:Imp:Pt:Bld MC:Nar:Genotyping,0
4765,Body Weight,Body weight:Mass:Pt:^Patient:Qn:Estimated,0
4766,Body Weight,Body weight^at birth:Mass:Pt:^Patient:Qn:Measured,0
4767,Opiates,Opiates:PrThr:Pt:Unk sub:Ord,0
4768,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:Indicator dilution,0
4769,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.right:Qn:US.doppler,0
4770,cefodizime,Cefodizime:Titr:Pt:Isolate+Ser:Qn:SBT,0
4771,Patient was hospitalized because of this condition,Patient was hospitalized because of this condition:Find:Pt:^Patient:Ord,0
4772,Patient demographics panel,Patient demographics panel:-:Pt:^Patient:-,0
4773,CYP4F2 gene product metabolic activity interpretation,CYP4F2 gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:CPIC,0
4774,Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes,Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes:PrThr:Pt:Stool:Ord:Non-probe.amp.tar,0
4775,Vitamin B12 intake,Vitamin B12 intake:MRat:24H:^Patient:Qn:Estimated,0
4776,Cells.CD8/100 cells,Cells.CD8/100 cells:Number Fraction:Point in time:Whole blood:Quantitative,0
4777,Discharge teaching note,Discharge teaching note:Find:Pt:Hospital:Doc:Cardiovascular disease,0
4778,History and physical note,History and physical note:Find:Pt:{Setting}:Doc:Critical Care Medicine,0
4779,Influenza A virus Bangkok Ab,Influenza virus A Bangkok Ab:ACnc:Pt:Ser:Qn,0
4780,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:Vag:Ord:Probe.amp.tar,0
4781,Marked operative site,Marked operative site:Finding:Point in time:^Patient:Ordinal,0
4782,Microsatellite instability markers assessed,Microsatellite instability markers assessed:Num:Pt:Cancer specimen:Qn,0
4783,Bartonella henselae IgM,Bartonella henselae Ab.IgM:Titr:Pt:Body fld:Qn,0
4784,Hydrogen/Expired gas,Hydrogen/Expired gas^4H post XXX challenge:VFr:Pt:Exhl gas:Qn,0
4785,Francisella tularensis antibody,Francisella tularensis Ab:Titr:Pt:Ser:Qn:LA,0
4786,Dodecanoylcarnitine (C12),Dodecanoylcarnitine (C12):SCnc:Pt:Urine:Qn,0
4787,Lycopersicon lycopersicum Ab.IgG4,Lycopersicon lycopersicum Ab.IgG4:MCnc:Pt:Ser:Qn,0
4788,Mytilus edulis Ab.IgG4,Mytilus edulis Ab.IgG4:MCnc:Pt:Ser:Qn,0
4789,Salmonella enterica subspecies enterica serovar Paratyphi C antibody,Salmonella paratyphi C Ab:Titr:Pt:Ser:Qn,0
4790,OTC - Keep out of reach of children section,OTC - Keep out of reach of children section:-:-:^FDA product label:Nar,0
4791,Populus balsamifera Ab.IgE,Populus balsamifera Ab.IgE:ACnc:Pt:Ser:Qn,0
4792,Herpes simplex virus 1 DNA,Herpes simplex virus 1 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar,0
4793,Cells.CD11b/100 cells,Cells.CD11b/100 cells:NFr:Pt:CSF:Qn,0
4794,Reticulin antibody,Reticulin Ab:Titr:Pt:Ser:Qn:IF,0
4795,HBA2 gene.c.429A>T,HBA2 gene.c.429A>T:PrThr:Pt:Bld:Ord:Molgen,0
4796,Hemoglobin Bart's,Hemoglobin Barts:PrThr:Pt:Bld:Ord:HPLC,0
4797,Ambrosia trifida Ab.IgG4,Ambrosia trifida Ab.IgG4:MCnc:Pt:Ser:Qn,0
4798,Dactylis glomerata leukotriene release,Dactylis glomerata leukotriene release:MCnc:Pt:WBC:Qn,0
4799,Dihydrocodeine.free+Hydrocodol.free,Dihydrocodeine.free+Hydrocodol.free:MCnc:Pt:Ser/Plas:Qn,0
4800,Cells.CD23/100 cells,Cells.CD23/100 cells:NFr:Pt:Tiss:Qn,0
4801,Cells.CD3+CD57+/100 cells,Cells.CD3+CD57+/100 cells:Number Fraction:Point in time:Marrow (bone):Quantitative,0
4802,Cells.CD3+CD57+/100 cells,Cells.CD3+CD57+/100 cells:NFr:Pt:Bld:Qn,0
4803,Borrelia burgdorferi 49736 IgG,Borrelia burgdorferi 49736 Ab.IgG:ACnc:Pt:Ser:Qn:IA,0
4804,Helicobacter pylori antibody,Helicobacter pylori Ab:ACnc:Pt:Ser:Qn:IA,0
4805,"Salmonella Paratyphi A, H antibody",Salmonella paratyphi A H Ab:PrThr:Pt:Ser:Ord:LA,0
4806,Arginine/Phenylalanine,Arginine/Phenylalanine:SRto:Pt:Bld.dot:Qn,0
4807,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4),Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4):SRto:Pt:Bld.dot:Qn,0
4808,Fetus,Fetuses:Number:Point in time:^Patient:Quantitative,0
4809,Physical examination by body areas,Physical examination by body areas:-:Pt:^Patient:Set,0
4810,Ristocetin induced platelet aggregation,Platelet aggregation.ristocetin induced^500 mg/L:PrThr:Pt:PRP:Ord,0
4811,Bean white Ab.IgG4,Bean white Ab.IgG4:MCnc:Pt:Ser:Qn,0
4812,Pork Ab.IgG4,Pork Ab.IgG4:MCnc:Pt:Ser:Qn,0
4813,Chronic leukemia markers,Chronic leukemia markers:Impression/interpretation of study:Point in time:To be specified in another part of the message:Nominal,0
4814,Cortodoxone,11-Deoxycortisol^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
4815,Cells.CD4+CD7-/100 cells,Cells.CD4+CD7-/100 cells:NFr:Pt:Bone mar:Qn,0
4816,Cells.CD4+CD7-/100 cells,Cells.CD4+CD7-/100 cells:NFr:Pt:Body fld:Qn,0
4817,Chlamydia trachomatis rRNA,Chlamydia trachomatis rRNA:PrThr:Pt:Vag:Ord:Probe.amp.tar,0
4818,Dicarboxystearoylcarnitine (C18-DC),Dicarboxystearoylcarnitine (C18-DC):SCnc:Pt:Amnio fld:Qn,0
4819,fibroblast growth factor 23,Fibroblast growth factor 23 ^pre XXX challenge:ACnc:Pt:Plas:Qn:IA,0
4820,Choriogonadotropin.beta subunit,Choriogonadotropin.beta subunit:MCnc:Pt:Ser/Plas:Qn,0
4821,Ethanol+Methanol+Isopropyl alcohol+Acetone,Ethanol+Methanol+Isopropyl alcohol+Acetone:SCnc:Pt:Ser/Plas:Qn,0
4822,HLA-Dw6 antigen,HLA-Dw6:PrThr:Pt:Bld/Tiss:Ord,0
4823,Hepatitis B virus DNA,Hepatitis B virus DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar,0
4824,Listeria monocytogenes rRNA,Listeria monocytogenes rRNA:PrThr:Pt:XXX:Ord:Probe,0
4825,Chlamydophila pneumoniae Ab,Chlamydophila pneumoniae Ab:ACnc:Pt:Ser:Qn,0
4826,Cells.CD57/100 cells,Cells.CD57/100 cells:NFr:Pt:Body fld:Qn,0
4827,Bacteria identified,Bacteria identified:Prid:Pt:Sptt:Nom:Culture,0
4828,Glucose,Glucose^30M pre dose betaxolol:SCnc:Pt:Ser/Plas:Qn,0
4829,Crystal Structure,Crystals:PrThr:Pt:Urine sed:Ord:Microscopy.light,0
4830,Coagulation tissue factor induced.PIVKA insensitive actual/Normal,Coagulation tissue factor induced.PIVKA insensitive actual/Normal:RelTime:Pt:BldC:Qn:Coag,0
4831,Asparagine/Amino acids.total,Asparagine/Amino acids.total:SFr:Pt:Ser/Plas:Qn,0
4832,HLA-B67 antigen,HLA-B67:PrThr:Pt:Bld/Tiss:Ord,0
4833,Orientia tsutsugamushi Karp IgG,Orientia tsutsugamushi Karp Ab.IgG:Titr:Pt:Ser:Qn:IF,0
4834,HLA-DQ5(1),HLA-DQ5(1):PrThr:Pt:Bld/Tiss^Donor:Ord,0
4835,Boron/Creatinine,Boron/Creatinine:SRto:Pt:Urine:Qn,0
4836,Gastrin,Gastrin^pre or post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
4837,heart rate,Heart rate:NRat:Enctr^max:Arterial system:Qn,0
4838,Short blood count panel,Short blood count panel:-:Pt:Bld:Qn,0
4839,Antithrombin III,Deprecated Antithrombin in Platelet poor plasma,0
4840,Oxygen content level,Oxygen content:SCnc:Pt:BldCo:Qn,0
4841,Orientia tsutsugamushi,Orientia tsutsugamushi:PrThr:Pt:XXX:Ord:Organism specific culture,0
4842,syndecan 1 protein,CD138 Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
4843,Paraquat,Paraquat:SCnc:Pt:Ser/Plas:Qn,0
4844,Herpes virus 8 IgG,Herpes virus 8 Ab.IgG:ACnc:Pt:Ser:Qn:IA,0
4845,Rheumatoid Factor,Rheumatoid factor:ACnc:Pt:Plr fld:Qn,0
4846,Peptidyl-Dipeptidase A,Angiotensin converting enzyme:CCnc:Pt:Periton fld:Qn,0
4847,Gamma globulin.abnormal band/Protein.total,Gamma globulin.abnormal band/Protein.total:MFr:Pt:Ser/Plas:Qn:Electrophoresis,0
4848,HEDIS 2009 Tests used in early prenatal care - ABO & Rh (PPC-C),HEDIS 2009 Tests used in early prenatal care - ABO & Rh (PPC-C):-:Point in time:^Patient:-,0
4849,Endocrine newborn screening panel (SI units),Endocrine newborn screening panel (SI units):-:Point in time:Blood filter paper:-,0
4850,CD44 Antigens,Deprecated CD44 cells/100 cells in Blood,0
4851,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone^1H post dose corticotropin:SCnc:Pt:Ser/Plas:Qn,0
4852,CD97 Antigen,Deprecated CD97 cells/100 cells in Blood,0
4853,Cortodoxone,11-Deoxycortisol^4D post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
4854,GF border code,GF border code:Find:Pt:Eye.left:Nom:Perimetry,0
4855,Multisection,Multisection^WO contrast:Find:Pt:Head>Brain.temporal:Doc:MR,0
4856,Coxiella burnetii phase 1 IgG,Coxiella burnetii phase 1 Ab.IgG:Titr:Pt:Body fld:Qn:IF,0
4857,Coxiella burnetii phase 2 IgA,Coxiella burnetii phase 2 Ab.IgA:Titr:Pt:Body fld:Qn:IF,0
4858,Orientia tsutsugamushi Gilliam IgM,Orientia tsutsugamushi Gilliam Ab.IgM:Titr:Pt:Body fld:Qn:IF,0
4859,Strontium,Strontium:SRat:24H:Urine:Qn,0
4860,Clostridium tetani antibody,Clostridium tetani Ab:PrThr:Pt:Ser:Ord,0
4861,Hemoglobin pattern,Hemoglobin pattern:Find:Pt:Bld.dot:Nom:Isoelectric focusing,0
4862,Platelet aggregation.adenosine diphosphate induced ATP secretion,Platelet aggregation.adenosine diphosphate induced ATP secretion^5 umol/L:PrThr:Pt:Bld:Ord,0
4863,Views runoff,View runoff^WO & W contrast IA:Find:Pt:Lower extremity>Femoral artery:Doc:RF.angio,0
4864,CV2 Ab,CV2 Ab:Titr:Pt:Ser/Plas:Qn:IF,0
4865,Cefoperazone- and sulbactam-containing product,Cefoperazone+Sulbactam:Susc:Pt:Isolate:OrdQn,0
4866,Human leukocyte antigen Cw10(w3),HLA-Cw10(w3):PrThr:Pt:Bld/Tiss^Donor:Ord,0
4867,Dodecenedioate/Creatinine,Dodecenedioate/Creatinine:SRto:Pt:Urine:Qn,0
4868,Package label.Side panel,Package label.Side panel:-:-:^FDA product label:Nar,0
4869,Glutamate decarboxylase 65 antibody,Glutamate decarboxylase 65 Ab:SCnc:Pt:CSF:Qn,0
4870,Intercellular adhesion molecule 1,Deprecated CD54 cells/100 cells in Blood,0
4871,Furosemide,Furosemide:SCnc:Pt:Ser/Plas:Qn,0
4872,Indomethacin,Indomethacin:SCnc:Pt:Ser/Plas:Qn,0
4873,Oxyphenbutazone,Oxyphenbutazone:SCnc:Pt:Ser/Plas:Qn,0
4874,Hand dominance - use an eraser,Hand dominance - use an eraser:Find:Pt:^Patient:Nom:EHI,0
4875,HLA-Cw1 antigen,HLA-Cw1:PrThr:Pt:Bld/Tiss^Donor:Ord,0
4876,Platelet glycoprotein Ib-Ix Ab,Platelet glycoprotein Ib-Ix Ab:PrThr:Pt:Ser:Ord:IA,0
4877,Glucose,Glucose^3 AM specimen:MCnc:Pt:Ser/Plas:Qn,0
4878,Hydrocortisone,Cortisol^6 PM specimen:MCnc:Pt:Ser/Plas:Qn,0
4879,neutrophil,Neutrophils:PrThr:Pt:Nose:Ord:Wright stain,0
4880,Respiratory syncytial virus Ab.IgG & IgM panel,Respiratory syncytial virus Ab.IgG & IgM panel:ACnc:Pt:Ser:Qn,0
4881,Hydrogen/Expired gas,Hydrogen/Expired gas^30M post XXX challenge:VFr:Pt:Exhl gas:Qn,0
4882,C-Peptide,C peptide^6th specimen:SCnc:Pt:Ser/Plas:Qn,0
4883,Nocardia sp identified,Nocardia sp identified:Prid:Pt:Isolate:Nom,0
4884,HFE gene.c.187G>C,HFE gene.c.187G>C:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
4885,Influenzavirus A antigen,Influenza virus A Ag:Prid:Pt:Isolate:Nom,0
4886,Creatinine,Creatinine:SRat:12H:Urine:Qn,0
4887,Herpes simplex virus 1 IgG,Herpes simplex virus 1 Ab.IgG:ACnc:Pt:Ser:Qn:IA,0
4888,Immunoglobulin G antibody to Rickettsia typhi,Rickettsia typhi Ab.IgG:Titr:Pt:Ser:Qn:IF,0
4889,Insulin bovine Ab.IgG4,Insulin bovine Ab.IgG4:MCnc:Pt:Ser:Qn,0
4890,TGM1 gene targeted mutation analysis,TGM1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen,0
4891,Intact parathyrin,Parathyrin.intact^6th specimen:MCnc:Pt:Ser/Plas:Qn,0
4892,Glucose,Glucose:SCnc:Pt:BldC:Qn,0
4893,sperm cell,Spermatozoa^post vasectomy:NCnc:Pt:Semen:Qn,0
4894,Herpes simplex virus 2 Ab,Herpes simplex virus 2 Ab:ACnc:Pt:Ser:Qn:IA,0
4895,Yeast.hyphae,Yeast.hyphae:Naric:Pt:Urine:Qn:Computer assisted,0
4896,Transitional Epithelial Cells,Transitional cells:NCnc:Pt:Urine:Qn:Computer assisted,0
4897,Trisomy 21,Trisomy 21:Hx:Pt:^Patient:Ord,0
4898,Palmitoylcarnitine (C16),Palmitoylcarnitine (C16):SCnc:Pt:CSF:Qn,0
4899,Hamster epithelium Ab.IgG4,Hamster epithelium Ab.IgG4:MCnc:Pt:Ser:Qn,0
4900,Thymidine,Thymidine:SCnc:Pt:Ser/Plas:Qn,0
4901,Orientia tsutsugamushi identified,Orientia tsutsugamushi identified:Prid:Pt:XXX:Nom:Sequencing,0
4902,Cortodoxone,11-Deoxycortisol^30M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn,0
4903,Glucose tolerance 3H panel,Glucose tolerance 3H panel:-:-:Ser/Plas:Qn,0
4904,Blasts.cytoplasmic CD3,Blasts.cytoplasmic CD3:ACnc:Pt:Bone mar:Qn,0
4905,Reticulocytes.high light scatter/Reticulocytes.total,Reticulocytes.high light scatter/Reticulocytes.total:NFr:Pt:Bld:Qn,0
4906,Humulus lupus Ab.IgG4,Humulus lupus Ab.IgG4:MCnc:Pt:Ser:Qn,0
4907,Sorghum halepense Ab.IgG4,Sorghum halepense Ab.IgG4:MCnc:Pt:Ser:Qn,0
4908,Lycopersicon lycopersicum leukotriene release,Lycopersicon lycopersicum leukotriene release:MCnc:Pt:WBC:Qn,0
4909,Fibrinogen,Fibrinogen:MCnc:Pt:PPP:Qn:Coag.derived,0
4910,IgG.intrathecally synthesized,IgG.intrathecally synthesized:MCnc:Pt:Ser+CSF:Qn,0
4911,Orientia tsutsugamushi Gilliam IgM,Orientia tsutsugamushi Gilliam Ab.IgM:Titr:Pt:Ser:Qn,0
4912,Hydrocortisone,Cortisol^10th specimen post XXX challenge:MCnc:Pt:Saliva:Qn,0
4913,Hydrocortisone,Cortisol^11th specimen post XXX challenge:SCnc:Pt:Saliva:Qn,0
4914,Frankfort horizontal plane to mandibular plane using constructed Gonion,Frankfort horizontal plane to mandibular plane using constructed Gonion:Angle:Pt:Skull:Qn:XR.measured,0
4915,"How often did you drink regular colas and root beer (with caffeine, not diet)","How often did you drink regular colas and root beer (with caffeine, not diet):Find:Pt:^Patient:Ord:PhenX",0
4916,Solidago virgaurea Ab.IgG,Solidago virgaurea Ab.IgG:MCnc:Pt:Ser:Qn,0
4917,micafungin,Micafungin:Susc:Pt:Isolate:OrdQn,0
4918,Have you ever had medical treatment to dissolve or remove gallstones,Have you ever had medical treatment to dissolve or remove gallstones:Find:Pt:^Patient:Ord:PhenX,0
4919,Study year,Study year:Time:Pt:Study:Qn:PhenX,0
4920,11-ketoetiocholanolone,11-Ketoetiocholanolone^pre dose dexamethasone:MCnc:24H:Urine:Qn,0
4921,Titanium,Titanium:MCnc:Pt:Urine:Qn,0
4922,Hydrocortisone,Cortisol^pre 1 ug/kg CRH IV:MCnc:Pt:Saliva:Qn,0
4923,Leucocyte esterase,Leukocyte esterase:PrThr:Pt:CSF:Ord:Test strip,0
4924,Plasminogen Activator Inhibitor 1,Plasminogen activator inhibitor 1:MCnc:Pt:PPP:Qn:Chromo,0
4925,Plasminogen Activator Inhibitor 2,Plasminogen activator inhibitor 2:ACnc:Pt:PPP:Qn:Chromo,0
4926,Brassica oleracea var capitata Ab.IgG,Brassica oleracea var capitata Ab.IgG:MCnc:Pt:Ser:Qn,0
4927,How many Y did you take vitamin B 6,How many Y did you take vitamin B 6:Time:Pt:^Patient:Qn:PhenX,0
4928,I cannot go out of the house to do the shopping,I cannot go out of the house to do the shopping:Find:Pt:^Patient:Ord:PhenX,0
4929,"Do you have a bone or joint problem, for example, back, knee or hip, that could be made worse by a change in your physical activity","Do you have a bone or joint problem, for example, back, knee or hip, that could be made worse by a change in your physical activity:Find:Pt:^Patient:Ord:rPARQ",0
4930,microscopic observation,Microscopic observation:Prid:Pt:XXX:Nom:Giemsa stain,0
4931,Time adult activity starts,Time adult activity starts:Time:Pt:^Patient:Qn:PhenX,0
4932,Can exact number of adenomas be determined,Can exact number of adenomas be determined:Find:Pt:^Patient:Ord:PhenX,0
4933,TNM pathologic staging - nodal involvement - N,Deprecated TNM pathologic staging - nodal involvement - N [PhenX],0
4934,17-alpha-Hydroxyprogesterone,17-Hydroxyprogesterone^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
4935,Creatinine,Creatinine:SCnc:Pt:Bld:Qn,0
4936,Pre ejection time,Pre ejection time:Time:Pt:Heart.ventricle.left:Qn:NI-ICG,0
4937,"Problem when you stopped, cut down or went without marijuana for 2D or longer","Problem when you stopped, cut down or went without marijuana for 2D or longer:Find:Pt:^Patient:Nom:SSAGA II",0
4938,Does your child complain of an upset stomach at night,Does your child complain of an upset stomach at night:Find:Pt:^Patient:Ord:PhenX,0
4939,Leptospira sp identified,Leptospira sp identified:Prid:Pt:CSF:Nom:Organism specific culture,0
4940,Do you worry that you might be trapped without any way to escape,Do you worry that you might be trapped without any way to escape:Find:Pt:^Patient:Ord:CIDI-SF,0
4941,"Length of your highs as a rule, on the average","Length of your highs as a rule, on the average:Time:Pt:^Patient:Qn:HCL-32",0
4942,"How much difficulty do you have managing your money, such as keeping track of your expenses or paying bills","How much difficulty do you have managing your money, such as keeping track of your expenses or paying bills:Find:Pt:^Patient:Ord:PhenX",0
4943,How much difficulty do you have getting in or out of bed,How much difficulty do you have getting in or out of bed:Find:Pt:^Patient:Ord:PhenX,0
4944,My child usually speaks - frequency,My child usually speaks - frequency:Find:Pt:^Patient:Ord:PhenX,0
4945,Transcobalamin I+Transcobalamin III,Transcobalamin I+Transcobalamin III:SCnc:Pt:Ser:Qn,0
4946,Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2),Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2):SRto:Pt:Bld.dot:Qn,0
4947,Cryptosporidium species antigen,Cryptosporidium sp Ag:PrThr:Pt:Stool:Ord:IA,0
4948,"Has a health professional ever said that your child has attention-deficit disorder, ADD, or attention-deficit-hyperactivity disorder, ADHD","Has a health professional ever said that your child has attention-deficit disorder, ADD, or attention-deficit-hyperactivity disorder, ADHD:Find:Pt:^Patient:Ord:PhenX",0
4949,Date your child has taken this medication,Date your child has taken this medication:Date:Pt:^Patient:Qn:PhenX,0
4950,Rubella virus identified,Rubella virus identified:Prid:Pt:Ser:Nom:Organism specific culture,0
4951,Stay was longer than 30 consecutive Ds 2Ys ago,Stay was longer than 30 consecutive Ds 2Ys ago:Find:Pt:^Patient:Ord:PhenX,0
4952,Cortolone,Alpha cortolone^2D post high dose dexamethasone:MRat:24H:Urine:Qn,0
4953,Androsterone,Androsterone^pre high dose dexamethasone:MCnc:24H:Urine:Qn,0
4954,Well child visit note,Well child visit note:Finding:Point in time:{Setting}:Document:{Provider},0
4955,Dextromethorphan,Dextromethorphan:SCnc:Pt:Gast fld:Qn,0
4956,Myelin antibody,Myelin Ab:PrThr:Pt:CSF:Ord:IF,0
4957,I am very careful,I am very careful:Find:Pt:^Patient:Ord:UPPS-R-C,0
4958,"I like to know what to expect, before doing something new","I like to know what to expect, before doing something new:Find:Pt:^Patient:Ord:UPPS-R-C",0
4959,Growth Hormone,Somatotropin^8H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,0
4960,Follicle Stimulating Hormone,Follitropin^10M pre dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn,0
4961,Toxocara canis antibody,Toxocara canis Ab:ACnc:Pt:Body fld:Qn,0
4962,Vacuolated lymphocyte,Lymphocytes.vacuolated:PrThr:Pt:Bld:Ord:Microscopy.light,0
4963,PhenX measure - oral health - number of natural teeth,PhenX measure - oral health - number of natural teeth:-:Point in time:^Patient:-:PhenX,0
4964,Was emphysema confirmed by a doctor,Was emphysema confirmed by a doctor:Find:Pt:^Patient:Ord:PhenX,0
4965,For how many H per D were you exposed to smoke from other peoples cigarettes or tobacco products during this time at this location,For how many H per D were you exposed to smoke from other peoples cigarettes or tobacco products during this time at this location:NRat:Pt:^Patient:Qn:PhenX,0
4966,Have you ever had vaginal intercourse,Have you ever had vaginal intercourse:Find:Pt:^Patient:Ord:PhenX,0
4967,Reviewer initials,Reviewer initials:ID:Pt:XXX:Nom,0
4968,Volume expired during 6.0 s of forced expiration,Volume^at 6.0 s post forced expiration/predicted:Volume:Point in time:Respiratory system:Quantitative:PhenX,0
4969,cefepime,Deprecated Cefepime [Susceptibility] by Disk diffusion (KB),0
4970,Spermatozoa.double forms/100 spermatozoa,Spermatozoa.double forms/100 spermatozoa:NFr:Pt:Semen:Qn,0
4971,Ever had angioplasty for claudication or peripheral arterial disease,Ever had angioplasty for claudication or peripheral arterial disease:Finding:Point in time:^Patient:Quantitative,0
4972,Leucocyte esterase,Leukocyte esterase:PrThr:Pt:Urine:Ord:Test strip.automated,0
4973,Sambucus nigra Ab.IgE,Sambucus nigra Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative,0
4974,Lysosomal storage disorders suspected,Lysosomal storage disorders suspected:Prid:Pt:Bld.dot:Nom,0
4975,How many Y in total did you take premarin - exclude those periods when you temporarily stopped,How many Y in total did you take premarin - exclude those periods when you temporarily stopped:Time:Pt:^Patient:Qn:California Teachers Study,0
4976,Did you have symptoms of gallstones,Did you have symptoms of gallstones:Find:Pt:^Patient:Ord:PhenX,0
4977,Do you currently take this pain-relieving medication at least once a week,Do you currently take this pain-relieving medication at least once a week:Find:Pt:^Patient:Ord:California Teachers Study,0
4978,When did your child first start wearing an eye patch,When did your child first start wearing an eye patch:TmStp:Pt:^Patient:Qn:PhenX,0
4979,Image name,Image name:ID:Pt:Knee:Nom:PhenX,0
4980,Urea,Urea:MCnc:24H:Dial fld prt:Qn,0
4981,Chest discomfort when quiet or resting,Chest discomfort when quiet or resting:Finding:Point in time:^Patient:Ordinal,0
4982,Intact parathyrin,Parathyrin.intact^post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
4983,Oxygen saturation test result,Oxygen saturation^pre treatment:MFr:Pt:BldA:Qn:Pulse oximetry,0
4984,Platelet factor 4 Ag,Platelet factor 4 Ag:MCnc:Pt:PPP:Qn:IA,0
4985,Campylobacter lari rRNA,Campylobacter lari rRNA:PrThr:Pt:XXX:Ord:Probe,0
4986,Mumps virus antigen,Mumps virus Ag:PrThr:Pt:Ser:Ord:IF,0
4987,Equivalent visual acuity from table based on number of letters read correctly,Equivalent visual acuity from table based on number of letters read correctly:Find:Pt:^Patient:Nom:PhenX,0
4988,Do you feel weak all over most of the time,Do you feel weak all over most of the time:Find:Pt:^Patient:Ord:PhenX,0
4989,"Metals, Heavy",Heavy metals:PrThr:Pt:Urine:Ord:Reinsch,0
4990,Referral note,Referral note:Find:Pt:{Setting}:Doc:Rheumatology,0
4991,Thyroid stimulating immunoglobulins,Thyrotropin receptor Ab:ACnc:Pt:Ser:Qn:IA,0
4992,hydroxybupropion,Hydroxybupropion:MCnc:Pt:Body fld:Qn,0
4993,Thyroperoxidase Antibody,Thyroperoxidase Ab:ACnc:Pt:Body fld:Qn:IA,0
4994,Chronic urticaria index,Chronic urticaria index:ACnc:Pt:Ser:Qn,0
4995,About how long has it been since you last visited a dentist,About how long has it been since you last visited a dentist:Time:Pt:^Patient:Qn:PhenX,0
4996,I have nightmares about my parents,I have nightmares about my parents:Find:Pt:^Patient:Ord:SCARED-R,0
4997,How well do you write in english,How well do you write in english:Find:Pt:^Patient:Ord:NLAAS,0
4998,Phencyclidine/Creatinine,Phencyclidine/Creatinine:MRto:Pt:Urine:Qn,0
4999,Tricyclic antidepressants/Creatinine,Tricyclic antidepressants/Creatinine:MRto:Pt:Urine:Qn,0
5000,Nitrous oxide gas delivered.case,Nitrous oxide gas delivered.case:Vol:Procedure dur:Gas delivery system:Qn,0
5001,Face all,Face all:Len:Pt:Skull:Qn:XR.measured,0
5002,Pinus strobus Ab.IgE,Pinus strobus Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative,0
5003,Inhalation challenge test report,Inhalation challenge test report^W methacholine inhaled:Find:Pt:^Patient:Doc,0
5004,Do you sometimes feel a fullness or blockage in your ears,Do you sometimes feel a fullness or blockage in your ears:Find:Pt:^Patient:Ord:PhenX,0
5005,Tobramycin Ab.IgE,Tobramycin Ab.IgE:ACnc:Pt:Ser:Qn,0
5006,GD1a IgG ganglioside antibody,Ganglioside GD1a Ab.IgG:ACnc:Pt:CSF:Qn:IA,0
5007,topiramate,Topiramate:MCnc:Pt:Bld:Qn,0
5008,Stopped or paused before 6M,Stopped or paused before 6M:Finding:Point in time:^Patient:Ordinal,0
5009,Problems or unusual findings,Problems or unusual findings:Find:Pt:Eye.left:Nom,0
5010,Tropomyosin Ab.IgE,Tropomyosin Ab.IgE:ACnc:Pt:Ser:Qn,0
5011,Fractional excretion of urea,Fractional excretion of urea:Ratio:XXX:Urine+Ser/Plas:Qn,0
5012,CD3+CD8+ cell,Cells.CD3+CD8+:NCnc:Pt:CSF:Qn,0
5013,"On the average of the entire time you smoked, how many cigarettes did you smoke per D","On the average of the entire time you smoked, how many cigarettes did you smoke per D:NRat:Pt:^Patient:Qn:PhenX",0
5014,Amoeba identified,Amoeba identified:Prid:Pt:XXX:Nom:Organism specific culture,0
5015,Suicidality notes,Suicidality notes:Txt:Pt:^Patient:Nom:DI-PAD CGP V 1.4,0
5016,Elevated mood,Elevated mood:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4,0
5017,Hallucinations in any modality,Hallucinations in any modality:Find:Pt:^Patient:Ord:DI-PAD CGP V 1.4,0
5018,didesethylflurazepam,N-desalkylflurazepam:MCnc:Pt:Bld:Qn,0
5019,didesethylflurazepam,N-desalkylflurazepam:MCnt:Pt:Meconium:Qn:Confirm,0
5020,Body Temperature,Body temperature:Temp:Pt:Arterial system:Qn,0
5021,PhenX measure - calcium intake,PhenX measure - calcium intake:-:Point in time:^Patient:-:PhenX,0
5022,PhenX measure - childhood maltreatment,PhenX measure - childhood maltreatment:-:Point in time:^Patient:-:PhenX,0
5023,Petroselinum crispum Ab.IgG,Petroselinum crispum Ab.IgG:MCnc:Pt:Ser:Qn,0
5024,Albumins,Albumin:MRat:18H:Urine:Qn:Detection limit <= 20 mg/L,0
5025,"I see myself as someone who is ingenious, a deep thinker","I see myself as someone who is ingenious, a deep thinker:Find:Pt:^Patient:Ord:BFI",0
5026,Age diabetes-related problem occurred,Age diabetes-related problem occurred:Time:Pt:^Patient:Qn:PhenX,0
5027,Magnesium,Magnesium:MRat:12H:Urine:Qn,0
5028,17-methylandrost-2-en-17-ol,Desoxymethyltestosterone:PrThr:Pt:Urine:Ord,0
5029,Closure to opening,Closure to opening:Time:Pt:Heart.valve.XXX:Qn:US,0
5030,desflurane,Desflurane:VFr/PPres:Pt:Gas delivery system:Qn,0
5031,desflurane,Desflurane^during expiration:VFr/PPres:Pt:Airway adaptor:Qn,0
5032,"Compared to others your age who currently smoke, what do you think are your chances of being diagnosed with lung cancer during your lifetime","Compared to others your age who currently smoke, what do you think are your chances of being diagnosed with lung cancer during your lifetime:Find:Pt:^Patient:Ord:PLCO",0
5033,Personal health monitoring report,Personal health monitoring report:Find:Pt:{Setting}:Doc:Automated,0
5034,"Since the event, have you found yourself unable to see a future for yourself","Since the event, have you found yourself unable to see a future for yourself:Find:Pt:^Patient:Ord:PhenX",0
5035,I've often missed things I promised to attend,I've often missed things I promised to attend:Find:Pt:^Patient:Ord:PhenX,0
5036,"How many times in the last Y have you been paid, or received other favors for having sex with someone","How many times in the last Y have you been paid, or received other favors for having sex with someone:NRat:1Y:^Patient:Qn:Denver Youth Survey",0
5037,You don't get paid enough for what you do,You don't get paid enough for what you do:Find:Pt:^Patient:Ord:PhenX,0
5038,Phenylbutazone Ab.IgE,Phenylbutazone Ab.IgE:ACnc:Pt:Ser:Qn,0
5039,Cells.myeloperoxidase,Cells.myeloperoxidase:PrThr:Pt:Body fld:Ord,0
5040,Galactitol,Galactitol:PrThr:Pt:Urine:Ord,0
5041,Corticotropin,Corticotropin^3H post dose glucagon:SCnc:Pt:Plas:Qn,0
5042,Corticotropin,Corticotropin^8 AM specimen:SCnc:Pt:Plas:Qn,0
5043,Corticotropin,Corticotropin^pre dose dexamethasone:MCnc:Pt:Plas:Qn,0
5044,Nordazepam,Nordiazepam:MCnc:Pt:Bld:Qn,0
5045,Record ID section,Record ID section:-:Point in time:^Patient:Set:NAACCR v.12,0
5046,Acremonium sp Ab.IgG,Acremonium sp Ab.IgG:MCnc:Pt:Ser:Qn,0
5047,Centromere antibody,Centromere Ab:Titr:Pt:Body fld:Qn:IF,0
5048,Chlamydia trachomatis rRNA,Deprecated Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by DNA probe,0
5049,H little e Ab,H little e Ab:PrThr:Pt:Ser/Plas:Ord,0
5050,Ku antibody,K little u Ab:PrThr:Pt:Ser/Plas:Ord,0
5051,Older adult activity,Older adult activity:Find:Pt:^Patient:Nom:PhenX,0
5052,Leukocytes other,Leukocytes other:NCnc:Pt:Bld^Fetus:Qn:Manual count,0
5053,Has anyone ever threatened to hurt you when they were standing right in front of you,Has anyone ever threatened to hurt you when they were standing right in front of you:Find:Pt:^Patient:Ord:LTVH,0
5054,"t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript","t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen",0
5055,Ibuprofen induced neutrophil Ab.IgG,Ibuprofen induced neutrophil Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
5056,Trisomy 18 prior risk,Trisomy 18 prior risk:Likelihood:Point in time:^Fetus:Narrative:Based on maternal age,0
5057,Parainfluenza virus 4 RNA,Parainfluenza virus 4 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar,0
5058,History and physical note,History and physical note:Find:Pt:{Setting}:Doc:Pediatric nephrology,0
5059,Macular retinal edema,Macular edema:Find:Pt:Eye.right:Ord:Ophthalmoscopy,0
5060,"1,3-dimethylamylamine","1,3-Dimethylamylamine:MCnc:Pt:Urine:Qn:Confirm",0
5061,MAM-2201 pentanoate,MAM-2201 pentanoate:PrThr:Pt:Bld:Ord,0
5062,Maprotiline,Maprotiline^trough:MCnc:Pt:Ser/Plas:Qn,0
5063,gabapentin,Gabapentin^trough:MCnc:Pt:Ser/Plas:Qn,0
5064,Haloperidol,Haloperidol^trough:MCnc:Pt:Ser/Plas:Qn,0
5065,Insulin,Insulin^1.75H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,0
5066,Gas flow at 25-75% of forced expiration,Gas flow at 25-75% of forced expiration^pre bronchodilation:VRat:Pt:Respiratory system:Qn,0
5067,Electrocardiogram,ECG:Type:Pt:^Patient:Nom:NEMSIS,0
5068,Tunneling,Tunneling:Find:Pt:Wound:Ord,0
5069,Temazepam,Temazepam:MCnc:Pt:Saliva:Qn:Confirm,0
5070,desomorphine,Desomorphine:MCnc:Pt:Urine:Qn:Confirm,0
5071,Prunus domestica Ab.IgG,Prunus domestica Ab.IgG:ACnc:Pt:Ser:Qn,0
5072,HLA-A+B+C Ab.IgG,HLA-A+B+C Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IA,0
5073,NPM1 gene.c.956dupTCTG transcript/control transcript,NPM1 gene.c.956dupTCTG transcript/control transcript:NRto:Pt:Bone mar:Qn:Molgen,0
5074,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA:PrThr:Pt:Tiss:Ord:Probe,0
5075,Other cells/100 leukocytes,Other cells/100 leukocytes:NFr:Pt:Bld^Fetus:Qn,0
5076,Poplar sp Ab.IgE,Deprecated Poplar sp Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Quantitative,0
5077,Positive end expiratory pressure (finding),Pressure.positive end expiratory^on ventilator:Pres:Pt:Respiratory system:Qn,0
5078,ARGININOSUCCINATE SYNTHASE,Argininosuccinate synthase:CCnt:Pt:Amnio fld cells:Qn,0
5079,Engraulis encrasicolus Ab.IgE,Engraulis encrasicolus Ab.IgE:ACnc:Pt:Ser:Qn,0
5080,Neutrophils/leukocytes,Neutrophils/leukocytes:NFr.DF:Pt:Bld:Qn:Manual count,0
5081,"t(11;14)(q13;q32)(CCND1,IGH) fusion transcript","t(11;14)(q13;q32)(CCND1,IGH) fusion transcript:PrThr:Pt:Bone mar:Ord:Molgen",0
5082,"16-Beta,18-dihydroxydehydroepiandrosterone","16-Beta,18-dihydroxydehydroepiandrosterone:SRat:24H:Urine:Qn",0
5083,Pork Ab.IgG,Pork Ab.IgG:ACnc:Pt:Ser:Qn,0
5084,"Centers for medicare - medicaid, CMS, service level","Centers for medicare - medicaid, CMS, service level:Find:Pt:^Patient:Ord:NEMSIS",0
5085,Interleukin-3,Interleukin 3:MCnc:Pt:Ser/Plas:Qn,0
5086,Rabies virus IgM,Rabies virus Ab.IgM:Titr:Pt:CSF:Qn:IF,0
5087,Alert,Alert:Type:Point in time:^Patient:Nominal,0
5088,Glutaryl-CoA dehydrogenase,Glutaryl CoA dehydrogenase:CCnt:Pt:Fibroblasts:Qn,0
5089,Homogentisate/Creatinine,Homogentisate/Creatinine:SRto:24H:Urine:Qn,0
5090,Crystal Structure,Crystals:Prid:Pt:Body fld:Nom:Microscopy.light,0
5091,Obstructive apnea index,Obstructive apnea index:NRat:24H:^Patient:Qn,0
5092,Erythrocytes,Erythrocytes:PrThr:Pt:XXX:Ord:Wet preparation,0
5093,1-methylhistidine,1-Methylhistidine:SCnc:Pt:Ser/Plas^Fetus:Qn,0
5094,Lacrimal,Lacrimal:Finding:Point in time:^Patient:Narrative,0
5095,6-O-monoacetylmorphine,6-Monoacetylmorphine:MCnc:Pt:Saliva:Qn:Confirm,0
5096,Problems with your heart or circulation,Problems with your heart or circulation:Hx:Pt:^Patient:Nom:PhenX,0
5097,3-hydroxysebacate,3-Hydroxysebacate:SCnc:Pt:Ser/Plas:Qn,0
5098,Oxygen saturation test result,Oxygen saturation:MFr:Pt:BldMV:Qn:Calculated from oxygen partial pressure,0
5099,Chemotherapy or other medication for this condition,Chemotherapy or other medication for this condition:Hx:Pt:^Patient:Nom:PhenX,0
5100,Stroke scale overall interpretation,Stroke scale overall interpretation:Imp:Pt:^Patient:Nom:NEMSIS,0
5101,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 E6+E7 mRNA,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 E6+E7 mRNA:PrThr:Pt:Cvx:Ord:Probe.amp.tar,0
5102,Phencyclidine,Phencyclidine:PrThr:Pt:Saliva:Ord:Confirm,0
5103,Have you ever been unfairly denied a promotion,Have you ever been unfairly denied a promotion:Find:Pt:^Patient:Ord:PhenX,0
5104,Lymphocytes.abnormal/100 leukocytes,Lymphocytes.abnormal/100 leukocytes:NFr:Pt:Vitr fld:Qn:Manual count,0
5105,macrophage,Macrophages:NCnc:Pt:Pericard fld:Qn:Manual count,0
5106,Oxygen saturation test result,Oxygen saturation:MFr.DF:Pt:BldA:Qn:Calculated from oxygen partial pressure,0
5107,Oval fat bodies (globules),Oval fat bodies (globules):Naric:Pt:Stool:Qn:Microscopy.light.LPF,0
5108,Nucleated cell,Nucleated cells:NCnc:Pt:Body fld:Qn:Manual count,0
5109,EMS exposures or injuries of EMS personnel,EMS exposures or injuries of EMS personnel:-:Pt:Provider:Nar:NEMSIS,0
5110,EMS billing,EMS billing:-:Pt:^Patient:Nar:NEMSIS,0
5111,Phenylbutazone,Phenylbutazone:SCnc:Pt:Gast fld:Qn,0
5112,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:CT,0
5113,Cholesterol.periton fld/Cholesterol.serum,Cholesterol.periton fld/Cholesterol.serum:RelRto:Pt:Periton fld+Ser/Plas:Qn,0
5114,Multisection,Multisection:Find:Pt:Chest>Axilla.left:Doc:US,0
5115,Sertraline induced neutrophil Ab.IgM,Sertraline induced neutrophil Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
5116,Sertraline induced neutrophil Ab.IgG,Sertraline induced neutrophil Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
5117,Methotrexate induced platelet Ab.IgM,Methotrexate induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
5118,finafloxacin,Finafloxacin:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
5119,fropenem,Faropenem:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
5120,fondaparinux,Fondaparinux:MCnc:Pt:Ser/Plas:Qn:LC/MS/MS,0
5121,Promethazine,Promethazine:MCnc:Pt:Bld:Qn:Confirm,0
5122,"t(11;19)(q23;p13.1)(MLL,ELL) fusion transcript","t(11;19)(q23;p13.1)(MLL,ELL) fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen",0
5123,Birch White Ab.IgE,Deprecated Birch White Ab.IgE,0
5124,methylone,Methylone:PrThr:Pt:Urine:Ord:Screen,0
5125,Summary registry report,Summary registry report:Find:Pt:{Setting}:Doc:HIV,0
5126,tapentadol,Tapentadol:MCnc:Pt:Ser/Plas/Bld:Qn,0
5127,Rubus idaeus basophil bound Ab,Rubus idaeus basophil bound Ab:ACnc:Pt:Bld:Qn:LHR,0
5128,At which age did you start smoking,At which age did you start smoking:Time:Pt:^Patient:Qn:PhenX,0
5129,"HEDIS 2012, 2013 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E)","HEDIS 2012, 2013 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E):-:Point in time:^Patient:-",0
5130,La Crosse virus ribonucleic acid,La Crosse virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
5131,2-hydroxysebacate,2-Hydroxysebacate:SCnc:Pt:Ser/Plas:Qn,0
5132,Polymorphonuclear cells/100 leukocytes,Polymorphonuclear cells/100 leukocytes:NFr:Pt:Body fld:Qn:Automated count,0
5133,Alpha 1 globulin/Protein.total,Alpha 1 globulin/Protein.total:MFr.DF:24H:Urine:Qn:Electrophoresis,0
5134,INS gene full mutation analysis,INS gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing,0
5135,IEEE Rosetta gas delivery panel,IEEE Rosetta gas delivery panel:-:Pt:Gas delivery system:-,0
5136,Mumps virus antigen,Mumps virus Ag:PrThr:Pt:Isolate:Ord:IF,0
5137,Post-operative evaluation and management note,Postoperative evaluation and management note:Find:Pt:Hospital:Doc:{Role},0
5138,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity.bilateral:Doc:MR,0
5139,Azithromycin,Azithromycin:Susc:Pt:Isolate:OrdQn:Gradient strip,0
5140,Gentamicin induced neutrophil Ab.IgM,Gentamicin induced neutrophil Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
5141,Note (document),Note:Find:Pt:{Setting}:Doc:Mental health.case manager,0
5142,Air delivered.total,Air delivered.total:Vol:RptPeriod:Gas delivery system:Qn,0
5143,Diagnostic study note,Diagnostic study note:Find:Pt:{Setting}:Doc:Allergy+Immunology,0
5144,2-hydroxyadipate,2-Hydroxyadipate:SCnc:Pt:Ser/Plas:Qn,0
5145,"Metanephrine, Normetanephrine, 3-Methoxytyramine & Creatinine panel","Metanephrine, Normetanephrine, 3-Methoxytyramine & Creatinine panel:-:Pt:Urine:-",0
5146,Human immunodeficiency virus 1 proviral DNA,HIV 1 proviral DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
5147,Note (document),Note:Find:Pt:Outpatient:Doc:Pharmacology,0
5148,ST amplitude.lead V5,ST amplitude.lead V5:Elpot:Pt:Heart:Qn:EKG,0
5149,Anesthetic agent.XXX,Anesthetic agent.XXX:VFr/PPres:Pt:Airway adaptor:Qn,0
5150,Photographic image,Photographic image:Find:Pt:{Setting}:Doc:{Author Type},0
5151,Epicoccum purpurascens Ab.IgE,Deprecated Epicoccum purpurascens IgE Ab [Units/volume] in Serum,0
5152,Eptifibatide induced platelet Ab.IgM,Eptifibatide induced platelet Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Flow cytometry,0
5153,"2,4,4'-trichlorobiphenyl","2,4,4'-Trichlorobiphenyl:MCnc:Pt:Ser/Plas:Qn:Confirm",0
5154,Progress note,Progress note:Find:Pt:Telehealth:Doc:{Role},0
5155,Allium cepa basophil bound Ab,Allium cepa basophil bound Ab:ACnc:Pt:Bld:Qn:LHR,0
5156,Transferrin saturation measurement,Deprecated Iron/Iron binding capacity.total [Mass ratio] in Serum or Plasma,0
5157,cyclobenzaprine,Cyclobenzaprine:MCnc:Pt:Ser/Plas:Qn,0
5158,Discharge summary note,Discharge summary note:Find:Pt:{Setting}:Doc:Pain medicine,0
5159,Appearance,Appearance:Aper:Pt:Periton fld:Nom,0
5160,Cotton western Ab.IgE.RAST class,Cotton western Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5161,Vendor model number,Vendor model number:Prid:Pt:Intravascular tube:Nom,0
5162,Vendor model number,Vendor model number:Prid:Pt:Nasogastric tube:Nom,0
5163,Amyloid.microscopic observation,Amyloid.microscopic observation:Prid:Pt:Tiss:Nom:Bennhold stain.Putchler modified,0
5164,Aminolevulinate,Delta aminolevulinate:MCnc:Pt:Urine:Qn,0
5165,little i -2 Ab,Deprecated little i-2 Antibody:Arbitrary Concentration:Point in time:Serum:Ordinal:AGGLUTINATION RBC,0
5166,2-Oxoisovalerate/Creatinine,2-Oxoisovalerate/Creatinine:MRto:Pt:Urine:Qn,0
5167,alpha-Fetoproteins,Alpha-1-Fetoprotein:SCnc:Pt:Amnio fld:Qn,0
5168,(Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE,(Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk,0
5169,Echinococcus sp Ab.IgE.RAST class,Echinococcus sp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5170,Vendor serial number,Vendor serial number:ID:Pt:Nasogastric tube:Nom,0
5171,Fungus.microscopic observation,Fungus.microscopic observation:Prid:Pt:Tiss:Nom:Methenamine silver stain.Grocott,0
5172,Asparagine/Creatinine,Asparagine/Creatinine:MRto:Pt:Urine:Qn,0
5173,Glutaconate/Creatinine,Glutaconate/Creatinine:MRto:Pt:Urine:Qn,0
5174,Smooth muscle antibody,Smooth muscle Ab:PrThr:Pt:Ser:Ord,0
5175,Copper,Copper:SCnc:Pt:Ser/Plas:Qn,0
5176,Desipramine,Desipramine:SCnc:Pt:Urine:Qn,0
5177,Bacteria identified,Bacteria identified:Prid:Pt:Urethra:Nom:Culture,0
5178,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from AC.Campbell 1975,0
5179,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from CRL.Nelson 1981,0
5180,Salmonella typhi O D Ab,S typhi O D Ab Ser Ql,0
5181,butalbital,Butalbital:MCnc:Pt:Urine:Qn:Confirm,0
5182,Secobarbital,Secobarbital:MCnc:Pt:Urine:Qn:Confirm,0
5183,Setomelanomma rostrata Ab.IgE.RAST class,Setomelanomma rostrata Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5184,Carya illinoinensis nut Ab.IgE.RAST class,Carya illinoinensis nut Antibody.immunoglobulin E.RAST class:Arbitrary Concentration:Point in time:Serum:Ordinal,0
5185,Insulin bovine Ab.IgE.RAST class,Insulin bovine Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5186,Echinochloa crus-galli Ab.IgE.RAST class,Echinochloa crus-galli Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5187,ED disposition consult &or referral,ED disposition consult &or referral:Type:Pt:^Patient:Nom,0
5188,Gestational Age,Gestational age:Time:Point in time:^Fetus:Quantitative:ULTRASOUND.estimated from GSD.Rempen.91,0
5189,P Blood group antibodies,Deprecated P NOS Ab [Presence] in Serum or Plasma from Blood product unit,0
5190,Palinurus spp Ab.IgE.RAST class,Palinurus spp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5191,BR-2 Ag,BR-2 Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
5192,basement membrane antibody,Basement membrane Ab:Titr:Pt:Ser:Qn,0
5193,Leukocytes other,Leukocytes other:NCnc:Pt:CSF:Qn:Manual count,0
5194,S' wave amplitude.lead I,S' wave amplitude.lead I:Elpot:Pt:Heart:Qn:EKG,0
5195,Long axis.mean,Long axis.mean:Len:Pt:Radius.diaphysis^Fetus:Qn:Estimated from gestational age.Merz 1987,0
5196,Perimeter topographical modifier,Perimeter:Len:Pt:Abdomen^Fetus:Qn:US.measured.ellipse overlay,0
5197,Hydroxytriazolam,Hydroxytriazolam:PrThr:Pt:Stool:Ord,0
5198,Cystine,Cystine:MCnc:Pt:CSF:Qn,0
5199,Thyrotropin,Thyrotropin^1.5H post dose TRH IV:MCnc:Pt:Ser/Plas:Qn,0
5200,Magnesium,Magnesium:PrThr:Pt:Calculus:Ord,0
5201,Raphanus sativus Ab.IgE.RAST class,Raphanus sativus Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5202,S' wave duration.lead AVF,S' wave duration.lead AVF:Time:Pt:Heart:Qn:EKG,0
5203,Vendor model number,Vendor model number:Prid:Pt:Upper GI tube:Nom,0
5204,Chromogranin A antigen,Chromogranin A Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
5205,Follitropin.alpha subunit Ag,Follitropin.alpha subunit Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
5206,Ephestia kuehniella Ab.IgE,Ephestia kuehniella Ab.IgE:ACnc:Pt:Ser:Qn,0
5207,Physical findings,Physical findings:Finding:Point in time:Foot:Narrative:Observed,0
5208,microscopic observation,Microscopic observation:Prid:Pt:CSF:Nom:Gram stain,0
5209,Leukocytes other/100 leukocytes,Leukocytes other/100 leukocytes:NFr:Pt:Synv fld:Qn:Manual count,0
5210,Tyrophagus putrescentiae Ab.IgE.RAST class,Tyrophagus putrescentiae Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5211,Astragalus spp Ab.IgE.RAST class,Astragalus spp Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5212,Physical findings,Physical findings:Finding:Point in time:Hip:Nominal:Observed,0
5213,Calcium/Osmolality,Calcium/Osmolality:MRto:Pt:Ser/Plas:Qn,0
5214,Thallium/Creatinine,Thallium/Creatinine:MRto:Pt:Urine:Qn,0
5215,Mycobacterium tuberculosis DNA,Mycobacterium tuberculosis DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
5216,Glucose,Glucose^1.5H post 0.5 g/kg glucose IV:MCnc:Pt:Ser/Plas:Qn,0
5217,(Avena sativa+Fagopyrum esculentum+Sesamum indicum+Triticum aestivum+Zea mays) Ab.IgE,(Avena sativa+Fagopyrum esculentum+Sesamum indicum+Triticum aestivum+Zea mays) Antibody.immunoglobulin E:Arbitrary Concentration:Point in time:Serum:Ordinal:Multidisk,0
5218,ACROSIN,Acrosin:EntCat:Pt:Spermatozoa:Qn,0
5219,microscopic observation,Microscopic observation:Prid:Pt:Bone mar:Nom:Wright Giemsa stain,0
5220,albumin/protein.total,Albumin/Protein.total:MFr:Pt:CSF:Qn:Electrophoresis,0
5221,Uroporphyrin 1 isomer,Uroporphyrin 1 isomer:SCnc:Pt:Ser/Plas:Qn,0
5222,Uroporphyrin 3 isomer,Uroporphyrin 3 isomer:SCnc:Pt:Ser/Plas:Qn,0
5223,Abnormal blood cells.CD13/Abnormal blood cells.total,Abnormal blood cells.CD13/Abnormal blood cells.total:NFr:Pt:Bld:Qn,0
5224,Abnormal blood cells.CD14/Abnormal blood cells.total,Abnormal blood cells.CD14/Abnormal blood cells.total:NFr:Pt:Bld:Qn,0
5225,Infectious bronchitis virus Ark-99 Ab,Infectious bronchitis virus Ark-99 Ab:Titr:Pt:Ser:Qn:HAI,0
5226,Temazepam,Deprecated Temazepam [Mass/volume] in Serum or Plasma,0
5227,Melatonin,Melatonin:MCnc:Pt:Ser/Plas:Qn,0
5228,Melatonin,Melatonin:VRat:24H:Urine:Qn,0
5229,metharbital,Metharbital:PrThr:Pt:Stool:Ord,0
5230,Cell positive for CD34 antigen,Cells.CD34:NCnc:Pt:Bld:Qn,0
5231,Procainamide+N-acetylprocainamide,Procainamide+N-acetylprocainamide:SCnc:Pt:Ser/Plas:Qn,0
5232,ST wave displacement.end.lead AVF,ST wave displacement.end.lead AVF:Elpot:Pt:Heart:Qn:EKG,0
5233,Cells other than spermatozoa,Cells other than spermatozoa:NCnc:Pt:Semen:Qn,0
5234,Thiazolidine-2-Thione-4-Carboxylic acid,Thiazolidine-2-Thione-4-Carboxylic acid:MCnc:Pt:Urine:Qn,0
5235,Xylose,Xylose^5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
5236,microscopic observation,Microscopic observation:Prid:Pt:Bld:Nom:Crystal violet stain,0
5237,Ciprofloxacin,Ciprofloxacin^trough:MCnc:Pt:Ser/Plas:Qn,0
5238,Hydrocortisone,Cortisol^1H post 250 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn,0
5239,Carbon Dioxide,Carbon dioxide:SCnc:Pt:Stool:Qn,0
5240,Chlamydia trachomatis,Chlamydia trachomatis:PrThr:Pt:Urine sed:Ord:Organism specific culture,0
5241,Creatine kinase.BB/Creatine kinase.total,Creatine kinase.BB/Creatine kinase.total:CFr:Pt:Ser/Plas:Qn:Electrophoresis,0
5242,Parrot serum proteins Ab.IgE.RAST class,Parrot serum proteins Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5243,Vespa crabro Ab.IgE,Vespa crabro Ab.IgE:ACnc:Pt:Ser:Qn,0
5244,Parainfluenza virus 1 IgG,Parainfluenza virus 1 Ab.IgG:PrThr:Pt:Ser:Ord,0
5245,Activities,Activity:Finding:Point in time:Trunk^Fetus:Nominal:ULTRASOUND,0
5246,Systolic flow/Diastolic flow,Systolic flow/Diastolic flow:VelRto:Pt:Ovarian artery.left:Qn:US.doppler,0
5247,C-Peptide,C peptide^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
5248,Phosphatidylethanolamine Ab.IgG,Phosphatidylethanolamine Ab.IgG:ACnc:Pt:Ser:Qn,0
5249,Glucose,Glucose^1H post 50 g glucose PO:MCnc:Pt:Urine:Qn,0
5250,Glucagon,Glucagon:SCnc:Pt:Ser/Plas:Qn,0
5251,Service comment 28,Service comment 28:Impression/interpretation of study:Point in time:To be specified in another part of the message:Nominal,0
5252,Service comment 37,Service comment 37:Impression/interpretation of study:Point in time:To be specified in another part of the message:Nominal,0
5253,Equine herpesvirus 1 Ab,Equine herpesvirus 1 Ab:Titr:Pt:Ser:Qn:Neut,0
5254,Equine influenza virus A1 Ab,Equine influenza virus A1 Ab:Titr:Pt:Ser:Qn:HAI,0
5255,Present illness,History of present illness:Finding:Point in time:^Patient:Narrative:Reported,0
5256,Spermatozoa.motile with IgG/100 spermatozoa,Spermatozoa.motile with IgG/100 spermatozoa:NFr:Pt:Semen:Qn:Mixed antiglobulin reaction,0
5257,Megakaryocytes/100 cells,Megakaryocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count,0
5258,Blood flow.mean,Blood flow.mean:Vel:Pt:Umbilical artery.at placenta^Fetus:Qn:US.doppler,0
5259,Antigen in LW blood group system,LW Ag:PrThr:Pt:RBC:Ord,0
5260,Creatinine renal clearance/1.73 sq M,CREATININE RENAL CLEARANCE/1.73 SQ M:VOLUME RATE:24 HOURS:URINE AND SERUM/PLASMA:QUANTITATIVE,0
5261,Asialoganglioside GM1 Ab.IgG,Deprecated Asialoganglioside GM1 Ab.IgG,0
5262,Temazepam,Temazepam:PrThr:Pt:Ser/Plas:Ord,0
5263,Pneumocystis jiroveci antigen,Pneumocystis jiroveci Ag:PrThr:Pt:Thrt:Ord:IF,0
5264,Chromium,Chromium:SCnc:Pt:Bld:Qn,0
5265,Ethanol,Ethanol:SCnc:Pt:Bld:Qn,0
5266,Symptoms & diseases,History of symptoms & diseases:Finding:Point in time:Musculoskeletal system:Narrative:Reported,0
5267,Phosphate/Creatinine,Phosphate/Creatinine:MRto:Pt:Urine:Qn,0
5268,Beta lactoglobulin Ab.IgG,Beta lactoglobulin Ab.IgG:ACnc:Pt:Ser:Qn,0
5269,Blood flow.systolic.max,Blood flow.systolic.max:Vel:Pt:Heart.ventricle.left.outflow tract^Fetus:Qn:US.doppler,0
5270,Glucose,Glucose^12H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
5271,Blatella germanica Ab.IgE.RAST class,Blatella germanica Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5272,Vendor model number,Vendor model number:Prid:Pt:Cardiac measurement device:Nom,0
5273,Renin,Deprecated Renin [Enzymatic activity/volume] in Plasma,0
5274,Immune complex,Immune complex:MCnc:Pt:Ser/Plas:Qn:PEG assay,0
5275,cholesteryl sulfate,Cholesterol sulfate:MCnc:Pt:Ser:Qn,0
5276,Complement C3b.inactive,Complement C3b.inactive:MCnc:Pt:Plas:Qn,0
5277,Streptococcus pneumoniae Danish serotype 23F Ab,Streptococcus pneumoniae 23f Ab^2nd specimen:ACnc:Pt:Ser:Qn,0
5278,Streptococcus pneumoniae Danish serotype 3 Ab,Deprecated Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --2nd specimen,0
5279,Complement C1 esterase inhibitor free Ab.IgM,Complement C1 esterase inhibitor free Ab.IgM:MCnc:Pt:Ser/Plas:Qn,0
5280,Carbon Dioxide,Carbon dioxide^post chest physiotherapy:PPres:Pt:BldC:Qn,0
5281,Volume expired during 1.0 s of forced expiration/Forced vital capacity,Volume at 1.0 s post forced expiration/Vital capacity.forced:Volume Ratio:Point in time:Respiratory system:Quantitative:Predicted,0
5282,Path report.relevant Hx,Path report.relevant Hx:Find:Pt:Specimen:Nar,0
5283,Path report.staging evidence,Path report.staging evidence:Find:Pt:Specimen:Nar,0
5284,Theileria parva Ab,Theileria parva Ab:Titr:Pt:Ser:Qn:IF,0
5285,Borrelia burgdorferi Ab index,Borrelia burgdorferi Ab index:PrThr:Pt:Ser+CSF:Ord,0
5286,Glutathione,Glutathione:MCnc:Pt:RBC:Qn,0
5287,beta-Galactosidase,Beta galactosidase:CCnt:Pt:Tiss:Qn,0
5288,Oxyhemoglobin/Hemoglobin.total,Deprecated Fractional oxyhemoglobin in 8 hour minimum by Pulse oximetry,0
5289,Maximum,Max^during inspiration on ventilator:Pres:Pt:Trachea.airway:Qn,0
5290,Calcium,Calcium:SCnc:Pt:Dial fld:Qn,0
5291,Oxygen saturation test result,Oxygen saturation:MFr:Pt:Bld:Qn,0
5292,Plant identified,PLANT IDENTIFIED:TYPE:POINT IN TIME:PLANT:NOMINAL,0
5293,Avian infectious laryngotracheitis virus Ag,Avian infectious laryngotracheitis virus Ag:PrThr:Pt:Trac:Ord:IA,0
5294,Transmissible gastroenteritis virus Ag,Transmissible gastroenteritis virus Ag:PrThr:Pt:Tsmi:Ord:IF,0
5295,Coproporphyrins,Deprecated Coproporphyrin [Mass/time] in 24 hour Stool,0
5296,Comparison.study,Comparison.study:Impression/interpretation of study:Point in time:Heart:Narrative:EKG,0
5297,Arginine,Arginine:MRat:24H:Urine:Qn,0
5298,Nalidixate,Nalidixate:Susc:Pt:Isolate:OrdQn,0
5299,Ethylmorphine,Ethylmorphine:PrThr:Pt:Urine:Ord:Confirm,0
5300,Sarcocystis neurona antibody,Sarcocystis neurona Ab:PrThr:Pt:Body fld:Ord:IB,0
5301,Shigella sp identified,Shigella sp identified:Prid:Pt:Feed:Nom:Organism specific culture,0
5302,Leptospira interrogans serovar Pomona antibody,Leptospira interrogans serovar Pomona Ab:PrThr:Pt:Ser:Ord:Aggl,0
5303,Leptospira species antibody,Leptospira sp Ab:PrThr:Pt:Ser:Ord:IA,0
5304,Osmotic Fragility test,Osmotic fragility^0.75% sodium chloride 24H 37 deg C incubation:NFr:Pt:RBC:Qn,0
5305,Trichinella spiralis antibody,Trichinella spiralis Ab:PrThr:Pt:Ser:Ord:LA,0
5306,Coproporphyrins,Coproporphyrin:MCnc:Pt:Bld:Qn,0
5307,Clarithromycin,Clarithromycin:Susc:Pt:Isolate:OrdQn,0
5308,Peak inspiratory flow rate,Peak inspiratory flow^at 1.5 liter per second on ventilator:Pres:Pt:Respiratory system.airway opening:Qn,0
5309,Peak inspiratory flow rate,Peak inspiratory flow^at 2.0 liter per second on ventilator:Pres:Pt:Respiratory system.airway opening:Qn,0
5310,Border disease virus Ab,Border disease virus Ab:Titr:Pt:Ser:Qn:Neut,0
5311,Border disease virus Ag,Border disease virus Ag:PrThr:Pt:Bld:Ord:IA,0
5312,Spontaneous tidal volume,Tidal volume.spontaneous^on ventilator:Vol:Pt:Respiratory system:Qn,0
5313,Albumins,Albumin^2H post peritoneal dialysis:MCnc:Pt:Ser/Plas:Qn,0
5314,Pisum sativum Ab.IgG.RAST class,Pisum sativum Ab.IgG.RAST class:PrThr:Pt:Ser:Ord,0
5315,Prunus persica Ab.IgG.RAST class,Prunus persica Ab.IgG.RAST class:PrThr:Pt:Ser:Ord,0
5316,Pepper cayenne Ab.IgG.RAST class,Pepper cayenne Ab.IgG.RAST class:PrThr:Pt:Ser:Ord,0
5317,Bovine diarrhea virus Antigen,Bovine diarrhea virus Ag:PrThr:Pt:Bld:Ord:IA,0
5318,Lutropin/Follitropin,Follitropin/Lutropin:SRto:Pt:Ser/Plas:Qn,0
5319,Alpha 2 globulin/Protein.total,Alpha 2 globulin/Protein.total:MFr:Pt:Body fld:Qn:Electrophoresis,0
5320,Aspergillus terreus Ab.IgE.RAST class,Aspergillus terreus Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5321,Version used,Version used:ID:Pt:TNM classification:Nom,0
5322,Date 1st cancer Rx (any).SEERS,Date 1st cancer Rx (any).SEERS:Time Stamp -- Date and Time:Point in time:Cancer.To be specified in another part of the message:Quantitative,0
5323,3-methylhistidine,3-Methylhistidine:PrThr:Pt:Ser/Plas:Ord,0
5324,"5,10-Methylenetetrahydrofolate Reductase (FADH2)","5,10-Methylenetetrahydrofolate reductase:CCnc:Pt:Ser:Qn",0
5325,Chlortetracycline,Chlortetracycline:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
5326,Albumin bound estradiol,Estradiol.albumin bound:MCnc:Pt:Ser/Plas:Qn,0
5327,Circumference.XXX/Circumference 2.XXX,Circumference.XXX/Circumference 2.XXX:CircFr:Pt:Region of interest.XXX:Qn:US,0
5328,Dx &or stage,Dx &or stage:ID:Pt:Procedure:Nom,0
5329,Gastrin releasing peptide,Gastrin releasing polypeptide:MCnc:Pt:CSF:Qn,0
5330,Viral hemorrhagic disease virus Ab,Viral hemorrhagic disease virus Ab:Titr:Pt:Ser:Qn,0
5331,Adenosine Triphosphate,Adenosine triphosphate:MCnc:Pt:Bld:Qn,0
5332,Neutrophil Ab.IgM,Neutrophil Ab.IgM:ACnc:Pt:Ser:Qn,0
5333,Cardiac Output,Cardiac output:VRat:Pt:Heart.ventricle.XXX:Qn:US.2D+Calculated by modified Simpson method,0
5334,End-diastolic volume,End-diastolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.cubed.calculated,0
5335,Site&laterality&sequence number override flag,Site&laterality&sequence number override flag:Arb:Pt:Cancer case.XXX:Ord,0
5336,Surgery&diagnosis confirm override flag,Surgery&diagnosis confirm override flag:Arb:Pt:Cancer case.XXX:Ord,0
5337,CRC checksum,CRC checksum:Number:Point in time:Cancer case.To be specified in another part of the message:Quantitative,0
5338,Streptococcus pneumoniae Danish serotype 14 IgG,Deprecated Streptococcus pneumoniae 14 IgG Ab [Units/volume] in Serum,0
5339,Fructose,Fructose:MCnc:Pt:Semen:Qn,0
5340,Mycoplasma putrefaciens Ab,Mycoplasma putrefaciens Ab:PrThr:Pt:Ser:Ord:IA,0
5341,Maximal Voluntary Ventilation,Voluntary ventilation.max^pre bronchodilator/Voluntary ventilation.max predicted:RelVRat:Pt:Respiratory system:Qn,0
5342,Cells.CD56/100 cells,CD56 Cells fr XXX,0
5343,Text diagnosis battery,Deprecated Text diagnosis battery,0
5344,Strongyloides species antibody,Deprecated Strongyloides sp Ab [Units/volume] in Serum,0
5345,Campylobacter fetus antigen,Campylobacter fetus Ag:PrThr:Pt:Tiss:Ord:IF,0
5346,Glucose,Glucose^1st specimen post XXX challenge:PrThr:Pt:Urine:Ord,0
5347,Haemophilus influenzae IgG,Haemophilus influenzae Ab.IgG:ACnc:Pt:Ser:Qn,0
5348,A-C duration,A-C duration:Time:Pt:Mitral valve.leaflet.anterior:Qn:US.M-mode,0
5349,Acetylcarnitine (C2),Acetylcarnitine (C2):MCnc:Pt:Ser/Plas:Qn,0
5350,Diameter.systole,Diameter.systole:Len:Pt:Heart.ventricle.right:Qn:US,0
5351,Stroke Volume,Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane ellipse method,0
5352,Eastern equine encephalitis virus Antibody,Eastern equine encephalitis virus Ab:PrThr:Pt:Ser:Ord:HAI,0
5353,Wheat dust Ab.IgE,Wheat dust Ab.IgE:ACnc:Pt:Ser:Qn,0
5354,Blastomyces dermatitidis antibody,Blastomyces dermatitidis Ab:ACnc:Pt:Ser:Qn,0
5355,Cinoxacin,Cinoxacin:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
5356,Cis-4-decenoylcarnitine (Cis 4 C10:1),Cis-4-decenoylcarnitine (Cis 4 C10:1):MCnc:Pt:Ser/Plas:Qn,0
5357,Metoclopramide,Metoclopramide:MCnc:Pt:Urine:Qn,0
5358,Prostate-Specific Antigen,Prostate specific Ag:SCnc:Pt:Ser/Plas:Qn,0
5359,Prostate-Specific Antigen,Prostate specific Ag:MCnc:Pt:Semen:Qn,0
5360,Psilocybin cutoff,Psilocybin cutoff:MCnc:Pt:Urine:Qn:Screen,0
5361,Magnesium,Magnesium:SCnc:24H:Stool:Qn,0
5362,Pasteurella multocida serotype,Pasteurella multocida serotype:Prid:Pt:XXX:Nom:IF,0
5363,Canine distemper virus Ab.IgM,Canine distemper virus Ab.IgM:Titr:Pt:Ser:Qn:IF,0
5364,Herpes simplex virus 2 DNA,Herpes simplex virus 2 DNA:PrThr:Pt:Ser/Plas:Ord:Probe.amp.tar,0
5365,Herpes simplex virus 2 DNA,Herpes simplex virus 2 DNA:PrThr:Pt:CSF:Ord:Probe.amp.tar,0
5366,Alanine Transaminase,Alanine aminotransferase:CCnc:Pt:Ser/Plas:Qn:With P-5'-P,0
5367,Phenazopyridine,Phenazopyridine:MCnc:Pt:Ser/Plas:Qn,0
5368,Reference beat,Reference beat:Type:Point in time:Reference beat:Nominal:EKG,0
5369,Icteric Specimen,Sample icteric:PrThr:Pt:Ser/Plas:Ord,0
5370,Cobalt,Cobalt:MCnc:24H:Urine:Qn,0
5371,CFTR gene mutations tested for,CFTR gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen,0
5372,fumarate,Fumarate:MCnc:Pt:Urine:Qn,0
5373,Duck hepatitis virus 2 Ab,Duck hepatitis virus 2 Ab:PrThr:Pt:Ser:Ord:Neut,0
5374,Eastern equine encephalitis virus Antibody,Eastern equine encephalitis virus Ab:PrThr:Pt:Ser:Ord:Neut,0
5375,Ionized calcium,Calcium.ionized^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
5376,Rotavirus antigen,Rotavirus Ag:PrThr:Pt:Stool:Ord,0
5377,Plasminogen activator inhibitor-2 antigen,Plasminogen activator inhibitor 2 Ag:ACnc:Pt:PPP:Qn:IA,0
5378,ST amplitude.J point+20 ms,ST amplitude.J point+20 ms:Elpot:Pt:Lead V6:Qn:EKG,0
5379,Benzodiazepines cutoff,Benzodiazepines cutoff:MCnc:Pt:Urine:Qn:Confirm,0
5380,Sheep whey Ab.IgE,Sheep whey Ab.IgE:ACnc:Pt:Ser:Qn,0
5381,Alloisoleucine,Alloisoleucine:SCnc:Pt:CSF:Qn,0
5382,Coproporphyrins,Coproporphyrin:SCnc:Pt:Ser/Plas:Qn,0
5383,Cannabinoids,Cannabinoids:MCnc:Pt:Ser/Plas:Qn:Confirm,0
5384,Pseudomonas aeruginosa antibody,Pseudomonas aeruginosa Ab:ACnc:Pt:Ser:Qn,0
5385,Carnitine,Carnitine:PrThr:Pt:Ser/Plas:Ord,0
5386,Leptospira species,Leptospira sp:PrThr:Pt:Tiss:Ord:Organism specific culture,0
5387,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subspecies paratuberculosis:PrThr:Pt:Tiss:Ord:Organism specific culture,0
5388,Estriol,Estriol.unconjugated^^unadjusted:MoM:Pt:Ser/Plas:Qn,0
5389,Glutamine/Creatinine,Glutamine/Creatinine:SRto:Pt:Urine:Qn,0
5390,Equine arteritis virus antibody,Equine arteritis virus Ab:Titr:Pt:Ser:Qn:Comp fix,0
5391,Equine herpesvirus 1+4 Ab,Equine herpesvirus 1+4 Ab:Titr:Pt:Ser:Qn:Neut,0
5392,Equine herpesvirus 1+4 Ab,Equine herpesvirus 1+4 Ab:Titr:Pt:Ser:Qn:Comp fix,0
5393,GD1b IgM ganglioside antibody,Ganglioside GD1b Ab.IgM:Titr:Pt:CSF:Qn:IA,0
5394,Cystathionine,Cystathionine:PrThr:Pt:Urine:Ord,0
5395,Catecholamines,Catecholamines^5th specimen post XXX challenge:MCnc:Pt:Plas:Qn,0
5396,Insulin,Insulin^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
5397,Measles antibody,Measles virus Ab:ACnc:Pt:CSF:Qn,0
5398,Alpha hydroxyalprazolam cutoff,Alpha hydroxyalprazolam cutoff:MCnc:Pt:Urine:Qn:Confirm,0
5399,Chorionic Gonadotropin,Choriogonadotropin:MoM:Pt:Ser/Plas:Qn,0
5400,Coxsackievirus B1 Ab,Coxsackievirus B1 Ab:Titr:Pt:CSF:Qn,0
5401,Coxsackievirus B3 Ab,Coxsackievirus B3 Ab:Titr:Pt:Ser:Qn,0
5402,Salmonella Pullorum Ab,Salmonella pullorum Ab:Titr:Pt:Ser:Qn:Aggl,0
5403,Isocyanate Ab.IgM,Isocyanate Ab.IgM:ACnc:Pt:Ser:Qn,0
5404,St. Louis encephalitis virus antibody,Saint Louis encephalitis virus Ab:ACnc:Pt:CSF:Qn,0
5405,Study observation,Study observation:Finding:Point in time:Heart.valves:Narrative:ULTRASOUND,0
5406,Apolipoprotein A-I,Apolipoprotein A-I:MCnc:Pt:Ser/Plas:Qn,0
5407,Amphetamine cutoff,Amphetamine cutoff:MCnc:Pt:Urine:Qn:Confirm,0
5408,aprobarbital,Aprobarbital:MCnc:Pt:Urine:Qn:Confirm,0
5409,Anatid herpesvirus 1 antibody,Duck enteritis virus Ab:PrThr:Pt:Ser:Ord,0
5410,African horse sickness virus Ab,African horse sickness virus Ab:Titr:Pt:Ser:Qn,0
5411,Coccidioides immitis IgG,Coccidioides immitis Ab.IgG:ACnc:Pt:CSF:Qn,0
5412,Dinoprost,Prostaglandin F2 alpha:MCnc:Pt:Urine:Qn,0
5413,Streptococcus pneumoniae Danish serotype 1 Ab,Deprecated Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --2nd specimen,0
5414,Streptococcus pneumoniae Danish serotype 12F Ab,Deprecated Streptococcus pneumoniae 12 Ab [Ratio] in Serum --2nd specimen/1st specimen,0
5415,Chocolate Ab.IgE.RAST class,Chocolate Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5416,2-methylcitrate,2-Methylcitrate:SCnc:Pt:Ser/Plas:Qn,0
5417,Serine,Serine:MCnc:Pt:Ser/Plas:Qn,0
5418,West Nile virus antibody,West Nile virus Ab:Titr:Pt:XXX:Qn,0
5419,Flunitrazepam,Flunitrazepam:SCnc:Pt:Ser/Plas:Qn,0
5420,Dopamine,Dopamine^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
5421,Blood flow.systole.max/Blood flow.diastole.max,Blood flow.systole.max/Blood flow.diastole.max:VelRto:Pt:Pulmonary vein.left upper:Qn:US.doppler,0
5422,neutrophil,Polymorphonuclear cells:PrThr:Pt:Synv fld:Ord:Wright stain,0
5423,Leukocytes other,Leukocytes other:NCnc:Pt:CSF:Qn,0
5424,Prism base distance,Prism base distance:InvLen:Pt:Glasses prescription.lens.left:Qn,0
5425,Cylinder N 2,Cylinder N 2:InvLen:Pt:Glasses prescription.lens.left:Qn,0
5426,Views max abduction,Views max abduction:Find:Pt:Pelvis & Lower extremity.bilateral>Hip:Doc:XR,0
5427,View,Views:Find:Pt:Upper extremity>Finger.fourth:Doc:XR,0
5428,F2 gene targeted mutation analysis,F2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen,0
5429,(Ambrosia elatior+Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Salsola kali) Ab.IgE.RAST class,(Ambrosia elatior+Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Salsola kali) Ab.IgE.RAST class:PrThr:Pt:Ser:Ord:Multidisk,0
5430,neutrophil,Neutrophils:NCnc:Pt:Plr fld:Qn,0
5431,Blood Platelets,Platelets:NCnc:Pt:Plas:Qn,0
5432,Herpes virus 6 deoxyribonucleic acid,Herpes virus 6 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
5433,Cysticercus antibody,Deprecated Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid,0
5434,CD16+CD56+ cell,Cells.CD16+CD56+:NCnc:Pt:XXX:Qn,0
5435,Ammonia,Ammonia:MCnc:24H:Urine:Qn,0
5436,Methadone,Methadone:MCnc:Pt:Milk:Qn,0
5437,Lactation established (finding),Milk production:MRat:24H:^Patient:Qn,0
5438,View,Views^W contrast IA:Find:Pt:Abdomen>Aorta.abdominal:Doc:RF.angio,0
5439,Borrelia burgdorferi Ab.IgG band pattern,Borrelia burgdorferi Ab.IgG band pattern:Imp:Pt:CSF:Nom:IB,0
5440,Cannabinoids,Cannabinoids:MCnt:Pt:Stool:Qn,0
5441,Streptococcus pneumoniae 9 Ab,Deprecated Streptococcus pneumoniae 9 Ab [Mass/volume] in Serum,0
5442,Beryllium/Creatinine,Beryllium/Creatinine:MRto:24H:Urine:Qn,0
5443,Cytomegalovirus IgM Antibody,Cytomegalovirus Ab.IgM:PrThr:Pt:Ser/Plas:Ord,0
5444,C-Peptide,C peptide^13th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
5445,Cladosporium cladosporioides Ab.IgG,Cladosporium cladosporioides Ab.IgG:ACnc:Pt:Ser:Qn,0
5446,Leucine,Leucine:MCnc:Pt:Ser/Plas:Qn,0
5447,5-hydroxylysine,Hydroxylysine:SCnc:Pt:Ser/Plas:Qn,0
5448,phosphoethanolamine,Phosphoethanolamine:SCnc:Pt:Ser/Plas:Qn,0
5449,Bile Acids,Bile acid^2H post meal:SCnc:Pt:Ser:Qn,0
5450,14-3-3 Ag,14-3-3 Ag:ACnc:Pt:CSF:Qn:IA,0
5451,Vanadium,Vanadium:MCnc:24H:Urine:Qn,0
5452,Eosinophils/100 leukocytes,Eosinophils/100 leukocytes:NFr:Pt:Plr fld:Qn,0
5453,Human immunodeficiency virus 1 RNA,HIV 1 RNA:Imp:Pt:Ser:Nom,0
5454,View,Views:Find:Pt:Upper extremity.bilateral>Radius+Ulna:Doc:XR,0
5455,View,Views:Find:Pt:Upper extremity.bilateral>Thumb:Doc:XR,0
5456,Jamestown canyon virus Ab,Jamestown canyon virus Ab:PrThr:Pt:Ser:Ord,0
5457,Comment,Comment:Imp:Pt:LM glasses.lens.left:Nom,0
5458,2-Ethyl-3-Hydroxypropionate/Creatinine,2-Ethyl-3-Hydroxypropionate/Creatinine:SRto:Pt:Urine:Qn,0
5459,Cesium/Creatinine,Cesium/Creatinine:MRto:24H:Urine:Qn,0
5460,Interferon.beta 1 Ab,Interferon.beta 1 Ab:ACnc:Pt:Ser/Plas:Qn,0
5461,Perimeter format,Perimeter format:Prid:Pt:Visual sensory:Nom:Perimetry.Kowa,0
5462,Monocytes.abnormal/100 leukocytes,Monocytes.abnormal/100 leukocytes:NFr:Pt:Bld:Qn,0
5463,LACROSSE VIRUS ANTIBODY,La Crosse virus Ab:PrThr:Pt:XXX:Ord,0
5464,Influenzavirus A antigen,Influenza virus A Ag:PrThr:Pt:XXX:Ord,0
5465,Multisection,Multisection:Find:Pt:Upper extremity>Wrist:Doc:US,0
5466,Multisection,Multisection:Find:Pt:Chest>Brachial plexus.left:Doc:MR,0
5467,Physical findings,Physical findings:Find:Pt:Iris.left:Nar,0
5468,(Budgerigar feather+Canary feather+Parrot feather+Finch feather) Ab.IgE,(Budgerigar feather+Canary feather+Parrot feather+Finch feather) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk,0
5469,Date of other vaccinations given within 4W prior to the date of vaccine causing adverse event,Date of other vaccinations given within 4 weeks prior to the date of vaccine causing adverse event:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative,0
5470,GM1 IgM ganglioside antibody,Ganglioside GM1 Ab.IgM:ACnc:Pt:Ser:Qn,0
5471,Neisseria gonorrhoeae DNA,Neisseria gonorrhoeae DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
5472,View,Views^during surgery:Find:Pt:XXX:Doc:RF,0
5473,Magnesium,Magnesium:SCnt:Pt:Stool:Qn,0
5474,Cocaine,Cocaine:MCnc:Pt:Vitr fld:Qn,0
5475,Platelet associated antibody,Deprecated Platelet associated Ab [Presence] in Blood,0
5476,Insulin,Insulin^2H post XXX challenge:ACnc:Pt:Ser/Plas:Qn,0
5477,Lecithin,Lecithin:MCnc:Pt:Plas:Qn,0
5478,Delavirdine,Delavirdine:ACnc:Pt:Ser/Plas:Qn,0
5479,Growth Hormone,Somatotropin^4H post XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
5480,Luteinizing Hormone,Lutropin:ACnc:24H:Urine:Qn,0
5481,Voltage-gated calcium-channel antibody,Voltage-gated calcium channel Ab:PrThr:Pt:Ser:Ord,0
5482,Tetrahydrocortisone/Creatinine,Tetrahydrocortisone/Creatinine:MRto:Pt:Urine:Qn,0
5483,Tetrahydroaldosterone/Creatinine,Tetrahydroaldosterone/Creatinine:MRto:Pt:Urine:Qn,0
5484,Mycoplasma pneumoniae IgA,Mycoplasma pneumoniae Ab.IgA:PrThr:Pt:Ser:Ord,0
5485,Sample weight,Specimen weight:Mass:Pt:XXX:Qn,0
5486,Immunoglobulin IgG4,IgG subclass 4:MCnc:Pt:Ser:Qn,0
5487,Follicle Stimulating Hormone,Follitropin^3rd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn,0
5488,Mycoplasma pneumoniae antibody,Mycoplasma pneumoniae Ab:Titr:Pt:CSF:Qn:Comp fix,0
5489,Rickettsia australis antibody,Rickettsia australis Ab:PrThr:Pt:Ser:Ord,0
5490,Burkholderia pseudomallei IgG,Burkholderia pseudomallei Ab.IgG:Titr:Pt:XXX:Qn:IF,0
5491,Legionella pneumophila 1 IgM,Legionella pneumophila 1 Ab.IgM:Titr:Pt:CSF:Qn:IF,0
5492,Multisection,Multisection:Find:Pt:Upper extremity>Forearm:Doc:MR,0
5493,Staphylococcus aureus enterotoxin C Ab.IgE.RAST class,Staphylococcus aureus enterotoxin C Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5494,Mephentermine,Mephentermine:MCnc:Pt:Urine:Qn,0
5495,Methadone,Methadone:MCnt:Pt:Stool:Qn,0
5496,Taurine/Creatinine,Taurine/Creatinine:Ratio:Pt:Urine:Qn,0
5497,Canine parvovirus Ab,Canine parvovirus Ab:PrThr:Pt:Stool:Ord:HAI,0
5498,Haptoglobins,Haptoglobin:MCnc:Pt:Body fld:Qn,0
5499,Multisection,Multisection^WO & W contrast IV:Find:Pt:Neck>Neck vessels:Doc:CT.angio,0
5500,Rhodococcus equi Ab,Rhodococcus equi Ab:PrThr:Pt:Ser:Ord,0
5501,Lactate,Lactate:SCnc:Pt:CSF:Qn,0
5502,3-Methylhistidine/Creatinine,3-Methylhistidine/Creatinine:SRto:24H:Urine:Qn,0
5503,Multisection limited,Multisection limited:Find:Pt:Breast.right:Doc:US,0
5504,Guidance for reposition of central venous catheter,Guidance for reposition of central venous catheter^W contrast IV:Find:Pt:XXX>Vein.bilateral:Doc:RF.angio,0
5505,Calcium,Calcium:PrThr:Pt:Urine:Ord,0
5506,Rubella virus antigen,Rubella virus Ag:PrThr:Pt:Eye:Ord,0
5507,Polio virus 3 Ab,Polio virus 3 Ab^2nd specimen:Titr:Pt:Ser:Qn,0
5508,LACROSSE VIRUS ANTIBODY,La Crosse virus Ab^1st specimen:Titr:Pt:Ser:Qn,0
5509,Beta alanine/Creatinine,Beta alanine/Creatinine:SRto:24H:Urine:Qn,0
5510,Coproporphyrins,Coproporphyrin:SCnc:24H:Urine:Qn,0
5511,Creatinine,Creatinine:SCnc:24H:Urine:Qn,0
5512,Testosterone/Creatinine,Testosterone/Creatinine:MRto:24H:Urine:Qn,0
5513,Lipid bound sialate,Sialate.lipid bound:MCnc:Pt:Ser/Plas:Qn,0
5514,2-hydroxyisobutyrate,2-Hydroxyisobutyrate:PrThr:Pt:Urine:Ord,0
5515,Cylinder (shape),Cylinder:InvLen:Pt:Eye.left:Qn:Autorefractor.auto,0
5516,View,Views:Find:Pt:Chest:Doc:RF,0
5517,Views 3,Views 3:Find:Pt:Upper extremity.right>Hand:Doc:XR,0
5518,Visual Acuity,Deprecated Visual acuity Left eye Autorefractor.sciascopy,0
5519,Aspergillus fumigatus 2 Ab,Aspergillus fumigatus 2 Ab:PrThr:Pt:Ser:Ord,0
5520,Multisection,Multisection^W contrast IT:Find:Pt:Neck>Spine.cervical:Doc:CT,0
5521,Bacteria,Bacteria:PrThr:Pt:Plr fld:Ord:Microscopy.light,0
5522,Multisection limited,Multisection limited:Find:Pt:Abdomen+Pelvis>Iliac graft:Doc:US.doppler,0
5523,Acylcarnitine/Carnitine.free (C0),Acylcarnitine/Carnitine.free (C0):Ratio:Pt:Urine:Qn,0
5524,Babesia species antibody,Babesia sp Ab:PrThr:Pt:Ser:Ord,0
5525,Cyclic AMP,Deprecated Adenosine monophosphate.cyclic/Creatinine [Ratio] in Urine --6th specimen post XXX challenge,0
5526,FGF23 gene targeted mutation analysis,FGF23 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN,0
5527,View,Views:Finding:Point in time:Sella turcica:Narrative:XR,0
5528,Views for tumor,Views for tumor^W radionuclide IV:Find:Pt:Whole body:Doc:NM,0
5529,Bromides,Bromide:SCnc:Pt:Urine:Qn,0
5530,Echovirus 30 Ab,Echovirus 30 Ab:PrThr:Pt:Body fld:Ord,0
5531,Creatinine,Creatinine^2H specimen:SCnc:Pt:Dial fld:Qn,0
5532,Borrelia burgdorferi 23kD IgG,Deprecated Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoassay,0
5533,Salmonella typhi O D Ab,Deprecated Salmonella typhi O D Antibody:Arbitrary Concentration:Point in time:Serum:Ordinal,0
5534,Bacteria identified,Bacteria identified^^^7:Prid:Pt:XXX:Nom:Culture,0
5535,Bacteria identified,Bacteria identified^^^6:Prid:Pt:XXX:Nom:Anaerobic culture,0
5536,Epithelial Cells,Epithelial cells:Naric:Pt:Urine sed:Qn:Microscopy.light.LPF,0
5537,Arachis hypogaea leukotriene release,Arachis hypogaea leukotriene release:MCnc:Pt:WBC:Qn,0
5538,Epstein Barr virus capsid IgM,Epstein Barr virus capsid Ab.IgM:PrThr:Pt:Ser:Ord:IF,0
5539,Coxsackievirus A Ab,Coxsackievirus A Ab:Titr:Pt:CSF:Qn,0
5540,Ethosuximide,Ethosuximide^trough:MCnc:Pt:Ser/Plas:Qn,0
5541,Giardia lamblia IgM,Giardia lamblia Ab.IgM:PrThr:Pt:Ser:Ord,0
5542,Josamycin,Josamycine:Susc:Pt:Isolate:OrdQn:Gradient strip,0
5543,Borrelia burgdorferi DNA,Borrelia burgdorferi DNA:PrThr:Pt:^Tick:Ord:Probe.amp.tar,0
5544,Hemoglobin A/Hemoglobin.total,Hemoglobin A/Hemoglobin.total:MFr:Pt:Bld:Qn:HPLC,0
5545,Parrot droppings Ab.IgG,Parrot droppings Ab.IgG:PrThr:Pt:Ser:Ord,0
5546,GLUTATHIONE PEROXIDASE,Glutathione peroxidase:CCnt:Pt:RBC:Qn,0
5547,Maprotiline,Maprotiline:SCnc:Pt:Gast fld:Qn,0
5548,Proinsulin,Proinsulin^baseline:SCnc:Pt:Ser/Plas:Qn,0
5549,HLA-A*23 antigen,HLA-A23(9):PrThr:Pt:Bld/Tiss^Donor:Ord,0
5550,Medium &or short chain acyl-CoA dehydrogenase deficiency,Medium &or short chain acyl-CoA dehydrogenase deficiency:Imp:Pt:Bld.dot:Nom,0
5551,Interleukin-12,Interleukin 12:MCnc:Pt:Body fld:Qn:IA,0
5552,Views quantitative,Views quantitative^W radionuclide IV:Find:Pt:Chest>Lung:Doc:NM,0
5553,Practolol,Practolol:Mass:Pt:Dose:Qn,0
5554,Fatty acids pattern,Fatty acids:Impression/interpretation of study:Point in time:Serum/Plasma:Nominal,0
5555,Herpes simplex virus 2 Antigen,Herpes simplex virus 2 Ag:PrThr:Pt:Anal:Ord,0
5556,Leucine crystals (substance),Leucine crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.LPF,0
5557,Yeasts,Yeast:PrThr:Pt:Stool:Ord,0
5558,Multisection,Multisection:Find:Pt:Head>Orbit:Doc:CT,0
5559,Guidance for biopsy.needle,Deprecated CT Guidance for needle biopsy of Pancreas,0
5560,Phosphatidylcholine Ab.IgG.B2GP1 independent,Phosphatidylcholine Ab.IgG.B2GP1 independent:MoM:Pt:Ser:Qn,0
5561,Phosphatidylserine Ab.IgM.B2GP1 dependent,Phosphatidylserine Ab.IgM.B2GP1 dependent:MoM:Pt:Ser:Qn,0
5562,Herpes simplex virus antigen,Herpes simplex virus Ag:PrThr:Pt:Vag:Ord,0
5563,Theophylline,Theophylline:MCnc:Pt:Bld:Qn,0
5564,11-Oxo-Androsterone/Creatinine,11-Oxo-Androsterone/Creatinine:MRto:24H:Urine:Qn,0
5565,VWF gene.p.Arg816Trp,VWF gene.p.Arg816Trp:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
5566,Mitogen-Activated protein kinase 14 Antigen,Mitogen-Activated protein kinase 14 Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
5567,Hemoglobin A2/Hemoglobin.total,Hemoglobin A2/Hemoglobin.total:MFr:Pt:Bld:Qn:Electrophoresis pH 6.3,0
5568,Coagulation thrombin induced,Coagulation thrombin induced^after addition of heparinase:Time:Pt:PPP:Qn:Coag,0
5569,Tube number,Tube number:ID:Pt:Ser/Plas/Bld:Nom,0
5570,Protriptyline,Protriptyline:PrThr:Pt:Ser/Plas:Ord,0
5571,Enoxacin,Enoxacin:Mass:Pt:Dose:Qn,0
5572,HLA Ab positive cells,HLA Ab positive cells:Num:Pt:Ser:Qn,0
5573,Erythrocytes,Erythrocytes:NCnc:Pt:Dial fld prt:Qn:Manual count,0
5574,Gross blood,Gross blood:PrThr:Pt:Stool:Ord,0
5575,View,Views:Find:Pt:Lower extremity>Foot.sesamoid bones:Doc:XR,0
5576,Legionella pneumophila 9 IgG,Legionella pneumophila 9 Ab.IgG:Titr:Pt:Ser:Qn,0
5577,Legionella pneumophila 9 IgM,Legionella pneumophila 9 Ab.IgM:Titr:Pt:Ser:Qn,0
5578,Norovirus RNA,Norovirus RNA:PrThr:Pt:XXX:Ord:Probe,0
5579,Views AP,View AP:Find:Pt:Neck:Doc:XR,0
5580,Treponema pallidum antibody,Treponema pallidum Ab:ACnc:Pt:Body fld:Qn,0
5581,Extension.passive range of motion,Extension.passive range of motion:Angle:Pt:Elbow:Qn,0
5582,Yeast.hyphae,Yeast.hyphae:PrThr:Pt:Urine:Ord:Computer assisted,0
5583,Chlamydophila pneumoniae IgM,Chlamydophila pneumoniae Ab.IgM:PrThr:Pt:Ser:Ord:IF,0
5584,Views for shunt patency,Views for shunt patency^W Tc-99m MAA inj:Find:Pt:Abdomen+Pelvis:Doc:NM,0
5585,Choriogonadotropin.intact,Choriogonadotropin.intact:ACnc:Pt:Amnio fld:Qn,0
5586,Multisection for graft,Multisection for graft:Find:Pt:Upper extremity.bilateral>Upper extremity vessel:Doc:US.doppler,0
5587,Chlamydia trachomatis DNA,Chlamydia trachomatis DNA:PrThr:Pt:Anal:Ord:Probe.amp.tar,0
5588,Chlamydia trachomatis antigen,Chlamydia trachomatis Ag:PrThr:Pt:Genital:Ord,0
5589,Multisection,Multisection^W contrast IV:Find:Pt:Breast.unilateral:Doc:MR,0
5590,Multisection,Multisection^W contrast IV:Find:Pt:Lower extremity>Lower extremity vessels:Doc:MR.angio,0
5591,Confirmatory consultation note,Confirmatory consultation note:Find:Pt:{Setting}:Doc:{Role},0
5592,Legionella pneumophila 14 IgG,Legionella pneumophila 14 Ab.IgG:Titr:Pt:Ser:Qn:IF,0
5593,Glucose,Glucose^4M post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
5594,Vespula spp Ab.IgG,Vespula spp Ab.IgG:MCnc:Pt:Ser:Qn,0
5595,West Nile virus antibody,West Nile virus Ab:PrThr:Pt:Ser:Ord,0
5596,Vendor device name,Vendor device name:ID:Pt:Height device:Nom,0
5597,"15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine","15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine:MRto:Pt:Urine:Qn",0
5598,Chlamydia sp identified,Chlamydia sp identified:Prid:Pt:Body fld:Nom:Organism specific culture,0
5599,hemoglobin G Philadelphia,Hemoglobin G-Philadelphia:PrThr:Pt:Bld:Ord:Electrophoresis pH 8.9,0
5600,Salicylates,Salicylates:PrThr:Pt:Urine:Ord,0
5601,Snowshoe hare virus Ab,Snowshoe hare virus Ab:Titr:Pt:Ser:Qn,0
5602,Immunoglobulin A antibody to Influenza A virus,Influenza virus A Ab.IgA:PrThr:Pt:Ser:Ord,0
5603,Benztropine,Benztropine:PrThr:Pt:Ser/Plas:Ord,0
5604,Vesicular stomatitis Indiana virus Ag,Vesicular stomatitis Indiana virus Ag:PrThr:Pt:XXX:Ord:IA,0
5605,Ascorbate,Ascorbate^post dose:SCnc:Pt:Ser/Plas:Qn,0
5606,Epinephrine,Epinephrine^2H post 300 ug cloNIDine PO:SCnc:Pt:Plas:Qn,0
5607,Parasite identified,Parasite identified:Prid:Pt:Bld:Nom:Thick film,0
5608,Polio virus 3 Ab,Polio virus 3 Ab:Titr:Pt:Body fld:Qn,0
5609,Views GE 3,Finger fifth - right Narrative X-ray GE 3 views,0
5610,Streptomycin,Streptomycin:Susc:Pt:Isolate:Qn:MLC,0
5611,Coagulation tissue factor induced.INR,Coagulation tissue factor induced.INR:RelTime:Pt:BldC:Qn:Coag,0
5612,Erythrocytes,Erythrocytes:Naric:Pt:Urine sed:Qn:Automated count,0
5613,Citrate (si)-Synthase,Citrate synthase:CCnt:Pt:Fibroblasts:Qn,0
5614,Bartonella henselae Ab.IgG & IgM panel,Bartonella henselae Ab.IgG & IgM panel:-:Pt:Ser:Qn,0
5615,Collaborative staging site-specific factor 5,Collaborative staging site-specific factor 5:Prid:Pt:Cancer.XXX:Nom,0
5616,Complement activity.cell surface induced,Complement activity.cell surface induced:ACnc:Pt:Ser/Plas:Qn,0
5617,Complement Factor Bb,Complement factor Bb:MCnc:Pt:Ser/Plas:Qn,0
5618,Chlamydia trachomatis L2 DNA,Chlamydia trachomatis L2 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar,0
5619,bentiromide,Deprecated Bentiromide SerPl-mCnc,0
5620,Triazolam,Triazolam:MCnc:Pt:Ser/Plas:Qn,0
5621,Views GE 3,Deprecated Finger.5th-R XR GE 3V,0
5622,Bordetella pertussis antigen,Bordetella pertussis Ag:PrThr:Pt:Nph:Ord,0
5623,Pancreatic islet cell complement fixing Ab,Pancreatic islet cell complement fixing Ab:Titr:Pt:Ser:Qn:IF,0
5624,Aspergillus fumigatus B Ab,Aspergillus fumigatus B Ab:PrThr:Pt:Ser:Ord,0
5625,Note (document),Note:Find:Pt:Hospital:Doc:{Role},0
5626,crotetamide,Crotetamide:MCnc:Pt:Urine:Qn,0
5627,Dichlorphenamide,Dichlorphenamide:MRat:24H:Urine:Qn,0
5628,tetrahydrofuran,Tetrahydrofuran:MCnc:Pt:Urine:Qn,0
5629,Multisection,Multisection:Find:Pt:Lower extremity.left:Doc:US,0
5630,Pseudocholinesterase phenotype,Pseudocholinesterase phenotype:Prid:Pt:Ser/Plas:Nom,0
5631,Neuronal nuclear type 1 antibody,Neuronal nuclear type 1 Ab:PrThr:Pt:Ser:Ord,0
5632,Cells.CD10+CD25+,Cells.CD10+CD25+:NCnc:Pt:Bld:Qn,0
5633,Docosapentaenate w3,Docosapentaenate w3:SCnc:Pt:Ser/Plas:Qn,0
5634,View lateral spot,View lateral spot:Find:Pt:Abdomen+Pelvis>Spine.lumbosacral junction:Doc:XR,0
5635,Penicillin V,Penicillin V:Titr:Pt:Isolate+Ser:Qn:SBT,0
5636,Homocysteine cysteine disulfide,Homocysteine cysteine disulfide:SCnc:Pt:Ser/Plas:Qn,0
5637,Gestational Age,Gestational age:Time:Pt:^Fetus:Qn:US+Estimated from HC.Lessoway 1998,0
5638,Protein pattern,Protein pattern:Impression/interpretation of study:Point in time:Serum/Plasma:Nominal,0
5639,Protons,Hydrogen ion:SCnc:Pt:BldA:Qn,0
5640,Multisection,Multisection^W contrast IV:Find:Pt:Head+Neck>Larynx:Doc:CT,0
5641,Proteins,Protein:MCnc:XXX:Urine:Qn,0
5642,Multisection,Multisection^WO contrast:Find:Pt:Abdomen>Adrenal gland:Doc:MR,0
5643,Spermatozoa Ab.IgG,Spermatozoa Ab.IgG:PrThr:Pt:Ser:Ord,0
5644,ACADM gene.c.985A>G,ACADM gene.c.985A>G:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
5645,17-Ketosteroids/Creatinine,17-Ketosteroids/Creatinine:SRto:Pt:Urine:Qn,0
5646,phosphate ion,Phosphate [Mass or Molecules/volume] in Dialysis fluid,0
5647,"N,N-Dimethyltryptamine",Dimethyltryptamine:MCnc:Pt:Ser/Plas:Qn,0
5648,Multisection,Multisection^W contrast IV:Find:Pt:Upper extremity.left>Elbow:Doc:MR,0
5649,View Jones,View Jones:Find:Pt:Upper extremity.left>Elbow:Doc:XR,0
5650,View,Views^W contrast IV:Find:Pt:Lower extremity>Lower extremity vessels:Doc:RF.angio,0
5651,Glucose,Glucose^9H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
5652,West Nile virus antibody,West Nile virus Ab:ACnc:Pt:Ser:Qn,0
5653,17-Ketosteroids/Creatinine,17-Ketosteroids/Creatinine:MRto:Pt:Urine:Qn,0
5654,Agglutinated spermatozoa,Spermatozoa.agglutinated:PrThr:Pt:Semen:Ord,0
5655,Mycoplasma species,Mycoplasma sp:PrThr:Pt:XXX:Ord:Hoechst stain,0
5656,Chlamydia sp rRNA,Chlamydia sp rRNA:PrThr:Pt:Nose:Ord:Probe,0
5657,Multisection,Multisection^W contrast IV:Find:Pt:Upper extremity.left>Forearm:Doc:CT,0
5658,Multisection,Multisection^W contrast IV:Find:Pt:Chest>Heart:Doc:MR,0
5659,Views lateral,View lateral:Find:Pt:Upper extremity>Finger.fifth:Doc:XR,0
5660,Guidance limited for localization of tumor,Guidance limited for localization of tumor^W radionuclide IV:Find:Pt:XXX:Doc:NM,0
5661,"Sulfates, Inorganic",Sulfate:MRat:24H:Urine:Qn,0
5662,Cystine crystals,Cystine crystals:PrThr:Pt:Urine:Ord:Computer assisted,0
5663,MEN1 gene targeted mutation analysis,MEN1 GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NAR:MOLGEN,0
5664,dipipanone,Dipipanone:PrThr:Pt:Urine:Ord,0
5665,Etilefrine,Etilefrine:PrThr:Pt:Urine:Ord,0
5666,View,Views:Find:Pt:Upper extremity.bilateral>Hand:Doc:XR,0
5667,Albumins,Albumin^pre XXX challenge:MCnc:Pt:Ser/Plas:Qn,0
5668,Glucose,Glucose^16H post XXX challenge:SCnc:Pt:Ser/Plas:Qn,0
5669,Heptacarboxylporphyrin/Creatinine,Heptacarboxylporphyrin/Creatinine:SRto:24H:Urine:Qn,0
5670,Karyotype (cell structure),Karyotype:Presence or Identity:Point in time:CVS:Nominal,0
5671,Cotinine,Cotinine:SCnc:Pt:Urine:Qn,0
5672,Cephalexin,Cephalexin:Susc:Pt:Isolate:OrdQn:Gradient strip,0
5673,Pain severity.consolability,Pain severity.consolability:Find:Pt:^Patient:Ord:Observed.FLACC,0
5674,"1,2,4-trichlorobenzene","1,2,4-Trichlorobenzene:MCnc:Pt:Air:Qn",0
5675,Trichloroethylene,Trichloroethylene:MCnc:Pt:Air:Qn,0
5676,Neisseria gonorrhoeae DNA,Neisseria gonorrhoeae DNA:PrThr:Pt:Vag:Ord:Probe.amp.tar,0
5677,Sodium,Sodium:SCnc:Pt:BldA:Qn,0
5678,Aminocaproate,Aminocaproate^trough:MCnc:Pt:Ser/Plas:Qn,0
5679,Carbenicillin,Carbenicillin:MCnc:Pt:Ser/Plas:Qn,0
5680,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Occupational medicine,0
5681,Amylases,Amylase^3rd specimen post dose sincalide:CCnc:Pt:Body fld:Qn,0
5682,Multisection,Multisection^W contrast IV:Find:Pt:Lower extremity.right>Lower leg:Doc:CT,0
5683,Multisection,Multisection^WO & W contrast IV:Find:Pt:Abdomen>Aorta.abdominal:Doc:MR.angio,0
5684,Brucella canis IgG,Brucella canis Ab.IgG:PrThr:Pt:Ser:Ord,0
5685,Acetate,Acetate:MCnc:Pt:Air:Qn,0
5686,Views for shunt detection,Views for shunt detection^W Tc-99m MAA IV:Find:Pt:Chest>Heart:Doc:NM,0
5687,Histidine,Histidine:SCnc:Pt:Body fld:Qn,0
5688,11-Ketoandrosterone/Creatinine,11-Ketoandrosterone/Creatinine:SRto:Pt:Urine:Qn,0
5689,Salmonella enterica subspecies enterica serovar Typhi H antibody,Salmonella typhi H Ab:Titr:Pt:Ser:Qn:Aggl,0
5690,Coproporphyrin/Hemoglobin,Coproporphyrin/Hemoglobin:MRto:Pt:RBC:Qn,0
5691,Doxylamine,Doxylamine:PrThr:Pt:Ser/Plas:Ord,0
5692,Multisection,Multisection^WO & W contrast IV:Find:Pt:Lower extremity:Doc:CT,0
5693,Views 3,Views 3:Find:Pt:Upper extremity.bilateral>Elbow:Doc:XR,0
5694,Views 3,Views 3:Find:Pt:Upper extremity>Finger:Doc:XR,0
5695,Multisection,Multisection^WO contrast:Find:Pt:XXX>Soft tissue:Doc:MR,0
5696,Morphine.free,Morphine.free:PrThr:Pt:Urine:Ord,0
5697,BCL2 Ag,BCL2 Ag:PrThr:Pt:Tiss:Ord:Immune stain,0
5698,Clindamycin,Clindamycin:MCnc:Pt:Ser/Plas:Qn,0
5699,Ampicillin / Sulbactam,Ampicillin+Sulbactam:Titr:Pt:Isolate+Ser:Qn:SBT,0
5700,Rickettsia sp Ab.IgG,Rickettsia sp Ab.IgG:ACnc:Pt:Ser:Qn,0
5701,Views magnification,Views magnification:Find:Pt:Breast.bilateral:Doc:MG,0
5702,View,Views^W standing:Find:Pt:Abdomen>Spine.lumbar:Doc:XR,0
5703,vinyl bromide,Vinyl bromide:MCnc:Pt:Air:Qn,0
5704,"Toluene 2,4-Diisocyanate","2,4-Toluene diisocyanate:MCnc:Pt:Air:Qn",0
5705,Prion protein.abnormal,Prion protein.abnormal:PrThr:Pt:Tiss:Ord:IB,0
5706,View West Point,View West Point:Find:Pt:Upper extremity.right>Shoulder:Doc:XR,0
5707,View,Views:Find:Pt:Pelvis & Lower extremity.right>Hip:Doc:XR,0
5708,Unidentified cell,Unidentified cells:NCnc:Pt:Pericard fld:Qn,0
5709,Multisection,Multisection^WO & W contrast IV:Find:Pt:Head>Temporomandibular joint:Doc:MR,0
5710,Views 5,Views 5:Find:Pt:Upper extremity.right>Wrist:Doc:XR,0
5711,View,Views^W contrast intra lymphatic:Find:Pt:Extremity.right>Extremity lymphatic vessels:Doc:RF.angio,0
5712,Amoxapine,Amoxapine:PrThr:Pt:Ser/Plas:Ord,0
5713,Immunoglobulin light chains.lambda.free,Immunoglobulin light chains.lambda.free:MCnc:Pt:Ser/Plas:Qn,0
5714,SHOX gene targeted mutation analysis,SHOX GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NAR:MOLGEN,0
5715,EGR2 gene targeted mutation analysis,EGR2 gene mutation analysis:Prid:Pt:Bld/Tiss:Nar:Molgen,0
5716,neutrophil,Polymorphonuclear cells:NCnc:Pt:Plr fld:Qn,0
5717,clorprenaline,Clorprenaline:MCnc:Pt:Urine:Qn,0
5718,Multisection,Multisection^WO & W contrast IV:Find:Pt:Abdomen>Portal vein:Doc:MR.angio,0
5719,Multisection,Multisection^WO contrast:Find:Pt:Head>Temporomandibular joint:Doc:MR,0
5720,View,Views:Find:Pt:Abdomen>Spine.lumbar & Pelvis>Sacrum:Doc:XR,0
5721,Multisection,Multisection^W contrast IV:Find:Pt:Upper extremity.left>Shoulder:Doc:MR,0
5722,Multisection,Multisection^WO contrast:Find:Pt:Upper extremity.left:Doc:MR,0
5723,Views 2 oblique,Views 2 oblique:Find:Pt:Upper extremity.left>Elbow:Doc:XR,0
5724,Tooth space discrepancy,Tooth space discrepancy:Len:Pt:{Dental arch}:Qn:Estimated,0
5725,Inspiratory breath,Inspiratory breath^on ventilator:Time:Pt:^Patient:Qn,0
5726,Tooth development evaluation,Tooth development evaluation:Find:Pt:{Subject tooth}+{Reference tooth}:Nom,0
5727,"Hemogram, Platelets, Differential & Reticulocyte panel","Deprecated Hemogram, Platelets, Differential & Reticulocyte panel in Blood",0
5728,HEXA gene.c.1277insTATC,HEXA gene.c.1277insTATC:PrThr:Pt:Bld/Tiss:Ord:Molgen,0
5729,Multisection,Multisection:Find:Pt:Upper extremity.left>Hand:Doc:CT,0
5730,Multisection,Multisection:Find:Pt:Upper extremity>Wrist+Hand:Doc:MR,0
5731,Multisection,Multisection^WO & W contrast IV:Find:Pt:Head>Head vessels:Doc:MR.angio,0
5732,View,Views^W I-131 MIBG IV:Find:Pt:XXX:Doc:NM,0
5733,Physical findings,Physical findings:Find:Pt:Nostril:Nom:Observed,0
5734,Physical findings,Physical findings:Find:Pt:Pupil:Nom:Observed,0
5735,West Nile virus antibody,West Nile virus Ab:PrThr:Pt:XXX:Ord,0
5736,Edentulous ridge relationship,Edentulous ridge relationship:Find:Pt:Maxilla.left+Mandible.left:Nom,0
5737,Cephalothin,Cephalothin:MCnc:Pt:Ser/Plas:Qn,0
5738,Body temperature panel,Body temperature panel:-:Point in time:^Patient:-,0
5739,Views 2,Views 2:Find:Pt:Abdomen>Spine.lumbar:Doc:XR,0
5740,MLL gene mutations tested for,MLL gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen,0
5741,PTCH gene targeted mutation analysis,PTCH GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NOM:MOLGEN,0
5742,Amiodarone,Amiodarone^peak:MCnc:Pt:Ser/Plas:Qn,0
5743,Retention - dental,Retention:Imp:Pt:{Dental arch}.denture.complete:Ord:Reported,0
5744,Support - dental,Support:Imp:Pt:{Dental arch}.denture.partial:Ord:Observed,0
5745,Brompheniramine,Brompheniramine:PrThr:Pt:Ser/Plas:Ord,0
5746,Anti-thyrotropin antibody,Thyrotropin Ab:PrThr:Pt:Ser:Ord,0
5747,Saccharum officinarum Ab.IgG,Saccharum officinarum Ab.IgG:MCnc:Pt:Ser:Qn,0
5748,Netilmicin,Netilmicin:Susc:Pt:Isolate:OrdQn:Agar diffusion,0
5749,Multisection,Multisection:Find:Pt:Head>Brain:Doc:MR.spectroscopy,0
5750,SDHC gene targeted mutation analysis,SDHC GENE MUTATION ANALYSIS:PRID:PT:BLD/TISS:NAR:MOLGEN,0
5751,VA C&P exam.brain &or spinal cord note,VA C&P exam.brain &or spinal cord note:Find:Pt:{Setting}:Doc:{Role},0
5752,Bilirubin.non-glucuronidated,Bilirubin.non-glucuronidated:SCnc:Pt:Body fld:Qn,0
5753,Cells.CD3+CD25+,Cells.CD3+CD25+:NCnc:Pt:XXX:Qn,0
5754,Plan of care note,Plan of care note:Find:Pt:{Setting}:Doc:Clinical genetics,0
5755,Phadiatop Infant Ab.IgE.RAST class,Phadiatop Infant Ab.IgE.RAST class:PrThr:Pt:Ser:Ord,0
5756,Phencyclidine,Phencyclidine:PrThr:Pt:Unk sub:Ord,0
5757,Surgical operation note date,Surgical operation note date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative,0
5758,Stroke volume/Body surface area,Stroke volume/Body surface area:ArVol:Pt:Heart.ventricle.right:Qn:Angiography.single plane,0
5759,Plasmodium malariae IgG,Plasmodium malariae Ab.IgG:ACnc:Pt:Ser:Qn,0
5760,Salmonella sp Ab.IgG,Salmonella sp Ab.IgG:ACnc:Pt:Ser:Qn,0
5761,chlorobenzene,Chlorobenzene:MCnc:Pt:Ser/Plas:Qn,0
5762,Nordazepam,Nordiazepam:SCnc:Pt:XXX:Qn,0
5763,Pupil shape,Pupil shape:Shape:Pt:Pupil.left:Nom:Slit lamp biomicroscopy,0
5764,tetrahydrocorticosterone,Tetrahydrocorticosterone:MRat:24H:Urine:Qn,0
5765,View Harris,Deprecated Hindfoot - bilateral and Midfoot - bilateral X-ray Harris,0
5766,Thunnus albacares basophil bound Ab,Thunnus albacares basophil bound Ab:ACnc:Pt:Bld:Qn:LHR,0
5767,Methylenedioxypyrovalerone cutoff,Methylenedioxypyrovalerone cutoff:MCnc:Pt:Urine:Qn:Confirm,0
5768,Sulfate.total/Creatinine,Sulfate.total/Creatinine:SRto:Pt:Urine:Qn,0
5769,Fluid intake.enteral tube.nutritional formula composition,Fluid intake.enteral tube.nutritional formula composition:Find:Pt:^Patient:Nom,0
5770,activity level,Activity level:Acceleration:Point in time:^Patient:Quantitative,0
5771,Tissue velocity.A wave.max,Tissue velocity.A wave.max:Vel:Pt:Mitral valve.annulus.medial:Qn:US.tissue doppler,0
5772,Sulfides,Sulfide:MCnc:Pt:Bld:Qn,0
5773,AM-2201 4-hydroxypentyl cutoff,AM-2201 4-hydroxypentyl cutoff:MCnc:Pt:Urine:Qn:Confirm,0
5774,Discharge summary note,Discharge summary note:Find:Pt:{Setting}:Doc:Geriatric medicine,0
5775,Intravascular diastolic,Intravascular diastolic:Pres:Pt:Celiac trunk artery:Qn,0
5776,Silicone Ab.IgE,Silicone Ab.IgE:ACnc:Pt:Ser:Qn,0
5777,Smelt Ab.IgE,Smelt Ab.IgE:ACnc:Pt:Ser:Qn,0
5778,Enhanced note,Enhanced note:Find:Pt:{Setting}:Doc:{Author Type},0
5779,Blood group antibody screen.cells I+II+III,Blood group antibody screen.cells I+II+III:PrThr:Pt:Ser/Plas:Ord:Prewarmed,0
5780,End-systolic volume/Body surface area,End-systolic volume/Body surface area:ArVol:Pt:Heart.atrium.left:Qn:US.2D+Calculated by area-length method,0
5781,Astrovirus,Astrovirus:PrThr:Pt:Stool:Ord:Microscopy.electron,0
5782,N-caproylglycine,Hexanoylglycine:SCnc:Pt:Ser/Plas:Qn,0
5783,Guidance for biopsy.core needle,Deprecated US Guidance for core needle biopsy of Breast - right,0
5784,Consultation note,Consultation note:Find:Pt:{Setting}:Doc:Clinical pathology,0
5785,protein intake,Protein intake:Mass:Pt:^Patient:Qn:Estimated,0
5786,microscopic observation,Deprecated Microscopic observation [Identifier] in Stool by Ova and Parasite Preparation,0
5787,Legionella pneumophila serogroup 1 antibody,Legionella pneumophila 1 Ab:Titr:Pt:Ser:Qn:IF,0
5788,Reporting,Report:Finding:Point in time:{Setting}:Document:{Role},0
5789,Progress note,Progress note:Find:Pt:{Setting}:Doc:Pharmacology,0
5790,Intravascular systolic,Intravascular systolic:Pres:24H^mean:Arterial system:Qn,0
5791,Intravascular mean,Intravascular mean:Pres:Pt:Dorsal pedal artery:Qn,0
5792,Body temperature special circumstances,Body temperature special circumstances^*:Type:Point in time:^Patient:Nominal,0
5793,Childhood,Juvenile osteochondrosis of acetabulum,0
5794,Childhood,Anxiety disorder of childhood OR adolescence,0
5795,Childhood,Chronic Bullous Disease of Childhood,0
5796,Childhood,"Dysmorphic sialidosis, juvenile form",0
5797,Childhood,"Reactive attachment disorder of infancy OR early childhood, disinhibited type",0
5798,Childhood,Separation anxiety disorder of childhood,0
5799,Childhood,"Dermatomyositis, Childhood Type",0
5800,Childhood,Childhood bronchiectasis,0
5801,Childhood,Benign granulocytopenia in childhood,0
5802,Childhood,Chronic benign neutropenia of childhood,0
5803,Childhood,Childhood growth AND/OR development finding,0
5804,Childhood,Childhood growth AND/OR development alteration,0
5805,Childhood,Overanxious disorder of childhood,0
5806,Childhood,Juvenile osteochondrosis of pelvis,0
5807,Childhood,"Benign Focal Epilepsy, Childhood",0
5808,Childhood,"Conduct disorder, childhood-onset type",0
5809,Childhood,"Gangliosidosis, Generalized GM1, Type 2",0
5810,Childhood,Oppositional Defiant Disorder,0
5811,Childhood,Active infantile autism,0
5812,Childhood,Residual infantile autism,0
5813,Childhood,Active disintegrative psychoses,0
5814,Childhood,Residual disintegrative psychoses,0
5815,Childhood,Atypical childhood psychoses,0
5816,Childhood,Borderline psychosis of childhood,0
5817,Childhood,Transient childhood tic,0
5818,Childhood,Aggressive unsocial conduct disorder,0
5819,Childhood,Group delinquency,0
5820,Childhood,Childhood disorder of conduct and emotion,0
5821,Childhood,Neurotic delinquency,0
5822,Childhood,Disturbance of anxiety and fearfulness in childhood and adolescence,0
5823,Childhood,Childhood and adolescent fearfulness disturbance,0
5824,Childhood,Childhood and adolescent relationship problem,0
5825,Childhood,Sibling jealousy,0
5826,Childhood,Childhood or adolescent identity disorder,0
5827,Childhood,Academic underachievement disorder,0
5828,Childhood,Childhood phobic anxiety disorder,0
5829,Childhood,Childhood or adolescent disorder of social functioning,0
5830,Childhood,Psychogenic feeding disorder of infancy and childhood,0
5831,Childhood,Pica of infancy and childhood,0
5832,Childhood,Distal muscular dystrophy with juvenile onset,0
5833,Childhood,"Infantile, juvenile and presenile cataract",0
5834,Childhood,Combined form of nonsenile cataract,0
5835,Childhood,Juvenile polyarteritis,0
5836,Childhood,Chronic polyarticular juvenile rheumatoid arthritis,0
5837,Childhood,Systemic onset juvenile chronic arthritis,0
5838,Childhood,Monarticular juvenile rheumatoid arthritis,0
5839,Childhood,Juvenile arthritis in Crohn disease,0
5840,Childhood,Juvenile arthritis in ulcerative colitis,0
5841,Childhood,Calve's vertebral osteochondrosis,0
5842,Childhood,Juvenile osteochondrosis of head of humerus,0
5843,Childhood,Alpers Syndrome (disorder),0
5844,Childhood,Childhood Progressive Bulbar Palsy,0
5845,Childhood,Progressive neuronal degeneration of childhood,0
5846,Childhood,Progressive neuronal degeneration without liver cirrhosis,0
5847,Childhood,"Frontal Epilepsy, Benign, Childhood",0
5848,Childhood,"Epilepsy, Benign Psychomotor, Childhood",0
5849,Childhood,Benign atypical partial epilepsy in childhood,0
5850,Childhood,Epilepsy with recurrent unilateral seizures in children,0
5851,Childhood,Childhood Benign Occipital Epilepsy,0
5852,Childhood,Panayiotopoulos Syndrome,0
5853,Childhood,Benign occipital epilepsy of childhood - late onset variant,0
5854,Childhood,Chronic progressive epilepsia partialis continua of childhood,0
5855,Childhood,"Early Childhood Epilepsy, Myoclonic",0
5856,Childhood,Juvenile Absence Epilepsy,0
5857,Childhood,Infantile Severe Myoclonic Epilepsy,0
5858,Childhood,Alternating hemiplegia of childhood,0
5859,Childhood,"Reactive attachment disorder of infancy OR early childhood, inhibited type",0
5860,Childhood,Behavioral and emotional disorder with onset in childhood,0
5861,Childhood,Adolescent - emotional problem,0
5862,Childhood,Conduct disorder - in family context,0
5863,Childhood,Conduct disorder - unsocialized,0
5864,Childhood,Depressive conduct disorder,0
5865,Childhood,Central retinal vein occlusion - juvenile,0
5866,Childhood,Central retinal vein occlusion - juvenile with neovascularization,0
5867,Childhood,Central retinal vein occlusion - juvenile with macular edema,0
5868,Childhood,Childhood asthma,0
5869,Childhood,Transient erythroblastopenia of childhood,0
5870,Childhood,Irritable bowel syndrome variant of childhood,0
5871,Childhood,Irritable bowel syndrome variant of childhood with diarrhea,0
5872,Childhood,Irritable bowel syndrome variant of childhood with constipation,0
5873,Childhood,Juvenile Graves' disease,0
5874,Childhood,Total hexosaminidase deficiency - juvenile,0
5875,Childhood,B variant hexosaminidase A deficiency - juvenile,0
5876,Childhood,Juvenile plantar dermatosis,0
5877,Childhood,Classical juvenile pityriasis rubra pilaris,0
5878,Childhood,Circumscribed juvenile pityriasis rubra pilaris,0
5879,Childhood,Atypical juvenile pityriasis rubra pilaris,0
5880,Childhood,calcifying aponeurotic fibroma,0
5881,Childhood,Juvenile elastofibromatosis,0
5882,Childhood,Juvenile colloid milium,0
5883,Childhood,Facial Afro-Caribbean childhood eruption,0
5884,Childhood,Juvenile arthritis,0
5885,Childhood,Early onset pauciarticular chronic arthritis,0
5886,Childhood,Late onset pauciarticular chronic arthritis,0
5887,Childhood,Early onset polyarticular juvenile chronic arthritis,0
5888,Childhood,Late onset polyarticular juvenile chronic arthritis,0
5889,Childhood,Juvenile psoriatic arthritis,0
5890,Childhood,Juvenile psoriatic arthritis with psoriasis,0
5891,Childhood,Juvenile psoriatic arthritis without psoriasis,0
5892,Childhood,Juvenile spondyloarthropathy,0
5893,Childhood,Juvenile reactive arthritis,0
5894,Childhood,Juvenile reactive arthritis triad,0
5895,Childhood,Juvenile arthritis of inflammatory bowel disease,0
5896,Childhood,Severe autosomal recessive muscular dystrophy of childhood - North African type (disorder),0
5897,Childhood,Hip juvenile osteochondropathy,0
5898,Childhood,Juvenile tabes dorsalis,0
5899,Childhood,Endovascular papillary angioendothelioma of childhood,0
5900,Childhood,Juvenile fibroadenoma of breast,0
5901,Childhood,Cerebral degeneration in childhood,0
5902,Childhood,Juvenile osteochondrosis of capitulum of humerus,0
5903,Childhood,Nonaggressive unsocial conduct disorder,0
5904,Childhood,Unsocial childhood truancy,0
5905,Childhood,Childhood emotional disorder,0
5906,Childhood,Childhood and adolescent disturbance with sensitivity,0
5907,Childhood,Childhood and adolescent disturbance with shyness,0
5908,Childhood,Childhood and adolescent disturbance with introversion,0
5909,Childhood,Childhood and adolescent disturbance with elective mutism,0
5910,Childhood,Childhood disinhibited attachment disorder,0
5911,Childhood,Juvenile Myelomonocytic Leukemia,0
5912,Childhood,Juvenile elastoma,0
5913,Childhood,Childhood hypophosphatasia (disorder),0
5914,Childhood,Juvenile osteochondrosis of iliac crest,0
5915,Childhood,Hemolytic uremic syndrome of childhood,0
5916,Childhood,Anxiety disorder of adolescence,0
5917,Childhood,Avoidant disorder of childhood OR adolescence,0
5918,Childhood,Socialized behavior disorder,0
5919,Childhood,Mental disorder in childhood,0
5920,Childhood,Fucosidosis Type II,0
5921,Childhood,Childhood atopic dermatitis,0
5922,Childhood,Frictional lichenoid eruption,0
5923,Childhood,Retropulsion petit mal,0
5924,Childhood,Juvenile arthritis,0
5925,Childhood,Chronic arthritis of juvenile onset,0
5926,Childhood,Juvenile rheumatoid arthritis,0
5927,Childhood,Juvenile seropositive polyarthritis,0
5928,Childhood,"Polyarticular Juvenile Idiopathic Arthritis, Rheumatoid Factor Negative",0
5929,Childhood,"Juvenile idiopathic arthritis, oligoarthritis",0
5930,Childhood,"Juvenile idiopathic arthritis, persistent oligoarthritis",0
5931,Childhood,"Juvenile idiopathic arthritis, extended oligoarthritis",0
5932,Childhood,"Juvenile idiopathic arthritis, enthesitis related arthritis",0
5933,Childhood,"Juvenile idiopathic arthritis, undifferentiated arthritis",0
5934,Childhood,Childhood duodenal ulcer,0
5935,Childhood,Autistic Disorder,0
5936,Childhood,Reactive attachment disorder of early childhood,0
5937,Childhood,Childhood seizure,0
5938,Childhood,Pediatric Obesity,0
5939,Childhood,Polyarticular juvenile rheumatoid arthritis,0
5940,Childhood,Juvenile apophysitis,0
5941,Childhood,Familial juvenile gout,0
5942,Childhood,Aggressive Periodontitis,0
5943,Childhood,Juvenile hemochromatosis,0
5944,Childhood,Childhood Absence Epilepsy,0
5945,Childhood,Infantile Neuroaxonal Dystrophy,0
5946,Childhood,Scheuermann's Disease,0
5947,Childhood,Anxiety disorder of childhood,0
5948,Childhood,Juvenile dermatitis herpetiformis,0
5949,Childhood,Indian childhood cirrhosis,0
5950,Childhood,Avoidant disorder of childhood,0
5951,Childhood,Juvenile epiphysitis,0
5952,Childhood,Hypoglycemia of childhood,0
5953,Childhood,Glaucoma of childhood,0
5954,Childhood,Benign paroxysmal vertigo of childhood,0
5955,Childhood,Selective Mutism,0
5956,Childhood,Childhood disintegrative disorder,0
5957,Childhood,Juvenile osteochondrosis of symphysis pubis,0
5958,Childhood,Pauciarticular juvenile rheumatoid arthritis,0
5959,Childhood,Acute polyarticular juvenile rheumatoid arthritis,0
5960,Childhood,Juvenile cerebellar degeneration AND myoclonus,0
5961,Childhood,Bullous eruption of childhood,0
5962,Childhood,Shyness disorder of childhood,0
5963,Childhood,"Separation anxiety disorder of childhood, early onset",0
5964,Childhood,Avoidant disorder of adolescence,0
5965,Childhood,Juvenile GM 2 gangliosidosis,0
5966,Congenital qualifier,Coffin-Siris syndrome,0
5967,Congenital qualifier,"Ehlers-Danlos syndrome, non hydroxylysine deficient ocular type",0
5968,Congenital qualifier,Turner's tooth,0
5969,Congenital qualifier,Bilateral congenital dislocation of hip,0
5970,Congenital qualifier,BADS Syndrome,0
5971,Congenital qualifier,"Triploidy, diploidy, mixoploidy syndrome",0
5972,Congenital qualifier,Achromatopsia 1,0
5973,Congenital qualifier,Congenital stenosis of cervical canal,0
5974,Congenital qualifier,Accessory spleen,0
5975,Congenital qualifier,Extrapulmonary subpleural pulmonary sequestration,0
5976,Congenital qualifier,Lesch-Nyhan Syndrome,0
5977,Congenital qualifier,Double Aortic Arch,0
5978,Congenital qualifier,Hyperplasia of islet alpha cells with gastrin excess,0
5979,Congenital qualifier,Tetrasomy X,0
5980,Congenital qualifier,13q partial trisomy syndrome,0
5981,Congenital qualifier,Osteochondrodysplasias,0
5982,Congenital qualifier,Skeletal dysplasia,0
5983,Congenital qualifier,Malformation defect spectrum,0
5984,Congenital qualifier,Malformation association,0
5985,Congenital qualifier,Malformation sequence,0
5986,Congenital qualifier,"Congenital anomaly of tongue, salivary gland AND/OR pharynx",0
5987,Congenital qualifier,Cyst of female embryonic structure,0
5988,Congenital qualifier,Regional congenital anomaly,0
5989,Congenital qualifier,Trilobed left lung,0
5990,Congenital qualifier,Congenital mandibular hyperplasia,0
5991,Congenital qualifier,Lipoidosis,0
5992,Congenital qualifier,"Atrophy, Muscular, Spinobulbar",0
5993,Congenital qualifier,Posterior lingual occlusion of mandibular teeth,0
5994,Congenital qualifier,Congenital malposition of heart,0
5995,Congenital qualifier,Congenital pancreatic enterokinase deficiency,0
5996,Congenital qualifier,Congenital atresia of pulmonary artery,0
5997,Congenital qualifier,Goldenhar Syndrome,0
5998,Congenital qualifier,Intermandibular dysostosis,0
5999,Congenital qualifier,Temporo-auro-mandibular dysostosis,0
6000,Congenital qualifier,Zygo-auro-mandibular dysostosis,0
6001,Congenital qualifier,Temporo-aural dysostosis,0
6002,Congenital qualifier,Maxillary dysostosis,0
6003,Congenital qualifier,Maxillo-zygomatic dysostosis,0
6004,Congenital qualifier,Naso-maxillary dysostosis,0
6005,Congenital qualifier,Intermaxillo-palatine dysostosis,0
6006,Congenital qualifier,Anterior perimaxillary faciosynostosis,0
6007,Congenital qualifier,Complete perimaxillary faciosynostosis,0
6008,Congenital qualifier,Posterior perimaxillary faciosynostosis,0
6009,Congenital qualifier,Premaxillo-maxillary dysostosis,0
6010,Congenital qualifier,Vomero-premaxillary faciosynostosis,0
6011,Congenital qualifier,Internasal dysostosis,0
6012,Congenital qualifier,Frontal dysostosis,0
6013,Congenital qualifier,Interfrontal craniofaciosynostosis,0
6014,Congenital qualifier,Fronto-frontal dysostosis,0
6015,Congenital qualifier,Fronto-naso-ethmoidal dysostosis,0
6016,Congenital qualifier,Fronto-parietal craniofaciosynostosis,0
6017,Congenital qualifier,Fronto-malar faciosynostosis,0
6018,Congenital qualifier,Sphenoidal dysostosis,0
6019,Congenital qualifier,Spheno-frontal dysostosis,0
6020,Congenital qualifier,Spheno-fronto-parietal craniofaciosynostosis,0
6021,Congenital qualifier,Synostotic Posterior Plagiocephaly,0
6022,Congenital qualifier,Sagittal craniosynostosis,0
6023,Congenital qualifier,Mandibuloacral dysostosis,0
6024,Congenital qualifier,Dysostoses,0
6025,Congenital qualifier,Accessory cuboid bone,0
6026,Congenital qualifier,Accessory navicular bone of foot (disorder),0
6027,Congenital qualifier,Single right ventricle,0
6028,Congenital qualifier,Single left ventricle,0
6029,Congenital qualifier,Perimembranous ventricular septal defect,0
6030,Congenital qualifier,Single muscular ventricular septum defect,0
6031,Congenital qualifier,Multiple muscular ventricular septum defect,0
6032,Congenital qualifier,Ebstein-like malformation of the mitral valve,0
6033,Congenital qualifier,Anomalous cardiac muscle bands,0
6034,Congenital qualifier,Congenital anomaly of oral mucosa,0
6035,Congenital qualifier,Moon's molar teeth,0
6036,Congenital qualifier,Exaggerated cusp of tooth,0
6037,Congenital qualifier,False anodontia,0
6038,Congenital qualifier,Congenital absence of one tooth,0
6039,Congenital qualifier,Anodontia of primary dentition,0
6040,Congenital qualifier,Anodontia of Permanent Dentition,0
6041,Congenital qualifier,"Congenital hypodontia, multiple teeth, unrelated to systemic disease",0
6042,Congenital qualifier,"Congenital hypodontia, multiple teeth, related to systemic disease",0
6043,Congenital qualifier,Familial hypodontia,0
6044,Congenital qualifier,Supernumerary permanent tooth,0
6045,Congenital qualifier,Supernumerary tooth identifiable by tooth number,0
6046,Congenital qualifier,Supernumerary tooth unidentifiable by tooth number,0
6047,Congenital qualifier,Erupted mesiodens,0
6048,Congenital qualifier,Impacted mesiodens,0
6049,Congenital qualifier,Inverted mesiodens,0
6050,Congenital qualifier,Multiple supernumerary teeth unrelated to systemic condition,0
6051,Congenital qualifier,Multiple supernumerary teeth related to systemic condition,0
6052,Congenital qualifier,Fusion of crown of teeth,0
6053,Congenital qualifier,Intrinsic enamel discoloration of erythroblastosis fetalis,0
6054,Congenital qualifier,"Amelogenesis Imperfecta, Type III",0
6055,Congenital qualifier,"Amelogenesis imperfecta, hypomaturation hypoplasia type with taurodontism",0
6056,Congenital qualifier,"Amelogenesis imperfecta, hypoplastic type with microdontia",0
6057,Congenital qualifier,Amelogenesis imperfecta pigmented hypomaturation type,0
6058,Congenital qualifier,Amelogenesis Imperfecta hypomaturation type,0
6059,Congenital qualifier,Amelogenesis imperfecta local hypoplastic form,0
6060,Congenital qualifier,Amelogenesis imperfecta nephrocalcinosis,0
6061,Congenital qualifier,Kohlschutter Tonz syndrome,0
6062,Congenital qualifier,Crossbite,0
6063,Congenital qualifier,"Reverse posterior crossbite, single tooth",0
6064,Congenital qualifier,"Reverse posterior crossbite, multiple teeth",0
6065,Congenital qualifier,Crowding of teeth due to supernumerary teeth,0
6066,Congenital qualifier,Abnormal root proximity between adjacent teeth,0
6067,Congenital qualifier,Protrusion of a tooth,0
6068,Congenital qualifier,Congenital mandibular asymmetry,0
6069,Congenital qualifier,Congenital maxillary asymmetry,0
6070,Congenital qualifier,Congenital retrognathism,0
6071,Congenital qualifier,Macrogenia,0
6072,Congenital qualifier,Congenital horizontal mandibular hyperplasia,0
6073,Congenital qualifier,Congenital vertical mandibular hyperplasia,0
6074,Congenital qualifier,Congenital transverse mandibular hyperplasia,0
6075,Congenital qualifier,Congenital alveolar hyperplasia of mandible,0
6076,Congenital qualifier,Congenital alveolar hyperplasia of maxilla,0
6077,Congenital qualifier,Microgenia,0
6078,Congenital qualifier,Congenital horizontal mandibular hypoplasia,0
6079,Congenital qualifier,Congenital vertical mandibular hypoplasia,0
6080,Congenital qualifier,Congenital transverse mandibular hypoplasia,0
6081,Congenital qualifier,Congenital alveolar hypoplasia of mandible,0
6082,Congenital qualifier,Congenital alveolar hypoplasia of maxilla,0
6083,Congenital qualifier,Congenital transverse maxillary hypoplasia,0
6084,Congenital qualifier,Congenital vertical maxillary hypoplasia,0
6085,Congenital qualifier,Precocious exfoliation related to ectopic eruption of proximate tooth,0
6086,Congenital qualifier,Precocious exfoliation of teeth related to idiopathic root resorption,0
6087,Congenital qualifier,Precocious exfoliation of teeth related to root resorption associated with trauma,0
6088,Congenital qualifier,Cleft of primary palate,0
6089,Congenital qualifier,Bilateral cleft of primary palate,0
6090,Congenital qualifier,Congenital anomaly of lip,0
6091,Congenital qualifier,Congenital commissural pits,0
6092,Congenital qualifier,Aberrant insertion of labial frenulum,0
6093,Congenital qualifier,Buccal bifurcation cyst,0
6094,Congenital qualifier,Ectopic oral gastrointestinal cyst,0
6095,Congenital qualifier,Aberrant insertion of frenum of tongue,0
6096,Congenital qualifier,Congenital anomaly of uvula,0
6097,Congenital qualifier,Cystic testicular dysplasia,0
6098,Congenital qualifier,Cerebrofacial dysplasia,0
6099,Congenital qualifier,Dental arch length loss secondary to congenitally missing teeth,0
6100,Congenital qualifier,Congenital talipes equinus,0
6101,Congenital qualifier,Bifid nail,0
6102,Congenital qualifier,Congenital fistula of lip,0
6103,Congenital qualifier,Howel-Evans' syndrome,0
6104,Congenital qualifier,"Porokeratosis, Palmoplantar",0
6105,Congenital qualifier,Arthrogryposis,0
6106,Congenital qualifier,Saddle nose,0
6107,Congenital qualifier,Sjogren-Larsson Syndrome,0
6108,Congenital qualifier,LEOPARD Syndrome,0
6109,Congenital qualifier,Donohue Syndrome,0
6110,Congenital qualifier,Neurologic form of cretinism,0
6111,Congenital qualifier,8q partial trisomy syndrome,0
6112,Congenital qualifier,Ring chromosome 11 syndrome,0
6113,Congenital qualifier,20p partial trisomy syndrome,0
6114,Congenital qualifier,Anomaly of chromosome X,0
6115,Congenital qualifier,Longitudinal deficiency of tibia AND/OR fibula,0
6116,Congenital qualifier,Arrhinia,0
6117,Congenital qualifier,"Cystic Adenomatoid Malformation of Lung, Congenital",0
6118,Congenital qualifier,"Truncus arteriosus, Edwards' type IV",0
6119,Congenital qualifier,Left ventricular hypoplasia,0
6120,Congenital qualifier,Right aortic arch (disorder),0
6121,Congenital qualifier,Anomalous pulmonary vein,0
6122,Congenital qualifier,Total anomalous pulmonary venous return,0
6123,Congenital qualifier,Congenital absence of breast,0
6124,Congenital qualifier,Posterior crossbite,0
6125,Congenital qualifier,Congenital anomaly of salivary gland,0
6126,Congenital qualifier,Congenital diverticulum of pharynx,0
6127,Congenital qualifier,Congenital prolapsed rectum,0
6128,Congenital qualifier,Congenital rectovaginal fistula,0
6129,Congenital qualifier,Caroli Disease,0
6130,Congenital qualifier,Male Pseudohermaphroditism,0
6131,Congenital qualifier,Congenital anomaly of genital system,0
6132,Congenital qualifier,Embryonic cyst of epoophoron,0
6133,Congenital qualifier,Congenital absence of vulva,0
6134,Congenital qualifier,Congenital lateral curvature of penis,0
6135,Congenital qualifier,Dyke-Davidoff-Masson syndrome,0
6136,Congenital qualifier,Agenesis of nerve,0
6137,Congenital qualifier,Congenital anomaly of ear with impairment of hearing,0
6138,Congenital qualifier,Cephalodiprosopus,0
6139,Congenital qualifier,Chemically-induced lipidosis,0
6140,Congenital qualifier,"Dysmorphic sialidosis, juvenile form",0
6141,Congenital qualifier,Mucolipidosis Type IV,0
6142,Congenital qualifier,Tay-Sachs Disease,0
6143,Congenital qualifier,"Cutis Laxa, Autosomal Dominant",0
6144,Congenital qualifier,Cockayne-Touraine Disease,0
6145,Congenital qualifier,Acatalasia,0
6146,Congenital qualifier,Chediak-Higashi Syndrome,0
6147,Congenital qualifier,Conjoined twins causing disproportion,0
6148,Congenital qualifier,Congenital stricture of osseous meatus of middle ear,0
6149,Congenital qualifier,Suspected damage to fetus from disease in the mother,0
6150,Congenital qualifier,Congenital hereditary muscular dystrophy,0
6151,Congenital qualifier,Fukuyama Type Congenital Muscular Dystrophy,0
6152,Congenital qualifier,"Muscular dystrophy congenital, merosin negative",0
6153,Congenital qualifier,Walker-Warburg congenital muscular dystrophy,0
6154,Congenital qualifier,"Muscle-eye-brain disease, congenital muscular dystrophy",0
6155,Congenital qualifier,"Distal muscular dystrophy, Miyoshi type",0
6156,Congenital qualifier,"Muscular Dystrophy, Emery-Dreifuss",0
6157,Congenital qualifier,Thyroid Hormone Resistance Syndrome,0
6158,Congenital qualifier,Congenital atransferrinemia,0
6159,Congenital qualifier,Reticular dysgenesis,0
6160,Congenital qualifier,SCID due to absent IL-2 receptor,0
6161,Congenital qualifier,Dysfibrinogenemia,0
6162,Congenital qualifier,Brown oculocutaneous albinism,0
6163,Congenital qualifier,Glycogen Storage Disease Type IV,0
6164,Congenital qualifier,Congenital anomaly of anus,0
6165,Congenital qualifier,Hydrorhachis,0
6166,Congenital qualifier,Congenital anomaly of pharynx,0
6167,Congenital qualifier,Oculocutaneous albinoidism,0
6168,Congenital qualifier,Upper esophageal web,0
6169,Congenital qualifier,Congenital valvular insufficiency,0
6170,Congenital qualifier,Persistent urogenital sinus,0
6171,Congenital qualifier,Mucopolysaccharidoses,0
6172,Congenital qualifier,Congenital coronary artery fistula,0
6173,Congenital qualifier,Congenital microcheilia,0
6174,Congenital qualifier,Complete congenital duodenal obstruction,0
6175,Congenital qualifier,Multiple congenital anomalies,0
6176,Congenital qualifier,X-linked agammaglobulinemia,0
6177,Congenital qualifier,Congenital stenosis of pulmonary veins,0
6178,Congenital qualifier,Congenital inversion of nipple,0
6179,Congenital qualifier,Hemicephaly,0
6180,Congenital qualifier,Neck webbing,0
6181,Congenital qualifier,Congenital malformation of the urinary system,0
6182,Congenital qualifier,Congenital absence of ovary,0
6183,Congenital qualifier,Congenital stenosis of larynx,0
6184,Congenital qualifier,Congenital hypoplasia of ascending aorta,0
6185,Congenital qualifier,Congenital rectocloacal fistula,0
6186,Congenital qualifier,"Gaucher Disease, Type 2 (disorder)",0
6187,Congenital qualifier,Congenital absence of sternum,0
6188,Congenital qualifier,Mesio-occlusion of teeth,0
6189,Congenital qualifier,Persistent fetal uterus,0
6190,Congenital qualifier,Congenital articular rigidity with myopathy,0
6191,Congenital qualifier,Congenital eventration of left crus of diaphragm,0
6192,Congenital qualifier,Tooth Crowding,0
6193,Congenital qualifier,Congenital deformity of scapula,0
6194,Congenital qualifier,Congenital anomaly of humerus,0
6195,Congenital qualifier,Congenital anomaly of radius,0
6196,Congenital qualifier,Congenital anomaly of ulna,0
6197,Congenital qualifier,Congenital anomaly of femur,0
6198,Congenital qualifier,Congenital anomaly of fibula,0
6199,Congenital qualifier,Congenital anomaly of tibia,0
6200,Congenital qualifier,Congenital anomaly of calcaneus,0
6201,Congenital qualifier,Congenital anomaly of tarsal bone,0
6202,Congenital qualifier,Congenital anomaly of metatarsal bone,0
6203,Congenital qualifier,Congenital anomaly of carpal bone,0
6204,Congenital qualifier,Congenital anomaly of metacarpal bone,0
6205,Congenital qualifier,Congenital anomaly of rib,0
6206,Congenital qualifier,"deformity; genital organs, female, congenital, external",0
6207,Congenital qualifier,Gynandromorphism syndrome,0
6208,Congenital qualifier,Group chromosomal alteration,0
6209,Congenital qualifier,Chromosomal alterations of group A,0
6210,Congenital qualifier,Chromosomal alterations of group B,0
6211,Congenital qualifier,Chromosomal alterations of group C and X,0
6212,Congenital qualifier,Chromosomal alterations of group D,0
6213,Congenital qualifier,Chromosomal alterations of group E,0
6214,Congenital qualifier,Chromosomal alterations of group F,0
6215,Congenital qualifier,Chromosomal alterations of group G and Y,0
6216,Congenital qualifier,Congenital anomaly of lower respiratory system,0
6217,Congenital qualifier,Accessory structure of lower respiratory tract,0
6218,Congenital qualifier,Congenital atresia of cardiac valve,0
6219,Congenital qualifier,Congenital stenosis of cardiac valve,0
6220,Congenital qualifier,Congenital cleft of cardiac valve,0
6221,Congenital qualifier,Dextrorotation of heart,0
6222,Congenital qualifier,Levoatrial cardinal vein,0
6223,Congenital qualifier,Persistent dorsal mesentery,0
6224,Congenital qualifier,Uterus bicornis unicollis with septate vagina,0
6225,Congenital qualifier,Rudimentary uterus in male,0
6226,Congenital qualifier,"Hereditary methemoglobinemia, enzymatic type",0
6227,Congenital qualifier,Congenital anteversion of femur,0
6228,Congenital qualifier,Lactate Dehydrogenase Deficiency,0
6229,Congenital qualifier,Deficiency of D-lactate dehydrogenase,0
6230,Congenital qualifier,Deficiency of L-lactate dehydrogenase (cytochrome),0
6231,Congenital qualifier,"Xanthinuria, Type I",0
6232,Congenital qualifier,Deficiency of butyryl-CoA dehydrogenase,0
6233,Congenital qualifier,NADH cytochrome B5 reductase deficiency,0
6234,Congenital qualifier,Deficiency of NADPH-ferrihemoprotein reductase,0
6235,Congenital qualifier,Deficiency of NAPH cytochrome-c>2< reductase,0
6236,Congenital qualifier,Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency,0
6237,Congenital qualifier,"Adrenal hyperplasia, congenital, type 5",0
6238,Congenital qualifier,Guanidinoacetate methyltransferase deficiency,0
6239,Congenital qualifier,Carnitine Acetyltransferase Deficiency,0
6240,Congenital qualifier,"Adrenocortical Hypofunction, Chronic Primary Congenital",0
6241,Congenital qualifier,Adenine phosphoribosyltransferase deficiency,0
6242,Congenital qualifier,Congenital macrognathism,0
6243,Congenital qualifier,Malonic aciduria,0
6244,Congenital qualifier,HMG CoA lyase deficiency,0
6245,Congenital qualifier,Deficiency of enoyl-CoA hydratase,0
6246,Congenital qualifier,Histidinemia,0
6247,Congenital qualifier,Methylmalonyl-Coenzyme A mutase deficiency,0
6248,Congenital qualifier,"von Willebrand disease, type IIF",0
6249,Congenital qualifier,Brachymetatarsia,0
6250,Congenital qualifier,Patent ductus arteriosus with left-to-right shunt,0
6251,Congenital qualifier,Patent ductus arteriosus with right-to-left shunt,0
6252,Congenital qualifier,Multiple malformation syndrome with senile-like appearance,0
6253,Congenital qualifier,Talocalcaneal coalition,0
6254,Congenital qualifier,Congenital anomaly of perineum,0
6255,Congenital qualifier,Congenital anomaly of intestinal tract,0
6256,Congenital qualifier,Cytochrome b>3< deficiency,0
6257,Congenital qualifier,"Knuckle pads, leuconychia and sensorineural deafness",0
6258,Congenital qualifier,Trifid tongue,0
6259,Congenital qualifier,Congenital absence of skeletal bone,0
6260,Congenital qualifier,Congenital anomaly of visual system,0
6261,Congenital qualifier,Cyanotic congenital heart disease,0
6262,Congenital qualifier,Isologous chimera,0
6263,Congenital qualifier,Longitudinal deficiency of foot,0
6264,Congenital qualifier,Congenital portal-systemic shunt,0
6265,Congenital qualifier,Congenital extrahepatic portal-systemic shunt,0
6266,Congenital qualifier,Congenital absence of portal vein,0
6267,Congenital qualifier,Congenital partial portal-systemic shunt,0
6268,Congenital qualifier,Congenital splenorenal shunt,0
6269,Congenital qualifier,Congenital intrahepatic portal-systemic shunt,0
6270,Congenital qualifier,"Duane's syndrome, type 1",0
6271,Congenital qualifier,"Duane's syndrome, type 2",0
6272,Congenital qualifier,"Duane's syndrome, type 3",0
6273,Congenital qualifier,von Willebrand disease type IB,0
6274,Congenital qualifier,Congenital anomaly of central nervous system,0
6275,Congenital qualifier,Inherited metabolic disorder of nervous system,0
6276,Congenital qualifier,Rubella encephalomyelitis,0
6277,Congenital qualifier,"Hereditary Sensory Autonomic Neuropathy, Type 5",0
6278,Congenital qualifier,Dysostosis of bone of skull,0
6279,Congenital qualifier,Congenital anomaly of maxilla,0
6280,Congenital qualifier,Congenital anomaly of mandible,0
6281,Congenital qualifier,Congenital anomaly of nose,0
6282,Congenital qualifier,Congenital anomaly of nasal sinuses,0
6283,Congenital qualifier,Congenital anomaly of ocular adnexa,0
6284,Congenital qualifier,Congenital anomaly of duodenum,0
6285,Congenital qualifier,Congenital anomaly of peritoneum,0
6286,Congenital qualifier,Congenital anomaly of gastrointestinal tract,0
6287,Congenital qualifier,Congenital anomaly of cornea,0
6288,Congenital qualifier,Congenital anomaly of lens,0
6289,Congenital qualifier,Micropapilla,0
6290,Congenital qualifier,Congenital anomaly of posterior segment of eye,0
6291,Congenital qualifier,Congenital anomaly of talus,0
6292,Congenital qualifier,Congenital coronary artery fistula to left atrium,0
6293,Congenital qualifier,Congenital coronary artery fistula to left ventricle,0
6294,Congenital qualifier,Congenital coronary artery fistula to right atrium,0
6295,Congenital qualifier,Congenital coronary artery fistula to right ventricle,0
6296,Congenital qualifier,Juxtaposed atrial appendage,0
6297,Congenital qualifier,Congenital pulmonary vein confluence,0
6298,Congenital qualifier,Congenital pulmonary venous atrium,0
6299,Congenital qualifier,Congenital systemic venous atrium,0
6300,Congenital qualifier,Left ventricle outflow chamber,0
6301,Congenital qualifier,Right ventricle outflow chamber,0
6302,Congenital qualifier,Congenital pulmonary artery conduit,0
6303,Congenital qualifier,Medium-chain acyl-coenzyme A dehydrogenase deficiency,0
6304,Congenital qualifier,Congenital absence of bile duct,0
6305,Congenital qualifier,Congenital stricture of ureteropelvic junction,0
6306,Congenital qualifier,Congenital anomaly of iris,0
6307,Congenital qualifier,Thiamine-responsive megaloblastic anemia,0
6308,Congenital qualifier,Deafness-symphalangism syndrome of Herrmann,0
6309,Congenital qualifier,Congenital coronary artery fistula to pulmonary artery,0
6310,Congenital qualifier,Congenital neurogenic ileus syndrome,0
6311,Congenital qualifier,"Nemaline myopathy, early onset type",0
6312,Congenital qualifier,"Nemaline myopathy, late onset type",0
6313,Congenital qualifier,Congenital ichthyosis,0
6314,Congenital qualifier,Methylcrotonyl-CoA carboxylase deficiency,0
6315,Congenital qualifier,Congenital heart disease,0
6316,Congenital qualifier,Congenital spondylolisthesis,0
6317,Congenital qualifier,Synechia vulvae,0
6318,Congenital qualifier,Femoral hypoplasia - unusual facies syndrome,0
6319,Congenital qualifier,Congenital corneal opacity interfering with vision,0
6320,Congenital qualifier,Ablepharon,0
6321,Congenital qualifier,Os trigonum disorder,0
6322,Congenital qualifier,Congenital adhesions,0
6323,Congenital qualifier,Melnick-Needles Syndrome,0
6324,Congenital qualifier,Anomalous muscle bands of left ventricle,0
6325,Congenital qualifier,Congenital anomaly of lacrimal system,0
6326,Congenital qualifier,congenital lobulation of kidney,0
6327,Congenital qualifier,Fistula of lip,0
6328,Congenital qualifier,Ring chromosome 22 syndrome,0
6329,Congenital qualifier,Congenital duplication of stomach,0
6330,Congenital qualifier,Ectrodactyly,0
6331,Congenital qualifier,Congenital absence of lobe of liver,0
6332,Congenital qualifier,Brachycephaly,0
6333,Congenital qualifier,Congenital stricture of urethra,0
6334,Congenital qualifier,Anomaly of chromosome pair 3,0
6335,Congenital qualifier,Congenital anomaly of aortic valve,0
6336,Congenital qualifier,Uterus unicornis,0
6337,Congenital qualifier,Congenital anomaly of urethra,0
6338,Congenital qualifier,Preductal coarctation of aorta,0
6339,Congenital qualifier,Lenz Majewski hyperostotic dwarfism,0
6340,Congenital qualifier,Derencephalus,0
6341,Congenital qualifier,12p partial trisomy syndrome,0
6342,Congenital qualifier,Double renal pelvis (disorder),0
6343,Congenital qualifier,Hypoplastic chondrodystrophy,0
6344,Congenital qualifier,Lipofuscinosis,0
6345,Congenital qualifier,Congenital prolapse of bladder,0
6346,Congenital qualifier,Congenital stenosis of small intestine,0
6347,Congenital qualifier,Dandy-Walker Syndrome,0
6348,Congenital qualifier,Anomalous origin of right subclavian artery,0
6349,Congenital qualifier,Congenital anomaly of trachea,0
6350,Congenital qualifier,Vestigial remnants of canal of Cloquet,0
6351,Congenital qualifier,Microstomia,0
6352,Congenital qualifier,Late-Infantile Neuronal Ceroid Lipfuscinosis,0
6353,Congenital qualifier,Uterus cordiformis,0
6354,Congenital qualifier,Gouty tophus of pinna,0
6355,Congenital qualifier,20q partial trisomy syndrome,0
6356,Congenital qualifier,Situs ambiguus,0
6357,Congenital qualifier,"Achondrogenesis, type IB (disorder)",0
6358,Congenital qualifier,Abdominal heart,0
6359,Congenital qualifier,Congenital anomaly of large intestine,0
6360,Congenital qualifier,Aarskog syndrome,0
6361,Congenital qualifier,Retinal dystrophy in systemic lipidosis,0
6362,Congenital qualifier,Russell-Silver syndrome,0
6363,Congenital qualifier,Myotubular myopathy with type I atrophy,0
6364,Congenital qualifier,Congenital insufficiency of pulmonary valve,0
6365,Congenital qualifier,Congenital stricture of bile duct,0
6366,Congenital qualifier,Congenital transposition of stomach,0
6367,Congenital qualifier,Coffin-Lowry syndrome,0
6368,Congenital qualifier,Congenital phlebectasia,0
6369,Congenital qualifier,Origin of innominate artery from left side of aortic arch,0
6370,Congenital qualifier,Adenylosuccinate lyase deficiency (disorder),0
6371,Congenital qualifier,Holocarboxylase Synthetase Deficiency,0
6372,Congenital qualifier,"Hypoalphalipoproteinemia, Familial",0
6373,Congenital qualifier,kidney; double pelvis,0
6374,Congenital qualifier,Central nervous system malformation in fetus affecting obstetrical care,0
6375,Congenital qualifier,Congenital pyloric membrane,0
6376,Congenital qualifier,Omphalocele with obstruction,0
6377,Congenital qualifier,Congenital dislocation of knee with genu recurvatum,0
6378,Congenital qualifier,Endocardial Cushion Defects,0
6379,Congenital qualifier,Congenital hypofibrinogenemia,0
6380,Congenital qualifier,Congenital duplication of uterus,0
6381,Congenital qualifier,"Osteogenesis imperfecta, recessive perinatal lethal, with microcephaly AND cataracts",0
6382,Congenital qualifier,Goldenhar Syndrome,0
6383,Congenital qualifier,Congenital absence of lobe of lung,0
6384,Congenital qualifier,Placenta previa centralis,0
6385,Congenital qualifier,Encephalocele of orbit,0
6386,Congenital qualifier,Congenital cleft thyroid cartilage,0
6387,Congenital qualifier,Maxillary prognathism,0
6388,Congenital qualifier,21q partial monosomy syndrome,0
6389,Congenital qualifier,Congenital absence of vertebra,0
6390,Congenital qualifier,Albinism,0
6391,Congenital qualifier,MPS III D,0
6392,Congenital qualifier,Desmiognathus,0
6393,Congenital qualifier,"Glycogen storage disease, muscular form",0
6394,Congenital qualifier,Severe steroid 21-hydroxylase deficiency,0
6395,Congenital qualifier,Cerebellar Hypoplasia,0
6396,Congenital qualifier,Congenital generalized flexion contractures of lower limb joints,0
6397,Congenital qualifier,Heterodymus,0
6398,Congenital qualifier,10q partial monosomy syndrome,0
6399,Congenital qualifier,Hereditary orotic aciduria,0
6400,Congenital qualifier,Congenital hydronephrosis,0
6401,Congenital qualifier,Congenital duodenal stenosis,0
6402,Congenital qualifier,O/E - auricle of ear - tophi,0
6403,Congenital qualifier,O/E - hands - arachnodactyly,0
6404,Congenital qualifier,Ectopic kidney,0
6405,Congenital qualifier,Congenital absence of membranous labyrinth,0
6406,Congenital qualifier,Cerebral lipidosis,0
6407,Congenital qualifier,Dermatoglyphs - skin lines,0
6408,Congenital qualifier,Mesocardia,0
6409,Congenital qualifier,Anomaly of chromosome pair 15,0
6410,Congenital qualifier,Congenital spade-like hand,0
6411,Congenital qualifier,Talipomanus,0
6412,Congenital qualifier,Congenital occlusion of ureter,0
6413,Congenital qualifier,Fabry Disease,0
6414,Congenital qualifier,Hyperuricuria,0
6415,Congenital qualifier,Longitudinal deficiency of humerus,0
6416,Congenital qualifier,Incomplete congenital absence of thigh AND leg,0
6417,Congenital qualifier,Accessory lung lobe anomaly,0
6418,Congenital qualifier,Developmental absence of tooth,0
6419,Congenital qualifier,Congenital aneurysm of aorta,0
6420,Congenital qualifier,"Congenital absence of leg, including foot and toes",0
6421,Congenital qualifier,Aortopulmonary Septal Defect,0
6422,Congenital qualifier,"Ehlers-Danlos Syndrome, Type IV",0
6423,Congenital qualifier,Wolf-Hirschhorn Syndrome,0
6424,Congenital qualifier,Congenital eventration of diaphragm,0
6425,Congenital qualifier,Congenital absence of uterus,0
6426,Congenital qualifier,Fibrochondrogenesis,0
6427,Congenital qualifier,Pili Torti,0
6428,Congenital qualifier,Congenital diaphragmatic hernia,0
6429,Congenital qualifier,Dextraposition of aorta,0
6430,Congenital qualifier,Congenital meningocele,0
6431,Congenital qualifier,Fetal valproate syndrome,0
6432,Congenital qualifier,Allantoic cyst,0
6433,Congenital qualifier,Clinodactyly of fingers,0
6434,Congenital qualifier,Ebstein's anomaly with atrial septal defect,0
6435,Congenital qualifier,Ectopic thymic tissue,0
6436,Congenital qualifier,Fused Teeth,0
6437,Congenital qualifier,Polyorchism,0
6438,Congenital qualifier,Atresia of pupil,0
6439,Congenital qualifier,Sacralization of lumbar vertebra,0
6440,Congenital qualifier,Overriding skull bones,0
6441,Congenital qualifier,Sclerosteosis,0
6442,Congenital qualifier,Congenital subluxation of carpus,0
6443,Congenital qualifier,Asplenia Syndrome,0
6444,Congenital qualifier,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,0
6445,Congenital qualifier,Agenesis of both forepaws and both hindpaws,0
6446,Congenital qualifier,Thoracodidymus,0
6447,Congenital qualifier,Persistent Ostium Primum,0
6448,Congenital qualifier,Anomaly of chromosome pair 13,0
6449,Congenital qualifier,Mohr Syndrome,0
6450,Congenital qualifier,Supernumerary mesiodens tooth,0
6451,Congenital qualifier,Azygos lobe of lung,0
6452,Congenital qualifier,Leri-Weill dyschondrosteosis,0
6453,Congenital qualifier,Cross syndrome,0
6454,Congenital qualifier,Thyroid Dyshormonogenesis 4,0
6455,Congenital qualifier,"Elliptocytosis, Hereditary",0
6456,Congenital qualifier,Primary Hyperoxaluria,0
6457,Congenital qualifier,Gaucher Disease,0
6458,Congenital qualifier,Trichorhinophalangeal syndrome,0
6459,Congenital qualifier,Congenital deformity of sacroiliac joint,0
6460,Congenital qualifier,Accessory breast,0
6461,Congenital qualifier,Urethral obstruction sequence,0
6462,Congenital qualifier,Congenital duodenal obstruction,0
6463,Congenital qualifier,Unstable hemoglobin disease,0
6464,Congenital qualifier,Diastematocrania,0
6465,Congenital qualifier,Microcolon,0
6466,Congenital qualifier,Oligomeganephronic hypoplasia of kidney,0
6467,Congenital qualifier,Congenital stenosis of aortic valve,0
6468,Congenital qualifier,Accessory nose,0
6469,Congenital qualifier,Congenital Rubella Syndrome,0
6470,Congenital qualifier,Bronchopulmonary Sequestration,0
6471,Congenital qualifier,Early congenital syphilis - latent,0
6472,Congenital qualifier,Congenital syphilis with gumma,0
6473,Congenital qualifier,Late congenital syphilitic oculopathy,0
6474,Congenital qualifier,Congenital omphalocele,0
6475,Congenital qualifier,Congenital Koilonychia,0
6476,Congenital qualifier,"Gangliosidosis, Generalized GM1, Type 2",0
6477,Congenital qualifier,H-type congenital tracheoesophageal fistula,0
6478,Congenital qualifier,"Congenital secretory diarrhea, sodium type (disorder)",0
6479,Congenital qualifier,Preauricular cyst,0
6480,Congenital qualifier,Dysplasia of eye,0
6481,Congenital qualifier,Centrofacial lentiginosis syndrome,0
6482,Congenital qualifier,Schinzel-Giedion syndrome,0
6483,Congenital qualifier,Cleft uvula,0
6484,Congenital qualifier,"Niemann-Pick Disease, Type D",0
6485,Congenital qualifier,Ectopic breast tissue,0
6486,Congenital qualifier,Ovotestis,0
6487,Congenital qualifier,Congenital Hypothyroidism,0
6488,Congenital qualifier,Congenital prolapse of urethra,0
6489,Congenital qualifier,Congenital adrenal hyperplasia,0
6490,Congenital qualifier,Cystinosis,0
6491,Congenital qualifier,Disorders of pyruvate metabolism and gluconeogenesis,0
6492,Congenital qualifier,"von Willebrand disease, type IIC",0
6493,Congenital qualifier,Gouty tophus of hand,0
6494,Congenital qualifier,Hypophosphatasia,0
6495,Congenital qualifier,"Porphyria, Erythropoietic",0
6496,Congenital qualifier,Xanthinuria,0
6497,Congenital qualifier,Hyperuricemia without signs of inflammatory arthritis and tophaceous disease,0
6498,Congenital qualifier,Holt-Oram syndrome,0
6499,Congenital qualifier,Defect in post-translational modification of lysosomal enzymes,0
6500,Congenital qualifier,Enterokinase Deficiency,0
6501,Congenital qualifier,Pancreatic trypsinogen deficiency,0
6502,Congenital qualifier,Autosomal recessive SCID,0
6503,Congenital qualifier,Thymic aplasia or dysplasia with immunodeficiency,0
6504,Congenital qualifier,Severe combined immunodeficiency with reticular dysgenesis,0
6505,Congenital qualifier,Severe combined immunodeficiency with low T- and B-cell numbers,0
6506,Congenital qualifier,Severe combined immunodeficiency with low or normal B-cell numbers,0
6507,Congenital qualifier,Major histocompatibility complex class I deficiency,0
6508,Congenital qualifier,Major histocompatibility complex class II deficiency,0
6509,Congenital qualifier,Common variable immunodeficiency with predominant abnormalities of B-cell numbers and functions,0
6510,Congenital qualifier,Common variable immunodeficiency with predominant immunoregulatory T-cell disorders,0
6511,Congenital qualifier,Common variable immunodeficiency with autoantibodies to B- or T-cells,0
6512,Congenital qualifier,Syringomyelobulbia,0
6513,Congenital qualifier,Congenital folate malabsorption anemia,0
6514,Congenital qualifier,Hereditary vascular fragility,0
6515,Congenital qualifier,Neurofibromatoses,0
6516,Congenital qualifier,Chronic granulomatous disease,0
6517,Congenital qualifier,Epidermodysplasia Verruciformis,0
6518,Congenital qualifier,Ischiopagus,0
6519,Congenital qualifier,Congenital syphilitic hepatomegaly,0
6520,Congenital qualifier,Congenital absence of urethra,0
6521,Congenital qualifier,Premature closure of foramen ovale,0
6522,Congenital qualifier,Osteopetrosis,0
6523,Congenital qualifier,Congenital cerebral cyst,0
6524,Congenital qualifier,B variant hexosaminidase A deficiency,0
6525,Congenital qualifier,Retinal dystrophy in cerebroretinal lipidosis,0
6526,Congenital qualifier,Syringomyelia and syringobulbia,0
6527,Congenital qualifier,Clutton's joints,0
6528,Congenital qualifier,Congenital paraplegia,0
6529,Congenital qualifier,Myoclonic Seizures,0
6530,Congenital qualifier,Congenital and developmental myasthenia,0
6531,Congenital qualifier,Benign congenital myopathy,0
6532,Congenital qualifier,Distal muscular dystrophy with juvenile onset,0
6533,Congenital qualifier,Leber Congenital Amaurosis,0
6534,Congenital qualifier,Ectopic pancreas,0
6535,Congenital qualifier,Ankyloblepharon,0
6536,Congenital qualifier,Vascular anomaly of eyelid,0
6537,Congenital qualifier,Congenital nasolacrimal duct obstruction,0
6538,Congenital qualifier,Macrocephaly,0
6539,Congenital qualifier,Eye Abnormalities,0
6540,Congenital qualifier,8p partial monosomy syndrome,0
6541,Congenital qualifier,Occipital dysplasia,0
6542,Congenital qualifier,"von Willebrand Disease, Type 2B",0
6543,Congenital qualifier,Congenital deficiency of pigment of skin,0
6544,Congenital qualifier,22q partial monosomy syndrome,0
6545,Congenital qualifier,Preauricular dimple,0
6546,Congenital qualifier,Triglyceride storage disease with ichthyosis,0
6547,Congenital qualifier,Midline deviation of dental arch,0
6548,Congenital qualifier,Anterior imbrication of teeth,0
6549,Congenital qualifier,Posterior imbrication of teeth,0
6550,Congenital qualifier,Anterior Diastema of Teeth,0
6551,Congenital qualifier,Posterior Diastema of Teeth,0
6552,Congenital qualifier,Impacted incisors,0
6553,Congenital qualifier,Impacted premolars,0
6554,Congenital qualifier,Impacted molars,0
6555,Congenital qualifier,branchial vestige,0
6556,Congenital qualifier,Longitudinal absence of radius AND ulna,0
6557,Congenital qualifier,Omphalocele with gangrene,0
6558,Congenital qualifier,Omphalocele - irreducible,0
6559,Congenital qualifier,Simple omphalocele,0
6560,Congenital qualifier,Secondary megacolon - congenital,0
6561,Congenital qualifier,Congenital celiac disease,0
6562,Congenital qualifier,Finnish congenital nephrotic syndrome,0
6563,Congenital qualifier,Congenital vaginal enterocele,0
6564,Congenital qualifier,Nodular calcific aortic valve stenosis,0
6565,Congenital qualifier,Sturge-Weber Syndrome,0
6566,Congenital qualifier,Macerated fetus,0
6567,Congenital qualifier,Papyraceous fetus - delivered,0
6568,Congenital qualifier,Papyraceous fetus - not delivered,0
6569,Congenital qualifier,Congenital cardiovascular disorder during pregnancy - baby delivered,0
6570,Congenital qualifier,Congenital cardiovascular disorder in the puerperium - baby delivered during current episode of care,0
6571,Congenital qualifier,Congenital cardiovascular disorder during pregnancy - baby not yet delivered,0
6572,Congenital qualifier,Congenital cardiovascular disorder in the puerperium - baby delivered during previous episode of care,0
6573,Congenital qualifier,Known or suspected fetal abnormality,0
6574,Congenital qualifier,Fetus with central nervous system malformation - delivered,0
6575,Congenital qualifier,fetal central nervous system abnormality affecting care of mother as antepartum condition,0
6576,Congenital qualifier,Fetus with chromosomal abnormality - delivered,0
6577,Congenital qualifier,Fetus with chromosomal abnormality with antenatal problem,0
6578,Congenital qualifier,Fetus with hereditary disease,0
6579,Congenital qualifier,Fetus with hereditary disease - delivered,0
6580,Congenital qualifier,Fetus with hereditary disease with antenatal problem,0
6581,Congenital qualifier,Fetus with viral damage via mother - delivered,0
6582,Congenital qualifier,Fetus with viral damage via mother with antenatal problem,0
6583,Congenital qualifier,Fetus with drug damage,0
6584,Congenital qualifier,Fetus with drug damage - delivered,0
6585,Congenital qualifier,Fetus with drug damage with antenatal problem,0
6586,Congenital qualifier,Fetus with radiation damage,0
6587,Congenital qualifier,Fetus with radiation damage - delivered,0
6588,Congenital qualifier,Fetus with radiation damage with antenatal problem,0
6589,Congenital qualifier,Fetus with damage due to intrauterine contraceptive device,0
6590,Congenital qualifier,Fetus with damage due to intrauterine contraceptive device - delivered,0
6591,Congenital qualifier,Fetus with damage due to intrauterine contraceptive device with antenatal problem,0
6592,Congenital qualifier,Skin Abnormalities,0
6593,Congenital qualifier,Keratoderma plantare sulcata,0
6594,Congenital qualifier,"Porokeratosis of Mibelli, plaque type",0
6595,Congenital qualifier,Accessory carpal bones,0
6596,Congenital qualifier,Secondary orotic aciduria,0
6597,Congenital qualifier,Gouty arthritis of the shoulder region,0
6598,Congenital qualifier,Gouty arthritis of the upper arm,0
6599,Congenital qualifier,Gouty arthritis of the forearm,0
6600,Congenital qualifier,Gouty arthritis of the hand,0
6601,Congenital qualifier,Gouty arthritis of the pelvic region and thigh,0
6602,Congenital qualifier,Gouty arthritis of the lower leg,0
6603,Congenital qualifier,Gouty arthritis of the ankle and/or foot,0
6604,Congenital qualifier,Gouty arthritis of multiple sites,0
6605,Congenital qualifier,Hexadactyly,0
6606,Congenital qualifier,Becker Generalized Myotonia,0
6607,Congenital qualifier,14q partial distal trisomy syndrome,0
6608,Congenital qualifier,X-Linked Combined Immunodeficiency Diseases,0
6609,Congenital qualifier,Congenital entropion,0
6610,Congenital qualifier,Anencephalus and similar anomalies,0
6611,Congenital qualifier,Acrania,0
6612,Congenital qualifier,Iniencephaly - closed,0
6613,Congenital qualifier,Iniencephaly - open,0
6614,Congenital qualifier,Cervical spina bifida with hydrocephalus,0
6615,Congenital qualifier,Thoracic spina bifida with hydrocephalus,0
6616,Congenital qualifier,Lumbar spina bifida with hydrocephalus,0
6617,Congenital qualifier,Cervical spina bifida with hydrocephalus - open,0
6618,Congenital qualifier,Thoracic spina bifida with hydrocephalus - open,0
6619,Congenital qualifier,Lumbar spina bifida with hydrocephalus - open,0
6620,Congenital qualifier,Sacral spina bifida with hydrocephalus - open,0
6621,Congenital qualifier,Spina bifida with hydrocephalus - closed,0
6622,Congenital qualifier,Cervical spina bifida with hydrocephalus - closed,0
6623,Congenital qualifier,Thoracic spina bifida with hydrocephalus - closed,0
6624,Congenital qualifier,Lumbar spina bifida with hydrocephalus - closed,0
6625,Congenital qualifier,Sacral spina bifida with hydrocephalus - closed,0
6626,Congenital qualifier,Spina bifida with hydrocephalus of late onset,0
6627,Congenital qualifier,Spina bifida with stenosis of aqueduct of Sylvius,0
6628,Congenital qualifier,Dandy-Walker syndrome with spina bifida,0
6629,Congenital qualifier,Congenital spinal hydromeningocele,0
6630,Congenital qualifier,Cervical spinal hydromeningocele,0
6631,Congenital qualifier,Cervical spinal hydromeningocele,0
6632,Congenital qualifier,Thoracic hydromyelocele,0
6633,Congenital qualifier,Lumbar hydromyelocele,0
6634,Congenital qualifier,Spinal meningocele,0
6635,Congenital qualifier,Cervical spinal meningocele,0
6636,Congenital qualifier,Thoracic spinal meningocele,0
6637,Congenital qualifier,Lumbar spinal meningocele,0
6638,Congenital qualifier,Cervical meningomyelocele,0
6639,Congenital qualifier,Thoracic meningomyelocele,0
6640,Congenital qualifier,Lumbar meningomyelocele,0
6641,Congenital qualifier,Cervical myelocele,0
6642,Congenital qualifier,Thoracic myelocele,0
6643,Congenital qualifier,Lumbar myelocele,0
6644,Congenital qualifier,Myelocystocele,0
6645,Congenital qualifier,Cervical myelocystocele,0
6646,Congenital qualifier,Thoracic myelocystocele,0
6647,Congenital qualifier,Lumbar myelocystocele,0
6648,Congenital qualifier,Cervical spina bifida without hydrocephalus - open,0
6649,Congenital qualifier,Thoracic spina bifida without hydrocephalus - open,0
6650,Congenital qualifier,Lumbar spina bifida without hydrocephalus - open,0
6651,Congenital qualifier,Sacral spina bifida without hydrocephalus - open,0
6652,Congenital qualifier,Spina bifida without hydrocephalus - closed,0
6653,Congenital qualifier,Cervical spina bifida without hydrocephalus - closed,0
6654,Congenital qualifier,Thoracic spina bifida without hydrocephalus - closed,0
6655,Congenital qualifier,Lumbar spina bifida without hydrocephalus - closed,0
6656,Congenital qualifier,Sacral spina bifida without hydrocephalus - closed,0
6657,Congenital qualifier,Encephalomyelocele,0
6658,Congenital qualifier,Hydrencephalomeningocele,0
6659,Congenital qualifier,Reduction deformities of brain,0
6660,Congenital qualifier,Lissencephaly,0
6661,Congenital qualifier,Anomalies of cerebrum,0
6662,Congenital qualifier,Agenesis of cerebrum,0
6663,Congenital qualifier,Congenital malformation of corpus callosum,0
6664,Congenital qualifier,Hypoplasia of corpus callosum,0
6665,Congenital qualifier,Anomalies of hypothalamus,0
6666,Congenital qualifier,Anomalies of cerebellum,0
6667,Congenital qualifier,Aplasia of cerebellum,0
6668,Congenital qualifier,Cebocephaly,0
6669,Congenital qualifier,Congenital atresia of foramen of Magendie,0
6670,Congenital qualifier,Congenital atresia of foramen of Luschka,0
6671,Congenital qualifier,Single congenital cerebral cyst,0
6672,Congenital qualifier,Multiple congenital cerebral cysts,0
6673,Congenital qualifier,Congenital adhesions of cerebral meninges,0
6674,Congenital qualifier,Multiple brain anomalies,0
6675,Congenital qualifier,Defective development of the cauda equina,0
6676,Congenital qualifier,Spinal cord hypoplasia,0
6677,Congenital qualifier,Anophthalmos,0
6678,Congenital qualifier,Cryptophthalmos syndrome,0
6679,Congenital qualifier,Microphthalmos,0
6680,Congenital qualifier,Congenital keratoglobus,0
6681,Congenital qualifier,Cortical and zonular cataract,0
6682,Congenital qualifier,Congenital lamellar cataract,0
6683,Congenital qualifier,congenital total and subtotal cataract,0
6684,Congenital qualifier,Congenital anomaly of lens shape,0
6685,Congenital qualifier,Coloboma of lens,0
6686,Congenital qualifier,"Cataract, congenital, cerulean type 1",0
6687,Congenital qualifier,Congenital membranous cataract,0
6688,Congenital qualifier,Corneal size and shape anomalies,0
6689,Congenital qualifier,Cornea plana,0
6690,Congenital qualifier,Congenital corneal opacity with visual deficit,0
6691,Congenital qualifier,Congenital corneal opacity without visual deficit,0
6692,Congenital qualifier,Axenfeld anomaly (disorder),0
6693,Congenital qualifier,Irido-corneo-trabecular dysgenesis (disorder),0
6694,Congenital qualifier,Rieger eye malformation sequence,0
6695,Congenital qualifier,Polycoria,0
6696,Congenital qualifier,Specified congenital anomalies of sclera,0
6697,Congenital qualifier,Blue sclera,0
6698,Congenital qualifier,Multiple anterior segment anomalies,0
6699,Congenital qualifier,Congenital vitreous opacity,0
6700,Congenital qualifier,Congenital fold and cyst of posterior segment of eye,0
6701,Congenital qualifier,Congenital folds of the posterior segment,0
6702,Congenital qualifier,congenital cysts of posterior segment,0
6703,Congenital qualifier,Congenital macular changes,0
6704,Congenital qualifier,Congenital retinal fold,0
6705,Congenital qualifier,Posterior segment vascular anomalies,0
6706,Congenital qualifier,Congenital arteriovenous malformation of retina,0
6707,Congenital qualifier,Congenital stricture of retinal artery,0
6708,Congenital qualifier,Specified anomalies of choroid,0
6709,Congenital qualifier,Coloboma of choroid,0
6710,Congenital qualifier,"Congenital anomalies of eyelid, lacrimal system and orbit",0
6711,Congenital qualifier,Hypoplasia of eyelid,0
6712,Congenital qualifier,Agenesis of punctum lacrimale,0
6713,Congenital qualifier,Accessory eye muscles,0
6714,Congenital qualifier,Hypoplasia of eye muscle,0
6715,Congenital qualifier,"Ear, face and neck congenital anomalies",0
6716,Congenital qualifier,"Congenital anomaly of middle ear, except ossicles",0
6717,Congenital qualifier,Ear osseous meatus atresia,0
6718,Congenital qualifier,Congenital stricture of osseous meatus,0
6719,Congenital qualifier,Accessory tragus,0
6720,Congenital qualifier,Congenital abnormality of Eustachian tube,0
6721,Congenital qualifier,Congenital stenosis of eustachian tube,0
6722,Congenital qualifier,Congenital pointed ear,0
6723,Congenital qualifier,Congenital prominent auricle,0
6724,Congenital qualifier,Congenital ridge ear,0
6725,Congenital qualifier,Branchial cleft cyst or fistula; preauricular sinus,0
6726,Congenital qualifier,Branchial cleft external sinus,0
6727,Congenital qualifier,Branchial cleft internal sinus,0
6728,Congenital qualifier,Preauricular sinus or fistula,0
6729,Congenital qualifier,Congenital preauricular sinus,0
6730,Congenital qualifier,"Preauricular Fistulae, Congenital",0
6731,Congenital qualifier,Congenital absence of chin,0
6732,Congenital qualifier,Discordant ventriculoarterial connection,0
6733,Congenital qualifier,Transposition of Great Vessels,0
6734,Congenital qualifier,Dextrotransposition of aorta,0
6735,Congenital qualifier,Incomplete great vessel transposition,0
6736,Congenital qualifier,Pentalogy of Fallot,0
6737,Congenital qualifier,Eisenmenger Complex,0
6738,Congenital qualifier,"Foramen Ovale, Patent",0
6739,Congenital qualifier,Persistent ostium secundum,0
6740,Congenital qualifier,Lutembacher Syndrome,0
6741,Congenital qualifier,Common atrioventricular-type ventricular septal defect,0
6742,Congenital qualifier,Congenital pulmonary valve abnormality,0
6743,Congenital qualifier,Congenital atresia of pulmonary valve,0
6744,Congenital qualifier,Congenital hypoplasia of pulmonary valve,0
6745,Congenital qualifier,Congenital fusion of pulmonic cusps,0
6746,Congenital qualifier,Congenital fusion of pulmonary valve segment,0
6747,Congenital qualifier,Trilogy of Fallot,0
6748,Congenital qualifier,Supernumerary pulmonary valve cusps,0
6749,Congenital qualifier,Congenital tricuspid atresia and stenosis,0
6750,Congenital qualifier,Ebstein Anomaly,0
6751,Congenital qualifier,Supernumerary cusps of the mitral valve,0
6752,Congenital qualifier,Pulmonary Subvalvular Stenosis,0
6753,Congenital qualifier,Congenital coronary aneurysm,0
6754,Congenital qualifier,Congenital stenosis of coronary artery,0
6755,Congenital qualifier,Congenital complete heart block,0
6756,Congenital qualifier,Congenital incomplete atrioventricular heart block,0
6757,Congenital qualifier,Hypoplasia of cardiac vein,0
6758,Congenital qualifier,Congenital anomaly of myocardium,0
6759,Congenital qualifier,Congenital aneurysm of heart,0
6760,Congenital qualifier,Cor triloculare,0
6761,Congenital qualifier,Congenital epicardial cyst,0
6762,Congenital qualifier,Hemicardia,0
6763,Congenital qualifier,Anomalous origin of the aortic arch,0
6764,Congenital qualifier,Persistent aortic arch convolutions,0
6765,Congenital qualifier,Atresia and stenosis of aorta,0
6766,Congenital qualifier,Congenital atresia of pulmonary artery,0
6767,Congenital qualifier,Atresia of pulmonary artery with septal defect,0
6768,Congenital qualifier,Anomalies of great veins,0
6769,Congenital qualifier,Subdiaphragmatic total anomalous pulmonary venous return,0
6770,Congenital qualifier,Supradiaphragmatic total anomalous pulmonary venous return,0
6771,Congenital qualifier,Anomalous portal vein termination,0
6772,Congenital qualifier,Pulmonary vein atresia,0
6773,Congenital qualifier,Congenital varix,0
6774,Congenital qualifier,Arteriovenous malformation of precerebral vessels,0
6775,Congenital qualifier,Congenital stricture of cerebral artery,0
6776,Congenital qualifier,Choanal Atresia,0
6777,Congenital qualifier,Atresia of the anterior nares,0
6778,Congenital qualifier,Atresia of the posterior nares,0
6779,Congenital qualifier,Congenital stenosis of the anterior nares,0
6780,Congenital qualifier,Congenital hypoplasia of nose,0
6781,Congenital qualifier,Congenital cleft nose,0
6782,Congenital qualifier,Congenital perforation of the nasal sinus wall,0
6783,Congenital qualifier,Congenital fissure of nose,0
6784,Congenital qualifier,Congenital glottic web of larynx,0
6785,Congenital qualifier,Congenital subglottic web of larynx,0
6786,Congenital qualifier,"Agenesis of larynx, trachea and bronchus",0
6787,Congenital qualifier,Congenital absence of bronchus,0
6788,Congenital qualifier,Agenesis of larynx,0
6789,Congenital qualifier,Anomaly of cricoid cartilage,0
6790,Congenital qualifier,Atresia of larynx and trachea,0
6791,Congenital qualifier,"Congenital stenosis of larynx, trachea and bronchus",0
6792,Congenital qualifier,Congenital bronchial stenosis,0
6793,Congenital qualifier,Congenital Subglottic Stenosis,0
6794,Congenital qualifier,Congenital supraglottic stenosis,0
6795,Congenital qualifier,Congenital fissure of epiglottis,0
6796,Congenital qualifier,Congenital cleft of posterior cricoid cartilage,0
6797,Congenital qualifier,Laryngeal cleft,0
6798,Congenital qualifier,"Congenital agenesis, hypoplasia, and dysplasia of lung",0
6799,Congenital qualifier,Congenital absence of lung fissures,0
6800,Congenital qualifier,Fusion of lobes of lung,0
6801,Congenital qualifier,Central cleft lip,0
6802,Congenital qualifier,Bilateral complete cleft palate with cleft lip,0
6803,Congenital qualifier,Bilateral incomplete cleft palate with cleft lip,0
6804,Congenital qualifier,Central complete cleft palate with cleft lip,0
6805,Congenital qualifier,Central incomplete cleft palate with cleft lip,0
6806,Congenital qualifier,"Cleft hard palate with cleft lip, bilateral",0
6807,Congenital qualifier,Congenital cleft tongue,0
6808,Congenital qualifier,Congenital fissure of tongue,0
6809,Congenital qualifier,Congenital salivary gland fistula,0
6810,Congenital qualifier,Congenital pharyngeal polyp,0
6811,Congenital qualifier,"Ranula, congenital",0
6812,Congenital qualifier,Congenital ectropion of lip,0
6813,Congenital qualifier,Congenital esophageal fistula,0
6814,Congenital qualifier,Esophageal Atresia,0
6815,Congenital qualifier,Congenital absence of esophagus with tracheo-esophageal fistula,0
6816,Congenital qualifier,Esophageal atresia with tracheoesophageal fistula (disorder),0
6817,Congenital qualifier,Congenital diverticulum of esophagus,0
6818,Congenital qualifier,Congenital pyloric spasm,0
6819,Congenital qualifier,Congenital constriction of pylorus,0
6820,Congenital qualifier,Ectopic gastric mucosa,0
6821,Congenital qualifier,Displaced Meckel's diverticulum,0
6822,Congenital qualifier,Small intestine atresia and stenosis,0
6823,Congenital qualifier,Congenital absence of duodenum,0
6824,Congenital qualifier,Congenital absence of jejunum,0
6825,Congenital qualifier,Congenital absence of ileum,0
6826,Congenital qualifier,Congenital jejunal stenosis,0
6827,Congenital qualifier,Congenital ileal stenosis,0
6828,Congenital qualifier,Jejunal Atresia,0
6829,Congenital qualifier,Congenital absence of anus with fistula,0
6830,Congenital qualifier,Congenital absence of rectum with fistula,0
6831,Congenital qualifier,Congenital atresia of large intestine,0
6832,Congenital qualifier,"Anus, Imperforate",0
6833,Congenital qualifier,Congenital atresia of appendix,0
6834,Congenital qualifier,Atresia of anus with fistula,0
6835,Congenital qualifier,Atresia of rectum with fistula,0
6836,Congenital qualifier,Congenital occlusion of anus with fistula,0
6837,Congenital qualifier,Congenital stricture of anus,0
6838,Congenital qualifier,Congenital stricture of anus with fistula,0
6839,Congenital qualifier,Congenital stricture of rectum with fistula,0
6840,Congenital qualifier,"Anus, Imperforate",0
6841,Congenital qualifier,Imperforate anus with fistula,0
6842,Congenital qualifier,Imperforate large intestine,0
6843,Congenital qualifier,Hirschsprung Disease,0
6844,Congenital qualifier,Long segment Hirschsprung's disease,0
6845,Congenital qualifier,Short segment Hirschsprung's disease,0
6846,Congenital qualifier,Total intestinal aganglionosis,0
6847,Congenital qualifier,Congenital intestinal adhesions,0
6848,Congenital qualifier,Malrotation of colon and cecum,0
6849,Congenital qualifier,Transposition of cecum,0
6850,Congenital qualifier,Megaduodenum,0
6851,Congenital qualifier,Congenital fecal fistula,0
6852,Congenital qualifier,Congenital absence of hepatic ducts,0
6853,Congenital qualifier,Atresia of hepatic ducts,0
6854,Congenital qualifier,Congenital absence of liver and/or gallbladder,0
6855,Congenital qualifier,Congenital atrophy of left lobe of liver,0
6856,Congenital qualifier,Liver and/or biliary duplication,0
6857,Congenital qualifier,Congenital floating liver,0
6858,Congenital qualifier,Congenital dilation of bile duct,0
6859,Congenital qualifier,Congenital diverticulum of bile duct,0
6860,Congenital qualifier,Liver hyperplasia,0
6861,Congenital qualifier,Anomalies of pancreas,0
6862,Congenital qualifier,Congenital pancreatic cyst,0
6863,Congenital qualifier,Congenital malformation of genital organs,0
6864,Congenital qualifier,Fallopian tube and broad ligament anomalies,0
6865,Congenital qualifier,Embryonic cyst of epoophoron,0
6866,Congenital qualifier,Uterus bilocularis,0
6867,Congenital qualifier,Congenital fistulae between uterus and digestive and urinary tracts,0
6868,Congenital qualifier,Congenital uterointestinal fistula,0
6869,Congenital qualifier,Congenital uterovesical fistula,0
6870,Congenital qualifier,"Cervical, vaginal and external female genital anomalies",0
6871,Congenital qualifier,"Embryonic cyst of cervix, vagina, and external female genitalia",0
6872,Congenital qualifier,Cryptorchidism,0
6873,Congenital qualifier,Hypospadias and epispadias,0
6874,Congenital qualifier,Penile hypospadias,0
6875,Congenital qualifier,"Hypospadias, penoscrotal",0
6876,Congenital qualifier,"Hypospadias, perineal",0
6877,Congenital qualifier,"Hypospadias, balanic",0
6878,Congenital qualifier,Congenital absence of prostate,0
6879,Congenital qualifier,Congenital aplasia of round ligament,0
6880,Congenital qualifier,Congenital aplasia of scrotum,0
6881,Congenital qualifier,Aplasia of penis,0
6882,Congenital qualifier,Calcaneonavicular bar,0
6883,Congenital qualifier,Cyst of hydatid of Morgagni,0
6884,Congenital qualifier,Cyst of Wolffian duct,0
6885,Congenital qualifier,Hydatid cyst of Morgagni - male,0
6886,Congenital qualifier,Hydatid cyst of Morgagni - female,0
6887,Congenital qualifier,Wolffian duct cyst - male,0
6888,Congenital qualifier,Wolffian duct cyst - female,0
6889,Congenital qualifier,Cyst of embryonic remnant - male,0
6890,Congenital qualifier,Cyst of embryonic remnant - female,0
6891,Congenital qualifier,Hooded penis,0
6892,Congenital qualifier,Renal agenesis and dysgenesis,0
6893,Congenital qualifier,Congenital renal atrophy,0
6894,Congenital qualifier,Congenital absence of kidney,0
6895,Congenital qualifier,Renal dysplasia,0
6896,Congenital qualifier,Bilateral renal dysplasia,0
6897,Congenital qualifier,Medullary cystic disease OS,0
6898,Congenital qualifier,Renal pelvis and ureter obstructive defects,0
6899,Congenital qualifier,Congenital ureterocele,0
6900,Congenital qualifier,Impervious ureter,0
6901,Congenital qualifier,Congenital malposition of kidney,0
6902,Congenital qualifier,Fused Kidney,0
6903,Congenital qualifier,Deviation of ureter,0
6904,Congenital qualifier,Atresia of bladder neck,0
6905,Congenital qualifier,Atresia of anterior urethra,0
6906,Congenital qualifier,Atresia of urinary meatus,0
6907,Congenital qualifier,Congenital obstruction of urethra,0
6908,Congenital qualifier,Malformation of urachus,0
6909,Congenital qualifier,Congenital hernia of bladder,0
6910,Congenital qualifier,Congenital prolapse of bladder mucosa,0
6911,Congenital qualifier,Congenital hourglass bladder,0
6912,Congenital qualifier,"Epispadias, female",0
6913,Congenital qualifier,"Hypospadias, female",0
6914,Congenital qualifier,"Squashed or bent nose, congenital",0
6915,Congenital qualifier,Congenital anomaly of spine,0
6916,Congenital qualifier,Congenital scoliosis due to bony malformation,0
6917,Congenital qualifier,Congenital dislocation and subluxation of the hip,0
6918,Congenital qualifier,"Congenital subluxation of hip, bilateral",0
6919,Congenital qualifier,Bilateral dysplastic hip,0
6920,Congenital qualifier,Bilateral unstable hip,0
6921,Congenital qualifier,Congenital genu recurvatum,0
6922,Congenital qualifier,Congenital dislocation of knee grade I,0
6923,Congenital qualifier,Congenital dislocation of knee grade II,0
6924,Congenital qualifier,Congenital dislocation of knee grade III,0
6925,Congenital qualifier,Congenital dislocation of the patella,0
6926,Congenital qualifier,Congenital bowing of fibula,0
6927,Congenital qualifier,Congenital complex varus foot deformity,0
6928,Congenital qualifier,Vertical Talus,0
6929,Congenital qualifier,Congenital talipes calcaneovalgus,0
6930,Congenital qualifier,Congenital pes cavus,0
6931,Congenital qualifier,Congenital claw foot,0
6932,Congenital qualifier,Congenital short Achilles tendon,0
6933,Congenital qualifier,Congenital talipes equinus,0
6934,Congenital qualifier,Torsion of accessory fallopian tube,0
6935,Congenital qualifier,Congenital pectus carinatum,0
6936,Congenital qualifier,Congenital flexion contracture of hip,0
6937,Congenital qualifier,Congenital abduction contracture of hip,0
6938,Congenital qualifier,Congenital flexion contracture of knee,0
6939,Congenital qualifier,Congenital short quadriceps,0
6940,Congenital qualifier,"Hyperkeratosis, Epidermolytic",0
6941,Congenital qualifier,Radial polydactyly Wassel 1,0
6942,Congenital qualifier,Radial polydactyly Wassel 2,0
6943,Congenital qualifier,Radial polydactyly Wassel 3,0
6944,Congenital qualifier,Radial polydactyly Wassel 4,0
6945,Congenital qualifier,Radial polydactyly Wassel 5,0
6946,Congenital qualifier,Radial polydactyly Wassel 6,0
6947,Congenital qualifier,Radial polydactyly Wassel 7,0
6948,Congenital qualifier,Central polydactyly of fingers,0
6949,Congenital qualifier,Ulnar polydactyly of fingers,0
6950,Congenital qualifier,Preaxial polydactyly of toe,0
6951,Congenital qualifier,Postaxial polydactyly of toe,0
6952,Congenital qualifier,Radial polydactyly,0
6953,Congenital qualifier,Simple syndactyly of fingers - first web,0
6954,Congenital qualifier,Simple syndactyly of fingers - second to fourth web,0
6955,Congenital qualifier,Osseous syndactyly of fingers - first web,0
6956,Congenital qualifier,Osseous syndactyly of fingers - second to fourth web,0
6957,Congenital qualifier,Syndactyly of toes without bone fusion,0
6958,Congenital qualifier,"Simple syndactyly of toes, first web space",0
6959,Congenital qualifier,Simple syndactyly lesser toes,0
6960,Congenital qualifier,Osseous syndactyly of toes first web space,0
6961,Congenital qualifier,Osseous syndactyly lesser toes,0
6962,Congenital qualifier,Hemimelia of upper limb,0
6963,Congenital qualifier,Congenital complete absence of upper limb,0
6964,Congenital qualifier,Congenital amputation of upper limb,0
6965,Congenital qualifier,"Transverse deficiency of arm, upper arm level - short",0
6966,Congenital qualifier,"Transverse deficiency of arm, upper arm level - long",0
6967,Congenital qualifier,Rudimentary arm,0
6968,Congenital qualifier,Congenital hypoplasia of radius,0
6969,Congenital qualifier,Partial radial absence,0
6970,Congenital qualifier,Hypoplastic thumb-Blauth 1,0
6971,Congenital qualifier,Hypoplastic thumb-Blauth 2,0
6972,Congenital qualifier,Hypoplastic thumb-Blauth 3,0
6973,Congenital qualifier,Hypoplastic thumb-Blauth 4,0
6974,Congenital qualifier,Hypoplastic thumb-Blauth 5,0
6975,Congenital qualifier,Partial defect of ulna,0
6976,Congenital qualifier,Ulnar and humeroulnar synostosis,0
6977,Congenital qualifier,Transverse arrest carpal level,0
6978,Congenital qualifier,Transverse arrest metacarpal first ray,0
6979,Congenital qualifier,Transverse arrest phalangeal level first ray,0
6980,Congenital qualifier,Transverse arrest phalangeal level second ray,0
6981,Congenital qualifier,Transverse arrest phalangeal level third ray,0
6982,Congenital qualifier,Transverse arrest phalangeal level fourth ray,0
6983,Congenital qualifier,Transverse arrest phalangeal level fifth ray,0
6984,Congenital qualifier,Congenital absence of leg and foot,0
6985,Congenital qualifier,Congenital absence of lower limb,0
6986,Congenital qualifier,Transverse deficiency lower limb - metatarsal level,0
6987,Congenital qualifier,Transverse deficiency lower limb - through femur,0
6988,Congenital qualifier,Transverse deficiency lower limb - through tibia/fibula,0
6989,Congenital qualifier,Proximal femoral focal deficiency,0
6990,Congenital qualifier,Congenital tibial deficiency type I,0
6991,Congenital qualifier,Congenital tibial deficiency type II,0
6992,Congenital qualifier,Congenital tibial deficiency type III,0
6993,Congenital qualifier,Congenital fibular deficiency type I,0
6994,Congenital qualifier,Congenital fibular deficiency type II,0
6995,Congenital qualifier,Congenital fibular deficiency type III,0
6996,Congenital qualifier,Agenesis of tarsals and metatarsals,0
6997,Congenital qualifier,Agenesis of multiple tarsal bones,0
6998,Congenital qualifier,Agenesis of first metatarsal,0
6999,Congenital qualifier,Agenesis of fifth metatarsal,0
7000,Congenital qualifier,Agenesis of fourth and fifth metatarsals,0
7001,Congenital qualifier,Congenital absence of great toe,0
7002,Congenital qualifier,Congenital absence of fifth toe,0
7003,Congenital qualifier,Congenital absence of fourth and fifth toes,0
7004,Congenital qualifier,Proximal radioulnar synostosis,0
7005,Congenital qualifier,Radioulnar synostosis and dislocation of radial head,0
7006,Congenital qualifier,Distal radioulnar synostosis,0
7007,Congenital qualifier,Apert syndrome,0
7008,Congenital qualifier,Acrocephalopolysyndactyly,0
7009,Congenital qualifier,Macrodactyly of fingers - simple,0
7010,Congenital qualifier,Macrodactyly of fingers- fatty nerve tumor,0
7011,Congenital qualifier,Cleft hand - first cleft,0
7012,Congenital qualifier,Cleft hand - central,0
7013,Congenital qualifier,Cleft hand with syndactyly,0
7014,Congenital qualifier,Cleft hand with polydactyly,0
7015,Congenital qualifier,Windblown hand,0
7016,Congenital qualifier,Aberrant forearm flexor muscle,0
7017,Congenital qualifier,Aberrant forearm extensor muscle,0
7018,Congenital qualifier,Thumb in palm deformity,0
7019,Congenital qualifier,Congenital trigger thumb,0
7020,Congenital qualifier,Lunate-triquetrum synostosis,0
7021,Congenital qualifier,Capitate-hamate synostosis,0
7022,Congenital qualifier,Scaphoid-lunate synostosis,0
7023,Congenital qualifier,Proximal interphalangeal joint symphalangism,0
7024,Congenital qualifier,Distal interphalangeal joint symphalangism,0
7025,Congenital qualifier,Duplication of whole limb,0
7026,Congenital qualifier,Duplication of humerus,0
7027,Congenital qualifier,Duplication of radius,0
7028,Congenital qualifier,Duplication of whole hand,0
7029,Congenital qualifier,Overgrowth of whole upper limb,0
7030,Congenital qualifier,Overgrowth of partial upper limb,0
7031,Congenital qualifier,Undergrowth of whole limb,0
7032,Congenital qualifier,Undergrowth of whole hand,0
7033,Congenital qualifier,Constriction ring syndrome of upper limb,0
7034,Congenital qualifier,Acrosyndactyly of upper limb,0
7035,Congenital qualifier,Constriction ring of upper limb with acrosyndactyly and amputation,0
7036,Congenital qualifier,Congenital complete absence of upper limb,0
7037,Congenital qualifier,Triphalangeal thumb,0
7038,Congenital qualifier,Brachydactyly-all 3 phalanges,0
7039,Congenital qualifier,Brachydactyly-missing phalanx,0
7040,Congenital qualifier,Camptodactyly-little finger,0
7041,Congenital qualifier,Clinodactyly with delta phalanx,0
7042,Congenital qualifier,"Clinodactyly, with no delta phalanx",0
7043,Congenital qualifier,Brachymesophalangia,0
7044,Congenital qualifier,Radioulnar dysostosis,0
7045,Congenital qualifier,Congenital humeral varus,0
7046,Congenital qualifier,Ramer Ladda syndrome,0
7047,Congenital qualifier,Humeroulnar synostosis,0
7048,Congenital qualifier,Macrodactyly of toes - simple,0
7049,Congenital qualifier,Macrodactyly of toes - fatty nerve tumor,0
7050,Congenital qualifier,Brachydactyly of toes,0
7051,Congenital qualifier,Congenital crossed toes,0
7052,Congenital qualifier,Congenital curly toes,0
7053,Congenital qualifier,Brachyphalangia of little toe,0
7054,Congenital qualifier,Perodactylia of great toe,0
7055,Congenital qualifier,Perodactylia of lesser toe,0
7056,Congenital qualifier,Perodactylia of multiple toes,0
7057,Congenital qualifier,Triphalangeal great toe,0
7058,Congenital qualifier,Split foot,0
7059,Congenital qualifier,Vertical Talus,0
7060,Congenital qualifier,Talocalcaneal coalition,0
7061,Congenital qualifier,Naviculocuneiform bar,0
7062,Congenital qualifier,Complex tarsal coalition,0
7063,Congenital qualifier,Failure of soft tissue differentiation of lower limb,0
7064,Congenital qualifier,Aberrant muscle of the lower limb,0
7065,Congenital qualifier,Failure of differentiation of bones of lower limb,0
7066,Congenital qualifier,Congenital synostosis of lower limb bones,0
7067,Congenital qualifier,Duplication of lower limb bone,0
7068,Congenital qualifier,Congenital overgrowth of lower limb,0
7069,Congenital qualifier,Congenital overgrowth of proximal lower limb,0
7070,Congenital qualifier,Congenital overgrowth of distal lower limb,0
7071,Congenital qualifier,Congenital overgrowth of foot,0
7072,Congenital qualifier,Congenital overgrowth of whole lower limb,0
7073,Congenital qualifier,Hemiatrophy of lower limb,0
7074,Congenital qualifier,Congenital undergrowth of foot,0
7075,Congenital qualifier,Brachymetapodia of first metatarsal,0
7076,Congenital qualifier,Brachymetapodia of fourth metatarsal,0
7077,Congenital qualifier,Congenital undergrowth of whole of lower limb,0
7078,Congenital qualifier,Constriction ring syndrome of lower limb,0
7079,Congenital qualifier,Constriction ring syndrome of lower limb,0
7080,Congenital qualifier,Constriction ring of lower limb with lymphedema,0
7081,Congenital qualifier,Intrauterine amputation of lower limb,0
7082,Congenital qualifier,Constriction ring syndrome of lower limb with amputation,0
7083,Congenital qualifier,Congenital angulation of tibia,0
7084,Congenital qualifier,Congenital varus ankle,0
7085,Congenital qualifier,Congenital valgus ankle,0
7086,Congenital qualifier,Congenital ball and socket ankle,0
7087,Congenital qualifier,Sacral agenesis,0
7088,Congenital qualifier,Cervical hemivertebra- balanced,0
7089,Congenital qualifier,Cervical hemivertebra - unbalanced,0
7090,Congenital qualifier,Thoracic hemivertebra- balanced,0
7091,Congenital qualifier,Thoracic hemivertebra - unbalanced,0
7092,Congenital qualifier,Lumbar hemivertebra - balanced,0
7093,Congenital qualifier,Lumbar hemivertebra - unbalanced,0
7094,Congenital qualifier,Congenital complete fusion of spine,0
7095,Congenital qualifier,Congenital partial fusion of spine - balanced,0
7096,Congenital qualifier,Congenital partial fusion of spine - unbalanced,0
7097,Congenital qualifier,Congenital partial fusion of spine with hemivertebra - balanced,0
7098,Congenital qualifier,Congenital partial fusion of spine with hemivertebra - unbalanced,0
7099,Congenital qualifier,Defect of vertebral segmentation,0
7100,Congenital qualifier,Hypoplasia of spine,0
7101,Congenital qualifier,Accessory rib,0
7102,Congenital qualifier,Chondrodysplasia,0
7103,Congenital qualifier,Hypochondroplasia (disorder),0
7104,Congenital qualifier,Mesomelic dysplasia,0
7105,Congenital qualifier,Dysplasia epiphysealis hemimelica,0
7106,Congenital qualifier,Metachondromatosis,0
7107,Congenital qualifier,Lethal retarded ossification syndromes,0
7108,Congenital qualifier,Hypochondrogenesis,0
7109,Congenital qualifier,Short Rib-Polydactyly Syndrome,0
7110,Congenital qualifier,Chondrodysplasia OS,0
7111,Congenital qualifier,Osteodysplasia NOS,0
7112,Congenital qualifier,"Osteogenesis imperfecta, dominant perinatal lethal",0
7113,Congenital qualifier,Osteogenesis imperfecta type IV (disorder),0
7114,Congenital qualifier,Osteopetrosis - unclassified,0
7115,Congenital qualifier,Osteopetrosis - delayed type,0
7116,Congenital qualifier,Craniodiaphyseal dysplasia,0
7117,Congenital qualifier,Aplasia of muscle,0
7118,Congenital qualifier,Congenital elephantiasis,0
7119,Congenital qualifier,Harlequin Fetus,0
7120,Congenital qualifier,Congenital Nonbullous Ichthyosiform Erythroderma,0
7121,Congenital qualifier,Abnormal palmar creases,0
7122,Congenital qualifier,Congenital pigmentary skin anomalies,0
7123,Congenital qualifier,Brugsch's syndrome,0
7124,Congenital qualifier,Focal Dermal Hypoplasia,0
7125,Congenital qualifier,Keratoderma areata,0
7126,Congenital qualifier,Congenital localized alopecia,0
7127,Congenital qualifier,Taenzer's hair,0
7128,Congenital qualifier,"Trisomy 21, Meiotic Nondisjunction",0
7129,Congenital qualifier,Trisomy 21- mitotic nondisjunction mosaicism,0
7130,Congenital qualifier,"Trisomy 13, meiotic nondisjunction",0
7131,Congenital qualifier,Trisomy 13 - mitotic nondisjunction mosaicism,0
7132,Congenital qualifier,Trisomy 18 - meiotic nondisjunction,0
7133,Congenital qualifier,Trisomy 18 - mitotic nondisjunction mosaicism,0
7134,Congenital qualifier,Monosomy and deletion from autosome,0
7135,Congenital qualifier,Deletion of long arm of chromosome 13,0
7136,Congenital qualifier,Deletion seen only at prometaphase,0
7137,Congenital qualifier,Whole chromosome monosomy - meiotic nondisjunction,0
7138,Congenital qualifier,"Monosomy 21, mosaicism",0
7139,Congenital qualifier,Whole chromosome trisomy syndrome,0
7140,Congenital qualifier,Trisomy 6,0
7141,Congenital qualifier,Trisomy 7,0
7142,Congenital qualifier,"Chromosome 8, trisomy",0
7143,Congenital qualifier,"Chromosome 9, trisomy",0
7144,Congenital qualifier,Trisomy 10,0
7145,Congenital qualifier,Trisomy 11,0
7146,Congenital qualifier,Trisomy 12,0
7147,Congenital qualifier,Trisomy 22,0
7148,Congenital qualifier,Whole chromosome trisomy meiotic nondisjunction,0
7149,Congenital qualifier,"Whole chromosome trisomy, mosaicism",0
7150,Congenital qualifier,Partial trisomy syndromes,0
7151,Congenital qualifier,Major partial trisomy,0
7152,Congenital qualifier,Minor partial trisomy,0
7153,Congenital qualifier,Duplication seen only at prometaphase,0
7154,Congenital qualifier,Duplication with other complex rearrangement,0
7155,Congenital qualifier,Ovarian dysgenesis,0
7156,Congenital qualifier,Noonan Syndrome,0
7157,Congenital qualifier,"Karyotype 46, X iso (Xq)",0
7158,Congenital qualifier,"Karyotype 46, X with abnormal sex chromosome except iso (Xq)",0
7159,Congenital qualifier,"Turner's phenotype, mosaicism 45, X; 46, XX or 45, X; 46, XY",0
7160,Congenital qualifier,"Mosaicism, 45,X/other cell line(s) with abnormal sex chromosome",0
7161,Congenital qualifier,"XY, female phenotype",0
7162,Congenital qualifier,Klinefelter's syndrome - male with 46 XX karyotype,0
7163,Congenital qualifier,"Klinefelter's syndrome, XXYY",0
7164,Congenital qualifier,"Klinefelter's syndrome, XY/XXY mosaic",0
7165,Congenital qualifier,Additional sex chromosome,0
7166,Congenital qualifier,Sex chromosome mosaicism,0
7167,Congenital qualifier,Mosaic XO/XY,0
7168,Congenital qualifier,Mosaic XO/XX,0
7169,Congenital qualifier,Mosaic XY/XXY,0
7170,Congenital qualifier,Mosaic including XXXXY,0
7171,Congenital qualifier,"Chimera 46, XX; 46, XY",0
7172,Congenital qualifier,"46, XX true hermaphrodite",0
7173,Congenital qualifier,Fragile X chromosome,0
7174,Congenital qualifier,Ectopic spleen,0
7175,Congenital qualifier,Splenic Hypoplasia,0
7176,Congenital qualifier,Mis-shapen spleen,0
7177,Congenital qualifier,Congenital cyst of adrenal gland,0
7178,Congenital qualifier,Congenital absence of pituitary gland,0
7179,Congenital qualifier,Accessory pituitary gland,0
7180,Congenital qualifier,Aberrant parathyroid gland,0
7181,Congenital qualifier,Aberrant thymus gland,0
7182,Congenital qualifier,Complete situs inversus with dextrocardia,0
7183,Congenital qualifier,Levocardia,0
7184,Congenital qualifier,Craniopagus frontalis,0
7185,Congenital qualifier,Craniopagus parasiticus,0
7186,Congenital qualifier,double; monster,0
7187,Congenital qualifier,Fetal Alcohol Syndrome,0
7188,Congenital qualifier,Fetal or neonatal effect of maternal use of alcohol,0
7189,Congenital qualifier,"Single monster, specified type",0
7190,Congenital qualifier,Congenital malformation syndromes affecting facial appearance,0
7191,Congenital qualifier,Cyclocephaly,0
7192,Congenital qualifier,Congenital malformation syndromes associated with short stature,0
7193,Congenital qualifier,Congenital malformation syndromes involving limbs,0
7194,Congenital qualifier,Acrocephalopolysyndactyly type 2,0
7195,Congenital qualifier,Hanhart's syndrome,0
7196,Congenital qualifier,Multiple pterygium syndrome,0
7197,Congenital qualifier,Congenital contractural arachnodactyly,0
7198,Congenital qualifier,Noonan Syndrome,0
7199,Congenital qualifier,Congenital malformation syndromes with metabolic disturbances,0
7200,Congenital qualifier,Biemond's syndrome,0
7201,Congenital qualifier,Acardia,0
7202,Congenital qualifier,Acephalobrachius,0
7203,Congenital qualifier,Acephalogaster,0
7204,Congenital qualifier,Acephalothorax,0
7205,Congenital qualifier,Congenital staphylococcal pneumonia,0
7206,Congenital qualifier,Congenital group A hemolytic streptococcal pneumonia,0
7207,Congenital qualifier,Congenital group B hemolytic streptococcal pneumonia,0
7208,Congenital qualifier,Congenital Escherichia coli pneumonia,0
7209,Congenital qualifier,Congenital pseudomonal pneumonia,0
7210,Congenital qualifier,Congenital chlamydial pneumonia,0
7211,Congenital qualifier,Pseudomonas pyocyaneus congenital infection,0
7212,Congenital qualifier,Congenital viral hepatitis,0
7213,Congenital qualifier,Congenital hepatitis A infection,0
7214,Congenital qualifier,Late anemia of newborn due to isoimmunization,0
7215,Congenital qualifier,Congenital anemia from fetal blood loss,0
7216,Congenital qualifier,Congenital fecaliths causing obstruction,0
7217,Congenital qualifier,Congenital cardiac failure,0
7218,Congenital qualifier,Congenital hypertonia,0
7219,Congenital qualifier,Persistent Fetal Circulation Syndrome,0
7220,Congenital qualifier,Adult hypophosphatasia (disorder),0
7221,Congenital qualifier,Ehlers-Danlos syndrome type 2,0
7222,Congenital qualifier,Neurocutaneous melanosis sequence,0
7223,Congenital qualifier,Exstrophy of cloaca sequence,0
7224,Congenital qualifier,Congenital cubitus varus,0
7225,Congenital qualifier,Romano-Ward Syndrome,0
7226,Congenital qualifier,Congenital liver grooves,0
7227,Congenital qualifier,Congenital postural scoliosis,0
7228,Congenital qualifier,Congenital anomaly of finger,0
7229,Congenital qualifier,Anisomelia,0
7230,Congenital qualifier,Cockayne Syndrome,0
7231,Congenital qualifier,Patau syndrome,0
7232,Congenital qualifier,Congenital stenosis of aorta,0
7233,Congenital qualifier,Lingual Thyroid,0
7234,Congenital qualifier,suspected damage to fetus from maternal alcohol addiction,0
7235,Congenital qualifier,Ambiguous Genitalia,0
7236,Congenital qualifier,Double uterus affecting pregnancy,0
7237,Congenital qualifier,Colloid cysts of third ventricle,0
7238,Congenital qualifier,Autosomal dominant variant form of albumin,0
7239,Congenital qualifier,Ectopic thyroid tissue (disorder),0
7240,Congenital qualifier,Complete trisomy 14 syndrome,0
7241,Congenital qualifier,"Chronic granulomatous disease, type IV",0
7242,Congenital qualifier,beta-Aminoisobutyricaciduria,0
7243,Congenital qualifier,Cephalothoracopagus,0
7244,Congenital qualifier,Accessory broad ligament,0
7245,Congenital qualifier,Congenital hypothyroidism with ectopic thyroid,0
7246,Congenital qualifier,Congenital lamellar cataract,0
7247,Congenital qualifier,Borjeson-Forssman-Lehmann syndrome,0
7248,Congenital qualifier,Retinal hemangioblastomatosis,0
7249,Congenital qualifier,Renal carnitine transport defect,0
7250,Congenital qualifier,Congenital iodine deficiency syndrome,0
7251,Congenital qualifier,Angiokeratoma circumscriptum,0
7252,Congenital qualifier,Plagiocephaly,0
7253,Congenital qualifier,Interrupted aortic arch,0
7254,Congenital qualifier,Hereditary hemorrhagic telangiectasia,0
7255,Congenital qualifier,Manus valga,0
7256,Congenital qualifier,Congenital anomaly of middle ear,0
7257,Congenital qualifier,Pili annulati,0
7258,Congenital qualifier,Single coronary artery,0
7259,Congenital qualifier,Bannayan-Riley-Ruvalcaba Syndrome,0
7260,Congenital qualifier,Robert's pelvis,0
7261,Congenital qualifier,Orbital separation excessive,0
7262,Congenital qualifier,"X-linked glutaric aciduria, type 2",0
7263,Congenital qualifier,Congenital valgus deformity of foot,0
7264,Congenital qualifier,Congenital anomaly of vena cava,0
7265,Congenital qualifier,Congenital anomaly of the peripheral nervous system,0
7266,Congenital qualifier,Congenital absence of ear lobe,0
7267,Congenital qualifier,Anterior chamber cleavage syndrome,0
7268,Congenital qualifier,Nail-Patella Syndrome,0
7269,Congenital qualifier,Chimera disorder,0
7270,Congenital qualifier,"Osteoarthropathy, Primary Hypertrophic",0
7271,Congenital qualifier,Severe combined immunodeficiency due to adenosine deaminase deficiency,0
7272,Congenital qualifier,X-linked absence of thyroxine-binding globulin,0
7273,Congenital qualifier,Congenital absence of bladder,0
7274,Congenital qualifier,Hemispheric cerebellar agenesis,0
7275,Congenital qualifier,9q partial trisomy syndrome,0
7276,Congenital qualifier,Uterus bilocularis,0
7277,Congenital qualifier,Iodide transport defect,0
7278,Congenital qualifier,Pseudoachondroplasia,0
7279,Congenital qualifier,Aplasia of Lacrimal and Salivary Glands,0
7280,Congenital qualifier,Atretocephalus,0
7281,Congenital qualifier,21q partial distal trisomy syndrome,0
7282,Congenital qualifier,Anomalous pulmonary venous drainage to abdominal portion of inferior vena cava,0
7283,Congenital qualifier,Metatropic dwarfism,0
7284,Congenital qualifier,21q partial trisomy syndrome,0
7285,Congenital qualifier,Class III malocclusion,0
7286,Congenital qualifier,Juvenile nephropathic cystinosis (disorder),0
7287,Congenital qualifier,Phocomelia,0
7288,Congenital qualifier,Congenital septation of gallbladder,0
7289,Congenital qualifier,Longitudinal deficiency of phalanges of hand,0
7290,Congenital qualifier,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,0
7291,Congenital qualifier,G-6-PD class I variant anemia,0
7292,Congenital qualifier,"Porphyria, Erythropoietic",0
7293,Congenital qualifier,Congenital auditory imperception,0
7294,Congenital qualifier,Focal Dermal Hypoplasia,0
7295,Congenital qualifier,Internal malleolar torsion,0
7296,Congenital qualifier,External malleolar torsion,0
7297,Congenital qualifier,Congenital forefoot varus,0
7298,Congenital qualifier,Congenital rearfoot varus,0
7299,Congenital qualifier,Plantarflexed cuboid,0
7300,Congenital qualifier,Late congenital syphilitic meningitis,0
7301,Congenital qualifier,Pachygyria,0
7302,Congenital qualifier,Type III transitional Pelizaeus-Merzbacher disease,0
7303,Congenital qualifier,Type IV adult Pelizaeus-Merzbacher disease,0
7304,Congenital qualifier,Type V atypical Pelizaeus-Merzbacher disease,0
7305,Congenital qualifier,Type VI Cockayne Pelizaeus-Merzbacher disease,0
7306,Congenital qualifier,MERRF Syndrome,0
7307,Congenital qualifier,Congenital anosmia,0
7308,Congenital qualifier,Tilted optic disc,0
7309,Congenital qualifier,Optic disc pit,0
7310,Congenital qualifier,Myelinated nerve fibers of optic disc,0
7311,Congenital qualifier,Congenital disorders of eye and eyelid movements,0
7312,Congenital qualifier,Congenital failure of eye elevation,0
7313,Congenital qualifier,Congenital nuclear ophthalmoplegia,0
7314,Congenital qualifier,Congenital disorder of facial nerve,0
7315,Congenital qualifier,Congenital facial nerve palsy,0
7316,Congenital qualifier,Congenital polyneuropathy,0
7317,Congenital qualifier,Congenital neuropathy with arthrogryposis multiplex congenita,0
7318,Congenital qualifier,Congenital hypomyelinating neuropathy,0
7319,Congenital qualifier,Late congenital syphilitic polyneuropathy,0
7320,Congenital qualifier,Anomaly of cricoid cartilage,0
7321,Congenital qualifier,Congenital atresia of mitral valve,0
7322,Congenital qualifier,"Myasthenic Syndromes, Congenital",0
7323,Congenital qualifier,Congenital end-plate acetylcholine receptor deficiency,0
7324,Congenital qualifier,Congenital end-plate acetylcholinesterase deficiency,0
7325,Congenital qualifier,Late secondary abnormalities of the central nervous system,0
7326,Congenital qualifier,"Leukomalacia, Periventricular",0
7327,Congenital qualifier,Congenital spastic foot,0
7328,Congenital qualifier,Congenital pseudobulbar palsy,0
7329,Congenital qualifier,Congenital dysarthria,0
7330,Congenital qualifier,Congenital dysphasia,0
7331,Congenital qualifier,Congenital expressive dysphasia,0
7332,Congenital qualifier,Congenital receptive dysphasia,0
7333,Congenital qualifier,Neuronal choristoma,0
7334,Congenital qualifier,Talipes Calcaneus,0
7335,Congenital qualifier,Proteus Syndrome,0
7336,Congenital qualifier,Mild maple syrup urine disease,0
7337,Congenital qualifier,"Lattice corneal dystrophy, isolated form",0
7338,Congenital qualifier,Traumatic aniridia,0
7339,Congenital qualifier,Laurence-Moon Syndrome,0
7340,Congenital qualifier,"Night blindness, congenital stationary",0
7341,Congenital qualifier,Congenital hypertrophy of retinal pigment epithelium,0
7342,Congenital qualifier,Congenital esotropia,0
7343,Congenital qualifier,Esotropia with dissociated vertical deviation,0
7344,Congenital qualifier,Esotropia with nystagmus,0
7345,Congenital qualifier,Esotropia with nystagmus block,0
7346,Congenital qualifier,Strabismus fixus,0
7347,Congenital qualifier,Vertical retraction syndrome,0
7348,Congenital qualifier,Congenital axial myopia,0
7349,Congenital qualifier,Congenital color blindness,0
7350,Congenital qualifier,Congenital deformity of pinna,0
7351,Congenital qualifier,"Cholesteatoma, Congenital",0
7352,Congenital qualifier,Structural anomaly of the cochlea and vestibular labyrinth,0
7353,Congenital qualifier,Aplasia of the cochlea and vestibular labyrinth,0
7354,Congenital qualifier,Congenital deformity of labyrinth,0
7355,Congenital qualifier,Incomplete formation of the bony cochlea,0
7356,Congenital qualifier,Mondini defect,0
7357,Congenital qualifier,Earpit syndrome,0
7358,Congenital qualifier,Vertical overbite,0
7359,Congenital qualifier,Goldblatt Viljoen syndrome,0
7360,Congenital qualifier,Choanal atresia with CHARGE association,0
7361,Congenital qualifier,Common Variable Immunodeficiency,0
7362,Congenital qualifier,Agenesis of nasal cartilages,0
7363,Congenital qualifier,Median nasal dermoid fistula,0
7364,Congenital qualifier,Bifid epiglottis,0
7365,Congenital qualifier,Congenital Vocal Cord Palsy,0
7366,Congenital qualifier,Congenital laryngeal abductor palsy,0
7367,Congenital qualifier,Congenital laryngeal adductor palsy,0
7368,Congenital qualifier,Laryngeal cleft,0
7369,Congenital qualifier,Multiple malformation syndrome with facial-limb defects as major feature,0
7370,Congenital qualifier,Congenital cystic bronchiectasis,0
7371,Congenital qualifier,"Chylothorax, congenital",0
7372,Congenital qualifier,Primary ciliary dyskinesia due to transposition of ciliary microtubules,0
7373,Congenital qualifier,"Immotile cilia syndrome, due to defective radial spokes",0
7374,Congenital qualifier,Young Syndrome,0
7375,Congenital qualifier,Ciliary Discoordination Due To Random Ciliary Orientation,0
7376,Congenital qualifier,Pulmonary tuberose sclerosis,0
7377,Congenital qualifier,Pulmonary lipid storage disease,0
7378,Congenital qualifier,Congenital tracheal fistula,0
7379,Congenital qualifier,Calcific aortic stenosis - bicuspid valve,0
7380,Congenital qualifier,Congenital His bundle tachycardia,0
7381,Congenital qualifier,Congenital ureterovesical obstruction,0
7382,Congenital qualifier,Congenital flat foot,0
7383,Congenital qualifier,Lymphatic Abnormalities,0
7384,Congenital qualifier,Capillary malformation (disorder),0
7385,Congenital qualifier,Venous valvular anomaly,0
7386,Congenital qualifier,Deep vein aplasia,0
7387,Congenital qualifier,Deep vein hypoplasia,0
7388,Congenital qualifier,True congenital varicose veins,0
7389,Congenital qualifier,Splenoportal Vascular Anomalies,0
7390,Congenital qualifier,Congenital abnormality of great veins and coronary sinus,0
7391,Congenital qualifier,Capillary-venous malformation,0
7392,Congenital qualifier,Venous-lymphatic malformation,0
7393,Congenital qualifier,Capillary-venous-lymphatic malformation,0
7394,Congenital qualifier,Bannayan-Riley-Ruvalcaba Syndrome,0
7395,Congenital qualifier,Vascular neurocutaneous syndrome,0
7396,Congenital qualifier,Congenital arteriovenous malformation,0
7397,Congenital qualifier,"Arteriovenous Malformations, Cerebral",0
7398,Congenital qualifier,Sturge-Weber Syndrome,0
7399,Congenital qualifier,Hennekam lymphangiectasia-lymphedema syndrome,0
7400,Congenital qualifier,Arteriovenous angioma,0
7401,Congenital qualifier,Congenital arteriovenous fistula,0
7402,Congenital qualifier,Congenital arteriovenous fistula of brain,0
7403,Congenital qualifier,Congenital arteriovenous fistula occlusion,0
7404,Congenital qualifier,Congenital arteriovenous fistula stenosis,0
7405,Congenital qualifier,Congenital arteriovenous fistula thrombosis,0
7406,Congenital qualifier,Congenital arteriovenous fistula infection,0
7407,Congenital qualifier,Congenital arteriovenous fistula aneurysm,0
7408,Congenital qualifier,Congenital arteriovenous fistula hemorrhage,0
7409,Congenital qualifier,Congenital arteriovenous fistula rupture,0
7410,Congenital qualifier,Arteriovenous-lymphatic malformation,0
7411,Congenital qualifier,Mixed vascular malformation,0
7412,Congenital qualifier,Multiple dysplasia syndrome,0
7413,Congenital qualifier,Weber's true diffuse phlebarteriectasis,0
7414,Congenital qualifier,Congenital transferrin deficiency,0
7415,Congenital qualifier,Congenital deficiency of intrinsic factor,0
7416,Congenital qualifier,Biermer's congenital pernicious anemia,0
7417,Congenital qualifier,"Anemia, Diamond-Blackfan",0
7418,Congenital qualifier,Congenital red cell hypoplasia,0
7419,Congenital qualifier,Congenital methemoglobinaema with defective methemoglobin-reducing system,0
7420,Congenital qualifier,Congenital methemoglobinemia with abnormal methemoglobins,0
7421,Congenital qualifier,Glycogen Storage Disease Type VII,0
7422,Congenital qualifier,Uridine monophosphate hydrolase deficiency,0
7423,Congenital qualifier,Congenital factor IX deficiency variant,0
7424,Congenital qualifier,Congenital factor IX deficiency with inhibitor,0
7425,Congenital qualifier,Congenital von Willebrand's disease,0
7426,Congenital qualifier,Congenital von Willebrand's disease type I,0
7427,Congenital qualifier,Congenital von Willebrand's disease type II,0
7428,Congenital qualifier,Congenital von Willebrand's disease type III,0
7429,Congenital qualifier,Congenital fibrinogen abnormality,0
7430,Congenital qualifier,Hypodysfibrinogenemia,0
7431,Congenital qualifier,Alpha chain defect dysfibrinogenemia,0
7432,Congenital qualifier,Beta chain defect dysfibrinogenemia,0
7433,Congenital qualifier,Gamma chain defect dysfibrinogenemia,0
7434,Congenital qualifier,X-linked agammaglobulinemia with growth hormone deficiency,0
7435,Congenital qualifier,Autosomal agammaglobulinemia with absent B-cells,0
7436,Congenital qualifier,Severe combined immunodeficiency with maternofetal engraftment,0
7437,Congenital qualifier,WHIM syndrome,0
7438,Congenital qualifier,Leukocyte adhesion deficiency type 1,0
7439,Congenital qualifier,"Congenital disorder of glycosylation, type 2C",0
7440,Congenital qualifier,Conical supernumerary tooth,0
7441,Congenital qualifier,Tuberculate supernumerary tooth,0
7442,Congenital qualifier,"Amelogenesis Imperfecta, Type IB",0
7443,Congenital qualifier,Amelogenesis imperfecta - hypoplastic autosomal dominant - smooth,0
7444,Congenital qualifier,Amelogenesis imperfecta - hypoplastic autosomal dominant - rough,0
7445,Congenital qualifier,Amelogenesis imperfecta - recessive - rough,0
7446,Congenital qualifier,Amelogenesis imperfecta - hypomaturation - recessive pigmented,0
7447,Congenital qualifier,Amelogenesis imperfecta - hypomaturation - snow capped teeth,0
7448,Congenital qualifier,Hyperargininemia,0
7449,Congenital qualifier,Class II buccal segment relationship - half unit,0
7450,Congenital qualifier,Class III buccal segment relationship - half unit,0
7451,Congenital qualifier,Lateral openbite,0
7452,Congenital qualifier,Lateral openbite - right,0
7453,Congenital qualifier,Lateral openbite - left,0
7454,Congenital qualifier,Spacing of anterior teeth,0
7455,Congenital qualifier,Atresia of salivary duct,0
7456,Congenital qualifier,Congenital lip pits,0
7457,Congenital qualifier,Congenital commissural pits,0
7458,Congenital qualifier,Midline sinus of the upper lip,0
7459,Congenital qualifier,Thyroid Dyshormonogenesis 3,0
7460,Congenital qualifier,Congenital stenosis of vagina,0
7461,Congenital qualifier,Rud Syndrome,0
7462,Congenital qualifier,Congenital metatarsus varus,0
7463,Congenital qualifier,Microvillus inclusion disease,0
7464,Congenital qualifier,Familial absence of villi,0
7465,Congenital qualifier,Malrotation of the intestine type IA,0
7466,Congenital qualifier,Malrotation of the intestine type IIA,0
7467,Congenital qualifier,Malrotation of the intestine type IIB,0
7468,Congenital qualifier,Malrotation of the intestine type IIC,0
7469,Congenital qualifier,Malrotation of the intestine type IIIA,0
7470,Congenital qualifier,Malrotation of the intestine type IIIB,0
7471,Congenital qualifier,Lysosomal Storage Diseases,0
7472,Congenital qualifier,Pericellular fibrosis of congenital syphilis,0
7473,Congenital qualifier,"Glycogen storage disease, type IX",0
7474,Congenital qualifier,Ichthyosis Congenita With Biliary Atresia,0
7475,Congenital qualifier,Polycystic disease of pancreas,0
7476,Congenital qualifier,Anomalies of pancreas,0
7477,Congenital qualifier,Fibrocystic Disease of Pancreas,0
7478,Congenital qualifier,Congenital umbilical defect,0
7479,Congenital qualifier,ANONYCHIA,0
7480,Congenital qualifier,Familial mesangial sclerosis,0
7481,Congenital qualifier,Congenital nephrotic syndrome with focal glomerulosclerosis,0
7482,Congenital qualifier,Denys-Drash Syndrome,0
7483,Congenital qualifier,Medullary sponge kidney,0
7484,Congenital qualifier,De Toni-Debre-Fanconi Syndrome,0
7485,Congenital qualifier,Congenital renal artery aneurysm,0
7486,Congenital qualifier,"Prune Belly Syndrome with Pulmonic Stenosis, Mental Retardation, and Deafness",0
7487,Congenital qualifier,Pulmonic Stenosis and Congenital Nephrosis,0
7488,Congenital qualifier,Ochoa syndrome,0
7489,Congenital qualifier,Primary vesicoureteric reflux,0
7490,Congenital qualifier,Derodidymis,0
7491,Congenital qualifier,Congenital familial idiopathic priapism,0
7492,Congenital qualifier,Congenital abnormality of scrotum,0
7493,Congenital qualifier,Bifid scrotum,0
7494,Congenital qualifier,Congenital pyloric antral membrane,0
7495,Congenital qualifier,Congenital male infertility,0
7496,Congenital qualifier,Male infertility of chromosomal origin,0
7497,Congenital qualifier,Male infertility of genetic origin,0
7498,Congenital qualifier,Azoospermia with absent vasa in association with cystic fibrosis trait,0
7499,Congenital qualifier,Male infertility of developmental origin,0
7500,Congenital qualifier,Hypogonadism with prune belly syndrome,0
7501,Congenital qualifier,Androgen resistance - infertile male,0
7502,Congenital qualifier,Congenitally impaired spermatogenesis,0
7503,Congenital qualifier,Primary spermatogenic failure,0
7504,Congenital qualifier,Oligosynaptic Infertility,0
7505,Congenital qualifier,Congenital impairment of sperm motility,0
7506,Congenital qualifier,"Male Infertility with Large-Headed, Multiflagellar, Polyploid Spermatozoa",0
7507,Congenital qualifier,Congenital obstructive azoospermia,0
7508,Congenital qualifier,Ring Chromosome 20 Syndrome,0
7509,Congenital qualifier,Fetal congenital tumor causing disproportion,0
7510,Congenital qualifier,Suspect fetal damage from maternal alcohol,0
7511,Congenital qualifier,suspected damage to fetus from maternal toxoplasmosis,0
7512,Congenital qualifier,Suspect cystic fibrosis fetus,0
7513,Congenital qualifier,Suspect fetal anencephaly,0
7514,Congenital qualifier,Bicornuate uterus complicating postpartum care - baby delivered during previous episode of care,0
7515,Congenital qualifier,"Bicornuate uterus complicating antenatal care, baby not yet delivered",0
7516,Congenital qualifier,Bicornuate uterus - baby delivered with postpartum complication,0
7517,Congenital qualifier,Bicornuate uterus - baby delivered,0
7518,Congenital qualifier,Bicornuate uterus affecting obstetric care,0
7519,Congenital qualifier,"Bicornuate uterus in pregnancy, childbirth and the puerperium",0
7520,Congenital qualifier,Congenital heart disease in pregnancy,0
7521,Congenital qualifier,Lithopedion,0
7522,Congenital qualifier,Congenital anomaly of bone and joint,0
7523,Congenital qualifier,Congenital hypothyroidism without goiter,0
7524,Congenital qualifier,Congenital thyroid hypoplasia,0
7525,Congenital qualifier,Congenital atrophy of thyroid,0
7526,Congenital qualifier,Hypothyroidism due to iodide organification defect,0
7527,Congenital qualifier,Thyroid Hormone Resistance Syndrome,0
7528,Congenital qualifier,Generalized Thyroid Hormone Resistance,0
7529,Congenital qualifier,Congenital iodine deficiency syndrome - mixed type,0
7530,Congenital qualifier,Congenital iodine deficiency syndrome - neurological type,0
7531,Congenital qualifier,Virilization-adrenogenital syndrome,0
7532,Congenital qualifier,"Pseudohermaphrodite, female with adrenocortical disorder",0
7533,Congenital qualifier,Congenital adrenal hyperplasia,0
7534,Congenital qualifier,Salt-losing congenital adrenal hyperplasia,0
7535,Congenital qualifier,Late onset congenital adrenal hyperplasia,0
7536,Congenital qualifier,CAH - desmolase deficiency,0
7537,Congenital qualifier,X-linked Adrenal Hypoplasia,0
7538,Congenital qualifier,Ectopic parathyroid hormone-related protein secretion,0
7539,Congenital qualifier,Hypophosphatemic rickets with nephrotic-glycosuric dwarfism,0
7540,Congenital qualifier,Autosomal dominant hypophosphatemic rickets,0
7541,Congenital qualifier,autosomal dominant hypophosphatemic bone disease,0
7542,Congenital qualifier,"Vitamin D-Dependent Rickets, Type 2A",0
7543,Congenital qualifier,Vitamin D-dependent rickets type II without alopecia,0
7544,Congenital qualifier,Klein-Waardenberg's syndrome,0
7545,Congenital qualifier,Minimal pigment oculocutaneous albinism,0
7546,Congenital qualifier,Temperature-sensitive oculocutaneous albinism,0
7547,Congenital qualifier,Complete deficiency of methylmalonyl-CoA mutase,0
7548,Congenital qualifier,Partial deficiency of methylmalonyl-CoA mutase,0
7549,Congenital qualifier,Glycogen synthase deficiency,0
7550,Congenital qualifier,GLYCOGEN STORAGE DISEASE Ic,0
7551,Congenital qualifier,Glycogen storage disease type Id,0
7552,Congenital qualifier,Glycogen storage disease type II,0
7553,Congenital qualifier,Generalized glycogen storage disease of infants,0
7554,Congenital qualifier,"Lysosomal alpha-1,4-glucosidase deficiency - juvenile onset",0
7555,Congenital qualifier,"Glycogen storage disease due to acid maltase deficiency, late-onset",0
7556,Congenital qualifier,Glycogen Storage Disease Type VI,0
7557,Congenital qualifier,Disorder of pyruvate metabolism and mitochondrial respiratory chain,0
7558,Congenital qualifier,Lactate Dehydrogenase Deficiency,0
7559,Congenital qualifier,Fumarase deficiency,0
7560,Congenital qualifier,Neuropathy ataxia and retinis pigmentosa,0
7561,Congenital qualifier,Pearson's marrow-pancreas syndrome,0
7562,Congenital qualifier,Disorder of mitochondrial respiratory chain complexes,0
7563,Congenital qualifier,Deficiency in enzyme complexes of mitochondrial respiratory chain,0
7564,Congenital qualifier,Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency,0
7565,Congenital qualifier,Succinate-coenzyme Q reductase deficiency,0
7566,Congenital qualifier,Ubiquinone dehydrogenase deficiency,0
7567,Congenital qualifier,ATP synthase deficiency,0
7568,Congenital qualifier,Combined complex deficiencies,0
7569,Congenital qualifier,Deletion and duplication of mitochondrial DNA,0
7570,Congenital qualifier,Depletion of mitochondrial DNA,0
7571,Congenital qualifier,Long chain acyl-CoA dehydrogenase deficiency,0
7572,Congenital qualifier,Very long chain acyl-CoA dehydrogenase deficiency,0
7573,Congenital qualifier,Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency,0
7574,Congenital qualifier,Trifunctional Protein Deficiency With Myopathy And Neuropathy,0
7575,Congenital qualifier,Combined deficiency of long chain 3-hydroxyacyl-CoA dehydrogenase and enoyl-CoA hydratase,0
7576,Congenital qualifier,Carnitine palmitoyl transferase 1A deficiency,0
7577,Congenital qualifier,Carnitine palmitoyl transferase 2 deficiency,0
7578,Congenital qualifier,Carnitine-Acylcarnitine Translocase Deficiency,0
7579,Congenital qualifier,Succinyl-CoA:3-oxoacid CoA transferase deficiency,0
7580,Congenital qualifier,"Purine-Pyrimidine Metabolism, Inborn Errors",0
7581,Congenital qualifier,Adenine phosphoribosyl transferase deficiency type I,0
7582,Congenital qualifier,Adenine phosphoribosyl transferase deficiency type II,0
7583,Congenital qualifier,Inosine Triphosphatase Deficiency,0
7584,Congenital qualifier,Thiopurine S methyltranferase deficiency,0
7585,Congenital qualifier,Cytosine diphosphate choline phosphotransferase deficiency,0
7586,Congenital qualifier,Dihydropyrimidinase deficiency,0
7587,Congenital qualifier,Total hexosaminidase deficiency - infantile,0
7588,Congenital qualifier,Total hexosaminidase deficiency - juvenile,0
7589,Congenital qualifier,Total hexosaminidase deficiency - adult,0
7590,Congenital qualifier,B variant hexosaminidase A deficiency - infantile,0
7591,Congenital qualifier,B variant hexosaminidase A deficiency - juvenile,0
7592,Congenital qualifier,B variant hexosaminidase A deficiency - adult,0
7593,Congenital qualifier,B1 variant hexosaminidase A deficiency,0
7594,Congenital qualifier,Gangliosidosis GM1,0
7595,Congenital qualifier,"Gangliosidosis, Generalized GM1, Type 1 (disorder)",0
7596,Congenital qualifier,"Gangliosidosis, Generalized GM1, Type 3",0
7597,Congenital qualifier,Disorder of glycosaminoglycan metabolism,0
7598,Congenital qualifier,Mucopolysaccharidosis type IVB,0
7599,Congenital qualifier,Disorder of glycoprotein metabolism,0
7600,Congenital qualifier,beta-Mannosidosis,0
7601,Congenital qualifier,"Schindler Disease, Type I",0
7602,Congenital qualifier,Congenital Disorders of Glycosylation,0
7603,Congenital qualifier,Disorder of sialic acid metabolism,0
7604,Congenital qualifier,Sialuria,0
7605,Congenital qualifier,Homozygous erythropoietic protoporphyria,0
7606,Congenital qualifier,Peroxisomal Disorders,0
7607,Congenital qualifier,"Peroxisomal Dysfunction, General",0
7608,Congenital qualifier,"Adrenoleukodystrophy, Neonatal",0
7609,Congenital qualifier,Infantile Refsum Disease (disorder),0
7610,Congenital qualifier,"Peroxisomal Dysfunction, Multiple",0
7611,Congenital qualifier,Zellweger-Like Syndrome,0
7612,Congenital qualifier,Pseudoinfantile Refsum's disease,0
7613,Congenital qualifier,"Peroxisomal Dysfunction, Single",0
7614,Congenital qualifier,Pseudo-Zellweger syndrome,0
7615,Congenital qualifier,Bifunctional peroxisomal enzyme deficiency,0
7616,Congenital qualifier,Peroxisomal ACYL-COA oxidase deficiency,0
7617,Congenital qualifier,Glutaric Aciduria III,0
7618,Congenital qualifier,Dihydroxycholestanoic acidemia and trihydroxycholestanoic acidemia,0
7619,Congenital qualifier,Isolated dihydroxyacetone phosphate acyltransferase deficiency,0
7620,Congenital qualifier,Isolated alkyldihydroxyacetone phosphate synthase deficiency,0
7621,Congenital qualifier,Familial hypobetalipoproteinemia - homozygous form,0
7622,Congenital qualifier,Familial hypobetalipoproteinemia - heterozygous form,0
7623,Congenital qualifier,Lacrimoauriculodentodigital syndrome,0
7624,Congenital qualifier,Congenital anomaly of bone and joint,0
7625,Congenital qualifier,Sandhoff Disease,0
7626,Congenital qualifier,Follicular ichthyosis,0
7627,Congenital qualifier,"Porokeratosis, Linear",0
7628,Congenital qualifier,Giant porokeratosis,0
7629,Congenital qualifier,Disseminated superficial porokeratosis,0
7630,Congenital qualifier,Congenital dislocation of shoulder,0
7631,Congenital qualifier,Generalized essential telangiectasia (disorder),0
7632,Congenital qualifier,Simple lymphangioma,0
7633,Congenital qualifier,Lymphangioma circumscriptum,0
7634,Congenital qualifier,Diffuse lymphangioma,0
7635,Congenital qualifier,Congenital anomaly of peripheral nerve,0
7636,Congenital qualifier,Lymphangiectasis,0
7637,Congenital qualifier,Oral lymphangioma,0
7638,Congenital qualifier,Systemic lymphangiomatosis,0
7639,Congenital qualifier,Localized abdominal wall skin atrophy,0
7640,Congenital qualifier,"Extensive congenital erosions, vesicles and reticulate scarring",0
7641,Congenital qualifier,Progeria,0
7642,Congenital qualifier,"Acrogeria, gottron type",0
7643,Congenital qualifier,Acrogeria,0
7644,Congenital qualifier,Wiedemann-Rautenstrauch syndrome,0
7645,Congenital qualifier,Wrinkly skin syndrome,0
7646,Congenital qualifier,Congenital diffuse lipomatosis,0
7647,Congenital qualifier,Encephalocraniocutaneous lipomatosis,0
7648,Congenital qualifier,"Skin Diseases, Genetic",0
7649,Congenital qualifier,Ectodermal dysplasia with hair-tooth-nail-sweating defect,0
7650,Congenital qualifier,Christ-Siemens-Touraine syndrome,0
7651,Congenital qualifier,Roselli-Gulienetti ectodermal dysplasia,0
7652,Congenital qualifier,"Alopecia, onychodysplasia, hypohidrosis, deafness ectodermal dysplasia",0
7653,Congenital qualifier,Basan syndrome,0
7654,Congenital qualifier,Greither type of ectodermal dysplasia,0
7655,Congenital qualifier,Anonychia with bizarre flexural pigmentation,0
7656,Congenital qualifier,Tricho-onychodental dysplasia,0
7657,Congenital qualifier,Ectodermal dysplasia with hair-tooth-nail defects,0
7658,Congenital qualifier,Schoepf-Schulz-Passage syndrome,0
7659,Congenital qualifier,Odonto-onychial dysplasia with alopecia,0
7660,Congenital qualifier,Fried's tooth and nail syndrome,0
7661,Congenital qualifier,Hypodontia and nail dysgenesis,0
7662,Congenital qualifier,Dermodental dysplasia,0
7663,Congenital qualifier,"Woolly hair, hypotrichosis, everted lower lip and outstanding ears",0
7664,Congenital qualifier,"Ectodermal dysplasia, syndactyly and pili torti",0
7665,Congenital qualifier,"Dwarfism, alopecia, pseudoanodontia, cutis laxa",0
7666,Congenital qualifier,Hypohidrosis-diabetes insipidus syndrome,0
7667,Congenital qualifier,Ectodermal dysplasia with hair-tooth defects,0
7668,Congenital qualifier,"Growth retardation, Alopecia, Pseudoanodontia and Optic atrophy",0
7669,Congenital qualifier,Orofaciodigital syndrome 3,0
7670,Congenital qualifier,Orofaciodigital syndrome 4,0
7671,Congenital qualifier,Berlin syndrome,0
7672,Congenital qualifier,Ectodermal dysplasia with hair-nail defect,0
7673,Congenital qualifier,Tricho-oculodermovertebral syndrome,0
7674,Congenital qualifier,Curly hair-ankyloblepharon-nail dysplasia syndrome,0
7675,Congenital qualifier,Kirman syndrome,0
7676,Congenital qualifier,Ectodermal dysplasia with tooth-nail defects,0
7677,Congenital qualifier,Dento-oculocutaneous syndrome,0
7678,Congenital qualifier,Ectodermal dysplasia with tooth-sweating defect,0
7679,Congenital qualifier,Sandman-Andra syndrome,0
7680,Congenital qualifier,Ectodermal dysplasia with nail defect,0
7681,Congenital qualifier,Triphalangeal thumbs with onychodystrophy,0
7682,Congenital qualifier,Ectodermal dysplasia with sweating defect,0
7683,Congenital qualifier,Hypohidrosis with neurolabyrinthitis,0
7684,Congenital qualifier,"Alopecia, nail dystrophy, ophthalmic complications, thyroid dysfunction, hypohidrosis, ephelides, enteropathy and respiratory tract infections",0
7685,Congenital qualifier,Congenital ectodermal dysplasia of face,0
7686,Congenital qualifier,Multiple benign annular creases of extremities,0
7687,Congenital qualifier,Reticulate pigmented anomaly of flexures,0
7688,Congenital qualifier,Hereditary clubbing,0
7689,Congenital qualifier,Flynn Aird syndrome,0
7690,Congenital qualifier,Cutaneous syndrome with ichthyosis,0
7691,Congenital qualifier,Keratitis-Ichthyosis-Deafness Syndrome,0
7692,Congenital qualifier,Atypical ichthyosis vulgaris with hypogonadism,0
7693,Congenital qualifier,Keratosis pilaris with ichthyosis and deafness,0
7694,Congenital qualifier,Malignant Atrophic Papulosis,0
7695,Congenital qualifier,Erythrokeratoderma progressiva of Gottron,0
7696,Congenital qualifier,Keratolytic winter erythema,0
7697,Congenital qualifier,Keratolysis exfoliativa,0
7698,Congenital qualifier,Hereditary palmoplantar keratoderma,0
7699,Congenital qualifier,Palmoplantar keratoderma transgrediens,0
7700,Congenital qualifier,Autosomal dominant mutilating keratoderma,0
7701,Congenital qualifier,Meleda Disease,0
7702,Congenital qualifier,Progressive palmoplantar keratoderma of Greither,0
7703,Congenital qualifier,Epidermolytic palmoplantar keratoderma of Vorner,0
7704,Congenital qualifier,Congenital palmoplantar and perioral keratoderma of Olmsted,0
7705,Congenital qualifier,Circumscribed palmoplantar keratoderma,0
7706,Congenital qualifier,Keratoderma with pachyonychia congenita,0
7707,Congenital qualifier,Keratoderma with scleroatrophy of the extremities,0
7708,Congenital qualifier,Keratoderma with mental retardation and spastic paraplegia,0
7709,Congenital qualifier,Papuloverrucous palmoplantar keratoderma of Jakac-Wolf,0
7710,Congenital qualifier,Inherited cutaneous hyperpigmentation,0
7711,Congenital qualifier,Dyschromatosis universalis,0
7712,Congenital qualifier,Naegeli syndrome,0
7713,Congenital qualifier,Symmetrical dyschromatosis of extremities,0
7714,Congenital qualifier,Dermatopathia pigmentosa reticularis,0
7715,Congenital qualifier,Acromelanosis,0
7716,Congenital qualifier,Achondrogenesis,0
7717,Congenital qualifier,Ectopic splenic tissue,0
7718,Congenital qualifier,Congenital erector pili hamartoma,0
7719,Congenital qualifier,Diffuse smooth muscle hamartoma,0
7720,Congenital qualifier,"Preauricular sinus, pit or fistula",0
7721,Congenital qualifier,Median raphe cyst,0
7722,Congenital qualifier,Congenital absence of skin on scalp,0
7723,Congenital qualifier,Congenital absence of skin on scalp with epidermal nevi,0
7724,Congenital qualifier,Lumpy scalp syndrome,0
7725,Congenital qualifier,Imperfect fusion of skull,0
7726,Congenital qualifier,Secondary gout,0
7727,Congenital qualifier,Gout secondary to renal impairment,0
7728,Congenital qualifier,Gout secondary to drug,0
7729,Congenital qualifier,Gout secondary to lead,0
7730,Congenital qualifier,Gout secondary to enzyme defect,0
7731,Congenital qualifier,Gouty bursitis,0
7732,Congenital qualifier,X-linked muscular dystrophy with limb girdle distribution,0
7733,Congenital qualifier,X-linked muscular dystrophy with abnormal dystrophin,0
7734,Congenital qualifier,Intermediate X-linked muscular dystrophy,0
7735,Congenital qualifier,Manifesting female carrier of X-linked muscular dystrophy,0
7736,Congenital qualifier,X-linked limb girdle muscular dystrophy with normal dystrophin,0
7737,Congenital qualifier,Ji muscular dystrophy,0
7738,Congenital qualifier,Hereditary myopathy limited to females,0
7739,Congenital qualifier,Autosomal recessive muscular dystrophy with abnormal dystrophin-associated glycoprotein,0
7740,Congenital qualifier,Severe autosomal recessive muscular dystrophy of childhood - North African type (disorder),0
7741,Congenital qualifier,Autosomal recessive muscular dystrophy with gene located at 15q,0
7742,Congenital qualifier,Reunion-Indiana Amish type muscular dystrophy,0
7743,Congenital qualifier,Congenital muscular dystrophy (disorder),0
7744,Congenital qualifier,Western type of congenital muscular dystrophy,0
7745,Congenital qualifier,Congenital muscular dystrophy with arthrogryposis multiplex congenita,0
7746,Congenital qualifier,Ullrich congenital muscular dystrophy,0
7747,Congenital qualifier,Eichsfeld type congenital muscular dystrophy,0
7748,Congenital qualifier,Limb-girdle muscular dystrophy type 2H,0
7749,Congenital qualifier,Adult onset autosomal recessive muscular dystrophy with normal dystrophin,0
7750,Congenital qualifier,Autosomal dominant muscular dystrophy with limb girdle distribution,0
7751,Congenital qualifier,Autosomal dominant muscular dystrophy with gene located at 5q31,0
7752,Congenital qualifier,Late onset proximal muscular dystrophy with dysarthria,0
7753,Congenital qualifier,X-linked muscular dystrophy not predominantly limb girdle,0
7754,Congenital qualifier,Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder),0
7755,Congenital qualifier,Autosomal recessive muscular dystrophy not predominantly limb girdle,0
7756,Congenital qualifier,"Muscular Dystrophy, Scapulohumeral",0
7757,Congenital qualifier,Autosomal dominant muscular dystrophy not predominantly limb girdle,0
7758,Congenital qualifier,Benign scapuloperoneal muscular dystrophy,0
7759,Congenital qualifier,Benign congenital muscular dystrophy with finger flexion contractures,0
7760,Congenital qualifier,Distal muscular dystrophy with adult onset,0
7761,Congenital qualifier,Benign congenital hypotonia,0
7762,Congenital qualifier,"Myopathy, Centronuclear, Autosomal Recessive",0
7763,Congenital qualifier,Myopathy with abnormality of histochemical fiber type,0
7764,Congenital qualifier,Myopathy with type I hypotrophy,0
7765,Congenital qualifier,Congenital Fiber Type Disproportion,0
7766,Congenital qualifier,Congenital myopathy with uniform fiber type,0
7767,Congenital qualifier,Myopathy with cytoplasmic inclusions,0
7768,Congenital qualifier,Tubular Aggregate Myopathy,0
7769,Congenital qualifier,Myopathy with Abnormal Lipid Metabolism,0
7770,Congenital qualifier,Congenital Myotonic Dystrophy,0
7771,Congenital qualifier,Juvenile idiopathic generalized osteoporosis,0
7772,Congenital qualifier,Osteochondrodysplasias,0
7773,Congenital qualifier,Congenital parvoviral infection,0
7774,Congenital qualifier,Chronic congenital cytomegalic inclusion disease,0
7775,Congenital qualifier,late congential neurovascular syphilis,0
7776,Congenital qualifier,Hutchinson's triad,0
7777,Congenital qualifier,Congenital Lyme disease,0
7778,Congenital qualifier,Median mandibular cyst,0
7779,Congenital qualifier,Complete bilateral cleft palate,0
7780,Congenital qualifier,Congenital chorioretinal degeneration,0
7781,Congenital qualifier,Distal arthrogryposis syndrome,0
7782,Congenital qualifier,Congenital dilatation of colon,0
7783,Congenital qualifier,Xiphopagus,0
7784,Congenital qualifier,Cystathionine beta-Synthase Deficiency Disease,0
7785,Congenital qualifier,Meromicrosomia,0
7786,Congenital qualifier,Accessory thymic tissue,0
7787,Congenital qualifier,Iniencephaly,0
7788,Congenital qualifier,Congenital chloride diarrhea,0
7789,Congenital qualifier,Thoracodelphus,0
7790,Congenital qualifier,Mutilating keratoderma,0
7791,Congenital qualifier,Primary gout,0
7792,Congenital qualifier,Accessory eyelid,0
7793,Congenital qualifier,Situs ambiguus,0
7794,Congenital qualifier,Posterior open bite,0
7795,Congenital qualifier,Jansen type metaphyseal chondrodysplasia,0
7796,Congenital qualifier,G-6-PD class III variant anemia,0
7797,Congenital qualifier,"von Willebrand disease, type IIH",0
7798,Congenital qualifier,Thoracopagus parasiticus,0
7799,Congenital qualifier,Cone monochromatism,0
7800,Congenital qualifier,Retinal arteriovenous shunt,0
7801,Congenital qualifier,Retinal cirsoid aneurysm,0
7802,Congenital qualifier,Morning glory disc,0
7803,Congenital qualifier,Optic disc vascular anomaly,0
7804,Congenital qualifier,Paving stone nevus,0
7805,Congenital qualifier,Raised birthmark,0
7806,Congenital qualifier,Flat birthmark,0
7807,Congenital qualifier,Townes syndrome,0
7808,Congenital qualifier,Cortical Congenital Hyperostosis,0
7809,Congenital qualifier,7p partial monosomy syndrome,0
7810,Congenital qualifier,Congenital absence of broad ligament,0
7811,Congenital qualifier,Potter's facies,0
7812,Congenital qualifier,Aberrant artery,0
7813,Congenital qualifier,Congenital lordosis due to bony malformation,0
7814,Congenital qualifier,Congenital cerebral arteriovenous aneurysm,0
7815,Congenital qualifier,Congenital anomaly of sternocleidomastoid muscle,0
7816,Congenital qualifier,Benign adult cystinosis,0
7817,Congenital qualifier,Right ventricular fibromuscular infundibular stenosis,0
7818,Congenital qualifier,Right ventricular muscular infundibular stenosis,0
7819,Congenital qualifier,Bicuspid doming of aortic cusp,0
7820,Congenital qualifier,Aortic root congenital abnormality,0
7821,Congenital qualifier,Lymphopenic agammaglobulinemia - short-limbed dwarfism syndrome,0
7822,Congenital qualifier,Hydromeningocele,0
7823,Congenital qualifier,Congenital absence of uvula,0
7824,Congenital qualifier,Congenital malformation of angle of anterior chamber of eye,0
7825,Congenital qualifier,Goniodysgenesis,0
7826,Congenital qualifier,Barkan membrane,0
7827,Congenital qualifier,Coalition of calcaneus,0
7828,Congenital qualifier,Brachyphalangia of toe,0
7829,Congenital qualifier,Neural Tube Defects,0
7830,Congenital qualifier,Congenital endaural hernia,0
7831,Congenital qualifier,Congenital cerebral hernia,0
7832,Congenital qualifier,Encephalocystocele,0
7833,Congenital qualifier,Frontal Encephalocele,0
7834,Congenital qualifier,Frontoethmoidal encephalocele,0
7835,Congenital qualifier,Nasofrontal encephalocele,0
7836,Congenital qualifier,Nasopharyngeal encephalocele,0
7837,Congenital qualifier,Temporal encephalocele,0
7838,Congenital qualifier,Parietal encephalocele,0
7839,Congenital qualifier,Thoracolumbar spina bifida without hydrocephalus - closed,0
7840,Congenital qualifier,Fissured spine,0
7841,Congenital qualifier,Rachischisis with hydrocephalus,0
7842,Congenital qualifier,Myelocele with hydrocephalus,0
7843,Congenital qualifier,Hydromyelocele with hydrocephalus,0
7844,Congenital qualifier,Fissured spine with hydrocephalus,0
7845,Congenital qualifier,Closed spina bifida with Arnold-Chiari malformation,0
7846,Congenital qualifier,Thoracolumbar spina bifida with hydrocephalus - closed,0
7847,Congenital qualifier,Hemimyelocele,0
7848,Congenital qualifier,Lipomeningocele,0
7849,Congenital qualifier,Spinal Cord Myelodysplasia,0
7850,Congenital qualifier,Spinal hamartoma,0
7851,Congenital qualifier,Neuroenteric cyst and associated malformation,0
7852,Congenital qualifier,Neurenteric Cyst,0
7853,Congenital qualifier,Abnormality of neurogenesis,0
7854,Congenital qualifier,Hydrocephalus associated with late onset aqueduct stenosis,0
7855,Congenital qualifier,Defect of telencephalic division,0
7856,Congenital qualifier,Lobar Holoprosencephaly,0
7857,Congenital qualifier,Alobar Holoprosencephaly,0
7858,Congenital qualifier,Semilobar Holoprosencephaly,0
7859,Congenital qualifier,Agenesis of corpus callosum with lipoma,0
7860,Congenital qualifier,Partial agenesis of corpus callosum,0
7861,Congenital qualifier,Dysgenesis of corpus callosum,0
7862,Congenital qualifier,Atrophy of corpus callosum,0
7863,Congenital qualifier,Reduction anomaly of hypothalamus,0
7864,Congenital qualifier,Disorder of neuronal migration and differentiation,0
7865,Congenital qualifier,Classical Lissencephaly,0
7866,Congenital qualifier,Miller Dieker syndrome,0
7867,Congenital qualifier,Cobblestone Lissencephaly,0
7868,Congenital qualifier,Neuronal heterotopia,0
7869,Congenital qualifier,Nodular heterotopia,0
7870,Congenital qualifier,Laminar heterotopia,0
7871,Congenital qualifier,Cortical Dysplasia,0
7872,Congenital qualifier,Localized cortical dysplasia,0
7873,Congenital qualifier,Cortical dysplasia with hemimegalencephaly,0
7874,Congenital qualifier,Early secondary malformation of the central nervous system,0
7875,Congenital qualifier,Hydranencephaly with Proliferative Vasculopathy,0
7876,Congenital qualifier,Schizencephaly,0
7877,Congenital qualifier,Colpocephaly,0
7878,Congenital qualifier,Arachnoid / ependymal cyst,0
7879,Congenital qualifier,Lateral meningocele,0
7880,Congenital qualifier,Microdysgenesis,0
7881,Congenital qualifier,Familial megalencephaly,0
7882,Congenital qualifier,Sporadic megalencephaly,0
7883,Congenital qualifier,Hemimegalencephaly,0
7884,Congenital qualifier,Dysgenesis of the cerebellum,0
7885,Congenital qualifier,Agenesis of cerebellum,0
7886,Congenital qualifier,Aplasia of the vermis,0
7887,Congenital qualifier,Familial aplasia of the vermis,0
7888,Congenital qualifier,Gillespie syndrome,0
7889,Congenital qualifier,Granular cell hypoplasia,0
7890,Congenital qualifier,Cerebellar cortical dysplasia,0
7891,Congenital qualifier,Dysgenesis of the brainstem,0
7892,Congenital qualifier,Olive dysplasia,0
7893,Congenital qualifier,Dentate dysplasia,0
7894,Congenital qualifier,Olivary heterotopia,0
7895,Congenital qualifier,Arnold Chiari Malformation,0
7896,Congenital qualifier,"Arnold-Chiari Malformation, Type I",0
7897,Congenital qualifier,"Arnold-Chiari Malformation, Type III",0
7898,Congenital qualifier,"Arnold-Chiari Malformation, Type IV",0
7899,Congenital qualifier,Abnormality of canalization and retrogressive differentiation,0
7900,Congenital qualifier,Sacral dysgenesis,0
7901,Congenital qualifier,Lumbosacral agenesis,0
7902,Congenital qualifier,Sirenomelia,0
7903,Congenital qualifier,Fibrolipoma of filum terminale,0
7904,Congenital qualifier,Central Nervous System Vascular Malformations,0
7905,Congenital qualifier,Persistent embryonic trigeminal artery,0
7906,Congenital qualifier,Persistent embryonic otic artery,0
7907,Congenital qualifier,Persistent embryonic hypoglossal artery,0
7908,Congenital qualifier,Persistent embryonic proatlantal intersegmental artery,0
7909,Congenital qualifier,Congenital malformation of the meninges,0
7910,Congenital qualifier,Hypoplasia of brain gyri,0
7911,Congenital qualifier,"Congenital malformation of eye, ear and neck",0
7912,Congenital qualifier,Congenital obstruction of lacrimal canal,0
7913,Congenital qualifier,Congenital malformation of the eyebrow,0
7914,Congenital qualifier,Synophrys,0
7915,Congenital qualifier,Absent eyebrow,0
7916,Congenital qualifier,Double eyebrow,0
7917,Congenital qualifier,Congenital epiblepharon,0
7918,Congenital qualifier,Congenital ankyloblepharon,0
7919,Congenital qualifier,Congenital distichiasis,0
7920,Congenital qualifier,Alacrima,0
7921,Congenital qualifier,Agenesis of punctum lacrimale,0
7922,Congenital qualifier,Supernumerary lacrimal punctum,0
7923,Congenital qualifier,Agenesis of nasolacrimal duct,0
7924,Congenital qualifier,Congenital lacrimal fistula,0
7925,Congenital qualifier,Lenticonus,0
7926,Congenital qualifier,Congenital polar cataract,0
7927,Congenital qualifier,Congenital anterior polar cataract,0
7928,Congenital qualifier,Congenital posterior polar cataract,0
7929,Congenital qualifier,Congenital sutural cataract,0
7930,Congenital qualifier,Rubella cataract,0
7931,Congenital qualifier,Embryotoxon,0
7932,Congenital qualifier,Congenital anterior embryotoxon,0
7933,Congenital qualifier,Congenital anterior staphyloma,0
7934,Congenital qualifier,Aniridia type 1,0
7935,Congenital qualifier,Aniridia type 2,0
7936,Congenital qualifier,Pseudo-polycoria,0
7937,Congenital qualifier,Congenital heterochromia iridis,0
7938,Congenital qualifier,Congenital cyst of iris,0
7939,Congenital qualifier,Congenital malformation of vitreous humor,0
7940,Congenital qualifier,Partial hypoplasia of optic disc,0
7941,Congenital qualifier,Sectorial hypoplasia of optic disc,0
7942,Congenital qualifier,Trabecular dysgenesis,0
7943,Congenital qualifier,Orbital dystopia,0
7944,Congenital qualifier,Horizontal orbital dystopia,0
7945,Congenital qualifier,Vertical orbital dystopia,0
7946,Congenital qualifier,Rotational orbital dystopia,0
7947,Congenital qualifier,Congenital stricture of osseous meatus,0
7948,Congenital qualifier,Posteriorly rotated ear,0
7949,Congenital qualifier,Stahl ear,0
7950,Congenital qualifier,Cat ear,0
7951,Congenital qualifier,Aztec ear,0
7952,Congenital qualifier,Simple ear,0
7953,Congenital qualifier,Congenital cystic ear,0
7954,Congenital qualifier,Branchial Clefts-Congenital disorder,0
7955,Congenital qualifier,Sinus of branchial cleft (disorder),0
7956,Congenital qualifier,"Congenital disease and abnormality of heart, thoracic aorta and pericardium",0
7957,Congenital qualifier,"Congenital heart disease, septal and bulbar anomalies",0
7958,Congenital qualifier,Congenital malrotation of heart,0
7959,Congenital qualifier,Congenital abnormality of relationship of cardiac component,0
7960,Congenital qualifier,Abnormal relationship of right ventricle to left ventricle,0
7961,Congenital qualifier,Crisscross Heart,0
7962,Congenital qualifier,Abnormal relationship of aortic orifice to pulmonary orifice,0
7963,Congenital qualifier,Mirror-imaged heart,0
7964,Congenital qualifier,Congenital abnormality of cardiac connection,0
7965,Congenital qualifier,Heart Septal Defects,0
7966,Congenital qualifier,Abnormal atrioventricular connection,0
7967,Congenital qualifier,Abnormal atrioventricular connection - biventricular,0
7968,Congenital qualifier,Common atrium,0
7969,Congenital qualifier,Discordant atrioventricular connection,0
7970,Congenital qualifier,Ambiguous atrioventricular connection,0
7971,Congenital qualifier,Absent atrioventricular connection with straddling valve,0
7972,Congenital qualifier,Abnormal atrioventricular connection - univentricular,0
7973,Congenital qualifier,Double inlet ventricle,0
7974,Congenital qualifier,Double inlet right ventricle,0
7975,Congenital qualifier,Double inlet left ventricle,0
7976,Congenital qualifier,Double inlet to ventricle of indeterminate morphology,0
7977,Congenital qualifier,Absent right sided atrioventricular connection,0
7978,Congenital qualifier,Left sided atrium connecting to left ventricle,0
7979,Congenital qualifier,Left sided atrium connecting to right ventricle,0
7980,Congenital qualifier,Left sided atrium connecting to both ventricles,0
7981,Congenital qualifier,Left sided atrium connecting to ventricle of indeterminate morphology,0
7982,Congenital qualifier,Absent left sided atrioventricular connection,0
7983,Congenital qualifier,Right sided atrium connecting to right ventricle,0
7984,Congenital qualifier,Right sided atrium connecting to both ventricles,0
7985,Congenital qualifier,Right sided atrium connecting to ventricle of indeterminate morphology,0
7986,Congenital qualifier,Abnormal ventriculoarterial connection,0
7987,Congenital qualifier,Transposition of aorta,0
7988,Congenital qualifier,"Double Outlet Right Ventricle, Subaortic VSD",0
7989,Congenital qualifier,"Double Outlet Right Ventricle, Noncommitted VSD",0
7990,Congenital qualifier,Double outlet right ventricle with doubly committed ventricular septal defect,0
7991,Congenital qualifier,Double outlet from ventricle of indeterminate morphology,0
7992,Congenital qualifier,Single outlet ventriculoarterial connection,0
7993,Congenital qualifier,Solitary aortic trunk with pulmonary atresia,0
7994,Congenital qualifier,Solitary pulmonary trunk with aortic atresia,0
7995,Congenital qualifier,Solitary arterial trunk,0
7996,Congenital qualifier,Abnormality of right superior vena cava,0
7997,Congenital qualifier,Atretic right superior vena cava,0
7998,Congenital qualifier,Absent right superior vena cava,0
7999,Congenital qualifier,Saccular dilatation of right superior vena cava,0
8000,Congenital qualifier,Anomalous insertion of right superior vena cava to left atrium,0
8001,Congenital qualifier,Bilateral superior vena cava,0
8002,Congenital qualifier,Absent bridging vein,0
8003,Congenital qualifier,Inferior vena cava interruption with left sided hemiazygos continuation,0
8004,Congenital qualifier,Inferior vena cava interruption with right sided azygos continuation,0
8005,Congenital qualifier,Inferior vena cava interruption with bilateral azygos continuation,0
8006,Congenital qualifier,Abnormal inferior vena caval connection,0
8007,Congenital qualifier,Inferior vena cava connecting to morphological left atrium,0
8008,Congenital qualifier,Inferior vena cava connecting to coronary sinus,0
8009,Congenital qualifier,Inferior vena cava to left of spine,0
8010,Congenital qualifier,Inferior cava to left of spine with right descending aorta,0
8011,Congenital qualifier,Anomalous termination of right pulmonary vein,0
8012,Congenital qualifier,Coronary sinus abnormality,0
8013,Congenital qualifier,Coronary sinus defect in left atrium,0
8014,Congenital qualifier,Coronary sinus orifice atresia,0
8015,Congenital qualifier,Congenital coronary sinus stenosis,0
8016,Congenital qualifier,Coronary sinus to left ventricle fistula,0
8017,Congenital qualifier,Ductus venosus abnormality,0
8018,Congenital qualifier,Patent Ductus Venosus,0
8019,Congenital qualifier,Closed ductus venosus,0
8020,Congenital qualifier,Abnormal connection of hepatic vein to atrium,0
8021,Congenital qualifier,Congenital abnormality of atria and atrial septum,0
8022,Congenital qualifier,Isomerism of atrial appendages,0
8023,Congenital qualifier,Isomerism of right atrial appendage,0
8024,Congenital qualifier,Isomerism of left atrial appendage,0
8025,Congenital qualifier,Mirror imaged atria,0
8026,Congenital qualifier,Prominent valve of inferior vena cava,0
8027,Congenital qualifier,Obstructive Eustachian valve,0
8028,Congenital qualifier,Prolapse of Eustachian valve,0
8029,Congenital qualifier,Anomalous valve of coronary sinus,0
8030,Congenital qualifier,Abnormality of right atrial appendage,0
8031,Congenital qualifier,Right atrial appendage absent,0
8032,Congenital qualifier,Right atrial appendage - left - juxtaposition,0
8033,Congenital qualifier,Right atrial appendage aneurysm,0
8034,Congenital qualifier,Right atrial endocardial fibroelastosis,0
8035,Congenital qualifier,Right atrial hypoplasia,0
8036,Congenital qualifier,Giant right atrium,0
8037,Congenital qualifier,Divided left atrium,0
8038,Congenital qualifier,Supramitral left atrial ring,0
8039,Congenital qualifier,Abnormality of left atrial appendage,0
8040,Congenital qualifier,Left atrial appendage absent,0
8041,Congenital qualifier,Left atrial appendage - right - juxtaposition,0
8042,Congenital qualifier,Left atrial appendage aneurysm,0
8043,Congenital qualifier,Left atrial endocardial fibroelastosis,0
8044,Congenital qualifier,Left atrial hypoplasia,0
8045,Congenital qualifier,Uterus parvicollis,0
8046,Congenital qualifier,Giant left atrium,0
8047,Congenital qualifier,Foramen ovale valvar aneurysm,0
8048,Congenital qualifier,Atrial septal defect through coronary sinus orifice,0
8049,Congenital qualifier,Restrictive atrial septal defect with obligatory shunt,0
8050,Congenital qualifier,Partial atrioventricular canal,0
8051,Congenital qualifier,Congenital abnormality of atrioventricular valves in atrioventricular septal defect,0
8052,Congenital qualifier,Tricuspid annulus hypoplasia,0
8053,Congenital qualifier,Dilatation of tricuspid annulus,0
8054,Congenital qualifier,Overriding tricuspid valve,0
8055,Congenital qualifier,Straddling tricuspid valve,0
8056,Congenital qualifier,Double orifice of tricuspid valve,0
8057,Congenital qualifier,Accessory tissue on tricuspid leaflet,0
8058,Congenital qualifier,Parachute malformation of tricuspid valve,0
8059,Congenital qualifier,Overriding mitral valve,0
8060,Congenital qualifier,Straddling mitral valve,0
8061,Congenital qualifier,Congenital absence of vena cava,0
8062,Congenital qualifier,Ebstein-like downward displacement of mitral valve,0
8063,Congenital qualifier,Anterior leaflet of mitral valve attached to septum,0
8064,Congenital qualifier,Accessory tissue on mitral leaflet,0
8065,Congenital qualifier,Absent mitral papillary muscle,0
8066,Congenital qualifier,Fused mitral papillary muscles,0
8067,Congenital qualifier,Hypoplastic mitral papillary muscle,0
8068,Congenital qualifier,Atrioventricular septal defect and common atrioventricular junction,0
8069,Congenital qualifier,Atrioventricular septal defect - isolated ventricular component,0
8070,Congenital qualifier,Complete atrioventricular septal defect,0
8071,Congenital qualifier,Atrioventricular septal defect - ventricular component,0
8072,Congenital qualifier,Atrioventricular septal defect - ventricular component under superior bridging leaflet,0
8073,Congenital qualifier,Atrioventricular septal defect with ventricular component under superior bridging leaflet with chords at crest ventricular septum,0
8074,Congenital qualifier,Atrioventricular septal defect with ventricular component under superior bridging leaflet with chords to papillary muscle on right ventricular side septum,0
8075,Congenital qualifier,Atrioventricular septal defect with ventricular component under free floating superior bridging leaflet and chords to papillary muscle at right ventricular free wall,0
8076,Congenital qualifier,Atrioventricular septal defect - ventricular component under inferior bridging leaflet,0
8077,Congenital qualifier,Malaligned atrial septum,0
8078,Congenital qualifier,Double outlet right atrium,0
8079,Congenital qualifier,Double outlet left atrium,0
8080,Congenital qualifier,Parachute malformation of common atrioventricular valve,0
8081,Congenital qualifier,Abnormality of right atrioventricular valve in double inlet ventricle,0
8082,Congenital qualifier,Tricuspid Atresia,0
8083,Congenital qualifier,Imperforate right atrioventricular valve,0
8084,Congenital qualifier,Right atrioventricular valve dysplasia,0
8085,Congenital qualifier,Right atrioventricular valve hypoplasia,0
8086,Congenital qualifier,Right atrioventricular valve regurgitation,0
8087,Congenital qualifier,Overriding right atrioventricular valve,0
8088,Congenital qualifier,Straddling right atrioventricular valve,0
8089,Congenital qualifier,Parachute malformation of right atrioventricular valve,0
8090,Congenital qualifier,Parachute malformation of left atrioventricular valve,0
8091,Congenital qualifier,Congenital abnormality of ventricles and ventricular septum,0
8092,Congenital qualifier,Tetralogy of Fallot with pulmonary stenosis,0
8093,Congenital qualifier,Tetralogy of Fallot with pulmonary atresia,0
8094,Congenital qualifier,Dextraposition of aorta in Fallot's tetralogy,0
8095,Congenital qualifier,Ventricular septal defect in Fallot's tetralogy,0
8096,Congenital qualifier,Diffuse hypoplasia of right ventricle,0
8097,Congenital qualifier,Hypoplasia of right ventricular inflow tract,0
8098,Congenital qualifier,Hypoplasia of right ventricular outflow tract,0
8099,Congenital qualifier,Hypoplasia of right ventricular outflow tract and trabecular area,0
8100,Congenital qualifier,Primary right ventricular endocardial fibroelastosis,0
8101,Congenital qualifier,Two chambered right ventricle,0
8102,Congenital qualifier,Congenital right ventricular diverticulum,0
8103,Congenital qualifier,Congenital right ventricular aneurysm,0
8104,Congenital qualifier,Arrhythmogenic Right Ventricular Dysplasia,0
8105,Congenital qualifier,Right ventricular outflow tract abnormality,0
8106,Congenital qualifier,Right ventricular outflow tract obstruction,0
8107,Congenital qualifier,Right ventricular outflow obstruction - localized,0
8108,Congenital qualifier,Right ventricular outflow obstruction - tubular,0
8109,Congenital qualifier,Right ventricular outflow tract atresia,0
8110,Congenital qualifier,Right ventricular outflow tract absent,0
8111,Congenital qualifier,Left ventricular hypoplasia,0
8112,Congenital qualifier,Diffuse hypoplasia of left ventricle,0
8113,Congenital qualifier,Hypoplasia of left ventricular inflow tract,0
8114,Congenital qualifier,Hypoplasia of left ventricular outflow tract,0
8115,Congenital qualifier,Hypoplasia of left ventricular outflow tract and trabecular area,0
8116,Congenital qualifier,Abnormal left ventricular muscle band,0
8117,Congenital qualifier,Primary left ventricular endocardial fibroelastosis,0
8118,Congenital qualifier,Congenital left ventricular aneurysm,0
8119,Congenital qualifier,Left ventricular outflow tract abnormality,0
8120,Congenital qualifier,Left ventricular outflow tract obstruction,0
8121,Congenital qualifier,Left ventricular outflow tract atresia,0
8122,Congenital qualifier,Indeterminate ventricular outflow tract obstruction,0
8123,Congenital qualifier,Perimembranous ventricular septal defect with extension to right ventricular inlet,0
8124,Congenital qualifier,Perimembranous ventricular septal defect with extension to right ventricular trabecular component,0
8125,Congenital qualifier,Perimembranous ventricular septal defect with extension to right ventricular outlet,0
8126,Congenital qualifier,Perimembranous ventricular septal defect with extension to all right ventricular components,0
8127,Congenital qualifier,Ventricular septal defect with malaligned outlet septum to right,0
8128,Congenital qualifier,Ventricular septal defect with malaligned outlet septum to right overriding aortic valve,0
8129,Congenital qualifier,Ventricular septal defect with malaligned outlet septum to right overriding pulmonary valve,0
8130,Congenital qualifier,Ventricular septal defect with malaligned outlet septum to left,0
8131,Congenital qualifier,Ventricular septal defect with malaligned outlet septum to left overriding aortic valve,0
8132,Congenital qualifier,Ventricular septal defect with malaligned outlet septum to left overriding pulmonary valve,0
8133,Congenital qualifier,Ventricular septal defect with absent outlet septum and overriding truncal valve,0
8134,Congenital qualifier,Muscular ventricular septal defect in inlet septum,0
8135,Congenital qualifier,Muscular ventricular septal defect in central trabecular septum,0
8136,Congenital qualifier,Muscular ventricular septal defect in apical trabecular septum,0
8137,Congenital qualifier,Muscular ventricular septal defect in marginal septum,0
8138,Congenital qualifier,Muscular ventricular septal defect in outlet septum,0
8139,Congenital qualifier,Doubly committed subarterial ventricular septal defect with membranous septum extension,0
8140,Congenital qualifier,Doubly committed subarterial ventricular septal defect with muscular posterior inferior rim,0
8141,Congenital qualifier,Right ventricular outflow tract abnormality,0
8142,Congenital qualifier,Subpulmonary infundibulum,0
8143,Congenital qualifier,Subaortic infundibulum,0
8144,Congenital qualifier,Bilateral muscular infundibula,0
8145,Congenital qualifier,Bilateral deficient infundibula,0
8146,Congenital qualifier,Congenital abnormality of arterial valves,0
8147,Congenital qualifier,Truncal valve abnormality,0
8148,Congenital qualifier,Truncal valve dysplasia,0
8149,Congenital qualifier,Truncal valve stenosis,0
8150,Congenital qualifier,Truncal valve regurgitation,0
8151,Congenital qualifier,Truncal valve prolapse,0
8152,Congenital qualifier,Accessory tissue on truncal valve cusp,0
8153,Congenital qualifier,Congenital hypoplasia of pulmonary valve,0
8154,Congenital qualifier,Pulmonary valve ring hypoplasia,0
8155,Congenital qualifier,Commissural fusion of pulmonary valve,0
8156,Congenital qualifier,Pulmonary valve dysplasia,0
8157,Congenital qualifier,Pulmonary Atresia with Intact Ventricular Septum,0
8158,Congenital qualifier,Pulmonary Atresia With Ventricular Septal Defect,0
8159,Congenital qualifier,Pulmonary valve atresia without ventricular outflow tract,0
8160,Congenital qualifier,Imperforate pulmonary valve,0
8161,Congenital qualifier,Muscular pulmonary atresia,0
8162,Congenital qualifier,Absent pulmonary valve syndrome,0
8163,Congenital qualifier,Accessory tissue on pulmonary valve cusp,0
8164,Congenital qualifier,Unicuspid pulmonary valve,0
8165,Congenital qualifier,Bicuspid pulmonary valve,0
8166,Congenital qualifier,Quadricuspid pulmonary valve,0
8167,Congenital qualifier,Aortic valve ring hypoplasia,0
8168,Congenital qualifier,Commissural fusion of aortic valve,0
8169,Congenital qualifier,Eccentric opening of aortic valve,0
8170,Congenital qualifier,Hypoplasia of aortic valve cusp,0
8171,Congenital qualifier,Accessory tissue on aortic valve cusp,0
8172,Congenital qualifier,Abnormal number of aortic valve cusps,0
8173,Congenital qualifier,Unicuspid aortic valve,0
8174,Congenital qualifier,Quadricuspid aortic valve,0
8175,Congenital qualifier,Aortic valve cusp prolapse,0
8176,Congenital qualifier,Tubular hypoplasia of aorta,0
8177,Congenital qualifier,Anomalies of the aorta excluding coarction,0
8178,Congenital qualifier,Refsum Disease,0
8179,Congenital qualifier,Pulmonary trunk stenosis,0
8180,Congenital qualifier,Pulmonary trunk hypoplasia,0
8181,Congenital qualifier,Pulmonary trunk atresia,0
8182,Congenital qualifier,Pulmonary atresia with confluent pulmonary arteries,0
8183,Congenital qualifier,Pulmonary atresia with absent pulmonary artery,0
8184,Congenital qualifier,Pulmonary trunk absent with confluent pulmonary arteries,0
8185,Congenital qualifier,Pulmonary trunk absent with non-confluent pulmonary arteries,0
8186,Congenital qualifier,Pulmonary trunk absent with absent pulmonary artery,0
8187,Congenital qualifier,Abnormal origin of right pulmonary artery,0
8188,Congenital qualifier,Anomalous origin of right pulmonary artery from ductus arteriosus,0
8189,Congenital qualifier,Anomalous origin of right pulmonary artery from ascending aorta,0
8190,Congenital qualifier,Abnormal origin of left pulmonary artery,0
8191,Congenital qualifier,Anomalous origin of left pulmonary artery from ductus arteriosus,0
8192,Congenital qualifier,Anomalous origin of left pulmonary artery from ascending aorta,0
8193,Congenital qualifier,Anomalous origin of left pulmonary artery from right pulmonary artery,0
8194,Congenital qualifier,Ascending aortic atresia,0
8195,Congenital qualifier,Ascending aorta absent,0
8196,Congenital qualifier,Congenital aneurysm of ascending aorta,0
8197,Congenital qualifier,Sinus of Valsalva abnormality,0
8198,Congenital qualifier,Sinus of Valsalva aneurysm with rupture,0
8199,Congenital qualifier,Aortic tunnel,0
8200,Congenital qualifier,Aorta to right ventricle tunnel,0
8201,Congenital qualifier,Right descending aorta,0
8202,Congenital qualifier,Left aortic arch and right descending aorta,0
8203,Congenital qualifier,Right aortic arch and right descending aorta,0
8204,Congenital qualifier,Right aortic arch and left descending aorta,0
8205,Congenital qualifier,Aortic arch centrally descending,0
8206,Congenital qualifier,Cervical aortic arch,0
8207,Congenital qualifier,Persisting fifth aortic arch,0
8208,Congenital qualifier,Double aortic arch with both patent,0
8209,Congenital qualifier,Double aortic arch with unilateral hypoplasia,0
8210,Congenital qualifier,Double aortic arch with unilateral atresia,0
8211,Congenital qualifier,Vascular ring with left aortic arch,0
8212,Congenital qualifier,Vascular ring with right aortic arch,0
8213,Congenital qualifier,Vascular ring components,0
8214,Congenital qualifier,Aberrant retroesophageal brachiocephalic artery,0
8215,Congenital qualifier,Isolation of subclavian artery,0
8216,Congenital qualifier,Ductus arteriosus from subclavian artery,0
8217,Congenital qualifier,Ductus arteriosus from retro-esophageal aortic diverticulum,0
8218,Congenital qualifier,Arterial duct in normal left sided position,0
8219,Congenital qualifier,Preductal aortic stenosis,0
8220,Congenital qualifier,Preductal interruption of aorta,0
8221,Congenital qualifier,Preductal hypoplasia of aorta,0
8222,Congenital qualifier,Juxtaductal aortic coarctation,0
8223,Congenital qualifier,Postductal aortic stenosis,0
8224,Congenital qualifier,Postductal interruption of aorta,0
8225,Congenital qualifier,Thoracic aortic coarctation,0
8226,Congenital qualifier,Abdominal aortic coarctation,0
8227,Congenital qualifier,Postductal hypoplasia of aorta,0
8228,Congenital qualifier,Interrupted aortic arch distal to left subclavian artery,0
8229,Congenital qualifier,Interrupted aortic arch between left subclavian and left common carotid artery,0
8230,Congenital qualifier,Interrupted aortic arch between left common carotid and brachiocephalic artery,0
8231,Congenital qualifier,Delayed closure of patent arterial duct,0
8232,Congenital qualifier,Abnormal origin of arterial duct,0
8233,Congenital qualifier,Collaterals to pulmonary arteries,0
8234,Congenital qualifier,Major aortopulmonary collateral artery,0
8235,Congenital qualifier,Systemic collateral artery to lung,0
8236,Congenital qualifier,Stenosis of systemic to pulmonary artery collateral artery,0
8237,Congenital qualifier,Bronchopulmonary collateral artery,0
8238,Congenital qualifier,Congenital abnormalities of thoracic aortic branches,0
8239,Congenital qualifier,Distal origin of brachiocephalic trunk,0
8240,Congenital qualifier,Isolation of branch of aortic arch,0
8241,Congenital qualifier,Isolation of brachiocephalic trunk,0
8242,Congenital qualifier,Variant coronary origin from aortic sinus,0
8243,Congenital qualifier,Variant coronary origin from left sinus,0
8244,Congenital qualifier,Variant coronary origin from right sinus,0
8245,Congenital qualifier,Anomalous origin of coronary artery from non-facing sinus,0
8246,Congenital qualifier,Anomalous origin of left anterior descending from right coronary artery,0
8247,Congenital qualifier,Anomalous origin of coronary artery from pulmonary arterial tree,0
8248,Congenital qualifier,Anomalous origin of coronary artery from right pulmonary artery,0
8249,Congenital qualifier,Anomalous origin of coronary artery from left pulmonary artery,0
8250,Congenital qualifier,Coronary orifice asymmetrical,0
8251,Congenital qualifier,Dual coronary orifice,0
8252,Congenital qualifier,Coronary orifice atresia,0
8253,Congenital qualifier,Abnormal coronary artery course,0
8254,Congenital qualifier,Intramural coronary artery course,0
8255,Congenital qualifier,Aberrant course of left anterior descending coronary artery from right coronary artery crossing right ventricular outflow tract,0
8256,Congenital qualifier,Coronary artery runs between aorta and pulmonary trunk,0
8257,Congenital qualifier,Circumflex runs posterior to pulmonary trunk,0
8258,Congenital qualifier,Circumflex runs posterior to aorta,0
8259,Congenital qualifier,Congenital coronary arteriovenous fistula,0
8260,Congenital qualifier,Congenital coronary artery calcification,0
8261,Congenital qualifier,Right dominant coronary system,0
8262,Congenital qualifier,Left dominant coronary system,0
8263,Congenital qualifier,Balanced coronary system,0
8264,Congenital qualifier,Partial agenesis of pericardium,0
8265,Congenital qualifier,Totally absent pericardium,0
8266,Congenital qualifier,Pleuropericardial cyst,0
8267,Congenital qualifier,Pericardial diverticulum,0
8268,Congenital qualifier,"Midline fissured, notched and cleft nose",0
8269,Congenital qualifier,Laryngeal hypoplasia,0
8270,Congenital qualifier,Congenital laryngomalacia,0
8271,Congenital qualifier,Congenital malformation of trachea and bronchus,0
8272,Congenital qualifier,Congenital tracheo-esophageal cleft,0
8273,Congenital qualifier,Primary congenital bronchomalacia,0
8274,Congenital qualifier,Secondary congenital bronchomalacia,0
8275,Congenital qualifier,Dysplasia of lung,0
8276,Congenital qualifier,Ectopic bone and cartilage in lung,0
8277,Congenital qualifier,Bronchopulmonary isomerism,0
8278,Congenital qualifier,"Congenital malformation of tongue, mouth and pharynx",0
8279,Congenital qualifier,Flat palate,0
8280,Congenital qualifier,Lobulated tongue,0
8281,Congenital qualifier,Congenital malformation of salivary glands and ducts,0
8282,Congenital qualifier,Displacement of Wharton's duct,0
8283,Congenital qualifier,Accessory salivary duct,0
8284,Congenital qualifier,Congenital palato-esophageal incoordination,0
8285,Congenital qualifier,Malformation of throat,0
8286,Congenital qualifier,Congenital stenosis of esophagus,0
8287,Congenital qualifier,Congenital displacement of gastric mucosa,0
8288,Congenital qualifier,"Congenital absence, atresia and stenosis of small intestine",0
8289,Congenital qualifier,Congenital functional disorders of the small intestine,0
8290,Congenital qualifier,Congenital dysmotility of small intestine,0
8291,Congenital qualifier,Congenital stenosis of colon,0
8292,Congenital qualifier,Congenital stenosis of appendix,0
8293,Congenital qualifier,High anorectal malformation,0
8294,Congenital qualifier,Low anorectal malformation,0
8295,Congenital qualifier,Congenital fistula of rectum,0
8296,Congenital qualifier,Congenital fistula of anus,0
8297,Congenital qualifier,Congenital functional disorders of the colon,0
8298,Congenital qualifier,"Aganglionosis, Colonic",0
8299,Congenital qualifier,Megacystis microcolon intestinal hypoperistalsis syndrome,0
8300,Congenital qualifier,Small left colon syndrome,0
8301,Congenital qualifier,Neuronal intestinal dysplasia,0
8302,Congenital qualifier,Hyperganglionosis,0
8303,Congenital qualifier,Generalized congenital intestinal dysmotility,0
8304,Congenital qualifier,Congenital volvulus,0
8305,Congenital qualifier,Congenital malrotation of intestine,0
8306,Congenital qualifier,Congenital blind loop syndrome,0
8307,Congenital qualifier,Congenital diverticulosis,0
8308,Congenital qualifier,Congenital redundant rectal mucosa,0
8309,Congenital qualifier,Congenital redundant colon,0
8310,Congenital qualifier,Enteric duplication,0
8311,Congenital qualifier,Jejunum duplex,0
8312,Congenital qualifier,Ileum duplex,0
8313,Congenital qualifier,Partial duplication of appendix,0
8314,Congenital qualifier,Complete duplication of appendix,0
8315,Congenital qualifier,Triplication of appendix,0
8316,Congenital qualifier,Mesenteric Cyst,0
8317,Congenital qualifier,Gallbladder anomaly congenital,0
8318,Congenital qualifier,Congenital anomaly of bile ducts,0
8319,Congenital qualifier,Congenital Intrahepatic Biliary Atresia,0
8320,Congenital qualifier,Congenital kink of cystic duct,0
8321,Congenital qualifier,Abnormal liver lobulation,0
8322,Congenital qualifier,Trilobular liver,0
8323,Congenital qualifier,Ectopic liver,0
8324,Congenital qualifier,Focal nodular hypoplasia of liver,0
8325,Congenital qualifier,Pancreatic duct anomaly,0
8326,Congenital qualifier,Congenital absent hemidiaphragm - bilateral,0
8327,Congenital qualifier,Congenital malformation of anterior abdominal wall,0
8328,Congenital qualifier,Developmental ovarian cyst,0
8329,Congenital qualifier,Congenital torsion of ovary,0
8330,Congenital qualifier,Embryonic cyst of ovary,0
8331,Congenital qualifier,Congenital hydrosalpinx,0
8332,Congenital qualifier,Embryonic cyst of broad ligament,0
8333,Congenital qualifier,Congenital malformation of uterus and cervix,0
8334,Congenital qualifier,Mullerian aplasia,0
8335,Congenital qualifier,Solid rudimentary uterus,0
8336,Congenital qualifier,Hypoplasia of uterus and cervix,0
8337,Congenital qualifier,Embryonic cyst of cervix,0
8338,Congenital qualifier,Agenesis of lower vagina,0
8339,Congenital qualifier,Atresia of lower vagina,0
8340,Congenital qualifier,Hypoplasia of vagina,0
8341,Congenital qualifier,Congenital urethrovaginal fistula,0
8342,Congenital qualifier,Congenital absence of labium minor,0
8343,Congenital qualifier,Congenital absence of labium major,0
8344,Congenital qualifier,Duplication of external genitalia,0
8345,Congenital qualifier,Congenital malformation of clitoris,0
8346,Congenital qualifier,Hooded clitoris,0
8347,Congenital qualifier,Duplication of clitoris,0
8348,Congenital qualifier,"Maldescent of testis, bilateral",0
8349,Congenital qualifier,Congenital buried penis,0
8350,Congenital qualifier,Rotated penis,0
8351,Congenital qualifier,Diphallus,0
8352,Congenital qualifier,Webbed penis,0
8353,Congenital qualifier,Congenital phimosis,0
8354,Congenital qualifier,Short preputial frenulum,0
8355,Congenital qualifier,Congenital parameatal cyst,0
8356,Congenital qualifier,False hermaphrodite,0
8357,Congenital qualifier,Congenital malformation of the urinary system,0
8358,Congenital qualifier,Pyelon triplex,0
8359,Congenital qualifier,Trifid kidney,0
8360,Congenital qualifier,Renal cysts and diabetes syndrome,0
8361,Congenital qualifier,"Crossed ectopia of kidney, without fusion",0
8362,Congenital qualifier,Crossed ectopia of kidney with fusion anomaly,0
8363,Congenital qualifier,Thoracic kidney,0
8364,Congenital qualifier,Cake Kidney,0
8365,Congenital qualifier,Bifid kidney,0
8366,Congenital qualifier,Duplex kidney with reflux in one ureter,0
8367,Congenital qualifier,Duplex kidney with reflux in both ureters,0
8368,Congenital qualifier,Congenital calyceal diverticulum,0
8369,Congenital qualifier,Medullary sponge kidney with nephrocalcinosis,0
8370,Congenital qualifier,Medullary sponge kidney without nephrocalcinosis,0
8371,Congenital qualifier,Congenital obstructive defect of renal pelvis,0
8372,Congenital qualifier,Congenital ureteric valves,0
8373,Congenital qualifier,Triplex ureter,0
8374,Congenital qualifier,Crossed ectopic ureter,0
8375,Congenital qualifier,Transcaval ureter,0
8376,Congenital qualifier,Congenital diverticulum of ureter,0
8377,Congenital qualifier,Congenital polyp of ureter,0
8378,Congenital qualifier,Ectopic ureterocele,0
8379,Congenital qualifier,"Congenital vesicoureterorenal reflux, bilateral",0
8380,Congenital qualifier,Urachal diverticulum,0
8381,Congenital qualifier,Congenital posterior urethral valves,0
8382,Congenital qualifier,Congenital urethral posterior valvular stricture,0
8383,Congenital qualifier,Atresia of urethra,0
8384,Congenital qualifier,Congenital short urethra,0
8385,Congenital qualifier,Megacystis-megaureter syndrome,0
8386,Congenital qualifier,Megalourethra,0
8387,Congenital qualifier,Congenital urethral syringocele,0
8388,Congenital qualifier,Congenital anterior urethral valve,0
8389,Congenital qualifier,Congenital gastrointestinal-urinary tract fistula,0
8390,Congenital qualifier,Multiple congenital articular rigidities,0
8391,Congenital qualifier,Withered limb,0
8392,Congenital qualifier,Aberrant muscle of the upper limb,0
8393,Congenital qualifier,Failure of differentiation of bones of forearm,0
8394,Congenital qualifier,Duplication of upper limb,0
8395,Congenital qualifier,Duplication of whole upper limb,0
8396,Congenital qualifier,Overgrowth of upper limb,0
8397,Congenital qualifier,Hemiatrophy of upper limb,0
8398,Congenital qualifier,Undergrowth of whole upper limb,0
8399,Congenital qualifier,Undergrowth of partial upper limb,0
8400,Congenital qualifier,Acrosyndactyly of the thumb,0
8401,Congenital qualifier,Acrosyndactyly of the fingers,0
8402,Congenital qualifier,Phocomelia of upper limb,0
8403,Congenital qualifier,Hypoplasia of upper limb,0
8404,Congenital qualifier,Carpal synostosis,0
8405,Congenital qualifier,Synbrachydactyly,0
8406,Congenital qualifier,Brachysyndactyly of thumb,0
8407,Congenital qualifier,Hitch-hiker thumb,0
8408,Congenital qualifier,Hypoplasia of thumb,0
8409,Congenital qualifier,Hypoplasia of thumb,0
8410,Congenital qualifier,Congenital abnormality of lower limb and pelvic girdle,0
8411,Congenital qualifier,Duplication of whole lower limb,0
8412,Congenital qualifier,Duplication of femur,0
8413,Congenital qualifier,Duplication of tibia,0
8414,Congenital qualifier,Duplication of fibula,0
8415,Congenital qualifier,Duplication of tarsal bone,0
8416,Congenital qualifier,Duplication of the whole foot,0
8417,Congenital qualifier,Congenital overgrowth of partial lower limb,0
8418,Congenital qualifier,Congenital undergrowth of partial lower limb,0
8419,Congenital qualifier,Congenital leg bone bowing,0
8420,Congenital qualifier,Congenital clicking hip,0
8421,Congenital qualifier,Predislocation status of hip at birth,0
8422,Congenital qualifier,Dislocatable hip,0
8423,Congenital qualifier,Subluxatable hip,0
8424,Congenital qualifier,Congenital deformity of foot and ankle,0
8425,Congenital qualifier,Congenital metatarsus valgus,0
8426,Congenital qualifier,Hypoplasia of lower limb,0
8427,Congenital qualifier,Brachymelia of leg,0
8428,Congenital qualifier,Rudimentary leg,0
8429,Congenital qualifier,Phocomelia of lower limb,0
8430,Congenital qualifier,Agenesis of multiple metatarsal bones,0
8431,Congenital qualifier,Congenital abnormality of foot and toes,0
8432,Congenital qualifier,Mesoaxial polydactyly of toe,0
8433,Congenital qualifier,Simple syndactyly of toes second to fourth web,0
8434,Congenital qualifier,Osseous syndactyly of toes second to fourth web,0
8435,Congenital qualifier,Perodactylia,0
8436,Congenital qualifier,Syndactyly of the thumb,0
8437,Congenital qualifier,Congenital sternomastoid tumor,0
8438,Congenital qualifier,Congenital anomaly of skull,0
8439,Congenital qualifier,Defect of skull ossification,0
8440,Congenital qualifier,Congenital anomaly of jaw,0
8441,Congenital qualifier,Cleft palate with cleft lip,0
8442,Congenital qualifier,Bilateral complete and incomplete cleft lip,0
8443,Congenital qualifier,Cleft Palate,0
8444,Congenital qualifier,Bilateral incomplete cleft lip and alveolus,0
8445,Congenital qualifier,bilateral complete cleft lip or alveolus,0
8446,Congenital qualifier,"Cleft hard palate, central",0
8447,Congenital qualifier,"Cleft hard palate, bilateral",0
8448,Congenital qualifier,Incomplete cleft hard and soft palate,0
8449,Congenital qualifier,Complete cleft hard and soft palate,0
8450,Congenital qualifier,Cleft Soft Palate,0
8451,Congenital qualifier,"Cleft soft palate, bilateral",0
8452,Congenital qualifier,Complete cleft of soft palate,0
8453,Congenital qualifier,Incomplete cleft of soft palate,0
8454,Congenital qualifier,Occult submucous cleft palate,0
8455,Congenital qualifier,Midline facial cleft - Tessier cleft 0,0
8456,Congenital qualifier,Midline facial cleft - Tessier cleft 14,0
8457,Congenital qualifier,Midline facial cleft - Tessier cleft 30,0
8458,Congenital qualifier,Paramedian facial cleft - Tessier cleft 1,0
8459,Congenital qualifier,Paramedian facial cleft - Tessier cleft 2,0
8460,Congenital qualifier,Paramedian facial cleft - Tessier cleft 3,0
8461,Congenital qualifier,Supraorbital facial cleft - Tessier cleft 8,0
8462,Congenital qualifier,Supraorbital facial cleft - Tessier cleft 9,0
8463,Congenital qualifier,Tessier cleft 10 of facial cleft,0
8464,Congenital qualifier,Tessier cleft 11 of facial cleft,0
8465,Congenital qualifier,Tessier cleft 12 of facial cleft,0
8466,Congenital qualifier,Supraorbital facial cleft - Tessier cleft 13,0
8467,Congenital qualifier,Infraorbital facial cleft - Tessier cleft 4,0
8468,Congenital qualifier,Infraorbital facial cleft - Tessier cleft 5,0
8469,Congenital qualifier,Infraorbital facial cleft - Tessier cleft 6,0
8470,Congenital qualifier,Infraorbital facial cleft - Tessier cleft 7,0
8471,Congenital qualifier,Unicoronal craniosynostosis,0
8472,Congenital qualifier,Bicoronal craniosynostosis,0
8473,Congenital qualifier,Kleeblattschaedel syndrome,0
8474,Congenital qualifier,Congenital abnormality of skull shape,0
8475,Congenital qualifier,Hemifacial microsomia,0
8476,Congenital qualifier,Goldenhar Syndrome,0
8477,Congenital qualifier,Bilateral craniofacial microsomia,0
8478,Congenital qualifier,Congenital postural curvature of spine,0
8479,Congenital qualifier,Congenital deformity of lumbosacral region,0
8480,Congenital qualifier,Congenital deformity of lumbosacral joint,0
8481,Congenital qualifier,Congenital absence of spine,0
8482,Congenital qualifier,Congenital lumbosacral fusion,0
8483,Congenital qualifier,Congenital sacrococcygeal anomaly,0
8484,Congenital qualifier,Congenital malformation of sternum,0
8485,Congenital qualifier,Defects of the tubular (and flat) bones and/or axial skeleton,0
8486,Congenital qualifier,Hereditary Multiple Exostoses,0
8487,Congenital qualifier,Spondylodysplasia,0
8488,Congenital qualifier,"Spondylodysplasia, San Diego type",0
8489,Congenital qualifier,"Spondylodysplasia, Torrance type",0
8490,Congenital qualifier,"Spondylodysplasia, Luton type",0
8491,Congenital qualifier,Schneckenbecken dysplasia,0
8492,Congenital qualifier,Short rib dysplasia,0
8493,Congenital qualifier,"Short rib-polydactyly syndrome, Verma-Naumoff type",0
8494,Congenital qualifier,"Short rib-polydactyly syndrome, Beemer type",0
8495,Congenital qualifier,Atelosteogenesis/diastrophic dysplasia,0
8496,Congenital qualifier,Boomerang dysplasia,0
8497,Congenital qualifier,Atelosteogenesis type 2,0
8498,Congenital qualifier,Omodysplasia I,0
8499,Congenital qualifier,Omodysplasia II,0
8500,Congenital qualifier,Pseudodiastrophic dysplasia,0
8501,Congenital qualifier,Kniest-Stickler dysplasia,0
8502,Congenital qualifier,Otospondylomegaepiphyseal dysplasia,0
8503,Congenital qualifier,Achondrogenesis type 2,0
8504,Congenital qualifier,Spondyloepimetaphyseal disorder,0
8505,Congenital qualifier,"Spondyloepimetaphyseal Dysplasia, Irapa Type",0
8506,Congenital qualifier,Namaqualand hip dysplasia,0
8507,Congenital qualifier,Progressive pseudorheumatoid dysplasia,0
8508,Congenital qualifier,Wolcott-Rallison syndrome,0
8509,Congenital qualifier,Immuno-osseous dysplasia,0
8510,Congenital qualifier,Opsismodysplasia,0
8511,Congenital qualifier,Pfaundler-Hurler Syndrome,0
8512,Congenital qualifier,"Spondylometaphyseal dysplasia, 'corner fracture' type",0
8513,Congenital qualifier,Spondyloenchondrodysplasia,0
8514,Congenital qualifier,Epiphyseal dysplasia,0
8515,Congenital qualifier,"Chondrodysplasia punctata, X-linked recessive type",0
8516,Congenital qualifier,"Chondrodysplasia Punctata, Tibia-Metacarpal Type",0
8517,Congenital qualifier,Metaphyseal chondrodysplasia Spahr type,0
8518,Congenital qualifier,Metaphyseal anadysplasia,0
8519,Congenital qualifier,Brachyolmia Type 3,0
8520,Congenital qualifier,Brachyolmia,0
8521,Congenital qualifier,Ostrum-Furst,0
8522,Congenital qualifier,Acromicric Dysplasia,0
8523,Congenital qualifier,Trichorhinophalangeal dysplasia type I,0
8524,Congenital qualifier,Mainzer-Saldino Disease,0
8525,Congenital qualifier,Cranioectodermal dysplasia,0
8526,Congenital qualifier,Dysplasias with significant membranous bone involvement,0
8527,Congenital qualifier,Bent bone dysplasia,0
8528,Congenital qualifier,Kyphomelic dysplasia,0
8529,Congenital qualifier,Stuve-Wiedemann dysplasia,0
8530,Congenital qualifier,Multiple dislocations with dysplasia,0
8531,Congenital qualifier,Desbuquois syndrome,0
8532,Congenital qualifier,Spondyloepimetaphyseal Dysplasia With Joint Laxity,0
8533,Congenital qualifier,Osteodysplastic primordial dwarfism,0
8534,Congenital qualifier,"MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I",0
8535,Congenital qualifier,"Microcephalic Osteodysplastic Primordial Dwarfism, Type II",0
8536,Congenital qualifier,Dysplasia with decreased bone density,0
8537,Congenital qualifier,"Osteogenesis imperfecta, dominant perinatal lethal",0
8538,Congenital qualifier,"Osteogenesis imperfecta, type 2B",0
8539,Congenital qualifier,Osteoporosis with pseudoglioma,0
8540,Congenital qualifier,Bruck syndrome,0
8541,Congenital qualifier,Singleton Merten syndrome,0
8542,Congenital qualifier,Geroderma osteodysplastica,0
8543,Congenital qualifier,Dysplasia with defective mineralization,0
8544,Congenital qualifier,Dysplasia with increased bone density,0
8545,Congenital qualifier,Osteopetrosis - intermediate type,0
8546,Congenital qualifier,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3",0
8547,Congenital qualifier,Dysosteosclerosis,0
8548,Congenital qualifier,Craniofacial Dysostosis with Diaphyseal Hyperplasia,0
8549,Congenital qualifier,Axial osteosclerosis,0
8550,Congenital qualifier,Osteomesopycnosis,0
8551,Congenital qualifier,Osteopathia striata cranial sclerosis,0
8552,Congenital qualifier,Endosteal hyperostoses,0
8553,Congenital qualifier,Worth disease,0
8554,Congenital qualifier,Endosteal hyperostoses with cerebellar hypoplasia,0
8555,Congenital qualifier,Pachydermoperiostosis - familial,0
8556,Congenital qualifier,Craniometaphyseal dysplasia - severe type,0
8557,Congenital qualifier,Craniometaphyseal dysplasia - mild type,0
8558,Congenital qualifier,Oculodento-osseous dysplasia,0
8559,Congenital qualifier,Oculodento-osseous dysplasia - severe type,0
8560,Congenital qualifier,Oculodento-osseous dysplasia - mild type,0
8561,Congenital qualifier,Disorganized development of cartilaginous and fibrous components of the skeleton,0
8562,Congenital qualifier,Pseudochondroplasia,0
8563,Congenital qualifier,Osteoglophonic dwarfism,0
8564,Congenital qualifier,Fibrous Dysplasia,0
8565,Congenital qualifier,Infantile myofibromatosis,0
8566,Congenital qualifier,Idiopathic osteolyses,0
8567,Congenital qualifier,Hereditary acroosteolysis,0
8568,Congenital qualifier,Carpal-tarsal osteolysis with nephropathy,0
8569,Congenital qualifier,Winchester syndrome (disorder),0
8570,Congenital qualifier,Torg type osteolysis,0
8571,Congenital qualifier,Familial expansile osteolysis,0
8572,Congenital qualifier,Ectodermal Dysplasia,0
8573,Congenital qualifier,"Ichthyosiform Erythroderma, Congenital",0
8574,Congenital qualifier,Ichthyosis Vulgaris,0
8575,Congenital qualifier,Autosomal dominant ichthyosis vulgaris,0
8576,Congenital qualifier,Severe ichthyoses,0
8577,Congenital qualifier,Erythrodermic lamellar ichthyosis,0
8578,Congenital qualifier,Non-erythrodermic lamellar ichthyosis,0
8579,Congenital qualifier,"Lamellar ichthyosis, autosomal dominant form",0
8580,Congenital qualifier,Non-bullous ichthyosiform erythroderma,0
8581,Congenital qualifier,Bullous ichthyosis,0
8582,Congenital qualifier,"Hyperkeratosis, Epidermolytic",0
8583,Congenital qualifier,Localized bullous ichthyosiform erythroderma,0
8584,Congenital qualifier,Ichthyosis Bullosa of Siemens,0
8585,Congenital qualifier,Ichthyosis hystrix of Curth-Macklin,0
8586,Congenital qualifier,Maleformatio ectodermalis generalisata of Bafverstedt,0
8587,Congenital qualifier,Ichthyosis hystrix gravior of Rheydt,0
8588,Congenital qualifier,Hystrix ichthyosis with deafness,0
8589,Congenital qualifier,Ichthyosis hystrix gravior,0
8590,Congenital qualifier,Progressive recessive dystrophic epidermolysis bullosa,0
8591,Congenital qualifier,Epidermolysis bullosa simplex with hypodontia,0
8592,Congenital qualifier,Epidermolysis bullosa simplex herpetiformis,0
8593,Congenital qualifier,Epidermolysis bullosa simplex with mottled pigmentation,0
8594,Congenital qualifier,Primordial cyst,0
8595,Congenital qualifier,Epidermolysis simplex superficialis,0
8596,Congenital qualifier,Epidermolysis bullosa simplex with neuromuscular disease,0
8597,Congenital qualifier,Lethal autosomal recessive epidermolysis bullosa simplex,0
8598,Congenital qualifier,Epidermolysis Bullosa Dystrophica,0
8599,Congenital qualifier,Localized dystrophic epidermolysis bullosa,0
8600,Congenital qualifier,Localized recessive dystrophic epidermolysis bullosa,0
8601,Congenital qualifier,Generalized dystrophic epidermolysis bullosa,0
8602,Congenital qualifier,Generalized recessive dystrophic epidermolysis bullosa mitis,0
8603,Congenital qualifier,Localized junctional epidermolysis bullosa,0
8604,Congenital qualifier,Inverse junctional epidermolysis bullosa,0
8605,Congenital qualifier,Progressive junctional epidermolysis bullosa (neurotrophic),0
8606,Congenital qualifier,Generalized junctional epidermolysis bullosa,0
8607,Congenital qualifier,Junctional epidermolysis bullosa mitis,0
8608,Congenital qualifier,Cicatricial junctional epidermolysis bullosa,0
8609,Congenital qualifier,Strawberry nevus of skin,0
8610,Congenital qualifier,Reticulate vascular nevus,0
8611,Congenital qualifier,Vascular hamartoma of skin,0
8612,Congenital qualifier,Mixed hemangioma,0
8613,Congenital qualifier,Port-Wine Stain,0
8614,Congenital qualifier,Inherited disorder of keratinization,0
8615,Congenital qualifier,Erythrokeratoderma,0
8616,Congenital qualifier,Hereditary erythrokeratolysis,0
8617,Congenital qualifier,Hereditary acantholytic dermatosis,0
8618,Congenital qualifier,Hereditary follicular keratoses,0
8619,Congenital qualifier,"Comedones, Familial Dyskeratotic",0
8620,Congenital qualifier,Inherited cutis laxa,0
8621,Congenital qualifier,Cutis Laxa-Marfanoid Syndrome,0
8622,Congenital qualifier,"Cutis laxa, recessive, type I",0
8623,Congenital qualifier,"Cutis laxa, recessive, type II",0
8624,Congenital qualifier,Congenital alopecia with keratin cysts,0
8625,Congenital qualifier,Hypotrichosis with keratosis pilaris and lentiginosis,0
8626,Congenital qualifier,congenital morphological disturbances of hair,0
8627,Congenital qualifier,Uncombable hair syndrome,0
8628,Congenital qualifier,"Woolly hair, congenital",0
8629,Congenital qualifier,Congenital ringed hair,0
8630,Congenital qualifier,Marie Unna syndrome,0
8631,Congenital qualifier,Congenital enlarged nails,0
8632,Congenital qualifier,Focal facial dermal dysplasia,0
8633,Congenital qualifier,Congenital retraction of nipple,0
8634,Congenital qualifier,Neurofibromatosis 3,0
8635,Congenital qualifier,Neurofibromatosis type 5,0
8636,Congenital qualifier,"Ash leaf spot, tuberous sclerosis",0
8637,Congenital qualifier,congenital malformation syndromes due to known exogenous causes,0
8638,Congenital qualifier,Congenital malformation due to cytotoxic agents,0
8639,Congenital qualifier,Fetal benzodiazepine syndrome,0
8640,Congenital qualifier,Fetal captopril/enalapril syndrome,0
8641,Congenital qualifier,Fetal carbamazepine syndrome,0
8642,Congenital qualifier,Fetal cocaine syndrome,0
8643,Congenital qualifier,"Autosomal recessive glutaric aciduria, type 2",0
8644,Congenital qualifier,Fetal minoxidil syndrome,0
8645,Congenital qualifier,Fetal misoprostol syndrome,0
8646,Congenital qualifier,Fetal primidone syndrome,0
8647,Congenital qualifier,Fetal toluene syndrome,0
8648,Congenital qualifier,Congenital malformation of anterior pituitary,0
8649,Congenital qualifier,Congenital malformation of posterior pituitary,0
8650,Congenital qualifier,Synchephalus twins,0
8651,Congenital qualifier,Pseudotrisomy 18,0
8652,Congenital qualifier,"Down Syndrome, Partial Trisomy 21",0
8653,Congenital qualifier,Partial trisomy 18 in Edward's syndrome,0
8654,Congenital qualifier,Partial trisomy 13 in Patau's syndrome,0
8655,Congenital qualifier,Whole chromosome trisomy meiotic nondisjunction,0
8656,Congenital qualifier,Whole chromosome trisomy - mitotic nondisjunction mosaicism,0
8657,Congenital qualifier,Triploidy and polyploidy,0
8658,Congenital qualifier,Autosomal deletion - mosaicism,0
8659,Congenital qualifier,Deletion of part of autosome,0
8660,Congenital qualifier,Sex chromosome abnormality - female phenotype,0
8661,Congenital qualifier,"Turner's phenotype, partial X deletion karyotype",0
8662,Congenital qualifier,Turner's phenotype - ring chromosome karyotype,0
8663,Congenital qualifier,Female with more than three X chromosomes,0
8664,Congenital qualifier,Mosaicism - lines with various numbers of X chromosomes,0
8665,Congenital qualifier,Sex chromosome abnormality - male phenotype,0
8666,Congenital qualifier,Male with structurally abnormal sex chromosome,0
8667,Congenital qualifier,Male with sex chromosome mosaicism,0
8668,Congenital qualifier,FRAXA Syndrome,0
8669,Congenital qualifier,FRAXE Syndrome,0
8670,Congenital qualifier,Malignant melanoma arising in congenital nevus,0
8671,Congenital qualifier,Cobb's syndrome,0
8672,Congenital qualifier,Bregeat's syndrome,0
8673,Congenital qualifier,Cutis marmorata telangiectatica congenita,0
8674,Congenital qualifier,Arteriovenous malformation of skin,0
8675,Congenital qualifier,Blue rubber bleb nevus syndrome,0
8676,Congenital qualifier,Verrucous hemangioma of skin,0
8677,Congenital qualifier,Cavernous lymphangioma of skin,0
8678,Congenital qualifier,GIANT PIGMENTED HAIRY NEVUS,0
8679,Congenital qualifier,Nevus of Ota,0
8680,Congenital qualifier,Lymphangioma,0
8681,Congenital qualifier,Congenital absence of left pulmonary artery,0
8682,Congenital qualifier,Syndactyly of fingers with fusion of bones,0
8683,Congenital qualifier,Ehlers-Danlos syndrome type 6,0
8684,Congenital qualifier,Congenital duodenal obstruction due to malrotation of intestine,0
8685,Congenital qualifier,Congenital fissure of sternum,0
8686,Congenital qualifier,Kearns-Sayre syndrome,0
8687,Congenital qualifier,Congenital atresia of ileum,0
8688,Congenital qualifier,Congenital secretory diarrhea,0
8689,Congenital qualifier,Dubowitz syndrome,0
8690,Congenital qualifier,Congenital absence of rectum,0
8691,Congenital qualifier,"Maroteaux-Lamy syndrome, intermediate form",0
8692,Congenital qualifier,Congenital absence of external auditory canal,0
8693,Congenital qualifier,Microcornea,0
8694,Congenital qualifier,5-oxoprolinase deficiency,0
8695,Congenital qualifier,Band of Ladd,0
8696,Congenital qualifier,Transposition of Great Vessels,0
8697,Congenital qualifier,Spinal arteriovenous malformation,0
8698,Congenital qualifier,Ectopic bone tissue congenital,0
8699,Congenital qualifier,Esophageal Atresia,0
8700,Congenital qualifier,Frog fetus,0
8701,Congenital qualifier,Aortic left ventricular tunnel,0
8702,Congenital qualifier,Vitellointestinal band,0
8703,Congenital qualifier,Senter syndrome,0
8704,Congenital qualifier,"Chronic granulomatous disease, type IIA",0
8705,Congenital qualifier,Uterus incudiformis,0
8706,Congenital qualifier,Congenital obstruction of small intestine,0
8707,Congenital qualifier,Oculocutaneous albinism type 2,0
8708,Congenital qualifier,Ectopic placenta,0
8709,Congenital qualifier,Anterolateral muscle band,0
8710,Congenital qualifier,Bilateral atria,0
8711,Congenital qualifier,Bilateral isomeric atria,0
8712,Congenital qualifier,"Albinism, Ocular",0
8713,Congenital qualifier,Epoophoron (disorder),0
8714,Congenital qualifier,Congenital tracheocele,0
8715,Congenital qualifier,Malaligned outlet septum,0
8716,Congenital qualifier,"Congenital dyserythropoietic anemia, type III",0
8717,Congenital qualifier,Posteromedial muscle band,0
8718,Congenital qualifier,Simonart's band,0
8719,Congenital qualifier,Agyria,0
8720,Congenital qualifier,Persistent vertical vein,0
8721,Congenital qualifier,Cat eye syndrome,0
8722,Congenital qualifier,False tendon - heart,0
8723,Congenital qualifier,Persistent Gartner's duct,0
8724,Congenital qualifier,Mullerian remnant,0
8725,Congenital qualifier,Septoparietal trabeculations,0
8726,Congenital qualifier,11p partial trisomy syndrome,0
8727,Congenital qualifier,Upper moiety ureter of duplex kidney,0
8728,Congenital qualifier,Lower moiety ureter of duplex kidney,0
8729,Congenital qualifier,Aland eye disease and ocular albinism,0
8730,Congenital qualifier,Faun tail syndrome,0
8731,Congenital qualifier,Congenital absence of lower limb,0
8732,Congenital qualifier,Congenital ectropion,0
8733,Congenital qualifier,Syringobulbia,0
8734,Congenital qualifier,Congenital absence of part of brain,0
8735,Congenital qualifier,Early congenital syphilis with symptoms,0
8736,Congenital qualifier,Late congenital syphilis (2 years OR more),0
8737,Congenital qualifier,Developmental absence of tooth,0
8738,Congenital qualifier,Ectopic neuronal tissue (disorder),0
8739,Congenital qualifier,Robinson nail dystrophy-deafness syndrome,0
8740,Congenital qualifier,"Congenital cardiovascular disorders during pregnancy, childbirth and the puerperium",0
8741,Congenital qualifier,"Congenital abnormality of uterus in pregnancy, childbirth or the puerperium",0
8742,Congenital qualifier,Congenital abnormality of uterus affecting obstetric care,0
8743,Congenital qualifier,Congenital abnormality of uterus - baby delivered,0
8744,Congenital qualifier,Congenital abnormality of uterus - baby delivered with postpartum complication,0
8745,Congenital qualifier,"Congenital abnormality of uterus complicating antenatal care, baby not yet delivered",0
8746,Congenital qualifier,Congenital abnormality of uterus complicating postpartum care - baby delivered during previous episode of care,0
8747,Congenital qualifier,Fetus with central nervous system malformation,0
8748,Congenital qualifier,Fetus with chromosomal abnormality,0
8749,Congenital qualifier,Fetus with viral damage via mother,0
8750,Congenital qualifier,Persistent thyroglossal duct,0
8751,Congenital qualifier,Congenital Nonbullous Ichthyosiform Erythroderma,0
8752,Congenital qualifier,Glycogen storage disease type II,0
8753,Congenital qualifier,Hurler-Scheie Syndrome,0
8754,Congenital qualifier,Acatalasia,0
8755,Congenital qualifier,Congenital thrombocytopenic purpura,0
8756,Congenital qualifier,Congenital Methemoglobinemia,0
8757,Congenital qualifier,Rieger eye malformation sequence,0
8758,Congenital qualifier,Coarctation of pulmonary artery,0
8759,Congenital qualifier,Spina bifida with hydrocephalus - open,0
8760,Congenital qualifier,Spina bifida without hydrocephalus - open,0
8761,Congenital qualifier,Congenital keratoglobus,0
8762,Congenital qualifier,Congenital cataract and lens anomalies,0
8763,Congenital qualifier,Congenital corneal opacity,0
8764,Congenital qualifier,Specified congenital anomalies of optic disc,0
8765,Congenital qualifier,Congenital ptosis,0
8766,Congenital qualifier,Ear auricle and external auditory canal absent,0
8767,Congenital qualifier,Misplaced ear,0
8768,Congenital qualifier,Branchial cleft sinus and fistula (disorder),0
8769,Congenital qualifier,Bulbus cordis and cardiac septal closure anomalies,0
8770,Congenital qualifier,Right hypoplastic heart syndrome,0
8771,Congenital qualifier,Hypoplasia of aorta,0
8772,Congenital qualifier,Congenital pulmonary artery aneurysm,0
8773,Congenital qualifier,Congenital peripheral aneurysm,0
8774,Congenital qualifier,Congenital bronchogenic cyst,0
8775,Congenital qualifier,Ectopic tissue in lung,0
8776,Congenital qualifier,Central incomplete cleft palate,0
8777,Congenital qualifier,"Esophageal atresia, stenosis and fistula",0
8778,Congenital qualifier,"Atresia and stenosis of large intestine, rectum and anal canal (disorder)",0
8779,Congenital qualifier,Hirschsprung's disease and allied congenital conditions,0
8780,Congenital qualifier,Idiopathic congenital megacolon (disorder),0
8781,Congenital qualifier,Embryonic cyst of fallopian tube and broad ligament,0
8782,Congenital qualifier,Congenital fusion of labia,0
8783,Congenital qualifier,Bilateral Cryptorchidism,0
8784,Congenital qualifier,Indeterminate sex and pseudohermaphroditism,0
8785,Congenital qualifier,Bilateral renal hypoplasia,0
8786,Congenital qualifier,Fibrocystic kidney disease,0
8787,Congenital qualifier,Congenital bladder neck stenosis,0
8788,Congenital qualifier,Congenital urethral valvular stricture,0
8789,Congenital qualifier,Certain congenital musculoskeletal deformities,0
8790,Congenital qualifier,Congenital abnormality of skull and face bones,0
8791,Congenital qualifier,Congenital torticollis,0
8792,Congenital qualifier,Genu recurvatum and long leg bone bowing,0
8793,Congenital qualifier,Harlequin Fetus,0
8794,Congenital qualifier,Cutis marmorata,0
8795,Congenital qualifier,Syndactyly of fingers,0
8796,Congenital qualifier,Acrocephalosyndactylia,0
8797,Congenital qualifier,Constriction ring syndrome of upper limb,0
8798,Congenital qualifier,Constriction ring of upper limb with lymphedema,0
8799,Congenital qualifier,Congenital anomalies of elbow and upper arm,0
8800,Congenital qualifier,Enchondromatosis,0
8801,Congenital qualifier,Congenital exostosis,0
8802,Congenital qualifier,"Ichthyosiform Erythroderma, Congenital",0
8803,Congenital qualifier,Congenital generalized alopecia,0
8804,Congenital qualifier,Hypoplasia of nipple,0
8805,Congenital qualifier,Chromosome replaced with ring or dicentric,0
8806,Congenital qualifier,Klinefelter's syndrome - male with more than two X chromosomes,0
8807,Congenital qualifier,Aberrant Thyroid Gland Disorder,0
8808,Congenital qualifier,Absence of superior vena cava,0
8809,Congenital qualifier,Fetal or neonatal effect of placental or breast transfer of alcohol,0
8810,Congenital qualifier,Cervical auricle (disorder),0
8811,Congenital qualifier,Congenital renal failure,0
8812,Congenital qualifier,Epidermolysis Bullosa With Congenital Localized Absence Of Skin And Deformity Of Nails,0
8813,Congenital qualifier,Anterior crossbite,0
8814,Congenital qualifier,"Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive",0
8815,Congenital qualifier,Anomalous communication of coronary artery,0
8816,Congenital qualifier,Central complete cleft palate,0
8817,Congenital qualifier,Congenital macroglossia,0
8818,Congenital qualifier,Triple kidney with triple pelvis,0
8819,Congenital qualifier,Agenesis of carpals and metacarpals,0
8820,Congenital qualifier,Localized congenital skull defect,0
8821,Congenital qualifier,Whole chromosome monosomy - mitotic nondisjunction mosaicism,0
8822,Congenital qualifier,Trisomy and partial trisomy of autosome,0
8823,Congenital qualifier,Deletion of long arm of chromosome 18,0
8824,Congenital qualifier,Chromosome 18p deletion syndrome,0
8825,Congenital qualifier,Congenital absence of thumb,0
8826,Congenital qualifier,Congenital instability of hip joint,0
8827,Congenital qualifier,Congenital absence of tendon,0
8828,Congenital qualifier,Congenital absence of breast with absent nipple,0
8829,Congenital qualifier,Congenital enlarged kidney,0
8830,Congenital qualifier,Congenital stenosis of nasolacrimal duct,0
8831,Congenital qualifier,Congenital renal artery stenosis,0
8832,Congenital qualifier,Congenital amputation of upper limb,0
8833,Congenital qualifier,Aberrant intrinsic muscles of hand,0
8834,Congenital qualifier,Congenital abnormality of thoracic aorta and pulmonary arteries,0
8835,Congenital qualifier,Congenital partial fusion of spine,0
8836,Congenital qualifier,Tarsal Coalition,0
8837,Congenital qualifier,Anomaly of chromosome pair 14,0
8838,Congenital qualifier,Congenital malformation of ovaries and fallopian tubes,0
8839,Congenital qualifier,Congenital absence of pectoral muscle,0
8840,Congenital qualifier,Byzanthine arch palate,0
8841,Congenital qualifier,Gouty tophus of heart,0
8842,Congenital qualifier,Congenital maxillary hypoplasia,0
8843,Congenital qualifier,Saldino-Noonan Syndrome,0
8844,Congenital qualifier,Congenital macrocheilia,0
8845,Congenital qualifier,Absent testicle (congenital),0
8846,Congenital qualifier,Generalized glycogen storage disease of infants,0
8847,Congenital qualifier,Congenital deformity of hip joint,0
8848,Congenital qualifier,Deletion with complex rearrangement,0
8849,Congenital qualifier,Divided right atrium,0
8850,Congenital qualifier,Gilbert Disease (disorder),0
8851,Congenital qualifier,Congenital ear anomaly NOS (disorder),0
8852,Congenital qualifier,Congenital abnormality of respiratory system,0
8853,Congenital qualifier,Congenital malformation of upper alimentary tract,0
8854,Congenital qualifier,Klinefelter's syndrome XXXY,0
8855,Congenital qualifier,Klinefelter's syndrome XXXXY,0
8856,Congenital qualifier,Adactyly,0
8857,Congenital qualifier,Congenital syphilitic chronic coryza,0
8858,Congenital qualifier,Double kidney with double pelvis,0
8859,Congenital qualifier,Congenital bilateral aplasia of vas deferens,0
8860,Congenital qualifier,Congenital atresia of uterus,0
8861,Congenital qualifier,Unclassified metabolic disorder,0
8862,Congenital qualifier,Congenital Cerebral Palsy,0
8863,Congenital qualifier,Congenital spastic cerebral palsy,0
8864,Congenital qualifier,"Cerebral Palsy, Quadriplegic, Infantile",0
8865,Congenital qualifier,Diplegic Infantile Cerebral Palsy,0
8866,Congenital qualifier,Peripheral arteriovenous malformation,0
8867,Congenital qualifier,Hyperlipoproteinemia Type I,0
8868,Congenital qualifier,Dextrocardia,0
8869,Congenital qualifier,"Dysmorphic sialidosis, congenital form",0
8870,Congenital qualifier,Congenital clubnail,0
8871,Congenital qualifier,Congenital syphilitic periostitis,0
8872,Congenital qualifier,Transient tricuspid regurgitation of newborn,0
8873,Congenital qualifier,Neonatal chloridorrhea,0
8874,Congenital qualifier,Physiological anemia of infancy,0
8875,Congenital qualifier,Late anemia of newborn,0
8876,Congenital qualifier,Congenital nephritis,0
8877,Congenital qualifier,Congenital uremia,0
8878,Congenital qualifier,Congenital Abnormality,0
8879,Congenital qualifier,Congenital Abnormality,0
8880,Congenital qualifier,Fetal postural deformity,0
8881,Congenital qualifier,Congenital viral disease,0
8882,Congenital qualifier,Congenital human parvovirus infection,0
8883,Congenital qualifier,Congenital coxsackie infection,0
8884,Congenital qualifier,Congenital acquired immune deficiency syndrome,0
8885,Congenital qualifier,Congenital human immunodeficiency virus positive status syndrome,0
8886,Congenital qualifier,congenital non-A non-B hepatitis,0
8887,Congenital qualifier,Congenital non-bacterial non-viral infection,0
8888,Congenital qualifier,Congenital falciparum malaria,0
8889,Congenital qualifier,Congenital candidiasis,0
8890,Congenital qualifier,Congenital viral pneumonia,0
8891,Congenital qualifier,Congenital bacterial pneumonia,0
8892,Congenital qualifier,Congenital syphilitic rhinitis,0
8893,Congenital qualifier,Dysmorphism,0
8894,Congenital qualifier,Intrahepatic biliary hypoplasia,0
8895,Congenital qualifier,Embryological remnant,0
8896,Congenital qualifier,Congenital hyperplasia of sebaceous glands of lip,0
8897,Congenital qualifier,Maple Syrup Urine Disease,0
8898,Congenital qualifier,Pyloric Atresia,0
8899,Congenital qualifier,Ruptured cerebral arteriovenous malformation,0
8900,Congenital qualifier,Ruptured spinal arteriovenous malformation,0
8901,Congenital qualifier,Dysmorphological structure,0
8902,Congenital qualifier,VATER Association,0
8903,Congenital qualifier,Secondary pulmonary hypoplasia,0
8904,Congenital qualifier,Pulmonary hypoplasia associated with short gestation,0
8905,Congenital qualifier,Vascular loops of inner ear,0
8906,Congenital qualifier,Vascular malformation of inner ear,0
8907,Congenital qualifier,Posterior buccal occlusion of mandibular teeth,0
8908,Congenital qualifier,Congenital Varicella Syndrome,0
8909,Congenital qualifier,Primary pulmonary hypoplasia,0
8910,Congenital qualifier,Congenital deformity of ankle joint,0
8911,Congenital qualifier,Weyers acrofacial dysostosis,0
8912,Congenital qualifier,Trichodental syndrome,0
8913,Congenital qualifier,Laryngoonychocutaneous syndrome,0
8914,Congenital qualifier,Congenital disorder of glycosylation type 1A,0
8915,Congenital qualifier,Congenital disorder of glycosylation type 2A,0
8916,Congenital qualifier,"Congenital Disorder Of Glycosylation, Type I-IIX",0
8917,Congenital qualifier,Atelencephaly,0
8918,Congenital qualifier,Aprosencephaly,0
8919,Congenital qualifier,schprintzen,0
8920,Congenital qualifier,Combined malformation of central nervous system and skeletal muscle,0
8921,Congenital qualifier,Muscle eye brain disease,0
8922,Congenital qualifier,Duplex ureter structure,0
8923,Congenital qualifier,Pyle metaphyseal dysplasia,0
8924,Congenital qualifier,Congenital hypothyroidism with diffuse goiter,0
8925,Congenital qualifier,Congenital non-progressive ataxia,0
8926,Congenital qualifier,Atresia of nasolacrimal duct,0
8927,Congenital qualifier,Congenital hydrocalicosis,0
8928,Congenital qualifier,Transverse deficiency lower limb - knee level,0
8929,Congenital qualifier,Dental midlines coincident and incorrect,0
8930,Congenital qualifier,Spondylodysplastic group,0
8931,Congenital qualifier,Short rib dysplasia group (with or without polydactyly),0
8932,Congenital qualifier,Kniest-Stickler dysplasia group,0
8933,Congenital qualifier,"Spondyloepiphyseal dysplasia, congenita",0
8934,Congenital qualifier,Chondrodysplasia Punctata,0
8935,Congenital qualifier,Bent bone dysplasia group,0
8936,Congenital qualifier,Schwartz-Lelek syndrome,0
8937,Congenital qualifier,Idiopathic Multicentric Osteolyses,0
8938,Congenital qualifier,Pseudohypoparathyroidism and pseudopseudohypoparathyroidism type I,0
8939,Congenital qualifier,Transient mitral regurgitation of newborn,0
8940,Congenital qualifier,Congenital hepatitis C infection,0
8941,Congenital qualifier,Sialic storage disease,0
8942,Congenital qualifier,Congenital abnormality of nipple,0
8943,Congenital qualifier,Dysostosis multiplex group,0
8944,Congenital qualifier,Acromesomelic dysplasia Hunter-Thompson type,0
8945,Congenital qualifier,"Osteogenesis imperfecta, type IV B",0
8946,Congenital qualifier,Congenital glucose-galactose malabsorption,0
8947,Congenital qualifier,Mesenteric Cyst,0
8948,Congenital qualifier,Congenital pulmonary arteriovenous aneurysm,0
8949,Congenital qualifier,Tubule of epoophoron,0
8950,Congenital qualifier,Duct of epoophoron,0
8951,Congenital qualifier,Vesicular appendix of ovary,0
8952,Congenital qualifier,Paroophoron,0
8953,Congenital qualifier,Tubule of paroophoron,0
8954,Congenital qualifier,Venous remnant,0
8955,Congenital qualifier,Persistent descending vein,0
8956,Congenital qualifier,"Osteogenesis imperfecta, type IV A",0
8957,Congenital qualifier,Jackson's membrane,0
8958,Congenital qualifier,Congenital lip pits,0
8959,Congenital qualifier,Intralobar bronchopulmonary sequestration,0
8960,Congenital qualifier,Congenital maxillary hyperplasia,0
8961,Congenital qualifier,Arterial embryological remnant,0
8962,Congenital qualifier,Methylene THF reductase deficiency AND homocystinuria,0
8963,Congenital qualifier,Congenital stricture of common bile duct,0
8964,Congenital qualifier,Vestigial gastrointestinal remnant,0
8965,Congenital qualifier,Gouty tophus of bursa,0
8966,Congenital qualifier,Gouty tophus of tendon,0
8967,Congenital qualifier,Gouty tophus of olecranon bursa,0
8968,Congenital qualifier,Gouty tophus of prepatellar bursa,0
8969,Congenital qualifier,Lumbarized first sacral vertebra,0
8970,Congenital qualifier,Sacralization of fifth lumbar vertebra,0
8971,Congenital qualifier,Crossed ectopia of testis,0
8972,Congenital qualifier,Pentalogy of Cantrell,0
8973,Congenital qualifier,Congenital vascular anomaly of eye,0
8974,Congenital qualifier,"Fructose-1,6-Diphosphatase Deficiency",0
8975,Congenital qualifier,Lymphadenopathy due to congenital toxoplasmosis,0
8976,Congenital qualifier,Congenital hydrocephalus due to toxoplasmosis,0
8977,Congenital qualifier,Congenital arterial aneurysm,0
8978,Congenital qualifier,Congenital abnormality of external ear,0
8979,Congenital qualifier,Congenital abnormality of nose and nasopharynx,0
8980,Congenital qualifier,Inherited arthrogryposis,0
8981,Congenital qualifier,Congenital abnormality of salivary duct,0
8982,Congenital qualifier,Intestinal lipofuscinosis,0
8983,Congenital qualifier,"Crigler Najjar syndrome, type 1",0
8984,Congenital qualifier,Congenital stenosis of nares (disorder),0
8985,Congenital qualifier,Uhl anomaly,0
8986,Congenital qualifier,Intercritical gout,0
8987,Congenital qualifier,Visceral gout,0
8988,Congenital qualifier,Familial generalized lipodystrophy,0
8989,Congenital qualifier,Interval gout,0
8990,Congenital qualifier,Congenital capsular cataract,0
8991,Congenital qualifier,Geleophysic dysplasia,0
8992,Congenital qualifier,Congenital anomaly of coronary artery,0
8993,Congenital qualifier,Manifest-latent nystagmus,0
8994,Congenital qualifier,Pyridoxine dependency syndrome,0
8995,Congenital qualifier,Congenital insufficiency of aortic valve,0
8996,Congenital qualifier,Metaphyseal chondrodysplasia,0
8997,Congenital qualifier,Congenital duplication of colon,0
8998,Congenital qualifier,Amino acid/carbohydrate metabolic disorder,0
8999,Congenital qualifier,Congenital anomaly of nervous system of head/neck,0
9000,Congenital qualifier,Urogenital Abnormalities,0
9001,Congenital qualifier,Congenital lordosis/scoliosis,0
9002,Congenital qualifier,Trigonocephaly,0
9003,Congenital qualifier,Autosomal Recessive Polycystic Kidney Disease,0
9004,Congenital qualifier,Congenital bowing of tibia/fibula/femur,0
9005,Congenital qualifier,Gastric atresia,0
9006,Congenital qualifier,Weill-Marchesani syndrome,0
9007,Congenital qualifier,Craniofacial Dysostosis,0
9008,Congenital qualifier,Anomaly of chromosome pair 10,0
9009,Congenital qualifier,Branchio-Oto-Renal Syndrome,0
9010,Congenital qualifier,Bilobed right lung,0
9011,Congenital qualifier,Venous anomaly of umbilical cord,0
9012,Congenital qualifier,Meckel-Gruber syndrome,0
9013,Congenital qualifier,Congenital absence of small intestine,0
9014,Congenital qualifier,Schwartz-Jampel Syndrome,0
9015,Congenital qualifier,Ectromelia of upper limb,0
9016,Congenital qualifier,Metaphyseal chondrodysplasia Schmid type,0
9017,Congenital qualifier,Chromosome 13q deletion syndrome,0
9018,Congenital qualifier,Congenital Camptodactyly,0
9019,Congenital qualifier,"Chronic granulomatous disease, type I",0
9020,Congenital qualifier,Glycogen Storage Disease Type VI,0
9021,Congenital qualifier,Craniolacunia,0
9022,Congenital qualifier,Ectopic hyperparathyroidism,0
9023,Congenital qualifier,Notomelus,0
9024,Congenital qualifier,Congenital atresia of ejaculatory duct,0
9025,Congenital qualifier,Thanatophoric Dysplasia,0
9026,Congenital qualifier,Abnormal number of cusps,0
9027,Congenital qualifier,8q partial monosomy syndrome,0
9028,Congenital qualifier,Klippel's disease,0
9029,Congenital qualifier,Weber-Cockayne Syndrome,0
9030,Congenital qualifier,Suspected damage to fetus from radiation,0
9031,Congenital qualifier,Polymorphous corneal dystrophy,0
9032,Congenital qualifier,Peg-shaped teeth,0
9033,Congenital qualifier,Longitudinal deficiency of tarsal bone,0
9034,Congenital qualifier,Congenital total cataract,0
9035,Congenital qualifier,Congenital atresia of pharynx,0
9036,Congenital qualifier,Glycogen Storage Disease,0
9037,Congenital qualifier,Congenital adhesions of peritoneum,0
9038,Congenital qualifier,alopecia congenita,0
9039,Congenital qualifier,Combined molybdoflavoprotein enzyme deficiency,0
9040,Congenital qualifier,Darwin's tubercle,0
9041,Congenital qualifier,Congenital urethral valve,0
9042,Congenital qualifier,Duodenal web,0
9043,Congenital qualifier,Macrodactyly of the hand,0
9044,Congenital qualifier,Congenital abnormality of arterial duct,0
9045,Congenital qualifier,Congenital abnormality of vein,0
9046,Congenital qualifier,Disorder of creatine synthesis,0
9047,Congenital qualifier,"Glycogen phosphorylase kinase deficiency, X-linked",0
9048,Congenital qualifier,"Glycogen phosphorylase kinase deficiency, autosomal recessive",0
9049,Congenital qualifier,Cardiac glycogen phosphorylase kinase deficiency,0
9050,Congenital qualifier,Hepatic and muscle glycogen phosphorylase kinase deficiency,0
9051,Congenital qualifier,Glycogen Storage Disease Type VIII,0
9052,Congenital qualifier,Substernal thyroid,0
9053,Congenital qualifier,NADH cytochrome B5 reductase deficiency,0
9054,Congenital qualifier,Congenital insufficiency of mitral valve,0
9055,Congenital qualifier,Anomalous pulmonary venous drainage to coronary sinus,0
9056,Congenital qualifier,Extralobar bronchopulmonary sequestration,0
9057,Congenital qualifier,Myelatelia,0
9058,Congenital qualifier,Congenital malrotation of intestine,0
9059,Congenital qualifier,"Porokeratosis of Mibelli, superficial disseminated type",0
9060,Congenital qualifier,Hydranencephaly,0
9061,Congenital qualifier,Spondyloschisis,0
9062,Congenital qualifier,Congenital dilatation of esophagus,0
9063,Congenital qualifier,Glucose-6-phosphate transport defect,0
9064,Congenital qualifier,Childhood hypophosphatasia (disorder),0
9065,Congenital qualifier,alpha 1-Antitrypsin Deficiency,0
9066,Congenital qualifier,Congenital abnormality of iris and ciliary body,0
9067,Congenital qualifier,Congenital Foot Deformity,0
9068,Congenital qualifier,Congenital rearfoot valgus,0
9069,Congenital qualifier,Congenital forefoot valgus,0
9070,Congenital qualifier,Pygoamorphus,0
9071,Congenital qualifier,Accessory kidney,0
9072,Congenital qualifier,Kundrat's syndrome,0
9073,Congenital qualifier,Progressive congenital rubella encephalomyelitis,0
9074,Congenital qualifier,Hydrocephalus associated with congenital aqueduct stenosis,0
9075,Congenital qualifier,Abnormal number of pulmonary valve cusps,0
9076,Congenital qualifier,Accessory salivary gland or duct,0
9077,Congenital qualifier,Congenital broncho-esophageal fistula without atresia,0
9078,Congenital qualifier,"Congenital absence, atresia and stenosis of large intestine, part unspecified",0
9079,Congenital qualifier,"Congenital macrocolon, not aganglionic",0
9080,Congenital qualifier,Congenital fistula of rectum and anus,0
9081,Congenital qualifier,Embryonic cyst of fallopian tube,0
9082,Congenital qualifier,Congenital extension contracture of the knee,0
9083,Congenital qualifier,Transverse deficiency of hand,0
9084,Congenital qualifier,Transverse arrest metacarpal second to fifth rays,0
9085,Congenital qualifier,Congenital absence of multiple toes,0
9086,Congenital qualifier,Duplication of lower limb,0
9087,Congenital qualifier,"Mosaicism 45, X; 46, XX",0
9088,Congenital qualifier,Hereditary splenic hypoplasia,0
9089,Congenital qualifier,Paratubal cyst arising in mesonephric duct,0
9090,Congenital qualifier,Propionyl-CoA carboxylase deficiency pccA complementation group,0
9091,Congenital qualifier,Propionyl-CoA carboxylase deficiency pccBC complementation group,0
9092,Congenital qualifier,Thyroglossal duct anomaly,0
9093,Congenital qualifier,1q partial monosomy syndrome,0
9094,Congenital qualifier,Bilateral cleft lip,0
9095,Congenital qualifier,Talipes Calcaneovarus,0
9096,Congenital qualifier,"Metaphyseal chondrodysplasia, McKusick type with associated immunodeficiency",0
9097,Congenital qualifier,Dolichocolon (disorder),0
9098,Congenital qualifier,Omocephalus,0
9099,Congenital qualifier,Fanconi Anemia,0
9100,Congenital qualifier,Brachymetatarsia,0
9101,Congenital qualifier,Thoracic spina bifida,0
9102,Congenital qualifier,"Ehlers-Danlos syndrome, type 3 (disorder)",0
9103,Congenital qualifier,Laryngeal cleft type I,0
9104,Congenital qualifier,Laryngeal cleft type II,0
9105,Congenital qualifier,Laryngeal cleft type III,0
9106,Congenital qualifier,Laryngeal cleft type IV,0
9107,Congenital qualifier,Isolated long chain hydroxyacyl-CoA dehydrogenase deficiency,0
9108,Congenital qualifier,Combined long chain hydroxyacyl-CoA dehydrogenase deficiency,0
9109,Congenital qualifier,3-Ketoacyl-CoA triolase deficiency,0
9110,Congenital qualifier,Ruvalcaba Syndrome,0
9111,Congenital qualifier,Congenital athetosis,0
9112,Congenital qualifier,Congenital agenesis of brainstem nuclei,0
9113,Congenital qualifier,Congenital nystagmus with sensory abnormality,0
9114,Congenital qualifier,X-Linked Infantile Nystagmus,0
9115,Congenital qualifier,Holoprosencephaly,0
9116,Congenital qualifier,Congenital ischemic atrophy of central nervous system structure,0
9117,Congenital qualifier,Brachydactyly of hand,0
9118,Congenital qualifier,Synbrachydactyly of hand,0
9119,Congenital qualifier,Brachyphalangia of toe,0
9120,Congenital qualifier,Pericarditis secondary to Mulibrey nanism,0
9121,Congenital qualifier,Total congenital alopecia,0
9122,Congenital qualifier,Aberrant retroesophageal subclavian artery causing dysphagia lusoria,0
9123,Congenital qualifier,Penoscrotal transposition,0
9124,Congenital qualifier,Epignathus,0
9125,Congenital qualifier,Ichthyosis linearis circumflexa,0
9126,Congenital qualifier,Polysomatous monster,0
9127,Congenital qualifier,Alpha-2-antitrypsin deficiency,0
9128,Congenital qualifier,Congenital hydroureter,0
9129,Congenital qualifier,Oculo-dento-digital syndrome,0
9130,Congenital qualifier,Severe Combined Immunodeficiency,0
9131,Congenital qualifier,Ring chromosome 21 syndrome,0
9132,Congenital qualifier,Multiple epiphyseal dysplasia tarda type IIIa,0
9133,Congenital qualifier,Congenital cyst of vulva,0
9134,Congenital qualifier,"Maple Syrup Urine Disease, Thiamine Responsive",0
9135,Congenital qualifier,Bicornuate uterus,0
9136,Congenital qualifier,Persistent Hyperplastic Primary Vitreous,0
9137,Congenital qualifier,Cerebral cortical dysgenesis,0
9138,Congenital qualifier,Congenital myogenic ptosis,0
9139,Congenital qualifier,Congenital exotropia,0
9140,Congenital qualifier,Congenital conduction defect,0
9141,Congenital qualifier,Congenital dysgenetic ptosis,0
9142,Congenital qualifier,Congenital atresia of artery,0
9143,Congenital qualifier,Congenital talipes calcaneovalgus,0
9144,Congenital qualifier,Congenital anomaly of intestinal tract,0
9145,Congenital qualifier,Alagille Syndrome,0
9146,Congenital qualifier,"Corneal fragility keratoglobus, blue sclerae AND joint hypermobility (disorder)",0
9147,Congenital qualifier,Deviation of ureter,0
9148,Congenital qualifier,Hereditary factor I deficiency disease,0
9149,Congenital qualifier,12p partial monosomy syndrome,0
9150,Congenital qualifier,Congenital anomaly of face bones,0
9151,Congenital qualifier,Anomaly of chromosome pair 17,0
9152,Congenital qualifier,Syndactyly of the toes,0
9153,Congenital qualifier,Anomalous pulmonary venous drainage to hepatic veins,0
9154,Congenital qualifier,Craniorachischisis,0
9155,Congenital qualifier,Spina bifida of cervical region,0
9156,Congenital qualifier,Anomaly of chromosome pair 2,0
9157,Congenital qualifier,Longitudinal deficiency of metacarpal bone,0
9158,Congenital qualifier,Congenital anomaly of the thyroid gland,0
9159,Congenital qualifier,Manus extensa,0
9160,Congenital qualifier,Disorder of purine metabolism,0
9161,Congenital qualifier,Microglossia,0
9162,Congenital qualifier,Congenital hypoplasia of kidney,0
9163,Congenital qualifier,Congenital syphilitic encephalitis,0
9164,Congenital qualifier,Congenital anomaly of sclera,0
9165,Congenital qualifier,Congenital skin fragility of animals,0
9166,Congenital qualifier,Rotor Syndrome,0
9167,Congenital qualifier,Gangliosidosis GM1,0
9168,Congenital qualifier,Micrognathism,0
9169,Congenital qualifier,Greig cephalopolysyndactyly syndrome,0
9170,Congenital qualifier,Floppy infant syndrome,0
9171,Congenital qualifier,Hemimelia,0
9172,Congenital qualifier,Anorectal Malformations,0
9173,Congenital qualifier,Microphthalmos associated with other anomalies of eye AND/OR adnexa,0
9174,Congenital qualifier,Congenital duplication of digestive organs,0
9175,Congenital qualifier,Radioulnar Synostosis,0
9176,Congenital qualifier,"Gangliosidoses, GM2",0
9177,Congenital qualifier,Congenital deformity of forehead,0
9178,Congenital qualifier,Marshall syndrome,0
9179,Congenital qualifier,Talipes Calcaneus,0
9180,Congenital qualifier,Congenital anomaly of lens shape,0
9181,Congenital qualifier,Congenital bowing of femur,0
9182,Congenital qualifier,Adult junctional epidermolysis bullosa (disorder),0
9183,Congenital qualifier,7q partial trisomy syndrome,0
9184,Congenital qualifier,"Cleft upper lip, upper jaw AND palate",0
9185,Congenital qualifier,Congenital coxa valga,0
9186,Congenital qualifier,"Cleft upper lip, upper jaw AND palate",0
9187,Congenital qualifier,"Cleft upper lip, upper jaw AND palate",0
9188,Congenital qualifier,Nievergelt syndrome,0
9189,Congenital qualifier,Ectopic parotid gland tissue,0
9190,Congenital qualifier,Syndactyly of fingers,0
9191,Congenital qualifier,Congenital Hand Deformities,0
9192,Congenital qualifier,SCID due to absent peripheral T cell maturation,0
9193,Congenital qualifier,Storage disease,0
9194,Congenital qualifier,Congenital duplication of vagina,0
9195,Congenital qualifier,Dimelia,0
9196,Congenital qualifier,Mandibular retrognathism,0
9197,Congenital qualifier,Zebra body myopathy,0
9198,Congenital qualifier,Infantile Sialic Acid Storage Disease,0
9199,Congenital qualifier,Pelvis justo major,0
9200,Congenital qualifier,Ichthyosis linearis circumflexa,0
9201,Congenital qualifier,Camurati-Engelmann Syndrome,0
9202,Congenital qualifier,MVRCS association,0
9203,Congenital qualifier,Adams Oliver syndrome,0
9204,Congenital qualifier,Congenital absence of bronchus,0
9205,Congenital qualifier,Congenital stenosis of choanae,0
9206,Congenital qualifier,G-6-PD class II variant anemia,0
9207,Congenital qualifier,Congenital hypoplasia of penis,0
9208,Congenital qualifier,Megaloblastic anemia due to inborn errors of metabolism,0
9209,Congenital qualifier,Type I Mucolipidosis,0
9210,Congenital qualifier,Hanhart's syndrome,0
9211,Congenital qualifier,De Vaal's syndrome,0
9212,Congenital qualifier,Congenital small ears,0
9213,Congenital qualifier,"von Willebrand disease, type IID",0
9214,Congenital qualifier,Cervical thymic remnant,0
9215,Congenital qualifier,Trisomy X syndrome,0
9216,Congenital qualifier,Reticular dysgenesis with congenital aleukocytosis,0
9217,Congenital qualifier,Hypoplasia of cementum,0
9218,Congenital qualifier,Congenital duplication of appendix,0
9219,Congenital qualifier,Microphakia,0
9220,Congenital qualifier,Congenital aphakia,0
9221,Congenital qualifier,Aplasia Cutis Congenita,0
9222,Congenital qualifier,Nager syndrome,0
9223,Congenital qualifier,Accessory auricle of ear,0
9224,Congenital qualifier,Accessory trachea,0
9225,Congenital qualifier,Holoacardius acephalus,0
9226,Congenital qualifier,Open Bite,0
9227,Congenital qualifier,Diastema of Teeth,0
9228,Congenital qualifier,Deradelphus,0
9229,Congenital qualifier,Persistent Fetal Circulation Syndrome,0
9230,Congenital qualifier,GALACTOSIALIDOSIS,0
9231,Congenital qualifier,"Syphilis, Congenital",0
9232,Congenital qualifier,Ribose-phosphate pyrophosphokinase overactivity,0
9233,Congenital qualifier,Megaloblastic anemia due to error of folate metabolism,0
9234,Congenital qualifier,Infantile uterus,0
9235,Congenital qualifier,Hyperuricemia,0
9236,Congenital qualifier,Amegakaryocytic thrombocytopenia with congenital malformation,0
9237,Congenital qualifier,Nevus comedonicus,0
9238,Congenital qualifier,Congenital anomaly of nail,0
9239,Congenital qualifier,Neonatal disseminated listeriosis,0
9240,Congenital qualifier,Hereditary von Willebrand disease type IA,0
9241,Congenital qualifier,Hereditary von Willebrand disease type IA,0
9242,Congenital qualifier,Hereditary von Willebrand disease type IA,0
9243,Congenital qualifier,"von Willebrand Disease, Type 2A",0
9244,Congenital qualifier,"von Willebrand Disease, Type 2B",0
9245,Congenital qualifier,"incomplete anencephaly, hemicrania",0
9246,Congenital qualifier,Congenital absence of part of arm,0
9247,Congenital qualifier,Meningocele - cranial,0
9248,Congenital qualifier,Fibrous skin tumor of tuberous sclerosis,0
9249,Congenital qualifier,Thyrotoxicosis due to pituitary thyroid hormone resistance,0
9250,Congenital qualifier,Thyrotoxicosis due to pituitary thyroid hormone resistance,0
9251,Congenital qualifier,Doubling of uterus with doubling of cervix and vagina,0
9252,Congenital qualifier,Dysplastic ovary,0
9253,Congenital qualifier,Dysplastic ovary,0
9254,Congenital qualifier,Congenital epiblepharon-inferior oblique syndrome,0
9255,Congenital qualifier,Swan's syndrome II,0
9256,Congenital qualifier,Aganglionosis of Auerbach's plexus,0
9257,Congenital qualifier,Congenital dilatation of colon,0
9258,Congenital qualifier,"Aganglionosis, Colonic",0
9259,Congenital qualifier,Mesonephric cyst,0
9260,Congenital qualifier,Congenital muscular subaortic stenosis,0
9261,Congenital qualifier,Common atrioventricular canal,0
9262,Congenital qualifier,Jejunal Atresia,0
9263,Congenital qualifier,Malrotation of the intestine type IIID,0
9264,Congenital qualifier,Megaloblastic anemia due to inborn errors of metabolism,0
9265,Congenital qualifier,Henck-Assman disease,0
9266,Congenital qualifier,Chondrodysplasia Punctata,0
9267,Congenital qualifier,Congenital Epulides,0
9268,Congenital qualifier,Congenital complete absence of upper limb,0
9269,Congenital qualifier,Diplomyelia,0
9270,Congenital qualifier,Myeloschisis,0
9271,Congenital qualifier,Wiskott-Aldrich Syndrome,0
9272,Congenital qualifier,Double cardiac valve orifice,0
9273,Congenital qualifier,Deficiency of prolidase,0
9274,Congenital qualifier,Anomalous pulmonary artery,0
9275,Congenital qualifier,Female Kallman's syndrome,0
9276,Congenital qualifier,Sex phenotype-karyotype dissociation syndrome,0
9277,Congenital qualifier,Congenital small renal papilla,0
9278,Congenital qualifier,Congenital small renal papilla,0
9279,Congenital qualifier,Malonic aciduria,0
9280,Congenital qualifier,Congenital absence of pelvis and lower limb,0
9281,Congenital qualifier,Congenital absence of pelvis and lower limb,0
9282,Congenital qualifier,Paravaginal cyst arising in mesonephric duct,0
9283,Congenital qualifier,Congenital arteriovenous fistula of kidney,0
9284,Congenital qualifier,Congenital stenosis of external auditory canal,0
9285,Congenital qualifier,Congenital macrocheilia,0
9286,Congenital qualifier,Abnormal position of cardiac valve,0
9287,Congenital qualifier,Congenital Immunodeficiency Diseases,0
9288,Congenital qualifier,Congenital subluxation of hip,0
9289,Congenital qualifier,Thalidomide embryopathy syndrome,0
9290,Congenital qualifier,Congenital stenosis of tricuspid valve,0
9291,Congenital qualifier,Septate vagina affecting pregnancy,0
9292,Congenital qualifier,Anomaly of chromosome pair,0
9293,Congenital qualifier,Autosomal recessive SCID,0
9294,Congenital qualifier,Branchial Clefts-Congenital disorder,0
9295,Congenital qualifier,Complement component deficiency,0
9296,Congenital qualifier,Congenital anomaly of abdomen,0
9297,Congenital qualifier,Congenital anomaly of back,0
9298,Congenital qualifier,Congenital anomaly of body cavity,0
9299,Congenital qualifier,Congenital anomaly of body wall,0
9300,Congenital qualifier,Congenital anomaly of cardiovascular structure of trunk,0
9301,Congenital qualifier,Congenital anomaly of epidermal appendages,0
9302,Congenital qualifier,Congenital anomaly of lower trunk,0
9303,Congenital qualifier,Congenital anomaly of lymphatic structure of trunk,0
9304,Congenital qualifier,Congenital anomaly of musculoskeletal structure of trunk,0
9305,Congenital qualifier,Congenital anomaly of neural structure of trunk,0
9306,Congenital qualifier,Congenital anomaly of thorax,0
9307,Congenital qualifier,Congenital anomaly of tympanic anulus,0
9308,Congenital qualifier,Congenital anomaly of upper trunk,0
9309,Congenital qualifier,Congenital bacterial disorder,0
9310,Congenital qualifier,Congenital connective tissue disorder,0
9311,Congenital qualifier,Congenital immunodeficiency involving the hematopoietic system,0
9312,Congenital qualifier,Congenital nonspherocytic hemolytic anemia due to inborn error of metabolism,0
9313,Congenital qualifier,Congenital sequelae of disorders,0
9314,Congenital qualifier,Dolichopellic pelvis,0
9315,Congenital qualifier,Parathyromatosis,0
9316,Congenital qualifier,1p partial monosomy syndrome,0
9317,Congenital qualifier,Congenital absence of esophagus,0
9318,Congenital qualifier,Transposition of pulmonary veins,0
9319,Congenital qualifier,Congenital absence of liver,0
9320,Congenital qualifier,Polyostotic fibrous dysplasia,0
9321,Congenital qualifier,Transverse deficiency of leg,0
9322,Congenital qualifier,Lethal glossopharyngeal defect,0
9323,Congenital qualifier,Schwartz-Lelek syndrome,0
9324,Congenital qualifier,16q partial monosomy syndrome,0
9325,Congenital qualifier,Congenital duplication of cystic duct,0
9326,Congenital qualifier,Hepatomphalocele,0
9327,Congenital qualifier,Congenital notching of tip of nose,0
9328,Congenital qualifier,Deficiency of limit dextrinase,0
9329,Congenital qualifier,Weber-Cockayne Syndrome,0
9330,Congenital qualifier,Acrania,0
9331,Congenital qualifier,Goldenhar Syndrome,0
9332,Congenital qualifier,Congenital atresia of nares,0
9333,Congenital qualifier,Infantile malignant osteopetrosis,0
9334,Congenital qualifier,Hirschsprung Disease,0
9335,Congenital qualifier,Polydactyly,0
9336,Congenital qualifier,Bloch Sulzberger syndrome,0
9337,Congenital qualifier,Congenital splenomegaly,0
9338,Congenital qualifier,"Spondyloepiphyseal dysplasia, congenita",0
9339,Congenital qualifier,"Tooth, Supernumerary",0
9340,Congenital qualifier,Displaced ureteric orifice,0
9341,Congenital qualifier,Glutamate-cysteine ligase deficiency,0
9342,Congenital qualifier,Monocephalus tripus dibrachius,0
9343,Congenital qualifier,Isotretinoin embryopathy like syndrome,0
9344,Congenital qualifier,SCID due to absent adenosine deaminase,0
9345,Congenital qualifier,Inherited disorder of thyroid metabolism,0
9346,Congenital qualifier,Transverse deficiency of upper limb,0
9347,Congenital qualifier,Juvenile tabes,0
9348,Congenital qualifier,Congenital arthrogryposis due to teratogen,0
9349,Congenital qualifier,Hepatoportal microvascular dysplasia,0
9350,Congenital qualifier,Transitional vertebra,0
9351,Congenital qualifier,Schistosomus reflexus,0
9352,Congenital qualifier,Mittendorf dot,0
9353,Congenital qualifier,Congenital anomaly of anterior chamber of eye,0
9354,Congenital qualifier,Congenital atresia of colon,0
9355,Congenital qualifier,Congenital anomaly of endocrine ovary,0
9356,Congenital qualifier,Congenital absence of both testes,0
9357,Congenital qualifier,Congenital enlargement of coronary sinus,0
9358,Congenital qualifier,Translocation Down syndrome,0
9359,Congenital qualifier,Congenital syringomyelia,0
9360,Congenital qualifier,Congenital leg length discrepancy,0
9361,Congenital qualifier,Congenital anomaly of endocrine gonad,0
9362,Congenital qualifier,Congenital anomaly of endocrine testis,0
9363,Congenital qualifier,Bilateral acheiria,0
9364,Congenital qualifier,Bilateral congenital absence of feet,0
9365,Congenital qualifier,Congenital absence of foot,0
9366,Congenital qualifier,Congenital absence of hand,0
9367,Congenital qualifier,Cervical malformation - malarticulation,0
9368,Congenital qualifier,Congenital cerebellar cortical atrophy,0
9369,Congenital qualifier,Congenital dislocation of elbow,0
9370,Congenital qualifier,Abnormal number of leaflets,0
9371,Congenital qualifier,Congenital absence of all toes,0
9372,Congenital qualifier,Congenital tuberculosis,0
9373,Congenital qualifier,Cyclops hypognathus,0
9374,Congenital qualifier,Congenital eventration of right crus of diaphragm,0
9375,Congenital qualifier,Syndactyly,0
9376,Congenital qualifier,Congenital bony fusion of phalanges,0
9377,Congenital qualifier,Mule foot deformity,0
9378,Congenital qualifier,Royer Syndrome,0
9379,Congenital qualifier,Congenital obstructive megaureter,0
9380,Congenital qualifier,Congenital pelviureteric junction obstruction,0
9381,Congenital qualifier,Congenital ureterovesical obstruction,0
9382,Congenital qualifier,Congenital urinary meatus obstruction,0
9383,Congenital qualifier,Chiari malformation type II,0
9384,Congenital qualifier,Congenital vesicoureterorenal reflux,0
9385,Congenital qualifier,Cleft lip and alveolus,0
9386,Congenital qualifier,Hypoplasia of optic disc,0
9387,Congenital qualifier,Optic disc structural anomaly,0
9388,Congenital qualifier,Anomaly of chromosome pair 7,0
9389,Congenital qualifier,Meckel Diverticulum,0
9390,Congenital qualifier,"Fetal or suspected fetal spina bifida, with myelomeningocele, affecting management of mother",0
9391,Congenital qualifier,Jervell-Lange Nielsen Syndrome,0
9392,Congenital qualifier,Failure of rotation of colon,0
9393,Congenital qualifier,4q partial monosomy syndrome,0
9394,Congenital qualifier,Malrotation of cecum,0
9395,Congenital qualifier,Anomaly of chromosome pair 12,0
9396,Congenital qualifier,Hypopigmentation-immunodeficiency disease,0
9397,Congenital qualifier,Suspected damage to fetus from maternal drug use,0
9398,Congenital qualifier,Anomalous pulmonary venous drainage to right atrium,0
9399,Congenital qualifier,Glycogen storage disease type X,0
9400,Congenital qualifier,Congenital absence of cervix,0
9401,Congenital qualifier,Holoacardius,0
9402,Congenital qualifier,Deformity of nasal sinus wall,0
9403,Congenital qualifier,Mucopolysaccharidosis IV,0
9404,Congenital qualifier,Enamel pearls,0
9405,Congenital qualifier,Uterine Anomalies,0
9406,Congenital qualifier,Discoid kidney,0
9407,Congenital qualifier,Congenital anomaly of the bladder,0
9408,Congenital qualifier,Accessory ovary,0
9409,Congenital qualifier,Congenital fissure of tongue,0
9410,Congenital qualifier,Rotation of tooth,0
9411,Congenital qualifier,Functional asplenia,0
9412,Congenital qualifier,Hydromyelocele,0
9413,Congenital qualifier,Congenital anomaly of integument (disorder),0
9414,Congenital qualifier,Encephalo-ophthalmic dysplasia,0
9415,Congenital qualifier,Oculo-dento-digital syndrome,0
9416,Congenital qualifier,Congenital anomaly of ovary,0
9417,Congenital qualifier,Warfarin syndrome,0
9418,Congenital qualifier,Congenital porencephaly,0
9419,Congenital qualifier,Poland Syndrome,0
9420,Congenital qualifier,Persistent left posterior cardinal vein,0
9421,Congenital qualifier,Uterus arcuatus,0
9422,Congenital qualifier,Cranial duplication,0
9423,Congenital qualifier,Congenital duplication of intestine,0
9424,Congenital qualifier,Langer Mesomelic Dysplasia Syndrome,0
9425,Congenital qualifier,Lobstein Disease,0
9426,Congenital qualifier,Osteogenesis imperfecta type III (disorder),0
9427,Congenital qualifier,Imperforate vagina,0
9428,Congenital qualifier,Pharyngeal pituitary tissue,0
9429,Congenital qualifier,Mummified Fetus,0
9430,Congenital qualifier,Suspected damage to fetus from viral disease in mother,0
9431,Congenital qualifier,Becker Muscular Dystrophy,0
9432,Congenital qualifier,Chronic granulomatous disease,0
9433,Congenital qualifier,Congenital absence of skeletal muscle,0
9434,Congenital qualifier,Type I Mucolipidosis,0
9435,Congenital qualifier,Turner Syndrome,0
9436,Congenital qualifier,Congenital anomaly of the thymus,0
9437,Congenital qualifier,Congenital fusion of spine,0
9438,Congenital qualifier,"49,XXXXY Syndrome",0
9439,Congenital qualifier,Congenital anomaly of appendix,0
9440,Congenital qualifier,Syndactyly of toes with fusion of bones,0
9441,Congenital qualifier,Congenital fecaliths,0
9442,Congenital qualifier,Klippel-Feil Syndrome,0
9443,Congenital qualifier,"Thanatophoric dysplasia, type 1",0
9444,Congenital qualifier,"Thanatophoric dysplasia, type 2",0
9445,Congenital qualifier,Mild spondyloepiphyseal dysplasia with premature onset arthrosis,0
9446,Congenital qualifier,Spondyloepiphyseal dysplasia with joint laxity,0
9447,Congenital qualifier,"Spondyloepimetaphyseal dysplasia, sponastrime type",0
9448,Congenital qualifier,Acroscyphodysplasia,0
9449,Congenital qualifier,"Metaphyseal chondrodysplasia, Sedaghatian type",0
9450,Congenital qualifier,Brachyolmia - Hobaek type,0
9451,Congenital qualifier,"SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE",0
9452,Congenital qualifier,Trichorhinophalangeal dysplasia type III,0
9453,Congenital qualifier,Hunter-Thompson dysplasia,0
9454,Congenital qualifier,Brachydactyly syndrome type B,0
9455,Congenital qualifier,Brachydactyly syndrome type C,0
9456,Congenital qualifier,Precocious osteodysplasty,0
9457,Congenital qualifier,Yunis-Varon dysplasia,0
9458,Congenital qualifier,Congenital absence of auricle with atresia of auditory canal,0
9459,Congenital qualifier,Osteoplastic dysplasia,0
9460,Congenital qualifier,"Osteodysplastic dysplasia, type I",0
9461,Congenital qualifier,"Osteodysplastic dysplasia, type II",0
9462,Congenital qualifier,SAUL-WILSON SYNDROME,0
9463,Congenital qualifier,Cole-Carpenter dysplasia,0
9464,Congenital qualifier,Mixed sclerosing bone dysplasia,0
9465,Congenital qualifier,Ghosal Hematodiaphyseal Dysplasia,0
9466,Congenital qualifier,Diaphyseal medullary stenosis with bone malignancy,0
9467,Congenital qualifier,Neonatal osteosclerotic dysplasia,0
9468,Congenital qualifier,Blomstrand dysplasia,0
9469,Congenital qualifier,Raine dysplasia,0
9470,Congenital qualifier,Lethal chondrodysplasia with fragmented bone,0
9471,Congenital qualifier,HEM dysplasia,0
9472,Congenital qualifier,Dappled diaphyseal dysplasia,0
9473,Congenital qualifier,Astley-Kendall syndrome,0
9474,Congenital qualifier,Genochondromatosis,0
9475,Congenital qualifier,Spondyloenchondrodysplasia,0
9476,Congenital qualifier,Spondyloenchondromatosis with basal ganglia calcification,0
9477,Congenital qualifier,Carpotarsal osteochondromatosis,0
9478,Congenital qualifier,Cherubism with gingival fibromatosis,0
9479,Congenital qualifier,Whyte Hemingway carpal tarsal phalangeal osteolyses,0
9480,Congenital qualifier,Patella dysplasia,0
9481,Congenital qualifier,Scypho-patellar dysplasia,0
9482,Congenital qualifier,Tricho-dento-osseous syndrome (disorder),0
9483,Congenital qualifier,Brachyphalangia,0
9484,Congenital qualifier,Gluthathione synthetase deficiency,0
9485,Congenital qualifier,Congenital anomaly of spinal meninges,0
9486,Congenital qualifier,Congenital pectus excavatum,0
9487,Congenital qualifier,Posterior embryotoxon,0
9488,Congenital qualifier,Congenital ectopic pupil,0
9489,Congenital qualifier,Fundus coloboma,0
9490,Congenital qualifier,"Niemann-Pick Disease, Type B",0
9491,Congenital qualifier,Dolichocephalic dwarfism,0
9492,Congenital qualifier,Pachyonychia Congenita,0
9493,Congenital qualifier,Suspected fetal damage from intrauterine contraceptive device,0
9494,Congenital qualifier,Thyroglossal Cyst,0
9495,Congenital qualifier,Congenital stricture of rectum,0
9496,Congenital qualifier,Congenital malformation of thumb,0
9497,Congenital qualifier,Congenital atresia of vas deferens,0
9498,Congenital qualifier,Redundant prepuce,0
9499,Congenital qualifier,Congenital depression in skull,0
9500,Congenital qualifier,Monocephalus (disorder),0
9501,Congenital qualifier,Pallister-Killian syndrome,0
9502,Congenital qualifier,Congenital positional talipes,0
9503,Congenital qualifier,Congenital hypoplasia of inner granular layer of cerebellum,0
9504,Congenital qualifier,Hypoplasia of right heart,0
9505,Congenital qualifier,Transposition of intestine (disorder),0
9506,Congenital qualifier,Congenital tracheal collapse,0
9507,Congenital qualifier,Choledochal Cyst,0
9508,Congenital qualifier,Rudiger syndrome 1,0
9509,Congenital qualifier,Congenital pericardial defect,0
9510,Congenital qualifier,Congenital clubfoot,0
9511,Congenital qualifier,"Epidermolysis bullosa simplex, Ogna type",0
9512,Congenital qualifier,Ehlers-Danlos Syndrome,0
9513,Congenital qualifier,Autosomal dominant epidermolysis bullosa simplex,0
9514,Congenital qualifier,Choledochal Cyst,0
9515,Congenital qualifier,Congenital anomaly of face,0
9516,Congenital qualifier,Cutaneous asthenia in dogs AND/OR cats,0
9517,Congenital qualifier,Congenital anomaly of face,0
9518,Congenital qualifier,Talipes,0
9519,Congenital qualifier,Persistent umbilical sinus,0
9520,Congenital qualifier,Congenital melanocytic nevus,0
9521,Congenital qualifier,Congenital tracheal agenesis,0
9522,Congenital qualifier,"Chondrodysplasia punctata, X-linked dominant type",0
9523,Congenital qualifier,Rudimentary nipple,0
9524,Congenital qualifier,Bovine achondroplasia,0
9525,Congenital qualifier,Congenital melanocytic nevus,0
9526,Congenital qualifier,"Chondrodysplasia punctata, X-linked dominant type",0
9527,Congenital qualifier,Fucosidosis Type II,0
9528,Congenital qualifier,L - transposition of the great vessels,0
9529,Congenital qualifier,Scimitar Syndrome,0
9530,Congenital qualifier,"Propionic acidemia, type I",0
9531,Congenital qualifier,"Muscular Dystrophy, Facioscapulohumeral",0
9532,Congenital qualifier,Primary seborrhea,0
9533,Congenital qualifier,"Propionic acidemia, type II",0
9534,Congenital qualifier,D - transposition of the great vessels,0
9535,Congenital qualifier,Tetralogy of Fallot with absent pulmonary valve,0
9536,Congenital qualifier,Adult fucosidosis,0
9537,Congenital qualifier,Disorder of fatty acid metabolism,0
9538,Congenital qualifier,Congenital absence of right pulmonary artery,0
9539,Congenital qualifier,"Lymphangioma, Cystic",0
9540,Congenital qualifier,Progeria short stature pigmented nevi,0
9541,Congenital qualifier,"Fascial Dystrophy, Congenital",0
9542,Congenital qualifier,Unna-Thost Syndrome,0
9543,Congenital qualifier,Premature aging syndrome,0
9544,Congenital qualifier,Congenital hamartoma,0
9545,Congenital qualifier,Junctional Epidermolysis Bullosa,0
9546,Congenital qualifier,Ectodermal dysplasia with tooth-nail-sweating defect,0
9547,Congenital qualifier,Congenital vascular disorder,0
9548,Congenital qualifier,Hereditary benign intraepithelial dyskeratosis,0
9549,Congenital qualifier,Mixed vascular malformation,0
9550,Congenital qualifier,Acrokeratosis verruciformis of Darier disease,0
9551,Congenital qualifier,Hypoplastic enamel-onycholysis-hypohidrosis syndrome,0
9552,Congenital qualifier,Congenital malformation syndrome,0
9553,Congenital qualifier,Cutaneous vascular malformation,0
9554,Congenital qualifier,Congenital hamartoma of skin,0
9555,Congenital qualifier,Acrokeratosis Verruciformis of Hopf,0
9556,Congenital qualifier,"Keratoderma, Palmoplantar, Diffuse",0
9557,Congenital qualifier,Herlitz Disease,0
9558,Congenital qualifier,Congenital vascular anomaly,0
9559,Congenital qualifier,Congenital hyperplasia of intrahepatic bile duct,0
9560,Congenital qualifier,Monster with cranial anomalies,0
9561,Congenital qualifier,Congenital anomaly of neck,0
9562,Congenital qualifier,Congenital sixth nerve palsy,0
9563,Congenital qualifier,Congenital Fibrosis of the Extraocular Muscles,0
9564,Congenital qualifier,Congenital fibrosis of inferior rectus muscle,0
9565,Congenital qualifier,Cryptophthalmos,0
9566,Congenital qualifier,Ankyloblepharon filiforme adnatum,0
9567,Congenital qualifier,Congenital tarsal kink,0
9568,Congenital qualifier,Congenital euryblepharon,0
9569,Congenital qualifier,"Microcoria, congenital",0
9570,Congenital qualifier,"Mydriasis, Congenital",0
9571,Congenital qualifier,Congenital iris ectropion,0
9572,Congenital qualifier,Nicolaides Baraitser syndrome,0
9573,Congenital qualifier,Pena-Shokeir syndrome type I,0
9574,Congenital qualifier,Spina bifida without hydrocephalus,0
9575,Congenital qualifier,Smith-Magenis syndrome,0
9576,Congenital qualifier,Congenital neutrophil actin dysfunction,0
9577,Congenital qualifier,Papillon-Lefevre Disease,0
9578,Congenital qualifier,"Glycogen storage disease, type IX",0
9579,Congenital qualifier,"Chronic granulomatous disease, type IA",0
9580,Congenital qualifier,Congenital floating liver,0
9581,Congenital qualifier,Tophus,0
9582,Congenital qualifier,Gouty tophus of digit,0
9583,Congenital qualifier,Immunodeficiency with multicarboxylase deficiency,0
9584,Congenital qualifier,Congenital malignant melanoma,0
9585,Congenital qualifier,Congenital vascular malformation of skin,0
9586,Congenital qualifier,Developmental anomaly of vitelline duct,0
9587,Congenital qualifier,Congenital absence of coronary sinus,0
9588,Congenital qualifier,Congenital/genetic syndrome with poikiloderma,0
9589,Congenital qualifier,Autosomal dominant ichthyosis,0
9590,Congenital qualifier,"Ichthyosis, X-Linked",0
9591,Congenital qualifier,Autosomal recessive ichthyosis,0
9592,Congenital qualifier,Punctate palmoplantar keratoderma,0
9593,Congenital qualifier,Genetic defect of hair shaft,0
9594,Congenital qualifier,Inherited epidermolysis bullosa,0
9595,Congenital qualifier,Genetic disorder of lipid storage,0
9596,Congenital qualifier,Congenital vascular malformation due to inherited syndrome,0
9597,Congenital qualifier,Congenital malformation of cutaneous lymphatics,0
9598,Congenital qualifier,Developmental malformation of branchial arch,0
9599,Congenital qualifier,Cutaneous lymphangiectasia,0
9600,Congenital qualifier,Lymphangiectasia with chylous reflux,0
9601,Congenital qualifier,Congenital/hereditary angiokeratoma,0
9602,Congenital qualifier,Mental retardation Mietens Weber type,0
9603,Congenital qualifier,Annular pancreas,0
9604,Congenital qualifier,Double auditory canal,0
9605,Congenital qualifier,Congenital onychodysplasia of index fingers,0
9606,Congenital qualifier,Congenital malalignment of the toenails,0
9607,Congenital qualifier,Congenital pterygium of nail,0
9608,Congenital qualifier,Congenital onychoatrophy,0
9609,Congenital qualifier,Fordyce spots of lips,0
9610,Congenital qualifier,Fordyce spots of buccal mucosa,0
9611,Congenital qualifier,Solitary infantile myofibromatosis,0
9612,Congenital qualifier,Multicentric infantile myofibromatosis,0
9613,Congenital qualifier,Aggressive systemic infantile myofibromatosis,0
9614,Congenital qualifier,Familial generalized lipodystrophy,0
9615,Congenital qualifier,Congenital lower lip pits,0
9616,Congenital qualifier,Urban Schosser Spohn syndrome,0
9617,Congenital qualifier,Patent vitelline duct,0
9618,Congenital qualifier,Vitelline duct polyp,0
9619,Congenital qualifier,Hypertrichosis with congenital macrogingivae,0
9620,Congenital qualifier,Vertical alopecia,0
9621,Congenital qualifier,Sutural alopecia,0
9622,Congenital qualifier,Triangular alopecia,0
9623,Congenital qualifier,Congenital pigmented nevus with atypical melanocytic proliferation,0
9624,Congenital qualifier,Cornelia De Lange Syndrome,0
9625,Congenital qualifier,Port-wine stain with associated anomalies,0
9626,Congenital qualifier,Port-wine stain with oculocutaneous melanosis,0
9627,Congenital qualifier,Lymphangiomatosis,0
9628,Congenital qualifier,Segmental lymphangiomatosis,0
9629,Congenital qualifier,Aplasia cutis congenita due to underlying malformation (Type 4),0
9630,Congenital qualifier,Aplasia cutis congenita associated with fetus papyraceus (Type 5),0
9631,Congenital qualifier,Aplasia cutis congenita in association with epidermolysis bullosa (Type 6),0
9632,Congenital qualifier,Aplasia cutis congenita due to teratogenic drug (Type 7),0
9633,Congenital qualifier,Aplasia cutis congenita following intra-uterine infection (Type 8),0
9634,Congenital qualifier,Aplasia cutis congenita secondary to malformation syndrome (Type 9),0
9635,Congenital qualifier,"Oculo-cerebro-cutaneous syndrome (aplasia cutis, skin tags, eye & brain defects)",0
9636,Congenital qualifier,Constricting band of extremity,0
9637,Congenital qualifier,Midline cervical cleft,0
9638,Congenital qualifier,Cutaneous lesion resulting from spinal dysraphism,0
9639,Congenital qualifier,Port-wine stain associated with spinal dysraphism,0
9640,Congenital qualifier,Cutaneous lesion resulting from spina bifida,0
9641,Congenital qualifier,Rudimentary digit,0
9642,Congenital qualifier,Aplasia cutis in Trisomy 13 syndrome,0
9643,Congenital qualifier,Aplasia cutis in Chromosome 4 short-arm deletion syndrome (Wolf-Hirschhorn),0
9644,Congenital qualifier,Café-au-lait spots and ring chromosome 11,0
9645,Congenital qualifier,"48,XXYY Syndrome",0
9646,Congenital qualifier,Poly Y syndrome,0
9647,Congenital qualifier,Odonto-onycho-dermal dysplasia,0
9648,Congenital qualifier,Aplasia cutis in Johanson-Blizzard syndrome,0
9649,Congenital qualifier,Odontomicronychial ectodermal dysplasia,0
9650,Congenital qualifier,Port-wine stain in Rubinstein-Taybi syndrome,0
9651,Congenital qualifier,Rosenthal-Kloepfer syndrome,0
9652,Congenital qualifier,Acrocephalopolysyndactyly type 2,0
9653,Congenital qualifier,Sakati syndrome,0
9654,Congenital qualifier,Cardio-acral-facial syndrome,0
9655,Congenital qualifier,Cardio-facio-cutaneous syndrome,0
9656,Congenital qualifier,Congenital ectodermal dysplasia of face,0
9657,Congenital qualifier,Cleft Palate-Lateral Synechia Syndrome,0
9658,Congenital qualifier,"Facial milia, lobate tongue, lingual and labial frenula syndrome",0
9659,Congenital qualifier,Hereditary sclerosing poikiloderma of Weary,0
9660,Congenital qualifier,Angioma hereditary neurocutaneous,0
9661,Congenital qualifier,Lamellar ichthyosis (limited type),0
9662,Congenital qualifier,X-linked dominant chondrodysplasia punctata of Happle,0
9663,Congenital qualifier,Dykes Markes Harper syndrome,0
9664,Congenital qualifier,"Ichthyosiform erythroderma, corneal involvement, deafness",0
9665,Congenital qualifier,"Photosensitivity with ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature syndrome",0
9666,Congenital qualifier,Ichthyosis follicularis with alopecia and photophobia (IFAP),0
9667,Congenital qualifier,Flexural Darier's disease,0
9668,Congenital qualifier,Hypertrophic Darier's disease,0
9669,Congenital qualifier,Linear/nevoid/zosteriform Darier's disease,0
9670,Congenital qualifier,Acral Darier's disease,0
9671,Congenital qualifier,Palmar pitting due to Darier's disease,0
9672,Congenital qualifier,Nail dystrophy due to Darier's disease,0
9673,Congenital qualifier,Palmoplantar hyperkeratosis-hyperpigmentation syndrome of Cantu,0
9674,Congenital qualifier,Keratoderma with deafness,0
9675,Congenital qualifier,Keratoderma due to Dowling-Meara type epidermolysis bullosa simplex,0
9676,Congenital qualifier,Autosomal dominant familial woolly hair,0
9677,Congenital qualifier,Autosomal recessive familial woolly hair,0
9678,Congenital qualifier,Amish Brittle Hair Brain Syndrome,0
9679,Congenital qualifier,Genetic defect of hair shaft,0
9680,Congenital qualifier,alopecia congenita,0
9681,Congenital qualifier,Congenital hypertrichosis lanuginosa,0
9682,Congenital qualifier,Pachyonychia congenita type II of Jackson-Lawler,0
9683,Congenital qualifier,Pachyonychia congenita type III of Schafer-Brunauer,0
9684,Congenital qualifier,Tietz syndrome,0
9685,Congenital qualifier,Ziprkowski-Margolis syndrome,0
9686,Congenital qualifier,Phylloid hypomelanosis,0
9687,Congenital qualifier,Generalized recessive non-mutilating dystrophic epidermolysis bullosa,0
9688,Congenital qualifier,Dystrophic epidermolysis bullosa inverse type,0
9689,Congenital qualifier,Epidermolysis Bullosa Pruriginosa,0
9690,Congenital qualifier,Localized congenital cutis laxa,0
9691,Congenital qualifier,Axillary freckling due to neurofibromatosis,0
9692,Congenital qualifier,Multiple café-au-lait macules due to neurofibromatosis,0
9693,Congenital qualifier,Multiple neurofibromas in neurofibromatosis,0
9694,Congenital qualifier,Elephantiasis neurofibromatosa,0
9695,Congenital qualifier,Cafe-au-lait macules with pulmonary stenosis,0
9696,Congenital qualifier,Café-au-lait macules with temporal dysrhythmia,0
9697,Congenital qualifier,Familial multiple café-au-lait macules without neurofibromatosis,0
9698,Congenital qualifier,"Hyper-IgM Immunodeficiency Syndrome, Type 1",0
9699,Congenital qualifier,Autosomal recessive hyperimmunoglobulin M syndrome,0
9700,Congenital qualifier,Wiskott-Aldrich autosomal dominant variant syndrome,0
9701,Congenital qualifier,Congenital anomaly of digit,0
9702,Congenital qualifier,Port-wine stain in proteus syndrome,0
9703,Congenital qualifier,12q partial trisomy syndrome,0
9704,Congenital qualifier,Congenital anomaly of macula,0
9705,Congenital qualifier,Familial sea-blue histiocytosis,0
9706,Congenital qualifier,Mongolian Spot,0
9707,Congenital qualifier,Intermediate Maple Syrup Urine Disease,0
9708,Congenital qualifier,Intermittent Maple Syrup Urine Disease,0
9709,Congenital qualifier,Fistula of coronary sinus,0
9710,Congenital qualifier,Equine polysaccharide storage myopathy,0
9711,Congenital qualifier,Atrial Septal Defects,0
9712,Congenital qualifier,Klinefelter Syndrome,0
9713,Congenital qualifier,Congenital kyphoscoliosis,0
9714,Congenital qualifier,Congenital absence of vein,0
9715,Congenital qualifier,Epispadias,0
9716,Congenital qualifier,"Epispadias, male (disorder)",0
9717,Congenital qualifier,"Congenital absence of forearm, including hand and fingers",0
9718,Congenital qualifier,Pseudocryptorchism,0
9719,Congenital qualifier,Congenital hepatomegaly,0
9720,Congenital qualifier,Persistent hyperphenylalaninemia AND tyrosinemia,0
9721,Congenital qualifier,"Metachromatic Leukodystrophy, Infant",0
9722,Congenital qualifier,Sulfocysteinuria,0
9723,Congenital qualifier,Congenital anomaly of the hematopoietic system,0
9724,Congenital qualifier,Nevus anemicus,0
9725,Congenital qualifier,Primary hyperoxaluria type 2,0
9726,Congenital qualifier,Hydrencephalomeningocele,0
9727,Congenital qualifier,Congenital anomaly of aortic arch AND/OR descending aorta,0
9728,Congenital qualifier,Congenital anomaly in number of teeth,0
9729,Congenital qualifier,Total anodontia of permanent dentition,0
9730,Congenital qualifier,Argininosuccinic Aciduria,0
9731,Congenital qualifier,Down Syndrome,0
9732,Congenital qualifier,Holoacardius amorphus,0
9733,Congenital qualifier,Langer-Giedion Syndrome,0
9734,Congenital qualifier,Dicephalus tripus tribrachius,0
9735,Congenital qualifier,Late-Onset Globoid Cell Leukodystrophy,0
9736,Congenital qualifier,"Congenital abnormality of uterus, affecting pregnancy",0
9737,Congenital qualifier,Blepharophimosis syndrome Ohdo type,0
9738,Congenital qualifier,Congenital esophagobronchial fistula,0
9739,Congenital qualifier,Cerebrooculofacioskeletal Syndrome 1,0
9740,Congenital qualifier,X-linked reduction of thyroxine-binding globulin,0
9741,Congenital qualifier,Ectopic gastric mucosa - multiple sites,0
9742,Congenital qualifier,Pancreas divisum - complete,0
9743,Congenital qualifier,Pancreas divisum - incomplete,0
9744,Congenital qualifier,"Twins, Conjoined",0
9745,Congenital qualifier,WAGR Syndrome,0
9746,Congenital qualifier,Macrodactyly of toe,0
9747,Congenital qualifier,Congenital absence of heart structure,0
9748,Congenital qualifier,Congenital failure of fusion between maxillary and mandibular processes,0
9749,Congenital qualifier,Congenital labial adhesions,0
9750,Congenital qualifier,Duane syndrome with vertical deviation,0
9751,Congenital qualifier,Congenital anomalies of fetus,0
9752,Congenital qualifier,Multiple malformation syndrome with limb defect as major feature,0
9753,Congenital qualifier,Infertility due to testicular hypoplasia,0
9754,Congenital qualifier,Uterus acollis,0
9755,Congenital qualifier,Meningomyelocele,0
9756,Congenital qualifier,De Sanctis-Cacchione syndrome,0
9757,Congenital qualifier,Mesonephric duct cyst of broad ligament,0
9758,Congenital qualifier,"Multiple malformation syndrome, small stature, without skeletal dysplasia",0
9759,Congenital qualifier,"Porokeratosis, Disseminated Superficial Actinic",0
9760,Congenital qualifier,Congenital supravalvular mitral stenosis,0
9761,Congenital qualifier,Congenital hypertrophy of sphenoid bone,0
9762,Congenital qualifier,Primary congenital glaucoma,0
9763,Congenital qualifier,Glycogen Storage Disease Type VIII,0
9764,Congenital qualifier,Thoracic hydromeningocele,0
9765,Congenital qualifier,Mucopolysaccharidosis Type IIIA,0
9766,Congenital qualifier,Congenital anomaly of upper respiratory system,0
9767,Congenital qualifier,Hypospadias,0
9768,Congenital qualifier,Congenital anomaly of lacrimal gland,0
9769,Congenital qualifier,Port-Wine Stain,0
9770,Congenital qualifier,Leri's pleonosteosis syndrome,0
9771,Congenital qualifier,Congenital hereditary endothelial dystrophy type 1,0
9772,Congenital qualifier,Microspherophakia,0
9773,Congenital qualifier,Vein of Galen Malformations,0
9774,Congenital qualifier,Epicapsular star,0
9775,Congenital qualifier,"Ehlers-Danlos syndrome, procollagen proteinase resistant",0
9776,Congenital qualifier,Accessory lacrimal canal,0
9777,Congenital qualifier,Horseshoe Kidney,0
9778,Congenital qualifier,Congenital hereditary endothelial dystrophy type 2,0
9779,Congenital qualifier,Lethal white syndrome of foals,0
9780,Congenital qualifier,Axenfeld-Rieger syndrome,0
9781,Congenital qualifier,Congenital hereditary endothelial dystrophy,0
9782,Congenital qualifier,Holoanencephaly,0
9783,Congenital qualifier,"5,10-Methylenetetrahydrofolate reductase deficiency",0
9784,Congenital qualifier,Congenital absence of lacrimal drainage structure,0
9785,Congenital qualifier,Congenital anomaly of endocrine gland,0
9786,Congenital qualifier,Secondary lens coloboma,0
9787,Congenital qualifier,Symbrachydactyly,0
9788,Congenital qualifier,Intrauterine keratitis,0
9789,Congenital qualifier,Left ventricular-right atrial communication,0
9790,Congenital qualifier,Longitudinal deficiency of carpal bone,0
9791,Congenital qualifier,Glycogen Storage Disease Type IIb,0
9792,Congenital qualifier,Scaphycephaly,0
9793,Congenital qualifier,von Hippel internal corneal ulcer,0
9794,Congenital qualifier,Lentiglobus,0
9795,Congenital qualifier,Congenital corneal keloid,0
9796,Congenital qualifier,Congenital duplication of anus,0
9797,Congenital qualifier,Primary lens coloboma,0
9798,Congenital qualifier,Oligohydramnios sequence,0
9799,Congenital qualifier,18p partial trisomy syndrome,0
9800,Congenital qualifier,Congenital abnormality of lacrimal drainage system,0
9801,Congenital qualifier,Neuronal Ceroid-Lipofuscinoses,0
9802,Congenital qualifier,Congenital talipes varus,0
9803,Congenital qualifier,Pseudohypoparathyroidism Type 2,0
9804,Congenital qualifier,Congenital absence of abdominal muscle,0
9805,Congenital qualifier,Dysgenesis of lacrimal punctum,0
9806,Congenital qualifier,Cochleate uterus,0
9807,Congenital qualifier,Molded baby syndrome,0
9808,Congenital qualifier,Eruption cyst of jaw,0
9809,Congenital qualifier,Congenital duplication of cecum,0
9810,Congenital qualifier,Congenital pelvic obliquity,0
9811,Congenital qualifier,Dural carotid cavernous fistula,0
9812,Congenital qualifier,Occipital Encephalocele,0
9813,Congenital qualifier,Kartagener Syndrome,0
9814,Congenital qualifier,Myocardial bridge of coronary artery,0
9815,Congenital qualifier,18q partial monosomy syndrome,0
9816,Congenital qualifier,"OTOPALATODIGITAL SYNDROME, TYPE II",0
9817,Congenital qualifier,Prepapillary Vascular Loops,0
9818,Congenital qualifier,HNSHA due to hexokinase deficiency,0
9819,Congenital qualifier,Spina bifida aperta of cervical spine,0
9820,Congenital qualifier,Congenital spondylolisthesis of cervical vertebra,0
9821,Congenital qualifier,"Anemia, Hemolytic, Congenital",0
9822,Congenital qualifier,Congenital atresia of fallopian tube,0
9823,Congenital qualifier,Congenital factor IX deficiency without inhibitor,0
9824,Congenital qualifier,Long-chain fatty acid transport deficiency,0
9825,Congenital qualifier,Congenital anomaly of tracheal cartilage,0
9826,Congenital qualifier,Nesidioblastosis,0
9827,Congenital qualifier,Congenital contracture of gastrocnemius muscle,0
9828,Congenital qualifier,Congenital arteriovenous malformation of small intestine,0
9829,Congenital qualifier,Spina bifida aperta of thoracic spine,0
9830,Congenital qualifier,Achondrogenesis type 1A,0
9831,Congenital qualifier,Congenital velopharyngeal incompetence,0
9832,Congenital qualifier,Congenital lobulation of spleen,0
9833,Congenital qualifier,Congenital asymmetry of forehead,0
9834,Congenital qualifier,Longitudinal deficiency of tibia,0
9835,Congenital qualifier,Congenital anomaly of male urogenital tract,0
9836,Congenital qualifier,Congenital vascular malformation of lip,0
9837,Congenital qualifier,Congenital coronary artery sclerosis,0
9838,Congenital qualifier,Congenital female urogenital anomaly,0
9839,Congenital qualifier,Gouty arthritis of toe,0
9840,Congenital qualifier,Congenital flat back deformity,0
9841,Congenital qualifier,Congenital inguinal hernia,0
9842,Congenital qualifier,"Amino Acid Metabolism, Inborn Errors",0
9843,Congenital qualifier,Congenital vascular malformation of orbit,0
9844,Congenital qualifier,Congenital anomaly of anterior segment of eye,0
9845,Congenital qualifier,Congenital hypoplasia of fovea centralis,0
9846,Congenital qualifier,Spina bifida aperta of lumbar spine,0
9847,Congenital qualifier,"Myopathy, congenital nonprogressive with Moebius and Robin sequences",0
9848,Congenital qualifier,Cryptotia,0
9849,Congenital qualifier,Congenital anomaly of peripheral blood vessel,0
9850,Congenital qualifier,Ectromelia,0
9851,Congenital qualifier,Mesatipellic pelvis,0
9852,Congenital qualifier,Congenital atresia of osseous meatus of middle ear,0
9853,Congenital qualifier,Spinal dysgenesis,0
9854,Congenital qualifier,Aplasia of cerebellum,0
9855,Congenital qualifier,Acardiacus anceps,0
9856,Congenital qualifier,VACTERL Association,0
9857,Congenital qualifier,Central Core Myopathy (disorder),0
9858,Congenital qualifier,Ectopic tooth,0
9859,Congenital qualifier,Congenital hypoplasia of tricuspid valve,0
9860,Congenital qualifier,Congenital malformation of sphenoid wing,0
9861,Congenital qualifier,Fetal macrocephaly,0
9862,Congenital qualifier,Gouty iritis,0
9863,Congenital qualifier,Limb-girdle muscular dystrophy type 2H,0
9864,Congenital qualifier,Congenital anomaly of blood vessel of upper limb,0
9865,Congenital qualifier,Congenital anomaly of renal blood vessel,0
9866,Congenital qualifier,"49,XXXXX syndrome",0
9867,Congenital qualifier,Jacobsen Distal 11q Deletion Syndrome,0
9868,Congenital qualifier,Congenital asymmetry of breasts,0
9869,Congenital qualifier,Congenital absence of quadriceps muscle,0
9870,Congenital qualifier,Congenital abnormal shape of inner ear,0
9871,Congenital qualifier,Congenital diverticulum of bronchus,0
9872,Congenital qualifier,Fetus in fetu,0
9873,Congenital qualifier,9q partial monosomy syndrome,0
9874,Congenital qualifier,Ectopic glial tissue,0
9875,Congenital qualifier,Submucous cleft of hard palate,0
9876,Congenital qualifier,Thyroglobulin proteolysis defect,0
9877,Congenital qualifier,double; monster,0
9878,Congenital qualifier,Inborn error of lipoprotein metabolism,0
9879,Congenital qualifier,Brachydactyly,0
9880,Congenital qualifier,Congenital stricture of external auditory canal,0
9881,Congenital qualifier,Early congenital syphilis (less than 2 years),0
9882,Congenital qualifier,Congenital anomaly of tricuspid valve,0
9883,Congenital qualifier,"Atelosteogenesis, type 1",0
9884,Congenital qualifier,"Microphthalmia, syndromic 1",0
9885,Congenital qualifier,Perisylvian syndrome,0
9886,Congenital qualifier,Situs Inversus,0
9887,Congenital qualifier,Hereditary thrombophilic dysfibrinogenemia,0
9888,Congenital qualifier,Hypoplasia of aorta,0
9889,Congenital qualifier,Congenital hypofibrinogenemia,0
9890,Congenital qualifier,Mucopolysaccharidosis VII,0
9891,Congenital qualifier,Deformity of toe due to amniotic band,0
9892,Congenital qualifier,Smith-Lemli-Opitz Syndrome,0
9893,Congenital qualifier,Congenital stenosis of vagina affecting pregnancy,0
9894,Congenital qualifier,Partial congenital duodenal obstruction,0
9895,Congenital qualifier,Persistent hyperphenylalaninemia,0
9896,Congenital qualifier,Endemic congenital iodine deficiency syndrome of myxedematous type,0
9897,Congenital qualifier,Deformity due to amniotic band,0
9898,Congenital qualifier,Muenke Syndrome,0
9899,Congenital qualifier,Congenital deformity of scapula,0
9900,Congenital qualifier,Congenital anomaly of male genital system,0
9901,Congenital qualifier,Deformity of digit of hand due to amniotic band,0
9902,Congenital qualifier,Delta phalanx of finger,0
9903,Congenital qualifier,Oto-onycho-peroneal syndrome,0
9904,Congenital qualifier,Congenital arthrogryposis due to Akabane virus,0
9905,Congenital qualifier,Radiation chimera disorder,0
9906,Congenital qualifier,Rhombencephalosynapsis,0
9907,Congenital qualifier,Lipoid congenital adrenal hyperplasia,0
9908,Congenital qualifier,Congenital long QT syndrome,0
9909,Congenital qualifier,Coloboma of optic disc,0
9910,Congenital qualifier,Congenital absence of auricle with stenosis of auditory canal,0
9911,Congenital qualifier,Congenital Abnormality,0
9912,Congenital qualifier,Functional single ventricle,0
9913,Congenital qualifier,Bloom Syndrome,0
9914,Congenital qualifier,Multiple congenital anomalies,0
9915,Congenital qualifier,Longitudinal deficiency of ulna,0
9916,Congenital qualifier,Congenital deformity of pharynx,0
9917,Congenital qualifier,Congenital scleral show,0
9918,Congenital qualifier,Glycogen storage disease type Ia,0
9919,Congenital qualifier,Congenital aplasia of odontoid process,0
9920,Congenital qualifier,Bifid apex of heart,0
9921,Congenital qualifier,Meningomyelocele of lumbosacral spine,0
9922,Congenital qualifier,"2,4-Dienoyl-CoA Reductase Deficiency",0
9923,Congenital qualifier,Atrioventricular septal defect with common atrioventricular orifice,0
9924,Congenital qualifier,Lungs in mirror image arrangement,0
9925,Congenital qualifier,Congenital hemolytic uremic syndrome,0
9926,Congenital qualifier,Left ventricular outflow tract obstruction due to malaligned outlet septum,0
9927,Congenital qualifier,Atrioventricular septal defect with separate atrioventricular orifices,0
9928,Congenital qualifier,Left ventricular outflow tract obstruction due to subpulmonary fibromuscular shelf,0
9929,Congenital qualifier,Left superior caval vein persisting to coronary sinus,0
9930,Congenital qualifier,Congenital dilation of left pulmonary artery,0
9931,Congenital qualifier,Encephalocele of vertex,0
9932,Congenital qualifier,Congenital anomaly of the kidney,0
9933,Congenital qualifier,Left ventricular outflow tract obstruction due to fibromuscular tunnel,0
9934,Congenital qualifier,Congenital dilation of right pulmonary artery,0
9935,Congenital qualifier,Symbrachydactyly of toe,0
9936,Congenital qualifier,Congenital dilation of ascending aorta,0
9937,Congenital qualifier,Celosomus,0
9938,Congenital qualifier,Congenital hypoplasia of right pulmonary artery,0
9939,Congenital qualifier,Congenital hypoplasia of left pulmonary artery,0
9940,Congenital qualifier,Polydactyly preaxial type 1,0
9941,Congenital qualifier,Left ventricular outflow tract obstruction due to anterolateral muscle band,0
9942,Congenital qualifier,Nance-Horan syndrome,0
9943,Congenital qualifier,Atrioventricular septal defect with ventricular imbalance consisting of dominant left ventricle and hypoplastic right ventricle,0
9944,Congenital qualifier,Apex of heart anterior to cardiac base,0
9945,Congenital qualifier,Aortic orifice left side by side with respect to pulmonary orifice,0
9946,Congenital qualifier,Aortic sinus of Valsalva aneurysm from noncoronary sinus,0
9947,Congenital qualifier,Aortic sinus of Valsalva aneurysm from left coronary sinus,0
9948,Congenital qualifier,Aortic sinus of Valsalva aneurysm from right coronary sinus,0
9949,Congenital qualifier,Common atrioventricular orifice in double inlet ventricle,0
9950,Congenital qualifier,Infracardiac location of anomalous pulmonary venous connections to portal system,0
9951,Congenital qualifier,Aortic orifice anterior with respect to pulmonary orifice,0
9952,Congenital qualifier,Atrioventricular septal defect with ventricular imbalance consisting of dominant right ventricle and hypoplastic left ventricle,0
9953,Congenital qualifier,Cleft of alveolar ridge,0
9954,Congenital qualifier,Spina bifida of sacral region,0
9955,Congenital qualifier,Diastematomyelia,0
9956,Congenital qualifier,Left ventricular outflow tract obstruction due to diaphragm,0
9957,Congenital qualifier,Complex syndactyly of toes,0
9958,Congenital qualifier,Right atrioventricular valve leaflets absent in double inlet ventricle (unguarded orifice),0
9959,Congenital qualifier,Atrioventricular septal defect with additional muscular ventricular septal defect,0
9960,Congenital qualifier,Complex syndactyly of fingers,0
9961,Congenital qualifier,Isolation of left subclavian artery,0
9962,Congenital qualifier,Isolation of right subclavian artery,0
9963,Congenital qualifier,Infracardiac location of anomalous pulmonary venous connections to inferior caval vein,0
9964,Congenital qualifier,Aortic orifice posterior with respect to pulmonary orifice,0
9965,Congenital qualifier,Congenital neurogenic urinary bladder,0
9966,Congenital qualifier,Apex of heart posterior to cardiac base,0
9967,Congenital qualifier,Left superior caval vein persisting to left sided atrium,0
9968,Congenital qualifier,Left ventricular outflow tract obstruction due to aneurysm of membranous septum,0
9969,Congenital qualifier,Left ventricular outflow tract obstruction due to atrioventricular valve,0
9970,Congenital qualifier,Occipital meningocele,0
9971,Congenital qualifier,Congenital malformation of blood vessel of orbit proper,0
9972,Congenital qualifier,"Jaundice, Chronic Idiopathic",0
9973,Congenital qualifier,Intracardiac location of anomalous pulmonary venous connections to bilateral isomeric atriums,0
9974,Congenital qualifier,Congenital asymmetry of tonsils,0
9975,Congenital qualifier,Aortic orifice posterior left with respect to pulmonary orifice,0
9976,Congenital qualifier,Aortic orifice anterior right with respect to pulmonary orifice,0
9977,Congenital qualifier,Aortic orifice anterior left with respect to pulmonary orifice,0
9978,Congenital qualifier,Abnormal atrial arrangement,0
9979,Congenital qualifier,Eisenmenger Complex,0
9980,Congenital qualifier,Orbital separation diminished,0
9981,Congenital qualifier,Congenital anomaly of organ of Corti,0
9982,Congenital qualifier,Congenital hypoplasia of umbilical artery,0
9983,Congenital qualifier,Premature restriction of foramen ovale,0
9984,Congenital qualifier,Pulmonary venous hypoplasia,0
9985,Congenital qualifier,Persistent Hyperplastic Primary Vitreous,0
9986,Congenital qualifier,Spherophakia,0
9987,Congenital qualifier,Mirror image bronchial anatomy,0
9988,Congenital qualifier,Criss-cross heart with rightward rotation,0
9989,Congenital qualifier,Ventricular imbalance with dominant left ventricle and hypoplastic right ventricle,0
9990,Congenital qualifier,Two atrioventricular valves in double inlet ventricle,0
9991,Congenital qualifier,Aortic orifice right side by side with respect to pulmonary orifice,0
9992,Congenital qualifier,Obstructed pulmonary venous connection at coronary sinus orifice,0
9993,Congenital qualifier,Midline apex of heart,0
9994,Congenital qualifier,Functionally univentricular heart,0
9995,Congenital qualifier,LIPOPROTEIN GLOMERULOPATHY,0
9996,Congenital qualifier,Melorheostosis,0
9997,Congenital qualifier,Functionally congenital single lung,0
9998,Congenital qualifier,Anomaly of chromosome pair 6,0
9999,Congenital qualifier,Tricuspid valve primary chords absent,0
10000,Congenital qualifier,Persistent common pulmonary vein,0
10001,Congenital qualifier,Alveolar capillary dysplasia with pulmonary venous misalignment,0
10002,Congenital qualifier,Solitary ventricle of indeterminate morphology,0
10003,Congenital qualifier,Double outlet right ventricle with intact ventricular septum,0
10004,Congenital qualifier,Ventricular imbalance,0
10005,Congenital qualifier,Ventricular imbalance with dominant right ventricle and hypoplastic left ventricle,0
10006,Congenital qualifier,Criss-cross heart with leftward rotation,0
10007,Congenital qualifier,Median raphe cyst of penis,0
10008,Congenital qualifier,Ectopic ureter,0
10009,Congenital qualifier,Feline osteogenesis imperfecta,0
10010,Congenital qualifier,Cryptodidymus,0
10011,Congenital qualifier,Adenosine deaminase deficiency,0
10012,Congenital qualifier,Congenital hypertrophy of ureteric valve,0
10013,Congenital qualifier,Congenital fusion of testis,0
10014,Congenital qualifier,"LYMPHANGIECTASIA, PULMONARY, CONGENITAL",0
10015,Congenital qualifier,Punctate keratosis,0
10016,Congenital qualifier,Congenital pontocerebellar hypoplasia,0
10017,Congenital qualifier,Alopecia epilepsy oligophrenia syndrome of Moynahan,0
10018,Congenital qualifier,Hypouricemia,0
10019,Congenital qualifier,Congenital dilatation of aorta,0
10020,Congenital qualifier,Madelung Deformity,0
10021,Congenital qualifier,"Dysfibrinogenemia, Congenital",0
10022,Congenital qualifier,SCID due to absent IL-2 production,0
10023,Congenital qualifier,Partial aphalangia of upper limb,0
10024,Congenital qualifier,Partial ablepharon,0
10025,Congenital qualifier,Congenital stenosis of superior vena cava,0
10026,Congenital qualifier,Common ventricle,0
10027,Congenital qualifier,16q partial trisomy syndrome,0
10028,Congenital qualifier,Rubinstein-Taybi Syndrome,0
10029,Congenital qualifier,Manus cava,0
10030,Congenital qualifier,Spinal cord hypoplasia,0
10031,Congenital qualifier,Ocular melanosis,0
10032,Congenital qualifier,Congenital cardiospasm,0
10033,Congenital qualifier,Reduction deformity of upper limb,0
10034,Congenital qualifier,Pelvis plana (disorder),0
10035,Congenital qualifier,Congenital shortening of tendon,0
10036,Congenital qualifier,Bannayan-Riley-Ruvalcaba Syndrome,0
10037,Congenital qualifier,Pierre Robin Syndrome,0
10038,Congenital qualifier,Maffucci Syndrome,0
10039,Congenital qualifier,Parasitic twin of asymmetrical conjoined twins,0
10040,Congenital qualifier,"Early latent congenital syphilis, positive serology, negative spinal fluid",0
10041,Congenital qualifier,Congenital obstruction of bladder neck,0
10042,Congenital qualifier,Multiple renal arteries,0
10043,Congenital qualifier,Assimilation pelvis,0
10044,Congenital qualifier,Congenital heart block,0
10045,Congenital qualifier,Von Hippel-Lindau Syndrome,0
10046,Congenital qualifier,Female infertility due to structural congenital anomaly of vagina,0
10047,Congenital qualifier,Pyruvate Dehydrogenase Complex Deficiency Disease,0
10048,Congenital qualifier,Dicephalus dipus dibrachius,0
10049,Congenital qualifier,Congenital anomaly of pleural folds,0
10050,Congenital qualifier,Estren-Dameshek anemia,0
10051,Congenital qualifier,Familial juvenile gout,0
10052,Congenital qualifier,X-linked centronuclear myopathy,0
10053,Congenital qualifier,Developmental displacement of brachial plexus,0
10054,Congenital qualifier,Anomalies of pancreas,0
10055,Congenital qualifier,Congenital duplication of gallbladder,0
10056,Congenital qualifier,Agenesis of left lung,0
10057,Congenital qualifier,Ring chromosome 1 syndrome,0
10058,Congenital qualifier,Inherited disorder of folate metabolism,0
10059,Congenital qualifier,Congenital hiatus hernia,0
10060,Congenital qualifier,Congenital Hydrocephalus,0
10061,Congenital qualifier,Septate vagina,0
10062,Congenital qualifier,Congenital web of larynx,0
10063,Congenital qualifier,Congenital rubella pneumonitis,0
10064,Congenital qualifier,Congenital anomaly of bile ducts,0
10065,Congenital qualifier,Congenital leukonychia,0
10066,Congenital qualifier,Congenital anomaly of lung,0
10067,Congenital qualifier,Long tubular intestinal duplication,0
10068,Congenital qualifier,Congenital absence of femur,0
10069,Congenital qualifier,Congenital shortening of the leg,0
10070,Congenital qualifier,Waardenburg Syndrome,0
10071,Congenital qualifier,Naso-palatine duct cyst,0
10072,Congenital qualifier,Rieger syndrome,0
10073,Congenital qualifier,Fetal sacral teratoma causing disproportion,0
10074,Congenital qualifier,HNSHA due to NADH diaphorase deficiency,0
10075,Congenital qualifier,CHARGE Syndrome,0
10076,Congenital qualifier,Congenital anomaly of the pelvis,0
10077,Congenital qualifier,Orotic aciduria,0
10078,Congenital qualifier,Incomplete bilateral cleft palate,0
10079,Congenital qualifier,Congenital absence of humerus,0
10080,Congenital qualifier,Valinemia,0
10081,Congenital qualifier,Corticosterone Methyl Oxidase Type I Deficiency,0
10082,Congenital qualifier,Congenital absence of muscle AND/OR tendon,0
10083,Congenital qualifier,Congenital emphysema,0
10084,Congenital qualifier,Manus vara,0
10085,Congenital qualifier,Pelvis justo minor,0
10086,Congenital qualifier,Congenital calculus of kidney,0
10087,Congenital qualifier,Acrocephaly,0
10088,Congenital qualifier,Anomaly of chromosome pair 8,0
10089,Congenital qualifier,Congenital cardiomegaly,0
10090,Congenital qualifier,Otocephaly,0
10091,Congenital qualifier,Congenital anisocoria,0
10092,Congenital qualifier,Congenital absence of finger,0
10093,Congenital qualifier,"Hip Dislocation, Congenital",0
10094,Congenital qualifier,Congenital stricture of urinary meatus,0
10095,Congenital qualifier,Congenital pseudoporencephaly,0
10096,Congenital qualifier,"Arthritis, Gouty",0
10097,Congenital qualifier,Congenital macrodactylia,0
10098,Congenital qualifier,Congenital metatarsus varus,0
10099,Congenital qualifier,Congenital atresia of cardiac vein,0
10100,Congenital qualifier,Hallopeau-Siemens Disease,0
10101,Congenital qualifier,Incontinentia Pigmenti Achromians,0
10102,Congenital qualifier,Hypomyelinogenesis congenita,0
10103,Congenital qualifier,Accessory parotid gland (disorder),0
10104,Congenital qualifier,Keratosis Follicularis,0
10105,Congenital qualifier,Multiple malformation syndrome with early overgrowth,0
10106,Congenital qualifier,"Pyloric Stenosis, Hypertrophic",0
10107,Congenital qualifier,Accessory fallopian tube,0
10108,Congenital qualifier,Roberts-SC phocomelia syndrome,0
10109,Congenital qualifier,11q partial trisomy syndrome,0
10110,Congenital qualifier,10p partial trisomy syndrome,0
10111,Congenital qualifier,Congenital hernia of foramen of Morgagni,0
10112,Congenital qualifier,Cranioschisis,0
10113,Congenital qualifier,"Nephrosis, congenital",0
10114,Congenital qualifier,17q partial trisomy syndrome,0
10115,Congenital qualifier,suspected damage to fetus from maternal listeriosis,0
10116,Congenital qualifier,Tyrosine Transaminase Deficiency Disease,0
10117,Congenital qualifier,Congenital obstruction of urethra,0
10118,Congenital qualifier,Malrotation of kidney,0
10119,Congenital qualifier,17 alpha-Hydroxyprogesterone aldolase deficiency,0
10120,Congenital qualifier,4p partial trisomy syndrome,0
10121,Congenital qualifier,Duhamel's syndrome,0
10122,Congenital qualifier,Increased uric acid level,0
10123,Congenital qualifier,Acetyl-CoA: carboxylase deficiency,0
10124,Congenital qualifier,Supernumerary ear lobule,0
10125,Congenital qualifier,Brachymetapody,0
10126,Congenital qualifier,Lecithin Acyltransferase Deficiency,0
10127,Congenital qualifier,Megaloblastic anemia due to inborn errors of metabolism,0
10128,Congenital qualifier,Immature fetus,0
10129,Congenital qualifier,Diastematomyelia,0
10130,Congenital qualifier,Congenital anomaly of retina,0
10131,Congenital qualifier,Microgyria,0
10132,Congenital qualifier,Angioma serpiginosum,0
10133,Congenital qualifier,Ectopic adrenal gland,0
10134,Congenital qualifier,Double ureter,0
10135,Congenital qualifier,Impervious ureter,0
10136,Congenital qualifier,SCID due to absent T cell receptor,0
10137,Congenital qualifier,Adult chronic GM 2 gangliosidosis,0
10138,Congenital qualifier,Gallbladder anomaly congenital,0
10139,Congenital qualifier,succinic semialdehyde dehydrogenase deficiency,0
10140,Congenital qualifier,Bilateral congenital macrostomia,0
10141,Congenital qualifier,Disto-occlusion of teeth,0
10142,Congenital qualifier,Podencephalus,0
10143,Congenital qualifier,Ectopic fetus,0
10144,Congenital qualifier,Familial lipoprotein deficiency,0
10145,Congenital qualifier,FG syndrome,0
10146,Congenital qualifier,Osteochondrodysplasia with osteopetrosis,0
10147,Congenital qualifier,Beals auriculo-osteodysplasia syndrome,0
10148,Congenital qualifier,Congenital enlargement of nasopharynx,0
10149,Congenital qualifier,Funnel-shaped pelvis,0
10150,Congenital qualifier,Generalized Thyroid Hormone Resistance,0
10151,Congenital qualifier,Congenital stenosis of aqueduct of Sylvius,0
10152,Congenital qualifier,Anomaly of chromosome pair 9,0
10153,Congenital qualifier,Congenital atresia of bronchus,0
10154,Congenital qualifier,Fordyce's disease,0
10155,Congenital qualifier,17-Hydroxysteroid Dehydrogenase Deficiency,0
10156,Congenital qualifier,"47, XYY syndrome",0
10157,Congenital qualifier,Sinus Pericranii,0
10158,Congenital qualifier,Accessory skeletal muscle,0
10159,Congenital qualifier,"Ehlers-Danlos Syndrome, Type VIII",0
10160,Congenital qualifier,Brachypellic pelvis,0
10161,Congenital qualifier,Ectopic testis,0
10162,Congenital qualifier,Grob's syndrome,0
10163,Congenital qualifier,Job Syndrome,0
10164,Congenital qualifier,Congenital anomaly of bronchus,0
10165,Congenital qualifier,Accessory nipple,0
10166,Congenital qualifier,Gangliosidoses,0
10167,Congenital qualifier,Urachal fistula,0
10168,Congenital qualifier,22q partial trisomy syndrome,0
10169,Congenital qualifier,Agenesis of corpus callosum,0
10170,Congenital qualifier,Erythropoietic Protoporphyria,0
10171,Congenital qualifier,Congenital obstruction of bile duct,0
10172,Congenital qualifier,Diprosopus tetrophthalmus,0
10173,Congenital qualifier,Congenital constriction of pylorus,0
10174,Congenital qualifier,Birthmark,0
10175,Congenital qualifier,Duodenal atresia,0
10176,Congenital qualifier,Congenital melanosis of sclera,0
10177,Congenital qualifier,Epitheliogenesis imperfecta lingua bovis,0
10178,Congenital qualifier,Bifid thumb,0
10179,Congenital qualifier,Asymmetric crying face association,0
10180,Congenital qualifier,Cranio-orbito-ocular dysraphia syndrome,0
10181,Congenital qualifier,Congenital atresia of aortic valve,0
10182,Congenital qualifier,"Color Blindness, Red",0
10183,Congenital qualifier,Complete trisomy 18 syndrome,0
10184,Congenital qualifier,Congenital laryngocele,0
10185,Congenital qualifier,Ectopic anus,0
10186,Congenital qualifier,Werner Syndrome,0
10187,Congenital qualifier,Congenital malaria,0
10188,Congenital qualifier,Congenital absence of all fingers,0
10189,Congenital qualifier,Congenital anomaly of skull,0
10190,Congenital qualifier,Congenital absence of prostate,0
10191,Congenital qualifier,Cerebrocostomandibular Syndrome,0
10192,Congenital qualifier,Congenital malposition of cardiac apex,0
10193,Congenital qualifier,Congenital anomaly of ureter,0
10194,Congenital qualifier,17p partial trisomy syndrome,0
10195,Congenital qualifier,Prune Belly Syndrome,0
10196,Congenital qualifier,"Color Blindness, Blue",0
10197,Congenital qualifier,"Spondyloepiphyseal Dysplasia Tarda, X-Linked",0
10198,Congenital qualifier,"Dysmorphic sialidosis, infantile form",0
10199,Congenital qualifier,Congenital bent nose,0
10200,Congenital qualifier,Congenital absence of ulna,0
10201,Congenital qualifier,Myxomatosis of cardiac valve,0
10202,Congenital qualifier,Congenital human immunodeficiency virus infection,0
10203,Congenital qualifier,Infantile lobar overinflation of lung,0
10204,Congenital qualifier,"von Willebrand disease, type IIE",0
10205,Congenital qualifier,Universal mesentery,0
10206,Congenital qualifier,"Niemann-Pick Disease, Type A",0
10207,Congenital qualifier,Ocular albinism-lentigines-deafness syndrome,0
10208,Congenital qualifier,"Sialidosis, type 2",0
10209,Congenital qualifier,Congenital absence of coronary artery,0
10210,Congenital qualifier,Fetal disproportion due to fetal myelomeningocele,0
10211,Congenital qualifier,Meningoencephalocele,0
10212,Congenital qualifier,Low assimilation pelvis,0
10213,Congenital qualifier,Accessory lung,0
10214,Congenital qualifier,Deficiency of steroid 21-monooxygenase,0
10215,Congenital qualifier,Freeman-Sheldon syndrome,0
10216,Congenital qualifier,Mucopolysaccharidosis VI,0
10217,Congenital qualifier,Albinoidism,0
10218,Congenital qualifier,Iodide oxidation defect,0
10219,Congenital qualifier,Congenital supravalvular pulmonary stenosis,0
10220,Congenital qualifier,Congenital Dysplasia Of The Hip,0
10221,Congenital qualifier,Longitudinal deficiency of femur,0
10222,Congenital qualifier,Congenital absence of vas deferens,0
10223,Congenital qualifier,Orofaciodigital Syndromes,0
10224,Congenital qualifier,Congenital atresia of glottis,0
10225,Congenital qualifier,Congenital anomaly of vagina,0
10226,Congenital qualifier,Congenital dyserythropoietic anemia,0
10227,Congenital qualifier,Congenital gastric perforation,0
10228,Congenital qualifier,Congenital atresia of trachea,0
10229,Congenital qualifier,Vascular compression of esophagus by aberrant artery,0
10230,Congenital qualifier,"Pyruvate Metabolism, Inborn Errors",0
10231,Congenital qualifier,Spina bifida with hydrocephalus,0
10232,Congenital qualifier,Platypellic pelvis,0
10233,Congenital qualifier,"Chromosome 20, trisomy",0
10234,Congenital qualifier,Phosphoenolpyruvate carboxykinase deficiency,0
10235,Congenital qualifier,Anomaly of chromosome pair 16,0
10236,Congenital qualifier,Testicular regression syndrome,0
10237,Congenital qualifier,Embryonal nuclear cataract (disorder),0
10238,Congenital qualifier,Peutz-Jeghers polyps of small bowel,0
10239,Congenital qualifier,Uterus subseptus,0
10240,Congenital qualifier,Accessory lacrimal canal,0
10241,Congenital qualifier,Anemia following fetal blood loss,0
10242,Congenital qualifier,Congenital junctional epidermolysis bullosa-pyloric atresia syndrome,0
10243,Congenital qualifier,Encephalocystocele,0
10244,Congenital qualifier,Beaked pelvis,0
10245,Congenital qualifier,Congenital hallux valgus,0
10246,Congenital qualifier,Nodular embryo,0
10247,Congenital qualifier,"Lactase Deficiency, Congenital",0
10248,Congenital qualifier,Lithopedion,0
10249,Congenital qualifier,Congenital anomaly of renal pelvis,0
10250,Congenital qualifier,Kniest dysplasia,0
10251,Congenital qualifier,Sternal cleft,0
10252,Congenital qualifier,Oto-Palato-digital syndrome type 1,0
10253,Congenital qualifier,Classic Maple Syrup Urine Disease,0
10254,Congenital qualifier,Congenital syphilitic mucous patches,0
10255,Congenital qualifier,Monocuspid cardiac valve,0
10256,Congenital qualifier,Congenital pancreatic trypsin deficiency,0
10257,Congenital qualifier,Congenital aneurysm of sinus of Valsalva,0
10258,Congenital qualifier,Congenital cyst of canal of Nuck,0
10259,Congenital qualifier,Hidrotic Ectodermal Dysplasia,0
10260,Congenital qualifier,suspected damage to fetus from maternal toxoplasmosis,0
10261,Congenital qualifier,Congenital anomaly of cerebral artery,0
10262,Congenital qualifier,Transposition of appendix,0
10263,Congenital qualifier,Ichthyosis linearis circumflexa,0
10264,Congenital qualifier,Congenital corneal opacity not interfering with vision,0
10265,Congenital qualifier,Congenital fusion of ossicles of ear,0
10266,Congenital qualifier,Peutz-Jeghers Syndrome,0
10267,Congenital qualifier,3 beta-Hydroxysteroid dehydrogenase deficiency,0
10268,Congenital qualifier,Pancreas divisum,0
10269,Congenital qualifier,Congenital hypertrophy of pylorus,0
10270,Congenital qualifier,Xanthinuria,0
10271,Congenital qualifier,Uterus biforis,0
10272,Congenital qualifier,Congenital hypoplasia of pulmonary artery,0
10273,Congenital qualifier,Mobile cecum,0
10274,Congenital qualifier,Synchilia,0
10275,Congenital qualifier,Ectopic gray matter in centrum ovale,0
10276,Congenital qualifier,13p partial trisomy syndrome,0
10277,Congenital qualifier,Straight back syndrome,0
10278,Congenital qualifier,Congenital anomaly of orbit,0
10279,Congenital qualifier,Multiple Sulfatase Deficiency Disease,0
10280,Congenital qualifier,Monster (disorder),0
10281,Congenital qualifier,Aspartylglucosaminuria,0
10282,Congenital qualifier,Double kidney (disorder),0
10283,Congenital qualifier,Congenital muscular hypertrophy-cerebral syndrome,0
10284,Congenital qualifier,Multi-core congenital myopathy,0
10285,Congenital qualifier,Congenital anomaly of small intestine,0
10286,Congenital qualifier,Dens in Dente,0
10287,Congenital qualifier,Infantile hypophosphatasia,0
10288,Congenital qualifier,X-linked excess of thyroxine-binding globulin,0
10289,Congenital qualifier,Congenital pseudoarthrosis of tibia,0
10290,Congenital qualifier,2p partial trisomy syndrome,0
10291,Congenital qualifier,Congenital laryngeal stridor,0
10292,Congenital qualifier,Cor Triatriatum,0
10293,Congenital qualifier,Vascular compression of esophagus by aberrant right subclavian artery arising from descending aorta,0
10294,Congenital qualifier,Congenital malposition of kidney,0
10295,Congenital qualifier,Anomalous origin of left circumflex artery from right coronary artery,0
10296,Congenital qualifier,Nezelof's syndrome,0
10297,Congenital qualifier,Congenital anomaly of testis,0
10298,Congenital qualifier,Congenital diverticulum of trachea,0
10299,Congenital qualifier,Ethmocephalus,0
10300,Congenital qualifier,"EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE",0
10301,Congenital qualifier,Arylsulfatase deficiency without MLD,0
10302,Congenital qualifier,Muscle L-lactate dehydrogenase deficiency,0
10303,Congenital qualifier,Albinotic fundus,0
10304,Congenital qualifier,Hay-Wells syndrome,0
10305,Congenital qualifier,Essential benign pentosuria,0
10306,Congenital qualifier,Athyrotic hypothyroidism sequence,0
10307,Congenital qualifier,Complete phocomelia of lower limb,0
10308,Congenital qualifier,Hyperplasia of kidney,0
10309,Congenital qualifier,Glycogen Storage Disease Type V,0
10310,Congenital qualifier,Encephalocele,0
10311,Congenital qualifier,Klippel-Feil Syndrome,0
10312,Congenital qualifier,Congenital duplication of biliary duct,0
10313,Congenital qualifier,Hypothyroidism due to defect in thyroid hormone synthesis,0
10314,Congenital qualifier,Pseudohypoparathyroidism type I B,0
10315,Congenital qualifier,Pelvic kidney,0
10316,Congenital qualifier,Thyroxine transport defect,0
10317,Congenital qualifier,Congenital syphilitic splenomegaly,0
10318,Congenital qualifier,Hemispheric cerebral agenesis,0
10319,Congenital qualifier,Bardet-Biedl Syndrome,0
10320,Congenital qualifier,Leydig cell agenesis,0
10321,Congenital qualifier,Congenital subaortic stenosis of tunnel type,0
10322,Congenital qualifier,Longitudinal deficiency of upper limb,0
10323,Congenital qualifier,Nasal glial heterotopia,0
10324,Congenital qualifier,Ulegyria,0
10325,Congenital qualifier,Inherited disorder of bilirubin metabolism,0
10326,Congenital qualifier,Congenital hypotrichia,0
10327,Congenital qualifier,Cohen syndrome,0
10328,Congenital qualifier,Blunderbuss pelvis,0
10329,Congenital qualifier,18p partial monosomy syndrome,0
10330,Congenital qualifier,Enterokinase Deficiency,0
10331,Congenital qualifier,"Hunter's syndrome, mild form",0
10332,Congenital qualifier,Pallister-Hall syndrome,0
10333,Congenital qualifier,"Chondrodysplasia Punctata, Rhizomelic",0
10334,Congenital qualifier,Congenital anomaly of subcutaneous tissue,0
10335,Congenital qualifier,Congenital hypertrichosis,0
10336,Congenital qualifier,Cervical thyroid remnant,0
10337,Congenital qualifier,Achromatopsia,0
10338,Congenital qualifier,Uterus bicornis unicollis,0
10339,Congenital qualifier,Microcystic renal disease,0
10340,Congenital qualifier,"Hyperammonemia, type III",0
10341,Congenital qualifier,Congenital anomaly of brain,0
10342,Congenital qualifier,Cholesterol Ester Storage Disease,0
10343,Congenital qualifier,Craniosynostosis,0
10344,Congenital qualifier,Congenital obstruction of large intestine,0
10345,Congenital qualifier,Anomaly of chromosome pair 5,0
10346,Congenital qualifier,Congenital absence of external ear,0
10347,Congenital qualifier,Congenital Tracheobronchomegaly,0
10348,Congenital qualifier,Fetal or suspected fetal anencephaly affecting management of mother,0
10349,Congenital qualifier,Congenital anomaly of spleen,0
10350,Congenital qualifier,Pseudovaginal Perineoscrotal Hypospadias,0
10351,Congenital qualifier,Multiple malformation syndrome due to non-infectious environmental agents,0
10352,Congenital qualifier,Hepatic methionine adenosyltransferase deficiency,0
10353,Congenital qualifier,Acid Phosphatase Deficiency,0
10354,Congenital qualifier,Seckel syndrome,0
10355,Congenital qualifier,Janiceps (disorder),0
10356,Congenital qualifier,Congenital adhesions of omentum,0
10357,Congenital qualifier,Generalized Myotonia of Thomsen,0
10358,Congenital qualifier,Congenital absence of tibia AND fibula,0
10359,Congenital qualifier,Congenital hypergammaglobulinemia,0
10360,Congenital qualifier,"Hamartoma Syndrome, Multiple",0
10361,Congenital qualifier,"Mannosidosis, type II",0
10362,Congenital qualifier,Uterine cervix double,0
10363,Congenital qualifier,Phenylketonuria II,0
10364,Congenital qualifier,Infantile neuronal ceroid lipofuscinosis,0
10365,Congenital qualifier,"Maroteaux-Lamy syndrome, severe form",0
10366,Congenital qualifier,Gingival odontogenic cyst,0
10367,Congenital qualifier,Congenital syphilitic osteochondritis,0
10368,Congenital qualifier,Spinal cord dysplasia,0
10369,Congenital qualifier,Niemann-Pick Diseases,0
10370,Congenital qualifier,Spina Bifida Cystica,0
10371,Congenital qualifier,Diastrophic dysplasia,0
10372,Congenital qualifier,"Optic Atrophy, Hereditary, Leber",0
10373,Congenital qualifier,Familial disease with storage of sterols (other than cholesterol),0
10374,Congenital qualifier,Abnormal accessory lacrimal gland,0
10375,Congenital qualifier,Congenital exomphalos,0
10376,Congenital qualifier,Reifenstein Syndrome,0
10377,Congenital qualifier,Bilateral arterial duct,0
10378,Congenital qualifier,Distal Muscular Dystrophies,0
10379,Congenital qualifier,"Pseudohypoparathyroidism, Type Ia",0
10380,Congenital qualifier,Congenital cystic eyeball,0
10381,Congenital qualifier,Congenital aneurysm of anterior communicating artery,0
10382,Congenital qualifier,Anomaly of chromosome pair 18,0
10383,Congenital qualifier,Congenital anomaly of female genital system,0
10384,Congenital qualifier,Congenital dislocation of knee,0
10385,Congenital qualifier,Partial aphalangia of lower limb,0
10386,Congenital qualifier,Klippel-Trenaunay-Weber Syndrome,0
10387,Congenital qualifier,Congenital honeycomb lung,0
10388,Congenital qualifier,Menkes Kinky Hair Syndrome,0
10389,Congenital qualifier,Longitudinal deficiency of radius AND ulna,0
10390,Congenital qualifier,"Cutis laxa, x-linked",0
10391,Congenital qualifier,Congenital atresia of nasopharynx,0
10392,Congenital qualifier,"Cutis laxa, autosomal recessive",0
10393,Congenital qualifier,Heart Septal Defects,0
10394,Congenital qualifier,Congenital absence of large intestine,0
10395,Congenital qualifier,Congenital cytomegalovirus infection,0
10396,Congenital qualifier,"Congenital dyserythropoietic anemia, type I",0
10397,Congenital qualifier,Holoacardius acormus,0
10398,Congenital qualifier,"Gaucher Disease, Type 3 (disorder)",0
10399,Congenital qualifier,Anomalous pulmonary venous drainage,0
10400,Congenital qualifier,"Pelizaeus-Merzbacher disease, connatal variant",0
10401,Congenital qualifier,Congenital fusion of sacroiliac joint,0
10402,Congenital qualifier,Manus plana,0
10403,Congenital qualifier,Congenital tremor syndrome,0
10404,Congenital qualifier,Multiple Epiphyseal Dysplasia,0
10405,Congenital qualifier,Congenital syphilitic pemphigus,0
10406,Congenital qualifier,Trifid kidney,0
10407,Congenital qualifier,Glutamate formiminotransferase deficiency,0
10408,Congenital qualifier,Van Buchem disease,0
10409,Congenital qualifier,Thoracopagus,0
10410,Congenital qualifier,Congenital enlarged kidney,0
10411,Congenital qualifier,2q partial trisomy syndrome,0
10412,Congenital qualifier,Branchioma,0
10413,Congenital qualifier,Congenital anomaly of aorta,0
10414,Congenital qualifier,Congenital absence of penis,0
10415,Congenital qualifier,MPS III B,0
10416,Congenital qualifier,10p partial monosomy syndrome,0
10417,Congenital qualifier,Moderate steroid 21-hydroxylase deficiency,0
10418,Congenital qualifier,Congenital stricture of artery,0
10419,Congenital qualifier,Common arterial trunk and separate origin of pulmonary arteries,0
10420,Congenital qualifier,Congenital dislocation of one hip with subluxation of other,0
10421,Congenital qualifier,"MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE",0
10422,Congenital qualifier,Familial hypobetalipoproteinemia,0
10423,Congenital qualifier,Stunted embryo,0
10424,Congenital qualifier,Partial congenital absence of limb,0
10425,Congenital qualifier,Cleft leaflet of tricuspid valve,0
10426,Congenital qualifier,Congenital absence of clitoris,0
10427,Congenital qualifier,Duane Retraction Syndrome,0
10428,Congenital qualifier,Dermatofibrosis lenticularis disseminata,0
10429,Congenital qualifier,Congenital anomaly of tongue,0
10430,Congenital qualifier,"Limb Deformities, Congenital",0
10431,Congenital qualifier,Congenital viral hepatitis B infection,0
10432,Congenital qualifier,Megaloblastic anemia due to congenital deficiency of intrinsic factor,0
10433,Congenital qualifier,Optic disc structural anomaly,0
10434,Congenital qualifier,Maternal PKU fetal effect,0
10435,Congenital qualifier,Congenital anomaly of adrenal gland,0
10436,Congenital qualifier,Ring chromosome 9 syndrome,0
10437,Congenital qualifier,Congenital cyst of mediastinum,0
10438,Congenital qualifier,Duplication of duodenum,0
10439,Congenital qualifier,Compound monster,0
10440,Congenital qualifier,"Atrial septal defect with endocardial cushion defect, partial type",0
10441,Congenital qualifier,Purine-nucleoside phosphorylase deficiency,0
10442,Congenital qualifier,"Glycogen storage disease, hepatic form",0
10443,Congenital qualifier,Congenital hypoplasia of aortic arch,0
10444,Congenital qualifier,Gardner Syndrome,0
10445,Congenital qualifier,Anomaly of chromosome pair 11,0
10446,Congenital qualifier,Heterologous chimera,0
10447,Congenital qualifier,Urocanase deficiency,0
10448,Congenital qualifier,Congenital esophagotracheal fistula,0
10449,Congenital qualifier,Epidermolysis Bullosa,0
10450,Congenital qualifier,Proline dehydrogenase deficiency,0
10451,Congenital qualifier,Ectopic intestinal mucosa,0
10452,Congenital qualifier,Microphthalmos,0
10453,Congenital qualifier,Fucosidosis Type I,0
10454,Congenital qualifier,Congenital deformity of knee joint,0
10455,Congenital qualifier,Fragile X Syndrome,0
10456,Congenital qualifier,Jarcho-Levin syndrome,0
10457,Congenital qualifier,Embryonic cyst of vagina,0
10458,Congenital qualifier,Glycogenosis with glucoaminophosphaturia,0
10459,Congenital qualifier,Congenital oculocutaneous hypopigmentation,0
10460,Congenital qualifier,Juvenile Neuronal Ceroid Lipofuscinosis,0
10461,Congenital qualifier,Turcot syndrome (disorder),0
10462,Congenital qualifier,Bladder Exstrophy,0
10463,Congenital qualifier,Glycogen storage disease type X,0
10464,Congenital qualifier,Rachischisis,0
10465,Congenital qualifier,Ask-Upmark kidney,0
10466,Congenital qualifier,Homologous chimera,0
10467,Congenital qualifier,Longitudinal deficiency of radius,0
10468,Congenital qualifier,"Truncus Arteriosus, Persistent",0
10469,Congenital qualifier,Adult Neuronal Ceroid Lipofuscinosis,0
10470,Congenital qualifier,Arterial anomaly of umbilical cord,0
10471,Congenital qualifier,Splenogonadal fusion,0
10472,Congenital qualifier,Congenital hourglass stomach,0
10473,Congenital qualifier,Fetal methyl mercury syndrome,0
10474,Congenital qualifier,Congenital rectovaginal constriction of Jersey cattle,0
10475,Congenital qualifier,Punctate oculocutaneous albinoidism,0
10476,Congenital qualifier,Etat Marbre,0
10477,Congenital qualifier,Diprosopus,0
10478,Congenital qualifier,Familial arthrogryposis-cholestatic hepatorenal syndrome,0
10479,Congenital qualifier,Polydactyly of toes,0
10480,Congenital qualifier,Arachnodactyly,0
10481,Congenital qualifier,"Mannosidosis, type I",0
10482,Congenital qualifier,"Cystinosis, Infantile Nephropathic",0
10483,Congenital qualifier,Congenital stenosis of inferior vena cava,0
10484,Congenital qualifier,Glucose-6-phosphate dehydrogenase deficiency anemia,0
10485,Congenital qualifier,Infantile GM 2 gangliosidosis,0
10486,Congenital qualifier,Accessory bladder,0
10487,Congenital qualifier,Ellis-Van Creveld Syndrome,0
10488,Congenital qualifier,Hyperammonemia Due to Carbamoyl Phosphate Synthetase 1 Deficiency,0
10489,Congenital qualifier,Ectopic ovary,0
10490,Congenital qualifier,"Folate Malabsorption, Hereditary",0
10491,Congenital qualifier,Amelia,0
10492,Congenital qualifier,9p partial monosomy syndrome,0
10493,Congenital qualifier,Multiple synostosis syndrome,0
10494,Congenital qualifier,Congenital cyst of posterior segment of eye,0
10495,Congenital qualifier,Failure of rotation of cecum,0
10496,Congenital qualifier,Congenital deviation of nasal septum,0
10497,Congenital qualifier,Congenital syphilitic meningitis,0
10498,Congenital qualifier,Franceschetti-Klein syndrome,0
10499,Congenital qualifier,Frontometaphyseal dysplasia,0
10500,Congenital qualifier,Incomplete bilateral cleft lip,0
10501,Congenital qualifier,Congenital anomaly of vas deferens,0
10502,Congenital qualifier,Congenital dilatation of trachea,0
10503,Congenital qualifier,"Antley-Bixler Syndrome, Autosomal Dominant",0
10504,Congenital qualifier,Persistent tunica vasculosa lentis,0
10505,Congenital qualifier,15q partial monosomy syndrome,0
10506,Congenital qualifier,Tricuspid Atresia,0
10507,Congenital qualifier,Single umbilical artery,0
10508,Congenital qualifier,Weaver syndrome,0
10509,Congenital qualifier,Hajdu-Cheney Syndrome,0
10510,Congenital qualifier,Thyroid Dyshormonogenesis 5,0
10511,Congenital qualifier,Peripheral congenital arteriovenous aneurysm,0
10512,Congenital qualifier,Decreased uric acid level,0
10513,Congenital qualifier,Congenital keratoconus,0
10514,Congenital qualifier,"Xanthomatosis, Cerebrotendinous",0
10515,Congenital qualifier,Williams Syndrome,0
10516,Congenital qualifier,Congenital rectovestibular fistula,0
10517,Congenital qualifier,"Hyperglycinemia, Nonketotic, Type I",0
10518,Congenital qualifier,Acephalocheiria,0
10519,Congenital qualifier,Larsen syndrome,0
10520,Congenital qualifier,Ulnar dimelia,0
10521,Congenital qualifier,Accessory ossification center,0
10522,Congenital qualifier,"ALBINISM, OCULOCUTANEOUS, TYPE III",0
10523,Congenital qualifier,Congenital anemia,0
10524,Congenital qualifier,Uranostaphyloschisis,0
10525,Congenital qualifier,Dens evaginatus,0
10526,Congenital qualifier,Alstrom Syndrome,0
10527,Congenital qualifier,Brachydactyly syndrome type E,0
10528,Congenital qualifier,Overbite,0
10529,Congenital qualifier,Inverted pelvis,0
10530,Congenital qualifier,"Albinism, Oculocutaneous",0
10531,Congenital qualifier,"Osteogenesis imperfecta, type 1A",0
10532,Congenital qualifier,Congenital subtotal cataract,0
10533,Congenital qualifier,Overriding aorta,0
10534,Congenital qualifier,Congenital absence of eyelash,0
10535,Congenital qualifier,Hemimelia of upper limb,0
10536,Congenital qualifier,Porphobilinogen synthase deficiency,0
10537,Congenital qualifier,Multiple malformation syndrome with unusual brain and/or neuromuscular findings,0
10538,Congenital qualifier,Parovarian Cyst,0
10539,Congenital qualifier,Ethanolaminosis,0
10540,Congenital qualifier,Median palatal cyst,0
10541,Congenital qualifier,Congenital rectovesical fistula,0
10542,Congenital qualifier,Congenital chordee,0
10543,Congenital qualifier,Aganglionosis of parasympathetic nerve ganglia,0
10544,Congenital qualifier,Osteogenesis imperfecta with blue sclerae AND normal teeth,0
10545,Congenital qualifier,Anakatadidymus,0
10546,Congenital qualifier,Endemic congenital iodine deficiency syndrome of myxedematous type,0
10547,Congenital qualifier,Congenital clubnail,0
10548,Congenital qualifier,Congenital nystagmus,0
10549,Congenital qualifier,Fucosidase Deficiency Disease,0
10550,Congenital qualifier,Accessory ureter,0
10551,Congenital qualifier,Malrotation of colon,0
10552,Congenital qualifier,Piebaldism,0
10553,Congenital qualifier,Oculocutaneous albinism type 1A,0
10554,Congenital qualifier,Sarcosinemia,0
10555,Congenital qualifier,Pelizaeus-Merzbacher Disease,0
10556,Congenital qualifier,Congenital rhabdomyoma of heart,0
10557,Congenital qualifier,Congenital incomplete atrioventricular heart block,0
10558,Congenital qualifier,Hypodontia,0
10559,Congenital qualifier,Congenital atresia of larynx,0
10560,Congenital qualifier,Congenital anomaly of hair,0
10561,Congenital qualifier,Accessory parathyroid gland,0
10562,Congenital qualifier,Anterior segment mesenchymal dysgenesis,0
10563,Congenital qualifier,Multiple malformation syndrome with facial defects as major feature,0
10564,Congenital qualifier,Spinal meningocele,0
10565,Congenital qualifier,Ectopic spleen,0
10566,Congenital qualifier,Deventer's pelvis,0
10567,Congenital qualifier,Accessory thyroid gland disorder,0
10568,Congenital qualifier,Congenital anomaly of parathyroid glands,0
10569,Congenital qualifier,Pfaundler-Hurler Syndrome,0
10570,Congenital qualifier,Ectopic pituitary tissue,0
10571,Congenital qualifier,Adrenoleukodystrophy,0
10572,Congenital qualifier,Sitosterolemia with xanthomatosis,0
10573,Congenital qualifier,Nasal encephalocele,0
10574,Congenital qualifier,"Primary hyperoxaluria, type I",0
10575,Congenital qualifier,Mannosidase Deficiency Diseases,0
10576,Congenital qualifier,High assimilation pelvis,0
10577,Congenital qualifier,Congenital anomaly of cerebrovascular system,0
10578,Congenital qualifier,Congenital genu recurvatum,0
10579,Congenital qualifier,Congenital anomaly of vulva,0
10580,Congenital qualifier,Reniform pelvis,0
10581,Congenital qualifier,Pseudo-Hurler Polydystrophy,0
10582,Congenital qualifier,"APRT deficiency, Japanese type",0
10583,Congenital qualifier,X-linked agammaglobulinemia,0
10584,Congenital qualifier,"Hymen, Imperforate",0
10585,Congenital qualifier,Bayonet hair,0
10586,Congenital qualifier,Cleidocranial Dysplasia,0
10587,Congenital qualifier,Fetal aminopterin syndrome,0
10588,Congenital qualifier,Congenital fold of posterior segment of eye,0
10589,Congenital qualifier,Genee-Wiedemann syndrome,0
10590,Congenital qualifier,Congenital hyperplasia of muscle,0
10591,Congenital qualifier,Odontodysplasia,0
10592,Congenital qualifier,Congenital shortening of the leg,0
10593,Congenital qualifier,Parrot's pseudoparalysis,0
10594,Congenital qualifier,Congenital Disorders,0
10595,Congenital qualifier,Congenital fusion of ribs,0
10596,Congenital qualifier,Hyperplasia of pancreatic islet beta cell,0
10597,Congenital qualifier,Autosomal dominant excess of transthyretin,0
10598,Congenital qualifier,Congenital absence of toe,0
10599,Congenital qualifier,Fetal trimethadione syndrome,0
10600,Congenital qualifier,"Congenital cardiovascular disorder in mother complicating pregnancy, childbirth AND/OR puerperium",0
10601,Congenital qualifier,Vascular ring,0
10602,Congenital qualifier,Craniopagus parietalis,0
10603,Congenital qualifier,Congenital absence of lung,0
10604,Congenital qualifier,Congenital cortical cataract,0
10605,Congenital qualifier,"Upper Extremity Deformities, Congenital",0
10606,Congenital qualifier,Arylsulfatase A Deficiency,0
10607,Congenital qualifier,Cervicoaural fistula,0
10608,Congenital qualifier,Triploidy syndrome,0
10609,Congenital qualifier,Anadidymus,0
10610,Congenital qualifier,"Niemann-Pick Disease, Type C",0
10611,Congenital qualifier,Acrodysostosis,0
10612,Congenital qualifier,Popliteal pterygium syndrome,0
10613,Congenital qualifier,Congenital absence of alimentary tract,0
10614,Congenital qualifier,Anomalous pulmonary venous drainage to superior vena cava,0
10615,Congenital qualifier,Congenital duplication of esophagus,0
10616,Congenital qualifier,Congenital absence of patella,0
10617,Congenital qualifier,Glycogen Storage Disease Type III,0
10618,Congenital qualifier,Cleft palate with cleft lip,0
10619,Congenital qualifier,18q partial trisomy syndrome,0
10620,Congenital qualifier,Congenital emphysema,0
10621,Congenital qualifier,Pyloric antral atresia,0
10622,Congenital qualifier,"Vitamin D-dependent rickets, type 1",0
10623,Congenital qualifier,Epidermolysis Bullosa Simplex,0
10624,Congenital qualifier,Ehlers-Danlos syndrome type 5,0
10625,Congenital qualifier,Ectopic pancreas in duodenum,0
10626,Congenital qualifier,Sirenomelia,0
10627,Congenital qualifier,Congenital stenosis of pulmonary valve,0
10628,Congenital qualifier,Anterior open bite,0
10629,Congenital qualifier,Wyburn Mason's syndrome,0
10630,Congenital qualifier,Longitudinal deficiency of limb,0
10631,Congenital qualifier,Cytochrome-c Oxidase Deficiency,0
10632,Congenital qualifier,Shell teeth,0
10633,Congenital qualifier,Ichthyosis hystrix,0
10634,Congenital qualifier,Spina Bifida,0
10635,Congenital qualifier,"Epidermolysis bullosa, pretibial",0
10636,Congenital qualifier,Ankyloglossia,0
10637,Congenital qualifier,Pili torti-deafness syndrome,0
10638,Congenital qualifier,"Hyperglycinemia, Nonketotic, Type II",0
10639,Congenital qualifier,"Maroteaux-Lamy syndrome, mild form",0
10640,Congenital qualifier,"Niemann-Pick disease, type C, subacute form",0
10641,Congenital qualifier,Congenital obstruction of aqueduct of Sylvius,0
10642,Congenital qualifier,Dwarf pelvis,0
10643,Congenital qualifier,Lhermitte-Duclos disease,0
10644,Congenital qualifier,Congenital anomaly of membranous labyrinth,0
10645,Congenital qualifier,Congenital anomaly of cartilage,0
10646,Congenital qualifier,"Crigler Najjar syndrome, type 2",0
10647,Congenital qualifier,Mixed congenital myopathy,0
10648,Congenital qualifier,Anomalous origin of pulmonary artery,0
10649,Congenital qualifier,Congenital hypoplasia of bile duct,0
10650,Congenital qualifier,Congenital myopathy with abnormal subcellular organelles,0
10651,Congenital qualifier,Partial anomalous pulmonary venous connection,0
10652,Congenital qualifier,Talipes Equinovalgus,0
10653,Congenital qualifier,Accessory adrenal gland,0
10654,Congenital qualifier,Congenital hemivertebra,0
10655,Congenital qualifier,VACTEL syndrome,0
10656,Congenital qualifier,Chronic gouty arthritis,0
10657,Congenital qualifier,Complete trisomy 8 syndrome,0
10658,Congenital qualifier,Ataxia Telangiectasia,0
10659,Congenital qualifier,Congenital bronchopulmonary foregut malformation,0
10660,Congenital qualifier,Limb reduction-ichthyosis syndrome,0
10661,Congenital qualifier,Talipes planovalgus,0
10662,Congenital qualifier,Congenital hypoplasia of pancreas,0
10663,Congenital qualifier,Latent nystagmus,0
10664,Congenital qualifier,Megaloblastic anemia due to error of cobalamin metabolism,0
10665,Congenital qualifier,Situs inversus abdominalis,0
10666,Congenital qualifier,Congenital keratoderma,0
10667,Congenital qualifier,Juvenile taboparesis,0
10668,Congenital qualifier,"Congenital dyserythropoietic anemia, type II",0
10669,Congenital qualifier,Triplet monster,0
10670,Congenital qualifier,Congenital mesenteroaxial volvulus of stomach,0
10671,Congenital qualifier,Fetus with suspected rubella damage via mother,0
10672,Congenital qualifier,Benign neonatal hyperaminoaciduria,0
10673,Congenital qualifier,Double urethra,0
10674,Congenital qualifier,Macrotia,0
10675,Congenital qualifier,Propionic acidemia,0
10676,Congenital qualifier,Rothmund-Thomson syndrome,0
10677,Congenital qualifier,Congenital anomaly of fixation of intestine,0
10678,Congenital qualifier,Aniridia,0
10679,Congenital qualifier,Cleft lip sequence,0
10680,Congenital qualifier,Macrodactylia of fingers,0
10681,Congenital qualifier,Mucopolysaccharidosis VI,0
10682,Congenital qualifier,Pancreatic colipase deficiency,0
10683,Congenital qualifier,Monilethrix,0
10684,Congenital qualifier,"Hereditary orotic aciduria, type 1",0
10685,Congenital qualifier,Combined immunodeficiency disease in Arab foals,0
10686,Congenital qualifier,Ecchordosis physaliphora,0
10687,Congenital qualifier,Unilobar lung,0
10688,Congenital qualifier,Congenital anomaly of esophagus,0
10689,Congenital qualifier,Congenital occlusion of anus,0
10690,Congenital qualifier,Residual ovary syndrome,0
10691,Congenital qualifier,Persistent primary vitreous,0
10692,Congenital qualifier,Congenital absence of pulmonic valve,0
10693,Congenital qualifier,Asymmetrical conjoined twins,0
10694,Congenital qualifier,Erythrokeratodermia variabilis,0
10695,Congenital qualifier,Fetal hydantoin syndrome,0
10696,Congenital qualifier,Congenital cubitus valgus,0
10697,Congenital qualifier,Anomaly of chromosome pair 21,0
10698,Congenital qualifier,Cri-du-Chat Syndrome,0
10699,Congenital qualifier,Hyperthermia-induced defect,0
10700,Congenital qualifier,Congenital anomaly of superior vena cava,0
10701,Congenital qualifier,Type II Mucolipidosis,0
10702,Congenital qualifier,Congenital adhesions of tongue,0
10703,Congenital qualifier,"Overjet, Dental",0
10704,Congenital qualifier,Crooked calf syndrome,0
10705,Congenital qualifier,Congenital anomaly of penis,0
10706,Congenital qualifier,Congenital anomaly of heart valve,0
10707,Congenital qualifier,15q partial trisomy syndrome,0
10708,Congenital qualifier,Pendred's syndrome,0
10709,Congenital qualifier,XTE syndrome,0
10710,Congenital qualifier,Pfeiffer Syndrome,0
10711,Congenital qualifier,Ectopic gastric tissue,0
10712,Congenital qualifier,Anomaly of chromosome pair 22,0
10713,Congenital qualifier,Dermal Sinus,0
10714,Congenital qualifier,HNSHA due to NADH-methemoglobin reductase deficiency,0
10715,Congenital qualifier,Mucolipidoses,0
10716,Congenital qualifier,Tethered Cord Syndrome,0
10717,Congenital qualifier,Streak ovary,0
10718,Congenital qualifier,Incomplete development of membranous labyrinth,0
10719,Congenital qualifier,Kinking of descending aorta,0
10720,Congenital qualifier,"Ehlers-Danlos syndrome, recessive type 4",0
10721,Congenital qualifier,Pygopagus,0
10722,Congenital qualifier,Congenital discoid meniscus,0
10723,Congenital qualifier,Accessory salivary gland,0
10724,Congenital qualifier,Mucopolysaccharidosis II,0
10725,Congenital qualifier,Bronchial atresia with segmental pulmonary emphysema,0
10726,Congenital qualifier,Congenital pseudarthrosis of clavicle,0
10727,Congenital qualifier,Single monster,0
10728,Congenital qualifier,Longitudinal deficiency of upper limb,0
10729,Congenital qualifier,Allemann's syndrome,0
10730,Congenital qualifier,Congenital absence of rib,0
10731,Congenital qualifier,Situs inversus thoracis,0
10732,Congenital qualifier,Multiseptate gallbladder,0
10733,Congenital qualifier,Dicheirus (disorder),0
10734,Congenital qualifier,Omental cyst,0
10735,Congenital qualifier,Congenital absence of upper arm AND forearm,0
10736,Congenital qualifier,Congenital spinal hydromeningocele,0
10737,Congenital qualifier,"Tay-Sachs Disease, AB Variant",0
10738,Congenital qualifier,Congenital kyphosis,0
10739,Congenital qualifier,"Joint laxity, familial",0
10740,Congenital qualifier,"Osteogenesis imperfecta, dominant perinatal lethal",0
10741,Congenital qualifier,Dipygus,0
10742,Congenital qualifier,Celoschisis,0
10743,Congenital qualifier,"Steroid 21-monooxygenase deficiency, salt wasting type",0
10744,Congenital qualifier,Congenital absence of ear,0
10745,Congenital qualifier,Congenital supravalvular aortic stenosis,0
10746,Congenital qualifier,"Maple syrup urine disease, multiple dehydrogenase form",0
10747,Congenital qualifier,Trisomy 22,0
10748,Congenital qualifier,"von Willebrand disease, type IIG",0
10749,Congenital qualifier,X-linked hydrocephalus syndrome,0
10750,Congenital qualifier,Anophthalmos,0
10751,Congenital qualifier,Congenital contracted pelvis,0
10752,Congenital qualifier,Bare Lymphocyte Syndrome,0
10753,Congenital qualifier,Infective pneumonia acquired prenatally,0
10754,Congenital qualifier,Congenital anomaly of broad ligament,0
10755,Congenital qualifier,Congenital aplasia of inner ear,0
10756,Congenital qualifier,Aase syndrome,0
10757,Congenital qualifier,Tuberous Sclerosis,0
10758,Congenital qualifier,Abnormal fetal duplication,0
10759,Congenital qualifier,Congenital anomaly of nose,0
10760,Congenital qualifier,fetal abnormality due to environmental toxins,0
10761,Congenital qualifier,Long narrow head,0
10762,Congenital qualifier,Postductal coarctation of aorta,0
10763,Congenital qualifier,Hypoplasia of cardiac vein,0
10764,Congenital qualifier,Inborn error of glutathione metabolism,0
10765,Congenital qualifier,Congenital anomaly of larynx,0
10766,Congenital qualifier,Bicuspid aortic valve,0
10767,Congenital qualifier,Congenital absence of diaphragm,0
10768,Congenital qualifier,Polysplenia Syndrome,0
10769,Congenital qualifier,"Niemann-Pick disease, type C, chronic form",0
10770,Congenital qualifier,"Ichthyosis, X-Linked",0
10771,Congenital qualifier,Cervical rib,0
10772,Congenital qualifier,"Mucopolysaccharidosis, MPS-IV-A",0
10773,Congenital qualifier,Uterus bicornis bicollus,0
10774,Congenital qualifier,Glycogen Storage Disease Type I,0
10775,Congenital qualifier,Total placenta previa with intrapartum hemorrhage,0
10776,Congenital qualifier,"Xanthinuria, Type I",0
10777,Congenital qualifier,Familial Hypophosphatemic Rickets,0
10778,Congenital qualifier,Prognathism,0
10779,Congenital qualifier,Megaloappendix,0
10780,Congenital qualifier,Dwarfism stiff joint ocular abnormalities,0
10781,Congenital qualifier,Majewski Syndrome,0
10782,Congenital qualifier,Polycystic liver disease,0
10783,Congenital qualifier,Anomaly of epiglottis,0
10784,Congenital qualifier,Gastroschisis,0
10785,Congenital qualifier,Polyploidy,0
10786,Congenital qualifier,10q partial trisomy syndrome,0
10787,Congenital qualifier,Aortic coarctation,0
10788,Congenital qualifier,X-linked variant form of thyroxine-binding globulin,0
10789,Congenital qualifier,Mucopolysaccharidosis V,0
10790,Congenital qualifier,"Hunter's syndrome, severe form",0
10791,Congenital qualifier,Pena-Shokeir phenotype,0
10792,Congenital qualifier,Accessory adrenal cortex,0
10793,Congenital qualifier,Congenital malformation of the urinary system,0
10794,Congenital qualifier,Marshall-Smith syndrome,0
10795,Congenital qualifier,Congenital absence of parathyroid gland,0
10796,Congenital qualifier,Hemimyelia,0
10797,Congenital qualifier,"Niemann-Pick Disease, Type E",0
10798,Congenital qualifier,Opocephalus,0
10799,Congenital qualifier,Congenital absence of germinal epithelium of testes,0
10800,Congenital qualifier,Congenital musculoskeletal anomalies,0
10801,Congenital qualifier,Congenital subaortic stenosis,0
10802,Congenital qualifier,Double outlet left ventricle,0
10803,Congenital qualifier,Common arterial trunk and common origin of pulmonary arteries,0
10804,Congenital qualifier,Congenital cutaneous angiomatosis,0
10805,Congenital qualifier,"Gangliosidosis, Generalized GM1, Type 3",0
10806,Congenital qualifier,Chronic tophaceous gout,0
10807,Congenital qualifier,"Toxoplasmosis, Congenital",0
10808,Congenital qualifier,Congenital malposition of digestive organs,0
10809,Congenital qualifier,5p partial trisomy syndrome,0
10810,Congenital qualifier,Congenital anomaly of pituitary gland,0
10811,Congenital qualifier,Isolated dextrocardia,0
10812,Congenital qualifier,Partial tetrasomy 9 syndrome,0
10813,Congenital qualifier,Coronary artery arising from main pulmonary artery,0
10814,Congenital qualifier,Congenital scar,0
10815,Congenital qualifier,Congenital absence of fibula,0
10816,Congenital qualifier,Female infertility due to structural congenital anomaly of cervix,0
10817,Congenital qualifier,Opodidymus,0
10818,Congenital qualifier,Woolf's syndrome,0
10819,Congenital qualifier,Congenital chromosomal disease,0
10820,Congenital qualifier,Complete trisomy 9 syndrome,0
10821,Congenital qualifier,Micromelia,0
10822,Congenital qualifier,Congenital atresia of aorta,0
10823,Congenital qualifier,Manus flexa,0
10824,Congenital qualifier,XX males,0
10825,Congenital qualifier,Craniopagus,0
10826,Congenital qualifier,Kommerell's diverticulum,0
10827,Congenital qualifier,Diplopodia,0
10828,Congenital qualifier,Crossed renal ectopia,0
10829,Congenital qualifier,Congenital short hard palate,0
10830,Congenital qualifier,Jugular lymphatic obstruction sequence,0
10831,Congenital qualifier,Hydrorhachis,0
10832,Congenital qualifier,Anomaly of chromosome pair 1,0
10833,Congenital qualifier,Tongue absent,0
10834,Congenital qualifier,Congenital atresia of epiglottis,0
10835,Congenital qualifier,Congenital coxa vara,0
10836,Congenital qualifier,Persistent cloaca,0
10837,Congenital qualifier,Double Outlet Right Ventricle,0
10838,Congenital qualifier,Congenital anomaly of spine,0
10839,Congenital qualifier,Absence of inferior vena cava,0
10840,Congenital qualifier,Dyskeratosis Congenita,0
10841,Congenital qualifier,Congenital stricture of ureter,0
10842,Congenital qualifier,CAMPOMELIC DYSPLASIA,0
10843,Congenital qualifier,Ectopia Lentis,0
10844,Congenital qualifier,Jeune thoracic dystrophy,0
10845,Congenital qualifier,Endemic Cretinism,0
10846,Congenital qualifier,"Myopathies, Nemaline",0
10847,Congenital qualifier,Amyelencephalus,0
10848,Congenital qualifier,Pseudohermaphroditism,0
10849,Congenital qualifier,Persistent tuberculum impar,0
10850,Congenital qualifier,Congenital absence of eustachian tube,0
10851,Congenital qualifier,MPS III C,0
10852,Congenital qualifier,Congenital diverticulum of left ventricle,0
10853,Congenital qualifier,Congenital absence of ossicles of ear,0
10854,Congenital qualifier,Congenital keratoconus posticus circumscriptus,0
10855,Congenital qualifier,Congenital atresia of external auditory canal,0
10856,Congenital qualifier,Congenital anomaly of mitral valve,0
10857,Congenital qualifier,Anomalous origin of coronary artery,0
10858,Congenital qualifier,Congenital absent nipple,0
10859,Congenital qualifier,Amyotrophia congenita,0
10860,Congenital qualifier,Congenital deformity of chest wall,0
10861,Congenital qualifier,"Hamartosis, NOS",0
10862,Congenital qualifier,Mucopolysaccharidosis I,0
10863,Congenital qualifier,Omphalopagus,0
10864,Congenital qualifier,Congenital anoperineal fistula,0
10865,Congenital qualifier,Familial renal iminoglycinuria,0
10866,Congenital qualifier,Benign autosomal dominant osteopetrosis,0
10867,Congenital qualifier,Lingual Goiter,0
10868,Congenital qualifier,Classical phenylketonuria,0
10869,Congenital qualifier,Pleonotia,0
10870,Congenital qualifier,14q partial trisomy syndrome,0
10871,Congenital qualifier,"Dominant dystrophic epidermolysis bullosa, albopapular type (disorder)",0
10872,Congenital qualifier,Brachymegalodactyly,0
10873,Congenital qualifier,19q partial trisomy syndrome,0
10874,Congenital qualifier,Congenital anomaly of ossicles of ear,0
10875,Congenital qualifier,Congenital absence of anus,0
10876,Congenital qualifier,Brachymetacarpia,0
10877,Congenital qualifier,Sotos' syndrome,0
10878,Congenital qualifier,Johanson-Blizzard syndrome,0
10879,Congenital qualifier,Double urinary meatus,0
10880,Congenital qualifier,Platyspondylia,0
10881,Congenital qualifier,Agenesis of right lung,0
10882,Congenital qualifier,Symmetrical conjoined twins,0
10883,Congenital qualifier,Septo-Optic Dysplasia,0
10884,Congenital qualifier,Bat ear,0
10885,Congenital qualifier,"Chronic granulomatous disease, type IVA",0
10886,Congenital qualifier,Bicuspid cardiac valve,0
10887,Congenital qualifier,Rudimentary tracheal bronchus,0
10888,Congenital qualifier,Congenital lumbosacral stenosis,0
10889,Congenital qualifier,"6q+ Syndrome, Partial",0
10890,Congenital qualifier,Incomplete congenital absence of arm AND forearm,0
10891,Congenital qualifier,Robinow Syndrome,0
10892,Congenital qualifier,Hyperphosphatasia-osteoectasia syndrome,0
10893,Congenital qualifier,Congenital subcapsular cataract,0
10894,Congenital qualifier,"Muscular Dystrophy, Duchenne",0
10895,Congenital qualifier,Longitudinal deficiency of fibula,0
10896,Congenital qualifier,Complete aphalangia of upper limb,0
10897,Congenital qualifier,Angelman Syndrome,0
10898,Congenital qualifier,Spina Bifida Occulta,0
10899,Congenital qualifier,Amyoplasia congenita disruptive sequence,0
10900,Congenital qualifier,"Muscular Dystrophy, Oculopharyngeal",0
10901,Congenital qualifier,X-Linked Lymphoproliferative Disorder,0
10902,Congenital qualifier,DiGeorge Syndrome,0
10903,Congenital qualifier,Cartilage-hair hypoplasia,0
10904,Congenital qualifier,Thoracopagus epigastricus,0
10905,Congenital qualifier,Spina bifida of lumbar region,0
10906,Congenital qualifier,Complete trisomy 16 syndrome,0
10907,Congenital qualifier,Acephalorhachia,0
10908,Congenital qualifier,Autosomal dominant hypohidrotic ectodermal dysplasia syndrome (disorder),0
10909,Congenital qualifier,Omphaloangiopagus,0
10910,Congenital qualifier,"Chronic granulomatous disease, type II",0
10911,Congenital qualifier,Congenital leukocyte adherence deficiency,0
10912,Congenital qualifier,Dihydropyrimidine Dehydrogenase Deficiency,0
10913,Congenital qualifier,Cheilognathoschisis,0
10914,Congenital qualifier,Synotus,0
10915,Congenital qualifier,Deuteranomaly,0
10916,Congenital qualifier,Biliary Atresia,0
10917,Congenital qualifier,3p partial trisomy syndrome,0
10918,Congenital qualifier,"Chromosome 9, partial trisomy 9p",0
10919,Congenital qualifier,"Chondrodysplasia, Grebe type",0
10920,Congenital qualifier,Congenital bronchiectasis,0
10921,Congenital qualifier,Reduction deformity of lower limb,0
10922,Congenital qualifier,Baller-Gerold syndrome,0
10923,Congenital qualifier,Paraspadias,0
10924,Congenital qualifier,Dicephalus dipus tribrachius,0
10925,Congenital qualifier,8p partial trisomy syndrome,0
10926,Congenital qualifier,Double aortic valve,0
10927,Congenital qualifier,"Multiple malformation syndrome, moderate short stature, facial",0
10928,Congenital qualifier,Storage disease of the lung,0
10929,Congenital qualifier,Congenital absence of ureter,0
10930,Congenital qualifier,Syphilitic saddle nose,0
10931,Congenital qualifier,Complete trisomy 10 syndrome,0
10932,Congenital qualifier,Neu-Laxova syndrome,0
10933,Congenital qualifier,Congenital abnormality of respiratory system,0
10934,Congenital qualifier,Myotonic Dystrophy,0
10935,Congenital qualifier,Pygomelus,0
10936,Congenital qualifier,Persistent left superior vena cava,0
10937,Congenital qualifier,Complete phocomelia of upper limb,0
10938,Congenital qualifier,Atlanto-occipital malformation,0
10939,Congenital qualifier,Hydromicrocephaly,0
10940,Congenital qualifier,Glycoprotein storage disorder,0
10941,Congenital qualifier,Double mitral valve,0
10942,Congenital qualifier,Ectopia Cordis,0
10943,Congenital qualifier,Tuberculum paramolare (disorder),0
10944,Congenital qualifier,Osteogenesis Imperfecta,0
10945,Congenital qualifier,XXXY syndrome,0
10946,Congenital qualifier,Quadricuspid cardiac valve,0
10947,Congenital qualifier,Intrahepatic gallbladder,0
10948,Congenital qualifier,Rudimentary finger,0
10949,Congenital qualifier,Acyanotic congenital heart disease,0
10950,Congenital qualifier,Amelogenesis Imperfecta,0
10951,Congenital qualifier,Cleft leaflet of mitral valve,0
10952,Congenital qualifier,Neurocutaneous Syndromes,0
10953,Congenital qualifier,gamma-Glutamyltransferase deficiency,0
10954,Congenital qualifier,Congenital anomaly of trunk,0
10955,Congenital qualifier,"Ocular albinism, type I",0
10956,Congenital qualifier,Stickler syndrome (disorder),0
10957,Congenital qualifier,Congenital hypoplasia of part of brain,0
10958,Congenital qualifier,Gastrothoracopagus,0
10959,Congenital qualifier,Complete monosomy 21 syndrome,0
10960,Congenital qualifier,Globulo-maxillary cyst,0
10961,Congenital qualifier,Amyelia,0
10962,Congenital qualifier,Congenital pneumonia,0
10963,Congenital qualifier,Autosomal recessive ocular albinism,0
10964,Congenital qualifier,Right ductus arteriosus (disorder),0
10965,Congenital qualifier,Pancreatic triacylglycerol lipase deficiency,0
10966,Congenital qualifier,Hallermann's Syndrome,0
10967,Congenital qualifier,Accessory pancreas,0
10968,Congenital qualifier,Cylindrical embryo,0
10969,Congenital qualifier,Sprengel deformity,0
10970,Congenital qualifier,Congenital genu varum,0
10971,Congenital qualifier,Congenital absence of tibia,0
10972,Congenital qualifier,Congenital anomaly of muscle AND/OR tendon,0
10973,Congenital qualifier,Congenital deformity of clavicle,0
10974,Congenital qualifier,Bifid patella,0
10975,Congenital qualifier,Lumbosacral prespondylolisthesis,0
10976,Congenital qualifier,Van der Woude syndrome,0
10977,Congenital qualifier,Expanded rubella syndrome,0
10978,Congenital qualifier,Oculocerebrorenal Syndrome,0
10979,Congenital qualifier,Asymmetric talipes,0
10980,Congenital qualifier,Congenital cataract,0
10981,Congenital qualifier,Autosomal dominant oculocutaneous albinism,0
10982,Congenital qualifier,Freemartin,0
10983,Congenital qualifier,Congenital anomaly of aortic arch,0
10984,Congenital qualifier,Familial benign pemphigus,0
10985,Congenital qualifier,Thyroxine plasma membrane transport defect,0
10986,Congenital qualifier,Congenital displacement of esophagus,0
10987,Congenital qualifier,Congenital duplication of liver,0
10988,Congenital qualifier,"Hepatic Fibrosis, Congenital",0
10989,Congenital qualifier,Congenital listeriosis,0
10990,Congenital qualifier,1q partial trisomy syndrome,0
10991,Congenital qualifier,Anomaly of chromosome pair 19,0
10992,Congenital qualifier,Wildervanck's syndrome,0
10993,Congenital qualifier,Monocephalus tetrapus dibrachius,0
10994,Congenital qualifier,Atresia of urinary meatus,0
10995,Congenital qualifier,Congenital leptomeningeal angiomatosis,0
10996,Congenital qualifier,Talipes valgus,0
10997,Congenital qualifier,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS (disorder)",0
10998,Congenital qualifier,Junctional Epidermolysis Bullosa,0
10999,Congenital qualifier,Mirror hands,0
11000,Congenital qualifier,Farber Lipogranulomatosis,0
11001,Congenital qualifier,Congenital hallux varus,0
11002,Congenital qualifier,Congenital atresia of broad ligament,0
11003,Congenital qualifier,Congenital hypoplasia of patella,0
11004,Congenital qualifier,Plummer-Vinson Syndrome,0
11005,Congenital qualifier,Fetal or suspected fetal hydrocephalus affecting management of mother,0
11006,Congenital qualifier,Cleft upper lip,0
11007,Congenital qualifier,Congenital anomaly of thyroid cartilage,0
11008,Congenital qualifier,Roger's disease,0
11009,Congenital qualifier,Porokeratosis of Mibelli,0
11010,Congenital qualifier,Complete bilateral cleft lip,0
11011,Congenital qualifier,Uterus bicornuatus vetularum,0
11012,Congenital qualifier,Aicardi's syndrome,0
11013,Congenital qualifier,Juvenile pelvis,0
11014,Congenital qualifier,Floating gallbladder,0
11015,Congenital qualifier,Congenital spondylolysis of lumbosacral region,0
11016,Congenital qualifier,Marinesco-Sjogren syndrome,0
11017,Congenital qualifier,Multiple pterygium syndrome,0
11018,Congenital qualifier,Congenital stricture of vesicourethral orifice,0
11019,Congenital qualifier,Congenital hypoplasia of lung,0
11020,Congenital qualifier,Omphalomesenteric duct cyst,0
11021,Congenital qualifier,Ornithine carbamoyltransferase deficiency,0
11022,Congenital qualifier,G-6-PD class V variant anemia,0
11023,Congenital qualifier,Congenital anomaly of spinal cord,0
11024,Congenital qualifier,Congenital atresia of vein,0
11025,Congenital qualifier,Congenital diverticulum of bladder,0
11026,Congenital qualifier,Ectrodactyly,0
11027,Congenital qualifier,7q partial monosomy syndrome,0
11028,Congenital qualifier,Ischiomelus,0
11029,Congenital qualifier,Polysyndactyly,0
11030,Congenital qualifier,Congenital anomaly of abdominal wall,0
11031,Congenital qualifier,Anomaly of chromosome Y,0
11032,Congenital qualifier,"opacity; vitreous body, congenital",0
11033,Congenital qualifier,Hydromeningomyelocele,0
11034,Congenital qualifier,"Metatarsus primus varus, congenital",0
11035,Congenital qualifier,Congenital anomaly of inferior vena cava,0
11036,Congenital qualifier,Mulibrey Nanism,0
11037,Congenital qualifier,Ring chromosome 4 syndrome,0
11038,Congenital qualifier,Hemimelia of lower limb,0
11039,Congenital qualifier,"Opitz GBBB Syndrome, X-Linked",0
11040,Congenital qualifier,Beckwith-Wiedemann Syndrome,0
11041,Congenital qualifier,Hand polydactyly,0
11042,Congenital qualifier,Alexander Disease,0
11043,Congenital qualifier,Iodide peroxidase defect,0
11044,Congenital qualifier,Nephrosialidosis,0
11045,Congenital qualifier,Cor biloculare,0
11046,Congenital qualifier,G-6-PD class IV variant anemia,0
11047,Congenital qualifier,Thoracoparacephalus,0
11048,Congenital qualifier,Congenital debility of fetus,0
11049,Congenital qualifier,Myelocele,0
11050,Congenital qualifier,Congenital hydrocele,0
11051,Congenital qualifier,Centronuclear myopathy,0
11052,Congenital qualifier,Mandibulofacial Dysostosis,0
11053,Congenital qualifier,"Vitamin D-Resistant Rickets, X-Linked",0
11054,Congenital qualifier,Hyperimmunoglobulin M syndrome,0
11055,Congenital qualifier,"Chronic granulomatous disease, type III",0
11056,Congenital qualifier,Acyl-CoA dehydrogenase deficiency,0
11057,Congenital qualifier,Late congenital syphilis (2 years OR more),0
11058,Congenital qualifier,"46, XY female",0
11059,Congenital qualifier,Yellow mutant oculocutaneous albinism,0
11060,Congenital qualifier,Congenital infectious disease,0
11061,Congenital qualifier,Multiple system malformation syndrome,0
11062,Congenital qualifier,Primary endocardial fibroelastosis,0
11063,Congenital qualifier,Giant esophagus,0
11064,Congenital qualifier,Congenital stenosis of mitral valve,0
11065,Congenital qualifier,Wolman Disease,0
11066,Congenital qualifier,Embryonic cyst of Gartner's duct,0
11067,Congenital qualifier,Congenital cystic kidney disease,0
11068,Congenital qualifier,Female infertility due to congenital anomaly of fallopian tube,0
11069,Congenital qualifier,Accessory urethra,0
11070,Congenital qualifier,White Heifer Disease,0
11071,Congenital qualifier,Osteopathia striata,0
11072,Congenital qualifier,Dyggve-Melchior-Clausen syndrome,0
11073,Congenital qualifier,"Late congenital syphilis, latent (+ sero., - C.S.F., 2 years OR more)",0
11074,Congenital qualifier,Fibrodysplasia Ossificans Progressiva,0
11075,Congenital qualifier,7p partial trisomy syndrome,0
11076,Congenital qualifier,Astragaloscaphoid synostosis,0
11077,Congenital qualifier,Congenital anomaly of prostate,0
11078,Congenital qualifier,Congenital atresia of extrahepatic bile duct,0
11079,Congenital qualifier,Kenny-Caffey syndrome,0
11080,Congenital qualifier,Congenital absence of pancreas,0
11081,Congenital qualifier,Dementia paralytica juvenilis,0
11082,Congenital qualifier,Caudal Regression Syndrome,0
11083,Congenital qualifier,Saethre-Chotzen Syndrome,0
11084,Congenital qualifier,Congenital partial absence of alimentary tract,0
11085,Congenital qualifier,Shprintzen syndrome,0
11086,Congenital qualifier,Congenital insufficiency of tricuspid valve,0
11087,Congenital qualifier,Eisenmenger Complex,0
11088,Congenital qualifier,Abnormal dermatoglyphic pattern,0
11089,Congenital qualifier,Congenital absence of adrenal gland,0
11090,Congenital qualifier,Congenital anomaly of spermatic cord,0
11091,Congenital qualifier,Patent ductus arteriosus,0
11092,Congenital qualifier,Ehlers-Danlos syndrome type 1,0
11093,Congenital qualifier,Congenital syphilitic coryza,0
11094,Congenital qualifier,Congenital anomaly of breast,0
11095,Congenital qualifier,"Gonadal Dysgenesis, Mixed",0
11096,Congenital qualifier,14q partial proximal trisomy syndrome,0
11097,Congenital qualifier,"Ehlers-Danlos syndrome, dysfibronectinemic",0
11098,Congenital qualifier,Micrognathism,0
11099,Congenital qualifier,Congenital microgastria,0
11100,Congenital qualifier,6p partial trisomy syndrome,0
11101,Congenital qualifier,Maxillary retrognathism,0
11102,Congenital qualifier,Congenitally Corrected Transposition of the Great Arteries,0
11103,Congenital qualifier,Congenital ear anomaly NOS (disorder),0
11104,Congenital qualifier,Agnathus (disorder),0
11105,Congenital qualifier,Infantile pelvis,0
11106,Congenital qualifier,Congenital absence of skull bone,0
11107,Congenital qualifier,Arteriovenous malformation of liver,0
11108,Congenital qualifier,Chondrodystrophy malacia,0
11109,Congenital qualifier,"alpha, alpha-Trehalase deficiency",0
11110,Congenital qualifier,Atresia of small intestine,0
11111,Congenital qualifier,Congenital accessory skin tag,0
11112,Congenital qualifier,Exencephaly,0
11113,Congenital qualifier,Congenital anomaly of skeletal bone,0
11114,Congenital qualifier,Bifid tongue,0
11115,Congenital qualifier,Pygodidymus,0
11116,Congenital qualifier,Polysyndactyly,0
11117,Congenital qualifier,Acardius,0
11118,Congenital qualifier,Anomaly of chromosome pair 4,0
11119,Congenital qualifier,"Mottled teeth, congenital",0
11120,Congenital qualifier,"Lower Extremity Deformities, Congenital",0
11121,Congenital qualifier,Sporadic cretinism,0
11122,Congenital qualifier,Streak gonad,0
11123,Congenital qualifier,Dural arteriovenous malformation,0
11124,Congenital qualifier,Congenital absence of radius,0
11125,Congenital qualifier,Facial palsy as birth trauma,0
11126,Congenital qualifier,Congenital anomaly of fallopian tubes,0
11127,Congenital qualifier,Common arterial trunk and widely separate origin of pulmonary arteries,0
11128,Congenital qualifier,Splayleg in piglets,0
11129,Congenital qualifier,Congenital malformation of vitreous humor,0
11130,Congenital qualifier,Uterus bicameratus vetularum,0
11131,Congenital qualifier,Congenital hammer toe,0
11132,Congenital qualifier,Congenital hypoplasia of testis,0
11133,Congenital qualifier,Disorder of pyrimidine metabolism,0
11134,Congenital qualifier,Dicephalus dipus tetrabrachius,0
11135,Congenital qualifier,Phosphate Diabetes,0
11136,Congenital qualifier,Thrombocytopenia-Absent Radius Syndrome,0
11137,Congenital qualifier,Craniopagus occipitalis,0
11138,Congenital qualifier,"incomplete anencephaly, hemicrania",0
11139,Congenital qualifier,Syncephalus,0
11140,Congenital qualifier,Microhepatia (disorder),0
11141,Congenital qualifier,Congenital duodenal obstruction due to annular pancreas,0
11142,Congenital qualifier,Congenital diverticulum of colon,0
11143,Congenital qualifier,Megacalycosis,0
11144,Congenital qualifier,Inborn Errors of Metabolism,0
11145,Congenital qualifier,Ciliary Motility Disorders,0
11146,Congenital qualifier,Agenesis of pulmonary artery,0
11147,Congenital qualifier,Achondroplasia,0
11148,Congenital qualifier,Thoracomelus,0
11149,Congenital qualifier,Tetralogy of Fallot,0
11150,Congenital qualifier,Schwartz-Jampel Syndrome,0
11151,Congenital qualifier,Lymphedema distichiasis syndrome,0
11152,Congenital qualifier,Bertolotti's syndrome,0
11153,Congenital qualifier,Congenital hernia of foramen of Bochdalek,0
11154,Congenital qualifier,Hutchinson's Teeth,0
11155,Congenital qualifier,"Niemann-Pick disease, type C, acute form",0
11156,Congenital qualifier,Solitary multilocular renal cyst,0
11157,Congenital qualifier,"Osteogenesis imperfecta, recessive perinatal lethal",0
11158,Congenital qualifier,Congenital anomaly of thoracic cage,0
11159,Congenital qualifier,"Gallbladder, Agenesis Of",0
11160,Congenital qualifier,Hypoplasia of eye,0
11161,Congenital qualifier,Ectodermal Dysplasia,0
11162,Congenital qualifier,Congenital mesocolic hernia,0
11163,Congenital qualifier,Frontonasal dysplasia sequence,0
11164,Congenital qualifier,Diplopodia,0
11165,Congenital qualifier,Kasabach-Merritt syndrome,0
11166,Congenital qualifier,"Ehlers-Danlos syndrome, dominant type 4",0
11167,Congenital qualifier,Congenital ankylosis of elbow,0
11168,Congenital qualifier,Glucose-6-phosphate dehydrogenase variant enzyme deficiency anemia,0
11169,Congenital qualifier,Abnormal fetus,0
11170,Congenital qualifier,Angioectopia,0
11171,Congenital qualifier,Bird tongue,0
11172,Congenital qualifier,Congenital anomaly of rectum,0
11173,Congenital qualifier,Ring chromosome 10 syndrome,0
11174,Congenital qualifier,Congenital cyst of esophagus,0
11175,Congenital qualifier,"Sialic Acid Storage Disease, Finnish Type (disorder)",0
11176,Congenital qualifier,Congenital urethrorectal fistula,0
11177,Congenital qualifier,Congenital cystic lung,0
11178,Congenital qualifier,Congenital subaortic stenosis due to fibromuscular shelf,0
11179,Congenital qualifier,Congenital absence of appendix,0
11180,Congenital qualifier,Hyperplasia of islet alpha cells with glucagon excess,0
11181,Congenital qualifier,Congenital anomaly of head,0
11182,Congenital qualifier,Supernumerary vertebra,0
11183,Congenital qualifier,Monorchism,0
11184,Congenital qualifier,Congenital syphilis with gumma,0
11185,Congenital qualifier,Agenesis of vagina,0
11186,Congenital qualifier,"von Willebrand Disease, Type 2A",0
11187,Congenital qualifier,Hyperplastic chondrodystrophy,0
11188,Congenital qualifier,Ectopic gallbladder,0
11189,Congenital qualifier,Hecht syndrome (disorder),0
11190,Congenital qualifier,Classic Pelizaeus-Merzbacher Disease,0
11191,Congenital qualifier,Pyruvate Carboxylase Deficiency Disease,0
11192,Congenital qualifier,Isovaleryl-CoA dehydrogenase deficiency,0
11193,Congenital qualifier,Rokitansky sequence,0
11194,Congenital qualifier,Cleft Palate,0
11195,Congenital qualifier,Female Pseudohermaphroditism,0
11196,Congenital qualifier,Congenital megalogastria,0
11197,Congenital qualifier,Biotinidase Deficiency,0
11198,Congenital qualifier,Nodular renal blastema,0
11199,Congenital qualifier,Congenital onychauxis,0
11200,Congenital qualifier,Ring chromosome 18 syndrome,0
11201,Congenital qualifier,Congenital stenosis of vena cava,0
11202,Congenital qualifier,16p partial trisomy syndrome,0
11203,Congenital qualifier,Congenital anomaly of diaphragm,0
11204,Congenital qualifier,Mucopolysaccharidosis III,0
11205,Congenital qualifier,Congenital neurologic anomalies,0
11206,Congenital qualifier,Displaced ureteric orifice,0
11207,Congenital qualifier,Anomalous muscle bands of right ventricle,0
11208,Congenital qualifier,Zellweger Syndrome,0
11209,Congenital qualifier,Lateral developmental cyst of jaw,0
11210,Congenital qualifier,Nagele's pelvis,0
11211,Congenital qualifier,Coronary artery arising from aorta,0
11212,Congenital qualifier,Congenital absence of spermatic cord,0
11213,Congenital qualifier,Cheilognathoprosoposchisis,0
11214,Congenital qualifier,Congenital anomaly of cervix,0
11215,Congenital qualifier,"Anemia, Diamond-Blackfan",0
11216,Congenital qualifier,4q partial trisomy syndrome,0
11217,Congenital qualifier,Congenital hypoplasia of breast,0
11218,Congenital qualifier,Congenital web of esophagus,0
11219,Congenital qualifier,Polymelia,0
11220,Congenital qualifier,Congenital prolapsed uterus,0
11221,Congenital qualifier,"Crigler Najjar syndrome, type 1",0
11222,Congenital qualifier,Anencephaly,0
11223,Congenital qualifier,Congenital displacement of stomach,0
11224,Congenital qualifier,Prader-Willi Syndrome,0
11225,Congenital qualifier,Gastrothoracopagus dipygus,0
11226,Congenital qualifier,Complete aphalangia of lower limb,0
11227,Congenital qualifier,Mobius Syndrome,0
11228,Congenital qualifier,Shwachman syndrome,0
11229,Congenital qualifier,Persistent human tail,0
11230,Congenital qualifier,Arakawa syndrome 2,0
11231,Congenital qualifier,Glycogen Storage Disease Type VII,0
11232,Congenital qualifier,Katadidymus,0
11233,Congenital qualifier,Pycnodysostosis,0
11234,Congenital qualifier,Congenital neutropenia,0
11235,Congenital qualifier,Congenital genu valgum,0
11236,Congenital qualifier,Transposition of colon,0
11237,Congenital qualifier,Congenital anomaly of skeletal muscle,0
11238,Congenital qualifier,Ectopic pancreatic tissue in stomach,0
11239,Congenital qualifier,Orotic Aciduria II,0
11240,Congenital qualifier,Fetus papyraceous,0
11241,Congenital qualifier,Frontal bossing,0
11242,Congenital qualifier,"Porokeratosis of Mibelli, linear unilateral type",0
11243,Congenital qualifier,Autositic twin of asymmetrical conjoined twins,0
11244,Congenital qualifier,Aplasia of aorta,0
11245,Congenital qualifier,Congenital varicella infection,0
11246,Congenital qualifier,Epidermolysis Bullosa Simplex Kobner,0
11247,Congenital qualifier,Congenital anomaly of artery,0
11248,Congenital qualifier,Carnitine palmitoyltransferase deficiency,0
11249,Congenital qualifier,Gout,0
11250,Congenital qualifier,Persistent lanugo,0
11251,Congenital qualifier,Congenital diverticulum of stomach,0
11252,Congenital qualifier,Congenital asymmetry of jaw,0
11253,Congenital qualifier,Partial Trisomy 3q Syndrome,0
11254,Congenital qualifier,Cordate pelvis,0
11255,Congenital qualifier,Muscle AMP deaminase deficiency,0
11256,Congenital qualifier,Walker-Warburg congenital muscular dystrophy,0
11257,Congenital qualifier,Cephalodymus,0
11258,Congenital qualifier,Sirenomelia,0
11259,Congenital qualifier,Congenital anomaly of eyelid,0
11260,Congenital qualifier,Congenital anourethral fistula,0
11261,Congenital qualifier,Ectopic adrenal cortex,0
11262,Congenital qualifier,Capillary fragility abnormality,0
11263,Congenital qualifier,Congenital atresia of rectum,0
11264,Congenital qualifier,Accessory bronchus,0
11265,Congenital qualifier,Osteopoikilosis (disorder),0
11266,Congenital qualifier,Congenital herpes simplex,0
11267,Congenital qualifier,Congenital absence of artery,0
11268,Congenital qualifier,Fused commissures of mitral valve,0
11269,Congenital qualifier,Abnormal communication between pericardial sac and peritoneal cavity,0
11270,Congenital qualifier,Abnormal lung lobation,0
11271,Congenital qualifier,Supernumerary gallbladder,0
11272,Congenital qualifier,Accessory gonad,0
11273,Congenital qualifier,Supernumerary metacarpal bone,0
11274,Congenital qualifier,Accessory sternebral ossification site,0
11275,Congenital qualifier,Acephaly,0
11276,Congenital qualifier,Acephalostomia,0
11277,Congenital qualifier,Congenital absence of stomach,0
11278,Congenital qualifier,Congenital absence of alisphenoid bone,0
11279,Congenital qualifier,Congenital absence of basioccipital bone,0
11280,Congenital qualifier,Congenital absence of basisphenoid bone,0
11281,Congenital qualifier,Congenital absence of calcaneus,0
11282,Congenital qualifier,Congenital absence of carpal bone,0
11283,Congenital qualifier,Congenital absence of arch of caudal vertebra,0
11284,Congenital qualifier,Congenital absence of centrum of caudal vertebra,0
11285,Congenital qualifier,Congenital absence of caudal vertebra,0
11286,Congenital qualifier,Congenital absence of centrum of cervical vertebra,0
11287,Congenital qualifier,Congenital absence of centrum of sacral vertebra,0
11288,Congenital qualifier,Congenital absence of arch of cervical vertebra,0
11289,Congenital qualifier,"Cervical Vertebrae, Agenesis Of",0
11290,Congenital qualifier,Congenital absence of claw,0
11291,Congenital qualifier,Congenital absence of epididymis,0
11292,Congenital qualifier,Congenital absence of exoccipital bone,0
11293,Congenital qualifier,Congenital absence of forepaw phalanx,0
11294,Congenital qualifier,Congenital absence of frontal bone,0
11295,Congenital qualifier,Congenital absence of hindpaw phalanx,0
11296,Congenital qualifier,Congenital absence of hyoid bone,0
11297,Congenital qualifier,Congenital absence of ilium,0
11298,Congenital qualifier,Congenital absence of interparietal bone,0
11299,Congenital qualifier,Congenital absence of intestinal tract,0
11300,Congenital qualifier,Congenital absence of ischium,0
11301,Congenital qualifier,Congenital absence of lacrimal bone,0
11302,Congenital qualifier,Congenital absence of arch of lumbar vertebra,0
11303,Congenital qualifier,Congenital absence of centrum of lumbar vertebra,0
11304,Congenital qualifier,Congenital absence of lumbar vertebra,0
11305,Congenital qualifier,Congenital absence of mandible,0
11306,Congenital qualifier,Congenital absence of maxilla,0
11307,Congenital qualifier,Congenital absence of metacarpal bone,0
11308,Congenital qualifier,Congenital absence of metatarsal bone,0
11309,Congenital qualifier,Congenital absence of nasal bone,0
11310,Congenital qualifier,Congenital absence of palatine bone,0
11311,Congenital qualifier,Congenital absence of parietal bone,0
11312,Congenital qualifier,Congenital absence of premaxilla,0
11313,Congenital qualifier,Congenital absence of presphenoid bone,0
11314,Congenital qualifier,Congenital absence of pubis,0
11315,Congenital qualifier,Congenital absence of arch of sacral vertebra,0
11316,Congenital qualifier,Congenital absence of sacral vertebra,0
11317,Congenital qualifier,Congenital absence of scapula,0
11318,Congenital qualifier,Congenital absence of squamosal bone,0
11319,Congenital qualifier,Congenital absence of sternebra,0
11320,Congenital qualifier,Congenital absence of supraoccipital bone,0
11321,Congenital qualifier,Congenital absence of tail,0
11322,Congenital qualifier,Congenital absence of talus,0
11323,Congenital qualifier,Congenital absence of tarsal bone,0
11324,Congenital qualifier,Congenital absence of arch of thoracic vertebra,0
11325,Congenital qualifier,Congenital absence of centrum of thoracic vertebra,0
11326,Congenital qualifier,Congenital absence of thoracic vertebra,0
11327,Congenital qualifier,Congenital absence of thymus,0
11328,Congenital qualifier,Congenital absence of tympanic anulus,0
11329,Congenital qualifier,Congenital absence of vomer,0
11330,Congenital qualifier,Congenital absence of zygomatic bone,0
11331,Congenital qualifier,Congenital absence of jaw,0
11332,Congenital qualifier,Congenital absence of paw,0
11333,Congenital qualifier,Benign neoplasm of ectopic male breast tissue,0
11334,Congenital qualifier,Impacted teeth with abnormal position,0
11335,Congenital qualifier,Cleft cartilaginous centrum of cervical vertebra,0
11336,Congenital qualifier,Cleft cartilaginous centrum of lumbar vertebra,0
11337,Congenital qualifier,Cleft cartilaginous centrum of sacral vertebra,0
11338,Congenital qualifier,Cleft cartilaginous centrum of thoracic vertebra,0
11339,Congenital qualifier,Bipartite ossification of centrum of caudal vertebra,0
11340,Congenital qualifier,Bipartite ossification of centrum of cervical vertebra,0
11341,Congenital qualifier,Bipartite ossification of interparietal bone,0
11342,Congenital qualifier,Bipartite ossification of centrum of lumbar vertebra,0
11343,Congenital qualifier,Bipartite ossification of centrum of sacral vertebra,0
11344,Congenital qualifier,Bipartite ossification of sternebra,0
11345,Congenital qualifier,Bipartite ossification of supraoccipital bone,0
11346,Congenital qualifier,Bipartite ossification of centrum of thoracic vertebra,0
11347,Congenital qualifier,Congenital cleft of thymus,0
11348,Congenital qualifier,Neurofibromatosis 2,0
11349,Congenital qualifier,Bilateral crossbite,0
11350,Congenital qualifier,Buccal crossbite,0
11351,Congenital qualifier,Congenital bowing of tibia and/or fibula,0
11352,Congenital qualifier,Carcinoma in situ of ectopic male breast tissue,0
11353,Congenital qualifier,Caudal hemivertebra,0
11354,Congenital qualifier,Cervical hemivertebra,0
11355,Congenital qualifier,Cleft face,0
11356,Congenital qualifier,Cleft mandible,0
11357,Congenital qualifier,Neurofibromatosis 1,0
11358,Congenital qualifier,Combined valvular-subvalvular pulmonic stenosis,0
11359,Congenital qualifier,Congenital abnormal fusion of adrenal glands,0
11360,Congenital qualifier,Congenital abnormal fusion of alisphenoid bone,0
11361,Congenital qualifier,Congenital abnormal fusion of arch of caudal vertebra,0
11362,Congenital qualifier,Congenital abnormal fusion of arch of cervical vertebra,0
11363,Congenital qualifier,Congenital abnormal fusion of arch of lumbar vertebra,0
11364,Congenital qualifier,Congenital abnormal fusion of arch of sacral vertebra,0
11365,Congenital qualifier,Congenital abnormal fusion of arch of thoracic vertebra,0
11366,Congenital qualifier,Congenital abnormal fusion of basioccipital bone,0
11367,Congenital qualifier,Congenital abnormal fusion of basisphenoid bone,0
11368,Congenital qualifier,Congenital abnormal fusion of calcaneus,0
11369,Congenital qualifier,Congenital abnormal fusion of carpal bone,0
11370,Congenital qualifier,Congenital abnormal fusion of centrum cartilage of cervical vertebra,0
11371,Congenital qualifier,Congenital abnormal fusion of centrum cartilage of lumbar vertebra,0
11372,Congenital qualifier,Congenital abnormal fusion of centrum cartilage of sacral vertebra,0
11373,Congenital qualifier,Congenital abnormal fusion of centrum cartilage of thoracic vertebra,0
11374,Congenital qualifier,Congenital abnormal fusion of centrum of caudal vertebra,0
11375,Congenital qualifier,Congenital abnormal fusion of centrum of cervical vertebra,0
11376,Congenital qualifier,Congenital abnormal fusion of centrum of lumbar vertebra,0
11377,Congenital qualifier,Congenital abnormal fusion of centrum of sacral vertebra,0
11378,Congenital qualifier,Congenital abnormal fusion of centrum of thoracic vertebra,0
11379,Congenital qualifier,Congenital abnormal fusion of exoccipital bone,0
11380,Congenital qualifier,Congenital abnormal fusion of femur,0
11381,Congenital qualifier,Congenital abnormal fusion of fibula,0
11382,Congenital qualifier,Congenital abnormal fusion of forepaw phalanx,0
11383,Congenital qualifier,Congenital abnormal fusion of frontal bone,0
11384,Congenital qualifier,Congenital abnormal fusion of hindpaw phalanx,0
11385,Congenital qualifier,Congenital abnormal fusion of humerus,0
11386,Congenital qualifier,Congenital abnormal fusion of ilium,0
11387,Congenital qualifier,Congenital abnormal fusion of interparietal bone,0
11388,Congenital qualifier,Congenital abnormal fusion of ischium,0
11389,Congenital qualifier,Congenital abnormal fusion of lacrimal bone,0
11390,Congenital qualifier,Congenital abnormal fusion of liver lobes,0
11391,Congenital qualifier,Congenital abnormal fusion of mandible,0
11392,Congenital qualifier,Congenital abnormal fusion of maxilla,0
11393,Congenital qualifier,Congenital abnormal fusion of metacarpal bone,0
11394,Congenital qualifier,Congenital abnormal fusion of metatarsal bone,0
11395,Congenital qualifier,Congenital abnormal fusion of nasal bone,0
11396,Congenital qualifier,Congenital abnormal fusion of palatine bone,0
11397,Congenital qualifier,Congenital abnormal fusion of parietal bone,0
11398,Congenital qualifier,Congenital abnormal fusion of premaxilla,0
11399,Congenital qualifier,Congenital abnormal fusion of presphenoid bone,0
11400,Congenital qualifier,Congenital abnormal fusion of radius,0
11401,Congenital qualifier,Congenital abnormal fusion of rib cartilage,0
11402,Congenital qualifier,Congenital abnormal fusion of squamosal bone,0
11403,Congenital qualifier,Congenital abnormal fusion of supraoccipital bone,0
11404,Congenital qualifier,Congenital abnormal fusion of talus,0
11405,Congenital qualifier,Congenital abnormal fusion of tarsal bone,0
11406,Congenital qualifier,Congenital abnormal fusion of tibia,0
11407,Congenital qualifier,Congenital abnormal fusion of tympanic anulus,0
11408,Congenital qualifier,Congenital abnormal fusion of ulna,0
11409,Congenital qualifier,Congenital abnormal fusion of vomer,0
11410,Congenital qualifier,Congenital abnormal fusion of zygomatic bone,0
11411,Congenital qualifier,Congenital abnormal long growth of bile duct,0
11412,Congenital qualifier,Congenital abnormal shape of adrenal gland,0
11413,Congenital qualifier,Congenital abnormal shape of alisphenoid bone,0
11414,Congenital qualifier,Congenital abnormal shape of aortic valve,0
11415,Congenital qualifier,Congenital abnormal shape of arch of caudal vertebra,0
11416,Congenital qualifier,Congenital abnormal shape of arch of cervical vertebra,0
11417,Congenital qualifier,Congenital abnormal shape of arch of lumbar vertebra,0
11418,Congenital qualifier,Congenital abnormal shape of arch of sacral vertebra,0
11419,Congenital qualifier,Congenital abnormal shape of arch of thoracic vertebra,0
11420,Congenital qualifier,Congenital abnormal shape of auditory ossicles,0
11421,Congenital qualifier,Congenital abnormal shape of basioccipital bone,0
11422,Congenital qualifier,Congenital abnormal shape of basisphenoid bone,0
11423,Congenital qualifier,Congenital abnormal shape of calcaneus,0
11424,Congenital qualifier,Congenital abnormal shape of carpal bone,0
11425,Congenital qualifier,Congenital abnormal shape of centrum of caudal vertebra,0
11426,Congenital qualifier,Congenital abnormal shape of centrum of cervical vertebra,0
11427,Congenital qualifier,Congenital abnormal shape of centrum of lumbar vertebra,0
11428,Congenital qualifier,Congenital abnormal shape of centrum of sacral vertebra,0
11429,Congenital qualifier,Congenital abnormal shape of centrum of thoracic vertebra,0
11430,Congenital qualifier,Congenital abnormal shape of cerebellum,0
11431,Congenital qualifier,Congenital abnormal shape of cerebrum,0
11432,Congenital qualifier,Congenital abnormal shape of clavicle,0
11433,Congenital qualifier,Congenital abnormal shape of digit,0
11434,Congenital qualifier,Congenital abnormal shape of exoccipital bone,0
11435,Congenital qualifier,Congenital abnormal shape of femur,0
11436,Congenital qualifier,Congenital abnormal shape of fibula,0
11437,Congenital qualifier,Congenital abnormal shape of forepaw phalanx,0
11438,Congenital qualifier,Congenital abnormal shape of frontal bone,0
11439,Congenital qualifier,Congenital abnormal shape of gallbladder,0
11440,Congenital qualifier,Congenital abnormal shape of hindpaw phalanx,0
11441,Congenital qualifier,Congenital abnormal shape of humerus,0
11442,Congenital qualifier,Congenital abnormal shape of hyoid bone,0
11443,Congenital qualifier,Congenital abnormal shape of ilium,0
11444,Congenital qualifier,Congenital abnormal shape of inner ear,0
11445,Congenital qualifier,Congenital abnormal shape of interparietal bone,0
11446,Congenital qualifier,Congenital abnormal shape of ischium,0
11447,Congenital qualifier,Congenital abnormal shape of kidney,0
11448,Congenital qualifier,Congenital abnormal shape of lacrimal bone,0
11449,Congenital qualifier,Congenital abnormal shape of mitral valve,0
11450,Congenital qualifier,Congenital abnormal shape of liver,0
11451,Congenital qualifier,Congenital abnormal shape of lung,0
11452,Congenital qualifier,Congenital abnormal shape of mandible,0
11453,Congenital qualifier,Congenital abnormal shape of maxilla,0
11454,Congenital qualifier,Congenital abnormal shape of metacarpal bone,0
11455,Congenital qualifier,Congenital abnormal shape of metatarsal bone,0
11456,Congenital qualifier,Congenital abnormal shape of nasal bone,0
11457,Congenital qualifier,Congenital abnormal shape of ovary,0
11458,Congenital qualifier,Congenital abnormal shape of fallopian tube,0
11459,Congenital qualifier,Congenital abnormal shape of palate rugae,0
11460,Congenital qualifier,Congenital abnormal shape of palatine bone,0
11461,Congenital qualifier,Congenital abnormal shape of parietal bone,0
11462,Congenital qualifier,Congenital abnormal shape of pinna,0
11463,Congenital qualifier,Congenital abnormal shape of premaxilla,0
11464,Congenital qualifier,Congenital abnormal shape of presphenoid bone,0
11465,Congenital qualifier,Congenital abnormal shape of pubis,0
11466,Congenital qualifier,Congenital abnormal shape of pulmonary valve,0
11467,Congenital qualifier,Congenital abnormal shape of radius,0
11468,Congenital qualifier,Congenital abnormal shape of rib,0
11469,Congenital qualifier,Congenital abnormal shape of tricuspid valve,0
11470,Congenital qualifier,Congenital deformity of scapula,0
11471,Congenital qualifier,Congenital abnormal shape of spleen,0
11472,Congenital qualifier,Congenital abnormal shape of squamosal bone,0
11473,Congenital qualifier,Congenital abnormal shape of sternebra,0
11474,Congenital qualifier,Congenital abnormal shape of supraoccipital bone,0
11475,Congenital qualifier,Congenital abnormal shape of talus,0
11476,Congenital qualifier,Congenital abnormal shape of tarsal bone,0
11477,Congenital qualifier,Congenital abnormal shape of testis,0
11478,Congenital qualifier,Congenital abnormal shape of thymus,0
11479,Congenital qualifier,Congenital abnormal shape of tibia,0
11480,Congenital qualifier,Congenital abnormal shape of tympanic anulus,0
11481,Congenital qualifier,Congenital abnormal shape of ulna,0
11482,Congenital qualifier,Congenital abnormal shape of uterus,0
11483,Congenital qualifier,Congenital abnormal shape of vomer,0
11484,Congenital qualifier,Congenital abnormal shape of zygomatic bone,0
11485,Congenital qualifier,Congenital absence of aortic valve,0
11486,Congenital qualifier,Congenital absence of azygos vein,0
11487,Congenital qualifier,Congenital absence of carotid artery,0
11488,Congenital qualifier,Congenital absence of chordae tendineae,0
11489,Congenital qualifier,Agenesis of clavicle,0
11490,Congenital qualifier,Congenital absence of ductus arteriosus,0
11491,Congenital qualifier,Congenital absence of eye bulge,0
11492,Congenital qualifier,Congenital absence of genital tubercle,0
11493,Congenital qualifier,Congenital absence of gonads,0
11494,Congenital qualifier,Congenital absence of mitral valve,0
11495,Congenital qualifier,Congenital absence of nasal turbinate,0
11496,Congenital qualifier,Uterus bicornis affecting pregnancy,0
11497,Congenital qualifier,Congenital absence of nasal septum,0
11498,Congenital qualifier,Monophthalmos,0
11499,Congenital qualifier,Congenital absence of papillary muscle,0
11500,Congenital qualifier,Congenital absence of renal papilla,0
11501,Congenital qualifier,Congenital absence of tricuspid valve,0
11502,Congenital qualifier,Congenital absence of subclavian artery,0
11503,Congenital qualifier,Thyroid Agenesis,0
11504,Congenital qualifier,Congenital ankylodactyly,0
11505,Congenital qualifier,Congenital fenestration of alisphenoid bone,0
11506,Congenital qualifier,Congenital bent clavicle,0
11507,Congenital qualifier,Congenital bent humerus,0
11508,Congenital qualifier,Congenital bent hyoid bone,0
11509,Congenital qualifier,Congenital bent ilium,0
11510,Congenital qualifier,Congenital bent ischium,0
11511,Congenital qualifier,Congenital bent pubis,0
11512,Congenital qualifier,Congenital bent radius,0
11513,Congenital qualifier,Congenital bent rib,0
11514,Congenital qualifier,Congenital bent scapula,0
11515,Congenital qualifier,Congenital bent tail,0
11516,Congenital qualifier,Congenital bent ulna,0
11517,Congenital qualifier,Congenital anomaly of alisphenoid bone,0
11518,Congenital qualifier,Congenital anomaly of animal tail,0
11519,Congenital qualifier,Congenital anomaly of azygos vein,0
11520,Congenital qualifier,Congenital anomaly of basioccipital bone,0
11521,Congenital qualifier,Congenital anomaly of basisphenoid bone,0
11522,Congenital qualifier,Congenital anomaly of caudal vertebra,0
11523,Congenital qualifier,Congenital anomaly of cervical vertebra,0
11524,Congenital qualifier,Congenital anomaly of claw,0
11525,Congenital qualifier,Congenital anomaly of epididymis,0
11526,Congenital qualifier,Congenital anomaly of exoccipital bone,0
11527,Congenital qualifier,Congenital anomaly of fetal head bones,0
11528,Congenital qualifier,Congenital anomaly of frontal bone,0
11529,Congenital qualifier,Congenital anomaly of hyoid bone,0
11530,Congenital qualifier,Congenital anomaly of ilium,0
11531,Congenital qualifier,Congenital anomaly of interparietal bone,0
11532,Congenital qualifier,Congenital anomaly of ischium,0
11533,Congenital qualifier,Congenital anomaly of lacrimal bone,0
11534,Congenital qualifier,Congenital anomaly of lumbar vertebra,0
11535,Congenital qualifier,Congenital anomaly of nasal bone,0
11536,Congenital qualifier,Congenital anomaly of nasal turbinate,0
11537,Congenital qualifier,Congenital anomaly of palatine bone,0
11538,Congenital qualifier,Congenital anomaly of parietal bone,0
11539,Congenital qualifier,Congenital anomaly of paw,0
11540,Congenital qualifier,Congenital anomaly of pelvic bones,0
11541,Congenital qualifier,Congenital anomaly of pericardium,0
11542,Congenital qualifier,Congenital anomaly of premaxilla,0
11543,Congenital qualifier,Congenital anomaly of presphenoid bone,0
11544,Congenital qualifier,Congenital anomaly of pubis,0
11545,Congenital qualifier,Congenital anomaly of rib cartilage,0
11546,Congenital qualifier,Congenital anomaly of sacral vertebra,0
11547,Congenital qualifier,Congenital anomaly of squamosal bone,0
11548,Congenital qualifier,Congenital anomaly of sternebra,0
11549,Congenital qualifier,Congenital anomaly of supraoccipital bone,0
11550,Congenital qualifier,Congenital anomaly of thoracic vertebra,0
11551,Congenital qualifier,Congenital anomaly of vomer,0
11552,Congenital qualifier,Congenital anomaly of zygomatic bone,0
11553,Congenital qualifier,Congenital absence of spleen,0
11554,Congenital qualifier,Congenital atresia of inferior vena cava,0
11555,Congenital qualifier,Congenital atresia of intestinal tract,0
11556,Congenital qualifier,Congenital atresia of superior vena cava,0
11557,Congenital qualifier,Congenital atresia of uterus,0
11558,Congenital qualifier,Congenital fenestration of basioccipital bone,0
11559,Congenital qualifier,Congenital fenestration of basisphenoid bone,0
11560,Congenital qualifier,Congenital branched rib,0
11561,Congenital qualifier,Congenital branched rib cartilage,0
11562,Congenital qualifier,Congenital bilobed gallbladder,0
11563,Congenital qualifier,Congenital blepharophimosis,0
11564,Congenital qualifier,Congenital blunt-tipped tail,0
11565,Congenital qualifier,Congenital clubbed paw,0
11566,Congenital qualifier,Congenital convoluted ureter,0
11567,Congenital qualifier,Congenital curled tail,0
11568,Congenital qualifier,Congenital cyst of bladder,0
11569,Congenital qualifier,"congenital; cyst, ovary",0
11570,Congenital qualifier,Congenital cyst of oviduct,0
11571,Congenital qualifier,Congenital cyst of spleen,0
11572,Congenital qualifier,Congenital dilatation of aortic arch,0
11573,Congenital qualifier,Congenital dilatation of atrium,0
11574,Congenital qualifier,Congenital dilatation of bladder,0
11575,Congenital qualifier,Congenital dilatation of cardiac ventricle,0
11576,Congenital qualifier,Congenital dilatation of carotid artery,0
11577,Congenital qualifier,Congenital dilatation of ductus arteriosus,0
11578,Congenital qualifier,Congenital dilatation of inferior vena cava,0
11579,Congenital qualifier,Congenital dilatation of innominate artery,0
11580,Congenital qualifier,Congenital dilatation of intestinal tract,0
11581,Congenital qualifier,Congenital dilatation of pulmonary artery,0
11582,Congenital qualifier,Congenital dilatation of stomach,0
11583,Congenital qualifier,Congenital dilatation of subclavian artery,0
11584,Congenital qualifier,Congenital dilatation of superior vena cava,0
11585,Congenital qualifier,Congenital diverticulum of intestinal tract,0
11586,Congenital qualifier,Congenital duplication of aorta,0
11587,Congenital qualifier,Congenital double-tipped tail,0
11588,Congenital qualifier,Congenital downward displacement of stomach,0
11589,Congenital qualifier,Congenital elongation of innominate artery,0
11590,Congenital qualifier,Congenital hypertrophy of adrenal gland,0
11591,Congenital qualifier,Congenital hypertrophy of aortic valve,0
11592,Congenital qualifier,Congenital enlargement of fontanel,0
11593,Congenital qualifier,Congenital hypertrophy of lung,0
11594,Congenital qualifier,Congenital hypertrophy of nasal cavity,0
11595,Congenital qualifier,Congenital hypertrophy of ovary,0
11596,Congenital qualifier,Congenital hypertrophy of fallopian tube,0
11597,Congenital qualifier,Congenital hypertrophy of pulmonary valve,0
11598,Congenital qualifier,Congenital hypertrophy of tricuspid valve,0
11599,Congenital qualifier,Congenital hypertrophy of testis,0
11600,Congenital qualifier,Congenital hypertrophy of cardiac ventricle,0
11601,Congenital qualifier,Congenital fenestration of exoccipital bone,0
11602,Congenital qualifier,Congenital exophthalmos,0
11603,Congenital qualifier,Congenital fenestration of frontal bone,0
11604,Congenital qualifier,Congenital fenestration of interparietal bone,0
11605,Congenital qualifier,Congenital fenestration of nasal bone,0
11606,Congenital qualifier,Congenital fenestration of parietal bone,0
11607,Congenital qualifier,Congenital fenestration of premaxilla,0
11608,Congenital qualifier,Congenital fenestration of presphenoid bone,0
11609,Congenital qualifier,Congenital fenestration of squamosal bone,0
11610,Congenital qualifier,Congenital fenestration of supraoccipital bone,0
11611,Congenital qualifier,Congenital thread-like tail,0
11612,Congenital qualifier,Congenital fistula of intestinal tract,0
11613,Congenital qualifier,Congenital fleshy tail tab,0
11614,Congenital qualifier,Congenital focal enlargement of rib,0
11615,Congenital qualifier,Congenital hooked tail,0
11616,Congenital qualifier,Congenital hyperextension of limb,0
11617,Congenital qualifier,Lack of ossification of fibula,0
11618,Congenital qualifier,Lack of ossification of forepaw phalanx,0
11619,Congenital qualifier,Lack of ossification of frontal bone,0
11620,Congenital qualifier,Lack of ossification of hindpaw phalanx,0
11621,Congenital qualifier,Lack of ossification of humerus,0
11622,Congenital qualifier,Lack of ossification of hyoid bone,0
11623,Congenital qualifier,Lack of ossification of ilium,0
11624,Congenital qualifier,Lack of ossification of interparietal bone,0
11625,Congenital qualifier,Lack of ossification of lacrimal bone,0
11626,Congenital qualifier,Lack of ossification of mandible,0
11627,Congenital qualifier,Lack of ossification of maxilla,0
11628,Congenital qualifier,Lack of ossification of metacarpal bone,0
11629,Congenital qualifier,Lack of ossification of metatarsal bone,0
11630,Congenital qualifier,Lack of ossification of nasal bone,0
11631,Congenital qualifier,Hermanski-Pudlak Syndrome,0
11632,Congenital qualifier,Lack of ossification of palatine bone,0
11633,Congenital qualifier,Lack of ossification of parietal bone,0
11634,Congenital qualifier,Lack of ossification of premaxilla,0
11635,Congenital qualifier,Lack of ossification of presphenoid bone,0
11636,Congenital qualifier,Lack of ossification of radius,0
11637,Congenital qualifier,Lack of ossification of rib,0
11638,Congenital qualifier,Lack of ossification of scapula,0
11639,Congenital qualifier,Lack of ossification of squamosal bone,0
11640,Congenital qualifier,Lack of ossification of sternebra,0
11641,Congenital qualifier,Lack of ossification of supraoccipital bone,0
11642,Congenital qualifier,Lack of ossification of talus,0
11643,Congenital qualifier,Lack of ossification of tarsal bone,0
11644,Congenital qualifier,Lack of ossification of tibia,0
11645,Congenital qualifier,Lack of ossification of tympanic anulus,0
11646,Congenital qualifier,Lack of ossification of ulna,0
11647,Congenital qualifier,Lack of ossification of vomer,0
11648,Congenital qualifier,Lack of ossification of zygomatic bone,0
11649,Congenital qualifier,Leptocephaly (disorder),0
11650,Congenital qualifier,Dyssegmental dysplasia,0
11651,Congenital qualifier,Lingual crossbite,0
11652,Congenital qualifier,Lumbar hemivertebra,0
11653,Congenital qualifier,Macromelia,0
11654,Congenital qualifier,Macrophthalmus,0
11655,Congenital qualifier,Congenital hyperextension of paw,0
11656,Congenital qualifier,Congenital hyperflexion of limb,0
11657,Congenital qualifier,Congenital hyperflexion of paw,0
11658,Congenital qualifier,Congenital hypertrophy of mitral valve,0
11659,Congenital qualifier,Congenital hypoplasia of adrenal gland,0
11660,Congenital qualifier,Congenital hypoplasia of alisphenoid bone,0
11661,Congenital qualifier,Congenital hypoplasia of aortic valve,0
11662,Congenital qualifier,Congenital hypoplasia of arch of caudal vertebra,0
11663,Congenital qualifier,Congenital hypoplasia of arch of cervical vertebra,0
11664,Congenital qualifier,Congenital hypoplasia of arch of lumbar vertebra,0
11665,Congenital qualifier,Congenital hypoplasia of arch of sacral vertebra,0
11666,Congenital qualifier,Congenital hypoplasia of arch of thoracic vertebra,0
11667,Congenital qualifier,Congenital hypoplasia of basioccipital bone,0
11668,Congenital qualifier,Congenital hypoplasia of basisphenoid bone,0
11669,Congenital qualifier,Congenital hypoplasia of bladder,0
11670,Congenital qualifier,Congenital hypoplasia of calcaneus,0
11671,Congenital qualifier,Congenital hypoplasia of cardiac ventricle,0
11672,Congenital qualifier,Congenital hypoplasia of carpal bone,0
11673,Congenital qualifier,Congenital hypoplasia of cerebrum,0
11674,Congenital qualifier,Congenital hypoplasia of clavicle,0
11675,Congenital qualifier,Congenital hypoplasia of claw,0
11676,Congenital qualifier,Congenital hypoplasia of epididymis,0
11677,Congenital qualifier,Congenital hypoplasia of exoccipital bone,0
11678,Congenital qualifier,Congenital hypoplasia of eye bulge,0
11679,Congenital qualifier,Congenital hypoplasia of femur,0
11680,Congenital qualifier,Congenital hypoplasia of fibula,0
11681,Congenital qualifier,Congenital hypoplasia of forepaw phalanx,0
11682,Congenital qualifier,Congenital hypoplasia of frontal bone,0
11683,Congenital qualifier,Congenital hypoplasia of gallbladder,0
11684,Congenital qualifier,Congenital hypoplasia of genital tubercle,0
11685,Congenital qualifier,Congenital hypoplasia of gonad,0
11686,Congenital qualifier,Congenital hypoplasia of heart,0
11687,Congenital qualifier,Congenital hypoplasia of hindpaw phalanx,0
11688,Congenital qualifier,Congenital hypoplasia of humerus,0
11689,Congenital qualifier,Congenital hypoplasia of hyoid bone,0
11690,Congenital qualifier,Congenital hypoplasia of ilium,0
11691,Congenital qualifier,Congenital hypoplasia of interparietal bone,0
11692,Congenital qualifier,Congenital hypoplasia of intestinal tract,0
11693,Congenital qualifier,Congenital hypoplasia of ischium,0
11694,Congenital qualifier,Congenital hypoplasia of lacrimal bone,0
11695,Congenital qualifier,Congenital hypoplasia of mitral valve,0
11696,Congenital qualifier,Congenital hypoplasia of metacarpal bone,0
11697,Congenital qualifier,Congenital hypoplasia of metatarsal bone,0
11698,Congenital qualifier,Congenital hypoplasia of nasal bone,0
11699,Congenital qualifier,Congenital hypoplasia of nasal cavity,0
11700,Congenital qualifier,Congenital hypoplasia of nasal turbinate,0
11701,Congenital qualifier,Congenital hypoplasia of nasal septum,0
11702,Congenital qualifier,Congenital hypoplasia of nose,0
11703,Congenital qualifier,Congenital hypoplasia of ovary,0
11704,Congenital qualifier,Congenital hypoplasia of fallopian tube,0
11705,Congenital qualifier,Congenital hypoplasia of palatine bone,0
11706,Congenital qualifier,Congenital hypoplasia of parietal bone,0
11707,Congenital qualifier,Congenital hypoplasia of paw,0
11708,Congenital qualifier,Congenital hypoplasia of premaxilla,0
11709,Congenital qualifier,Congenital hypoplasia of presphenoid bone,0
11710,Congenital qualifier,Congenital hypoplasia of pubis,0
11711,Congenital qualifier,Congenital hypoplasia of pulmonary valve,0
11712,Congenital qualifier,Congenital hypoplasia of radius,0
11713,Congenital qualifier,Congenital hypoplasia of renal pelvis,0
11714,Congenital qualifier,Congenital hypoplasia of rib,0
11715,Congenital qualifier,Splenic Hypoplasia,0
11716,Congenital qualifier,Congenital hypoplasia of squamosal bone,0
11717,Congenital qualifier,Congenital hypoplasia of supraoccipital bone,0
11718,Congenital qualifier,Congenital hypoplasia of talus,0
11719,Congenital qualifier,Congenital hypoplasia of tarsal bone,0
11720,Congenital qualifier,Congenital hypoplasia of thymus,0
11721,Congenital qualifier,Congenital hypoplasia of tibia,0
11722,Congenital qualifier,Congenital hypoplasia of tympanic anulus,0
11723,Congenital qualifier,Congenital hypoplasia of ulna,0
11724,Congenital qualifier,Congenital hypoplasia of vas deferens,0
11725,Congenital qualifier,Congenital hypoplasia of vomer,0
11726,Congenital qualifier,Congenital hypoplasia of zygomatic bone,0
11727,Congenital qualifier,Congenital malposition of adrenal gland,0
11728,Congenital qualifier,Congenital malposition of aorta,0
11729,Congenital qualifier,Congenital malposition of arch of caudal vertebra,0
11730,Congenital qualifier,Congenital malposition of arch of cervical vertebra,0
11731,Congenital qualifier,Congenital malposition of arch of lumbar vertebra,0
11732,Congenital qualifier,Congenital malposition of arch of sacral vertebra,0
11733,Congenital qualifier,Congenital malposition of arch of thoracic vertebra,0
11734,Congenital qualifier,Congenital malposition of calcaneus,0
11735,Congenital qualifier,Congenital malposition of carotid artery,0
11736,Congenital qualifier,Congenital malposition of carpal bone,0
11737,Congenital qualifier,Congenital malposition of caudal vertebra,0
11738,Congenital qualifier,Congenital malposition of cervical vertebra,0
11739,Congenital qualifier,Congenital malposition of claw,0
11740,Congenital qualifier,Congenital malposition of digit,0
11741,Congenital qualifier,Congenital malposition of ductus arteriosus,0
11742,Congenital qualifier,Congenital malposition of epididymis,0
11743,Congenital qualifier,Congenital malposition of eye,0
11744,Congenital qualifier,Congenital malposition of femur,0
11745,Congenital qualifier,Congenital malposition of fibula,0
11746,Congenital qualifier,Congenital malposition of forepaw phalanx,0
11747,Congenital qualifier,Congenital malposition of gallbladder,0
11748,Congenital qualifier,Congenital malposition of hindpaw phalanx,0
11749,Congenital qualifier,Congenital malposition of humerus,0
11750,Congenital qualifier,Congenital malposition of ilium,0
11751,Congenital qualifier,Congenital malposition of inferior vena cava,0
11752,Congenital qualifier,Congenital malposition of innominate artery,0
11753,Congenital qualifier,Congenital malposition of intestinal tract,0
11754,Congenital qualifier,Congenital malposition of ischium,0
11755,Congenital qualifier,Congenital malposition of liver,0
11756,Congenital qualifier,Congenital malposition of lumbar vertebra,0
11757,Congenital qualifier,Congenital malposition of lung,0
11758,Congenital qualifier,Congenital malposition of metacarpal bone,0
11759,Congenital qualifier,Congenital malposition of metatarsal bone,0
11760,Congenital qualifier,Congenital malposition of nares,0
11761,Congenital qualifier,Congenital malposition of nasal turbinate,0
11762,Congenital qualifier,Congenital malposition of nasal septum,0
11763,Congenital qualifier,Congenital malposition of nose,0
11764,Congenital qualifier,Congenital malposition of ovary,0
11765,Congenital qualifier,Congenital malposition of fallopian tube,0
11766,Congenital qualifier,Congenital malposition of palate rugae,0
11767,Congenital qualifier,Congenital malposition of paw,0
11768,Congenital qualifier,Congenital malposition of pinna,0
11769,Congenital qualifier,Congenital malposition of pubis,0
11770,Congenital qualifier,Congenital malposition of pulmonary artery,0
11771,Congenital qualifier,Congenital malposition of radius,0
11772,Congenital qualifier,Congenital malposition of rib,0
11773,Congenital qualifier,Congenital malposition of sacral vertebra,0
11774,Congenital qualifier,Congenital malposition of spleen,0
11775,Congenital qualifier,Congenital malposition of sternebra,0
11776,Congenital qualifier,Aberrant subclavian artery,0
11777,Congenital qualifier,Congenital malposition of superior vena cava,0
11778,Congenital qualifier,Congenital malposition of tail,0
11779,Congenital qualifier,Congenital malposition of talus,0
11780,Congenital qualifier,Congenital malposition of tarsal bone,0
11781,Congenital qualifier,Congenital malposition of testis,0
11782,Congenital qualifier,Congenital malposition of the thyroid gland,0
11783,Congenital qualifier,Congenital malposition of thoracic vertebra,0
11784,Congenital qualifier,Congenital malposition of thymus,0
11785,Congenital qualifier,Congenital malposition of tibia,0
11786,Congenital qualifier,Congenital malposition of trachea,0
11787,Congenital qualifier,Congenital malposition of ulna,0
11788,Congenital qualifier,Congenital malposition of vas deferens,0
11789,Congenital qualifier,Congenital malrotation of claw,0
11790,Congenital qualifier,Congenital malrotation of limb,0
11791,Congenital qualifier,Congenital malrotation of paw,0
11792,Congenital qualifier,Congenital microhepatia,0
11793,Congenital qualifier,Congenital misalignment of arch of caudal vertebra,0
11794,Congenital qualifier,Congenital misalignment of centrum of caudal vertebra,0
11795,Congenital qualifier,Congenital misalignment of arch of cervical vertebra,0
11796,Congenital qualifier,Congenital misalignment of centrum of cervical vertebra,0
11797,Congenital qualifier,Congenital misalignment of arch of lumbar vertebra,0
11798,Congenital qualifier,Congenital misalignment of centrum of lumbar vertebra,0
11799,Congenital qualifier,Congenital misalignment of palate rugae,0
11800,Congenital qualifier,Congenital misalignment of pubis,0
11801,Congenital qualifier,Congenital misalignment of rib,0
11802,Congenital qualifier,Congenital misalignment of arch of sacral vertebra,0
11803,Congenital qualifier,Congenital misalignment of centrum of sacral vertebra,0
11804,Congenital qualifier,Congenital misalignment of sternebra,0
11805,Congenital qualifier,Congenital misalignment of arch of thoracic vertebra,0
11806,Congenital qualifier,Congenital misalignment of centrum of thoracic vertebra,0
11807,Congenital qualifier,Congenital stenosis of aortic arch,0
11808,Congenital qualifier,Congenital stenosis of innominate artery,0
11809,Congenital qualifier,Congenital stenosis of intestinal tract,0
11810,Congenital qualifier,Congenital stenosis of stomach,0
11811,Congenital qualifier,Congenital stenosis of subclavian artery,0
11812,Congenital qualifier,Congenital narrowed tail,0
11813,Congenital qualifier,Congenital ocular coloboma (disorder),0
11814,Congenital qualifier,Congenital protrusion of tongue,0
11815,Congenital qualifier,Congenital short growth of innominate artery,0
11816,Congenital qualifier,Congenital short tail,0
11817,Congenital qualifier,Congenital short trunk,0
11818,Congenital qualifier,Congenital small anus,0
11819,Congenital qualifier,Congenital stenosis of carotid artery,0
11820,Congenital qualifier,Congenital thickening of clavicle,0
11821,Congenital qualifier,Congenital thickening of femur,0
11822,Congenital qualifier,Congenital thickening of fibula,0
11823,Congenital qualifier,Congenital thickening of forepaw phalanx,0
11824,Congenital qualifier,Congenital thickening of hindpaw phalanx,0
11825,Congenital qualifier,Congenital thickening of humerus,0
11826,Congenital qualifier,Congenital thickening of ilium,0
11827,Congenital qualifier,Congenital thickening of ischium,0
11828,Congenital qualifier,Congenital thickening of pubis,0
11829,Congenital qualifier,Congenital thickening of radius,0
11830,Congenital qualifier,Congenital thickening of rib,0
11831,Congenital qualifier,Congenital thickening of scapula,0
11832,Congenital qualifier,Congenital thickening of talus,0
11833,Congenital qualifier,Congenital thickening of tarsal bone,0
11834,Congenital qualifier,Congenital thickening of tibia,0
11835,Congenital qualifier,Congenital thickening of ulna,0
11836,Congenital qualifier,Thoracoceloschisis,0
11837,Congenital qualifier,Congenital thoracostenosis,0
11838,Congenital qualifier,Congenital transposition of azygos vein,0
11839,Congenital qualifier,Congenitally short snout,0
11840,Congenital qualifier,Decreased anogenital distance,0
11841,Congenital qualifier,Discontinuous rib,0
11842,Congenital qualifier,Domed head,0
11843,Congenital qualifier,Dumbbell ossification of centrum of caudal vertebra,0
11844,Congenital qualifier,Dumbbell ossification of centrum of cervical vertebra,0
11845,Congenital qualifier,Dumbbell ossification of centrum of lumbar vertebra,0
11846,Congenital qualifier,Dumbbell ossification of centrum of sacral vertebra,0
11847,Congenital qualifier,Dumbbell ossification of centrum of thoracic vertebra,0
11848,Congenital qualifier,Dumbbell-shaped cartilaginous centrum of cervical vertebra,0
11849,Congenital qualifier,Dumbbell-shaped cartilaginous centrum of lumbar vertebra,0
11850,Congenital qualifier,Dumbbell-shaped cartilaginous centrum of sacral vertebra,0
11851,Congenital qualifier,Dumbbell-shaped cartilaginous centrum of thoracic vertebra,0
11852,Congenital qualifier,Extracapsular adrenal tissue,0
11853,Congenital qualifier,Full supernumerary rib,0
11854,Congenital qualifier,Gonadal dysgenesis XX type deafness,0
11855,Congenital qualifier,Hemicentric caudal centrum,0
11856,Congenital qualifier,Hemicentric cervical centrum,0
11857,Congenital qualifier,Hemicentric lumbar centrum,0
11858,Congenital qualifier,Hemicentric sacral centrum,0
11859,Congenital qualifier,Hemicentric thoracic centrum,0
11860,Congenital qualifier,Hologastroschisis,0
11861,Congenital qualifier,Holorachischisis,0
11862,Congenital qualifier,Kallmann Syndrome,0
11863,Congenital qualifier,Incomplete ossification of alisphenoid bone,0
11864,Congenital qualifier,Incomplete ossification of arch of caudal vertebra,0
11865,Congenital qualifier,Incomplete ossification of arch of cervical vertebra,0
11866,Congenital qualifier,Incomplete ossification of arch of lumbar vertebra,0
11867,Congenital qualifier,Incomplete ossification of arch of sacral vertebra,0
11868,Congenital qualifier,Incomplete ossification of arch of thoracic vertebra,0
11869,Congenital qualifier,Incomplete ossification of basioccipital bone,0
11870,Congenital qualifier,Incomplete ossification of basisphenoid bone,0
11871,Congenital qualifier,Incomplete ossification of calcaneus,0
11872,Congenital qualifier,Incomplete ossification of carpal bone,0
11873,Congenital qualifier,Incomplete ossification of centrum of caudal vertebra,0
11874,Congenital qualifier,Incomplete ossification of centrum of cervical vertebra,0
11875,Congenital qualifier,Incomplete ossification of centrum of lumbar vertebra,0
11876,Congenital qualifier,Incomplete ossification of centrum of sacral vertebra,0
11877,Congenital qualifier,Incomplete ossification of centrum of thoracic vertebra,0
11878,Congenital qualifier,Incomplete ossification of clavicle,0
11879,Congenital qualifier,Incomplete ossification of exoccipital bone,0
11880,Congenital qualifier,Incomplete ossification of femur,0
11881,Congenital qualifier,Incomplete ossification of fibula,0
11882,Congenital qualifier,Incomplete ossification of forepaw phalanx,0
11883,Congenital qualifier,Incomplete ossification of frontal bone,0
11884,Congenital qualifier,Incomplete ossification of hindpaw phalanx,0
11885,Congenital qualifier,Incomplete ossification of humerus,0
11886,Congenital qualifier,Incomplete ossification of hyoid bone,0
11887,Congenital qualifier,Incomplete ossification of interparietal bone,0
11888,Congenital qualifier,Incomplete ossification of lacrimal bone,0
11889,Congenital qualifier,Incomplete ossification of mandible,0
11890,Congenital qualifier,Incomplete ossification of maxilla,0
11891,Congenital qualifier,Incomplete ossification of metacarpal bone,0
11892,Congenital qualifier,Incomplete ossification of metatarsal bone,0
11893,Congenital qualifier,Incomplete ossification of nasal bone,0
11894,Congenital qualifier,Incomplete ossification of palatine bone,0
11895,Congenital qualifier,Incomplete ossification of parietal bone,0
11896,Congenital qualifier,Incomplete ossification of premaxilla,0
11897,Congenital qualifier,Incomplete ossification of presphenoid bone,0
11898,Congenital qualifier,Incomplete ossification of radius,0
11899,Congenital qualifier,Incomplete ossification of rib,0
11900,Congenital qualifier,Incomplete ossification of scapula,0
11901,Congenital qualifier,Incomplete ossification of squamosal bone,0
11902,Congenital qualifier,Incomplete ossification of sternebra,0
11903,Congenital qualifier,Incomplete ossification of supraoccipital bone,0
11904,Congenital qualifier,Incomplete ossification of talus,0
11905,Congenital qualifier,Incomplete ossification of tarsal bone,0
11906,Congenital qualifier,Incomplete ossification of tibia,0
11907,Congenital qualifier,Incomplete ossification of tympanic anulus,0
11908,Congenital qualifier,Incomplete ossification of ulna,0
11909,Congenital qualifier,Incomplete ossification of vomer,0
11910,Congenital qualifier,Incomplete ossification of zygomatic bone,0
11911,Congenital qualifier,Increased anogenital distance,0
11912,Congenital qualifier,Intercostal rib,0
11913,Congenital qualifier,Lack of ossification of alisphenoid bone,0
11914,Congenital qualifier,Lack of ossification of arch of caudal vertebra,0
11915,Congenital qualifier,Lack of ossification of arch of cervical vertebra,0
11916,Congenital qualifier,Lack of ossification of arch of lumbar vertebra,0
11917,Congenital qualifier,Lack of ossification of arch of sacral vertebra,0
11918,Congenital qualifier,Lack of ossification of arch of thoracic vertebra,0
11919,Congenital qualifier,Lack of ossification of auditory ossicles,0
11920,Congenital qualifier,Lack of ossification of basioccipital bone,0
11921,Congenital qualifier,Lack of ossification of basisphenoid bone,0
11922,Congenital qualifier,Lack of ossification of calcaneus,0
11923,Congenital qualifier,Lack of ossification of carpal bone,0
11924,Congenital qualifier,Lack of ossification of centrum of caudal vertebra,0
11925,Congenital qualifier,Lack of ossification of centrum of cervical vertebra,0
11926,Congenital qualifier,Lack of ossification of centrum of lumbar vertebra,0
11927,Congenital qualifier,Lack of ossification of centrum of sacral vertebra,0
11928,Congenital qualifier,Lack of ossification of centrum of thoracic vertebra,0
11929,Congenital qualifier,Lack of ossification of clavicle,0
11930,Congenital qualifier,Lack of ossification of exoccipital bone,0
11931,Congenital qualifier,Lack of ossification of femur,0
11932,Congenital qualifier,Gouty neuritis,0
11933,Congenital qualifier,Membranous ventricular septum defect,0
11934,Congenital qualifier,Congenital retinal aneurysm,0
11935,Congenital qualifier,Congenital coloboma of iris,0
11936,Congenital qualifier,Microblepharia,0
11937,Congenital qualifier,Microdactyly,0
11938,Congenital qualifier,Multiple congenital cardiac defects,0
11939,Congenital qualifier,Multiple intracardiac shunts,0
11940,Congenital qualifier,Muscular ventricular septum defect,0
11941,Congenital qualifier,"Pure Gonadal Dysgenesis, 46, XX",0
11942,Congenital qualifier,Coloboma of eyelid,0
11943,Congenital qualifier,Swyer Syndrome,0
11944,Congenital qualifier,Pure gonadal dysgenesis,0
11945,Congenital qualifier,Retrocaval Ureter,0
11946,Congenital qualifier,Retroesophageal aortic arch,0
11947,Congenital qualifier,Retroesophageal carotid artery,0
11948,Congenital qualifier,Retroesophageal pulmonary artery,0
11949,Congenital qualifier,Retroesophageal subclavian artery,0
11950,Congenital qualifier,Reverse posterior crossbite,0
11951,Congenital qualifier,Rhinocephaly,0
11952,Congenital qualifier,Right-sided pulmonary arterial trunk,0
11953,Congenital qualifier,"Dyssegmental dysplasia, Rolland-Desbuquois type",0
11954,Congenital qualifier,Sacral hemivertebra,0
11955,Congenital qualifier,Short supernumerary rib,0
11956,Congenital qualifier,Single naris,0
11957,Congenital qualifier,Single supernumerary tooth,0
11958,Congenital qualifier,Pallister-Killian syndrome,0
11959,Congenital qualifier,Supernumerary arch of cervical vertebra,0
11960,Congenital qualifier,Supernumerary arch of lumbar vertebra,0
11961,Congenital qualifier,Supernumerary arch of sacral vertebra,0
11962,Congenital qualifier,Supernumerary arch of thoracic vertebra,0
11963,Congenital qualifier,Supernumerary azygos vein,0
11964,Congenital qualifier,Supernumerary calcaneus,0
11965,Congenital qualifier,Supernumerary caudal vertebra,0
11966,Congenital qualifier,Supernumerary centrum of cervical vertebra,0
11967,Congenital qualifier,Supernumerary centrum of lumbar vertebra,0
11968,Congenital qualifier,Supernumerary centrum of sacral vertebra,0
11969,Congenital qualifier,Supernumerary centrum of thoracic vertebra,0
11970,Congenital qualifier,Supernumerary cervical vertebra,0
11971,Congenital qualifier,Supernumerary forepaw phalanx,0
11972,Congenital qualifier,Supernumerary fused sternebra,0
11973,Congenital qualifier,Supernumerary hindpaw phalanx,0
11974,Congenital qualifier,Supernumerary lumbar vertebra,0
11975,Congenital qualifier,Supernumerary metatarsal bone,0
11976,Congenital qualifier,Supernumerary sacral vertebra,0
11977,Congenital qualifier,Supernumerary tarsal bone,0
11978,Congenital qualifier,Supernumerary thoracic vertebra,0
11979,Congenital qualifier,Thoracic hemivertebra,0
11980,Congenital qualifier,Thoracoschisis,0
11981,Congenital qualifier,Distichiasis,0
11982,Congenital qualifier,Juvenile GM 2 gangliosidosis,0
11983,Congenital qualifier,Shortened trunk,0
11984,Congenital qualifier,Sex Chromosome Aberrations,0
11985,Congenital qualifier,Congenital anomaly of joint,0
11986,Congenital qualifier,Congenital absence of cranial vault,0
11987,Congenital qualifier,Congenital claw toe,0
11988,Congenital qualifier,Congenital perforation of nasal septum,0
11989,Congenital qualifier,Congenital tracheomalacia,0
11990,Congenital qualifier,Congenital bronchomalacia,0
11991,Congenital qualifier,Abnormal plantar creases,0
11992,Congenital qualifier,Congenital arteriovenous malformation of the gastrointestinal tract,0
11993,Congenital qualifier,Multiple gastrointestinal atresias (disorder),0
11994,Congenital qualifier,Congenital anomaly of jaw,0
11995,Congenital qualifier,Congenital vesico-ureteric reflux,0
11996,Congenital qualifier,Congenital degeneration of nervous system,0
11997,Congenital qualifier,Congenital sacral meningocele,0
11998,Congenital qualifier,Congenital sclerocornea,0
11999,Congenital qualifier,Anterior lenticonus,0
12000,Congenital qualifier,Anterior lentiglobus,0
12001,Congenital qualifier,Posterior lenticonus,0
12002,Congenital qualifier,Posterior lentiglobus,0
12003,Congenital qualifier,Congenital pigmentation of lens,0
12004,Congenital qualifier,Congenital anterior capsular pigmentation,0
12005,Congenital qualifier,Congenital blindness,0
12006,Congenital qualifier,Congenital macular corneal dystrophy,0
12007,Congenital qualifier,Congenital conjunctival cyst,0
12008,Congenital qualifier,Congenital anomaly of choroid,0
12009,Congenital qualifier,Congenital hypoplasia of choroid,0
12010,Congenital qualifier,Congenital hypopigmentation of choroid,0
12011,Congenital qualifier,Congenital retinoschisis,0
12012,Congenital qualifier,Retinal Dysplasia,0
12013,Congenital qualifier,Multifocal retinal dysplasia,0
12014,Congenital qualifier,Geographic retinal dysplasia,0
12015,Congenital qualifier,Diffuse retinal dysplasia,0
12016,Congenital qualifier,Congenital myelin deficiency of the optic disc,0
12017,Congenital qualifier,Optic Nerve Hypoplasia,0
12018,Congenital qualifier,Persistent pupillary membranes,0
12019,Congenital qualifier,Retinal arteriovenous malformation,0
12020,Congenital qualifier,Congenital anomaly of optic nerve,0
12021,Congenital qualifier,Macropalpebral fissure,0
12022,Congenital qualifier,Ectopic cilia of eyelid,0
12023,Congenital qualifier,Congenitally small punctum lacrimale,0
12024,Congenital qualifier,Congenital displacement of punctum lacrimale,0
12025,Congenital qualifier,Congenital diverticulum of lacrimal canaliculus,0
12026,Congenital qualifier,Congenital obstruction of lacrimal canal,0
12027,Congenital qualifier,Congenital strabismus,0
12028,Congenital qualifier,Congenital anomaly of third eyelid,0
12029,Congenital qualifier,Congenital cartilage anomaly of third eyelid,0
12030,Congenital qualifier,Hypopigmentation of third eyelid,0
12031,Congenital qualifier,Low set ears,0
12032,Congenital qualifier,Congenital brain damage,0
12033,Congenital qualifier,Congenital flaccid paralysis,0
12034,Congenital qualifier,Hypoplasia of iris,0
12035,Congenital qualifier,Congenital hearing disorder,0
12036,Congenital qualifier,Congenital deafness,0
12037,Congenital qualifier,Facial Hemiatrophy,0
12038,Congenital qualifier,Congenital dislocation of radial head,0
12039,Congenital qualifier,Congenital stenosis of trachea,0
12040,Congenital qualifier,Hyperphosphatasemia with bone disease,0
12041,Congenital qualifier,Macroencephaly,0
12042,Congenital qualifier,Anorectal agenesis,0
12043,Congenital qualifier,Anomaly of chromosome pair 20,0
12044,Congenital qualifier,Placenta multipartita,0
12045,Congenital qualifier,Congenital anomaly of cardiovascular system (disorder),0
12046,Congenital qualifier,Congenital Nephroptosis,0
12047,Congenital qualifier,Congenital syphilitic choroiditis,0
12048,Neonatal (qualifier value),Perinatal jaundice due to hepatocellular damage,0
12049,Neonatal (qualifier value),Palatal cyst of newborn,0
12050,Neonatal (qualifier value),Neonatal alveolar lymphangioma,0
12051,Neonatal (qualifier value),Perinatal partial atelectasis,0
12052,Neonatal (qualifier value),Transitory neonatal endocrine AND/OR metabolic disorder,0
12053,Neonatal (qualifier value),Infectious neonatal hepatitis,0
12054,Neonatal (qualifier value),Neonatal urinary tract infection,0
12055,Neonatal (qualifier value),Hemorrhagic Disease of Newborn,0
12056,Neonatal (qualifier value),Neonatal infectious disorder,0
12057,Neonatal (qualifier value),Transitory neonatal electrolyte disturbance,0
12058,Neonatal (qualifier value),Large baby of diabetic mother,0
12059,Neonatal (qualifier value),Apnea in the newborn,0
12060,Neonatal (qualifier value),Hypothermia of newborn,0
12061,Neonatal (qualifier value),Neonatal thyrotoxicosis,0
12062,Neonatal (qualifier value),Alloimmune neonatal neutropenia,0
12063,Neonatal (qualifier value),Transitory amino acid metabolic disorder,0
12064,Neonatal (qualifier value),Neonatal agitation,0
12065,Neonatal (qualifier value),Neonatal jaundice due to delayed conjugation,0
12066,Neonatal (qualifier value),Neonatal cardiac arrest,0
12067,Neonatal (qualifier value),Neonatal cardiorespiratory arrest,0
12068,Neonatal (qualifier value),Late neonatal hypocalcemia,0
12069,Neonatal (qualifier value),Familial benign hypercalcemia,0
12070,Neonatal (qualifier value),Leukemoid reaction of the newborn,0
12071,Neonatal (qualifier value),Acquired neutropenia in newborn,0
12072,Neonatal (qualifier value),Persistent neonatal myasthenia gravis,0
12073,Neonatal (qualifier value),Neonatal enamel hypoplasia,0
12074,Neonatal (qualifier value),Postnatal enamel hypoplasia,0
12075,Neonatal (qualifier value),Neonatal Hypotonia,0
12076,Neonatal (qualifier value),Subcutaneous fat necrosis due to birth injury,0
12077,Neonatal (qualifier value),Meconium Aspiration Syndrome,0
12078,Neonatal (qualifier value),Aspiration of vomit in newborn,0
12079,Neonatal (qualifier value),Neonatal aspiration of milk and regurgitated food,0
12080,Neonatal (qualifier value),Neonatal acrocyanosis,0
12081,Neonatal (qualifier value),Neonatal dacryocystitis and conjunctivitis (disorder),0
12082,Neonatal (qualifier value),Neonatal candidiasis of perineum,0
12083,Neonatal (qualifier value),Neonatal candidiasis of intestine,0
12084,Neonatal (qualifier value),Neonatal candidiasis of lung,0
12085,Neonatal (qualifier value),Sepsis of the newborn,0
12086,Neonatal (qualifier value),Sepsis of newborn due to Staphylococcus aureus,0
12087,Neonatal (qualifier value),Sepsis of newborn due to Escherichia coli,0
12088,Neonatal (qualifier value),Sepsis of newborn due to anaerobes,0
12089,Neonatal (qualifier value),Newborn slipped umbilical ligature,0
12090,Neonatal (qualifier value),Neonatal vaginal hemorrhage,0
12091,Neonatal (qualifier value),Perinatal transient vaginal bleeding,0
12092,Neonatal (qualifier value),Neonatal hematemesis,0
12093,Neonatal (qualifier value),Neonatal melena,0
12094,Neonatal (qualifier value),Neonatal rectal hemorrhage,0
12095,Neonatal (qualifier value),Late anemia of newborn due to isoimmunization,0
12096,Neonatal (qualifier value),Neonatal jaundice with glucose-6-phosphate dehydrogenase deficiency,0
12097,Neonatal (qualifier value),Perinatal jaundice from bruising,0
12098,Neonatal (qualifier value),Perinatal jaundice from maternal transmission of drug or toxin,0
12099,Neonatal (qualifier value),Perinatal jaundice from polycythemia,0
12100,Neonatal (qualifier value),Perinatal jaundice from swallowed maternal blood,0
12101,Neonatal (qualifier value),Perinatal jaundice from bleeding,0
12102,Neonatal (qualifier value),Delayed conjugation causing neonatal jaundice associated with another disorder,0
12103,Neonatal (qualifier value),Neonatal jaundice with Crigler-Najjar syndrome,0
12104,Neonatal (qualifier value),Neonatal jaundice with Dubin-Johnson syndrome,0
12105,Neonatal (qualifier value),Neonatal jaundice with Gilbert's syndrome,0
12106,Neonatal (qualifier value),Neonatal jaundice with congenital hypothyroidism,0
12107,Neonatal (qualifier value),Neonatal jaundice with porphyria,0
12108,Neonatal (qualifier value),Neonatal jaundice with Rotor's syndrome,0
12109,Neonatal (qualifier value),Perinatal jaundice due to congenital obstruction of bile duct,0
12110,Neonatal (qualifier value),Perinatal jaundice due to galactosemia,0
12111,Neonatal (qualifier value),Perinatal jaundice due to cystic fibrosis,0
12112,Neonatal (qualifier value),Kernicterus not due to isoimmunization,0
12113,Neonatal (qualifier value),Transitory neonatal hypernatremia,0
12114,Neonatal (qualifier value),Transitory neonatal hyponatremia,0
12115,Neonatal (qualifier value),Transitory neonatal hyperkalemia,0
12116,Neonatal (qualifier value),Transitory neonatal hypokalemia,0
12117,Neonatal (qualifier value),Disturbances of sodium balance of newborn,0
12118,Neonatal (qualifier value),Disturbances of potassium balance of newborn,0
12119,Neonatal (qualifier value),Transient neonatal thrombocytopenia due to exchange transfusion,0
12120,Neonatal (qualifier value),Transient neonatal thrombocytopenia due to idiopathic maternal thrombocytopenia,0
12121,Neonatal (qualifier value),Transient neonatal thrombocytopenia due to isoimmunization,0
12122,Neonatal (qualifier value),Neonatal necrotizing enterocolitis,0
12123,Neonatal (qualifier value),Sclerema Neonatorum,0
12124,Neonatal (qualifier value),Bronze baby,0
12125,Neonatal (qualifier value),Neonatal skin infection,0
12126,Neonatal (qualifier value),Drug reaction AND/OR intoxication specific to newborn,0
12127,Neonatal (qualifier value),Neonatal cerebral ischemia,0
12128,Neonatal (qualifier value),Neonatal Cerebral Leukomalacia,0
12129,Neonatal (qualifier value),Congenital cardiac failure,0
12130,Neonatal (qualifier value),Neonatal hypertension,0
12131,Neonatal (qualifier value),Neonatal candida septicaemia,0
12132,Neonatal (qualifier value),Fetal OR neonatal jaundice from polycythemia,0
12133,Neonatal (qualifier value),Syndrome of infant of diabetic mother,0
12134,Neonatal (qualifier value),Fetal OR neonatal jaundice from drugs AND/OR toxins transmitted from mother,0
12135,Neonatal (qualifier value),Endocrine AND/OR metabolic disorder specific to the fetus OR newborn,0
12136,Neonatal (qualifier value),Neonatal disorder,0
12137,Neonatal (qualifier value),Familial benign neonatal epilepsy,0
12138,Neonatal (qualifier value),"Benign Neonatal Epilepsy, Nonfamilial",0
12139,Neonatal (qualifier value),Transient neonatal myasthenia,0
12140,Neonatal (qualifier value),Transient Neonatal Thrombocytopenia,0
12141,Neonatal (qualifier value),Neonatal chlamydial pneumonia,0
12142,Neonatal (qualifier value),Neonatal pneumonia,0
12143,Neonatal (qualifier value),Persistent Fetal Circulation Syndrome,0
12144,Neonatal (qualifier value),"Anemia, Neonatal",0
12145,Neonatal (qualifier value),Hematemesis AND/OR melena due to swallowed maternal blood,0
12146,Neonatal (qualifier value),Neonatal gonococcal vulvovaginitis,0
12147,Neonatal (qualifier value),Neonatal dacryocystitis,0
12148,Neonatal (qualifier value),Neonatal mastitis,0
12149,Neonatal (qualifier value),Transient neonatal diabetes mellitus,0
12150,Neonatal (qualifier value),"Adrenoleukodystrophy, Neonatal",0
12151,Neonatal (qualifier value),Wiedemann-Rautenstrauch syndrome,0
12152,Neonatal (qualifier value),Transient neonatal pustulosis,0
12153,Neonatal (qualifier value),Perianal dermatitis of newborn,0
12154,Neonatal (qualifier value),Subcutaneous fat necrosis of newborn,0
12155,Neonatal (qualifier value),Neonatal adnexal polyp,0
12156,Neonatal (qualifier value),Gangrene of newborn,0
12157,Neonatal (qualifier value),Erythema toxicum neonatorum,0
12158,Neonatal (qualifier value),Panniculitis in newborn,0
12159,Neonatal (qualifier value),Neonatal Alloimmune Thrombocytopenia,0
12160,Neonatal (qualifier value),Neonatal coxsackie virus syndrome,0
12161,Neonatal (qualifier value),Neonatal echovirus disease,0
12162,Neonatal (qualifier value),Neonatal gonococcal infection,0
12163,Neonatal (qualifier value),Neonatal chlamydial infection,0
12164,Neonatal (qualifier value),Neonatal chlamydial conjunctivitis,0
12165,Neonatal (qualifier value),Hemorrhagic disease of the newborn due to factor II deficiency,0
12166,Neonatal (qualifier value),Neonatal hyperparathyroidism,0
12167,Neonatal (qualifier value),Neonatal iminoglycinuria,0
12168,Neonatal (qualifier value),Neonatal cerebral hemorrhage,0
12169,Neonatal (qualifier value),Isolated persistent neonatal hypoparathyroidism,0
12170,Neonatal (qualifier value),Fetal OR neonatal jaundice from swallowed maternal blood,0
12171,Neonatal (qualifier value),Cold injury syndrome of newborn,0
12172,Neonatal (qualifier value),Aspiration of liquor or mucus in newborn,0
12173,Neonatal (qualifier value),Neonatal dacryocystitis or conjunctivitis due to Escherichia coli,0
12174,Neonatal (qualifier value),Neonatal dacryocystitis or conjunctivitis due to staphylococcus,0
12175,Neonatal (qualifier value),Neonatal dacryocystitis or conjunctivitis due to virus,0
12176,Neonatal (qualifier value),Neonatal dacryocystitis or conjunctivitis due to chlamydiae,0
12177,Neonatal (qualifier value),Neonatal hypocalcemia,0
12178,Neonatal (qualifier value),Neonatal diarrhea,0
12179,Neonatal (qualifier value),Congenital renal failure,0
12180,Neonatal (qualifier value),Neonatal jaundice due to deficiency of enzyme system for bilirubin conjugation,0
12181,Neonatal (qualifier value),Blue baby,0
12182,Neonatal (qualifier value),Neonatal dysrhythmia,0
12183,Neonatal (qualifier value),Neonatal cardiac failure,0
12184,Neonatal (qualifier value),Myocardial ischemia of newborn,0
12185,Neonatal (qualifier value),Transient myocardial ischemia of newborn,0
12186,Neonatal (qualifier value),Transient tricuspid regurgitation of newborn,0
12187,Neonatal (qualifier value),Neonatal hypotension,0
12188,Neonatal (qualifier value),Transitory ileus of prematurity,0
12189,Neonatal (qualifier value),Neonatal peritonitis,0
12190,Neonatal (qualifier value),Transient neonatal colitis,0
12191,Neonatal (qualifier value),Neonatal chloridorrhea,0
12192,Neonatal (qualifier value),Peptic ulcer of newborn,0
12193,Neonatal (qualifier value),Chylous ascites of newborn,0
12194,Neonatal (qualifier value),Gastritis of newborn,0
12195,Neonatal (qualifier value),Newborn thermal injury,0
12196,Neonatal (qualifier value),Newborn environmental hypothermia,0
12197,Neonatal (qualifier value),Mild transient tachypnea of newborn,0
12198,Neonatal (qualifier value),Severe transient tachypnea of newborn,0
12199,Neonatal (qualifier value),Neonatal aspiration syndromes,0
12200,Neonatal (qualifier value),Neonatal pulmonary air leak,0
12201,Neonatal (qualifier value),Respiratory insufficiency syndrome of newborn,0
12202,Neonatal (qualifier value),Chronic pulmonary insufficiency of prematurity,0
12203,Neonatal (qualifier value),Newborn ingestion of maternal blood,0
12204,Neonatal (qualifier value),Neonatal aspiration of amniotic fluid,0
12205,Neonatal (qualifier value),Neonatal aspiration of mucus,0
12206,Neonatal (qualifier value),Neonatal aspiration of milk,0
12207,Neonatal (qualifier value),Apnea of prematurity,0
12208,Neonatal (qualifier value),Obstructive apnea of newborn,0
12209,Neonatal (qualifier value),Prolonged apnea of newborn,0
12210,Neonatal (qualifier value),Neonatal tracheal perforation,0
12211,Neonatal (qualifier value),Newborn physiological jaundice,0
12212,Neonatal (qualifier value),Prolonged newborn physiological jaundice,0
12213,Neonatal (qualifier value),Neonatal hyperglycemia,0
12214,Neonatal (qualifier value),Transient neonatal hyperglycemia,0
12215,Neonatal (qualifier value),Iatrogenic neonatal hyperglycemia,0
12216,Neonatal (qualifier value),Diabetes mellitus in neonate small for gestational age,0
12217,Neonatal (qualifier value),Transitory neonatal hypoglycemia,0
12218,Neonatal (qualifier value),Iatrogenic neonatal hypoglycemia,0
12219,Neonatal (qualifier value),Idiopathic transient neonatal hyperinsulinemia,0
12220,Neonatal (qualifier value),Congenital goiter,0
12221,Neonatal (qualifier value),Transient neonatal hypothyroidism,0
12222,Neonatal (qualifier value),Autoimmune neonatal thrombocytopenia,0
12223,Neonatal (qualifier value),Neutropenia of the small for gestational age baby,0
12224,Neonatal (qualifier value),Physiological anemia of infancy,0
12225,Neonatal (qualifier value),Late anemia of newborn,0
12226,Neonatal (qualifier value),Newborn drug reaction,0
12227,Neonatal (qualifier value),Newborn drug intoxication,0
12228,Neonatal (qualifier value),Newborn renal dysfunction,0
12229,Neonatal (qualifier value),Neonatal nephrocalcinosis,0
12230,Neonatal (qualifier value),Transient neonatal renal tubular acidosis,0
12231,Neonatal (qualifier value),Fifth day fits,0
12232,Neonatal (qualifier value),Umbilical polyp of newborn,0
12233,Neonatal (qualifier value),Neonatal facial petechiae,0
12234,Neonatal (qualifier value),Traumatic neonatal facial cyanosis,0
12235,Neonatal (qualifier value),Neonatal scalp injury,0
12236,Neonatal (qualifier value),Neonatal scalp abrasion,0
12237,Neonatal (qualifier value),Neonatal bruising of scalp,0
12238,Neonatal (qualifier value),Congenital uremia,0
12239,Neonatal (qualifier value),Hypomagnesemic tetany in newborn,0
12240,Neonatal (qualifier value),Acquired subglottic stenosis in newborn,0
12241,Neonatal (qualifier value),Neonatal overhydration,0
12242,Neonatal (qualifier value),"Hypercalcemia, Infantile",0
12243,Neonatal (qualifier value),Clinical infection of newborn,0
12244,Neonatal (qualifier value),Bacterial sepsis of newborn,0
12245,Neonatal (qualifier value),Congenital candidiasis,0
12246,Neonatal (qualifier value),Neonatal meningitis,0
12247,Neonatal (qualifier value),Neonatal infection of the eye,0
12248,Neonatal (qualifier value),Neonatal pyoderma,0
12249,Neonatal (qualifier value),Neonatal breast abscess,0
12250,Neonatal (qualifier value),Neonatal bacterial conjunctivitis,0
12251,Neonatal (qualifier value),Neonatal chlamydial dacryocystitis,0
12252,Neonatal (qualifier value),Neonatal viral conjunctivitis,0
12253,Neonatal (qualifier value),Neonatal inclusion blennorrhea,0
12254,Neonatal (qualifier value),Neonatal bacterial dacryocystitis,0
12255,Neonatal (qualifier value),Neonatal viral dacryocystitis,0
12256,Neonatal (qualifier value),Neonatal dacryocystitis due to Escherichia coli,0
12257,Neonatal (qualifier value),Coliform ophthalmia neonatorum,0
12258,Neonatal (qualifier value),Neonatal dacryocystitis due to staphylococcus,0
12259,Neonatal (qualifier value),Staphylococcal ophthalmia neonatorum,0
12260,Neonatal (qualifier value),Acquired neonatal pneumonia,0
12261,Neonatal (qualifier value),Neonatal aspiration pneumonia,0
12262,Neonatal (qualifier value),Third fontanelle,0
12263,Neonatal (qualifier value),Neonatal rickets,0
12264,Neonatal (qualifier value),Recurrent apnea of newborn,0
12265,Neonatal (qualifier value),Pemphigus neonatorum,0
12266,Neonatal (qualifier value),Postnatal hypoxic encephalopathy,0
12267,Neonatal (qualifier value),Neonatal asphyxial encephalopathy,0
12268,Neonatal (qualifier value),Idiopathic infantile hypercalcemia - severe form,0
12269,Neonatal (qualifier value),Perinatal pneumoperitoneum,0
12270,Neonatal (qualifier value),Neonatal annular erythema,0
12271,Neonatal (qualifier value),Meconium Aspiration Syndrome,0
12272,Neonatal (qualifier value),Transient mitral regurgitation of newborn,0
12273,Neonatal (qualifier value),Pseudomonas ophthalmia neonatorum,0
12274,Neonatal (qualifier value),Biochemical rickets,0
12275,Neonatal (qualifier value),Familial benign neonatal epilepsy,0
12276,Neonatal (qualifier value),Poor condition at birth without known asphyxia,0
12277,Neonatal (qualifier value),"Hyperbilirubinemia, Neonatal",0
12278,Neonatal (qualifier value),Neonatal unconjugated hyperbilirubinemia,0
12279,Neonatal (qualifier value),Neonatal conjugated hyperbilirubinemia,0
12280,Neonatal (qualifier value),Gonococcal Ophthalmia Neonatorum,0
12281,Neonatal (qualifier value),Perinatal jaundice from excessive hemolysis,0
12282,Neonatal (qualifier value),Neonatal cystine-lysinuria,0
12283,Neonatal (qualifier value),"Citrullinemia, neonatal type",0
12284,Neonatal (qualifier value),Environmentally-induced hyperthermia in newborn,0
12285,Neonatal (qualifier value),Neonatal infection of mouth caused by Candida,0
12286,Neonatal (qualifier value),Neonatal tracheobronchial hemorrhage,0
12287,Neonatal (qualifier value),Neonatal extracranial head trauma,0
12288,Neonatal (qualifier value),Transitory neonatal hypoparathyroidism,0
12289,Neonatal (qualifier value),Transient neonatal disorder of coagulation,0
12290,Neonatal (qualifier value),Neonatal polycythemia,0
12291,Neonatal (qualifier value),Ophthalmia Neonatorum,0
12292,Neonatal (qualifier value),aseptic myocarditis of newborn,0
12293,Neonatal (qualifier value),Disseminated intravascular coagulation in newborn,0
12294,Neonatal (qualifier value),Neonatal infective mastitis,0
12295,Neonatal (qualifier value),Perinatal respiratory distress,0
12296,Neonatal (qualifier value),Drug reaction AND/OR intoxication specific to newborn,0
12297,Neonatal (qualifier value),Infant Gynecomastia,0
12298,Neonatal (qualifier value),Kernicterus due to isoimmunization,0
12299,Neonatal (qualifier value),Acquired periventricular cysts of newborn,0
12300,Neonatal (qualifier value),Neonatal disseminated listeriosis,0
12301,Neonatal (qualifier value),Congenital epulis of newborn,0
12302,Neonatal (qualifier value),Perinatal pneumopericardium,0
12303,Neonatal (qualifier value),Primary sleep apnea of newborn,0
12304,Neonatal (qualifier value),Neonatal gastrointestinal disorder,0
12305,Neonatal (qualifier value),Neonatal metabolic and endocrinologic disorder,0
12306,Neonatal (qualifier value),Neonatal neuromuscular disorder,0
12307,Neonatal (qualifier value),Neonatal ophthalmologic disorder,0
12308,Neonatal (qualifier value),Neonatal renal disorder,0
12309,Neonatal (qualifier value),Neonatal respiratory system disorder,0
12310,Neonatal (qualifier value),Neonatal traumatic disorder,0
12311,Neonatal (qualifier value),Neonatal cardiovascular disorder,0
12312,Neonatal (qualifier value),Swimmer pup,0
12313,Neonatal (qualifier value),Seizures complicating intracranial hemorrhage in the newborn,0
12314,Neonatal (qualifier value),Immature autonomic system,0
12315,Neonatal (qualifier value),Immature eyes,0
12316,Neonatal (qualifier value),Neonatal stroke,0
12317,Neonatal (qualifier value),Neonatal colibacillosis,0
12318,Neonatal (qualifier value),Central nervous system dysfunction in newborn,0
12319,Neonatal (qualifier value),Seizures complicating infection in the newborn,0
12320,Neonatal (qualifier value),Neonatal hypermethioninemia,0
12321,Neonatal (qualifier value),Benign neonatal epilepsy,0
12322,Neonatal (qualifier value),Polycythemia due to donor twin transfusion,0
12323,Neonatal (qualifier value),Neonatal Jaundice,0
12324,Neonatal (qualifier value),Transient neonatal hyperparathyroidism,0
12325,Neonatal (qualifier value),Neonatal osteosclerotic dysplasia,0
12326,Neonatal (qualifier value),Blomstrand dysplasia,0
12327,Neonatal (qualifier value),Raine dysplasia,0
12328,Neonatal (qualifier value),Inflammation of fetal umbilical artery,0
12329,Neonatal (qualifier value),Disorder of neonatal umbilicus,0
12330,Neonatal (qualifier value),Neonatal dermatosis,0
12331,Neonatal (qualifier value),Neonatal viral infection of skin,0
12332,Neonatal (qualifier value),Neonatal pyogenic infection of skin,0
12333,Neonatal (qualifier value),Neonatal fungal infection of skin,0
12334,Neonatal (qualifier value),Neonatal disorder of subcutaneous fat,0
12335,Neonatal (qualifier value),Physiological anomaly of neonatal skin,0
12336,Neonatal (qualifier value),Neonatal cutis marmorata,0
12337,Neonatal (qualifier value),Neonatal necrotizing fasciitis,0
12338,Neonatal (qualifier value),Neonatal bacterial paronychia,0
12339,Neonatal (qualifier value),Neonatal staphylococcal scalded skin syndrome,0
12340,Neonatal (qualifier value),Neonatal systemic candidiasis,0
12341,Neonatal (qualifier value),Telogen effluvium of the newborn,0
12342,Neonatal (qualifier value),Neonatal cold panniculitis,0
12343,Neonatal (qualifier value),Neonatal staphylococcal infection of skin,0
12344,Neonatal (qualifier value),Staphylococcal omphalitis,0
12345,Neonatal (qualifier value),Neonatal streptococcal infection,0
12346,Neonatal (qualifier value),Streptococcal omphalitis,0
12347,Neonatal (qualifier value),Neonatal pseudomonas infection,0
12348,Neonatal (qualifier value),Neonatal eosinophilic pustular folliculitis,0
12349,Neonatal (qualifier value),Neonatal bullous dermatosis due to maternal antibodies,0
12350,Neonatal (qualifier value),Neonatal iatrogenic skin trauma,0
12351,Neonatal (qualifier value),Neonatal sebaceous gland hyperplasia,0
12352,Neonatal (qualifier value),Neonatal sucking blisters,0
12353,Neonatal (qualifier value),Neonatal physiological scaling,0
12354,Neonatal (qualifier value),Neonatal milia,0
12355,Neonatal (qualifier value),Neonatal ecthyma gangrenosum,0
12356,Neonatal (qualifier value),Retinopathy of prematurity stage 1 - demarcation line,0
12357,Neonatal (qualifier value),Retinopathy of prematurity stage 2 - intraretinal ridge,0
12358,Neonatal (qualifier value),Retinopathy of prematurity stage 3 - ridge with extraretinal fibrovascular proliferation,0
12359,Neonatal (qualifier value),Retinopathy of prematurity stage 4 - subtotal retinal detachment,0
12360,Neonatal (qualifier value),Retinopathy of prematurity stage 5 - total retinal detachment,0
12361,Neonatal (qualifier value),Omphalophlebitis,0
12362,Neonatal (qualifier value),Neonatal herpes simplex virus conjunctivitis,0
12363,Neonatal (qualifier value),Sepsis of the newborn,0
12364,Neonatal (qualifier value),Neonatal bradycardia,0
12365,Neonatal (qualifier value),Neonatal tachycardia,0
12366,Neonatal (qualifier value),"Neonatal Sleep Myoclonus, Benign",0
12367,Neonatal (qualifier value),Bohn's nodule,0
12368,Neonatal (qualifier value),Coxsackie myocarditis of newborn,0
12369,Neonatal (qualifier value),Disorder of cellular component of blood in newborn,0
12370,Neonatal (qualifier value),Disorder of hematopoietic system in newborn,0
12371,Neonatal (qualifier value),Epstein's pearl,0
12372,Neonatal (qualifier value),Gingival cyst of newborn,0
12373,Neonatal (qualifier value),Neonatal botulism,0
12374,Neonatal (qualifier value),Neonatal candidiasis,0
12375,Neonatal (qualifier value),Neonatal pulmonary hemorrhage,0
12376,Neonatal (qualifier value),Retinopathy of Prematurity,0
12377,Neonatal (qualifier value),TORCH syndrome,0
12378,Neonatal (qualifier value),Omphalitis of the newborn,0
12379,Neonatal (qualifier value),Urticaria neonatorum,0
12380,Neonatal (qualifier value),"Primary atelectasis, in perinatal period",0
12381,Neonatal (qualifier value),Primary apnea in the newborn,0
12382,Neonatal (qualifier value),Hemorrhage of skin in neonate,0
12383,Neonatal (qualifier value),Neonatal hypoxemia,0
12384,Neonatal (qualifier value),Cholestasis in newborn,0
12385,Neonatal (qualifier value),Tetanus neonatorum,0
12386,Neonatal (qualifier value),Slipped umbilical ligature with hemorrhage,0
12387,Neonatal (qualifier value),"Respiratory Distress Syndrome, Newborn",0
12388,Neonatal (qualifier value),Anemia of prematurity,0
12389,Neonatal (qualifier value),Noninfective mastitis of newborn,0
12390,Neonatal (qualifier value),Lucey-Driscoll syndrome (disorder),0
12391,Neonatal (qualifier value),Vomiting in newborn,0
12392,Neonatal (qualifier value),Dehydration fever in newborn,0
12393,Neonatal (qualifier value),Newborn cerebral irritability,0
12394,Neonatal (qualifier value),Neonatal acne,0
12395,Neonatal (qualifier value),Neonatal diabetes mellitus,0
12396,Neonatal (qualifier value),Kernicterus,0
12397,Neonatal (qualifier value),Hypoglycemia of piglets,0
12398,Neonatal (qualifier value),"Hyperglycinemia, Transient Neonatal",0
12399,Neonatal (qualifier value),Head lag in the newborn,0
12400,Neonatal (qualifier value),Neonatal hypoglycemia,0
12401,Neonatal (qualifier value),Lethal neonatal spasticity,0
12402,Neonatal (qualifier value),Intestinal obstruction by inspissated milk in newborn,0
12403,Neonatal (qualifier value),Perinatal atelectasis,0
12404,Neonatal (qualifier value),Transient neonatal neutropenia (disorder),0
12405,Neonatal (qualifier value),Neonatal transient hyperthyroidism,0
12406,Neonatal (qualifier value),Perinatal jaundice from hereditary hemolytic anemia,0
12407,Neonatal (qualifier value),Meconium peritonitis,0
12408,Neonatal (qualifier value),Natal Teeth,0
12409,Neonatal (qualifier value),Perinatal secondary atelectasis,0
12410,Neonatal (qualifier value),Neonatal Graves' disease,0
12411,Neonatal (qualifier value),Transitory fever of newborn,0
12412,Neonatal (qualifier value),Perinatal interstitial emphysema,0
12413,Neonatal (qualifier value),Tetanus omphalitis,0
12414,Neonatal (qualifier value),Neonatal hemochromatosis,0
12415,Neonatal (qualifier value),Neonatal Abstinence Syndrome,0
12416,Neonatal (qualifier value),Neonatal thrombocytopenia due to idiopathic maternal thrombocytopenia,0
12417,Neonatal (qualifier value),Cow's milk hypocalcemia of newborn,0
12418,Neonatal (qualifier value),Perinatal pneumomediastinum,0
12419,Neonatal (qualifier value),Abnormal cerebral signs in the newborn,0
12420,Neonatal (qualifier value),Neonatal hypoparathyroidism,0
12421,Neonatal (qualifier value),Abnormal fetal heart beat noted before labor in liveborn infant,0
12422,Neonatal (qualifier value),Perinatal pulmonary collapse,0
12423,Neonatal (qualifier value),Bronchopulmonary Dysplasia,0
12424,Neonatal (qualifier value),Neonatal jaundice due to bruising,0
12425,Neonatal (qualifier value),Disturbance of temperature regulation of newborn,0
12426,Neonatal (qualifier value),Benign neonatal hyperaminoaciduria,0
12427,Neonatal (qualifier value),Neonatal jaundice due to delayed conjugation from delayed development of conjugating system,0
12428,Neonatal (qualifier value),Neonatal hepatitis,0
12429,Neonatal (qualifier value),Hyperthermia in newborn,0
12430,Neonatal (qualifier value),Complement component 5 deficiency,0
12431,Neonatal (qualifier value),Neonatal jaundice associated with preterm delivery,0
12432,Neonatal (qualifier value),Perinatal jaundice due to inspissated bile syndrome,0
12433,Neonatal (qualifier value),Dermatitis of the newborn,0
12434,Neonatal (qualifier value),Urine ascites of the neonate,0
12435,Neonatal (qualifier value),Transient neonatal hypertyrosinemia,0
12436,Neonatal (qualifier value),Transitory tachypnea of newborn,0
12437,Neonatal (qualifier value),Polycythemia due to maternal-fetal transfusion,0
12438,Neonatal (qualifier value),Gray syndrome from chloramphenicol administration in newborn,0
12439,Neonatal (qualifier value),Hypocalcemia and hypomagnesemia of newborn,0
12440,Neonatal (qualifier value),Neonatal dehydration,0
12441,Neonatal (qualifier value),Edema of newborn,0
12442,Neonatal (qualifier value),Neonatal thrombocytopenia associated with maternal idiopathic thrombocytopenic purpura,0
12443,Neonatal (qualifier value),Maternal transfer neutropenia,0
12444,Neonatal (qualifier value),Neonatal hepatosplenomegaly,0
12445,Neonatal (qualifier value),Neonatal hyperhistidinemia,0
12446,Neonatal (qualifier value),Neonatal Myasthenia Gravis,0
12447,Neonatal (qualifier value),Transitory ileus of newborn,0
12448,Neonatal (qualifier value),Neonatal jaundice due to delayed conjugation from breast milk inhibitor,0
12449,Neonatal (qualifier value),Neonatal thrombocytopenia (disorder),0
12450,Neonatal (qualifier value),Umbilical hemorrhage after birth,0
12451,Neonatal (qualifier value),Neonatal osteomyelitis of jaw,0
12452,Neonatal (qualifier value),Hemorrhage of newborn,0
12453,Neonatal (qualifier value),Cerebral depression in newborn,0
12454,Neonatal (qualifier value),Convulsions in the newborn,0
12455,Neonatal (qualifier value),Neonatal hypomagnesemia,0
12456,Neonatal (qualifier value),Fetal OR neonatal jaundice from infection,0
12457,Neonatal (qualifier value),Neonatal thrombocytopenia due to exchange transfusion,0
12458,Neonatal (qualifier value),Coma in the newborn,0
12459,Neonatal (qualifier value),Neonatal hepatocellular damage,0
12460,Neonatal (qualifier value),Neonatal Systemic lupus erythematosus,0
12461,Neonatal (qualifier value),Neonatal hypoventilation,0
12462,Neonatal (qualifier value),Neonatal respiratory acidosis,0
12463,Neonatal (qualifier value),Neonatal respiratory alkalosis,0
12464,Neonatal (qualifier value),Neonatal circulatory failure,0
12465,Neonatal (qualifier value),Neonatal apneic attack,0
12466,Neonatal (qualifier value),Neonatal cyanosis,0
12467,Neonatal (qualifier value),Neonatal respiratory depression,0
12468,Neonatal (qualifier value),Neonatal respiratory failure,0
12469,Neonatal (qualifier value),Thrombophlebitis of the newborn,0
12470,Neonatal (qualifier value),Respiratory tract hemorrhage of the newborn,0
12471,Neonatal (qualifier value),Neonatal coagulation disorder,0
12472,Neonatal (qualifier value),Neonatal lymphocytopenia,0
12473,Neonatal (qualifier value),Paralytic ileus of the newborn,0
12474,Neonatal (qualifier value),Spastic ileus of the newborn,0
12475,Neonatal (qualifier value),Fever of the newborn,0
12476,Neonatal (qualifier value),Neonatal encephalopathy,0
12477,Neonatal (qualifier value),Drowsiness of the newborn,0
12478,Neonatal (qualifier value),Neonatal hypokinesia,0
12479,Neonatal (qualifier value),Neonatal respiratory arrest,0
12480,Neonatal (qualifier value),Late metabolic acidosis of newborn,0
12481,Neonatal (qualifier value),Perinatal jaundice due to fetal OR neonatal hepatitis,0
12482,Adolescence,"Reactive attachment disorder of infancy OR early childhood, disinhibited type",0
12483,Adolescence,Adolescent emancipation disorder,0
12484,Adolescence,Childhood and adolescent fearfulness disturbance,0
12485,Adolescence,Childhood and adolescent relationship problem,0
12486,Adolescence,Sibling jealousy,0
12487,Adolescence,Childhood or adolescent identity disorder,0
12488,Adolescence,Childhood or adolescent disorder of social functioning,0
12489,Adolescence,Juvenile arthritis in Crohn disease,0
12490,Adolescence,Juvenile arthritis in ulcerative colitis,0
12491,Adolescence,Adolescent idiopathic scoliosis,0
12492,Adolescence,"Reactive attachment disorder of infancy OR early childhood, inhibited type",0
12493,Adolescence,Adolescent - emotional problem,0
12494,Adolescence,Juvenile acne,0
12495,Adolescence,Juvenile ankylosing spondylitis,0
12496,Adolescence,Juvenile arthritis of inflammatory bowel disease,0
12497,Adolescence,Acute adolescent mastitis,0
12498,Adolescence,Childhood and adolescent disturbance with sensitivity,0
12499,Adolescence,Childhood and adolescent disturbance with shyness,0
12500,Adolescence,Childhood and adolescent disturbance with introversion,0
12501,Adolescence,Childhood and adolescent disturbance with elective mutism,0
12502,Adolescence,Childhood disinhibited attachment disorder,0
12503,Adolescence,Adolescent striae,0
12504,Adolescence,Adolescent mastitis,0
12505,Adolescence,Avoidant disorder of childhood OR adolescence,0
12506,Adolescence,Reactive attachment disorder of early childhood,0
12507,Adolescence,"Conduct disorder, adolescent-onset type",0
12508,Adolescence,Delayed female puberty,0
12509,Adolescence,Selective Mutism,0
12510,Adolescence,Adolescent postural kyphosis,0
12511,Old age,Elderly feeding problem,0
12512,Old age,Elderly vasovagal syndrome,0
12513,Fetal period,Condition of fetal growth AND/OR malnutrition,0
12514,Fetal period,Fetal finding,0
12515,Fetal period,Fetal sign,0
12516,Fetal period,Intrauterine sepsis of fetus,0
12517,Fetal period,Hydrocephalic disproportion,0
12518,Fetal period,Conjoined twins causing disproportion,0
12519,Fetal period,Suspected damage to fetus from disease in the mother,0
12520,Fetal period,Right sacroposterior position,0
12521,Fetal period,Brow left anterior position,0
12522,Fetal period,Quickening of fetus,0
12523,Fetal period,"Prenatal state of fetus, 1st trimester",0
12524,Fetal period,Left occipitoanterior position,0
12525,Fetal period,Intra-amniotic infection of fetus,0
12526,Fetal period,Fetal presentation finding,0
12527,Fetal period,Position of fetus,0
12528,Fetal period,Compound presentation,0
12529,Fetal period,Fetal neoplasm,0
12530,Fetal period,Infectious disorder of the fetus,0
12531,Fetal period,Fetal distress affecting management of mother,0
12532,Fetal period,Fetal Distress,0
12533,Fetal period,Fetus-to-fetus placental transfusion syndrome,0
12534,Fetal period,"Prenatal state of fetus, 3rd trimester",0
12535,Fetal period,Fetal acidemia affecting management of mother,0
12536,Fetal period,Asynclitism,0
12537,Fetal period,Fetal Malpresentation,0
12538,Fetal period,Immune Hydrops Fetalis,0
12539,Fetal period,Right lateral brow position,0
12540,Fetal period,Synclitism,0
12541,Fetal period,O/E - vertex presentation,0
12542,Fetal period,O/E - breech presentation,0
12543,Fetal period,O/E -fetal presentation unsure,0
12544,Fetal period,O/E - presenting part position,0
12545,Fetal period,O/E - presenting part LOA,0
12546,Fetal period,O/E - presenting ROA,0
12547,Fetal period,O/E - presenting part LOP,0
12548,Fetal period,O/E - presenting part ROP,0
12549,Fetal period,O/E - presenting part LSA,0
12550,Fetal period,O/E - presenting part RSA,0
12551,Fetal period,O/E - presenting part free-5/5,0
12552,Fetal period,O/E - presenting part free-4/5,0
12553,Fetal period,O/E - partial engagement - 3/5,0
12554,Fetal period,O/E - partial engagement - 2/5,0
12555,Fetal period,O/E - presentation engaged-1/5,0
12556,Fetal period,O/E - fetal movements,0
12557,Fetal period,O/E - fetal movements seen,0
12558,Fetal period,O/E - fetal movements felt,0
12559,Fetal period,O/E - fetus very active,0
12560,Fetal period,O/E - fetal movement diminished,0
12561,Fetal period,O/E - fetal heart heard,0
12562,Fetal period,O/E - fetal heart < 40,0
12563,Fetal period,O/E - fetal heart 40-80,0
12564,Fetal period,O/E - fetal heart 80-100,0
12565,Fetal period,O/E - fetal heart 100-120,0
12566,Fetal period,O/E - fetal heart 120-160,0
12567,Fetal period,O/E - fetal heart 160-180,0
12568,Fetal period,O/E - fetal heart 180-200,0
12569,Fetal period,O/E - fetal heart > 200,0
12570,Fetal period,O/E - fetal heart -type 1 dips,0
12571,Fetal period,O/E - fetal heart -type 2 dips,0
12572,Fetal period,Fetal movements seen,0
12573,Fetal period,Fetal size accords with dates,0
12574,Fetal period,Fetal size does not accord with dates,0
12575,Fetal period,Fetal bradycardia affecting management of mother,0
12576,Fetal period,Fetal death from asphyxia AND/OR anoxia during labor,0
12577,Fetal period,"Fetal death from asphyxia AND/OR anoxia, not clear if noted before OR after onset of labor",0
12578,Fetal period,Normal birth weight infant,0
12579,Fetal period,Normal fetal growth,0
12580,Fetal period,Slow fetal growth AND/OR fetal malnutrition,0
12581,Fetal period,Frank Breech Presentation,0
12582,Fetal period,Fetal descent,0
12583,Fetal period,Left occipitolateral position,0
12584,Fetal period,Light-for-dates without fetal malnutrition,0
12585,Fetal period,Macerated fetus,0
12586,Fetal period,Papyraceous fetus - delivered,0
12587,Fetal period,Papyraceous fetus - not delivered,0
12588,Fetal period,Breech presentation - delivered,0
12589,Fetal period,Breech presentation with antenatal problem,0
12590,Fetal period,Face presentation - delivered,0
12591,Fetal period,Face presentation with antenatal problem,0
12592,Fetal period,Brow presentation - delivered,0
12593,Fetal period,Brow presentation with antenatal problem,0
12594,Fetal period,Cephalopelvic Disproportion,0
12595,Fetal period,Mixed feto-pelvic disproportion,0
12596,Fetal period,Mixed feto-pelvic disproportion - delivered,0
12597,Fetal period,Mixed feto-pelvic disproportion with antenatal problem,0
12598,Fetal period,Large fetus causing disproportion - delivered,0
12599,Fetal period,Large fetus causing disproportion with antenatal problem,0
12600,Fetal period,Hydrocephalic disproportion,0
12601,Fetal period,Hydrocephalic disproportion - delivered,0
12602,Fetal period,Hydrocephalic disproportion with antenatal problem,0
12603,Fetal period,Known or suspected fetal abnormality,0
12604,Fetal period,Fetus with central nervous system malformation - delivered,0
12605,Fetal period,fetal central nervous system abnormality affecting care of mother as antepartum condition,0
12606,Fetal period,Fetus with chromosomal abnormality - delivered,0
12607,Fetal period,Fetus with chromosomal abnormality with antenatal problem,0
12608,Fetal period,Fetus with hereditary disease,0
12609,Fetal period,Fetus with hereditary disease - delivered,0
12610,Fetal period,Fetus with hereditary disease with antenatal problem,0
12611,Fetal period,Fetus with viral damage via mother - delivered,0
12612,Fetal period,Fetus with viral damage via mother with antenatal problem,0
12613,Fetal period,Fetus with drug damage,0
12614,Fetal period,Fetus with drug damage - delivered,0
12615,Fetal period,Fetus with drug damage with antenatal problem,0
12616,Fetal period,Fetus with radiation damage,0
12617,Fetal period,Fetus with radiation damage - delivered,0
12618,Fetal period,Fetus with radiation damage with antenatal problem,0
12619,Fetal period,Fetus with damage due to intrauterine contraceptive device,0
12620,Fetal period,Fetus with damage due to intrauterine contraceptive device - delivered,0
12621,Fetal period,Fetus with damage due to intrauterine contraceptive device with antenatal problem,0
12622,Fetal period,Fetal-maternal hemorrhage - delivered,0
12623,Fetal period,Fetal-maternal hemorrhage with antenatal problem,0
12624,Fetal period,Fetal distress - delivered,0
12625,Fetal period,Fetal distress with antenatal problem,0
12626,Fetal period,Intrauterine death - delivered,0
12627,Fetal period,Intrauterine death with antenatal problem,0
12628,Fetal period,Small-for-dates with antenatal problem,0
12629,Fetal period,Large-for-dates fetus,0
12630,Fetal period,Large-for-dates with antenatal problem,0
12631,Fetal period,Finding of ballottement of fetal parts,0
12632,Fetal period,Fetal or neonatal effect of ectopic pregnancy,0
12633,Fetal period,Fetal or neonatal effect of abdominal ectopic pregnancy,0
12634,Fetal period,Fetal or neonatal effect of intraperitoneal ectopic pregnancy,0
12635,Fetal period,Fetal or neonatal effect of tubal ectopic pregnancy,0
12636,Fetal period,Fetal or neonatal effect of maternal use of nutritional chemical substance,0
12637,Fetal period,Fetal or neonatal effect of maternal exposure to environmental chemical substances,0
12638,Fetal period,Fetus small-for-dates with signs of malnutrition,0
12639,Fetal period,Cephalhematoma due to birth trauma,0
12640,Fetal period,Fetal death due to prelabor anoxia,0
12641,Fetal period,Fetal death due to labor anoxia,0
12642,Fetal period,Liveborn with prelabor fetal distress,0
12643,Fetal period,Liveborn with prelabor abnormal heart beat,0
12644,Fetal period,Liveborn with prelabor hypoxia,0
12645,Fetal period,Liveborn with prelabor meconium in liquor,0
12646,Fetal period,Liveborn with labor fetal distress,0
12647,Fetal period,Liveborn with labor abnormal heart beat,0
12648,Fetal period,Liveborn with labor hypoxia,0
12649,Fetal period,Liveborn with labor meconium in liquor,0
12650,Fetal period,Clostridial intra-amniotic fetal infection,0
12651,Fetal period,Escherichia coli intra-amniotic fetal infection,0
12652,Fetal period,Pseudomonas pyocyaneus congenital infection,0
12653,Fetal period,Fetal blood loss,0
12654,Fetal period,"Hydrops Fetalis, Non-Immune",0
12655,Fetal period,suspected damage to fetus from maternal alcohol addiction,0
12656,Fetal period,Meconium in amniotic fluid noted before labor in liveborn infant,0
12657,Fetal period,Left sacroposterior position,0
12658,Fetal period,Face presentation,0
12659,Fetal period,Fetal Viability,0
12660,Fetal period,Fetal Growth Retardation,0
12661,Fetal period,"Abnormal fetal heart beat, not clear if noted before OR after onset of labor in liveborn infant",0
12662,Fetal period,Fetal congenital tumor causing disproportion,0
12663,Fetal period,Suspect fetal damage from maternal alcohol,0
12664,Fetal period,suspected damage to fetus from maternal toxoplasmosis,0
12665,Fetal period,Suspect cystic fibrosis fetus,0
12666,Fetal period,Suspect fetal anencephaly,0
12667,Fetal period,Lithopedion,0
12668,Fetal period,Head entrapment during breech delivery,0
12669,Fetal period,Antepartum fetal death,0
12670,Fetal period,Fetal intrapartum death,0
12671,Fetal period,Intrauterine death of one twin,0
12672,Fetal period,Acromion presentation,0
12673,Fetal period,Fetal tachycardia,0
12674,Fetal period,Fetal bradycardia,0
12675,Fetal period,Fetal acidosis,0
12676,Fetal period,Fetal rotation,0
12677,Fetal period,Right mentoanterior position,0
12678,Fetal period,Presenting part not applied,0
12679,Fetal period,Presenting part loosely applied,0
12680,Fetal period,Presenting part well applied,0
12681,Fetal period,Presenting part tightly applied,0
12682,Fetal period,Fetal movements not palpable,0
12683,Fetal period,Fetal heart finding,0
12684,Fetal period,Fetal heart sounds present,0
12685,Fetal period,Small fetus,0
12686,Fetal period,Large fetus,0
12687,Fetal period,Finding of fetal parts,0
12688,Fetal period,Fetal parts not palpable per abdomen,0
12689,Fetal period,Fetal parts palpable per abdomen,0
12690,Fetal period,Multiple fetal parts palpable,0
12691,Fetal period,Fetal parts not distinguishable per abdomen,0
12692,Fetal period,Fetal parts distinguished abdominally,0
12693,Fetal period,Longitudinal lie,0
12694,Fetal period,Uncertain lie,0
12695,Fetal period,Deflexed fetal attitude,0
12696,Fetal period,Extended fetal attitude,0
12697,Fetal period,No fetal parts presenting vaginally,0
12698,Fetal period,Direct occipitoposterior position,0
12699,Fetal period,Occipitolateral position,0
12700,Fetal period,Sutures touching without overlapping,0
12701,Fetal period,Reducible suture overlap,0
12702,Fetal period,Fixed suture overlap,0
12703,Fetal period,Fontanelles presenting,0
12704,Fetal period,Both fontanelles presenting,0
12705,Fetal period,Anterior fontanelle presenting,0
12706,Fetal period,Posterior fontanelle presenting,0
12707,Fetal period,Mentoanterior position,0
12708,Fetal period,Direct mentoanterior position,0
12709,Fetal period,Mentoposterior position,0
12710,Fetal period,Direct mentoposterior position,0
12711,Fetal period,Mentolateral position,0
12712,Fetal period,Mentum presentation,0
12713,Fetal period,Orbital ridges presenting,0
12714,Fetal period,Anterior brow position,0
12715,Fetal period,Posterior brow position,0
12716,Fetal period,Lateral brow position,0
12717,Fetal period,Footling breech presentation,0
12718,Fetal period,Direct sacroposterior position,0
12719,Fetal period,Sacrolateral position,0
12720,Fetal period,Anterior shoulder presentation,0
12721,Fetal period,Shoulder right anterior position,0
12722,Fetal period,Shoulder left anterior position,0
12723,Fetal period,Posterior shoulder presentation,0
12724,Fetal period,Presentation in multiple pregnancy,0
12725,Fetal period,Head engaged,0
12726,Fetal period,Head partially engaged,0
12727,Fetal period,Head deeply engaged,0
12728,Fetal period,Engagement of breech,0
12729,Fetal period,Breech engaged,0
12730,Fetal period,Breech not engaged,0
12731,Fetal period,No presenting part at brim of pelvis,0
12732,Fetal period,Descent of presenting part during labor,0
12733,Fetal period,Presenting part above spines,0
12734,Fetal period,Presenting part at spines,0
12735,Fetal period,Presenting part below spines,0
12736,Fetal period,Cardiotochogram finding,0
12737,Fetal period,Reactive CTG tracing,0
12738,Fetal period,Nonreactive CTG tracing,0
12739,Fetal period,Fetal heart deceleration,0
12740,Fetal period,Early fetal heart deceleration,0
12741,Fetal period,Late fetal heart deceleration,0
12742,Fetal period,Fetal heart acceleration,0
12743,Fetal period,Cephalopelvic Disproportion,0
12744,Fetal period,Frog fetus,0
12745,Fetal period,Shoulder right posterior position,0
12746,Fetal period,Fetus with central nervous system malformation,0
12747,Fetal period,Fetus with chromosomal abnormality,0
12748,Fetal period,Fetus with viral damage via mother,0
12749,Fetal period,Fetal distress-affecting care,0
12750,Fetal period,Small for gestational age fetus,0
12751,Fetal period,Harlequin Fetus,0
12752,Fetal period,Fetal movements felt,0
12753,Fetal period,O/E - fetal presentation,0
12754,Fetal period,O/E - multiple presentation,0
12755,Fetal period,On examination - presenting part station,0
12756,Fetal period,Fetal vital sign,0
12757,Fetal period,Intrauterine hypoxia,0
12758,Fetal period,O/E - lie of fetus,0
12759,Fetal period,On examination - triplet presentation,0
12760,Fetal period,O/E - twin presentation,0
12761,Fetal period,O/E - PP free - not engaged,0
12762,Fetal period,O/E - presenting part engaged,0
12763,Fetal period,Baby kicks a lot,0
12764,Fetal period,Reduced fetal movement,0
12765,Fetal period,Baby not moving,0
12766,Fetal period,Strong fetal movements,0
12767,Fetal period,Weak fetal movements,0
12768,Fetal period,Fetal heart sounds loud,0
12769,Fetal period,Fetal heart sounds quiet,0
12770,Fetal period,Fetal Death,0
12771,Fetal period,Hydrops Fetalis,0
12772,Fetal period,"Hydrops Fetalis, Non-Immune",0
12773,Fetal period,Fetal dysrhythmia,0
12774,Fetal period,Antepartum fetal acidosis,0
12775,Fetal period,Intrapartum fetal acidosis,0
12776,Fetal period,Fetus at risk,0
12777,Fetal period,Fetal stress,0
12778,Fetal period,Fetal growth abnormality,0
12779,Fetal period,Asymmetrical growth retardation,0
12780,Fetal period,Symmetrical growth retardation,0
12781,Fetal period,Fetal Malnutrition,0
12782,Fetal period,Fetal Hypoxia,0
12783,Fetal period,Antepartum fetal hypoxia,0
12784,Fetal period,Intrapartum fetal hypoxia,0
12785,Fetal period,Fetal Anoxia,0
12786,Fetal period,Antepartum fetal asphyxia,0
12787,Fetal period,Fetal postural deformity,0
12788,Fetal period,Fetal cytomegalovirus syndrome,0
12789,Fetal period,Fetal trauma,0
12790,Fetal period,Poor clinical fetal growth,0
12791,Fetal period,Unsatisfactory CTG tracing,0
12792,Fetal period,Reactivity reduced,0
12793,Fetal period,Normal fetal heart baseline pattern,0
12794,Fetal period,Sinusoidal pattern of fetal heart,0
12795,Fetal period,Variable deceleration - finding,0
12796,Fetal period,Prolonged deceleration - finding,0
12797,Fetal period,Mixed deceleration - finding,0
12798,Fetal period,Normal baseline fetal heart rate,0
12799,Fetal period,Well flexed fetal head,0
12800,Fetal period,Deflexed fetal head,0
12801,Fetal period,Shoulder left posterior position,0
12802,Fetal period,External fetal rotation finding,0
12803,Fetal period,Finding of arrangement of fetus,0
12804,Fetal period,Transverse/oblique lie,0
12805,Fetal period,Fetal distress - prelabor,0
12806,Fetal period,Fetal distress - in labor,0
12807,Fetal period,Fetal cerebral hemorrhage,0
12808,Fetal period,Good baseline variability in fetal heart rate,0
12809,Fetal period,Poor baseline variability in fetal heart rate,0
12810,Fetal period,Normal CTG tracing,0
12811,Fetal period,CTG tracing problem,0
12812,Fetal period,Fetus present,0
12813,Fetal period,Fetus absent,0
12814,Fetal period,Fetus not seen,0
12815,Fetal period,Finding of form of fetus,0
12816,Fetal period,Presenting part ballottable,0
12817,Fetal period,Ballottement of fetal head abdominally,0
12818,Fetal period,Ballottement of fetal head at fundus,0
12819,Fetal period,Ballottement of fetal head in suprapubic area,0
12820,Fetal period,Ballottement of fetal head vaginally,0
12821,Fetal period,Presenting part not ballottable,0
12822,Fetal period,Fetal head flexed,0
12823,Fetal period,Fetal head partially flexed,0
12824,Fetal period,Fetal head extended,0
12825,Fetal period,Finding of position of vertex presentation,0
12826,Fetal period,Finding of malposition of fetus,0
12827,Fetal period,Malposition of fetus in face presentation,0
12828,Fetal period,Malposition of fetus in brow presentation,0
12829,Fetal period,Malposition of fetus in shoulder presentation,0
12830,Fetal period,Fetal head 5/5 above pelvic brim,0
12831,Fetal period,Fetal head 4/5 above pelvic brim,0
12832,Fetal period,Fetal head 3/5 above pelvic brim,0
12833,Fetal period,Fetal head 2/5 above pelvic brim,0
12834,Fetal period,Fetal head 1/5 above pelvic brim,0
12835,Fetal period,Fetal head 0/5 above pelvic brim,0
12836,Fetal period,Breech deeply engaged,0
12837,Fetal period,Finding of fetal descent in relation to ischial spines,0
12838,hemorrhage during pregnancy threatening abortion,Threatened abortion,0
12839,Threatened abortion,hemorrhage during pregnancy threatening abortion,0
12840,Threatened abortion,hemorrhage during pregnancy threatening abortion with baby delivered,0
12841,Threatened abortion,hemorrhage during pregnancy threatening abortion as antepartum condition,0
12842,hemorrhage during pregnancy threatening abortion with baby delivered,Threatened abortion,0
12843,hemorrhage during pregnancy threatening abortion as antepartum condition,Threatened abortion,0
12844,Grafting procedure,Complication of artificial skin graft,0
12845,Lupus Erythematosus,Subcutaneous nodule associated with lupus erythematosus,0
12846,Operative Surgical Procedures,Granuloma of surgical wound,0
12847,Subcutaneous nodule associated with lupus erythematosus,Lupus Erythematosus,0
12848,Complication of artificial skin graft and decellularized allodermis,Interventional procedure,0
12849,Complication of artificial skin graft and decellularized allodermis,Artificial skin,0
12850,Leakage of peritoneal dialysate into subcutaneous tissue of abdominal wall,Peritoneal Dialysis,0
12851,Leakage of peritoneal dialysate into pleural cavity,Peritoneal Dialysis,0
12852,Granuloma of surgical wound,Operative Surgical Procedures,0
12853,Complication of artificial skin graft,Grafting procedure,0
12854,Catheter related infection,Catheterization,0
12855,Encapsulating peritoneal sclerosis associated with peritoneal dialysis,Peritoneal Dialysis,0
12856,Catheterization,Catheter related infection,0
12857,Peritoneal Dialysis,Leakage of peritoneal dialysate into subcutaneous tissue of abdominal wall,0
12858,Peritoneal Dialysis,Leakage of peritoneal dialysate into pleural cavity,0
12859,Peritoneal Dialysis,Encapsulating peritoneal sclerosis associated with peritoneal dialysis,0
12860,Interventional procedure,Complication of artificial skin graft and decellularized allodermis,0
12861,Artificial skin,Complication of artificial skin graft and decellularized allodermis,0
12862,Focal Infection,Localized enamel hypomineralization associated with localized infection,0
12863,Connective Tissue Diseases,Scleroderma-associated necrotizing vasculitis,0
12864,Localized enamel hypomineralization associated with localized infection,Focal Infection,0
12865,Failure of dental post,Interventional procedure,0
12866,Blocked central line,Interventional procedure,0
12867,Miscarriage due to Leptospira,Leptospirosis,0
12868,Mechanical complication of chin prosthesis,Interventional procedure,0
12869,Mycoplasma Infections,Erythema multiforme due to mycoplasma infection,0
12870,Lymphogranuloma Venereum,Lymphedema due to lymphogranuloma venereum,0
12871,Toxoplasmosis,suspected damage to fetus from maternal toxoplasmosis,0
12872,Complication of implant,Interventional procedure,0
12873,Nervous system complication from surgically implanted device,Interventional procedure,0
12874,Mucocutaneous Lymph Node Syndrome,Fever,0
12875,Urinary calculus in schistosomiasis,Schistosoma hematobium infection,0
12876,Complete miscarriage with genital tract or pelvic infection,Communicable Diseases,0
12877,Fetus with viral damage via mother,Virus Diseases,0
12878,Fetus with viral damage via mother - delivered,Virus Diseases,0
12879,Fetus with viral damage via mother with antenatal problem,Virus Diseases,0
12880,Fetus with viral damage via mother,Virus Diseases,0
12881,"Mechanical complication of nervous system device, implant AND/OR graft",Interventional procedure,0
12882,Mechanical complication of nervous system device,Interventional procedure,0
12883,Mechanical complication of dorsal column stimulator,Interventional procedure,0
12884,Mechanical complication of electrodes implanted in brain,Interventional procedure,0
12885,"Mechanical complication of nervous system device, implant AND/OR graft",Interventional procedure,0
12886,"Mechanical complication of other specified prosthetic device, implant, and graft",Interventional procedure,0
12887,"Mechanical complication of prosthetic device, unspecified",Interventional procedure,0
12888,Mechanical complication of chin prosthesis,Interventional procedure,0
12889,Mechanical complication of eye orbit prosthesis,Interventional procedure,0
12890,Graft complications,Interventional procedure,0
12891,"Mechanical complication of other specified prosthetic device, implant, and graft",Interventional procedure,0
12892,"Other complications of internal prosthetic device, implant, and graft",Interventional procedure,0
12893,Disruption of nerve repair,Neuroplasty,0
12894,Vacuolar myelopathy,Acquired Immunodeficiency Syndrome,0
12895,Disorder of nerve repair,Neuroplasty,0
12896,Dehiscence of nerve repair,Neuroplasty,0
12897,Neuroma of nerve repair,Neuroplasty,0
12898,Toxic inhalation-induced febrile illness,Fever,0
12899,Humidifier fever,Fever,0
12900,Pulmonary mycotoxicosis,Fever,0
12901,Lymphedema due to lymphogranuloma venereum,Lymphogranuloma Venereum,0
12902,Disorder of dental prosthesis,Interventional procedure,0
12903,Dental Prosthesis Failure,Interventional procedure,0
12904,suspected damage to fetus from maternal toxoplasmosis,Toxoplasmosis,0
12905,Organ dysfunction syndrome,Systemic inflammatory response syndrome associated with organ dysfunction,0
12906,Allergic contact dermatitis caused by nickel implant,Interventional procedure,0
12907,Febrile proteinuria,Fever,0
12908,Fetus with viral damage via mother,Virus Diseases,0
12909,Intrauterine Devices,Retained intrauterine contraceptive device in pregnancy,0
12910,Mechanical complication of central nervous system device,Interventional procedure,0
12911,Mechanical complication of central nervous system device,Interventional procedure,0
12912,Breakage of prosthesis,Interventional procedure,0
12913,Disorders of prostheses and implants of the nervous system,Interventional procedure,0
12914,Disorder of dorsal column stimulator,Interventional procedure,0
12915,Disorder of electrodes implanted in brain,Interventional procedure,0
12916,Neuroplasty,Disruption of nerve repair,0
12917,Neuroplasty,Disorder of nerve repair,0
12918,Neuroplasty,Dehiscence of nerve repair,0
12919,Neuroplasty,Neuroma of nerve repair,0
12920,Fractured maxillofacial prosthesis,Interventional procedure,0
12921,Parametritis,Abortion with parametritis,0
12922,"complications; prosthetic, mechanical",Interventional procedure,0
12923,Incomplete inevitable miscarriage complicated by genital tract and pelvic infection,Communicable Diseases,0
12924,Disorder of prostheses and implants,Interventional procedure,0
12925,Postprocedural intra-abdominal sepsis,Interventional procedure,0
12926,Welders ague,Fever,0
12927,Dislocated intraocular lens,Interventional procedure,0
12928,Dislocated intraocular lens into vitreous,Interventional procedure,0
12929,Disorders of prostheses and implants of the eye,Interventional procedure,0
12930,Disorder of intraocular lens,Interventional procedure,0
12931,Deposits on intraocular lens,Interventional procedure,0
12932,YAG laser pit in intraocular lens,Interventional procedure,0
12933,Silicone oil droplets on intraocular lens,Interventional procedure,0
12934,Migration of spinal cord stimulator,Interventional procedure,0
12935,Polymer fume fever,Fever,0
12936,Mycoses,Mycotic abortion,0
12937,Female pelvic peritonitis,pelvic peritonitis following abortion,0
12938,Virus Diseases,Fetus with viral damage via mother,0
12939,Virus Diseases,Fetus with viral damage via mother - delivered,0
12940,Virus Diseases,Fetus with viral damage via mother with antenatal problem,0
12941,Virus Diseases,Fetus with viral damage via mother,0
12942,Virus Diseases,Fetus with viral damage via mother,0
12943,Migration of implant or internal device,Interventional procedure,0
12944,infection of genital tract involving pelvis following abortion,Communicable Diseases,0
12945,salpingitis following abortion,Salpingitis,0
12946,pelvic peritonitis following abortion,Female pelvic peritonitis,0
12947,Miscarriage complicated by genital-pelvic infection,Communicable Diseases,0
12948,endometritis; abortion,Endometritis,0
12949,Abortion with parametritis,Parametritis,0
12950,salpingo-oophoritis following abortion,Tubo-ovarian inflammatory disease,0
12951,Legal termination of pregnancy complicated by genital-pelvic infection,Communicable Diseases,0
12952,Illegal termination of pregnancy complicated by genital-pelvic infection,Communicable Diseases,0
12953,Fever,Mucocutaneous Lymph Node Syndrome,0
12954,Fever,Toxic inhalation-induced febrile illness,0
12955,Fever,Humidifier fever,0
12956,Fever,Pulmonary mycotoxicosis,0
12957,Fever,Febrile proteinuria,0
12958,Fever,Welders ague,0
12959,Fever,Polymer fume fever,0
12960,Fever,Sweet's disease due to drug,0
12961,Fever,Febrile Ulceronecrotic Mucha-Habermann disease,0
12962,Fever,Sweet's disease following infection,0
12963,Fever,Disorder characterized by fever,0
12964,Fever,Copper fever,0
12965,Fever,Myoclonus associated with fever,0
12966,Fever,Metal fever,0
12967,Fever,Febrile transfusion reaction,0
12968,Fever,Brass-founders' fever,0
12969,Fever,Mucocutaneous Lymph Node Syndrome,0
12970,Fever,Grain fever,0
12971,Fever,Sweet Syndrome,0
12972,Operative Surgical Procedures,Dehiscence of internal surgical wound,0
12973,Sweet's disease due to drug,Fever,0
12974,Febrile Ulceronecrotic Mucha-Habermann disease,Fever,0
12975,Erythema nodosum due to bacterial infection,Bacterial Infections,0
12976,Erythema nodosum due to streptococcal infection,Streptococcal Infections,0
12977,Erythema nodosum due to Yersinia enterocolitica,Infection by Yersinia enterocolitica,0
12978,Erythema multiforme due to mycoplasma infection,Mycoplasma Infections,0
12979,Sweet's disease following infection,Fever,0
12980,Scleroderma-associated necrotizing vasculitis,Connective Tissue Diseases,0
12981,Scleroderma-associated nail dystrophy,Dermatologic disorders,0
12982,Dental prosthesis infection,Interventional procedure,0
12983,Communicable Diseases,Complete miscarriage with genital tract or pelvic infection,0
12984,Communicable Diseases,Incomplete inevitable miscarriage complicated by genital tract and pelvic infection,0
12985,Communicable Diseases,infection of genital tract involving pelvis following abortion,0
12986,Communicable Diseases,Miscarriage complicated by genital-pelvic infection,0
12987,Communicable Diseases,Legal termination of pregnancy complicated by genital-pelvic infection,0
12988,Communicable Diseases,Illegal termination of pregnancy complicated by genital-pelvic infection,0
12989,Communicable Diseases,Fetal OR neonatal jaundice from infection,0
12990,Pharmaceutical Preparations,Myotonia due to drug,0
12991,Pharmaceutical Preparations,Dependence on unknown drug,0
12992,Disorder characterized by fever,Fever,0
12993,Opacification of intraocular lens,Interventional procedure,0
12994,"Unspecified complication of internal orthopedic prosthetic device, implant and graft",Interventional procedure,0
12995,Dislocated capsular tension ring,Interventional procedure,0
12996,Opacification of intraocular lens,Interventional procedure,0
12997,Exudative maculopathy with type 1 diabetes mellitus,Diabetes Mellitus,0
12998,Decentered intraocular lens implant,Interventional procedure,0
12999,Listeriosis,Listeria miscarriage,0
13000,Brucella abortus infection,Miscarriage due to Brucella abortus,0
13001,Infection due to Brucella canis,Abortion due to Brucella canis,0
13002,Miscarriage due to Brucella abortus,Brucella abortus infection,0
13003,Abortion due to Brucella canis,Infection due to Brucella canis,0
13004,Copper fever,Fever,0
13005,Destot sign,Fracture of pelvis,0
13006,Systemic inflammatory response syndrome associated with organ dysfunction,Organ dysfunction syndrome,0
13007,Myoclonus associated with fever,Fever,0
13008,Multiple complications due to diabetes mellitus,Diabetes Mellitus,0
13009,Myotonia due to drug,Pharmaceutical Preparations,0
13010,Hyperglycemic crisis in diabetes mellitus,Diabetes Mellitus,0
13011,Dependence on unknown drug,Pharmaceutical Preparations,0
13012,Hepatitis B associated with Human immunodeficiency virus infection,HIV Infections,0
13013,Dehiscence of internal surgical wound,Operative Surgical Procedures,0
13014,Cloudy peritoneal dialysis effluent,Peritoneal Dialysis,0
13015,Failure of osseointegration of dental implant,Interventional procedure,0
13016,Non-Hodgkin lymphoma associated with Human immunodeficiency virus infection,HIV Infections,0
13017,Tubo-ovarian inflammatory disease,salpingo-oophoritis following abortion,0
13018,Mechanical complication of eye orbit prosthesis,Interventional procedure,0
13019,Mechanical complication of bile duct prosthesis,Interventional procedure,0
13020,Listeria miscarriage,Listeriosis,0
13021,Schistosoma hematobium infection,Urinary calculus in schistosomiasis,0
13022,Mycotic abortion,Mycoses,0
13023,Acquired Immunodeficiency Syndrome,Vacuolar myelopathy,0
13024,mechanical complication due to ocular lens prosthesis,Interventional procedure,0
13025,Peritoneal Dialysis,Cloudy peritoneal dialysis effluent,0
13026,Interventional procedure,Failure of dental post,0
13027,Interventional procedure,Blocked central line,0
13028,Interventional procedure,Mechanical complication of chin prosthesis,0
13029,Interventional procedure,Complication of implant,0
13030,Interventional procedure,Nervous system complication from surgically implanted device,0
13031,Interventional procedure,"Mechanical complication of nervous system device, implant AND/OR graft",0
13032,Interventional procedure,Mechanical complication of nervous system device,0
13033,Interventional procedure,Mechanical complication of dorsal column stimulator,0
13034,Interventional procedure,Mechanical complication of electrodes implanted in brain,0
13035,Interventional procedure,"Mechanical complication of nervous system device, implant AND/OR graft",0
13036,Interventional procedure,"Mechanical complication of other specified prosthetic device, implant, and graft",0
13037,Interventional procedure,"Mechanical complication of prosthetic device, unspecified",0
13038,Interventional procedure,Mechanical complication of chin prosthesis,0
13039,Interventional procedure,Mechanical complication of eye orbit prosthesis,0
13040,Interventional procedure,Graft complications,0
13041,Interventional procedure,"Mechanical complication of other specified prosthetic device, implant, and graft",0
13042,Interventional procedure,"Other complications of internal prosthetic device, implant, and graft",0
13043,Interventional procedure,Disorder of dental prosthesis,0
13044,Interventional procedure,Dental Prosthesis Failure,0
13045,Interventional procedure,Allergic contact dermatitis caused by nickel implant,0
13046,Interventional procedure,Mechanical complication of central nervous system device,0
13047,Interventional procedure,Mechanical complication of central nervous system device,0
13048,Interventional procedure,Breakage of prosthesis,0
13049,Interventional procedure,Disorders of prostheses and implants of the nervous system,0
13050,Interventional procedure,Disorder of dorsal column stimulator,0
13051,Interventional procedure,Disorder of electrodes implanted in brain,0
13052,Interventional procedure,Fractured maxillofacial prosthesis,0
13053,Interventional procedure,"complications; prosthetic, mechanical",0
13054,Interventional procedure,Disorder of prostheses and implants,0
13055,Interventional procedure,Postprocedural intra-abdominal sepsis,0
13056,Interventional procedure,Dislocated intraocular lens,0
13057,Interventional procedure,Dislocated intraocular lens into vitreous,0
13058,Interventional procedure,Disorders of prostheses and implants of the eye,0
13059,Interventional procedure,Disorder of intraocular lens,0
13060,Interventional procedure,Deposits on intraocular lens,0
13061,Interventional procedure,YAG laser pit in intraocular lens,0
13062,Interventional procedure,Silicone oil droplets on intraocular lens,0
13063,Interventional procedure,Migration of spinal cord stimulator,0
13064,Interventional procedure,Migration of implant or internal device,0
13065,Interventional procedure,Dental prosthesis infection,0
13066,Interventional procedure,Opacification of intraocular lens,0
13067,Interventional procedure,"Unspecified complication of internal orthopedic prosthetic device, implant and graft",0
13068,Interventional procedure,Dislocated capsular tension ring,0
13069,Interventional procedure,Opacification of intraocular lens,0
13070,Interventional procedure,Decentered intraocular lens implant,0
13071,Interventional procedure,Failure of osseointegration of dental implant,0
13072,Interventional procedure,Mechanical complication of eye orbit prosthesis,0
13073,Interventional procedure,Mechanical complication of bile duct prosthesis,0
13074,Interventional procedure,mechanical complication due to ocular lens prosthesis,0
13075,Interventional procedure,Mechanical complication of aortic graft,0
13076,Interventional procedure,Implant site reaction,0
13077,Interventional procedure,Drug implant site reaction,0
13078,Interventional procedure,Drug implant site rejection,0
13079,Interventional procedure,Adverse effect of prosthetic device,0
13080,Metal fever,Fever,0
13081,Diabetes Mellitus,Exudative maculopathy with type 1 diabetes mellitus,0
13082,Diabetes Mellitus,Multiple complications due to diabetes mellitus,0
13083,Diabetes Mellitus,Hyperglycemic crisis in diabetes mellitus,0
13084,Febrile transfusion reaction,Fever,0
13085,Brass-founders' fever,Fever,0
13086,Mucocutaneous Lymph Node Syndrome,Fever,0
13087,Leptospirosis,Miscarriage due to Leptospira,0
13088,Fracture of pelvis,Destot sign,0
13089,Endometritis,endometritis; abortion,0
13090,Mechanical complication of aortic graft,Interventional procedure,0
13091,Grain fever,Fever,0
13092,Infection by Yersinia enterocolitica,Erythema nodosum due to Yersinia enterocolitica,0
13093,Sweet Syndrome,Fever,0
13094,Streptococcal Infections,Erythema nodosum due to streptococcal infection,0
13095,HIV Infections,Hepatitis B associated with Human immunodeficiency virus infection,0
13096,HIV Infections,Non-Hodgkin lymphoma associated with Human immunodeficiency virus infection,0
13097,Bacterial Infections,Erythema nodosum due to bacterial infection,0
13098,Salpingitis,salpingitis following abortion,0
13099,Fetal OR neonatal jaundice from infection,Communicable Diseases,0
13100,Retained intrauterine contraceptive device in pregnancy,Intrauterine Devices,0
13101,Dermatologic disorders,Scleroderma-associated nail dystrophy,0
13102,Implant site reaction,Interventional procedure,0
13103,Drug implant site reaction,Interventional procedure,0
13104,Drug implant site rejection,Interventional procedure,0
13105,Adverse effect of prosthetic device,Interventional procedure,0
13106,Mycobacterium tuberculosis,Exposure to Mycobacterium tuberculosis,0
13107,Neutrophil count decreased,Neutropenic sepsis,0
13108,Exposure to Bacillus anthracis,Bacillus anthracis,0
13109,Neisseria meningitidis,Exposure to Neisseria meningitidis,0
13110,HIV,Exposure to Human immunodeficiency virus,0
13111,Dementia associated with another disease,Disease,0
13112,Myopathy due to systemic sclerosis,Systemic Scleroderma,0
13113,Human herpesvirus 3,Exposure to varicella,0
13114,Human herpes simplex virus,Exposure to anogenital Herpes simplex virus,0
13115,Bacillus anthracis,Exposure to Bacillus anthracis,0
13116,Trichomonas vaginalis,Exposure to genital trichomoniasis,0
13117,Construction of conduit - right atrium to pulmonary trunk,Leakage of conduit from right atrium to pulmonary artery,0
13118,insulin resistance in diabetes,Pharmaceutical Preparations,0
13119,Insulin resistance - type A,Pharmaceutical Preparations,0
13120,Insulin resistance - type B,Pharmaceutical Preparations,0
13121,Wound hematoma,Infection of wound hematoma,0
13122,Smallpox Viruses,Exposure to Variola virus,0
13123,Leptospira,Exposure to Leptospira,0
13124,Salmonella,Exposure to Salmonella,0
13125,Pediculus humanus capitis (eukaryote),Exposure to Pediculus humanus capitus,0
13126,Complication of gastrostomy,Gastrostomy,0
13127,Drug resistance,Pharmaceutical Preparations,0
13128,Hepatitis A Virus,Exposure to Hepatitis A virus,0
13129,Osteoporosis due to corticosteroid,Pharmaceutical Preparations,0
13130,Organism,Exposure to organism,0
13131,Pharmaceutical Preparations,insulin resistance in diabetes,0
13132,Pharmaceutical Preparations,Insulin resistance - type A,0
13133,Pharmaceutical Preparations,Insulin resistance - type B,0
13134,Pharmaceutical Preparations,Drug resistance,0
13135,Pharmaceutical Preparations,Osteoporosis due to corticosteroid,0
13136,Pharmaceutical Preparations,Drug resistance to antiretroviral therapy,0
13137,Pharmaceutical Preparations,Insulin Resistance,0
13138,Pharmaceutical Preparations,Increased drug resistance,0
13139,Pharmaceutical Preparations,Drug resistance to corticoids,0
13140,SARS coronavirus,Exposure to severe acute respiratory syndrome coronavirus,0
13141,Calymmatobacterium granulomatis,Exposure to Klebsiella granulomatis,0
13142,Exposure to Mumps virus (event),Mumps virus,0
13143,Drug resistance to antiretroviral therapy,Pharmaceutical Preparations,0
13144,Malfunction of gastrostomy tube,Gastrostomy,0
13145,Abscess of gastrostomy button site,Gastrostomy,0
13146,Human poliovirus,Exposure to Human poliovirus,0
13147,"Influenza A Virus, H1N1 Subtype",Exposure to Influenza A virus subtype H1N1,0
13148,Infection of gastrostomy site,Gastrostomy,0
13149,Disorder of cornea associated with contact lens,Contact Lenses,0
13150,Leakage of conduit from right atrium to pulmonary artery,Construction of conduit - right atrium to pulmonary trunk,0
13151,Developmentally disabled (finding),Developmental Disabilities,0
13152,Infection of tick bite,Tick bite (disorder),0
13153,Neutropenic sepsis,Neutrophil count decreased,0
13154,Exposure to organism,Organism,0
13155,Infection of wound hematoma,Wound hematoma,0
13156,Erythropoietin resistance in anemia of chronic kidney disease,Erythropoietin,0
13157,Exposure to Variola virus,Smallpox Viruses,0
13158,Exposure to Human immunodeficiency virus,HIV,0
13159,Exposure to Neisseria meningitidis,Neisseria meningitidis,0
13160,Exposure to Klebsiella granulomatis,Calymmatobacterium granulomatis,0
13161,Exposure to Gardnerella vaginalis,Gardnerella vaginalis,0
13162,Exposure to Human poliovirus,Human poliovirus,0
13163,Exposure to Haemophilus ducreyi,Hemophilus ducreyi,0
13164,Exposure to Neisseria gonorrhoeae,Neisseria gonorrhoeae,0
13165,Exposure to Treponema pallidum,Treponema pallidum,0
13166,Exposure to Vibrio cholerae (event),Vibrio cholerae,0
13167,Exposure to Enterobius vermicularis,Enterobius vermicularis,0
13168,Exposure to Bordetella pertussis,Bordetella pertussis,0
13169,Exposure to anaerobic bacterial vaginosis,"Bacteria, Anaerobic",0
13170,Exposure to Legionella,Legionella,0
13171,Exposure to Leptospira,Leptospira,0
13172,Exposure to Streptococcus (event),Streptococcus,0
13173,Exposure to Chlamydia trachomatis,Chlamydia trachomatis,0
13174,Exposure to Pediculus humanus capitus,Pediculus humanus capitis (eukaryote),0
13175,Exposure to Influenza A virus subtype H1N1,"Influenza A Virus, H1N1 Subtype",0
13176,Rubeola exposure,Measles virus,0
13177,Exposure to genital trichomoniasis,Trichomonas vaginalis,0
13178,Exposure to varicella,Human herpesvirus 3,0
13179,Exposure to Rubella virus,Rubella virus,0
13180,Exposure to Rabies virus,Rabies virus,0
13181,Exposure to lymphogranuloma venereum,Chlamydia trachomatis,0
13182,Exposure to severe acute respiratory syndrome coronavirus,SARS coronavirus,0
13183,Exposure to Hepatitis B virus,Hepatitis B Virus,0
13184,Exposure to anogenital Herpes simplex virus,Human herpes simplex virus,0
13185,Exposure to Salmonella,Salmonella,0
13186,Exposure to Hepatitis A virus,Hepatitis A Virus,0
13187,Exposure to Mycobacterium tuberculosis,Mycobacterium tuberculosis,0
13188,Exposure to rubella in pregnancy,Rubella virus,0
13189,Insulin Resistance,Pharmaceutical Preparations,0
13190,Mumps virus,Exposure to Mumps virus (event),0
13191,Polyarthropathy associated with another disorder,Disease,0
13192,Rubella virus,Exposure to Rubella virus,0
13193,Rubella virus,Exposure to rubella in pregnancy,0
13194,Bordetella pertussis,Exposure to Bordetella pertussis,0
13195,Measles virus,Rubeola exposure,0
13196,Developmental Disabilities,Developmentally disabled (finding),0
13197,Gastrostomy,Complication of gastrostomy,0
13198,Gastrostomy,Malfunction of gastrostomy tube,0
13199,Gastrostomy,Abscess of gastrostomy button site,0
13200,Gastrostomy,Infection of gastrostomy site,0
13201,Enterobius vermicularis,Exposure to Enterobius vermicularis,0
13202,Contact Lenses,Disorder of cornea associated with contact lens,0
13203,Streptococcus,Exposure to Streptococcus (event),0
13204,"Bacteria, Anaerobic",Exposure to anaerobic bacterial vaginosis,0
13205,Rabies virus,Exposure to Rabies virus,0
13206,Polyarthritis associated with another disorder,Disease,0
13207,Chlamydia trachomatis,Exposure to Chlamydia trachomatis,0
13208,Chlamydia trachomatis,Exposure to lymphogranuloma venereum,0
13209,Gardnerella vaginalis,Exposure to Gardnerella vaginalis,0
13210,Disease,Dementia associated with another disease,0
13211,Disease,Polyarthropathy associated with another disorder,0
13212,Disease,Polyarthritis associated with another disorder,0
13213,Hemophilus ducreyi,Exposure to Haemophilus ducreyi,0
13214,Neisseria gonorrhoeae,Exposure to Neisseria gonorrhoeae,0
13215,Treponema pallidum,Exposure to Treponema pallidum,0
13216,Sleep Apnea Syndromes,Hypersomnia with sleep apnea,0
13217,Legionella,Exposure to Legionella,0
13218,Vibrio cholerae,Exposure to Vibrio cholerae (event),0
13219,Hypersomnia with sleep apnea,Sleep Apnea Syndromes,0
13220,Hepatitis B Virus,Exposure to Hepatitis B virus,0
13221,Erythropoietin,Erythropoietin resistance in anemia of chronic kidney disease,0
13222,Systemic Scleroderma,Myopathy due to systemic sclerosis,0
13223,Tick bite (disorder),Infection of tick bite,0
13224,Increased drug resistance,Pharmaceutical Preparations,0
13225,Drug resistance to corticoids,Pharmaceutical Preparations,0
13226,Friedreich Ataxia,Cardiomyopathy in Friedreich's ataxia,0
13227,Skeletal dysplasia,Lordosis in skeletal dysplasia,0
13228,Skeletal dysplasia,Scoliosis in skeletal dysplasia,0
13229,Cobalt poisoning,Cobalt cardiomyopathy,0
13230,Grafting procedure,Graft versus host disease in skin,0
13231,Dilated cardiomyopathy secondary to radiation,Disease,0
13232,Granulomatous disorder,Restrictive cardiomyopathy secondary to granulomas,0
13233,Complication of electronic internal device,Insertion of therapeutic device,0
13234,Restrictive cardiomyopathy secondary to infiltrations,Disease,0
13235,Peripartum cardiomyopathy,Disease,0
13236,"Mechanical complication of internal fixation device such as nail, plate AND/OR rod",Insertion of therapeutic device,0
13237,Dietary selenium deficiency,Keshan disease,0
13238,Cystic Fibrosis,Fibrosing colonopathy,0
13239,Neurofibromatoses,Scoliosis in neurofibromatosis,0
13240,Cardiomyopathy in Friedreich's ataxia,Friedreich Ataxia,0
13241,Dilated cardiomyopathy secondary to toxic reaction,Disease,0
13242,Arthropathy in Crohn's disease,Crohn Disease,0
13243,Lordosis in skeletal dysplasia,Skeletal dysplasia,0
13244,Lordosis in hip disease,Disorder of hip joint,0
13245,Scoliosis in skeletal dysplasia,Skeletal dysplasia,0
13246,Scoliosis in neurofibromatosis,Neurofibromatoses,0
13247,Secondary dilated cardiomyopathy,Disease,0
13248,Mechanical complication of internal nail fixing device,Insertion of therapeutic device,0
13249,Mechanical complication of internal rod fixation device,Insertion of therapeutic device,0
13250,Mechanical complication of internal plate fixing device,Insertion of therapeutic device,0
13251,Breakage of plate,Insertion of therapeutic device,0
13252,Loosening of plate,Insertion of therapeutic device,0
13253,Prominence of plate,Insertion of therapeutic device,0
13254,Breakage of screw,Insertion of therapeutic device,0
13255,Epithelial Component Present,Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8,1
13256,Well Differentiated Neuroendocrine Lesion,Pancreatic Vipoma,1
13257,Metastatic Lesion,Lung squamous cell carcinoma stage IV,1
13258,Mitotic Activity,"Testicular Yolk Sac Tumor, Solid Pattern",1
13259,Carcinomatous Component Present,Stage IVB Major Salivary Gland Cancer AJCC v8,1
13260,Neuroendocrine Differentiation,Thymic Atypical Carcinoid Tumor,1
13261,Cutaneous Involvement,"Carcinoma, Skin Appendage",1
13262,Malignant Cellular Infiltrate,"Peripheral Nerve Neoplasms, Malignant",1
13263,Epithelial Component Present,Stage IV Small Intestinal Adenocarcinoma AJCC v8,1
13264,Monophasic Pattern,Pleural Monophasic Synovial Sarcoma,1
13265,In Situ Lesion,Pathologic Stage 0 Gastric Cancer AJCC v8,1
13266,Varicosity,Congenital Vena Cava Abnormality,1
13267,Carcinomatous Component Present,Stage IB Hepatocellular Carcinoma AJCC v8,1
13268,Malignant Cellular Infiltrate,Stage I Adult Hodgkin Lymphoma,1
13269,Microvascular Proliferation,Childhood Brain Stem Gliosarcoma,1
13270,Malignant Cellular Infiltrate,Stage IV Small Intestinal Adenocarcinoma AJCC v8,1
13271,Refractory Disease,Refractory Extensive Stage Lung Small Cell Carcinoma,1
13272,Secondary Lesion,Metastatic Prostate Small Cell Carcinoma,1
13273,Malignant Cellular Infiltrate,Splenic T Lymphoblastic Lymphoma,1
13274,Carcinomatous Component Present,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",1
13275,Malignant Cellular Infiltrate,Grade 1 Endometrial Mucinous Adenocarcinoma,1
13276,Intestinal metaplasia,Intestinal-Type Sinonasal Adenocarcinoma,1
13277,Nodular Pattern,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic,1
13278,Recurrent disease,Recurrent Myelodysplastic Syndrome,1
13279,Burn injury,Old Burn Scar-Related Cutaneous Melanoma,1
13280,Epithelial Component Present,Penis carcinoma,1
13281,Malignant Cellular Infiltrate,"Cancer, Supratentorial",1
13282,High Mitotic Activity,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
13283,Malignant Cellular Infiltrate,Stage III Carcinoma of Penis,1
13284,Mesenchymal Component Present,Vulvar Ectopic Fibroadenoma,1
13285,Extraosseous Lesion,Cardiac Extraskeletal Osteosarcoma,1
13286,Benign Cellular Infiltrate,Ovarian Seromucinous Adenofibroma,1
13287,Metastatic/Recurrent Disease,Kidney Synovial Sarcoma,1
13288,Epithelial Component Present,Prognostic Stage IV Breast Cancer AJCC v8,1
13289,Epithelial Component Present,Lactating adenoma,1
13290,Secondary Lesion,Metastatic Ewing's Sarcoma,1
13291,Low Mitotic Activity,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
13292,Immunologic Deficiency Syndromes,AIDS-Related Vulvovaginal Candidiasis,1
13293,Malignant Cellular Infiltrate,Childhood Malignant Solid Neoplasm,1
13294,Malignant Cellular Infiltrate,Breast cancer recurrent,1
13295,Carcinomatous Component Present,Stage IIB Colorectal Cancer AJCC v8,1
13296,Chronic lymphocytic inflammation,"Thymoma, type B1",1
13297,Malignant Cellular Infiltrate,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,1
13298,Recurrent disease,Extra-osseous Ewing's sarcoma recurrent,1
13299,Bone Marrow Dysplasia Present,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
13300,Well-Circumscribed Lesion,Myofibroblastoma,1
13301,Carcinomatous Component Present,Acantholytic squamous cell carcinoma,1
13302,Malignant Cellular Infiltrate,BCLC Stage D Adult Hepatocellular Carcinoma,1
13303,Malignant Cellular Infiltrate,Stage 0 Colon Cancer AJCC v6 and v7,1
13304,Childhood Lesion,PRETEXT Stage 4 Hepatoblastoma,1
13305,Cutaneous Involvement,Benign Dermal Neoplasm,1
13306,Carcinomatous Component Present,Acinar cell cystadenocarcinoma,1
13307,Epithelial Component Present,Colon Neuroendocrine Tumor,1
13308,Well Differentiated Neuroendocrine Lesion,Stage III Appendix Neuroendocrine Tumor AJCC v7,1
13309,Malignant Cellular Infiltrate,Stage II Ampulla of Vater Cancer AJCC v8,1
13310,Anaplasia,Adult Systemic Anaplastic Large Cell Lymphoma,1
13311,Osseous Differentiation,Breast Extraskeletal Osteosarcoma,1
13312,Hereditary Lesion,"Pyknocytosis, infantile",1
13313,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Squamous Cell Carcinoma,1
13314,Carcinomatous Component Present,Metastatic Digestive System Neuroendocrine Carcinoma,1
13315,Recurrent disease,Recurrent Paranasal Sinus Squamous Cell Carcinoma,1
13316,Severe cytologic atypia,small cell carcinoma of extrahepatic bile duct,1
13317,Carcinomatous Component Present,Stage IIA Fallopian Tube Cancer AJCC v8,1
13318,Carcinomatous Component Present,Stage I Lip Basal Cell Carcinoma,1
13319,Carcinomatous Component Present,Breast Carcinoma by Gene Expression Profile,1
13320,Carcinomatous Component Present,Distal 1/3 of the Common Bile Duct Adenocarcinoma,1
13321,Metastatic Lesion,Secondary malignant neoplasm of choroid,1
13322,Encapsulated Mass,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
13323,Necrotic changes (finding),Metastatic Prostate Small Cell Carcinoma,1
13324,Epithelial Component Present,Gastrointestinal Mixed Adenoneuroendocrine Carcinoma,1
13325,Cutaneous Involvement,Seborrheic dermatitis,1
13326,Malignant Cellular Infiltrate,"Lymphoma, AIDS-Related",1
13327,Childhood Lesion,Childhood Undifferentiated Pleomorphic Sarcoma,1
13328,Malignant Cellular Infiltrate,Colon Cancer by AJCC v7 Stage,1
13329,Microcystic Change,Ovarian Microcystic Stromal Tumor,1
13330,Well-Circumscribed Lesion,"Cystadenoma, Serous",1
13331,Mixed Cellular Population,Pleomorphic adenoma of lacrimal gland,1
13332,Carcinomatous Component Present,Stage IIA Colon Cancer AJCC v7,1
13333,Malignant Cellular Infiltrate,Stage IV Adult Hodgkin Lymphoma,1
13334,Childhood Lesion,Childhood Brain Stem Glioma,1
13335,Carcinomatous Component Present,Stage II Gallbladder Cancer AJCC v8,1
13336,Thyroglobulin Positive Neoplastic Cells Present,Recurrent Thyroid Gland Papillary Carcinoma,1
13337,Mitotic Activity,Endodermal sinus tumor of ovary,1
13338,Borderline Lesion,Borderline epithelial tumor of ovary,1
13339,Epithelial Component Present,Adult Craniopharyngioma,1
13340,Neuroendocrine Differentiation,Atypical carcinoid tumor,1
13341,Malignant Cellular Infiltrate,Prostate Kaposi Sarcoma,1
13342,Diffuse Cellular Infiltrate,Hereditary Diffuse Gastric Adenocarcinoma,1
13343,Metastatic Lesion,Advanced Melanoma,1
13344,Epithelial Component Present,Stage III Ampulla of Vater Cancer AJCC v8,1
13345,Malignant Cellular Infiltrate,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
13346,Carcinomatous Component Present,Recurrent Ovarian Clear Cell Adenocarcinoma,1
13347,Malignant Cellular Infiltrate,Unresectable Gallbladder Carcinoma,1
13348,Epithelial Component Present,Stage IIIC Esophageal Adenocarcinoma AJCC v7,1
13349,Epithelial Component Present,Stage IVA Cervical Cancer AJCC v6 and v7,1
13350,Rapidly Enlarging Mass,Fusion-Negative Alveolar Rhabdomyosarcoma,1
13351,Carcinomatous Component Present,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
13352,Immunologic Deficiency Syndromes,"Leukoplakia, Hairy",1
13353,Carcinomatous Component Present,Stage I Appendix Carcinoma AJCC v8,1
13354,Exophytic Polypoid Lesion,Polyp of gallbladder,1
13355,Nuclear pleomorphism,Recurrent Salivary Duct Carcinoma,1
13356,Poorly Differentiated Neuroendocrine Lesion,Colorectal Large Cell Neuroendocrine Carcinoma,1
13357,Angiosarcoma-Like Areas Present,Skin Pseudovascular Squamous Cell Carcinoma,1
13358,Fibrotic Stroma Formation,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8,1
13359,Carcinomatous Component Present,FIGO Stage III Carcinoma of the Fallopian Tube,1
13360,Malignant Cellular Infiltrate,Recurrent Fibrosarcoma,1
13361,Rapidly Enlarging Mass,embryonal rhabdomyosarcoma of orbit,1
13362,Malignant Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
13363,Malignant Cellular Infiltrate,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
13364,Carcinomatous Component Present,Stage II Merkel Cell Carcinoma AJCC v7,1
13365,Nuclear Grooves,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
13366,Epithelial Component Present,Stage IVB Colon Cancer AJCC v7,1
13367,Benign Cellular Infiltrate,Anastomosing Hemangioma,1
13368,Borderline Lesion,Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder,1
13369,Intraductal Lesion,Intraductal Breast Papillomatosis,1
13370,Carcinomatous Component Present,Villous adenocarcinoma,1
13371,Metastatic Lesion,Poor Prognosis Metastatic Gestational Trophoblastic Tumor,1
13372,Malignant Cellular Infiltrate,Desmoplastic Medulloblastoma,1
13373,Malignant Cellular Infiltrate,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma,1
13374,Multifocal Lesion,Lipomatosis of Nerve,1
13375,Epithelial Component Present,Clear cell adenoma,1
13376,Malignant Cellular Infiltrate,Pathologic Stage 0 Cutaneous Melanoma AJCC v8,1
13377,Secondary Lesion,Metastatic carcinoid tumor,1
13378,Acquired Lesion,Acquired keratoderma,1
13379,Epithelial Component Present,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,1
13380,Benign Cellular Infiltrate,Vaginal Dermoid Cyst,1
13381,Epithelial Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
13382,Malignant Cellular Infiltrate,Recurrent Ovarian Germ Cell Tumor,1
13383,Carcinomatous Component Present,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
13384,Epithelial Component Present,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,1
13385,High Mitotic Activity,Primary hepatic neuroendocrine carcinoma,1
13386,Cutaneous Involvement,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
13387,CD1a-Positive Neoplastic Cells Present,Letterer-Siwe Disease,1
13388,Refractory Disease,Non-Hodgkin's lymphoma refractory,1
13389,Human Papillomavirus Negative,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
13390,Childhood Lesion,Malignant Childhood Central Nervous System Neoplasm,1
13391,Carcinomatous Component Present,Paget Disease of the Scrotum,1
13392,Malignant Cellular Infiltrate,Anaplastic Ependymoma,1
13393,Tissue Differentiation Uncertain,Childhood Synovial Sarcoma,1
13394,Dysplasia,Gastric adenoma,1
13395,Tissue Differentiation Uncertain,Advanced Synovial Sarcoma,1
13396,Poorly Differentiated Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma,1
13397,Indolent Clinical Course,Inner Ear Lipoma,1
13398,Neoplastic Promonocytes in Bone Marrow Markedly Increased,M5b Acute differentiated monocytic leukemia,1
13399,Chromogranin A Positive Neoplastic Cells Present,Ascending Colon Neuroendocrine Tumor G1,1
13400,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage 0,1
13401,Adnexal Differentiation,Carcinoma of apocrine gland,1
13402,Malignant Cellular Infiltrate,Stage 0 Testicular Cancer AJCC v6 and v7,1
13403,Malignant Cellular Infiltrate,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,1
13404,Malignant Cellular Infiltrate,Recurrent Childhood Glioblastoma,1
13405,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage 0,1
13406,Carcinomatous Component Present,Renal Pelvis and Ureter Cancer by AJCC v7 Stage,1
13407,Carcinomatous Component Present,Anal Cancer by AJCC v8 Stage,1
13408,Precise Histogenesis Unknown,Central Nervous System Hemangioblastoma,1
13409,Aggressive Clinical Course,Refractory High Risk Myelodysplastic Syndrome,1
13410,Recurrent Genetic Abnormalities Present,Acute Promyelocytic Leukemia,1
13411,Epithelial Component Present,Stage IIIB Gallbladder Cancer AJCC v7,1
13412,Malignant Cellular Infiltrate,Recurrent Liver Carcinoma,1
13413,Localized Lesion,Nodular amyloidosis,1
13414,Borderline Lesion,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
13415,Malignant Cellular Infiltrate,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
13416,Cutaneous Involvement,inverted follicular keratosis,1
13417,Vascular Channel Formation,Skin Cavernous Hemangioma,1
13418,Epithelial Component Present,Stage I Hypopharyngeal Carcinoma AJCC v6,1
13419,Carcinomatous Component Present,High Grade Salivary Gland Carcinoma,1
13420,Carcinomatous Component Present,Stage IV Major Salivary Gland Cancer AJCC v8,1
13421,Lymphoplasmacytic Infiltrate,Suprasellar Germinoma,1
13422,Mixed Cellular Population,Adult Brain Stem Mixed Glioma,1
13423,Epithelial Component Present,"Papilloma, Intraductal",1
13424,Epithelial Component Present,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas,1
13425,Cartilaginous Differentiation,Primary chondrosarcoma of bone,1
13426,Infiltrative Growth Pattern,Multifocal Glioblastomas,1
13427,Malignant Cellular Infiltrate,Stage I Eyelid Carcinoma AJCC v8,1
13428,Human Papillomavirus Positive,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage,1
13429,Epithelial Component Present,"Adenocarcinoma, Oxyphilic",1
13430,Well Differentiated Neuroendocrine Lesion,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
13431,Carcinomatous Component Present,Adenocarcinoid tumor,1
13432,Malignant Cellular Infiltrate,Stage IA Bone Cancer AJCC v7,1
13433,Malignant Cellular Infiltrate,Lung squamous cell carcinoma stage IV,1
13434,Therapy-Related Toxicity,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
13435,Malignant Cellular Infiltrate,Malignant Splenic Soft Tissue Neoplasm,1
13436,Epithelial Component Present,Extra-Adrenal Retroperitoneal Paraganglioma,1
13437,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid adenocarcinoma metastatic,1
13438,Malignant Cellular Infiltrate,Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7,1
13439,Papillary Pattern,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
13440,Benign Cellular Infiltrate,Intravenous leiomyomatosis,1
13441,Dysplasia,Carcinoma in situ of trachea,1
13442,Malignant Cellular Infiltrate,Double-Hit Lymphoma,1
13443,Malignant Cellular Infiltrate,Cerebral Hodgkin Lymphoma,1
13444,Ineffective hematopoiesis,Myelodysplastic Syndrome with Gene Mutation,1
13445,Epithelial Component Present,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
13446,Epithelial Component Present,Recurrent Oral Cavity Carcinoma,1
13447,atypia morphology,Angiocentric immunoproliferative lesion grade 2,1
13448,Malignant Cellular Infiltrate,Vulvar Non-Keratinizing Squamous Cell Carcinoma,1
13449,Malignant Cellular Infiltrate,Stage I Major Salivary Gland Cancer AJCC v8,1
13450,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Childhood Acute Monoblastic Leukemia,1
13451,Malignant Cellular Infiltrate,Occult Lung Cancer AJCC v8,1
13452,Cartilaginous Component Present,Bizarre parosteal osteochondromatous proliferation,1
13453,Increased Cellularity Present,Frontal Lobe Anaplastic Astrocytoma,1
13454,Secondary Lesion,Metastatic Carcinoma in the Liver,1
13455,Neuroendocrine Differentiation,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
13456,Cutaneous Involvement,Fibrous Hamartoma of Infancy,1
13457,Malignant Cellular Infiltrate,Medulloblastoma,1
13458,Epithelial Component Present,"Adenoma, Sweat Gland",1
13459,Local disease,Localized Non-Resectable Adult Liver Carcinoma,1
13460,Cutaneous Involvement,Clinical Stage 0 Cutaneous Melanoma AJCC v8,1
13461,Collagenous Stroma Formation,Myofibroblastoma,1
13462,Severe dysplasia,Carcinoma in situ of trachea,1
13463,Hyperkeratosis,Anal Verrucous Carcinoma,1
13464,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
13465,Cytoplasmic Accumulation of Black Pigment,Thyroid Gland Black Follicular Adenoma,1
13466,Cutaneous Involvement,Follicular Myxoma,1
13467,Biphasic Pattern,Pleural Biphasic Mesothelioma,1
13468,Epithelial Component Present,Anatomic Stage I Breast Cancer AJCC v8,1
13469,Pathologic TNM Finding,Pathologic Stage IA Cutaneous Melanoma AJCC v8,1
13470,Hyperplastic Epithelial Tissue Present,Breast hyperplasia,1
13471,Borderline Lesion,"Papillary cystadenoma, borderline malignancy",1
13472,Benign Cellular Infiltrate,Benign neoplasm of epididymis,1
13473,Diffuse Pattern,Recurrent Childhood Glioblastoma,1
13474,Carcinomatous Component Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
13475,Hereditary Lesion,Hereditary pyropoikilocytosis,1
13476,Presence of a Hormonal Syndrome,"Glucagonoma, malignant",1
13477,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Adult Central Nervous System Choriocarcinoma,1
13478,Epithelial Component Present,Stage IIIB Colorectal Cancer AJCC v7,1
13479,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",1
13480,Follicular Cell Differentiation,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential,1
13481,Cystic Change,Proliferating Brenner Tumor,1
13482,Monoclonal Cellular Population Present,Thyroid Gland Spindle Cell Follicular Adenoma,1
13483,Mixed Cellular Population,Breast Phyllodes Tumor,1
13484,Malignant Cellular Infiltrate,Female Urethral Malignant Neoplasm,1
13485,Malignant Cellular Infiltrate,Stage IIB Anal Cancer AJCC v8,1
13486,Epithelial Component Present,Papillary Urothelial Neoplasm,1
13487,Carcinomatous Component Present,Stage III Nasopharyngeal Carcinoma AJCC v8,1
13488,Carcinomatous Component Present,Esophageal Large Cell Neuroendocrine Carcinoma,1
13489,Childhood Lesion,Childhood Supratentorial Neoplasm,1
13490,Benign Cellular Infiltrate,Perineurioma,1
13491,Malignant Cellular Infiltrate,Localized Unresectable Adult Hepatocellular Carcinoma,1
13492,Local disease,Lipoma of spermatic cord,1
13493,Recurrent Lymphoma,Recurrent Grade III Lymphomatoid Granulomatosis,1
13494,Recurrent disease,Recurrent Langerhans Cell Histiocytosis,1
13495,Carcinomatous Component Present,Cervical Lymphoepithelioma-Like Carcinoma,1
13496,Vascular Channel Formation,Angiomatosis,1
13497,Malignant Cellular Infiltrate,Fallopian Tube Papillary Adenocarcinoma,1
13498,Malignant Cellular Infiltrate,Central Nervous System Kaposi Sarcoma,1
13499,Malignant Cellular Infiltrate,Stage II Breast Cancer AJCC v6 and v7,1
13500,Cystic Change,Mucoepidermoid carcinoma of parotid gland,1
13501,Cutaneous Involvement,Hemangioma of skin,1
13502,Malignant Cellular Infiltrate,Stage 0 Pancreatic Cancer AJCC v8,1
13503,Carcinomatous Component Present,Differentiated Thyroid Gland Carcinoma,1
13504,Well-Circumscribed Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp,1
13505,Epithelial Component Present,Unresectable Lung Carcinoma,1
13506,Well-Circumscribed Lesion,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
13507,Diffuse Lesion,Papillomatosis,1
13508,Benign Cellular Infiltrate,Nevus spilus,1
13509,Malignant Cellular Infiltrate,Malignant melanoma of retina,1
13510,Biphasic Pattern,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
13511,Malignant Cellular Infiltrate,Secondary Acute Myeloid Leukemia,1
13512,Epithelial Component Present,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
13513,Malignant Cellular Infiltrate,Stage 0 Lung Cancer AJCC v6 and v7,1
13514,Refractory Disease,Refractory Hypopharyngeal Squamous Cell Carcinoma,1
13515,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Vulvar Dysplastic Melanocytic Nevus,1
13516,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,1
13517,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Tumor G2,1
13518,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage I,1
13519,Diffuse Pattern,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
13520,Cutaneous Involvement,Stage I Acral Lentiginous Melanoma AJCC v7,1
13521,Biphasic Pattern,Adenocarcinofibroma,1
13522,Mesenchymal Differentiation,Recurrent Gliosarcoma,1
13523,Non-Hereditary Lesion,Sporadic Cylindroma,1
13524,High Mitotic Activity,Bartholin Gland Small Cell Carcinoma,1
13525,Epithelial Component Present,Parathyroid Adenoma,1
13526,Well Differentiated Neuroendocrine Lesion,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
13527,Malignant Cellular Infiltrate,Large B-cell lymphoma with IRF4 rearrangement,1
13528,Stromal Invasion,clear cell adenocarcinofibroma of ovary,1
13529,Well Differentiated Neuroendocrine Lesion,Transverse Colon Neuroendocrine Tumor G1,1
13530,Acanthosis,Verrucous carcinoma of oral cavity,1
13531,High Mitotic Activity,Sellar Embryonal Carcinoma,1
13532,Malignant Cellular Infiltrate,Advanced Oral Cavity Squamous Cell Carcinoma,1
13533,Malignant Cellular Infiltrate,"Undifferentiated Sarcoma, Not Otherwise Specified",1
13534,Epithelial Component Present,Colorectal Adenoma with Mild Dysplasia,1
13535,Unresectable Mass,Unresectable Carcinoid Tumor,1
13536,Hyperplastic Tissue Present,Epithelial hyperplasia of skin,1
13537,Malignant Cellular Infiltrate,Mixed Cell Uveal Melanoma,1
13538,Misplaced Exocytosis Present,Sparsely Granulated Lactotroph Adenoma,1
13539,Geographic Necrosis,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7,1
13540,Low Grade Lesion,Congenital Mesoblastic Nephroma,1
13541,Malignant Cellular Infiltrate,Stage IB Lung Adenocarcinoma AJCC v7,1
13542,In Situ Lesion,Stage 0 Anal Cancer AJCC v8,1
13543,Epithelial Component Present,Stage III Breast Cancer AJCC v6,1
13544,Malignant Cellular Infiltrate,Diencephalic Glioblastoma,1
13545,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes,1
13546,Carcinomatous Component Present,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
13547,Carcinomatous Component Present,"Carcinoma, Spindle-Cell",1
13548,Childhood Lesion,Primary Childhood Soft Tissue Sarcoma,1
13549,Multinodular Mass,Angiosarcoma non-metastatic,1
13550,Carcinomatous Component Present,Prostate Undifferentiated Carcinoma,1
13551,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma stage IV,1
13552,High Grade Lesion,Abdominal Rhabdomyosarcoma,1
13553,Malignant Cellular Infiltrate,Unresectable Chordoma,1
13554,Nodular Pattern,"Trophoblastic tumor, epithelioid",1
13555,Malignant Cellular Infiltrate,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
13556,Malignant Cellular Infiltrate,Cholangiocarcinoma metastatic,1
13557,Pregnancy Complications,Chorioamnionitis,1
13558,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic-Myeloproliferative Diseases,1
13559,Malignant Cellular Infiltrate,Stage I Gastric Carcinoma,1
13560,Poorly Differentiated Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
13561,Malignant Cellular Infiltrate,Major Salivary Gland Non-Hodgkin Lymphoma,1
13562,Malignant Cellular Infiltrate,Adult Lymphoblastic Lymphoma,1
13563,Malignant Cellular Infiltrate,Stage II Testicular Seminoma AJCC v6 and v7,1
13564,Recurrent disease,Recurrent Gastrointestinal Stromal Tumor,1
13565,Epithelial Component Present,Stage 0a Penile Cancer AJCC v8,1
13566,Mixed Cellular Population,Pericanalicular fibroadenoma,1
13567,Epithelial Component Present,Breast Carcinoma Metastatic in the Spine,1
13568,Indolent Clinical Course,Histiocytoid hemangioma,1
13569,Cutaneous Involvement,Acrodermatitis,1
13570,Malignant Cellular Infiltrate,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7,1
13571,Refractory Disease,Refractory Malignant Central Nervous System Neoplasm,1
13572,Benign Cellular Infiltrate,Bizarre parosteal osteochondromatous proliferation,1
13573,Carcinomatous Component Present,Basal-Like Prostate Carcinoma,1
13574,Epithelial Component Present,Primary hepatic neuroendocrine carcinoma,1
13575,Epithelial Component Present,Adenocarcinoma with cartilaginous and osseous metaplasia,1
13576,Epithelial Component Present,Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7,1
13577,Carcinomatous Component Present,Stage IIA Lung Adenosquamous Carcinoma AJCC v7,1
13578,Malignant Cellular Infiltrate,Clear cell adenocarcinoma of ovary,1
13579,Malignant Cellular Infiltrate,Mixed Cell Type Kidney Wilms Tumor,1
13580,Epithelial Component Present,Stage IV Renal Cell Cancer AJCC v8,1
13581,Malignant Cellular Infiltrate,Intraosseous well differentiated osteosarcoma,1
13582,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",1
13583,Immunologic Deficiency Syndromes,Engraftment syndrome,1
13584,Mixed Cellular Population,carcinoma ex pleomorphic adenoma of salivary gland,1
13585,Benign Cellular Infiltrate,Benign Ovarian Luteinized Thecoma,1
13586,Secondary Lesion,Cholangiocarcinoma metastatic,1
13587,Malignant Cellular Infiltrate,Stage III Adrenal Cortex Carcinoma AJCC v7,1
13588,Carcinomatous Component Present,Stage I Hypopharyngeal Carcinoma AJCC v6,1
13589,'Starry-sky' pattern,Stage I Childhood Burkitt Lymphoma,1
13590,Carcinomatous Component Present,Clear Cell Hepatocellular Carcinoma,1
13591,Carcinomatous Component Present,Stage IIIB Ampulla of Vater Cancer AJCC v8,1
13592,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,1
13593,Malignant Primitive Cellular Infiltrate,Non-Gestational Ovarian Choriocarcinoma,1
13594,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Childhood Acute Promyelocytic Leukemia with PML-RARA,1
13595,Malignant Cellular Infiltrate,Pancreatic Foamy Gland Adenocarcinoma,1
13596,Malignant Cellular Infiltrate,Stage IB Mycosis Fungoides AJCC v7,1
13597,Malignant Cellular Infiltrate,Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
13598,Malignant Cellular Infiltrate,Cervical Adenocarcinoma In Situ,1
13599,Benign Cellular Infiltrate,Lipoma of spinal cord,1
13600,Malignant Cellular Infiltrate,Hereditary Kidney Wilms Tumor,1
13601,Malignant Cellular Infiltrate,Sellar Chondroid Chordoma,1
13602,Carcinomatous Component Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
13603,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
13604,Epithelial Component Present,Stage 0is Bladder Cancer AJCC v8,1
13605,Carcinomatous Component Present,Stage IVC Major Salivary Gland Cancer AJCC v7,1
13606,Endocervical Type Epithelium Present,"Cervical Adenomyoma, Endocervical Type",1
13607,Malignant Cellular Infiltrate,Stage IIB Bone Cancer AJCC v8,1
13608,Follicular Cell Differentiation,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
13609,Epithelial Component Present,Secretory adenoma of pituitary,1
13610,Epithelial Component Present,Thyroid Gland Clear Cell Follicular Adenoma,1
13611,Duct-Like Structures Present,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",1
13612,Epithelial Component Present,Metastatic Genitourinary System Carcinoma,1
13613,Malignant Cellular Infiltrate,Uterine Corpus Sarcoma,1
13614,Epithelial Component Present,Stage 0 Oropharyngeal Carcinoma,1
13615,Carcinomatous Component Present,clear cell adenocarcinoma of urethra,1
13616,Anaplasia,Sarcomatoid carcinoma of the lung,1
13617,Complex Glandular Pattern,Uterine Corpus Atypical Polypoid Adenomyoma,1
13618,Intraosseous Lesion,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
13619,Hyalinized Vessels Present,Adult Pilocytic Astrocytoma,1
13620,Anaplasia,Epithelioid glioblastoma,1
13621,Diffuse Pattern,Childhood Gliosarcoma,1
13622,bone marrow fibrosis,"Leukemia, Mast-Cell",1
13623,Well-Circumscribed Lesion,Familial medullary thyroid carcinoma,1
13624,Splenomegaly,Progressive Hairy Cell Leukemia Initial Treatment,1
13625,Carcinomatous Component Present,apocrine adenocarcinoma of vulva,1
13626,Epithelial Component Present,FIGO Stage IIIA1 Ovarian Cancer,1
13627,Malignant Cellular Infiltrate,Ewings sarcoma-primitive neuroectodermal tumor (PNET),1
13628,Cystic Change,Borderline cystadenoma,1
13629,Malignant Cellular Infiltrate,Epithelioid sarcoma metastatic,1
13630,Transformed Phase of Disease,Recurrent Transformed Chronic Lymphocytic Leukemia,1
13631,Malignant Cellular Infiltrate,Malignant neoplasm of retina,1
13632,Benign Cellular Infiltrate,Central Nervous System Hemangioma,1
13633,Carcinomatous Component Present,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
13634,Metastatic Lesion,Secondary Central Nervous System Hodgkin Lymphoma,1
13635,Benign Cellular Infiltrate,Perineurioma,1
13636,Poorly Differentiated Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
13637,Indolent Clinical Course,Benign neoplasm of gum,1
13638,Malignant Cellular Infiltrate,Bile duct adenocarcinoma resectable,1
13639,Extensive Stage Lesion,Pleural mesothelioma malignant advanced,1
13640,Malignant Cellular Infiltrate,Stage I Rectosigmoid Cancer AJCC v6 and v7,1
13641,Cutaneous Involvement,Stage I Lip Basal Cell Carcinoma,1
13642,Epithelial Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v6,1
13643,Malignant Cellular Infiltrate,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,1
13644,Locally Aggressive Lesion,Metastasizing Chondroblastoma,1
13645,Malignant Cellular Infiltrate,acute undifferentiated leukemia in relapse,1
13646,Malignant Cellular Infiltrate,Rectosigmoid Cancer by AJCC v7 Stage,1
13647,Malignant Cellular Infiltrate,Primary Cutaneous Hodgkin Lymphoma,1
13648,Refractory Disease,Refractory Malignant Solid Neoplasm,1
13649,Necrotic changes (finding),Malignant Testicular Leydig Cell Tumor,1
13650,Epithelial Component Present,Renal Cell Carcinoma Associated with inv(X)(p11;q12),1
13651,Mixed Cellular Population,Anal Ectopic Fibroadenoma,1
13652,Osseous Differentiation,Cementoma,1
13653,Malignant Cellular Infiltrate,Ewings sarcoma-primitive neuroectodermal tumor (PNET),1
13654,Malignant Cellular Infiltrate,Ciliary Body Epithelioid Cell Melanoma,1
13655,Geographic Necrosis,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7,1
13656,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage I,1
13657,Carcinomatous Component Present,Appendix Mixed Adenoneuroendocrine Carcinoma,1
13658,Childhood Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
13659,atypia morphology,Liver Dysplastic Nodule,1
13660,Malignant Cellular Infiltrate,Vulvar Neuroendocrine Carcinoma,1
13661,Recurrent disease,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,1
13662,Recurrent Genetic Abnormalities Present,B-lymphoblastic leukemia lymphoma BCR-ABL1-like,1
13663,Carcinomatous Component Present,Human Papillomavirus-Related Verrucous Carcinoma,1
13664,Necrotic changes (finding),Refractory Dedifferentiated Liposarcoma,1
13665,Carcinomatous Component Present,Hard Palate Squamous Cell Carcinoma,1
13666,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,MYELODYSPLASTIC SYNDROME,1
13667,Malignant Cellular Infiltrate,Stage 0 Penile Cancer AJCC v6,1
13668,Recurrent disease,Recurrent Aggressive Adult Non-Hodgkin Lymphoma,1
13669,Epithelial Component Present,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,1
13670,In Situ Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
13671,Stromal Invasion,Recurrent Malignant Ovarian Brenner Tumor,1
13672,Malignant Cellular Infiltrate,Metastatic Oral Cavity Carcinoma,1
13673,Epithelial Component Present,Bladder Urachal Urothelial Carcinoma,1
13674,Cytoplasmic Membrane-Bound Granules Present,Stage II Merkel Cell Carcinoma AJCC v7,1
13675,Pregnancy Complications,Placenta Increta,1
13676,Angiodestructive Pattern,Grade I Lymphomatoid Granulomatosis,1
13677,Epithelial Component Present,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,1
13678,Primary Lesion,Transplant-Related Hepatocellular Carcinoma,1
13679,Monoclonal Gammapathies,Familial Waldenstrom's Macroglobulinaemia,1
13680,Epithelial Component Present,verrucous carcinoma of esophagus,1
13681,Benign Cellular Infiltrate,Myoma,1
13682,Malignant Cellular Infiltrate,Stage 0 Gastric Cancer AJCC v6 and v7,1
13683,High Mitotic Activity,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
13684,Pseudopapillary Pattern,Childhood Testicular Embryonal Carcinoma,1
13685,Well-Circumscribed Lesion,Lactating adenoma,1
13686,Epithelial Component Present,Condyloma acuminata of vagina,1
13687,Epithelial Component Present,Carcinoma of the Floor of the Mouth,1
13688,Exophytic Polypoid Lesion,Nasal Polyps,1
13689,Epithelial Component Present,Fallopian Tube Endometrioid Adenocarcinoma,1
13690,Mesenchymal Component Present,Malignant Phyllodes Tumor of Prostate,1
13691,Myxoid Stroma Formation,Epithelioid hemangioendothelioma,1
13692,Epithelial Component Present,Pre-Malignant Skin Epithelial Lesion,1
13693,Well Differentiated Neuroendocrine Lesion,Stage III Ileal Neuroendocrine Tumor AJCC v8,1
13694,Epithelial Component Present,Adult Type Ovarian Granulosa Cell Tumor,1
13695,Nuclear Pseudoinclusion,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
13696,High Mitotic Activity,Adult Anaplastic Ependymoma,1
13697,Fibrotic Stroma Formation,Fallopian Tube Serous Adenofibroma,1
13698,Severe dysplasia,Anatomic Stage 0 Breast Cancer AJCC v8,1
13699,Well-Circumscribed Lesion,Mixed Cell Adrenal Cortical Adenoma,1
13700,Carcinomatous Component Present,Unresectable Intrahepatic Cholangiocarcinoma,1
13701,Malignant Cellular Infiltrate,Localized Gallbladder Carcinoma,1
13702,Carcinomatous Component Present,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7,1
13703,Neuroendocrine Differentiation,Extrahepatic Bile Duct Carcinoid Tumor,1
13704,Aggressive Clinical Course,"Endometrial stromal sarcoma, high grade",1
13705,Epithelial Component Present,"Lung Squamous Cell Carcinoma, Small Cell Variant",1
13706,Cutaneous Involvement,Cutaneous Lipomatous Neoplasm,1
13707,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage I,1
13708,Exophytic Polypoid Lesion,tubular adenoma of extrahepatic bile duct,1
13709,Carcinomatous Component Present,Urothelial carcinoma ureter metastatic,1
13710,Carcinomatous Component Present,Lung Mucinous Adenocarcinoma In Situ,1
13711,Endophytic Tumor Growth,verrucous carcinoma of bladder,1
13712,Borderline Lesion,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,1
13713,Castration Resistance,Hormone refractory prostate cancer,1
13714,Malignant Cellular Infiltrate,Localized Parathyroid Gland Carcinoma,1
13715,Malignant Cellular Infiltrate,Mesothelioma malignant advanced,1
13716,atypia morphology,"Endometrioid adenoma, borderline malignancy",1
13717,Myxoid Stroma Formation,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
13718,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
13719,Exophytic Papillary Lesion,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
13720,Epithelial Component Present,Stage II Laryngeal Cancer AJCC v6 and v7,1
13721,Fibrotic Stroma Formation,Borderline Ovarian Mucinous Adenofibroma,1
13722,Neuroendocrine Differentiation,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,1
13723,Epithelial Component Present,Stage IV Lung Small Cell Carcinoma AJCC v7,1
13724,Cystic Change,Cystic tumor of atrio-ventricular node,1
13725,Malignant Cellular Infiltrate,Mediastinal Myeloid Sarcoma,1
13726,Monomorphic Cellular Infiltrate,Lung Basaloid Squamous Cell Carcinoma,1
13727,Epithelial Component Present,Stage III Ureter Cancer AJCC v8,1
13728,Benign Cellular Infiltrate,"Schneiderian papilloma, inverted",1
13729,Epithelial Component Present,Stage III Hypopharyngeal Carcinoma AJCC v6,1
13730,High Grade Lesion,Combined Lung Carcinoma,1
13731,Malignant Cellular Infiltrate,Angiocentric lymphoma stage I,1
13732,Carcinomatous Component Present,mucinous adenocarcinoma of salivary gland,1
13733,atypia morphology,Borderline cystadenoma,1
13734,Malignant Cellular Infiltrate,Hairy cell leukemia variant,1
13735,Pregnancy Complications,Morbidly adherent placenta (disorder),1
13736,Mass of body structure,Mediastinal Myeloid Sarcoma,1
13737,High Grade Lesion,Fusion-Negative Rhabdomyosarcoma,1
13738,Diffuse Pattern,Recurrent Extranodal Diffuse Large B-cell Lymphoma,1
13739,Adnexal Differentiation,Eccrine Poroma,1
13740,Epithelial Component Present,Hepatocellular Adenoma,1
13741,Absence of Stromal Invasion,"Papillary cystadenoma, borderline malignancy",1
13742,Localized Lesion,Well-differentiated papillary mesothelioma,1
13743,Tissue of Mullerian Origin Present,Advanced Uterine Corpus Carcinosarcoma,1
13744,Carcinomatous Component Present,Papillary serous endometrial carcinoma,1
13745,Extraosseous Lesion,Childhood Extraskeletal Osteosarcoma,1
13746,Villous atrophy,Small Intestinal Enteropathy-Associated T-Cell Lymphoma,1
13747,Carcinomatous Component Present,Pathologic Stage II Gastric Cancer AJCC v8,1
13748,Malignant Cellular Infiltrate,Adenocarcinoma of small intestine,1
13749,Intracanalicular Growth Pattern,Borderline Breast Phyllodes Tumor,1
13750,Epithelial Component Present,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
13751,Trabecular Pattern,Somatostatinoma,1
13752,Malignant Cellular Infiltrate,Recurrent Hematologic Malignancy,1
13753,Mucoid Stroma Formation,Acinar Prostate Mucinous Adenocarcinoma,1
13754,Malignant Cellular Infiltrate,Stage IV Childhood Hodgkin Lymphoma,1
13755,Benign Cellular Infiltrate,Benign Skeletal Muscle Neoplasm,1
13756,Vascular Channel Formation,Cardiac Epithelioid Hemangioendothelioma,1
13757,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
13758,Carcinomatous Component Present,Nasal cavity carcinoma,1
13759,Epithelial Component Present,Fallopian Tube Mucinous Adenocarcinoma,1
13760,Capillary Sized Vascular Channel Formation,Senile angioma,1
13761,Primary Lesion,Astrocytoma of brain,1
13762,Chronic lymphocytic inflammation,Salivary Gland Sebaceous Lymphadenoma,1
13763,Immunologic Deficiency Syndromes,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder,1
13764,Malignant Cellular Infiltrate,Recurrent B Acute Lymphoblastic Leukemia,1
13765,Birbeck Granules Present,Thyroid Gland Langerhans Cell Histiocytosis,1
13766,Carcinomatous Component Present,Stage IV Vaginal Cancer AJCC v6 and v7,1
13767,Well Differentiated Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor,1
13768,Epithelial Component Present,Ovarian Clear Cell Cystadenocarcinoma,1
13769,Mixed Cellular Population,Cervical Wilms Tumor,1
13770,Childhood Lesion,Recurrent Diffuse Intrinsic Pontine Glioma,1
13771,Carcinomatous Component Present,Adenocarcinoma of lung stage IIIB,1
13772,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8,1
13773,"Fully Differentiated ""Adult-Type"" Tissues Present",Sellar Mature Teratoma,1
13774,Recurrent disease,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
13775,Anaplasia,Anaplastic large cell lymphoma T- and null-cell types refractory,1
13776,Pseudoencapsulated Mass,Glandular malignant peripheral nerve sheath tumor,1
13777,High Grade Lesion,Leiomyosarcoma NCI Grade 3,1
13778,Duct-Like Structures Present,Epithelial-myoepithelial carcinoma,1
13779,Myxoid Stroma Formation,Chordoma,1
13780,Epithelial Component Present,Retroperitoneal Carcinoma,1
13781,Composite Lesion,"Ganglioneuroblastoma, Nodular",1
13782,Schwannian Stroma More than 50 Percent of the Tumor Volume,Central Nervous System Ganglioneuroblastoma,1
13783,Necrotic changes (finding),"Perivascular epithelioid tumor, malignant",1
13784,Epithelial Component Present,Borderline serous tumor of ovary,1
13785,Monoclonal Eosinophils Present,Childhood Acute Eosinophilic Leukemia,1
13786,Well-Circumscribed Lesion,villous adenoma of stomach,1
13787,Epithelial Component Present,Lymphoepithelial malignant thymoma,1
13788,Neuroendocrine Differentiation,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,1
13789,Necrotic changes (finding),Stage I Lung Small Cell Carcinoma AJCC v7,1
13790,Well Differentiated Neuroendocrine Lesion,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
13791,Perivascular Arrangement of Tumor Cells,"Glomus tumor, malignant",1
13792,Malignant Cellular Infiltrate,Stage III Breast Cancer AJCC v6,1
13793,Carcinomatous Component Present,Resectable Renal Cell Carcinoma,1
13794,High Mitotic Activity,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
13795,Refractory Disease,Refractory Peripheral Primitive Neuroectodermal Tumor,1
13796,Carcinomatous Component Present,Stage IA Lung Large Cell Carcinoma AJCC v7,1
13797,Malignant Cellular Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v7,1
13798,Epithelial Component Present,Disseminated adenocarcinoma,1
13799,Childhood Lesion,Childhood Brain Stem Neoplasm,1
13800,Epithelial Component Present,Adenocarcinoma of Unknown Primary,1
13801,High Mitotic Activity,Small cell neuroendocrine carcinoma of bladder,1
13802,Exophytic Papillary Lesion,Vaginal Papillary Carcinoma,1
13803,Indolent Clinical Course,Lung Myoepithelioma,1
13804,Regional Disease,Locally Advanced Bile Duct Carcinoma,1
13805,Epithelial Component Present,Stage IVB Lip and Oral Cavity Cancer AJCC v8,1
13806,Multifocal Lesion,Multifocal superficial basal cell carcinoma,1
13807,High Mitotic Activity,Colon Small Cell Neuroendocrine Carcinoma,1
13808,Borderline Lesion,Serous papillary cystic tumor of borderline malignancy,1
13809,Pseudopapillary Pattern,Testicular embryonal carcinoma,1
13810,Carcinomatous Component Present,verrucous carcinoma of vulva,1
13811,Therapy-Related Toxicity,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder,1
13812,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Vaginal Carcinosarcoma,1
13813,Epithelial Component Present,Combined Lung Small Cell and Squamous Cell Carcinoma,1
13814,Dysplastic Dentin Formation,Dentinogenic Ghost Cell Tumor,1
13815,Malignant Cellular Infiltrate,Adenocarcinoma of ampulla of Vater,1
13816,Epidermotropic Lymphocytic Infiltrate,Type D Lymphomatoid Papulosis,1
13817,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8,1
13818,Epithelial Component Present,Stage IIIC Appendix Carcinoma AJCC v8,1
13819,Recurrent disease,Recurrent Brain Neoplasm,1
13820,Diffuse Pattern,Pleural Desmoplastic Mesothelioma,1
13821,Epithelial Component Present,Klatskin Tumor,1
13822,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Amyloidosis,1
13823,Recurrent disease,Recurrent T Acute Lymphoblastic Leukemia,1
13824,Malignant Cellular Infiltrate,Recurrent Parotid Gland Mucoepidermoid Carcinoma,1
13825,Malignant Cellular Infiltrate,Submandibular Gland Acinic Cell Carcinoma,1
13826,High Grade Lesion,"Anaplastic Astrocytoma, IDH-Mutant",1
13827,Mitotic Activity,Anaplastic Hemispheric Astrocytoma,1
13828,Neuroendocrine Differentiation,Rectal Small Cell Neuroendocrine Carcinoma,1
13829,Malignant Cellular Infiltrate,Blastoid Variant Mantle Cell Lymphoma,1
13830,Malignant Cellular Infiltrate,Refractory Chronic Myelomonocytic Leukemia,1
13831,Epithelial Component Present,Stage IB Eyelid Carcinoma AJCC v7,1
13832,Epithelial Component Present,Stage IIIA Colorectal Cancer AJCC v7,1
13833,Indolent Clinical Course,Angiomatosis,1
13834,Absence of Invasion or Limited Invasion Present,Pleural Well Differentiated Papillary Mesothelioma,1
13835,Low Grade Lesion,Third Ventricle Pilocytic Astrocytoma,1
13836,Ground Glass Nuclear Inclusion,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
13837,Carcinomatous Component Present,Ampulla of Vater Cancer by AJCC v7 Stage,1
13838,Childhood Lesion,Childhood Ovarian Immature Teratoma,1
13839,Malignant Cellular Infiltrate,Vaginal Large Cell Neuroendocrine Carcinoma,1
13840,Carcinomatous Component Present,Stage IVB Colon Cancer AJCC v7,1
13841,Sarcomatous Component Present,Ovarian Dermoid Cyst with Secondary Sarcoma,1
13842,Papillary Pattern,Verrucous carcinoma of the oral cavity recurrent,1
13843,Carcinomatous Component Present,Urothelial cancer of renal pelvis,1
13844,Recurrent disease,Recurrent Malignant Extragonadal Germ Cell Tumor,1
13845,Geographic Necrosis,Testicular embryonal carcinoma stage III,1
13846,atypia morphology,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,1
13847,Malignant Cellular Infiltrate,Sweat gland adenocarcinoma,1
13848,Monocytosis,Recurrent Chronic Myelomonocytic Leukemia,1
13849,Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
13850,Epithelial Component Present,Paranasal Sinus Schneiderian Papilloma,1
13851,Keratin pearl formation,External Ear Squamous Cell Carcinoma,1
13852,Malignant Cellular Infiltrate,"Sarcoma, Myeloid",1
13853,Local disease,Localized Primitive Neuroectodermal Tumor,1
13854,Carcinomatous Component Present,Stage IVC Hypopharyngeal Carcinoma AJCC v7,1
13855,Malignant Cellular Infiltrate,Recurrent Uterine Corpus Sarcoma,1
13856,Carcinomatous Component Present,Locally Advanced Small Intestinal Carcinoma,1
13857,Malignant Cellular Infiltrate,Stage IIB Gastric Cancer AJCC v7,1
13858,Benign Cellular Infiltrate,Cervical Adenomyoma,1
13859,Carcinomatous Component Present,Transplant-Related Carcinoma,1
13860,Benign Cellular Infiltrate,Lung Myolipoma,1
13861,Epithelial Component Present,Stage IV Adrenal Cortex Carcinoma AJCC v7,1
13862,High Mitotic Activity,Cutaneous Leiomyosarcoma,1
13863,Epithelial Component Present,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",1
13864,Carcinomatous Component Present,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,1
13865,Malignant Cellular Infiltrate,Ewing's sarcoma recurrent,1
13866,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia recurrent,1
13867,Carcinomatous Component Present,Vaginal Papillary Carcinoma,1
13868,Hereditary Lesion,Familial Atypical Mole Melanoma Syndrome,1
13869,Cutaneous Involvement,Ductal Eccrine Carcinoma with Squamous Metaplasia,1
13870,Nuclear Grooves,Childhood Thyroid Gland Papillary Carcinoma,1
13871,Malignant Cellular Infiltrate,Bile duct adenocarcinoma resectable,1
13872,Epithelial Component Present,clear cell adenocarcinofibroma of ovary,1
13873,Cutaneous Involvement,Hidradenoma Papilliferum,1
13874,Carcinomatous Component Present,External Ear Squamous Cell Carcinoma,1
13875,Monoclonal Cellular Population Present,Thyroid Gland Lipoadenoma,1
13876,Extracutaneous Dissemination of Disease,Mycosis fungoides stage II,1
13877,Malignant Cellular Infiltrate,Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8,1
13878,Well-Circumscribed Lesion,Osteoid osteoma,1
13879,Malignant Cellular Infiltrate,Human Papillomavirus-Related Adenocarcinoma,1
13880,Low Grade Lesion,Low-grade fibromyxoid sarcoma,1
13881,Malignant Cellular Infiltrate,Thymic Typical Carcinoid Tumor,1
13882,Fibrotic Stroma Formation,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
13883,Indolent Clinical Course,Benign neoplasm of spleen,1
13884,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
13885,Vascular proliferation,Gingival Angiofibroma,1
13886,Epithelial Component Present,large cell neuroendocrine carcinoma of bladder,1
13887,Metastatic Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma,1
13888,Epithelial Component Present,Stage IVB Thymoma AJCC v8,1
13889,Mitotic Activity,Mesenchymal Glioblastoma,1
13890,Local disease,Pagetoid reticulosis,1
13891,Malignant Cellular Infiltrate,Angiocentric lymphoma stage I,1
13892,Carcinomatous Component Present,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated),1
13893,Osteoid formation,Osteoma,1
13894,Malignant Cellular Infiltrate,Ductal Eccrine Carcinoma with Squamous Metaplasia,1
13895,Well Differentiated Neuroendocrine Lesion,Non functioning pancreatic endocrine tumor,1
13896,Necrotic changes (finding),Stage IIA Lung Small Cell Carcinoma AJCC v7,1
13897,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm to the Leptomeninges,1
13898,Mitotic Activity,Sellar Yolk Sac Tumor,1
13899,Adnexal Differentiation,Vulvar Adenocarcinoma of Sweat Gland Type,1
13900,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of esophagus,1
13901,Epithelial Component Present,Stage III Cervical Cancer AJCC v8,1
13902,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,High Risk Myelodysplastic Syndrome,1
13903,Metastatic Lesion,Metastatic Unresectable Malignant Neoplasm,1
13904,Malignant Cellular Infiltrate,mucosa-associated lymphoid tissue (MALT) lymphoma of thyroid,1
13905,Adulthood Lesion,Stage IV adult soft tissue sarcoma,1
13906,CD56-Positive Neoplastic Cells Present,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,1
13907,Cutaneous Involvement,eccrine adenocarcinoma of vulva,1
13908,Absence of Stromal Invasion,Fallopian Tube Metaplastic Papillary Tumor,1
13909,Malignant Cellular Infiltrate,Ann Arbor Stage I Follicular Lymphoma,1
13910,High Mitotic Activity,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
13911,Cystic Change,Clear Cell Papillary Cystadenoma,1
13912,Benign Cellular Infiltrate,Benign Teratoma,1
13913,In Situ Lesion,Intraductal carcinoma and lobular carcinoma in situ,1
13914,Carcinomatous Component Present,Primary ameloblastic carcinoma,1
13915,Metastatic/Recurrent Disease,Extrarenal rhabdoid tumor,1
13916,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,1
13917,Hyaline Cartilage Differentiation,Childhood Myxoid Chondrosarcoma,1
13918,Malignant Cellular Infiltrate,Post polycythaemia vera myelofibrosis,1
13919,Epithelial Component Present,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",1
13920,Anaplasia,Cerebral Glioblastoma,1
13921,Neuroectodermal Differentiation,Ganglioneuroblastoma,1
13922,Perineural spread,adenoid cystic carcinoma of floor of mouth,1
13923,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory anemia with ringed sideroblasts,1
13924,Carcinomatous Component Present,Advanced Oral Cavity Squamous Cell Carcinoma,1
13925,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8,1
13926,Malignant Cellular Infiltrate,Splenic diffuse red pulp small B-cell lymphoma,1
13927,Epithelial Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v8,1
13928,Villous Pattern,Ampulla of Vater Villous Adenoma,1
13929,Borderline Lesion,"Papillary mucinous cystadenoma, borderline malignancy",1
13930,Well-Circumscribed Lesion,Large Bowel Juvenile Polyp,1
13931,Carcinomatous Component Present,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",1
13932,Malignant Cellular Infiltrate,Stage I Soft Tissue Sarcoma AJCC v7,1
13933,CD30-Positive Neoplastic Cells Present,"lymphomatoid papulosis, type A",1
13934,Metastatic Lesion,Advanced Head and Neck Carcinoma,1
13935,Carcinomatous Component Present,Recurrent Pancreatic Neuroendocrine Carcinoma,1
13936,Malignant Cellular Infiltrate,Stage II Bone Cancer AJCC v8,1
13937,Benign Cellular Infiltrate,Benign neoplasm of urinary system,1
13938,Thin-Walled Branching Vascular Pattern,Dedifferentiated Solitary Fibrous Tumor,1
13939,Malignant Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant",1
13940,Epithelial Component Present,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
13941,Metastatic Lesion,"Sarcoma, metastatic",1
13942,Benign Cellular Infiltrate,Bartholin Gland Adenomyoma,1
13943,Recurrent disease,Recurrent Gastroesophageal Junction Adenocarcinoma,1
13944,Epithelial Component Present,"Papillary squamous cell carcinoma, non-invasive",1
13945,Well Differentiated Neuroendocrine Lesion,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,1
13946,Epithelial Component Present,Hard Palate Adenoid Cystic Carcinoma,1
13947,Malignant Cellular Infiltrate,Melanoma Metastatic in the Central Nervous System,1
13948,High Mitotic Activity,Malignant medulloepithelioma of ciliary body,1
13949,Cutaneous Involvement,Vulvar Keratoacanthoma,1
13950,Psammoma Body Formation,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
13951,Malignant Cellular Infiltrate,Stage III Kidney Wilms Tumor,1
13952,Malignant Cellular Infiltrate,Stage IB Hepatocellular Carcinoma AJCC v8,1
13953,Malignant Cellular Infiltrate,Vaginal Undifferentiated Carcinoma,1
13954,Myxoid Changes Present,Dermal nerve sheath myxoma,1
13955,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8,1
13956,Malignant Cellular Infiltrate,Labia Majora Carcinoma,1
13957,Papillary Pattern,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
13958,Epithelial Component Present,Malignant Cardiac Paraganglioma,1
13959,Malignant Cellular Infiltrate,Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
13960,Carcinomatous Component Present,Hormone-Resistant Prostate Carcinoma,1
13961,Carcinomatous Component Present,Rectal Signet Ring Cell Adenocarcinoma,1
13962,Childhood Lesion,Hepatoblastoma resectable,1
13963,Vascular Channel Formation,AIDS-Related Gastric Kaposi Sarcoma,1
13964,Carcinomatous Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
13965,Epithelial Component Present,Gallbladder Cribriform Carcinoma,1
13966,Epithelial Component Present,Recurrent Liver Carcinoma,1
13967,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Neoplasm,1
13968,Secondary Lesion,Metastatic Lung Carcinoma,1
13969,Carcinomatous Component Present,Hard Palate Adenoid Cystic Carcinoma,1
13970,Benign Cellular Infiltrate,Histiocytoma,1
13971,Epithelial Component Present,Clear cell odontogenic carcinoma,1
13972,Epithelial Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
13973,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
13974,Carcinomatous Component Present,Biochemically Recurrent Prostate Carcinoma,1
13975,Low Mitotic Activity,Pancreatic Vipoma,1
13976,Vascular Channel Formation,malignant epithelioid hemangioendothelioma of liver,1
13977,Malignant Cellular Infiltrate,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
13978,Primary Lesion,Recurrent Childhood Pineoblastoma,1
13979,Malignant Cellular Infiltrate,Bladder Enteric Type Adenocarcinoma,1
13980,Carcinomatous Component Present,"Adenocarcinoma, Clear Cell",1
13981,Dysplasia,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",1
13982,Epithelial Component Present,Stage II Major Salivary Gland Cancer AJCC v8,1
13983,High Grade Lesion,Chondroblastic osteosarcoma,1
13984,Perineural spread,adenoid cystic carcinoma of accessory sinus,1
13985,Benign Cellular Infiltrate,Diffuse Lipomatosis,1
13986,Epithelial Component Present,Juvenile granulosa cell tumor,1
13987,Locally Aggressive Lesion,Intermediate Blood Vessel Neoplasm,1
13988,Well-Circumscribed Lesion,Polyp of middle ear,1
13989,Malignant Cellular Infiltrate,Breast Columnar Cell Mucinous Carcinoma,1
13990,Malignant Cellular Infiltrate,Adenocarcinoma of lung (disorder),1
13991,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma,1
13992,Nuclear Molding,Combined Lung Small Cell and Squamous Cell Carcinoma,1
13993,Malignant Cellular Infiltrate,Synchronous Multifocal Osteosarcoma,1
13994,Monomorphic Cellular Infiltrate,Splenic diffuse red pulp small B-cell lymphoma,1
13995,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
13996,Carcinomatous Component Present,Carcinoma ex pleomorphic adenoma of parotid gland,1
13997,Poorly Differentiated Lesion,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,1
13998,Recurrent disease,Recurrent Central Nervous System Non-Hodgkin Lymphoma,1
13999,Dysplasia,Colon Adenoma with Severe Dysplasia,1
14000,Carcinomatous Component Present,keratinizing squamous cell carcinoma of lung,1
14001,Perivascular Arrangement of Tumor Cells,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
14002,Slow Growing Mass,Olfactory Neuroblastoma,1
14003,Malignant Cellular Infiltrate,Uterine Corpus Adenosarcoma,1
14004,Epithelial Component Present,Stage IIA Cervical Cancer AJCC v7,1
14005,Malignant Cellular Infiltrate,Splenic diffuse red pulp small B-cell lymphoma,1
14006,Epithelial Component Present,Refractory Hormone Receptor Positive Breast Carcinoma,1
14007,Borderline Lesion,Grade I Lymphomatoid Granulomatosis,1
14008,Epithelial Component Present,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,1
14009,Epithelial Component Present,Recurrent Carcinoma of Unknown Primary,1
14010,Epithelial Component Present,Stage III Small Intestinal Adenocarcinoma AJCC v8,1
14011,Malignant Cellular Infiltrate,Ciliary Body Mixed Cell Melanoma,1
14012,Malignant Cellular Infiltrate,Squamous Cell Carcinoma of Unknown Primary,1
14013,Recurrent disease,Recurrent Childhood Oligoastrocytoma,1
14014,High Grade Lesion,Alveolar soft part sarcoma recurrent,1
14015,Borderline Lesion,Type B Lymphomatoid Papulosis,1
14016,Carcinomatous Component Present,Stage I Vulvar Cancer,1
14017,Carcinomatous Component Present,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage,1
14018,Refractory Disease,Refractory Childhood Acute Lymphoblastic Leukemia,1
14019,Malignant Cellular Infiltrate,Locally Advanced Angiosarcoma,1
14020,Neuroendocrine Differentiation,Stage IV Colon Neuroendocrine Tumor AJCC v8,1
14021,Papillary Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
14022,High Grade Lesion,Platinum-Resistant Lung Small Cell Carcinoma,1
14023,Hyalinized Stroma Formation,Cardiac Epithelioid Hemangioendothelioma,1
14024,Biphasic Pattern,Female Reproductive System Adenofibroma,1
14025,Epithelial Component Present,Salivary gland carcinoma,1
14026,Epithelial Component Present,inverted follicular keratosis,1
14027,BRAF V600E Mutation Present,Splenic Manifestation of Hairy Cell Leukemia,1
14028,Malignant Cellular Infiltrate,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
14029,Recurrent disease,Recurrent T-Cell Prolymphocytic Leukemia,1
14030,Epithelial Component Present,Stage IVA Major Salivary Gland Cancer AJCC v7,1
14031,Epithelial Component Present,Stage IV Ovarian Carcinoma,1
14032,Chronic Inflammatory Infiltrate,Dysgerminoma,1
14033,Malignant Cellular Infiltrate,Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
14034,Hemorrhagic,Central Nervous System Angiosarcoma,1
14035,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid adenocarcinoma recurrent,1
14036,Malignant Cellular Infiltrate,Metastatic Malignant Pancreatic Neoplasm,1
14037,Acanthosis,Verrucous carcinoma of the oral cavity recurrent,1
14038,Epithelial Component Present,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor,1
14039,Benign Cellular Infiltrate,Respiratory papilloma,1
14040,Malignant Cellular Infiltrate,Familial Retinoblastoma,1
14041,Benign Cellular Infiltrate,Enchondromatosis,1
14042,Cutaneous Involvement,"Mastocytosis, Diffuse Cutaneous",1
14043,Metastatic/Recurrent Disease,"Ossifying fibromyxoid tumor, malignant",1
14044,Indolent Clinical Course,Lipoma,1
14045,Malignant Cellular Infiltrate,Childhood Immunoblastic Lymphoma,1
14046,Recurrent disease,Recurrent Gastroesophageal Junction Adenocarcinoma,1
14047,Congenital Lesion,Congenital melanocytic nevus,1
14048,Carcinomatous Component Present,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
14049,Lymphoplasmacytic Infiltrate,Sellar Germinoma,1
14050,Epithelial Component Present,Platinum-Resistant Lung Small Cell Carcinoma,1
14051,Epithelial Component Present,Parotid Gland Carcinoma,1
14052,Extraosseous Lesion,Cardiac Extraskeletal Osteosarcoma,1
14053,Severe dysplasia,Pathologic Stage 0 Gastric Cancer AJCC v8,1
14054,Well-Circumscribed Lesion,Adenomatous Polyps,1
14055,Acanthosis,Upper Gingival Verrucous Carcinoma,1
14056,Cutaneous Involvement,Cystic basal cell carcinoma,1
14057,Extraosseous Lesion,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
14058,Carcinomatous Component Present,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
14059,Malignant Cellular Infiltrate,Locally Advanced Melanoma,1
14060,Invasive Lesion,"Glycogen-Rich, Clear Cell Breast Carcinoma",1
14061,Metastatic Lesion,Metastatic Gastric Neuroendocrine Carcinoma,1
14062,Benign Cellular Infiltrate,Benign Childhood Germ Cell Tumor,1
14063,Malignant Cellular Infiltrate,FIGO Stage IIIB Ovarian Cancer,1
14064,Epithelial Component Present,Pancreatic Cancer by AJCC v8 Stage,1
14065,Epithelial Component Present,Urothelial carcinoma ureter metastatic,1
14066,Argentaffin Positive Neoplastic Cells Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
14067,Carcinomatous Component Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
14068,Benign Cellular Infiltrate,Metanephric stromal tumor,1
14069,Malignant Cellular Infiltrate,Stage III Uterine Corpus Cancer AJCC v6,1
14070,Indolent Clinical Course,Peripheral Odontogenic Fibroma,1
14071,Malignant Cellular Infiltrate,Laryngeal Leiomyosarcoma,1
14072,Bone marrow depression,Hypocellular Myelodysplastic Syndrome,1
14073,Papillary Pattern,Intracystic papillary adenoma,1
14074,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage IV,1
14075,Dysplasia,High Grade Esophageal Glandular Intraepithelial Neoplasia,1
14076,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern",1
14077,Epithelial Component Present,Endometrioid tumor,1
14078,Neuroendocrine Differentiation,Stage IIB Rectal Neuroendocrine Tumor AJCC v8,1
14079,Minimal Invasion Present,"Bronchiolo-alveolar carcinoma, non-mucinous",1
14080,Peripheral Nuclear Palisading,Combined Lung Small Cell and Squamous Cell Carcinoma,1
14081,Mitotic Activity,Adult Glioblastoma,1
14082,Immature Granulocytes in Peripheral Blood Under 10 Percent,Recurrent Chronic Myelomonocytic Leukemia,1
14083,Squamous metaplasia of bladder,Bladder squamous cell carcinoma recurrent,1
14084,Malignant Cellular Infiltrate,St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8,1
14085,Carcinomatous Component Present,Stage IVA Gallbladder Carcinoma,1
14086,Mitotic Activity,"Testicular Yolk Sac Tumor, Hepatoid Pattern",1
14087,Malignant Cellular Infiltrate,Stage IIIC Colorectal Cancer AJCC v7,1
14088,Monoclonal Gammapathies,Waldenstrom's macroglobulinemia recurrent,1
14089,Malignant Cellular Infiltrate,Esophageal Cancer by AJCC v8 Stage,1
14090,Benign Cellular Infiltrate,Atypical neurofibroma,1
14091,Malignant Cellular Infiltrate,Stage IIIC Lung Cancer AJCC v8,1
14092,Malignant Cellular Infiltrate,Bladder Papillary Clear Cell Adenocarcinoma,1
14093,Mixed Cellular Population,Uterine Corpus Carcinofibroma,1
14094,Cutaneous Involvement,Carcinoma Metastatic to the Skin,1
14095,Metastatic Lesion,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
14096,Tissue of Mullerian Origin Present,Mucinous cystadenofibroma,1
14097,Mixed Cellular Population,Recurrent Childhood Oligoastrocytoma,1
14098,Secondary Lesion,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
14099,Mesenchymal Component Present,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
14100,Epithelial Component Present,FIGO Stage IIIC Ovarian Cancer,1
14101,Refractory Disease,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
14102,Adulthood Lesion,Adult Brain Stem Astrocytoma,1
14103,Benign Cellular Infiltrate,Benign neoplasm of ear,1
14104,Carcinomatous Component Present,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation,1
14105,Carcinomatous Component Present,Stage 0 Hilar Cholangiocarcinoma AJCC v8,1
14106,Malignant Cellular Infiltrate,Adenocarcinoma of Unknown Primary,1
14107,Epithelial Component Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
14108,Carcinomatous Component Present,Refractory Fallopian Tube Carcinoma,1
14109,Epithelial Component Present,Stage I Skin Cancer,1
14110,Malignant Cellular Infiltrate,Thymic Sarcomatoid Carcinoma,1
14111,Carcinomatous Component Present,Adenocarcinoma of small intestine,1
14112,Benign Cellular Infiltrate,Enchondroma,1
14113,Polymorphic Cellular Infiltrate,Angiocentric immunoproliferative lesion grade 2,1
14114,Papillary Pattern,Bronchial adenoma,1
14115,Carcinomatous Component Present,Renal cell carcinoma recurrent,1
14116,Epithelial Component Present,Hereditary Ovarian Carcinoma,1
14117,Carcinomatous Component Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
14118,Epithelial Component Present,Malignant neoplasm of stomach stage III,1
14119,Malignant Cellular Infiltrate,mesenchymal chondrosarcoma of bone,1
14120,High Grade Lesion,Childhood Rhabdomyosarcoma,1
14121,Malignant Cellular Infiltrate,Refractory anemias,1
14122,Diffuse Pattern,Adult Grade III Lymphomatoid Granulomatosis,1
14123,Epithelial Component Present,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
14124,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v6,1
14125,Histiocytosis,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
14126,HMB-45-Positive Neoplastic Cells Present,Lymphangioleiomyomatosis of skin,1
14127,Malignant Cellular Infiltrate,Carcinosarcoma of cervix uteri,1
14128,Carcinomatous Component Present,Unresectable Lung Carcinoma,1
14129,Nuclear Pseudoinclusion,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
14130,Adulthood Lesion,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
14131,Indolent Clinical Course,Trichodiscoma,1
14132,Papillary Pattern,Common wart,1
14133,Diffuse Immunoblastic Proliferation,Infectious Mononucleosis,1
14134,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
14135,Epithelial Component Present,Urothelial carcinoma ureter metastatic,1
14136,Malignant Cellular Infiltrate,Stage IB Testicular Cancer AJCC v6 and v7,1
14137,Osseous Differentiation,Extraskeletal Osteosarcoma,1
14138,Malignant Cellular Infiltrate,Stage IV Choroidal and Ciliary Body Melanoma AJCC v8,1
14139,Non-Hereditary Lesion,Gastric Tubular Adenocarcinoma,1
14140,Recurrent disease,Plasma cell myeloma recurrent,1
14141,Hereditary Lesion,Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations,1
14142,Carcinomatous Component Present,Stage I Ampulla of Vater Cancer AJCC v8,1
14143,Plasma cell inflammation,Retroperitoneal Inflammatory Myofibroblastic Tumor,1
14144,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
14145,Epithelial Component Present,Recurrent Rectal Cancer,1
14146,Malignant Cellular Infiltrate,Cholangiocarcinoma metastatic,1
14147,Epithelial Component Present,Borderline Ovarian Serous Adenofibroma,1
14148,Malignant Cellular Infiltrate,Malignant fibrous histiocytoma recurrent,1
14149,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,1
14150,Epithelial Component Present,Hereditary Kidney Oncocytoma,1
14151,Recurrent disease,Recurrent Pancreatic Cystadenocarcinoma,1
14152,Cutaneous Involvement,Abscess of skin AND/OR subcutaneous tissue,1
14153,Carcinomatous Component Present,Stage IIIB Breast Carcinoma,1
14154,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Childhood Acute Myelomonocytic Leukemia,1
14155,Lymphatic Spread,Inflammatory carcinoma of breast recurrent,1
14156,Carcinomatous Component Present,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type",1
14157,Epithelial Component Present,Undifferentiated carcinoma of ovary,1
14158,Non-Invasive Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm,1
14159,Malignant Cellular Infiltrate,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
14160,Cystic Change,Borderline cystadenoma,1
14161,Malignant Cellular Infiltrate,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,1
14162,Epithelial Component Present,Stage III Adult Liver Cancer AJCC v7,1
14163,Epithelial Component Present,Gingival Squamous Cell Carcinoma,1
14164,Mass of body structure,Granulocytic Sarcoma,1
14165,Papillary Pattern,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
14166,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Isolated del(5q),1
14167,Epithelial Component Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8,1
14168,Malignant Cellular Infiltrate,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
14169,Benign Cellular Infiltrate,Pyogenic granuloma of oral mucosa,1
14170,Cystic Change,Clear Cell Papillary Cystadenoma,1
14171,Carcinomatous Component Present,Bladder cancer stage IV,1
14172,Carcinomatous Component Present,undifferentiated carcinoma of liver,1
14173,Refractory Disease,Refractory Urothelial Carcinoma,1
14174,HMB-45-Positive Neoplastic Cells Present,Angiomyolipoma,1
14175,Malignant Cellular Infiltrate,Stage IA Ovarian Cancer AJCC v8,1
14176,Benign Cellular Infiltrate,Central Breast Papilloma,1
14177,Anaplasia,Recurrent Anaplastic Astrocytoma,1
14178,Perivascular Arrangement of Tumor Cells,Sellar Solitary Fibrous Tumor/Hemangiopericytoma,1
14179,Malignant Germinomatous Cellular Infiltrate,Stage III Testicular Seminoma AJCC v6 and v7,1
14180,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Signet Ring Variant",1
14181,Chromogranin A Positive Neoplastic Cells Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
14182,Thick-Walled Hyalinized Vessels Present,Schwannomatosis,1
14183,Cutaneous Involvement,Granulomatous dermatitis,1
14184,Epithelial Component Present,Clinical Stage IVB Gastric Cancer AJCC v8,1
14185,Carcinomatous Component Present,Stage IV Renal Pelvis and Ureter Cancer AJCC v7,1
14186,Benign Cellular Infiltrate,Liver Cavernous Hemangioma,1
14187,Absence of Malignant Features,Childhood Choroid Plexus Papilloma,1
14188,Collagenous Stroma Formation,Central Nervous System Myofibroblastoma,1
14189,Cutaneous Involvement,Invasive Cutaneous Melanoma,1
14190,Diffuse Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
14191,Absence of Invasion,Stage 0 Oral Cavity Cancer AJCC v6 and v7,1
14192,Carcinomatous Component Present,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
14193,Clinical TNM Finding,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
14194,Malignant Cellular Infiltrate,Childhood T Lymphoblastic Leukemia/Lymphoma,1
14195,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Immature Teratoma,1
14196,Exophytic Polypoid Lesion,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
14197,Secondary Lesion,Advanced Prostate Carcinoma,1
14198,Hepatomegaly,Recurrent Hepatosplenic T-Cell Lymphoma,1
14199,Meckel Diverticulum,Meckel Diverticulum Neuroendocrine Tumor G1,1
14200,High Grade Lesion,Recurrent Gliosarcoma,1
14201,Cicatrix,Old Burn Scar-Related Cutaneous Melanoma,1
14202,Nodular and Diffuse Pattern,Large B-cell lymphoma with IRF4 rearrangement,1
14203,Encapsulated Mass,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,1
14204,Malignant Cellular Infiltrate,Cervix carcinoma,1
14205,Malignant Cellular Infiltrate,Metastatic Unresectable Carcinoma,1
14206,Neuroendocrine Differentiation,Gastrinoma,1
14207,Adulthood Lesion,Adult Spinal Cord Neoplasm,1
14208,Childhood Lesion,Childhood Ganglioneuroblastoma,1
14209,Malignant Cellular Infiltrate,Metastatic Penile Cancer,1
14210,Primary Lesion,Anaplastic Hemispheric Astrocytoma,1
14211,Neoplastic Plasma Cells Present in Bone Marrow,RISS Stage II Plasma Cell Myeloma,1
14212,Benign Cellular Infiltrate,Cartilaginous exostosis,1
14213,Well Differentiated Hyaline Cartilage Present,Central Nervous System Mesenchymal Chondrosarcoma,1
14214,Indolent Clinical Course,Gastric Plexiform Fibromyxoma,1
14215,Carcinomatous Component Present,Stage 0 Penile Cancer AJCC v7,1
14216,Carcinomatous Component Present,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8,1
14217,Epithelial Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
14218,Malignant Cellular Infiltrate,Advanced Neuroendocrine Carcinoma,1
14219,Carcinomatous Component Present,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
14220,Epithelial Component Present,Stage IVA Primary Peritoneal Cancer AJCC v8,1
14221,Carcinomatous Component Present,Stage I Carcinoma of Bladder,1
14222,Mixed Cellular Population,Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
14223,EBV-Positive Neoplastic Cells Present,Systemic EBV positive T-cell lymphoproliferative disease of childhood,1
14224,Well-Circumscribed Lesion,Ampulla of Vater Tubular Adenoma,1
14225,Epithelial Component Present,Metastatic Thyroid Gland Follicular Carcinoma,1
14226,Immunologic Deficiency Syndromes,AIDS-Related Lymphoblastic Lymphoma,1
14227,Infiltrating Tumor Margins Present,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
14228,Unclassifiable Lesion,"Supratentorial Embryonal Tumor, Not Otherwise Specified",1
14229,Carcinomatous Component Present,Lymphoepithelial carcinoma,1
14230,Stromal Invasion,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
14231,Carcinomatous Component Present,Paget's disease and intraductal carcinoma of breast,1
14232,Carcinomatous Component Present,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
14233,Malignant Cellular Infiltrate,Childhood Acute Monoblastic and Monocytic Leukemia,1
14234,Presence of a Hormonal Syndrome,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
14235,Childhood Lesion,Childhood Testicular Immature Teratoma,1
14236,Poorly Differentiated Lesion,"Transitional cell carcinoma, spindle cell",1
14237,Malignant Cellular Infiltrate,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,1
14238,Malignant Cellular Infiltrate,Prostate Acinar Adenocarcinoma,1
14239,Malignant Cellular Infiltrate,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
14240,Epithelial Component Present,Stage IVA Oropharyngeal Carcinoma AJCC v7,1
14241,Malignant Cellular Infiltrate,Recurrent Pancreatic Neuroendocrine Carcinoma,1
14242,Malignant Cellular Infiltrate,Recurrent Spindle Cell Sarcoma,1
14243,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
14244,Neuroendocrine Differentiation,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,1
14245,Carcinomatous Component Present,Stage III Prostate Cancer AJCC v7,1
14246,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Seminoma,1
14247,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma,1
14248,Neuroendocrine Differentiation,Neuroendocrine neoplasm of gallbladder,1
14249,Carcinomatous Component Present,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
14250,Tissue of Mullerian Origin Present,mucinous adenocarcinofibroma of ovary,1
14251,Recurrent disease,Recurrent Malignant Central Nervous System Neoplasm,1
14252,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma,1
14253,Lymphatic Spread,Inflammatory carcinoma of breast stage IV,1
14254,Follicular Cell Differentiation,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
14255,Benign Cellular Infiltrate,Breast Ductal Adenoma,1
14256,Malignant Cellular Infiltrate,Small cell neuroendocrine carcinoma of bladder,1
14257,Adulthood Lesion,Stage IV Adult Soft Tissue Sarcoma AJCC v7,1
14258,Malignant Cellular Infiltrate,Stage IV Esophageal Squamous Cell Carcinoma,1
14259,Epithelial Component Present,Ovarian gonadoblastoma,1
14260,Cutaneous Involvement,Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
14261,Epithelial Component Present,Medullary carcinoma of thyroid,1
14262,Malignant Cellular Infiltrate,Head and neck cancer metastatic,1
14263,Cutaneous Involvement,Vitiligo,1
14264,CD56-Positive Neoplastic Cells Present,adult nasal type extranodal NK/T-cell lymphoma,1
14265,Epithelial Component Present,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8,1
14266,Malignant Cellular Infiltrate,Adult Hodgkin Lymphoma by Ann Arbor Stage,1
14267,Adulthood Lesion,Adult Grade I Meningioma,1
14268,Carcinomatous Component Present,Lung Basaloid Squamous Cell Carcinoma,1
14269,Carcinomatous Component Present,"Adenocarcinoma, metastatic",1
14270,Malignant Cellular Infiltrate,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
14271,Severe cytologic atypia,Colorectal Large Cell Neuroendocrine Carcinoma,1
14272,Diffuse Pattern,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,1
14273,Comedo Necrosis,Colon Cribriform Comedo-Type Adenocarcinoma,1
14274,Perineural spread,Adenoid cystic breast carcinoma,1
14275,Carcinomatous Component Present,Nipple Carcinoma,1
14276,Epithelial Component Present,Glucagonoma,1
14277,Childhood Lesion,Childhood Fibrillary Astrocytoma,1
14278,Infiltrative Growth Pattern,Multifocal Glioblastomas,1
14279,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
14280,Malignant Cellular Infiltrate,Invasive micropapillary carcinoma of breast,1
14281,Recurrent disease,Recurrent Head and Neck Squamous Cell Carcinoma,1
14282,Primary Lesion,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative",1
14283,Primary Lesion,Ependymoma of brain,1
14284,Epithelial Component Present,Small intestine carcinoma stage IV,1
14285,Malignant Cellular Infiltrate,cloacogenic carcinoma of rectum,1
14286,Epithelial Component Present,Anal margin Paget's disease,1
14287,Carcinomatous Component Present,Invasive carcinoma of breast,1
14288,Well-Circumscribed Lesion,Refractory Myxoid Liposarcoma,1
14289,Epithelial Component Present,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma,1
14290,Neuroendocrine Differentiation,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation,1
14291,Carcinomatous Component Present,Stage IV Lung Small Cell Carcinoma AJCC v7,1
14292,Malignant Cellular Infiltrate,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
14293,Epithelial Component Present,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
14294,Metastatic Lesion,Secondary malignant neoplasm of pituitary gland,1
14295,Carcinomatous Component Present,Stage IB Cervical Cancer AJCC v8,1
14296,Pseudopapillary Pattern,Childhood Ovarian Embryonal Carcinoma,1
14297,Carcinomatous Component Present,Anal cancer recurrent,1
14298,Malignant Cellular Infiltrate,non-Hodgkin's lymphoma of nasal cavity,1
14299,Cutaneous Involvement,"Dermatitis, Occupational",1
14300,Stromal Invasion,Recurrent BRCA-Mutated Ovarian Carcinoma,1
14301,Hyalinized Vessels Present,Juvenile Pilocytic Astrocytoma,1
14302,Hyperplastic Tissue Present,Cervical Microglandular Hyperplasia,1
14303,Malignant Cellular Infiltrate,Peripheral T-Cell Lymphoma,1
14304,Malignant Cellular Infiltrate,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,1
14305,Epithelial Component Present,Resectable Renal Cell Carcinoma,1
14306,Well-Circumscribed Lesion,Appendix Traditional Serrated Adenoma,1
14307,Low Mitotic Activity,Regional Digestive System Neuroendocrine Tumor G1,1
14308,Malignant Cellular Infiltrate,Carcinoma of soft palate,1
14309,Extensive Stage Lesion,Pleural mesothelioma malignant advanced,1
14310,Tubular Pattern,Appendix Tubular Adenoma,1
14311,Regional Disease,Locally Advanced Cervical Carcinoma,1
14312,Benign Cellular Infiltrate,Cervical Adenofibroma,1
14313,Benign Cellular Infiltrate,Benign Cerebellar Neoplasms,1
14314,Malignant Cellular Infiltrate,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
14315,Florid Follicular Hyperplasia,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
14316,Malignant Cellular Infiltrate,"Carcinoma, Skin Appendage",1
14317,Cystic Change,Ovarian Mucinous Cystic Tumor with Mural Nodules,1
14318,Neuronal Differentiation,Hypothalamic Gangliocytoma,1
14319,Metastatic Lesion,Stage IV adult soft tissue sarcoma,1
14320,Epithelial Component Present,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma,1
14321,Malignant Cellular Infiltrate,Esophageal Malignant Peripheral Nerve Sheath Tumor,1
14322,Mixed Cellular Population,carcinosarcoma of extrahepatic bile duct,1
14323,Malignant Cellular Infiltrate,Unresectable Ureter Urothelial Carcinoma,1
14324,Epithelial Component Present,Anal Intraepithelial Neoplasia 1,1
14325,Absence of Stromal Invasion,Serous papillary cystic tumor of borderline malignancy,1
14326,Osteoid formation,Osteoblastic Osteosarcoma,1
14327,Organoid Pattern,Childhood Alveolar Soft Part Sarcoma,1
14328,Epithelial Component Present,Cervical Cancer by AJCC v8 Stage,1
14329,Malignant Cellular Infiltrate,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",1
14330,Malignant Cellular Infiltrate,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
14331,Malignant Cellular Infiltrate,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
14332,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Enteric Pattern",1
14333,Epithelial Component Present,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,1
14334,Skin nodule,Proliferative dermal lesion in congenital nevus,1
14335,Epithelial Component Present,Submandibular Gland Undifferentiated Carcinoma,1
14336,Hemorrhagic,Adrenal Gland Angiosarcoma,1
14337,Epithelial Component Present,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
14338,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v7,1
14339,Severe dysplasia,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
14340,Carcinomatous Component Present,Squamous cell breast carcinoma,1
14341,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",1
14342,Epithelial Component Present,Small cell lung cancer limited stage,1
14343,Recurrent disease,Melanoma recurrent,1
14344,Low Grade Lesion,Congenital Mesoblastic Nephroma,1
14345,Recurrent disease,Squamous cell carcinoma of the oral cavity recurrent,1
14346,"Amorphus, Eosinophilic, and Acellular Deposit",Refractory Primary Amyloidosis,1
14347,Fibrotic Stroma Formation,Acanthomatous ameloblastoma,1
14348,Malignant Cellular Infiltrate,Childhood Burkitt Lymphoma,1
14349,Neuroendocrine Differentiation,Advanced Pancreatic Neuroendocrine Tumor,1
14350,Well-Circumscribed Lesion,Juxtaglomerular tumor,1
14351,Hereditary Lesion,Hereditary spherocytosis,1
14352,Secondary Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
14353,Splenomegaly,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
14354,Epithelial Component Present,Carcinoid tumor of ileum,1
14355,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant",1
14356,Epithelial Component Present,insulinoma,1
14357,In Situ Lesion,Serous Tubal Intraepithelial Carcinoma,1
14358,Carcinomatous Component Present,Skin Clear Cell Basal Cell Carcinoma,1
14359,Cystic Change,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
14360,Malignant Cellular Infiltrate,Advanced Well Differentiated Neuroendocrine Neoplasm,1
14361,Necrotic changes (finding),Glioblastoma,1
14362,Malignant Cellular Infiltrate,Unresectable Soft Tissue Sarcoma,1
14363,Malignant Cellular Infiltrate,Pediatric follicular lymphoma,1
14364,Refractory Disease,Refractory Myelodysplastic Syndrome,1
14365,Malignant Cellular Infiltrate,Malignant Mediastinal Germ Cell Tumor with Associated Hematologic Malignancy,1
14366,Abundant Intracytoplasmic Lipofuscin Present,Heavily Pigmented Adrenal Cortical Adenoma,1
14367,Carcinomatous Component Present,Lung Non-Keratinizing Squamous Cell Carcinoma,1
14368,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Myeloid Leukemia with Minimal Differentiation,1
14369,Malignant Cellular Infiltrate,Advanced B-Cell Neoplasm,1
14370,Splenomegaly,Splenic marginal zone lymphoma recurrent,1
14371,Malignant Cellular Infiltrate,Metastatic Breast Neuroendocrine Neoplasm,1
14372,Radiation Sickness,Solar Radiation-Related Malignant Neoplasm,1
14373,Malignant Cellular Infiltrate,Refractory Oral Cavity Squamous Cell Carcinoma,1
14374,Primary Lesion,Primary Lung Meningioma,1
14375,Malignant Cellular Infiltrate,Pleural Biphasic Synovial Sarcoma,1
14376,Malignant Cellular Infiltrate,Peritoneal Desmoplastic Small Round Cell Tumor,1
14377,Locally Aggressive Lesion,Central Nervous System Desmoid-Type Fibromatosis,1
14378,Neuroendocrine Differentiation,Childhood Adrenal Gland Pheochromocytoma,1
14379,Malignant Cellular Infiltrate,Alveolar soft part sarcoma metastatic,1
14380,Benign Cellular Infiltrate,Ganglioneuroma of mediastinum,1
14381,High Grade Lesion,large cell neuroendocrine carcinoma of lung,1
14382,Carcinomatous Component Present,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
14383,Malignant Cellular Infiltrate,Primary Peritoneal Cancer by AJCC v7 Stage,1
14384,Malignant Cellular Infiltrate,Stage III Laryngeal Cancer AJCC v6 and v7,1
14385,Microvascular Proliferation,Childhood Brain Stem Gliosarcoma,1
14386,Malignant Cellular Infiltrate,Thymic Squamous Cell Carcinoma,1
14387,Tissue of Mullerian Origin Present,Stage II Uterine Corpus Adenosarcoma AJCC v8,1
14388,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
14389,Vascular Channel Formation,Colon Lymphangioma,1
14390,Epithelial Component Present,Stage IIIA Gallbladder Cancer AJCC v8,1
14391,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
14392,Malignant Cellular Infiltrate,Laryngeal Giant Cell Carcinoma,1
14393,Malignant Cellular Infiltrate,Undifferentiated Carcinoma of Unknown Primary,1
14394,Acanthosis,Verrucous carcinoma,1
14395,Malignant Cellular Infiltrate,Peritoneal Desmoplastic Small Round Cell Tumor,1
14396,Epithelial Differentiation,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
14397,Malignant Cellular Infiltrate,Stage IV Esophageal Squamous Cell Carcinoma AJCC v7,1
14398,Juvenile Lesion,Juvenile Type Testicular Granulosa Cell Tumor,1
14399,Indolent Clinical Course,Genital rhabdomyoma,1
14400,Severe dysplasia,Carcinoma in situ of prostate,1
14401,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,1
14402,Hyalinized Vessels Present,Recurrent Childhood Pilocytic Astrocytoma,1
14403,Carcinomatous Component Present,Stage III Lip and Oral Cavity Cancer AJCC v8,1
14404,Benign Cellular Infiltrate,Non-Functioning Adrenal Cortex Adenoma,1
14405,Severe cytologic atypia,Anal Canal Small Cell Neuroendocrine Carcinoma,1
14406,Intraluminal Tumor Growth,Pulmonary Artery Intimal Sarcoma,1
14407,Carcinomatous Component Present,Stage IIA1 Cervical Cancer AJCC v7,1
14408,Indolent Clinical Course,Epidural Spinal Canal Angiolipoma,1
14409,Epithelial Component Present,Biliary Intraepithelial Neoplasia,1
14410,Childhood Lesion,Recurrent Childhood Oligodendroglioma,1
14411,Stromal Invasion,FIGO Stage IIIA1(i) Ovarian Cancer,1
14412,Malignant Cellular Infiltrate,Metastatic Oral Cavity Carcinoma,1
14413,Tissue of Mullerian Origin Present,Cervical Adenomyoma,1
14414,Stromal Invasion,Malignant Ovarian Surface Epithelial-Stromal Tumor,1
14415,Benign Cellular Infiltrate,Squamous Papilloma of the Larynx,1
14416,Slow Growing Mass,Recurrent Ependymoma,1
14417,Biphasic Pattern,mesenchymal chondrosarcoma of bone,1
14418,Primary Lesion,Primary Vitreoretinal Lymphoma,1
14419,Resectable Mass,Resectable Neuroblastoma,1
14420,Malignant Cellular Infiltrate,Gallbladder Cribriform Carcinoma,1
14421,Borderline Lesion,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,1
14422,Immunologic Deficiency Syndromes,AIDS-Related Plasmablastic Lymphoma,1
14423,Carcinomatous Component Present,Bladder Diffuse Clear Cell Adenocarcinoma,1
14424,Recurrent disease,Peritoneal mesothelioma malignant recurrent,1
14425,Neuroendocrine Differentiation,Advanced Gastric Neuroendocrine Carcinoma,1
14426,Diffuse Pattern,Immunoblastic Large-Cell Lymphoma,1
14427,Benign Cellular Infiltrate,Benign germ cell tumor of ovary,1
14428,Benign Cellular Infiltrate,Desmoplastic Nevus,1
14429,Carcinomatous Component Present,Acinar Prostate Mucinous Adenocarcinoma,1
14430,Malignant Cellular Infiltrate,Stage III Ampulla of Vater Cancer AJCC v8,1
14431,Mild cytologic atypia,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
14432,Benign Cellular Infiltrate,Lung Pleomorphic Adenoma,1
14433,Pseudopapillary Pattern,Cerebellar Papillary Meningioma,1
14434,Malignant Cellular Infiltrate,Secondary malignant neoplasm of vagina,1
14435,Insular Pattern,Pancreatic Somatostatinoma,1
14436,Malignant Cellular Infiltrate,Mature B-Cell Non-Hodgkin Lymphoma,1
14437,Borderline Lesion,Recurrent Childhood Lymphomatoid Granulomatosis,1
14438,Epithelial Component Present,Breast cancer recurrent,1
14439,Aggressive Clinical Course,NUT midline carcinoma,1
14440,Epithelial Component Present,Stage IIA Ovarian Cancer AJCC v8,1
14441,Nuclear pleomorphism,Anaplastic Medulloblastoma,1
14442,Benign Cellular Infiltrate,Bronchial adenoma,1
14443,Cutaneous Involvement,"Xeroderma pigmentosum, group A",1
14444,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory High Risk Myelodysplastic Syndrome,1
14445,Malignant Cellular Infiltrate,Refractory Oropharyngeal Squamous Cell Carcinoma,1
14446,Carcinomatous Component Present,Small intestine adenocarcinoma metastatic NOS,1
14447,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma,1
14448,Cystic Change,Vulvar Papillary Hidradenoma,1
14449,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP E",1
14450,In Situ Lesion,Stage 0is Ureter Cancer AJCC v7,1
14451,In Situ Lesion,Carcinoma in situ of vagina,1
14452,atypia morphology,Primary ameloblastic carcinoma,1
14453,Well-Circumscribed Lesion,Spinal hemangioblastoma,1
14454,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Thoracic Cavity,1
14455,Low Mitotic Activity,Colorectal Neuroendocrine Tumor by AJCC v8 Stage,1
14456,Malignant Cellular Infiltrate,Stage IA Ovarian Cancer AJCC v8,1
14457,Tubular Pattern,Malignant Pancreatic Somatostatinoma,1
14458,Epithelial Component Present,Wolffian tumor,1
14459,Cutaneous Involvement,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
14460,Hereditary Lesion,Neurofibromatosis 1,1
14461,Malignant Cellular Infiltrate,Recurrent Childhood Hodgkin Lymphoma,1
14462,Neuroendocrine Differentiation,Carcinoid tumor of intestine,1
14463,Benign Cellular Infiltrate,"Nevus, Intradermal",1
14464,Well-Circumscribed Lesion,Hyperplastic Polyp,1
14465,Epithelial Component Present,Basal cell carcinoma - follicular,1
14466,Resectable Mass,Carcinoma duodenum resectable,1
14467,Benign Cellular Infiltrate,Fibrous Hamartoma of Infancy,1
14468,Malignant Cellular Infiltrate,Synovial sarcoma recurrent,1
14469,Malignant Cellular Infiltrate,mucinous adenocarcinoma of anus,1
14470,Villous Pattern,Cecum Villous Adenoma,1
14471,Carcinomatous Component Present,Stage IVC Colorectal Cancer AJCC v8,1
14472,Fibrotic Stroma Formation,Cystadenofibroma,1
14473,Childhood Lesion,Lugano Classification Stage IE Childhood Hodgkin Lymphoma AJCC v8,1
14474,Syncytial Pattern,Cervical Lymphoepithelioma-Like Carcinoma,1
14475,Epithelial Component Present,Rectal Neuroendocrine Tumor by AJCC v8 Stage,1
14476,Alternative Fascicle (Bundle) Pattern,leiomyoma of extrahepatic bile duct,1
14477,Malignant Cellular Infiltrate,Pelvic Cancer,1
14478,Carcinomatous Component Present,Stage IIIB Eyelid Carcinoma AJCC v8,1
14479,Mixed Cellular Population,Mixed Neoplasm,1
14480,Carcinomatous Component Present,Intraductal carcinoma and lobular carcinoma in situ,1
14481,Refractory Disease,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
14482,Presence of a Hormonal Syndrome,Hormone secreting pituitary neoplasms,1
14483,Benign Cellular Infiltrate,Encephalocraniocutaneous lipomatosis,1
14484,Epithelial Component Present,"Adenoma, Sweat Gland",1
14485,Epithelial Component Present,Human Papillomavirus-Related Squamous Cell Carcinoma,1
14486,Carcinomatous Component Present,Thyroid Gland Mucoepidermoid Carcinoma,1
14487,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,1
14488,Invasive Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
14489,Primary Site Unknown,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
14490,Serrated Glandular Architecture,Colorectal Sessile Serrated Adenoma/Polyp,1
14491,Extensive Stage Lesion,Uveal Melanoma Metastatic in the Liver,1
14492,Diffuse Pattern,large B-cell diffuse lymphoma of accessory sinus,1
14493,Papillary Pattern,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,1
14494,Primary Lesion,Childhood Infratentorial Ependymoma,1
14495,Epithelial Component Present,Stage IA Fallopian Tube Cancer AJCC v6 and v7,1
14496,Malignant Cellular Infiltrate,Resectable Sarcoma,1
14497,Carcinomatous Component Present,Intracystic Papillary Breast Carcinoma,1
14498,Epithelial Component Present,Refractory Cholangiocarcinoma,1
14499,Carcinomatous Component Present,Stage III Esophageal Squamous Cell Carcinoma AJCC v7,1
14500,High Grade Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
14501,Malignant Cellular Infiltrate,Colon Hodgkin Lymphoma,1
14502,Immunologic Deficiency Syndromes,AIDS-Related Pelvic Inflammatory Disease,1
14503,Epithelial Component Present,Lung Mucinous Adenocarcinoma In Situ,1
14504,Malignant Cellular Infiltrate,Malignant neoplasm of stomach,1
14505,Epithelial Component Present,Metastatic Urethral Carcinoma,1
14506,Diffuse Pattern,Glioblastoma,1
14507,Carcinomatous Component Present,Stage IV Ureter Cancer AJCC v7,1
14508,Absence of a Hormonal Syndrome,Non-Functioning Endocrine Neoplasm,1
14509,Lobulated Growth Pattern,Primary myoepithelial carcinoma of lung,1
14510,Malignant Cellular Infiltrate,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,1
14511,Epithelial Component Present,Carcinoid tumor of the cecum,1
14512,Vascular Channel Formation,Venous Angioleiomyoma,1
14513,Necrotic changes (finding),large cell neuroendocrine carcinoma of gallbladder,1
14514,Generalized illness,"Langerhans Cell Histiocytosis, Disseminated",1
14515,Malignant Cellular Infiltrate,Stage IIC Testicular Cancer AJCC v8,1
14516,Indolent Clinical Course,Proliferative fasciitis,1
14517,Slow Growing Mass,Childhood Craniopharyngioma,1
14518,Malignant Cellular Infiltrate,Metastatic Cervical Adenosquamous Carcinoma,1
14519,Varicosity,Infective Phlebitis,1
14520,Malignant Cellular Infiltrate,Invasive Malignant Neoplasm,1
14521,Stromal Invasion,large cell neuroendocrine carcinoma of ovary,1
14522,Carcinomatous Component Present,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,1
14523,Nuclear Clearing,Atypical follicular adenoma,1
14524,Carcinomatous Component Present,"Adenocarcinoma, endocervical type",1
14525,Follicular Structures Present,Thyroid Gland Spindle Cell Follicular Adenoma,1
14526,Microvascular Proliferation,MGMT-Unmethylated Glioblastoma,1
14527,Biphasic Pattern,carcinosarcoma of liver,1
14528,Carcinomatous Component Present,Metaplastic carcinoma of breast,1
14529,Epithelial Component Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
14530,Refractory Disease,Refractory Digestive System Neuroendocrine Carcinoma,1
14531,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Cancer AJCC v8,1
14532,Hereditary Lesion,Myeloid Neoplasms with Germline GATA2 Mutation,1
14533,Severe dysplasia,Lung Adenocarcinoma In Situ,1
14534,Neuroendocrine Differentiation,Stage III Gastric Neuroendocrine Tumor AJCC v8,1
14535,Malignant Cellular Infiltrate,Mycosis fungoides stage IV,1
14536,Severe dysplasia,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7,1
14537,Dysplasia,"Gastric Adenoma, Gastric-Type",1
14538,Carcinomatous Component Present,Lobular carcinoma in situ of breast,1
14539,Philadelphia chromosome negative,Recurrent Ph-Like Acute Lymphoblastic Leukemia,1
14540,Polymorphic Cellular Infiltrate,Infectious Mononucleosis,1
14541,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
14542,Neuroendocrine Differentiation,Stage 0 Merkel Cell Carcinoma AJCC v7,1
14543,Diffuse Pattern,Gastric Diffuse Large B-Cell Lymphoma,1
14544,Carcinomatous Component Present,Stage II Ampulla of Vater Cancer AJCC v7,1
14545,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
14546,Malignant Cellular Infiltrate,Stage III Rectal Cancer AJCC v7,1
14547,Hyperplastic Tissue Present,Complex Endometrial Hyperplasia with Atypia,1
14548,Perineural spread,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
14549,High Mitotic Activity,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
14550,Malignant Cellular Infiltrate,Medulloblastoma with Leptomeningeal Spread,1
14551,Carcinomatous Component Present,Stage III Primary Peritoneal Cancer AJCC v7,1
14552,Malignant Cellular Infiltrate,Lung Squamous Cell Carcinoma In Situ,1
14553,Malignant Cellular Infiltrate,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
14554,Carcinomatous Component Present,Stage 0 Urethral Cancer AJCC v7,1
14555,In Situ Lesion,Adenocarcinoma in situ in tubular adenoma,1
14556,Cutaneous Involvement,"Xeroderma pigmentosum, group A",1
14557,Malignant Cellular Infiltrate,Recurrent Acute Monoblastic and Monocytic Leukemia,1
14558,Neuroendocrine Differentiation,Primary malignant neoplasm of glomus jugulare,1
14559,Perineural spread,Adenoid cystic carcinoma of the oral cavity recurrent,1
14560,Malignant Cellular Infiltrate,Stage IV Uterine Sarcoma AJCC v7,1
14561,Epithelial Component Present,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
14562,Carcinomatous Component Present,Prostatic Duct Urothelial Carcinoma,1
14563,Carcinomatous Component Present,Nasal cavity carcinoma,1
14564,Malignant Cellular Infiltrate,Classical Hodgkin's Lymphoma,1
14565,Hyperplastic Tissue Present,Follicular Lymph Node Hyperplasia,1
14566,Epithelial Component Present,Vulvar Syringoma,1
14567,Well Differentiated Lesion,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
14568,Malignant Cellular Infiltrate,Refractory Primary Vitreoretinal Lymphoma,1
14569,More than 5 Mitoses per 50HPF,"Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
14570,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage IV,1
14571,Gastrin Positive Neoplastic Cells Present,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
14572,Infiltrative Growth Pattern,Gemistocytic astrocytoma,1
14573,Epithelial Component Present,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
14574,Carcinomatous Component Present,Stage III Cervical Cancer AJCC v8,1
14575,Cystic Change,Ovarian serous cystadenofibroma,1
14576,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,1
14577,Malignant Cellular Infiltrate,Carcinoma in Situ,1
14578,Malignant Cellular Infiltrate,"Paget's Disease, Mammary",1
14579,Carcinomatous Component Present,Stage III Lung Small Cell Carcinoma AJCC v7,1
14580,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 1 Follicular Lymphoma,1
14581,Secondary Lesion,Benzene-Related Acute Myeloid Leukemia,1
14582,Indolent Clinical Course,Adenoameloblastoma,1
14583,Chronic lymphocytic inflammation,Lymphohistiocytoid Mesothelioma,1
14584,Malignant Cellular Infiltrate,Endometrial Clear Cell Adenocarcinoma,1
14585,Invasive Lesion,Thymoma malignant invasive,1
14586,Epithelial Component Present,Stage I Thymoma AJCC v8,1
14587,Pseudoencapsulated Mass,Childhood Malignant Peripheral Nerve Sheath Tumor,1
14588,Metastatic Lesion,"Sarcoma, metastatic",1
14589,Necrotic changes (finding),Prostate Stromal Sarcoma,1
14590,Epithelial Component Present,Stage IIC Rectal Cancer AJCC v8,1
14591,Recurrent disease,Recurrent Human Papillomavirus-Related Malignant Neoplasm,1
14592,Epithelial Component Present,Stage IIIA Primary Peritoneal Cancer AJCC v8,1
14593,Dysplasia,Squamous intraepithelial lesion,1
14594,Low Mitotic Activity,Stage I Ileal Neuroendocrine Tumor AJCC v8,1
14595,Primary Lesion,Third Ventricle Ependymal Tumor,1
14596,Cutaneous Involvement,Lichen Planus,1
14597,Epithelial Component Present,Gallbladder Papillary Adenoma,1
14598,Malignant Cellular Infiltrate,Eyelid Carcinoma by AJCC v8 Stage,1
14599,Epithelial Component Present,Ovarian mixed epithelial carcinoma,1
14600,Malignant Cellular Infiltrate,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma,1
14601,Cystic Change,Solid pseudopapillary tumor of the pancreas,1
14602,Well Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor,1
14603,High Grade Lesion,Cardiac Synovial Sarcoma,1
14604,Epithelial Component Present,Adenomatous polyp of rectum,1
14605,Cystic Change,Ovarian Cystic Teratoma,1
14606,Low Grade Lesion,Adult Epithelioid Hemangioendothelioma,1
14607,Childhood Lesion,Recurrent Childhood Non-Hodgkin Lymphoma,1
14608,Complete Spontaneous Regression,Type B Lymphomatoid Papulosis,1
14609,Papillary Pattern,Fallopian Tube Metaplastic Papillary Tumor,1
14610,Low Mitotic Activity,Malignant Pancreatic Somatostatinoma,1
14611,Malignant Cellular Infiltrate,Pathologic Stage IA Gastric Cancer AJCC v8,1
14612,Epithelial Component Present,Recurrent Endometrial Serous Adenocarcinoma,1
14613,Neuroectodermal Differentiation,Childhood Ganglioneuroblastoma,1
14614,Carcinomatous Component Present,Prostate carcinoma,1
14615,Malignant Cellular Infiltrate,Low Grade Malignant Peripheral Nerve Sheath Tumor,1
14616,Hemorrhagic Neuroblastic Nodules Present,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
14617,Monomorphic Cellular Infiltrate,Ependymoma of brain stem,1
14618,Neuroendocrine Differentiation,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
14619,Malignant Cellular Infiltrate,Stage IA Pleural Malignant Mesothelioma AJCC v7,1
14620,Cellular Stratification,Borderline Ovarian Mucinous Tumor,1
14621,Carcinomatous Component Present,Metastatic Breast Carcinoma,1
14622,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage,1
14623,Nuclear Molding,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
14624,Cutaneous Involvement,Parapsoriasis en Plaques,1
14625,Regional Disease,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,1
14626,Epithelial Component Present,Neuroendocrine carcinoma of the bladder,1
14627,Epithelial Component Present,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
14628,Secondary Lesion,Metastatic Esophageal Carcinoma,1
14629,Childhood Lesion,Childhood Brain Glioblastoma,1
14630,Carcinomatous Component Present,Minor Salivary Gland Adenoid Cystic Carcinoma,1
14631,Carcinomatous Component Present,Refractory Uterine Corpus Carcinosarcoma,1
14632,Hypercellular bone marrow,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",1
14633,Malignant Cellular Infiltrate,Anaplastic astrocytoma,1
14634,Severe cytologic atypia,Primary hepatic neuroendocrine carcinoma,1
14635,Clinical TNM Finding,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
14636,Neuroendocrine Differentiation,Small cell lung cancer recurrent,1
14637,Hyperkeratosis,Verrucous carcinoma of oral cavity,1
14638,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Gangliocytic Paraganglioma,1
14639,Somatostatin Positive Neoplastic Cells Present,Pancreatic Somatostatinoma,1
14640,Carcinomatous Component Present,Hepatoid adenocarcinoma,1
14641,HMB-45-Positive Neoplastic Cells Present,Malignant Lung PEComa,1
14642,Well Differentiated Neuroendocrine Lesion,insulinoma,1
14643,Rapidly Enlarging Mass,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
14644,Malignant Cellular Infiltrate,Vertebral chordoma,1
14645,Splenomegaly,Recurrent Hairy Cell Leukemia,1
14646,Carcinomatous Component Present,Stage IA Vaginal Cancer AJCC v8,1
14647,Cutaneous Involvement,Stage III Skin Cancer,1
14648,Vascular Channel Formation,Childhood Angiosarcoma,1
14649,Malignant Cellular Infiltrate,Lynch Syndrome,1
14650,Malignant Cellular Infiltrate,Anaplastic Malignant Neoplasm,1
14651,Epithelial Component Present,Stage IIIA1 Ovarian Cancer AJCC v8,1
14652,Cellular Pleomorphism,Malignant Uterine Corpus PEComa,1
14653,Adulthood Lesion,Adult Grade III Meningioma,1
14654,Malignant Cellular Infiltrate,Recurrent Childhood Giant Cell Glioblastoma,1
14655,Carcinomatous Component Present,Carcinoma of anal canal,1
14656,Carcinomatous Component Present,Stage IV Ureter Cancer AJCC v8,1
14657,Epithelial Component Present,Laryngeal verrucous carcinoma stage IV,1
14658,Malignant Cellular Infiltrate,Stage I Nasopharyngeal Carcinoma,1
14659,Carcinomatous Component Present,Invasive Ductal and Lobular Carcinoma,1
14660,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome stage IV,1
14661,Immature Myeloid Cells Increased in Bone Marrow,Treatment related acute myeloid leukaemia,1
14662,Lymphoplasmacytic Infiltrate,Third Ventricle Germinoma,1
14663,Malignant Cellular Infiltrate,Refractory Malignant Head and Neck Neoplasm,1
14664,Malignant Cellular Infiltrate,"Medulloblastoma, Not Otherwise Specified",1
14665,Benign Cellular Infiltrate,Benign Dermal Schwannoma,1
14666,Malignant Cellular Infiltrate,Stage IIIA Lung Cancer AJCC v8,1
14667,Epithelial Component Present,Platinum-Resistant Fallopian Tube Carcinoma,1
14668,Adnexal Differentiation,Malignant Vulvar Sweat Gland Neoplasm,1
14669,Firm mass,Low Grade Malignant Peripheral Nerve Sheath Tumor,1
14670,Benign Cellular Infiltrate,Serous adenofibroma,1
14671,Metastatic Lesion,Secondary Cerebral Hodgkin Lymphoma,1
14672,Malignant Cellular Infiltrate,Adenocarcinoma of lung stage IIIB,1
14673,Indolent Clinical Course,"Fibro-odontoma, Ameloblastic",1
14674,Glandular cell atypia,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
14675,Epithelial Component Present,Densely Granulated Somatotroph Adenoma,1
14676,Malignant Cellular Infiltrate,Invasive Prostate Carcinoma,1
14677,Invasive Lesion,Submucosal Invasive Colon Adenocarcinoma,1
14678,Childhood Lesion,Childhood Anaplastic Oligoastrocytoma,1
14679,Indolent Clinical Course,Colon Lymphangioma,1
14680,Malignant Cellular Infiltrate,Advanced Carcinoma,1
14681,Prominent Squamous Eddies Present,inverted follicular keratosis,1
14682,Papillary Pattern,Papillary tumor of renal pelvis,1
14683,Cystic Change,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
14684,Antoni B Pattern,Acoustic Neuroma,1
14685,Metastatic/Recurrent Disease,Unresectable Synovial Sarcoma,1
14686,Epithelial Component Present,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
14687,Childhood Lesion,Recurrent Childhood Hodgkin Lymphoma,1
14688,Cutaneous Involvement,Unresectable Cutaneous Melanoma,1
14689,Cutaneous Involvement,Solar Radiation-Related Cutaneous Melanoma,1
14690,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G1,1
14691,Malignant Cellular Infiltrate,Stage III Adult Liver Cancer AJCC v7,1
14692,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of the oral cavity stage III,1
14693,Epithelial Component Present,Hormone refractory breast cancer,1
14694,Epithelial Component Present,Infiltrating duct and lobular carcinoma,1
14695,Adnexal Differentiation,Vulvar Papillary Hidradenoma,1
14696,Malignant Cellular Infiltrate,Stage IIIB Esophageal Adenocarcinoma AJCC v7,1
14697,Neuroectodermal Differentiation,Ewings sarcoma-primitive neuroectodermal tumor (PNET),1
14698,Malignant Cellular Infiltrate,Primary cerebral lymphoma,1
14699,Multilineage Dysplasia Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
14700,Epithelial Component Present,Stage IA Eyelid Carcinoma AJCC v7,1
14701,Malignant Cellular Infiltrate,epithelial-myoepithelial carcinoma of lung,1
14702,Large Mass,Giant fibroadenoma of breast,1
14703,Epithelial Component Present,Stage I Urethral Cancer AJCC v8,1
14704,Borderline Lesion,Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,1
14705,Cutaneous Involvement,Paget's disease of vulva,1
14706,Childhood Lesion,Recurrent Childhood Lymphoblastic Lymphoma,1
14707,Carcinomatous Component Present,Lung Large Cell Carcinoma by AJCC v7 Stage,1
14708,Malignant Cellular Infiltrate,Gastric Fundus Carcinoma,1
14709,Absence of Invasion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,1
14710,Epithelial Component Present,Infiltrating duct and lobular carcinoma,1
14711,Epithelial Component Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated",1
14712,Malignant Cellular Infiltrate,Metastatic Lung Adenosquamous Carcinoma,1
14713,Insular Pattern,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
14714,Carcinomatous Component Present,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
14715,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of lung,1
14716,Carcinomatous Component Present,Breast Columnar Cell Mucinous Carcinoma,1
14717,High Mitotic Activity,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
14718,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage III,1
14719,Carcinomatous Component Present,adenoid cystic carcinoma of esophagus,1
14720,Malignant Cellular Infiltrate,Malignant Outer Hair Sheath and Infundibulum Neoplasm,1
14721,Increased Cellularity Present,Stage 2B Neuroblastoma,1
14722,Cambium Layer,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
14723,Adulthood Lesion,Adult Acute Monocytic Leukemia,1
14724,Benign Cellular Infiltrate,Recurrent Inverted Schneiderian Papilloma,1
14725,Carcinomatous Component Present,Familial Nonmedullary Thyroid Gland Carcinoma,1
14726,Well-Circumscribed Lesion,Uterine Corpus Adenomatoid Tumor,1
14727,Carcinomatous Component Present,Adenosquamous cell lung cancer recurrent,1
14728,Myxoid Stroma Formation,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
14729,Borderline Lesion,Bladder Urothelial Proliferation of Uncertain Malignant Potential,1
14730,Carcinomatous Component Present,Follicular thyroid carcinoma,1
14731,Thin Bands of Collagen Present,Sellar Solitary Fibrous Tumor/Hemangiopericytoma,1
14732,Emperipolesis,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,1
14733,Superficial Lesion,Superficial fibromatosis,1
14734,Secondary Lesion,Benzene-Related Acute Myeloid Leukemia,1
14735,Malignant Cellular Infiltrate,B-cell lymphoma stage IV,1
14736,Epithelial Component Present,Metaplastic carcinoma,1
14737,Carcinomatous Component Present,Stage I Colorectal Cancer AJCC v8,1
14738,Malignant Cellular Infiltrate,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
14739,Recurrent disease,Recurrent Myelodysplastic Syndrome,1
14740,In Situ Lesion,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,1
14741,Mixed Cellular Population,Childhood Kidney Wilms Tumor,1
14742,Carcinomatous Component Present,Papillary adenocarcinoma,1
14743,Cutaneous Involvement,Stage IIIC Cutaneous Melanoma AJCC v7,1
14744,Malignant Cellular Infiltrate,Serous cystadenocarcinoma of pancreas,1
14745,Carcinomatous Component Present,Stage IVC Oral Cavity Cancer AJCC v6 and v7,1
14746,atypia morphology,Fallopian Tube Metaplastic Papillary Tumor,1
14747,Carcinomatous Component Present,Carcinoma of lung,1
14748,Epithelial Component Present,Unresectable Renal Pelvis Urothelial Carcinoma,1
14749,Dysplasia,Vulvar Dysplastic Melanocytic Nevus,1
14750,Neuroendocrine Differentiation,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
14751,Childhood Lesion,Recurrent Childhood Glioblastoma,1
14752,Epithelial Component Present,Nodulo-ulcerative basal cell carcinoma,1
14753,Infantile Lesion,Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement,1
14754,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
14755,Malignant Cellular Infiltrate,T-Cell Prolymphocytic Leukemia,1
14756,Carcinomatous Component Present,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
14757,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma metastatic,1
14758,Hereditary Lesion,Hereditary Renal Cell Carcinoma,1
14759,Carcinomatous Component Present,Adult Liver Carcinoma,1
14760,Hereditary Lesion,Multiple fibrofolliculomas,1
14761,EBV-Positive Neoplastic Cells Present,EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood,1
14762,Malignant Cellular Infiltrate,Early Favorable Non-Hodgkin Lymphoma,1
14763,Epithelial Component Present,Colorectal Cancer by AJCC v8 Stage,1
14764,Epithelial Component Present,Oropharyngeal squamous cell carcinoma stage I,1
14765,Malignant Cellular Infiltrate,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease,1
14766,Geographic Necrosis,Adult Central Nervous System Embryonal Carcinoma,1
14767,Epithelial Component Present,Stage IIC Merkel Cell Carcinoma AJCC v7,1
14768,More than 5 Mitoses per 50HPF,Gastrointestinal Stromal Tumor by AJCC v8 Stage,1
14769,Benign Cellular Infiltrate,Intravenous leiomyomatosis,1
14770,Malignant Cellular Infiltrate,Childhood Mixed Germ Cell Tumor,1
14771,Primary Lesion,Brain Stem Glioma,1
14772,Carcinomatous Component Present,Anatomic Stage I Breast Cancer AJCC v8,1
14773,Calcitonin serum level increased,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,1
14774,Epithelial Component Present,Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7,1
14775,Benign Cellular Infiltrate,Enchondromatosis,1
14776,Epithelial Component Present,Cholangiocarcinoma metastatic,1
14777,Lymphocyte count increased,Monoclonal B-Cell Lymphocytosis,1
14778,Carcinomatous Component Present,Infiltrating Bladder Lymphoepithelioma-Like Carcinoma,1
14779,Poorly Differentiated Lesion,Spindle cell squamous cell carcinoma,1
14780,Malignant Cellular Infiltrate,Stage II Hypopharyngeal Carcinoma AJCC v8,1
14781,Childhood Lesion,Childhood Alveolar Soft Part Sarcoma,1
14782,Tubular Pattern,tubulovillous adenoma of stomach,1
14783,Malignant Cellular Infiltrate,Mucinous cystadenocarcinoma appendix,1
14784,Dysplasia,Stage 0 Vulvar Cancer,1
14785,Childhood Lesion,Lugano Classification Stage III Childhood Hodgkin Lymphoma AJCC v8,1
14786,Recurrent disease,Small intestine carcinoma recurrent,1
14787,Carcinomatous Component Present,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7,1
14788,Indolent Clinical Course,Lipoblastoma,1
14789,Tissue Differentiation Uncertain,"Perivascular epithelioid tumor, benign",1
14790,Infantile Lesion,Fibrous Hamartoma of Infancy,1
14791,Epithelial Component Present,Nasopharyngeal lymphoepithelioma stage III,1
14792,Cutaneous Involvement,Stage II Superficial Spreading Melanoma AJCC v6 and v7,1
14793,Well Differentiated Neuroendocrine Lesion,Ascending Colon Neuroendocrine Tumor G1,1
14794,Carcinomatous Component Present,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant",1
14795,Epithelial Component Present,Oropharyngeal squamous cell carcinoma stage II,1
14796,Primary Lesion,Adult Brain Stem Astrocytoma,1
14797,Epithelial Component Present,Inflammatory carcinoma of breast recurrent,1
14798,Malignant Cellular Infiltrate,Ciliary Body Spindle Cell Type A Melanoma,1
14799,Carcinomatous Component Present,Vulvar Sebaceous Carcinoma,1
14800,Epithelial Component Present,Anal Canal Neuroendocrine Tumor G1,1
14801,Malignant Cellular Infiltrate,Bladder Cancer by AJCC v8 Stage,1
14802,Malignant Cellular Infiltrate,Childhood Renal Cell Carcinoma,1
14803,Malignant Cellular Infiltrate,Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8,1
14804,Collagenous Stroma Formation,Sclerosing Epithelioid Fibrosarcoma,1
14805,Epithelial Component Present,Vaginal Papillary Carcinoma,1
14806,Nests of Tumor Cell Nuclei in a Fibrillary Matrix,Subependymal Glioma,1
14807,Childhood Lesion,Childhood Acute Megakaryoblastic Leukemia,1
14808,Diffuse Pattern,Primary cutaneous diffuse large cell B-cell lymphoma,1
14809,Primary Lesion,Primary Lung Meningioma,1
14810,Benign Cellular Infiltrate,Cervical Leiomyoma,1
14811,Dystrophic calcification,Adamantinous Craniopharyngioma,1
14812,Cutaneous Involvement,Digital papillary eccrine carcinoma of skin,1
14813,Cutaneous Involvement,Stage I Lip Basal Cell Carcinoma,1
14814,Carcinomatous Component Present,Follicular Variant Thyroid Gland Papillary Carcinoma,1
14815,Epithelial Component Present,Crooke Cell Adenoma,1
14816,Benign Cellular Infiltrate,Eccrine dermal cylindroma,1
14817,Primary Lesion,Recurrent Childhood Cerebral Astrocytoma,1
14818,Malignant Cellular Infiltrate,"Carcinoid, Goblet Cell",1
14819,Tissue of Mullerian Origin Present,Papillary adenofibroma,1
14820,Pathologic TNM Finding,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
14821,Epithelial Component Present,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
14822,High Mitotic Activity,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
14823,Severe cytologic atypia,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
14824,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome stage I,1
14825,Locally Aggressive Lesion,Lung Inflammatory Myofibroblastic Tumor,1
14826,Epithelial Component Present,Low Grade Mucoepidermoid Breast Carcinoma,1
14827,Well Differentiated Neuroendocrine Lesion,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,1
14828,Epithelial Component Present,"Carcinoma of urinary bladder, superficial",1
14829,Alternative Fascicle (Bundle) Pattern,Cutaneous leiomyoma,1
14830,Desmoplastic Stroma Formation,Desmoplastic Nevus,1
14831,Primary Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
14832,Primary Lesion,Lateral Ventricle Ependymal Tumor,1
14833,Ineffective hematopoiesis,"Myelodysplastic syndrome, no ICD-O subtype",1
14834,Hyperchromatism,Hepatocellular Small Cell Change,1
14835,Single Cell Necrosis,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
14836,Peau d'orange surface of breast,Inflammatory carcinoma of breast stage III,1
14837,High Grade Lesion,Abdominal Rhabdomyosarcoma,1
14838,Neuroendocrine Differentiation,Recurrent Adrenal Gland Pheochromocytoma,1
14839,Primary Lesion,"Brain Tumor, Primary",1
14840,Cutaneous Involvement,Syringoma,1
14841,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma,1
14842,Secondary Lesion,Secondary malignant neoplasm of pituitary gland,1
14843,Benign Cellular Infiltrate,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma,1
14844,Low Grade Neuroendocrine Lesion,Small Intestinal Carcinoid Tumor,1
14845,Carcinomatous Component Present,Acinic Cell Breast Carcinoma,1
14846,Epithelial Component Present,Small Intestinal Mixed Adenoneuroendocrine Carcinoma,1
14847,Lymphoplasmacytic Infiltrate,Childhood Central Nervous System Germinoma,1
14848,Benign Cellular Infiltrate,Central Nervous System Mature Teratoma,1
14849,Childhood Lesion,Childhood Thyroid Gland Medullary Carcinoma,1
14850,Malignant Cellular Infiltrate,Adenosquamous carcinoma,1
14851,Primary Lesion,Primary Effusion Lymphoma,1
14852,Cutaneous Involvement,Pemphigus Vulgaris,1
14853,Epithelial Component Present,Stage IVB Pharyngeal Carcinoma,1
14854,Severe dysplasia,Carcinoma in situ of trachea,1
14855,Well-Circumscribed Lesion,Uterine Corpus Adenomatoid Tumor,1
14856,Malignant Cellular Infiltrate,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,1
14857,Mixed Cellular Population,Invasive Ductal and Lobular Carcinoma,1
14858,Endobronchial Lesion,Respiratory papilloma,1
14859,Solid Growth Pattern,Solid Lung Adenocarcinoma,1
14860,Malignant Cellular Infiltrate,Stage IB Merkel Cell Carcinoma AJCC v7,1
14861,Carcinomatous Component Present,Low Grade Ductal Breast Carcinoma In Situ,1
14862,Malignant Cellular Infiltrate,Stage IVA Nasopharyngeal Carcinoma AJCC v7,1
14863,In Situ Lesion,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
14864,Epithelial Component Present,Stage IB Lung Squamous Cell Carcinoma AJCC v7,1
14865,Malignant Cellular Infiltrate,Refractory Endometrial Serous Adenocarcinoma,1
14866,Blasts Expressing B-Lymphoid and Myeloid Markers Present,Mixed phenotype acute leukemia B/myeloid,1
14867,Malignant Cellular Infiltrate,Stage 0 Distal Bile Duct Cancer AJCC v8,1
14868,High Grade Lesion,Pleural Monophasic Synovial Sarcoma,1
14869,Neuroendocrine Differentiation,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,1
14870,Dysplasia,Vulval intraepithelial neoplasia,1
14871,Lobular Pattern,Trichilemmocarcinoma,1
14872,Childhood Lesion,Childhood Nodular Sclerosis Classic Hodgkin Lymphoma,1
14873,Junctional Proliferation,"Nevus, Spindle Cell",1
14874,Carcinomatous Component Present,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8,1
14875,Malignant Cellular Infiltrate,Stage IA Osteosarcoma AJCC v7,1
14876,Malignant Cellular Infiltrate,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
14877,Benign Cellular Infiltrate,Perineurioma,1
14878,Diffuse Pattern,Refractory Diffuse Intrinsic Pontine Glioma,1
14879,Adnexal Differentiation,Skin Basal Cell Carcinoma with Sebaceous Differentiation,1
14880,Malignant Cellular Infiltrate,Stage 0 Distal Bile Duct Cancer AJCC v7,1
14881,Diffuse Pattern,"Malignant lymphoma centroblastic, diffuse",1
14882,Regional Disease,Locally Advanced Sarcoma,1
14883,Epithelial Component Present,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8",1
14884,Slow Growing Mass,Third Ventricle Pilocytic Astrocytoma,1
14885,Epithelial Component Present,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
14886,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma,1
14887,Childhood Lesion,Childhood Brain Neoplasm,1
14888,Secondary Lesion,Secondary malignant neoplasm of choroid,1
14889,Stable Disease,Indolent multiple myeloma,1
14890,Low Grade Neuroendocrine Lesion,Carcinoid tumor of appendix,1
14891,Epithelial Component Present,Adenocarcinoma gastric recurrent,1
14892,In Situ Lesion,Carcinoma in situ of trachea,1
14893,Absence of Invasion,solid type ductal carcinoma in situ of breast,1
14894,Cutaneous Involvement,Hypertrophic lichen planus,1
14895,'Starry-sky' pattern,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder,1
14896,Mesenchymal Differentiation,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",1
14897,Epithelial Component Present,Hereditary Ovarian Carcinoma,1
14898,Malignant Cellular Infiltrate,Refractory Hypopharyngeal Squamous Cell Carcinoma,1
14899,Epithelial Component Present,Papillary transitional cell carcinoma,1
14900,Epithelial Component Present,Stage IIIA Appendix Carcinoma AJCC v8,1
14901,Adulthood Lesion,Adult Classical Hodgkin Lymphoma,1
14902,Low Grade Lesion,Low-grade fibromyxoid sarcoma,1
14903,Benign Cellular Infiltrate,Cardiac Lipoma,1
14904,Malignant Cellular Infiltrate,Stage IIA Cutaneous Melanoma AJCC v6 and v7,1
14905,Gastrin Positive Neoplastic Cells Present,Gastric Gastrin-Producing Neuroendocrine Tumor,1
14906,Malignant Cellular Infiltrate,ROSE Cluster 3,1
14907,Vascular Channel Formation,Mediastinal Angiosarcoma,1
14908,Epithelial Component Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
14909,CD4-Positive Neoplastic Cells Present,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,1
14910,Malignant Cellular Infiltrate,Lip and Oral Cavity Squamous Cell Carcinoma,1
14911,Low Cellularity Present,Childhood Protoplasmic Astrocytoma,1
14912,Benign Cellular Infiltrate,Benign neoplasm of adnexa of skin,1
14913,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
14914,Malignant Cellular Infiltrate,Peripheral primitive neuroectodermal bone tumor,1
14915,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,High Risk Myelodysplastic Syndrome,1
14916,Borderline Lesion,Pancreatic Intraductal Tubulopapillary Neoplasm,1
14917,Childhood Lesion,Childhood Burkitt Lymphoma,1
14918,Mixed Cellular Population,Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm,1
14919,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
14920,Infiltrative Growth Pattern,Unresectable Desmoid-Type Fibromatosis,1
14921,Epithelial Component Present,Squamous cell carcinoma of oropharynx,1
14922,Severe dysplasia,Stage 0is Renal Pelvis Cancer AJCC v8,1
14923,Malignant Cellular Infiltrate,Stage IIIB Gastric Carcinoma,1
14924,Epithelial Component Present,Occult Lung Cancer AJCC v8,1
14925,Malignant Cellular Infiltrate,Adenocarcinoma,1
14926,Cartilaginous Differentiation,"Chondrosarcoma, Clear Cell",1
14927,Cutaneous Involvement,Skin Neoplasms,1
14928,Epithelial Component Present,Malignant Pancreatic Somatostatinoma,1
14929,Cutaneous Involvement,"Ichthyosis, X-Linked",1
14930,Epithelial Component Present,Infiltrating duct and lobular carcinoma,1
14931,Epithelial Component Present,Metastatic Unresectable Basal Cell Carcinoma,1
14932,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Melanocytic Nevus,1
14933,Malignant Cellular Infiltrate,Parotid Gland Sarcoma,1
14934,Secondary Lesion,Metastatic Pharyngeal Carcinoma,1
14935,Neuroendocrine Differentiation,"Carcinoid, Goblet Cell",1
14936,Multinodular Pattern,Eccrine dermal cylindroma,1
14937,Locally Aggressive Lesion,Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential,1
14938,Tissue Differentiation Uncertain,"Synovial sarcoma, epithelioid cell",1
14939,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage II supradiaphragmatic,1
14940,Metastatic Lesion,Metastatic Kidney Medullary Carcinoma,1
14941,Carcinomatous Component Present,Recurrent Carcinoma of Unknown Primary,1
14942,Epithelial Component Present,Locally Advanced Adrenal Gland Pheochromocytoma,1
14943,Malignant Cellular Infiltrate,"Acute myeloid leukemia, t(8;21) (q22;q22)",1
14944,Radiation Sickness,Solar Radiation-Related Malignant Neoplasm,1
14945,Diffuse Pattern,Refractory Glioblastoma,1
14946,Childhood Lesion,Childhood Central Nervous System Neoplasm,1
14947,Clinical TNM Finding,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage,1
14948,Malignant Cellular Infiltrate,Chondroblastic osteosarcoma,1
14949,Lobulated Growth Pattern,Ventricular myxoma,1
14950,Carcinomatous Component Present,Stage 0 Lung Cancer AJCC v8,1
14951,Malignant Cellular Infiltrate,Stage IVA Cervical Cancer AJCC v6 and v7,1
14952,Hereditary Lesion,Hereditary Melanoma,1
14953,Malignant Cellular Infiltrate,Childhood Paranasal Sinus Carcinoma,1
14954,Benign Cellular Infiltrate,Leiomyomatosis,1
14955,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Myelodysplastic Syndrome,1
14956,Epithelial Component Present,Stage I Renal Pelvis and Ureter Cancer AJCC v8,1
14957,Metastatic Lesion,Extraskeletal osteosarcoma metastatic,1
14958,Epithelial Component Present,Carcinoma ex Eccrine Spiradenoma,1
14959,Malignant Cellular Infiltrate,Stage II Burkitt Lymphoma,1
14960,Blasts 5-19 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-2,1
14961,Malignant Cellular Infiltrate,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8",1
14962,Primary Lesion,Recurrent Malignant Glioma,1
14963,Epithelial Component Present,Stage IVB Appendix Carcinoma AJCC v7,1
14964,Malignant Cellular Infiltrate,Sacral Chordoma,1
14965,Metastatic Lesion,Advanced Synovial Sarcoma,1
14966,Biphasic Pattern,Recurrent Childhood Gliosarcoma,1
14967,Epithelial Component Present,Benign Ovarian Transitional Cell Tumor,1
14968,Intraosseous Lesion,Basal Cell Ameloblastoma,1
14969,Low Grade Lesion,Low Grade Broad Ligament Serous Adenocarcinoma,1
14970,Curvilinear Thin-Walled Vascular Pattern,Cardiac Myxofibrosarcoma,1
14971,Diffuse Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",1
14972,Carcinomatous Component Present,Stage IV Ovarian Cancer AJCC v8,1
14973,Malignant Cellular Infiltrate,squamous cell carcinoma of ureter,1
14974,Carcinomatous Component Present,Stage III Colon Cancer AJCC v7,1
14975,Epithelial Component Present,Growth Hormone-Producing Pituitary Gland Neoplasm,1
14976,Aggressive Clinical Course,"Thymoma, type AB, malignant",1
14977,Epithelial Component Present,Vaginal cancer recurrent,1
14978,Epithelial Component Present,Pathologic Stage IIIA Gastric Cancer AJCC v8,1
14979,Secondary Lesion,Secondary malignant neoplasm of stomach,1
14980,Carcinomatous Component Present,Colon Carcinoma,1
14981,Nuclear Atypia,MGMT-Methylated Glioblastoma,1
14982,Cutaneous Involvement,Unresectable Skin Carcinoma,1
14983,Infiltrative Growth Pattern,Multifocal Glioblastomas,1
14984,Infiltrative Growth Pattern,Adult Glioblastoma,1
14985,Hereditary Lesion,TUBEROUS SCLEROSIS 2 (disorder),1
14986,Benign Cellular Infiltrate,Benign Mastocytoma,1
14987,Recurrent disease,Recurrent Transformed Chronic Lymphocytic Leukemia,1
14988,Malignant Cellular Infiltrate,Malignant tumor of supraglottis,1
14989,Poorly Cohesive Malignant Cellular Infiltrate,Poorly Cohesive Gastric Carcinoma,1
14990,Carcinomatous Component Present,Grade 3 Endometrial Mucinous Adenocarcinoma,1
14991,Epithelial Component Present,Metastatic Carcinoma in the Lung,1
14992,Epithelial Component Present,Germinative Follicular Epithelium Neoplasm,1
14993,Low Mitotic Activity,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
14994,Extensive Stage Lesion,Advanced Gastric Neuroendocrine Carcinoma,1
14995,Malignant Cellular Infiltrate,Pathologic Stage III Cutaneous Melanoma AJCC v8,1
14996,Epithelial Component Present,Endometrial Adenosquamous Carcinoma,1
14997,Malignant Cellular Infiltrate,Thymic Carcinoma,1
14998,Cutaneous Involvement,"Carcinoma, Basal Cell",1
14999,Exophytic Polypoid Lesion,Fibrous polyp,1
15000,Malignant Cellular Infiltrate,"Pheochromocytoma, malignant",1
15001,Carcinomatous Component Present,Small Intestinal Large Cell Neuroendocrine Carcinoma,1
15002,Malignant Cellular Infiltrate,Refractory Primary Effusion Lymphoma,1
15003,Childhood Lesion,Refractory Childhood Hodgkin Lymphoma,1
15004,Malignant Cellular Infiltrate,Stage IIC Prostate Cancer AJCC v8,1
15005,Malignant Cellular Infiltrate,Stage IVB Prostate Cancer AJCC v8,1
15006,Malignant Cellular Infiltrate,Stage I Paranasal Sinus Cancer,1
15007,Epithelial Component Present,Rectal Adenosquamous Carcinoma,1
15008,Malignant Cellular Infiltrate,Stage II Rectal Cancer,1
15009,Low Mitotic Activity,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,1
15010,Primary Lesion,Liposarcoma non-metastatic,1
15011,Carcinomatous Component Present,Stage I Renal Cell Carcinoma,1
15012,Immunosuppression-Related Post-Transplant Toxicity,Renal transplant rejection,1
15013,Borderline Lesion,Angiocentric immunoproliferative lesion grade 2,1
15014,Well-Circumscribed Lesion,Clear cell sarcoma of kidney,1
15015,Refractory Disease,Refractory Medulloblastoma,1
15016,Pathologic TNM Finding,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
15017,Mixed Cellular Population,Eccrine mixed tumor of skin,1
15018,Recurrent disease,Recurrent Lip and Oral Cavity Squamous Cell Carcinoma,1
15019,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
15020,Stromal Invasion,Stage IV Ovarian Cancer AJCC v8,1
15021,Well-Circumscribed Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp,1
15022,Cystic Change,Seborrheic keratosis,1
15023,Malignant Cellular Infiltrate,EBV-Related Carcinoma,1
15024,Perivascular Arrangement of Tumor Cells,Lymphangioleiomyomatosis of skin,1
15025,Misplaced Exocytosis Present,Acidophil Stem Cell Pituitary Gland Adenoma,1
15026,Papillary Pattern,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
15027,Malignant Cellular Infiltrate,Meningothelial sarcoma,1
15028,Malignant Cellular Infiltrate,Endodermal sinus tumor of ovary,1
15029,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage,1
15030,Osteoid formation,Chondroblastic osteosarcoma,1
15031,Extensive Stage Lesion,Advanced Urothelial Carcinoma,1
15032,Carcinomatous Component Present,Locally Advanced Unresectable Cervical Adenocarcinoma,1
15033,Neuroectodermal Differentiation,Peripheral primitive neuroectodermal tumor of soft tissue,1
15034,Epithelial Component Present,Stage IIA Fallopian Tube Cancer AJCC v6 and v7,1
15035,Childhood Lesion,Childhood Acute Myeloid Leukemia Not Otherwise Specified,1
15036,Carcinomatous Component Present,Papillary thyroid carcinoma,1
15037,Primary Lesion,Osteosarcoma by AJCC v7 Stage,1
15038,Epithelial Component Present,Fallopian Tube Serous Adenofibroma,1
15039,Malignant Cellular Infiltrate,Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8,1
15040,Carcinomatous Component Present,Platinum-Resistant Ovarian Carcinoma,1
15041,Capsular Invasion,"Thymoma, type B2, malignant",1
15042,Indolent Clinical Course,Benign neoplasm of mesothelial tissue of peritoneum,1
15043,Hereditary Lesion,Cherubism,1
15044,Slow Growing Mass,Hypothalamic Gangliocytoma,1
15045,Mild dysplasia,Cervical Squamous Intraepithelial Neoplasia 1,1
15046,Refractory Disease,Refractory Visual Pathway Glioma,1
15047,Diffuse Pattern,Diffuse large B-cell lymphoma refractory,1
15048,Carcinomatous Component Present,Stage III Rectosigmoid Cancer AJCC v7,1
15049,Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells,Erythroleukemia (Erythroid/Myeloid),1
15050,Unresectable Mass,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
15051,Fibromyxoid Stroma Formation,Myxofibroma,1
15052,Carcinomatous Component Present,Stage I Cervical Cancer AJCC v8,1
15053,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
15054,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
15055,Carcinomatous Component Present,Lung squamous cell carcinoma stage I,1
15056,Epithelial Component Present,Metastatic Carcinoma in the Adrenal Cortex,1
15057,Diffuse Pattern,Adult Gliosarcoma,1
15058,Epithelial Component Present,Stage IV Colon Cancer AJCC v8,1
15059,Splenomegaly,Post polycythaemia vera myelofibrosis,1
15060,Epithelial Component Present,Beta-Catenin-Activated Hepatocellular Adenoma,1
15061,Malignant Cellular Infiltrate,Rectal Carcinoma Metastatic in the Liver,1
15062,Multinodular Mass,Angiosarcoma Associated with Lymphedema,1
15063,Epithelial Component Present,Masaoka-Koga Stage III,1
15064,Carcinomatous Component Present,Gastric Large Cell Neuroendocrine Carcinoma,1
15065,Comedo Necrosis,Colorectal Cribriform Comedo-Type Adenocarcinoma,1
15066,Malignant Cellular Infiltrate,Metastatic Malignant Germ Cell Tumor,1
15067,Malignant Cellular Infiltrate,Gastric Cardia Carcinoma In Situ AJCC v6 and v7,1
15068,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma,1
15069,Resectable Mass,Resectable Intrahepatic Cholangiocarcinoma,1
15070,Epithelial Component Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
15071,Epithelial Component Present,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
15072,Indolent Clinical Course,Mediastinal Rhabdomyoma,1
15073,Malignant Cellular Infiltrate,Unresectable Cutaneous Melanoma,1
15074,Fibrotic Stroma Formation,Stage I Intrahepatic Cholangiocarcinoma AJCC v8,1
15075,Delicate Vascular Network Formation,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
15076,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Hepatoid Pattern",1
15077,Epithelial Component Present,Anal Canal Cancer by AJCC v6 and v7 Stage,1
15078,Malignant Cellular Infiltrate,Thymic Papillary Adenocarcinoma,1
15079,Mesenchymal Component Present,Hard Palate Pleomorphic Adenoma,1
15080,Serrated Glandular Architecture,Colon Traditional Serrated Adenoma,1
15081,Exophytic Polypoid Lesion,Nasal Polyps,1
15082,Bile Pigment Present,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
15083,Epithelial Component Present,Pedunculated conjunctival papilloma,1
15084,Malignant Cellular Infiltrate,Refractory Hairy Cell Leukemia,1
15085,Malignant Cellular Infiltrate,Malignant neoplasm of mouth,1
15086,Epithelial Component Present,Colorectal Adenosquamous Carcinoma,1
15087,Above the Diaphragm Disease,Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
15088,Epithelial Component Present,Stage IA Pancreatic Cancer AJCC v6 and v7,1
15089,Locally Aggressive Lesion,Metastasizing Chondroblastoma,1
15090,Malignant Cellular Infiltrate,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
15091,Neuroendocrine Differentiation,Localized Digestive System Neuroendocrine Tumor G1,1
15092,Tissue Differentiation Uncertain,Advanced Synovial Sarcoma,1
15093,Refractory Disease,Refractory Cholangiocarcinoma,1
15094,Malignant Cellular Infiltrate,Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma,1
15095,S-100-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
15096,Metastatic Lesion,Colorectal Carcinoma Metastatic in the Liver,1
15097,Primary Lesion,Stage IV Primary Peritoneal Cancer AJCC v8,1
15098,Slow Growing Mass,Clivus Chondroid Chordoma,1
15099,Malignant Cellular Infiltrate,Broad Ligament Serous Adenocarcinoma,1
15100,Secondary Lesion,Metastatic Signet Ring Cell Breast Carcinoma,1
15101,Cutaneous Involvement,Cutaneous Mantle Cell Lymphoma,1
15102,Recurrent disease,Oropharyngeal cancer recurrent,1
15103,Acanthosis,Verrucous carcinoma of oral cavity,1
15104,Malignant Cellular Infiltrate,Parotid Gland Kaposi Sarcoma,1
15105,Fibrotic Stroma Formation,Biliary Adenofibroma,1
15106,Comedo Necrosis,High Grade Ductal Breast Carcinoma In Situ,1
15107,Malignant Cellular Infiltrate,Refractory Adult Acute Lymphoblastic Leukemia,1
15108,Carcinomatous Component Present,Anal cancer recurrent,1
15109,Malignant Cellular Infiltrate,Marginal zone lymphoma stage I,1
15110,Carcinomatous Component Present,Metastatic Microsatellite Stable Colorectal Carcinoma,1
15111,Malignant Cellular Infiltrate,Malignant eccrine spiradenoma,1
15112,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21,1
15113,Epithelial Component Present,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
15114,Primary Lesion,"Brain Tumor, Primary",1
15115,Carcinomatous Component Present,Stage III Laryngeal Cancer AJCC v8,1
15116,Benign Cellular Infiltrate,Central Nervous System Hibernoma,1
15117,Unresectable Mass,Small intestine carcinoma non-resectable,1
15118,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
15119,Malignant Cellular Infiltrate,Malignant neoplasm of breast,1
15120,Birbeck Granules Present,Refractory Langerhans Cell Histiocytosis,1
15121,High Mitotic Activity,Stage IIB Merkel Cell Carcinoma AJCC v7,1
15122,Indolent Clinical Course,benign neoplasm of lower jaw bone,1
15123,Secondary Lesion,Stage IV Laryngeal Carcinoma,1
15124,Cervical Glandular Dysplasia,High grade cervical glandular intraepithelial neoplasia,1
15125,Metastatic Lesion,Endometrioid adenocarcinoma metastatic,1
15126,Rapidly Enlarging Mass,Fusion-Positive Rhabdomyosarcoma,1
15127,Epithelial Component Present,"Serous cystadenoma, borderline malignancy",1
15128,Increased Cellularity Present,Anaplastic Oligoastrocytoma,1
15129,Metastatic Lesion,Metastatic hepatocellular carcinoma,1
15130,Aggressive Clinical Course,"Endometrial stromal sarcoma, high grade",1
15131,Metastatic/Recurrent Disease,Cardiac Monophasic Synovial Sarcoma,1
15132,Solitary mass,Adult Epithelioid Hemangioendothelioma,1
15133,Carcinomatous Component Present,Metastatic Oral Cavity Carcinoma,1
15134,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
15135,Malignant Cellular Infiltrate,Pleural Sarcomatoid Mesothelioma,1
15136,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
15137,Epithelioid Component Present,"Synovial sarcoma, epithelioid cell",1
15138,Malignant Cellular Infiltrate,Anaplastic Malignant Neoplasm,1
15139,Carcinomatous Component Present,Refractory Oral Cavity Squamous Cell Carcinoma,1
15140,Childhood Lesion,Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8,1
15141,Diffuse Pattern,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,1
15142,Carcinomatous Component Present,Parathyroid Gland Adenocarcinoma,1
15143,Pregnancy Complications,"Pregnancy, Tubal",1
15144,Metastatic Lesion,Metastatic Cervical Adenosquamous Carcinoma,1
15145,Macrofollicular Structures Present,Juvenile Type Testicular Granulosa Cell Tumor,1
15146,Mesenchymal Component Present,Benign Prostate Phyllodes Tumor,1
15147,Fenestrating Pattern,Fibroepithelioma of Pinkus,1
15148,Epithelial Component Present,Prostate Phyllodes Tumor,1
15149,Dysplasia,High-Grade Squamous Intraepithelial Lesions,1
15150,Epithelial Component Present,Vaginal high grade squamous intraepithelial lesion,1
15151,Favorable Clinical Outcome,Duodenal-type follicular lymphoma,1
15152,Malignant Cellular Infiltrate,Stage I Colorectal Cancer AJCC v6 and v7,1
15153,Carcinomatous Component Present,Glycogen-rich carcinoma,1
15154,Secondary Lesion,Small intestine adenocarcinoma metastatic NOS,1
15155,Indolent Clinical Course,Benign Bone Schwannoma,1
15156,Carcinomatous Component Present,Resectable Carcinoma,1
15157,Presence of a Hormonal Syndrome,Malignant Pancreatic Insulinoma,1
15158,Malignant Cellular Infiltrate,Stage IB Lung Squamous Cell Carcinoma AJCC v7,1
15159,Swelling,Subungual exostoses,1
15160,Myxoid Stroma Formation,Chondromyxoid fibroma,1
15161,Carcinomatous Component Present,Stage I Intrahepatic Cholangiocarcinoma AJCC v7,1
15162,Exophytic Polypoid Lesion,Colorectal Adenomatous Polyp,1
15163,Malignant Cellular Infiltrate,Mixed Germ Cell Tumor,1
15164,Recurrent disease,Recurrent Human Papillomavirus-Related Malignant Neoplasm,1
15165,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma,1
15166,Secondary Lesion,Metastatic Fallopian Tube Carcinoma,1
15167,Carcinomatous Component Present,Stage IV Appendix Carcinoma AJCC v8,1
15168,Metastatic Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
15169,Stromal Invasion,FIGO Stage IIIA1(ii) Ovarian Cancer,1
15170,Malignant Cellular Infiltrate,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
15171,Malignant Cellular Infiltrate,Stage IV Hypopharyngeal Carcinoma AJCC v6,1
15172,Malignant Cellular Infiltrate,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8,1
15173,Carcinomatous Component Present,Stage IA2 Cervical Cancer AJCC v8,1
15174,Low Mitotic Activity,Stage III Duodenal Neuroendocrine Tumor AJCC v8,1
15175,Malignant Cellular Infiltrate,Fallopian Tube Lymphoma,1
15176,Mixed Cellular Population,Cystadenofibroma,1
15177,Pregnancy Complications,Stage II Gestational Trophoblastic Neoplasm AJCC v8,1
15178,Indolent Clinical Course,Leiomyoma of ciliary body,1
15179,Recurrent disease,Ewing's sarcoma recurrent,1
15180,Malignant Cellular Infiltrate,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,1
15181,Cutaneous Involvement,Acral Lentiginous Malignant Melanoma,1
15182,Epithelial Component Present,Cervical Clear Cell Adenocarcinoma,1
15183,Increased Cellularity Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",1
15184,Benign Cellular Infiltrate,Benign neoplasm of rectum,1
15185,Primary Lesion,Ventricular Ependymal Tumor,1
15186,Tissue of Mullerian Origin Present,Refractory Uterine Corpus Carcinosarcoma,1
15187,Cystic Change,Clear Cell Papillary Cystadenoma,1
15188,Primary Lesion,Primary Systemic Mastocytosis,1
15189,Histiocytosis haematophagic,Secondary haemophagocytic lymphohistiocytosis,1
15190,Malignant Cellular Infiltrate,Ann Arbor Stage III Grade 3 Follicular Lymphoma,1
15191,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21,1
15192,Carcinomatous Component Present,Stage IB Ovarian Cancer AJCC v6 and v7,1
15193,Papillary Pattern,Cervical Squamous Papilloma,1
15194,Cellular Pleomorphism,Adult Undifferentiated Pleomorphic Sarcoma,1
15195,Firm mass,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
15196,Benign Cellular Infiltrate,Lymphangioma of skin,1
15197,Malignant Cellular Infiltrate,Hypodiploid B Acute Lymphoblastic Leukemia,1
15198,Papillary Pattern,Epididymal Papillary Cystadenoma,1
15199,Benign Cellular Infiltrate,Appendix Leiomyoma,1
15200,Epithelial Component Present,Lung Pleomorphic Carcinoma,1
15201,Dysplasia,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",1
15202,1p/19q Codeletion Status Unknown,oligodendroglioma,1
15203,Nuclear Molding,Stage I Lung Small Cell Carcinoma AJCC v7,1
15204,Cutaneous Involvement,Sporadic Cylindroma,1
15205,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7,1
15206,Diffuse Pattern,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
15207,Carcinomatous Component Present,Stage IB Lung Adenocarcinoma AJCC v7,1
15208,Recurrent disease,Testis cancer recurrent,1
15209,Epithelial Component Present,Urethral Cancer by AJCC v8 Stage,1
15210,Childhood Lesion,Childhood Malignant Penile Neoplasm,1
15211,Well-Circumscribed Lesion,Blastema Predominant Kidney Wilms Tumor,1
15212,Carcinomatous Component Present,Stage 0 Pancreatic Cancer AJCC v8,1
15213,Recurrent Genetic Abnormalities Present,Acute promyelocytic leukemia - hypogranular variant,1
15214,Cutaneous Involvement,Mycosis fungoides stage II,1
15215,Malignant Cellular Infiltrate,Fallopian Tube Squamous Cell Carcinoma,1
15216,Malignant Cellular Infiltrate,Recurrent Malignant Bone Neoplasm,1
15217,Epithelial Component Present,Condyloma anal,1
15218,Malignant Cellular Infiltrate,ENSAT Stage IV Adrenal Cortex Carcinoma,1
15219,Dysplasia,Appendix Tubular Adenoma,1
15220,Well-Circumscribed Lesion,Papillary serous cystadenoma,1
15221,Epithelial Component Present,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
15222,Nuclear Atypia,Glioblastoma,1
15223,Carcinomatous Component Present,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
15224,Benign Cellular Infiltrate,Thyroid Gland Black Follicular Adenoma,1
15225,Polymorphic Cellular Infiltrate,Refractory Langerhans Cell Histiocytosis,1
15226,Childhood Lesion,Childhood Esophageal Carcinoma,1
15227,Absence of Invasion,Lobular Neoplasia,1
15228,Rapidly Enlarging Mass,Nodular fasciitis,1
15229,Exophytic Polypoid Lesion,Preauricular skin tag,1
15230,Benign Cellular Infiltrate,"Adenoma, Basal Cell",1
15231,Spontaneous Regression,Vulvar Keratoacanthoma,1
15232,Neuroendocrine Differentiation,Small cell lung cancer recurrent,1
15233,Diffuse Pattern,Pituitary Gland Diffuse Large B-Cell Lymphoma,1
15234,Adulthood Lesion,Recurrent Indolent Adult Non-Hodgkin Lymphoma,1
15235,Splenomegaly,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
15236,Intravascular Fibrin Thrombus Formation,Epidural Spinal Canal Angiolipoma,1
15237,Hereditary Lesion,Familial Testicular Germ Cell Tumor,1
15238,Malignant Cellular Infiltrate,Stage 0 Ampulla of Vater Cancer AJCC v8,1
15239,Malignant Cellular Infiltrate,Recurrent Head and Neck Carcinoma,1
15240,Low Mitotic Activity,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
15241,Epithelial Component Present,Stage IV Ureter Cancer AJCC v7,1
15242,Vascular Channel Formation,hemangioendothelial sarcoma of bone,1
15243,Epithelial Component Present,Benign Ovarian Seromucinous Tumor,1
15244,Vascular Channel Formation,Cervical Angiosarcoma,1
15245,Hemorrhagic,Colorectal Angiosarcoma,1
15246,Neuroendocrine Differentiation,Vulvar Merkel Cell Carcinoma,1
15247,Epithelial Component Present,Stage IB Lung Small Cell Carcinoma AJCC v7,1
15248,Carcinomatous Component Present,Stage II Liver Cancer,1
15249,Malignant Cellular Infiltrate,alveolar rhabdomyosarcoma of orbit,1
15250,Epithelial Component Present,Stage III Anal Canal Cancer AJCC v6 and v7,1
15251,Diffuse Pattern,Stage III Adult Immunoblastic Lymphoma,1
15252,Vascular Channel Formation,Chorioangioma,1
15253,Epithelial Component Present,mucinous adenocarcinoma of cervix,1
15254,Malignant Cellular Infiltrate,fibrosarcoma of breast,1
15255,Epithelial Component Present,High-Grade Squamous Intraepithelial Lesions,1
15256,Malignant Cellular Infiltrate,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,1
15257,Recurrent disease,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1
15258,Borderline Lesion,IgM monoclonal gammopathy of uncertain significance,1
15259,Benign Cellular Infiltrate,"Transitional cell papilloma, inverted",1
15260,Epithelial Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,1
15261,Recurrent disease,Recurrent WHO Grade II Glioma,1
15262,Biphasic Pattern,Childhood Mesenchymal Chondrosarcoma,1
15263,Malignant Cellular Infiltrate,Grade 2 Rectal Adenocarcinoma,1
15264,Acanthosis,Bowen's Disease,1
15265,Primary Lesion,Childhood Spindle Cell Rhabdomyosarcoma,1
15266,Carcinomatous Component Present,Lung Cancer by AJCC v7 Stage,1
15267,Malignant Cellular Infiltrate,Vulvar Alveolar Soft Part Sarcoma,1
15268,Gastric-Type Epithelial Differentiation,"Cervical Mucinous Adenocarcinoma, Gastric Type",1
15269,Intraductal Lesion,Intraductal papillomatosis,1
15270,Malignant Cellular Infiltrate,"Adenocarcinoma of lung, stage II",1
15271,Epithelial Component Present,Undifferentiated carcinoma of ovary,1
15272,Epithelial Component Present,Stage IIB Ampulla of Vater Cancer AJCC v8,1
15273,S-100-Positive Neoplastic Cells Present,Uterine Corpus PEComa,1
15274,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer,1
15275,Malignant Cellular Infiltrate,Thoracic Esophagus Adenocarcinoma,1
15276,Necrotic changes (finding),Vulvar Large Cell Neuroendocrine Carcinoma,1
15277,Storiform Growth Pattern,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
15278,Epithelial Component Present,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
15279,Indolent Clinical Course,fibroma of testis,1
15280,Dysplasia,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
15281,High Mitotic Activity,"Perineurioma, malignant",1
15282,Malignant Cellular Infiltrate,Small Intestinal Neuroendocrine Carcinoma,1
15283,Malignant Cellular Infiltrate,Pulmonary Blastoma,1
15284,Epithelial Component Present,Recurrent Neuroendocrine Neoplasm,1
15285,Malignant Cellular Infiltrate,Refractory Myxoid Liposarcoma,1
15286,Malignant Cellular Infiltrate,Pituitary Gland Diffuse Large B-Cell Lymphoma,1
15287,Diffuse Pattern,Recurrent Childhood Oligoastrocytoma,1
15288,Papillary Pattern,Cervical Mullerian Papilloma,1
15289,Malignant Cellular Infiltrate,Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7,1
15290,Epithelial Component Present,Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
15291,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Carcinoma,1
15292,Malignant Cellular Infiltrate,Vaginal Non-Keratinizing Squamous Cell Carcinoma,1
15293,Epithelial Component Present,Stage IVB Laryngeal Cancer AJCC v7,1
15294,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Skin,1
15295,Follicular Structures Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
15296,Alcohol Toxicity,Alcohol-Related Carcinoma,1
15297,Benign Cellular Infiltrate,"Hemangioma, Cavernous",1
15298,Malignant Cellular Infiltrate,Submandibular Gland Acinic Cell Carcinoma,1
15299,Carcinomatous Component Present,mucoepidermoid carcinoma of lung,1
15300,Generalized Hydropic Villous Change,Complete hydatidiform mole,1
15301,Epithelial Component Present,Biliary Intraepithelial Neoplasia,1
15302,Glomeruloid Vessels Present,Juvenile Pilocytic Astrocytoma,1
15303,Diffuse Pattern,Immunoblastic Large-Cell Lymphoma,1
15304,Epithelial Component Present,sialadenoma papilliferum of salivary gland,1
15305,Absence of a Hormonal Syndrome,Non-Functioning Endocrine Neoplasm,1
15306,Well-Circumscribed Lesion,Vaginal Angiomyofibroblastoma,1
15307,Malignant Cellular Infiltrate,Malignant melanoma of conjunctiva,1
15308,Malignant Cellular Infiltrate,Refractory Neutropenia,1
15309,Primary Lesion,Recurrent Primary Effusion Lymphoma,1
15310,Malignant Cellular Infiltrate,Small Intestinal Signet Ring Cell Carcinoma,1
15311,Carcinomatous Component Present,Stage IIB Lung Cancer AJCC v8,1
15312,Malignant Cellular Infiltrate,Stage II Merkel Cell Carcinoma AJCC v7,1
15313,Malignant Cellular Infiltrate,Stage IVA Bladder Cancer AJCC v8,1
15314,Nuclear pleomorphism,Anaplastic Medulloblastoma,1
15315,Malignant Cellular Infiltrate,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
15316,Malignant Cellular Infiltrate,Ovarian Adenosarcoma,1
15317,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",1
15318,Increased Cellularity Present,pineoblastoma,1
15319,Cavernous Vascular Space Formation,Cavernous hemangioma of orbit,1
15320,Single Cell Necrosis,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
15321,Secondary Lesion,Metastatic Thyroid Gland Papillary Carcinoma,1
15322,Low Grade Lesion,Metastatic Epithelioid Hemangioendothelioma,1
15323,Epithelial Component Present,Castration-Naive Prostate Carcinoma,1
15324,Splenomegaly,"Myeloid Leukemia, Chronic",1
15325,Secondary Lesion,Locally Advanced Gastrointestinal Stromal Tumor,1
15326,Cutaneous Involvement,Mongolian Spot,1
15327,Exophytic Polypoid Lesion,Colon adenoma,1
15328,Cysts Containing Proteinaceous Fluid Present,Broad Ligament Serous Cystadenoma,1
15329,Malignant Cellular Infiltrate,Secondary malignant neoplasm of axilla,1
15330,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP D1",1
15331,Well Differentiated Neuroendocrine Lesion,Extrahepatic Bile Duct Carcinoid Tumor,1
15332,Malignant Cellular Infiltrate,Malignant neoplasm of prostate,1
15333,Malignant Cellular Infiltrate,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
15334,Nuclear pleomorphism,High Grade Ductal Breast Carcinoma In Situ,1
15335,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Adult Acute Monoblastic and Monocytic Leukemia,1
15336,Carcinomatous Component Present,Stage III Intrahepatic Cholangiocarcinoma AJCC v8,1
15337,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia,1
15338,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage III,1
15339,Malignant Cellular Infiltrate,Pericardial Sarcoma,1
15340,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage I,1
15341,Locally Aggressive Lesion,Prostate Stromal Proliferation of Uncertain Malignant Potential,1
15342,Carcinomatous Component Present,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,1
15343,Dysplasia,Cervical intraepithelial neoplasia grade 1,1
15344,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Central Nervous System,1
15345,Refractory Disease,Refractory Malignant Solid Neoplasm,1
15346,Exophytic Polypoid Lesion,Villous adenoma of duodenum,1
15347,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Basophilic Leukemia,1
15348,Epithelial Component Present,Metaplastic carcinoma,1
15349,Malignant Cellular Infiltrate,Unresectable Carcinoma,1
15350,Malignant Cellular Infiltrate,Acinar Prostate Mucinous Adenocarcinoma,1
15351,Malignant Cellular Infiltrate,Metastatic Urethral Carcinoma,1
15352,Epithelial Component Present,Ovarian Endometrioid Tumor,1
15353,Malignant Cellular Infiltrate,Secondary malignant neoplasm of large intestine,1
15354,Secondary Lesion,Uveal Melanoma Metastatic in the Liver,1
15355,Chromogranin A Positive Neoplastic Cells Present,Malignant carcinoid tumor of lung,1
15356,Malignant Cellular Infiltrate,Mantle cell lymphoma stage III,1
15357,Unresectable Mass,Locally Advanced Unresectable Malignant Neoplasm,1
15358,Malignant Cellular Infiltrate,Stage I Cutaneous Melanoma AJCC v7,1
15359,High Mitotic Activity,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,1
15360,High Mitotic Activity,Adult Anaplastic Ependymoma,1
15361,Neuroectodermal Differentiation,Childhood Central Nervous System Ganglioneuroblastoma,1
15362,Syncytial Pattern,Medullary carcinoma of breast,1
15363,Eosinophil count raised (finding),"Leukemia, Eosinophilic, Acute",1
15364,Malignant Cellular Infiltrate,Stage IIIA Retroperitoneal Sarcoma AJCC v8,1
15365,Carcinomatous Component Present,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
15366,Biphasic Pattern,Prostate Phyllodes Tumor,1
15367,Epithelial Component Present,Small intestine carcinoma stage I,1
15368,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,1
15369,More than 5 Mitoses per 50HPF,"Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
15370,Refractory Disease,Refractory Desmoplastic Small Round Cell Tumor,1
15371,Malignant Cellular Infiltrate,Serous cystadenocarcinoma of pancreas,1
15372,Immunologic Deficiency Syndromes,AIDS-Related Pneumocystis Pneumonia,1
15373,Thyroglobulin Positive Neoplastic Cells Present,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
15374,Papillary Pattern,Squamous papillomatosis,1
15375,Secondary Lesion,Colorectal Carcinoma Metastatic in the Liver,1
15376,Neoplastic Plasma Cells Present in Bone Marrow,RISS Stage II Plasma Cell Myeloma,1
15377,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Solid Pattern",1
15378,Epithelial Component Present,Stage IIB Gastric Cancer AJCC v7,1
15379,Thyroglobulin Positive Neoplastic Cells Present,Papillary Thyroid Microcarcinoma,1
15380,Carcinomatous Component Present,"Carcinoma, Cribriform",1
15381,Malignant Cellular Infiltrate,Kaposi Sarcoma Related to Immunosuppressive Treatment,1
15382,Myxoid Stroma Formation,Vulvar Angiomyxoma,1
15383,Epithelial Component Present,Unclassified Renal Cell Carcinoma,1
15384,Carcinomatous Component Present,Stage IIIA Gallbladder Cancer AJCC v7,1
15385,Hemorrhagic,Skin Angiosarcoma,1
15386,Carcinomatous Component Present,Locally Advanced Urothelial Carcinoma,1
15387,Epithelial Component Present,Ethmoid Sinus Schneiderian Papilloma,1
15388,Epithelial Component Present,Intermediate Grade Lung Neuroendocrine Neoplasm,1
15389,Diffuse Pattern,Stage IV Diffuse Large B-Cell Lymphoma,1
15390,Cribriform Pattern,Intraductal Cribriform Breast Adenocarcinoma,1
15391,Nodular Pattern,Grade 3a Follicular Lymphoma,1
15392,Fascicles of Spindly Tumor Cells Present,Tanycytic ependymoma,1
15393,Epithelial Component Present,"Transitional cell papilloma, benign",1
15394,Epithelial Component Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
15395,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity refractory,1
15396,Low Mitotic Activity,Advanced Pancreatic Neuroendocrine Tumor,1
15397,Intraductal Lesion,Papillary Ductal Breast Hyperplasia,1
15398,Epithelial Component Present,Bladder adenocarcinoma stage II,1
15399,CD30-Positive Neoplastic Cells Present,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",1
15400,Malignant Cellular Infiltrate,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia,1
15401,Secondary Lesion,Adenocarcinoma of Unknown Primary,1
15402,Indolent Clinical Course,Cellular fibroma,1
15403,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
15404,Malignant Cellular Infiltrate,Stage IIIC Uveal Melanoma AJCC v7,1
15405,Malignant Cellular Infiltrate,Proximal-Type Epithelioid Sarcoma,1
15406,Malignant Cellular Infiltrate,Stage III Esophageal Cancer AJCC v7,1
15407,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged,1
15408,Epithelial Component Present,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
15409,Carcinomatous Component Present,"Transitional cell carcinoma, micropapillary",1
15410,Epithelial Component Present,Ovarian Sertoli Cell Tumor,1
15411,Severe cytologic atypia,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
15412,Unresectable Mass,Unresectable Thymic Carcinoma,1
15413,Anaplasia,Recurrent Gliosarcoma,1
15414,Vascular Channel Formation,Glomeruloid hemangioma,1
15415,Metastatic Lesion,Metastatic Squamous Cell Carcinoma of the Larynx,1
15416,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Clinical Stage,1
15417,Secondary Lesion,Metastatic Carcinoma in the Adrenal Medulla,1
15418,Malignant Cellular Infiltrate,Stage IVA Hilar Cholangiocarcinoma AJCC v8,1
15419,Recurrent disease,Recurrent Desmoplastic Small Round Cell Tumor,1
15420,Pregnancy Complications,Hypertension associated disorders of pregnancy,1
15421,Childhood Lesion,Childhood Testicular Immature Teratoma,1
15422,Myxoid Stroma Formation,Right atrial myxoma,1
15423,Somatostatin Positive Neoplastic Cells Present,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
15424,More than 10 Mitoses per 10HPF,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
15425,Benign Cellular Infiltrate,Syringocystadenoma Papilliferum,1
15426,Carcinomatous Component Present,Stage IA Merkel Cell Carcinoma AJCC v7,1
15427,Slow Growing Mass,Cerebral Hemangioblastoma,1
15428,Papillary Pattern,Vaginal Papillary Carcinoma,1
15429,Benign Cellular Infiltrate,Sellar Mature Teratoma,1
15430,Epithelial Component Present,Stage IVC Lip and Oral Cavity Cancer AJCC v8,1
15431,Childhood Lesion,Recurrent Childhood Hepatocellular Carcinoma,1
15432,Secondary Lesion,Locally Advanced Bile Duct Carcinoma,1
15433,Cutaneous Involvement,Junctional Epidermolysis Bullosa,1
15434,Intraocular Lesion,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
15435,Malignant Cellular Infiltrate,Stage IV Renal Cell Cancer,1
15436,Malignant Cellular Infiltrate,Myeloid or lymphoid neoplasm with alpha-type platelet-derived growth factor receptor gene rearrangement,1
15437,Thick-Walled Hyalinized Vessels Present,Conventional Schwannoma,1
15438,Non-Hereditary Lesion,Gastric Intestinal-Type Adenocarcinoma,1
15439,Malignant Cellular Infiltrate,FIGO Stage IC1 Ovarian Cancer,1
15440,Regional Disease,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
15441,Malignant Cellular Infiltrate,Advanced Oral Cavity Squamous Cell Carcinoma,1
15442,Malignant Germinomatous Cellular Infiltrate,Testicular Spermatocytic Seminoma with Sarcoma,1
15443,Systemic disease,Primary Systemic Amyloidosis,1
15444,Extensive Stage Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma,1
15445,Absence of a Hormonal Syndrome,Pituitary Gland Oncocytic Adenoma,1
15446,Cutaneous Involvement,Contact dermatitis due to acid,1
15447,Well-Circumscribed Lesion,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
15448,Malignant Cellular Infiltrate,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
15449,VIP Positive Neoplastic Cells Present,Malignant Pancreatic Vipoma,1
15450,Epithelial Component Present,Adenoma of rete ovarii,1
15451,Epithelial Component Present,Benign Apocrine Neoplasm,1
15452,Benign Cellular Infiltrate,Benign neoplasm of thyroid gland,1
15453,Epithelial Component Present,Benign neuroendocrine tumor,1
15454,High Grade Lesion,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
15455,Recurrent disease,Recurrent Lip Basal Cell Carcinoma,1
15456,Indolent Clinical Course,Genital rhabdomyoma,1
15457,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
15458,Chromogranin A Positive Neoplastic Cells Present,Colorectal Neuroendocrine Tumor G1,1
15459,Benign Cellular Infiltrate,Spinal Cord Neurofibroma,1
15460,Indolent Clinical Course,Vaginal Myofibroblastoma,1
15461,"Undifferentiated ""Fetal-Type"" Tissues Present",Immature Ovarian Teratoma,1
15462,Adnexal Differentiation,"Carcinoma, Skin Appendage",1
15463,Follicular Cell Differentiation,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",1
15464,Epithelial Component Present,Thymoma,1
15465,Malignant Cellular Infiltrate,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes",1
15466,Malignant Cellular Infiltrate,Stage IV Adrenal Cortex Carcinoma AJCC v8,1
15467,Cutaneous Involvement,Clinical Stage III Cutaneous Melanoma AJCC v8,1
15468,Malignant Cellular Infiltrate,Stage IA Esophageal Adenocarcinoma AJCC v7,1
15469,Well Differentiated Lesion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
15470,Malignant Cellular Infiltrate,Prognostic Stage I Breast Cancer AJCC v8,1
15471,Malignant Cellular Infiltrate,Malignant Vulvar Sweat Gland Neoplasm,1
15472,Epithelial Component Present,"Testicular Sertoli Cell Tumor, Lipid Rich Variant",1
15473,Cutaneous Involvement,Skin Squamous Cell Carcinoma In Situ,1
15474,Malignant Cellular Infiltrate,Vulvar Alveolar Soft Part Sarcoma,1
15475,Primary Lesion,Recurrent Primary Vitreoretinal Lymphoma,1
15476,Collagenous Stroma Formation,Sclerosing PEComa,1
15477,Epithelial Component Present,Uterine Ligament Serous Adenocarcinoma,1
15478,Infiltrative Growth Pattern,Adult Glioblastoma,1
15479,Recurrent disease,Esophageal carcinoma recurrent,1
15480,Edematous Stroma Formation,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
15481,Epithelial Component Present,Carcinoma duodenum resectable,1
15482,Non-Invasive Lesion,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
15483,Epithelial Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v7,1
15484,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Ligament Endometrioid Adenocarcinoma,1
15485,Multicentric Lesion,Multicentric Breast Carcinoma,1
15486,Malignant Cellular Infiltrate,Recurrent Follicular Lymphoma,1
15487,atypia morphology,Borderline Uterine Ligament Neoplasm,1
15488,Malignant Cellular Infiltrate,Stage II Lip and Oral Cavity Cancer AJCC v8,1
15489,Benign Cellular Infiltrate,Mucous Membrane Hemangioma,1
15490,Secondary Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
15491,Mixture of Germ Cell Neoplastic Components Present,Teratocarcinoma,1
15492,Malignant Cellular Infiltrate,Vagina Carcinoma,1
15493,Carcinomatous Component Present,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma,1
15494,Cutaneous Involvement,Stage I Merkel Cell Carcinoma AJCC v7,1
15495,Malignant Cellular Infiltrate,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
15496,Benign Cellular Infiltrate,Benign neoplasm of sebaceous gland,1
15497,Malignant Cellular Infiltrate,Stage IIIA Ampulla of Vater Cancer AJCC v8,1
15498,Malignant Cellular Infiltrate,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,1
15499,Well Differentiated Neuroendocrine Lesion,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
15500,Malignant Cellular Infiltrate,Refractory Transformed B-cell Non-Hodgkin Lymphoma,1
15501,Epithelial Component Present,Common wart,1
15502,Papillary Pattern,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
15503,Epithelial Component Present,Childhood Choroid Plexus Carcinoma,1
15504,Epithelial Component Present,Recurrent Parathyroid Gland Carcinoma,1
15505,Childhood Lesion,Recurrent Childhood Central Nervous System Embryonal Neoplasm,1
15506,Cartilaginous Differentiation,Solitary Osteochondroma,1
15507,Malignant Cellular Infiltrate,Distantly Metastatic Malignant Neoplasm,1
15508,Papillary Pattern,Urethral Urothelial Papilloma,1
15509,Epithelial Component Present,Skin Clear Cell Basal Cell Carcinoma,1
15510,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage I,1
15511,Malignant Cellular Infiltrate,Advanced Melanoma,1
15512,Malignant Cellular Infiltrate,Soft Palate Squamous Cell Carcinoma,1
15513,Cutaneous Involvement,Granuloma annulare aggravated,1
15514,Solid Growth Pattern,solid type ductal carcinoma in situ of breast,1
15515,Adulthood Lesion,Non-Hodgkin Lymphoma During Pregnancy,1
15516,Malignant Cellular Infiltrate,Stage III Ovarian Germ Cell Tumor AJCC v6 and v7,1
15517,Malignant Cellular Infiltrate,"Polycythemia Vera, Polycythemic Phase",1
15518,Vascular Channel Formation,"Neoplasms, Vascular Tissue",1
15519,Oligodendroglial Component Present,Childhood Anaplastic Oligoastrocytoma,1
15520,Indolent Clinical Course,Spindle cell hemangioma,1
15521,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Alkylating Agent-Related Acute Myeloid Leukemia,1
15522,Hyperkeratosis,papillary squamous cell carcinoma of larynx,1
15523,Epithelial Component Present,Ureter Carcinoma,1
15524,Malignant Cellular Infiltrate,Cardiac Monophasic Synovial Sarcoma,1
15525,Epithelial Component Present,Recurrent Childhood Hepatocellular Carcinoma,1
15526,Indolent Clinical Course,Benign Cutaneous Vascular Neoplasm,1
15527,Carcinomatous Component Present,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
15528,Carcinomatous Component Present,Adenocarcinoma with neuroendocrine differentiation,1
15529,Malignant Cellular Infiltrate,Gastrointestinal melanoma,1
15530,Nuclear Molding,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
15531,Exophytic Polypoid Lesion,Colorectal Tubulovillous Adenoma,1
15532,Malignant Cellular Infiltrate,Type 1 Papillary Renal Cell Carcinoma,1
15533,Angiocentric Pattern,Recurrent Lymphomatoid Granulomatosis,1
15534,Ground Glass Nuclear Inclusion,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
15535,Malignant Cellular Infiltrate,Recurrent Acute Megakaryoblastic Leukemia,1
15536,Anaplasia,Fibroblastic osteosarcoma,1
15537,Chromogranin A Positive Neoplastic Cells Present,Foregut Carcinoid Tumor,1
15538,Recurrent disease,Colon cancer recurrent,1
15539,Diffuse Pattern,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
15540,Carcinomatous Component Present,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8,1
15541,Malignant Cellular Infiltrate,Postsurgical Stage I Hepatoblastoma,1
15542,Unilineage Dysplasia Present,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
15543,Benign Cellular Infiltrate,Colon Leiomyoma,1
15544,Epithelial Component Present,Metastatic Well Differentiated Neuroendocrine Neoplasm,1
15545,Anaplasia,Recurrent Childhood Gliosarcoma,1
15546,Malignant Cellular Infiltrate,Stage I Malignant Mediastinal Germ Cell Tumor,1
15547,Multilocular Lesion,Childhood Multilocular Cystic Renal Neoplasm,1
15548,Malignant Cellular Infiltrate,Malignant neoplasm of nasopharynx,1
15549,Resectable Mass,Resectable Extrahepatic Bile Duct Adenocarcinoma,1
15550,Epithelial Component Present,Stage I Vulvar Cancer AJCC v8,1
15551,Childhood Lesion,Stage III Childhood Hepatocellular Carcinoma AJCC v7,1
15552,Pathologic TNM Finding,Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8,1
15553,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage,1
15554,Anaplasia,Stage III Childhood Anaplastic Large Cell Lymphoma,1
15555,Cutaneous Involvement,Urticaria,1
15556,Massive Sinusoidal Histiocytic Infiltrate,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,1
15557,Malignant Cellular Infiltrate,Gestational choriocarcinoma,1
15558,Malignant Cellular Infiltrate,Temporal Lobe Anaplastic Astrocytoma,1
15559,Epithelial Component Present,Non-small cell lung cancer stage III,1
15560,Epithelial Component Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
15561,Cribriform Pattern,Rectal Cribriform Comedo-Type Adenocarcinoma,1
15562,Nuclear Atypia,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation,1
15563,Malignant Cellular Infiltrate,Non-Small Cell Adenocarcinoma,1
15564,Unresectable Mass,Localized Unresectable Neuroblastoma,1
15565,Solid Growth Pattern,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
15566,Benign Cellular Infiltrate,Dermoid cyst of skin,1
15567,Invasive Lesion,Infiltrating angiolipoma,1
15568,Malignant Cellular Infiltrate,Testicular Follicular Lymphoma,1
15569,Carcinomatous Component Present,Stage IVB Oral Cavity Cancer AJCC v6 and v7,1
15570,Necrotic changes (finding),Small cell carcinoma of lung,1
15571,Malignant Cellular Infiltrate,Sarcoma by NCI Grade,1
15572,Epithelial Component Present,Bartholin Gland Squamous Cell Carcinoma,1
15573,Nodular lesions,Giant Cell Tumor of Soft Tissue,1
15574,Secondary Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma,1
15575,Cutaneous Involvement,Tumor of dermis,1
15576,Multinodular Mass,Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor),1
15577,Single Cell Necrosis,Recurrent Merkel Cell Carcinoma,1
15578,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage I,1
15579,Carcinomatous Component Present,Clinical Stage II Gastric Cancer AJCC v8,1
15580,Cutaneous Involvement,Senile nevus,1
15581,Pleural effusion disorder,Pulmonary lymphangioleiomyomatosis,1
15582,Malignant Cellular Infiltrate,Plasma Cell Post-Transplant Lymphoproliferative Disorder,1
15583,Epithelial Component Present,Pathologic Stage IB Gastric Cancer AJCC v8,1
15584,Mesenchymal Component Present,Perineal Ectopic Fibroadenoma,1
15585,Recurrent Genetic Abnormalities Present,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,1
15586,Crystal deposition,Cervical Alveolar Soft Part Sarcoma,1
15587,Malignant Cellular Infiltrate,Grade 2 Endometrial Endometrioid Adenocarcinoma,1
15588,Carcinomatous Component Present,Lower Gingival Verrucous Carcinoma,1
15589,Epithelial Component Present,Bile duct clear cell adenocarcinoma,1
15590,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage III,1
15591,Refractory Disease,Refractory Hepatoblastoma,1
15592,Intracytoplasmic Eosinophilic Inclusion,Rhabdoid Tumor,1
15593,Hyalinized Stroma Formation,Nodular tenosynovitis,1
15594,Primary Lesion,Recurrent Glioblastoma,1
15595,Carcinomatous Component Present,Sublingual Gland Adenocarcinoma,1
15596,Local disease,Localized Digestive System Neuroendocrine Tumor G1,1
15597,Epithelial Component Present,Paget disease of anal canal,1
15598,Malignant Cellular Infiltrate,Stage IV Ampulla of Vater Cancer AJCC v7,1
15599,Malignant Cellular Infiltrate,Stage II Kidney Wilms Tumor,1
15600,Malignant Cellular Infiltrate,Stage IVB Hilar Cholangiocarcinoma AJCC v7,1
15601,Myxoid Stroma Formation,Myxoma,1
15602,Immunoglobulin Heavy Chain Deposition,Heavy Chain Deposition Disease,1
15603,Epithelial Component Present,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,1
15604,Melanosomes Present,Melanotic malignant nerve sheath tumor,1
15605,Malignant Cellular Infiltrate,FIGO Stage IIIC Ovarian Cancer,1
15606,Tissue Differentiation Uncertain,Epithelioid sarcoma recurrent,1
15607,Malignant Cellular Infiltrate,Large cell carcinoma with rhabdoid phenotype,1
15608,Epithelial Component Present,Fallopian Tube Gestational Choriocarcinoma,1
15609,High Grade Lesion,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
15610,Malignant Cellular Infiltrate,Bronchioloalveolar Adenocarcinoma,1
15611,Secondary Lesion,Metastatic Malignant Genitourinary System Neoplasm,1
15612,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
15613,Malignant Cellular Infiltrate,Stage IV Hilar Cholangiocarcinoma AJCC v8,1
15614,Metastatic Lesion,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
15615,Malignant Cellular Infiltrate,Stage III Esophageal Squamous Cell Carcinoma AJCC v7,1
15616,Hereditary Lesion,Rhabdoid tumor predisposition syndrome,1
15617,Malignant Cellular Infiltrate,Squamous cell carcinoma in situ with questionable stromal invasion,1
15618,Malignant Cellular Infiltrate,Colorectal Signet Ring Cell Carcinoma,1
15619,Epithelial Component Present,Vulvar Trichoepithelioma,1
15620,Mixed Cellular Population,Adenosarcoma,1
15621,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,MYELODYSPLASTIC SYNDROME,1
15622,Malignant Cellular Infiltrate,Kaposi's sarcoma of cornea,1
15623,Benign Cellular Infiltrate,Mature Gastric Teratoma,1
15624,Epithelial Component Present,Metastatic Gastric Carcinoma,1
15625,Rapidly Enlarging Mass,rhabdomyosarcoma of mediastinum,1
15626,Neuroendocrine Differentiation,Benign neuroendocrine tumor,1
15627,Epithelial Component Present,Malignant Paraganglionic Neoplasm,1
15628,Malignant Cellular Infiltrate,Proximal Urethral Carcinoma,1
15629,Benign Cellular Infiltrate,Verrucous keratotic hemangioma,1
15630,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Ovarian Immature Teratoma,1
15631,Carcinomatous Component Present,Lung squamous cell carcinoma stage III,1
15632,Carcinomatous Component Present,Salivary duct carcinoma,1
15633,Endophytic Tumor Growth,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
15634,Epithelial Component Present,Rectosigmoid cancer,1
15635,Malignant Cellular Infiltrate,Localized Gastroesophageal Junction Adenocarcinoma,1
15636,Well-Circumscribed Lesion,Rectal hyperplastic polyp,1
15637,Malignant Cellular Infiltrate,Malignant Lung and Pleural Neoplasm,1
15638,Complex Glandular Pattern,Cervical Atypical Polypoid Adenomyoma,1
15639,Diffuse Lesion,Diffuse Intrinsic Pontine Glioma,1
15640,Carcinomatous Component Present,Stage IV Intrahepatic Bile Duct Cancer AJCC v8,1
15641,Low Grade Lesion,Tibial adamantinoma,1
15642,Carcinomatous Component Present,Hereditary Diffuse Gastric Adenocarcinoma,1
15643,Epithelial Component Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
15644,Neuroendocrine Differentiation,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
15645,Oligodendroglial Component Present,Oligodendroglial Neoplasm,1
15646,Carcinomatous Component Present,Adenocarcinoma in multiple adenomatous polyps,1
15647,Malignant Cellular Infiltrate,Stage IVB Gallbladder Carcinoma,1
15648,Non-Hereditary Lesion,Vulvar Acquired Melanocytic Nevus,1
15649,Complete Spontaneous Regression,Type D Lymphomatoid Papulosis,1
15650,Epithelial Component Present,Stage II Lung Cancer AJCC v7,1
15651,Malignant Cellular Infiltrate,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
15652,Carcinomatous Component Present,Stage I Anal Cancer AJCC v8,1
15653,Malignant Cellular Infiltrate,Childhood Melanoma,1
15654,Mixed Cellular Population,Intraductal carcinoma and lobular carcinoma in situ,1
15655,Intermediate Grade Neuroendocrine Lesion,malignant gastrinoma of pancreas,1
15656,Low Mitotic Activity,Small Intestinal Gangliocytic Paraganglioma,1
15657,Cystic Change,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,1
15658,Carcinomatous Component Present,Stage IIA Small Intestinal Cancer AJCC v7,1
15659,High Grade Lesion,Cervical Alveolar Soft Part Sarcoma,1
15660,Stromal Invasion,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
15661,Malignant Cellular Infiltrate,Malignant melanoma of choroid,1
15662,Malignant Cellular Infiltrate,"Lymphoma, Mixed-Cell, Follicular",1
15663,Malignant Cellular Infiltrate,Stage I Testicular Cancer AJCC v6 and v7,1
15664,Low Mitotic Activity,Pancreatic Neuroendocrine Tumor G1,1
15665,Malignant Cellular Infiltrate,Stage IC Ovarian Cancer AJCC v6 and v7,1
15666,Epithelial Component Present,Metastatic Oral Cavity Squamous Cell Carcinoma,1
15667,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of submandibular gland,1
15668,Increased Cellularity Present,Kadish Stage B Olfactory Neuroblastoma,1
15669,Epithelial Component Present,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,1
15670,Diffuse Pattern,Bladder Diffuse Clear Cell Adenocarcinoma,1
15671,Papillary Pattern,Papillary adenoma,1
15672,Extraosseous Lesion,Extraskeletal osteosarcoma recurrent,1
15673,Necrotic changes (finding),Thymic Small Cell Carcinoma,1
15674,Carcinomatous Component Present,Mucinous adenocarcinoma gastric,1
15675,Epithelial Component Present,Colorectal Adenoma with Mild Dysplasia,1
15676,Tissue Differentiation Uncertain,Pericardial Synovial Sarcoma,1
15677,Epithelial Component Present,Ovarian Microcystic Stromal Tumor,1
15678,Carcinomatous Component Present,Oral Cavity Carcinoma,1
15679,Malignant Cellular Infiltrate,Stage I Prostate Cancer AJCC v8,1
15680,Malignant Cellular Infiltrate,Metastatic Digestive System Carcinoma,1
15681,Cystic Change,Benign mixed epithelial and stromal tumor of kidney,1
15682,In Situ Lesion,Carcinoma in situ of cecum,1
15683,Nuclear Clearing,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
15684,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Childhood Acute Monoblastic and Monocytic Leukemia,1
15685,Carcinomatous Component Present,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
15686,Malignant Cellular Infiltrate,Cardiac Extraskeletal Osteosarcoma,1
15687,Malignant Cellular Infiltrate,undifferentiated carcinoma of pancreas,1
15688,Epithelial Component Present,Recurrent Parotid Gland Acinic Cell Carcinoma,1
15689,Cystic Change,Cystic basal cell carcinoma,1
15690,Childhood Lesion,Classic Congenital Mesoblastic Nephroma,1
15691,Recurrent disease,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder,1
15692,Carcinomatous Component Present,Appendix Carcinoma by AJCC v8 Stage,1
15693,Recurrent disease,Pancreatic carcinoma recurrent,1
15694,Poorly Differentiated Lesion,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
15695,Malignant Cellular Infiltrate,ISS Stage I Plasma Cell Myeloma,1
15696,Adnexal Differentiation,Clear cell hidradenoma,1
15697,Recurrent disease,Recurrent Ependymal Tumor,1
15698,Neuroendocrine Differentiation,Familial Adrenal Gland Pheochromocytoma,1
15699,Carcinomatous Component Present,Stage III Cervical Cancer AJCC v8,1
15700,Adulthood Lesion,BCLC Stage B Adult Hepatocellular Carcinoma,1
15701,Epithelial Component Present,Stage 0is Ureter Cancer AJCC v7,1
15702,Fibrosis,Breast Sclerosing Adenosis,1
15703,Malignant Cellular Infiltrate,"Papillary transitional cell carcinoma, non-invasive",1
15704,Metastatic Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,1
15705,Malignant Cellular Infiltrate,Squamous cell carcinoma of buccal mucosa,1
15706,Low Cellularity Present,Childhood Protoplasmic Astrocytoma,1
15707,Malignant Cellular Infiltrate,Adult Meningeal Melanoma,1
15708,Neuroendocrine Differentiation,Benign Carotid Body Paraganglioma,1
15709,Hemorrhagic,Colorectal Angiosarcoma,1
15710,Carcinomatous Component Present,Schneiderian carcinoma,1
15711,Carcinomatous Component Present,AIDS-Related Anal Canal Carcinoma,1
15712,Malignant Cellular Infiltrate,MiT Family Translocation-Associated Renal Cell Carcinoma,1
15713,Perineural spread,Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
15714,Cutaneous Involvement,Basal cell carcinoma - adamantinoid,1
15715,High Mitotic Activity,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
15716,Perineural spread,adenoid cystic carcinoma of lung,1
15717,Poorly Differentiated Neuroendocrine Lesion,Anal Canal Small Cell Neuroendocrine Carcinoma,1
15718,Malignant Cellular Infiltrate,Stage IIC Appendix Carcinoma AJCC v8,1
15719,Malignant Cellular Infiltrate,"Thymoma, type B3",1
15720,Carcinomatous Component Present,"Adenocarcinoma, Tubular",1
15721,Malignant Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
15722,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute Basophilic Leukemia,1
15723,Antoni A Pattern,Thyroid Gland Schwannoma,1
15724,Metastatic Lesion,Small intestine adenocarcinoma metastatic NOS,1
15725,Biphasic Pattern,Atypical polypoid adenomyoma,1
15726,Malignant Cellular Infiltrate,Intracortical osteosarcoma,1
15727,Malignant Cellular Infiltrate,Stage IIIC1 Uterine Corpus Cancer AJCC v7,1
15728,Multilocular Lesion,Juvenile Type Testicular Granulosa Cell Tumor,1
15729,Slow Growing Mass,Kadish Stage C Olfactory Neuroblastoma,1
15730,Fibrotic Stroma Formation,Odontoameloblastoma,1
15731,High Grade Lesion,Small cell lung cancer recurrent,1
15732,Malignant Cellular Infiltrate,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
15733,Malignant Cellular Infiltrate,Stage III Renal Pelvis Cancer AJCC v8,1
15734,Human Papillomavirus Positive,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
15735,Heterologous Elements Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
15736,Sarcomatous Component Present,Advanced Uterine Corpus Carcinosarcoma,1
15737,Metastatic Lesion,Metastatic Urethral Carcinoma,1
15738,Epithelial Component Present,adenoid cystic carcinoma of floor of mouth,1
15739,Epithelial Component Present,Metastatic Gastric Carcinoma,1
15740,Epithelial Component Present,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
15741,Secondary Lesion,Liposarcoma metastatic,1
15742,Neuroendocrine Differentiation,Colon Neuroendocrine Tumor by AJCC v8 Stage,1
15743,High Mitotic Activity,Recurrent Childhood Anaplastic Oligodendroglioma,1
15744,Carcinomatous Component Present,Stage IIA Cervical Cancer AJCC v8,1
15745,Epithelial Component Present,Adult Craniopharyngioma,1
15746,Eccrine Differentiation,Benign Eccrine Neoplasm,1
15747,Benign Cellular Infiltrate,Spindle cell hemangioma,1
15748,Refractory Disease,Refractory Malignant Glioma,1
15749,Epithelial Component Present,Ovarian gonadoblastoma,1
15750,Indolent Clinical Course,Cardiac Capillary Hemangioma,1
15751,Malignant Cellular Infiltrate,Papillary Renal Cell Carcinoma,1
15752,Capillary Sized Vascular Channel Formation,Infantile hemangioma,1
15753,Cutaneous Involvement,Benign Pilar-Associated Mesenchyme Neoplasm,1
15754,Locally Aggressive Lesion,Giant Cell Tumor of Bone,1
15755,Malignant Cellular Infiltrate,Recurrent Urethral Cancer,1
15756,Malignant Cellular Infiltrate,Primary hepatic neuroendocrine carcinoma,1
15757,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma recurrent,1
15758,Mild dysplasia,Low Grade Squamous Intraepithelial Neoplasia,1
15759,Malignant Cellular Infiltrate,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
15760,Epithelial Component Present,High Grade Salivary Gland Carcinoma,1
15761,Malignant Cellular Infiltrate,High Grade Ductal Breast Carcinoma In Situ,1
15762,Carcinomatous Component Present,Adenosquamous carcinoma,1
15763,Malignant Cellular Infiltrate,Childhood Thyroid Gland Medullary Carcinoma,1
15764,Secondary Lesion,Metastatic Malignant Neoplasm in the Sellar Region,1
15765,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
15766,Carcinomatous Component Present,Stage IVA Laryngeal Cancer AJCC v7,1
15767,Epithelial Component Present,Oropharyngeal squamous cell carcinoma recurrent,1
15768,Epithelial Component Present,Stage IB2 Cervical Cancer AJCC v8,1
15769,Ineffective hematopoiesis,Myelodysplastic Syndrome with Isolated del(5q),1
15770,Epithelial Component Present,Metastatic Carcinoma in the Adrenal Medulla,1
15771,Slow Growing Mass,Venous Angioleiomyoma,1
15772,Refractory Disease,Refractory Bile Duct Carcinoma,1
15773,Increased Cellularity Present,Metanephric adenoma,1
15774,Malignant Cellular Infiltrate,Adult Pleomorphic Rhabdomyosarcoma,1
15775,Cystic Change,Laryngeal Mucoepidermoid Carcinoma,1
15776,Hyperkeratosis,Laryngeal verrucous carcinoma,1
15777,Poorly Differentiated Neuroendocrine Lesion,Digestive System Large Cell Neuroendocrine Carcinoma,1
15778,Malignant Cellular Infiltrate,Fallopian Tube Mucinous Adenocarcinoma,1
15779,Epithelial Component Present,Pathologic Stage 0 Gastric Cancer AJCC v8,1
15780,Indolent Clinical Course,Hobnail Hemangioma,1
15781,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Signet Ring Variant",1
15782,Malignant Cellular Infiltrate,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
15783,Sebaceous Differentiation,Vulvar Sebaceous Carcinoma,1
15784,Non-Specific Glandular Pattern,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",1
15785,Epithelial Component Present,Ampulla of Vater Hepatoid Adenocarcinoma,1
15786,Benign Cellular Infiltrate,Vulvar Leiomyoma,1
15787,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
15788,Benign Cellular Infiltrate,Benign neoplasm of breast,1
15789,Epithelial Component Present,Lepidic Predominant Adenocarcinoma,1
15790,Tissue Differentiation Uncertain,Cardiac Biphasic Synovial Sarcoma,1
15791,Low Grade Lesion,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,1
15792,Cutaneous Involvement,Ancell-Spiegler cylindromas,1
15793,Primary Lesion,Bone Surface (Peripheral) Osteosarcoma,1
15794,Cutaneous Involvement,Stage IIIB Cutaneous Melanoma AJCC v7,1
15795,Malignant Cellular Infiltrate,Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage,1
15796,Carcinomatous Component Present,Stage III Lip and Oral Cavity Cancer AJCC v6 and v7,1
15797,Mesenchymal Component Present,Pleomorphic adenoma of parotid gland,1
15798,Single Cell Necrosis,Merkel cell carcinoma,1
15799,Neuroendocrine Differentiation,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
15800,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7,1
15801,Fibrotic Stroma Formation,Cystadenofibroma,1
15802,Carcinomatous Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck,1
15803,Neuronal Differentiation,Ganglioneuroma,1
15804,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,1
15805,Cutaneous Involvement,"Skin Diseases, Bacterial",1
15806,Epithelial Component Present,Major Salivary Gland Adenoid Cystic Carcinoma,1
15807,Well-Circumscribed Lesion,Cellular angiofibroma,1
15808,Indolent Clinical Course,Pleomorphic Lipoma,1
15809,Epithelial Component Present,Stage IVA Basal Cell Lip Carcinoma,1
15810,Rapidly Enlarging Mass,Rhabdomyosarcoma,1
15811,Adulthood Lesion,Adult Pleomorphic Rhabdomyosarcoma,1
15812,Exophytic Polypoid Lesion,Polyp of esophagus,1
15813,Childhood Lesion,Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8,1
15814,Locally Aggressive Lesion,Plexiform fibrohistiocytic tumor,1
15815,Cutaneous Involvement,Pathologic Stage IIIB Cutaneous Melanoma AJCC v8,1
15816,Carcinomatous Component Present,Stage IIA Prostate Cancer AJCC v7,1
15817,Malignant Cellular Infiltrate,Early Hepatocellular Carcinoma,1
15818,Epithelial Component Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8,1
15819,Epithelial Component Present,Childhood Choroid Plexus Carcinoma,1
15820,Malignant Cellular Infiltrate,Biochemically Recurrent Prostate Carcinoma,1
15821,Malignant Cellular Infiltrate,Localized Resectable Adult Hepatocellular Carcinoma,1
15822,Epithelial Component Present,Stage III Urethral Cancer AJCC v7,1
15823,Vascular Channel Formation,Aortic Angiosarcoma,1
15824,No Identifiable Line of Differentiation,Unresectable Undifferentiated Pleomorphic Sarcoma,1
15825,Mixed Cellular Population,Juvenile fibroadenoma of breast,1
15826,Cystic Change,Polycystic liver disease,1
15827,Nuclear Molding,Refractory Extensive Stage Lung Small Cell Carcinoma,1
15828,Severe dysplasia,Anal Intraepithelial Neoplasia 3,1
15829,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,1
15830,Carcinomatous Component Present,Bartholin Gland Small Cell Carcinoma,1
15831,Local disease,Lung Myolipoma,1
15832,Malignant Cellular Infiltrate,Anatomic Stage IIB Breast Cancer AJCC v8,1
15833,Well-Circumscribed Lesion,tubular adenoma of extrahepatic bile duct,1
15834,Epithelial Component Present,Breast adenoma,1
15835,Congenital Lesion,Congenital anomaly of eyelid,1
15836,Exophytic Polypoid Lesion,tubulopapillary adenoma of extrahepatic bile duct,1
15837,Malignant Cellular Infiltrate,Lymphoma by Site,1
15838,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Childhood Myelodysplastic Syndrome,1
15839,Stromal Invasion,Ovarian mixed epithelial carcinoma,1
15840,Carcinomatous Component Present,Adenocarcinoma in adenomatous polyp,1
15841,Epithelial Component Present,Opisthorchis Viverrini-Related Cholangiocarcinoma,1
15842,Mixed Cellular Population,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,1
15843,Diffuse Pattern,Childhood Diffuse Large B-Cell Lymphoma,1
15844,Cutaneous Involvement,Anal margin basal cell carcinoma,1
15845,Malignant Cellular Infiltrate,Unresectable Adrenal Cortex Carcinoma,1
15846,Metastatic/Recurrent Disease,Distal-Type Epithelioid Sarcoma,1
15847,Carcinomatous Component Present,Metastatic Colorectal Carcinoma,1
15848,Epithelial Component Present,Stage IV Paranasal Sinus Cancer AJCC v7,1
15849,Refractory Disease,Refractory Digestive System Neuroendocrine Neoplasm,1
15850,Vascular Channel Formation,Lymphangioma circumscriptum,1
15851,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Pure Erythroid Leukemia,1
15852,Borderline Lesion,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,1
15853,Metastatic Lesion,Secondary malignant neoplasm of female breast,1
15854,Cutaneous Involvement,basal cell carcinoma of scrotum,1
15855,Vascular Channel Formation,Gastric Hemangioma,1
15856,Diffuse Pattern,Bladder Diffuse Clear Cell Adenocarcinoma,1
15857,Epithelial Component Present,Stage IB Esophageal Adenocarcinoma AJCC v7,1
15858,Malignant Cellular Infiltrate,sarcoma of mediastinum,1
15859,Submucosal Lesion,Submucosal Invasive Colon Adenocarcinoma,1
15860,Malignant Cellular Infiltrate,Ph-Like Acute Lymphoblastic Leukemia,1
15861,Epithelial Component Present,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
15862,Carcinomatous Component Present,Carcinoma of supraglottis,1
15863,Benign Cellular Infiltrate,Papilloma of nasal vestibule,1
15864,Epithelial Component Present,Squamous cell carcinoma of cornea,1
15865,Carcinomatous Component Present,Recurrent Endometrial Mixed Cell Adenocarcinoma,1
15866,Epithelial Component Present,Non-small cell lung cancer stage IIIA,1
15867,Malignant Cellular Infiltrate,Parathyroid Gland Adenocarcinoma,1
15868,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Apoplectic Leiomyoma,1
15869,Mixed Cellular Population,Uterine Corpus Adenosarcoma,1
15870,Low Cellularity Present,Desmoplastic fibroblastoma,1
15871,Alternative Fascicle (Bundle) Pattern,Uterine Fibroids,1
15872,Epithelial Component Present,Locally Advanced Prostate Carcinoma,1
15873,Dysplasia,Vulvar Dysplastic Melanocytic Nevus,1
15874,Malignant Cellular Infiltrate,Cellular Congenital Mesoblastic Nephroma,1
15875,Malignant Cellular Infiltrate,Laryngeal verrucous carcinoma,1
15876,Carcinomatous Component Present,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
15877,Well-Circumscribed Lesion,Appendix Mucinous Cystadenoma,1
15878,Neuroendocrine Differentiation,'Refractory Paraganglioma',1
15879,In Situ Lesion,Gastric Antrum Carcinoma In Situ AJCC v6 and v7,1
15880,Biphasic Pattern,Intracanalicular fibroadenoma,1
15881,Epithelial Component Present,High Grade Esophageal Glandular Intraepithelial Neoplasia,1
15882,Neuroectodermal Differentiation,Central Nervous System Ganglioneuroblastoma,1
15883,Eccrine Differentiation,Syringofibroadenoma,1
15884,Follicular Cell Differentiation,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
15885,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes,1
15886,Immunologic Deficiency Syndromes,Autoimmune Lymphoproliferative Syndrome-Associated Lymphoma,1
15887,Adulthood Lesion,BCLC Stage B Adult Hepatocellular Carcinoma,1
15888,Chronic Inflammatory Infiltrate,benign fibrous histiocytoma of bone,1
15889,Nodular Pattern,Myxoid liposarcoma metastatic,1
15890,Benign Cellular Infiltrate,Rete Ovarii Cystadenoma,1
15891,Indolent Clinical Course,Vaginal Rhabdomyoma,1
15892,Lymphoplasmacytic Infiltrate,Lung Lymphoepithelioma-Like Carcinoma,1
15893,Invasive Lesion,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",1
15894,Epithelial Component Present,Locally Advanced Unresectable Carcinoma,1
15895,Malignant Cellular Infiltrate,Secondary malignant neoplasm of vertebral column,1
15896,Malignant Cellular Infiltrate,Stage IA Pancreatic Cancer AJCC v8,1
15897,Neuroendocrine Differentiation,Colon Neuroendocrine Tumor G1,1
15898,Carcinomatous Component Present,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
15899,Indolent Clinical Course,Leiomyoma of small intestine,1
15900,Recurrent disease,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,1
15901,Epithelial Component Present,Benign Ovarian Thecoma,1
15902,Epithelial Component Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34),1
15903,Cartilaginous Differentiation,Dedifferentiated chondrosarcoma,1
15904,Malignant Cellular Infiltrate,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8,1
15905,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
15906,Malignant Cellular Infiltrate,Grade I Chondrosarcoma,1
15907,Hyaline Cartilage Differentiation,Mediastinal Chondroma,1
15908,Diffuse Pattern,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
15909,Carcinomatous Component Present,Undifferentiated Fallopian Tube Carcinoma,1
15910,Diffuse Cellular Infiltrate,Sporadic Diffuse Gastric Adenocarcinoma,1
15911,Cutaneous Involvement,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,1
15912,Tissue Differentiation Uncertain,Intramuscular Myxoma,1
15913,"Fully Differentiated ""Adult-Type"" Tissues Present",Ovarian Solid Teratoma,1
15914,Rapidly Enlarging Mass,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
15915,Childhood Lesion,Hydroa vacciniforme-like lymphoma,1
15916,Well-Circumscribed Lesion,Compact Cell Adrenal Cortical Adenoma,1
15917,Metastatic/Recurrent Disease,Adult Desmoplastic Small Round Cell Tumor,1
15918,Cauliflower-Like Mass,Childhood Choroid Plexus Papilloma,1
15919,Primary Lesion,"lymphomatoid papulosis, type C",1
15920,Malignant Cellular Infiltrate,Invasive Malignant Neoplasm,1
15921,Hyperplastic Tissue Present,Diffuse hyperplasia,1
15922,Malignant Cellular Infiltrate,Opisthorchis Viverrini-Related Cholangiocarcinoma,1
15923,Metastatic/Recurrent Disease,Epithelioid sarcoma non-metastatic,1
15924,Glandular Pattern,Pancreatic Somatostatinoma,1
15925,Epithelial Component Present,Gastric Cardia Carcinoma,1
15926,Malignant Cellular Infiltrate,Stage IA Lung Adenocarcinoma AJCC v7,1
15927,Infiltrative Growth Pattern,Recurrent Desmoid-Type Fibromatosis,1
15928,Poorly Differentiated Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
15929,Adulthood Lesion,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
15930,Malignant Cellular Infiltrate,Refractory High Risk Myelodysplastic Syndrome,1
15931,Malignant Cellular Infiltrate,Malignant neoplasm of glottis,1
15932,Malignant Cellular Infiltrate,mucinous adenocarcinoma of ovary,1
15933,Lesion with Diameter of 10mm or Less,Non-Functioning Pituitary Gland Microadenoma,1
15934,Diffuse Pattern,"Diffuse Astrocytoma, IDH-Wildtype",1
15935,Regional Disease,Locally Advanced Unresectable Malignant Neoplasm,1
15936,Malignant Cellular Infiltrate,Stage I Adult Burkitt Lymphoma,1
15937,Adulthood Lesion,Stage IV Adult Immunoblastic Lymphoma,1
15938,Childhood Lesion,Childhood Testicular Immature Teratoma,1
15939,Benign Cellular Infiltrate,Central Nervous System Angiolipoma,1
15940,Malignant Cellular Infiltrate,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,1
15941,Epithelial Component Present,Oropharyngeal squamous cell carcinoma recurrent,1
15942,Invasive Lesion,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,1
15943,Mild dysplasia,Cervical intraepithelial neoplasia grade 1,1
15944,Adnexal Differentiation,Syringocystadenoma Papilliferum,1
15945,Cutaneous Involvement,Skin disorder arising from mental factors,1
15946,High Mitotic Activity,Childhood Testicular Embryonal Carcinoma,1
15947,Well Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,1
15948,Malignant Cellular Infiltrate,Mesothelioma malignant localized,1
15949,Cutaneous Involvement,Skin Papilloma,1
15950,Glial Differentiation,Childhood Ganglioglioma,1
15951,HMB-45-Positive Neoplastic Cells Present,Lung PEComa,1
15952,Tissue Differentiation Uncertain,Pulmonary lymphangioleiomyomatosis,1
15953,Epithelial Component Present,Childhood Craniopharyngioma,1
15954,Osseous Differentiation,Stage III Osteosarcoma AJCC v7,1
15955,Malignant Cellular Infiltrate,Cervical carcinoma stage II AJCC v7,1
15956,Encapsulated Mass,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
15957,Tartrate Resistant Acid Phosphatase Positive Cells Present,Hairy Cell Leukemia,1
15958,Carcinomatous Component Present,mixed acinar-endocrine carcinoma of pancreas,1
15959,Epithelial Component Present,Anaplastic adrenocortical carcinoma,1
15960,Epithelial Component Present,Transverse Colon Neuroendocrine Tumor G1,1
15961,Nodular Pattern,Adenoameloblastoma,1
15962,Malignant Cellular Infiltrate,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
15963,Fibrovascular Stroma Formation,Fibroepithelioma of Pinkus,1
15964,Absence of Invasion,Stage 0 Lung Cancer AJCC v6 and v7,1
15965,Malignant Cellular Infiltrate,Bladder Cancer by AJCC v7 Stage,1
15966,Malignant Cellular Infiltrate,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
15967,Vascular Channel Formation,Intermediate Blood Vessel Neoplasm,1
15968,Increased Cellularity Present,Childhood Brain Anaplastic Astrocytoma,1
15969,Carcinomatous Component Present,Primary Carcinoma,1
15970,Adnexal Differentiation,Malignant Breast Eccrine Spiradenoma,1
15971,Carcinomatous Component Present,Pancreatic Ductal Adenocarcinoma,1
15972,Oligodendroglial Component Present,Recurrent Childhood Oligodendroglioma,1
15973,Carcinomatous Component Present,Sphenoid Sinus Squamous Cell Carcinoma,1
15974,Indolent Clinical Course,fibroma of testis,1
15975,Epithelial Component Present,Anal Canal Small Cell Neuroendocrine Carcinoma,1
15976,Neuroectodermal Differentiation,Peripheral Ganglioneuroblastoma,1
15977,Carcinomatous Component Present,Stage IIB Gallbladder Cancer AJCC v8,1
15978,Childhood Lesion,Recurrent Childhood Acute Lymphoblastic Leukemia,1
15979,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
15980,Stromal Invasion,Stage IIB Ovarian Cancer AJCC v6 and v7,1
15981,Malignant Cellular Infiltrate,Gallbladder papillary adenocarcinoma,1
15982,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Ovarian Endometrioid Adenofibroma,1
15983,Pushing Tumor Margin,"Phyllodes tumor, benign",1
15984,High Mitotic Activity,Stage IIB Merkel Cell Carcinoma AJCC v7,1
15985,Carcinomatous Component Present,Anal canal squamous cell carcinoma,1
15986,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Dysgerminoma,1
15987,Infiltrative Growth Pattern,Small cell glioblastoma,1
15988,Epithelial Component Present,Central Nervous System Paraganglioma,1
15989,Carcinomatous Component Present,Primary Carcinoma,1
15990,Malignant Cellular Infiltrate,Extra-osseous Ewing's sarcoma non-metastatic,1
15991,Tissue Differentiation Uncertain,Extrarenal Rhabdoid Tumor of the Liver,1
15992,Cutaneous Involvement,Seborrheic keratosis of eyelid,1
15993,Epithelial Component Present,Squamous cell carcinoma of tongue,1
15994,Anaplasia,Recurrent Childhood Giant Cell Glioblastoma,1
15995,Benign Cellular Infiltrate,Uterine Corpus Epithelioid Leiomyoma,1
15996,Stromal Invasion,Malignant Ovarian Surface Epithelial-Stromal Tumor,1
15997,Encapsulated Mass,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
15998,Benign Cellular Infiltrate,Epididymal Papillary Cystadenoma,1
15999,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer AJCC v7,1
16000,Cafe-au-Lait Spots,Recurrent Neurofibromatosis Type 1,1
16001,Malignant Cellular Infiltrate,Chromophobe Renal Cell Carcinoma,1
16002,Presence of a Hormonal Syndrome,Hormone secreting pituitary neoplasms,1
16003,Well Differentiated Lesion,Pleural Well Differentiated Papillary Mesothelioma,1
16004,Cutaneous Involvement,Plantar wart,1
16005,Acinar Proliferation,Breast Sclerosing Adenosis,1
16006,Hyperkeratosis,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
16007,Benign Cellular Infiltrate,Atypical polypoid adenomyoma,1
16008,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8,1
16009,Monomorphic Cellular Infiltrate,Splenic diffuse red pulp small B-cell lymphoma,1
16010,Tissue Differentiation Uncertain,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
16011,Papillary Pattern,Papillomatosis,1
16012,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage I,1
16013,Hyperplastic Tissue Present,Flat Urothelial Hyperplasia,1
16014,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v8,1
16015,Primary Lesion,Lymphoepithelioma-Like Hepatocellular Carcinoma,1
16016,Hereditary Lesion,TUBEROUS SCLEROSIS 1 (disorder),1
16017,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Hydropic Leiomyoma,1
16018,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Squamous Cell Carcinoma,1
16019,Malignant Cellular Infiltrate,Malignant neoplasm of carotid body,1
16020,Glandular Pattern,"Somatostatinoma, malignant",1
16021,Recurrent disease,"Recurrent Medulloblastoma, SHH-Activated",1
16022,'Starry-sky' pattern,Burkitt Lymphoma,1
16023,Angiodestructive Pattern,Recurrent Childhood Lymphomatoid Granulomatosis,1
16024,Exophytic Polypoid Lesion,Juvenile Polyp of the Small Intestine,1
16025,Diffuse Pattern,Fibrillary Astrocytoma,1
16026,Mitotic Activity,Supratentorial Glioblastoma,1
16027,Carcinomatous Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v7,1
16028,Malignant Cellular Infiltrate,Ghost Cell Odontogenic Carcinoma,1
16029,Epithelial Component Present,Cervical Squamous Intraepithelial Neoplasia 1,1
16030,HMB-45-Positive Neoplastic Cells Present,Hepatic Angiomyolipoma,1
16031,Local disease,Hibernoma,1
16032,Primary Lesion,High grade surface osteosarcoma,1
16033,Childhood Lesion,Childhood Brain Glioblastoma,1
16034,Malignant Cellular Infiltrate,Stage IIIb Penile Cancer AJCC v7,1
16035,In Situ Lesion,Carcinoma in situ of middle ear,1
16036,Malignant Cellular Infiltrate,Histiocytic sarcoma,1
16037,Monoclonal Cellular Population Present,Aggressive Systemic Mastocytosis,1
16038,Cord-Like Pattern,Syringoma,1
16039,Fibrosis,Lipomatosis of Nerve,1
16040,Primary Lesion,Adult Primary Melanocytic Lesion of Meninges,1
16041,Mild dysplasia,Vaginal intraepithelial neoplasia grade 1,1
16042,Primary Lesion,Recurrent Combined Thymic Epithelial Neoplasm,1
16043,atypia morphology,Atypical Mesothelial Hyperplasia,1
16044,Mixed Cellular Population,Carcinoma ex pleomorphic adenoma,1
16045,Refractory Disease,Refractory Rhabdomyosarcoma,1
16046,Malignant Cellular Infiltrate,Intracranial Melanoma,1
16047,Papillary Pattern,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
16048,Cystic Change,Intracystic papillary adenoma,1
16049,Localized Hydropic Villous Change,"Hydatidiform Mole, Partial",1
16050,Cystic Change,Kidney Mixed Epithelial and Stromal Tumor Family,1
16051,Malignant Cellular Infiltrate,Stage IIB Prostate Cancer AJCC v8,1
16052,Metastatic Lesion,Secondary malignant neoplasm of lymph node,1
16053,Epithelial Component Present,Functioning Pituitary Gland Microadenoma,1
16054,Benign Cellular Infiltrate,Water-clear cell adenoma,1
16055,Alternative Fascicle (Bundle) Pattern,Leiomyoma of lung,1
16056,Epithelial Component Present,Adenosquamous cell lung cancer stage I,1
16057,Malignant Cellular Infiltrate,Metastatic basal cell carcinoma,1
16058,Epithelial Component Present,Inverting papilloma of the paranasal sinus,1
16059,Tissue Differentiation Uncertain,Mediastinal Synovial Sarcoma,1
16060,Thyroglobulin Positive Neoplastic Cells Present,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage,1
16061,Primary Lesion,Adult Brain Stem Gliosarcoma,1
16062,Mixed Cellular Population,Breast Fibroepithelial Neoplasm,1
16063,Carcinomatous Component Present,Squamous cell carcinoma of conjunctiva,1
16064,Metastatic Lesion,Stage IV Nasopharyngeal Carcinoma,1
16065,Primary Lesion,Unresectable Hepatocellular Carcinoma,1
16066,Cystic Change,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
16067,Carcinomatous Component Present,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
16068,Infiltrative Growth Pattern,gliosarcoma,1
16069,Epithelial Component Present,Breast Neuroendocrine Neoplasm,1
16070,Dermal Involvement,Compound nevus of skin,1
16071,Malignant Cellular Infiltrate,Stage IVA Gallbladder Cancer AJCC v8,1
16072,Carcinomatous Component Present,undifferentiated carcinoma of anal canal,1
16073,Malignant Cellular Infiltrate,Desmoplastic Neurotropic Melanoma,1
16074,Malignant Cellular Infiltrate,Superficial spreading malignant melanoma of skin,1
16075,Malignant Cellular Infiltrate,Colon Hodgkin Lymphoma,1
16076,Vertical Growth Phase,Desmoplastic Neurotropic Melanoma,1
16077,Epithelial Component Present,Stage IIIC Hepatocellular Carcinoma AJCC v7,1
16078,Refractory Disease,Hodgkin's disease nodular sclerosis refractory,1
16079,Epithelial Differentiation,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
16080,Malignant Cellular Infiltrate,Metastatic Malignant Pancreatic Neoplasm,1
16081,Benign Cellular Infiltrate,Adenomatoid Tumor,1
16082,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis,1
16083,Regional Disease,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
16084,Decreased platelet count,Myeloid Neoplasms with Germline RUNX1 Mutation,1
16085,Indolent Clinical Course,Mediastinal Chondroma,1
16086,Epithelial Component Present,Bladder squamous cell carcinoma recurrent,1
16087,Low Grade Lesion,Pilocytic astrocytoma of cerebellum,1
16088,Mixed Cellular Population,Pericanalicular fibroadenoma,1
16089,Metastatic/Recurrent Disease,synovial sarcoma,1
16090,Immunologic Deficiency Syndromes,Transplant-Related Lung Carcinoma,1
16091,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Corpus Carcinosarcoma,1
16092,Immunoglobulin Deposition,Light chain disease,1
16093,Therapy-Related Toxicity,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,1
16094,Malignant Cellular Infiltrate,Stage IIB Small Intestinal Adenocarcinoma AJCC v8,1
16095,Dysplasia,Low Grade Gastric Intraepithelial Neoplasia,1
16096,Dysplasia,Oral Intraepithelial Neoplasia,1
16097,Malignant Cellular Infiltrate,Ovarian Low Grade Endometrioid Stromal Sarcoma,1
16098,Cutaneous Involvement,Vulvar Seborrheic Keratosis,1
16099,Carcinomatous Component Present,Stage I Colon Cancer AJCC v8,1
16100,Ineffective hematopoiesis,Myelodysplastic Syndrome with Isolated del(5q),1
16101,Vascular Channel Formation,Kaposi's sarcoma of lung,1
16102,Epithelioid Component Present,Pleural Biphasic Synovial Sarcoma,1
16103,Carcinomatous Component Present,Invasive Mucinous Lung Adenocarcinoma,1
16104,Secondary Lesion,Malignant Neoplasm with Regional Lymph Node Involvement,1
16105,Unresectable Mass,Small intestine carcinoma non-resectable,1
16106,Malignant Cellular Infiltrate,Lung Monophasic Synovial Sarcoma,1
16107,Cutaneous Involvement,Verrucous keratotic hemangioma,1
16108,Epithelial Component Present,Small intestine adenocarcinoma metastatic NOS,1
16109,Recurrent disease,Recurrent Burkitt Leukemia,1
16110,Carcinomatous Component Present,Stage IVB Liver Cancer,1
16111,Severe dysplasia,Lung Adenocarcinoma In Situ,1
16112,Malignant Cellular Infiltrate,Pharyngeal cancer stage I,1
16113,Epithelial Component Present,Non-Functioning Pancreatic Neuroendocrine Tumor G2,1
16114,Numerous Stromal Mast Cells Present,Vaginal Myofibroblastoma,1
16115,Well-Circumscribed Lesion,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,1
16116,Refractory Disease,Refractory Malignant Solid Neoplasm,1
16117,Metastatic Lesion,Disseminated adenocarcinoma,1
16118,Epithelial Component Present,Gastric Neuroendocrine Tumor G2,1
16119,Cutaneous Involvement,Aleukemic Leukemia Cutis,1
16120,Primary Lesion,Stage IIIC Primary Peritoneal Cancer AJCC v8,1
16121,Malignant Cellular Infiltrate,Botryoid-Type Embryonal Rhabdomyosarcoma,1
16122,Adulthood Lesion,Refractory Indolent Adult Non-Hodgkin Lymphoma,1
16123,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",1
16124,Epithelial Component Present,Encapsulated Thymoma,1
16125,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
16126,Dysplasia,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant",1
16127,Malignant Cellular Infiltrate,Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7,1
16128,Numerous Stromal Mast Cells Present,Myofibroblastoma,1
16129,Carcinomatous Component Present,squamous cell carcinoma of lacrimal gland,1
16130,Nuclear Pseudoinclusion,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
16131,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Fetal Lung Adenocarcinoma,1
16132,Epithelial Component Present,Stage IA Distal Bile Duct Cancer AJCC v7,1
16133,Benign Cellular Infiltrate,Liver Lipoma,1
16134,Malignant Cellular Infiltrate,Recurrent Childhood Glioblastoma,1
16135,Nuclear pleomorphism,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
16136,Epithelial Component Present,Bile duct carcinoma,1
16137,Epithelial Component Present,Stage IIA Ovarian Cancer AJCC v8,1
16138,Collagenous Stroma Formation,Pelvic Fibromatosis,1
16139,Stromal Invasion,Stage IV Ovarian Carcinoma,1
16140,Malignant Cellular Infiltrate,Stage I Adult Immunoblastic Lymphoma,1
16141,Malignant Cellular Infiltrate,Stage IB Bone Cancer AJCC v8,1
16142,Benign Cellular Infiltrate,Congenital Cystic Hygroma,1
16143,Epithelial Component Present,Adenosquamous cell lung cancer stage II,1
16144,Radiation Sickness,Radiation-Induced Cancer,1
16145,Follicular Cell Differentiation,Multicentric Thyroid Gland Papillary Carcinoma,1
16146,Primary Lesion,Recurrent Testicular Lymphoma,1
16147,Malignant Cellular Infiltrate,Renal Cell Cancer by AJCC v6 Stage,1
16148,Epithelial Component Present,Stage IVA Hypopharyngeal Carcinoma AJCC v8,1
16149,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Corticotropin Secreting Adenoma,1
16150,Malignant Cellular Infiltrate,Rectal Cancer by AJCC v7 Stage,1
16151,Malignant Cellular Infiltrate,Asynchronous Multifocal Osteosarcoma,1
16152,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory High Risk Myelodysplastic Syndrome,1
16153,Well Differentiated Neuroendocrine Lesion,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
16154,Childhood Lesion,Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1,1
16155,Mixed Cellular Population,Uterine Corpus Carcinofibroma,1
16156,Malignant Cellular Infiltrate,Stage IIIC Colon Cancer AJCC v7,1
16157,Progressive Clinical Course,Rapidly progressive glomerulonephritis,1
16158,Malignant Cellular Infiltrate,Distal Bile Duct Cancer by AJCC v8 Stage,1
16159,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory cytopenia with unilineage dysplasia,1
16160,Adulthood Lesion,Adult Non-Hodgkin Lymphoma,1
16161,Neuroendocrine Differentiation,Stage I Ileal Neuroendocrine Tumor AJCC v8,1
16162,Tissue Differentiation Uncertain,Atypical fibroxanthoma of skin,1
16163,Diffuse Pattern,Stage I Adult Immunoblastic Lymphoma,1
16164,Epithelial Component Present,Bile duct cancer recurrent,1
16165,Pseudostratified Columnar Tumor Cells Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
16166,Epithelial Component Present,Skin Nodular Solid Basal Cell Carcinoma,1
16167,Pathologic TNM Finding,Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
16168,Ground Glass Nuclear Inclusion,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
16169,Malignant Cellular Infiltrate,Malignant neoplasm of thoracic esophagus,1
16170,Neuroendocrine Differentiation,Carcinoid tumor of appendix,1
16171,Epithelial Component Present,Ovarian Neuroendocrine Neoplasm,1
16172,Tissue Differentiation Uncertain,Tongue Alveolar Soft Part Sarcoma',1
16173,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
16174,"Fully Differentiated ""Adult-Type"" Tissues Present",Adult Central Nervous System Mature Teratoma,1
16175,Hemorrhagic,Angiosarcoma of the breast,1
16176,Recurrent disease,Recurrent Ampulla of Vater Adenocarcinoma,1
16177,Malignant Cellular Infiltrate,Noninfiltrating intraductal papillary adenocarcinoma,1
16178,Absence of Invasion,Pre-Malignant Skin Epithelial Lesion,1
16179,Secondary Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma,1
16180,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
16181,Secondary Lesion,Advanced Uveal Melanoma,1
16182,Finding related to pregnancy,Non-Hodgkin Lymphoma During Pregnancy,1
16183,Cutaneous Involvement,Bullous Dermatitis,1
16184,Carcinomatous Component Present,Adenocarcinoma of the rete testis,1
16185,Epithelial Component Present,Prostatic Duct Urothelial Carcinoma,1
16186,Carcinomatous Component Present,Keratinizing Head and Neck Squamous Cell Carcinoma,1
16187,Secondary Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
16188,Poorly Differentiated Neuroendocrine Lesion,Neuroendocrine carcinoma of appendix,1
16189,Carcinomatous Component Present,Refractory Bile Duct Carcinoma,1
16190,Epithelial Component Present,Stage I Thymoma AJCC v8,1
16191,Malignant Cellular Infiltrate,Transplant-Related Renal Cell Carcinoma,1
16192,Malignant Cellular Infiltrate,Ductal Carcinoma In Situ with Microinvasion,1
16193,Recurrent disease,B-cell lymphoma recurrent,1
16194,Carcinomatous Component Present,Endometrial Transitional Cell Carcinoma,1
16195,Epithelial Component Present,Stage I Prostate Cancer AJCC v8,1
16196,Neuroendocrine Differentiation,Low Grade Lung Neuroendocrine Neoplasm,1
16197,Malignant Cellular Infiltrate,Ann Arbor Stage IV Grade 1 Follicular Lymphoma,1
16198,Pathologic TNM Finding,Pathologic Stage 0 Gastric Cancer AJCC v8,1
16199,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer recurrent,1
16200,Mucocele of appendix,Appendix Mucinous Cystadenoma,1
16201,Epithelial Component Present,Rectal Adenoma with Severe Dysplasia,1
16202,Diffuse Pattern,Diencephalic Glioblastoma,1
16203,Epithelial Component Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
16204,Mixed Cellular Population,Breast Pleomorphic Adenoma,1
16205,Carcinomatous Component Present,Stage III Rectal Cancer AJCC v6,1
16206,Hyalinized Stroma Formation,Pleural Epithelioid Hemangioendothelioma,1
16207,Well Differentiated Neuroendocrine Lesion,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
16208,Hereditary Lesion,Familial Paraganglioma-Pheochromocytoma Syndrome,1
16209,Thin Bands of Collagen Present,Hemangiopericytoma of meninges,1
16210,Metastatic Lesion,Advanced Cervical Adenocarcinoma,1
16211,Epithelial Component Present,Parotid monomorphic adenoma,1
16212,Exophytic Polypoid Lesion,Gallbladder Hyperplastic Polyp,1
16213,Carcinomatous Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
16214,Adulthood Lesion,Stage III Adult Non-Hodgkin Lymphoma,1
16215,Hyaline Cartilage Differentiation,Chondrosarcoma metastatic,1
16216,Carcinomatous Component Present,Papillary carcinoma in situ,1
16217,Malignant Cellular Infiltrate,Lung Acinar Adenocarcinoma,1
16218,Malignant Cellular Infiltrate,Angiosarcoma of the breast,1
16219,Malignant Cellular Infiltrate,Uterine Ligament Serous Adenocarcinoma,1
16220,Edematous Stroma Formation,Vulvar Superficial Angiomyxoma,1
16221,Severe dysplasia,Stage 0 Ampulla of Vater Cancer AJCC v8,1
16222,Carcinomatous Component Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
16223,Cystic Change,Eccrine hidrocystoma,1
16224,Recurrent disease,Recurrent Malignant Male Reproductive System Neoplasm,1
16225,Collagenous Stroma Formation,Myofibroblastoma,1
16226,Epithelial Component Present,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
16227,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,1
16228,Indolent Clinical Course,Bizarre parosteal osteochondromatous proliferation,1
16229,Carcinomatous Component Present,Stage 0 Oropharyngeal Carcinoma,1
16230,Exophytic Polypoid Lesion,Giant Fibrovascular Esophageal Polyp,1
16231,Malignant Cellular Infiltrate,Stage IIB Bone Cancer AJCC v7,1
16232,Dysplasia,villous adenoma of stomach,1
16233,Epithelial Component Present,Tubulovillous adenoma of rectum,1
16234,Carcinomatous Component Present,Stage IIIA Bladder Cancer AJCC v8,1
16235,Cutaneous Involvement,Skin-associated lymphoid tissue lymphoma,1
16236,Hyaline Cartilage Differentiation,Childhood Mesenchymal Chondrosarcoma,1
16237,Cutaneous Involvement,Skin Pigmentation Disorder,1
16238,Carcinomatous Component Present,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,1
16239,Epithelial Component Present,Stage 0 Penile Cancer AJCC v6,1
16240,Cutaneous Involvement,Ganglioneuroma of skin,1
16241,Epithelial Component Present,Colorectal Sarcomatoid Carcinoma,1
16242,Secondary Lesion,Secondary malignant neoplasm of neck,1
16243,Carcinomatous Component Present,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
16244,Cutaneous Involvement,Lichen Sclerosus et Atrophicus,1
16245,Benign Cellular Infiltrate,Benign Esophageal Schwannoma,1
16246,Benign Cellular Infiltrate,Benign neoplasm of retroperitoneum,1
16247,Anaplasia,alk-positive anaplastic large cell lymphoma,1
16248,Carcinomatous Component Present,Unresectable Skin Squamous Cell Carcinoma,1
16249,Carcinomatous Component Present,Stage IIIA Rectal Cancer AJCC v7,1
16250,Carcinomatous Component Present,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
16251,Cysts Containing Proteinaceous Fluid Present,Papillary serous cystadenocarcinoma,1
16252,Eosinophil count raised (finding),Adult Acute Eosinophilic Leukemia,1
16253,High Mitotic Activity,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8,1
16254,Enterochromaffin Type Granules Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
16255,Mild cytologic atypia,verrucous carcinoma of vagina,1
16256,Carcinomatous Component Present,Primary Prostate Urothelial Carcinoma,1
16257,Cytoplasmic Membrane-Bound Granules Present,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
16258,Malignant Cellular Infiltrate,Carcinoma duodenum resectable,1
16259,Epithelial Component Present,Childhood Thyroid Gland Follicular Carcinoma,1
16260,Malignant Cellular Infiltrate,Tracheal Carcinoma,1
16261,Cellular Changes Resembling Foveolar Epithelium Cells,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
16262,Malignant Cellular Infiltrate,Malignant Cervical Soft Tissue Neoplasm,1
16263,Epithelial Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
16264,Carcinomatous Component Present,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
16265,Delicate Vascular Network Formation,Grade 1 Clear Cell Renal Cell Carcinoma,1
16266,Vascular proliferation,Giant Cell Tumor of Soft Tissue,1
16267,Carcinomatous Component Present,Lung Pleomorphic Carcinoma,1
16268,Epithelial Component Present,Stage II Prostate Cancer AJCC v8,1
16269,Malignant Cellular Infiltrate,Endometrioid adenocarcinoma metastatic,1
16270,Alternative Fascicle (Bundle) Pattern,Colorectal Leiomyoma,1
16271,Malignant Cellular Infiltrate,Metastatic Neuroblastoma,1
16272,Intracanalicular Growth Pattern,Benign phyllodes neoplasm of breast,1
16273,Anaplasia,Adult Anaplastic Astrocytoma,1
16274,Diffuse Pattern,Recurrent Intravascular Large B-Cell Lymphoma,1
16275,Paucicellular Stroma Present,canalicular adenoma of salivary gland,1
16276,Tissue of Mullerian Origin Present,endometrioid adenofibroma of ovary,1
16277,Metastatic Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
16278,Epithelial Component Present,Paget Disease Extramammary,1
16279,Carcinomatous Component Present,Tonsillar Carcinoma,1
16280,Malignant Cellular Infiltrate,Anaplastic small cell lymphoma,1
16281,Rapidly Enlarging Mass,Vulvar Keratoacanthoma,1
16282,Malignant Cellular Infiltrate,Esophageal Synovial Sarcoma,1
16283,Follicular Cell Differentiation,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
16284,Indolent Clinical Course,Uterine Corpus Adenomyoma,1
16285,Epithelial Component Present,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,1
16286,Low Mitotic Activity,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
16287,Fibrosis,"Breast Fibrocystic Change, Non-Proliferative Type",1
16288,Carcinomatous Component Present,Bladder adenocarcinoma stage 0,1
16289,Severe dysplasia,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
16290,Recurrent disease,Endometrioid adenocarcinoma recurrent,1
16291,Malignant Cellular Infiltrate,Sellar Neuroblastoma,1
16292,Malignant Cellular Infiltrate,Sarcomatoid Renal Cell Carcinoma,1
16293,VIP Positive Neoplastic Cells Present,Small Intestinal VIP-Producing Neuroendocrine Tumor,1
16294,Epithelial Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral",1
16295,Cystic Change,Adult cystic teratoma,1
16296,Hyperplastic Tissue Present,Squamous Hyperplasia,1
16297,Clinical TNM Finding,Clinical Stage 0 Gastric Cancer AJCC v8,1
16298,Multinodular Pattern,Proximal-Type Epithelioid Sarcoma,1
16299,Absence of Basal Cell Layer,Acinar Prostate Mucinous Adenocarcinoma,1
16300,Epithelial Component Present,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
16301,Malignant Cellular Infiltrate,Angiocentric lymphoma stage IV,1
16302,Carcinomatous Component Present,Cholangiocarcinoma non-resectable,1
16303,Monomorphic Cellular Infiltrate,Lung Basaloid Large Cell Carcinoma,1
16304,Low Mitotic Activity,Esophageal Neuroendocrine Tumor,1
16305,Epithelial Component Present,Gastric Cancer by AJCC v8 Stage,1
16306,Malignant Cellular Infiltrate,Stage IIIC Vulvar Cancer AJCC v7,1
16307,Benign Cellular Infiltrate,Colon Lipoma,1
16308,Blasts of Mixed Phenotype Present,Infant Acute Biphenotypic Leukemia,1
16309,Benign Cellular Infiltrate,Esophageal Fibroma,1
16310,Atypical Mitotic Figures,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
16311,Malignant Cellular Infiltrate,Childhood Acute Myelomonocytic Leukemia,1
16312,Vascular Channel Formation,Epithelioid hemangioendothelioma,1
16313,Borderline Lesion,Glomus Tumor of Uncertain Malignant Potential,1
16314,Cutaneous Involvement,Unresectable Cutaneous Melanoma,1
16315,Primary Lesion,Ethmoid Sinus Primary Ectopic Meningioma,1
16316,Malignant Cellular Infiltrate,Digestive System Neuroendocrine Carcinoma,1
16317,Pushing Tumor Margin,Anal Verrucous Carcinoma,1
16318,Malignant Cellular Infiltrate,Malignant retroperitoneal tumor,1
16319,Pathologic TNM Finding,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8,1
16320,Epithelial Component Present,Liver Adenosquamous Carcinoma,1
16321,Infiltrative Growth Pattern,Metastatic Kidney Medullary Carcinoma,1
16322,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Soft Tissues,1
16323,Benign Cellular Infiltrate,Cystadenofibroma,1
16324,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,"Myelodysplastic syndrome, no ICD-O subtype",1
16325,Malignant Cellular Infiltrate,Adenocarcinoma of nasal cavity,1
16326,Mixed Cellular Population,Invasive Mixed Breast Carcinoma,1
16327,Poorly Differentiated Lesion,"Lung Squamous Cell Carcinoma, Small Cell Variant",1
16328,Epithelial Component Present,Lung Non-Mucinous Adenocarcinoma In Situ,1
16329,Carcinomatous Component Present,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
16330,Carcinomatous Component Present,Stage 0a Ureter Cancer AJCC v8,1
16331,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,1
16332,Necrotic changes (finding),Glioblastoma,1
16333,Epithelial Component Present,Oncocytic Schneiderian papilloma,1
16334,Childhood Lesion,Childhood Ovarian Teratoma,1
16335,Mixed Cellular Population,Infiltrating duct and lobular carcinoma,1
16336,Intermediate Grade Neuroendocrine Lesion,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
16337,Biphasic Pattern,"Uterine Carcinosarcoma, Heterologous Type",1
16338,Malignant Cellular Infiltrate,Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7,1
16339,Epithelial Component Present,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
16340,Malignant Cellular Infiltrate,Intracranial Melanoma,1
16341,Keratin pearl formation,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant",1
16342,Steatohepatitis,Inflammatory Hepatocellular Adenoma,1
16343,Malignant Cellular Infiltrate,Malignant neoplasm of cerebrum,1
16344,Tubular Structures Present,Malignant Kidney Mixed Epithelial and Stromal Tumor,1
16345,Fibrotic Stroma Formation,carcinoma of pancreas with osteoclast-like giant cells,1
16346,Malignant Cellular Infiltrate,Epithelioid sarcoma metastatic,1
16347,Epithelial Component Present,Urothelial carcinoma ureter recurrent,1
16348,Malignant Cellular Infiltrate,Superior Vena Cava Angiosarcoma,1
16349,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma stage IV,1
16350,Carcinomatous Component Present,Skin Nodular Basal Cell Carcinoma,1
16351,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline ETV6 Mutation,1
16352,S-100-Positive Neoplastic Cells Present,"Perivascular epithelioid tumor, benign",1
16353,Epithelial Component Present,Renal Pelvis and Ureter Urothelial Carcinoma,1
16354,Neuroendocrine Differentiation,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
16355,Secondary Lesion,Reactive systemic amyloidosis,1
16356,Epithelial Component Present,Fallopian Tube Metaplastic Papillary Tumor,1
16357,Tissue Differentiation Uncertain,Pulmonary lymphangioleiomyomatosis,1
16358,Carcinomatous Component Present,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
16359,Collagenous Stroma Formation,Vulvar Superficial Myofibroblastoma,1
16360,Malignant Cellular Infiltrate,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,1
16361,Mixed Cellular Population,Serous adenofibroma,1
16362,Anaplasia,Esophageal Spindle Cell Carcinoma,1
16363,Unifocal Lesion,Pulmonary Histiocytosis X,1
16364,Benign Cellular Infiltrate,Cutaneous neurofibroma,1
16365,Carcinomatous Component Present,Papillary renal cell carcinoma type 2,1
16366,Carcinomatous Component Present,Recurrent Digestive System Carcinoma,1
16367,Carcinomatous Component Present,Stage IV Fallopian Tube Cancer AJCC v8,1
16368,Childhood Lesion,Childhood Thyroid Gland Carcinoma,1
16369,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
16370,Mitotic Activity,MGMT-Methylated Glioblastoma,1
16371,Malignant Cellular Infiltrate,High Grade Appendix Mucinous Adenocarcinoma,1
16372,Childhood Lesion,Childhood Gastric Carcinoma,1
16373,Papillary Pattern,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
16374,Malignant Cellular Infiltrate,Malignant tumor of base of tongue,1
16375,Local disease,Transitional cell cancer of the renal pelvis and ureter localized,1
16376,Carcinomatous Component Present,Stage IIIC Appendix Carcinoma AJCC v8,1
16377,Carcinomatous Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v6,1
16378,Hydropic Villous Change,Complete hydatidiform mole,1
16379,Epithelial Component Present,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
16380,Thyroglobulin Positive Neoplastic Cells Present,Papillary Thyroid Microcarcinoma,1
16381,Indolent Clinical Course,Vulvar Lipoma,1
16382,Malignant Cellular Infiltrate,Stage IVB Uterine Sarcoma AJCC v7,1
16383,Malignant Cellular Infiltrate,Stage II Choroidal and Ciliary Body Melanoma AJCC v8,1
16384,Carcinomatous Component Present,squamous cell carcinoma of the thyroid gland,1
16385,Adnexal Differentiation,Benign neoplasm of sweat gland,1
16386,Vascular Channel Formation,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,1
16387,Well Differentiated Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor G2,1
16388,Islands of Neuropil-Like Matrix Present,Glioneuronal Tumor with Neuropil-Like Islands,1
16389,Secondary Lesion,Stage IV Major Salivary Gland Carcinoma with Metastasis,1
16390,Epithelial Component Present,Hepatocellular Carcinoma by AJCC v6 Stage,1
16391,Benign Cellular Infiltrate,Desmoplastic trichilemmoma,1
16392,Pre-existing condition,Myeloid Neoplasms with Germline Predisposition Associated with Other Organ Dysfunction,1
16393,Therapy-Related Toxicity,Alkylating Agent-Related Acute Myeloid Leukemia,1
16394,Peripheral Nuclear Palisading,Small cell carcinoma of lung,1
16395,Epithelial Component Present,Stage IIIB Thymus Epithelial Neoplasm AJCC v8,1
16396,Solid Growth Pattern,Breast Columnar Cell Mucinous Carcinoma,1
16397,Gyriform Trabecular Pattern,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
16398,Osteoid formation,Mediastinal Extraskeletal Osteosarcoma,1
16399,Adulthood Lesion,Lugano Classification Stage II Adult Lymphoma AJCC v8,1
16400,Epithelial Component Present,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
16401,Tissue of Mullerian Origin Present,Carcinosarcoma of ovary,1
16402,Invasive Lesion,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
16403,Metastatic Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
16404,Metaplasia,Intestinal-Type Sinonasal Adenocarcinoma,1
16405,Carcinomatous Component Present,Bladder squamous cell carcinoma stage I,1
16406,Malignant Cellular Infiltrate,Lugano Classification Stage IIE Adult Hodgkin Lymphoma AJCC v8,1
16407,Epithelial Component Present,Colorectal Adenocarcinoma Metastatic in the Liver,1
16408,Hereditary Lesion,Neurofibromatosis aggravated,1
16409,Tissue Differentiation Uncertain,Kidney Synovial Sarcoma,1
16410,Malignant Cellular Infiltrate,Temporal Lobe Anaplastic Astrocytoma,1
16411,Recurrent disease,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
16412,Carcinomatous Component Present,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7,1
16413,Metastatic Lesion,Secondary malignant neoplasm of liver,1
16414,Epithelial Component Present,Vaginal Papillary Carcinoma,1
16415,Mixed Cellular Population,clear cell adenocarcinofibroma of ovary,1
16416,Monocytosis,Chronic Myelomonocytic Leukemia-2,1
16417,Mitotic Activity,Glioblastoma,1
16418,Epithelial Component Present,Small Intestinal High Grade Intraepithelial Neoplasia,1
16419,Epithelial Component Present,Adenocarcinoma with cartilaginous metaplasia,1
16420,Epithelial Component Present,Stage 0 Gallbladder Cancer AJCC v6 and v7,1
16421,Malignant Cellular Infiltrate,Gastric Intramucosal Adenocarcinoma,1
16422,Malignant Cellular Infiltrate,Malignant Ovarian Teratoma,1
16423,Epithelial Component Present,adenosquamous carcinoma of breast,1
16424,Benign Cellular Infiltrate,Inverted Squamous Cell Papilloma,1
16425,Carcinomatous Component Present,Squamous cell carcinoma of the head and neck,1
16426,Mixed Cellular Population,Adult Mixed Glioma,1
16427,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Signet Ring Variant",1
16428,Severe dysplasia,Carcinoma in situ of ampulla of Vater,1
16429,Pathologic TNM Finding,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
16430,Diffuse Pattern,Adult Anaplastic Astrocytoma,1
16431,Benign Cellular Infiltrate,Dermoid Cyst of the Spinal Cord,1
16432,Malignant Cellular Infiltrate,Stage IIB Distal Bile Duct Cancer AJCC v7,1
16433,Malignant Cellular Infiltrate,Refractory Hodgkin Lymphoma,1
16434,In Situ Lesion,Stage 0 Vulvar Cancer,1
16435,Geographic Necrosis,Adult Central Nervous System Embryonal Carcinoma,1
16436,Favorable Clinical Outcome,"lymphomatoid papulosis, type C",1
16437,Ineffective hematopoiesis,Refractory Cytopenia of Childhood,1
16438,Epithelial Component Present,Malignant Sertoli Cell Tumor,1
16439,Nuclear pleomorphism,Type D Lymphomatoid Papulosis,1
16440,Carcinomatous Component Present,Stage IIIC Vulvar Cancer AJCC v7,1
16441,Vascular Channel Formation,Intermediate (Locally Aggressive) Blood Vessel Neoplasm,1
16442,Epithelial Component Present,Appendix Intraepithelial Neoplasia,1
16443,atypia morphology,Malignant Solitary Fibrous Tumor,1
16444,Carcinomatous Component Present,Esophageal Large Cell Neuroendocrine Carcinoma,1
16445,Epithelial Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
16446,Exophytic Polypoid Lesion,Appendix Tubulovillous Adenoma,1
16447,Benign Cellular Infiltrate,Hemangioma of bone,1
16448,Benign Cellular Infiltrate,Cellular Blue Nevus,1
16449,High Grade Lesion,Botryoid-Type Embryonal Rhabdomyosarcoma,1
16450,Malignant Cellular Infiltrate,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,1
16451,Malignant Cellular Infiltrate,Malignant neoplasm of cerebellum,1
16452,Malignant Cellular Infiltrate,Metastatic Adrenal Gland Pheochromocytoma,1
16453,Malignant Cellular Infiltrate,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
16454,Adulthood Lesion,Stage III Indolent Adult Non-Hodgkin Lymphoma,1
16455,Nuclear pleomorphism,"Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type",1
16456,Cartilaginous Differentiation,"Chondrosarcoma, Clear Cell",1
16457,Low Mitotic Activity,Functioning Pancreatic Neuroendocrine Tumor,1
16458,Infiltrative Growth Pattern,Diffuse Astrocytoma,1
16459,atypia morphology,Vulvar Dysplastic Melanocytic Nevus,1
16460,Metastatic Lesion,Metastatic Pharyngeal Carcinoma,1
16461,Epithelial Component Present,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,1
16462,Epithelial Component Present,Stage IVA Prostate Cancer AJCC v8,1
16463,Epithelial Component Present,Neuroendocrine Tumors,1
16464,Recurrent disease,Recurrent Primary Peritoneal Carcinoma,1
16465,Pathologic TNM Finding,Pathologic Stage IIA Gastric Cancer AJCC v8,1
16466,Malignant Cellular Infiltrate,Stage IVC Appendix Carcinoma AJCC v7,1
16467,Intraductal Lesion,intraductal micropapillary carcinoma of breast,1
16468,Mixed Cellular Population,Advanced Uterine Corpus Carcinosarcoma,1
16469,Epithelial Component Present,Fallopian Tube Endometrioid Adenocarcinoma,1
16470,Malignant Cellular Infiltrate,Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
16471,Epithelial Component Present,Hard Palate Monomorphic Adenoma,1
16472,Immunologic Deficiency Syndromes,EBV-Related Post-Transplant Lymphoproliferative Disorder,1
16473,Malignant Cellular Infiltrate,Unfavorable Non-Hodgkin Lymphoma,1
16474,Neuroendocrine Differentiation,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
16475,Epithelial Component Present,Grade II Glandular Intraepithelial Neoplasia,1
16476,Malignant Cellular Infiltrate,Childhood Testicular Choriocarcinoma,1
16477,Carcinomatous Component Present,Fallopian Tube Cancer by AJCC v6 Stage,1
16478,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
16479,Eosinophil count raised (finding),Hypereosinophilic syndrome,1
16480,Neuroendocrine Differentiation,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,1
16481,Carcinomatous Component Present,Stage I Lip and Oral Cavity Cancer AJCC v8,1
16482,Cutaneous Involvement,Stage IV Cutaneous Melanoma AJCC v6 and v7,1
16483,Necrotic changes (finding),Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
16484,Carcinomatous Component Present,Stage IVA Major Salivary Gland Cancer AJCC v8,1
16485,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
16486,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Seminoma,1
16487,Epithelial Component Present,Stage III Intrahepatic Cholangiocarcinoma AJCC v7,1
16488,Carcinomatous Component Present,Stage IIIB Rectal Cancer AJCC v8,1
16489,Carcinomatous Component Present,Skin squamous cell carcinoma metastatic,1
16490,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,1
16491,Carcinomatous Component Present,Recurrent Merkel Cell Carcinoma,1
16492,Adulthood Lesion,Lugano Classification Stage IE Adult Non-Hodgkin Lymphoma AJCC v8,1
16493,High Mitotic Activity,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
16494,Neuroendocrine Differentiation,Malignant Intrathoracic Paravertebral Paraganglioma,1
16495,Epithelial Component Present,Stage IIIC Esophageal Cancer AJCC v7,1
16496,Carcinomatous Component Present,Metastatic Vaginal Carcinoma,1
16497,Malignant Cellular Infiltrate,Stage IVA Lip and Oral Cavity Cancer AJCC v8,1
16498,Hyperkeratosis,Urethral Verrucous Carcinoma,1
16499,Malignant Cellular Infiltrate,Non-Resectable Malignant Liver Neoplasm,1
16500,Serrated Glandular Architecture,Rectal Sessile Serrated Adenoma/Polyp,1
16501,Epithelial Component Present,Bladder Adenocarcinoma,1
16502,Hyaline Cartilage Differentiation,Myxoid chondrosarcoma,1
16503,Tissue Differentiation Uncertain,Proximal-Type Epithelioid Sarcoma,1
16504,Malignant Cellular Infiltrate,Fibrin-Associated Diffuse Large B-Cell Lymphoma,1
16505,Carcinomatous Component Present,Metastatic Prostate Small Cell Carcinoma,1
16506,Epithelial Component Present,Stage IV Colorectal Cancer AJCC v7,1
16507,Carcinomatous Component Present,Colorectal Signet Ring Cell Carcinoma,1
16508,Epithelial Component Present,Vaginal Large Cell Neuroendocrine Carcinoma,1
16509,Vascular Channel Formation,"Hemangioma, Intramuscular",1
16510,Neuroendocrine Differentiation,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
16511,Epithelial Component Present,Crooke Cell Adenoma,1
16512,High Mitotic Activity,Anaplastic adrenocortical carcinoma,1
16513,Ependymal Differentiation,Angiocentric glioma,1
16514,Malignant Cellular Infiltrate,Stage III Cervical Cancer AJCC v6 and v7,1
16515,Neuroendocrine Differentiation,Uterine Corpus Neuroendocrine Neoplasm,1
16516,Endophytic Tumor Growth,Verrucous carcinoma of the oral cavity recurrent,1
16517,Fibrosis,Mediastinal (Thymic) Large B-Cell Lymphoma,1
16518,Malignant Cellular Infiltrate,Unresectable Dedifferentiated Liposarcoma,1
16519,Vascular Channel Formation,Thyroid Angiosarcoma,1
16520,Malignant Cellular Infiltrate,Choroid Spindle Cell Type B Melanoma,1
16521,Cutaneous Involvement,Contact dermatitis due to alkali,1
16522,Benign Cellular Infiltrate,Benign Uveal Neoplasm,1
16523,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
16524,Carcinomatous Component Present,small cell carcinoma of larynx,1
16525,Epithelial Component Present,Gastric Neuroendocrine Tumor,1
16526,Epithelial Component Present,Stage II Appendix Neuroendocrine Tumor AJCC v8,1
16527,Follicular Cell Differentiation,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential,1
16528,Follicular Cell Differentiation,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,1
16529,Malignant Cellular Infiltrate,Secondary Cerebral Hodgkin Lymphoma,1
16530,Malignant Cellular Infiltrate,Cutaneous Squamous Cell Carcinoma of the Head and Neck,1
16531,Complete Spontaneous Regression,"lymphomatoid papulosis, type A",1
16532,Pseudoencapsulated Mass,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
16533,Carcinomatous Component Present,Barrett's Adenocarcinoma,1
16534,Firm mass,Adult Malignant Peripheral Nerve Sheath Tumor,1
16535,Marked Thickening of the Bladder Urothelium Present,Bladder Urothelial Proliferation of Uncertain Malignant Potential,1
16536,Hemorrhagic,Skin Angiosarcoma,1
16537,Blasts of Mixed Phenotype Present,Acute biphenotypic leukemia,1
16538,Epithelial Component Present,Stage IVB Bladder Cancer AJCC v8,1
16539,Epithelial Component Present,Appendix Tubular Carcinoid,1
16540,Carcinomatous Component Present,Adenocarcinoma of anal glands,1
16541,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
16542,Malignant Cellular Infiltrate,Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8,1
16543,Epithelial Component Present,Invasive Carcinoma,1
16544,Vascular Channel Formation,Parotid Gland Kaposi Sarcoma,1
16545,Malignant Cellular Infiltrate,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
16546,Carcinomatous Component Present,squamous cell carcinoma of ovary,1
16547,Metastatic Lesion,Secondary malignant neoplasm of vagina,1
16548,Invasive Lesion,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation,1
16549,Lobular Pattern,Pilar tumor,1
16550,Epithelial Component Present,Borderline Resectable Carcinoma,1
16551,Solitary mass,Sellar Chordoma,1
16552,Epithelial Component Present,Colorectal Small Cell Neuroendocrine Carcinoma,1
16553,Epithelial Component Present,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
16554,Cutaneous Involvement,Sweat Gland Neoplasms,1
16555,Benign Cellular Infiltrate,Myofibroblastoma,1
16556,Cutaneous Involvement,Stage II Cutaneous Melanoma AJCC v6 and v7,1
16557,More than 10 Mitoses per 10HPF,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
16558,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage 0,1
16559,Epithelial Component Present,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
16560,Benign Cellular Infiltrate,Intracranial Benign Fibrous Histiocytoma,1
16561,Neuroendocrine Differentiation,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
16562,Chronic Inflammatory Infiltrate,Chronic lymphadenitis,1
16563,Malignant Cellular Infiltrate,Secondary Chondrosarcoma,1
16564,Malignant Cellular Infiltrate,Refractory Mixed Phenotype Acute Leukemia,1
16565,Carcinomatous Component Present,Colorectal Cancer by AJCC v7 Stage,1
16566,Multinodular Mass,Dedifferentiated Dermatofibrosarcoma Protuberans,1
16567,Osseous Differentiation,High grade surface osteosarcoma,1
16568,Cystic Change,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
16569,Necrotic changes (finding),Refractory Malignant Peripheral Nerve Sheath Tumor,1
16570,Malignant Cellular Infiltrate,Cervical Non-Keratinizing Squamous Cell Carcinoma,1
16571,Metastatic Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,1
16572,Benign Cellular Infiltrate,Rete Ovarii Cystadenoma,1
16573,Diffuse Lesion,"Diffuse midline glioma, point mutation K27M in histone H3",1
16574,Carcinomatous Component Present,Adult Fibrolamellar Carcinoma,1
16575,Lymphoplasmacytic Infiltrate,"Castleman Disease, Plasma Cell Type",1
16576,Epithelial Component Present,Stage 0 Penile Cancer AJCC v6,1
16577,Diffuse Pattern,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
16578,Secondary Lesion,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
16579,Poorly Differentiated Neuroendocrine Lesion,Metastatic Gastric Neuroendocrine Carcinoma,1
16580,Epithelial Component Present,Alcohol-Related Hepatocellular Carcinoma,1
16581,Carcinomatous Component Present,Growth Hormone-Producing Pituitary Gland Carcinoma,1
16582,Cystic Change,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
16583,Epithelial Component Present,Stage 0 Lung Cancer AJCC v6 and v7,1
16584,Epithelial Component Present,Stage 0 Urethral Cancer AJCC v7,1
16585,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic,1
16586,Stromal Invasion,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
16587,Malignant Cellular Infiltrate,Testicular choriocarcinoma stage II,1
16588,Dermal Involvement,Vaginal Blue Nevus,1
16589,Carcinomatous Component Present,Stage III Lung Cancer AJCC v6,1
16590,Adulthood Lesion,Adult Burkitt Lymphoma,1
16591,Epithelial Component Present,Endometrioid carcinoma of prostate,1
16592,Malignant Cellular Infiltrate,Malignant tumor of base of tongue,1
16593,Carcinomatous Component Present,Colorectal Squamous Cell Carcinoma,1
16594,Epithelial Component Present,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,1
16595,Immunologic Deficiency Syndromes,AIDS-Related Anal Non-Hodgkin Lymphoma,1
16596,Invasive Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
16597,Epithelial Component Present,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",1
16598,Invasive Lesion,pleomorphic carcinoma of breast,1
16599,Dysplasia,Low Grade Squamous Intraepithelial Neoplasia,1
16600,Adnexal Differentiation,Vulvar Adenocarcinoma of Sweat Gland Type,1
16601,Multilocular Lesion,Childhood Multilocular Cystic Renal Neoplasm,1
16602,Malignant Cellular Infiltrate,adenoid cystic carcinoma of accessory sinus,1
16603,Retiform Structures Comprise 90% or More of the Tumor,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
16604,Increased Cellularity Present,"Anaplastic Astrocytoma, IDH-Mutant",1
16605,Cartilaginous Component Present,Osteochondromyxoma,1
16606,Low Mitotic Activity,Colon Neuroendocrine Tumor G1,1
16607,Epithelial Component Present,Undifferentiated Fallopian Tube Carcinoma,1
16608,Epithelial Component Present,adenoma of extrahepatic bile duct,1
16609,Diffuse Pattern,mixed gliomas,1
16610,Glandular Pattern,"Testicular Yolk Sac Tumor, Enteric Pattern",1
16611,Firm mass,Recurrent Malignant Peripheral Nerve Sheath Tumor,1
16612,Carcinomatous Component Present,Cervical Esophagus Squamous Cell Carcinoma,1
16613,Biphasic Pattern,Ovarian Mucinous Cystadenofibroma,1
16614,Epithelial Component Present,"Extra-adrenal paraganglioma, malignant",1
16615,Malignant Cellular Infiltrate,Esophageal Lymphoma,1
16616,Malignant Cellular Infiltrate,Metastatic Digestive System Neuroendocrine Tumor G1,1
16617,Immunologic Deficiency Syndromes,AIDS-Related Gastric Kaposi Sarcoma,1
16618,Diffuse Pattern,"Mesothelioma, biphasic, malignant",1
16619,Malignant Cellular Infiltrate,Prostate Stromal Sarcoma,1
16620,Malignant Cellular Infiltrate,Childhood Embryonal Rhabdomyosarcoma,1
16621,Carcinomatous Component Present,Stage IIA Ovarian Cancer AJCC V6 and v7,1
16622,Epithelial Component Present,signet ring cell carcinoma of pancreas,1
16623,Carcinomatous Component Present,Stage I Merkel Cell Carcinoma AJCC v7,1
16624,Malignant Cellular Infiltrate,Adult Nodular Sclerosis Classical Hodgkin Lymphoma,1
16625,Malignant Cellular Infiltrate,Stage IIB Lung Squamous Cell Carcinoma AJCC v7,1
16626,Epithelial Component Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,1
16627,Malignant Cellular Infiltrate,Stage II Hodgkin Lymphoma,1
16628,Malignant Cellular Infiltrate,Uterine Angiosarcoma,1
16629,Recurrent disease,Recurrent Spinal Cord Neoplasm,1
16630,Malignant Cellular Infiltrate,mucinous adenocarcinoma of bladder,1
16631,Arborizing Vascular Channel Formation,Retiform hemangioendothelioma,1
16632,Neuroendocrine Differentiation,Minor Salivary Gland Small Cell Carcinoma,1
16633,Epithelial Component Present,Early gastric cancer,1
16634,Osseous Differentiation,Bone island,1
16635,Well Differentiated Lesion,Laryngeal verrucous carcinoma,1
16636,Malignant Cellular Infiltrate,Advanced Extracranial Malignant Solid Neoplasm,1
16637,Cutaneous Involvement,Tufted angioma of skin,1
16638,Primary Site Unknown,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary,1
16639,Epithelial Component Present,Lung Non-Mucinous Adenocarcinoma In Situ,1
16640,Epithelial Component Present,Functioning Pituitary Gland Microadenoma,1
16641,Exophytic Papillary Lesion,Condyloma Acuminatum with Dysplasia,1
16642,Malignant Cellular Infiltrate,Malignant mastocytosis,1
16643,Perivascular Arrangement of Tumor Cells,Benign Glomus Tumor,1
16644,Borderline Lesion,Atypical Spitz Nevus,1
16645,Peripheral Nuclear Palisading,Skin Basaloid Carcinoma,1
16646,Epithelial Component Present,Stage IB Ovarian Cancer AJCC v8,1
16647,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm to the Leptomeninges,1
16648,Epithelial Component Present,Paget Disease,1
16649,Malignant Cellular Infiltrate,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
16650,Carcinomatous Component Present,Stage III Small Intestinal Adenocarcinoma AJCC v8,1
16651,Secondary Lesion,Metastatic urothelial carcinoma,1
16652,Pseudopapillary Pattern,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7,1
16653,Osseous Differentiation,Small cell osteosarcoma,1
16654,Malignant Cellular Infiltrate,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
16655,Carcinomatous Component Present,Cloacogenic carcinoma,1
16656,Anaplasia,Adult Brain Stem Gliosarcoma,1
16657,Metastatic Lesion,Secondary malignant neoplasm of stomach,1
16658,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type",1
16659,Epithelial Component Present,Stage I Ampulla of Vater Cancer AJCC v8,1
16660,Carcinomatous Component Present,squamous cell carcinoma of renal pelvis,1
16661,Epithelial Component Present,Adenocarcinoma,1
16662,Epithelial Component Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
16663,Pregnancy Complications,Stage IIB Gestational Trophoblastic Tumor AJCC v7,1
16664,Malignant Cellular Infiltrate,Stage III Ampulla of Vater Cancer AJCC v8,1
16665,Epithelial Component Present,Ampulla of Vater Neuroendocrine Carcinoma,1
16666,Nodular Pattern,Recurrent Myxoid Liposarcoma,1
16667,Mixed Cellular Population,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
16668,Carcinomatous Component Present,Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
16669,Neuroendocrine Differentiation,Gastric Gastrin-Producing Neuroendocrine Tumor,1
16670,Carcinomatous Component Present,Stage IV Oral Cavity Cancer AJCC v6 and v7,1
16671,Recurrent disease,Recurrent Hematologic Malignancy,1
16672,Myxoid Stroma Formation,Neurothekeoma,1
16673,Epithelial Component Present,Infiltrating duct and lobular carcinoma,1
16674,Malignant Cellular Infiltrate,Diffuse follicle center lymphoma,1
16675,CD56-Positive Neoplastic Cells Present,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,1
16676,Eosinophilic inflammation,Epithelioid hemangioma of skin,1
16677,Thyroglobulin Positive Neoplastic Cells Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
16678,Invasive Lesion,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
16679,Malignant Cellular Infiltrate,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
16680,In Situ Lesion,Carcinoma in Situ,1
16681,Epithelial Component Present,Sessile Serrated Adenoma/Polyp,1
16682,Malignant Cellular Infiltrate,Advanced Squamous Cell Carcinoma of the Oropharynx,1
16683,Malignant Cellular Infiltrate,Stage IVC Lip Cancer AJCC v6 and v7,1
16684,Osteoid formation,Extraskeletal osteosarcoma non-metastatic,1
16685,Extensive Stage Lesion,Advanced Melanoma,1
16686,Malignant Epithelial Cells with Abundant Cytoplasmic Neutral Lipids Present,lipid-rich carcinoma of breast,1
16687,Parakeratosis,Classic Type Trichilemmoma,1
16688,Pregnancy Complications,Benign neoplasm of placenta,1
16689,Unresectable Mass,Unresectable Neuroblastoma,1
16690,Carcinomatous Component Present,BCLC Stage A Adult Hepatocellular Carcinoma,1
16691,Poorly Differentiated Lesion,Stage IIIB Lung Large Cell Carcinoma AJCC v7,1
16692,Epithelial Component Present,Fallopian Tube Carcinoma,1
16693,Dysplasia,Intraductal carcinoma and lobular carcinoma in situ,1
16694,Epithelial Component Present,Resectable Digestive System Carcinoma,1
16695,Absence of Invasion,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
16696,Refractory Disease,Refractory Extranodal Diffuse Large B-cell Lymphoma,1
16697,Low Mitotic Activity,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,1
16698,Malignant Cellular Infiltrate,Peripheral primitive neuroectodermal bone tumor,1
16699,Nuclear Grooves,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
16700,Malignant Cellular Infiltrate,Primary Cutaneous Follicle Center Lymphoma,1
16701,Locally Aggressive Lesion,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,1
16702,Primary Lesion,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
16703,Epithelial Component Present,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,1
16704,Epithelial Component Present,Anatomic Stage IIIC Breast Cancer AJCC v8,1
16705,Nuclear Atypia,MGMT-Unmethylated Glioblastoma,1
16706,Epithelial Component Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
16707,Carcinomatous Component Present,Alcohol-Related Hepatocellular Carcinoma,1
16708,Locally Aggressive Lesion,Lipofibromatosis,1
16709,Recurrent disease,Recurrent Malignant Neoplasm,1
16710,Epithelial Component Present,Skin Squamous Cell Carcinoma In Situ,1
16711,Acute inflammation,Acute lymphadenitis,1
16712,Malignant Cellular Infiltrate,Liver Fibrosarcoma,1
16713,Epithelial Component Present,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
16714,Local disease,Tendon Sheath Lipoma,1
16715,High Grade Lesion,Adult Glioblastoma,1
16716,Neuroendocrine Differentiation,Esophageal Large Cell Neuroendocrine Carcinoma,1
16717,Necrotic changes (finding),Neural Glioblastoma,1
16718,Malignant Cellular Infiltrate,Metastatic Pancreatic Neuroendocrine Carcinoma,1
16719,Carcinomatous Component Present,Metastatic Signet Ring Cell Breast Carcinoma,1
16720,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Pathologic Stage,1
16721,Carcinomatous Component Present,combined small cell carcinoma of lung,1
16722,Lymphadenopathy,Monocytoid B-cell lymphoma,1
16723,Carcinomatous Component Present,Unclassified Renal Cell Carcinoma,1
16724,Vascular Channel Formation,Cutaneous Radiation-Related Angiosarcoma,1
16725,Benign Cellular Infiltrate,Squamous Papilloma of the Larynx,1
16726,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage IV,1
16727,Infiltrating Tumor Margins Present,Malignant phyllodes tumor of breast,1
16728,Tissue Differentiation Uncertain,Vulvar Angiomyxoma,1
16729,Papillary Pattern,papillary carcinoma of penis,1
16730,Stromal Invasion,adenosquamous carcinoma of ovary,1
16731,Epithelial Component Present,Stage III Ureter Cancer AJCC v8,1
16732,Malignant Epithelial Cells with Abundant Clear Cytoplasm Containing Glycogen Present,Glycogen-rich carcinoma,1
16733,Cutaneous Involvement,Aleukemic Monocytic Leukemia Cutis,1
16734,Epithelial Component Present,Adenocarcinoma of the prostate stage IV,1
16735,Cutaneous Involvement,Superficial spreading malignant melanoma of skin,1
16736,Benign Cellular Infiltrate,Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm,1
16737,"Fully Differentiated ""Adult-Type"" Tissues Present",Benign Teratoma,1
16738,High Mitotic Activity,Recurrent Anaplastic Oligoastrocytoma,1
16739,Epithelial Component Present,Ameloblastic Carcinoma Derived From Odontogenic Cyst,1
16740,Benign Cellular Infiltrate,Benign neoplasm of retroperitoneum,1
16741,Metastatic Lesion,Secondary malignant neoplasm of sternum,1
16742,Severe dysplasia,Stage 0is Ureter Cancer AJCC v7,1
16743,Well Differentiated Lesion,Grade I Chondrosarcoma,1
16744,Malignant Cellular Infiltrate,Metastatic Bone Sarcoma,1
16745,Neuroendocrine Differentiation,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
16746,Metastatic Lesion,Metastatic Malignant Germ Cell Tumor,1
16747,Nuclear pleomorphism,Large Cell Dysplasia,1
16748,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Pathologic Stage,1
16749,Epithelial Component Present,Adenoma of the nipple,1
16750,Chronic lymphocytic inflammation,Retroperitoneal Inflammatory Myofibroblastic Tumor,1
16751,Recurrent disease,Recurrent Adenoid Cystic Carcinoma,1
16752,Neuroendocrine Differentiation,Glucagonoma,1
16753,Carcinomatous Component Present,Uterine Carcinosarcoma,1
16754,Cysts Containing Proteinaceous Fluid Present,"Cystadenoma, Serous",1
16755,Endophytic Tumor Growth,Ethmoid Sinus Inverted Papilloma,1
16756,Recurrent disease,Recurrent Chromophobe Renal Cell Carcinoma,1
16757,Rapidly Enlarging Mass,Childhood Rhabdomyosarcoma,1
16758,Carcinomatous Component Present,small cell carcinoma of kidney,1
16759,Well-Circumscribed Lesion,Ureteric polyp,1
16760,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Hypergranular promyelocytic leukemia,1
16761,Metastatic Lesion,Metastatic Unresectable Malignant Neoplasm,1
16762,Carcinomatous Component Present,Carcinoma of lower gum,1
16763,Epithelial Component Present,Proximal Urethral Carcinoma,1
16764,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage II,1
16765,Osteoid formation,Breast Extraskeletal Osteosarcoma,1
16766,Carcinomatous Component Present,"Carcinoma of urinary bladder, superficial",1
16767,Carcinomatous Component Present,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8,1
16768,Local disease,Localized Lymphoma,1
16769,Dysplasia,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",1
16770,Diffuse Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",1
16771,Hemorrhagic,Angiosarcoma NCI Grade 2,1
16772,Metastatic/Recurrent Disease,"Sarcoma, Epithelioid",1
16773,Mixed Cellular Population,"Neoplasms, Fibroepithelial",1
16774,High Mitotic Activity,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
16775,Dysplasia,Esophageal High Grade Intraepithelial Neoplasia,1
16776,Primary Lesion,Extra-osseous Ewing's sarcoma recurrent,1
16777,Carcinomatous Component Present,Stage IVB Basal Cell Lip Carcinoma,1
16778,Malignant Cellular Infiltrate,Unresectable Urothelial Carcinoma,1
16779,Carcinomatous Component Present,Refractory Endometrial Serous Adenocarcinoma,1
16780,Malignant Cellular Infiltrate,PNET of bone localized,1
16781,Epithelial Component Present,Stage 0is Renal Pelvis Cancer AJCC v7,1
16782,Carcinomatous Component Present,Locally Advanced Unresectable Prostate Carcinoma,1
16783,Immunoglobulin Deposition,Immunoglobulin deposition disease,1
16784,Ground Glass Nuclear Inclusion,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
16785,Epithelial Component Present,Carcinoma of the Appendix,1
16786,Mixed Cellular Population,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
16787,Epithelial Component Present,Mixed Somatotroph and Lactotroph Adenoma,1
16788,Malignant Cellular Infiltrate,Primary malignant neoplasm of glomus jugulare,1
16789,Recurrent disease,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1
16790,Well Differentiated Lesion,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type",1
16791,Papillary Pattern,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
16792,Numerous Stromal Mast Cells Present,Central Nervous System Myofibroblastoma,1
16793,Malignant Cellular Infiltrate,Uterine Corpus Sarcoma by AJCC v8 Stage,1
16794,Epithelial Component Present,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
16795,Hyperkeratosis,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
16796,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity recurrent,1
16797,Recurrent disease,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
16798,Malignant Cellular Infiltrate,Esophageal Basaloid Carcinoma,1
16799,Carcinomatous Component Present,Stage I Prostate Cancer AJCC v8,1
16800,Malignant Cellular Infiltrate,Brain Glioblastoma,1
16801,Fibrotic Stroma Formation,Malignant Brenner Tumor,1
16802,Increased Cellularity Present,Anaplastic Oligodendroglioma,1
16803,Pseudorosette Formation,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
16804,Recurrent disease,Recurrent Malignant Skin Neoplasm,1
16805,Myxoid Stroma Formation,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
16806,Increased Cellularity Present,Refractory Neuroblastoma,1
16807,Diffuse Pattern,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,1
16808,Hemorrhagic,Skin Angiosarcoma,1
16809,Malignant Cellular Infiltrate,Type I Endometrial Adenocarcinoma,1
16810,Carcinomatous Component Present,Stage IIA Small Intestinal Cancer AJCC v7,1
16811,Epithelial Component Present,Stage IA1 Cervical Cancer AJCC v8,1
16812,Nodular Pattern,Distal-Type Epithelioid Sarcoma,1
16813,Carcinomatous Component Present,mucoepidermoid carcinoma of esophagus,1
16814,Epithelial Component Present,Intrahepatic Bile Duct Papillary Neoplasm,1
16815,Malignant Cellular Infiltrate,Recurrent Childhood Medulloblastoma,1
16816,Regional Disease,Locally Advanced Pancreatic Ductal Adenocarcinoma,1
16817,Malignant Cellular Infiltrate,large B-cell diffuse lymphoma of liver,1
16818,Carcinomatous Component Present,Stage II Penile Cancer AJCC v8,1
16819,Cystic Change,Keratocystic Odontogenic Tumor,1
16820,Cellular Pleomorphism,Malignant Testicular Sertoli Cell Tumor,1
16821,New bone formation (morphologic abnormality),Giant Cell Lesion of Small Bones,1
16822,High Mitotic Activity,Stage I Lung Small Cell Carcinoma AJCC v7,1
16823,Intermediate Filaments Present,Atypical Teratoid Rhabdoid Tumor,1
16824,Dilated Thin-Walled Vascular Space Formation,Vulvar Angiomyofibroblastoma,1
16825,Benign Cellular Infiltrate,"Testicular Sertoli Cell Tumor, Lipid Rich Variant",1
16826,Epithelial Differentiation,Papillary tumor of the pineal region,1
16827,Hyperkeratosis,Bowen's Disease,1
16828,Carcinomatous Component Present,Small Intestinal Squamous Cell Carcinoma,1
16829,Neuroendocrine Differentiation,Adrenal Gland Composite Pheochromocytoma,1
16830,Carcinomatous Component Present,Acinar Prostate Mucinous Adenocarcinoma,1
16831,Malignant Cellular Infiltrate,Acute promyelocytic leukemia - hypogranular variant,1
16832,Carcinomatous Component Present,Bladder adenocarcinoma stage 0,1
16833,Malignant Cellular Infiltrate,Non-Resectable Malignant Liver Neoplasm,1
16834,Hemorrhagic,Giant Cell Lesion of Small Bones,1
16835,Epithelial Component Present,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,1
16836,Nuclear Atypia,Anaplastic astrocytoma,1
16837,Dysplasia,Appendix Sessile Serrated Adenoma/Polyp,1
16838,Malignant Cellular Infiltrate,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
16839,Epithelial Component Present,Adult Pleomorphic Hepatocellular Carcinoma,1
16840,Epithelial Component Present,adenocarcinoma of epididymis,1
16841,Anaplasia,Glioblastoma with Primitive Neuronal Component,1
16842,Intracanalicular Growth Pattern,Malignant phyllodes tumor of breast,1
16843,Epithelial Component Present,Carcinoma of soft palate,1
16844,Diffuse Pattern,Immunoblastic lymphoma associated with AIDS,1
16845,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type III,1
16846,Epithelial Component Present,Cervical Cancer by AJCC v6 Stage,1
16847,Malignant Cellular Infiltrate,Ovarian germ cell tumor mixed,1
16848,Epithelial Component Present,Colon Cancer by AJCC v8 Stage,1
16849,Malignant Cellular Infiltrate,Anatomic Stage 0 Breast Cancer AJCC v8,1
16850,Epithelial Component Present,Anal Ectopic Fibroadenoma,1
16851,Hyperkeratosis,Papillary squamous cell carcinoma,1
16852,Malignant Cellular Infiltrate,Refractory Human Papillomavirus-Related Malignant Neoplasm,1
16853,Neuroendocrine Differentiation,Small cell carcinoma of lung,1
16854,Epithelial Component Present,Supraglottic Verrucous Carcinoma,1
16855,Unclassifiable Lesion,"Intestinal T-Cell Lymphoma, Not Otherwise Specified",1
16856,Seminomatous Component Present,Testicular Mixed Embryonal Carcinoma and Seminoma,1
16857,Malignant Cellular Infiltrate,Stage IVB Colon Cancer AJCC v7,1
16858,Diffuse Pattern,Anaplastic Oligodendroglioma,1
16859,High Mitotic Activity,Platinum-Sensitive Lung Small Cell Carcinoma,1
16860,Poorly Differentiated Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
16861,Hyperkeratosis,Cervical Papillary Squamous Cell Carcinoma,1
16862,Adulthood Lesion,Adult Subependymoma,1
16863,Pre-existing condition,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes,1
16864,Carcinomatous Component Present,Familial medullary thyroid carcinoma,1
16865,Extraosseous Lesion,Extra-osseous Ewing's sarcoma non-metastatic,1
16866,Secondary Lesion,Peripheral neuroepithelioma of bone metastatic,1
16867,In Situ Lesion,Stage 0 Colon Cancer AJCC v6 and v7,1
16868,Endocervical Type Epithelium Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",1
16869,Human Papillomavirus Positive,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage,1
16870,Childhood Lesion,Stage IV Childhood Hepatocellular Carcinoma AJCC v7,1
16871,Well-Circumscribed Lesion,Small Intestinal Tubulovillous Adenoma,1
16872,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
16873,Dysplasia,Precancerous Polyp,1
16874,Malignant Cellular Infiltrate,Stage IV Non-Hodgkin Lymphoma,1
16875,Cutaneous Involvement,Neuronevus,1
16876,Epithelial Component Present,Functioning Endocrine Neoplasm,1
16877,Low Mitotic Activity,Classic Congenital Mesoblastic Nephroma,1
16878,Slow Growing Mass,Sellar Chondroid Chordoma,1
16879,Adulthood Lesion,Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma,1
16880,Dysplasia,Stage 0 Ureter Cancer AJCC v7,1
16881,High Mitotic Activity,large cell neuroendocrine carcinoma of anal canal,1
16882,"Fully Differentiated ""Adult-Type"" Tissues Present",Dermoid cyst of skin,1
16883,In Situ Lesion,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7,1
16884,Papillary Pattern,Bladder Non-Invasive Papillary Urothelial Neoplasm,1
16885,Malignant Cellular Infiltrate,Stage III Rectosigmoid Cancer AJCC v6,1
16886,Carcinomatous Component Present,Stage IVB Liver Cancer,1
16887,Refractory Disease,Refractory Soft Tissue Sarcoma,1
16888,Epithelial Component Present,Glomus Jugulare Tumor,1
16889,Malignant Cellular Infiltrate,Grade 1 Diffuse Follicular Lymphoma,1
16890,Exophytic Polypoid Lesion,Vaginal Rhabdomyoma,1
16891,Indolent Clinical Course,Colon Leiomyoma,1
16892,Malignant Primitive Cellular Infiltrate,Ovarian Primitive Germ Cell Tumor,1
16893,Carcinomatous Component Present,Stage I Lung Small Cell Carcinoma AJCC v7,1
16894,Hyaline Cartilage Differentiation,Grade III Chondrosarcoma,1
16895,Carcinomatous Component Present,High Grade Ovarian Serous Adenocarcinoma,1
16896,Metastatic Lesion,Metastatic Malignant Neoplasm in the Sellar Region,1
16897,Exophytic Polypoid Lesion,Rectal Tubular Adenoma,1
16898,Malignant Cellular Infiltrate,Infratentorial Glioblastoma,1
16899,Malignant Cellular Infiltrate,Uterine Carcinosarcoma,1
16900,Malignant Cellular Infiltrate,Primary Childhood Soft Tissue Sarcoma,1
16901,Biphasic Pattern,carcinosarcoma of extrahepatic bile duct,1
16902,Malignant Cellular Infiltrate,recurrent gastric cancer,1
16903,Epidermotropic Lymphocytic Infiltrate,Stage IA Mycosis Fungoides AJCC v7,1
16904,Carcinomatous Component Present,minimally invasive follicular carcinoma of the thyroid gland,1
16905,Single Cell Necrosis,Stage IIA Merkel Cell Carcinoma AJCC v7,1
16906,Carcinomatous Component Present,Stage 0a Renal Pelvis Cancer AJCC v7,1
16907,Hyperkeratosis,Verrucous carcinoma of the oral cavity recurrent,1
16908,Nuclear Atypia,Grade III Childhood Astrocytoma,1
16909,Absence of Invasion,Stage 0is Urethral Cancer AJCC v7,1
16910,Secondary Lesion,Locally Advanced Chordoma,1
16911,Malignant Cellular Infiltrate,"Peripheral Nerve Neoplasms, Malignant",1
16912,Neuroectodermal Differentiation,Refractory Neuroblastoma,1
16913,Erythema,Inflammatory Breast Carcinoma,1
16914,Malignant Cellular Infiltrate,EBV-Related Non-Hodgkin Lymphoma,1
16915,Epithelial Component Present,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
16916,Epithelial Component Present,undifferentiated carcinoma of liver,1
16917,Benign Cellular Infiltrate,Benign Intraocular Teratoid Medulloepithelioma,1
16918,Necrotic changes (finding),Choroid Necrotic Melanoma,1
16919,Carcinomatous Component Present,Stage IIB Esophageal Carcinoma,1
16920,Malignant Cellular Infiltrate,Recurrent Grade III Lymphomatoid Granulomatosis,1
16921,Papillary Pattern,Bladder Urothelial Papilloma,1
16922,Epithelial Component Present,Anterior Tongue Carcinoma,1
16923,Refractory Disease,Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
16924,CD4-Positive Neoplastic Cells Present,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm,1
16925,Carcinomatous Component Present,Stage 0 Oropharyngeal Carcinoma,1
16926,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,1
16927,Tubular Pattern,Vaginal Tubular Adenoma,1
16928,Cutaneous Involvement,Classical Poroma,1
16929,Regional Disease,Regional Digestive System Neuroendocrine Tumor G1,1
16930,Peripheral Blood Involvement,Leukemic Phase of Non-Hodgkin's Lymphoma,1
16931,Malignant Cellular Infiltrate,Acantholytic squamous cell carcinoma,1
16932,Benign Cellular Infiltrate,Thyroid Gland Mucinous Follicular Adenoma,1
16933,Intestinal metaplasia,Intestinal-Type Sinonasal Adenocarcinoma,1
16934,Epithelial Component Present,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
16935,Epithelial Component Present,AIDS-Related Anal Canal Carcinoma,1
16936,S-100-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell",1
16937,Indolent Clinical Course,Leiomyomatosis,1
16938,Carcinomatous Component Present,Metastatic Lip and Oral Cavity Carcinoma,1
16939,Multifocal Lesion,Gardner Syndrome,1
16940,Unresectable Mass,Unresectable Gallbladder Carcinoma,1
16941,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with NUP98 Rearrangement,1
16942,Severe cytologic atypia,small cell carcinoma of extrahepatic bile duct,1
16943,Cystic Change,Ovarian Cystic Teratoma,1
16944,Necrotic changes (finding),Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,1
16945,High Grade Lesion,rhabdomyosarcoma of liver,1
16946,Malignant Cellular Infiltrate,Bladder Urachal Urothelial Carcinoma,1
16947,Nested Pattern,Testicular gonadoblastoma,1
16948,Dysplasia,Stage 0is Ureter Cancer AJCC v8,1
16949,Metastatic Lesion,Small intestine carcinoma metastatic,1
16950,High Grade Lesion,Adult Synovial Sarcoma,1
16951,Malignant Cellular Infiltrate,Locally Advanced Cervical Carcinoma,1
16952,Necrotic changes (finding),large cell neuroendocrine carcinoma of lung,1
16953,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
16954,Edematous Stroma Formation,Vulvar Superficial Angiomyxoma,1
16955,Epithelial Component Present,"Squamous cell carcinoma, large cell, nonkeratinizing",1
16956,Malignant Cellular Infiltrate,Refractory Thymic Carcinoma,1
16957,Hereditary Lesion,X-linked agammaglobulinemia,1
16958,Epithelial Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v8,1
16959,Glucagon-Like Peptide Positive Neoplastic Cells Present,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
16960,Epithelial Component Present,Colorectal Adenoma with Moderate Dysplasia,1
16961,Malignant Cellular Infiltrate,Adenocarcinoma in situ in villous adenoma,1
16962,Malignant Cellular Infiltrate,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
16963,Benign Cellular Infiltrate,Nephrogenic adenofibroma,1
16964,Primary Lesion,BCLC Stage D Adult Hepatocellular Carcinoma,1
16965,Epithelial Component Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
16966,Metastatic Lesion,Advanced Sarcoma,1
16967,Malignant Cellular Infiltrate,Peripheral neuroepithelioma of bone recurrent,1
16968,Hypergammaglobulinemia,Multi-centric Castleman's Disease,1
16969,Epithelial Component Present,Papillary carcinoma of the breast,1
16970,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with t(11;17)(q13;q21),1
16971,Diffuse Pattern,Adult Anaplastic Oligodendroglioma,1
16972,Immunosuppression-Related Post-Transplant Toxicity,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,1
16973,Malignant Cellular Infiltrate,Stage IV Lung Cancer AJCC v8,1
16974,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Large Cell Lymphoma,1
16975,Stromal Invasion,Ovarian Serous Adenocarcinoma,1
16976,Epithelial Component Present,Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
16977,Malignant Cellular Infiltrate,Secondary malignant neoplasm of lung,1
16978,Metastatic/Recurrent Disease,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
16979,Malignant Cellular Infiltrate,Urethral Carcinoma,1
16980,Villous Pattern,Cecum Villous Adenoma,1
16981,Carcinomatous Component Present,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
16982,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged,1
16983,Cutaneous Involvement,Cystic basal cell carcinoma,1
16984,Adulthood Lesion,Advanced Adult Hepatocellular Carcinoma,1
16985,Anaplasia,Stage I Anaplastic Large Cell Lymphoma,1
16986,Malignant Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype",1
16987,Clinical TNM Finding,Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
16988,Epithelial Component Present,Small Intestinal Medullary Carcinoma,1
16989,Malignant Cellular Infiltrate,"Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",1
16990,Cystic Change,Cystic basal cell carcinoma,1
16991,Epithelial Component Present,Malignant Ovarian Surface Epithelial-Stromal Tumor,1
16992,Secondary Lesion,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
16993,Recurrent disease,Recurrent Soft Tissue Sarcoma,1
16994,Blasts Under 10 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-1,1
16995,Epithelial Component Present,Vaginal Mesonephric Adenocarcinoma,1
16996,Crystal deposition,Alveolar soft part sarcoma recurrent,1
16997,Unresectable Mass,Unresectable Digestive System Carcinoma,1
16998,Primary Lesion,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
16999,Benign Cellular Infiltrate,Breast Apocrine Adenoma,1
17000,Epithelial Component Present,Low grade cervical glandular intraepithelial neoplasia,1
17001,Malignant Cellular Infiltrate,Villous adenocarcinoma,1
17002,Benign Cellular Infiltrate,Benign Childhood Cerebral Neoplasm,1
17003,Nuclear Expression of STAT6 Protein,Hemangiopericytoma of meninges,1
17004,Indolent Clinical Course,"Lipomatosis, Multiple Symmetrical",1
17005,Lobulated Growth Pattern,Locally Advanced Chordoma,1
17006,Cystic Lesion,Recurrent Craniopharyngioma,1
17007,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,1
17008,Angiodestructive Pattern,Grade I Lymphomatoid Granulomatosis,1
17009,Necrotic changes (finding),Resectable Dedifferentiated Liposarcoma,1
17010,Immature Myeloid Cells Increased in Bone Marrow,Treatment related acute myeloid leukaemia,1
17011,Malignant Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",1
17012,Chronic lymphocytic inflammation,Breast Inflammatory Myofibroblastic Tumor,1
17013,Carcinomatous Component Present,Adenocarcinoma of lacrimal gland,1
17014,Malignant Cellular Infiltrate,Recurrent Lung Carcinoma Cell Type Unspecified,1
17015,Malignant Cellular Infiltrate,Ear carcinoma,1
17016,High Grade Lesion,Childhood Brain Glioblastoma,1
17017,Malignant Germinomatous Cellular Infiltrate,germinoma of brain,1
17018,Cellular Pleomorphism,Malignant Testicular Sertoli Cell Tumor,1
17019,Malignant Cellular Infiltrate,Stage II Uterine Corpus Cancer AJCC v6,1
17020,Birbeck Granules Present,Tumors Derived from Langerhans Cells,1
17021,Epithelial Component Present,Stage IIIB Hilar Cholangiocarcinoma AJCC v8,1
17022,Malignant Cellular Infiltrate,Non-hodgkin lymphoma of colon,1
17023,Epithelial Component Present,Metastatic Carcinoma in the Adrenal Medulla,1
17024,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
17025,Well-Circumscribed Lesion,Vulvar Nodular Hidradenoma,1
17026,Carcinomatous Component Present,Stage 0 Penile Cancer AJCC v7,1
17027,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v7 Stage,1
17028,Skin nodule,Nodulo-ulcerative basal cell carcinoma,1
17029,Carcinomatous Component Present,Stage IIA Anal Cancer AJCC v8,1
17030,Carcinomatous Component Present,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
17031,Epithelial Component Present,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8,1
17032,Unresectable Mass,Unresectable Low Grade Glioma,1
17033,Low Mitotic Activity,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8,1
17034,Malignant Cellular Infiltrate,Prostate Kaposi Sarcoma,1
17035,Neuroendocrine Differentiation,Unresectable Pancreatic Neuroendocrine Carcinoma,1
17036,Epithelial Component Present,Stage IIB Lung Squamous Cell Carcinoma AJCC v7,1
17037,Delicate Vascular Network Formation,Grade 1 Clear Cell Renal Cell Carcinoma,1
17038,Malignant Cellular Infiltrate,Malignant lymphoma - lymphoplasmacytic,1
17039,Fibrotic Stroma Formation,endometrioid adenofibroma of ovary,1
17040,Well Differentiated Neuroendocrine Lesion,Stage IV Appendix Neuroendocrine Tumor AJCC v8,1
17041,Malignant Cellular Infiltrate,Ureter Lymphoma,1
17042,Well-Circumscribed Lesion,Rectal hyperplastic polyp,1
17043,Low Grade Lesion,"Invasive Lobular Breast Carcinoma, Solid Variant",1
17044,Malignant Cellular Infiltrate,B-cell lymphoma refractory,1
17045,Endocervical Type Epithelium Present,"Cervical Adenomyoma, Endocervical Type",1
17046,Malignant Cellular Infiltrate,Refractory Transformed B-cell Non-Hodgkin Lymphoma,1
17047,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",1
17048,Secondary Lesion,Disseminated adenocarcinoma,1
17049,Acute inflammation,Inflammatory malignant fibrous histiocytoma,1
17050,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Teratoma,1
17051,Carcinomatous Component Present,Paget Disease of the Breast without Invasive Carcinoma,1
17052,Anaplasia,Anaplastic Oligoastrocytoma,1
17053,Epithelial Component Present,BCLC Stage 0 Adult Hepatocellular Carcinoma,1
17054,Metastatic Lesion,Metastatic basal cell carcinoma,1
17055,Epithelial Component Present,Borderline Ovarian Clear Cell Tumor,1
17056,Secondary Lesion,"Glioblastoma, IDH-Mutant",1
17057,Epithelial Component Present,Lymphoepithelial malignant thymoma,1
17058,Necrotic changes (finding),Childhood Glioblastoma,1
17059,Epithelial Component Present,Grade 2 Colon Adenocarcinoma,1
17060,Immunologic Deficiency Syndromes,AIDS-Related Carcinoma,1
17061,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-0,1
17062,Epithelial Component Present,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor,1
17063,Malignant Cellular Infiltrate,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,1
17064,Refractory Disease,Splenic marginal zone lymphoma refractory,1
17065,Epithelial Component Present,Recurrent Thyroid Gland Medullary Carcinoma,1
17066,Carcinomatous Component Present,Unresectable Renal Cell Carcinoma,1
17067,Diffuse Pattern,Anaplastic Brain Stem Astrocytoma,1
17068,Epithelial Component Present,Cervical Mesonephric Adenocarcinoma,1
17069,Epithelial Component Present,Anaplastic adrenocortical carcinoma,1
17070,Nuclear Expression of STAT6 Protein,Pericardial Solitary Fibrous Tumor,1
17071,Malignant Cellular Infiltrate,Stage III renal cell cancer,1
17072,Increased Cellularity Present,Differentiating Neuroblastoma,1
17073,Vascular Channel Formation,Liver Cavernous Hemangioma,1
17074,Epithelial Component Present,Recurrent Rectal Cancer,1
17075,Adulthood Lesion,Refractory Indolent Adult Non-Hodgkin Lymphoma,1
17076,Extensive Stage Lesion,Advanced Laryngeal Squamous Cell Carcinoma,1
17077,Translocations Involving Tyrosine Kinases or Cytokine Receptors Present,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",1
17078,Papillary Pattern,Gallbladder Papillomatosis,1
17079,Multifocal Lesion,Erdheim-Chester Disease,1
17080,Delicate Vascular Network Formation,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
17081,Malignant Cellular Infiltrate,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
17082,Multinodular Mass,Dermatofibrosarcoma Protuberans,1
17083,Carcinomatous Component Present,Stage III Laryngeal Cancer AJCC v8,1
17084,Diffuse Pattern,Extracavitary Primary Effusion Lymphoma,1
17085,Carcinomatous Component Present,Colon Medullary Carcinoma,1
17086,Recurrent disease,Colon cancer recurrent,1
17087,Malignant Cellular Infiltrate,Childhood Embryonal Carcinoma,1
17088,Multinodular Lesion,Uterine Corpus Dissecting Leiomyoma,1
17089,Malignant Cellular Infiltrate,Recurrent Anal Mucinous Adenocarcinoma,1
17090,Malignant Cellular Infiltrate,Biochemically Recurrent Prostate Carcinoma,1
17091,Pathologic TNM Finding,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
17092,Malignant Cellular Infiltrate,Sinonasal undifferentiated carcinoma,1
17093,Bone Marrow Dysplasia Present,Chronic Myelomonocytic Leukemia-0,1
17094,Epithelial Component Present,Anatomic Stage I Breast Cancer AJCC v8,1
17095,Epithelial Component Present,Stage I Ureter Cancer AJCC v7,1
17096,Carcinomatous Component Present,Prostate Cancer by AJCC v8 Stage,1
17097,Carcinomatous Component Present,Small intestine carcinoma resectable,1
17098,Benign Cellular Infiltrate,Neurothekeoma,1
17099,Malignant Cellular Infiltrate,FNCLCC Sarcoma Grade 2,1
17100,Encapsulated Mass,Thyroid Gland Mucinous Follicular Adenoma,1
17101,Epithelial Component Present,Stage IIC Appendix Carcinoma AJCC v7,1
17102,Poorly Differentiated Lesion,Large cell lung cancer recurrent,1
17103,Well-Circumscribed Lesion,Conventional Cardiac Rhabdomyoma,1
17104,Cutaneous Involvement,Stage IIIC Cutaneous Melanoma AJCC v7,1
17105,Epithelial Component Present,Pathologic Stage 0 Gastric Cancer AJCC v8,1
17106,Carcinomatous Component Present,Bile duct carcinoma,1
17107,Diffuse Lesion,Liver Lymphangiomatosis,1
17108,Absence of Invasion,External Ear Actinic Keratosis,1
17109,Epithelial Component Present,Combined Lung Small Cell and Squamous Cell Carcinoma,1
17110,Exophytic Polypoid Lesion,"Adenoma, Villous",1
17111,Recurrent disease,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
17112,Epithelial Component Present,Stage II Colorectal Cancer AJCC v8,1
17113,Glomerular Hypertrophy,Focal Segmental Glomerulosclerosis Cellular Variant,1
17114,Carcinomatous Component Present,Choroid Plexus Carcinoma,1
17115,Carcinomatous Component Present,Gallbladder Cancer by AJCC v7 Stage,1
17116,Benign Cellular Infiltrate,Myoblastoma,1
17117,Carcinomatous Component Present,Mucoepidermoid carcinoma of the oral cavity,1
17118,Metaplasia,Gastric Intestinal-Type Adenocarcinoma,1
17119,Carcinomatous Component Present,Stage III Breast Cancer AJCC v6,1
17120,Poorly Differentiated Neuroendocrine Lesion,Primary hepatic neuroendocrine carcinoma,1
17121,Malignant Cellular Infiltrate,Endometrial Dedifferentiated Carcinoma,1
17122,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Corpus Carcinosarcoma,1
17123,Epithelial Component Present,Stage III Appendix Neuroendocrine Tumor AJCC v7,1
17124,Pseudoencapsulated Mass,Glandular malignant peripheral nerve sheath tumor,1
17125,Malignant Cellular Infiltrate,Laryngeal Adenosquamous Carcinoma,1
17126,Mitotic Activity,"Testicular Yolk Sac Tumor, Myxomatous Pattern",1
17127,Oligodendroglial Component Present,Anaplastic Oligoastrocytoma,1
17128,Benign Cellular Infiltrate,Benign Uveal Neoplasm,1
17129,Epithelial Component Present,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
17130,Benign Cellular Infiltrate,"Lipomatosis, Multiple Symmetrical",1
17131,Malignant Cellular Infiltrate,Metastatic Unresectable Sarcoma,1
17132,Malignant Cellular Infiltrate,Low-grade fibromyxoid sarcoma,1
17133,Malignant Cellular Infiltrate,Stage IVA Vaginal Cancer AJCC v8,1
17134,Epithelial Component Present,Stage IIIC Vulvar Cancer AJCC v8,1
17135,Mixed Cellular Population,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
17136,Childhood Lesion,Recurrent Childhood Glioblastoma,1
17137,Malignant Cellular Infiltrate,Refractory Transformed Non-Hodgkin Lymphoma,1
17138,Malignant Cellular Infiltrate,Anaplastic (Malignant) Intracranial Meningioma,1
17139,atypia morphology,Dedifferentiated Solitary Fibrous Tumor,1
17140,Malignant Cellular Infiltrate,Extraocular Cutaneous Sebaceous Carcinoma,1
17141,Nuclear Pseudoinclusion,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
17142,Epithelial Component Present,Oropharyngeal lymphepithelioma,1
17143,Dysplasia,Pancreatic Intraepithelial Neoplasia-1B,1
17144,Metastatic Lesion,"Adenocarcinoma, metastatic",1
17145,Carcinomatous Component Present,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
17146,More than 10 Mitoses per 10HPF,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
17147,Primary Lesion,Stage I Hepatocellular Carcinoma AJCC v8,1
17148,Primary Lesion,Fourth Ventricle and Brain Stem Ependymal Tumor,1
17149,Localized Lesion,Solitary Osseous Plasmacytoma,1
17150,Epithelial Component Present,Bowen's Disease,1
17151,Tissue Differentiation Uncertain,Benign Soft Tissue Tumor of Uncertain Differentiation,1
17152,Well-Circumscribed Lesion,"Polyposis, Gastric",1
17153,High Mitotic Activity,embryonal carcinoma of mediastinum,1
17154,Malignant Cellular Infiltrate,Splenic Manifestation of Hairy Cell Leukemia,1
17155,Unifocal Lesion,Pulmonary Histiocytosis X,1
17156,Carcinomatous Component Present,"Uterine Carcinosarcoma, Homologous Type",1
17157,Epithelial Component Present,Stage III Nasopharyngeal Carcinoma AJCC v7,1
17158,Carcinomatous Component Present,Lung Adenosquamous Carcinoma by AJCC v7 Stage,1
17159,Benign Cellular Infiltrate,Hemangioma of liver,1
17160,Malignant Cellular Infiltrate,Localized tumors of the Ewing's family,1
17161,Carcinomatous Component Present,Sweat Gland Tubular Carcinoma,1
17162,Primary Lesion,Recurrent Childhood Gliomatosis Cerebri,1
17163,Increased Cellularity Present,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,1
17164,Childhood Lesion,Childhood Burkitt Lymphoma,1
17165,Malignant Cellular Infiltrate,Eyelid Sebaceous Gland Carcinoma,1
17166,High Grade Lesion,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
17167,Epithelial Component Present,Metastatic Genitourinary System Carcinoma,1
17168,Epithelial Component Present,Malignant Paraganglionic Neoplasm,1
17169,Childhood Lesion,Recurrent Childhood Non-Hodgkin Lymphoma,1
17170,Neuroendocrine Differentiation,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
17171,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Choriocarcinoma and Yolk Sac Tumor,1
17172,Benign Cellular Infiltrate,Borderline Ovarian Mucinous Adenofibroma,1
17173,Solitary mass,Sellar Dedifferentiated Chordoma,1
17174,Epithelial Component Present,Stage I Colorectal Cancer AJCC v8,1
17175,Recurrent disease,Recurrent Sarcoma,1
17176,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
17177,Well Differentiated Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G2,1
17178,Mixed Cellular Population,carcinosarcoma of fallopian tube,1
17179,Primary Lesion,Anaplastic Hemispheric Astrocytoma,1
17180,Carcinomatous Component Present,carcinosarcoma of gallbladder,1
17181,Epithelial Component Present,Stage II Jejunal Neuroendocrine Tumor AJCC v8,1
17182,Malignant Cellular Infiltrate,Prostate Basal Cell Carcinoma,1
17183,Cutaneous Involvement,Pigmented hairy epidermal nevus,1
17184,Neuroendocrine Differentiation,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
17185,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma stage III,1
17186,Epithelial Component Present,Recurrent Lip Basal Cell Carcinoma,1
17187,Recurrent disease,Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
17188,Neuroectodermal Differentiation,Extracranial Neuroblastoma,1
17189,Recurrent disease,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma,1
17190,Unclassifiable Lesion,"Recurrent NK-Cell Lymphoma, Unclassifiable",1
17191,Carcinomatous Component Present,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
17192,Malignant Cellular Infiltrate,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
17193,Carcinomatous Component Present,Stage IIB Appendix Carcinoma AJCC v7,1
17194,Epithelial Component Present,Colorectal Neuroendocrine Tumor by AJCC v8 Stage,1
17195,Perivascular Arrangement of Tumor Cells,Childhood Kidney Angiomyolipoma,1
17196,Slow Growing Mass,Subependymal Giant Cell Astrocytoma,1
17197,Malignant Cellular Infiltrate,Anterior Tongue Squamous Cell Carcinoma,1
17198,Multinodular Mass,Conventional Angiosarcoma,1
17199,Smooth Muscle Component Present,Epithelioid Type Angiomyolipoma,1
17200,Epithelial Component Present,Recurrent Cervical Adenocarcinoma,1
17201,Indolent Clinical Course,Adenomatoid tumor of epididymis,1
17202,Neoplastic Plasma Cells Present in Bone Marrow,Indolent multiple myeloma,1
17203,Epithelial Component Present,Bladder adenocarcinoma stage 0,1
17204,Adulthood Lesion,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,1
17205,Myxoid Stroma Formation,Childhood Epithelioid Hemangioendothelioma,1
17206,Epithelial Component Present,Salivary duct carcinoma,1
17207,Recurrent disease,Esophageal carcinoma recurrent,1
17208,Biphasic Pattern,Ovarian Mucinous Adenofibroma,1
17209,In Situ Lesion,Stage 0 Major Salivary Gland Cancer AJCC v8,1
17210,Malignant Cellular Infiltrate,Malignant melanoma of vulva,1
17211,Malignant Cellular Infiltrate,Thymic Adenosquamous Carcinoma,1
17212,Metastatic Lesion,Castration-Naive Prostate Carcinoma,1
17213,Epithelial Differentiation,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
17214,Necrotic changes (finding),Multifocal Glioblastomas,1
17215,Epithelial Component Present,Gallbladder Biliary Intraepithelial Neoplasia,1
17216,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Uterine Corpus Carcinosarcoma,1
17217,Epithelial Component Present,Advanced Head and Neck Carcinoma,1
17218,Vascular Channel Formation,Colon Lymphangioma,1
17219,Severe dysplasia,Carcinoma in Situ,1
17220,Low Grade Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G1,1
17221,Primary Lesion,Stage IB Osteosarcoma AJCC v7,1
17222,Blasts Under 20 Percent of Peripheral Blood White Cells,Recurrent Chronic Myelomonocytic Leukemia,1
17223,Mixed Cellular Population,Childhood Anaplastic Oligoastrocytoma,1
17224,Osseous Differentiation,Stage IB Osteosarcoma AJCC v7,1
17225,Monomorphic Cellular Infiltrate,Small cell glioblastoma,1
17226,Encapsulated Mass,Stage I Thyroid Gland Follicular Carcinoma AJCC v7,1
17227,Secondary Lesion,Locally Advanced Cervical Adenocarcinoma,1
17228,Tissue Differentiation Uncertain,Cardiac Monophasic Synovial Sarcoma,1
17229,Malignant Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement,1
17230,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Monodermal and Highly Specialized Teratoma,1
17231,Metastatic Lesion,Stage IV Nasopharyngeal Carcinoma,1
17232,Vascular Channel Formation,Hemangioma of subcutaneous tissue,1
17233,Malignant Cellular Infiltrate,Refractory Urothelial Carcinoma,1
17234,Epithelial Component Present,Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
17235,Cellular Pleomorphism,Chondroblastic osteosarcoma,1
17236,Monoclonal Langerhans Cells Present,Adult Langerhans Cell Histiocytosis,1
17237,Malignant Cellular Infiltrate,Bladder Papillary Clear Cell Adenocarcinoma,1
17238,Malignant Cellular Infiltrate,Central Nervous System Leiomyosarcoma,1
17239,Metastatic/Recurrent Disease,Adult Synovial Sarcoma,1
17240,In Situ Lesion,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
17241,Carcinomatous Component Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
17242,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Choriocarcinoma,1
17243,Blasts 5 Percent or More of Bone Marrow Nucleated Cells,High Risk Myelodysplastic Syndrome,1
17244,Myxoid Stroma Formation,Chordoma of clivus,1
17245,Fibrotic Stroma Formation,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,1
17246,Neuroendocrine Differentiation,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
17247,Carcinomatous Component Present,BCLC Stage D Hepatocellular Carcinoma,1
17248,Malignant Cellular Infiltrate,Papillary carcinoma in situ,1
17249,Metastatic Lesion,Lung Carcinoma Metastatic in the Central Nervous System,1
17250,Infiltrative Growth Pattern,Childhood Protoplasmic Astrocytoma,1
17251,Nuclear Atypia,Multifocal Glioblastomas,1
17252,Thin Bands of Collagen Present,Malignant Solitary Fibrous Tumor,1
17253,Epithelial Component Present,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
17254,Chronic lymphocytic inflammation,Parotid Gland Warthin Tumor,1
17255,Carcinomatous Component Present,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,1
17256,Monoclonal Gammapathies,IgM monoclonal gammopathy of uncertain significance,1
17257,Epithelial Component Present,Papillary Thyroid Microcarcinoma,1
17258,Neuroendocrine Differentiation,Regional Digestive System Neuroendocrine Tumor G1,1
17259,Fenestrated Pattern,Desmoplastic trichoepithelioma,1
17260,Deep Lesion,"Liposarcoma, well differentiated",1
17261,Benign Cellular Infiltrate,Testicular Large Cell Calcifying Sertoli Cell Tumor,1
17262,Carcinomatous Component Present,Stage II Rectal Cancer AJCC v7,1
17263,High Mitotic Activity,Stage IA Merkel Cell Carcinoma AJCC v7,1
17264,Epithelial Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage,1
17265,Cutaneous Involvement,Vulvar Nodular Hidradenoma,1
17266,Encapsulated Mass,minimally invasive follicular carcinoma of the thyroid gland,1
17267,Malignant Cellular Infiltrate,Prostate cancer stage B,1
17268,Epithelial Component Present,Gastric Cancer by AJCC v7 Stage,1
17269,Malignant Cellular Infiltrate,Stage IIC Colorectal Cancer AJCC v7,1
17270,Malignant Cellular Infiltrate,Frontal Lobe Anaplastic Oligodendroglioma,1
17271,Epithelial Component Present,"Carcinoma, Transitional Cell",1
17272,Malignant Cellular Infiltrate,Unresectable Carcinoma,1
17273,Cutaneous Involvement,Leukemic infiltration of skin,1
17274,Fibrotic Stroma Formation,Ovarian Mucinous Cystadenofibroma,1
17275,Biphasic Pattern,Stage III Uterine Corpus Adenosarcoma AJCC v8,1
17276,Metaplasia,intestinal type adenocarcinoma of gallbladder,1
17277,Epithelial Component Present,Bladder squamous cell carcinoma stage I,1
17278,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage I,1
17279,Diffuse Pattern,MGMT-Methylated Glioblastoma,1
17280,Malignant Cellular Infiltrate,Superior Sulcus Lung Carcinoma,1
17281,Malignant Cellular Infiltrate,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
17282,Hereditary Lesion,X-linked agammaglobulinemia,1
17283,Epithelial Component Present,Pyriform Fossa Carcinoma,1
17284,Malignant Cellular Infiltrate,Peripheral T-cell lymphoma unspecified refractory,1
17285,Borderline Lesion,"Papillary mucinous cystadenoma, borderline malignancy",1
17286,Infiltrating Tumor Margins Present,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
17287,Anaplasia,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
17288,Thick-Walled Hyalinized Vessels Present,Gastric Schwannoma,1
17289,Malignant Cellular Infiltrate,Large cell lung cancer stage III,1
17290,Rarely Metastasizing Lesion,Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm,1
17291,Pathologic TNM Finding,Pathologic Stage IV Cutaneous Melanoma AJCC v8,1
17292,Carcinomatous Component Present,Adenocarcinoma,1
17293,Anaplasia,anaplastic large cell lymphoma of central nervous system,1
17294,Carcinomatous Component Present,AIDS-Related Anal Canal Carcinoma,1
17295,Childhood Lesion,Pediatric Neoplasm,1
17296,Malignant Cellular Infiltrate,"Liposarcoma, Pleomorphic",1
17297,Carcinomatous Component Present,External Ear Squamous Cell Carcinoma,1
17298,Malignant Cellular Infiltrate,Nasopharyngeal squamous cell carcinoma stage III,1
17299,Malignant Cellular Infiltrate,Microcystic adnexal carcinoma,1
17300,Cutaneous Involvement,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
17301,Invasive Lesion,Adenocarcinoma of the prostate stage II,1
17302,Epithelial Component Present,Stage III Esophageal Squamous Cell Carcinoma AJCC v7,1
17303,Nodular Pattern,Grade 3 Cutaneous Follicular Lymphoma,1
17304,Diffuse Pattern,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
17305,Splenomegaly,"T-Cell Prolymphocytic Leukemia, Small Cell Variant",1
17306,Mixed Cellular Population,Vaginal Carcinosarcoma,1
17307,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,"Myelodysplastic syndrome, no ICD-O subtype",1
17308,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
17309,Indolent Clinical Course,Nuchal-type fibroma,1
17310,Carcinomatous Component Present,Stage II Colorectal Cancer AJCC v8,1
17311,Epithelial Component Present,Penile Cancer by AJCC v8 Stage,1
17312,Benign Cellular Infiltrate,Leiomyoma of Gallbladder,1
17313,Mesenchymal Differentiation,gliosarcoma,1
17314,Epithelial Component Present,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
17315,Complete Spontaneous Regression,Lymphomatoid Papulosis with Chromosome 6p25 Rearrangement,1
17316,Malignant Cellular Infiltrate,Childhood Desmoplastic Small Round Cell Tumor,1
17317,Indolent Clinical Course,Hemangioma of bone,1
17318,Malignant Cellular Infiltrate,AIDS-Related Plasmablastic Lymphoma of Mucosa Site,1
17319,Carcinomatous Component Present,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
17320,Vascular Channel Formation,Blood Vessel Tumors,1
17321,Immunologic Deficiency Syndromes,Immunodeficiency-associated Burkitt's lymphoma,1
17322,Carcinomatous Component Present,Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
17323,Malignant Cellular Infiltrate,Unresectable Ureter Urothelial Carcinoma,1
17324,Neuroendocrine Differentiation,Extra-Adrenal Retroperitoneal Paraganglioma,1
17325,Invasive Lesion,"Squamous cell carcinoma, microinvasive",1
17326,Necrotic changes (finding),"Liposarcoma, Dedifferentiated",1
17327,Borderline Lesion,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
17328,Poorly Differentiated Neuroendocrine Lesion,Gastric Large Cell Neuroendocrine Carcinoma,1
17329,Hyperkeratosis,Trichilemmoma,1
17330,Malignant Cellular Infiltrate,Stage IVA Colon Cancer AJCC v7,1
17331,Malignant Cellular Infiltrate,Bone Sarcoma by AJCC v7 Stage,1
17332,Primary Lesion,Refractory Central Nervous System Lymphoma,1
17333,Composite Lesion,"Ganglioneuroblastoma, Nodular",1
17334,Benign Cellular Infiltrate,Dermal Duct Tumor,1
17335,Malignant Cellular Infiltrate,Stage IIB Uterine Sarcoma AJCC v7,1
17336,Diffuse Pattern,Malignant Peripheral Nerve Sheath Tumor,1
17337,Benign Cellular Infiltrate,Paranasal Sinus Schneiderian Papilloma,1
17338,Epithelial Component Present,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,1
17339,Carcinomatous Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,1
17340,Exophytic Polypoid Lesion,Ampulla of Vater Tubulovillous Adenoma,1
17341,High Mitotic Activity,Small Intestinal Neuroendocrine Carcinoma,1
17342,Epithelial Component Present,Stage IB Lung Large Cell Carcinoma AJCC v7,1
17343,Nested Pattern,Gonadoblastoma,1
17344,Immunosuppression-Related Post-Transplant Toxicity,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder,1
17345,Epithelial Component Present,Stage IIA Fallopian Tube Cancer AJCC v6 and v7,1
17346,Local disease,Localized Gastroesophageal Junction Adenocarcinoma,1
17347,Numerous Stromal Mast Cells Present,Palisaded Lymph Node Myofibroblastoma,1
17348,Malignant Cellular Infiltrate,Aleukemic Lymphoid Leukemia,1
17349,Cutaneous Involvement,Ichthyosis Vulgaris,1
17350,Epithelial Component Present,Ovarian Sertoli Cell Tumor,1
17351,Poorly Cohesive Malignant Cellular Infiltrate,Poorly Cohesive Gastric Carcinoma,1
17352,Diffuse Pattern,Childhood Gliomatosis Cerebri,1
17353,Malignant Cellular Infiltrate,Malignant Placental Neoplasm,1
17354,Papillary Pattern,Renal papillary adenoma,1
17355,Carcinomatous Component Present,Breast cancer recurrent,1
17356,Arborizing Vascular Channel Formation,Retiform hemangioendothelioma,1
17357,Melanin Pigment Present,Vulvar Blue Nevus,1
17358,Malignant Cellular Infiltrate,Malignant Abdominal Neoplasm,1
17359,Diffuse Pattern,Stage III Adult Immunoblastic Lymphoma,1
17360,Carcinomatous Component Present,Lung Lymphoepithelioma-Like Carcinoma,1
17361,Malignant Cellular Infiltrate,Acute lymphocytic leukemia,1
17362,Malignant Cellular Infiltrate,Recurrent Sarcoma,1
17363,Carcinomatous Component Present,Stage IIIA Fallopian Tube Cancer AJCC v8,1
17364,Carcinomatous Component Present,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
17365,Low Grade Neuroendocrine Lesion,Meckel Diverticulum Neuroendocrine Tumor G1,1
17366,Thick-Walled Vessels Present,Endometrial Polyp,1
17367,High Grade Lesion,Stage II Lung Small Cell Carcinoma AJCC v7,1
17368,Malignant Cellular Infiltrate,Grade 2 Rectal Adenocarcinoma,1
17369,Eosinophilic inflammation,Lung Inflammatory Myofibroblastic Tumor,1
17370,Secondary Lesion,Reactive systemic amyloidosis,1
17371,Malignant Cellular Infiltrate,Anal Lymphoma,1
17372,Mixed Cellular Population,Blastema Predominant Kidney Wilms Tumor,1
17373,Neuroendocrine Differentiation,Cervical Atypical Carcinoid Tumor,1
17374,Epithelial Component Present,Frontal Sinus Schneiderian Papilloma,1
17375,Immunosuppression-Related Post-Transplant Toxicity,Renal Allograft Thrombosis,1
17376,Epithelial Component Present,Sporadic Cylindroma,1
17377,Metastatic/Recurrent Disease,"Synovial sarcoma, spindle cell",1
17378,Primary Lesion,Brain Glioblastoma,1
17379,Carcinomatous Component Present,Low Grade Ovarian Serous Adenocarcinoma,1
17380,Malignant Cellular Infiltrate,Rectal Cancer by AJCC v6 Stage,1
17381,Immunologic Deficiency Syndromes,Autoimmune Lymphoproliferative Syndrome-Associated Lymphoma,1
17382,Carcinomatous Component Present,Carcinoma of Male Breast,1
17383,Intestinal metaplasia of gastric mucosa,tubular adenoma of stomach,1
17384,Epithelial Component Present,Syringoma,1
17385,Carcinomatous Component Present,Unresectable Thymic Carcinoma,1
17386,Benign Cellular Infiltrate,Benign Uterine Ligament Neoplasm,1
17387,Epithelial Component Present,Minor Salivary Gland Acinic Cell Carcinoma,1
17388,Malignant Cellular Infiltrate,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
17389,Carcinomatous Component Present,Oropharyngeal Basaloid Carcinoma,1
17390,Benign Cellular Infiltrate,Benign neoplasm of the lip,1
17391,Epithelial Component Present,Fallopian Tube Carcinoma,1
17392,Epithelial Component Present,Stage IV Cervical Cancer AJCC v8,1
17393,Malignant Cellular Infiltrate,Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7,1
17394,Childhood Lesion,Primary Childhood Soft Tissue Sarcoma,1
17395,Chromogranin A Positive Neoplastic Cells Present,Metastatic carcinoid tumor,1
17396,Borderline Lesion,Serous papillary cystic tumor of borderline malignancy,1
17397,Non-Invasive Lesion,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,1
17398,Malignant Cellular Infiltrate,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
17399,Benign Cellular Infiltrate,Benign Extragonadal Germ Cell Tumor,1
17400,Indolent Clinical Course,Myolipoma,1
17401,Malignant Cellular Infiltrate,Refractory cytopenia with unilineage dysplasia,1
17402,Slow Growing Mass,Tanycytic ependymoma,1
17403,Mixed Cellular Population,Mixed Neoplasm,1
17404,Low Grade Neuroendocrine Lesion,Recurrent Digestive System Neuroendocrine Tumor G1,1
17405,Carcinomatous Component Present,Intrahepatic cholangiocarcinoma recurrent,1
17406,Vascular Channel Formation,Digestive System Hemangioma,1
17407,Malignant Cellular Infiltrate,Malignant Uterine Corpus Neoplasm,1
17408,Epithelial Component Present,Metanephric adenoma,1
17409,Desmoplastic Stroma Formation,Recurrent Desmoplastic Small Round Cell Tumor,1
17410,Epithelial Component Present,keratinizing squamous cell carcinoma of nasal cavity,1
17411,Epithelial Component Present,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
17412,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Acute myelomonocytic leukemia,1
17413,Epithelial Component Present,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
17414,Carcinomatous Component Present,Pancreatic adenocarcinoma recurrent,1
17415,Neuroendocrine Differentiation,Metastatic carcinoid tumor,1
17416,In Situ Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,1
17417,Multifocal Lesion,Atypical Breast Myoepitheliosis,1
17418,Mitotic Activity,Testicular Mixed Choriocarcinoma and Yolk Sac Tumor,1
17419,Epithelial Component Present,Biliary Intraepithelial Neoplasia,1
17420,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Leiomyosarcoma AJCC v8,1
17421,Carcinomatous Component Present,Large cell neuroendocrine carcinoma,1
17422,Polymorphic Cellular Infiltrate,Infectious Mononucleosis,1
17423,Mitotic Activity,Adult Gliosarcoma,1
17424,Unifocal Lesion,Pulmonary Histiocytosis X,1
17425,Malignant Cellular Infiltrate,Invasive Malignant Neoplasm,1
17426,Carcinomatous Component Present,adenocarcinoma of renal pelvis,1
17427,Adnexal Differentiation,Microcystic adnexal carcinoma,1
17428,Carcinomatous Component Present,Stage IIIB Hilar Cholangiocarcinoma AJCC v7,1
17429,Well-Circumscribed Lesion,Breast Ductal Adenoma,1
17430,Metastatic Lesion,Metastatic Fibrolamellar Carcinoma,1
17431,Splenomegaly,Philadelphia chromosome negative chronic myelogenous leukemia,1
17432,Mitotic Activity,Recurrent Giant Cell Glioblastoma,1
17433,Mixture of Morphologic Patterns,Bladder Mixed Adenocarcinoma,1
17434,Adnexal Differentiation,Piloleiomyoma,1
17435,Inflammatory infiltrate,Inflammatory Leiomyosarcoma,1
17436,Macrocystic Change,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant",1
17437,Epithelial Component Present,Refractory Small Intestinal Carcinoma,1
17438,Biphasic Pattern,"Cervical Adenomyoma, Endocervical Type",1
17439,Malignant Cellular Infiltrate,"Synovial sarcoma, epithelioid cell",1
17440,Severe dysplasia,Stage 0is Ureter Cancer AJCC v7,1
17441,Odontogenic Cysts,Ameloblastic Carcinoma Derived From Odontogenic Cyst,1
17442,Favorable Clinical Outcome,Type D Lymphomatoid Papulosis,1
17443,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Desmoplastic infantile astrocytoma,1
17444,High Grade Lesion,Childhood Brain Glioblastoma,1
17445,Benign Cellular Infiltrate,benign mature teratoma of pancreas,1
17446,Neuroendocrine Differentiation,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8,1
17447,Epithelial Component Present,Thymoma malignant invasive,1
17448,Malignant Cellular Infiltrate,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated),1
17449,Necrotic changes (finding),Refractory Extensive Stage Lung Small Cell Carcinoma,1
17450,Adulthood Lesion,Stage IIA Adult Soft Tissue Sarcoma AJCC v7,1
17451,Cartilaginous Differentiation,Mesenchymal Chondrosarcoma,1
17452,Swelling,Osteoclastic Giant Cell-Rich Tumor of Bone,1
17453,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage II,1
17454,Secondary Lesion,Metastatic Malignant Neoplasm in the Adult Brain,1
17455,Low Mitotic Activity,Stage I Duodenal Neuroendocrine Tumor AJCC v8,1
17456,Vascular Channel Formation,Synovial Hemangioma,1
17457,Malignant Cellular Infiltrate,Indolent Non-Hodgkin Lymphoma,1
17458,Melanin-Forming Neuroepithelial Cells Present,Melanotic medulloblastoma,1
17459,Carcinomatous Component Present,Stage II Esophageal Adenocarcinoma AJCC v7,1
17460,Epithelial Component Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8,1
17461,Multilayered Rosette Formation,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
17462,Myxoid Stroma Formation,Fibrous Hamartoma of Infancy,1
17463,Malignant Cellular Infiltrate,Disseminated Malignant Neoplasm,1
17464,Hyaline Cartilage Differentiation,Dedifferentiated chondrosarcoma,1
17465,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma refractory,1
17466,Epithelial Component Present,Ureter Urothelial Papilloma,1
17467,Epithelial Component Present,Metaplastic carcinoma of breast,1
17468,Carcinomatous Component Present,Carcinoma in a polyp,1
17469,Malignant Cellular Infiltrate,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",1
17470,Infantile Lesion,Desmoplastic infantile astrocytoma,1
17471,Carcinomatous Component Present,Recurrent Parotid Gland Squamous Cell Carcinoma,1
17472,Recurrent disease,Recurrent Uterine Corpus Sarcoma,1
17473,Epithelial Component Present,Minor Salivary Gland Carcinoma,1
17474,Severe dysplasia,Stage 0 Esophageal Cancer AJCC v6,1
17475,Adulthood Lesion,recurrent adult acute myeloid leukemia,1
17476,Secondary Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",1
17477,Myxoid Stroma Formation,Childhood Epithelioid Hemangioendothelioma,1
17478,Encapsulated Mass,minimally invasive follicular carcinoma of the thyroid gland,1
17479,Slow Growing Mass,Skull Base Chordoma,1
17480,Neuroectodermal Differentiation,Undifferentiated Neuroblastoma,1
17481,Refractory Disease,Refractory Urothelial Carcinoma,1
17482,Hyperplastic Tissue Present,Atypical hyperplasia,1
17483,Epithelial Component Present,Stage III Jejunal Neuroendocrine Tumor AJCC v8,1
17484,Epithelial Component Present,Vulvar Cancer by AJCC v6 Stage,1
17485,Cutaneous Involvement,Subcutaneous panniculitis-like T-cell lymphoma,1
17486,Malignant Cellular Infiltrate,Uterine Ligament Mucinous Adenocarcinoma,1
17487,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
17488,High Mitotic Activity,Stage IV Lung Small Cell Carcinoma AJCC v7,1
17489,Dysplasia,Low Grade Esophageal Squamous Intraepithelial Neoplasia,1
17490,Anaplasia,Systemic Anaplastic Large Cell Lymphoma,1
17491,Mild cytologic atypia,Verrucous carcinoma,1
17492,Inclusion-Like Nucleoli,Myxoinflammatory fibroblastic sarcoma,1
17493,High Grade Lesion,Diencephalic Glioblastoma,1
17494,Ineffective hematopoiesis,Childhood Myelodysplastic Syndrome,1
17495,Malignant Cellular Infiltrate,small cell carcinoma of extrahepatic bile duct,1
17496,Precise Histogenesis Unknown,Neoplasm of Uncertain Histogenesis,1
17497,Multinodular Mass,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema,1
17498,Epithelial Component Present,Adenocarcinoma in situ in tubular adenoma,1
17499,atypia morphology,Columnar Cell Hyperplasia of the Breast with Atypia,1
17500,Monocytosis,"Leukemia, Myelomonocytic, Chronic",1
17501,Epithelial Component Present,Stage IIA Pancreatic Cancer AJCC v8,1
17502,Carcinomatous Component Present,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",1
17503,Multihormonal Immunoreactivity Present,Plurimorphous Plurihormonal Pituitary Gland Adenoma,1
17504,Infiltrating Tumor Margins Present,Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
17505,Malignant Cellular Infiltrate,Squamous cell carcinoma of buccal mucosa,1
17506,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Epipodophyllotoxin-Related Myelodysplastic Syndrome,1
17507,High Grade Lesion,Pleural Synovial Sarcoma,1
17508,Epithelial Component Present,Extrahepatic Bile Duct Neuroendocrine Tumor,1
17509,Epithelial Component Present,Tobacco Chewing-Related Carcinoma,1
17510,Pathologic TNM Finding,Pathologic Stage III Retinoblastoma AJCC v8,1
17511,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,1
17512,Malignant Cellular Infiltrate,Clinical Stage III Cutaneous Melanoma AJCC v8,1
17513,Stromal Invasion,Ovarian Cancer by AJCC v8 Stage,1
17514,Calcitonin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
17515,Malignant Cellular Infiltrate,"Thrombocythemia, Essential",1
17516,Recurrent disease,Recurrent Childhood Oligoastrocytoma,1
17517,Neuroendocrine Differentiation,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,1
17518,Carcinomatous Component Present,Stage IVC Lip Cancer AJCC v6 and v7,1
17519,Cystic Change,Breast Mucinous Cystadenocarcinoma,1
17520,Cystic Change,Brenner Tumor,1
17521,Adulthood Lesion,Lugano Classification Stage IE Adult Lymphoma AJCC v8,1
17522,Hyperplastic Tissue Present,Neoplastic C-Cell Hyperplasia,1
17523,Epithelial Component Present,Papillary serous endometrial carcinoma,1
17524,Malignant Cellular Infiltrate,Colon Leiomyosarcoma,1
17525,Neuroendocrine Differentiation,Advanced Gastric Neuroendocrine Carcinoma,1
17526,Metastatic Lesion,Secondary malignant neoplasm of pleura,1
17527,Solid Growth Pattern,Solid Alveolar Rhabdomyosarcoma,1
17528,Malignant Germinomatous Cellular Infiltrate,Germinoma,1
17529,Cutaneous Involvement,Fibroepithelioma of Pinkus,1
17530,Ground Glass Nuclear Inclusion,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
17531,Secondary Lesion,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,1
17532,Primary Lesion,Refractory Malignant Neoplasm of Multiple Primary Sites,1
17533,Epithelial Component Present,Papillary cystic tumor,1
17534,Carcinomatous Component Present,Distal Bile Duct Carcinoma,1
17535,Carcinomatous Component Present,Refractory Bladder Carcinoma,1
17536,Malignant Cellular Infiltrate,Early gastric cancer,1
17537,Epithelial Component Present,Papillary thyroid carcinoma,1
17538,Papillary Pattern,Verrucous carcinoma of penis,1
17539,Epithelial Component Present,"Cystadenocarcinoma, Mucinous",1
17540,Metastatic Lesion,Locally Advanced Unresectable Basal Cell Carcinoma,1
17541,'Starry-sky' pattern,Stage I Burkitt Lymphoma,1
17542,Epithelial Component Present,Regional Adrenal Gland Pheochromocytoma,1
17543,Fibrotic Stroma Formation,Mucinous adenofibroma,1
17544,Carcinomatous Component Present,Adenocarcinoma in adenomatous polyposis coli,1
17545,Benign Cellular Infiltrate,Frontal Sinus Schneiderian Papilloma,1
17546,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Malignant Ovarian Endometrioid Tumor,1
17547,Epithelial Component Present,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7,1
17548,Adnexal Differentiation,External Auditory Canal Ceruminous Adenoma,1
17549,Polyvesicular Vitelline Pattern,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
17550,Epithelial Component Present,Minor Salivary Gland Small Cell Carcinoma,1
17551,Splenomegaly,Splenic Manifestation of Prolymphocytic Leukemia,1
17552,Metastatic Lesion,Metastatic Vulvar Carcinoma,1
17553,Epithelial Component Present,large cell neuroendocrine carcinoma of anal canal,1
17554,Malignant Cellular Infiltrate,Pharyngeal Carcinoma by AJCC v7 Stage,1
17555,Below the Diaphragm Disease,Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
17556,Neuroendocrine Differentiation,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
17557,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,1
17558,Clinical TNM Finding,Clinical Stage III Esophageal Adenocarcinoma AJCC v8,1
17559,Carcinomatous Component Present,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
17560,Recurrent disease,Recurrent Malignant Germ Cell Tumor,1
17561,Malignant Cellular Infiltrate,Locally Advanced Unresectable Prostate Adenocarcinoma,1
17562,Epithelial Component Present,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
17563,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
17564,Malignant Cellular Infiltrate,Prostate cancer recurrent,1
17565,Epithelial Component Present,Platinum-Resistant Ovarian Carcinoma,1
17566,Benign Cellular Infiltrate,Kidney Lipoma,1
17567,Carcinomatous Component Present,Bartholin's gland carcinoma,1
17568,Nodular lesions,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
17569,Alternative Fascicle (Bundle) Pattern,Intravenous leiomyomatosis,1
17570,Infiltrative Growth Pattern,Recurrent Childhood Anaplastic Astrocytoma,1
17571,Generalized illness,Disseminated adenocarcinoma,1
17572,Exophytic Polypoid Lesion,Peutz Jehgers polyp,1
17573,Calcitonin Positive Neoplastic Cells Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
17574,Hyalinized Stroma Formation,Hemangiopericytoma of meninges,1
17575,Vascular Channel Formation,Lymphangioma,1
17576,Cutaneous Involvement,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
17577,Human Papillomavirus Negative,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
17578,Malignant Cellular Infiltrate,Locally Advanced Squamous Cell Carcinoma,1
17579,Invasive Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
17580,Epithelial Component Present,Glomus Jugulare Tumor,1
17581,Epithelial Component Present,Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
17582,Neuronal Differentiation,Medulloblastoma with extensive nodularity,1
17583,Absence of Invasion,Intraepithelial Squamous Cell Carcinoma,1
17584,Primary Lesion,Stage II Primary Peritoneal Cancer AJCC v8,1
17585,Epithelial Component Present,Granulosa cell tumor of the testis,1
17586,CD30-Positive Neoplastic Cells Present,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
17587,Secondary Lesion,Metastatic Renal Cell Carcinoma,1
17588,Immunosuppression-Related Post-Transplant Toxicity,Monomorphic Post-Transplant Lymphoproliferative Disorder,1
17589,Diffuse Pattern,Adult Mixed Glioma,1
17590,Malignant Cellular Infiltrate,Adult Pleomorphic Hepatocellular Carcinoma,1
17591,Dysplasia,Tubulovillous adenoma of rectum,1
17592,Mesenchymal Differentiation,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
17593,Malignant Cellular Infiltrate,Burkitt Lymphoma,1
17594,Dysplasia,Serous Tubal Intraepithelial Carcinoma,1
17595,Mitotic Activity,Grade III Childhood Astrocytoma,1
17596,Rapidly Enlarging Mass,Breast Rhabdomyosarcoma,1
17597,Immunoglobulin Deposition,Immunoglobulin deposition disease,1
17598,Carcinomatous Component Present,Stage IVA Vulvar Cancer AJCC v7,1
17599,Diffuse Pattern,"Diffuse large B-cell lymphoma, unclassifiable, NOS",1
17600,CD56-Positive Neoplastic Cells Present,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma,1
17601,Malignant Cellular Infiltrate,Intracortical osteosarcoma,1
17602,Epithelial Component Present,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
17603,Rare Lesion,Sex Hormone-Producing Adrenal Cortex Adenoma,1
17604,Cutaneous Involvement,Mycosis fungoides recurrent,1
17605,Malignant Cellular Infiltrate,Stage II Pancreatic Cancer AJCC v6 and v7,1
17606,Local disease,Epicardial Lipoma,1
17607,Primary Lesion,Diffuse large B-cell lymphoma of central nervous system,1
17608,Myxoid Stroma Formation,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
17609,Epithelial Component Present,Stage IIIC Ovarian Cancer,1
17610,Necrotic changes (finding),Solid pseudopapillary tumor of the pancreas,1
17611,Carcinomatous Component Present,Pseudomyxoma Peritonei,1
17612,Malignant Cellular Infiltrate,"Lymphoma, Follicular, Grade 1",1
17613,Well-Circumscribed Lesion,Classic Rhabdomyoma,1
17614,Malignant Cellular Infiltrate,Hodgkin Lymphoma During Pregnancy,1
17615,Diffuse Pattern,Diffuse large B-cell lymphoma of central nervous system,1
17616,Nodular Pattern,Ann Arbor Stage III Grade 2 Follicular Lymphoma,1
17617,Malignant Cellular Infiltrate,Stage II Childhood Lymphoblastic Lymphoma,1
17618,Epithelial Component Present,Sarcomatoid Hepatocellular Carcinoma,1
17619,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Gastric Choriocarcinoma,1
17620,Epithelial Component Present,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
17621,Epithelial Component Present,Stage IA Eyelid Carcinoma AJCC v7,1
17622,Metastatic Lesion,Secondary malignant neoplasm of stomach,1
17623,Adnexal Differentiation,Benign Eccrine Neoplasm,1
17624,Extensive Stage Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,1
17625,Epithelial Component Present,"Carcinoid, Goblet Cell",1
17626,Epithelial Component Present,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
17627,Malignant Cellular Infiltrate,Hepatoblastoma non-resectable,1
17628,Carcinomatous Component Present,Stage IVA Colon Cancer AJCC v8,1
17629,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP C",1
17630,Metastatic Lesion,Secondary malignant neoplasm of thymus,1
17631,Fibrotic Stroma Formation,Borderline Ovarian Serous Adenofibroma,1
17632,Mixed Cellular Population,Epithelial Predominant Kidney Wilms Tumor,1
17633,Well-Circumscribed Lesion,Anal polyp,1
17634,Secondary Lesion,Metastatic Renal Cell Carcinoma,1
17635,Carcinomatous Component Present,Bronchioloalveolar Adenocarcinoma,1
17636,Adnexal Differentiation,Eyelid Sebaceous Gland Carcinoma,1
17637,Therapy-Related Toxicity,Transplant-Related Carcinoma,1
17638,Epithelial Component Present,"Mesonephroma, benign",1
17639,Benign Cellular Infiltrate,Benign Extraskeletal Cartilaginous and Osseous Neoplasm,1
17640,Indolent Clinical Course,fibroma of testis,1
17641,Anaplasia,Childhood Systemic Anaplastic Large Cell Lymphoma,1
17642,Malignant Cellular Infiltrate,Stage III Gallbladder Cancer AJCC v8,1
17643,Epithelial Component Present,Stage IIA1 Cervical Cancer AJCC v8,1
17644,Malignant Cellular Infiltrate,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,1
17645,Malignant Cellular Infiltrate,Primary cutaneous lymphoma,1
17646,Argentaffin Positive Neoplastic Cells Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
17647,Calcitonin serum level increased,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,1
17648,Nuclear Grooves,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
17649,Absence of Invasion,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
17650,Epithelial Component Present,Stage IB2 Cervical Cancer,1
17651,Perineural spread,adenoid cystic carcinoma of pharynx,1
17652,Malignant Cellular Infiltrate,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
17653,Primary Lesion,Extra-osseous Ewing's sarcoma recurrent,1
17654,Thin-Walled Branching Vascular Pattern,Sellar Solitary Fibrous Tumor/Hemangiopericytoma,1
17655,Cutaneous Involvement,Anal margin basal cell carcinoma,1
17656,Primary Lesion,Asynchronous Multifocal Osteosarcoma,1
17657,Biphasic Pattern,Recurrent Ovarian Carcinosarcoma,1
17658,Primary Lesion,Recurrent Cutaneous Melanoma of the Extremity,1
17659,Hyperplastic Tissue Present,Hyperplasia of Brunner glands of duodenum,1
17660,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx recurrent,1
17661,Adnexal Differentiation,Benign neoplasm of adnexa of skin,1
17662,Benign Cellular Infiltrate,Benign neoplasm of maxillary sinus,1
17663,Carcinomatous Component Present,Small intestine carcinoma stage I,1
17664,Adulthood Lesion,Hodgkin Lymphoma During Pregnancy,1
17665,High Mitotic Activity,Ampulla of Vater Neuroendocrine Carcinoma,1
17666,Moderate dysplasia,Grade II Penile Intraepithelial Neoplasia,1
17667,Cutaneous Involvement,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
17668,Carcinomatous Component Present,Advanced Cervical Adenocarcinoma,1
17669,Malignant Cellular Infiltrate,Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
17670,Metastatic Lesion,Advanced Head and Neck Squamous Cell Carcinoma,1
17671,Lymphoplasmacytic Infiltrate,Adult Central Nervous System Germinoma,1
17672,Refractory Disease,Refractory Malignant Peripheral Nerve Sheath Tumor,1
17673,Locally Aggressive Lesion,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,1
17674,Malignant Cellular Infiltrate,Cervical Papillary Squamous Cell Carcinoma,1
17675,Metastatic/Recurrent Disease,Childhood Clear Cell Sarcoma of Soft Parts,1
17676,Carcinomatous Component Present,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
17677,Benign Cellular Infiltrate,Benign neoplasm of epiglottis,1
17678,Malignant Cellular Infiltrate,Primary Cutaneous Intravascular Large B-Cell Lymphoma,1
17679,Carcinomatous Component Present,Stage IIIC Anal Cancer AJCC v8,1
17680,Malignant Cellular Infiltrate,Olfactory Neuroblastoma,1
17681,Carcinomatous Component Present,Stage 0is Renal Pelvis Cancer AJCC v7,1
17682,Recurrent disease,Malignant neoplasm of stomach recurrent,1
17683,Benign Cellular Infiltrate,Intra-Abdominal Lymphangioma,1
17684,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Carcinoma AJCC v7,1
17685,Blasts 5-19 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-2,1
17686,Intermediate Grade Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G2,1
17687,Squamous metaplasia of bladder,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
17688,Carcinomatous Component Present,Lung Cancer by AJCC v8 Stage,1
17689,Epithelial Component Present,Stage II Rectal Cancer AJCC v7,1
17690,Thick-Walled Hyalinized Vessels Present,Gastric Schwannoma,1
17691,High Grade Lesion,Unresectable Rhabdomyosarcoma,1
17692,Vascular Channel Formation,Thyroid Angiosarcoma,1
17693,Malignant Cellular Infiltrate,Malignant neoplasm of retina,1
17694,Sarcomatous Component Present,Pleuropulmonary blastoma type III,1
17695,Fibrotic Stroma Formation,Ossifying Fibroma,1
17696,Somatostatin Positive Neoplastic Cells Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
17697,Rapidly Enlarging Mass,Cardiac Rhabdomyosarcoma,1
17698,Glomerular Hypertrophy,Secondary Focal Segmental Glomerulosclerosis,1
17699,Cutaneous Involvement,Refractory Malignant Skin Neoplasm,1
17700,Indolent Clinical Course,Mediastinal Leiomyoma,1
17701,Carcinomatous Component Present,Eccrine carcinoma of skin,1
17702,Carcinomatous Component Present,Hard Palate Mucoepidermoid Carcinoma,1
17703,Carcinomatous Component Present,Multifocal breast carcinoma,1
17704,Carcinomatous Component Present,large cell neuroendocrine carcinoma of bladder,1
17705,Multilocular Lesion,Cystic Partially Differentiated Nephroblastoma,1
17706,CD1a-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis,1
17707,Koilocytotic atypia,Cervical Papillary Squamous Cell Carcinoma,1
17708,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Angiosarcoma,1
17709,Lymphoplasmacytic Infiltrate,Lymphoepithelial malignant thymoma,1
17710,Clinical TNM Finding,Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
17711,Malignant Cellular Infiltrate,malignant neoplasm of breast stage I,1
17712,Severe dysplasia,Bladder Urothelial Carcinoma in Situ,1
17713,Epithelial Component Present,Ovarian Clear Cell Cystadenocarcinoma,1
17714,Well-Circumscribed Lesion,Central Nervous System Hemangioblastoma,1
17715,"Fully Differentiated ""Adult-Type"" Tissues Present",Ovarian Solid Teratoma,1
17716,Carcinomatous Component Present,Bladder adenocarcinoma stage IV,1
17717,Malignant Cellular Infiltrate,Medulloblastoma with Leptomeningeal Spread,1
17718,Malignant Cellular Infiltrate,Centroblastic lymphoma refractory,1
17719,Malignant Cellular Infiltrate,Breast Extraskeletal Osteosarcoma,1
17720,Malignant Cellular Infiltrate,Ovarian Liposarcoma,1
17721,Hyperplastic Epithelial Tissue Present,Atypical hyperplasia of breast,1
17722,Adulthood Lesion,Lugano Classification Stage II Adult Hodgkin Lymphoma AJCC v8,1
17723,Indolent Clinical Course,Desmoplastic fibroblastoma,1
17724,Carcinomatous Component Present,Stage IV Renal Pelvis Cancer AJCC v8,1
17725,Low Mitotic Activity,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
17726,Malignant Cellular Infiltrate,Paget's Disease of the Nipple,1
17727,Immunosuppression-Related Post-Transplant Toxicity,Engraftment syndrome,1
17728,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
17729,Recurrent disease,Recurrent Childhood Cerebral Astrocytoma,1
17730,Malignant Cellular Infiltrate,Secondary Cerebral Hodgkin Lymphoma,1
17731,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v7,1
17732,Malignant Cellular Infiltrate,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
17733,Indolent Clinical Course,Uterine Corpus Hydropic Leiomyoma,1
17734,atypia morphology,Malignant Ovarian Granulosa Cell Tumor,1
17735,Mast Cells 20 Percent or More of Bone Marrow Nucleated Cells,"Leukemia, Mast-Cell",1
17736,Carcinomatous Component Present,Salivary duct carcinoma,1
17737,Carcinomatous Component Present,Vulvar Small Cell Carcinoma,1
17738,Malignant Cellular Infiltrate,Malignant germ cell neoplasm of mediastinum,1
17739,Recurrent disease,Recurrent Non-Cutaneous Melanoma,1
17740,Neuroendocrine Differentiation,"Pheochromocytoma, Extra-Adrenal",1
17741,Malignant Cellular Infiltrate,Refractory Cutaneous Melanoma,1
17742,Dysplasia,Vulvar Dysplastic Melanocytic Nevus,1
17743,Cutaneous Involvement,Lichen Planus,1
17744,Epithelial Component Present,Squamous cell carcinoma of the oral cavity stage I,1
17745,"Amorphus, Eosinophilic, and Acellular Deposit",Refractory Primary Amyloidosis,1
17746,Infiltrative Growth Pattern,Glioblastoma,1
17747,Carcinomatous Component Present,Stage IIA Anal Cancer AJCC v8,1
17748,Local disease,Spindle Cell/Pleomorphic Lipoma,1
17749,Carcinomatous Component Present,Transplant-Related Renal Cell Carcinoma,1
17750,Chromogranin A Positive Neoplastic Cells Present,Metastatic carcinoid tumor,1
17751,Epithelial Component Present,Stage III Rectal Cancer AJCC v7,1
17752,Malignant Cellular Infiltrate,Childhood Pleomorphic Rhabdomyosarcoma,1
17753,Neuroendocrine Differentiation,Cardiac Paraganglioma,1
17754,Secondary Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
17755,Pathologic TNM Finding,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
17756,Immunologic Deficiency Syndromes,Immunodeficiency-Related Neoplasm,1
17757,Malignant Primitive Cellular Infiltrate,Endodermal sinus tumor of ovary,1
17758,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
17759,Epithelial Component Present,undifferentiated carcinoma of anal canal,1
17760,Pregnancy Complications,Placental aromatase deficiency,1
17761,Epithelial Component Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
17762,Malignant Cellular Infiltrate,Ovarian Myxoid Liposarcoma,1
17763,Secondary Lesion,Metastatic Rectal Carcinoma,1
17764,Blasts Expressing CD56 and Immature T-Cell Markers Present,NK-lymphoblastic leukemia/lymphoma,1
17765,Malignant Cellular Infiltrate,Sarcoma of breast,1
17766,Malignant Cellular Infiltrate,MYELODYSPLASTIC SYNDROME,1
17767,Mucoid Stroma Formation,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",1
17768,Non-Invasive Lesion,Stage 0 Renal Pelvis Cancer AJCC v7,1
17769,Malignant Cellular Infiltrate,Stage IVB Appendix Carcinoma AJCC v7,1
17770,atypia morphology,Grade III Lymphomatoid Granulomatosis,1
17771,Metastatic Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
17772,Severe cytologic atypia,Digestive System Large Cell Neuroendocrine Carcinoma,1
17773,Oligodendroglial Component Present,Brain Oligodendroglioma,1
17774,Malignant Cellular Infiltrate,Stage I Lentigo Maligna Melanoma AJCC v7,1
17775,Osseous Differentiation,Osteoblastoma,1
17776,Mitotic Activity,Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7,1
17777,Malignant Cellular Infiltrate,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
17778,Bone Marrow Eosinophilia,"Acute myeloid leukemia, t(16;16)(p13;q22)",1
17779,Epithelial Component Present,Stage IB Eyelid Carcinoma AJCC v8,1
17780,Multinodular Pattern,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
17781,Carcinomatous Component Present,Maxillary Sinus Adenocarcinoma,1
17782,Slow Growing Mass,Sellar Ependymoma,1
17783,Epithelial Component Present,Stage IVA Colon Cancer AJCC v7,1
17784,Malignant Cellular Infiltrate,Transitional cell cancer of renal pelvis and ureter metastatic,1
17785,Ground Glass Nuclear Inclusion,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
17786,Metastatic Lesion,Metastatic Benign Neoplasm,1
17787,Fibrotic Stroma Formation,Sarcomatoid Intrahepatic Cholangiocarcinoma,1
17788,Ground Glass Nuclear Inclusion,Nonencapsulated sclerosing tumor,1
17789,Malignant Cellular Infiltrate,Malignant Soft Tissue Tumor of Uncertain Differentiation,1
17790,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
17791,Malignant Cellular Infiltrate,Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension,1
17792,Malignant Cellular Infiltrate,Conventional Angiosarcoma,1
17793,Cutaneous Involvement,Merkel Cell Carcinoma by AJCC v8 Stage,1
17794,Secondary Lesion,Metastatic Lip and Oral Cavity Carcinoma,1
17795,Carcinomatous Component Present,Stage I Liver Carcinoma,1
17796,Pregnancy Complications,Placental polyp,1
17797,High Grade Lesion,Adult Gliosarcoma,1
17798,Carcinomatous Component Present,Adenocarcinoma in villous adenoma,1
17799,Cystic Change,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
17800,Fibrotic Stroma Formation,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,1
17801,Carcinomatous Component Present,BCLC Stage C Adult Hepatocellular Carcinoma,1
17802,Myxoid Stroma Formation,"Dermatofibrosarcoma Protuberans, Myxoid",1
17803,Epithelial Component Present,Widely Invasive Thymoma,1
17804,Papillary Pattern,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
17805,Malignant Cellular Infiltrate,Lymphoma,1
17806,Carcinomatous Component Present,Gastric Carcinoma with Lymphoid Stroma,1
17807,Secondary Lesion,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,1
17808,Carcinomatous Component Present,Minor Salivary Gland Undifferentiated Carcinoma,1
17809,Epithelial Component Present,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,1
17810,Epithelial Component Present,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,1
17811,Adulthood Lesion,Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma,1
17812,Neuroendocrine Differentiation,Familial Paraganglioma,1
17813,Capillary Sized Vascular Channel Formation,Breast Capillary Hemangioma,1
17814,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
17815,Epithelial Component Present,Stage III Paranasal Sinus Cancer AJCC v6 and v7,1
17816,Increased Cellularity Present,Childhood Anaplastic Ependymoma,1
17817,Epithelial Component Present,Carcinoma of submandibular gland,1
17818,Epithelial Component Present,Anal Extramucosal (Perianal) Adenocarcinoma,1
17819,Childhood Lesion,Childhood Astrocytoma,1
17820,Tubal Diverticulosis,Salpingitis isthmica nodosa,1
17821,Malignant Cellular Infiltrate,Radiation-Induced Cancer,1
17822,Malignant Cellular Infiltrate,Childhood Non-Hodgkin Lymphoma,1
17823,Carcinomatous Component Present,Triple-Negative Breast Carcinoma,1
17824,Malignant Cellular Infiltrate,Childhood Acute Myelomonocytic Leukemia,1
17825,Malignant Cellular Infiltrate,Stage III Uterine Corpus Cancer AJCC v6,1
17826,Severe dysplasia,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
17827,Absence of Invasion,Carcinoma in situ of ampulla of Vater,1
17828,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Gestational Ovarian Choriocarcinoma,1
17829,Secondary Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma,1
17830,Dysplasia,Low Grade Prostatic Intraepithelial Neoplasia,1
17831,Carcinomatous Component Present,Stage I Vulvar Carcinoma,1
17832,Primary Site Unknown,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
17833,Carcinomatous Component Present,Throat cancer,1
17834,Carcinomatous Component Present,Bladder squamous cell carcinoma stage III,1
17835,Carcinomatous Component Present,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
17836,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma recurrent,1
17837,Poorly Differentiated Lesion,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
17838,Secondary Lesion,Ameloblastic Carcinoma-Secondary Type (Dedifferentiated),1
17839,Malignant Cellular Infiltrate,Minor Salivary Gland Adenoid Cystic Carcinoma,1
17840,Diffuse Pattern,Cerebral Glioblastoma,1
17841,Malignant Cellular Infiltrate,"Glomus tumor, malignant",1
17842,Tissue of Mullerian Origin Present,Ovarian Endometrioid Cystadenofibroma,1
17843,Malignant Cellular Infiltrate,Melanoma Metastatic in the Central Nervous System,1
17844,Malignant Cellular Infiltrate,Eyelid Sebaceous Gland Carcinoma,1
17845,Epithelial Component Present,Childhood Colorectal Carcinoma,1
17846,Nuclear Atypia,Classical Glioblastoma,1
17847,Low Mitotic Activity,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
17848,Low Mitotic Activity,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma,1
17849,Recurrent Genetic Abnormalities Present,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
17850,Malignant Cellular Infiltrate,Clinical Stage II Retinoblastoma AJCC v8,1
17851,Mixed Cellular Population,combined small cell carcinoma of lung,1
17852,Invasive Lesion,Invasive Apocrine Breast Carcinoma,1
17853,Epithelial Component Present,Vagina Carcinoma,1
17854,Severe dysplasia,Rectal Adenoma with Severe Dysplasia,1
17855,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
17856,Epithelial Component Present,Esophageal Neuroendocrine Tumor G2,1
17857,Papillary Pattern,Cervical Mullerian Papilloma,1
17858,Cutaneous Involvement,"Adenoma, Sweat Gland",1
17859,Papillary Pattern,Papillary mucinous cystadenoma,1
17860,Pain,Juxtacortical chondrosarcoma,1
17861,Neuroendocrine Differentiation,Primary hepatic neuroendocrine carcinoma,1
17862,Malignant Cellular Infiltrate,Stage IB Osteosarcoma AJCC v7,1
17863,Malignant Cellular Infiltrate,Trabecular adenocarcinoma,1
17864,Epithelial Component Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7,1
17865,Carcinomatous Component Present,Stage IV Vaginal Cancer AJCC v8,1
17866,Borderline Lesion,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,1
17867,Epithelial Component Present,Hormone refractory breast cancer,1
17868,Capillary Sized Vascular Channel Formation,Multiple Lobular Capillary Hemangiomas,1
17869,Malignant Cellular Infiltrate,Stage 0 Renal Pelvis Cancer AJCC v7,1
17870,Carcinomatous Component Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
17871,Carcinomatous Component Present,Stage I Renal Cell Carcinoma,1
17872,Carcinomatous Component Present,Stage I Nasopharyngeal Carcinoma AJCC v7,1
17873,Cutaneous Involvement,Dermatophytosis,1
17874,Epithelial Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
17875,Hyperplastic Tissue Present,Benign Prostatic Hyperplasia,1
17876,Epithelial Component Present,Stage I Colon Cancer AJCC v8,1
17877,Diffuse Pattern,Childhood Brain Oligodendroglioma,1
17878,Epithelial Component Present,Stage II Nasopharyngeal Carcinoma AJCC v7,1
17879,Malignant Cellular Infiltrate,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
17880,Perineural spread,Adenoid cystic eccrine carcinoma,1
17881,Malignant Cellular Infiltrate,Stage IIB Esophageal Adenocarcinoma AJCC v7,1
17882,Carcinomatous Component Present,Schneiderian carcinoma,1
17883,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma,1
17884,Metastatic/Recurrent Disease,"Synovial sarcoma, biphasic",1
17885,Tissue Differentiation Uncertain,Alveolar Soft Part Sarcoma,1
17886,Nuclear Molding,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
17887,Tissue Differentiation Uncertain,Epithelioid sarcoma metastatic,1
17888,Metastatic Lesion,Locally Advanced Unresectable Prostate Carcinoma,1
17889,Epithelial Component Present,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",1
17890,Epithelial Component Present,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7,1
17891,Malignant Cellular Infiltrate,Well Differentiated Prostate Adenocarcinoma,1
17892,Invasive Lesion,Grade 3 Invasive Breast Carcinoma,1
17893,Malignant Cellular Infiltrate,Acute myeloid leukemia refractory,1
17894,High Mitotic Activity,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
17895,Necrotic changes (finding),"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
17896,Malignant Cellular Infiltrate,Waldenstrom's macroglobulinemia refractory,1
17897,Adulthood Lesion,Adult T Lymphoblastic Lymphoma,1
17898,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
17899,Carcinomatous Component Present,Stage II Rectal Cancer AJCC v8,1
17900,Childhood Lesion,Macrotrabecular Hepatoblastoma,1
17901,Epithelial Component Present,Fallopian Tube Mucinous Neoplasm,1
17902,Primary Lesion,Stage I Hepatocellular Carcinoma AJCC v8,1
17903,Carcinomatous Component Present,Stage IIIB Appendix Carcinoma AJCC v8,1
17904,Epithelial Component Present,Stage IV Ampulla of Vater Cancer AJCC v8,1
17905,Benign Cellular Infiltrate,Benign squamous cell tumor,1
17906,Carcinomatous Component Present,Papillary mucinous cystadenocarcinoma,1
17907,Epithelial Component Present,Pancreatic Vipoma,1
17908,Epithelial Component Present,Gastric Cardia Adenocarcinoma,1
17909,Malignant Cellular Infiltrate,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
17910,Epithelial Component Present,Stage III Ureter Cancer AJCC v7,1
17911,Carcinomatous Component Present,Vaginal Mesonephric Adenocarcinoma,1
17912,Absence of Stromal Invasion,Borderline epithelial tumor of ovary,1
17913,Hemorrhagic,Recurrent Skin Angiosarcoma,1
17914,Chronic lymphocytic inflammation,Micronodular thymoma with lymphoid stroma,1
17915,Extensive Stage Lesion,Advanced Uterine Corpus Carcinosarcoma,1
17916,Epithelial Component Present,Breast adenoma,1
17917,Epithelial Component Present,Stage IIB Breast Carcinoma,1
17918,Indolent Clinical Course,Uterine Corpus Apoplectic Leiomyoma,1
17919,Systemic disease,Lipoid dermatoarthritis,1
17920,Carcinomatous Component Present,Stage IIIA2 Ovarian Cancer AJCC v8,1
17921,Malignant Cellular Infiltrate,"Medulloblastoma, SHH-Activated, TP53-Mutant",1
17922,Nuclear Expression of STAT6 Protein,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",1
17923,Glandular Differentiation,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
17924,Biphasic Pattern,Adult Brain Stem Gliosarcoma,1
17925,Preserved Nuclear Polarity,Inverted urothelial papilloma,1
17926,Carcinomatous Component Present,Clinical Stage IV Esophageal Adenocarcinoma AJCC v8,1
17927,Indolent Clinical Course,Uterine Corpus Dissecting Leiomyoma,1
17928,Cystic Change,Minor Salivary Gland Mucoepidermoid Carcinoma,1
17929,Toxic effect,Solar Radiation-Related Skin Squamous Cell Carcinoma,1
17930,Benign Cellular Infiltrate,Benign Vaginal Melanocytic Nevus,1
17931,Carcinomatous Component Present,Endometrioid adenocarcinoma recurrent,1
17932,Chromogranin A Positive Neoplastic Cells Present,Unresectable Carcinoid Tumor,1
17933,Secondary Lesion,Metastatic Carcinoma in the Adrenal Cortex,1
17934,Primary Lesion,Refractory Central Nervous System Non-Hodgkin Lymphoma,1
17935,Malignant Cellular Infiltrate,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,1
17936,Well Differentiated Neuroendocrine Lesion,Stage I Ileal Neuroendocrine Tumor AJCC v8,1
17937,Mitotic Activity,Grade III Childhood Astrocytoma,1
17938,Rapidly Enlarging Mass,rhabdomyosarcoma of testis,1
17939,Carcinomatous Component Present,Stage IV Cervical Cancer AJCC v6 and v7,1
17940,Epithelial Component Present,Carcinoid tumor of the liver,1
17941,Nodular Pattern,Eccrine spiradenoma,1
17942,Epithelial Component Present,Mammosomatotroph Adenoma,1
17943,"Fully Differentiated ""Adult-Type"" Tissues Present",Pineal Region Immature Teratoma,1
17944,Secondary Lesion,Metastatic Pharyngeal Carcinoma,1
17945,Vascular Channel Formation,Kaposi Sarcoma NCI Grade 2,1
17946,Tissue of Mullerian Origin Present,Ovarian serous cystadenofibroma,1
17947,Carcinomatous Component Present,Stage I Gallbladder Cancer AJCC v8,1
17948,Epithelial Component Present,signet ring cell carcinoma of gallbladder,1
17949,Malignant Cellular Infiltrate,Hodgkin Lymphoma by Clinical Course,1
17950,Dysplasia,Rectal Tubular Adenoma,1
17951,Malignant Cellular Infiltrate,Adenoid Cystic Carcinoma,1
17952,Malignant Cellular Infiltrate,small cell carcinoma of gallbladder,1
17953,Epithelial Component Present,Metastatic Squamous Cell Breast Carcinoma,1
17954,Malignant Cellular Infiltrate,Refractory Malignant Central Nervous System Neoplasm,1
17955,Adulthood Lesion,Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma,1
17956,Biphasic Pattern,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
17957,Immunologic Deficiency Syndromes,Graft-vs-Host Disease,1
17958,Recurrent disease,Recurrent Pancreatic Cystadenocarcinoma,1
17959,Mixed Cellular Population,Mixed cell adenoma,1
17960,Mixed Cellular Population,Nephroblastoma,1
17961,Thin-Walled Branching Vascular Pattern,Pleural Solitary Fibrous Tumor,1
17962,Epithelial Component Present,Hepatic cancer stage IVA,1
17963,Epithelial Component Present,Glomus vagale tumor,1
17964,Malignant Cellular Infiltrate,"Lung Squamous Cell Carcinoma, Clear Cell Variant",1
17965,Increased Cellularity Present,Anaplastic astrocytoma,1
17966,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v8 Stage,1
17967,Carcinomatous Component Present,Stage I Ampulla of Vater Cancer AJCC v8,1
17968,Malignant Cellular Infiltrate,Stage IIA Cutaneous Melanoma AJCC v6 and v7,1
17969,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Melanocytic Lesion,1
17970,Refractory Disease,Refractory Lymphoproliferative Disorder,1
17971,Malignant Cellular Infiltrate,Thyroid Hurthle Cell Carcinoma,1
17972,Necrotic changes (finding),Large cell neuroendocrine carcinoma,1
17973,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
17974,Carcinomatous Component Present,Ocular Sebaceous Carcinoma,1
17975,Vascular Channel Formation,Recurrent Kaposi Sarcoma,1
17976,Absence of Invasion,Stage 0 Lung Cancer AJCC v6 and v7,1
17977,Pushing Tumor Margin,verrucous carcinoma of esophagus,1
17978,atypia morphology,Borderline Fallopian Tube Endometrioid Tumor,1
17979,Therapy-Related Toxicity,Radiation-Related Osteosarcoma,1
17980,Dysplasia,Cervical high grade squamous intraepithelial lesion,1
17981,Resectable Mass,Resectable Extrahepatic Bile Duct Adenocarcinoma,1
17982,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
17983,Benign Cellular Infiltrate,Vaginal Blue Nevus,1
17984,Carcinomatous Component Present,Stage I Anal Canal Cancer AJCC v6 and v7,1
17985,Poorly Differentiated Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,1
17986,High Mitotic Activity,Unresectable Pancreatic Neuroendocrine Carcinoma,1
17987,Fibrosarcomatous Component Present,Metastatic Dermatofibrosarcoma Protuberans,1
17988,Mild cytologic atypia,Pancreatic Intraepithelial Neoplasia-1A,1
17989,Extraosseous Lesion,Breast Extraskeletal Osteosarcoma,1
17990,Carcinomatous Component Present,Stage II Nasopharyngeal Carcinoma AJCC v6,1
17991,Indolent Clinical Course,fibroma of testis,1
17992,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Fibroblastic Variant",1
17993,Low Mitotic Activity,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
17994,Malignant Cellular Infiltrate,Pancreatic Small Cell Neuroendocrine Carcinoma,1
17995,Abnormal Eosinophilic Granules Present,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
17996,Cystic Change,Pancreatic Intraductal Neoplasms,1
17997,In Situ Lesion,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
17998,Fibrotic Stroma Formation,Vulvar Fibrolipoma,1
17999,Mixed Cellular Population,Carcinoma ex pleomorphic adenoma,1
18000,Lymphadenopathy,Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
18001,Low Cellularity Present,Protoplasmic astrocytoma,1
18002,In Situ Lesion,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8",1
18003,Malignant Cellular Infiltrate,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage,1
18004,Carcinomatous Component Present,Unresectable Ureter Urothelial Carcinoma,1
18005,Malignant Cellular Infiltrate,Stage III Bone Sarcoma AJCC v7,1
18006,Pregnancy Complications,Gestational Trophoblastic Neoplasms,1
18007,Low Mitotic Activity,Stage I Rectal Neuroendocrine Tumor AJCC v8,1
18008,Malignant Cellular Infiltrate,Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor,1
18009,Macrocystic Change,"Lymphangioma, Cystic",1
18010,Cutaneous Involvement,Stage II Superficial Spreading Melanoma AJCC v6 and v7,1
18011,Malignant Cellular Infiltrate,Refractory Medulloblastoma,1
18012,Well Differentiated Neuroendocrine Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
18013,Malignant Cellular Infiltrate,Acantholytic squamous cell carcinoma,1
18014,Indolent Clinical Course,Squamous odontogenic tumor,1
18015,Epithelial Component Present,Adenoid cystic eccrine carcinoma,1
18016,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Uterine Corpus Carcinosarcoma,1
18017,Carcinomatous Component Present,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type",1
18018,Myxoid Stroma Formation,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
18019,Malignant Cellular Infiltrate,carcinosarcoma of fallopian tube,1
18020,Nuclear pleomorphism,Choroid Plexus Carcinoma,1
18021,Carcinomatous Component Present,High Grade Ductal Breast Carcinoma In Situ,1
18022,Low Grade Lesion,Third Ventricle Pilocytic Astrocytoma,1
18023,Cystic Lesion,Desmoplastic infantile astrocytoma,1
18024,Below the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic,1
18025,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
18026,Pseudoglandular Pattern,Teratocarcinoma,1
18027,Below the Diaphragm Disease,Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
18028,Epithelial Component Present,Choroid Plexus Carcinoma,1
18029,Calcitonin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7,1
18030,Wedge-Shaped Growth Pattern,Deep Penetrating Nevus,1
18031,Metastatic/Recurrent Disease,Extrarenal Rhabdoid Tumor of the Liver,1
18032,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage II,1
18033,Low Mitotic Activity,Non-Functioning Pancreatic Neuroendocrine Tumor G1,1
18034,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Adenocarcinoma,1
18035,Malignant Germinomatous Cellular Infiltrate,Germinoma,1
18036,Malignant Cellular Infiltrate,Carcinoma in Situ,1
18037,Epithelial Component Present,Stage IV Rectal Neuroendocrine Tumor AJCC v8,1
18038,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage IV,1
18039,Monomorphic Cellular Infiltrate,Recurrent Childhood Ependymoma,1
18040,Malignant Cellular Infiltrate,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",1
18041,Carcinomatous Component Present,Stage 0 Colorectal Cancer AJCC v6 and v7,1
18042,Malignant Cellular Infiltrate,Stage IIIA1 Fallopian Tube Cancer AJCC v8,1
18043,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage II subdiaphragmatic,1
18044,Malignant Cellular Infiltrate,Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8,1
18045,Carcinomatous Component Present,Childhood Esophageal Carcinoma,1
18046,Nodular Pattern,Hodgkin's disease nodular sclerosis recurrent,1
18047,High Mitotic Activity,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
18048,Malignant Cellular Infiltrate,"Anaplastic Astrocytoma, IDH-Mutant",1
18049,Childhood Lesion,Childhood Visual Pathway Astrocytoma,1
18050,Hypertensive disease,Hypertensive episode,1
18051,Recurrent disease,Recurrent EBV-Related Lymphoma,1
18052,Angiodestructive Pattern,Adult Grade III Lymphomatoid Granulomatosis,1
18053,Epithelial Component Present,Urethral Carcinoma,1
18054,Well Differentiated Lesion,Pleural Well Differentiated Papillary Mesothelioma,1
18055,Human Papillomavirus Negative,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
18056,Insular Pattern,Pancreatic Somatostatinoma,1
18057,Carcinomatous Component Present,Advanced Prostate Carcinoma,1
18058,Secondary Lesion,Metastatic Uveal Melanoma,1
18059,Cystic Change,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant",1
18060,Malignant Cellular Infiltrate,Central Nervous System Epithelioid Hemangioendothelioma,1
18061,Epithelial Component Present,Vulvar Merkel Cell Carcinoma,1
18062,Carcinomatous Component Present,Adenocarcinoma of anal glands,1
18063,Benign Cellular Infiltrate,Lipomatosis of Nerve,1
18064,Psammoma Body Formation,Benign Mediastinal Psammomatous Schwannoma,1
18065,Indolent Clinical Course,Deep histiocytoma,1
18066,Fibrosarcomatous Component Present,Metastatic Dermatofibrosarcoma Protuberans,1
18067,Well-Circumscribed Lesion,Benign phyllodes neoplasm of breast,1
18068,Therapy-Related Toxicity,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder,1
18069,Adnexal Differentiation,Malignant Breast Eccrine Spiradenoma,1
18070,Diffuse Pattern,Low Grade Malignant Peripheral Nerve Sheath Tumor,1
18071,Malignant Cellular Infiltrate,Stage IVB Appendix Carcinoma AJCC v7,1
18072,Absence of Invasion,Adenocarcinoma in situ in villous adenoma,1
18073,High Grade Lesion,Metastatic Dermatofibrosarcoma Protuberans,1
18074,Anaplasia,Fibroblastic osteosarcoma,1
18075,atypia morphology,Borderline Ovarian Clear Cell Cystadenofibroma,1
18076,Well Differentiated Neuroendocrine Lesion,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,1
18077,Carcinomatous Component Present,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage,1
18078,Cystic Change,Seborrheic keratosis,1
18079,Mixed Cellular Population,Mixed epithelial tumor of ovary,1
18080,Cutaneous Involvement,Apocrine adenoma,1
18081,Malignant Cellular Infiltrate,Angiocentric lymphoma stage I,1
18082,Malignant Cellular Infiltrate,Refractory Nasopharyngeal Carcinoma,1
18083,Epithelial Component Present,Primary Peritoneal Low Grade Serous Adenocarcinoma,1
18084,Malignant Cellular Infiltrate,"Glandular intraepithelial neoplasia, grade III",1
18085,Malignant Cellular Infiltrate,Marginal zone lymphoma stage II,1
18086,Carcinomatous Component Present,Metaplastic carcinoma of breast,1
18087,Epithelial Component Present,Stage IIC Appendix Carcinoma AJCC v7,1
18088,Carcinomatous Component Present,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
18089,Malignant Cellular Infiltrate,Pathologic Stage III Gastric Cancer AJCC v8,1
18090,Epithelial Component Present,Stage IV Urethral Cancer AJCC v7,1
18091,Cutaneous Involvement,Acne Keloid,1
18092,Epithelial Component Present,Fallopian Tube Endometrioid Tumor,1
18093,Mass of body structure,Small Intestinal Myeloid Sarcoma,1
18094,Nuclear Grooves,Childhood Thyroid Gland Papillary Carcinoma,1
18095,Malignant Cellular Infiltrate,Malignant Skeletal Muscle Neoplasm,1
18096,Malignant Cellular Infiltrate,Stage IIIA Retroperitoneal Sarcoma AJCC v8,1
18097,Carcinomatous Component Present,Stage IV Renal Pelvis Cancer AJCC v7,1
18098,Epithelial Component Present,Sertoli cell tumor of testis,1
18099,Malignant Cellular Infiltrate,"Thymoma, type A, malignant",1
18100,Intraductal Lesion,"Papilloma, Intraductal",1
18101,Carcinomatous Component Present,Low Grade Broad Ligament Serous Adenocarcinoma,1
18102,Recurrent disease,Recurrent Primary Malignant Neoplasm,1
18103,Epithelial Component Present,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7,1
18104,Adulthood Lesion,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma,1
18105,Carcinomatous Component Present,Refractory Oropharyngeal Squamous Cell Carcinoma,1
18106,Cribriform Pattern,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,1
18107,No Identifiable Line of Differentiation,Resectable Undifferentiated Pleomorphic Sarcoma,1
18108,Epithelial Component Present,Small Intestinal Intraepithelial Neoplasia,1
18109,Malignant Cellular Infiltrate,Refractory Mixed Phenotype Acute Leukemia,1
18110,Benign Cellular Infiltrate,Prostatic Adenoma,1
18111,Tubular Pattern,Tubular adenoma of colon,1
18112,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Cancer AJCC v8,1
18113,Indolent Clinical Course,Elastofibroma,1
18114,Carcinomatous Component Present,Thyroid Gland Adenocarcinoma,1
18115,Benign Cellular Infiltrate,Maturing Ganglioneuroma,1
18116,Pregnancy Complications,Stage IV Gestational Trophoblastic Neoplasm AJCC v8,1
18117,Malignant Cellular Infiltrate,Stage IIB Gastric Cancer AJCC v7,1
18118,Invasive Lesion,signet ring cell carcinoma of breast,1
18119,Malignant Cellular Infiltrate,leiomyosarcoma of bone,1
18120,Non Lipogenic Sarcomatous Stroma Present,Recurrent Dedifferentiated Liposarcoma,1
18121,Malignant Cellular Infiltrate,Stage IV Penile Cancer AJCC v6,1
18122,Apocrine Differentiation,Apocrine Neoplasm,1
18123,Infiltrative Growth Pattern,Infiltrating basal cell carcinoma,1
18124,Malignant Cellular Infiltrate,Superior Vena Cava Angiosarcoma,1
18125,Tissue Differentiation Uncertain,Pleural Monophasic Synovial Sarcoma,1
18126,Malignant Cellular Infiltrate,Vaginal Keratinizing Squamous Cell Carcinoma,1
18127,Locally Aggressive Lesion,Retroperitoneal Inflammatory Myofibroblastic Tumor,1
18128,Well Differentiated Lesion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
18129,Malignant Cellular Infiltrate,Extrarenal Rhabdoid Tumor of the Liver,1
18130,Neoplastic Cells with TFH Cell Phenotype Present,Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin,1
18131,Cutaneous Involvement,Palmoplantar keratoderma with leukoplakia,1
18132,Diffuse Pattern,Recurrent Childhood Anaplastic Astrocytoma,1
18133,Exophytic Polypoid Lesion,Appendix adenoma,1
18134,Neuroendocrine Differentiation,Pancreatic Large Cell Neuroendocrine Carcinoma,1
18135,Metastatic Lesion,Castration-Naive Prostate Carcinoma,1
18136,Benign Cellular Infiltrate,Bladder papilloma,1
18137,Acanthosis,Common wart,1
18138,Intracytoplasmic and Extracytoplasmic Eosinophilic Material Present,Secretory breast carcinoma,1
18139,Epithelial Component Present,Primary Peritoneal Serous Adenocarcinoma,1
18140,Slow Growing Mass,Sellar Chordoma,1
18141,Slow Growing Mass,Papillary craniopharyngioma,1
18142,Stromal Invasion,Recurrent Ovarian Cystadenocarcinoma,1
18143,Swelling,Adult Mesenchymal Chondrosarcoma,1
18144,Increased megakaryocytes (bone marrow),Prefibrotic/Early Primary Myelofibrosis,1
18145,Epithelial Component Present,Colorectal Cribriform Comedo-Type Adenocarcinoma,1
18146,Malignant Cellular Infiltrate,Lung Cancer by AJCC v7 Stage,1
18147,Primary Lesion,Localized Resectable Adult Hepatocellular Carcinoma,1
18148,Perineural spread,Adenoid cystic carcinoma of oropharynx,1
18149,Carcinomatous Component Present,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
18150,Anaplasia,Giant Cell Glioblastoma,1
18151,Benign Cellular Infiltrate,Tonsillar Lipoma,1
18152,Basal Cells with Pale Cytoplasm Present,"Acanthoma, Clear Cell",1
18153,Benign Cellular Infiltrate,Ventricular myxoma,1
18154,Absence of Invasion,Stage 0is Urethral Cancer AJCC v8,1
18155,Carcinomatous Component Present,Stage II Colorectal Cancer,1
18156,Malignant Cellular Infiltrate,Malignant tumor of small intestine,1
18157,Necrotic changes (finding),Diencephalic Glioblastoma,1
18158,Recurrent disease,Recurrent Biliary Tract Carcinoma,1
18159,Primary Lesion,Refractory Central Nervous System Lymphoma,1
18160,Carcinomatous Component Present,Recurrent Chromophobe Renal Cell Carcinoma,1
18161,Malignant Cellular Infiltrate,Stage IV Hilar Cholangiocarcinoma AJCC v8,1
18162,Malignant Cellular Infiltrate,Stage IIC Prostate Cancer AJCC v8,1
18163,Severe dysplasia,Intraductal papillary neoplasm with high grade intraepithelial neoplasia,1
18164,Malignant Cellular Infiltrate,Undifferentiated Endocervical Sarcoma,1
18165,Epithelial Component Present,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
18166,Absence of Invasion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
18167,Monomorphic Cellular Infiltrate,Lung Basaloid Squamous Cell Carcinoma,1
18168,Diffuse Pattern,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
18169,Well-Circumscribed Lesion,Villous adenoma of rectum,1
18170,Mild dysplasia,Low Grade Gastric Intraepithelial Neoplasia,1
18171,Therapy-Related Toxicity,Monomorphic Post-Transplant Lymphoproliferative Disorder,1
18172,Well-Circumscribed Lesion,Ovarian Endometrioid Cystadenoma,1
18173,Toxic effect,Solar Radiation-Related Cutaneous Melanoma,1
18174,Metastatic Lesion,"Neoplasms, Unknown Primary",1
18175,Epithelial Component Present,Anal Canal Small Cell Neuroendocrine Carcinoma,1
18176,Malignant Cellular Infiltrate,Hodgkin's disease lymphocyte depletion type recurrent,1
18177,Absence of Invasion,Preinvasive Neoplasm of the Ampullary Region,1
18178,Epithelial Component Present,Urothelial carcinoma ureter recurrent,1
18179,Diffuse Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
18180,Malignant Cellular Infiltrate,Stage I Esophageal Cancer AJCC v7,1
18181,Cribriform Pattern,Intraductal Cribriform Breast Adenocarcinoma,1
18182,Carcinomatous Component Present,Carcinoma in situ of ampulla of Vater,1
18183,Carcinomatous Component Present,large cell neuroendocrine carcinoma of thymus,1
18184,Dysplasia,Grade II Prostatic Intraepithelial Neoplasia,1
18185,Carcinomatous Component Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
18186,Epithelial Component Present,Stage IIIA Bladder Cancer AJCC v8,1
18187,Carcinomatous Component Present,Posterior Pharyngeal Wall Squamous Cell Carcinoma,1
18188,Slow Growing Mass,Tanycytic ependymoma,1
18189,Mixed Cellular Population,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
18190,High Mitotic Activity,large cell neuroendocrine carcinoma of lung,1
18191,Dysplasia,Esophageal Squamous Intraepithelial Neoplasia,1
18192,Mitotic Activity,Recurrent Childhood Anaplastic Astrocytoma,1
18193,Subcutaneous nodule,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
18194,Tissue Differentiation Uncertain,Pleural Biphasic Synovial Sarcoma,1
18195,Well Differentiated Neuroendocrine Lesion,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,1
18196,Recurrent disease,Recurrent Human Papillomavirus-Related Malignant Neoplasm,1
18197,Neuroectodermal Differentiation,Askin's tumor,1
18198,Inconspicuous Syncytiotrophoblastic Cell Component,Testicular Monophasic Choriocarcinoma,1
18199,High Grade Lesion,Radiation-Related Osteosarcoma,1
18200,Carcinomatous Component Present,verrucous carcinoma of vulva,1
18201,Necrotic changes (finding),Malignant Peripheral Nerve Sheath Tumor,1
18202,Papillary Pattern,Common wart,1
18203,Malignant Cellular Infiltrate,Clear cell odontogenic carcinoma,1
18204,Absence of Invasion,Carcinoma in situ of ampulla of Vater,1
18205,Malignant Cellular Infiltrate,Adenocarcinoma of ampulla of Vater,1
18206,Cutaneous Involvement,Stage IA Mycosis Fungoides AJCC v7,1
18207,Malignant Cellular Infiltrate,Stage IVA Vaginal Cancer AJCC v6 and v7,1
18208,Severe dysplasia,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
18209,Adnexal Differentiation,Neoplasm of skin with adnexal differentiation,1
18210,Malignant Cellular Infiltrate,Lugano Classification Stage II Childhood Hodgkin Lymphoma AJCC v8,1
18211,Primary Lesion,Peripheral neuroepithelioma of bone recurrent,1
18212,Dysplasia,Adenoma of rectum,1
18213,Malignant Cellular Infiltrate,Adenocarcinoma of anal canal,1
18214,Neuroectodermal Differentiation,Childhood Neuroblastoma,1
18215,Primary Lesion,Supratentorial Glioblastoma,1
18216,Anaplasia,Recurrent Childhood Anaplastic Oligoastrocytoma,1
18217,effusion,Body Cavity Primary Effusion Lymphoma,1
18218,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
18219,Epithelial Component Present,Recurrent Childhood Hepatocellular Carcinoma,1
18220,Cystic Change,Dermoid cyst of ovary,1
18221,Malignant Cellular Infiltrate,Parosteal Osteosarcoma,1
18222,Epithelial Component Present,Glomerulosa Cell Adrenal Cortical Adenoma,1
18223,Epithelial Component Present,ENSAT Stage I Adrenal Cortex Carcinoma,1
18224,Perivascular Arrangement of Tumor Cells,Papillary Meningioma,1
18225,Osteoid formation,Adult Extraskeletal Osteosarcoma,1
18226,Thick-Walled Vessels Present,Angiomyolipoma of kidney,1
18227,Malignant Cellular Infiltrate,Non-Metastatic Childhood Soft Tissue Sarcoma,1
18228,Malignant Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
18229,Nuclear Pseudoinclusion,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
18230,Minimal Invasion Present,Bronchioloalveolar Adenocarcinoma,1
18231,Unresectable Mass,Localized Unresectable Neuroblastoma,1
18232,Carcinomatous Component Present,Lung Squamous Cell Carcinoma by AJCC v7 Stage,1
18233,Adnexal Differentiation,Desmoplastic trichoepithelioma,1
18234,Chronic Inflammatory Infiltrate,Childhood Lymphomatoid Granulomatosis,1
18235,Malignant Cellular Infiltrate,Sarcomatoid Carcinoma of the Penis,1
18236,Neuroendocrine Differentiation,Small cell carcinoma of prostate,1
18237,Malignant Cellular Infiltrate,Kaposi's sarcoma of lung,1
18238,atypia morphology,Liver Dysplastic Nodule,1
18239,Immunologic Deficiency Syndromes,AIDS-Related Diffuse Large B-cell Lymphoma,1
18240,BCR/ABL1 Fusion Negative,Ph-Like Acute Lymphoblastic Leukemia,1
18241,Epithelial Component Present,Appendix Neuroendocrine Tumor G2,1
18242,Malignant Cellular Infiltrate,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified",1
18243,Epithelial Component Present,Carcinoid tumor of rectum,1
18244,Monoclonal Eosinophils Present,"Leukemia, Eosinophilic, Acute",1
18245,Nuclear Atypia,Atypical follicular adenoma,1
18246,Carcinomatous Component Present,Cervical Mesonephric Adenocarcinoma,1
18247,Epithelial Component Present,Refractory Breast Carcinoma,1
18248,Malignant Cellular Infiltrate,Colorectal Lymphoma,1
18249,Malignant Cellular Infiltrate,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma,1
18250,Fibrosis,Fibrosclerosis of breast,1
18251,Poorly Differentiated Lesion,Poorly Differentiated Prostate Adenocarcinoma,1
18252,Serotonin Positive Neoplastic Cells Present,Carcinoid tumor of pancreas,1
18253,Carcinomatous Component Present,Stage IV Vulvar Cancer AJCC v6,1
18254,Dysplasia,Esophageal Glandular Intraepithelial Neoplasia,1
18255,Malignant Cellular Infiltrate,squamous cell carcinoma of middle ear,1
18256,Epithelial Component Present,Advanced Prostate Adenocarcinoma,1
18257,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage II Immature Testicular Teratoma AJCC v6 and v7,1
18258,Moderate dysplasia,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
18259,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",1
18260,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,1
18261,Immunologic Deficiency Syndromes,AIDS-Related Cryptococcosis,1
18262,Adulthood Lesion,Adult Medulloblastoma,1
18263,Epithelial Component Present,Lipid-rich carcinoma,1
18264,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Oligodendroglioma,1
18265,Carcinomatous Component Present,Thoracic Esophagus Adenocarcinoma,1
18266,Carcinomatous Component Present,Squamous cell carcinoma of tonsil,1
18267,Carcinomatous Component Present,Refractory Endometrial Carcinoma,1
18268,Malignant Cellular Infiltrate,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",1
18269,Recurrent disease,Recurrent T Acute Lymphoblastic Leukemia,1
18270,Adnexal Differentiation,Vulvar Syringoma,1
18271,Nodular lesions,Low Grade Liver Dysplastic Nodule,1
18272,Unresectable Mass,Unresectable Bladder Urothelial Carcinoma,1
18273,Malignant Cellular Infiltrate,Stage IV Hypopharyngeal Carcinoma AJCC v8,1
18274,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with Minimal Differentiation,1
18275,Splenomegaly,Post polycythaemia vera myelofibrosis,1
18276,Metastatic Lesion,Metastatic Prostate Carcinoma,1
18277,Malignant Cellular Infiltrate,Pancreatic carcinoma,1
18278,Hypercellular bone marrow,Blast Phase,1
18279,Tubular Pattern,Clear cell papillary renal cell carcinoma,1
18280,Malignant Cellular Infiltrate,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
18281,Malignant Cellular Infiltrate,follicular dendritic cell sarcoma of thyroid gland,1
18282,Malignant Cellular Infiltrate,Rectal Medullary Carcinoma,1
18283,Primary Lesion,Cerebral Astrocytoma,1
18284,Plexiform Vasculature Present,Low Grade Endometrioid Stromal Sarcoma of the Vagina,1
18285,Malignant Cellular Infiltrate,Verrucous carcinoma of penis,1
18286,Papillary Pattern,Condyloma anal,1
18287,Cystic Change,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
18288,Malignant Cellular Infiltrate,Stage IVC Lip Cancer AJCC v6 and v7,1
18289,Malignant Cellular Infiltrate,Adult Undifferentiated Pleomorphic Sarcoma,1
18290,Carcinomatous Component Present,Adenocarcinoma of cecum,1
18291,Malignant Cellular Infiltrate,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,1
18292,CD30-Positive Neoplastic Cells Present,Stage I Anaplastic Large Cell Lymphoma,1
18293,Acanthosis,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
18294,Carcinomatous Component Present,Stage IIA Primary Peritoneal Cancer AJCC v8,1
18295,Well Differentiated Neuroendocrine Lesion,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,1
18296,Tissue of Mullerian Origin Present,Adenomyoma,1
18297,Benign Cellular Infiltrate,Cystic tumor of atrio-ventricular node,1
18298,Malignant Cellular Infiltrate,Malignant neoplasm tonsil,1
18299,Malignant Cellular Infiltrate,AIDS-Related Malignant Cervical Neoplasm,1
18300,Epithelial Component Present,Nasopharyngeal Carcinoma by AJCC v8 Stage,1
18301,Low Grade Lesion,Cellular Congenital Mesoblastic Nephroma,1
18302,Adulthood Lesion,Adult Clear Cell Sarcoma of Soft Parts,1
18303,Carcinomatous Component Present,Stage IIIA Vulvar Cancer AJCC v8,1
18304,Perivascular fibrosis,Adult Nodular Sclerosis Classical Hodgkin Lymphoma,1
18305,Mesenchymal Component Present,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
18306,Malignant Cellular Infiltrate,Sclerosing liposarcoma,1
18307,Vascular Channel Formation,Osteoblastic Osteosarcoma,1
18308,Cutaneous Involvement,Mycosis Fungoides,1
18309,Malignant Cellular Infiltrate,Malignant Meningioma,1
18310,Benign Cellular Infiltrate,Aggressive angiomyxoma,1
18311,Epithelial Component Present,Stage IIIC Rectal Cancer AJCC v8,1
18312,Malignant Cellular Infiltrate,Stage IV Lung Squamous Cell Carcinoma AJCC v7,1
18313,Indolent Clinical Course,Disseminated Juvenile Xanthogranuloma,1
18314,Benign Cellular Infiltrate,Benign neoplasm of large intestine,1
18315,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Seminoma,1
18316,Tissue Differentiation Uncertain,Nonossifying Fibromyxoid Tumor,1
18317,Malignant Cellular Infiltrate,Malignant Reproductive System Neoplasm,1
18318,Apocrine Differentiation,External Auditory Canal Ceruminous Adenoma,1
18319,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage II,1
18320,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,1
18321,Cutaneous Involvement,Dermatophytosis of groin and perianal area,1
18322,Fibrotic Stroma Formation,endometrioid adenofibroma of ovary,1
18323,Koilocytotic atypia,Cervical Papillary Squamous Cell Carcinoma,1
18324,Benign Cellular Infiltrate,Colon Lymphangioma,1
18325,Recurrent disease,Non-Hodgkin's lymphoma transformed recurrent,1
18326,Malignant Cellular Infiltrate,Acute bilineal leukemia,1
18327,Malignant Cellular Infiltrate,Stage IVB Nasopharyngeal Carcinoma AJCC v7,1
18328,Cutaneous Involvement,Stage II Skin Cancer,1
18329,Indolent Clinical Course,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,1
18330,Malignant Cellular Infiltrate,Glioblastoma,1
18331,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides refractory,1
18332,High Grade Lesion,Synovial sarcoma metastatic,1
18333,Malignant Cellular Infiltrate,Refractory Malignant Soft Tissue Neoplasm,1
18334,Microvascular Proliferation,Pilocytic Astrocytoma,1
18335,Epithelial Component Present,Sarcomatoid carcinoma of the lung,1
18336,Malignant Cellular Infiltrate,Lymphoplasmacytic Lymphoma by Ann Arbor Stage,1
18337,Malignant Cellular Infiltrate,Stage IIIA1 Fallopian Tube Cancer AJCC v8,1
18338,Epithelial Component Present,Epiglottic carcinoma,1
18339,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
18340,Recurrent disease,Recurrent Paget Disease of the Breast,1
18341,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
18342,Angiodestructive Pattern,Adult Grade III Lymphomatoid Granulomatosis,1
18343,Invasive Lesion,Grade 1 Invasive Breast Carcinoma,1
18344,Epithelial Component Present,Pancreatic adenocarcinoma recurrent,1
18345,Mitotic Activity,Epithelioid glioblastoma,1
18346,Nodular lesions,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
18347,Carcinomatous Component Present,Stage IA Eyelid Carcinoma AJCC v7,1
18348,Diffuse Lesion,Diffuse melanocytosis,1
18349,Epithelial Component Present,squamous cell carcinoma of the thyroid gland,1
18350,Malignant Cellular Infiltrate,Trabecular adenocarcinoma,1
18351,Duct-Like Structures Present,epithelial-myoepithelial carcinoma of salivary gland,1
18352,Vascular proliferation,Gingival Angiofibroma,1
18353,Unresectable Mass,Unresectable Gastrointestinal Stromal Tumor,1
18354,Carcinomatous Component Present,Stage IIIA Fallopian Tube Cancer AJCC v8,1
18355,Malignant Cellular Infiltrate,FIGO Stage IVA Ovarian Cancer,1
18356,Regional Disease,Regional Adrenal Gland Pheochromocytoma,1
18357,Malignant Cellular Infiltrate,"Carcinoma, Small Cell",1
18358,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
18359,Unresectable Mass,Unresectable Intrahepatic Cholangiocarcinoma,1
18360,Epithelial Component Present,Stage II Renal Pelvis and Ureter Cancer AJCC v7,1
18361,Epithelial Component Present,Grade 3 Endometrial Endometrioid Adenocarcinoma,1
18362,Malignant Cellular Infiltrate,Childhood B Lymphoblastic Lymphoma,1
18363,Malignant Cellular Infiltrate,Anaplastic Oligoastrocytoma,1
18364,Metastatic Lesion,Metastatic signet ring cell carcinoma,1
18365,Malignant Cellular Infiltrate,Stage IB Pleural Malignant Mesothelioma AJCC v8,1
18366,Malignant Cellular Infiltrate,Stage II Uterine Corpus Adenosarcoma AJCC v8,1
18367,Recurrent Malignant Neoplasm,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
18368,Carcinomatous Component Present,Non-small cell lung cancer stage III,1
18369,Malignant Cellular Infiltrate,Primary Intraosseous Squamous Cell Carcinoma,1
18370,Indolent Clinical Course,Hemangioma of intra-abdominal structure,1
18371,Malignant Cellular Infiltrate,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,1
18372,Stromal Invasion,FIGO Stage IVA Ovarian Cancer,1
18373,Epithelial Component Present,Localized Non-Resectable Adult Liver Carcinoma,1
18374,Carcinomatous Component Present,Nasopharyngeal Carcinoma by AJCC v8 Stage,1
18375,Indolent Clinical Course,Soft Palate Pleomorphic Adenoma,1
18376,Malignant Cellular Infiltrate,Carcinosarcoma,1
18377,Severe cytologic atypia,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
18378,Precise Histogenesis Unknown,Peripheral Hemangioblastoma,1
18379,Mesenchymal Differentiation,Metaplastic meningioma,1
18380,Arborizing Vascular Channel Formation,Retiform hemangioendothelioma,1
18381,Multifocal Lesion,Bowenoid papulosis of penis,1
18382,Malignant Cellular Infiltrate,Malignant neoplasm of uvula,1
18383,Koilocytotic atypia,basaloid carcinoma of penis,1
18384,Carcinomatous Component Present,Recurrent Fallopian Tube Serous Adenocarcinoma,1
18385,Malignant Cellular Infiltrate,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
18386,Presence of a Hormonal Syndrome,Malignant Pancreatic Insulinoma,1
18387,Carcinomatous Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck,1
18388,Carcinomatous Component Present,Oncocytic Breast Carcinoma,1
18389,Malignant Cellular Infiltrate,Pituitary carcinoma,1
18390,High Grade Lesion,Gastric Synovial Sarcoma,1
18391,Epithelial Component Present,Stage IVA Oral Cavity Cancer AJCC v6 and v7,1
18392,Carcinomatous Component Present,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
18393,Malignant Cellular Infiltrate,Vaginal Adenosarcoma,1
18394,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome NOS,1
18395,Tissue Differentiation Uncertain,Adult Clear Cell Sarcoma of Soft Parts,1
18396,Malignant Cellular Infiltrate,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
18397,Myxoid Stroma Formation,Vertebral chordoma,1
18398,Castration-Sensitive,Castration-Sensitive Prostate Carcinoma,1
18399,Diffuse Pattern,Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
18400,Regional Disease,Locally Advanced Bile Duct Carcinoma,1
18401,Tissue of Mullerian Origin Present,Malignant Mixed Mesodermal (Mullerian) Tumor,1
18402,High Grade Lesion,Stage II Lung Small Cell Carcinoma AJCC v7,1
18403,Intermediate Grade Neuroendocrine Lesion,Gastric Neuroendocrine Tumor G2,1
18404,Bone Marrow Eosinophilia,Acute myeloid leukemia with abnormal marrow eosinophils,1
18405,Villous Pattern,Appendix Tubulovillous Adenoma,1
18406,Malignant Cellular Infiltrate,Malignant Kidney Mixed Epithelial and Stromal Tumor,1
18407,Epithelial Component Present,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
18408,Malignant Cellular Infiltrate,Stage III Esophageal Cancer AJCC v7,1
18409,Large Spaces Filled with Blood Present,"Bone Cysts, Aneurysmal",1
18410,Carcinomatous Component Present,Basal cell carcinoma - keratotic,1
18411,Vascular Channel Formation,"Hemangioma, Intramuscular",1
18412,Spindle Cell Osteo-Fibrous Component Present,Tibial adamantinoma,1
18413,Epithelial Component Present,Malignant Brenner Tumor,1
18414,Malignant Cellular Infiltrate,leukemia,1
18415,Carcinomatous Component Present,Occult Lung Large Cell Carcinoma,1
18416,Diffuse Pattern,Adult Oligodendroglioma,1
18417,Severe dysplasia,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
18418,Malignant Cellular Infiltrate,Hereditary Female Breast Carcinoma,1
18419,High Mitotic Activity,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
18420,Fibrous Septa Present,Stage III Ovarian Dysgerminoma AJCC v6 and v7,1
18421,Carcinomatous Component Present,Stage IIA Esophagus Carcinoma,1
18422,Benign Cellular Infiltrate,Respiratory papilloma,1
18423,Hyperkeratosis,Seborrheic keratosis,1
18424,Carcinomatous Component Present,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
18425,Anaplasia,Glioblastoma,1
18426,Cartilaginous Differentiation,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
18427,Carcinomatous Component Present,Stage I Major Salivary Gland Cancer AJCC v7,1
18428,Adnexal Differentiation,Pilar-Associated Mesenchyme Neoplasm,1
18429,Recurrent disease,Mycosis fungoides recurrent,1
18430,Mild cytologic atypia,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
18431,In Situ Lesion,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
18432,In Situ Lesion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
18433,Infiltrative Growth Pattern,Anaplastic astrocytoma,1
18434,Epithelial Component Present,"Leydig cell tumor, malignant",1
18435,Benign Cellular Infiltrate,Benign Cutaneous Fibroblastic Neoplasm,1
18436,Malignant Cellular Infiltrate,High Grade Astrocytic Tumor,1
18437,Carcinomatous Component Present,Prognostic Stage IA Breast Cancer AJCC v8,1
18438,Well-Circumscribed Lesion,Compact Cell Adrenal Cortical Adenoma,1
18439,Benign Cellular Infiltrate,Aggressive angiomyxoma,1
18440,Epithelial Component Present,Localized Resectable Adult Hepatocellular Carcinoma,1
18441,Epithelial Component Present,Stage IIIC Ovarian Cancer,1
18442,Tissue Differentiation Uncertain,Vulvar Angiomyxoma,1
18443,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
18444,Cutaneous Involvement,"Pemphigoid, Benign Mucous Membrane",1
18445,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Prolactin Secreting Adenoma,1
18446,Carcinomatous Component Present,Castration-Sensitive Prostate Carcinoma,1
18447,Hereditary Lesion,Werner Syndrome,1
18448,Carcinomatous Component Present,Stage 0 Pharynx Carcinoma,1
18449,Benign Cellular Infiltrate,Meyerson Nevus,1
18450,Epithelial Component Present,Esophageal Adenocarcinoma by AJCC v7 Stage,1
18451,Infantile Lesion,Infantile fibrosarcoma,1
18452,Epithelial Component Present,Metastatic Cervical Adenocarcinoma,1
18453,Recurrent disease,Recurrent Retinoblastoma,1
18454,Malignant Cellular Infiltrate,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia,1
18455,Mixed Cellular Population,Uterine Corpus Atypical Polypoid Adenomyoma,1
18456,Metastatic Lesion,Metastatic Colon Carcinoma,1
18457,Malignant Cellular Infiltrate,cystadenocarcinoma of salivary gland,1
18458,Carcinomatous Component Present,Vulvar Eccrine Porocarcinoma,1
18459,Carcinomatous Component Present,Skin Nodular Solid Basal Cell Carcinoma,1
18460,High Mitotic Activity,Atypical Pituitary Gland Adenoma,1
18461,Nuclear Grooves,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
18462,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,1
18463,Carcinomatous Component Present,Ductal Breast Carcinoma with Squamous Metaplasia,1
18464,Malignant Cellular Infiltrate,large B-cell diffuse lymphoma of spleen,1
18465,IDH Gene Family Mutation Status Unknown,Anaplastic Oligoastrocytoma,1
18466,Carcinomatous Component Present,Stage IIB Cervical Cancer AJCC v6 and v7,1
18467,Exophytic Polypoid Lesion,Duodenal Adenoma,1
18468,Malignant Cellular Infiltrate,Stage IIIB Penile Cancer AJCC v8,1
18469,Extensive Stage Lesion,Advanced Kaposi Sarcoma,1
18470,Indolent Clinical Course,Lung Myoepithelioma,1
18471,Intraductal Lesion,papillomatosis of extrahepatic bile duct,1
18472,Epithelial Component Present,Stage IA2 Cervical Cancer AJCC v8,1
18473,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
18474,Epithelial Component Present,Skin Basaloid Carcinoma,1
18475,Carcinomatous Component Present,Carcinoma of apocrine gland,1
18476,Nuclear Grooves,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
18477,Carcinomatous Component Present,Pathologic Stage IA Gastric Cancer AJCC v8,1
18478,Carcinomatous Component Present,Small intestine carcinoma recurrent,1
18479,Nuclear Expression of STAT6 Protein,Sellar Solitary Fibrous Tumor/Hemangiopericytoma,1
18480,Malignant Cellular Infiltrate,Adenocarcinoma with cartilaginous metaplasia,1
18481,Carcinomatous Component Present,Stage IVB Colon Cancer AJCC v7,1
18482,Childhood Lesion,Childhood Malignant Kidney Neoplasm,1
18483,Hemorrhagic,Radiation-Related Angiosarcoma,1
18484,Adnexal Differentiation,Apocrine Neoplasm,1
18485,Malignant Cellular Infiltrate,Refractory Aggressive Non-Hodgkin Lymphoma,1
18486,Benign Cellular Infiltrate,Benign Thalamic Neoplasm,1
18487,Carcinomatous Component Present,Endometrial adenocarcinoma,1
18488,Malignant Cellular Infiltrate,Gastric Synovial Sarcoma,1
18489,Moderate dysplasia,Moderate pancreatic duct dysplasia,1
18490,Epithelial Component Present,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,1
18491,Nodular Pattern,Recurrent Myxoid Liposarcoma,1
18492,Absence of Invasion,External Ear Actinic Keratosis,1
18493,Carcinomatous Component Present,Pancreatic adenocarcinoma recurrent,1
18494,Adnexal Differentiation,Sebaceous Breast Carcinoma,1
18495,Benign Cellular Infiltrate,Central Nervous System Leiomyoma,1
18496,Vascular Channel Formation,Angiomatosis,1
18497,Epithelial Component Present,Stage IA Lung Cancer AJCC v7,1
18498,Tissue Differentiation Uncertain,Phosphaturic Mesenchymal Tumor,1
18499,Metastatic Lesion,Locally Advanced Bone Sarcoma,1
18500,Minimal Invasion Present,minimally invasive follicular carcinoma of the thyroid gland,1
18501,Malignant Cellular Infiltrate,Small cell osteosarcoma,1
18502,Cutaneous Involvement,Mycosis fungoides stage III,1
18503,Childhood Lesion,Childhood Gastric Carcinoma,1
18504,Carcinomatous Component Present,Ampulla of Vater Squamous Cell Carcinoma,1
18505,Malignant Cellular Infiltrate,Malignant neoplasm of carotid body,1
18506,Osseous Component Present,Hamartoma of lung,1
18507,Carcinomatous Component Present,Refractory Endometrial Clear Cell Adenocarcinoma,1
18508,Epithelial Component Present,Stage IVB Appendix Carcinoma AJCC v7,1
18509,Mixed Cellular Population,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8,1
18510,Cutaneous Involvement,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
18511,S-100-Positive Neoplastic Cells Present,Eosinophilic Granuloma,1
18512,Malignant Cellular Infiltrate,Adult Grade III Lymphomatoid Granulomatosis,1
18513,Epithelial Component Present,Stage IIB Colon Cancer AJCC v7,1
18514,Adnexal Differentiation,Clear cell hidradenoma,1
18515,Benign Cellular Infiltrate,Benign neoplasm of myocardium,1
18516,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia,1
18517,Carcinomatous Component Present,Non-small cell lung cancer stage II,1
18518,Epithelial Component Present,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
18519,Poorly Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Carcinoma,1
18520,Carcinomatous Component Present,Sporadic Thyroid Gland Micromedullary Carcinoma,1
18521,Well Differentiated Lesion,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
18522,Thyroglobulin Positive Neoplastic Cells Present,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
18523,Epithelial Component Present,Unresectable Urothelial Carcinoma,1
18524,Benign Cellular Infiltrate,Infiltrating Intramuscular Lipoma,1
18525,High Mitotic Activity,Anaplastic thyroid carcinoma,1
18526,Secondary Lesion,Alkylating Agent-Related Acute Myeloid Leukemia,1
18527,Carcinomatous Component Present,Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
18528,Malignant Cellular Infiltrate,Ciliary Body Spindle Cell Melanoma,1
18529,Serotonin Positive Neoplastic Cells Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
18530,Epithelial Component Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8,1
18531,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
18532,Epithelial Component Present,Stage III Ileal Neuroendocrine Tumor AJCC v8,1
18533,Refractory Disease,Refractory Lymphoma,1
18534,Malignant Cellular Infiltrate,Refractory Myelodysplastic Syndrome,1
18535,Well-Circumscribed Lesion,Polyp of external auditory meatus,1
18536,"Amorphus, Eosinophilic, and Acellular Deposit",Senile cardiac amyloidosis,1
18537,Malignant Cellular Infiltrate,Recurrent Endometrial Cancer,1
18538,Oligodendroglial Component Present,Recurrent Childhood Anaplastic Oligodendroglioma,1
18539,Pseudopapillary Pattern,Cerebellar Papillary Meningioma,1
18540,Benign Cellular Infiltrate,"Adenoma, Sweat Gland",1
18541,Mixed Cellular Population,Stage IV Kidney Wilms Tumor,1
18542,Carcinomatous Component Present,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation,1
18543,Diffuse Pattern,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
18544,Benign Cellular Infiltrate,Lipoma of skin,1
18545,Cystic Change,Mucoepidermoid carcinoma of the oral cavity,1
18546,Malignant Cellular Infiltrate,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8,1
18547,Tissue of Mullerian Origin Present,Stage II Uterine Corpus Adenosarcoma AJCC v8,1
18548,Invasive Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,1
18549,Adulthood Lesion,Stage IV Adult Immunoblastic Lymphoma,1
18550,Clinical TNM Finding,Clinical Stage IIA Cutaneous Melanoma AJCC v8,1
18551,Perivascular fibrosis,Grade I Nodular Sclerosis Hodgkin's Lymphoma,1
18552,Lymphoplasmacytic Infiltrate,Angiolymphoid hyperplasia,1
18553,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Alveolar Variant",1
18554,CD56-Positive Neoplastic Cells Present,"NK-Cell Lymphoma, Unclassifiable",1
18555,Benign Cellular Infiltrate,Soft tissue chondroma,1
18556,Epithelial Component Present,Rectal Cancer by AJCC v7 Stage,1
18557,Benign Cellular Infiltrate,Thyroid Gland Clear Cell Follicular Adenoma,1
18558,Epithelial Component Present,Metastatic Adrenal Cortex Carcinoma,1
18559,Carcinomatous Component Present,Tonsillar Carcinoma,1
18560,Malignant Cellular Infiltrate,Squamous cell carcinoma of colon,1
18561,Lesion with Diameter Greater than 10mm,Non-Functioning Pituitary Gland Macroadenoma,1
18562,Adulthood Lesion,Lugano Classification Stage III Adult Lymphoma AJCC v8,1
18563,Cutaneous Involvement,Porphyria Cutanea Tarda,1
18564,Malignant Cellular Infiltrate,Leiomyosarcoma NCI Grade 3,1
18565,Malignant Cellular Infiltrate,Adult Myxoid Chondrosarcoma,1
18566,Epithelial Component Present,Stage 0 Cervical Cancer AJCC v6,1
18567,Cutaneous Involvement,Skin disorder arising from mental factors,1
18568,Eosinophilic inflammation,Breast Epithelioid Hemangioma,1
18569,Carcinomatous Component Present,Occult Lung Carcinoma,1
18570,Immunoglobulin Deposition,Primary amyloidosis,1
18571,In Situ Lesion,Stage 0 Vulvar Carcinoma,1
18572,Mild cytologic atypia,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
18573,Recurrent disease,Mycosis fungoides recurrent,1
18574,Diffuse Pattern,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease,1
18575,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like Variant",1
18576,Primary Lesion,Liver carcinoma,1
18577,Epithelial Component Present,Stage IIIC Esophageal Adenocarcinoma AJCC v7,1
18578,Malignant Cellular Infiltrate,"Lymphoma, Follicular",1
18579,Cutaneous Involvement,Pilar-Associated Mesenchyme Neoplasm,1
18580,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed stage III,1
18581,Tissue Differentiation Uncertain,Follicular Myxoma,1
18582,Absence of Invasion,Adenocarcinoma in situ in tubular adenoma,1
18583,Metastatic Lesion,Carcinoma bone,1
18584,Recurrent disease,Recurrent Adult Liver Carcinoma,1
18585,Tubular Pattern,Syringoma,1
18586,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Solid Variant",1
18587,Papillary Pattern,Intraductal papillomatosis,1
18588,Perineural spread,Metastatic Oral Cavity Adenoid Cystic Carcinoma,1
18589,Carcinomatous Component Present,carcinosarcoma of extrahepatic bile duct,1
18590,Epithelial Component Present,Pituitary Gland Mixed Gangliocytoma-Adenoma,1
18591,Vater-Pacini Corpuscles-Like Structures Present,Pacinian tumor,1
18592,Primary Lesion,Unresectable Hepatocellular Carcinoma,1
18593,Alternative Fascicle (Bundle) Pattern,Liver Leiomyoma,1
18594,Malignant Cellular Infiltrate,Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
18595,Mixed Cellular Population,Recurrent Anaplastic Oligoastrocytoma,1
18596,Carcinomatous Component Present,Colon Carcinoma Metastatic in the Lung,1
18597,Malignant Cellular Infiltrate,Occult Breast Carcinoma,1
18598,Metastatic Lesion,Pericardial mesothelioma malignant advanced,1
18599,Malignant Cellular Infiltrate,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia,1
18600,Malignant Cellular Infiltrate,Stage IA Bone Sarcoma AJCC v7,1
18601,Low Grade Lesion,Recurrent Childhood Subependymal Giant Cell Astrocytoma,1
18602,Malignant Cellular Infiltrate,Malignant melanoma of vulva,1
18603,Low Grade Neuroendocrine Lesion,Carcinoid tumor of the cecum,1
18604,Epithelial Component Present,Anatomic Stage IV Breast Cancer AJCC v8,1
18605,Malignant Cellular Infiltrate,Adult Hepatocellular Carcinoma,1
18606,Hypercellular bone marrow,"Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
18607,Recurrent disease,Recurrent Endometrial Serous Adenocarcinoma,1
18608,Carcinomatous Component Present,Stage IIIA Prostate Cancer AJCC v8,1
18609,Microvascular Proliferation,Glioblastoma,1
18610,Epithelial Component Present,Stage II Breast Cancer AJCC v6 and v7,1
18611,Malignant Cellular Infiltrate,Thymic Adenocarcinoma,1
18612,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Kaposi Sarcoma,1
18613,Epithelial Component Present,Cervical Squamotransitional Carcinoma,1
18614,Malignant Cellular Infiltrate,Recurrent Childhood Lymphoblastic Lymphoma,1
18615,atypia morphology,Primary ameloblastic carcinoma,1
18616,Well-Circumscribed Lesion,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,1
18617,Malignant Cellular Infiltrate,Adenosarcoma of cervix uteri,1
18618,Cutaneous Involvement,Stage 0 Cutaneous Melanoma AJCC v6 and v7,1
18619,Malignant Cellular Infiltrate,Recurrent Parotid Gland Squamous Cell Carcinoma,1
18620,Indolent Clinical Course,Perineural Hemangioma,1
18621,Epithelial Component Present,Sertoli-Leydig cell tumor of ovary,1
18622,CD56-Positive Neoplastic Cells Present,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,1
18623,Hyperplastic Tissue Present,Stromal hyperplasia,1
18624,Dysplasia,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
18625,Malignant Cellular Infiltrate,Bile duct mucinous adenocarcinoma,1
18626,Dysplasia,Gallbladder Papillary Adenoma,1
18627,Papillary Pattern,Epididymal Papillary Cystadenoma,1
18628,Well Differentiated Neuroendocrine Lesion,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
18629,Malignant Cellular Infiltrate,Glottis Verrucous Carcinoma,1
18630,Poorly Differentiated Lesion,Spindle cell squamous cell carcinoma,1
18631,Epithelial Component Present,Stage IV Esophagus Carcinoma,1
18632,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage,1
18633,Recurrent disease,Ewing's sarcoma recurrent,1
18634,Epithelial Component Present,Adult Type Ovarian Granulosa Cell Tumor,1
18635,Malignant Cellular Infiltrate,Malignant neoplasm of trachea,1
18636,Follicular Differentiation,Pilomatrixoma,1
18637,Carcinomatous Component Present,Cervical Verrucous Carcinoma,1
18638,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma,1
18639,Malignant Cellular Infiltrate,Stage II Ovarian Cancer AJCC v8,1
18640,Well Differentiated Lesion,Cervical Papillary Squamous Cell Carcinoma,1
18641,Multinodular Mass,Metastatic Dermatofibrosarcoma Protuberans,1
18642,Papillary Pattern,Vaginal Papillary Carcinoma,1
18643,Epithelial Component Present,Benign Ovarian Sex Cord-Stromal Tumor,1
18644,Primary Lesion,Recurrent Childhood Brain Stem Glioma,1
18645,Malignant Cellular Infiltrate,External Ear Squamous Cell Carcinoma,1
18646,Carcinomatous Component Present,Stage IV Oral Cavity Cancer AJCC v6 and v7,1
18647,Carcinomatous Component Present,"Carcinoma, Ovarian Epithelial",1
18648,Malignant Cellular Infiltrate,Ann Arbor Stage I Follicular Lymphoma,1
18649,Epithelial Component Present,Cervical Squamous Cell Carcinoma,1
18650,Epithelial Component Present,Ovarian Tumor of the Thecoma/Fibroma Group,1
18651,Hyperplastic Tissue Present,Mesonephric Hyperplasia,1
18652,Epithelial Component Present,Stage II Skin Cancer,1
18653,Papillary Pattern,"Cystadenoma, Papillary",1
18654,Superficial Lesion,Atypical Lipoma,1
18655,Epithelial Component Present,Stage IA Ampulla of Vater Cancer AJCC v7,1
18656,Epithelial Component Present,Foregut Carcinoid Tumor,1
18657,Tissue Differentiation Uncertain,Lung Synovial Sarcoma,1
18658,Malignant Cellular Infiltrate,Invasive Ductal and Invasive Lobular Breast Carcinoma,1
18659,Anaplasia,Childhood Gliosarcoma,1
18660,Acinar Cell Differentiation,Acinar cell cystadenocarcinoma,1
18661,Adulthood Lesion,Adult Oligodendroglioma,1
18662,Carcinomatous Component Present,Solar Radiation-Related Skin Squamous Cell Carcinoma,1
18663,Spontaneous Regression,Vulvar Keratoacanthoma,1
18664,Epithelial Component Present,Metastatic Squamous Cell Carcinoma of the Oropharynx,1
18665,Malignant Cellular Infiltrate,Osteosarcoma,1
18666,Perineural spread,Vaginal Adenoid Cystic Carcinoma,1
18667,Malignant Cellular Infiltrate,Enteropathy-Associated T-Cell Lymphoma,1
18668,Benign Cellular Infiltrate,Lactating adenoma,1
18669,Benign Cellular Infiltrate,Benign neoplasm of pleura,1
18670,More than 10 Mitoses per 10HPF,Occult Lung Small Cell Carcinoma,1
18671,Carcinomatous Component Present,Prostate Undifferentiated Carcinoma,1
18672,Epithelial Component Present,Mixed Cell Adrenal Cortical Adenoma,1
18673,CD30-Positive Neoplastic Cells Present,Ki-1+ Anaplastic Large Cell Lymphoma,1
18674,Rapidly Enlarging Mass,Adult Pleomorphic Rhabdomyosarcoma,1
18675,Cutaneous Involvement,Malignant neoplasm of sweat gland,1
18676,Nodular Pattern,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites",1
18677,Encapsulated Mass,Parotid Gland Warthin Tumor,1
18678,Adnexal Differentiation,Sebaceous Gland Neoplasms,1
18679,Epithelial Component Present,Hilus cell tumor of ovary,1
18680,Epithelial Component Present,Bile duct cystadenocarcinoma,1
18681,Metastatic Lesion,Metastatic Esophageal Carcinoma,1
18682,Epithelial Component Present,Breast Apocrine Adenoma,1
18683,Malignant Cellular Infiltrate,"Acute Myeloid Leukemia, M1",1
18684,Epithelial Component Present,Stage IVA Nasopharyngeal Carcinoma AJCC v8,1
18685,Monomorphic Cellular Infiltrate,Childhood Infratentorial Ependymoma,1
18686,Carcinomatous Component Present,Hard Palate Adenoid Cystic Carcinoma,1
18687,Epithelial Component Present,Frontal Sinus Squamous Cell Carcinoma,1
18688,Carcinomatous Component Present,Stage II Oral Cavity Cancer AJCC v6 and v7,1
18689,Carcinomatous Component Present,Major Salivary Gland Adenocarcinoma,1
18690,Malignant Cellular Infiltrate,Gonadal Polyembryoma,1
18691,Dysplasia,Grade II Prostatic Intraepithelial Neoplasia,1
18692,Encapsulated Mass,Thyroid Gland Spindle Cell Follicular Adenoma,1
18693,Borderline Lesion,Proliferating Brenner Tumor,1
18694,Absence of Malignant Features,Childhood Choroid Plexus Papilloma,1
18695,Malignant Cellular Infiltrate,Stage III Indolent Adult Non-Hodgkin Lymphoma,1
18696,Malignant Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma AJCC v8,1
18697,Tubular Pattern,Adenoma of the nipple,1
18698,Malignant Component Present,Ovarian Dermoid Cyst with Adenocarcinoma,1
18699,High Mitotic Activity,Occult Lung Small Cell Carcinoma,1
18700,Oligodendroglial Component Present,Recurrent Childhood Oligoastrocytoma,1
18701,Invasive Lesion,Invasive Malignant Neoplasm,1
18702,Metastatic Lesion,Secondary malignant neoplasm of chest wall,1
18703,Peripheral Nuclear Palisading,Small cell lung cancer limited stage,1
18704,Locally Aggressive Lesion,"Fibromatosis, Aggressive",1
18705,Presence of a Hormonal Syndrome,Functioning Endocrine Neoplasm,1
18706,Malignant Cellular Infiltrate,Malignant neoplasm of major salivary gland,1
18707,Extraosseous Lesion,Extra-osseous Ewing's sarcoma metastatic,1
18708,Diffuse Pattern,Recurrent Anaplastic Astrocytoma,1
18709,Well-Circumscribed Lesion,Large Bowel Juvenile Polyp,1
18710,Diffuse Pattern,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
18711,Carcinomatous Component Present,Mucoepidermoid carcinoma of salivary gland,1
18712,Defective Heavy Chain Present,Heavy Chain Disease,1
18713,Carcinomatous Component Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
18714,Malignant Cellular Infiltrate,Carcinoma Metastatic to the Skin,1
18715,Secondary Lesion,Metastatic Adrenal Gland Pheochromocytoma,1
18716,Nodular lesions,Thyroid Gland Follicular Adenoma,1
18717,Carcinomatous Component Present,Stage I Ovarian Cancer AJCC v6 and v7,1
18718,Benign Cellular Infiltrate,chondroma of lung,1
18719,Epithelial Component Present,Papillary renal cell carcinoma type 2,1
18720,Severe cytologic atypia,neuroendocrine carcinoma of anal canal,1
18721,Metastatic Lesion,Metastatic Neoplasm,1
18722,Malignant Cellular Infiltrate,Adult Desmoplastic Small Round Cell Tumor,1
18723,Therapy-Related Toxicity,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,1
18724,Benign Cellular Infiltrate,Balloon cell nevus,1
18725,Generalized illness,Disseminated Malignant Neoplasm,1
18726,Malignant Cellular Infiltrate,Low Grade Paranasal Sinus Sarcoma,1
18727,Malignant Cellular Infiltrate,Adenosarcoma,1
18728,Osteoid formation,Intracortical osteosarcoma,1
18729,Infiltrating Tumor Margins Present,Low Grade Endometrioid Stromal Sarcoma of the Vagina,1
18730,Fibrosis,Mediastinal (Thymic) Large B-Cell Lymphoma,1
18731,Malignant Cellular Infiltrate,Grade 1 Clear Cell Renal Cell Carcinoma,1
18732,Carcinomatous Component Present,Non-Small Cell Lung Carcinoma,1
18733,Benign Cellular Infiltrate,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",1
18734,Malignant Cellular Infiltrate,Stage II Superficial Spreading Melanoma AJCC v6 and v7,1
18735,Childhood Lesion,Childhood Embryonal Carcinoma,1
18736,Cutaneous Involvement,Verrucous epidermal nevus,1
18737,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
18738,Malignant Cellular Infiltrate,"Carcinoma, Skin Appendage",1
18739,Hypercellular bone marrow,Acute panmyelosis with myelofibrosis,1
18740,Benign Cellular Infiltrate,Benign Eccrine Neoplasm,1
18741,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma,1
18742,Malignant Cellular Infiltrate,Skin Basaloid Carcinoma,1
18743,Malignant Cellular Infiltrate,"Glomus tumor, malignant",1
18744,Carcinomatous Component Present,Stage III Vaginal Cancer AJCC v6 and v7,1
18745,Extracutaneous Dissemination of Disease,Disseminated Juvenile Xanthogranuloma,1
18746,Cutaneous Involvement,Locally Advanced Skin Squamous Cell Carcinoma,1
18747,Benign Cellular Infiltrate,Microcystic/Reticular Schwannoma,1
18748,Malignant Cellular Infiltrate,Stage IV Adult Liver Cancer AJCC v7,1
18749,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
18750,Epithelial Component Present,Stage IIIB Thymus Epithelial Neoplasm AJCC v8,1
18751,Epithelial Component Present,Exophytic Schneiderian Papilloma,1
18752,In Situ Lesion,Stage 0 Anal Canal Cancer AJCC v6 and v7,1
18753,Mucocele of appendix,Appendix Mucinous Cystadenoma,1
18754,Carcinomatous Component Present,Salivary Gland Myoepithelial Carcinoma,1
18755,Well-Circumscribed Lesion,Foveolar-Type Adenoma,1
18756,Immunologic Deficiency Syndromes,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder,1
18757,Primary Lesion,Pilocytic astrocytoma of cerebellum,1
18758,Mucoid Stroma Formation,mucinous adenocarcinoma of gallbladder,1
18759,Absence of Invasion,Bladder Urothelial Carcinoma in Situ,1
18760,Well-Circumscribed Lesion,Lung Mucinous Cystadenoma,1
18761,Malignant Cellular Infiltrate,Stage I Renal Pelvis Cancer AJCC v7,1
18762,Malignant Cellular Infiltrate,Stage IV Colon Carcinoma,1
18763,Benign Cellular Infiltrate,Oropharyngeal squamous papilloma,1
18764,Secondary Lesion,Metastatic Digestive System Neuroendocrine Carcinoma,1
18765,Carcinomatous Component Present,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8,1
18766,Epithelial Component Present,Stage IA Lung Large Cell Carcinoma AJCC v7,1
18767,Malignant Cellular Infiltrate,Stage II Anaplastic Large Cell Lymphoma,1
18768,Fibrotic Stroma Formation,Nasopharyngeal Angiofibroma,1
18769,Epithelial Component Present,Stage IB1 Cervical Cancer,1
18770,Neuroendocrine Differentiation,Combined Lung Carcinoma,1
18771,Necrotic changes (finding),Cervical Large Cell Neuroendocrine Carcinoma,1
18772,Aberrant Thyroid Tissue Present,Benign Struma Ovarii,1
18773,Epithelial Component Present,Prostate cancer stage A,1
18774,Carcinomatous Component Present,Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7,1
18775,Carcinomatous Component Present,Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8,1
18776,Low Mitotic Activity,Stage II Appendix Neuroendocrine Tumor AJCC v8,1
18777,Malignant Cellular Infiltrate,Recurrent Uveal Melanoma,1
18778,Epithelial Component Present,Ampulla of Vater Clear Cell Adenocarcinoma,1
18779,Carcinomatous Component Present,Stage II Lung Small Cell Carcinoma AJCC v7,1
18780,Chronic Inflammatory Infiltrate,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
18781,Childhood Lesion,Infant Acute Lymphoblastic Leukemia,1
18782,Biphasic Pattern,Benign Vaginal Mixed Tumor,1
18783,Dysplasia,Vaginal Tubular Adenoma,1
18784,Poorly Differentiated Lesion,carcinosarcoma of lung,1
18785,Primary Lesion,Small cell osteosarcoma,1
18786,Perivascular Arrangement of Tumor Cells,Childhood Kidney Angiomyolipoma,1
18787,Secondary Lesion,Locally Advanced Salivary Gland Carcinoma,1
18788,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Leiomyosarcoma AJCC v8,1
18789,Malignant Cellular Infiltrate,Refractory Burkitt Leukemia,1
18790,Malignant Cellular Infiltrate,Colorectal Kaposi Sarcoma,1
18791,Benign Cellular Infiltrate,Senile angioma,1
18792,Malignant Cellular Infiltrate,Stage III Bone Cancer AJCC v7,1
18793,Carcinomatous Component Present,Intracystic Papillary Breast Carcinoma,1
18794,Malignant Primitive Cellular Infiltrate,Childhood Ovarian Dysgerminoma,1
18795,Mesenchymal Component Present,Prostate Phyllodes Tumor,1
18796,Cutaneous Involvement,Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
18797,Serotonin Positive Neoplastic Cells Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
18798,Malignant Cellular Infiltrate,"Mesothelioma, biphasic, malignant",1
18799,Epithelial Component Present,Bladder Neuroendocrine Neoplasm,1
18800,Malignant Cellular Infiltrate,Lymphoma stage,1
18801,Childhood Lesion,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
18802,Rapidly Enlarging Mass,Rectal Rhabdomyosarcoma,1
18803,Low Mitotic Activity,Non-Functioning Pancreatic Neuroendocrine Tumor G1,1
18804,Refractory Disease,Refractory Childhood Spinal Cord Neoplasm,1
18805,Carcinomatous Component Present,Cervical Mesonephric Adenocarcinoma,1
18806,Indolent Clinical Course,"Synovioma, benign",1
18807,Malignant Cellular Infiltrate,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
18808,Benign Cellular Infiltrate,Epithelioid cell nevus,1
18809,Deep Lesion,Lumbosacral Lipoma,1
18810,Carcinomatous Component Present,Cervical Keratinizing Squamous Cell Carcinoma,1
18811,Malignant Cellular Infiltrate,Synchronous Bilateral Breast Carcinoma,1
18812,Cystic Change,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
18813,Epithelial Component Present,Stage II Hypopharyngeal Carcinoma AJCC v8,1
18814,Epithelial Component Present,Ovarian Endometrioid Cystadenoma,1
18815,Recurrent disease,Bladder cancer recurrent,1
18816,Primary Lesion,Hepatocellular Carcinoma by AJCC v8 Stage,1
18817,Carcinomatous Component Present,Lip and Oral Cavity Cancer by AJCC v8 Stage,1
18818,Carcinomatous Component Present,Gastric Papillary Adenocarcinoma,1
18819,Hemorrhagic,Uterine Angiosarcoma,1
18820,Malignant Cellular Infiltrate,Stage IA Lung Non-Small Cell Carcinoma AJCC v7,1
18821,Carcinomatous Component Present,Vulvar Adenocarcinoma of Sweat Gland Type,1
18822,Mild dysplasia,Colorectal Low Grade Intraepithelial Neoplasia,1
18823,Malignant Cellular Infiltrate,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype",1
18824,Epithelial Component Present,Stage IIB Eyelid Carcinoma AJCC v8,1
18825,Slow Growing Mass,Sacral Chordoma,1
18826,atypia morphology,Atypical fibroxanthoma of skin,1
18827,Malignant Cellular Infiltrate,Secondary malignant neoplasm of spinal cord,1
18828,Epithelial Component Present,Stage IIIB Esophageal Cancer AJCC v7,1
18829,Dysplasia,Large Cell Dysplasia,1
18830,Therapy-Related Toxicity,"Neoplasms, Therapy-Associated",1
18831,Epithelial Component Present,Bartholin's gland carcinoma,1
18832,Malignant Cellular Infiltrate,Carcinoma of anal margin,1
18833,Recurrent disease,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
18834,Metastatic Lesion,Advanced Neuroendocrine Carcinoma,1
18835,Stromal Invasion,Clear cell adenocarcinoma of ovary,1
18836,Mixed Cellular Population,Malignant Mixed Tumor of the Minor Salivary Gland,1
18837,Refractory Disease,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
18838,Metastatic Lesion,Metastatic Malignant Genitourinary System Neoplasm,1
18839,Local disease,Localized Peripheral Primitive Neuroectodermal Tumor,1
18840,Malignant Cellular Infiltrate,Ovarian Clear Cell Cystadenocarcinoma,1
18841,Carcinomatous Component Present,Hepatoid adenocarcinoma,1
18842,Carcinomatous Component Present,Stage IVA Fallopian Tube Cancer AJCC v8,1
18843,Malignant Cellular Infiltrate,"Squamous cell carcinoma, metastatic",1
18844,Malignant Cellular Infiltrate,Pleural Malignant Mesothelioma by AJCC v7 Stage,1
18845,Primary Lesion,Multinodular and Vacuolated Tumor of the Cerebrum,1
18846,Epithelial Component Present,Benign Ovarian Luteinized Thecoma,1
18847,Carcinomatous Component Present,Cholangiolocellular Carcinoma,1
18848,Malignant Cellular Infiltrate,Waldenstrom's macroglobulinemia refractory,1
18849,Carcinomatous Component Present,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
18850,Cutaneous Involvement,Primary Cutaneous Hodgkin Lymphoma,1
18851,Cutaneous Involvement,Stage I Lentigo Maligna Melanoma AJCC v7,1
18852,Negative Bone Marrow and Peripheral Blood,Small Lymphocytic Lymphoma by Ann Arbor Stage,1
18853,Carcinomatous Component Present,Stage IA Lung Small Cell Carcinoma AJCC v7,1
18854,Malignant Cellular Infiltrate,Papillary carcinoma of the breast,1
18855,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v8,1
18856,Malignant Cellular Infiltrate,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
18857,Refractory Disease,Refractory Hormone Receptor Positive Breast Carcinoma,1
18858,Rapidly Enlarging Mass,Vulvar Keratoacanthoma,1
18859,Adnexal Differentiation,Eccrine porocarcinoma,1
18860,Sebaceous Differentiation,Sebaceous Breast Carcinoma,1
18861,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged,1
18862,Exophytic Papillary Lesion,Glottis Verrucous Carcinoma,1
18863,Increased Cellularity Present,Metanephric adenoma,1
18864,Malignant Cellular Infiltrate,High Grade Sarcoma,1
18865,Malignant Cellular Infiltrate,Stage II Lip and Oral Cavity Cancer AJCC v6 and v7,1
18866,Epithelial Component Present,Stage III Hepatocellular Carcinoma AJCC v7,1
18867,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage III,1
18868,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma stage IV,1
18869,Malignant Cellular Infiltrate,Prostate Carcinoma Metastatic in the Soft Tissue,1
18870,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Vulvar Dysplastic Melanocytic Nevus,1
18871,Benign Cellular Infiltrate,Uterine Corpus Atypical Polypoid Adenomyoma,1
18872,Malignant Cellular Infiltrate,Advanced Malignant Solid Neoplasm,1
18873,Epithelial Component Present,Stage 0 Rectal Cancer AJCC v6 and v7,1
18874,No Evidence of Hormonal Immunoreactivity Present,Pituitary Gland Oncocytic Adenoma,1
18875,Epithelial Component Present,Adenocarcinoma of ampulla of Vater,1
18876,Carcinomatous Component Present,FIGO Stage IC3 Ovarian Cancer,1
18877,Epithelial Component Present,Stage II Bladder Cancer AJCC v8,1
18878,Ineffective hematopoiesis,Acute myeloid leukemia with multilineage dysplasia,1
18879,Low Mitotic Activity,Gastrinoma,1
18880,Vascular Channel Formation,Hobnail Hemangioma,1
18881,Epithelial Component Present,Nasopharyngeal Papillary Adenocarcinoma,1
18882,Carcinomatous Component Present,Thyroid carcinoma,1
18883,Hyperplastic Tissue Present,Reactive C-Cell Hyperplasia,1
18884,Acanthosis,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
18885,Unfavorable Clinical Outcome,Intermediate Atypical Prostate Carcinoma,1
18886,Malignant Cellular Infiltrate,Rectal Carcinoma,1
18887,Lymphoplasmacytic Infiltrate,Splenic Lymphoplasmacytic Lymphoma,1
18888,Tissue Differentiation Uncertain,"Perivascular epithelioid tumor, benign",1
18889,Recurrent disease,Recurrent Fallopian Tube Serous Adenocarcinoma,1
18890,Hyperplastic Tissue Present,Parathyroid chief-cell hyperplasia,1
18891,Fibrotic Stroma Formation,Clear cell cystadenofibroma,1
18892,Absence of Invasion,Lung Squamous Cell Carcinoma In Situ,1
18893,High Grade Lesion,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
18894,Fibrotic Stroma Formation,Scirrhous carcinoma of breast,1
18895,Malignant Cellular Infiltrate,Metastatic Ewing's Sarcoma,1
18896,Severe dysplasia,Lung Adenocarcinoma In Situ,1
18897,In Situ Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,1
18898,Tissue of Mullerian Origin Present,Stage IVB Uterine Corpus Adenosarcoma AJCC v8,1
18899,Recurrent disease,Recurrent Adult Non-Hodgkin Lymphoma,1
18900,Epithelial Component Present,Mucinous cystadenocarcinoma of ovary,1
18901,Pregnancy Complications,Placental aromatase deficiency,1
18902,Malignant Cellular Infiltrate,Poorly Differentiated Neuroblastoma,1
18903,Malignant Cellular Infiltrate,Acute myeloid leukemia with multilineage dysplasia,1
18904,Malignant Cellular Infiltrate,Childhood Burkitt Leukemia,1
18905,Diffuse Pattern,Adult Glioblastoma,1
18906,Recurrent disease,Angiocentric lymphoma recurrent,1
18907,Monomorphic Cellular Infiltrate,Recurrent Childhood Ependymoma,1
18908,Malignant Cellular Infiltrate,Malignant Adrenal Medulla Neoplasm,1
18909,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Central Nervous System Immature Teratoma,1
18910,Malignant Cellular Infiltrate,Carcinoma in situ of prostate,1
18911,Epithelial Component Present,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
18912,Malignant Cellular Infiltrate,Plasmacytoma anaplastic,1
18913,Malignant Cellular Infiltrate,leiomyosarcoma of breast,1
18914,Neuronal Differentiation,Cerebellar Neuronal and Mixed Neuronal-Glial Tumor,1
18915,Epithelial Component Present,Classic Variant of Chromophobe Renal Cell Carcinoma,1
18916,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v7,1
18917,Pseudoglandular Pattern,"Testicular Seminoma, Pseudoglandular Variant",1
18918,Benign Cellular Infiltrate,Ovarian Microcystic Stromal Tumor,1
18919,Neuroendocrine Differentiation,Sporadic Thyroid Gland Micromedullary Carcinoma,1
18920,Birbeck Granules Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
18921,Malignant Cellular Infiltrate,Stage IIB Pancreatic Cancer AJCC v6 and v7,1
18922,Malignant Cellular Infiltrate,Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7,1
18923,Anaplasia,Childhood Cerebellar Anaplastic Astrocytoma,1
18924,Cutaneous Involvement,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
18925,Low Mitotic Activity,Glucagonoma,1
18926,Epithelial Component Present,Contralateral Breast Carcinoma,1
18927,Carcinomatous Component Present,Stage IV Renal Pelvis Cancer AJCC v7,1
18928,Papillary Pattern,Lower Gingival Verrucous Carcinoma,1
18929,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Gene Mutation,1
18930,Malignant Cellular Infiltrate,Stage II Testicular Cancer AJCC v8,1
18931,Biphasic Pattern,endometrioid adenofibroma of ovary,1
18932,Biphasic Pattern,Cystadenofibroma of fallopian tube,1
18933,Storiform Growth Pattern,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
18934,Breast Microcalcification,Adult Brain Oligodendroglioma,1
18935,Biphasic Pattern,"Uterine Carcinosarcoma, Homologous Type",1
18936,Secondary Lesion,Secondary malignant neoplasm of peritoneum,1
18937,Cartilaginous Differentiation,Childhood Myxoid Chondrosarcoma,1
18938,Malignant Cellular Infiltrate,Moderately Differentiated Malignant Neoplasm,1
18939,Well-Circumscribed Lesion,Colorectal Mucin Poor Hyperplastic Polyp,1
18940,Microvascular Proliferation,Recurrent Childhood Pilocytic Astrocytoma,1
18941,Multilineage Dysplasia Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
18942,Malignant Cellular Infiltrate,Stage I Lip and Oral Cavity Cancer AJCC v8,1
18943,Benign Cellular Infiltrate,Cystadenofibroma,1
18944,Multinodular Mass,Superior Vena Cava Angiosarcoma,1
18945,Solid Growth Pattern,Breast Columnar Cell Mucinous Carcinoma,1
18946,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v7,1
18947,Metastatic Lesion,Metastatic Fibrolamellar Carcinoma,1
18948,Dysplasia,Appendix Mucinous Cystadenoma,1
18949,Malignant Cellular Infiltrate,Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma,1
18950,Splenomegaly,Recurrent T-Cell Prolymphocytic Leukemia,1
18951,Intestinal metaplasia,intestinal type adenocarcinoma of gallbladder,1
18952,Recurrent disease,Recurrent Extrahepatic Bile Duct Carcinoma,1
18953,Childhood Lesion,Recurrent Childhood Brain Neoplasm,1
18954,Tissue Differentiation Uncertain,"Synovial sarcoma, biphasic",1
18955,Carcinomatous Component Present,Carcinosarcoma,1
18956,Non-Hereditary Lesion,Signet-ring cell adenocarcinoma gastric,1
18957,Malignant Cellular Infiltrate,Hepatocellular Carcinoma by AJCC v6 Stage,1
18958,Papillary Pattern,papillary carcinoma of penis,1
18959,Negative Peripheral Blood,Aleukemic Acute Lymphoblastic Leukemia,1
18960,Borderline Lesion,Borderline Ovarian Clear Cell Adenofibroma,1
18961,Papillary Pattern,Vaginal Warty Carcinoma,1
18962,Epithelial Component Present,Small intestine carcinoma stage II,1
18963,Well-Circumscribed Lesion,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
18964,Dysplasia,Appendix Traditional Serrated Adenoma,1
18965,Benign Cellular Infiltrate,Unresectable Craniopharyngioma,1
18966,Adulthood Lesion,Stage IIIB Adult Liver Cancer AJCC v7,1
18967,Malignant Cellular Infiltrate,Stage III Anaplastic Large Cell Lymphoma,1
18968,Absence of Invasion,Carcinoma in situ of prostate,1
18969,Malignant Cellular Infiltrate,Bile duct signet-ring cell carcinoma,1
18970,Epithelial Component Present,Childhood Thyroid Gland Papillary Carcinoma,1
18971,Epithelial Component Present,Medullary carcinoma of breast,1
18972,Well Differentiated Lesion,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
18973,Malignant Cellular Infiltrate,basaloid squamous cell carcinoma of floor of mouth,1
18974,Carcinomatous Component Present,Endometrial Carcinoma,1
18975,Malignant Cellular Infiltrate,Lung Non-Small Cell Cancer by AJCC v7 Stage,1
18976,Indolent Clinical Course,Hemangioma of gingiva,1
18977,Malignant Cellular Infiltrate,Acute leukemia,1
18978,Epithelial Component Present,Apocrine adenoma,1
18979,Malignant Cellular Infiltrate,Pelvic Cancer,1
18980,Epithelial Component Present,Stage I Oropharyngeal Carcinoma,1
18981,Mixed Cellular Population,Benign Ovarian Seromucinous Tumor,1
18982,Neoplastic Promonocytes in Bone Marrow Markedly Increased,M5b Acute differentiated monocytic leukemia,1
18983,Aggressive Clinical Course,Mediastinal/Thymic NUT Carcinoma,1
18984,Metastatic Lesion,Secondary malignant neoplasm of pancreas,1
18985,Diffuse Pattern,Adult Diffuse Large B-Cell Lymphoma,1
18986,Therapy-Related Toxicity,Transplant-Related Kaposi Sarcoma,1
18987,Carcinomatous Component Present,Combined Lung Large Cell Neuroendocrine Carcinoma,1
18988,Carcinomatous Component Present,adenocarcinoma of breast with squamous metaplasia,1
18989,Microvascular Proliferation,Recurrent Pancreatic Acinar Cell Carcinoma,1
18990,Diffuse Pattern,Adult Giant Cell Glioblastoma,1
18991,Carcinomatous Component Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
18992,Diffuse Pattern,Adult Mixed Glioma,1
18993,Intracytoplasmic Eosinophilic Inclusion,Childhood Atypical Teratoid/Rhabdoid Tumor,1
18994,Therapy-Related Toxicity,Chemotherapy-Related Leukemia,1
18995,Epithelial Component Present,adenoid cystic carcinoma of pharynx,1
18996,Epithelial Component Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
18997,Fibrotic Stroma Formation,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
18998,atypia morphology,Borderline Ovarian Mucinous Adenofibroma,1
18999,Carcinomatous Component Present,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
19000,Malignant Cellular Infiltrate,Bladder cancer stage IV,1
19001,Malignant Cellular Infiltrate,Recurrent Malignant Neoplasm of Multiple Primary Sites,1
19002,Malignant Cellular Infiltrate,"Refractory Medulloblastoma, SHH-Activated",1
19003,Epithelial Component Present,Appendix Tubulovillous Adenoma,1
19004,Well Differentiated Lesion,keratoacanthoma,1
19005,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
19006,Epithelial Component Present,"Lung Squamous Cell Carcinoma, Clear Cell Variant",1
19007,Carcinomatous Component Present,Stage IIA Small Intestinal Cancer AJCC v7,1
19008,Epithelial Component Present,Masaoka-Koga Stage IVb,1
19009,Epithelial Component Present,Stage III Paranasal Sinus Cancer AJCC v6 and v7,1
19010,Carcinomatous Component Present,Clear cell squamous cell carcinoma of skin,1
19011,Diffuse Pattern,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
19012,Benign Cellular Infiltrate,Cellular Neurofibroma,1
19013,Thyroglobulin Positive Neoplastic Cells Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
19014,High Grade Lesion,Vulvar Alveolar Rhabdomyosarcoma,1
19015,Carcinomatous Component Present,Undifferentiated carcinoma of esophagus,1
19016,Neuroendocrine Differentiation,Lung Typical Carcinoid Tumor,1
19017,Blasts 10-19 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-2,1
19018,Neuroectodermal Differentiation,Stage 2A Neuroblastoma,1
19019,Desmoplastic Stroma Formation,Pilomatrix carcinoma of skin,1
19020,Secondary Lesion,Metastatic Unresectable Sarcoma,1
19021,Carcinomatous Component Present,Laryngeal Squamous Cell Carcinoma,1
19022,Well-Circumscribed Lesion,Spinal hemangioblastoma,1
19023,Parakeratinized Stratified Squamous Epithelium Present,Keratocystic Odontogenic Tumor,1
19024,Malignant Cellular Infiltrate,Epithelioid hemangioendothelioma of lung,1
19025,Malignant Cellular Infiltrate,Adrenocortical carcinoma,1
19026,Malignant Cellular Infiltrate,Carcinomatosis of peritoneal cavity,1
19027,Childhood Lesion,Clear cell sarcoma of kidney,1
19028,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Oncocytic Adenoma,1
19029,Malignant Cellular Infiltrate,Parotid Gland Carcinosarcoma,1
19030,High Mitotic Activity,Colorectal Large Cell Neuroendocrine Carcinoma,1
19031,Cutaneous Involvement,Ceruminous adenocarcinoma,1
19032,Cutaneous Involvement,Sezary Syndrome,1
19033,Malignant Cellular Infiltrate,Mycosis fungoides stage IV,1
19034,Mixed Cellular Population,Stage III Kidney Wilms Tumor,1
19035,Malignant Cellular Infiltrate,Stage II Malignant Mediastinal Germ Cell Tumor,1
19036,Metaplasia,"Vulvar Adenocarcinoma, Intestinal-Type",1
19037,Carcinomatous Component Present,Adenocarcinoma of lung stage IIIB,1
19038,Benign Cellular Infiltrate,Eccrine Poroma,1
19039,Benign Cellular Infiltrate,Benign Germinative Follicular Epithelium Neoplasm,1
19040,Refractory Disease,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
19041,Calcitonin serum level increased,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7,1
19042,Mixture of Germ Cell Neoplastic Components Present,Mediastinal Mixed Non-Seminomatous Germ Cell Tumor,1
19043,Non-Hereditary Lesion,Gastric Intramucosal Adenocarcinoma,1
19044,Intermediate Filaments Present,Recurrent Atypical Teratoid/Rhabdoid Tumor,1
19045,Malignant Cellular Infiltrate,Choriocarcinoma,1
19046,Epithelial Component Present,Cervical Mesonephric Adenocarcinoma,1
19047,Tubular Pattern,Small Intestinal Tubular Adenoma,1
19048,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma stage III,1
19049,Malignant Cellular Infiltrate,Ann Arbor Stage I Grade 1 Follicular Lymphoma,1
19050,Malignant Cellular Infiltrate,Testicular choriocarcinoma stage III,1
19051,Malignant Cellular Infiltrate,Esophageal carcinoma recurrent,1
19052,Carcinomatous Component Present,Stage IB Ampulla of Vater Cancer AJCC v7,1
19053,Malignant Cellular Infiltrate,Lung squamous cell carcinoma stage II,1
19054,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
19055,Malignant Cellular Infiltrate,ROSE Cluster 1,1
19056,Immunologic Deficiency Syndromes,AIDS-Related Retinopathy,1
19057,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory Neutropenia,1
19058,Malignant Cellular Infiltrate,Bladder cancer stage IV,1
19059,Malignant Cellular Infiltrate,Eyelid Sebaceous Gland Carcinoma,1
19060,High Mitotic Activity,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
19061,Malignant Cellular Infiltrate,Buccal Mucosa Verrucous Carcinoma,1
19062,Malignant Cellular Infiltrate,Recurrent Non-Cutaneous Melanoma,1
19063,Carcinomatous Component Present,Tracheal Carcinoma,1
19064,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Spindle Cell Follicular Adenoma,1
19065,Clinical TNM Finding,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
19066,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage II,1
19067,Pregnancy Complications,Stage I Gestational Trophoblastic Tumor AJCC v7,1
19068,Carcinomatous Component Present,"Cystadenocarcinoma, Mucinous",1
19069,Epithelial Component Present,Unresectable Carcinoid Tumor,1
19070,Neuroendocrine Differentiation,Esophageal Neuroendocrine Tumor G1,1
19071,Epithelial Component Present,Bladder Urothelial Carcinoma in Situ,1
19072,Malignant Cellular Infiltrate,Grade III Lymphomatoid Granulomatosis,1
19073,Malignant Cellular Infiltrate,Stage III Fallopian Tube Cancer AJCC v7,1
19074,Neuroendocrine Differentiation,"Neuroendocrine carcinoma, metastatic",1
19075,Adulthood Lesion,Localized Non-Resectable Adult Liver Carcinoma,1
19076,VIP Positive Neoplastic Cells Present,Malignant Pancreatic Vipoma,1
19077,Primary Lesion,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
19078,Epithelial Component Present,Esophageal Cancer by AJCC v7 Stage,1
19079,Carcinomatous Component Present,Bladder Squamous Cell Carcinoma,1
19080,Metastatic Lesion,Metastatic Urethral Carcinoma,1
19081,Epithelial Component Present,Hepatocellular Carcinoma by AJCC v8 Stage,1
19082,Nuclear Atypia,Supratentorial Glioblastoma,1
19083,Epithelial Component Present,Normal Breast-Like Subtype of Breast Carcinoma,1
19084,Epithelial Component Present,Pathologic Stage IV Gastric Cancer AJCC v8,1
19085,Borderline Lesion,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
19086,Epithelial Component Present,Stage IIIB Gallbladder Cancer AJCC v7,1
19087,Cutaneous Involvement,Unresectable Skin Carcinoma,1
19088,Carcinomatous Component Present,Pancreatic carcinoma non-resectable,1
19089,Malignant Cellular Infiltrate,Mediastinal T Lymphoblastic Lymphoma,1
19090,Spontaneous Regression,Vulvar Keratoacanthoma,1
19091,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of skin,1
19092,Benign Cellular Infiltrate,Papillary craniopharyngioma,1
19093,Epithelial Component Present,Stage III Duodenal Neuroendocrine Tumor AJCC v8,1
19094,Carcinomatous Component Present,Vulvar Small Cell Carcinoma,1
19095,Epithelial Component Present,Pituitary Adenoma,1
19096,Epithelial Component Present,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,1
19097,Epithelial Component Present,Ampulla of Vater Mucinous Adenocarcinoma,1
19098,Increased Cellularity Present,Stage 2A Neuroblastoma,1
19099,Epithelial Component Present,Bladder Urachal Squamous Cell Carcinoma,1
19100,Carcinomatous Component Present,Stage II Urethral Cancer AJCC v7,1
19101,Epithelial Component Present,Gastric Small Cell Carcinoma,1
19102,Monomorphic Cellular Infiltrate,Sellar Ependymoma,1
19103,Epithelial Component Present,Refractory Pancreatic Neuroendocrine Carcinoma,1
19104,Pregnancy Complications,Disorder of pregnancy,1
19105,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,1
19106,Carcinomatous Component Present,High Grade Ovarian Serous Adenocarcinoma,1
19107,Well-Circumscribed Lesion,Stage IV Kidney Wilms Tumor,1
19108,Malignant Cellular Infiltrate,Pathologic Stage IIIC Gastric Cancer AJCC v8,1
19109,Malignant Cellular Infiltrate,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8,1
19110,Epithelial Component Present,Stage II Gallbladder Cancer AJCC v7,1
19111,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma by Ann Arbor Stage,1
19112,Diffuse Lesion,Carcinomatosis,1
19113,Epithelial Component Present,Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7,1
19114,Malignant Cellular Infiltrate,Adult Angiosarcoma,1
19115,Malignant Cellular Infiltrate,"Testicular Seminoma, Tubular Variant",1
19116,Indolent Clinical Course,Gardner Fibroma,1
19117,Dentin formation,Ameloblastic fibrodentinoma,1
19118,Epithelial Component Present,basaloid carcinoma of anus,1
19119,Stromal Invasion,Malignant Ovarian Serous Tumor,1
19120,Neuroectodermal Differentiation,neuroblastoma of spinal cord,1
19121,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Myxoid Leiomyoma,1
19122,Papillary Pattern,Common wart,1
19123,Carcinomatous Component Present,Refractory Colon Carcinoma,1
19124,Unifocal Disease at Presentation,Mast-Cell Sarcoma,1
19125,Poorly Differentiated Lesion,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
19126,Biphasic Pattern,"Uterine Carcinosarcoma, Homologous Type",1
19127,Malignant Cellular Infiltrate,Sporadic Thyroid Gland Medullary Carcinoma,1
19128,Carcinomatous Component Present,Stage III Oropharyngeal Carcinoma AJCC v7,1
19129,Local disease,Parotid Gland Lipoma,1
19130,Epithelial Component Present,Barrett's Adenocarcinoma,1
19131,Epithelial Component Present,Carcinomatosis,1
19132,Malignant Cellular Infiltrate,Unresectable Ewing Sarcoma,1
19133,Hyperkeratosis,"Lung Squamous Cell Carcinoma, Papillary Variant",1
19134,Refractory Disease,Refractory Malignant Bone Neoplasm,1
19135,Indolent Clinical Course,Lipoma of spinal cord,1
19136,Eccrine Differentiation,eccrine adenocarcinoma of vulva,1
19137,Cutaneous Involvement,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8,1
19138,Malignant Cellular Infiltrate,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
19139,Epithelial Component Present,Stage III Vulvar Cancer AJCC v7,1
19140,Cutaneous Involvement,Dysplastic Nevus,1
19141,Intestinal metaplasia,Gastric Intestinal-Type Adenocarcinoma,1
19142,Microvascular Proliferation,Third Ventricle Pilocytic Astrocytoma,1
19143,Aggressive Clinical Course,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",1
19144,Borderline Lesion,"Post-transplant lymphoproliferative disorder, polymorphic",1
19145,Hereditary Lesion,Dominant hereditary optic atrophy,1
19146,Regional Disease,Locally Advanced Unresectable Malignant Neoplasm,1
19147,Non-Invasive Lesion,Stage 0a Ureter Cancer AJCC v8,1
19148,Parakeratosis,Classic Type Trichilemmoma,1
19149,Malignant Cellular Infiltrate,Childhood Cerebral Anaplastic Astrocytoma,1
19150,Carcinomatous Component Present,BCLC Stage D Hepatocellular Carcinoma,1
19151,Malignant Cellular Infiltrate,Trichilemmocarcinoma,1
19152,Epithelial Component Present,Gastric Neuroendocrine Carcinoma,1
19153,Malignant Cellular Infiltrate,Renal Cell Cancer by AJCC v7 Stage,1
19154,Microvascular Proliferation,Recurrent Pancreatic Acinar Cell Carcinoma,1
19155,Epithelial Component Present,Stage IIB Cervical Cancer AJCC v8,1
19156,Malignant Cellular Infiltrate,Central nervous system leukemia,1
19157,Multifocal Lesion,Bowenoid papulosis of penis,1
19158,Clinical TNM Finding,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
19159,Indolent Clinical Course,Gastric Plexiform Fibromyxoma,1
19160,Recurrent disease,Pharyngeal cancer recurrent,1
19161,In Situ Lesion,Stage 0 Colorectal Cancer AJCC v8,1
19162,Malignant Cellular Infiltrate,Borderline Resectable Pancreatic Adenocarcinoma,1
19163,Vascular Channel Formation,Hemangioma of subcutaneous tissue,1
19164,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma stage I,1
19165,Biphasic Pattern,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
19166,Epithelial Component Present,Malignant Ovarian Surface Epithelial-Stromal Tumor,1
19167,Carcinomatous Component Present,Stage IA Esophageal Cancer AJCC v7,1
19168,Biphasic Pattern,Parotid Gland Carcinosarcoma,1
19169,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,1
19170,Carcinomatous Component Present,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type",1
19171,Well-Circumscribed Lesion,Cortisol-Producing Adrenal Cortex Adenoma,1
19172,Malignant Cellular Infiltrate,Mucinous adenocarcinoma gastric,1
19173,Malignant Cellular Infiltrate,Epithelioid Cell Uveal Melanoma,1
19174,Carcinomatous Component Present,Fallopian Tube Serous Adenocarcinoma,1
19175,Ground Glass Nuclear Inclusion,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
19176,Malignant Cellular Infiltrate,Malignant neoplasm of sweat gland,1
19177,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8,1
19178,Carcinomatous Component Present,Advanced Renal Cell Carcinoma,1
19179,Benign Cellular Infiltrate,Thyroid Gland Lymphangioma,1
19180,Cystic Change,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,1
19181,Poorly Differentiated Lesion,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
19182,Epithelial Component Present,Lung Cancer by AJCC v8 Stage,1
19183,Carcinomatous Component Present,Small intestine carcinoma resectable,1
19184,Epithelial Component Present,Stage IV Vulvar Cancer AJCC v8,1
19185,Epithelial Component Present,Stage III Ovarian Cancer AJCC v8,1
19186,Malignant Cellular Infiltrate,Stage II Rectal Cancer AJCC v8,1
19187,Mitotic Activity,"Testicular Yolk Sac Tumor, Hepatoid Pattern",1
19188,Perivascular Arrangement of Tumor Cells,Glomangiomatosis,1
19189,Cervical lymphadenopathy,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,1
19190,Cutaneous Involvement,Mongolian Spot,1
19191,Diffuse Pattern,Childhood Diffuse Large B-Cell Lymphoma,1
19192,Malignant Cellular Infiltrate,Malignant Testicular Germ Cell Tumor,1
19193,Increased Cellularity Present,Stage 4S neuroblastoma,1
19194,Adnexal Differentiation,Eccrine hidrocystoma,1
19195,Storiform Growth Pattern,Deep histiocytoma,1
19196,Absence of a Hormonal Syndrome,Sparsely Granulated Non-Functioning Corticotroph Adenoma,1
19197,Human Papillomavirus Positive,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage,1
19198,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of salivary gland,1
19199,Cutaneous Involvement,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
19200,Epithelial Component Present,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
19201,Carcinomatous Component Present,Stage 0 Vaginal Cancer AJCC v7,1
19202,Epithelial Component Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
19203,Carcinomatous Component Present,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
19204,Benign Cellular Infiltrate,lipoma of bone,1
19205,Childhood Lesion,Childhood Testicular Mature Teratoma,1
19206,Malignant Cellular Infiltrate,Mixed Congenital Mesoblastic Nephroma,1
19207,Carcinomatous Component Present,Platinum-Resistant Lung Small Cell Carcinoma,1
19208,Infantile Lesion,Infantile fibrosarcoma,1
19209,Malignant Component Present,Ovarian Dermoid Cyst with Adenocarcinoma,1
19210,Epithelial Component Present,adenocarcinoma of extrahepatic bile duct,1
19211,Moderate dysplasia,Cervical intraepithelial neoplasia grade 2,1
19212,Epithelial Component Present,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
19213,Keratin pearl formation,Clear cell squamous cell carcinoma of skin,1
19214,Well-Circumscribed Lesion,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,1
19215,Primary Lesion,Childhood Infratentorial Ependymoma,1
19216,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,1
19217,Fibrosis,Breast Sclerosing Adenosis,1
19218,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Carcinosarcoma of cervix uteri,1
19219,Perivascular Arrangement of Tumor Cells,Angiomyolipoma of kidney,1
19220,Epithelial Component Present,Adenocarcinoma of small intestine,1
19221,Cutaneous Involvement,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
19222,Cutaneous Involvement,Tumor of follicular infundibulum,1
19223,Recurrent disease,Recurrent Childhood Anaplastic Astrocytoma,1
19224,Carcinomatous Component Present,Stage II Vulvar Cancer AJCC v7,1
19225,Lymphadenopathy,Nodal marginal zone B-cell lymphoma recurrent,1
19226,Lobulated Growth Pattern,Recurrent Chordoma,1
19227,Carcinomatous Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v8,1
19228,Vascular Channel Formation,Metastatic angiosarcoma,1
19229,Monoclonal Cellular Population Present,Urticaria Pigmentosa,1
19230,Carcinomatous Component Present,Metastatic Lung Non-Small Cell Carcinoma,1
19231,Mixed Cellular Population,Stage IV Uterine Corpus Adenosarcoma AJCC v8,1
19232,Papillary Pattern,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
19233,Malignant Cellular Infiltrate,Papillary serous cystadenocarcinoma,1
19234,High Mitotic Activity,Small cell carcinoma of the cervix,1
19235,Carcinomatous Component Present,Adenosquamous cell lung cancer stage I,1
19236,Extracutaneous Dissemination of Disease,Mycosis fungoides stage II,1
19237,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
19238,Complete Spontaneous Regression,Type E Lymphomatoid Papulosis,1
19239,Perineural spread,adenoid cystic carcinoma of esophagus,1
19240,Epithelial Component Present,Squamous Cell Carcinoma of Unknown Primary,1
19241,Malignant Cellular Infiltrate,"Myelodysplastic syndrome, no ICD-O subtype",1
19242,Carcinomatous Component Present,Ear carcinoma,1
19243,Carcinomatous Component Present,Malignant myoepithelioma,1
19244,Well-Circumscribed Lesion,Non-Functioning Adrenal Cortex Adenoma,1
19245,Secondary Lesion,Extra-osseous Ewing's sarcoma metastatic,1
19246,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
19247,Neuroendocrine Differentiation,Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
19248,In Situ Lesion,Anatomic Stage 0 Breast Cancer AJCC v8,1
19249,Monomorphic Cellular Infiltrate,Ependymoma of brain stem,1
19250,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of lung,1
19251,Malignant Cellular Infiltrate,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8,1
19252,Epithelial Component Present,Carcinoma in situ of cecum,1
19253,Carcinomatous Component Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),1
19254,Malignant Cellular Infiltrate,ISS Stage III Plasma Cell Myeloma,1
19255,Malignant Cellular Infiltrate,Esophageal Adenocarcinoma by AJCC v7 Stage,1
19256,Epithelial Component Present,Posterior Pharyngeal Wall Carcinoma,1
19257,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
19258,Adulthood Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
19259,Diffuse Pattern,Extracavitary Primary Effusion Lymphoma,1
19260,Epithelial Component Present,Stage IV Renal Pelvis and Ureter Cancer AJCC v7,1
19261,Epithelial Component Present,Schneiderian papilloma,1
19262,Five or Less Mitoses per 50HPF,"Gastrointestinal stromal tumor, benign",1
19263,Cutaneous Involvement,Granular cell tumor of skin,1
19264,Rarely Metastasizing Lesion,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,1
19265,Carcinomatous Component Present,adenocarcinoma of oral cavity,1
19266,CD56-Positive Neoplastic Cells Present,Nasal Type Extranodal NK/T-Cell Lymphoma,1
19267,Blasts of Mixed Phenotype Present,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes",1
19268,Malignant Cellular Infiltrate,Rectosigmoid cancer,1
19269,High Grade Lesion,Embryonal Rhabdomyosarcoma,1
19270,'Starry-sky' pattern,Burkitt's tumor of spleen,1
19271,Epithelial Component Present,Benign Ovarian Sex Cord-Stromal Tumor,1
19272,Mixed Cellular Population,Eccrine mixed tumor of skin,1
19273,Serrated Glandular Architecture,Traditional Serrated Adenoma,1
19274,Pseudoglandular Pattern,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7,1
19275,Metastatic Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,1
19276,Indolent Clinical Course,lipoma of mediastinum,1
19277,Lytic lesion,Solitary Osseous Plasmacytoma,1
19278,Malignant Cellular Infiltrate,Adenocarcinoma,1
19279,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,1
19280,Epithelial Component Present,Pathologic Stage IA Gastric Cancer AJCC v8,1
19281,Epithelial Component Present,Gastric Mixed Adenocarcinoma,1
19282,Epithelial Component Present,Supraglottic Verrucous Carcinoma,1
19283,Diffuse Cellular Infiltrate,Sporadic Diffuse Gastric Adenocarcinoma,1
19284,Malignant Cellular Infiltrate,Ceruminous adenocarcinoma,1
19285,Carcinomatous Component Present,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,1
19286,Cutaneous Involvement,Squamous cell papilloma of skin,1
19287,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v8 Stage,1
19288,Malignant Cellular Infiltrate,Urothelial carcinoma ureter recurrent,1
19289,Well Differentiated Lesion,Plantar Verrucous Skin Carcinoma,1
19290,Mesenchymal Differentiation,Recurrent Gliosarcoma,1
19291,Indolent Clinical Course,Myofibromatosis,1
19292,Malignant Cellular Infiltrate,Childhood Small Intestinal Leiomyosarcoma,1
19293,Epithelial Component Present,Ear carcinoma,1
19294,Malignant Cellular Infiltrate,Clinical Stage IV Gastric Cancer AJCC v8,1
19295,Hyperplastic Tissue Present,Nodular Bartholin Gland Hyperplasia,1
19296,Mesenchymal Differentiation,Childhood Brain Stem Gliosarcoma,1
19297,Melanin Pigment Present,Melanoacanthoma,1
19298,Monomorphic Cellular Infiltrate,Monomorphic epitheliotropic intestinal T-cell lymphoma,1
19299,Angiodestructive Pattern,Angiocentric immunoproliferative lesion grade 2,1
19300,Malignant Cellular Infiltrate,Metastatic Prostate Small Cell Carcinoma,1
19301,Cutaneous Involvement,Bullous Dermatitis,1
19302,Diffuse Cellular Infiltrate,Hereditary Diffuse Gastric Adenocarcinoma,1
19303,Organoid Pattern,Vulvar Alveolar Soft Part Sarcoma,1
19304,Epithelial Component Present,Stage IIIA Bladder Cancer AJCC v8,1
19305,Delicate Vascular Network Formation,Grade 4 Clear Cell Renal Cell Carcinoma,1
19306,Epithelial Component Present,Thyroid stimulating hormone-producing pituitary tumor,1
19307,Malignant Cellular Infiltrate,Malignant Submandibular Gland Mixed Tumor,1
19308,Carcinomatous Component Present,Carcinoma in situ of cecum,1
19309,Epithelial Component Present,Biliary Intraepithelial Neoplasia,1
19310,Cutaneous Involvement,Skin Squamous Cell Carcinoma In Situ,1
19311,Well Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G1,1
19312,Carcinomatous Component Present,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
19313,Mammary Gland Type Features Present,Vulvar Adenocarcinoma of Mammary Gland Type,1
19314,Vascular Channel Formation,Hemangioma of retina,1
19315,Malignant Cellular Infiltrate,Localized Unresectable Adult Hepatocellular Carcinoma,1
19316,Vascular Channel Formation,Hemangioendothelioma,1
19317,Cystic Change,Recurrent Malignant Ovarian Brenner Tumor,1
19318,No Identifiable Line of Differentiation,Giant Cell Fibrous Histiocytoma,1
19319,Fibrous Septa Present,Stage III Ovarian Dysgerminoma AJCC v6 and v7,1
19320,Primary Lesion,Cerebral Non-Hodgkin Lymphoma,1
19321,Cystic Change,Pancreatic Intraductal Papillary-Mucinous Adenoma,1
19322,Epithelial Component Present,Benign neoplasm of sebaceous gland,1
19323,Edematous Stroma Formation,Myxoma,1
19324,Cutaneous Involvement,Radiation-Recall Dermatitis,1
19325,Polymorphic Cellular Infiltrate,Central Nervous System Langerhans Cell Histiocytosis,1
19326,Epithelial Component Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
19327,Chronic lymphocytic inflammation,"Thymoma, type AB, malignant",1
19328,Malignant Component Present,Testicular Teratoma with Somatic-Type Malignancy,1
19329,Malignant Cellular Infiltrate,Embryonal Rhabdomyosarcoma,1
19330,Malignant Cellular Infiltrate,Refractory Malignant Bone Neoplasm,1
19331,Malignant Cellular Infiltrate,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,1
19332,Non-Invasive Lesion,Non-Invasive Urothelial Neoplasm,1
19333,Junctional Proliferation,Desmoplastic spindle and epithelioid cell melanocytic nevus of skin,1
19334,Diffuse Pattern,Glioblastoma by Gene Expression Profile,1
19335,Malignant Cellular Infiltrate,Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
19336,Anaplasia,Spindle cell squamous cell carcinoma,1
19337,Malignant Cellular Infiltrate,Rhabdomyosarcoma of cervix uteri,1
19338,Biphasic Pattern,mesenchymal chondrosarcoma of bone,1
19339,Malignant Cellular Infiltrate,Stage IVB Colorectal Cancer AJCC v8,1
19340,Malignant Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
19341,Malignant Cellular Infiltrate,Gastric Mixed Adenoneuroendocrine Carcinoma,1
19342,Cutaneous Involvement,Superficial spreading malignant melanoma of skin,1
19343,Epithelial Component Present,Pancreatic adenocarcinoma recurrent,1
19344,Carcinomatous Component Present,Stage IIIB Ampulla of Vater Cancer AJCC v8,1
19345,Epithelial Component Present,Metastatic Nasopharyngeal Undifferentiated Carcinoma,1
19346,Epithelial Component Present,Nasopharyngeal Papillary Adenocarcinoma,1
19347,Epithelial Component Present,Paget's disease of vulva,1
19348,Aggressive Clinical Course,Invasive micropapillary carcinoma of breast,1
19349,Secondary Lesion,Metastatic Oral Cavity Carcinoma,1
19350,Pathologic TNM Finding,Pathologic Stage IIID Cutaneous Melanoma AJCC v8,1
19351,Indolent Clinical Course,Angioma serpiginosum,1
19352,Thin-Walled Branching Vascular Pattern,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1",1
19353,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Monoallelic Mutations of CEBPA,1
19354,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) refractory,1
19355,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 4,1
19356,Breast Implant-Related Lesion,Breast implant-associated anaplastic large cell lymphoma,1
19357,Well-Circumscribed Lesion,Colorectal Adenoma with Severe Dysplasia,1
19358,Absence of Invasion,Carcinoma in situ of small intestine,1
19359,Carcinomatous Component Present,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
19360,Negative Peripheral Blood,Aleukemic Chronic Lymphocytic Leukemia,1
19361,Ineffective hematopoiesis,MYELODYSPLASTIC SYNDROME,1
19362,Malignant Cellular Infiltrate,External Ear Squamous Cell Carcinoma,1
19363,Recurrent disease,Recurrent Ovarian Adenocarcinoma,1
19364,Trabecular Pattern,Thyroid Hyalinizing Trabecular Adenoma,1
19365,Unresectable Mass,Unresectable Digestive System Carcinoma,1
19366,Mixed Cellular Population,Malignant Kidney Mixed Epithelial and Stromal Tumor,1
19367,Malignant Cellular Infiltrate,Refractory Bile Duct Carcinoma,1
19368,Biphasic Pattern,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
19369,Cutaneous Involvement,Tumor of dermis,1
19370,Malignant Cellular Infiltrate,Rectal Sarcomatoid Carcinoma,1
19371,Benign Cellular Infiltrate,Central Nervous System Myofibroblastoma,1
19372,Carcinomatous Component Present,Adenocarcinoma of Unknown Primary,1
19373,Dysplasia,Carcinoma in situ of prostate,1
19374,Cutaneous Involvement,Clinical Stage IB Cutaneous Melanoma AJCC v8,1
19375,Malignant Cellular Infiltrate,Pancreatic neuroendocrine tumor metastatic,1
19376,Indolent Clinical Course,Leiomyomatosis peritonealis disseminata,1
19377,Malignant Cellular Infiltrate,Gallbladder squamous cell carcinoma,1
19378,Carcinomatous Component Present,carcinoma of eye,1
19379,Carcinomatous Component Present,basaloid carcinoma of penis,1
19380,Malignant Cellular Infiltrate,Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension,1
19381,Malignant Cellular Infiltrate,Advanced B-Cell Neoplasm,1
19382,Rapidly Enlarging Mass,Pelvic Rhabdomyosarcoma,1
19383,Recurrent disease,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
19384,Malignant Cellular Infiltrate,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
19385,Well Differentiated Lesion,Anal Verrucous Carcinoma,1
19386,Benign Cellular Infiltrate,Ovarian Stromal-Leydig Cell Tumor,1
19387,Carcinomatous Component Present,Colorectal Sarcomatoid Carcinoma,1
19388,Nuclear Atypia,Recurrent Childhood Giant Cell Glioblastoma,1
19389,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,1
19390,Malignant Cellular Infiltrate,Gallbladder Kaposi's Sarcoma,1
19391,Malignant Cellular Infiltrate,Adult Nodular Sclerosis Classical Hodgkin Lymphoma,1
19392,Benign Cellular Infiltrate,Ovarian Serous Adenofibroma,1
19393,Tissue of Mullerian Origin Present,Ovarian serous cystadenofibroma,1
19394,Papillary Pattern,Choroid Plexus Papilloma,1
19395,Epithelial Component Present,Stage IVB Hepatocellular Carcinoma AJCC v7,1
19396,Microvascular Proliferation,Adult Brain Glioblastoma,1
19397,Carcinomatous Component Present,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
19398,Epithelial Component Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,1
19399,Carcinomatous Component Present,Stage I Lung Cancer AJCC v6,1
19400,Anaplasia,Sarcomatoid Renal Cell Carcinoma,1
19401,Tubular Pattern,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
19402,Epithelial Component Present,Stage I Nasal Cavity Cancer AJCC v6 and v7,1
19403,Malignant Cellular Infiltrate,"Neoplasms, Unknown Primary",1
19404,Epithelial Component Present,Malignant neoplasm of stomach stage III,1
19405,Epithelial Component Present,Appendix Low Grade Intraepithelial Neoplasia,1
19406,Melanin Pigment Present,Spindle cell nevus of Reed,1
19407,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis,1
19408,Malignant Cellular Infiltrate,Colon Burkitt Lymphoma,1
19409,Whorling Growth Pattern,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
19410,Local disease,Uterine Corpus Adenomatoid Tumor,1
19411,Carcinomatous Component Present,Invasive Mucinous Lung Adenocarcinoma,1
19412,Epithelial Component Present,Stage IIIC Vulvar Cancer AJCC v7,1
19413,Carcinomatous Component Present,Recurrent Biliary Tract Carcinoma,1
19414,Malignant Cellular Infiltrate,Unresectable Skin Squamous Cell Carcinoma,1
19415,No Identifiable Line of Differentiation,Undifferentiated spindle cell sarcoma,1
19416,Malignant Cellular Infiltrate,"Splenic B-Cell Lymphoma/Leukemia, Unclassifiable",1
19417,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP C",1
19418,Benign Cellular Infiltrate,Gastric Lipoma,1
19419,Carcinomatous Component Present,adenocarcinoma of renal pelvis,1
19420,Epithelial Component Present,Stage IVB Nasopharyngeal Carcinoma AJCC v7,1
19421,Malignant Cellular Infiltrate,Malignant tumor of dermis,1
19422,Capillary Sized Vascular Channel Formation,Strawberry nevus of skin,1
19423,Malignant Cellular Infiltrate,Juxtacortical chondrosarcoma,1
19424,Epithelial Component Present,Thyrotroph adenoma,1
19425,Malignant Cellular Infiltrate,Retinoblastoma by AJCC v8 Clinical Stage,1
19426,Primary Lesion,Recurrent Olfactory Neuroblastoma,1
19427,Carcinomatous Component Present,pleomorphic carcinoma of breast,1
19428,High Mitotic Activity,Advanced Small Intestinal Neuroendocrine Carcinoma,1
19429,Papillary Pattern,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
19430,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Overt Primary Myelofibrosis,1
19431,Malignant Cellular Infiltrate,Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
19432,Splenomegaly,"Leukemia, Myeloid, Chronic-Phase",1
19433,Nuclear Grooves,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
19434,Malignant Cellular Infiltrate,Combined Lung Small Cell and Squamous Cell Carcinoma,1
19435,Epithelial Component Present,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
19436,Adnexal Differentiation,Malignant eccrine spiradenoma,1
19437,Monoclonal Cellular Population Present,Skin Mastocytoma,1
19438,Absence of Invasion,Carcinoma in situ of ampulla of Vater,1
19439,Pregnancy Complications,Stage IV Gestational Trophoblastic Tumor AJCC v7,1
19440,Malignant Cellular Infiltrate,Malignant myoepithelioma,1
19441,Malignant Cellular Infiltrate,Stage IIA Cervical Cancer AJCC v8,1
19442,Epithelial Component Present,Adenoma of rectum,1
19443,High Mitotic Activity,Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
19444,Malignant Cellular Infiltrate,Anaplastic Oligoastrocytoma,1
19445,Epithelial Component Present,Metastatic carcinoid tumor,1
19446,Recurrent Genetic Abnormalities Present,Hypergranular promyelocytic leukemia,1
19447,Alternative Fascicle (Bundle) Pattern,Liver Leiomyoma,1
19448,Curvilinear Thin-Walled Vascular Pattern,Cardiac Myxofibrosarcoma,1
19449,Malignant Cellular Infiltrate,Malignant melanoma of anus,1
19450,Recurrent disease,Recurrent tumor,1
19451,More than 10 Mitoses per 10HPF,Stage IV Lung Small Cell Carcinoma AJCC v7,1
19452,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
19453,Exophytic Polypoid Lesion,Polyp of maxillary sinus,1
19454,Adulthood Lesion,Stage III Indolent Adult Non-Hodgkin Lymphoma,1
19455,Cutaneous Involvement,Eruptive collagenoma,1
19456,Chemotherapeutic Agent Toxicity,Alkylating Agent-Related Myelodysplastic Syndrome,1
19457,More than 10 Mitoses per 10HPF,Stage IV Lung Small Cell Carcinoma AJCC v7,1
19458,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
19459,Benign Cellular Infiltrate,Benign neoplasm of breast,1
19460,Dysplasia,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
19461,Locally Aggressive Lesion,Hemosiderotic Fibrolipomatous Tumor,1
19462,Pseudolobular Pattern,Ovarian Sclerosing Stromal Tumor,1
19463,Malignant Cellular Infiltrate,Metastatic malignant neoplasm to nasopharynx,1
19464,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v8 Stage,1
19465,Epithelial Component Present,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,1
19466,S-100-Positive Neoplastic Cells Present,Malignant Uterine Corpus PEComa,1
19467,Neuroendocrine Differentiation,Paraganglioma of head and neck,1
19468,Carcinomatous Component Present,Hereditary Female Breast Carcinoma,1
19469,Primary Lesion,Bone Surface (Peripheral) Osteosarcoma,1
19470,Carcinomatous Component Present,Stage II Colon Cancer,1
19471,Well-Circumscribed Lesion,Stromal Predominant Kidney Wilms Tumor,1
19472,Carcinomatous Component Present,Stage III Rectal Cancer AJCC v7,1
19473,"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present","Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified",1
19474,Nodular Pattern,"Lymphoma, Large-Cell, Follicular",1
19475,Epithelial Component Present,Recurrent Inverted Schneiderian Papilloma,1
19476,Benign Cellular Infiltrate,Inverting papilloma of the nasal cavity,1
19477,Epithelial Component Present,Thymic Carcinoid Tumor,1
19478,Epithelial Component Present,Squamous Cell Carcinoma In Situ of the Nipple,1
19479,Recurrent disease,Recurrent Gestational Trophoblastic Tumor,1
19480,Cribriform Pattern,Cribriform Neuroepithelial Tumor,1
19481,Epithelial Component Present,Rectosigmoid cancer,1
19482,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G2,1
19483,Tubular Structures Present,Sertoli Cell Tumor,1
19484,Malignant Cellular Infiltrate,Ann Arbor Stage I Mature T- and NK-Cell Lymphoma,1
19485,Malignant Cellular Infiltrate,Stage IA Testicular Cancer AJCC v8,1
19486,Epithelial Component Present,Broad Ligament Serous Adenofibroma,1
19487,Cellular Pseudostratification,cystic mucinous tumor of pancreas with moderate dysplasia,1
19488,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Cervical Endometrioid Adenocarcinoma,1
19489,Malignant Cellular Infiltrate,Stage II Kidney Wilms Tumor,1
19490,Malignant Cellular Infiltrate,Refractory Malignant Mesothelioma,1
19491,Recurrent disease,Recurrent Childhood Lymphoblastic Lymphoma,1
19492,Exophytic Polypoid Lesion,Gastric adenoma,1
19493,Absence of a Hormonal Syndrome,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
19494,Stromal Invasion,Recurrent Ovarian Endometrioid Adenocarcinoma,1
19495,Benign Cellular Infiltrate,Lipoma of breast,1
19496,Unresectable Mass,Localized Unresectable Adult Hepatocellular Carcinoma,1
19497,Immunologic Deficiency Syndromes,Engraftment syndrome,1
19498,Malignant Cellular Infiltrate,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
19499,Malignant Cellular Infiltrate,Secondary Chondrosarcoma,1
19500,Epithelial Component Present,Recurrent Skin Carcinoma,1
19501,Exophytic Polypoid Lesion,Fallopian Tube Endometrioid Polyp,1
19502,Vascular Channel Formation,Cardiac Kaposi's Sarcoma,1
19503,Perivascular Arrangement of Tumor Cells,Clear-Cell Myomelanocytic Tumors,1
19504,Malignant Cellular Infiltrate,adenosquamous carcinoma of pancreas,1
19505,Tissue Differentiation Uncertain,Extrarenal Rhabdoid Tumor of the Liver,1
19506,Epithelial Component Present,Rectal Tubular Adenoma,1
19507,Bone marrow reticulin fibrosis,Progressive Hairy Cell Leukemia Initial Treatment,1
19508,atypia morphology,"Borderline Ovarian Mucinous Tumor, Intestinal Type",1
19509,Carcinomatous Component Present,Stage IVC Rectal Cancer AJCC v8,1
19510,Epithelial Component Present,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
19511,Mitotic Activity,Childhood Ovarian Yolk Sac Tumor,1
19512,Cystic Change,Rete Ovarii Cystadenofibroma,1
19513,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",1
19514,Low Mitotic Activity,Malignant Pancreatic Insulinoma,1
19515,Mass of pleura,Pyothorax-Associated Lymphoma,1
19516,Secondary Lesion,Advanced Prostate Adenocarcinoma,1
19517,Well Differentiated Neuroendocrine Lesion,Glucagonoma,1
19518,Benign Cellular Infiltrate,Nephrogenic adenofibroma,1
19519,Diffuse Pattern,Centroblastic lymphoma stage IV,1
19520,Cutaneous Involvement,Hypertrophic lichen planus,1
19521,Childhood Lesion,Childhood Classic Hodgkin Lymphoma,1
19522,Refractory Disease,Refractory Aggressive Non-Hodgkin Lymphoma,1
19523,Malignant Cellular Infiltrate,Stage IA Ovarian Cancer,1
19524,Carcinomatous Component Present,FIGO Stage IVA Ovarian Cancer,1
19525,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,High Risk Myelodysplastic Syndrome,1
19526,Vascular Channel Formation,Aggressive angiomyxoma,1
19527,Malignant Cellular Infiltrate,AIDS-Related Carcinoma,1
19528,Cystic Change,Mucoepidermoid carcinoma of parotid gland,1
19529,Malignant Cellular Infiltrate,Metastatic melanoma,1
19530,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v7,1
19531,Extensive Stage Lesion,Advanced Gastric Neuroendocrine Carcinoma,1
19532,Malignant Cellular Infiltrate,intestinal type adenocarcinoma of gallbladder,1
19533,Carcinomatous Component Present,Stage II Vaginal Cancer AJCC v8,1
19534,Epithelial Component Present,Stage IV Nasopharyngeal Carcinoma,1
19535,Cystic Change,Recurrent Malignant Ovarian Brenner Tumor,1
19536,Perivascular Arrangement of Tumor Cells,Glomus tumor of skin,1
19537,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,1
19538,Slit-Like Stromal Retraction Present,Superficial basal cell carcinoma,1
19539,Epithelial Component Present,Malignant Phyllodes Tumor of Prostate,1
19540,Lymphoplasmacytic Infiltrate,Intracranial Germinoma,1
19541,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),1
19542,Pseudoglandular Pattern,Childhood Ovarian Embryonal Carcinoma,1
19543,Malignant Cellular Infiltrate,Stage III Bladder Cancer AJCC v6 and v7,1
19544,Carcinomatous Component Present,Lymphoepithelioma-Like Hepatocellular Carcinoma,1
19545,Severe dysplasia,Carcinoma in situ of ampulla of Vater,1
19546,Immunologic Deficiency Syndromes,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,1
19547,High Mitotic Activity,small cell carcinoma of breast,1
19548,Cartilaginous Component Present,Osteochondromyxoma,1
19549,Epithelial Component Present,Paget Disease of the Scrotum,1
19550,Neuroendocrine Differentiation,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,1
19551,Benign Cellular Infiltrate,Anastomosing Hemangioma,1
19552,Well-Circumscribed Lesion,Placental polyp,1
19553,Hyperkeratosis,Vaginal Warty Carcinoma,1
19554,Malignant Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
19555,Dysplasia,Tubular adenoma of colon,1
19556,Epithelial Component Present,FIGO Stage IC1 Ovarian Cancer,1
19557,Childhood Lesion,Childhood Alveolar Soft Part Sarcoma,1
19558,Absence of Invasion,Atypical Lobular Breast Hyperplasia,1
19559,Varicosity,Coronary Venous Dissection,1
19560,Epithelial Component Present,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7,1
19561,Entrapped Respiratory Epithelium Present,Endobronchial Hamartoma,1
19562,Carcinomatous Component Present,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
19563,Malignant Cellular Infiltrate,Multifocal superficial basal cell carcinoma,1
19564,Peripheral Nuclear Palisading,Lung Small Cell Carcinoma by AJCC v7 Stage,1
19565,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
19566,High Mitotic Activity,Ovarian Embryonal Carcinoma,1
19567,Nuclear Atypia,Childhood Cerebral Anaplastic Astrocytoma,1
19568,Immunologic Deficiency Syndromes,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder,1
19569,Carcinomatous Component Present,carcinoma of lacrimal gland,1
19570,Epithelial Component Present,Thyroid Gland Mucoepidermoid Carcinoma,1
19571,Hyalinized Stroma Formation,Chondroid lipoma,1
19572,Malignant Cellular Infiltrate,Distal Esophagus Adenocarcinoma,1
19573,Neuroendocrine Differentiation,Colorectal Small Cell Neuroendocrine Carcinoma,1
19574,Malignant Cellular Infiltrate,Bronchioloalveolar Adenocarcinoma,1
19575,Spindle Cell Osteo-Fibrous Component Present,Adamantinoma,1
19576,Malignant Cellular Infiltrate,Squamous non-small cell lung cancer,1
19577,Childhood Lesion,Childhood Refractory Malignant Solid Neoplasm,1
19578,Epithelial Component Present,Stage IIA Ampulla of Vater Cancer AJCC v8,1
19579,Malignant Cellular Infiltrate,Rectosigmoid Cancer by AJCC v6 Stage,1
19580,Unifocal Disease,Mastocytoma,1
19581,Diffuse Pattern,Glandular malignant peripheral nerve sheath tumor,1
19582,Malignant Cellular Infiltrate,Stage III Primary Peritoneal Cancer AJCC v8,1
19583,Well-Circumscribed Lesion,Colon Traditional Serrated Adenoma,1
19584,Papillary Pattern,Primary serous papillary carcinoma of peritoneum,1
19585,Malignant Cellular Infiltrate,Stage IIA Prostate Cancer AJCC v7,1
19586,Immunosuppression-Related Post-Transplant Toxicity,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,1
19587,Epithelial Component Present,Breast Carcinoma Metastatic in the Spine,1
19588,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Testicular choriocarcinoma stage III,1
19589,Local disease,Localized Unresectable Neuroblastoma,1
19590,Infiltrative Growth Pattern,Temporal Lobe Anaplastic Astrocytoma,1
19591,Malignant Cellular Infiltrate,Uterine Corpus Myxoid Leiomyosarcoma,1
19592,Malignant Cellular Infiltrate,Secondary Cerebral Hodgkin Lymphoma,1
19593,Well Differentiated Neuroendocrine Lesion,Small Intestinal Carcinoid Tumor,1
19594,Multifocal Lesion,Multiple Endocrine Neoplasia Type 1,1
19595,Unresectable Mass,Unresectable Malignant Mesothelioma,1
19596,Benign Cellular Infiltrate,Benign Cardiac Schwannoma,1
19597,Carcinomatous Component Present,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
19598,Immunologic Deficiency Syndromes,Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder,1
19599,Recurrent disease,Recurrent Sarcoma,1
19600,Carcinomatous Component Present,Stage IIC Appendix Carcinoma AJCC v7,1
19601,Nuclear Atypia,Childhood Brain Stem Gliosarcoma,1
19602,Perineural spread,Adenoid cystic carcinoma of oropharynx,1
19603,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Signet Ring Variant",1
19604,More than 10 Mitoses per 10HPF,Childhood Lung Small Cell Carcinoma,1
19605,Anaplasia,Pleomorphic carcinoma,1
19606,Carcinomatous Component Present,Recurrent Lip and Oral Cavity Squamous Cell Carcinoma,1
19607,Epithelial Component Present,Cauda Equina Paraganglioma,1
19608,Secondary Lesion,Metastatic Malignant Neoplasm to the Thyroid,1
19609,Malignant Cellular Infiltrate,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
19610,Mucoid Stroma Formation,Microcystic meningioma,1
19611,Carcinomatous Component Present,Renal Pelvis and Ureter Cancer by AJCC v8 Stage,1
19612,Carcinomatous Component Present,Acantholytic squamous cell carcinoma of skin,1
19613,Epithelial Component Present,Vulvar Squamous Neoplasm,1
19614,Invasive Lesion,Dermatofibrosarcoma Protuberans,1
19615,Anaplasia,Systemic Anaplastic Large Cell Lymphoma,1
19616,Tubular Structures Present,Sertoli cell tumor of testis,1
19617,Adnexal Differentiation,Eccrine Neoplasm,1
19618,Epithelial Component Present,Paget's disease and intraductal carcinoma of breast,1
19619,Papillary Pattern,intraductal papilloma of salivary gland,1
19620,Epithelial Component Present,HNF1alpha-Inactivated Hepatocellular Adenoma,1
19621,Epithelial Component Present,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",1
19622,Primary Lesion,Recurrent Childhood Central Nervous System Embryonal Neoplasm,1
19623,atypia morphology,Atypical Breast Papilloma,1
19624,Necrotic changes (finding),"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
19625,Carcinomatous Component Present,Carcinoma of submandibular gland,1
19626,Carcinomatous Component Present,Alcohol-Related Laryngeal Carcinoma,1
19627,Mixed Cellular Population,Borderline Ovarian Endometrioid Cystadenofibroma,1
19628,Carcinomatous Component Present,Lung Spindle Cell Carcinoma,1
19629,Recurrent disease,Recurrent WHO Grade II Glioma,1
19630,Epithelial Component Present,Breast Carcinoma,1
19631,Secondary Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,1
19632,Human Papillomavirus Negative,Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
19633,Childhood Lesion,Childhood Malignant Testicular Germ Cell Tumor,1
19634,Malignant Cellular Infiltrate,Recurrent Ovarian Cystadenocarcinoma,1
19635,Recurrent disease,Recurrent Endometrial Cancer,1
19636,Papillary Pattern,papillary carcinoma of renal pelvis,1
19637,Keratin pearl formation,"Lung Squamous Cell Carcinoma, Papillary Variant",1
19638,Epithelial Component Present,Fallopian Tube Endometrioid Adenocarcinoma,1
19639,atypia morphology,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,1
19640,Diffuse Pattern,High grade B-cell lymphoma,1
19641,High Grade Lesion,Advanced Synovial Sarcoma,1
19642,Bone Marrow Dysplasia Present,Refractory anaemia with excess blasts,1
19643,Perivascular Arrangement of Tumor Cells,Myopericytoma,1
19644,Epithelial Component Present,Serous Endometrial Intraepithelial Carcinoma,1
19645,Adnexal Differentiation,Malignant Germinative Follicular Epithelium Neoplasm,1
19646,Cystic Change,Cystic Partially Differentiated Nephroblastoma,1
19647,Adulthood Lesion,Stage I Adult Non-Hodgkin Lymphoma,1
19648,Epithelial Component Present,Stage IVA Rectal Cancer AJCC v7,1
19649,Indolent Clinical Course,Thyroid Gland Lymphangioma,1
19650,Benign Cellular Infiltrate,Benign germ cell tumor of ovary,1
19651,Intestinal metaplasia of gastric mucosa,tubular adenoma of stomach,1
19652,Carcinomatous Component Present,Lung Non-Keratinizing Squamous Cell Carcinoma,1
19653,Malignant Cellular Infiltrate,"Pheochromocytoma, malignant",1
19654,Necrotic changes (finding),Colon Small Cell Neuroendocrine Carcinoma,1
19655,Epithelial Component Present,Oropharyngeal lymphepithelioma,1
19656,Dysplasia,solid type ductal carcinoma in situ of breast,1
19657,Nidus Formation,Osteoid osteoma,1
19658,Carcinomatous Component Present,Nasopharyngeal Carcinoma by AJCC v7 Stage,1
19659,Epithelial Component Present,Stage IIIA Gallbladder Cancer AJCC v7,1
19660,Storiform Growth Pattern,Cutaneous Fibrous Histiocytoma,1
19661,Carcinomatous Component Present,"Squamous Cell Breast Carcinoma, Acantholytic Variant",1
19662,Carcinomatous Component Present,Eccrine carcinoma of skin,1
19663,Primary Lesion,Primary Carcinoma Unspecified Site,1
19664,Sarcomatoid Stroma Formation,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,1
19665,Carcinomatous Component Present,Stage II Bladder Cancer AJCC v8,1
19666,Malignant Cellular Infiltrate,Tonsillar Carcinoma,1
19667,Carcinomatous Component Present,Stage IIC Ovarian Carcinoma,1
19668,Non-Contiguous Disease,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,1
19669,Storiform Growth Pattern,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
19670,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
19671,Serrated Glandular Architecture,Rectal Sessile Serrated Adenoma/Polyp,1
19672,Childhood Lesion,Childhood Seminoma,1
19673,Dysplasia,Dysplasia of anus,1
19674,Locally Aggressive Lesion,Dermatofibrosarcoma Protuberans,1
19675,Malignant Cellular Infiltrate,Stage IIIC Lung Cancer AJCC v8,1
19676,In Situ Lesion,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
19677,Defective Heavy Chain Present,Heavy Chain Disease,1
19678,Well-Circumscribed Lesion,Nodular tenosynovitis,1
19679,Preserved Nuclear Polarity,Urethral Urothelial Papilloma,1
19680,Malignant Cellular Infiltrate,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
19681,Malignant Cellular Infiltrate,Brain Glioblastoma,1
19682,Neuroendocrine Differentiation,Locally Advanced Adrenal Gland Pheochromocytoma,1
19683,Invasive Lesion,Locally Advanced Prostate Adenocarcinoma,1
19684,Carcinomatous Component Present,Gingival Spindle Cell Carcinoma,1
19685,Dysplasia,Large Cell Dysplasia,1
19686,Childhood Lesion,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,1
19687,Diffuse Pattern,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
19688,Malignant Cellular Infiltrate,Secondary Peripheral Chondrosarcoma,1
19689,Primary Lesion,Recurrent Testicular Lymphoma,1
19690,Invasive Lesion,Invasive Cribriform Breast Carcinoma,1
19691,Epithelial Component Present,Malignant neoplasm of stomach stage IV,1
19692,Malignant Cellular Infiltrate,Unresectable Ewing Sarcoma,1
19693,Mixed Cellular Population,Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
19694,Cambium Layer,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
19695,Carcinomatous Component Present,Stage IB Ampulla of Vater Cancer AJCC v8,1
19696,Malignant Cellular Infiltrate,Recurrent Extranodal Diffuse Large B-cell Lymphoma,1
19697,Malignant Cellular Infiltrate,Metastatic osteosarcoma,1
19698,Cutaneous Involvement,Eccrine ductal carcinoma,1
19699,Malignant Cellular Infiltrate,Cutaneous Mature B-Cell Neoplasm,1
19700,Encapsulated Mass,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
19701,Vascular Channel Formation,Gastric Lymphangioma,1
19702,Malignant Cellular Infiltrate,Virus-Related Carcinoma,1
19703,Malignant Cellular Infiltrate,Mucinous carcinoma of breast,1
19704,Epithelial Component Present,Small Intestinal Undifferentiated Carcinoma,1
19705,Cystic Change,Bile duct cystadenoma,1
19706,Epithelial Component Present,Stage I Renal Cell Carcinoma,1
19707,Epithelial Component Present,Stage IVA Gallbladder Carcinoma,1
19708,Fibrotic Stroma Formation,Borderline Ovarian Serous Cystadenofibroma,1
19709,Carcinomatous Component Present,Stage 0 Ampulla of Vater Cancer AJCC v8,1
19710,Rapidly Enlarging Mass,Fusion-Positive Rhabdomyosarcoma,1
19711,Malignant Cellular Infiltrate,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,1
19712,Immunosuppression-Related Post-Transplant Toxicity,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
19713,Favorable Clinical Outcome,Unclassified Hepatocellular Adenoma,1
19714,Cutaneous Involvement,Dermatitis due to substances taken internally,1
19715,Extensive Stage Lesion,Advanced Head and Neck Squamous Cell Carcinoma,1
19716,Well-Circumscribed Lesion,Renal Pelvis Fibroepithelial Polyp,1
19717,Carcinomatous Component Present,Penis carcinoma,1
19718,Epithelial Component Present,Locally Advanced Cervical Adenocarcinoma,1
19719,Benign Cellular Infiltrate,Thyroid Gland Leiomyoma,1
19720,Carcinomatous Component Present,Stage IA1 Cervical Cancer,1
19721,Childhood Lesion,Childhood Craniopharyngioma,1
19722,Monocytosis,Chronic Myelomonocytic Leukemia with Eosinophilia,1
19723,Hereditary Lesion,Familial meningioma,1
19724,Epithelial Component Present,Adenosquamous cell lung cancer stage III,1
19725,Cysts Containing Proteinaceous Fluid Present,"Cystadenoma, Serous",1
19726,Cutaneous Involvement,Cutaneous T Lymphoblastic Leukemia/Lymphoma,1
19727,Hereditary Lesion,Hereditary Kidney Wilms Tumor,1
19728,Benign Cellular Infiltrate,Rete Ovarii Cystadenofibroma,1
19729,Invasive Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
19730,Alternative Fascicle (Bundle) Pattern,Laryngeal Leiomyoma,1
19731,Benign Cellular Infiltrate,Benign neoplasm of skin,1
19732,Low Mitotic Activity,Recurrent Digestive System Neuroendocrine Tumor G1,1
19733,Malignant Cellular Infiltrate,Hodgkin Disease,1
19734,Acinar Cell Differentiation,Recurrent Acinic Cell Breast Carcinoma,1
19735,Glandular Pattern,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
19736,Absence of Invasion,Stage 0 Colon Cancer AJCC v6 and v7,1
19737,Benign Cellular Infiltrate,Inverted urothelial papilloma,1
19738,Well Differentiated Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor,1
19739,Malignant Cellular Infiltrate,Cigarette Smoking-Related Carcinoma,1
19740,Deep Lesion,Deep Lipoma,1
19741,Carcinomatous Component Present,Recurrent Parotid Gland Squamous Cell Carcinoma,1
19742,High Grade Lesion,Synovial sarcoma non-metastatic,1
19743,Metastatic Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,1
19744,Metastatic Lesion,Advanced Uterine Corpus Carcinosarcoma,1
19745,'Starry-sky' pattern,Sporadic Burkitt's lymphoma,1
19746,Malignant Cellular Infiltrate,Epithelioid hemangioendothelioma,1
19747,Well Differentiated Lesion,Well Differentiated Adrenal Cortex Carcinoma,1
19748,High Mitotic Activity,Recurrent Childhood Anaplastic Oligodendroglioma,1
19749,Large Mass,Giant fibroadenoma of breast,1
19750,Endophytic Tumor Growth,Supraglottic Verrucous Carcinoma,1
19751,Well Differentiated Neuroendocrine Lesion,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
19752,Malignant Cellular Infiltrate,Pancreatic adenocarcinoma resectable,1
19753,Severe cytologic atypia,large cell neuroendocrine carcinoma of appendix,1
19754,Pseudoglandular Pattern,Moderately Differentiated Hepatocellular Carcinoma,1
19755,Epithelial Component Present,Lung Mucous Gland Adenoma,1
19756,Epithelial Component Present,Childhood Renal Cell Carcinoma,1
19757,Mucoid Stroma Formation,Mucinous adenocarcinoma of colon,1
19758,Diffuse Pattern,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,1
19759,Epithelial Component Present,Invasive Lobular Breast Carcinoma,1
19760,Carcinomatous Component Present,Locally Advanced Unresectable Renal Cell Carcinoma,1
19761,Neuroendocrine Differentiation,Digestive System Small Cell Neuroendocrine Carcinoma,1
19762,Acanthosis,Laryngeal verrucous carcinoma recurrent,1
19763,Histiocytosis,T-cell/histiocyte rich large B-cell lymphoma,1
19764,Malignant Cellular Infiltrate,Stage II Lentigo Maligna Melanoma AJCC v6 and v7,1
19765,Carcinomatous Component Present,Carcinoma of subglottis,1
19766,Benign Cellular Infiltrate,benign mature teratoma of pancreas,1
19767,Absence of Invasion,Stage 0is Bladder Cancer AJCC v8,1
19768,Cutaneous Involvement,"Nevus, Intradermal",1
19769,Primary Lesion,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",1
19770,Pathologic TNM Finding,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
19771,Malignant Cellular Infiltrate,Recurrent Grade III Lymphomatoid Granulomatosis,1
19772,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage,1
19773,Malignant Cellular Infiltrate,Squamous cell carcinoma of lip,1
19774,Diffuse Pattern,Plasmablastic lymphoma,1
19775,Epithelial Component Present,"Glycogen-Rich, Clear Cell Breast Carcinoma",1
19776,Epithelial Component Present,Unclassified Renal Cell Carcinoma,1
19777,Malignant Cellular Infiltrate,Laryngeal Cancer by AJCC v8 Stage,1
19778,Epithelial Component Present,Malignant neoplasm of stomach stage II,1
19779,Indolent Clinical Course,Subglottic Hemangioma,1
19780,Low Mitotic Activity,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,1
19781,Ischemia,Vascular insufficiency of intestine,1
19782,Epithelial Component Present,Carcinoma in situ of penis,1
19783,Malignant Cellular Infiltrate,Secondary malignant neoplasm of ovary,1
19784,Whorling Growth Pattern,"Dendritic Cell Sarcoma, Follicular",1
19785,Epithelial Component Present,"Vulvar Adenocarcinoma, Intestinal-Type",1
19786,Solar Radiation Toxicity,Solar Radiation-Related Malignant Neoplasm,1
19787,Carcinomatous Component Present,Stage II Vaginal Cancer AJCC v6 and v7,1
19788,Splenomegaly,Hepatosplenic T-cell lymphoma,1
19789,Malignant Cellular Infiltrate,sarcoma of accessory sinus,1
19790,White blood cell count increased (lab result),Juvenile Myelomonocytic Leukemia,1
19791,High Mitotic Activity,Merkel cell carcinoma,1
19792,Thyroglobulin Positive Neoplastic Cells Present,Poorly Differentiated Thyroid Carcinoma,1
19793,Carcinomatous Component Present,Oropharyngeal cancer recurrent,1
19794,Malignant Cellular Infiltrate,Esophageal Non-Hodgkin Lymphoma,1
19795,Adulthood Lesion,Adult Extracardiac Rhabdomyoma,1
19796,Carcinomatous Component Present,mucoepidermoid carcinoma of lacrimal gland,1
19797,Anaplasia,Sarcomatoid carcinoma of the lung,1
19798,Malignant Cellular Infiltrate,"Glandular intraepithelial neoplasia, grade III",1
19799,Carcinomatous Component Present,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
19800,Anaplasia,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative",1
19801,Malignant Cellular Infiltrate,Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8,1
19802,Myxoid Stroma Formation,Vertebral chordoma,1
19803,Monomorphic Cellular Infiltrate,Recurrent Childhood Oligodendroglioma,1
19804,Nuclear Molding,combined small cell carcinoma of lung,1
19805,Malignant Cellular Infiltrate,Stage IVB Gallbladder Cancer AJCC v8,1
19806,Diffuse Pattern,Recurrent Childhood Protoplasmic Astrocytoma,1
19807,Poorly Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,1
19808,Tissue of Mullerian Origin Present,Ovarian Mucinous Adenofibroma,1
19809,Malignant Germinomatous Cellular Infiltrate,Adult Central Nervous System Germinoma,1
19810,CD56-Positive Neoplastic Cells Present,Aggressive natural killer-cell leukemia,1
19811,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity recurrent,1
19812,Malignant Cellular Infiltrate,Unresectable Soft Tissue Sarcoma,1
19813,Indolent Clinical Course,Uterine Corpus Adenomatoid Tumor,1
19814,Epithelial Component Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
19815,Multifocal Lesion,Osteochondromatosis,1
19816,Carcinomatous Component Present,Laryngeal squamous cell carcinoma recurrent,1
19817,Metastatic Lesion,Metastatic Genitourinary System Carcinoma,1
19818,Diffuse Pattern,Recurrent Primary Effusion Lymphoma,1
19819,Carcinomatous Component Present,Stage IIIA Vulvar Cancer AJCC v7,1
19820,Malignant Cellular Infiltrate,Urethral cancer regional,1
19821,Epithelial Component Present,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
19822,Refractory Disease,Refractory Laryngeal Squamous Cell Carcinoma,1
19823,Malignant Cellular Infiltrate,Pleural Desmoplastic Mesothelioma,1
19824,Well Differentiated Lesion,Verrucous carcinoma of penis,1
19825,Benign Cellular Infiltrate,Tumorlet,1
19826,Pseudorosette Formation,"Gastrinoma, malignant",1
19827,atypia morphology,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor,1
19828,High Grade Lesion,Childhood Gliosarcoma,1
19829,Slow Growing Mass,Acral Fibromyxoma,1
19830,Epithelial Component Present,"Borderline Ovarian Mucinous Tumor, Intestinal Type",1
19831,Carcinomatous Component Present,Stage IIIA Gallbladder Cancer AJCC v8,1
19832,Mild cytologic atypia,Anal Verrucous Carcinoma,1
19833,Smooth Muscle Component Present,Endobronchial Hamartoma,1
19834,Tissue Differentiation Uncertain,Pleural Monophasic Synovial Sarcoma,1
19835,Benign Cellular Infiltrate,"Lymphangioma, Cystic",1
19836,Malignant Cellular Infiltrate,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
19837,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,1
19838,Neuroendocrine Differentiation,Ascending Colon Neuroendocrine Tumor G1,1
19839,Diffuse Pattern,Brain Glioblastoma,1
19840,Epithelial Component Present,Adenocarcinoma of anal glands,1
19841,Malignant Cellular Infiltrate,Acute Lymphoblastic Leukemia by Gene Expression Profile,1
19842,Carcinomatous Component Present,Recurrent Thyroid Gland Anaplastic Carcinoma,1
19843,Malignant Cellular Infiltrate,Stage IA Lung Non-Small Cell Carcinoma AJCC v7,1
19844,Well Differentiated Neuroendocrine Lesion,Non functioning pancreatic endocrine tumor,1
19845,Vascular proliferation,Vulvar Cellular Angiofibroma,1
19846,Metastatic Lesion,Locally Advanced Carcinoma,1
19847,Nodular Pattern,Grade 1 Cutaneous Follicular Lymphoma,1
19848,Primary Site Unknown,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
19849,Epithelial Component Present,Stage IIB Rectal Neuroendocrine Tumor AJCC v8,1
19850,Cavernous Vascular Space Formation,Giant Hemangioma,1
19851,Infiltrative Growth Pattern,Temporal Lobe Anaplastic Astrocytoma,1
19852,Therapy-Related Toxicity,Transplant-Related Kaposi Sarcoma,1
19853,Malignant Cellular Infiltrate,Stage 2 Neuroblastoma,1
19854,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
19855,Anaplasia,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
19856,Secondary Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,1
19857,Epithelial Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
19858,Diffuse Pattern,Childhood Diffuse Large B-Cell Lymphoma,1
19859,Malignant Cellular Infiltrate,Stage IVB Vaginal Cancer AJCC v6 and v7,1
19860,Malignant Cellular Infiltrate,Stage II Adult Burkitt Lymphoma,1
19861,Complete Spontaneous Regression,"lymphomatoid papulosis, type A",1
19862,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm in the Thoracic Cavity,1
19863,Childhood Lesion,Recurrent Childhood Acute Lymphoblastic Leukemia,1
19864,Myxoid Stroma Formation,Neurothekeoma,1
19865,Neuroendocrine Differentiation,Liver Neuroendocrine Neoplasm,1
19866,Severe cytologic atypia,Vaginal Undifferentiated Sarcoma,1
19867,Infiltrative Growth Pattern,gliosarcoma,1
19868,Malignant Cellular Infiltrate,Precursor cell lymphoblastic lymphoma,1
19869,Malignant Cellular Infiltrate,malignant tumor of male genital organ,1
19870,Recurrent disease,Recurrent Prostate Acinar Adenocarcinoma,1
19871,Carcinomatous Component Present,Intramucosal Adenocarcinoma,1
19872,Benign Cellular Infiltrate,Glomangiomatosis,1
19873,Progressive Clinical Course,Rapidly progressive glomerulonephritis,1
19874,Neuroendocrine Differentiation,Breast Solid Neuroendocrine Carcinoma,1
19875,Mixed Cellular Population,Recurrent Childhood Oligoastrocytoma,1
19876,Benign Cellular Infiltrate,Ovarian Solid Teratoma,1
19877,Dilated Thin-Walled Vascular Space Formation,Angiomyofibroblastoma,1
19878,Small Lesion,Luteoma,1
19879,Anaplasia,Small cell glioblastoma,1
19880,Malignant Cellular Infiltrate,Stage IIIA Colorectal Cancer AJCC v8,1
19881,Well Differentiated Neuroendocrine Lesion,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
19882,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,1
19883,Epithelial Component Present,Stage IC Ovarian Cancer AJCC v8,1
19884,Stromal Invasion,Malignant Ovarian Surface Epithelial-Stromal Tumor,1
19885,Malignant Cellular Infiltrate,Childhood Malignant Peripheral Nerve Sheath Tumor,1
19886,Papillary Pattern,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
19887,Stromal Invasion,serous surface papillary carcinoma of ovary,1
19888,Malignant Cellular Infiltrate,Malignant neoplasm of labium minus,1
19889,Malignant Cellular Infiltrate,Malignant neoplasm of pharynx,1
19890,Lymphoplasmacytic Infiltrate,"Castleman Disease, Hyaline-Vascular Type",1
19891,Carcinomatous Component Present,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8,1
19892,Epithelial Component Present,Pseudomyxoma Peritonei,1
19893,Malignant Cellular Infiltrate,Stage IA Lung Non-Small Cell Carcinoma AJCC v7,1
19894,Epithelial Component Present,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,1
19895,Heterologous Elements Present,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements,1
19896,Pushing Tumor Margin,Verrucous carcinoma,1
19897,Severe dysplasia,Stage 0 Esophageal Cancer AJCC v7,1
19898,Epithelial Component Present,clear cell adenocarcinoma of urethra,1
19899,Malignant Cellular Infiltrate,Hereditary Nonpolyposis Colorectal Cancer,1
19900,Heterologous Elements Present,Intraocular Teratoid Medulloepithelioma,1
19901,Epithelial Component Present,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7,1
19902,Malignant Cellular Infiltrate,Carcinoma of upper gum,1
19903,Malignant Cellular Infiltrate,"Myeloproliferative Neoplasm, Unclassifiable",1
19904,Cervical Glandular Dysplasia,intraepithelial glandular neoplasia of cervix,1
19905,Carcinomatous Component Present,Cervical Squamous Cell Carcinoma,1
19906,Carcinomatous Component Present,Endometrial Squamous Cell Carcinoma,1
19907,Malignant Cellular Infiltrate,Mature T- and NK-Cell Lymphoma by Ann Arbor Stage,1
19908,Adnexal Differentiation,Superficial Epithelioma with Sebaceous Differentiation,1
19909,Epithelial Component Present,Stage IV Jejunal Neuroendocrine Tumor AJCC v8,1
19910,Childhood Lesion,Stage III Childhood Hepatocellular Carcinoma AJCC v7,1
19911,Nuclear pleomorphism,Type D Lymphomatoid Papulosis,1
19912,Neuroendocrine Differentiation,Stage II Jejunal Neuroendocrine Tumor AJCC v8,1
19913,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Uterine Carcinosarcoma, Homologous Type",1
19914,Extensive Stage Lesion,Advanced Urothelial Carcinoma,1
19915,Benign Cellular Infiltrate,Adenomyoma,1
19916,Neuroendocrine Differentiation,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
19917,Malignant Cellular Infiltrate,T-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage,1
19918,Nuclear Grooves,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
19919,Epithelial Component Present,Gingival Squamous Cell Carcinoma,1
19920,Rapidly Enlarging Mass,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
19921,Nuclear Atypia,Recurrent Anaplastic Oligoastrocytoma,1
19922,Metastatic Lesion,Recurrent Carcinoma of Unknown Primary,1
19923,Epithelial Component Present,Recurrent Craniopharyngioma,1
19924,Epithelial Component Present,"Papilloma, Intraductal",1
19925,Calcinosis,"Retinoblastoma, spontaneously regressed",1
19926,Epithelial Component Present,Cholangiolocellular Carcinoma,1
19927,Carcinomatous Component Present,Thymic Squamous Cell Carcinoma,1
19928,Carcinomatous Component Present,Stage IV Lung Small Cell Carcinoma AJCC v7,1
19929,Epithelial Component Present,Intrahepatic Bile Duct Papillary Neoplasm,1
19930,Malignant Cellular Infiltrate,Ann Arbor Stage II Mantle Cell Lymphoma,1
19931,Unresectable Mass,Unresectable Skin Carcinoma,1
19932,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
19933,Malignant Cellular Infiltrate,Parotid Gland Carcinoma,1
19934,Cutaneous Involvement,Cutaneous leiomyoma,1
19935,Malignant Cellular Infiltrate,Childhood Malignant Ovarian Germ Cell Tumor,1
19936,Epithelial Component Present,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
19937,Infiltrative Growth Pattern,Malignant Uterine Corpus PEComa,1
19938,Malignant Cellular Infiltrate,Stage IV Rectal Cancer AJCC v7,1
19939,Malignant Cellular Infiltrate,Stage I Hepatocellular Carcinoma AJCC v8,1
19940,Epithelial Component Present,Breast Ductal Adenoma,1
19941,Low Mitotic Activity,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
19942,Malignant Cellular Infiltrate,Hepatosplenic T-cell lymphoma,1
19943,Cystic Change,Hidradenoma Papilliferum,1
19944,Papillary Pattern,Pleural Well Differentiated Papillary Mesothelioma,1
19945,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of anal canal,1
19946,Recurrent disease,Recurrent Breast Angiosarcoma,1
19947,Malignant Cellular Infiltrate,Prostate Basal Cell Carcinoma,1
19948,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of intestine,1
19949,Mild cytologic atypia,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
19950,Malignant Cellular Infiltrate,Non-small cell lung cancer stage IIIA,1
19951,Single Cell Necrosis,Stage 0 Merkel Cell Carcinoma AJCC v7,1
19952,Metastatic Lesion,Advanced Melanoma,1
19953,Malignant Cellular Infiltrate,Adult Epithelioid Sarcoma,1
19954,Malignant Cellular Infiltrate,Stage I Childhood Burkitt Lymphoma,1
19955,Malignant Cellular Infiltrate,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified",1
19956,Childhood Lesion,Pediatric Intraocular Retinoblastoma,1
19957,Epithelial Component Present,Stage IIA Esophagus Carcinoma,1
19958,Malignant Cellular Infiltrate,Hutchinson's Melanotic Freckle,1
19959,Neuroendocrine Differentiation,insulinoma,1
19960,Epithelial Component Present,Stage IIIC Appendix Carcinoma AJCC v7,1
19961,Clinical TNM Finding,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
19962,Hepatomegaly,Hepatosplenic T-cell lymphoma,1
19963,Epithelial Component Present,Locally Advanced Digestive System Carcinoma,1
19964,Malignant Cellular Infiltrate,Recurrent Prostate Acinar Adenocarcinoma,1
19965,Epithelial Component Present,Transverse Colon Neuroendocrine Tumor G1,1
19966,Epithelial Component Present,mucinous adenocarcinoma of anus,1
19967,Unresectable Mass,Unresectable Liposarcoma,1
19968,Peripheral Nuclear Palisading,Metastatic Lung Small Cell Carcinoma,1
19969,Benign Cellular Infiltrate,Benign digestive system neoplasms,1
19970,Carcinomatous Component Present,Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
19971,Carcinomatous Component Present,intestinal type adenocarcinoma of gallbladder,1
19972,Epithelial Component Present,adenocarcinoma of ureter,1
19973,High Mitotic Activity,Vaginal Small Cell Carcinoma,1
19974,Recurrent disease,Laryngeal squamous cell carcinoma recurrent,1
19975,Vascular Channel Formation,Small Intestinal Kaposi Sarcoma,1
19976,Neuroendocrine Differentiation,Unresectable Pancreatic Neuroendocrine Carcinoma,1
19977,Epithelial Component Present,Adult Fibrolamellar Carcinoma,1
19978,Hyperplastic Tissue Present,Esophageal Basal Cell Hyperplasia,1
19979,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Secondary Myelodysplastic Syndrome,1
19980,Epithelial Component Present,Anatomic Stage 0 Breast Cancer AJCC v8,1
19981,Refractory Disease,Refractory Breast Carcinoma,1
19982,Malignant Cellular Infiltrate,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
19983,Severe cytologic atypia,Colorectal Large Cell Neuroendocrine Carcinoma,1
19984,Non-Invasive Lesion,Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7,1
19985,Primary Lesion,Adult Brain Stem Gliosarcoma,1
19986,Indolent Clinical Course,Adenoameloblastoma,1
19987,Epithelial Component Present,Rectal Small Cell Neuroendocrine Carcinoma,1
19988,Carcinomatous Component Present,Pancreatic carcinoma,1
19989,Primary Lesion,Stage IV Primary Peritoneal Cancer AJCC v7,1
19990,Congenital Lesion,Congenital spondylolysis,1
19991,Microvascular Proliferation,Supratentorial Glioblastoma,1
19992,Well Differentiated Lesion,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
19993,Secondary Lesion,Locally Advanced Unresectable Renal Cell Carcinoma,1
19994,Well-Circumscribed Lesion,Central Nervous System Hemangioblastoma,1
19995,Neuroendocrine Differentiation,Recurrent Digestive System Neuroendocrine Tumor G1,1
19996,Epithelial Component Present,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,1
19997,Osteoid formation,High grade surface osteosarcoma,1
19998,Secondary Lesion,Breast Carcinoma Metastatic in the Central Nervous System,1
19999,Carcinomatous Component Present,Esophageal Adenocarcinoma by AJCC v8 Stage,1
20000,Papillary Pattern,Childhood Choroid Plexus Papilloma,1
20001,Hereditary Lesion,Gardner Syndrome,1
20002,Carcinomatous Component Present,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
20003,Pre-existing condition,Myeloid Neoplasms with Germline GATA2 Mutation,1
20004,Complete Spontaneous Regression,Type E Lymphomatoid Papulosis,1
20005,Local disease,Localized Resectable Adult Liver Carcinoma,1
20006,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,1
20007,Adulthood Lesion,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma,1
20008,Malignant Cellular Infiltrate,Minor Salivary Gland Acinic Cell Carcinoma,1
20009,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,1
20010,Mesenchymal Component Present,Carcinoma ex pleomorphic adenoma of lacrimal gland,1
20011,Carcinomatous Component Present,Bladder Adenocarcinoma,1
20012,Cavernous Vascular Space Formation,Skin Cavernous Hemangioma,1
20013,Well Differentiated Neuroendocrine Lesion,Ileal Neuroendocrine Tumor by AJCC v8 Stage,1
20014,Low Grade Lesion,Childhood Subependymal Giant Cell Astrocytoma,1
20015,Rapidly Enlarging Mass,Gallbladder Rhabdomyosarcoma,1
20016,Neuroendocrine Differentiation,Vaginal Large Cell Neuroendocrine Carcinoma,1
20017,Cutaneous Involvement,Benign Breast Eccrine Spiradenoma,1
20018,Nested Pattern,Calcifying Nested Epithelial Stromal Tumor of the Liver,1
20019,Well-Circumscribed Lesion,Stage II Kidney Wilms Tumor,1
20020,Carcinomatous Component Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
20021,Epithelial Component Present,Lung Mixed Squamous Cell and Glandular Papilloma,1
20022,Malignant Cellular Infiltrate,Urethral cancer regional,1
20023,Capillary Sized Vascular Channel Formation,Medullary Hemangioblastoma,1
20024,Epithelial Component Present,Infiltrating duct and lobular carcinoma,1
20025,Epithelial Component Present,Poorly Differentiated Hepatocellular Carcinoma,1
20026,Benign Cellular Infiltrate,Lymphangioma circumscriptum,1
20027,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
20028,Secondary Lesion,Metastatic Lip and Oral Cavity Carcinoma,1
20029,Epithelial Component Present,Low Grade Corneal Intraepithelial Neoplasia,1
20030,Secondary Lesion,Advanced Unfavorable Hodgkin Lymphoma,1
20031,Carcinomatous Component Present,Stage IB Lung Cancer AJCC v7,1
20032,Malignant Cellular Infiltrate,Fallopian Tube Lymphoma,1
20033,Vascular Channel Formation,Prostate Kaposi Sarcoma,1
20034,Plexiform Vasculature Present,Uterine Corpus Low Grade Endometrial Stromal Sarcoma,1
20035,Malignant Cellular Infiltrate,Metastatic Thyroid Gland Papillary Carcinoma,1
20036,Pathologic TNM Finding,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8,1
20037,Cutaneous Involvement,Benign Breast Eccrine Spiradenoma,1
20038,High Mitotic Activity,Childhood Lung Small Cell Carcinoma,1
20039,Aggressive Clinical Course,High Risk Myelodysplastic Syndrome,1
20040,Monoclonal Cellular Population Present,"Leukemia, Mast-Cell",1
20041,Hyaline Cartilage Differentiation,Adult Myxoid Chondrosarcoma,1
20042,Malignant Cellular Infiltrate,Nevoid Melanoma,1
20043,Epithelial Component Present,Stage IV Major Salivary Gland Carcinoma without Metastasis,1
20044,Locally Aggressive Lesion,Intermediate Soft Tissue Tumor,1
20045,Carcinomatous Component Present,Posterior Tongue Mucoepidermoid Carcinoma,1
20046,Pushing Tumor Margin,Benign phyllodes neoplasm of breast,1
20047,Trabecular Pattern,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
20048,Benign Cellular Infiltrate,Ameloblastic fibrodentinoma,1
20049,Malignant Cellular Infiltrate,papillary squamous cell carcinoma of larynx,1
20050,Epithelial Component Present,Stage II Eyelid Carcinoma AJCC v8,1
20051,Hyperplastic Tissue Present,Endometrial Hyperplasia without Atypia,1
20052,Recurrent disease,Cholangiocarcinoma recurrent,1
20053,Malignant Cellular Infiltrate,Lymphoma of colon,1
20054,Benign Cellular Infiltrate,Benign Mediastinal Psammomatous Schwannoma,1
20055,Well Differentiated Neuroendocrine Lesion,Stage II Jejunal Neuroendocrine Tumor AJCC v8,1
20056,Papillary Pattern,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
20057,Juvenile Lesion,Juvenile cataract,1
20058,Carcinomatous Component Present,Stage I Esophageal Cancer,1
20059,Malignant Cellular Infiltrate,Metastatic urothelial carcinoma,1
20060,Malignant Cellular Infiltrate,Childhood Central Nervous System Yolk Sac Tumor,1
20061,Borderline Lesion,Monoclonal Gammopathy of Renal Significance,1
20062,'Starry-sky' pattern,Recurrent Adult Burkitt Lymphoma,1
20063,Pre-existing condition,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes,1
20064,Extraocular Dissemination of Disease,Pediatric Extraocular Retinoblastoma,1
20065,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1
20066,Carcinomatous Component Present,Recurrent Submandibular Gland Undifferentiated Carcinoma,1
20067,Malignant Cellular Infiltrate,Region 17p13 Allelic Loss Associated Medulloblastoma,1
20068,Epithelial Component Present,Stage III Lip and Oral Cavity Cancer AJCC v6 and v7,1
20069,Epithelial Component Present,Lung Non-Small Cell Cancer by AJCC v7 Stage,1
20070,Benign Cellular Infiltrate,Benign neoplasm of chest wall,1
20071,Cutaneous Involvement,"Skin Diseases, Vascular",1
20072,Malignant Cellular Infiltrate,Clinical Stage IIC Cutaneous Melanoma AJCC v8,1
20073,Epithelial Component Present,Nonencapsulated sclerosing tumor,1
20074,In Situ Lesion,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,1
20075,Cutaneous Involvement,Cutis Laxa,1
20076,Carcinomatous Component Present,Paget disease of anal canal,1
20077,Slow Growing Mass,Venous Angioleiomyoma,1
20078,Malignant Cellular Infiltrate,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7,1
20079,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Lymphoma,1
20080,Pain,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,1
20081,Adulthood Lesion,Adult Type Granulosa Cell Tumor,1
20082,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
20083,Carcinomatous Component Present,"Cystadenocarcinoma, Serous",1
20084,CD30-Positive Neoplastic Cells Present,anaplastic large cell lymphoma of central nervous system,1
20085,Carcinomatous Component Present,Colloid Carcinoma of the Pancreas,1
20086,Benign Cellular Infiltrate,Benign Esophageal Schwannoma,1
20087,Carcinomatous Component Present,Eccrine ductal carcinoma,1
20088,Vascular Channel Formation,AIDS with Kaposi's sarcoma,1
20089,Nodular Pattern,Recurrent Follicular Lymphoma,1
20090,Fibrotic Stroma Formation,Ovarian Seromucinous Adenofibroma,1
20091,Carcinomatous Component Present,Stage IIA1 Cervical Cancer AJCC v7,1
20092,Carcinomatous Component Present,Acinar Cell Carcinoma,1
20093,Rarely Metastasizing Lesion,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma,1
20094,Malignant Cellular Infiltrate,Sporadic Diffuse Gastric Adenocarcinoma,1
20095,Epithelial Component Present,Uterine Corpus Carcinoid Tumor,1
20096,Epithelial Component Present,"Squamous cell carcinoma, small cell, nonkeratinizing",1
20097,Biphasic Pattern,Uterine Corpus Atypical Polypoid Adenomyoma,1
20098,High Grade Lesion,Childhood Pleomorphic Rhabdomyosarcoma,1
20099,High Mitotic Activity,Vulvar Small Cell Carcinoma,1
20100,Childhood Lesion,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
20101,Malignant Cellular Infiltrate,Breast Cancer by AJCC v7 Stage,1
20102,Cutaneous Involvement,Exfoliative dermatitis,1
20103,Monophasic Pattern,Lung Monophasic Synovial Sarcoma,1
20104,Carcinomatous Component Present,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
20105,Low Mitotic Activity,Small Intestinal Gangliocytic Paraganglioma,1
20106,Malignant Cellular Infiltrate,Ependymoblastoma,1
20107,Epithelial Component Present,Small Intestinal Squamous Cell Carcinoma,1
20108,Unresectable Mass,Unresectable Skin Squamous Cell Carcinoma,1
20109,Malignant Cellular Infiltrate,sarcoma of larynx,1
20110,Slow Growing Mass,Dedifferentiated chordoma,1
20111,Malignant Cellular Infiltrate,Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8,1
20112,High Mitotic Activity,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
20113,Malignant Cellular Infiltrate,Bronchioloalveolar Adenocarcinoma,1
20114,Benign Cellular Infiltrate,Hemangioma of gingiva,1
20115,Carcinomatous Component Present,Non-small cell lung cancer stage II,1
20116,Epithelial Component Present,Vaginal Squamous Neoplasm,1
20117,Carcinomatous Component Present,Extrapulmonary Small Cell Carcinoma,1
20118,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8,1
20119,Malignant Cellular Infiltrate,Stage IA Lung Non-Small Cell Carcinoma AJCC v7,1
20120,atypia morphology,Atypical hyperplasia of breast,1
20121,Epithelial Component Present,Classical Poroma,1
20122,Lesion with Diameter of 10mm or Less,Functioning Pituitary Gland Microadenoma,1
20123,Indolent Clinical Course,Capillary hemangioma of eyelid,1
20124,Neuroendocrine Differentiation,Ovarian Mucinous Carcinoid Tumor,1
20125,Recurrent disease,Recurrent Malignant Urinary System Neoplasm,1
20126,Malignant Cellular Infiltrate,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
20127,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
20128,Epithelial Component Present,Acinar Prostate Mucinous Adenocarcinoma,1
20129,Childhood Lesion,Postsurgical Stage I Hepatoblastoma,1
20130,Carcinomatous Component Present,Stage IV Intrahepatic Bile Duct Cancer AJCC v8,1
20131,Comedo Necrosis,Rectal Cribriform Comedo-Type Adenocarcinoma,1
20132,Carcinomatous Component Present,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
20133,Multinodular Mass,Hemangiosarcoma of heart,1
20134,Epithelial Component Present,Stage II Bladder Cancer AJCC v6 and v7,1
20135,Cauliflower-Like Mass,Choroid Plexus Papilloma,1
20136,Nested Pattern,Clear Cell Sarcoma of Soft Tissue,1
20137,Hereditary Lesion,Hereditary sideroblastic anemia,1
20138,Epithelial Component Present,inverted ductal papilloma of salivary gland,1
20139,Malignant Cellular Infiltrate,Gastric Adenosquamous Carcinoma,1
20140,Presence of a Hormonal Syndrome,malignant gastrinoma of pancreas,1
20141,Congenital Lesion,Congenital spondylolysis of lumbosacral region,1
20142,Carcinomatous Component Present,Stage IIIB Anal Cancer AJCC v8,1
20143,Mixed Cellular Population,Lung Adenofibroma,1
20144,Epithelial Component Present,Infiltrating duct and lobular carcinoma,1
20145,Malignant Cellular Infiltrate,Oral neoplasm malignant recurrent,1
20146,Carcinomatous Component Present,small cell carcinoma of ureter,1
20147,Benign Cellular Infiltrate,Ovarian Mucinous Adenofibroma,1
20148,Malignant Cellular Infiltrate,Sellar Embryonal Carcinoma,1
20149,atypia morphology,Borderline Ovarian Serous Tumor with Microinvasion,1
20150,atypia morphology,Complex Endometrial Hyperplasia with Atypia,1
20151,HMB-45-Positive Neoplastic Cells Present,Clear-Cell Myomelanocytic Tumors,1
20152,Benign Cellular Infiltrate,Benign tumor of pancreas,1
20153,Borderline Resectable Mass,Borderline Resectable Carcinoma,1
20154,Mixed Cellular Population,Benign phyllodes neoplasm of breast,1
20155,Papillary Pattern,Pedunculated conjunctival papilloma,1
20156,Carcinomatous Component Present,Squamous cell carcinoma of lung,1
20157,Epithelial Component Present,Bladder Cancer by AJCC v7 Stage,1
20158,Exophytic Papillary Lesion,Exophytic Schneiderian Papilloma,1
20159,Malignant Cellular Infiltrate,Infant Acute Lymphoblastic Leukemia,1
20160,Childhood Lesion,Childhood Choroid Plexus Papilloma,1
20161,Carcinomatous Component Present,Stage III Vaginal Cancer AJCC v8,1
20162,Angiosarcoma-Like Areas Present,Skin Pseudovascular Squamous Cell Carcinoma,1
20163,atypia morphology,Borderline Ovarian Clear Cell Tumor,1
20164,Recurrent disease,Endometrioid adenocarcinoma recurrent,1
20165,Carcinomatous Component Present,Large cell neuroendocrine carcinoma,1
20166,Secondary Lesion,Secondary Heart Lymphoma,1
20167,Epithelial Component Present,Gallbladder Cribriform Carcinoma,1
20168,Severe dysplasia,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7,1
20169,Adnexal Differentiation,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma,1
20170,Carcinomatous Component Present,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
20171,Pseudopapillary Pattern,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7,1
20172,Well-Circumscribed Lesion,Rectal Juvenile Polyp,1
20173,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Diffuse Leiomyomatosis,1
20174,Malignant Cellular Infiltrate,Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7,1
20175,Well-Circumscribed Lesion,Brain Stem Hemangioblastoma,1
20176,Exophytic Papillary Lesion,Exophytic Schneiderian Papilloma,1
20177,Carcinomatous Component Present,Recurrent Ovarian Carcinosarcoma,1
20178,Malignant Cellular Infiltrate,Stage IB Bone Cancer AJCC v7,1
20179,Malignant Cellular Infiltrate,Stage IIIB Retroperitoneal Sarcoma AJCC v8,1
20180,Primary Lesion,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",1
20181,Tubular Structures Present,Malignant Kidney Mixed Epithelial and Stromal Tumor,1
20182,Malignant Cellular Infiltrate,Angiosarcoma NCI Grade 3,1
20183,Carcinomatous Component Present,Stage IB Intrahepatic Bile Duct Cancer AJCC v8,1
20184,Malignant Cellular Infiltrate,Lung Squamous Cell Carcinoma In Situ,1
20185,Follicular Cell Differentiation,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,1
20186,Secondary Lesion,Secondary malignant neoplasm of testis,1
20187,Well Differentiated Neuroendocrine Lesion,Stage IV Jejunal Neuroendocrine Tumor AJCC v8,1
20188,Invasive Lesion,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
20189,Carcinomatous Component Present,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
20190,Carcinomatous Component Present,Invasive Ductal Breast Carcinoma,1
20191,Immunologic Deficiency Syndromes,Chronic rejection of renal transplant,1
20192,Hereditary Lesion,Hereditary Fallopian Tube Carcinoma,1
20193,Epithelial Component Present,Squamous Cell Carcinoma In Situ of the Nipple,1
20194,Malignant Cellular Infiltrate,Stage IV Rectal Carcinoma,1
20195,Epithelial Component Present,Unresectable Gastroesophageal Junction Adenocarcinoma,1
20196,Carcinomatous Component Present,squamous cell carcinoma of lacrimal gland,1
20197,Refractory Disease,Refractory Leukemia,1
20198,Malignant Cellular Infiltrate,Stage 0 Lung Cancer AJCC v6 and v7,1
20199,Extraosseous Lesion,Extra-osseous Ewing's sarcoma,1
20200,Absence of Invasion,Stage 0 Esophageal Cancer AJCC v6,1
20201,Metastatic/Recurrent Disease,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
20202,Malignant Cellular Infiltrate,Grade 2 Rectal Adenocarcinoma,1
20203,Unclassifiable Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",1
20204,Malignant Cellular Infiltrate,Extraskeletal Myxoid Chondrosarcoma,1
20205,Increased Cellularity Present,Anaplastic Oligoastrocytoma,1
20206,In Situ Lesion,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
20207,Recurrent disease,Recurrent Adenoid Cystic Carcinoma,1
20208,Epithelial Component Present,Stage III Merkel Cell Carcinoma AJCC v7,1
20209,Malignant Cellular Infiltrate,Metastatic Lobular Breast Carcinoma,1
20210,Epithelial Component Present,Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage,1
20211,Epithelial Component Present,Small intestine carcinoma stage II,1
20212,Endobronchial Lesion,Lung Mixed Squamous Cell and Glandular Papilloma,1
20213,Multifocal Unisystem Disease,"Histiocytosis, Langerhans-Cell",1
20214,Cystic Change,Borderline cystadenoma,1
20215,Epithelial Component Present,Prognostic Stage IIIB Breast Cancer AJCC v8,1
20216,Encapsulated Mass,Thyroid Gland Black Follicular Adenoma,1
20217,Locally Aggressive Lesion,"Phosphaturic mesenchymal tumor, benign",1
20218,Carcinomatous Component Present,Bladder squamous cell carcinoma stage I,1
20219,Benign Cellular Infiltrate,Pelvic lipomatosis,1
20220,High Grade Lesion,Central Nervous System Rhabdomyosarcoma,1
20221,Malignant Cellular Infiltrate,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
20222,Carcinomatous Component Present,Stage I Ureter Cancer AJCC v8,1
20223,Recurrent disease,Recurrent BRCA-Mutated Ovarian Carcinoma,1
20224,Cutaneous Involvement,Nevus of Ota,1
20225,Epithelial Component Present,Transitional Cell Neoplasm,1
20226,Epithelial Component Present,Collecting Duct Carcinoma of the Kidney,1
20227,Neuroectodermal Differentiation,Olfactory Neuroblastoma,1
20228,Diffuse Pattern,Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
20229,Epithelial Component Present,Gastric Body Carcinoma,1
20230,Malignant Cellular Infiltrate,malignant neoplasm of large intestine stage IV,1
20231,Non-Invasive Lesion,Stage 0 Renal Pelvis Cancer AJCC v7,1
20232,Recurrent disease,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
20233,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia- Modified Rai Staging System,1
20234,Benign Cellular Infiltrate,Chondromatosis,1
20235,Malignant Cellular Infiltrate,Angiosarcoma Associated with Lymphedema,1
20236,Malignant Cellular Infiltrate,Malignant Central Nervous System Neoplasm,1
20237,Childhood Lesion,Childhood Germ Cell Tumor,1
20238,Pseudorosette Formation,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
20239,Epithelial Component Present,Familial Adrenal Gland Pheochromocytoma,1
20240,Childhood Lesion,St. Jude Childhood Non-Hodgkin Lymphoma by AJCC v8 Stage,1
20241,Carcinomatous Component Present,Metastatic Squamous Cell Carcinoma of the Nasopharynx,1
20242,Malignant Cellular Infiltrate,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
20243,Regional Disease,Crohn's disease of small intestine,1
20244,Carcinomatous Component Present,Recurrent Parotid Gland Undifferentiated Carcinoma,1
20245,Epithelial Component Present,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",1
20246,Indolent Clinical Course,Mediastinal Leiomyoma,1
20247,Malignant Cellular Infiltrate,Plasmacytoma anaplastic,1
20248,Diffuse Pattern,Stage III Diffuse Large B-Cell Lymphoma,1
20249,More than 10 Mitoses per 10HPF,Small cell carcinoma of prostate,1
20250,Malignant Cellular Infiltrate,Uterine Corpus Adenosarcoma by AJCC v8 Stage,1
20251,Malignant Cellular Infiltrate,Undifferentiated carcinoma of esophagus,1
20252,Anaplasia,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,1
20253,Epithelial Component Present,Recurrent Endometrial Serous Adenocarcinoma,1
20254,Recurrent disease,Biochemically Recurrent Prostate Carcinoma,1
20255,Thin Bands of Collagen Present,Thymus Solitary Fibrous Tumor,1
20256,Cutaneous Involvement,Congenital hypotrichia,1
20257,Epithelial Component Present,Stage III Colorectal Cancer AJCC v7,1
20258,Dysplasia,Stage 0is Renal Pelvis Cancer AJCC v8,1
20259,Malignant Cellular Infiltrate,Solid carcinoma,1
20260,Invasive Lesion,ACTH-Producing Pituitary Gland Carcinoma,1
20261,Epithelial Component Present,Bile duct cancer resectable,1
20262,Malignant Cellular Infiltrate,Eccrine carcinoma of skin,1
20263,Malignant Cellular Infiltrate,Secondary malignant neoplasm of prostate,1
20264,Benign Cellular Infiltrate,Broad Ligament Serous Cystadenofibroma,1
20265,Secondary Lesion,Metastatic Kidney Carcinoma,1
20266,Acute inflammation,Acute lymphadenitis,1
20267,Epithelial Component Present,Relapsed Hypopharynx Carcinoma,1
20268,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage I Immature Testicular Teratoma AJCC v6 and v7,1
20269,Immunosuppression-Related Post-Transplant Toxicity,Acute humoral allograft nephropathy,1
20270,Nested Pattern,Adult Clear Cell Sarcoma of Soft Parts,1
20271,Invasive Lesion,Invasive Apocrine Breast Carcinoma,1
20272,Glomeruloid Vessels Present,Pilocytic Astrocytoma,1
20273,Malignant Cellular Infiltrate,Recurrent Cancer of Gallbladder,1
20274,Malignant Cellular Infiltrate,Advanced Laryngeal Squamous Cell Carcinoma,1
20275,More than 5 Mitoses per 50HPF,Locally Advanced Gastrointestinal Stromal Tumor,1
20276,Epithelial Component Present,Thymic Small Cell Carcinoma,1
20277,Carcinomatous Component Present,Colon Small Cell Neuroendocrine Carcinoma,1
20278,Borderline Lesion,Atypical follicular adenoma,1
20279,Intraductal Lesion,Intraductal Cribriform Breast Adenocarcinoma,1
20280,Infiltrating Tumor Margins Present,Uterine Corpus Endometrial Stromal Sarcoma,1
20281,Secondary Lesion,Therapy-related myelodysplastic syndrome,1
20282,Unclassifiable Lesion,"Refractory NK-Cell Lymphoma, Unclassifiable",1
20283,Malignant Cellular Infiltrate,Stage IIIA Colon Cancer AJCC v7,1
20284,Malignant Cellular Infiltrate,Childhood Cerebral Anaplastic Astrocytoma,1
20285,Pregnancy Complications,"Trophoblastic tumor, epithelioid",1
20286,Cystic Change,Broad Ligament Serous Cystadenoma,1
20287,Malignant Cellular Infiltrate,mucinous adenocarcinoma of gallbladder,1
20288,Malignant Cellular Infiltrate,Stage IIIA Anal Canal Cancer AJCC v6 and v7,1
20289,Epithelial Component Present,Endometrial adenocarcinoma metastatic,1
20290,Nuclear pleomorphism,Pleomorphic lobular carcinoma in situ of breast,1
20291,Borderline Lesion,Borderline Fallopian Tube Endometrioid Tumor,1
20292,Carcinomatous Component Present,Adenocarcinoma in tubulovillous adenoma,1
20293,Malignant Cellular Infiltrate,Stage IIIA Breast Carcinoma,1
20294,Infiltrative Growth Pattern,"Perivascular epithelioid tumor, malignant",1
20295,Epithelial Component Present,Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
20296,Malignant Cellular Infiltrate,Cerebellar Vermis Medulloblastoma,1
20297,Severe dysplasia,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
20298,Carcinomatous Component Present,Retromolar Trigone Squamous Cell Carcinoma,1
20299,Thyroglobulin Positive Neoplastic Cells Present,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
